{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL572","_score":1,"_source":{"id":"CHEMBL572","internal_compound":false,"type":"Small molecule","pref_name":"NITROFURANTOIN","year_first_approved":1953,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Ivadantin","NSC-2107","NSC-44150","Nitrofurantoin","Nitrofurantoin Macrocrystalline","Nitrofurantoin sodium"],"trade_names":["Berkfurin","Ceduran","Dantafur","Furadantin","Furalan","Genfura","Ivadantin","Macrobid","Macrodantin","Nitrofurantoin","Nitrofurantoin Macrocrystalline"],"cross_references":[{"source":"ChEBI","ids":[71415]},{"source":"DailyMed","ids":["nitrofurantoin","nitrofurantoin,%20macrocrystalline"]},{"source":"PubChem","ids":["17389788","26747377"]},{"source":"TG-GATEs","ids":["20"]},{"source":"Wikipedia","ids":["Nitrofurantoin"]},{"source":"drugbank","ids":["DB00698"]}],"canonical_smiles":"O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1","indications":[{"efo_id":"EFO_0003103","efo_label":"urinary tract infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003103","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00391651","NCT03425396"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00391651%22OR%22NCT03425396%22"]},{"source":"DailyMed","ids":["013433a1-c27c-4712-a03b-0949b2969fbb","047e8b1b-8888-40b7-b593-434e92eb333c","05f4b126-0fb9-5ee9-c89c-f229e60f84e3","1168f072-08be-485c-e054-00144ff8d46c","11dcea9c-0c62-4153-976b-bd1f8ef1f6d9","137038a6-12ed-47fd-a97c-01073c5141d1","1971e893-5fdb-41e3-a1e9-5e52deed03d1","1a86deef-0887-43b1-bb96-dbc222b15931","22061f76-2c05-4501-b8dd-a5c372abe7c2","380ec348-d23f-46d3-9c71-602d0549dc8c","3aada4c2-0c2a-4afb-8df1-bdac68972111","3b53f9bf-866a-4cb1-9180-7b13896e26ba","407a8f85-11c4-4404-8678-1c5e68860c8f","41b65a12-25d4-4e29-ae00-010df78b73ed","48a128ce-9279-4d39-b1eb-c4d2dd56f701","499f9dfd-b533-4021-a3ed-308f0f956c79","4dd6eeb7-1f49-41df-9525-934fec872e58","4e3b6837-afda-4c3b-9f0c-06cd6534a47a","602aeac6-9e4e-4e05-8a67-b9df4d804382","62c1bb9c-79a2-41e3-9dfa-352f92253881","66dcb616-42bb-4fed-ad78-2ea080c60dd6","6acc17e8-20e2-403c-b1c5-6512201fe6a8","6bdf87ae-daf1-4912-9d45-e06fa9eaaf1a","6d59ab27-fee9-4934-9972-1b3489d7d719","7ba9a729-a73a-4a13-a336-0284cc8a67e1","89d8696b-f9ce-9691-6222-8416ca143bba","8f270a9f-12a1-44d4-bc7e-873613555801","92c6c41b-21b8-44e6-89eb-8e8c9170f4db","944c0e5f-88ff-4a46-95ef-2ea7d55063ce","9a28e7c3-f25e-4341-9cda-f143be125e69","9a2c65c2-c778-490a-849b-f773a54d0ef9","9b15533c-61e8-4d76-8323-012c2e922bbe","a1f947e2-caec-4091-a3c9-98a0f8acd8d2","b044add2-528b-47ad-a934-63789c7268f1","b8434c69-527a-4e4b-b23f-25ba424d9660","be0fcd76-a1f2-4d5b-8714-30abcbfab627","bfba5de0-7abb-4b88-9715-088224b219f0","d0820e60-05a4-5072-05f3-fe01883cd985","d08bda24-bc54-4e1f-81e0-5d14b50af107","d0dbfce6-d5ea-41d8-b568-c021bc77457b","d4b372d8-88f8-42c2-87ea-61302258c917","d7a0d48d-a679-4fc6-bcc5-07328ed38809","dc6bc96c-9a40-469a-9b7c-9cb570b5fd85","e5b36fbf-4db1-43b3-bf04-39022f74d0b9","e6adddba-2477-4cfb-a6b9-2651643e05ac","e87d7f56-3666-4ba7-89b3-d8e19b78e02c","ec86b651-d77d-4a42-b493-24244456b3f6","fb4c9c55-63c4-4d8a-b89e-36e921b39e81"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?013433a1-c27c-4712-a03b-0949b2969fbb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?047e8b1b-8888-40b7-b593-434e92eb333c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?05f4b126-0fb9-5ee9-c89c-f229e60f84e3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1168f072-08be-485c-e054-00144ff8d46c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?11dcea9c-0c62-4153-976b-bd1f8ef1f6d9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?137038a6-12ed-47fd-a97c-01073c5141d1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1971e893-5fdb-41e3-a1e9-5e52deed03d1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1a86deef-0887-43b1-bb96-dbc222b15931","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?22061f76-2c05-4501-b8dd-a5c372abe7c2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?380ec348-d23f-46d3-9c71-602d0549dc8c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3aada4c2-0c2a-4afb-8df1-bdac68972111","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3b53f9bf-866a-4cb1-9180-7b13896e26ba","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?407a8f85-11c4-4404-8678-1c5e68860c8f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?41b65a12-25d4-4e29-ae00-010df78b73ed","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?48a128ce-9279-4d39-b1eb-c4d2dd56f701","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?499f9dfd-b533-4021-a3ed-308f0f956c79","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4dd6eeb7-1f49-41df-9525-934fec872e58","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4e3b6837-afda-4c3b-9f0c-06cd6534a47a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?602aeac6-9e4e-4e05-8a67-b9df4d804382","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?62c1bb9c-79a2-41e3-9dfa-352f92253881","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?66dcb616-42bb-4fed-ad78-2ea080c60dd6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6acc17e8-20e2-403c-b1c5-6512201fe6a8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6bdf87ae-daf1-4912-9d45-e06fa9eaaf1a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6d59ab27-fee9-4934-9972-1b3489d7d719","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7ba9a729-a73a-4a13-a336-0284cc8a67e1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?89d8696b-f9ce-9691-6222-8416ca143bba","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8f270a9f-12a1-44d4-bc7e-873613555801","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?92c6c41b-21b8-44e6-89eb-8e8c9170f4db","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?944c0e5f-88ff-4a46-95ef-2ea7d55063ce","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9a28e7c3-f25e-4341-9cda-f143be125e69","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9a2c65c2-c778-490a-849b-f773a54d0ef9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9b15533c-61e8-4d76-8323-012c2e922bbe","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a1f947e2-caec-4091-a3c9-98a0f8acd8d2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b044add2-528b-47ad-a934-63789c7268f1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b8434c69-527a-4e4b-b23f-25ba424d9660","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?be0fcd76-a1f2-4d5b-8714-30abcbfab627","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bfba5de0-7abb-4b88-9715-088224b219f0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d0820e60-05a4-5072-05f3-fe01883cd985","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d08bda24-bc54-4e1f-81e0-5d14b50af107","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d0dbfce6-d5ea-41d8-b568-c021bc77457b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d4b372d8-88f8-42c2-87ea-61302258c917","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d7a0d48d-a679-4fc6-bcc5-07328ed38809","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dc6bc96c-9a40-469a-9b7c-9cb570b5fd85","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e5b36fbf-4db1-43b3-bf04-39022f74d0b9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e6adddba-2477-4cfb-a6b9-2651643e05ac","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e87d7f56-3666-4ba7-89b3-d8e19b78e02c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ec86b651-d77d-4a42-b493-24244456b3f6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?fb4c9c55-63c4-4d8a-b89e-36e921b39e81"]},{"source":"FDA","ids":["09d16de0-e11e-4ca1-8073-cc0bb0677aa9","0deb6d89-5b08-4cb6-be89-0cb75b9e569a","1150f72d-ea97-4307-b2b8-d83cf37e18a2","3954bd0b-5ea5-46ff-9c6e-b82ba3cb02b1","422da094-da92-4e93-a7f5-4cd763bf0280","44fb3519-9b0d-4037-a6ea-cd237961b7a4","5067d98d-bfb3-4383-babc-8257fd20a2a2","51fb2df7-2569-4d17-be2f-9acc3c37cd84","59053c20-6db0-4519-81bd-35dcca13ff10","743fca6d-9482-4e9d-b072-ea9d18da2a23","7d97cb2f-90e4-4fa4-934b-b6cb891ff2b2","81fd4f9a-594f-444f-a0d4-d33dc4818a8a","9213d29e-80b2-447d-8ad2-9e1d7bc91e0c","9e81fa8b-d67d-4078-af60-1853c67a78f1","a26a211c-6d17-431f-8b9a-96a67247d343","c611e89d-dae2-4e45-a68c-a70a62e30201","d0b9ff2e-21eb-479b-86d5-42c5eed63b18","d3cd6c00-9059-4025-9032-75bb352de039","dfc9080d-8999-40c4-9284-439874eaf21d","ec23de8c-7f9c-41c6-a251-35181b447b78"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A09d16de0-e11e-4ca1-8073-cc0bb0677aa9","https://api.fda.gov/drug/label.json?search=set_id%3A0deb6d89-5b08-4cb6-be89-0cb75b9e569a","https://api.fda.gov/drug/label.json?search=set_id%3A1150f72d-ea97-4307-b2b8-d83cf37e18a2","https://api.fda.gov/drug/label.json?search=set_id%3A3954bd0b-5ea5-46ff-9c6e-b82ba3cb02b1","https://api.fda.gov/drug/label.json?search=set_id%3A422da094-da92-4e93-a7f5-4cd763bf0280","https://api.fda.gov/drug/label.json?search=set_id%3A44fb3519-9b0d-4037-a6ea-cd237961b7a4","https://api.fda.gov/drug/label.json?search=set_id%3A5067d98d-bfb3-4383-babc-8257fd20a2a2","https://api.fda.gov/drug/label.json?search=set_id%3A51fb2df7-2569-4d17-be2f-9acc3c37cd84","https://api.fda.gov/drug/label.json?search=set_id%3A59053c20-6db0-4519-81bd-35dcca13ff10","https://api.fda.gov/drug/label.json?search=set_id%3A743fca6d-9482-4e9d-b072-ea9d18da2a23","https://api.fda.gov/drug/label.json?search=set_id%3A7d97cb2f-90e4-4fa4-934b-b6cb891ff2b2","https://api.fda.gov/drug/label.json?search=set_id%3A81fd4f9a-594f-444f-a0d4-d33dc4818a8a","https://api.fda.gov/drug/label.json?search=set_id%3A9213d29e-80b2-447d-8ad2-9e1d7bc91e0c","https://api.fda.gov/drug/label.json?search=set_id%3A9e81fa8b-d67d-4078-af60-1853c67a78f1","https://api.fda.gov/drug/label.json?search=set_id%3Aa26a211c-6d17-431f-8b9a-96a67247d343","https://api.fda.gov/drug/label.json?search=set_id%3Ac611e89d-dae2-4e45-a68c-a70a62e30201","https://api.fda.gov/drug/label.json?search=set_id%3Ad0b9ff2e-21eb-479b-86d5-42c5eed63b18","https://api.fda.gov/drug/label.json?search=set_id%3Ad3cd6c00-9059-4025-9032-75bb352de039","https://api.fda.gov/drug/label.json?search=set_id%3Adfc9080d-8999-40c4-9284-439874eaf21d","https://api.fda.gov/drug/label.json?search=set_id%3Aec23de8c-7f9c-41c6-a251-35181b447b78"]}]},{"efo_id":"EFO_0003102","efo_label":"osteomyelitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003102","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT02099240"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02099240%22"]}]},{"efo_id":"EFO_1000025","efo_label":"cystitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000025","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["047e8b1b-8888-40b7-b593-434e92eb333c","05f4b126-0fb9-5ee9-c89c-f229e60f84e3","1168f072-08be-485c-e054-00144ff8d46c","137038a6-12ed-47fd-a97c-01073c5141d1","1971e893-5fdb-41e3-a1e9-5e52deed03d1","1a86deef-0887-43b1-bb96-dbc222b15931","22061f76-2c05-4501-b8dd-a5c372abe7c2","48a128ce-9279-4d39-b1eb-c4d2dd56f701","4dd6eeb7-1f49-41df-9525-934fec872e58","66dcb616-42bb-4fed-ad78-2ea080c60dd6","6d59ab27-fee9-4934-9972-1b3489d7d719","7ba9a729-a73a-4a13-a336-0284cc8a67e1","8f270a9f-12a1-44d4-bc7e-873613555801","9a28e7c3-f25e-4341-9cda-f143be125e69","9a2c65c2-c778-490a-849b-f773a54d0ef9","b044add2-528b-47ad-a934-63789c7268f1","b8434c69-527a-4e4b-b23f-25ba424d9660","bfba5de0-7abb-4b88-9715-088224b219f0","d0820e60-05a4-5072-05f3-fe01883cd985","d08bda24-bc54-4e1f-81e0-5d14b50af107","d0dbfce6-d5ea-41d8-b568-c021bc77457b","d7a0d48d-a679-4fc6-bcc5-07328ed38809","e5b36fbf-4db1-43b3-bf04-39022f74d0b9"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?047e8b1b-8888-40b7-b593-434e92eb333c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?05f4b126-0fb9-5ee9-c89c-f229e60f84e3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1168f072-08be-485c-e054-00144ff8d46c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?137038a6-12ed-47fd-a97c-01073c5141d1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1971e893-5fdb-41e3-a1e9-5e52deed03d1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1a86deef-0887-43b1-bb96-dbc222b15931","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?22061f76-2c05-4501-b8dd-a5c372abe7c2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?48a128ce-9279-4d39-b1eb-c4d2dd56f701","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4dd6eeb7-1f49-41df-9525-934fec872e58","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?66dcb616-42bb-4fed-ad78-2ea080c60dd6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6d59ab27-fee9-4934-9972-1b3489d7d719","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7ba9a729-a73a-4a13-a336-0284cc8a67e1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8f270a9f-12a1-44d4-bc7e-873613555801","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9a28e7c3-f25e-4341-9cda-f143be125e69","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9a2c65c2-c778-490a-849b-f773a54d0ef9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b044add2-528b-47ad-a934-63789c7268f1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b8434c69-527a-4e4b-b23f-25ba424d9660","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bfba5de0-7abb-4b88-9715-088224b219f0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d0820e60-05a4-5072-05f3-fe01883cd985","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d08bda24-bc54-4e1f-81e0-5d14b50af107","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d0dbfce6-d5ea-41d8-b568-c021bc77457b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d7a0d48d-a679-4fc6-bcc5-07328ed38809","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e5b36fbf-4db1-43b3-bf04-39022f74d0b9"]},{"source":"FDA","ids":["5067d98d-bfb3-4383-babc-8257fd20a2a2","59053c20-6db0-4519-81bd-35dcca13ff10","9e81fa8b-d67d-4078-af60-1853c67a78f1","d0b9ff2e-21eb-479b-86d5-42c5eed63b18"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A5067d98d-bfb3-4383-babc-8257fd20a2a2","https://api.fda.gov/drug/label.json?search=set_id%3A59053c20-6db0-4519-81bd-35dcca13ff10","https://api.fda.gov/drug/label.json?search=set_id%3A9e81fa8b-d67d-4078-af60-1853c67a78f1","https://api.fda.gov/drug/label.json?search=set_id%3Ad0b9ff2e-21eb-479b-86d5-42c5eed63b18"]}]},{"efo_id":"EFO_0000544","efo_label":"infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000544","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT04020341"],"urls":["https://clinicaltrials.gov/search?id=%22NCT04020341%22"]}]}],"mechanisms_of_action":[],"adverse_events":{"significant":[{"event":"drug hypersensitivity","count":71246,"llr":1015.420389},{"event":"autoimmune hepatitis","count":2284,"llr":238.3590088},{"event":"pulmonary fibrosis","count":3809,"llr":181.8236225},{"event":"drug-induced liver injury","count":7265,"llr":131.1121962},{"event":"jaundice","count":9877,"llr":113.3577729},{"event":"urinary tract infection","count":38069,"llr":68.76832711},{"event":"pulmonary toxicity","count":1545,"llr":67.97049946},{"event":"hepatic fibrosis","count":1098,"llr":62.60125919},{"event":"hepatitis","count":8668,"llr":59.01963393},{"event":"interstitial lung disease","count":12888,"llr":54.374231},{"event":"liver injury","count":4415,"llr":49.98040129},{"event":"systemic inflammatory response syndrome","count":1392,"llr":44.04959652},{"event":"dyspnoea","count":124409,"llr":43.80971928},{"event":"chromaturia","count":5181,"llr":40.74025512},{"event":"drug reaction with eosinophilia and systemic symptoms","count":9050,"llr":35.24948393},{"event":"liver function test abnormal","count":13429,"llr":34.97559783},{"event":"clostridium difficile infection","count":4220,"llr":34.44065247},{"event":"hepatic cirrhosis","count":3807,"llr":34.40292064},{"event":"eosinophilia","count":6224,"llr":33.81101681}],"critval":31.66953037},"child_chembl_ids":["CHEMBL1201000"],"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":2},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1255582","_score":1,"_source":{"id":"CHEMBL1255582","internal_compound":false,"type":"Small molecule","pref_name":"FIPAMEZOLE","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Fipamezole"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB06585"]}],"canonical_smiles":"CCC1(c2c[nH]cn2)Cc2ccc(F)cc2C1","indications":[{"efo_id":"EFO_0002508","efo_label":"Parkinson's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002508","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00559871"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00559871%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL267476","_score":1,"_source":{"id":"CHEMBL267476","internal_compound":false,"type":"Small molecule","pref_name":"LINOLEIC ACID","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["FEMA NO. 3380, LINOLEIC ACID-","Linoleic acid","NSC-281243","Octadeca-9,12-Dienoic Acid","Sodium Linolate"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[17351]},{"source":"PubChem","ids":["144204618","144209369","144213397","17388946","26752888"]},{"source":"Wikipedia","ids":["Linoleic_acid"]},{"source":"drugbank","ids":["DB14104"]}],"canonical_smiles":"CCCCC/C=C\\C/C=C\\CCCCCCCC(=O)O","indications":[{"efo_id":"EFO_0000270","efo_label":"asthma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000270","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00029679"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00029679%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT00908791"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00908791%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00951158"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00951158%22"]}]},{"efo_id":"EFO_0001073","efo_label":"obesity","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001073","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00204932","NCT02063802"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00204932%22OR%22NCT02063802%22"]}]},{"efo_id":"EFO_0001360","efo_label":"type II diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001360","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00607945"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00607945%22"]}]}],"child_chembl_ids":["CHEMBL3122088","CHEMBL571449"],"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":2},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":2},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2105617","_score":1,"_source":{"id":"CHEMBL2105617","internal_compound":false,"type":"Small molecule","pref_name":"AJMALINE","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Ajmaline","NSC-15627"],"trade_names":[],"canonical_smiles":"CCC1C2CC3C4N(C)c5ccccc5C45CC(C2[C@H]5O)N3C1O","indications":[{"efo_id":"EFO_0004269","efo_label":"cardiac arrhythmia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004269","max_phase_for_indication":3,"references":[{"source":"ATC","ids":["C01BA05"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C01BA05"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3707372","_score":1,"_source":{"id":"CHEMBL3707372","internal_compound":false,"type":"Small molecule","pref_name":"VOXILAPREVIR","year_first_approved":2017,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["GS-9857","Voxilaprevir"],"trade_names":[],"canonical_smiles":"CC[C@H]1[C@@H](C(=O)N[C@]2(C(=O)NS(=O)(=O)C3(C)CC3)C[C@H]2C(C)C)N2C[C@@H]1Oc1nc3cc(OC)ccc3nc1C(F)(F)CCCC[C@@H]1C[C@H]1OC(=O)N[C@@H](C(C)(C)C)C2=O","indications":[{"efo_id":"EFO_0000544","efo_label":"infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000544","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02397707","NCT02402452","NCT02533427"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02397707%22OR%22NCT02402452%22OR%22NCT02533427%22"]}]},{"efo_id":"EFO_0003047","efo_label":"hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003047","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02185794"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02185794%22"]}]},{"efo_id":"EFO_0004220","efo_label":"chronic hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004220","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT02745535"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02745535%22"]},{"source":"FDA","ids":["label/2017/209195s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2017%2F209195s000lbl.pdf"]}]}],"mechanisms_of_action":[{"target_type":"protein complex","target_name":"Hepatitis C virus serine protease, NS3/NS4A","action_type":"inhibitor","description":"Hepatitis C virus serine protease, NS3/NS4A inhibitor","references":[{"source":"FDA","ids":["label/2017/209195s002lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2017%2F209195s002lbl.pdf"]}]}],"adverse_events":{"significant":[{"event":"hepatocellular carcinoma","count":2310,"llr":17.46719545},{"event":"hepatitis c","count":4688,"llr":9.232804732},{"event":"alanine aminotransferase increased","count":24852,"llr":5.923321702}],"critval":5.725947739},"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2312181","_score":1,"_source":{"id":"CHEMBL2312181","internal_compound":false,"type":"Small molecule","pref_name":"P-276-00","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["P 276-00","P-276-00","P-27600"],"trade_names":[],"canonical_smiles":"CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4)oc23)C1CO","indications":[{"efo_id":"EFO_0000181","efo_label":"head and neck squamous cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000181","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00824343","NCT00899054"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00824343%22OR%22NCT00899054%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01903018"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01903018%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00407498","NCT00408018"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00407498%22OR%22NCT00408018%22"]}]},{"efo_id":"EFO_0000756","efo_label":"melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000756","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00835419"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00835419%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00547404","NCT00882063"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00547404%22OR%22NCT00882063%22"]}]},{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00898287"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00898287%22"]}]},{"efo_id":"EFO_1001469","efo_label":"Mantle cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001469","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00843050"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00843050%22"]}]}],"number_of_indications":7,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":7},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":2},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3039556","_score":1,"_source":{"id":"CHEMBL3039556","internal_compound":false,"type":"Oligonucleotide","pref_name":"APATORSEN","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Apatorsen","OGX-427"],"trade_names":[],"indications":[{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01844817"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01844817%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01829113"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01829113%22"]}]},{"efo_id":"EFO_0000292","efo_label":"bladder carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000292","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00959868"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00959868%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00487786"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00487786%22"]}]},{"efo_id":"EFO_0000708","efo_label":"squamous cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000708","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02423590"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02423590%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01120470","NCT01681433"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01120470%22OR%22NCT01681433%22"]}]}],"number_of_indications":6,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":6},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":2},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":2},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL190","_score":1,"_source":{"id":"CHEMBL190","internal_compound":false,"type":"Small molecule","pref_name":"THEOPHYLLINE","year_first_approved":1940,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Ambuphylline","Aminophylline","Bufylline","Choline Theophyllinate","Choline Theophylline","Dimethylxanthine","NSC-2066","NSC-7919","Oxtriphylline","Theophyllamine","Theophylline","Theophylline Ethylenediamine","Theophylline Olamine","Theophylline melting point standard","Theophylline monohydrate"],"trade_names":["Accurbron","Aerolate","Aerolate Iii","Aerolate Jr","Aerolate Sr","Aminophyllin","Aminophylline","Aminophylline Dye Free","Aminophylline In Sodium Chloride","Ammophyllin","Amnivent-225 Sr","Amnivent-350 Sr","Aquaphyllin","Bronkodyl","Butaphyllamine","Choledyl","Choledyl SA","Duraphyl","Elixicon","Elixomin","Elixophyllin","Elixophyllin Sr","Labid","Lanophyllin","Lasma","Nuelin","Nuelin SA","Nuelin SA-250","Oxtriphylline","Oxtriphylline Pediatric","Peterphyllin","Phyllocontin","Pro-Vent","Quibron","Quibron-T","Quibron-T/Sr","Respbid","Sabidal","Slo-Bid","Slo-Phyllin","Somophyllin","Somophyllin-Crt","Somophyllin-Df","Somophyllin-T","Sustaire","T-Phyl","Theo-24","Theo-Dur","Theobid","Theobid Jr.","Theochron","Theocin","Theoclear L.A.-130","Theoclear L.A.-260","Theoclear-100","Theoclear-200","Theoclear-80","Theograd","Theolair","Theolair-Sr","Theolixir","Theophyl","Theophyl-225","Theophyl-Sr","Theophylline","Theophylline-Sr","Theovent","Truphylline","Uni-Dur","Uniphyl","Uniphyllin Continus"],"cross_references":[{"source":"ChEBI","ids":[28177]},{"source":"DailyMed","ids":["aminophylline","theophylline"]},{"source":"PubChem","ids":["104171361","144204378","144209573","144210348","170466874","17389715","174007168","50103998","56463437","68760","855679","90341676"]},{"source":"TG-GATEs","ids":["96"]},{"source":"Wikipedia","ids":["Theophylline"]},{"source":"drugbank","ids":["DB00277"]},{"source":"DrugCentral","ids":["4390"]},{"source":"Wikipedia","ids":["Choline_theophyllinate"]},{"source":"drugbank","ids":["DB01303"]},{"source":"PubChem","ids":["11112968"]},{"source":"DailyMed","ids":["aminophylline"]},{"source":"PubChem","ids":["11111990","11111991","50105733","85231291"]},{"source":"drugbank","ids":["DB01223"]},{"source":"DrugCentral","ids":["4426"]},{"source":"drugbank","ids":["DB13812"]}],"canonical_smiles":"Cn1c(=O)c2nc[nH]c2n(C)c1=O","indications":[{"efo_id":"EFO_0000341","efo_label":"chronic obstructive pulmonary disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000341","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00299858","NCT00634413","NCT01599871","NCT02340520"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00299858%22OR%22NCT00634413%22OR%22NCT01599871%22OR%22NCT02340520%22"]}]},{"efo_id":"HP_0006536","efo_label":"Obstructive lung disease","efo_uri":"http://purl.obolibrary.org/obo/HP_0006536","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["R03DA04","R03DA54","R03DA74"],"urls":["https://www.whocc.no/atc_ddd_index/?code=R03DA04","https://www.whocc.no/atc_ddd_index/?code=R03DA54","https://www.whocc.no/atc_ddd_index/?code=R03DA74"]}]},{"efo_id":"EFO_0000270","efo_label":"asthma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000270","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00000578","NCT00119496","NCT00252785","NCT00252863","NCT01293734"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000578%22OR%22NCT00119496%22OR%22NCT00252785%22OR%22NCT00252863%22OR%22NCT01293734%22"]},{"source":"DailyMed","ids":["038c2b07-8028-4dc4-847c-adafe1b0e81a","06ab3df7-e64a-4c46-8a70-38561ffea5f5","1750235a-ad52-4231-abe5-d3c441ba39e8","25b2fdbe-2f18-4153-835a-7a67bff83ef8","2676f761-4fe5-40a9-a07d-ed2542847883","31f3c720-1597-4d43-9296-33017b90b15f","699a4e05-95cb-4b28-8927-d97a4afbf463","6ec9b686-2602-47a0-8491-58b9a9d029ee","78a99bfe-6ebe-4ace-80b0-ee019921435e","7a108fa0-c230-475f-be93-6f864b98a410","7a5a367f-8461-4b15-99fc-f89aa7d5936e","88d863a5-63ab-4b29-b181-6d7db38234ba","8e2de7dc-72bc-44cc-97bf-efe776331a2d","9940057a-831f-4bdb-8741-d10c0ca24925","b6a476e8-9ceb-4320-873d-946df820b502","bba266d2-1d22-49a9-b3db-e4f06802a8a9","c248b178-951c-4710-933b-d9a6a8555688","c3bb34c1-89b2-48c3-9ad2-16b4b2bce5f9","c4c80b87-fc6e-436d-84de-7a0cd9d895eb","c88d2f3e-3478-4ed4-b4da-44dece7818e9","d70152c7-9da5-4096-ac5b-c8118cf48500","def63108-2e96-446c-a7a8-a65d54de2859","e118df30-a578-4cf0-93c8-689d15415ec2","e58491b5-b7de-4497-ab7a-d6c12972e744","fc61fd7e-63ca-4714-851f-31b2a045903d","fd40d7d3-285e-fac0-11a1-6213d067a371"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?038c2b07-8028-4dc4-847c-adafe1b0e81a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?06ab3df7-e64a-4c46-8a70-38561ffea5f5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1750235a-ad52-4231-abe5-d3c441ba39e8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?25b2fdbe-2f18-4153-835a-7a67bff83ef8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2676f761-4fe5-40a9-a07d-ed2542847883","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?31f3c720-1597-4d43-9296-33017b90b15f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?699a4e05-95cb-4b28-8927-d97a4afbf463","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6ec9b686-2602-47a0-8491-58b9a9d029ee","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?78a99bfe-6ebe-4ace-80b0-ee019921435e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7a108fa0-c230-475f-be93-6f864b98a410","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7a5a367f-8461-4b15-99fc-f89aa7d5936e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?88d863a5-63ab-4b29-b181-6d7db38234ba","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8e2de7dc-72bc-44cc-97bf-efe776331a2d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9940057a-831f-4bdb-8741-d10c0ca24925","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b6a476e8-9ceb-4320-873d-946df820b502","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bba266d2-1d22-49a9-b3db-e4f06802a8a9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c248b178-951c-4710-933b-d9a6a8555688","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c3bb34c1-89b2-48c3-9ad2-16b4b2bce5f9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c4c80b87-fc6e-436d-84de-7a0cd9d895eb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c88d2f3e-3478-4ed4-b4da-44dece7818e9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d70152c7-9da5-4096-ac5b-c8118cf48500","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?def63108-2e96-446c-a7a8-a65d54de2859","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e118df30-a578-4cf0-93c8-689d15415ec2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e58491b5-b7de-4497-ab7a-d6c12972e744","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?fc61fd7e-63ca-4714-851f-31b2a045903d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?fd40d7d3-285e-fac0-11a1-6213d067a371"]},{"source":"FDA","ids":["09325220-e4c5-4fac-aefd-ee3e42602198","292f2650-c9fc-4490-a734-6ef76598ff8c","3576559a-b2a2-4511-a2db-33fd66450ffc","3e4221f1-dade-4482-b5e5-2d75a96154d6","4757323d-cad6-4b61-a651-08cccf04b0b1","5c6ec629-4c68-4d1b-9c82-db09ead1ab83","6e081706-6bcb-f81b-676d-df9cc2c1ac93","90f32fbc-cfb6-4391-83bd-014f0efc2f7c","92949b28-9d8f-4e6a-b81a-c49018c0e03c","ac7b43d5-3d14-4109-b6b4-e6f290d144d7","b3f30758-5bc3-4c7a-96f1-0207889ff1e6","d62bbc4f-a965-44bc-a3cb-4713dac26349","e0f680d7-5431-48ae-8aed-657f757eb92d","e18c0cee-a592-4c78-e08e-9898b7d4bf12","f24f8e9c-ac46-4101-9250-9005af0edf72","fde7e9b2-c2d8-47bb-abe1-ec987da951ab"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A09325220-e4c5-4fac-aefd-ee3e42602198","https://api.fda.gov/drug/label.json?search=set_id%3A292f2650-c9fc-4490-a734-6ef76598ff8c","https://api.fda.gov/drug/label.json?search=set_id%3A3576559a-b2a2-4511-a2db-33fd66450ffc","https://api.fda.gov/drug/label.json?search=set_id%3A3e4221f1-dade-4482-b5e5-2d75a96154d6","https://api.fda.gov/drug/label.json?search=set_id%3A4757323d-cad6-4b61-a651-08cccf04b0b1","https://api.fda.gov/drug/label.json?search=set_id%3A5c6ec629-4c68-4d1b-9c82-db09ead1ab83","https://api.fda.gov/drug/label.json?search=set_id%3A6e081706-6bcb-f81b-676d-df9cc2c1ac93","https://api.fda.gov/drug/label.json?search=set_id%3A90f32fbc-cfb6-4391-83bd-014f0efc2f7c","https://api.fda.gov/drug/label.json?search=set_id%3A92949b28-9d8f-4e6a-b81a-c49018c0e03c","https://api.fda.gov/drug/label.json?search=set_id%3Aac7b43d5-3d14-4109-b6b4-e6f290d144d7","https://api.fda.gov/drug/label.json?search=set_id%3Ab3f30758-5bc3-4c7a-96f1-0207889ff1e6","https://api.fda.gov/drug/label.json?search=set_id%3Ad62bbc4f-a965-44bc-a3cb-4713dac26349","https://api.fda.gov/drug/label.json?search=set_id%3Ae0f680d7-5431-48ae-8aed-657f757eb92d","https://api.fda.gov/drug/label.json?search=set_id%3Ae18c0cee-a592-4c78-e08e-9898b7d4bf12","https://api.fda.gov/drug/label.json?search=set_id%3Af24f8e9c-ac46-4101-9250-9005af0edf72","https://api.fda.gov/drug/label.json?search=set_id%3Afde7e9b2-c2d8-47bb-abe1-ec987da951ab"]}]},{"efo_id":"EFO_0003917","efo_label":"premature birth","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003917","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01066728"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01066728%22"]}]},{"efo_id":"EFO_0003884","efo_label":"chronic kidney disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003884","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02479451"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02479451%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00175812"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00175812%22"]}]},{"efo_id":"EFO_0000565","efo_label":"leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000565","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00003808"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003808%22"]}]},{"efo_id":"EFO_0001361","efo_label":"pulmonary arterial hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001361","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01566565"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01566565%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01017939"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01017939%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01799161","NCT02080078"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01799161%22OR%22NCT02080078%22"]}]},{"efo_id":"EFO_0003086","efo_label":"kidney disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003086","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02088502"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02088502%22"]}]},{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01263106"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01263106%22"]}]},{"efo_id":"EFO_1000782","efo_label":"altitude sickness","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000782","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01902758"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01902758%22"]}]},{"efo_id":"EFO_0000544","efo_label":"infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000544","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03990766"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03990766%22"]}]},{"efo_id":"HP_0006536","efo_label":"Obstructive lung disease","efo_uri":"http://purl.obolibrary.org/obo/HP_0006536","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["R03DA02"],"urls":["https://www.whocc.no/atc_ddd_index/?code=R03DA02"]}]},{"efo_id":"HP_0006536","efo_label":"Obstructive lung disease","efo_uri":"http://purl.obolibrary.org/obo/HP_0006536","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["R03DA05","R03DA55"],"urls":["https://www.whocc.no/atc_ddd_index/?code=R03DA05","https://www.whocc.no/atc_ddd_index/?code=R03DA55"]}]},{"efo_id":"EFO_0000270","efo_label":"asthma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000270","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00442338"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00442338%22"]},{"source":"DailyMed","ids":["53eaa46e-6b65-4e39-8535-0a072bb38e4d","9a663ef3-881f-48bd-2689-3713b24545c2","b15e5520-0a87-4943-9bbb-ead066456273","f6d3d076-fc15-4178-b159-4100fc39066e","f775d030-4a1a-4639-8de2-a4191c727900"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?53eaa46e-6b65-4e39-8535-0a072bb38e4d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9a663ef3-881f-48bd-2689-3713b24545c2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b15e5520-0a87-4943-9bbb-ead066456273","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f6d3d076-fc15-4178-b159-4100fc39066e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f775d030-4a1a-4639-8de2-a4191c727900"]},{"source":"FDA","ids":["4bc5d8ca-58de-4683-a27a-3e216b20e82b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A4bc5d8ca-58de-4683-a27a-3e216b20e82b"]}]},{"efo_id":"EFO_0000292","efo_label":"bladder carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000292","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT01240824"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01240824%22"]}]},{"efo_id":"EFO_0001361","efo_label":"pulmonary arterial hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001361","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01530464"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01530464%22"]}]},{"efo_id":"EFO_1000782","efo_label":"altitude sickness","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000782","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01587027","NCT01794078"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01587027%22OR%22NCT01794078%22"]}]},{"efo_id":"HP_0001919","efo_label":"Acute kidney injury","efo_uri":"http://purl.obolibrary.org/obo/HP_0001919","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02983422","NCT03897335"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02983422%22OR%22NCT03897335%22"]}]},{"efo_id":"EFO_0003917","efo_label":"premature birth","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003917","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03152942"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03152942%22"]}]},{"efo_id":"HP_0002315","efo_label":"Headache","efo_uri":"http://purl.obolibrary.org/obo/HP_0002315","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02522013"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02522013%22"]}]},{"efo_id":"EFO_0009492","efo_label":"cardiac arrest","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009492","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00312273"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00312273%22"]}]},{"efo_id":"HP_0006536","efo_label":"Obstructive lung disease","efo_uri":"http://purl.obolibrary.org/obo/HP_0006536","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["R03DA10"],"urls":["https://www.whocc.no/atc_ddd_index/?code=R03DA10"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000065989","approved_name":"phosphodiesterase 4A","approved_symbol":"PDE4A"},{"ensembl":"ENSG00000113448","approved_name":"phosphodiesterase 4D","approved_symbol":"PDE4D"},{"ensembl":"ENSG00000184588","approved_name":"phosphodiesterase 4B","approved_symbol":"PDE4B"},{"ensembl":"ENSG00000105650","approved_name":"phosphodiesterase 4C","approved_symbol":"PDE4C"}],"target_type":"protein family","target_name":"Phosphodiesterase 4","action_type":"inhibitor","description":"Phosphodiesterase 4 inhibitor","references":[{"source":"DailyMed","ids":["setid=25b2fdbe-2f18-4153-835a-7a67bff83ef8"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=25b2fdbe-2f18-4153-835a-7a67bff83ef8"]},{"source":"Wikipedia","ids":["Theophylline#Mechanisms_of_action"],"urls":["https://www.wikipedia.org/Theophylline#Mechanisms_of_action"]}]},{"target_components":[{"ensembl":"ENSG00000172572","approved_name":"phosphodiesterase 3A","approved_symbol":"PDE3A"},{"ensembl":"ENSG00000152270","approved_name":"phosphodiesterase 3B","approved_symbol":"PDE3B"}],"target_type":"protein family","target_name":"Phosphodiesterase 3","action_type":"inhibitor","description":"Phosphodiesterase 3 inhibitor","references":[{"source":"DailyMed","ids":["setid=25b2fdbe-2f18-4153-835a-7a67bff83ef8"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=25b2fdbe-2f18-4153-835a-7a67bff83ef8"]},{"source":"Wikipedia","ids":["Theophylline#Mechanisms_of_action"],"urls":["https://www.wikipedia.org/Theophylline#Mechanisms_of_action"]}]},{"target_components":[{"ensembl":"ENSG00000163485","approved_name":"adenosine A1 receptor","approved_symbol":"ADORA1"},{"ensembl":"ENSG00000170425","approved_name":"adenosine A2b receptor","approved_symbol":"ADORA2B"},{"ensembl":"ENSG00000282608","approved_name":"adenosine A3 receptor","approved_symbol":"ADORA3"},{"ensembl":"ENSG00000128271","approved_name":"adenosine A2a receptor","approved_symbol":"ADORA2A"}],"target_type":"protein family","target_name":"Adenosine receptor","action_type":"antagonist","description":"Adenosine receptor antagonist","references":[{"source":"PubMed","ids":["12954362","14992338","15980878","3588607"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12954362+OR+EXT_ID%3A14992338+OR+EXT_ID%3A15980878+OR+EXT_ID%3A3588607"]},{"source":"Wikipedia","ids":["Theophylline#Mechanisms_of_action"],"urls":["https://www.wikipedia.org/Theophylline#Mechanisms_of_action"]}]}],"adverse_events":{"significant":[{"event":"asthma","count":16236,"llr":265.3814991},{"event":"tachycardia","count":26994,"llr":125.0980462},{"event":"wheezing","count":9665,"llr":110.8789394},{"event":"toxicity to various agents","count":31033,"llr":107.7086805},{"event":"hypokalaemia","count":14556,"llr":98.02818545},{"event":"dyspnoea","count":124409,"llr":84.78235189},{"event":"drug toxicity","count":4494,"llr":82.71992378},{"event":"lung hyperinflation","count":176,"llr":82.28856638},{"event":"respiratory acidosis","count":1152,"llr":79.68629718},{"event":"airway peak pressure increased","count":64,"llr":72.54617588},{"event":"po2 decreased","count":466,"llr":70.71767252},{"event":"drug interaction","count":53526,"llr":70.08109446},{"event":"status asthmaticus","count":196,"llr":69.11321785},{"event":"convulsion","count":26614,"llr":68.97045187},{"event":"mental disability","count":99,"llr":66.88491456},{"event":"blood bicarbonate decreased","count":787,"llr":65.80791747},{"event":"pco2 increased","count":286,"llr":63.47025752},{"event":"blood lactic acid increased","count":1442,"llr":62.29849998},{"event":"supraventricular tachycardia","count":3329,"llr":61.41800067},{"event":"blood ph decreased","count":625,"llr":60.87049212},{"event":"sinus tachycardia","count":5084,"llr":59.80909313},{"event":"respiratory failure","count":13025,"llr":57.16062093},{"event":"hypercapnia","count":783,"llr":57.08317192},{"event":"rhabdomyolysis","count":16457,"llr":55.5618335},{"event":"drug hypersensitivity","count":71246,"llr":53.38034988},{"event":"obstructive airways disorder","count":2421,"llr":51.69003323},{"event":"respiratory rate increased","count":2341,"llr":48.92597964},{"event":"atrial fibrillation","count":25339,"llr":45.37307248},{"event":"vomiting","count":103943,"llr":44.01037044},{"event":"glaucoma","count":3701,"llr":43.13378},{"event":"suicide attempt","count":20244,"llr":41.94648577},{"event":"respiratory alkalosis","count":513,"llr":41.15037791},{"event":"oxygen saturation decreased","count":10498,"llr":40.28051532},{"event":"status epilepticus","count":3754,"llr":39.87514322},{"event":"clonic convulsion","count":288,"llr":38.19365789},{"event":"tachycardia foetal","count":187,"llr":37.28829872},{"event":"forced expiratory volume decreased","count":990,"llr":37.20124237},{"event":"lower respiratory tract infection","count":8977,"llr":34.86905023},{"event":"staphylococcus test positive","count":706,"llr":33.31261059},{"event":"metabolic acidosis","count":8683,"llr":33.30278466},{"event":"hypoxia","count":9218,"llr":32.01666522},{"event":"febrile convulsion","count":371,"llr":31.17425976},{"event":"peritonitis bacterial","count":913,"llr":30.54246094},{"event":"brain oedema","count":2176,"llr":30.3921737},{"event":"somnambulism","count":1422,"llr":29.17110103},{"event":"hearing impaired","count":1437,"llr":29.04939425},{"event":"cyanosis","count":4608,"llr":28.02165154},{"event":"hypotension","count":55121,"llr":27.96637451},{"event":"acute respiratory failure","count":3286,"llr":27.68897667},{"event":"palpitations","count":23550,"llr":26.69723715},{"event":"blood immunoglobulin e increased","count":622,"llr":26.59428624},{"event":"ventricular arrhythmia","count":944,"llr":26.50653179},{"event":"skin infection","count":2334,"llr":26.42911677},{"event":"motor dysfunction","count":2352,"llr":26.33429586},{"event":"tachyarrhythmia","count":970,"llr":26.2421471},{"event":"supraventricular extrasystoles","count":1373,"llr":26.18356257},{"event":"eye infection","count":1876,"llr":25.97367721},{"event":"encephalopathy","count":8151,"llr":25.59587629},{"event":"depressed level of consciousness","count":10912,"llr":24.3930522},{"event":"bronchospasm","count":4962,"llr":24.38778617},{"event":"pulmonary function test decreased","count":816,"llr":24.20564152},{"event":"foetal distress syndrome","count":821,"llr":24.15207059},{"event":"blood creatine phosphokinase increased","count":14851,"llr":22.13950241},{"event":"asthmatic crisis","count":432,"llr":21.45603076},{"event":"vital capacity decreased","count":91,"llr":21.36527755},{"event":"gastrointestinal necrosis","count":826,"llr":20.5012834},{"event":"mental retardation severity unspecified","count":31,"llr":20.49349249},{"event":"lipid metabolism disorder","count":109,"llr":20.46792179},{"event":"hyperglycaemia","count":9767,"llr":20.46375098},{"event":"stress cardiomyopathy","count":1774,"llr":20.43139347},{"event":"antasthmatic drug level above therapeutic","count":5,"llr":19.97418055},{"event":"grand mal convulsion","count":4865,"llr":19.8822506},{"event":"cerebral atrophy","count":1406,"llr":19.47497448},{"event":"eosinophilic pneumonia","count":997,"llr":19.04423007},{"event":"tachycardia induced cardiomyopathy","count":46,"llr":18.919118},{"event":"renal impairment","count":20843,"llr":18.5931437},{"event":"secondary adrenocortical insufficiency","count":375,"llr":18.3136376},{"event":"nikolsky's sign","count":176,"llr":18.09117312},{"event":"accidental exposure to product by child","count":1142,"llr":17.99881359},{"event":"breath sounds abnormal","count":1171,"llr":17.80637168},{"event":"generalised tonic-clonic seizure","count":4083,"llr":17.26144883},{"event":"pleural rub","count":13,"llr":17.10991083},{"event":"arrhythmia","count":9500,"llr":17.09166328},{"event":"cough","count":52232,"llr":16.90581132},{"event":"fatigue","count":147738,"llr":16.66833689}],"critval":16.66380913},"child_chembl_ids":["CHEMBL1200434","CHEMBL1355736","CHEMBL1370561","CHEMBL2104089","CHEMBL2107084"],"number_of_indications":25,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":9},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":8},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":5},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":4},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":3},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":2},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":1}],"number_of_mechanisms_of_action":3}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4298085","_score":1,"_source":{"id":"CHEMBL4298085","internal_compound":false,"type":"Antibody","pref_name":"FIANLIMAB","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Fianlimab","REGN-3767","REGN3767","Regn3767"],"trade_names":[],"indications":[{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03005782"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03005782%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL13","_score":1,"_source":{"id":"CHEMBL13","internal_compound":false,"type":"Small molecule","pref_name":"METOPROLOL","year_first_approved":1978,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["CGP-2175","CGP-2175C","CGP-2175E","H 93/26 Succinate","H-93/26","Lopressidone","Metoprolol","Metoprolol Fumarate","Metoprolol Succinate","Metoprolol Tartrate","Toprol-XL"],"trade_names":["Arbralene","Beloc Cor","Betaloc","Betaloc S.A.","Kapspargo sprinkle","Lopresor","Lopresor Sr","Lopressor","Mepranix 100","Mepranix 50","Metoprolol Succinate","Metoprolol Tartrate","Metoros","Metoros LS","Tensomex","Toprol","Toprol XL","Toprol Xl","Toprol-Xl"],"cross_references":[{"source":"ChEBI","ids":[6904]},{"source":"DailyMed","ids":["metoprolol%20succinate","metoprolol%20tartrate"]},{"source":"PubChem","ids":["251919670"]},{"source":"Wikipedia","ids":["Metoprolol"]},{"source":"drugbank","ids":["DB00264"]},{"source":"PubChem","ids":["85273800"]},{"source":"PubChem","ids":["855895"]},{"source":"PubChem","ids":["29216544"]},{"source":"DailyMed","ids":["metoprolol%20tartrate"]},{"source":"DailyMed","ids":["metoprolol%20succinate"]},{"source":"PubChem","ids":["144206706"]},{"source":"PubChem","ids":["144204338","144207077","170464652"]}],"canonical_smiles":"COCCc1ccc(OCC(O)CNC(C)C)cc1","indications":[{"efo_id":"Orphanet_848","efo_label":"Beta-thalassemia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_848","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01863173"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01863173%22"]}]},{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["C07AB02"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C07AB02"]},{"source":"ClinicalTrials","ids":["NCT00182039"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00182039%22"]}]},{"efo_id":"EFO_0000275","efo_label":"atrial fibrillation","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000275","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00313157","NCT00589303","NCT01211821","NCT03162120"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00313157%22OR%22NCT00589303%22OR%22NCT01211821%22OR%22NCT03162120%22"]}]},{"efo_id":"EFO_0000537","efo_label":"hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000537","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000499","NCT00142584","NCT00152633","NCT00547300","NCT00648895","NCT01337674","NCT02513927"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000499%22OR%22NCT00142584%22OR%22NCT00152633%22OR%22NCT00547300%22OR%22NCT00648895%22OR%22NCT01337674%22OR%22NCT02513927%22"]}]},{"efo_id":"EFO_0005252","efo_label":"orthostatic hypotension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005252","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00865917"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00865917%22"]}]},{"efo_id":"EFO_0003144","efo_label":"heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003144","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00589303"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00589303%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02269696"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02269696%22"]}]},{"efo_id":"EFO_0001360","efo_label":"type II diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001360","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01324388","NCT02737891","NCT02940379"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01324388%22OR%22NCT02737891%22OR%22NCT02940379%22"]}]},{"efo_id":"EFO_0003913","efo_label":"angina pectoris","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003913","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT02029118"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02029118%22"]}]},{"efo_id":"EFO_0000274","efo_label":"atopic eczema","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000274","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02647086","NCT03556592"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02647086%22OR%22NCT03556592%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01585623","NCT04082910"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01585623%22OR%22NCT04082910%22"]}]},{"efo_id":"EFO_0000676","efo_label":"psoriasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000676","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02772601"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02772601%22"]}]},{"efo_id":"EFO_0001068","efo_label":"malaria","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001068","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01523002"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01523002%22"]}]},{"efo_id":"EFO_0001073","efo_label":"obesity","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001073","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00993421"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00993421%22"]}]},{"efo_id":"EFO_0003777","efo_label":"heart disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003777","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00000499"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000499%22"]}]},{"efo_id":"EFO_0004264","efo_label":"vascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004264","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00000499"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000499%22"]}]},{"efo_id":"EFO_0004278","efo_label":"sudden cardiac arrest","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004278","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00401882"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00401882%22"]}]},{"efo_id":"EFO_0004287","efo_label":"ventricular fibrillation","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004287","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00401882"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00401882%22"]}]},{"efo_id":"EFO_0005306","efo_label":"ventricular tachycardia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005306","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00401882"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00401882%22"]}]},{"efo_id":"Orphanet_739","efo_label":"Prader-Willi syndrome","efo_uri":"http://www.orpha.net/ORDO/Orphanet_739","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03149445"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03149445%22"]}]},{"efo_id":"EFO_0003917","efo_label":"premature birth","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003917","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03696758"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03696758%22"]}]},{"efo_id":"EFO_0000612","efo_label":"myocardial infarction","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000612","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["011ee828-5c2a-49b9-bf8e-07f5eb5fc635","2a2ede6b-ad06-428a-ad65-4055e1cdc7b2","50efcc03-559c-4d53-89ff-f2dc35384241","5554af64-cb12-4712-6391-a4212842804a","712562fa-8458-49c2-8710-bbc7a95c4504","760c63bd-1c1c-4a89-9f02-48aadb750484","77b7b111-641c-4c1e-8412-0ada79ad25fb","7befd77c-3189-4082-9a2a-f357b7e133a8","7c1f998a-233d-4feb-6ea2-457702abd0d2","80b4eb61-0035-42a8-a599-235cb0fd5258","84c8542f-943f-4e37-842b-17b46a0ff389","8d79ceac-bb0d-4d84-a301-afeb32dc877c","91666161-880e-4a69-95f0-6f18314ea999","96361be5-6052-4409-9e43-c89cfd824a69","96ee7ca8-3498-4337-965d-94078664d03b","9e16b710-77a1-4127-bf26-05b9ab54fcc5","a670d75a-ec69-4570-a3be-c57b896fc553","a84d3f91-cef2-47a2-86b5-a86526f150fd","c5d7f565-6cbe-4306-b3dd-a93ab3eac094","d4eb0239-9e17-4681-b4c2-3ec2ad18e8dc","e89cb5ec-e11b-4ca9-b3e3-34a4f144d7fe","eb0cd037-1e48-42b1-92ef-4d4ede585bb8","ef8ecfce-482f-44cf-9a96-5370f6d5d92a","f2152494-0370-492d-9402-4f1368a277c7","ffd837ea-551d-4b98-96e1-80c29ac32b20"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?011ee828-5c2a-49b9-bf8e-07f5eb5fc635","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2a2ede6b-ad06-428a-ad65-4055e1cdc7b2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?50efcc03-559c-4d53-89ff-f2dc35384241","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5554af64-cb12-4712-6391-a4212842804a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?712562fa-8458-49c2-8710-bbc7a95c4504","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?760c63bd-1c1c-4a89-9f02-48aadb750484","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?77b7b111-641c-4c1e-8412-0ada79ad25fb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7befd77c-3189-4082-9a2a-f357b7e133a8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7c1f998a-233d-4feb-6ea2-457702abd0d2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?80b4eb61-0035-42a8-a599-235cb0fd5258","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?84c8542f-943f-4e37-842b-17b46a0ff389","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8d79ceac-bb0d-4d84-a301-afeb32dc877c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?91666161-880e-4a69-95f0-6f18314ea999","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?96361be5-6052-4409-9e43-c89cfd824a69","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?96ee7ca8-3498-4337-965d-94078664d03b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9e16b710-77a1-4127-bf26-05b9ab54fcc5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a670d75a-ec69-4570-a3be-c57b896fc553","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a84d3f91-cef2-47a2-86b5-a86526f150fd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c5d7f565-6cbe-4306-b3dd-a93ab3eac094","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d4eb0239-9e17-4681-b4c2-3ec2ad18e8dc","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e89cb5ec-e11b-4ca9-b3e3-34a4f144d7fe","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?eb0cd037-1e48-42b1-92ef-4d4ede585bb8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ef8ecfce-482f-44cf-9a96-5370f6d5d92a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f2152494-0370-492d-9402-4f1368a277c7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ffd837ea-551d-4b98-96e1-80c29ac32b20"]},{"source":"FDA","ids":["0ef9220b-b6b8-4d4e-a514-ecc17e4c9d25","1fa5ecbc-4e00-4083-af02-b0ee6d3ee56a","25afd2c2-b693-4db9-8869-6a059fd3b2ac","2b7709bd-9b56-473e-9b46-96a3609d519c","2f1fcf2f-2272-448f-8930-f4c5195228d7","38635b1c-3a32-4164-8717-a58dda73dd66","39454773-71c0-492b-82a0-328d66035b83","53ca5267-5cca-4654-a63e-8250071e4151","59b89b16-ff2d-4da5-86ca-4756d65d8cf8","5e134a0d-d886-4f5c-9b76-31f356e5518a","6b25e5ea-f53e-481f-b92a-929ae667529d","777be0dc-5961-4fa8-aa7c-3b136db627a0","805857e0-2560-4a09-ba2d-e78d9024b180","812f952c-ae0f-4f9f-9050-cd5c5d312e6f","829e13d3-922c-4dc2-bf3c-a2febe59045c","837a54d9-e335-4af2-b3c7-a993af619a6d","925a7336-965f-4d95-9718-eb1048cff0ff","93616722-245d-4751-8524-348cf8bfee98","987a4adf-cbc8-4789-a8b5-342801845306","a2914314-c1ed-4c1d-9e7e-4902b15deddc","a4d07b57-09e1-4732-a135-559febcab3ef","cb7b1509-7935-482b-88e6-70ab601ee632","cf3e8888-ccc7-49fb-bad0-b44b3a2ef65b","eaef3b7c-5322-4bae-8295-588b622272ca","f95ee854-a252-4d00-be6e-38c628fba6ad","fa5d5e26-79e9-4020-a4de-0502e830346b","fb8874a0-da29-434e-9c42-4505dc087a81","fe8c4122-0ed8-490c-8570-7106e980b999"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A0ef9220b-b6b8-4d4e-a514-ecc17e4c9d25","https://api.fda.gov/drug/label.json?search=set_id%3A1fa5ecbc-4e00-4083-af02-b0ee6d3ee56a","https://api.fda.gov/drug/label.json?search=set_id%3A25afd2c2-b693-4db9-8869-6a059fd3b2ac","https://api.fda.gov/drug/label.json?search=set_id%3A2b7709bd-9b56-473e-9b46-96a3609d519c","https://api.fda.gov/drug/label.json?search=set_id%3A2f1fcf2f-2272-448f-8930-f4c5195228d7","https://api.fda.gov/drug/label.json?search=set_id%3A38635b1c-3a32-4164-8717-a58dda73dd66","https://api.fda.gov/drug/label.json?search=set_id%3A39454773-71c0-492b-82a0-328d66035b83","https://api.fda.gov/drug/label.json?search=set_id%3A53ca5267-5cca-4654-a63e-8250071e4151","https://api.fda.gov/drug/label.json?search=set_id%3A59b89b16-ff2d-4da5-86ca-4756d65d8cf8","https://api.fda.gov/drug/label.json?search=set_id%3A5e134a0d-d886-4f5c-9b76-31f356e5518a","https://api.fda.gov/drug/label.json?search=set_id%3A6b25e5ea-f53e-481f-b92a-929ae667529d","https://api.fda.gov/drug/label.json?search=set_id%3A777be0dc-5961-4fa8-aa7c-3b136db627a0","https://api.fda.gov/drug/label.json?search=set_id%3A805857e0-2560-4a09-ba2d-e78d9024b180","https://api.fda.gov/drug/label.json?search=set_id%3A812f952c-ae0f-4f9f-9050-cd5c5d312e6f","https://api.fda.gov/drug/label.json?search=set_id%3A829e13d3-922c-4dc2-bf3c-a2febe59045c","https://api.fda.gov/drug/label.json?search=set_id%3A837a54d9-e335-4af2-b3c7-a993af619a6d","https://api.fda.gov/drug/label.json?search=set_id%3A925a7336-965f-4d95-9718-eb1048cff0ff","https://api.fda.gov/drug/label.json?search=set_id%3A93616722-245d-4751-8524-348cf8bfee98","https://api.fda.gov/drug/label.json?search=set_id%3A987a4adf-cbc8-4789-a8b5-342801845306","https://api.fda.gov/drug/label.json?search=set_id%3Aa2914314-c1ed-4c1d-9e7e-4902b15deddc","https://api.fda.gov/drug/label.json?search=set_id%3Aa4d07b57-09e1-4732-a135-559febcab3ef","https://api.fda.gov/drug/label.json?search=set_id%3Acb7b1509-7935-482b-88e6-70ab601ee632","https://api.fda.gov/drug/label.json?search=set_id%3Acf3e8888-ccc7-49fb-bad0-b44b3a2ef65b","https://api.fda.gov/drug/label.json?search=set_id%3Aeaef3b7c-5322-4bae-8295-588b622272ca","https://api.fda.gov/drug/label.json?search=set_id%3Af95ee854-a252-4d00-be6e-38c628fba6ad","https://api.fda.gov/drug/label.json?search=set_id%3Afa5d5e26-79e9-4020-a4de-0502e830346b","https://api.fda.gov/drug/label.json?search=set_id%3Afb8874a0-da29-434e-9c42-4505dc087a81","https://api.fda.gov/drug/label.json?search=set_id%3Afe8c4122-0ed8-490c-8570-7106e980b999"]}]},{"efo_id":"EFO_0000537","efo_label":"hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000537","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00223717"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00223717%22"]},{"source":"DailyMed","ids":["011ee828-5c2a-49b9-bf8e-07f5eb5fc635","2a2ede6b-ad06-428a-ad65-4055e1cdc7b2","364366b9-79ab-441d-8c90-d8713b5cf377","50efcc03-559c-4d53-89ff-f2dc35384241","5571dc11-1c5c-41c1-be20-ed91b7ba5cc8","67a67718-e59f-4988-8bfc-9b4ac103e370","712562fa-8458-49c2-8710-bbc7a95c4504","760c63bd-1c1c-4a89-9f02-48aadb750484","77b7b111-641c-4c1e-8412-0ada79ad25fb","7befd77c-3189-4082-9a2a-f357b7e133a8","80b4eb61-0035-42a8-a599-235cb0fd5258","84c8542f-943f-4e37-842b-17b46a0ff389","8d79ceac-bb0d-4d84-a301-afeb32dc877c","96361be5-6052-4409-9e43-c89cfd824a69","96ee7ca8-3498-4337-965d-94078664d03b","9e16b710-77a1-4127-bf26-05b9ab54fcc5","a84d3f91-cef2-47a2-86b5-a86526f150fd","b6cf0f43-8dc3-4535-b651-daf1f9e0336c","c5d7f565-6cbe-4306-b3dd-a93ab3eac094","d4eb0239-9e17-4681-b4c2-3ec2ad18e8dc","d8964894-3cd8-41c1-a844-148d2ef38a88","eb0cd037-1e48-42b1-92ef-4d4ede585bb8","ef8ecfce-482f-44cf-9a96-5370f6d5d92a","f2152494-0370-492d-9402-4f1368a277c7"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?011ee828-5c2a-49b9-bf8e-07f5eb5fc635","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2a2ede6b-ad06-428a-ad65-4055e1cdc7b2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?364366b9-79ab-441d-8c90-d8713b5cf377","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?50efcc03-559c-4d53-89ff-f2dc35384241","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5571dc11-1c5c-41c1-be20-ed91b7ba5cc8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?67a67718-e59f-4988-8bfc-9b4ac103e370","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?712562fa-8458-49c2-8710-bbc7a95c4504","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?760c63bd-1c1c-4a89-9f02-48aadb750484","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?77b7b111-641c-4c1e-8412-0ada79ad25fb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7befd77c-3189-4082-9a2a-f357b7e133a8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?80b4eb61-0035-42a8-a599-235cb0fd5258","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?84c8542f-943f-4e37-842b-17b46a0ff389","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8d79ceac-bb0d-4d84-a301-afeb32dc877c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?96361be5-6052-4409-9e43-c89cfd824a69","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?96ee7ca8-3498-4337-965d-94078664d03b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9e16b710-77a1-4127-bf26-05b9ab54fcc5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a84d3f91-cef2-47a2-86b5-a86526f150fd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b6cf0f43-8dc3-4535-b651-daf1f9e0336c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c5d7f565-6cbe-4306-b3dd-a93ab3eac094","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d4eb0239-9e17-4681-b4c2-3ec2ad18e8dc","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d8964894-3cd8-41c1-a844-148d2ef38a88","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?eb0cd037-1e48-42b1-92ef-4d4ede585bb8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ef8ecfce-482f-44cf-9a96-5370f6d5d92a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f2152494-0370-492d-9402-4f1368a277c7"]},{"source":"FDA","ids":["0ef9220b-b6b8-4d4e-a514-ecc17e4c9d25","1fa5ecbc-4e00-4083-af02-b0ee6d3ee56a","25afd2c2-b693-4db9-8869-6a059fd3b2ac","2b7709bd-9b56-473e-9b46-96a3609d519c","2f1fcf2f-2272-448f-8930-f4c5195228d7","38635b1c-3a32-4164-8717-a58dda73dd66","39454773-71c0-492b-82a0-328d66035b83","53ca5267-5cca-4654-a63e-8250071e4151","59b89b16-ff2d-4da5-86ca-4756d65d8cf8","5e134a0d-d886-4f5c-9b76-31f356e5518a","6b25e5ea-f53e-481f-b92a-929ae667529d","777be0dc-5961-4fa8-aa7c-3b136db627a0","812f952c-ae0f-4f9f-9050-cd5c5d312e6f","829e13d3-922c-4dc2-bf3c-a2febe59045c","837a54d9-e335-4af2-b3c7-a993af619a6d","925a7336-965f-4d95-9718-eb1048cff0ff","93616722-245d-4751-8524-348cf8bfee98","987a4adf-cbc8-4789-a8b5-342801845306","a2914314-c1ed-4c1d-9e7e-4902b15deddc","a4d07b57-09e1-4732-a135-559febcab3ef","cb7b1509-7935-482b-88e6-70ab601ee632","cf3e8888-ccc7-49fb-bad0-b44b3a2ef65b","eaef3b7c-5322-4bae-8295-588b622272ca","f95ee854-a252-4d00-be6e-38c628fba6ad","fa5d5e26-79e9-4020-a4de-0502e830346b","faaf13ce-5d8d-4c57-a49f-a7a73daa41a5","fb8874a0-da29-434e-9c42-4505dc087a81","fe8c4122-0ed8-490c-8570-7106e980b999"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A0ef9220b-b6b8-4d4e-a514-ecc17e4c9d25","https://api.fda.gov/drug/label.json?search=set_id%3A1fa5ecbc-4e00-4083-af02-b0ee6d3ee56a","https://api.fda.gov/drug/label.json?search=set_id%3A25afd2c2-b693-4db9-8869-6a059fd3b2ac","https://api.fda.gov/drug/label.json?search=set_id%3A2b7709bd-9b56-473e-9b46-96a3609d519c","https://api.fda.gov/drug/label.json?search=set_id%3A2f1fcf2f-2272-448f-8930-f4c5195228d7","https://api.fda.gov/drug/label.json?search=set_id%3A38635b1c-3a32-4164-8717-a58dda73dd66","https://api.fda.gov/drug/label.json?search=set_id%3A39454773-71c0-492b-82a0-328d66035b83","https://api.fda.gov/drug/label.json?search=set_id%3A53ca5267-5cca-4654-a63e-8250071e4151","https://api.fda.gov/drug/label.json?search=set_id%3A59b89b16-ff2d-4da5-86ca-4756d65d8cf8","https://api.fda.gov/drug/label.json?search=set_id%3A5e134a0d-d886-4f5c-9b76-31f356e5518a","https://api.fda.gov/drug/label.json?search=set_id%3A6b25e5ea-f53e-481f-b92a-929ae667529d","https://api.fda.gov/drug/label.json?search=set_id%3A777be0dc-5961-4fa8-aa7c-3b136db627a0","https://api.fda.gov/drug/label.json?search=set_id%3A812f952c-ae0f-4f9f-9050-cd5c5d312e6f","https://api.fda.gov/drug/label.json?search=set_id%3A829e13d3-922c-4dc2-bf3c-a2febe59045c","https://api.fda.gov/drug/label.json?search=set_id%3A837a54d9-e335-4af2-b3c7-a993af619a6d","https://api.fda.gov/drug/label.json?search=set_id%3A925a7336-965f-4d95-9718-eb1048cff0ff","https://api.fda.gov/drug/label.json?search=set_id%3A93616722-245d-4751-8524-348cf8bfee98","https://api.fda.gov/drug/label.json?search=set_id%3A987a4adf-cbc8-4789-a8b5-342801845306","https://api.fda.gov/drug/label.json?search=set_id%3Aa2914314-c1ed-4c1d-9e7e-4902b15deddc","https://api.fda.gov/drug/label.json?search=set_id%3Aa4d07b57-09e1-4732-a135-559febcab3ef","https://api.fda.gov/drug/label.json?search=set_id%3Acb7b1509-7935-482b-88e6-70ab601ee632","https://api.fda.gov/drug/label.json?search=set_id%3Acf3e8888-ccc7-49fb-bad0-b44b3a2ef65b","https://api.fda.gov/drug/label.json?search=set_id%3Aeaef3b7c-5322-4bae-8295-588b622272ca","https://api.fda.gov/drug/label.json?search=set_id%3Af95ee854-a252-4d00-be6e-38c628fba6ad","https://api.fda.gov/drug/label.json?search=set_id%3Afa5d5e26-79e9-4020-a4de-0502e830346b","https://api.fda.gov/drug/label.json?search=set_id%3Afaaf13ce-5d8d-4c57-a49f-a7a73daa41a5","https://api.fda.gov/drug/label.json?search=set_id%3Afb8874a0-da29-434e-9c42-4505dc087a81","https://api.fda.gov/drug/label.json?search=set_id%3Afe8c4122-0ed8-490c-8570-7106e980b999"]}]},{"efo_id":"EFO_0000275","efo_label":"atrial fibrillation","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000275","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00589303"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00589303%22"]}]},{"efo_id":"EFO_0003777","efo_label":"heart disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003777","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03138603"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03138603%22"]}]},{"efo_id":"EFO_0000537","efo_label":"hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000537","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00255502","NCT00255528","NCT00273052","NCT00547300","NCT00642096","NCT01970059","NCT03070184"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00255502%22OR%22NCT00255528%22OR%22NCT00273052%22OR%22NCT00547300%22OR%22NCT00642096%22OR%22NCT01970059%22OR%22NCT03070184%22"]},{"source":"DailyMed","ids":["01038198-b4f0-41f3-9a9c-5c84e5a0d3b9","14ab9921-4651-4abc-92dc-aab1719b6bb0","1b369f44-bb31-4eca-8d98-025ad18c28d5","2568f163-206f-410b-a353-cd0cfbf1e6d4","313ed89a-029c-44b1-bf55-11c731a5f2c4","361cc106-6167-43e1-93af-46b3faa5cedf","38c6c193-1bcb-4faf-ad43-13b184944363","3bb7dd79-89e2-4d5b-ab4b-8fa2a4025506","3eed9ead-7076-4b18-9e36-8c66d50a06a1","4141d2be-75b7-4b5b-93ce-a62de7efdd38","44f64f0e-1b68-4478-1fb7-c1bc9402deec","459fe5ce-14d1-4901-956a-b5597ea9016c","479f6625-349f-4d0c-b63b-55771278f973","498e064d-ece3-4885-a06f-1c9d7b83a8aa","4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4","53613463-d5b6-41e7-aa43-1b75633c61fd","5988bc0d-68dc-47bc-819d-2709572042ce","5d1aee2d-a706-418f-ad58-8b12b035e697","5ef12832-15cd-40f4-bf11-6cea7e48ff7f","6020703f-e676-4eb7-9d46-480896bd64a3","61289821-90a6-4c78-968d-af4099ffaf14","634bacdf-4191-4073-847d-413d0b0ee217","65a547ff-dab2-4d44-b2d6-352065ba2cd3","6d4d276e-59a6-4b91-beb0-c19a02c9e1ef","71c1d33e-be6f-6d59-b715-45075445891a","7bacd1ea-5546-47a1-8cff-a30327cadec3","7c058dfa-e40c-4bc9-89d0-a8209e0dbc4f","7d2303a0-f088-495a-a6d0-c59acfe5137b","7e87a7ee-b16e-464a-a77c-0f7a40e04cf7","8264e96e-7c68-40c2-8bfa-77e89f830466","8541c2ad-415c-4422-88b3-8bb31d19c55a","8649628f-25db-492d-9845-8cfc138e6cba","8cdaeafa-2255-4122-a016-853b3ed6a19b","90594d68-87f2-5f75-2d8a-1629f88ba8a9","92152712-efd5-42e9-baf3-63a2401c7b9d","98d31d43-eff0-4ba9-9953-f2f53c13b3d9","9cd0f81e-20f9-4cb3-a738-a578c707b1b5","9feb7a87-75be-46bd-9fe0-288d67b312b1","a0c8c0ac-863c-4385-94d2-f6691bee66d9","a4726da0-4015-43c0-a534-1b22cea0177c","ac561677-2058-479f-a545-623451ef89a6","acad5e19-27c5-44fb-80f7-c05aa6859ecf","af828aa9-95f6-49c4-8b83-b5309dbddbf0","ba79d7ec-a781-c617-beee-909ea2f0672b","bf080e0c-c100-4a39-b3d5-99f5b1bfef04","c20170ea-0e24-4e82-b9cb-aebdbfcc022a","c4fb991c-025c-4a1d-9766-4b62ad70b5fe","c50e8e36-42df-406b-8e63-eb8bf3f07e89","c56aec88-19bb-436c-9b44-71e7f10c9a19","c9e0d1db-55e2-4838-a37c-60ce7898d7ad","d1d9ee1c-c478-4ee5-b444-563819193dde","d48a9b57-a05a-45e9-8fb0-3bd6380bc3f8","d493a29e-adb1-4066-b022-dfce179fb71b","d603c82f-b1d3-421a-8c02-d58a556abbdc","d74c1d6c-f144-44a7-99b8-7cfe87e5473a","daaf5f8f-2861-4e18-9d8a-0124eb9e26e6","e13bbc27-d017-4d37-8500-5c3135c3a81f","e1a16fed-bcf7-4a7e-8203-7abc8a041a66","e52001cb-1daa-4651-a8b1-f48a4e9cdfd1","e525f000-a7cd-4665-910e-cc058360f1c6","eea16726-4802-415a-83a0-61cfad1ec405","f01e6b14-d72f-4cb5-b049-1d42d8acb144","f3f8162f-7c8b-4ec3-9dc3-cbf79b9eefb7","ff391fc7-a0ab-4f8c-927e-2588053c7021"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?01038198-b4f0-41f3-9a9c-5c84e5a0d3b9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?14ab9921-4651-4abc-92dc-aab1719b6bb0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1b369f44-bb31-4eca-8d98-025ad18c28d5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2568f163-206f-410b-a353-cd0cfbf1e6d4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?313ed89a-029c-44b1-bf55-11c731a5f2c4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?361cc106-6167-43e1-93af-46b3faa5cedf","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?38c6c193-1bcb-4faf-ad43-13b184944363","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3bb7dd79-89e2-4d5b-ab4b-8fa2a4025506","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3eed9ead-7076-4b18-9e36-8c66d50a06a1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4141d2be-75b7-4b5b-93ce-a62de7efdd38","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?44f64f0e-1b68-4478-1fb7-c1bc9402deec","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?459fe5ce-14d1-4901-956a-b5597ea9016c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?479f6625-349f-4d0c-b63b-55771278f973","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?498e064d-ece3-4885-a06f-1c9d7b83a8aa","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4a5762c6-d7a2-4e4c-10b7-8832b36fa5f4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?53613463-d5b6-41e7-aa43-1b75633c61fd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5988bc0d-68dc-47bc-819d-2709572042ce","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5d1aee2d-a706-418f-ad58-8b12b035e697","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5ef12832-15cd-40f4-bf11-6cea7e48ff7f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6020703f-e676-4eb7-9d46-480896bd64a3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?61289821-90a6-4c78-968d-af4099ffaf14","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?634bacdf-4191-4073-847d-413d0b0ee217","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?65a547ff-dab2-4d44-b2d6-352065ba2cd3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6d4d276e-59a6-4b91-beb0-c19a02c9e1ef","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?71c1d33e-be6f-6d59-b715-45075445891a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7bacd1ea-5546-47a1-8cff-a30327cadec3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7c058dfa-e40c-4bc9-89d0-a8209e0dbc4f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7d2303a0-f088-495a-a6d0-c59acfe5137b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7e87a7ee-b16e-464a-a77c-0f7a40e04cf7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8264e96e-7c68-40c2-8bfa-77e89f830466","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8541c2ad-415c-4422-88b3-8bb31d19c55a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8649628f-25db-492d-9845-8cfc138e6cba","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8cdaeafa-2255-4122-a016-853b3ed6a19b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?90594d68-87f2-5f75-2d8a-1629f88ba8a9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?92152712-efd5-42e9-baf3-63a2401c7b9d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?98d31d43-eff0-4ba9-9953-f2f53c13b3d9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9cd0f81e-20f9-4cb3-a738-a578c707b1b5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9feb7a87-75be-46bd-9fe0-288d67b312b1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a0c8c0ac-863c-4385-94d2-f6691bee66d9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a4726da0-4015-43c0-a534-1b22cea0177c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ac561677-2058-479f-a545-623451ef89a6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?acad5e19-27c5-44fb-80f7-c05aa6859ecf","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?af828aa9-95f6-49c4-8b83-b5309dbddbf0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ba79d7ec-a781-c617-beee-909ea2f0672b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bf080e0c-c100-4a39-b3d5-99f5b1bfef04","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c20170ea-0e24-4e82-b9cb-aebdbfcc022a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c4fb991c-025c-4a1d-9766-4b62ad70b5fe","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c50e8e36-42df-406b-8e63-eb8bf3f07e89","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c56aec88-19bb-436c-9b44-71e7f10c9a19","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c9e0d1db-55e2-4838-a37c-60ce7898d7ad","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d1d9ee1c-c478-4ee5-b444-563819193dde","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d48a9b57-a05a-45e9-8fb0-3bd6380bc3f8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d493a29e-adb1-4066-b022-dfce179fb71b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d603c82f-b1d3-421a-8c02-d58a556abbdc","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d74c1d6c-f144-44a7-99b8-7cfe87e5473a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?daaf5f8f-2861-4e18-9d8a-0124eb9e26e6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e13bbc27-d017-4d37-8500-5c3135c3a81f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e1a16fed-bcf7-4a7e-8203-7abc8a041a66","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e52001cb-1daa-4651-a8b1-f48a4e9cdfd1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e525f000-a7cd-4665-910e-cc058360f1c6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?eea16726-4802-415a-83a0-61cfad1ec405","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f01e6b14-d72f-4cb5-b049-1d42d8acb144","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f3f8162f-7c8b-4ec3-9dc3-cbf79b9eefb7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ff391fc7-a0ab-4f8c-927e-2588053c7021"]},{"source":"FDA","ids":["54f5dfe4-886a-446a-a972-8080ed903b0b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A54f5dfe4-886a-446a-a972-8080ed903b0b"]}]},{"efo_id":"EFO_0000373","efo_label":"congestive heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000373","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00038077","NCT00077948"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00038077%22OR%22NCT00077948%22"]},{"source":"DailyMed","ids":["1b369f44-bb31-4eca-8d98-025ad18c28d5","498e064d-ece3-4885-a06f-1c9d7b83a8aa","ba79d7ec-a781-c617-beee-909ea2f0672b","d493a29e-adb1-4066-b022-dfce179fb71b","ff391fc7-a0ab-4f8c-927e-2588053c7021"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1b369f44-bb31-4eca-8d98-025ad18c28d5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?498e064d-ece3-4885-a06f-1c9d7b83a8aa","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ba79d7ec-a781-c617-beee-909ea2f0672b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d493a29e-adb1-4066-b022-dfce179fb71b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ff391fc7-a0ab-4f8c-927e-2588053c7021"]}]},{"efo_id":"EFO_0003913","efo_label":"angina pectoris","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003913","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["1b369f44-bb31-4eca-8d98-025ad18c28d5","498e064d-ece3-4885-a06f-1c9d7b83a8aa","ba79d7ec-a781-c617-beee-909ea2f0672b","d493a29e-adb1-4066-b022-dfce179fb71b","ff391fc7-a0ab-4f8c-927e-2588053c7021"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1b369f44-bb31-4eca-8d98-025ad18c28d5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?498e064d-ece3-4885-a06f-1c9d7b83a8aa","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ba79d7ec-a781-c617-beee-909ea2f0672b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d493a29e-adb1-4066-b022-dfce179fb71b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ff391fc7-a0ab-4f8c-927e-2588053c7021"]}]},{"efo_id":"EFO_0000266","efo_label":"aortic stenosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000266","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02076711"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02076711%22"]}]},{"efo_id":"EFO_0000275","efo_label":"atrial fibrillation","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000275","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00589303","NCT01970501"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00589303%22OR%22NCT01970501%22"]}]},{"efo_id":"EFO_0000341","efo_label":"chronic obstructive pulmonary disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000341","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02587351"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02587351%22"]}]},{"efo_id":"EFO_0000538","efo_label":"hypertrophic cardiomyopathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000538","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03532802"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03532802%22"]}]},{"efo_id":"EFO_0003144","efo_label":"heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003144","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00589303","NCT02012075"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00589303%22OR%22NCT02012075%22"]}]},{"efo_id":"Orphanet_79292","efo_label":"Fish-eye disease","efo_uri":"http://www.orpha.net/ORDO/Orphanet_79292","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01884909"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01884909%22"]}]}],"adverse_events":{"significant":[{"event":"bradycardia","count":20091,"llr":2671.659081},{"event":"hypotension","count":55121,"llr":1137.982649},{"event":"syncope","count":31191,"llr":876.4391415},{"event":"dizziness","count":99375,"llr":491.6132195},{"event":"sinus bradycardia","count":4115,"llr":342.6228148},{"event":"cardiogenic shock","count":2837,"llr":291.4321746},{"event":"heart rate decreased","count":5985,"llr":287.8934298},{"event":"atrial fibrillation","count":25339,"llr":282.5435136},{"event":"blood pressure increased","count":25616,"llr":219.6452688},{"event":"suicide attempt","count":20244,"llr":195.6191579},{"event":"hyperkalaemia","count":12419,"llr":195.3039892},{"event":"cardiac arrest","count":9359,"llr":185.3364653},{"event":"palpitations","count":23550,"llr":182.9930981},{"event":"blood pressure inadequately controlled","count":1635,"llr":181.6128252},{"event":"fall","count":67604,"llr":178.2151406},{"event":"drug hypersensitivity","count":71246,"llr":174.8845771},{"event":"presyncope","count":6977,"llr":174.497755},{"event":"toxicity to various agents","count":31033,"llr":172.8596949},{"event":"atrial septal defect","count":3155,"llr":172.1310806},{"event":"orthostatic hypotension","count":6478,"llr":168.386548}],"critval":159.4769949},"child_chembl_ids":["CHEMBL1200337","CHEMBL1200840","CHEMBL1868892","CHEMBL2062335","CHEMBL2356097","CHEMBL3186768","CHEMBL3989566","CHEMBL545787"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000043591","approved_name":"adrenoceptor beta 1","approved_symbol":"ADRB1"}],"target_type":"single protein","target_name":"Beta-1 adrenergic receptor","action_type":"antagonist","description":"Beta-1 adrenergic receptor antagonist","references":[{"source":"DailyMed","ids":["setid=f3817543-544a-4afa-ac7c-c1b48c1307c2"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f3817543-544a-4afa-ac7c-c1b48c1307c2"]}]},{"target_components":[{"ensembl":"ENSG00000043591","approved_name":"adrenoceptor beta 1","approved_symbol":"ADRB1"}],"target_type":"single protein","target_name":"Beta-1 adrenergic receptor","action_type":"antagonist","description":"Beta-1 adrenergic receptor antagonist","references":[{"source":"DailyMed","ids":["setid=31d8610a-ab22-49e5-a762-6b08244ee93a"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31d8610a-ab22-49e5-a762-6b08244ee93a"]}]}],"number_of_indications":34,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":20},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":16},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":4},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":4},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":3},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":3},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":3},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":3},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":2},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":2},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":2},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2177390","_score":1,"_source":{"id":"CHEMBL2177390","internal_compound":false,"type":"Small molecule","pref_name":"IPATASERTIB","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["GDC-0068","Ipatasertib","RG-7440"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB11743"]}],"canonical_smiles":"CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3O)CC1)c1ccc(Cl)cc1","indications":[{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01090960","NCT02536391","NCT03498521"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01090960%22OR%22NCT02536391%22OR%22NCT03498521%22"]}]},{"efo_id":"EFO_0000178","efo_label":"gastric carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000178","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01896531"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01896531%22"]}]},{"efo_id":"EFO_0000196","efo_label":"metastatic prostate cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000196","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03072238"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03072238%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02301988","NCT03337724","NCT03395899","NCT03424005","NCT03800836","NCT03853707","NCT03959891","NCT04060862"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02301988%22OR%22NCT03337724%22OR%22NCT03395899%22OR%22NCT03424005%22OR%22NCT03800836%22OR%22NCT03853707%22OR%22NCT03959891%22OR%22NCT04060862%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01362374","NCT01562275"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01362374%22OR%22NCT01562275%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01485861"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01485861%22"]}]},{"efo_id":"EFO_0003869","efo_label":"breast neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003869","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02162719","NCT03280563"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02162719%22OR%22NCT03280563%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03337698"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03337698%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000105221","approved_name":"AKT serine/threonine kinase 2","approved_symbol":"AKT2"},{"ensembl":"ENSG00000117020","approved_name":"AKT serine/threonine kinase 3","approved_symbol":"AKT3"},{"ensembl":"ENSG00000142208","approved_name":"AKT serine/threonine kinase 1","approved_symbol":"AKT1"}],"target_type":"protein family","target_name":"Serine/threonine-protein kinase AKT","action_type":"inhibitor","description":"Serine/threonine-protein kinase AKT inhibitor","references":[{"source":"PubMed","ids":["22934575","23287563"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22934575+OR+EXT_ID%3A23287563"]}]}],"number_of_indications":8,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":8},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":4},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":3},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":2},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":2},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3187503","_score":1,"_source":{"id":"CHEMBL3187503","internal_compound":false,"type":"Small molecule","pref_name":"GSK-1292263","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["GSK-1292263","GSK-1292263A","GSK-263A","GSK1292263","Gsk 1292263","Gsk-1292263","Gsk1292263"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["174006808"]},{"source":"drugbank","ids":["DB12627"]}],"canonical_smiles":"CC(C)c1noc(N2CCC(COc3ccc(-c4ccc(S(C)(=O)=O)cc4)nc3)CC2)n1","indications":[{"efo_id":"EFO_0001360","efo_label":"type II diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001360","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01101568","NCT01119846","NCT01128621"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01101568%22OR%22NCT01119846%22OR%22NCT01128621%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1928262","_score":1,"_source":{"id":"CHEMBL1928262","internal_compound":false,"type":"Small molecule","pref_name":"GISADENAFIL","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Gisadenafil","Gisadenafil Besylate","UK-369003","UK-369003-26"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB11902"]}],"canonical_smiles":"CCOc1ncc(S(=O)(=O)N2CCN(CC)CC2)cc1-c1nc2c(CC)n(CCOC)nc2c(=O)[nH]1","indications":[{"efo_id":"EFO_0000284","efo_label":"benign prostatic hyperplasia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000284","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00408954","NCT00457457"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00408954%22OR%22NCT00457457%22"]}]},{"efo_id":"EFO_0000341","efo_label":"chronic obstructive pulmonary disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000341","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00163098"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00163098%22"]}]},{"efo_id":"EFO_0004234","efo_label":"erectile dysfunction","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004234","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00141349"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00141349%22"]}]},{"efo_id":"EFO_1000781","efo_label":"overactive bladder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000781","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00479505"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00479505%22"]}]}],"child_chembl_ids":["CHEMBL2103843"],"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":3},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":2},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297808","_score":1,"_source":{"id":"CHEMBL4297808","internal_compound":false,"type":"Unknown","pref_name":"PF-06823859","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["PF-06823859","PF06823859","Pf-06823859"],"trade_names":[],"indications":[{"efo_id":"EFO_0000398","efo_label":"dermatomyositis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000398","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03181893"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03181893%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2364652","_score":1,"_source":{"id":"CHEMBL2364652","internal_compound":false,"type":"Antibody","pref_name":"VANTICTUMAB","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["OMP-18R5","Vantictumab"],"trade_names":[],"indications":[{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01973309"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01973309%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01345201","NCT01957007"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01345201%22OR%22NCT01957007%22"]}]},{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02005315"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02005315%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000157240","approved_name":"frizzled class receptor 1","approved_symbol":"FZD1"}],"target_type":"single protein","target_name":"Frizzled-1","action_type":"antagonist","description":"Frizzled-1 antagonist","references":[{"source":"PubMed","ids":["22753465"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22753465"]}]},{"target_components":[{"ensembl":"ENSG00000180340","approved_name":"frizzled class receptor 2","approved_symbol":"FZD2"}],"target_type":"single protein","target_name":"Frizzled-2","action_type":"antagonist","description":"Frizzled-2 antagonist","references":[{"source":"PubMed","ids":["22753465"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22753465"]}]},{"target_components":[{"ensembl":"ENSG00000163251","approved_name":"frizzled class receptor 5","approved_symbol":"FZD5"}],"target_type":"single protein","target_name":"Frizzled-5","action_type":"antagonist","description":"Frizzled-5 antagonist","references":[{"source":"PubMed","ids":["22753465"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22753465"]}]},{"target_components":[{"ensembl":"ENSG00000155760","approved_name":"frizzled class receptor 7","approved_symbol":"FZD7"}],"target_type":"single protein","target_name":"Frizzled-7","action_type":"antagonist","description":"Frizzled-7 antagonist","references":[{"source":"PubMed","ids":["22753465"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22753465"]}]},{"target_components":[{"ensembl":"ENSG00000177283","approved_name":"frizzled class receptor 8","approved_symbol":"FZD8"}],"target_type":"single protein","target_name":"Frizzled-8","action_type":"antagonist","description":"Frizzled-8 antagonist","references":[{"source":"PubMed","ids":["22753465"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22753465"]}]}],"adverse_events":{"significant":[{"event":"multiple fractures","count":990,"llr":13.75261848},{"event":"pik3ca-activated mutation","count":21,"llr":9.866203864},{"event":"dysgeusia","count":15051,"llr":8.316974576}],"critval":7.560494074},"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1}],"number_of_mechanisms_of_action":5}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297775","_score":1,"_source":{"id":"CHEMBL4297775","internal_compound":false,"type":"Unknown","pref_name":"KAI-1678","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["KP-1678","Kai-1678"],"trade_names":[],"indications":[{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01015235"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01015235%22"]}]},{"efo_id":"EFO_1001919","efo_label":"Spinal cord injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001919","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01135108"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01135108%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545311","_score":1,"_source":{"id":"CHEMBL3545311","internal_compound":false,"type":"Small molecule","pref_name":"BRIGATINIB","year_first_approved":2017,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AP-26113","Brigatinib"],"trade_names":["Alunbrig"],"cross_references":[{"source":"DailyMed","ids":["brigatinib"]},{"source":"drugbank","ids":["DB12267"]}],"canonical_smiles":"COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1","indications":[{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT02094573","NCT02706626","NCT02737501","NCT03410108","NCT03420742","NCT03535740","NCT03707938","NCT03737994","NCT04005144","NCT04074993"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02094573%22OR%22NCT02706626%22OR%22NCT02737501%22OR%22NCT03410108%22OR%22NCT03420742%22OR%22NCT03535740%22OR%22NCT03707938%22OR%22NCT03737994%22OR%22NCT04005144%22OR%22NCT04074993%22"]},{"source":"FDA","ids":["label/2017/208772lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2017%2F208772lbl.pdf"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["L01XE43"],"urls":["https://www.whocc.no/atc_ddd_index/?code=L01XE43"]}]},{"efo_id":"EFO_0003032","efo_label":"anaplastic large cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003032","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03719898"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03719898%22"]}]},{"efo_id":"EFO_0003833","efo_label":"brain neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003833","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03868423"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03868423%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000171094","approved_name":"ALK receptor tyrosine kinase","approved_symbol":"ALK"}],"target_type":"single protein","target_name":"ALK tyrosine kinase receptor","action_type":"inhibitor","description":"ALK tyrosine kinase receptor inhibitor","references":[{"source":"Other","ids":["http://www.ariad.com/AP26113","http://www.ariad.com/pdf/Rivera_2012_AACR_POSTER_AP26113_noQRcode.pdf"],"urls":["http://www.ariad.com/AP26113","http://www.ariad.com/pdf/Rivera_2012_AACR_POSTER_AP26113_noQRcode.pdf"]},{"source":"PubMed","ids":["25888090"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25888090"]}]},{"target_components":[{"ensembl":"ENSG00000146648","approved_name":"epidermal growth factor receptor","approved_symbol":"EGFR"}],"target_type":"single protein","target_name":"Epidermal growth factor receptor erbB1","action_type":"inhibitor","description":"Epidermal growth factor receptor erbB1 inhibitor","references":[{"source":"Other","ids":["http://www.ariad.com/AP26113","http://www.ariad.com/pdf/Rivera_2012_AACR_POSTER_AP26113_noQRcode.pdf"],"urls":["http://www.ariad.com/AP26113","http://www.ariad.com/pdf/Rivera_2012_AACR_POSTER_AP26113_noQRcode.pdf"]},{"source":"PubMed","ids":["25888090"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25888090"]}]}],"adverse_events":{"significant":[{"event":"neoplasm progression","count":5699,"llr":292.1984187},{"event":"creatinine renal clearance abnormal","count":195,"llr":24.64448002},{"event":"blood creatine phosphokinase increased","count":14851,"llr":23.93979864},{"event":"metastases to central nervous system","count":2595,"llr":22.68324819},{"event":"pituitary infarction","count":25,"llr":19.39892419},{"event":"pneumonitis","count":6754,"llr":15.30981028},{"event":"photosensitivity reaction","count":4693,"llr":14.91590035},{"event":"eastern cooperative oncology group performance status worsened","count":145,"llr":14.13354576},{"event":"anti factor x activity increased","count":13,"llr":13.42549434},{"event":"activated partial thromboplastin time prolonged","count":2063,"llr":12.97652967},{"event":"cough","count":52232,"llr":10.2336522},{"event":"amino acid level increased","count":110,"llr":9.161082114},{"event":"blood creatine phosphokinase abnormal","count":166,"llr":8.341906402},{"event":"lung neoplasm malignant","count":3723,"llr":7.261068111},{"event":"aspartate aminotransferase increased","count":21532,"llr":7.028203447},{"event":"acid peptic disease","count":6,"llr":6.790863219},{"event":"meningioma malignant","count":11,"llr":6.185071487},{"event":"blood pressure increased","count":25616,"llr":5.914064545},{"event":"coagulation factor x level increased","count":19,"llr":5.639078296},{"event":"decreased appetite","count":40807,"llr":5.580962845},{"event":"diarrhoea","count":126514,"llr":5.548954779},{"event":"non-small cell lung cancer","count":698,"llr":5.50591833}],"critval":5.410654504},"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":4},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2104149","_score":1,"_source":{"id":"CHEMBL2104149","internal_compound":false,"type":"Small molecule","pref_name":"BEZITRAMIDE","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Bezitramide","R-4845"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB01459"]}],"canonical_smiles":"CCC(=O)n1c(=O)n(C2CCN(CCC(C#N)(c3ccccc3)c3ccccc3)CC2)c2ccccc21","indications":[{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["N02AC05"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N02AC05"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201662","_score":1,"_source":{"id":"CHEMBL1201662","internal_compound":false,"type":"Protein","pref_name":"DESIRUDIN","year_first_approved":2003,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["CGP-39393","Desirudin","Desirudin Recombinant","Desirudin recombinant","Hirudin desirudin"],"trade_names":["Iprivask"],"cross_references":[{"source":"DailyMed","ids":["desirudin"]},{"source":"DrugCentral","ids":["2990"]}],"indications":[{"efo_id":"EFO_0003907","efo_label":"deep vein thrombosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003907","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00329433"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00329433%22"]},{"source":"FDA","ids":["label/2003/021271lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2003%2F021271lbl.pdf"]}]},{"efo_id":"HP_0004419","efo_label":"Recurrent thrombophlebitis","efo_uri":"http://purl.obolibrary.org/obo/HP_0004419","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["B01AE01"],"urls":["https://www.whocc.no/atc_ddd_index/?code=B01AE01"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000180210","approved_name":"coagulation factor II, thrombin","approved_symbol":"F2"}],"target_type":"single protein","target_name":"Thrombin","action_type":"inhibitor","description":"Thrombin inhibitor","references":[{"source":"FDA","ids":["label/2014/021271s006lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2014%2F021271s006lbl.pdf"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":2}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4298109","_score":1,"_source":{"id":"CHEMBL4298109","internal_compound":false,"type":"Unknown","pref_name":"IRL-1620","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Irl-1620","SPI-1620","Spi-1620"],"trade_names":[],"indications":[{"efo_id":"EFO_0000313","efo_label":"carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000313","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00613691"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00613691%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL38827","_score":1,"_source":{"id":"CHEMBL38827","internal_compound":false,"type":"Small molecule","pref_name":"LUMEFANTRINE","year_first_approved":2009,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["CPG-56695","GNF-PF-1971","Lumefantrine"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[156095]},{"source":"DailyMed","ids":["lumefantrine"]},{"source":"PubChem","ids":["124893326","144206044","170465388","50112743"]},{"source":"Wikipedia","ids":["Lumefantrine"]},{"source":"drugbank","ids":["DB06708"]}],"canonical_smiles":"CCCCN(CCCC)CC(O)c1cc(Cl)cc2c1-c1ccc(Cl)cc1/C2=C/c1ccc(Cl)cc1","indications":[{"efo_id":"EFO_0001068","efo_label":"malaria","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001068","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00118794","NCT00123552","NCT00297882","NCT00406146","NCT00422084","NCT00541385","NCT00694694","NCT01152931","NCT01374581","NCT01445938","NCT01449045","NCT01603251","NCT01614964","NCT01845701","NCT01899820","NCT01916954","NCT01939886","NCT02001012","NCT02174900","NCT02411994","NCT02974348"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00118794%22OR%22NCT00123552%22OR%22NCT00297882%22OR%22NCT00406146%22OR%22NCT00422084%22OR%22NCT00541385%22OR%22NCT00694694%22OR%22NCT01152931%22OR%22NCT01374581%22OR%22NCT01445938%22OR%22NCT01449045%22OR%22NCT01603251%22OR%22NCT01614964%22OR%22NCT01845701%22OR%22NCT01899820%22OR%22NCT01916954%22OR%22NCT01939886%22OR%22NCT02001012%22OR%22NCT02174900%22OR%22NCT02411994%22OR%22NCT02974348%22"]},{"source":"DailyMed","ids":["7866ec19-dfac-47d4-a53f-511a12643cbf"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7866ec19-dfac-47d4-a53f-511a12643cbf"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01876966"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01876966%22"]}]},{"efo_id":"EFO_0007444","efo_label":"Plasmodium falciparum malaria","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007444","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00344006","NCT00386763","NCT00677833","NCT00709969","NCT01082705","NCT01103830","NCT01619878","NCT01935882","NCT02020330","NCT03452475","NCT04009343"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00344006%22OR%22NCT00386763%22OR%22NCT00677833%22OR%22NCT00709969%22OR%22NCT01082705%22OR%22NCT01103830%22OR%22NCT01619878%22OR%22NCT01935882%22OR%22NCT02020330%22OR%22NCT03452475%22OR%22NCT04009343%22"]}]},{"efo_id":"EFO_0007445","efo_label":"Plasmodium vivax malaria","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007445","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01625871","NCT02184637","NCT02348788","NCT02696928"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01625871%22OR%22NCT02184637%22OR%22NCT02348788%22OR%22NCT02696928%22"]}]}],"mechanisms_of_action":[],"adverse_events":{"significant":[{"event":"pyrexia","count":87334,"llr":14.76038644},{"event":"plasmodium falciparum infection","count":35,"llr":13.78304921},{"event":"swelling face","count":15924,"llr":11.6868829},{"event":"malaria","count":242,"llr":9.920240518},{"event":"malaria antibody test positive","count":3,"llr":8.648710121},{"event":"skin swelling","count":660,"llr":7.922462751},{"event":"umbilical granuloma","count":9,"llr":7.550226077},{"event":"labia enlarged","count":18,"llr":6.857271264},{"event":"conjunctival hyperaemia","count":1201,"llr":6.736547913},{"event":"asthenia","count":74334,"llr":6.700637538}],"critval":6.481364022},"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":4},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":3},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":3},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":3},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201116","_score":1,"_source":{"id":"CHEMBL1201116","internal_compound":false,"type":"Small molecule","pref_name":"HETACILLIN","year_first_approved":1982,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["BL-P-804","BRL-804","Hetacillin","Hetacillin Potassium"],"trade_names":["Hetacin","Natacillin","Versapen","Versapen-K"],"cross_references":[{"source":"ChEBI","ids":[5683]},{"source":"Wikipedia","ids":["Hetacillin"]},{"source":"drugbank","ids":["DB00739"]},{"source":"ChEBI","ids":[34789]}],"canonical_smiles":"CC1(C)S[C@@H]2[C@H](N3C(=O)[C@@H](c4ccccc4)NC3(C)C)C(=O)N2[C@H]1C(=O)O","mechanisms_of_action":[{"target_type":"protein family","target_name":"Penicillin-binding protein","action_type":"inhibitor","description":"Penicillin-binding protein inhibitor","references":[{"source":"PubMed","ids":["1095502","7447421"],"urls":["https://europepmc.org/search?query=EXT_ID%3A1095502+OR+EXT_ID%3A7447421"]}]}],"child_chembl_ids":["CHEMBL1201121"],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL108545","_score":1,"_source":{"id":"CHEMBL108545","internal_compound":false,"type":"Small molecule","pref_name":"METHYL SALICYLATE","year_first_approved":2008,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Betula Oil","Birch Oil, Sweet","FEMA NO. 2745","Gaultheria Oil","Methyl Salicylate","NSC-8204","Sweet Birch Oil","Teaberry Oil","Wintergreen Oil"],"trade_names":["Aspellin","Balmosa","Bengue's Balsam","Deep Heat","Dubam","Gppe Lin","Gppe Rub","Luma","Methyl Salicylate","Nasciodine","P.R.","Radian-B","Rhodiaflor","Sloans","Thera-gesic"],"cross_references":[{"source":"ChEBI","ids":[31832]},{"source":"DailyMed","ids":["methyl%20salicylate"]},{"source":"PubChem","ids":["144204632","144208741","144210457","17388914","26752907"]},{"source":"Wikipedia","ids":["Methyl_salicylate"]},{"source":"drugbank","ids":["DB09543"]}],"canonical_smiles":"COC(=O)c1ccccc1O","indications":[{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["95910cee-0a43-4ac9-aeb9-6a659757b3ba","a1eced33-f9ee-4757-ab94-75f238f9b2a9","aed1e7c1-6197-4152-ae5e-06cf2ec3020f","ba11070e-1a36-4d5d-9e48-c37b4e90c037","d9475b6c-edd1-4ea7-a22c-243e63c4d0f7"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?95910cee-0a43-4ac9-aeb9-6a659757b3ba","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a1eced33-f9ee-4757-ab94-75f238f9b2a9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?aed1e7c1-6197-4152-ae5e-06cf2ec3020f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ba11070e-1a36-4d5d-9e48-c37b4e90c037","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d9475b6c-edd1-4ea7-a22c-243e63c4d0f7"]},{"source":"FDA","ids":["2db23534-31bb-4897-b105-95039166f5a7"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A2db23534-31bb-4897-b105-95039166f5a7"]}]},{"efo_id":"HP_0003326","efo_label":"Myalgia","efo_uri":"http://purl.obolibrary.org/obo/HP_0003326","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["95910cee-0a43-4ac9-aeb9-6a659757b3ba","a1eced33-f9ee-4757-ab94-75f238f9b2a9","aed1e7c1-6197-4152-ae5e-06cf2ec3020f","ba11070e-1a36-4d5d-9e48-c37b4e90c037"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?95910cee-0a43-4ac9-aeb9-6a659757b3ba","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a1eced33-f9ee-4757-ab94-75f238f9b2a9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?aed1e7c1-6197-4152-ae5e-06cf2ec3020f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ba11070e-1a36-4d5d-9e48-c37b4e90c037"]},{"source":"FDA","ids":["2db23534-31bb-4897-b105-95039166f5a7"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A2db23534-31bb-4897-b105-95039166f5a7"]}]},{"efo_id":"EFO_0005856","efo_label":"arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005856","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["95910cee-0a43-4ac9-aeb9-6a659757b3ba","a1eced33-f9ee-4757-ab94-75f238f9b2a9","aed1e7c1-6197-4152-ae5e-06cf2ec3020f","ba11070e-1a36-4d5d-9e48-c37b4e90c037","d9475b6c-edd1-4ea7-a22c-243e63c4d0f7"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?95910cee-0a43-4ac9-aeb9-6a659757b3ba","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a1eced33-f9ee-4757-ab94-75f238f9b2a9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?aed1e7c1-6197-4152-ae5e-06cf2ec3020f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ba11070e-1a36-4d5d-9e48-c37b4e90c037","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d9475b6c-edd1-4ea7-a22c-243e63c4d0f7"]},{"source":"FDA","ids":["2db23534-31bb-4897-b105-95039166f5a7"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A2db23534-31bb-4897-b105-95039166f5a7"]}]},{"efo_id":"EFO_1000941","efo_label":"frozen shoulder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000941","max_phase_for_indication":4,"references":[{"source":"FDA","ids":["2db23534-31bb-4897-b105-95039166f5a7"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A2db23534-31bb-4897-b105-95039166f5a7"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT02666846"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02666846%22"]},{"source":"DailyMed","ids":["0a452a0b-6dea-4a03-b7ea-fec440f83c29","95910cee-0a43-4ac9-aeb9-6a659757b3ba"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0a452a0b-6dea-4a03-b7ea-fec440f83c29","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?95910cee-0a43-4ac9-aeb9-6a659757b3ba"]}]},{"efo_id":"EFO_1001434","efo_label":"Tendinopathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001434","max_phase_for_indication":4,"references":[{"source":"FDA","ids":["2db23534-31bb-4897-b105-95039166f5a7"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A2db23534-31bb-4897-b105-95039166f5a7"]}]}],"mechanisms_of_action":[],"adverse_events":{"significant":[{"event":"burns second degree","count":330,"llr":30.3482855},{"event":"drug hypersensitivity","count":71246,"llr":26.22892563},{"event":"food intolerance","count":586,"llr":21.05240767},{"event":"dyspepsia","count":15285,"llr":14.73956548},{"event":"application site pain","count":3142,"llr":14.36722291},{"event":"loss of personal independence in daily activities","count":3385,"llr":14.07228836},{"event":"synovitis","count":3755,"llr":13.66198447},{"event":"accidental exposure to product by child","count":1142,"llr":12.90348847},{"event":"injection site inflammation","count":1309,"llr":12.49617501},{"event":"urosepsis","count":2704,"llr":10.3375957},{"event":"burns fourth degree","count":2,"llr":9.525363768},{"event":"application site burn","count":599,"llr":9.060156352},{"event":"application site vesicles","count":841,"llr":8.384650802},{"event":"hepatic enzyme increased","count":17239,"llr":7.73481087},{"event":"chemical burn of gastrointestinal tract","count":12,"llr":7.733737236},{"event":"peritoneal infection","count":28,"llr":6.886652075},{"event":"immobilisation prolonged","count":32,"llr":6.753173857},{"event":"hyperaesthesia","count":1976,"llr":6.690972231},{"event":"rheumatoid arthritis","count":23147,"llr":6.630357215},{"event":"leukaemic infiltration","count":37,"llr":6.608058316},{"event":"burn infection","count":39,"llr":6.55544117},{"event":"fontanelle bulging","count":42,"llr":6.481373079}],"critval":6.446196546},"number_of_indications":6,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":3},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":3}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4298004","_score":1,"_source":{"id":"CHEMBL4298004","internal_compound":false,"type":"Antibody","pref_name":"VOPRATELIMAB","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["JTX-2011","Jtx-2011","Vopratelimab"],"trade_names":[],"indications":[{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02904226"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02904226%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL926","_score":1,"_source":{"id":"CHEMBL926","internal_compound":false,"type":"Small molecule","pref_name":"DOBUTAMINE","year_first_approved":1978,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["46236","COMPOUND-81929","Compound 81929","Dobutamine","Dobutamine HCl","Dobutamine Lactobionate","Dobutrex","NSC-299583"],"trade_names":["Dobutamine HCl","Dobutrex","Posiject"],"cross_references":[{"source":"ChEBI","ids":[4670]},{"source":"DailyMed","ids":["dobutamine%20hydrochloride"]},{"source":"PubChem","ids":["104171143","144203677","170465050","26751752","50104446","90341592"]},{"source":"Wikipedia","ids":["Dobutamine"]},{"source":"drugbank","ids":["DB00841"]},{"source":"ChEBI","ids":[4671]},{"source":"PubChem","ids":["46500392","50106131","50106132","56320684"]}],"canonical_smiles":"CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1","indications":[{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["C01CA07"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C01CA07"]}]},{"efo_id":"EFO_0003144","efo_label":"heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003144","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00348504","NCT00953303"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00348504%22OR%22NCT00953303%22"]}]},{"efo_id":"EFO_0006834","efo_label":"septic shock","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006834","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00093301","NCT00800306"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00093301%22OR%22NCT00800306%22"]}]},{"efo_id":"EFO_0000546","efo_label":"injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000546","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02019810"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02019810%22"]}]},{"efo_id":"EFO_0004610","efo_label":"acute lung injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004610","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00624650"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00624650%22"]}]},{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03098680"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03098680%22"]}]}],"adverse_events":{"significant":[{"event":"stress cardiomyopathy","count":1774,"llr":222.465937},{"event":"ventricular tachycardia","count":5901,"llr":129.2259899},{"event":"cardiac procedure complication","count":125,"llr":123.0073117},{"event":"eosinophilic myocarditis","count":135,"llr":93.54195082},{"event":"atrial fibrillation","count":25339,"llr":78.35190922},{"event":"arrhythmia","count":9500,"llr":43.32313489},{"event":"ventricular fibrillation","count":2934,"llr":37.19790568},{"event":"cardiogenic shock","count":2837,"llr":26.97833157},{"event":"chest pain","count":46262,"llr":26.84859537},{"event":"arteriospasm coronary","count":1404,"llr":26.46505924},{"event":"mean arterial pressure decreased","count":80,"llr":25.98056351},{"event":"electrocardiogram st segment elevation","count":1338,"llr":22.97088293},{"event":"haemodynamic instability","count":1660,"llr":21.28638897},{"event":"product label confusion","count":510,"llr":21.2148693},{"event":"hypotension","count":55121,"llr":19.50839667},{"event":"metabolic acidosis","count":8683,"llr":17.76343704},{"event":"shock","count":5269,"llr":17.71037254},{"event":"ventricular arrhythmia","count":944,"llr":17.57556645},{"event":"dry gangrene","count":149,"llr":17.41093705},{"event":"supraventricular tachycardia","count":3329,"llr":15.93025091},{"event":"left ventricular dysfunction","count":2183,"llr":15.85927356},{"event":"apgar score low","count":615,"llr":15.85050506},{"event":"torsade de pointes","count":3618,"llr":15.30074855},{"event":"mitral valve incompetence","count":3884,"llr":14.76678644},{"event":"cardiac arrest","count":9359,"llr":14.66783996},{"event":"cerebral vasoconstriction","count":316,"llr":14.42499742},{"event":"exposure via breast milk","count":444,"llr":13.08095148},{"event":"mucormycosis","count":447,"llr":13.054397},{"event":"inhibitory drug interaction","count":481,"llr":12.76548769},{"event":"peripheral ischaemia","count":1380,"llr":11.9065578},{"event":"bezold-jarisch reflex","count":16,"llr":11.77037454},{"event":"heart sounds abnormal","count":222,"llr":11.00998244},{"event":"dysphemia","count":873,"llr":10.43108648},{"event":"ischaemic hepatitis","count":315,"llr":9.972151516},{"event":"procedural complication","count":2098,"llr":9.903237886},{"event":"low birth weight baby","count":2450,"llr":9.172430127},{"event":"ventricular extrasystoles","count":4152,"llr":9.094912275},{"event":"anuria","count":2677,"llr":8.758221354},{"event":"akinesia","count":510,"llr":8.551495125},{"event":"ischaemia","count":1460,"llr":8.448752068},{"event":"diarrhoea","count":126514,"llr":8.343074222},{"event":"cardiomyopathy","count":4877,"llr":8.221223108},{"event":"infusion site swelling","count":596,"llr":8.094968661},{"event":"echovirus serology test positive","count":1,"llr":7.962716675},{"event":"left ventricle outflow tract obstruction","count":118,"llr":7.787210727},{"event":"hyperlactacidaemia","count":751,"llr":7.421233871},{"event":"drug interaction","count":53526,"llr":7.361153643},{"event":"venous pressure jugular increased","count":153,"llr":7.272174603},{"event":"rash","count":97330,"llr":6.933493136},{"event":"chronic myeloid leukaemia (in remission)","count":3,"llr":6.864360355},{"event":"epidural catheter placement","count":3,"llr":6.864360355},{"event":"hypermagnesaemia","count":210,"llr":6.646115952},{"event":"transient global amnesia","count":223,"llr":6.527647966},{"event":"arthralgia","count":75397,"llr":6.477748161},{"event":"tachycardia","count":26994,"llr":6.454183857},{"event":"asthenia","count":74334,"llr":6.353192629}],"critval":6.277798131},"child_chembl_ids":["CHEMBL1200418","CHEMBL4297079"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000043591","approved_name":"adrenoceptor beta 1","approved_symbol":"ADRB1"}],"target_type":"single protein","target_name":"Beta-1 adrenergic receptor","action_type":"agonist","description":"Beta-1 adrenergic receptor agonist","references":[{"source":"FDA","ids":["label/2013/020255s016lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2013%2F020255s016lbl.pdf"]}]},{"target_components":[{"ensembl":"ENSG00000169252","approved_name":"adrenoceptor beta 2","approved_symbol":"ADRB2"}],"target_type":"single protein","target_name":"Beta-2 adrenergic receptor","action_type":"agonist","description":"Beta-2 adrenergic receptor agonist","references":[{"source":"FDA","ids":["label/2013/020255s016lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2013%2F020255s016lbl.pdf"]}]}],"number_of_indications":6,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":3},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":2},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3833371","_score":1,"_source":{"id":"CHEMBL3833371","internal_compound":false,"type":"Small molecule","pref_name":"UPRIFOSBUVIR","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["IDX-21437","IDX21437","MK-3682","Uprifosbuvir"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB15206"]}],"canonical_smiles":"CC(C)OC(=O)[C@@H](C)N[P@@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(Cl)[C@@H]1O)Oc1ccccc1","indications":[{"efo_id":"EFO_0003047","efo_label":"hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003047","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02332707","NCT02332720","NCT02956629"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02332707%22OR%22NCT02332720%22OR%22NCT02956629%22"]}]},{"efo_id":"EFO_0004220","efo_label":"chronic hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004220","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01974687","NCT02666352","NCT02759315"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01974687%22OR%22NCT02666352%22OR%22NCT02759315%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1887147","_score":1,"_source":{"id":"CHEMBL1887147","internal_compound":false,"type":"Small molecule","pref_name":"ISOXAFLUTOLE","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["264-EUP-99","Isoxaflutole","Merlin","RPA-201772"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["144211240","26757421"]},{"source":"drugbank","ids":["DB12938"]}],"canonical_smiles":"CS(=O)(=O)c1cc(C(F)(F)F)ccc1C(=O)c1cnoc1C1CC1","indications":[{"efo_id":"EFO_1001347","efo_label":"Herpes Labialis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001347","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03192306"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03192306%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL349803","_score":1,"_source":{"id":"CHEMBL349803","internal_compound":false,"type":"Small molecule","pref_name":"PIRETANIDE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["HOE-118","Piretanide","S-734118"],"trade_names":["Arelix","Arlix"],"cross_references":[{"source":"PubChem","ids":["11112792","144204212","170465869","56463166"]},{"source":"drugbank","ids":["DB02925"]}],"canonical_smiles":"NS(=O)(=O)c1cc(C(=O)O)cc(N2CCCC2)c1Oc1ccccc1","indications":[{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["C03CA03"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C03CA03"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201758","_score":1,"_source":{"id":"CHEMBL1201758","internal_compound":false,"type":"Small molecule","pref_name":"BEPOTASTINE","year_first_approved":2009,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["BB","Bepotastine","Bepotastine Besilate","Bepotastine Besylate","Bepotastine benzenesulfonate salt","TAU-284"],"trade_names":["Bepreve"],"cross_references":[{"source":"ChEBI","ids":[71204]},{"source":"DailyMed","ids":["bepotastine%20besilate"]},{"source":"Wikipedia","ids":["Bepotastine"]},{"source":"ChEBI","ids":[31281]}],"canonical_smiles":"O=C(O)CCCN1CCC(O[C@@H](c2ccc(Cl)cc2)c2ccccn2)CC1","indications":[{"efo_id":"EFO_0003956","efo_label":"seasonal allergic rhinitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003956","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01277341","NCT01578278","NCT01753739"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01277341%22OR%22NCT01578278%22OR%22NCT01753739%22"]}]},{"efo_id":"EFO_0007141","efo_label":"allergic conjunctivitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007141","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00424398","NCT00586664","NCT01174823"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00424398%22OR%22NCT00586664%22OR%22NCT01174823%22"]}]},{"efo_id":"HP_0000964","efo_label":"Eczema","efo_uri":"http://purl.obolibrary.org/obo/HP_0000964","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01840605"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01840605%22"]}]},{"efo_id":"EFO_0005854","efo_label":"allergic rhinitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005854","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01222299"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01222299%22"]}]},{"efo_id":"EFO_1001417","efo_label":"Rhinitis, Allergic, Perennial","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001417","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01861522","NCT01900054"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01861522%22OR%22NCT01900054%22"]}]},{"efo_id":"EFO_0007141","efo_label":"allergic conjunctivitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007141","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00424398","NCT00586625"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00424398%22OR%22NCT00586625%22"]},{"source":"DailyMed","ids":["68bbf6a0-c4b5-47c1-8a1c-08220fbdbce6"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?68bbf6a0-c4b5-47c1-8a1c-08220fbdbce6"]}]},{"efo_id":"EFO_1001417","efo_label":"Rhinitis, Allergic, Perennial","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001417","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01425632","NCT02682745","NCT02686294"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01425632%22OR%22NCT02682745%22OR%22NCT02686294%22"]}]},{"efo_id":"HP_0000989","efo_label":"Pruritus","efo_uri":"http://purl.obolibrary.org/obo/HP_0000989","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03317301"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03317301%22"]}]}],"child_chembl_ids":["CHEMBL1201759"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000196639","approved_name":"histamine receptor H1","approved_symbol":"HRH1"}],"target_type":"single protein","target_name":"Histamine H1 receptor","action_type":"antagonist","description":"Histamine H1 receptor antagonist","references":[{"source":"FDA","ids":["label/2012/022288s003lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2012%2F022288s003lbl.pdf"]}]}],"number_of_indications":8,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":6},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":4},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":2},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":2}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL511099","_score":1,"_source":{"id":"CHEMBL511099","internal_compound":false,"type":"Small molecule","pref_name":"BICIFADINE","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Bicifadine","Bicifadine HCl","CL-220075"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB04889"]}],"canonical_smiles":"Cc1ccc(C23CNCC2C3)cc1","indications":[{"efo_id":"EFO_1000783","efo_label":"diabetic neuropathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000783","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00553592","NCT00597649"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00553592%22OR%22NCT00597649%22"]}]}],"child_chembl_ids":["CHEMBL544862"],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201653","_score":1,"_source":{"id":"CHEMBL1201653","internal_compound":false,"type":"Protein","pref_name":"INSULIN ZINC SUSP PURIFIED PORK","year_first_approved":1979,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Insulin Zinc Susp Purified Pork","Insulin zinc susp purified pork"],"trade_names":["Lente","Lente Iletin Ii (Pork)"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000171105","approved_name":"insulin receptor","approved_symbol":"INSR"}],"target_type":"single protein","target_name":"Insulin receptor","action_type":"agonist","description":"Insulin receptor agonist","references":[{"source":"FDA","ids":["label/2015/022472s006s008lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F022472s006s008lbl.pdf"]}]}],"adverse_events":{"significant":[{"event":"posterior lens capsulotomy","count":4,"llr":11.52441865}],"critval":8.798920528},"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3301594","_score":1,"_source":{"id":"CHEMBL3301594","internal_compound":false,"type":"Small molecule","pref_name":"FOSTEMSAVIR","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["BMS-663068","BMS-663068-03","Fostemsavir","Fostemsavir tromethamine","GSK3684934A"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB11796"]}],"canonical_smiles":"COc1cnc(-n2cnc(C)n2)c2c1c(C(=O)C(=O)N1CCN(C(=O)c3ccccc3)CC1)cn2COP(=O)(O)O","indications":[{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01384734","NCT02063360","NCT02138084","NCT02164045","NCT02234882","NCT02277600","NCT02362503","NCT02467335","NCT02480881","NCT02480894","NCT02508064","NCT02666001","NCT02666053","NCT02674581","NCT02805556","NCT02859259"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01384734%22OR%22NCT02063360%22OR%22NCT02138084%22OR%22NCT02164045%22OR%22NCT02234882%22OR%22NCT02277600%22OR%22NCT02362503%22OR%22NCT02467335%22OR%22NCT02480881%22OR%22NCT02480894%22OR%22NCT02508064%22OR%22NCT02666001%22OR%22NCT02666053%22OR%22NCT02674581%22OR%22NCT02805556%22OR%22NCT02859259%22"]}]}],"child_chembl_ids":["CHEMBL3301598"],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297187","_score":1,"_source":{"id":"CHEMBL4297187","internal_compound":false,"type":"Small molecule","pref_name":"DERAZANTINIB","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AQ14741087","ARQ 087","ARQ 087.2HCl","ARQ-087","ARQ087","Derazantinib","Derazantinib hydrochloride"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB14889"]}],"canonical_smiles":"COCCNCCc1cccc(Nc2ncc3c(n2)-c2ccccc2[C@H](c2ccccc2F)C3)c1","indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01752920"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01752920%22"]}]},{"efo_id":"EFO_1001961","efo_label":"intrahepatic cholangiocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001961","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03230318"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03230318%22"]}]},{"efo_id":"EFO_0008528","efo_label":"urothelial carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008528","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT04045613"],"urls":["https://clinicaltrials.gov/search?id=%22NCT04045613%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000068078","approved_name":"fibroblast growth factor receptor 3","approved_symbol":"FGFR3"},{"ensembl":"ENSG00000077782","approved_name":"fibroblast growth factor receptor 1","approved_symbol":"FGFR1"},{"ensembl":"ENSG00000160867","approved_name":"fibroblast growth factor receptor 4","approved_symbol":"FGFR4"},{"ensembl":"ENSG00000066468","approved_name":"fibroblast growth factor receptor 2","approved_symbol":"FGFR2"}],"target_type":"protein family","target_name":"Fibroblast growth factor receptor","action_type":"inhibitor","description":"Fibroblast growth factor receptor inhibitor","references":[{"source":"Other","ids":["http://meetinglibrary.asco.org/content/149025-156","http://www.arqule.com/res/pip/"],"urls":["http://meetinglibrary.asco.org/content/149025-156","http://www.arqule.com/res/pip/"]}]}],"child_chembl_ids":["CHEMBL4298156"],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109559","_score":1,"_source":{"id":"CHEMBL2109559","internal_compound":false,"type":"Antibody","pref_name":"J591 177LU","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["177 Lu-J591","HUJ591-GS","J591 177Lu"],"trade_names":[],"indications":[{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00195039","NCT00538668"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00195039%22OR%22NCT00538668%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000086205","approved_name":"folate hydrolase 1","approved_symbol":"FOLH1"}],"target_type":"single protein","target_name":"Glutamate carboxypeptidase II","action_type":"binding agent","description":"Glutamate carboxypeptidase II binding agent","references":[{"source":"PubMed","ids":["21219396"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21219396"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297998","_score":1,"_source":{"id":"CHEMBL4297998","internal_compound":false,"type":"Antibody","pref_name":"LACUTAMAB","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["IPH-4102","IPH4102","Iph4102","Lacutamab"],"trade_names":[],"indications":[{"efo_id":"EFO_0002913","efo_label":"Cutaneous T-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002913","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02593045"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02593045%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297926","_score":1,"_source":{"id":"CHEMBL4297926","internal_compound":false,"type":"Unknown","pref_name":"CJM-112","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["CJM-112","CJM112","Cjm-112","Cjm112"],"trade_names":[],"indications":[{"efo_id":"EFO_0000270","efo_label":"asthma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000270","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03299686"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03299686%22"]}]},{"efo_id":"EFO_0000676","efo_label":"psoriasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000676","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01828086"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01828086%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03111992"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03111992%22"]}]},{"efo_id":"EFO_0003894","efo_label":"acne","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003894","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02998671"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02998671%22"]}]},{"efo_id":"EFO_1000710","efo_label":"hidradenitis suppurativa","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000710","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02421172"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02421172%22"]}]}],"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":3},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL871","_score":1,"_source":{"id":"CHEMBL871","internal_compound":false,"type":"Small molecule","pref_name":"ETIDRONIC ACID","year_first_approved":1977,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Didronel","Etidronate","Etidronate Disodium","Etidronic Acid","M05BA01","NSC-227995"],"trade_names":["Didronel","Didronel IV","Didronel PMO","Etidronate Disodium"],"cross_references":[{"source":"ChEBI","ids":[4907]},{"source":"DailyMed","ids":["etidronate%20disodium"]},{"source":"PubChem","ids":["144207615","29215269","93576729"]},{"source":"Wikipedia","ids":["Etidronic_acid"]},{"source":"drugbank","ids":["DB01077"]},{"source":"ChEBI","ids":[4906]},{"source":"PubChem","ids":["11112988","144205149","170464730"]},{"source":"PubChem","ids":["144211688","26754462"]}],"canonical_smiles":"CC(O)(P(=O)(O)O)P(=O)(O)O","indications":[{"efo_id":"EFO_0004260","efo_label":"bone disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004260","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["M05BA01"],"urls":["https://www.whocc.no/atc_ddd_index/?code=M05BA01"]}]}],"adverse_events":{"significant":[{"event":"atypical femur fracture","count":1191,"llr":66.59982657},{"event":"femur fracture","count":7800,"llr":65.32683673},{"event":"osteonecrosis","count":10916,"llr":54.75241529},{"event":"jaw disorder","count":1782,"llr":35.09141035},{"event":"primary sequestrum","count":561,"llr":33.54607835},{"event":"fracture delayed union","count":399,"llr":29.84988933},{"event":"osteomyelitis","count":5427,"llr":29.06776699},{"event":"osteonecrosis of jaw","count":11946,"llr":27.87775875},{"event":"extraskeletal ossification","count":56,"llr":26.09737634},{"event":"low turnover osteopathy","count":1335,"llr":22.63867909},{"event":"fracture displacement","count":175,"llr":21.54416804},{"event":"tooth extraction","count":3855,"llr":20.17709303},{"event":"purulent discharge","count":1171,"llr":18.59473903},{"event":"tooth abscess","count":3063,"llr":17.72079553},{"event":"tooth disorder","count":5727,"llr":17.47621203},{"event":"tooth discolouration","count":508,"llr":17.29406003},{"event":"stress fracture","count":1561,"llr":17.1721418},{"event":"toothache","count":4205,"llr":15.86242433},{"event":"impaired healing","count":7834,"llr":15.36191827},{"event":"loose tooth","count":902,"llr":15.01252468},{"event":"fall","count":67604,"llr":14.21710451},{"event":"resorption bone increased","count":293,"llr":13.74499386},{"event":"oesophagitis","count":3670,"llr":12.97758209},{"event":"non-hodgkin's lymphoma stage iii","count":29,"llr":12.96504478},{"event":"necrotising ulcerative gingivostomatitis","count":31,"llr":12.83173918},{"event":"hypophosphataemic rickets","count":34,"llr":12.64710828},{"event":"reflux oesophagitis","count":426,"llr":12.62729028},{"event":"pathological fracture","count":1695,"llr":12.51941954},{"event":"rickets","count":64,"llr":11.3832205},{"event":"deafness","count":5329,"llr":11.17549898},{"event":"oesophageal carcinoma","count":710,"llr":11.10569704},{"event":"gastroenteritis escherichia coli","count":83,"llr":10.86403844},{"event":"bone development abnormal","count":93,"llr":10.63690646},{"event":"leukoplakia oral","count":99,"llr":10.51209721},{"event":"cytomegalovirus oesophagitis","count":110,"llr":10.30180055},{"event":"comminuted fracture","count":113,"llr":10.24810138},{"event":"portal hypertensive gastropathy","count":141,"llr":9.806437445},{"event":"hiatus hernia","count":3438,"llr":9.75696742},{"event":"oesophageal ulcer","count":1380,"llr":9.137654971},{"event":"oral cavity fistula","count":270,"llr":8.512090088},{"event":"gastrointestinal ulcer haemorrhage","count":272,"llr":8.497407034},{"event":"fistula discharge","count":341,"llr":8.04790828},{"event":"blood carbon monoxide decreased","count":4,"llr":7.766616922},{"event":"gingival hypertrophy","count":416,"llr":7.653196322},{"event":"actinomycosis","count":421,"llr":7.629494084},{"event":"osteosclerosis","count":444,"llr":7.523998012},{"event":"calcinosis","count":497,"llr":7.300511949},{"event":"haematemesis","count":6588,"llr":7.275562007},{"event":"scar","count":2653,"llr":7.225635388},{"event":"cytomegalovirus chorioretinitis","count":535,"llr":7.154624654},{"event":"gastric infection","count":535,"llr":7.154624654},{"event":"fistula","count":2732,"llr":7.140635955},{"event":"lip blister","count":547,"llr":7.11072354},{"event":"fracture nonunion","count":612,"llr":6.888664504},{"event":"bone pain","count":13854,"llr":6.721462569},{"event":"postoperative heterotopic calcification","count":12,"llr":6.66831534},{"event":"retinal disorder","count":714,"llr":6.584298742},{"event":"haematoma","count":8376,"llr":6.383256997},{"event":"dental examination abnormal","count":17,"llr":6.320202838},{"event":"vestibulitis","count":17,"llr":6.320202838},{"event":"lymphoproliferative disorder","count":868,"llr":6.199623417},{"event":"hepatic cirrhosis","count":3807,"llr":6.186439217},{"event":"hypophosphatasia","count":20,"llr":6.157800424},{"event":"inflammation","count":8958,"llr":6.136749859},{"event":"rib fracture","count":4118,"llr":5.962789719},{"event":"gingival disorder","count":997,"llr":5.927483029},{"event":"bone lesion","count":1012,"llr":5.898195685},{"event":"venous angioma of brain","count":26,"llr":5.895669191},{"event":"osteitis","count":1026,"llr":5.871257564},{"event":"fracture","count":4291,"llr":5.845969234},{"event":"idiopathic thrombocytopenic purpura","count":1041,"llr":5.842808298},{"event":"dental pulp disorder","count":29,"llr":5.786586415},{"event":"hand fracture","count":1098,"llr":5.738390729},{"event":"maxillofacial operation","count":32,"llr":5.688262858},{"event":"epstein-barr virus antigen positive","count":35,"llr":5.598767215}],"critval":5.594590432},"child_chembl_ids":["CHEMBL1201042","CHEMBL1874205"],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545365","_score":1,"_source":{"id":"CHEMBL3545365","internal_compound":false,"type":"Small molecule","pref_name":"ALTIRATINIB","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Altiratinib","DCC-2701","DP-5164"],"trade_names":[],"canonical_smiles":"O=C(Nc1cc(Oc2cc(F)c(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)ccn1)C1CC1","indications":[{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02228811"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02228811%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000105976","approved_name":"MET proto-oncogene, receptor tyrosine kinase","approved_symbol":"MET"}],"target_type":"single protein","target_name":"Hepatocyte growth factor receptor","action_type":"inhibitor","description":"Hepatocyte growth factor receptor inhibitor","references":[{"source":"Other","ids":["http://www.deciphera.com/pipeline"],"urls":["http://www.deciphera.com/pipeline"]},{"source":"PubMed","ids":["26285778"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26285778"]}]},{"target_components":[{"ensembl":"ENSG00000120156","approved_name":"TEK receptor tyrosine kinase","approved_symbol":"TEK"}],"target_type":"single protein","target_name":"Tyrosine-protein kinase TIE-2","action_type":"inhibitor","description":"Tyrosine-protein kinase TIE-2 inhibitor","references":[{"source":"Other","ids":["http://www.deciphera.com/pipeline"],"urls":["http://www.deciphera.com/pipeline"]},{"source":"PubMed","ids":["26285778"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26285778"]}]},{"target_components":[{"ensembl":"ENSG00000128052","approved_name":"kinase insert domain receptor","approved_symbol":"KDR"}],"target_type":"single protein","target_name":"Vascular endothelial growth factor receptor 2","action_type":"inhibitor","description":"Vascular endothelial growth factor receptor 2 inhibitor","references":[{"source":"Other","ids":["http://www.deciphera.com/pipeline"],"urls":["http://www.deciphera.com/pipeline"]},{"source":"PubMed","ids":["26285778"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26285778"]}]},{"target_components":[{"ensembl":"ENSG00000198400","approved_name":"neurotrophic receptor tyrosine kinase 1","approved_symbol":"NTRK1"},{"ensembl":"ENSG00000148053","approved_name":"neurotrophic receptor tyrosine kinase 2","approved_symbol":"NTRK2"},{"ensembl":"ENSG00000140538","approved_name":"neurotrophic receptor tyrosine kinase 3","approved_symbol":"NTRK3"}],"target_type":"protein family","target_name":"Neurotrophic tyrosine kinase receptor","action_type":"inhibitor","description":"Neurotrophic tyrosine kinase receptor inhibitor","references":[{"source":"Other","ids":["http://www.deciphera.com/pipeline"],"urls":["http://www.deciphera.com/pipeline"]},{"source":"PubMed","ids":["26285778"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26285778"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":4}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL41286","_score":1,"_source":{"id":"CHEMBL41286","internal_compound":false,"type":"Small molecule","pref_name":"DIACEREIN","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AC-201","Diacerein","M-01AX21","M01AX21","Rhein diacetate","SF-277"],"trade_names":["Fisiodar"],"cross_references":[{"source":"PubChem","ids":["104171387","144204407","170466475","26746957","855680"]},{"source":"Wikipedia","ids":["Diacerein"]},{"source":"drugbank","ids":["DB11994"]}],"canonical_smiles":"CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O","indications":[{"efo_id":"EFO_0005755","efo_label":"rheumatic disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005755","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["M01AX21"],"urls":["https://www.whocc.no/atc_ddd_index/?code=M01AX21"]}]},{"efo_id":"EFO_0002506","efo_label":"osteoarthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002506","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02688400"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02688400%22"]}]},{"efo_id":"EFO_0000685","efo_label":"rheumatoid arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000685","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01264211"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01264211%22"]}]},{"efo_id":"EFO_0001360","efo_label":"type II diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001360","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01276106","NCT03208309"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01276106%22OR%22NCT03208309%22"]}]},{"efo_id":"EFO_1000786","efo_label":"osteoarthritis, hip","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000786","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00451360"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00451360%22"]}]},{"efo_id":"Orphanet_304","efo_label":"Epidermolysis bullosa simplex","efo_uri":"http://www.orpha.net/ORDO/Orphanet_304","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03154333","NCT03389308"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03154333%22OR%22NCT03389308%22"]}]},{"efo_id":"EFO_0004274","efo_label":"gout","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004274","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01712204","NCT02287818"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01712204%22OR%22NCT02287818%22"]}]},{"efo_id":"EFO_1000690","efo_label":"epidermolysis bullosa","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000690","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03472287"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03472287%22"]}]},{"efo_id":"HP_0001873","efo_label":"Thrombocytopenia","efo_uri":"http://purl.obolibrary.org/obo/HP_0001873","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03754634"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03754634%22"]}]}],"mechanisms_of_action":[],"number_of_indications":9,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":5},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":2},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":2},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201508","_score":1,"_source":{"id":"CHEMBL1201508","internal_compound":false,"type":"Protein","pref_name":"GLUCAGON HYDROCHLORIDE RECOMBINANT","year_first_approved":1998,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Glucagon Hydrochloride Recombinant"],"trade_names":["Glucagen"],"indications":[{"efo_id":"HP_0001943","efo_label":"Hypoglycemia","efo_uri":"http://purl.obolibrary.org/obo/HP_0001943","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00745186","NCT02081001","NCT02459938","NCT02660008"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00745186%22OR%22NCT02081001%22OR%22NCT02459938%22OR%22NCT02660008%22"]}]},{"efo_id":"EFO_0001359","efo_label":"type I diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001359","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03176524"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03176524%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000215644","approved_name":"glucagon receptor","approved_symbol":"GCGR"}],"target_type":"single protein","target_name":"Glucagon receptor","action_type":"agonist","description":"Glucagon receptor agonist","references":[{"source":"PubMed","ids":["12529935"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12529935"]}]}],"adverse_events":{"significant":[{"event":"hypoglycaemic unconsciousness","count":382,"llr":10.95091393}],"critval":9.128925412},"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1236962","_score":1,"_source":{"id":"CHEMBL1236962","internal_compound":false,"type":"Small molecule","pref_name":"OMIPALISIB","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["GSK2126458","Omipalisib"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12703"]}],"canonical_smiles":"COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F","indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00972686"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00972686%22"]}]},{"efo_id":"EFO_0000768","efo_label":"idiopathic pulmonary fibrosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000768","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01725139"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01725139%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01248858"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01248858%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000145675","approved_name":"phosphoinositide-3-kinase regulatory subunit 1","approved_symbol":"PIK3R1"},{"ensembl":"ENSG00000051382","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta","approved_symbol":"PIK3CB"},{"ensembl":"ENSG00000105851","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma","approved_symbol":"PIK3CG"},{"ensembl":"ENSG00000121879","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha","approved_symbol":"PIK3CA"},{"ensembl":"ENSG00000105647","approved_name":"phosphoinositide-3-kinase regulatory subunit 2","approved_symbol":"PIK3R2"},{"ensembl":"ENSG00000171608","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta","approved_symbol":"PIK3CD"},{"ensembl":"ENSG00000141506","approved_name":"phosphoinositide-3-kinase regulatory subunit 5","approved_symbol":"PIK3R5"},{"ensembl":"ENSG00000117461","approved_name":"phosphoinositide-3-kinase regulatory subunit 3","approved_symbol":"PIK3R3"}],"target_type":"protein complex group","target_name":"PI3-kinase class I","action_type":"inhibitor","description":"PI3-kinase class I inhibitor","references":[{"source":"PubMed","ids":["15705718","24900173"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15705718+OR+EXT_ID%3A24900173"]}]},{"target_components":[{"ensembl":"ENSG00000198793","approved_name":"mechanistic target of rapamycin kinase","approved_symbol":"MTOR"}],"target_type":"single protein","target_name":"Serine/threonine-protein kinase mTOR","action_type":"inhibitor","description":"Serine/threonine-protein kinase mTOR inhibitor","references":[{"source":"PubMed","ids":["15705718","24900173"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15705718+OR+EXT_ID%3A24900173"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108734","_score":1,"_source":{"id":"CHEMBL2108734","internal_compound":false,"type":"Antibody","pref_name":"FLANVOTUMAB","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["20-D-7S","20D7S","Flanvotumab","IMC-20D7S"],"trade_names":[],"indications":[{"efo_id":"EFO_0000756","efo_label":"melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000756","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01137006"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01137006%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000107165","approved_name":"tyrosinase related protein 1","approved_symbol":"TYRP1"}],"target_type":"single protein","target_name":"5,6-dihydroxyindole-2-carboxylic acid oxidase","action_type":"other","description":"5,6-dihydroxyindole-2-carboxylic acid oxidase other","references":[{"source":"PubMed","ids":["27797971"],"urls":["https://europepmc.org/search?query=EXT_ID%3A27797971"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1213420","_score":1,"_source":{"id":"CHEMBL1213420","internal_compound":false,"type":"Small molecule","pref_name":"DROXICAM","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Droxicam"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[76133]},{"source":"drugbank","ids":["DB09215"]}],"canonical_smiles":"CN1c2c(oc(=O)n(-c3ccccn3)c2=O)-c2ccccc2S1(=O)=O","indications":[{"efo_id":"EFO_0005755","efo_label":"rheumatic disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005755","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["M01AC04"],"urls":["https://www.whocc.no/atc_ddd_index/?code=M01AC04"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL116943","_score":1,"_source":{"id":"CHEMBL116943","internal_compound":false,"type":"Small molecule","pref_name":"PENTYLENETETRAZOL","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["NSC-5729","NSC-66489","Pentamethylenetetrazol","Pentetrazol","Pentylenetetrazol","Pentylenetetrazole"],"trade_names":["Cardiazol"],"cross_references":[{"source":"ChEBI","ids":[34910]},{"source":"PubChem","ids":["11111647","11111648","124881152","26747621","50106807","90341004"]},{"source":"Wikipedia","ids":["Pentylenetetrazol"]},{"source":"drugbank","ids":["DB13415"]}],"canonical_smiles":"C1CCc2nnnn2CC1","indications":[{"efo_id":"EFO_0005246","efo_label":"hypersomnia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005246","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03542851"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03542851%22"]}]}],"child_chembl_ids":["CHEMBL350551"],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297507","_score":1,"_source":{"id":"CHEMBL4297507","internal_compound":false,"type":"Small molecule","pref_name":"DELGOCITINIB","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Delgocitinib","JTE-052","JTE-052A","LEO 124249","LEO 124249A","LEO-124249","LEO-124249A"],"trade_names":[],"canonical_smiles":"C[C@H]1CN(C(=O)CC#N)[C@]12CCN(c1ncnc3[nH]ccc13)C2","indications":[{"efo_id":"EFO_0000274","efo_label":"atopic eczema","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000274","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03826901"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03826901%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL588","_score":1,"_source":{"id":"CHEMBL588","internal_compound":false,"type":"Small molecule","pref_name":"FENOLDOPAM","year_first_approved":1997,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Fenoldopam","Fenoldopam Bromide","Fenoldopam mesilate","Fenoldopam mesylate","Fenoldopam methanesulfonate","SK&F-82526","SK&F-82526J","SK-82526","SK-82526-J"],"trade_names":["Corlopam","Fenoldopam Mesylate"],"cross_references":[{"source":"ChEBI","ids":[5002]},{"source":"DailyMed","ids":["fenoldopam%20mesylate"]},{"source":"PubChem","ids":["104171160","144203703","170465321","26752227","50104923","90340762"]},{"source":"Wikipedia","ids":["Fenoldopam"]},{"source":"drugbank","ids":["DB00800"]},{"source":"PubChem","ids":["49681595"]},{"source":"PubChem","ids":["50106351","57264385"]}],"canonical_smiles":"Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1","indications":[{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["C01CA19"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C01CA19"]}]},{"efo_id":"EFO_0000537","efo_label":"hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000537","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00592150"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00592150%22"]}]},{"efo_id":"HP_0001919","efo_label":"Acute kidney injury","efo_uri":"http://purl.obolibrary.org/obo/HP_0001919","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00557219","NCT00621790"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00557219%22OR%22NCT00621790%22"]}]},{"efo_id":"EFO_1002048","efo_label":"kidney failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1002048","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00982527"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00982527%22"]}]},{"efo_id":"HP_0001919","efo_label":"Acute kidney injury","efo_uri":"http://purl.obolibrary.org/obo/HP_0001919","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00286403"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00286403%22"]}]}],"child_chembl_ids":["CHEMBL1026","CHEMBL1256646"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000184845","approved_name":"dopamine receptor D1","approved_symbol":"DRD1"}],"target_type":"single protein","target_name":"Dopamine D1 receptor","action_type":"agonist","description":"Dopamine D1 receptor agonist","references":[{"source":"DailyMed","ids":["setid=df4cd207-c3b8-4008-5290-02f296c2b4a6"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=df4cd207-c3b8-4008-5290-02f296c2b4a6"]}]}],"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":2},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":2},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL231884","_score":1,"_source":{"id":"CHEMBL231884","internal_compound":false,"type":"Small molecule","pref_name":"DIOSMIN","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Diosmin"],"trade_names":["Diovenor"],"cross_references":[{"source":"ChEBI","ids":[4631]},{"source":"PubChem","ids":["144204945","170466258","50085952"]},{"source":"Wikipedia","ids":["Diosmin"]},{"source":"drugbank","ids":["DB08995"]}],"canonical_smiles":"COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O","indications":[{"efo_id":"EFO_0000545","efo_label":"infertility","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000545","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02134249"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02134249%22"]}]},{"efo_id":"HP_0000132","efo_label":"Menorrhagia","efo_uri":"http://purl.obolibrary.org/obo/HP_0000132","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02616731"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02616731%22"]}]},{"efo_id":"EFO_0004264","efo_label":"vascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004264","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01110512"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01110512%22"]}]}],"mechanisms_of_action":[],"adverse_events":{"significant":[{"event":"blood lactic acid","count":37,"llr":24.50087898},{"event":"myoglobin blood increased","count":675,"llr":22.27147095},{"event":"pulmonary fibrosis","count":3809,"llr":15.3743554},{"event":"cardiac arrest","count":9359,"llr":11.8219428},{"event":"lower respiratory tract congestion","count":255,"llr":11.63328629},{"event":"blood creatine phosphokinase increased","count":14851,"llr":10.01811},{"event":"intraventricular haemorrhage","count":583,"llr":9.982175194},{"event":"ventricular tachycardia","count":5901,"llr":9.332421855},{"event":"skin abrasion","count":831,"llr":9.275358953},{"event":"non-cardiac chest pain","count":1314,"llr":8.362986026},{"event":"scratch","count":1371,"llr":8.278532674},{"event":"bundle branch block left","count":1550,"llr":8.03459724},{"event":"ankylosing spondylitis","count":1567,"llr":8.012923032},{"event":"aortic injury","count":18,"llr":7.758325224},{"event":"scab","count":1897,"llr":7.633455386},{"event":"body temperature decreased","count":2359,"llr":7.201382897},{"event":"hyperkalaemia","count":12419,"llr":7.152899092},{"event":"increased appetite","count":2669,"llr":6.957038196}],"critval":6.742636492},"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1222251","_score":1,"_source":{"id":"CHEMBL1222251","internal_compound":false,"type":"Small molecule","pref_name":"INOSITOL","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Cyclohexanehexol","Inositol","Meso-Inositol","NSC-25142","NSC-404118","NSC-55551","NSC-8101"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[17268]},{"source":"PubChem","ids":["144205195","144212352","170465541","29215342","56324719","73813"]},{"source":"Wikipedia","ids":["Inositol"]},{"source":"drugbank","ids":["DB13178"]}],"canonical_smiles":"O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O","indications":[{"efo_id":"EFO_0000249","efo_label":"Alzheimer's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000249","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00934050"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00934050%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00783705"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00783705%22"]}]},{"efo_id":"EFO_0000660","efo_label":"polycystic ovary syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000660","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT01574261"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01574261%22"]}]},{"efo_id":"MP_0001914","efo_label":"hemorrhage","efo_uri":"http://purl.obolibrary.org/obo/MP_0001914","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01115127"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01115127%22"]}]},{"efo_id":"EFO_0000195","efo_label":"metabolic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000195","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01046500"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01046500%22"]}]},{"efo_id":"EFO_1001158","efo_label":"retinopathy of prematurity","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001158","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01954082"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01954082%22"]}]},{"efo_id":"EFO_0001071","efo_label":"lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001071","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00061997"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00061997%22"]}]},{"efo_id":"EFO_0001359","efo_label":"type I diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001359","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02730949"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02730949%22"]}]},{"efo_id":"Orphanet_3388","efo_label":"Neural tube defect","efo_uri":"http://www.orpha.net/ORDO/Orphanet_3388","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00452829"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00452829%22"]}]}],"number_of_indications":9,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":3},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":2},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108725","_score":1,"_source":{"id":"CHEMBL2108725","internal_compound":false,"type":"Oligonucleotide","pref_name":"ANIVAMERSEN","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Anivamersen","RB-007","RB007"],"trade_names":[],"indications":[{"efo_id":"EFO_0000378","efo_label":"coronary artery disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000378","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01848106"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01848106%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL51149","_score":1,"_source":{"id":"CHEMBL51149","internal_compound":false,"type":"Small molecule","pref_name":"GALLOPAMIL","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["(+/-)-Methoxyverapamil HCl","Gallopamil"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[34772]},{"source":"PubChem","ids":["104171189","124880748","26752312","26752313","50105237","50105238","90341545"]},{"source":"Wikipedia","ids":["Gallopamil"]},{"source":"drugbank","ids":["DB12923"]},{"source":"PubChem","ids":["144203747","170465991","50106604","855637"]}],"canonical_smiles":"COc1ccc(CCN(C)CCCC(C#N)(c2cc(OC)c(OC)c(OC)c2)C(C)C)cc1OC","indications":[{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":2,"references":[{"source":"ATC","ids":["C08DA02"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C08DA02"]}]},{"efo_id":"EFO_0000270","efo_label":"asthma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000270","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00896428"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00896428%22"]}]}],"child_chembl_ids":["CHEMBL1256940"],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3353541","_score":1,"_source":{"id":"CHEMBL3353541","internal_compound":false,"type":"Small molecule","pref_name":"GLPG-0974","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["GLPG-0974","GLPG0974","Glpg-0974","Glpg0974"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB15406"]}],"canonical_smiles":"C[C@]1(C(=O)N(CCCC(=O)O)Cc2cccc(Cl)c2)CCN1C(=O)c1csc2ccccc12","indications":[{"efo_id":"EFO_0000729","efo_label":"ulcerative colitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000729","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01829321"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01829321%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109572","_score":1,"_source":{"id":"CHEMBL2109572","internal_compound":false,"type":"Antibody","pref_name":"ANTI-SCLEROSTIN","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["ANTI-Sclerostin"],"trade_names":[],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000167941","approved_name":"sclerostin","approved_symbol":"SOST"}],"target_type":"single protein","target_name":"Sclerostin","action_type":"inhibitor","description":"Sclerostin inhibitor","references":[{"source":"PubMed","ids":["26768288"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26768288"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL599","_score":1,"_source":{"id":"CHEMBL599","internal_compound":false,"type":"Small molecule","pref_name":"MELOXICAM","year_first_approved":2000,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["Meloxicam","Meloxicam Sodium","N-1539","N1539","UH-AC 62XX","UH-AC-62 XX","UHAC-62XX"],"trade_names":["Meloxicam","Mobic","Qmiiz odt","Vivlodex"],"cross_references":[{"source":"ChEBI","ids":[6741]},{"source":"DailyMed","ids":["meloxicam"]},{"source":"PubChem","ids":["144205287","144206743","144208887","144213073","170464857","26747003","50085983","855815"]},{"source":"TG-GATEs","ids":["124"]},{"source":"Wikipedia","ids":["Meloxicam"]},{"source":"drugbank","ids":["DB00814"]},{"source":"PubChem","ids":["11111455","50106590","56463508","85231132"]},{"source":"PubChem","ids":["46500410"]}],"canonical_smiles":"Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1","indications":[{"efo_id":"EFO_0002506","efo_label":"osteoarthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002506","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00239395","NCT01787188","NCT01799213","NCT01801735","NCT02183064","NCT02405793","NCT02448199"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00239395%22OR%22NCT01787188%22OR%22NCT01799213%22OR%22NCT01801735%22OR%22NCT02183064%22OR%22NCT02405793%22OR%22NCT02448199%22"]},{"source":"DailyMed","ids":["0060d1b1-4cfc-4b69-86a8-9bd44a071e94","02f9696c-87d0-4f2b-a90f-d04b3ba767b1","0377e242-ce71-4570-afb9-ff881a575a13","03c871ed-6686-4bfe-9b15-6ca50b91af47","040fecdb-68cf-4967-90ce-c2130b520615","06623222-188c-4ab1-976a-4cdb2037a709","06a401f0-4380-4081-86ed-a309a25abf6b","0a5ccef7-edba-4498-bec2-6b25d551e04b","0edec862-f3e8-46f6-b6d0-de0bc21dd3fb","0fb333e0-5123-5f7a-e054-00144ff88e88","1ab45be4-b2b9-4374-95ab-620e0f90fb70","1d8b617a-b9b3-473c-be9b-f34a585a1b3b","20871c7f-1e36-49ef-8e2b-70112430ca1e","2adb9f9b-c49c-4137-9e2e-8be9065639e6","3ba4c6e0-cb83-43b5-a623-1f2af9c2b07c","3ce43f4a-c525-4ce1-b328-514b3912e305","3d3b548c-005e-40b0-98d0-443cf08fdcde","3fcb59d1-d547-415f-be6c-d88558fdda03","459bd9c0-1102-46d3-8020-5fec80d1ec36","4acea0aa-973f-40e5-88b4-0e2d85ea624c","4f7f4c26-d85d-4721-8371-49c52461a3f0","598c8808-e306-401a-9a16-e197cbfa0a0d","5afa7fd7-3362-4cab-9630-2d9db708165c","5eb2e439-2ef2-496c-9aec-042029ae1305","5fe76337-eae5-4e5c-96ef-6cfa97983c6e","64217ed0-7b53-4b8b-8e53-2b645640ab22","6513e46b-3229-685b-c83b-2209454fae71","676e73fb-51d2-449a-8749-1a7bcc257b11","6c015f72-5ce3-4f56-8237-776fc2165b0c","6ed06682-7507-4c11-a782-42e694c21b53","72d1ad20-a10d-4c1e-8a4a-a125426d400f","820f143f-4b0c-4466-be9a-212dab9d984b","8685a269-d533-4970-889e-d70e8b958ccd","87c6d3e2-7c66-479b-abe8-551cb8913921","8b2aa351-4ac3-4b5f-a20c-060805812cd0","9d648594-d657-4d9a-855e-0ea91eb49c98","a381942f-0cba-4e97-4741-ad04a6af2164","a3ec45d2-bd66-48d4-8ac8-0292f1e2385a","a9da4978-be10-4601-a693-7d436c8613b4","aa28251e-cab0-49a2-bf3f-ad820b1432cf","aafd2b0f-435a-4805-9b17-c02f99df59d5","ad18a9e9-2fa0-40b0-a438-9146a150ab39","bb83cd61-0a82-4fe0-b72e-5b715cbd656d","c172a767-eb26-4995-b2a2-f3c5e87b4943","c51f3abe-02bc-4544-a22f-0f2035fb2271","c5e48b73-e428-41bc-973c-72003811e653","c8683c04-0e54-4e97-992b-55c2d605793c","cb44be1a-a5c4-406f-9a2c-1835a2c3f0e0","d224143d-2199-4969-a64f-dc2e6b865ec4","d5e12448-1ca1-46a4-8de4-e8b94567e5a8","dbbc6373-e9ae-4215-8d08-5f6667a936d1","e65e3c28-a40b-4daa-8fd5-29f112575b68","eae60d2c-411c-460a-b673-05b5784ed943","ee8df8fa-d08a-8c8b-f048-813e5022a101","f2197492-9932-45c7-8fe0-5284ccfb8458","f6bf82d1-b768-49de-bc6c-1078dfc3c359","f8035130-1a60-4ba3-a9be-b1a739c946db","fe8480c4-b176-45ae-b4d6-fa59912fe286","fefb555f-ef66-4020-826d-002c76df0225"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0060d1b1-4cfc-4b69-86a8-9bd44a071e94","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?02f9696c-87d0-4f2b-a90f-d04b3ba767b1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0377e242-ce71-4570-afb9-ff881a575a13","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?03c871ed-6686-4bfe-9b15-6ca50b91af47","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?040fecdb-68cf-4967-90ce-c2130b520615","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?06623222-188c-4ab1-976a-4cdb2037a709","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?06a401f0-4380-4081-86ed-a309a25abf6b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0a5ccef7-edba-4498-bec2-6b25d551e04b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0edec862-f3e8-46f6-b6d0-de0bc21dd3fb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0fb333e0-5123-5f7a-e054-00144ff88e88","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1ab45be4-b2b9-4374-95ab-620e0f90fb70","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1d8b617a-b9b3-473c-be9b-f34a585a1b3b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?20871c7f-1e36-49ef-8e2b-70112430ca1e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2adb9f9b-c49c-4137-9e2e-8be9065639e6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3ba4c6e0-cb83-43b5-a623-1f2af9c2b07c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3ce43f4a-c525-4ce1-b328-514b3912e305","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3d3b548c-005e-40b0-98d0-443cf08fdcde","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3fcb59d1-d547-415f-be6c-d88558fdda03","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?459bd9c0-1102-46d3-8020-5fec80d1ec36","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4acea0aa-973f-40e5-88b4-0e2d85ea624c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4f7f4c26-d85d-4721-8371-49c52461a3f0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?598c8808-e306-401a-9a16-e197cbfa0a0d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5afa7fd7-3362-4cab-9630-2d9db708165c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5eb2e439-2ef2-496c-9aec-042029ae1305","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5fe76337-eae5-4e5c-96ef-6cfa97983c6e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?64217ed0-7b53-4b8b-8e53-2b645640ab22","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6513e46b-3229-685b-c83b-2209454fae71","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?676e73fb-51d2-449a-8749-1a7bcc257b11","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6c015f72-5ce3-4f56-8237-776fc2165b0c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6ed06682-7507-4c11-a782-42e694c21b53","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?72d1ad20-a10d-4c1e-8a4a-a125426d400f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?820f143f-4b0c-4466-be9a-212dab9d984b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8685a269-d533-4970-889e-d70e8b958ccd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?87c6d3e2-7c66-479b-abe8-551cb8913921","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8b2aa351-4ac3-4b5f-a20c-060805812cd0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9d648594-d657-4d9a-855e-0ea91eb49c98","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a381942f-0cba-4e97-4741-ad04a6af2164","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a3ec45d2-bd66-48d4-8ac8-0292f1e2385a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a9da4978-be10-4601-a693-7d436c8613b4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?aa28251e-cab0-49a2-bf3f-ad820b1432cf","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?aafd2b0f-435a-4805-9b17-c02f99df59d5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ad18a9e9-2fa0-40b0-a438-9146a150ab39","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bb83cd61-0a82-4fe0-b72e-5b715cbd656d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c172a767-eb26-4995-b2a2-f3c5e87b4943","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c51f3abe-02bc-4544-a22f-0f2035fb2271","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c5e48b73-e428-41bc-973c-72003811e653","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c8683c04-0e54-4e97-992b-55c2d605793c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cb44be1a-a5c4-406f-9a2c-1835a2c3f0e0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d224143d-2199-4969-a64f-dc2e6b865ec4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d5e12448-1ca1-46a4-8de4-e8b94567e5a8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dbbc6373-e9ae-4215-8d08-5f6667a936d1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e65e3c28-a40b-4daa-8fd5-29f112575b68","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?eae60d2c-411c-460a-b673-05b5784ed943","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ee8df8fa-d08a-8c8b-f048-813e5022a101","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f2197492-9932-45c7-8fe0-5284ccfb8458","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f6bf82d1-b768-49de-bc6c-1078dfc3c359","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f8035130-1a60-4ba3-a9be-b1a739c946db","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?fe8480c4-b176-45ae-b4d6-fa59912fe286","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?fefb555f-ef66-4020-826d-002c76df0225"]},{"source":"FDA","ids":["05605441-31ac-43c6-bafb-c2b07ed79381","0d266c0d-167c-4a28-a6ef-924d5d117e50","18a4fe07-f5f7-41d1-b7d1-85563b54d2cf","1c30ee68-878b-4dfc-ad05-ce801256a168","1d1d39cf-82d7-4980-8a96-46a3e5aabd16","2a015a04-6ea9-4c58-96a2-52d4e8196152","2e419114-8733-409c-ac5d-3c5ebbd2cb33","363a093f-140f-49a8-b6f8-860a486f7390","39bfb379-ef90-4a87-8b22-42ab0906785d","3d8946f4-722b-477d-9f7f-6da06c78301e","466a3880-d4b4-ddaa-42f4-b413f26ce697","4710e965-7e92-4fef-b7fa-d4ecece6a606","5b87b83c-f46a-4edf-9731-e8b0f0359cd2","60aa95a1-5f7d-4438-bf78-fba6127a022b","660b8bc5-c7ed-4486-a2da-8ac1f6ed254a","66a65b1b-631a-44c4-b500-b5ac21b4e7ec","6aecd9bf-6cfa-4bc7-be82-d2bc27b80fe9","6baa5e7f-c884-45dd-8dd7-4c3b4742eb0f","82207a72-07a0-4501-aff4-8a6f6e2bccb3","8aafb54e-99d8-4166-8504-49162a8ec0fb","976084ce-686e-4a82-b231-4ed0f6d12541","a13a0fb7-3c07-4e89-955e-2e1475c2ffeb","bda27f4a-6a16-4c59-b64c-c08df8bd2746","c06eef31-922f-48f7-8761-2cad7e45cb98","c7a79060-0369-4f9e-8fdd-f5351d23eeca","c983c578-d6c4-46e3-aca6-56de081f07ab","cf741f27-d8d0-4c47-a583-f7ed2e90c3de","d59e1f36-a683-4308-a184-3fa469f031b4","d6c156b2-99f6-4f26-9430-908cd966213c","e6adef68-a613-4edf-8e07-f46f61d185ae","f6c6d183-0a63-0d25-5cd7-43a2d0d63beb","label/2016/020938s026lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A05605441-31ac-43c6-bafb-c2b07ed79381","https://api.fda.gov/drug/label.json?search=set_id%3A0d266c0d-167c-4a28-a6ef-924d5d117e50","https://api.fda.gov/drug/label.json?search=set_id%3A18a4fe07-f5f7-41d1-b7d1-85563b54d2cf","https://api.fda.gov/drug/label.json?search=set_id%3A1c30ee68-878b-4dfc-ad05-ce801256a168","https://api.fda.gov/drug/label.json?search=set_id%3A1d1d39cf-82d7-4980-8a96-46a3e5aabd16","https://api.fda.gov/drug/label.json?search=set_id%3A2a015a04-6ea9-4c58-96a2-52d4e8196152","https://api.fda.gov/drug/label.json?search=set_id%3A2e419114-8733-409c-ac5d-3c5ebbd2cb33","https://api.fda.gov/drug/label.json?search=set_id%3A363a093f-140f-49a8-b6f8-860a486f7390","https://api.fda.gov/drug/label.json?search=set_id%3A39bfb379-ef90-4a87-8b22-42ab0906785d","https://api.fda.gov/drug/label.json?search=set_id%3A3d8946f4-722b-477d-9f7f-6da06c78301e","https://api.fda.gov/drug/label.json?search=set_id%3A466a3880-d4b4-ddaa-42f4-b413f26ce697","https://api.fda.gov/drug/label.json?search=set_id%3A4710e965-7e92-4fef-b7fa-d4ecece6a606","https://api.fda.gov/drug/label.json?search=set_id%3A5b87b83c-f46a-4edf-9731-e8b0f0359cd2","https://api.fda.gov/drug/label.json?search=set_id%3A60aa95a1-5f7d-4438-bf78-fba6127a022b","https://api.fda.gov/drug/label.json?search=set_id%3A660b8bc5-c7ed-4486-a2da-8ac1f6ed254a","https://api.fda.gov/drug/label.json?search=set_id%3A66a65b1b-631a-44c4-b500-b5ac21b4e7ec","https://api.fda.gov/drug/label.json?search=set_id%3A6aecd9bf-6cfa-4bc7-be82-d2bc27b80fe9","https://api.fda.gov/drug/label.json?search=set_id%3A6baa5e7f-c884-45dd-8dd7-4c3b4742eb0f","https://api.fda.gov/drug/label.json?search=set_id%3A82207a72-07a0-4501-aff4-8a6f6e2bccb3","https://api.fda.gov/drug/label.json?search=set_id%3A8aafb54e-99d8-4166-8504-49162a8ec0fb","https://api.fda.gov/drug/label.json?search=set_id%3A976084ce-686e-4a82-b231-4ed0f6d12541","https://api.fda.gov/drug/label.json?search=set_id%3Aa13a0fb7-3c07-4e89-955e-2e1475c2ffeb","https://api.fda.gov/drug/label.json?search=set_id%3Abda27f4a-6a16-4c59-b64c-c08df8bd2746","https://api.fda.gov/drug/label.json?search=set_id%3Ac06eef31-922f-48f7-8761-2cad7e45cb98","https://api.fda.gov/drug/label.json?search=set_id%3Ac7a79060-0369-4f9e-8fdd-f5351d23eeca","https://api.fda.gov/drug/label.json?search=set_id%3Ac983c578-d6c4-46e3-aca6-56de081f07ab","https://api.fda.gov/drug/label.json?search=set_id%3Acf741f27-d8d0-4c47-a583-f7ed2e90c3de","https://api.fda.gov/drug/label.json?search=set_id%3Ad59e1f36-a683-4308-a184-3fa469f031b4","https://api.fda.gov/drug/label.json?search=set_id%3Ad6c156b2-99f6-4f26-9430-908cd966213c","https://api.fda.gov/drug/label.json?search=set_id%3Ae6adef68-a613-4edf-8e07-f46f61d185ae","https://api.fda.gov/drug/label.json?search=set_id%3Af6c6d183-0a63-0d25-5cd7-43a2d0d63beb","https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2016%2F020938s026lbl.pdf"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00945763","NCT01084161","NCT01147289","NCT02183051","NCT02540265","NCT02675907","NCT02678286","NCT02720692","NCT03323385","NCT03434275"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00945763%22OR%22NCT01084161%22OR%22NCT01147289%22OR%22NCT02183051%22OR%22NCT02540265%22OR%22NCT02675907%22OR%22NCT02678286%22OR%22NCT02720692%22OR%22NCT03323385%22OR%22NCT03434275%22"]}]},{"efo_id":"EFO_0003898","efo_label":"ankylosing spondylitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003898","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02183168"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02183168%22"]}]},{"efo_id":"Orphanet_3389","efo_label":"Tuberculosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_3389","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02060006"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02060006%22"]}]},{"efo_id":"EFO_0005755","efo_label":"rheumatic disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005755","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["M01AC06","M01AC56"],"urls":["https://www.whocc.no/atc_ddd_index/?code=M01AC06","https://www.whocc.no/atc_ddd_index/?code=M01AC56"]}]},{"efo_id":"EFO_0000685","efo_label":"rheumatoid arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000685","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00042068","NCT00239382","NCT01750931"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00042068%22OR%22NCT00239382%22OR%22NCT01750931%22"]},{"source":"DailyMed","ids":["0060d1b1-4cfc-4b69-86a8-9bd44a071e94","02f9696c-87d0-4f2b-a90f-d04b3ba767b1","0377e242-ce71-4570-afb9-ff881a575a13","03c871ed-6686-4bfe-9b15-6ca50b91af47","040fecdb-68cf-4967-90ce-c2130b520615","06623222-188c-4ab1-976a-4cdb2037a709","06a401f0-4380-4081-86ed-a309a25abf6b","0a5ccef7-edba-4498-bec2-6b25d551e04b","0edec862-f3e8-46f6-b6d0-de0bc21dd3fb","0fb333e0-5123-5f7a-e054-00144ff88e88","1ab45be4-b2b9-4374-95ab-620e0f90fb70","1d8b617a-b9b3-473c-be9b-f34a585a1b3b","20871c7f-1e36-49ef-8e2b-70112430ca1e","2adb9f9b-c49c-4137-9e2e-8be9065639e6","3ba4c6e0-cb83-43b5-a623-1f2af9c2b07c","3ce43f4a-c525-4ce1-b328-514b3912e305","3d3b548c-005e-40b0-98d0-443cf08fdcde","3fcb59d1-d547-415f-be6c-d88558fdda03","459bd9c0-1102-46d3-8020-5fec80d1ec36","4acea0aa-973f-40e5-88b4-0e2d85ea624c","4f7f4c26-d85d-4721-8371-49c52461a3f0","598c8808-e306-401a-9a16-e197cbfa0a0d","5afa7fd7-3362-4cab-9630-2d9db708165c","5eb2e439-2ef2-496c-9aec-042029ae1305","5fe76337-eae5-4e5c-96ef-6cfa97983c6e","6513e46b-3229-685b-c83b-2209454fae71","676e73fb-51d2-449a-8749-1a7bcc257b11","6c015f72-5ce3-4f56-8237-776fc2165b0c","6ed06682-7507-4c11-a782-42e694c21b53","72d1ad20-a10d-4c1e-8a4a-a125426d400f","820f143f-4b0c-4466-be9a-212dab9d984b","8685a269-d533-4970-889e-d70e8b958ccd","87c6d3e2-7c66-479b-abe8-551cb8913921","8b2aa351-4ac3-4b5f-a20c-060805812cd0","9d648594-d657-4d9a-855e-0ea91eb49c98","a381942f-0cba-4e97-4741-ad04a6af2164","a3ec45d2-bd66-48d4-8ac8-0292f1e2385a","a9da4978-be10-4601-a693-7d436c8613b4","aa28251e-cab0-49a2-bf3f-ad820b1432cf","aafd2b0f-435a-4805-9b17-c02f99df59d5","ad18a9e9-2fa0-40b0-a438-9146a150ab39","bb83cd61-0a82-4fe0-b72e-5b715cbd656d","c172a767-eb26-4995-b2a2-f3c5e87b4943","c51f3abe-02bc-4544-a22f-0f2035fb2271","c5e48b73-e428-41bc-973c-72003811e653","c8683c04-0e54-4e97-992b-55c2d605793c","d224143d-2199-4969-a64f-dc2e6b865ec4","d5e12448-1ca1-46a4-8de4-e8b94567e5a8","dbbc6373-e9ae-4215-8d08-5f6667a936d1","e65e3c28-a40b-4daa-8fd5-29f112575b68","eae60d2c-411c-460a-b673-05b5784ed943","ee8df8fa-d08a-8c8b-f048-813e5022a101","f2197492-9932-45c7-8fe0-5284ccfb8458","f6bf82d1-b768-49de-bc6c-1078dfc3c359","f8035130-1a60-4ba3-a9be-b1a739c946db","fe8480c4-b176-45ae-b4d6-fa59912fe286","fefb555f-ef66-4020-826d-002c76df0225"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0060d1b1-4cfc-4b69-86a8-9bd44a071e94","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?02f9696c-87d0-4f2b-a90f-d04b3ba767b1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0377e242-ce71-4570-afb9-ff881a575a13","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?03c871ed-6686-4bfe-9b15-6ca50b91af47","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?040fecdb-68cf-4967-90ce-c2130b520615","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?06623222-188c-4ab1-976a-4cdb2037a709","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?06a401f0-4380-4081-86ed-a309a25abf6b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0a5ccef7-edba-4498-bec2-6b25d551e04b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0edec862-f3e8-46f6-b6d0-de0bc21dd3fb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0fb333e0-5123-5f7a-e054-00144ff88e88","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1ab45be4-b2b9-4374-95ab-620e0f90fb70","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1d8b617a-b9b3-473c-be9b-f34a585a1b3b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?20871c7f-1e36-49ef-8e2b-70112430ca1e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2adb9f9b-c49c-4137-9e2e-8be9065639e6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3ba4c6e0-cb83-43b5-a623-1f2af9c2b07c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3ce43f4a-c525-4ce1-b328-514b3912e305","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3d3b548c-005e-40b0-98d0-443cf08fdcde","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3fcb59d1-d547-415f-be6c-d88558fdda03","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?459bd9c0-1102-46d3-8020-5fec80d1ec36","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4acea0aa-973f-40e5-88b4-0e2d85ea624c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4f7f4c26-d85d-4721-8371-49c52461a3f0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?598c8808-e306-401a-9a16-e197cbfa0a0d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5afa7fd7-3362-4cab-9630-2d9db708165c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5eb2e439-2ef2-496c-9aec-042029ae1305","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5fe76337-eae5-4e5c-96ef-6cfa97983c6e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6513e46b-3229-685b-c83b-2209454fae71","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?676e73fb-51d2-449a-8749-1a7bcc257b11","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6c015f72-5ce3-4f56-8237-776fc2165b0c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6ed06682-7507-4c11-a782-42e694c21b53","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?72d1ad20-a10d-4c1e-8a4a-a125426d400f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?820f143f-4b0c-4466-be9a-212dab9d984b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8685a269-d533-4970-889e-d70e8b958ccd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?87c6d3e2-7c66-479b-abe8-551cb8913921","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8b2aa351-4ac3-4b5f-a20c-060805812cd0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9d648594-d657-4d9a-855e-0ea91eb49c98","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a381942f-0cba-4e97-4741-ad04a6af2164","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a3ec45d2-bd66-48d4-8ac8-0292f1e2385a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a9da4978-be10-4601-a693-7d436c8613b4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?aa28251e-cab0-49a2-bf3f-ad820b1432cf","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?aafd2b0f-435a-4805-9b17-c02f99df59d5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ad18a9e9-2fa0-40b0-a438-9146a150ab39","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bb83cd61-0a82-4fe0-b72e-5b715cbd656d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c172a767-eb26-4995-b2a2-f3c5e87b4943","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c51f3abe-02bc-4544-a22f-0f2035fb2271","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c5e48b73-e428-41bc-973c-72003811e653","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c8683c04-0e54-4e97-992b-55c2d605793c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d224143d-2199-4969-a64f-dc2e6b865ec4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d5e12448-1ca1-46a4-8de4-e8b94567e5a8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dbbc6373-e9ae-4215-8d08-5f6667a936d1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e65e3c28-a40b-4daa-8fd5-29f112575b68","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?eae60d2c-411c-460a-b673-05b5784ed943","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ee8df8fa-d08a-8c8b-f048-813e5022a101","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f2197492-9932-45c7-8fe0-5284ccfb8458","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f6bf82d1-b768-49de-bc6c-1078dfc3c359","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f8035130-1a60-4ba3-a9be-b1a739c946db","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?fe8480c4-b176-45ae-b4d6-fa59912fe286","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?fefb555f-ef66-4020-826d-002c76df0225"]},{"source":"FDA","ids":["05605441-31ac-43c6-bafb-c2b07ed79381","0d266c0d-167c-4a28-a6ef-924d5d117e50","18a4fe07-f5f7-41d1-b7d1-85563b54d2cf","1c30ee68-878b-4dfc-ad05-ce801256a168","1d1d39cf-82d7-4980-8a96-46a3e5aabd16","2a015a04-6ea9-4c58-96a2-52d4e8196152","2e419114-8733-409c-ac5d-3c5ebbd2cb33","363a093f-140f-49a8-b6f8-860a486f7390","39bfb379-ef90-4a87-8b22-42ab0906785d","3d8946f4-722b-477d-9f7f-6da06c78301e","466a3880-d4b4-ddaa-42f4-b413f26ce697","4710e965-7e92-4fef-b7fa-d4ecece6a606","5b87b83c-f46a-4edf-9731-e8b0f0359cd2","60aa95a1-5f7d-4438-bf78-fba6127a022b","660b8bc5-c7ed-4486-a2da-8ac1f6ed254a","66a65b1b-631a-44c4-b500-b5ac21b4e7ec","6aecd9bf-6cfa-4bc7-be82-d2bc27b80fe9","6baa5e7f-c884-45dd-8dd7-4c3b4742eb0f","82207a72-07a0-4501-aff4-8a6f6e2bccb3","8aafb54e-99d8-4166-8504-49162a8ec0fb","976084ce-686e-4a82-b231-4ed0f6d12541","a13a0fb7-3c07-4e89-955e-2e1475c2ffeb","bda27f4a-6a16-4c59-b64c-c08df8bd2746","c06eef31-922f-48f7-8761-2cad7e45cb98","c7a79060-0369-4f9e-8fdd-f5351d23eeca","c983c578-d6c4-46e3-aca6-56de081f07ab","cf741f27-d8d0-4c47-a583-f7ed2e90c3de","d59e1f36-a683-4308-a184-3fa469f031b4","d6c156b2-99f6-4f26-9430-908cd966213c","e6adef68-a613-4edf-8e07-f46f61d185ae","f6c6d183-0a63-0d25-5cd7-43a2d0d63beb","label/2016/020938s026lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A05605441-31ac-43c6-bafb-c2b07ed79381","https://api.fda.gov/drug/label.json?search=set_id%3A0d266c0d-167c-4a28-a6ef-924d5d117e50","https://api.fda.gov/drug/label.json?search=set_id%3A18a4fe07-f5f7-41d1-b7d1-85563b54d2cf","https://api.fda.gov/drug/label.json?search=set_id%3A1c30ee68-878b-4dfc-ad05-ce801256a168","https://api.fda.gov/drug/label.json?search=set_id%3A1d1d39cf-82d7-4980-8a96-46a3e5aabd16","https://api.fda.gov/drug/label.json?search=set_id%3A2a015a04-6ea9-4c58-96a2-52d4e8196152","https://api.fda.gov/drug/label.json?search=set_id%3A2e419114-8733-409c-ac5d-3c5ebbd2cb33","https://api.fda.gov/drug/label.json?search=set_id%3A363a093f-140f-49a8-b6f8-860a486f7390","https://api.fda.gov/drug/label.json?search=set_id%3A39bfb379-ef90-4a87-8b22-42ab0906785d","https://api.fda.gov/drug/label.json?search=set_id%3A3d8946f4-722b-477d-9f7f-6da06c78301e","https://api.fda.gov/drug/label.json?search=set_id%3A466a3880-d4b4-ddaa-42f4-b413f26ce697","https://api.fda.gov/drug/label.json?search=set_id%3A4710e965-7e92-4fef-b7fa-d4ecece6a606","https://api.fda.gov/drug/label.json?search=set_id%3A5b87b83c-f46a-4edf-9731-e8b0f0359cd2","https://api.fda.gov/drug/label.json?search=set_id%3A60aa95a1-5f7d-4438-bf78-fba6127a022b","https://api.fda.gov/drug/label.json?search=set_id%3A660b8bc5-c7ed-4486-a2da-8ac1f6ed254a","https://api.fda.gov/drug/label.json?search=set_id%3A66a65b1b-631a-44c4-b500-b5ac21b4e7ec","https://api.fda.gov/drug/label.json?search=set_id%3A6aecd9bf-6cfa-4bc7-be82-d2bc27b80fe9","https://api.fda.gov/drug/label.json?search=set_id%3A6baa5e7f-c884-45dd-8dd7-4c3b4742eb0f","https://api.fda.gov/drug/label.json?search=set_id%3A82207a72-07a0-4501-aff4-8a6f6e2bccb3","https://api.fda.gov/drug/label.json?search=set_id%3A8aafb54e-99d8-4166-8504-49162a8ec0fb","https://api.fda.gov/drug/label.json?search=set_id%3A976084ce-686e-4a82-b231-4ed0f6d12541","https://api.fda.gov/drug/label.json?search=set_id%3Aa13a0fb7-3c07-4e89-955e-2e1475c2ffeb","https://api.fda.gov/drug/label.json?search=set_id%3Abda27f4a-6a16-4c59-b64c-c08df8bd2746","https://api.fda.gov/drug/label.json?search=set_id%3Ac06eef31-922f-48f7-8761-2cad7e45cb98","https://api.fda.gov/drug/label.json?search=set_id%3Ac7a79060-0369-4f9e-8fdd-f5351d23eeca","https://api.fda.gov/drug/label.json?search=set_id%3Ac983c578-d6c4-46e3-aca6-56de081f07ab","https://api.fda.gov/drug/label.json?search=set_id%3Acf741f27-d8d0-4c47-a583-f7ed2e90c3de","https://api.fda.gov/drug/label.json?search=set_id%3Ad59e1f36-a683-4308-a184-3fa469f031b4","https://api.fda.gov/drug/label.json?search=set_id%3Ad6c156b2-99f6-4f26-9430-908cd966213c","https://api.fda.gov/drug/label.json?search=set_id%3Ae6adef68-a613-4edf-8e07-f46f61d185ae","https://api.fda.gov/drug/label.json?search=set_id%3Af6c6d183-0a63-0d25-5cd7-43a2d0d63beb","https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2016%2F020938s026lbl.pdf"]}]},{"efo_id":"EFO_0000673","efo_label":"prostate adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000673","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00152919"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00152919%22"]}]},{"efo_id":"EFO_0002609","efo_label":"juvenile idiopathic arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002609","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00034853","NCT00279747"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00034853%22OR%22NCT00279747%22"]}]},{"efo_id":"EFO_0002690","efo_label":"systemic lupus erythematosus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002690","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00731302"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00731302%22"]}]},{"efo_id":"EFO_0003821","efo_label":"migraine disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003821","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03896009"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03896009%22"]}]},{"efo_id":"HP_0100607","efo_label":"Dysmenorrhea","efo_uri":"http://purl.obolibrary.org/obo/HP_0100607","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02183025","NCT02255045"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02183025%22OR%22NCT02255045%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000073756","approved_name":"prostaglandin-endoperoxide synthase 2","approved_symbol":"PTGS2"}],"target_type":"single protein","target_name":"Cyclooxygenase-2","action_type":"inhibitor","description":"Cyclooxygenase-2 inhibitor","references":[{"source":"PubMed","ids":["8882380"],"urls":["https://europepmc.org/search?query=EXT_ID%3A8882380"]}]}],"adverse_events":{"significant":[{"event":"drug hypersensitivity","count":71246,"llr":565.4410401},{"event":"gastrointestinal haemorrhage","count":25270,"llr":232.0460393},{"event":"synovial fluid analysis","count":41,"llr":157.9190248},{"event":"gastric ulcer","count":5425,"llr":130.2058268},{"event":"duodenal ulcer","count":2784,"llr":124.1919613},{"event":"gastric haemorrhage","count":3864,"llr":120.753584},{"event":"tenosynovitis stenosans","count":183,"llr":116.1598358},{"event":"synovial cyst","count":1181,"llr":110.1642199},{"event":"fibromyalgia","count":3651,"llr":103.7965263},{"event":"melaena","count":7928,"llr":93.15430438},{"event":"scleritis","count":484,"llr":89.19502988},{"event":"rheumatoid nodule","count":811,"llr":86.16314058},{"event":"crepitations","count":1041,"llr":78.62800576},{"event":"impaired work ability","count":2874,"llr":77.99277035},{"event":"intestinal diaphragm disease","count":116,"llr":69.77040785},{"event":"pleuritic pain","count":1019,"llr":68.82557527},{"event":"cushingoid","count":1073,"llr":64.06822003},{"event":"antinuclear antibody positive","count":1607,"llr":62.6117685},{"event":"ulcer","count":3124,"llr":61.43417764},{"event":"bursitis","count":2524,"llr":60.50818602},{"event":"joint effusion","count":2013,"llr":53.41442435},{"event":"dry eye","count":6029,"llr":51.74807453},{"event":"gastric ulcer haemorrhage","count":1601,"llr":50.81197009},{"event":"conjunctivitis","count":4335,"llr":50.38888467},{"event":"upper gastrointestinal haemorrhage","count":4147,"llr":49.56957139},{"event":"nodule","count":3063,"llr":49.41881115},{"event":"rheumatoid arthritis","count":23147,"llr":49.15743788},{"event":"joint swelling","count":23084,"llr":47.95777982}],"critval":47.92353437},"child_chembl_ids":["CHEMBL1256873","CHEMBL1898907"],"number_of_indications":11,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":6},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":4},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":2},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":2},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL550961","_score":1,"_source":{"id":"CHEMBL550961","internal_compound":false,"type":"Small molecule","pref_name":"DIAZEPINOMICIN","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Amo-01","BU-4664L","Diazepinomicin","ECO-4601","TLN-4601"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12420"]}],"canonical_smiles":"CC(C)=CCC/C(C)=C/CC/C(C)=C/CN1C(=O)c2cccc(O)c2Nc2c(O)cc(O)cc21","indications":[{"efo_id":"EFO_0000519","efo_label":"glioblastoma multiforme","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000519","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00730262"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00730262%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2111016","_score":1,"_source":{"id":"CHEMBL2111016","internal_compound":false,"type":"Small molecule","pref_name":"TIBEZONIUM","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"canonical_smiles":"CC[N+](C)(CC)CCSC1=Nc2ccccc2N=C(c2ccc(Sc3ccccc3)cc2)C1","child_chembl_ids":["CHEMBL2107065"],"synonyms":["Tibezonium Iodide"],"indications":[{"efo_id":"EFO_0000544","efo_label":"infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000544","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["A01AB15"],"urls":["https://www.whocc.no/atc_ddd_index/?code=A01AB15"]}]}],"cross_references":[{"source":"drugbank","ids":["DB13702"]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545411","_score":1,"_source":{"id":"CHEMBL3545411","internal_compound":false,"type":"Small molecule","pref_name":"MF101","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["MF-101"],"trade_names":[],"indications":[{"efo_id":"EFO_0003922","efo_label":"menopause","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003922","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00454441"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00454441%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000140009","approved_name":"estrogen receptor 2","approved_symbol":"ESR2"}],"target_type":"single protein","target_name":"Estrogen receptor beta","action_type":"agonist","description":"Estrogen receptor beta agonist","references":[{"source":"PubMed","ids":["22616988"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22616988"]},{"source":"Wikipedia","ids":["Menerba"],"urls":["https://www.wikipedia.org/Menerba"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL166937","_score":1,"_source":{"id":"CHEMBL166937","internal_compound":false,"type":"Small molecule","pref_name":"SarCNU","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["2-[{[(2-Chloroethyl)(Nitroso)Amino]Carbonyl}(Methyl)Amino]Acetamide","NSC-364432","Sarcnu"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["466405"]},{"source":"drugbank","ids":["DB11688"]}],"canonical_smiles":"CN(CC(N)=O)C(=O)N(CCCl)N=O","indications":[{"efo_id":"EFO_0000326","efo_label":"central nervous system cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000326","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00036660"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00036660%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00003703","NCT00004079"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003703%22OR%22NCT00004079%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00028015"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00028015%22"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545001","_score":1,"_source":{"id":"CHEMBL3545001","internal_compound":false,"type":"Small molecule","pref_name":"MK-8353","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["MK-8353","SCH-900353"],"trade_names":[],"indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01358331","NCT03745989"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01358331%22OR%22NCT03745989%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02972034"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02972034%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000102882","approved_name":"mitogen-activated protein kinase 3","approved_symbol":"MAPK3"}],"target_type":"single protein","target_name":"MAP kinase ERK1","action_type":"inhibitor","description":"MAP kinase ERK1 inhibitor","references":[{"source":"Other","ids":["http://www.hra.nhs.uk/news/research-summaries/safey-tolerability-efficacy-of-mk-8353-in-subjects-with-solid-tumors/"],"urls":["http://www.hra.nhs.uk/news/research-summaries/safey-tolerability-efficacy-of-mk-8353-in-subjects-with-solid-tumors/"]}]},{"target_components":[{"ensembl":"ENSG00000100030","approved_name":"mitogen-activated protein kinase 1","approved_symbol":"MAPK1"}],"target_type":"single protein","target_name":"MAP kinase ERK2","action_type":"inhibitor","description":"MAP kinase ERK2 inhibitor","references":[{"source":"Other","ids":["http://www.hra.nhs.uk/news/research-summaries/safey-tolerability-efficacy-of-mk-8353-in-subjects-with-solid-tumors/"],"urls":["http://www.hra.nhs.uk/news/research-summaries/safey-tolerability-efficacy-of-mk-8353-in-subjects-with-solid-tumors/"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2105160","_score":1,"_source":{"id":"CHEMBL2105160","internal_compound":false,"type":"Small molecule","pref_name":"NAMINIDIL","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["BMS-234303","BMS-234303-01","Naminidil"],"trade_names":[],"canonical_smiles":"C[C@@H](N/C(=N\\C#N)Nc1ccc(C#N)cc1)C(C)(C)C","mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000187486","approved_name":"potassium inwardly rectifying channel subfamily J member 11","approved_symbol":"KCNJ11"},{"ensembl":"ENSG00000069431","approved_name":"ATP binding cassette subfamily C member 9","approved_symbol":"ABCC9"},{"ensembl":"ENSG00000006071","approved_name":"ATP binding cassette subfamily C member 8","approved_symbol":"ABCC8"},{"ensembl":"ENSG00000121361","approved_name":"potassium inwardly rectifying channel subfamily J member 8","approved_symbol":"KCNJ8"}],"target_type":"protein complex group","target_name":"Sulfonylurea receptors; K-ATP channels","action_type":"opener","description":"Sulfonylurea receptors; K-ATP channels opener","references":[{"source":"Other","ids":["http://www.kegg.jp/dbget-bin/www_bget?dr:D05114"],"urls":["http://www.kegg.jp/dbget-bin/www_bget?dr:D05114"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2179105","_score":1,"_source":{"id":"CHEMBL2179105","internal_compound":false,"type":"Small molecule","pref_name":"PF-04447943","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Pf-04447943"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB11953"]}],"canonical_smiles":"C[C@@H]1CN(Cc2ncccn2)C[C@H]1c1nc2c(cnn2C2CCOCC2)c(=O)[nH]1","indications":[{"efo_id":"EFO_0000249","efo_label":"Alzheimer's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000249","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00930059","NCT00988598"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00930059%22OR%22NCT00988598%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL494089","_score":1,"_source":{"id":"CHEMBL494089","internal_compound":false,"type":"Small molecule","pref_name":"GSK-690693","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["GSK 690693","GSK690693"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[90677]},{"source":"drugbank","ids":["DB12745"]}],"canonical_smiles":"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21","indications":[{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00493818","NCT00666081"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00493818%22OR%22NCT00666081%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000105221","approved_name":"AKT serine/threonine kinase 2","approved_symbol":"AKT2"},{"ensembl":"ENSG00000117020","approved_name":"AKT serine/threonine kinase 3","approved_symbol":"AKT3"},{"ensembl":"ENSG00000142208","approved_name":"AKT serine/threonine kinase 1","approved_symbol":"AKT1"}],"target_type":"protein family","target_name":"Serine/threonine-protein kinase AKT","action_type":"inhibitor","description":"Serine/threonine-protein kinase AKT inhibitor","references":[{"source":"PubMed","ids":["18800763"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18800763"]}]},{"target_components":[{"ensembl":"ENSG00000142875","approved_name":"protein kinase cAMP-activated catalytic subunit beta","approved_symbol":"PRKACB"},{"ensembl":"ENSG00000072062","approved_name":"protein kinase cAMP-activated catalytic subunit alpha","approved_symbol":"PRKACA"},{"ensembl":"ENSG00000165059","approved_name":"protein kinase cAMP-activated catalytic subunit gamma","approved_symbol":"PRKACG"}],"target_type":"protein family","target_name":"cAMP-dependent protein kinase (PKA)","action_type":"inhibitor","description":"cAMP-dependent protein kinase (PKA) inhibitor","references":[{"source":"PubMed","ids":["18800763"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18800763"]}]},{"target_components":[{"ensembl":"ENSG00000115825","approved_name":"protein kinase D3","approved_symbol":"PRKD3"},{"ensembl":"ENSG00000163558","approved_name":"protein kinase C iota","approved_symbol":"PRKCI"},{"ensembl":"ENSG00000154229","approved_name":"protein kinase C alpha","approved_symbol":"PRKCA"},{"ensembl":"ENSG00000126583","approved_name":"protein kinase C gamma","approved_symbol":"PRKCG"},{"ensembl":"ENSG00000163932","approved_name":"protein kinase C delta","approved_symbol":"PRKCD"},{"ensembl":"ENSG00000166501","approved_name":"protein kinase C beta","approved_symbol":"PRKCB"},{"ensembl":"ENSG00000067606","approved_name":"protein kinase C zeta","approved_symbol":"PRKCZ"},{"ensembl":"ENSG00000171132","approved_name":"protein kinase C epsilon","approved_symbol":"PRKCE"},{"ensembl":"ENSG00000027075","approved_name":"protein kinase C eta","approved_symbol":"PRKCH"},{"ensembl":"ENSG00000184304","approved_name":"protein kinase D1","approved_symbol":"PRKD1"},{"ensembl":"ENSG00000065675","approved_name":"protein kinase C theta","approved_symbol":"PRKCQ"}],"target_type":"protein family","target_name":"Protein kinase C (PKC)","action_type":"inhibitor","description":"Protein kinase C (PKC) inhibitor","references":[{"source":"PubMed","ids":["18800763"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18800763"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":3}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL516","_score":1,"_source":{"id":"CHEMBL516","internal_compound":false,"type":"Small molecule","pref_name":"CYPROHEPTADINE","year_first_approved":1961,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Cyproheptadine","Cyproheptadine HCl","Cyproheptadine hydrochloride hydrate","NSC-169911"],"trade_names":["Cyproheptadine HCl","Cyproheptadine Hydrocloride","Periactin"],"cross_references":[{"source":"ChEBI","ids":[4046]},{"source":"DailyMed","ids":["cyproheptadine%20hydrochloride"]},{"source":"PubChem","ids":["104171133","11110964","11110965","11113362","124879679","144203663","170465127","174007288","26751603","50100203","50104260","90341656"]},{"source":"Wikipedia","ids":["Cyproheptadine"]},{"source":"drugbank","ids":["DB00434"]},{"source":"ChEBI","ids":[59695]},{"source":"PubChem","ids":["50105994","50105995","56422142","855651"]}],"canonical_smiles":"CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1","indications":[{"efo_id":"EFO_0000712","efo_label":"stroke","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000712","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT01688570"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01688570%22"]}]},{"efo_id":"EFO_0003785","efo_label":"allergy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003785","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["R06AX02"],"urls":["https://www.whocc.no/atc_ddd_index/?code=R06AX02"]}]},{"efo_id":"EFO_0003829","efo_label":"alcohol dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003829","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01076283","NCT04108104"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01076283%22OR%22NCT04108104%22"]}]},{"efo_id":"HP_0002027","efo_label":"Abdominal pain","efo_uri":"http://purl.obolibrary.org/obo/HP_0002027","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01675050"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01675050%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01132547"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01132547%22"]}]}],"adverse_events":{"significant":[{"event":"serotonin syndrome","count":6002,"llr":160.9205989},{"event":"cardiogenic shock","count":2837,"llr":47.9144941},{"event":"pneumonia aspiration","count":5215,"llr":47.33783908},{"event":"symptom masked","count":166,"llr":45.42202799},{"event":"delirium","count":11053,"llr":42.22769148},{"event":"electrocardiogram qt prolonged","count":12378,"llr":40.26562132},{"event":"apallic syndrome","count":228,"llr":36.57796185},{"event":"pulseless electrical activity","count":675,"llr":34.23061485},{"event":"respiratory failure","count":13025,"llr":33.1435084},{"event":"pupil fixed","count":403,"llr":32.60131773},{"event":"cardiac arrest","count":9359,"llr":31.58392456},{"event":"atrial tachycardia","count":586,"llr":29.99160772},{"event":"hypoperfusion","count":355,"llr":27.76776689},{"event":"rhabdomyolysis","count":16457,"llr":26.81239856},{"event":"intestinal ischaemia","count":1073,"llr":25.78655284},{"event":"mental status changes","count":10001,"llr":24.49384656},{"event":"unresponsive to stimuli","count":6342,"llr":22.98582643},{"event":"neurogenic shock","count":78,"llr":22.92498748},{"event":"condition aggravated","count":52909,"llr":22.02264992},{"event":"mydriasis","count":3319,"llr":21.64687122},{"event":"depressed level of consciousness","count":10912,"llr":20.61798897},{"event":"initial insomnia","count":1234,"llr":20.34531404},{"event":"middle insomnia","count":2446,"llr":20.10093529},{"event":"drug interaction","count":53526,"llr":19.91358853},{"event":"haemodynamic instability","count":1660,"llr":18.59163413},{"event":"sinus tachycardia","count":5084,"llr":18.34086287},{"event":"shock","count":5269,"llr":18.06598273},{"event":"sleep apnoea syndrome","count":4137,"llr":16.52378274},{"event":"miosis","count":2714,"llr":15.70549841},{"event":"obsessive-compulsive disorder","count":1566,"llr":14.87357935},{"event":"femoral neck fracture","count":1653,"llr":14.6085066},{"event":"agitation","count":21093,"llr":13.97039532},{"event":"aphonia","count":1899,"llr":13.92971179},{"event":"ischaemic stroke","count":6287,"llr":13.72326242},{"event":"arrhythmia","count":9500,"llr":13.60341299},{"event":"cardiac disorder","count":13208,"llr":13.56513434},{"event":"drug withdrawal syndrome","count":13453,"llr":13.41433075},{"event":"cerebellar syndrome","count":1133,"llr":12.2854099},{"event":"bradykinesia","count":1223,"llr":11.98512611},{"event":"intracranial pressure increased","count":1369,"llr":11.54290147},{"event":"confusional state","count":40628,"llr":11.12952163},{"event":"hypotension","count":55121,"llr":10.93913625},{"event":"anticholinergic syndrome","count":527,"llr":10.62142037},{"event":"sedation","count":6964,"llr":10.30774143},{"event":"myoclonus","count":4355,"llr":9.928368823},{"event":"somnolence","count":38949,"llr":9.887693498},{"event":"electrocardiogram qrs complex shortened","count":125,"llr":9.12976718},{"event":"type i hypersensitivity","count":913,"llr":8.996362613},{"event":"palpitations","count":23550,"llr":8.977994453},{"event":"persistent postural-perceptual dizziness","count":1,"llr":8.694164511},{"event":"hyperthermia","count":2914,"llr":8.615002781},{"event":"clonus","count":1049,"llr":8.588089782},{"event":"insomnia","count":44658,"llr":8.584841567},{"event":"syncope","count":31191,"llr":8.534013765},{"event":"apnoeic attack","count":175,"llr":8.459885576},{"event":"muscle spasticity","count":3045,"llr":8.447068304},{"event":"pulse absent","count":1181,"llr":8.240570754},{"event":"acute kidney injury","count":33030,"llr":8.070878869},{"event":"reflexes abnormal","count":219,"llr":8.014009423},{"event":"tachycardia","count":26994,"llr":7.955630782},{"event":"weight increased","count":33631,"llr":7.926431324},{"event":"blood lactic acid increased","count":1442,"llr":7.657487218},{"event":"impaired gastric emptying","count":1476,"llr":7.589647753},{"event":"hyperreflexia","count":1491,"llr":7.560229093},{"event":"erythema multiforme","count":4083,"llr":7.336844049},{"event":"sinus bradycardia","count":4115,"llr":7.307562318},{"event":"liver function test abnormal","count":13429,"llr":6.758076712},{"event":"anorexia","count":4812,"llr":6.724047152},{"event":"hypoxia","count":9218,"llr":6.473802925},{"event":"dysphonia","count":9978,"llr":6.123754822},{"event":"intervertebral discitis","count":632,"llr":5.919675219},{"event":"thrombocytopenic purpura","count":635,"llr":5.910387805},{"event":"sopor","count":6099,"llr":5.85427462},{"event":"dysarthria","count":11020,"llr":5.690294966},{"event":"altered state of consciousness","count":6397,"llr":5.681585554},{"event":"iron deficiency anaemia","count":3027,"llr":5.529596629},{"event":"toxicity to various agents","count":31033,"llr":5.42549497}],"critval":5.142238981},"child_chembl_ids":["CHEMBL1716"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000196639","approved_name":"histamine receptor H1","approved_symbol":"HRH1"}],"target_type":"single protein","target_name":"Histamine H1 receptor","action_type":"antagonist","description":"Histamine H1 receptor antagonist","references":[{"source":"ISBN","ids":["9780702034718 PP. 333"],"urls":[]}]}],"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":2},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2135460","_score":1,"_source":{"id":"CHEMBL2135460","internal_compound":false,"type":"Protein","pref_name":"TERLIPRESSIN","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Terlipressin","Terlipressin acetate"],"trade_names":["Variquel"],"cross_references":[{"source":"PubChem","ids":["124896640","144206925"]},{"source":"drugbank","ids":["DB02638"]}],"canonical_smiles":"NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O","indications":[{"efo_id":"EFO_0001422","efo_label":"cirrhosis of liver","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001422","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00986817"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00986817%22"]}]},{"efo_id":"EFO_0006834","efo_label":"septic shock","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006834","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00481572","NCT00793559","NCT03038503"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00481572%22OR%22NCT00793559%22OR%22NCT03038503%22"]}]},{"efo_id":"MP_0001914","efo_label":"hemorrhage","efo_uri":"http://purl.obolibrary.org/obo/MP_0001914","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02588716","NCT03572088"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02588716%22OR%22NCT03572088%22"]}]},{"efo_id":"EFO_1002048","efo_label":"kidney failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1002048","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02368249"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02368249%22"]}]},{"efo_id":"HP_0001399","efo_label":"Hepatic failure","efo_uri":"http://purl.obolibrary.org/obo/HP_0001399","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01921985"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01921985%22"]}]}],"adverse_events":{"significant":[{"event":"electrocardiogram qt prolonged","count":12378,"llr":38.26575244},{"event":"ventricular fibrillation","count":2934,"llr":27.73467878},{"event":"cardiac arrest","count":9359,"llr":21.94656193}],"critval":13.16480711},"child_chembl_ids":["CHEMBL4088899"],"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":3},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1950289","_score":1,"_source":{"id":"CHEMBL1950289","internal_compound":false,"type":"Small molecule","pref_name":"TANZISERTIB","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["CC-930","JNK 930","JNK-930","Tanzisertib"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB11798"]}],"canonical_smiles":"O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1","indications":[{"efo_id":"EFO_0002690","efo_label":"systemic lupus erythematosus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002690","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01466725"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01466725%22"]}]},{"efo_id":"EFO_0000768","efo_label":"idiopathic pulmonary fibrosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000768","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01203943"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01203943%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000107643","approved_name":"mitogen-activated protein kinase 8","approved_symbol":"MAPK8"}],"target_type":"single protein","target_name":"c-Jun N-terminal kinase 1","action_type":"inhibitor","description":"c-Jun N-terminal kinase 1 inhibitor","references":[{"source":"PubMed","ids":["22244937"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22244937"]}]},{"target_components":[{"ensembl":"ENSG00000050748","approved_name":"mitogen-activated protein kinase 9","approved_symbol":"MAPK9"}],"target_type":"single protein","target_name":"c-Jun N-terminal kinase 2","action_type":"inhibitor","description":"c-Jun N-terminal kinase 2 inhibitor","references":[{"source":"PubMed","ids":["22244937"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22244937"]}]},{"target_components":[{"ensembl":"ENSG00000109339","approved_name":"mitogen-activated protein kinase 10","approved_symbol":"MAPK10"}],"target_type":"single protein","target_name":"c-Jun N-terminal kinase 3","action_type":"inhibitor","description":"c-Jun N-terminal kinase 3 inhibitor","references":[{"source":"PubMed","ids":["22244937"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22244937"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1}],"number_of_mechanisms_of_action":3}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2105666","_score":1,"_source":{"id":"CHEMBL2105666","internal_compound":false,"type":"Small molecule","pref_name":"TENIFATECAN","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["SN-2310","SN2310","Tenifatecan"],"trade_names":[],"canonical_smiles":"CCc1c2c(nc3ccc(OC(=O)CCC(=O)Oc4c(C)c(C)c5c(c4C)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O5)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC","indications":[{"efo_id":"EFO_0001071","efo_label":"lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001071","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00385177"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00385177%22"]}]},{"efo_id":"EFO_0003860","efo_label":"pancreatic neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003860","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00385177"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00385177%22"]}]},{"efo_id":"EFO_0003869","efo_label":"breast neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003869","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00385177"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00385177%22"]}]},{"efo_id":"EFO_0004142","efo_label":"colorectal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004142","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00385177"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00385177%22"]}]}],"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":4},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":2},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3707285","_score":1,"_source":{"id":"CHEMBL3707285","internal_compound":false,"type":"Small molecule","pref_name":"FERRIC HYDROXIDE","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Ferric hydroxide"],"trade_names":[],"indications":[{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01168505"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01168505%22"]}]}],"adverse_events":{"significant":[{"event":"protrusion tongue","count":205,"llr":8.450799555},{"event":"blood chloride decreased","count":1115,"llr":6.757437091},{"event":"blood phosphorus decreased","count":1181,"llr":6.699947168}],"critval":6.512200514},"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297930","_score":1,"_source":{"id":"CHEMBL4297930","internal_compound":false,"type":"Unknown","pref_name":"CYC-065","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Cyc-065","Cyc065"],"trade_names":[],"indications":[{"efo_id":"EFO_0000095","efo_label":"chronic lymphocytic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000095","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03739554"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03739554%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02552953"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02552953%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3301622","_score":1,"_source":{"id":"CHEMBL3301622","internal_compound":false,"type":"Small molecule","pref_name":"GILTERITINIB","year_first_approved":2018,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["ASP-2215","ASP-2215 HEMIFUMARATE","Gilteritinib","Gilteritinib fumarate"],"trade_names":["Xospata"],"cross_references":[{"source":"DailyMed","ids":["gilteritinib%20fumarate"]},{"source":"drugbank","ids":["DB12141"]}],"canonical_smiles":"CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1","indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02456883"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02456883%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02014558","NCT02115295","NCT02181660","NCT02236013","NCT02310321","NCT02421939","NCT02561455","NCT02752035","NCT02927262","NCT02997202","NCT03013998","NCT03182244","NCT03625505","NCT03730012","NCT03836209"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02014558%22OR%22NCT02115295%22OR%22NCT02181660%22OR%22NCT02236013%22OR%22NCT02310321%22OR%22NCT02421939%22OR%22NCT02561455%22OR%22NCT02752035%22OR%22NCT02927262%22OR%22NCT02997202%22OR%22NCT03013998%22OR%22NCT03182244%22OR%22NCT03625505%22OR%22NCT03730012%22OR%22NCT03836209%22"]}]},{"efo_id":"EFO_0001421","efo_label":"liver disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001421","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02571816"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02571816%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02495233"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02495233%22"]}]},{"efo_id":"EFO_0000198","efo_label":"myelodysplastic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000198","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02115295"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02115295%22"]}]},{"efo_id":"EFO_0000339","efo_label":"chronic myelogenous leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000339","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02115295"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02115295%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":4,"references":[{"source":"FDA","ids":["label/2018/211349s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2018%2F211349s000lbl.pdf"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000122025","approved_name":"fms related receptor tyrosine kinase 3","approved_symbol":"FLT3"}],"target_type":"single protein","target_name":"Tyrosine-protein kinase receptor FLT3","action_type":"inhibitor","description":"Tyrosine-protein kinase receptor FLT3 inhibitor","references":[{"source":"FDA","ids":["label/2018/211349s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2018%2F211349s000lbl.pdf"]},{"source":"Other","ids":["http://meetinglibrary.asco.org/content/131170-144"],"urls":["http://meetinglibrary.asco.org/content/131170-144"]},{"source":"PubMed","ids":["26555154","28516360"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26555154+OR+EXT_ID%3A28516360"]}]},{"target_components":[{"ensembl":"ENSG00000167601","approved_name":"AXL receptor tyrosine kinase","approved_symbol":"AXL"}],"target_type":"single protein","target_name":"Tyrosine-protein kinase receptor UFO","action_type":"inhibitor","description":"Tyrosine-protein kinase receptor UFO inhibitor","references":[{"source":"FDA","ids":["label/2018/211349s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2018%2F211349s000lbl.pdf"]},{"source":"Other","ids":["http://meetinglibrary.asco.org/content/131170-144"],"urls":["http://meetinglibrary.asco.org/content/131170-144"]},{"source":"PubMed","ids":["26555154","28516360"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26555154+OR+EXT_ID%3A28516360"]}]}],"adverse_events":{"significant":[{"event":"hepatic function abnormal","count":12036,"llr":23.96579726},{"event":"febrile neutropenia","count":19204,"llr":19.89404871},{"event":"encephalopathy","count":8151,"llr":19.49712486},{"event":"platelet count decreased","count":29394,"llr":19.11182636},{"event":"hepatitis","count":8668,"llr":19.07650177},{"event":"neutrophil count decreased","count":11062,"llr":17.41502851},{"event":"blast cell count increased","count":233,"llr":16.33843623},{"event":"pyrexia","count":87334,"llr":13.13981083},{"event":"bone marrow failure","count":8717,"llr":11.90237413},{"event":"myeloblast count increased","count":18,"llr":6.894298931},{"event":"leukaemic infiltration extramedullary","count":22,"llr":6.693710604}],"critval":6.643081078},"child_chembl_ids":["CHEMBL3301603"],"number_of_indications":7,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":6},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":4},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":4},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":3},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":3},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297456","_score":1,"_source":{"id":"CHEMBL4297456","internal_compound":false,"type":"Protein","pref_name":"ATN-161","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["ATN 161","ATN-161","Atn-161"],"trade_names":[],"canonical_smiles":"CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(N)=O","indications":[{"efo_id":"EFO_0000326","efo_label":"central nervous system cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000326","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00352313"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00352313%22"]}]},{"efo_id":"EFO_0000681","efo_label":"renal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000681","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00131651"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00131651%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL191886","_score":1,"_source":{"id":"CHEMBL191886","internal_compound":false,"type":"Small molecule","pref_name":"CICLETANINE","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["(+/-)BN-1270","BN-1270","Cicletanine","WIN-90000"],"trade_names":[],"cross_references":[{"source":"Wikipedia","ids":["Cicletanine"]},{"source":"drugbank","ids":["DB12766"]}],"canonical_smiles":"Cc1ncc2c(c1O)COC2c1ccc(Cl)cc1","indications":[{"efo_id":"EFO_0001361","efo_label":"pulmonary arterial hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001361","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00832507"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00832507%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL71595","_score":1,"_source":{"id":"CHEMBL71595","internal_compound":false,"type":"Small molecule","pref_name":"HYDROGEN PEROXIDE","year_first_approved":2017,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["A-101","Hydrogen Peroxide","NSC-19892","Oxydol"],"trade_names":["Crystacide","Eskata","Hioxyl","Peroxyl"],"cross_references":[{"source":"ChEBI","ids":[16240]},{"source":"DailyMed","ids":["hydrogen%20peroxide"]},{"source":"Wikipedia","ids":["Hydrogen_peroxide"]},{"source":"drugbank","ids":["DB11091"]}],"canonical_smiles":"OO","indications":[{"efo_id":"EFO_0000544","efo_label":"infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000544","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["A01AB02"],"urls":["https://www.whocc.no/atc_ddd_index/?code=A01AB02"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02757651","NCT03946202"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02757651%22OR%22NCT03946202%22"]}]},{"efo_id":"EFO_0000546","efo_label":"injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000546","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01008111"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01008111%22"]}]},{"efo_id":"EFO_1001216","efo_label":"tooth disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001216","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02935114"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02935114%22"]}]},{"efo_id":"EFO_0003819","efo_label":"dental caries","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003819","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT03678012"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03678012%22"]}]},{"efo_id":"EFO_0003894","efo_label":"acne","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003894","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03536637"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03536637%22"]}]},{"efo_id":"EFO_0005584","efo_label":"seborrheic keratosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005584","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT01986920","NCT02160626","NCT02260180","NCT02667236","NCT02667275","NCT02667288","NCT03148691"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01986920%22OR%22NCT02160626%22OR%22NCT02260180%22OR%22NCT02667236%22OR%22NCT02667275%22OR%22NCT02667288%22OR%22NCT03148691%22"]},{"source":"FDA","ids":["label/2017/209305s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2017%2F209305s000lbl.pdf"]}]}],"mechanisms_of_action":[],"adverse_events":{"significant":[{"event":"hypertrophic scar","count":35,"llr":41.08192705},{"event":"swelling of eyelid","count":217,"llr":31.96164755},{"event":"application site discolouration","count":456,"llr":28.25191004},{"event":"application site pain","count":3142,"llr":23.50614139},{"event":"application site ulcer","count":103,"llr":19.82446733},{"event":"application site erythema","count":2671,"llr":19.44336803},{"event":"chemical injury","count":130,"llr":19.126431},{"event":"product complaint","count":254,"llr":17.11877701},{"event":"application site inflammation","count":204,"llr":11.02248289},{"event":"bezoar","count":282,"llr":10.37602704},{"event":"end-tidal co2 abnormal","count":1,"llr":10.12583747},{"event":"suicide attempt","count":20244,"llr":9.555244052},{"event":"application site swelling","count":497,"llr":9.24574374},{"event":"administration site indentation","count":5,"llr":8.516457946},{"event":"pylorospasm","count":6,"llr":8.334150986},{"event":"hair colour changes","count":896,"llr":8.07276418},{"event":"incorrect product administration duration","count":932,"llr":7.994495605},{"event":"oedema","count":15307,"llr":7.824554927},{"event":"eye swelling","count":6631,"llr":7.42208797}],"critval":7.267724901},"number_of_indications":7,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":3},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109418","_score":1,"_source":{"id":"CHEMBL2109418","internal_compound":false,"type":"Antibody","pref_name":"3F8","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["3F8"],"trade_names":[],"indications":[{"efo_id":"EFO_0000621","efo_label":"neuroblastoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000621","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00002458","NCT00002560","NCT00002634","NCT00004110","NCT00037011","NCT00040872","NCT00072358","NCT00089258","NCT00450307","NCT00492167","NCT00877110","NCT01183416","NCT01183429","NCT01183884","NCT01183897","NCT01419834","NCT01662804"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002458%22OR%22NCT00002560%22OR%22NCT00002634%22OR%22NCT00004110%22OR%22NCT00037011%22OR%22NCT00040872%22OR%22NCT00072358%22OR%22NCT00089258%22OR%22NCT00450307%22OR%22NCT00492167%22OR%22NCT00877110%22OR%22NCT01183416%22OR%22NCT01183429%22OR%22NCT01183884%22OR%22NCT01183897%22OR%22NCT01419834%22OR%22NCT01662804%22"]}]}],"mechanisms_of_action":[],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108674","_score":1,"_source":{"id":"CHEMBL2108674","internal_compound":false,"type":"Protein","pref_name":"RAMATERCEPT","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["ACE-031","Ramatercept"],"trade_names":["ACE-031"],"indications":[{"efo_id":"EFO_0002970","efo_label":"muscular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002970","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00952887"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00952887%22"]}]},{"efo_id":"Orphanet_98896","efo_label":"Duchenne muscular dystrophy","efo_uri":"http://www.orpha.net/ORDO/Orphanet_98896","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01099761","NCT01239758"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01099761%22OR%22NCT01239758%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000138379","approved_name":"myostatin","approved_symbol":"MSTN"}],"target_type":"single protein","target_name":"Growth/differentiation factor 8","action_type":"inhibitor","description":"Growth/differentiation factor 8 inhibitor","references":[{"source":"Other","ids":["http://adisinsight.springer.com/drugs/800026145","http://www.ama-assn.org/resources/doc/usan/ramatercept.pdf"],"urls":["http://adisinsight.springer.com/drugs/800026145","http://www.ama-assn.org/resources/doc/usan/ramatercept.pdf"]},{"source":"PubMed","ids":["20466801","27462804"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20466801+OR+EXT_ID%3A27462804"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL361497","_score":1,"_source":{"id":"CHEMBL361497","internal_compound":false,"type":"Small molecule","pref_name":"ARTESUNATE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Artesunate","NSC-712571","Sodium Aresunate","Sodium Artesunate"],"trade_names":["Arsumax"],"cross_references":[{"source":"ChEBI","ids":[63918]},{"source":"drugbank","ids":["DB09274"]}],"canonical_smiles":"C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(=O)O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4","indications":[{"efo_id":"EFO_0000182","efo_label":"hepatocellular carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000182","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02304289"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02304289%22"]}]},{"efo_id":"EFO_0001068","efo_label":"malaria","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001068","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00118807","NCT00119132","NCT00123552","NCT00132548","NCT00132561","NCT00146731","NCT00243737","NCT00292929","NCT00292942","NCT00297882","NCT00298610","NCT00316329","NCT00330902","NCT00354380","NCT00373607","NCT00386503","NCT00403260","NCT00406146","NCT00422084","NCT00440999","NCT00519467","NCT00522132","NCT00538382","NCT00541385","NCT00545935","NCT00682630","NCT00694694","NCT01054248","NCT01152931","NCT01156389","NCT01165372","NCT01319448","NCT01374581","NCT01378286","NCT01523002","NCT01708876","NCT01845701","NCT01868438","NCT01939886","NCT01955382","NCT02411994","NCT02492178","NCT02563704","NCT02974348"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00118807%22OR%22NCT00119132%22OR%22NCT00123552%22OR%22NCT00132548%22OR%22NCT00132561%22OR%22NCT00146731%22OR%22NCT00243737%22OR%22NCT00292929%22OR%22NCT00292942%22OR%22NCT00297882%22OR%22NCT00298610%22OR%22NCT00316329%22OR%22NCT00330902%22OR%22NCT00354380%22OR%22NCT00373607%22OR%22NCT00386503%22OR%22NCT00403260%22OR%22NCT00406146%22OR%22NCT00422084%22OR%22NCT00440999%22OR%22NCT00519467%22OR%22NCT00522132%22OR%22NCT00538382%22OR%22NCT00541385%22OR%22NCT00545935%22OR%22NCT00682630%22OR%22NCT00694694%22OR%22NCT01054248%22OR%22NCT01152931%22OR%22NCT01156389%22OR%22NCT01165372%22OR%22NCT01319448%22OR%22NCT01374581%22OR%22NCT01378286%22OR%22NCT01523002%22OR%22NCT01708876%22OR%22NCT01845701%22OR%22NCT01868438%22OR%22NCT01939886%22OR%22NCT01955382%22OR%22NCT02411994%22OR%22NCT02492178%22OR%22NCT02563704%22OR%22NCT02974348%22"]}]},{"efo_id":"EFO_0007444","efo_label":"Plasmodium falciparum malaria","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007444","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00158548","NCT00289250","NCT00299208","NCT00331136","NCT00344006","NCT00356005","NCT00371735","NCT00378625","NCT00379821","NCT00459615","NCT00646126","NCT00682578","NCT00701961","NCT00894374","NCT00936767","NCT00959517","NCT00988507","NCT01144702","NCT01374126","NCT01407887","NCT01594931","NCT02389439","NCT02663700","NCT02996695","NCT03814616"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00158548%22OR%22NCT00289250%22OR%22NCT00299208%22OR%22NCT00331136%22OR%22NCT00344006%22OR%22NCT00356005%22OR%22NCT00371735%22OR%22NCT00378625%22OR%22NCT00379821%22OR%22NCT00459615%22OR%22NCT00646126%22OR%22NCT00682578%22OR%22NCT00701961%22OR%22NCT00894374%22OR%22NCT00936767%22OR%22NCT00959517%22OR%22NCT00988507%22OR%22NCT01144702%22OR%22NCT01374126%22OR%22NCT01407887%22OR%22NCT01594931%22OR%22NCT02389439%22OR%22NCT02663700%22OR%22NCT02996695%22OR%22NCT03814616%22"]}]},{"efo_id":"EFO_0007445","efo_label":"Plasmodium vivax malaria","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007445","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00158548","NCT00486694","NCT00682578","NCT01074905","NCT01288820"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00158548%22OR%22NCT00486694%22OR%22NCT00682578%22OR%22NCT01074905%22OR%22NCT01288820%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02353026"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02353026%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00764036"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00764036%22"]}]},{"efo_id":"EFO_0001062","efo_label":"cytomegalovirus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001062","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00284687"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00284687%22"]}]},{"efo_id":"EFO_0007530","efo_label":"urinary schistosomiasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007530","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00510159"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00510159%22"]}]},{"efo_id":"EFO_1001475","efo_label":"schistosomiasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001475","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01054651"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01054651%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03093129"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03093129%22"]}]}],"mechanisms_of_action":[],"adverse_events":{"significant":[{"event":"haemolytic anaemia","count":3565,"llr":86.4081624},{"event":"small for dates baby","count":1938,"llr":25.28152446},{"event":"hepatotoxicity","count":5998,"llr":22.77968075},{"event":"death neonatal","count":37,"llr":22.35250998},{"event":"stillbirth","count":1542,"llr":21.25955502},{"event":"haemolysis","count":2108,"llr":14.8485688},{"event":"drug-induced liver injury","count":7265,"llr":13.60370349},{"event":"herbal interaction","count":128,"llr":11.59522586},{"event":"glioblastoma multiforme","count":193,"llr":10.77502429},{"event":"prolonged labour","count":199,"llr":10.71389824},{"event":"nematodiasis","count":3,"llr":8.84937211},{"event":"autoimmune haemolytic anaemia","count":792,"llr":7.961588122},{"event":"hookworm infection","count":8,"llr":7.868630178}],"critval":7.804247615},"child_chembl_ids":["CHEMBL207675"],"number_of_indications":10,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":6},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":5},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":4},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":4},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":3},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL499915","_score":1,"_source":{"id":"CHEMBL499915","internal_compound":false,"type":"Small molecule","pref_name":"CARBENOXOLONE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Carbenoxolone","Carbenoxolone Disodium","Carbenoxolone Sodium"],"trade_names":["Biogastrone","Bioplex","Bioral","Duogastrone"],"cross_references":[{"source":"Wikipedia","ids":["Carbenoxolone"]},{"source":"drugbank","ids":["DB02329"]},{"source":"PubChem","ids":["144204320","170465951"]}],"canonical_smiles":"CC1(C)[C@@H](OC(=O)CCC(=O)O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C","indications":[{"efo_id":"EFO_0003948","efo_label":"gastroesophageal reflux disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003948","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["A02BX01","A02BX51","A02BX71"],"urls":["https://www.whocc.no/atc_ddd_index/?code=A02BX01","https://www.whocc.no/atc_ddd_index/?code=A02BX51","https://www.whocc.no/atc_ddd_index/?code=A02BX71"]}]},{"efo_id":"HP_0004398","efo_label":"Peptic ulcer","efo_uri":"http://purl.obolibrary.org/obo/HP_0004398","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["A02BX01","A02BX51","A02BX71"],"urls":["https://www.whocc.no/atc_ddd_index/?code=A02BX01","https://www.whocc.no/atc_ddd_index/?code=A02BX51","https://www.whocc.no/atc_ddd_index/?code=A02BX71"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000176387","approved_name":"hydroxysteroid 11-beta dehydrogenase 2","approved_symbol":"HSD11B2"},{"ensembl":"ENSG00000117594","approved_name":"hydroxysteroid 11-beta dehydrogenase 1","approved_symbol":"HSD11B1"}],"target_type":"protein family","target_name":"11-beta-hydroxysteroid dehydrogenase","action_type":"inhibitor","description":"11-beta-hydroxysteroid dehydrogenase inhibitor","references":[{"source":"Other","ids":["https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Aldrich/Product_Information_Sheet/c4790pis.pdf"],"urls":["https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Aldrich/Product_Information_Sheet/c4790pis.pdf"]},{"source":"PubMed","ids":["15071189","22473546","780088","8664169"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15071189+OR+EXT_ID%3A22473546+OR+EXT_ID%3A780088+OR+EXT_ID%3A8664169"]}]}],"adverse_events":{"significant":[{"event":"gingival hyperplasia","count":379,"llr":25.41830098}],"critval":14.47363369},"child_chembl_ids":["CHEMBL1697717"],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2107553","_score":1,"_source":{"id":"CHEMBL2107553","internal_compound":false,"type":"Small molecule","pref_name":"TERIZIDONE","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Terizidone"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12954"]}],"canonical_smiles":"O=C1NOCC1/N=C/c1ccc(/C=N/C2CONC2=O)cc1","indications":[{"efo_id":"EFO_0007381","efo_label":"multidrug-resistant tuberculosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007381","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02454205"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02454205%22"]}]}],"adverse_events":{"significant":[{"event":"drug resistance","count":7341,"llr":88.23516587},{"event":"psychotic disorder","count":11057,"llr":58.09104884},{"event":"anaemia","count":61405,"llr":55.13578122},{"event":"bicytopenia","count":451,"llr":45.57238157},{"event":"helicobacter gastritis","count":451,"llr":45.57238157},{"event":"drug-induced liver injury","count":7265,"llr":31.26223292},{"event":"gastroenteritis","count":4760,"llr":28.34458717},{"event":"neuropathy peripheral","count":20261,"llr":27.65429229},{"event":"haematemesis","count":6588,"llr":25.17711986},{"event":"generalised tonic-clonic seizure","count":4083,"llr":22.08716413},{"event":"hypothyroidism","count":7054,"llr":17.84878202},{"event":"meningitis tuberculous","count":159,"llr":14.97300306},{"event":"intracranial mass","count":196,"llr":14.34710776},{"event":"secondary syphilis","count":26,"llr":12.78342556},{"event":"meningitis bacterial","count":373,"llr":12.42502171},{"event":"pancreatitis chronic","count":561,"llr":11.20941605},{"event":"electrocardiogram qt prolonged","count":12378,"llr":11.01398184},{"event":"lactic acidosis","count":8744,"llr":10.50053827},{"event":"incorrect product administration duration","count":932,"llr":9.703990557},{"event":"toxic optic neuropathy","count":123,"llr":9.679826415},{"event":"heart rate decreased","count":5985,"llr":9.661795079},{"event":"pancreatitis","count":15810,"llr":9.458955514},{"event":"vomiting","count":103943,"llr":9.321938765},{"event":"pneumothorax spontaneous","count":193,"llr":8.782117441},{"event":"tuberculosis","count":3828,"llr":8.569777804},{"event":"intention tremor","count":236,"llr":8.381863036},{"event":"sputum culture positive","count":236,"llr":8.381863036},{"event":"blood sodium decreased","count":4728,"llr":7.767177719},{"event":"blood thyroid stimulating hormone increased","count":1855,"llr":7.682390799},{"event":"seborrhoeic dermatitis","count":367,"llr":7.504983936},{"event":"oral candidiasis","count":2639,"llr":6.661650556},{"event":"ototoxicity","count":625,"llr":6.452378189}],"critval":6.349451366},"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1100","_score":1,"_source":{"id":"CHEMBL1100","internal_compound":false,"type":"Small molecule","pref_name":"PARAMETHADIONE","year_first_approved":1949,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Isoethadione","Paramethadione"],"trade_names":["Paradione"],"cross_references":[{"source":"ChEBI","ids":[7921]},{"source":"Wikipedia","ids":["Paramethadione"]},{"source":"drugbank","ids":["DB00617"]}],"canonical_smiles":"CCC1(C)OC(=O)N(C)C1=O","indications":[{"efo_id":"EFO_0000474","efo_label":"epilepsy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000474","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N03AC01"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N03AC01"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000196557","approved_name":"calcium voltage-gated channel subunit alpha1 H","approved_symbol":"CACNA1H"},{"ensembl":"ENSG00000006283","approved_name":"calcium voltage-gated channel subunit alpha1 G","approved_symbol":"CACNA1G"},{"ensembl":"ENSG00000100346","approved_name":"calcium voltage-gated channel subunit alpha1 I","approved_symbol":"CACNA1I"}],"target_type":"protein family","target_name":"Voltage-gated T-type calcium channel","action_type":"blocker","description":"Voltage-gated T-type calcium channel blocker","references":[{"source":"PubMed","ids":["11641441","17291698"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11641441+OR+EXT_ID%3A17291698"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108264","_score":1,"_source":{"id":"CHEMBL2108264","internal_compound":false,"type":"Unknown","pref_name":"CARRAGEENAN","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Carrageenan","E-407","INS NO.407","INS-407"],"trade_names":["Marine Colloids"],"indications":[{"efo_id":"EFO_0001668","efo_label":"human papilloma virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001668","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02382419"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02382419%22"]}]},{"efo_id":"EFO_0008571","efo_label":"viral conjunctivitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008571","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03009799"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03009799%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297857","_score":1,"_source":{"id":"CHEMBL4297857","internal_compound":false,"type":"Unknown","pref_name":"AB-928","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AB-928","AB928","Ab-928","Ab928"],"trade_names":[],"indications":[{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03846310"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03846310%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL145","_score":1,"_source":{"id":"CHEMBL145","internal_compound":false,"type":"Small molecule","pref_name":"CAFFEIC ACID","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Caffeic acid","NSC-57197","NSC-623438","trans-Caffeate"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[16433]},{"source":"PubChem","ids":["106262","124883134","124883135","124883138","26746990","26751505","50104061","50104062","50104063","50104064","50104065","56422203","85231345","855772","90340699"]},{"source":"Wikipedia","ids":["Caffeic_acid"]},{"source":"drugbank","ids":["DB01880"]}],"canonical_smiles":"O=C(O)/C=C/c1ccc(O)c(O)c1","indications":[{"efo_id":"EFO_0007160","efo_label":"autoimmune thrombocytopenic purpura","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007160","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02351622"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02351622%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2103792","_score":1,"_source":{"id":"CHEMBL2103792","internal_compound":false,"type":"Oligonucleotide","pref_name":"AGATOLIMOD","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Agatolimod","Agatolimod Sodium","Agatolimod tricosasodium salt","CPG 7909","PF-03512676","PF-3512676"],"trade_names":[],"canonical_smiles":"Cc1cn([C@H]2C[C@H](O)[C@@H](COP(O)(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3CO)O2)c(=O)[nH]c1=O","indications":[{"efo_id":"EFO_0001068","efo_label":"malaria","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001068","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00427167"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00427167%22"]}]},{"efo_id":"EFO_0000756","efo_label":"melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000756","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00070642","NCT00085189","NCT00112242","NCT00145145"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00070642%22OR%22NCT00085189%22OR%22NCT00112242%22OR%22NCT00145145%22"]}]},{"efo_id":"EFO_0002913","efo_label":"Cutaneous T-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002913","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00043420"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00043420%22"]}]},{"efo_id":"EFO_0000095","efo_label":"chronic lymphocytic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000095","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00233506","NCT00438880"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00233506%22OR%22NCT00438880%22"]}]},{"efo_id":"EFO_0000096","efo_label":"neoplasm of mature B-cells","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000096","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00880581"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00880581%22"]}]},{"efo_id":"EFO_0000191","efo_label":"MALT lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000191","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00438880"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00438880%22"]}]},{"efo_id":"EFO_0000403","efo_label":"diffuse large B-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000403","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00438880"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00438880%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00040950"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00040950%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00070629","NCT00254904"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00070629%22OR%22NCT00254904%22"]}]},{"efo_id":"EFO_0003869","efo_label":"breast neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003869","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00471159"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00471159%22"]}]},{"efo_id":"EFO_0005952","efo_label":"non-Hodgkins lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005952","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00880581"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00880581%22"]}]},{"efo_id":"EFO_1001469","efo_label":"Mantle cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001469","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00438880","NCT00490529"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00438880%22OR%22NCT00490529%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00199836"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00199836%22"]}]},{"efo_id":"EFO_0000313","efo_label":"carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000313","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00031278","NCT00043394"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00031278%22OR%22NCT00043394%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00299728"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00299728%22"]}]},{"efo_id":"EFO_0000681","efo_label":"renal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000681","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00043407"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00043407%22"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00562939"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00562939%22"]}]},{"efo_id":"EFO_0001068","efo_label":"malaria","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001068","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00320658","NCT00414336","NCT00427167","NCT00889616","NCT00984763","NCT01351948"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00320658%22OR%22NCT00414336%22OR%22NCT00427167%22OR%22NCT00889616%22OR%22NCT00984763%22OR%22NCT01351948%22"]}]},{"efo_id":"EFO_0007444","efo_label":"Plasmodium falciparum malaria","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007444","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00344539"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00344539%22"]}]},{"efo_id":"EFO_0009441","efo_label":"Waldenstrom macroglobulinemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009441","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00438880"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00438880%22"]}]},{"efo_id":"EFO_1001051","efo_label":"mycosis fungoides","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001051","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00185965","NCT00226993"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00185965%22OR%22NCT00226993%22"]}]},{"efo_id":"HP_0100806","efo_label":"Sepsis","efo_uri":"http://purl.obolibrary.org/obo/HP_0100806","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01164514"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01164514%22"]}]}],"adverse_events":{"significant":[{"event":"metabolic encephalopathy","count":868,"llr":16.8981125}],"critval":11.78190278},"child_chembl_ids":["CHEMBL2103793"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000239732","approved_name":"toll like receptor 9","approved_symbol":"TLR9"}],"target_type":"single protein","target_name":"Toll-like receptor 9","action_type":"agonist","description":"Toll-like receptor 9 agonist","references":[{"source":"Other","ids":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=38660"],"urls":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=38660"]},{"source":"PubMed","ids":["18596994"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18596994"]}]}],"number_of_indications":22,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":17},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":13},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":10},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":6},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":4},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":4},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":4},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":4},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":2},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":2},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":2},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201608","_score":1,"_source":{"id":"CHEMBL1201608","internal_compound":false,"type":"Antibody","pref_name":"MUROMONAB-CD3","year_first_approved":1986,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["L04AA02","Muromonab cd3","Muromonab-Cd3","OKT-3","OKT3"],"trade_names":["Orthoclone Okt3"],"cross_references":[{"source":"DailyMed","ids":["muromonab-cd3"]},{"source":"DrugCentral","ids":["5177"]},{"source":"Wikipedia","ids":["Muromonab-CD3"]}],"indications":[{"efo_id":"EFO_0000540","efo_label":"immune system disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000540","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["L04AA02"],"urls":["https://www.whocc.no/atc_ddd_index/?code=L04AA02"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00202917","NCT00824135"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00202917%22OR%22NCT00824135%22"]}]},{"efo_id":"EFO_0000326","efo_label":"central nervous system cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000326","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00002572","NCT00004024"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002572%22OR%22NCT00004024%22"]}]},{"efo_id":"EFO_0000389","efo_label":"cutaneous melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000389","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00004022"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004022%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00002482"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002482%22"]}]},{"efo_id":"EFO_0000729","efo_label":"ulcerative colitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000729","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01287195"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01287195%22"]}]},{"efo_id":"EFO_0000756","efo_label":"melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000756","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00080353"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00080353%22"]}]},{"efo_id":"EFO_0002890","efo_label":"renal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002890","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00002589"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002589%22"]}]},{"efo_id":"EFO_0003865","efo_label":"kidney neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003865","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00091611"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00091611%22"]}]},{"efo_id":"EFO_1001249","efo_label":"non-alcoholic steatohepatitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001249","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01205087"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01205087%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000198851","approved_name":"CD3e molecule","approved_symbol":"CD3E"},{"ensembl":"ENSG00000160654","approved_name":"CD3g molecule","approved_symbol":"CD3G"},{"ensembl":"ENSG00000167286","approved_name":"CD3d molecule","approved_symbol":"CD3D"}],"target_type":"protein complex","target_name":"T cell surface glycoprotein CD3","action_type":"inhibitor","description":"T cell surface glycoprotein CD3 inhibitor","references":[{"source":"DailyMed","ids":["setid=2a1f1c18-fa95-45e6-bd00-ac53c73f4747"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2a1f1c18-fa95-45e6-bd00-ac53c73f4747"]},{"source":"PubMed","ids":["15136729"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15136729"]}]}],"adverse_events":{"significant":[{"event":"post transplant lymphoproliferative disorder","count":944,"llr":57.75178119},{"event":"bacterial test","count":126,"llr":47.51135033},{"event":"kidney transplant rejection","count":1782,"llr":23.9071842},{"event":"myelopathy","count":564,"llr":18.85919087},{"event":"polyomavirus interstitial nephritis","count":7,"llr":16.79306044},{"event":"chronic allograft nephropathy","count":339,"llr":14.78994045},{"event":"epstein-barr virus infection","count":1685,"llr":14.50704559},{"event":"cytomegalovirus test positive","count":553,"llr":13.32683186},{"event":"acute graft versus host disease in skin","count":622,"llr":12.97568655},{"event":"pancreatic duct dilatation","count":66,"llr":12.30695537},{"event":"cytomegalovirus viraemia","count":913,"llr":11.83105136},{"event":"dilatation intrahepatic duct acquired","count":121,"llr":11.09597406},{"event":"diffuse large b-cell lymphoma","count":1375,"llr":10.61335297},{"event":"glomerulonephritis proliferative","count":172,"llr":10.39376267},{"event":"leukoencephalopathy","count":1566,"llr":10.22757302},{"event":"cytomegalovirus infection","count":5010,"llr":10.2246998},{"event":"lymphadenectomy","count":210,"llr":9.99542806},{"event":"heart transplant rejection","count":247,"llr":9.671734496},{"event":"microangiopathic haemolytic anaemia","count":279,"llr":9.428838357},{"event":"meningitis cryptococcal","count":416,"llr":8.633105624},{"event":"epstein-barr virus associated lymphoproliferative disorder","count":435,"llr":8.54422986},{"event":"pyrexia","count":87334,"llr":8.086093107},{"event":"capillary leak syndrome","count":550,"llr":8.077783539},{"event":"opportunistic infection","count":660,"llr":7.715721362},{"event":"bk virus infection","count":769,"llr":7.412576641},{"event":"gastrointestinal anastomotic stenosis","count":14,"llr":7.004991215}],"critval":6.735681385},"number_of_indications":10,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":7},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":3},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":2},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":2},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":2},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297616","_score":1,"_source":{"id":"CHEMBL4297616","internal_compound":false,"type":"Small molecule","pref_name":"OLINCIGUAT","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["IW-1701","IW1701","Iw-1701","Olinciguat"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB15238"]}],"canonical_smiles":"NC(=O)[C@](O)(CNc1nc(-c2cc(-c3ccon3)n(Cc3ccccc3F)n2)ncc1F)C(F)(F)F","indications":[{"efo_id":"Orphanet_232","efo_label":"Sickle cell anemia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_232","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03285178"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03285178%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201439","_score":1,"_source":{"id":"CHEMBL1201439","internal_compound":false,"type":"Antibody","pref_name":"BASILIXIMAB","year_first_approved":1998,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["Basiliximab","CHI-621","SDZ-CHI-621"],"trade_names":["Simulect"],"cross_references":[{"source":"DailyMed","ids":["basiliximab"]},{"source":"DrugCentral","ids":["4940"]},{"source":"Wikipedia","ids":["Basiliximab"]}],"indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00626483"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00626483%22"]}]},{"efo_id":"EFO_0000729","efo_label":"ulcerative colitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000729","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00430898","NCT01061996"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00430898%22OR%22NCT01061996%22"]}]},{"efo_id":"EFO_0000540","efo_label":"immune system disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000540","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["L04AC02"],"urls":["https://www.whocc.no/atc_ddd_index/?code=L04AC02"]}]},{"efo_id":"EFO_0003884","efo_label":"chronic kidney disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003884","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00023244","NCT00890253","NCT00928811"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00023244%22OR%22NCT00890253%22OR%22NCT00928811%22"]}]},{"efo_id":"EFO_0004599","efo_label":"acute graft vs. host disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004599","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00235300","NCT00251004","NCT00555321","NCT01485055"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00235300%22OR%22NCT00251004%22OR%22NCT00555321%22OR%22NCT01485055%22"]}]},{"efo_id":"EFO_0002687","efo_label":"ischemia reperfusion injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002687","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01239563"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01239563%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01842139"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01842139%22"]}]},{"efo_id":"EFO_1001231","efo_label":"uveitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001231","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00646425"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00646425%22"]}]},{"efo_id":"EFO_0000183","efo_label":"Hodgkins lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000183","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01476839"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01476839%22"]}]},{"efo_id":"EFO_0000253","efo_label":"amyotrophic lateral sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000253","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01884571"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01884571%22"]}]},{"efo_id":"EFO_0000519","efo_label":"glioblastoma multiforme","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000519","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02366728"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02366728%22"]}]},{"efo_id":"EFO_0000544","efo_label":"infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000544","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00149890"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00149890%22"]}]},{"efo_id":"EFO_0001359","efo_label":"type I diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001359","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00434811","NCT00434850","NCT00464555","NCT00468117","NCT00468403","NCT00789308","NCT00790439","NCT00798785","NCT02464878"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00434811%22OR%22NCT00434850%22OR%22NCT00464555%22OR%22NCT00468117%22OR%22NCT00468403%22OR%22NCT00789308%22OR%22NCT00790439%22OR%22NCT00798785%22OR%22NCT02464878%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01526096"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01526096%22"]}]},{"efo_id":"EFO_0004236","efo_label":"focal segmental glomerulosclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004236","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02921789"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02921789%22"]}]},{"efo_id":"EFO_1000794","efo_label":"acute kidney tubular necrosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000794","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02561767"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02561767%22"]}]},{"efo_id":"Orphanet_567","efo_label":"22q11.2 deletion syndrome","efo_uri":"http://www.orpha.net/ORDO/Orphanet_567","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01220531"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01220531%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000134460","approved_name":"interleukin 2 receptor subunit alpha","approved_symbol":"IL2RA"},{"ensembl":"ENSG00000147168","approved_name":"interleukin 2 receptor subunit gamma","approved_symbol":"IL2RG"},{"ensembl":"ENSG00000100385","approved_name":"interleukin 2 receptor subunit beta","approved_symbol":"IL2RB"}],"target_type":"protein complex","target_name":"Interleukin-2 receptor","action_type":"inhibitor","description":"Interleukin-2 receptor inhibitor","references":[{"source":"DailyMed","ids":["setid=1af01887-b69d-444b-91ed-ebfe12784440"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1af01887-b69d-444b-91ed-ebfe12784440"]}]}],"adverse_events":{"significant":[{"event":"kidney transplant rejection","count":1782,"llr":1594.78802},{"event":"cytomegalovirus infection","count":5010,"llr":807.8634619},{"event":"transplant rejection","count":2524,"llr":652.2899115},{"event":"polyomavirus-associated nephropathy","count":605,"llr":477.2105185},{"event":"blood creatinine increased","count":21684,"llr":432.9025626},{"event":"lymphocyte count decreased","count":5692,"llr":298.826284},{"event":"incision site pain","count":315,"llr":263.9250683},{"event":"neutrophil count increased","count":4046,"llr":238.0529235},{"event":"delayed graft function","count":245,"llr":220.2646219},{"event":"blood urea increased","count":6508,"llr":198.9973093},{"event":"bk virus infection","count":769,"llr":194.5092433},{"event":"post transplant lymphoproliferative disorder","count":944,"llr":192.7253284},{"event":"red blood cells urine positive","count":375,"llr":189.8527732},{"event":"chronic allograft nephropathy","count":339,"llr":189.0591315},{"event":"pyrexia","count":87334,"llr":170.1993002},{"event":"cytomegalovirus viraemia","count":913,"llr":163.2568022},{"event":"renal tubular necrosis","count":3219,"llr":153.5048207},{"event":"protein urine present","count":1333,"llr":149.3929652},{"event":"ventricular remodelling","count":28,"llr":148.2297463},{"event":"haemoglobin decreased","count":33686,"llr":131.6438627},{"event":"leukopenia","count":17226,"llr":130.5171962},{"event":"posterior reversible encephalopathy syndrome","count":3497,"llr":128.7715596},{"event":"liver transplant rejection","count":657,"llr":128.2784489},{"event":"thrombotic microangiopathy","count":2397,"llr":124.7923192},{"event":"urinary tract infection","count":38069,"llr":123.2094868},{"event":"kaposi's sarcoma","count":983,"llr":121.7551739},{"event":"renal impairment","count":20843,"llr":115.7832798},{"event":"white blood cell count increased","count":13372,"llr":110.7997982},{"event":"lymphocele","count":375,"llr":104.8440846},{"event":"mucormycosis","count":447,"llr":104.5566785},{"event":"immunosuppressant drug level increased","count":896,"llr":100.572426},{"event":"nocardiosis","count":726,"llr":98.9738478},{"event":"urine output decreased","count":2326,"llr":98.90504691},{"event":"tubulointerstitial nephritis","count":4806,"llr":97.1636997},{"event":"parvovirus b19 infection","count":164,"llr":95.15607601},{"event":"ureteric stenosis","count":330,"llr":93.95558336},{"event":"nephropathy toxic","count":3566,"llr":93.5473784},{"event":"renal tubular atrophy","count":324,"llr":89.65801575},{"event":"diabetes mellitus","count":14312,"llr":88.71149358},{"event":"kidney fibrosis","count":605,"llr":87.35696567},{"event":"pseudomonas infection","count":1686,"llr":87.09277903},{"event":"transplant failure","count":618,"llr":86.79142186},{"event":"blood glucose increased","count":20555,"llr":81.97925264},{"event":"klebsiella infection","count":1124,"llr":81.95314109},{"event":"focal segmental glomerulosclerosis","count":544,"llr":81.59880469},{"event":"microsporidia infection","count":86,"llr":80.07703417},{"event":"anuria","count":2677,"llr":77.61419442},{"event":"c-reactive protein increased","count":10518,"llr":76.99540591},{"event":"cytomegalovirus colitis","count":556,"llr":76.8488629},{"event":"strongyloidiasis","count":419,"llr":74.68655915},{"event":"epstein-barr virus infection","count":1685,"llr":73.49712983},{"event":"graft loss","count":281,"llr":69.24342844},{"event":"oliguria","count":1950,"llr":69.14171328},{"event":"hyperuricaemia","count":1384,"llr":68.93915011},{"event":"pneumocystis jirovecii pneumonia","count":2343,"llr":66.73351346},{"event":"pneumonia cytomegaloviral","count":371,"llr":64.02319251},{"event":"urinary fistula","count":56,"llr":63.30823146},{"event":"viraemia","count":305,"llr":63.17247114},{"event":"jc virus infection","count":267,"llr":60.93618391},{"event":"blood albumin decreased","count":2695,"llr":59.59626917},{"event":"capillaritis","count":81,"llr":58.52635369},{"event":"herpes simplex","count":1665,"llr":57.52021641},{"event":"graft versus host disease","count":1579,"llr":55.63431349},{"event":"acid base balance abnormal","count":78,"llr":53.51645495},{"event":"cytomegalovirus test positive","count":553,"llr":52.62391263},{"event":"hydronephrosis","count":2386,"llr":51.47055071},{"event":"proteinuria","count":6145,"llr":51.36284243},{"event":"anaemia","count":61405,"llr":51.08622615},{"event":"diabetic macroangiopathy","count":18,"llr":50.71333418},{"event":"enterococcal infection","count":1106,"llr":50.38887482},{"event":"nephrosclerosis","count":228,"llr":49.67234768},{"event":"pathogen resistance","count":2318,"llr":49.34343467},{"event":"diffuse large b-cell lymphoma","count":1375,"llr":49.16773882},{"event":"renal graft loss","count":44,"llr":48.4813054},{"event":"urosepsis","count":2704,"llr":48.29992207},{"event":"renal vein thrombosis","count":183,"llr":47.99774202},{"event":"fatigue","count":147738,"llr":46.9175944},{"event":"glomerulonephritis","count":938,"llr":46.77066109},{"event":"adenovirus infection","count":524,"llr":45.76928648},{"event":"procedural pain","count":3925,"llr":43.81917103},{"event":"escherichia infection","count":1805,"llr":43.46238593},{"event":"renal tubular disorder","count":1390,"llr":42.65897774},{"event":"cytomegalovirus antigen positive","count":80,"llr":42.52656405},{"event":"drug hypersensitivity","count":71246,"llr":42.52120023},{"event":"toxicity to various agents","count":31033,"llr":40.89759987},{"event":"malacoplakia","count":30,"llr":40.05726445},{"event":"sarcopenia","count":37,"llr":38.38409828},{"event":"transplant dysfunction","count":675,"llr":38.25984235},{"event":"argentine haemorrhagic fever","count":6,"llr":37.96027042},{"event":"haemolytic uraemic syndrome","count":1065,"llr":37.93939446},{"event":"atypical haemolytic uraemic syndrome","count":132,"llr":37.55294184},{"event":"dyslipidaemia","count":1671,"llr":36.27907844},{"event":"nephropathy","count":1678,"llr":36.20423159},{"event":"hepatic artery thrombosis","count":93,"llr":35.98253039},{"event":"urinary tract infection enterococcal","count":343,"llr":35.91799723},{"event":"graft dysfunction","count":157,"llr":35.83491215},{"event":"tongue necrosis","count":24,"llr":35.67453257},{"event":"cytomegalovirus syndrome","count":52,"llr":35.67134488},{"event":"bilirubin conjugated increased","count":1089,"llr":34.43493822},{"event":"nephrectomy","count":277,"llr":34.29189671},{"event":"human herpesvirus 8 infection","count":115,"llr":34.0859823},{"event":"fall","count":67604,"llr":33.79927305},{"event":"iga nephropathy","count":412,"llr":33.76373841},{"event":"neutropenia","count":41585,"llr":33.67130469},{"event":"schistosomiasis","count":34,"llr":33.24295699},{"event":"pancreatitis acute","count":7957,"llr":33.10221492},{"event":"blood triglycerides increased","count":5126,"llr":32.6114366},{"event":"acute respiratory distress syndrome","count":3118,"llr":32.2947193},{"event":"renal transplant failure","count":233,"llr":31.93687011}],"critval":31.75027937},"number_of_indications":17,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":7},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":5},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":4},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":4},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":3},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":3},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":2},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201575","_score":1,"_source":{"id":"CHEMBL1201575","internal_compound":false,"type":"Antibody","pref_name":"EFALIZUMAB","year_first_approved":2003,"max_clinical_trial_phase":4,"withdrawn_flag":true,"withdrawn_reason":["Progressive multifocal leukoencephalopathy"],"withdrawn_year":2009,"withdrawn_country":["United States"],"withdrawn_class":["Neurotoxicity"],"black_box_warning":false,"synonyms":["Anti-Cd11A","Efalizumab","HU-1124","hu1124"],"trade_names":["Raptiva"],"cross_references":[{"source":"DrugCentral","ids":["4959"]},{"source":"Wikipedia","ids":["Efalizumab"]}],"indications":[{"efo_id":"EFO_0000676","efo_label":"psoriasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000676","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00096603","NCT00109252","NCT00109317","NCT00115076","NCT00256139","NCT00338143","NCT00368654","NCT00382512","NCT00442650"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00096603%22OR%22NCT00109252%22OR%22NCT00109317%22OR%22NCT00115076%22OR%22NCT00256139%22OR%22NCT00338143%22OR%22NCT00368654%22OR%22NCT00382512%22OR%22NCT00442650%22"]}]},{"efo_id":"EFO_0001359","efo_label":"type I diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001359","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00276250","NCT00501709","NCT00737763"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00276250%22OR%22NCT00501709%22OR%22NCT00737763%22"]}]},{"efo_id":"Orphanet_700","efo_label":"Alopecia totalis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_700","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00746980"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00746980%22"]}]},{"efo_id":"EFO_0000540","efo_label":"immune system disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000540","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["L04AA21"],"urls":["https://www.whocc.no/atc_ddd_index/?code=L04AA21"]},{"source":"ClinicalTrials","ids":["NCT00777400"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00777400%22"]}]},{"efo_id":"EFO_0000699","efo_label":"Sjogren syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000699","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00344448"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00344448%22"]}]},{"efo_id":"EFO_0000274","efo_label":"atopic eczema","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000274","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00146003","NCT00226057"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00146003%22OR%22NCT00226057%22"]}]},{"efo_id":"EFO_0000685","efo_label":"rheumatoid arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000685","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00034203"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00034203%22"]}]},{"efo_id":"EFO_0001365","efo_label":"age-related macular degeneration","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001365","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00726466"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00726466%22"]}]},{"efo_id":"EFO_0002690","efo_label":"systemic lupus erythematosus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002690","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00308204"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00308204%22"]}]},{"efo_id":"EFO_0003778","efo_label":"psoriatic arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003778","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00051662"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00051662%22"]}]},{"efo_id":"EFO_1000710","efo_label":"hidradenitis suppurativa","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000710","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00134134"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00134134%22"]}]},{"efo_id":"EFO_0003884","efo_label":"chronic kidney disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003884","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00472082"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00472082%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000005844","approved_name":"integrin subunit alpha L","approved_symbol":"ITGAL"},{"ensembl":"ENSG00000160255","approved_name":"integrin subunit beta 2","approved_symbol":"ITGB2"}],"target_type":"protein complex","target_name":"Integrin alpha-L/beta-2 (LFA-1)","action_type":"inhibitor","description":"Integrin alpha-L/beta-2 (LFA-1) inhibitor","references":[{"source":"FDA","ids":["label/2009/125075s130lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2009%2F125075s130lbl.pdf"]}]}],"adverse_events":{"significant":[{"event":"psoriasis","count":30767,"llr":554.682382},{"event":"white blood cell count increased","count":13372,"llr":90.43262721},{"event":"lymphocyte count increased","count":907,"llr":66.59620027},{"event":"lymphocytosis","count":787,"llr":57.41112401},{"event":"psoriatic arthropathy","count":6717,"llr":57.04026746},{"event":"erythrodermic psoriasis","count":357,"llr":48.97654347},{"event":"pustular psoriasis","count":1381,"llr":33.66034181},{"event":"meningitis aseptic","count":1201,"llr":32.36309669},{"event":"dermatitis exfoliative","count":2700,"llr":32.07837796},{"event":"arthritis","count":13179,"llr":31.97125614},{"event":"papillary cystadenoma lymphomatosum","count":25,"llr":31.78894312},{"event":"diarrhoea","count":126514,"llr":26.14789584},{"event":"skin exfoliation","count":9496,"llr":25.6980817},{"event":"skin plaque","count":2154,"llr":24.60368832},{"event":"influenza like illness","count":19494,"llr":24.24439056},{"event":"guttate psoriasis","count":242,"llr":22.37170422},{"event":"primary amyloidosis","count":17,"llr":21.11121671}],"critval":21.10316229},"number_of_indications":12,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":8},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":4},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":3},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":3},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":2},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3833389","_score":1,"_source":{"id":"CHEMBL3833389","internal_compound":false,"type":"Small molecule","pref_name":"DEXTROMORAMIDE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Dextromoramide","Dextromoramide tartrate"],"trade_names":["Dimorlin tartrate","Palfium"],"canonical_smiles":"C[C@@H](CC(C(=O)N1CCCC1)(c1ccccc1)c1ccccc1)N1CCOCC1","indications":[{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N02AC01"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N02AC01"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000082556","approved_name":"opioid receptor kappa 1","approved_symbol":"OPRK1"},{"ensembl":"ENSG00000116329","approved_name":"opioid receptor delta 1","approved_symbol":"OPRD1"},{"ensembl":"ENSG00000112038","approved_name":"opioid receptor mu 1","approved_symbol":"OPRM1"}],"target_type":"protein family","target_name":"Opioid receptors; mu/kappa/delta","action_type":"agonist","description":"Opioid receptors; mu/kappa/delta agonist","references":[{"source":"PubMed","ids":["10574310","15268688"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10574310+OR+EXT_ID%3A15268688"]}]}],"adverse_events":{"significant":[{"event":"type i hypersensitivity","count":913,"llr":29.55464932},{"event":"feeling hot","count":10305,"llr":19.86495827},{"event":"flushing","count":18642,"llr":17.49816943},{"event":"hyperhidrosis","count":28377,"llr":15.82262834}],"critval":10.8469823},"child_chembl_ids":["CHEMBL3833311"],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL306280","_score":1,"_source":{"id":"CHEMBL306280","internal_compound":false,"type":"Small molecule","pref_name":"DIFLOMOTECAN","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Diflomotecan"],"trade_names":[],"canonical_smiles":"CC[C@@]1(O)CC(=O)OCc2c1cc1n(c2=O)Cc2cc3cc(F)c(F)cc3nc2-1","indications":[{"efo_id":"EFO_0000702","efo_label":"small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000702","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00080015"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00080015%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL23393","_score":1,"_source":{"id":"CHEMBL23393","internal_compound":false,"type":"Small molecule","pref_name":"SODIUM LAURYL SULFATE","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["E487","NSC-402488","Sodium Lauryl Sulfate"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[8984]},{"source":"DrugCentral","ids":["4144"]},{"source":"PubChem","ids":["144204610","144208812","144210469","170465474","17388729","17388731","26752879"]},{"source":"Wikipedia","ids":["Sodium_dodecyl_sulfate"]},{"source":"drugbank","ids":["DB00815"]}],"canonical_smiles":"CCCCCCCCCCCCOS(=O)(=O)[O-].[Na+]","indications":[{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01771822","NCT01787448","NCT02169154"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01771822%22OR%22NCT01787448%22OR%22NCT02169154%22"]}]},{"efo_id":"EFO_0000701","efo_label":"skin disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000701","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01821274"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01821274%22"]}]},{"efo_id":"EFO_0007512","efo_label":"tinea pedis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007512","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00781664"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00781664%22"]}]},{"efo_id":"EFO_0000544","efo_label":"infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000544","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02160574"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02160574%22"]}]},{"efo_id":"EFO_1001434","efo_label":"Tendinopathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001434","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03502434"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03502434%22"]}]}],"adverse_events":{"significant":[{"event":"hyponatraemia","count":21598,"llr":11.3971372}],"critval":10.13169433},"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":2},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1237122","_score":1,"_source":{"id":"CHEMBL1237122","internal_compound":false,"type":"Small molecule","pref_name":"CARBOPROST","year_first_approved":1979,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["Carboprost","Carboprost Trometanol","Carboprost Tromethamine","U-32921","U-32921E"],"trade_names":["Hemabate"],"cross_references":[{"source":"DailyMed","ids":["carboprost%20tromethamine"]}],"canonical_smiles":"CCCCC[C@](C)(O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\\CCCC(=O)O","adverse_events":{"significant":[{"event":"bronchospasm","count":4962,"llr":27.82893309},{"event":"anaphylactic reaction","count":16695,"llr":18.32801753},{"event":"blood pressure increased","count":25616,"llr":18.00449142},{"event":"uterine atony","count":103,"llr":11.83082792},{"event":"oxygen saturation decreased","count":10498,"llr":11.32761095},{"event":"increased bronchial secretion","count":401,"llr":9.1180338},{"event":"postpartum haemorrhage","count":456,"llr":8.862017701},{"event":"carotid aneurysm rupture","count":4,"llr":8.463041635},{"event":"lochial infection","count":5,"llr":8.239917372},{"event":"uterine inversion","count":8,"llr":7.76997161}],"critval":7.221596855},"child_chembl_ids":["CHEMBL1237105"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000122420","approved_name":"prostaglandin F receptor","approved_symbol":"PTGFR"}],"target_type":"single protein","target_name":"Prostanoid FP receptor","action_type":"agonist","description":"Prostanoid FP receptor agonist","references":[{"source":"KEGG","ids":["D00682"],"urls":["https://www.genome.jp/dbget-bin/www_bget?dr:D00682"]},{"source":"PubMed","ids":["2225598"],"urls":["https://europepmc.org/search?query=EXT_ID%3A2225598"]},{"source":"Wikipedia","ids":["Carboprost"],"urls":["https://www.wikipedia.org/Carboprost"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1522","_score":1,"_source":{"id":"CHEMBL1522","internal_compound":false,"type":"Small molecule","pref_name":"ESZOPICLONE","year_first_approved":2004,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["(S)-Zopiclone","Eszopiclone","Eszopiclone civ","GSK-1755165","Zopiclone s-form"],"trade_names":["Eszopiclone","Lunesta"],"cross_references":[{"source":"ChEBI","ids":[53760]},{"source":"DailyMed","ids":["eszopiclone"]},{"source":"PubChem","ids":["144205286","170465445","29215492","49666409"]},{"source":"Wikipedia","ids":["Eszopiclone"]},{"source":"drugbank","ids":["DB00402"]}],"canonical_smiles":"CN1CCN(C(=O)O[C@H]2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1","indications":[{"efo_id":"EFO_0004698","efo_label":"insomnia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004698","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00352144","NCT00366093","NCT00368056","NCT00368160","NCT00515177","NCT00770510","NCT00770692","NCT01055834","NCT01100164","NCT01710631","NCT03668041"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00352144%22OR%22NCT00366093%22OR%22NCT00368056%22OR%22NCT00368160%22OR%22NCT00515177%22OR%22NCT00770510%22OR%22NCT00770692%22OR%22NCT01055834%22OR%22NCT01100164%22OR%22NCT01710631%22OR%22NCT03668041%22"]},{"source":"DailyMed","ids":["0755ade3-edbc-4b34-b261-99b15b759599","0b363b90-93dc-1fc1-0501-d140dfc762c7","12593790-e72f-45b1-8895-987cdd075134","1f468b3f-7edf-44aa-81e2-ddb1cc0c1724","20b122fb-42ec-4fa1-9a9e-e5930e5d2e7e","211f00b0-c858-4afc-8424-e74edad9b180","2435e2f1-bc52-488f-80e9-f1758e354aae","29295c36-c640-48a5-8b6b-bae3b559f2c9","29509260-7f22-41fd-9393-9181094f9af5","33bc1c5f-c8cf-4c91-ad78-89d1d68d245d","48925d07-1e06-4761-bbdc-d8b7e70ad155","49f71eb4-15ca-42e2-b62b-7963cc8ef115","50be8fdb-b97c-48fc-863f-878f3e9a3ec6","5469cc59-78f9-447a-9c33-12553bb4073d","584dc66c-063a-4552-a056-74b811e2bc80","5995098b-c770-4c2d-ac0c-7588484dff18","5e5929f1-bdd9-4001-b542-b83de39540ec","7068c455-691e-4c56-9857-b7b4e13f4784","77d38000-3d3d-4d05-a74a-2fcc11849ae7","7b069c49-007c-4f77-878c-0a6c564e2717","859e9681-9324-4d57-ac20-660e89600f0f","8b2dc950-9dc2-4bd2-bfc2-2fb859ef81c4","8bb1965e-7845-4c5b-b021-38e251303d68","ac62fdb3-868e-42ef-9212-5030e68e3b0b","d345e696-4d70-4720-a798-6ffe723e1d86","e711e994-a489-d14b-9a50-60557b9ed137","fd047b2b-05a6-4d99-95cb-955f14bf329f"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0755ade3-edbc-4b34-b261-99b15b759599","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0b363b90-93dc-1fc1-0501-d140dfc762c7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?12593790-e72f-45b1-8895-987cdd075134","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1f468b3f-7edf-44aa-81e2-ddb1cc0c1724","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?20b122fb-42ec-4fa1-9a9e-e5930e5d2e7e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?211f00b0-c858-4afc-8424-e74edad9b180","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2435e2f1-bc52-488f-80e9-f1758e354aae","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?29295c36-c640-48a5-8b6b-bae3b559f2c9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?29509260-7f22-41fd-9393-9181094f9af5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?33bc1c5f-c8cf-4c91-ad78-89d1d68d245d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?48925d07-1e06-4761-bbdc-d8b7e70ad155","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?49f71eb4-15ca-42e2-b62b-7963cc8ef115","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?50be8fdb-b97c-48fc-863f-878f3e9a3ec6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5469cc59-78f9-447a-9c33-12553bb4073d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?584dc66c-063a-4552-a056-74b811e2bc80","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5995098b-c770-4c2d-ac0c-7588484dff18","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5e5929f1-bdd9-4001-b542-b83de39540ec","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7068c455-691e-4c56-9857-b7b4e13f4784","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?77d38000-3d3d-4d05-a74a-2fcc11849ae7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7b069c49-007c-4f77-878c-0a6c564e2717","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?859e9681-9324-4d57-ac20-660e89600f0f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8b2dc950-9dc2-4bd2-bfc2-2fb859ef81c4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8bb1965e-7845-4c5b-b021-38e251303d68","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ac62fdb3-868e-42ef-9212-5030e68e3b0b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d345e696-4d70-4720-a798-6ffe723e1d86","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e711e994-a489-d14b-9a50-60557b9ed137","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?fd047b2b-05a6-4d99-95cb-955f14bf329f"]},{"source":"FDA","ids":["15e9888f-f6aa-4ca9-aa62-d434b1fdc47b","28f6984a-e2ed-4720-bcf5-f1aeea85b259","37654e57-66a0-4659-a92e-0e98200f2832","38e0e8e4-2b72-6415-4283-208e18d874e0","39a5dae2-49f7-4662-9eac-aa7b4c7807a4","52deb8f7-abaf-46ec-9f15-13e30d558769","62dc4040-8528-4438-a275-9e1241ef6ef3","6540d91d-60ed-4bf1-9c23-eea19b624860","97c2a286-77c8-4d6d-b0e9-2394a542d49e","a00527a4-2038-4caf-b137-ebb34f0e1b18","ea64734e-657a-4944-9e8e-ce16fd6e45b7"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A15e9888f-f6aa-4ca9-aa62-d434b1fdc47b","https://api.fda.gov/drug/label.json?search=set_id%3A28f6984a-e2ed-4720-bcf5-f1aeea85b259","https://api.fda.gov/drug/label.json?search=set_id%3A37654e57-66a0-4659-a92e-0e98200f2832","https://api.fda.gov/drug/label.json?search=set_id%3A38e0e8e4-2b72-6415-4283-208e18d874e0","https://api.fda.gov/drug/label.json?search=set_id%3A39a5dae2-49f7-4662-9eac-aa7b4c7807a4","https://api.fda.gov/drug/label.json?search=set_id%3A52deb8f7-abaf-46ec-9f15-13e30d558769","https://api.fda.gov/drug/label.json?search=set_id%3A62dc4040-8528-4438-a275-9e1241ef6ef3","https://api.fda.gov/drug/label.json?search=set_id%3A6540d91d-60ed-4bf1-9c23-eea19b624860","https://api.fda.gov/drug/label.json?search=set_id%3A97c2a286-77c8-4d6d-b0e9-2394a542d49e","https://api.fda.gov/drug/label.json?search=set_id%3Aa00527a4-2038-4caf-b137-ebb34f0e1b18","https://api.fda.gov/drug/label.json?search=set_id%3Aea64734e-657a-4944-9e8e-ce16fd6e45b7"]}]},{"efo_id":"EFO_0003918","efo_label":"obstructive sleep apnea","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003918","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00685269","NCT01102270"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00685269%22OR%22NCT01102270%22"]}]},{"efo_id":"EFO_0007191","efo_label":"cannabis dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007191","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00893269"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00893269%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000022355","approved_name":"gamma-aminobutyric acid type A receptor subunit alpha1","approved_symbol":"GABRA1"},{"ensembl":"ENSG00000145864","approved_name":"gamma-aminobutyric acid type A receptor subunit beta2","approved_symbol":"GABRB2"},{"ensembl":"ENSG00000113327","approved_name":"gamma-aminobutyric acid type A receptor subunit gamma2","approved_symbol":"GABRG2"},{"ensembl":"ENSG00000166206","approved_name":"gamma-aminobutyric acid type A receptor subunit beta3","approved_symbol":"GABRB3"},{"ensembl":"ENSG00000109158","approved_name":"gamma-aminobutyric acid type A receptor subunit alpha4","approved_symbol":"GABRA4"},{"ensembl":"ENSG00000182256","approved_name":"gamma-aminobutyric acid type A receptor subunit gamma3","approved_symbol":"GABRG3"},{"ensembl":"ENSG00000268089","approved_name":"gamma-aminobutyric acid type A receptor subunit theta","approved_symbol":"GABRQ"},{"ensembl":"ENSG00000011677","approved_name":"gamma-aminobutyric acid type A receptor subunit alpha3","approved_symbol":"GABRA3"},{"ensembl":"ENSG00000094755","approved_name":"gamma-aminobutyric acid type A receptor subunit pi","approved_symbol":"GABRP"},{"ensembl":"ENSG00000187730","approved_name":"gamma-aminobutyric acid type A receptor subunit delta","approved_symbol":"GABRD"},{"ensembl":"ENSG00000163285","approved_name":"gamma-aminobutyric acid type A receptor subunit gamma1","approved_symbol":"GABRG1"},{"ensembl":"ENSG00000163288","approved_name":"gamma-aminobutyric acid type A receptor subunit beta1","approved_symbol":"GABRB1"},{"ensembl":"ENSG00000102287","approved_name":"gamma-aminobutyric acid type A receptor subunit epsilon","approved_symbol":"GABRE"},{"ensembl":"ENSG00000151834","approved_name":"gamma-aminobutyric acid type A receptor subunit alpha2","approved_symbol":"GABRA2"},{"ensembl":"ENSG00000186297","approved_name":"gamma-aminobutyric acid type A receptor subunit alpha5","approved_symbol":"GABRA5"},{"ensembl":"ENSG00000145863","approved_name":"gamma-aminobutyric acid type A receptor subunit alpha6","approved_symbol":"GABRA6"}],"target_type":"protein complex group","target_name":"GABA-A receptor; anion channel","action_type":"positive allosteric modulator","description":"GABA-A receptor; anion channel positive allosteric modulator","references":[{"source":"FDA","ids":["label/2012/021476s024s026lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2012%2F021476s024s026lbl.pdf"]},{"source":"PubMed","ids":["18973287"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18973287"]},{"source":"Wikipedia","ids":["Eszopiclone"],"urls":["https://www.wikipedia.org/Eszopiclone"]}]}],"adverse_events":{"significant":[{"event":"dysgeusia","count":15051,"llr":2025.963273},{"event":"insomnia","count":44658,"llr":706.2914576},{"event":"middle insomnia","count":2446,"llr":209.7062372},{"event":"parasomnia","count":214,"llr":159.3276114},{"event":"initial insomnia","count":1234,"llr":141.0601617},{"event":"paradoxical drug reaction","count":1065,"llr":105.2225577},{"event":"suicide attempt","count":20244,"llr":102.9557983},{"event":"nightmare","count":7702,"llr":86.14197658},{"event":"somnolence","count":38949,"llr":74.53463516},{"event":"sleep walking","count":175,"llr":71.26814876},{"event":"amnesia","count":13293,"llr":64.25809145},{"event":"somnambulism","count":1422,"llr":36.32718062},{"event":"abnormal sleep-related event","count":279,"llr":36.2697541},{"event":"abnormal dreams","count":4584,"llr":35.18931707},{"event":"anterograde amnesia","count":205,"llr":30.62619891},{"event":"diarrhoea","count":126514,"llr":30.29452231},{"event":"dyspnoea","count":124409,"llr":27.94639457},{"event":"delirium","count":11053,"llr":27.61207894},{"event":"injection site pain","count":56727,"llr":26.7177147},{"event":"pyrexia","count":87334,"llr":25.73371321},{"event":"malaise","count":82447,"llr":25.28933387},{"event":"hallucination","count":16074,"llr":25.24232531},{"event":"fatigue","count":147738,"llr":24.75242688},{"event":"arthralgia","count":75397,"llr":23.86534349}],"critval":21.55702965},"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":3},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":3},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1187417","_score":1,"_source":{"id":"CHEMBL1187417","internal_compound":false,"type":"Small molecule","pref_name":"BENZALKONIUM","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Benzalkonium","Benzalkonium Chloride"],"trade_names":["Capitol","Dermax Therapeutic","Drapolene","Roccal","Zephiran Chloride"],"canonical_smiles":"CCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1","adverse_events":{"significant":[{"event":"methaemoglobinaemia","count":657,"llr":580.6080362},{"event":"anaphylactic reaction","count":16695,"llr":223.2985915},{"event":"toxicity to various agents","count":31033,"llr":217.6729137},{"event":"anaesthetic complication","count":778,"llr":216.7413065},{"event":"cardiac arrest","count":9359,"llr":191.5005987},{"event":"toxic anterior segment syndrome","count":602,"llr":188.1054187},{"event":"lagophthalmos","count":175,"llr":184.9288853},{"event":"hypotension","count":55121,"llr":164.0310996},{"event":"anaphylactic shock","count":6651,"llr":159.3916877},{"event":"unresponsive to stimuli","count":6342,"llr":109.9710996},{"event":"bradycardia","count":20091,"llr":97.26482735},{"event":"horner's syndrome","count":175,"llr":91.71059548},{"event":"ophthalmoplegia","count":459,"llr":87.85695841},{"event":"cyanosis","count":4608,"llr":83.77395967},{"event":"generalised tonic-clonic seizure","count":4083,"llr":80.88712929},{"event":"grand mal convulsion","count":4865,"llr":73.55807691},{"event":"myopathy toxic","count":223,"llr":71.85516608},{"event":"neurotoxicity","count":4628,"llr":70.45330427},{"event":"pulse absent","count":1181,"llr":63.802124},{"event":"ventricular tachycardia","count":5901,"llr":58.59797141},{"event":"pulseless electrical activity","count":675,"llr":58.57706777},{"event":"diarrhoea","count":126514,"llr":58.31436514},{"event":"delirium","count":11053,"llr":57.57913636},{"event":"oxygen saturation decreased","count":10498,"llr":52.20282998},{"event":"anaesthetic complication neurological","count":189,"llr":50.99179828},{"event":"electrocardiogram qrs complex prolonged","count":1553,"llr":50.72489142},{"event":"respiratory depression","count":3384,"llr":50.32970403},{"event":"spinal epidural haemorrhage","count":34,"llr":50.13204405},{"event":"convulsion","count":26614,"llr":46.87531457},{"event":"circulatory collapse","count":4559,"llr":46.49840872},{"event":"retinal artery occlusion","count":821,"llr":44.07433722},{"event":"peripheral nerve injury","count":161,"llr":43.77658132},{"event":"mydriasis","count":3319,"llr":43.32716512},{"event":"respiratory failure","count":13025,"llr":43.21699799},{"event":"coma","count":13175,"llr":42.75126463},{"event":"tachycardia","count":26994,"llr":42.04188938},{"event":"depressed level of consciousness","count":10912,"llr":41.51441795},{"event":"local anaesthetic systemic toxicity","count":29,"llr":39.59142312},{"event":"sinus tachycardia","count":5084,"llr":38.92740432},{"event":"cardio-respiratory arrest","count":2972,"llr":38.60723452},{"event":"pallor","count":6405,"llr":38.58893236},{"event":"parophthalmia","count":118,"llr":37.74927936},{"event":"respiratory arrest","count":3162,"llr":37.19414914},{"event":"loss of consciousness","count":30434,"llr":37.05658333}],"critval":35.92237257},"child_chembl_ids":["CHEMBL502109"],"indications":[{"efo_id":"EFO_0003966","efo_label":"eye disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003966","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00414739"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00414739%22"]}]}],"cross_references":[{"source":"PubChem","ids":["26748812"]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2105648","_score":1,"_source":{"id":"CHEMBL2105648","internal_compound":false,"type":"Small molecule","pref_name":"PALOVAROTENE","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["CLM-001","Palovarotene","R-667","RG-667","RO-3300074"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12320"]}],"canonical_smiles":"CC1(C)CCC(C)(C)c2cc(Cn3cccn3)c(/C=C/c3ccc(C(=O)O)cc3)cc21","indications":[{"efo_id":"Orphanet_337","efo_label":"Fibrodysplasia ossificans progressiva","efo_uri":"http://www.orpha.net/ORDO/Orphanet_337","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02190747","NCT02279095","NCT02521792","NCT02979769","NCT03312634"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02190747%22OR%22NCT02279095%22OR%22NCT02521792%22OR%22NCT02979769%22OR%22NCT03312634%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000172819","approved_name":"retinoic acid receptor gamma","approved_symbol":"RARG"}],"target_type":"single protein","target_name":"Retinoic acid receptor gamma","action_type":"agonist","description":"Retinoic acid receptor gamma agonist","references":[{"source":"Other","ids":["http://clementiapharma.com/pipeline/palovarotene-faqs/"],"urls":["http://clementiapharma.com/pipeline/palovarotene-faqs/"]},{"source":"PubMed","ids":["17498389","19876792","22282548"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17498389+OR+EXT_ID%3A19876792+OR+EXT_ID%3A22282548"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL103735","_score":1,"_source":{"id":"CHEMBL103735","internal_compound":false,"type":"Small molecule","pref_name":"ATIPRIMOD","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Atiprimod","Atiprimod Dihydrochloride","Atiprimod Dimaleate","SK&F-106615-12","SK&F-106615-A2","SKF-106615","SKF-106615-A2"],"trade_names":[],"cross_references":[{"source":"Wikipedia","ids":["Atiprimod"]},{"source":"drugbank","ids":["DB05513"]}],"canonical_smiles":"CCCC1(CCC)CCC2(CCN(CCCN(CC)CC)C2)CC1","indications":[{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00214838","NCT00430014"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00214838%22OR%22NCT00430014%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00086216"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00086216%22"]}]}],"child_chembl_ids":["CHEMBL3215883","CHEMBL3989809"],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL483","_score":1,"_source":{"id":"CHEMBL483","internal_compound":false,"type":"Small molecule","pref_name":"TENOFOVIR","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Atripla","GS-1275","GS-1278","PMP-A","PMPA","Tenofovir","Truvada"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[63625]},{"source":"Wikipedia","ids":["Tenofovir"]},{"source":"drugbank","ids":["DB14126"]}],"canonical_smiles":"C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O","indications":[{"efo_id":"EFO_0000180","efo_label":"HIV-1 infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000180","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01338883","NCT01345630","NCT01489046","NCT02275780","NCT02652260","NCT02987530","NCT03706924"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01338883%22OR%22NCT01345630%22OR%22NCT01489046%22OR%22NCT02275780%22OR%22NCT02652260%22OR%22NCT02987530%22OR%22NCT03706924%22"]}]},{"efo_id":"EFO_0000544","efo_label":"infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000544","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01033760","NCT02150993"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01033760%22OR%22NCT02150993%22"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002180","NCT00028132","NCT00044577","NCT00053638","NCT00119106","NCT00122577","NCT00214890","NCT00350272","NCT00365339","NCT00369941","NCT00428116","NCT00441298","NCT00540605","NCT00561496","NCT00573001","NCT00592124","NCT00594373","NCT00654147","NCT00669487","NCT00705679","NCT00745823","NCT00984971","NCT01061151","NCT01108926","NCT01114425","NCT01136759","NCT01153217","NCT01154673","NCT01174914","NCT01276600","NCT01340196","NCT01384734","NCT01386294","NCT01421368","NCT01490671","NCT01575405","NCT01575418","NCT01632345","NCT01641809","NCT01691768","NCT01701882","NCT01803074","NCT01813162","NCT01989663","NCT02116660","NCT02131233","NCT02280109","NCT02302547","NCT02403674","NCT02475915","NCT03988452"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002180%22OR%22NCT00028132%22OR%22NCT00044577%22OR%22NCT00053638%22OR%22NCT00119106%22OR%22NCT00122577%22OR%22NCT00214890%22OR%22NCT00350272%22OR%22NCT00365339%22OR%22NCT00369941%22OR%22NCT00428116%22OR%22NCT00441298%22OR%22NCT00540605%22OR%22NCT00561496%22OR%22NCT00573001%22OR%22NCT00592124%22OR%22NCT00594373%22OR%22NCT00654147%22OR%22NCT00669487%22OR%22NCT00705679%22OR%22NCT00745823%22OR%22NCT00984971%22OR%22NCT01061151%22OR%22NCT01108926%22OR%22NCT01114425%22OR%22NCT01136759%22OR%22NCT01153217%22OR%22NCT01154673%22OR%22NCT01174914%22OR%22NCT01276600%22OR%22NCT01340196%22OR%22NCT01384734%22OR%22NCT01386294%22OR%22NCT01421368%22OR%22NCT01490671%22OR%22NCT01575405%22OR%22NCT01575418%22OR%22NCT01632345%22OR%22NCT01641809%22OR%22NCT01691768%22OR%22NCT01701882%22OR%22NCT01803074%22OR%22NCT01813162%22OR%22NCT01989663%22OR%22NCT02116660%22OR%22NCT02131233%22OR%22NCT02280109%22OR%22NCT02302547%22OR%22NCT02403674%22OR%22NCT02475915%22OR%22NCT03988452%22"]}]},{"efo_id":"EFO_0000765","efo_label":"AIDS","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000765","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00302822","NCT00433056","NCT00958100","NCT02369965","NCT03986970"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00302822%22OR%22NCT00433056%22OR%22NCT00958100%22OR%22NCT02369965%22OR%22NCT03986970%22"]}]},{"efo_id":"EFO_0002614","efo_label":"insulin resistance","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002614","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02203461"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02203461%22"]}]},{"efo_id":"EFO_0004197","efo_label":"hepatitis B virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004197","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00524173","NCT00805675","NCT00994773","NCT02288208","NCT02431312","NCT02604199","NCT02604212","NCT02738008","NCT02797522","NCT02888106","NCT03236610","NCT03546621"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00524173%22OR%22NCT00805675%22OR%22NCT00994773%22OR%22NCT02288208%22OR%22NCT02431312%22OR%22NCT02604199%22OR%22NCT02604212%22OR%22NCT02738008%22OR%22NCT02797522%22OR%22NCT02888106%22OR%22NCT03236610%22OR%22NCT03546621%22"]}]},{"efo_id":"EFO_0004220","efo_label":"chronic hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004220","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01525628"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01525628%22"]}]},{"efo_id":"EFO_0004239","efo_label":"chronic hepatitis B virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004239","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00307489","NCT00410072","NCT00410202","NCT00605384","NCT00962871","NCT01027065","NCT01063036","NCT01848743","NCT02338674","NCT02391805","NCT02452528","NCT03759782"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00307489%22OR%22NCT00410072%22OR%22NCT00410202%22OR%22NCT00605384%22OR%22NCT00962871%22OR%22NCT01027065%22OR%22NCT01063036%22OR%22NCT01848743%22OR%22NCT02338674%22OR%22NCT02391805%22OR%22NCT02452528%22OR%22NCT03759782%22"]}]},{"efo_id":"EFO_0007304","efo_label":"hepatitis D virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007304","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01088659","NCT03546621"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01088659%22OR%22NCT03546621%22"]}]}],"adverse_events":{"significant":[{"event":"virologic failure","count":2156,"llr":1018.987307},{"event":"fanconi syndrome acquired","count":679,"llr":538.4196727},{"event":"drug resistance","count":7341,"llr":530.1527395},{"event":"renal tubular disorder","count":1390,"llr":423.5662133},{"event":"immune reconstitution inflammatory syndrome","count":2009,"llr":404.3049458},{"event":"osteoporosis","count":5957,"llr":395.9403299},{"event":"abortion spontaneous","count":14396,"llr":382.0720417},{"event":"viral load increased","count":990,"llr":335.5689497},{"event":"premature baby","count":8946,"llr":324.918189},{"event":"lipodystrophy acquired","count":879,"llr":288.7749166},{"event":"acute hiv infection","count":76,"llr":243.5982846},{"event":"immune reconstitution syndrome","count":646,"llr":222.7486843},{"event":"premature delivery","count":4411,"llr":216.1967633},{"event":"blood hiv rna increased","count":371,"llr":215.4507659},{"event":"stillbirth","count":1542,"llr":206.6255195},{"event":"renal failure acute","count":23893,"llr":201.7883396},{"event":"hypophosphataemia","count":2382,"llr":191.1426152},{"event":"fanconi syndrome","count":527,"llr":169.4775798},{"event":"viral mutation identified","count":1049,"llr":162.4815624},{"event":"injection site pain","count":56727,"llr":159.076618},{"event":"proteinuria","count":6145,"llr":157.1947999},{"event":"abnormal dreams","count":4584,"llr":149.4020527},{"event":"glycosuria","count":497,"llr":147.045805},{"event":"blood creatinine increased","count":21684,"llr":144.9895586},{"event":"renal failure","count":27897,"llr":141.0244538}],"critval":140.4443876},"child_chembl_ids":["CHEMBL3989702"],"number_of_indications":9,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":7},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":4},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":4},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":3},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":3},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201566","_score":1,"_source":{"id":"CHEMBL1201566","internal_compound":false,"type":"Protein","pref_name":"DARBEPOETIN ALFA","year_first_approved":2001,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["Darbepoetin alfa","KRN-321","KRN321","NESP"],"trade_names":["Aranesp","Aranesp SureClick"],"cross_references":[{"source":"DailyMed","ids":["darbepoetin%20alfa"]},{"source":"DrugCentral","ids":["5157"]}],"indications":[{"efo_id":"EFO_0004272","efo_label":"anemia (phenotype)","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004272","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["B03XA02"],"urls":["https://www.whocc.no/atc_ddd_index/?code=B03XA02"]},{"source":"ClinicalTrials","ids":["NCT00038064","NCT00077766","NCT00081471","NCT00090753","NCT00095277","NCT00117624","NCT00119587","NCT00148421","NCT00327535","NCT00344409","NCT00359840","NCT00394953","NCT00442702","NCT00454246","NCT00559273","NCT00605345","NCT00717821","NCT01684605","NCT01685671","NCT02241200","NCT02876835","NCT02892149","NCT02912494","NCT02969655","NCT03029208","NCT03446612","NCT03776032"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00038064%22OR%22NCT00077766%22OR%22NCT00081471%22OR%22NCT00090753%22OR%22NCT00095277%22OR%22NCT00117624%22OR%22NCT00119587%22OR%22NCT00148421%22OR%22NCT00327535%22OR%22NCT00344409%22OR%22NCT00359840%22OR%22NCT00394953%22OR%22NCT00442702%22OR%22NCT00454246%22OR%22NCT00559273%22OR%22NCT00605345%22OR%22NCT00717821%22OR%22NCT01684605%22OR%22NCT01685671%22OR%22NCT02241200%22OR%22NCT02876835%22OR%22NCT02892149%22OR%22NCT02912494%22OR%22NCT02969655%22OR%22NCT03029208%22OR%22NCT03446612%22OR%22NCT03776032%22"]},{"source":"DailyMed","ids":["0fd36cb9-c4f6-4167-93c9-8530865db3f9"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0fd36cb9-c4f6-4167-93c9-8530865db3f9"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00111137","NCT00135317"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00111137%22OR%22NCT00135317%22"]}]},{"efo_id":"EFO_0000403","efo_label":"diffuse large B-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000403","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00144755","NCT02890602"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00144755%22OR%22NCT02890602%22"]}]},{"efo_id":"EFO_0000198","efo_label":"myelodysplastic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000198","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00095264","NCT00230321","NCT00234143","NCT00443339","NCT01039350","NCT01196715","NCT01362140","NCT01497145","NCT02175277"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00095264%22OR%22NCT00230321%22OR%22NCT00234143%22OR%22NCT00443339%22OR%22NCT01039350%22OR%22NCT01196715%22OR%22NCT01362140%22OR%22NCT01497145%22OR%22NCT02175277%22"]}]},{"efo_id":"EFO_0003884","efo_label":"chronic kidney disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003884","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00093977","NCT00096915","NCT00213291","NCT00436995","NCT00527137","NCT01652872","NCT01888445","NCT02021318","NCT02988973","NCT03428594","NCT03431623","NCT04027517"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00093977%22OR%22NCT00096915%22OR%22NCT00213291%22OR%22NCT00436995%22OR%22NCT00527137%22OR%22NCT01652872%22OR%22NCT01888445%22OR%22NCT02021318%22OR%22NCT02988973%22OR%22NCT03428594%22OR%22NCT03431623%22OR%22NCT04027517%22"]},{"source":"DailyMed","ids":["0fd36cb9-c4f6-4167-93c9-8530865db3f9"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0fd36cb9-c4f6-4167-93c9-8530865db3f9"]}]},{"efo_id":"EFO_0000702","efo_label":"small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000702","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00119613"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00119613%22"]}]},{"efo_id":"EFO_0003086","efo_label":"kidney disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003086","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00111098","NCT00116701","NCT00124098"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00111098%22OR%22NCT00116701%22OR%22NCT00124098%22"]}]},{"efo_id":"EFO_0000612","efo_label":"myocardial infarction","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000612","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01043991","NCT01538771"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01043991%22OR%22NCT01538771%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00146562","NCT00261313","NCT00544232"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00146562%22OR%22NCT00261313%22OR%22NCT00544232%22"]}]},{"efo_id":"EFO_0000546","efo_label":"injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000546","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00375869"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00375869%22"]}]},{"efo_id":"HP_0002637","efo_label":"Cerebral ischemia","efo_uri":"http://purl.obolibrary.org/obo/HP_0002637","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01471015","NCT03071861"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01471015%22OR%22NCT03071861%22"]}]},{"efo_id":"EFO_0000565","efo_label":"leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000565","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01222195"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01222195%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00058422"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00058422%22"]}]},{"efo_id":"EFO_0001642","efo_label":"lymphoid neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001642","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00557817"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00557817%22"]}]},{"efo_id":"HP_0001919","efo_label":"Acute kidney injury","efo_uri":"http://purl.obolibrary.org/obo/HP_0001919","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01197235"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01197235%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01794169"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01794169%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000187266","approved_name":"erythropoietin receptor","approved_symbol":"EPOR"}],"target_type":"single protein","target_name":"Erythropoietin receptor","action_type":"agonist","description":"Erythropoietin receptor agonist","references":[{"source":"FDA","ids":["label/2013/103234s5323lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2013%2F103234s5323lbl.pdf"]},{"source":"PubMed","ids":["10318834"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10318834"]}]}],"adverse_events":{"significant":[{"event":"hospitalisation","count":28436,"llr":6402.958889},{"event":"haemodialysis","count":3742,"llr":2491.599424},{"event":"aplasia pure red cell","count":1777,"llr":2369.928338},{"event":"arteriovenous fistula site complication","count":341,"llr":930.6053935},{"event":"dialysis","count":3795,"llr":847.2220706},{"event":"transplant","count":734,"llr":792.7419583},{"event":"haemoglobin decreased","count":33686,"llr":559.8579676},{"event":"therapeutic response decreased","count":15645,"llr":520.1659569},{"event":"renal disorder","count":8278,"llr":423.7976931},{"event":"peritoneal dialysis","count":288,"llr":415.4826133},{"event":"haemoglobin abnormal","count":1301,"llr":344.1333917},{"event":"anti-erythropoietin antibody positive","count":192,"llr":323.6075189},{"event":"terminal state","count":1089,"llr":303.1100735},{"event":"transfusion","count":2875,"llr":287.3868942},{"event":"nausea","count":165652,"llr":241.9397297},{"event":"anaemia","count":61405,"llr":220.7758867},{"event":"renal transplant","count":760,"llr":218.3140254},{"event":"haemoglobin increased","count":990,"llr":196.5855224},{"event":"peritonitis","count":3134,"llr":176.568231},{"event":"headache","count":120638,"llr":159.6578697}],"critval":155.3011394},"number_of_indications":16,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":9},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":6},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":4},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":3},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":3},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":3},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":3},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL455136","_score":1,"_source":{"id":"CHEMBL455136","internal_compound":false,"type":"Small molecule","pref_name":"ALMOREXANT","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["ACT-078573","Almorexant"],"trade_names":[],"cross_references":[{"source":"Wikipedia","ids":["Almorexant"]},{"source":"drugbank","ids":["DB06673"]}],"canonical_smiles":"CNC(=O)[C@@H](c1ccccc1)N1CCc2cc(OC)c(OC)cc2[C@@H]1CCc1ccc(C(F)(F)F)cc1","indications":[{"efo_id":"EFO_0004698","efo_label":"insomnia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004698","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00608985","NCT00640848"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00608985%22OR%22NCT00640848%22"]}]}],"child_chembl_ids":["CHEMBL3542330"],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1980297","_score":1,"_source":{"id":"CHEMBL1980297","internal_compound":false,"type":"Small molecule","pref_name":"ILORASERTIB","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["A-968660","A-968660.0","ABBOTT-968660","ABT-348","Ilorasertib"],"trade_names":["ABT-348, A-968660"],"cross_references":[{"source":"PubChem","ids":["103904272"]},{"source":"drugbank","ids":["DB11694"]}],"canonical_smiles":"Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12","indications":[{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02478320"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02478320%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01110486","NCT02540876"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01110486%22OR%22NCT02540876%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000178999","approved_name":"aurora kinase B","approved_symbol":"AURKB"},{"ensembl":"ENSG00000105146","approved_name":"aurora kinase C","approved_symbol":"AURKC"},{"ensembl":"ENSG00000087586","approved_name":"aurora kinase A","approved_symbol":"AURKA"}],"target_type":"protein family","target_name":"Serine/threonine-protein kinase Aurora","action_type":"inhibitor","description":"Serine/threonine-protein kinase Aurora inhibitor","references":[{"source":"PubMed","ids":["22935731"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22935731"]}]},{"target_components":[{"ensembl":"ENSG00000102755","approved_name":"fms related receptor tyrosine kinase 1","approved_symbol":"FLT1"},{"ensembl":"ENSG00000037280","approved_name":"fms related receptor tyrosine kinase 4","approved_symbol":"FLT4"},{"ensembl":"ENSG00000128052","approved_name":"kinase insert domain receptor","approved_symbol":"KDR"}],"target_type":"protein family","target_name":"Vascular endothelial growth factor receptor","action_type":"inhibitor","description":"Vascular endothelial growth factor receptor inhibitor","references":[{"source":"PubMed","ids":["22935731"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22935731"]}]},{"target_components":[{"ensembl":"ENSG00000010810","approved_name":"FYN proto-oncogene, Src family tyrosine kinase","approved_symbol":"FYN"},{"ensembl":"ENSG00000197122","approved_name":"SRC proto-oncogene, non-receptor tyrosine kinase","approved_symbol":"SRC"},{"ensembl":"ENSG00000182866","approved_name":"LCK proto-oncogene, Src family tyrosine kinase","approved_symbol":"LCK"},{"ensembl":"ENSG00000176105","approved_name":"YES proto-oncogene 1, Src family tyrosine kinase","approved_symbol":"YES1"},{"ensembl":"ENSG00000136573","approved_name":"BLK proto-oncogene, Src family tyrosine kinase","approved_symbol":"BLK"},{"ensembl":"ENSG00000101336","approved_name":"HCK proto-oncogene, Src family tyrosine kinase","approved_symbol":"HCK"},{"ensembl":"ENSG00000254087","approved_name":"LYN proto-oncogene, Src family tyrosine kinase","approved_symbol":"LYN"},{"ensembl":"ENSG00000111816","approved_name":"fyn related Src family tyrosine kinase","approved_symbol":"FRK"},{"ensembl":"ENSG00000000938","approved_name":"FGR proto-oncogene, Src family tyrosine kinase","approved_symbol":"FGR"},{"ensembl":"ENSG00000125508","approved_name":"src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites","approved_symbol":"SRMS"}],"target_type":"protein family","target_name":"SRC","action_type":"inhibitor","description":"SRC inhibitor","references":[{"source":"PubMed","ids":["22935731"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22935731"]}]},{"target_components":[{"ensembl":"ENSG00000113721","approved_name":"platelet derived growth factor receptor beta","approved_symbol":"PDGFRB"},{"ensembl":"ENSG00000134853","approved_name":"platelet derived growth factor receptor alpha","approved_symbol":"PDGFRA"}],"target_type":"protein complex","target_name":"Platelet-derived growth factor receptor","action_type":"inhibitor","description":"Platelet-derived growth factor receptor inhibitor","references":[{"source":"PubMed","ids":["22935731"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22935731"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2}],"number_of_mechanisms_of_action":4}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3301571","_score":1,"_source":{"id":"CHEMBL3301571","internal_compound":false,"type":"Cell","pref_name":"VESIGENURTUCEL-L","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["HS-410","UM-UC-3-GP96-IG-HLA-A1","Vesigenurtucel-L"],"trade_names":[],"indications":[{"efo_id":"EFO_0000292","efo_label":"bladder carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000292","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02010203"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02010203%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201325","_score":1,"_source":{"id":"CHEMBL1201325","internal_compound":false,"type":"Small molecule","pref_name":"HEXOCYCLIUM","year_first_approved":1982,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Hexocyclium","Hexocyclium Methylsulfate","Hexocyclium Metilsulfate"],"trade_names":["TRAL"],"cross_references":[{"source":"ChEBI","ids":[5707]},{"source":"Wikipedia","ids":["Hexocyclium"]},{"source":"drugbank","ids":["DB06787"]},{"source":"PubChem","ids":["144206775"]}],"canonical_smiles":"C[N+]1(C)CCN(CC(O)(c2ccccc2)C2CCCCC2)CC1","child_chembl_ids":["CHEMBL1626570"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000133019","approved_name":"cholinergic receptor muscarinic 3","approved_symbol":"CHRM3"}],"target_type":"single protein","target_name":"Muscarinic acetylcholine receptor M3","action_type":"antagonist","description":"Muscarinic acetylcholine receptor M3 antagonist","references":[{"source":"ISBN","ids":["9780702034718 PP. 153"],"urls":[]},{"source":"PubMed","ids":["8075869","9183081"],"urls":["https://europepmc.org/search?query=EXT_ID%3A8075869+OR+EXT_ID%3A9183081"]}]},{"target_components":[{"ensembl":"ENSG00000168539","approved_name":"cholinergic receptor muscarinic 1","approved_symbol":"CHRM1"}],"target_type":"single protein","target_name":"Muscarinic acetylcholine receptor M1","action_type":"antagonist","description":"Muscarinic acetylcholine receptor M1 antagonist","references":[{"source":"ISBN","ids":["9780702034718 PP. 153"],"urls":[]},{"source":"PubMed","ids":["8075869","9183081"],"urls":["https://europepmc.org/search?query=EXT_ID%3A8075869+OR+EXT_ID%3A9183081"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL696","_score":1,"_source":{"id":"CHEMBL696","internal_compound":false,"type":"Small molecule","pref_name":"ETHOSUXIMIDE","year_first_approved":1960,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["CI-366","CN-10395","Ethosuximide","NSC-64013","PM-671"],"trade_names":["Emeside","Ethosuximide","Suxinutin","Zarontin"],"cross_references":[{"source":"ChEBI","ids":[4887]},{"source":"DailyMed","ids":["ethosuximide"]},{"source":"PubChem","ids":["144203921","170464802","174006922","26747515","26747516","50106318","50106319","85231037","90340672"]},{"source":"Wikipedia","ids":["Ethosuximide"]},{"source":"drugbank","ids":["DB00593"]}],"canonical_smiles":"CCC1(C)CC(=O)NC1=O","indications":[{"efo_id":"EFO_0000474","efo_label":"epilepsy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000474","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N03AD01","N03AD51"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N03AD01","https://www.whocc.no/atc_ddd_index/?code=N03AD51"]},{"source":"DailyMed","ids":["01e8e8ee-b19f-4b3f-a140-9c7391393e1c","0e008f33-70a1-4bc6-b3a0-d45214418ab6","2b8dd7cd-03a5-47a3-955a-03b6b08555b5","7bf3e616-45e8-4469-a75d-4d824ce951ea","8a5cc930-0b36-48a8-9ad0-de633b208742","b2f96a67-75a5-4c9e-a706-b88114d15a17","cb5577e2-e906-438f-b13d-e55709a0e7fd","e7d4b2a4-2dae-4026-a381-9d534d36c6b3"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?01e8e8ee-b19f-4b3f-a140-9c7391393e1c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0e008f33-70a1-4bc6-b3a0-d45214418ab6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2b8dd7cd-03a5-47a3-955a-03b6b08555b5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7bf3e616-45e8-4469-a75d-4d824ce951ea","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8a5cc930-0b36-48a8-9ad0-de633b208742","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b2f96a67-75a5-4c9e-a706-b88114d15a17","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cb5577e2-e906-438f-b13d-e55709a0e7fd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e7d4b2a4-2dae-4026-a381-9d534d36c6b3"]},{"source":"FDA","ids":["9d2075a7-8b88-42d5-8df5-05e4ca72f4b2"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A9d2075a7-8b88-42d5-8df5-05e4ca72f4b2"]}]},{"efo_id":"EFO_0003821","efo_label":"migraine disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003821","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01122381"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01122381%22"]}]},{"efo_id":"EFO_0000555","efo_label":"irritable bowel syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000555","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02973542"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02973542%22"]}]},{"efo_id":"EFO_0005762","efo_label":"neuropathic pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005762","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02100046"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02100046%22"]}]},{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT03887624"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03887624%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000196557","approved_name":"calcium voltage-gated channel subunit alpha1 H","approved_symbol":"CACNA1H"},{"ensembl":"ENSG00000006283","approved_name":"calcium voltage-gated channel subunit alpha1 G","approved_symbol":"CACNA1G"},{"ensembl":"ENSG00000100346","approved_name":"calcium voltage-gated channel subunit alpha1 I","approved_symbol":"CACNA1I"}],"target_type":"protein family","target_name":"Voltage-gated T-type calcium channel","action_type":"blocker","description":"Voltage-gated T-type calcium channel blocker","references":[{"source":"PubMed","ids":["11641441","17291698"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11641441+OR+EXT_ID%3A17291698"]},{"source":"Wikipedia","ids":["Ethosuximide#Mechanism_of_action"],"urls":["https://www.wikipedia.org/Ethosuximide#Mechanism_of_action"]}]}],"adverse_events":{"significant":[{"event":"aplastic anaemia","count":1397,"llr":137.0287924},{"event":"multiple-drug resistance","count":550,"llr":74.72547714},{"event":"intellectual disability","count":201,"llr":64.58825512},{"event":"petit mal epilepsy","count":1413,"llr":45.79453903},{"event":"developmental regression","count":21,"llr":41.63366231},{"event":"psychotic disorder","count":11057,"llr":36.07709295},{"event":"convulsion","count":26614,"llr":33.71378885},{"event":"myoclonic epilepsy","count":454,"llr":33.2878065},{"event":"seizure","count":19835,"llr":32.90412361},{"event":"mitral valve disease","count":532,"llr":32.02728512},{"event":"suicidal behaviour","count":944,"llr":31.97551105},{"event":"pneumococcal infection","count":162,"llr":29.38947943},{"event":"pyloric stenosis","count":384,"llr":29.35406237},{"event":"dropped head syndrome","count":87,"llr":26.67682927},{"event":"generalised tonic-clonic seizure","count":4083,"llr":25.49991913},{"event":"hepatic adenoma","count":137,"llr":24.41153521},{"event":"systemic lupus erythematosus","count":4830,"llr":23.72642182},{"event":"acute pulmonary oedema","count":1705,"llr":22.82792528},{"event":"drug resistance","count":7341,"llr":22.12479338},{"event":"electroencephalogram abnormal","count":1335,"llr":20.72770812},{"event":"benign rolandic epilepsy","count":11,"llr":20.66582121},{"event":"myocarditis","count":2475,"llr":19.92403847},{"event":"aggression","count":12814,"llr":18.26618959},{"event":"epilepsy","count":8950,"llr":17.35359461},{"event":"cognitive disorder","count":9869,"llr":16.37037139},{"event":"scleroderma-like reaction","count":50,"llr":16.12741285},{"event":"depressed mood","count":8822,"llr":15.02483848},{"event":"blepharospasm","count":913,"llr":15.00645496},{"event":"social avoidant behaviour","count":1250,"llr":13.4698205},{"event":"pancytopenia","count":17598,"llr":12.65771185},{"event":"hypokinesia","count":2834,"llr":12.48873169},{"event":"grand mal convulsion","count":4865,"llr":12.03213785},{"event":"congenital cardiovascular anomaly","count":207,"llr":11.88132713},{"event":"hiccups","count":1749,"llr":11.84093395},{"event":"petechiae","count":3194,"llr":11.8076598},{"event":"leukopenia","count":17226,"llr":10.98020835},{"event":"hyperandrogenism","count":31,"llr":10.89397135},{"event":"attention deficit/hyperactivity disorder","count":1098,"llr":10.40700242},{"event":"coma blister","count":46,"llr":10.10619566},{"event":"lymphadenopathy","count":9318,"llr":10.00794334},{"event":"treatment failure","count":12895,"llr":9.646790372},{"event":"language disorder","count":447,"llr":9.596270108},{"event":"antinuclear antibody positive","count":1607,"llr":8.935249233},{"event":"immune thrombocytopenic purpura","count":1610,"llr":8.928093963},{"event":"aphasia","count":8046,"llr":8.831804447},{"event":"hallucination, visual","count":5602,"llr":8.68037687},{"event":"hallucination, olfactory","count":124,"llr":8.130885429},{"event":"drug reaction with eosinophilia and systemic symptoms","count":9050,"llr":8.110181593},{"event":"congenital anomaly","count":2033,"llr":8.038001983},{"event":"sweat gland disorder","count":132,"llr":8.006662171},{"event":"protein-losing gastroenteropathy","count":141,"llr":7.875665875},{"event":"toxic epidermal necrolysis","count":4052,"llr":7.873795034},{"event":"learning disability","count":142,"llr":7.861633723},{"event":"psychomotor hyperactivity","count":4158,"llr":7.75543657},{"event":"bile output decreased","count":2,"llr":7.492027358},{"event":"abnormal behaviour","count":10841,"llr":7.027325387},{"event":"condition aggravated","count":52909,"llr":6.858084692},{"event":"intention tremor","count":236,"llr":6.855229486},{"event":"dyspepsia","count":15285,"llr":6.650850569},{"event":"lupus-like syndrome","count":2970,"llr":6.617119301},{"event":"ewing's sarcoma metastatic","count":5,"llr":6.576043944}],"critval":6.461772367},"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":3},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3833308","_score":1,"_source":{"id":"CHEMBL3833308","internal_compound":false,"type":"Antibody","pref_name":"BIIB059","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["BIIB059"],"trade_names":[],"indications":[{"efo_id":"EFO_0002690","efo_label":"systemic lupus erythematosus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002690","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02106897"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02106897%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000198178","approved_name":"C-type lectin domain family 4 member C","approved_symbol":"CLEC4C"}],"target_type":"single protein","target_name":"C-type lectin domain family 4 member C","action_type":"inhibitor","description":"C-type lectin domain family 4 member C inhibitor","references":[{"source":"PubMed","ids":["25762615"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25762615"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL602","_score":1,"_source":{"id":"CHEMBL602","internal_compound":false,"type":"Small molecule","pref_name":"CYSTEAMINE","year_first_approved":1994,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["CI-9148","Cystagon","Cysteamine","Cysteamine Bitartrate","Cysteamine HCl","L-1573","MEA","Mercaptamine","Mercaptamine bitartrate","NSC-647528","RP-103"],"trade_names":["Cystagon","Cystaran","Procysbi"],"cross_references":[{"source":"ChEBI","ids":[17141]},{"source":"DailyMed","ids":["cysteamine%20bitartrate","cysteamine%20hydrochloride"]},{"source":"PubChem","ids":["11111480","144206643","90341118"]},{"source":"Wikipedia","ids":["Cysteamine"]},{"source":"drugbank","ids":["DB00847"]},{"source":"DailyMed","ids":["cysteamine%20hydrochloride"]},{"source":"PubChem","ids":["11533072","144204796","170466795","26747565","50106573","542463"]},{"source":"ChEBI","ids":[50386]},{"source":"DailyMed","ids":["cysteamine%20bitartrate"]}],"canonical_smiles":"NCCS","indications":[{"efo_id":"Orphanet_213","efo_label":"Cystinosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_213","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00001213","NCT00001736"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00001213%22OR%22NCT00001736%22"]}]},{"efo_id":"HP_0001397","efo_label":"Hepatic steatosis","efo_uri":"http://purl.obolibrary.org/obo/HP_0001397","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00799578"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00799578%22"]}]},{"efo_id":"Orphanet_586","efo_label":"Cystic fibrosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_586","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02212431","NCT03000348"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02212431%22OR%22NCT03000348%22"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00002110"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002110%22"]}]},{"efo_id":"Orphanet_213","efo_label":"Cystinosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_213","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["b98ee838-ed23-42a9-93b5-72579e490fba"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b98ee838-ed23-42a9-93b5-72579e490fba"]}]},{"efo_id":"EFO_0003095","efo_label":"non-alcoholic fatty liver disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003095","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01529268"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01529268%22"]}]},{"efo_id":"Orphanet_213","efo_label":"Cystinosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_213","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00872729","NCT01000961","NCT01197378","NCT01733316"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00872729%22OR%22NCT01000961%22OR%22NCT01197378%22OR%22NCT01733316%22"]},{"source":"DailyMed","ids":["b7b6e290-5168-46dc-9e7f-5995420ec1c1","f495b76d-96c6-48e5-8fa3-30a4336628eb"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b7b6e290-5168-46dc-9e7f-5995420ec1c1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f495b76d-96c6-48e5-8fa3-30a4336628eb"]}]},{"efo_id":"Orphanet_68380","efo_label":"Mitochondrial disease","efo_uri":"http://www.orpha.net/ORDO/Orphanet_68380","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02023866","NCT02473445"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02023866%22OR%22NCT02473445%22"]}]},{"efo_id":"EFO_0000270","efo_label":"asthma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000270","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03883984"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03883984%22"]}]}],"adverse_events":{"significant":[{"event":"eye irritation","count":5686,"llr":77.13511654},{"event":"amino acid level increased","count":110,"llr":48.11589043},{"event":"intestinal diaphragm disease","count":116,"llr":40.78221672},{"event":"renal transplant","count":760,"llr":37.853701},{"event":"small intestinal stenosis","count":289,"llr":34.40354517},{"event":"vomiting","count":103943,"llr":25.27639258},{"event":"ocular hyperaemia","count":6875,"llr":24.66977861},{"event":"eye pain","count":7341,"llr":23.97805394},{"event":"hypoalbuminaemia","count":2309,"llr":23.90479758},{"event":"skin odour abnormal","count":675,"llr":23.48996485},{"event":"biopsy stomach abnormal","count":8,"llr":22.93211514},{"event":"multiple epiphyseal dysplasia","count":8,"llr":22.93211514},{"event":"intravascular papillary endothelial hyperplasia","count":9,"llr":22.57883172},{"event":"skin striae","count":335,"llr":22.14164584},{"event":"breath odour","count":466,"llr":20.49990782},{"event":"skin fragility","count":187,"llr":19.1396634},{"event":"laceration","count":3403,"llr":17.3430403},{"event":"small intestinal obstruction","count":3840,"llr":16.52561144},{"event":"erosive duodenitis","count":379,"llr":16.32651568},{"event":"papilloedema","count":1564,"llr":14.51739639},{"event":"benign intracranial hypertension","count":702,"llr":13.88206232},{"event":"normocytic anaemia","count":269,"llr":12.40345035},{"event":"blood gastrin increased","count":43,"llr":11.11216741},{"event":"ehlers-danlos syndrome","count":45,"llr":11.02137456},{"event":"photophobia","count":3837,"llr":10.17839971},{"event":"gastrointestinal disorder","count":14216,"llr":10.1326318},{"event":"pre-existing disease","count":75,"llr":10.00170175},{"event":"elbow deformity","count":88,"llr":9.682861674},{"event":"nephrotic syndrome","count":2560,"llr":8.828358182},{"event":"sensorimotor disorder","count":204,"llr":8.008945445},{"event":"intracranial pressure increased","count":1369,"llr":7.594347289},{"event":"knee deformity","count":259,"llr":7.535156607},{"event":"cystinosis","count":3,"llr":7.5223366},{"event":"completed suicide","count":284,"llr":7.352513042},{"event":"dialysis","count":3795,"llr":7.33451712},{"event":"abdominal pain upper","count":34037,"llr":7.243735876},{"event":"blood homocysteine abnormal","count":4,"llr":7.234720735},{"event":"dysplasia","count":316,"llr":7.141087557},{"event":"burning sensation","count":12178,"llr":6.881769851},{"event":"cartilage hypertrophy","count":8,"llr":6.541838385},{"event":"polyhydramnios","count":440,"llr":6.487200749},{"event":"nasal polyps","count":447,"llr":6.456094695},{"event":"autism spectrum disorder","count":461,"llr":6.395339164},{"event":"impetigo","count":469,"llr":6.361457352},{"event":"fibrosing colonopathy","count":11,"llr":6.223583277}],"critval":5.885942255},"child_chembl_ids":["CHEMBL1256137","CHEMBL2062263","CHEMBL3763421"],"number_of_indications":9,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":5},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":4},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":4},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":3},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":3},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":3},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL53366","_score":1,"_source":{"id":"CHEMBL53366","internal_compound":false,"type":"Small molecule","pref_name":"IMIDAFENACIN","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Imidafenacin","KRP-197","ONO-8025"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB09262"]}],"canonical_smiles":"Cc1nccn1CCC(C(N)=O)(c1ccccc1)c1ccccc1","indications":[{"efo_id":"EFO_1000781","efo_label":"overactive bladder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000781","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00212706","NCT00212732","NCT00512785"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00212706%22OR%22NCT00212732%22OR%22NCT00512785%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL205596","_score":1,"_source":{"id":"CHEMBL205596","internal_compound":false,"type":"Small molecule","pref_name":"CHOLIC ACID","year_first_approved":2015,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Cholic Acid","Cholic acid","E1000","NSC-6135"],"trade_names":["Cholbam","Kolbam","Orphacol"],"cross_references":[{"source":"ChEBI","ids":[16359]},{"source":"DailyMed","ids":["cholic%20acid"]},{"source":"PubChem","ids":["26754161","26754162"]},{"source":"Wikipedia","ids":["Cholic_acid"]},{"source":"drugbank","ids":["DB02659"]},{"source":"PubChem","ids":["56322624"]},{"source":"ChEBI","ids":[26711]},{"source":"PubChem","ids":["144209733","17388734","50085970"]},{"source":"PubChem","ids":["144203577"]}],"canonical_smiles":"C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O","indications":[{"efo_id":"Orphanet_68373","efo_label":"Peroxisomal disease","efo_uri":"http://www.orpha.net/ORDO/Orphanet_68373","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["e5b67402-8550-4604-97a0-c7b149fbf753"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e5b67402-8550-4604-97a0-c7b149fbf753"]}]},{"efo_id":"EFO_1001486","efo_label":"primary biliary cirrhosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001486","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT03253276"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03253276%22"]}]},{"efo_id":"HP_0001397","efo_label":"Hepatic steatosis","efo_uri":"http://purl.obolibrary.org/obo/HP_0001397","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00457639"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00457639%22"]}]},{"efo_id":"EFO_0001073","efo_label":"obesity","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001073","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02532335"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02532335%22"]}]},{"efo_id":"EFO_0001421","efo_label":"liver disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001421","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT04053023"],"urls":["https://clinicaltrials.gov/search?id=%22NCT04053023%22"]}]},{"efo_id":"EFO_0003095","efo_label":"non-alcoholic fatty liver disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003095","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02548351"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02548351%22"]}]},{"efo_id":"EFO_1001249","efo_label":"non-alcoholic steatohepatitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001249","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01265498","NCT02633956"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01265498%22OR%22NCT02633956%22"]}]},{"efo_id":"HP_0002014","efo_label":"Diarrhea","efo_uri":"http://purl.obolibrary.org/obo/HP_0002014","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01585025"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01585025%22"]}]},{"efo_id":"Orphanet_818","efo_label":"Smith-Lemli-Opitz syndrome","efo_uri":"http://www.orpha.net/ORDO/Orphanet_818","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03720990"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03720990%22"]}]},{"efo_id":"Orphanet_98306","efo_label":"Familial partial lipodystrophy","efo_uri":"http://www.orpha.net/ORDO/Orphanet_98306","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02430077"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02430077%22"]}]}],"mechanisms_of_action":[],"adverse_events":{"significant":[{"event":"iron deficiency anaemia","count":3027,"llr":13.52323267},{"event":"gastrostomy","count":459,"llr":11.90621577},{"event":"dental cosmetic procedure","count":4,"llr":9.970565487},{"event":"gastroenterostomy","count":22,"llr":8.265892465},{"event":"seizure","count":19835,"llr":7.945124339},{"event":"neuropathy peripheral","count":20261,"llr":7.882937673}],"critval":7.163550641},"child_chembl_ids":["CHEMBL1334097","CHEMBL1421383","CHEMBL3187726"],"number_of_indications":10,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":6},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":4},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":4},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":3},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":2},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":2},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4204869","_score":1,"_source":{"id":"CHEMBL4204869","internal_compound":false,"type":"Small molecule","pref_name":"ELENBECESTAT","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["E-2609","E2609","Elenbecestat"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB15391"]}],"canonical_smiles":"C[C@H]1OC[C@]2(c3cc(NC(=O)c4cnc(C(F)F)cn4)ccc3F)N=C(N)SC[C@H]12","indications":[{"efo_id":"EFO_0000249","efo_label":"Alzheimer's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000249","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01294540","NCT01600859","NCT01716897","NCT02322021","NCT02859207","NCT02956486","NCT03036280"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01294540%22OR%22NCT01600859%22OR%22NCT01716897%22OR%22NCT02322021%22OR%22NCT02859207%22OR%22NCT02956486%22OR%22NCT03036280%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000186318","approved_name":"beta-secretase 1","approved_symbol":"BACE1"}],"target_type":"single protein","target_name":"Beta-secretase 1","action_type":"inhibitor","description":"Beta-secretase 1 inhibitor","references":[{"source":"PubMed","ids":["25621019"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25621019"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL429844","_score":1,"_source":{"id":"CHEMBL429844","internal_compound":false,"type":"Small molecule","pref_name":"ORE-1001","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["GL1001","MLN-4760","ORE-1001 FREE ACID","ORE1001","Ore-1001","Ore1001"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12271"]}],"canonical_smiles":"CC(C)C[C@H](N[C@@H](Cc1cncn1Cc1cc(Cl)cc(Cl)c1)C(=O)O)C(=O)O","indications":[{"efo_id":"EFO_0000729","efo_label":"ulcerative colitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000729","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01039597"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01039597%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL260046","_score":1,"_source":{"id":"CHEMBL260046","internal_compound":false,"type":"Small molecule","pref_name":"EVOFOSFAMIDE","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Evofosfamide","HAP-302","TH-302"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB06091"]}],"canonical_smiles":"Cn1c(COP(=O)(NCCBr)NCCBr)cnc1[N+](=O)[O-]","indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02020226","NCT02076230"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02020226%22OR%22NCT02076230%22"]}]},{"efo_id":"EFO_0002617","efo_label":"metastatic melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002617","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01864538"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01864538%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01522872"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01522872%22"]}]},{"efo_id":"EFO_0000519","efo_label":"glioblastoma multiforme","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000519","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02342379"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02342379%22"]}]},{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01833546","NCT02047500"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01833546%22OR%22NCT02047500%22"]}]},{"efo_id":"EFO_0002916","efo_label":"esophageal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002916","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02598687"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02598687%22"]}]},{"efo_id":"EFO_0003891","efo_label":"biliary tract neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003891","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02433639"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02433639%22"]}]},{"efo_id":"EFO_1001968","efo_label":"soft tissue sarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001968","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00742963","NCT02255110"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00742963%22OR%22NCT02255110%22"]}]}],"mechanisms_of_action":[],"adverse_events":{"significant":[{"event":"neutropenia","count":41585,"llr":8.716092913},{"event":"influenza a virus test positive","count":80,"llr":6.916313532},{"event":"plasma cell leukaemia","count":81,"llr":6.903895443}],"critval":6.865856671},"number_of_indications":8,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":8},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":3},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":3},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2107366","_score":1,"_source":{"id":"CHEMBL2107366","internal_compound":false,"type":"Small molecule","pref_name":"REZATOMIDINE","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AGN-203818","Agn 203818","Rezatomidine"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12143"]}],"canonical_smiles":"Cc1cccc([C@H](C)c2c[nH]c(=S)[nH]2)c1C","indications":[{"efo_id":"EFO_0000555","efo_label":"irritable bowel syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000555","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00441766"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00441766%22"]}]},{"efo_id":"EFO_0005687","efo_label":"fibromyalgia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005687","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00445705"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00445705%22"]}]},{"efo_id":"EFO_1000783","efo_label":"diabetic neuropathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000783","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00381719"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00381719%22"]}]},{"efo_id":"EFO_1000869","efo_label":"chronic interstitial cystitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000869","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00380783"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00380783%22"]}]}],"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297839","_score":1,"_source":{"id":"CHEMBL4297839","internal_compound":false,"type":"Protein","pref_name":"TIRZEPATIDE","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["LY-3298176","LY3298176","Ly3298176","Tirzepatide"],"trade_names":[],"indications":[{"efo_id":"EFO_0001073","efo_label":"obesity","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001073","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT04081337"],"urls":["https://clinicaltrials.gov/search?id=%22NCT04081337%22"]}]},{"efo_id":"EFO_0001360","efo_label":"type II diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001360","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02759107","NCT03131687","NCT03311724","NCT03322631","NCT03730662","NCT03861039","NCT03861052","NCT03882970","NCT03951753","NCT03954834","NCT03987919","NCT04039503","NCT04093752"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02759107%22OR%22NCT03131687%22OR%22NCT03311724%22OR%22NCT03322631%22OR%22NCT03730662%22OR%22NCT03861039%22OR%22NCT03861052%22OR%22NCT03882970%22OR%22NCT03951753%22OR%22NCT03954834%22OR%22NCT03987919%22OR%22NCT04039503%22OR%22NCT04093752%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":2},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1712170","_score":1,"_source":{"id":"CHEMBL1712170","internal_compound":false,"type":"Small molecule","pref_name":"ETHYLMORPHINE","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Ethylmorphine","Ethylmorphine HCl"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[4902]},{"source":"PubChem","ids":["144206163","50113064"]},{"source":"drugbank","ids":["DB01466"]}],"canonical_smiles":"CCOc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314","indications":[{"efo_id":"HP_0012735","efo_label":"Cough","efo_uri":"http://purl.obolibrary.org/obo/HP_0012735","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["R05DA01"],"urls":["https://www.whocc.no/atc_ddd_index/?code=R05DA01"]}]}],"adverse_events":{"significant":[{"event":"miosis","count":2714,"llr":12.59890841},{"event":"respiratory arrest","count":3162,"llr":12.29346292},{"event":"hypothermia","count":3713,"llr":11.9723358},{"event":"sinus bradycardia","count":4115,"llr":11.76684338},{"event":"hyperglycaemia","count":9767,"llr":10.03957825},{"event":"coma","count":13175,"llr":9.441845766},{"event":"amnesia","count":13293,"llr":9.424043658},{"event":"blood pressure decreased","count":13298,"llr":9.423292831},{"event":"retrograde amnesia","count":187,"llr":8.019496826}],"critval":8.010879733},"child_chembl_ids":["CHEMBL2107695"],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2103774","_score":1,"_source":{"id":"CHEMBL2103774","internal_compound":false,"type":"Small molecule","pref_name":"TIBOLONE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["ORG OD 14","ORG-OD 14","Tibolone"],"trade_names":["Livial"],"cross_references":[{"source":"ChEBI","ids":[32223]},{"source":"PubChem","ids":["144205803","170465874"]},{"source":"drugbank","ids":["DB09070"]}],"canonical_smiles":"C#C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)C1=C(CC(=O)CC1)C[C@H]3C","indications":[{"efo_id":"EFO_0003922","efo_label":"menopause","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003922","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00299364","NCT00745108"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00299364%22OR%22NCT00745108%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00408863","NCT00725374"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00408863%22OR%22NCT00725374%22"]}]},{"efo_id":"EFO_0003882","efo_label":"osteoporosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003882","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00519857"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00519857%22"]}]},{"efo_id":"EFO_0004714","efo_label":"sexual dysfunction","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004714","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00413764"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00413764%22"]}]},{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01239888"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01239888%22"]}]}],"adverse_events":{"significant":[{"event":"acute hepatic failure","count":3420,"llr":28.37587479},{"event":"resorption bone increased","count":293,"llr":26.92936831},{"event":"spinal deformity","count":320,"llr":26.57692257},{"event":"gingival recession","count":435,"llr":25.34945199},{"event":"temporal arteritis","count":469,"llr":25.04861117},{"event":"umbilical hernia","count":925,"llr":22.33434382},{"event":"gingival disorder","count":997,"llr":22.03490991},{"event":"hyperkeratosis","count":1403,"llr":20.67066375},{"event":"body height decreased","count":1823,"llr":19.62548095},{"event":"tooth loss","count":1980,"llr":19.29588738},{"event":"hip arthroplasty","count":2789,"llr":17.92997342},{"event":"eating disorder","count":3349,"llr":17.20112649},{"event":"vaginal polyp","count":25,"llr":16.91326485},{"event":"knee arthroplasty","count":4354,"llr":16.15690057},{"event":"bone disorder","count":5209,"llr":15.44441481},{"event":"limb discomfort","count":5368,"llr":15.32501635},{"event":"osteoarthritis","count":9922,"llr":12.89279759},{"event":"general physical health deterioration","count":17224,"llr":10.7267126},{"event":"myalgia","count":42953,"llr":10.17606805}],"critval":9.967781638},"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":2},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3410450","_score":1,"_source":{"id":"CHEMBL3410450","internal_compound":false,"type":"Small molecule","pref_name":"PRESATOVIR","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["GS-5806","Presatovir"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12165"]}],"canonical_smiles":"Cc1cn2nc([C@@H]3CCCCN3C(=O)c3cc(Cl)ccc3NS(C)(=O)=O)cc2nc1N1CC[C@H](N)C1","indications":[{"efo_id":"EFO_1001413","efo_label":"Respiratory Syncytial Virus Infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001413","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01756482","NCT01797419","NCT01801293","NCT02135614","NCT02254408","NCT02254421","NCT02534350"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01756482%22OR%22NCT01797419%22OR%22NCT01801293%22OR%22NCT02135614%22OR%22NCT02254408%22OR%22NCT02254421%22OR%22NCT02534350%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545037","_score":1,"_source":{"id":"CHEMBL3545037","internal_compound":false,"type":"Small molecule","pref_name":"STX107","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["STX-107"],"trade_names":[],"indications":[{"efo_id":"Orphanet_908","efo_label":"Fragile X syndrome","efo_uri":"http://www.orpha.net/ORDO/Orphanet_908","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00965432","NCT01325740"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00965432%22OR%22NCT01325740%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000168959","approved_name":"glutamate metabotropic receptor 5","approved_symbol":"GRM5"}],"target_type":"single protein","target_name":"Metabotropic glutamate receptor 5","action_type":"negative allosteric modulator","description":"Metabotropic glutamate receptor 5 negative allosteric modulator","references":[{"source":"PMC","ids":["PMC172159"],"urls":["https://www.ncbi.nlm.nih.gov/pmc/articles/PMC172159"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297870","_score":1,"_source":{"id":"CHEMBL4297870","internal_compound":false,"type":"Antibody","pref_name":"MITAZALIMAB","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["ADC-1013","Adc-1013","JNJ-64457107","JNJ-7107","Jnj-64457107","Mitazalimab"],"trade_names":[],"indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02379741","NCT02829099"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02379741%22OR%22NCT02829099%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201621","_score":1,"_source":{"id":"CHEMBL1201621","internal_compound":false,"type":"Protein","pref_name":"SOMATROPIN","year_first_approved":1976,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["CB-311","DA-3002","LY-137998","LY137998","Somatotropin human growth hormone","Somatropin","Somatropin Recombinant"],"trade_names":["Accretropin","Asellacrin 10","Asellacrin 2","Bio-Tropin","Crescormon","Genotropin","Genotropin GoQuick","Genotropin Kabipen","Genotropin Kabiquick","Genotropin Kabivial","Genotropin MiniQuick","Genotropin [Rdna Origin]","Genotropin preservative free","Humatrope","Humatropen","Norditropin","Norditropin Flexpro","Norditropin Nordiflex","Norditropin Penset","Norditropin SimpleXx","Nutropin","Nutropin Aq","Nutropin Aq Pen","Nutropin Depot","Nutropin aq nuspin","Nutropinaq","Omnitrope","Omnitrope Pen 10","Omnitrope Pen 5","Omnitrope SurePal 10","Omnitrope SurePal 15","Omnitrope SurePal 5","Saizen","Saizen Click.easy","Saizen Easyject","Serostim","Serostim Lq","Tev-Tropin","Valtropin","Zomacton","Zorbtive"],"cross_references":[{"source":"DailyMed","ids":["somatropin","somatropin%20recombinant"]},{"source":"DrugCentral","ids":["4848"]}],"indications":[{"efo_id":"EFO_0000495","efo_label":"fetal growth restriction","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000495","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00174252","NCT00184691","NCT00184717","NCT00184756","NCT00191529","NCT00249821","NCT00452491","NCT00557336","NCT00625872","NCT00627523","NCT01067352","NCT01400698","NCT02375620","NCT02770157","NCT03221933","NCT03245333"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00174252%22OR%22NCT00184691%22OR%22NCT00184717%22OR%22NCT00184756%22OR%22NCT00191529%22OR%22NCT00249821%22OR%22NCT00452491%22OR%22NCT00557336%22OR%22NCT00625872%22OR%22NCT00627523%22OR%22NCT01067352%22OR%22NCT01400698%22OR%22NCT02375620%22OR%22NCT02770157%22OR%22NCT03221933%22OR%22NCT03245333%22"]}]},{"efo_id":"EFO_0005687","efo_label":"fibromyalgia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005687","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00933686"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00933686%22"]}]},{"efo_id":"Orphanet_881","efo_label":"Turner syndrome","efo_uri":"http://www.orpha.net/ORDO/Orphanet_881","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00001221","NCT00001343","NCT00004275","NCT00191113","NCT00250250","NCT00406926","NCT00870220","NCT01518036","NCT01813630"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00001221%22OR%22NCT00001343%22OR%22NCT00004275%22OR%22NCT00191113%22OR%22NCT00250250%22OR%22NCT00406926%22OR%22NCT00870220%22OR%22NCT01518036%22OR%22NCT01813630%22"]},{"source":"DailyMed","ids":["1058e17c-9261-459c-a3e6-fae38d196c14","139d2038-e6a9-4ab1-ab00-aa7d8aa8df5f","58d84ffa-4056-4e36-ad67-7bd4aef444a5","a774e1ae-3997-49ee-8b0e-99a2b315d409","aa9d3467-a450-4b06-885a-7d834dcbddff","ffebf88b-d257-4542-9808-74d9b7167765"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1058e17c-9261-459c-a3e6-fae38d196c14","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?139d2038-e6a9-4ab1-ab00-aa7d8aa8df5f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?58d84ffa-4056-4e36-ad67-7bd4aef444a5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a774e1ae-3997-49ee-8b0e-99a2b315d409","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?aa9d3467-a450-4b06-885a-7d834dcbddff","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ffebf88b-d257-4542-9808-74d9b7167765"]}]},{"efo_id":"Orphanet_586","efo_label":"Cystic fibrosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_586","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00005112","NCT00016445","NCT00079742","NCT00256555","NCT00803179"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00005112%22OR%22NCT00016445%22OR%22NCT00079742%22OR%22NCT00256555%22OR%22NCT00803179%22"]}]},{"efo_id":"HP_0001510","efo_label":"Growth delay","efo_uri":"http://purl.obolibrary.org/obo/HP_0001510","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00355030","NCT00396097","NCT00488124","NCT01248416","NCT01494779","NCT01746862","NCT01778023","NCT01786902","NCT02879747","NCT03288103"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00355030%22OR%22NCT00396097%22OR%22NCT00488124%22OR%22NCT01248416%22OR%22NCT01494779%22OR%22NCT01746862%22OR%22NCT01778023%22OR%22NCT01786902%22OR%22NCT02879747%22OR%22NCT03288103%22"]}]},{"efo_id":"EFO_0000253","efo_label":"amyotrophic lateral sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000253","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00635960"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00635960%22"]}]},{"efo_id":"EFO_0003884","efo_label":"chronic kidney disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003884","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00184652","NCT00244075","NCT00503698","NCT00943995","NCT01502137"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00184652%22OR%22NCT00244075%22OR%22NCT00503698%22OR%22NCT00943995%22OR%22NCT01502137%22"]},{"source":"DailyMed","ids":["139d2038-e6a9-4ab1-ab00-aa7d8aa8df5f"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?139d2038-e6a9-4ab1-ab00-aa7d8aa8df5f"]}]},{"efo_id":"Orphanet_739","efo_label":"Prader-Willi syndrome","efo_uri":"http://www.orpha.net/ORDO/Orphanet_739","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT02204163","NCT03554031"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02204163%22OR%22NCT03554031%22"]},{"source":"DailyMed","ids":["58d84ffa-4056-4e36-ad67-7bd4aef444a5","ffebf88b-d257-4542-9808-74d9b7167765"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?58d84ffa-4056-4e36-ad67-7bd4aef444a5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ffebf88b-d257-4542-9808-74d9b7167765"]}]},{"efo_id":"Orphanet_429","efo_label":"Hypochondroplasia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_429","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01111019"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01111019%22"]}]},{"efo_id":"EFO_0001379","efo_label":"endocrine system disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001379","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00163215","NCT00174187","NCT00174291"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00163215%22OR%22NCT00174187%22OR%22NCT00174291%22"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00071240","NCT00286676","NCT00294164","NCT00294918","NCT01077960","NCT03091374"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00071240%22OR%22NCT00286676%22OR%22NCT00294164%22OR%22NCT00294918%22OR%22NCT01077960%22OR%22NCT03091374%22"]},{"source":"DailyMed","ids":["62b01d29-90f0-45b2-a0c4-3a750ba36c8a"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?62b01d29-90f0-45b2-a0c4-3a750ba36c8a"]}]},{"efo_id":"EFO_0000545","efo_label":"infertility","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000545","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01298960","NCT01616225","NCT02338206","NCT02359695","NCT03373149"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01298960%22OR%22NCT01616225%22OR%22NCT02338206%22OR%22NCT02359695%22OR%22NCT03373149%22"]}]},{"efo_id":"EFO_0003144","efo_label":"heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003144","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00182169","NCT00501514","NCT01235273"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00182169%22OR%22NCT00501514%22OR%22NCT01235273%22"]}]},{"efo_id":"Orphanet_365563","efo_label":"Primary short bowel syndrome","efo_uri":"http://www.orpha.net/ORDO/Orphanet_365563","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00067860"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00067860%22"]},{"source":"DailyMed","ids":["c04b1b2c-5484-4a5d-887a-3f7ace8388a1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c04b1b2c-5484-4a5d-887a-3f7ace8388a1"]}]},{"efo_id":"EFO_0000384","efo_label":"Crohn's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000384","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00109473","NCT01647412"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00109473%22OR%22NCT01647412%22"]}]},{"efo_id":"EFO_0000546","efo_label":"injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000546","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00766038","NCT00929045","NCT01699308"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00766038%22OR%22NCT00929045%22OR%22NCT01699308%22"]}]},{"efo_id":"EFO_0001073","efo_label":"obesity","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001073","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00553852","NCT01169103"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00553852%22OR%22NCT01169103%22"]}]},{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00470002","NCT01572259"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00470002%22OR%22NCT01572259%22"]}]},{"efo_id":"EFO_0001380","efo_label":"hypopituitarism","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001380","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00133354","NCT01007071"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00133354%22OR%22NCT01007071%22"]}]},{"efo_id":"EFO_1001434","efo_label":"Tendinopathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001434","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02597660"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02597660%22"]}]},{"efo_id":"EFO_0000180","efo_label":"HIV-1 infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000180","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT01130376"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01130376%22"]}]},{"efo_id":"EFO_0000400","efo_label":"diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000400","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01020955"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01020955%22"]}]},{"efo_id":"EFO_0001422","efo_label":"cirrhosis of liver","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001422","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02451033","NCT03420144"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02451033%22OR%22NCT03420144%22"]}]},{"efo_id":"EFO_0003944","efo_label":"tibia fracture","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003944","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00254514"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00254514%22"]}]},{"efo_id":"EFO_0007312","efo_label":"HIV wasting syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007312","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00489528"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00489528%22"]}]},{"efo_id":"EFO_1000653","efo_label":"sarcopenia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000653","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00183040"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00183040%22"]}]},{"efo_id":"EFO_1001919","efo_label":"Spinal cord injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001919","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01329757"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01329757%22"]}]},{"efo_id":"GO_0007568","efo_label":"aging","efo_uri":"http://purl.obolibrary.org/obo/GO_0007568","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01410799"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01410799%22"]}]},{"efo_id":"HP_0100543","efo_label":"Cognitive impairment","efo_uri":"http://purl.obolibrary.org/obo/HP_0100543","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02553603"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02553603%22"]}]},{"efo_id":"Orphanet_269","efo_label":"Facioscapulohumeral dystrophy","efo_uri":"http://www.orpha.net/ORDO/Orphanet_269","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03123913"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03123913%22"]}]},{"efo_id":"Orphanet_583","efo_label":"Mucopolysaccharidosis type 6","efo_uri":"http://www.orpha.net/ORDO/Orphanet_583","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00748969"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00748969%22"]}]},{"efo_id":"Orphanet_648","efo_label":"Noonan syndrome","efo_uri":"http://www.orpha.net/ORDO/Orphanet_648","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00452725","NCT01529840","NCT01529944","NCT01927861"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00452725%22OR%22NCT01529840%22OR%22NCT01529944%22OR%22NCT01927861%22"]}]},{"efo_id":"Orphanet_666","efo_label":"Osteogenesis imperfecta","efo_uri":"http://www.orpha.net/ORDO/Orphanet_666","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00001305"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00001305%22"]}]},{"efo_id":"EFO_0002506","efo_label":"osteoarthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002506","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT03800810"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03800810%22"]}]},{"efo_id":"EFO_0008525","efo_label":"spinal muscular atrophy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008525","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00533221"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00533221%22"]}]},{"efo_id":"EFO_0008560","efo_label":"female infertility","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008560","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02179255","NCT03237117"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02179255%22OR%22NCT03237117%22"]}]},{"efo_id":"EFO_0009516","efo_label":"burn","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009516","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00673309","NCT00675714","NCT03038594"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00673309%22OR%22NCT00675714%22OR%22NCT03038594%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000112964","approved_name":"growth hormone receptor","approved_symbol":"GHR"}],"target_type":"single protein","target_name":"Growth hormone receptor","action_type":"agonist","description":"Growth hormone receptor agonist","references":[{"source":"DailyMed","ids":["setid=ffebf88b-d257-4542-9808-74d9b7167765"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ffebf88b-d257-4542-9808-74d9b7167765"]},{"source":"ISBN","ids":["9780702034718 PP. 396"],"urls":[]}]}],"adverse_events":{"significant":[{"event":"insulin-like growth factor increased","count":535,"llr":960.7310032},{"event":"insulin-like growth factor decreased","count":222,"llr":729.2873385},{"event":"craniopharyngioma","count":168,"llr":684.6988793},{"event":"growth retardation","count":1124,"llr":657.5547329},{"event":"scoliosis","count":1453,"llr":626.6155857},{"event":"headache","count":120638,"llr":487.3326383},{"event":"neoplasm recurrence","count":811,"llr":468.3876707},{"event":"epiphysiolysis","count":132,"llr":373.8633871},{"event":"pituitary tumour benign","count":632,"llr":339.8052977},{"event":"wrong technique in device usage process","count":618,"llr":302.5967629},{"event":"osteochondrosis","count":379,"llr":299.9723158},{"event":"sleep apnoea syndrome","count":4137,"llr":230.0199229},{"event":"intracranial pressure increased","count":1369,"llr":216.9218232},{"event":"blood thyroid stimulating hormone decreased","count":1034,"llr":210.8037304},{"event":"injection site pain","count":56727,"llr":192.9449363},{"event":"papilloedema","count":1564,"llr":192.3031897},{"event":"blood creatinine decreased","count":919,"llr":191.0146241},{"event":"bone density increased","count":133,"llr":172.8080229}],"critval":166.2256505},"number_of_indications":37,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":11},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":10},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":9},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":9},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":8},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":6},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":4},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":4},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":4},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":4},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":3},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":3},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":3},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":2},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":2},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":2},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"OTAR_0000014","therapeutic_label":"pregnancy or perinatal disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL105318","_score":1,"_source":{"id":"CHEMBL105318","internal_compound":false,"type":"Small molecule","pref_name":"ALOVUDINE","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Alovudine","CL 184824","CL-184,824","CL-184824","NSC-140025"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["144205929","170466324"]},{"source":"Wikipedia","ids":["Alovudine"]},{"source":"drugbank","ids":["DB06198"]}],"canonical_smiles":"Cc1cn([C@H]2C[C@H](F)[C@@H](CO)O2)c(=O)[nH]c1=O","indications":[{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02232581"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02232581%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3393588","_score":1,"_source":{"id":"CHEMBL3393588","internal_compound":false,"type":"Small molecule","pref_name":"BTA-9881","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AZD-9639","BTA9881","Bta-9881","Bta9881","MEDI-564"],"trade_names":[],"canonical_smiles":"O=C(c1cccnc1)N1CCN2C(=O)c3ccncc3[C@]12c1ccc(Cl)cc1","indications":[{"efo_id":"EFO_1001413","efo_label":"Respiratory Syncytial Virus Infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001413","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00504907"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00504907%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL940","_score":1,"_source":{"id":"CHEMBL940","internal_compound":false,"type":"Small molecule","pref_name":"GABAPENTIN","year_first_approved":1993,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["CI-945","DM-1796","GOE-3450","Gabapentin"],"trade_names":["Gabapentin","Gralise","Neurontin"],"cross_references":[{"source":"ChEBI","ids":[42797]},{"source":"DailyMed","ids":["gabapentin"]},{"source":"PubChem","ids":["104171164","11112806","11113327","124880194","144203708","170464715","50103936","855579","90340599"]},{"source":"Wikipedia","ids":["Gabapentin"]},{"source":"drugbank","ids":["DB00996"]}],"canonical_smiles":"NCC1(CC(=O)O)CCCCC1","indications":[{"efo_id":"EFO_0004698","efo_label":"insomnia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004698","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00163046","NCT00659100","NCT00666575","NCT00666770","NCT00666939","NCT00667108","NCT00674752","NCT00755508","NCT01421264","NCT03668041"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00163046%22OR%22NCT00659100%22OR%22NCT00666575%22OR%22NCT00666770%22OR%22NCT00666939%22OR%22NCT00667108%22OR%22NCT00674752%22OR%22NCT00755508%22OR%22NCT01421264%22OR%22NCT03668041%22"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00027963","NCT00221338","NCT00312260","NCT00624455","NCT00735124","NCT00934193","NCT01116583","NCT01776671","NCT02856750","NCT02918760","NCT03088306","NCT03679013","NCT03750773","NCT03867240"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00027963%22OR%22NCT00221338%22OR%22NCT00312260%22OR%22NCT00624455%22OR%22NCT00735124%22OR%22NCT00934193%22OR%22NCT01116583%22OR%22NCT01776671%22OR%22NCT02856750%22OR%22NCT02918760%22OR%22NCT03088306%22OR%22NCT03679013%22OR%22NCT03750773%22OR%22NCT03867240%22"]}]},{"efo_id":"HP_0000989","efo_label":"Pruritus","efo_uri":"http://purl.obolibrary.org/obo/HP_0000989","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01092520"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01092520%22"]}]},{"efo_id":"EFO_0004273","efo_label":"scoliosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004273","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00684112"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00684112%22"]}]},{"efo_id":"Orphanet_232","efo_label":"Sickle cell anemia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_232","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01954927"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01954927%22"]}]},{"efo_id":"EFO_0000474","efo_label":"epilepsy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000474","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N03AX12"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N03AX12"]},{"source":"ClinicalTrials","ids":["NCT01738893"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01738893%22"]},{"source":"DailyMed","ids":["01aafb0d-6cf4-406d-baad-560a6c91b33f","03646015-2d86-4d6d-958f-94687899b838","036c0c4f-edcc-4974-9ae1-5becb9654cab","06f5461f-0a34-42e1-b84a-567ffafd8e99","0c27d406-45de-4df0-8db0-c3d654fe7637","119ff7cc-5a38-490a-a982-7431b34d061c","13f9f0bb-17c0-4f15-a733-3e28868e4ade","182472eb-d955-0b0b-5028-e93c67a913e7","1a619a14-0b63-4cba-80e7-474c9a1c90b9","1bc85f95-c26a-4037-a02a-2248f6518fe2","1dc96b52-7d43-4274-922f-3a070a165086","237b3a0c-8389-40e1-8fb0-1f6f4ed5bfb4","25cf6c40-a239-4dd0-9cad-28da84d285db","29a70e2d-d3fd-4e32-95dd-7ee721d87388","310ce005-5a24-489a-b23c-d42ab6a3bfed","3180998f-f510-491a-a045-485802230b34","35fee7b8-c127-4345-bae0-bcf46d3b8ccb","3769f1e4-a5ff-43b8-9128-124bc35346d0","383fd4de-4d2a-42dc-9a15-48bee7efb0ba","3848adc8-e3d4-4001-a183-11cda56d6bc2","3865a6e3-112c-490c-82ac-35401336b16e","3a6ffb9f-4e3f-449c-a7e4-1315c7f026bd","3ec0d1db-210c-4480-8cd6-2bd8603b1085","417231e9-129a-4a47-ab2e-cda97d096950","41f1e929-7c1f-4b3e-b142-4b7533300ee2","48017784-d2b7-43cc-94bf-5c950d6be263","493e0603-8148-457b-a743-342f51c4c57a","4a4627ab-3a14-4cf2-8556-01d688cd7f19","501e8d07-bfc3-4427-b7d5-93c4d5874ab4","507bf6d0-e7a2-413d-9848-cd2445a1411d","520b11e8-5f16-4c01-a9da-3ca5e31df3ae","52e49778-03f1-43cb-b75d-6c1adbb96ec6","57ac19da-e60a-4fd3-a412-bb362f87bd4e","591e0212-71ac-4f7a-b30a-8f4b745b263b","5969871e-6c71-4c37-9d63-370718ccc80c","5ac5271e-316c-4802-a172-aa602d22571f","5bf08c96-e0fa-4f67-ba31-c28937dd4815","636f4f87-7a1a-4d02-a9e5-f0cec260513c","69f74e22-9e4f-47e6-ae04-5e323cb91677","6b3ca748-7172-4c53-b5ae-7e17dad918eb","6dcaf09c-d3fb-4528-b7de-97dfbbd36594","722de2a9-38b3-4518-b262-ba0d1346d0ba","74a05b3b-8e4f-4c72-881c-8215d40d14b9","772d9e7a-3811-455a-99e6-f2a3d0769b9b","783d8373-b7af-4a6b-8966-50c5ddb2803b","7a4cd51c-9f24-4905-bbdd-c540777a4e23","7d1c0aab-5385-4d42-805c-7be2b6cdfe4b","7dbc4275-2472-4eba-a8b1-6e4fe5cab5bf","81437733-9a56-42b3-ab28-fb58bfbb0f9d","83b8c92a-84fd-4992-8d79-5ce34cee7453","842b5778-c796-420c-a9ea-168ac930fb03","91bfbccd-2cd2-4ff7-9b3e-70dbdded1e2b","9508cb1b-3f9f-48bd-8f34-a6fbb68c9a4a","98bb408d-c402-4da6-8f9d-5de4833dedc4","99adb2c7-4725-4768-a2d9-856a87f33192","a2109f51-f1e5-4ba5-b3b1-3e3ebee6cf1d","a4c5d9e0-1de0-4de6-a382-5e5f56bf16e3","a99cffb0-4504-4e61-b8a7-69aa35c04b01","aa2e353f-860b-4d10-9a62-aad1c533b8aa","aacc7c2b-efdc-49b6-869f-107b48cc60a5","aaf4d420-13a9-412e-b0ea-64234b49a57e","b033c169-4943-4ad9-ace0-7e4a1f0dc100","b11dbff5-ceee-4a63-a093-f6efebdc2f6f","b1a9ef34-092b-409b-a6b0-59cb079bad0a","b2df0e0e-43ba-47ab-b8f9-22c8010772ba","b452453b-add6-48a0-9ae8-9db6c48eec17","b53c69ca-3f9d-285d-7568-aba4a6c87b05","b5f455c0-d2f1-4e12-bdfe-cd4a50debb30","b846004f-a71d-4ebe-a1aa-1f9b6ac89ee0","bbe6bcf4-f7d3-4067-93af-218c641059dc","bdef074d-a8b5-4891-a9a9-52e1ac0ddc53","be462235-9fa6-457d-b4bb-31277eab1387","c375ec41-b099-4bb0-a23a-76f3f7a858b7","c78f5574-a2e3-400a-9fad-a73727f0ef74","c79d94ec-117d-4fb6-845d-1954e3472bb0","c8369a3f-6155-f4b5-a1e2-ba392b1d2442","c9a05f0c-b5f0-422c-9d67-6d0efc921a74","cd2d3b9d-09cc-4342-9888-9b2e792a51ee","cd606ad3-9c12-473a-948c-1ad7759a7727","cfeb2b37-c295-46d0-be1e-68334c0a7f90","cff7de45-148b-4e96-88fd-6052bf75b5f7","d08562ff-7ebf-4669-a824-933bf66b6328","d576364c-9aa6-4356-a31b-321b0292a8fe","d65099f2-b10d-47a8-ba7e-fe113fdb98d1","dab71f43-6644-410b-a5c0-362da371e7e7","de7207ad-2c50-4c9d-87af-a262ac5e962f","dee07488-7a2b-4d45-89e1-d65ab895fd52","df12230c-09ea-b03b-c32e-800390ce3e33","e116597c-1782-4fc1-9550-4a08777d1056","e2c1bea3-3c6d-4fe9-9bfd-09dbbce0fd7c","e312d01f-570f-2eb8-e877-c13c2cddc088","e4832536-fe56-40b2-b6c1-6edd3511e2ff","e5462645-2b46-4764-87ef-bccb1a64067a","e9f2d8a6-fabe-436d-8fba-4976229692f9","ea6016be-2f5d-4bd0-a228-fa8f455abeae","ee629b60-a461-457d-a9c4-97428a7fc274","ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388","f08849b1-a914-4e94-bbce-ebd72e785986","f3e0e02b-7762-42c7-b144-3714fb31c22b","f6d93c20-6a77-4e88-8ec1-3607c48dde19"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?01aafb0d-6cf4-406d-baad-560a6c91b33f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?03646015-2d86-4d6d-958f-94687899b838","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?036c0c4f-edcc-4974-9ae1-5becb9654cab","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?06f5461f-0a34-42e1-b84a-567ffafd8e99","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0c27d406-45de-4df0-8db0-c3d654fe7637","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?119ff7cc-5a38-490a-a982-7431b34d061c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?13f9f0bb-17c0-4f15-a733-3e28868e4ade","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?182472eb-d955-0b0b-5028-e93c67a913e7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1a619a14-0b63-4cba-80e7-474c9a1c90b9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1bc85f95-c26a-4037-a02a-2248f6518fe2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1dc96b52-7d43-4274-922f-3a070a165086","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?237b3a0c-8389-40e1-8fb0-1f6f4ed5bfb4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?25cf6c40-a239-4dd0-9cad-28da84d285db","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?29a70e2d-d3fd-4e32-95dd-7ee721d87388","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?310ce005-5a24-489a-b23c-d42ab6a3bfed","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3180998f-f510-491a-a045-485802230b34","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?35fee7b8-c127-4345-bae0-bcf46d3b8ccb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3769f1e4-a5ff-43b8-9128-124bc35346d0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?383fd4de-4d2a-42dc-9a15-48bee7efb0ba","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3848adc8-e3d4-4001-a183-11cda56d6bc2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3865a6e3-112c-490c-82ac-35401336b16e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3a6ffb9f-4e3f-449c-a7e4-1315c7f026bd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3ec0d1db-210c-4480-8cd6-2bd8603b1085","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?417231e9-129a-4a47-ab2e-cda97d096950","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?41f1e929-7c1f-4b3e-b142-4b7533300ee2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?48017784-d2b7-43cc-94bf-5c950d6be263","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?493e0603-8148-457b-a743-342f51c4c57a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4a4627ab-3a14-4cf2-8556-01d688cd7f19","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?501e8d07-bfc3-4427-b7d5-93c4d5874ab4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?507bf6d0-e7a2-413d-9848-cd2445a1411d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?520b11e8-5f16-4c01-a9da-3ca5e31df3ae","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?52e49778-03f1-43cb-b75d-6c1adbb96ec6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?57ac19da-e60a-4fd3-a412-bb362f87bd4e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?591e0212-71ac-4f7a-b30a-8f4b745b263b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5969871e-6c71-4c37-9d63-370718ccc80c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5ac5271e-316c-4802-a172-aa602d22571f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5bf08c96-e0fa-4f67-ba31-c28937dd4815","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?636f4f87-7a1a-4d02-a9e5-f0cec260513c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?69f74e22-9e4f-47e6-ae04-5e323cb91677","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6b3ca748-7172-4c53-b5ae-7e17dad918eb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6dcaf09c-d3fb-4528-b7de-97dfbbd36594","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?722de2a9-38b3-4518-b262-ba0d1346d0ba","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?74a05b3b-8e4f-4c72-881c-8215d40d14b9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?772d9e7a-3811-455a-99e6-f2a3d0769b9b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?783d8373-b7af-4a6b-8966-50c5ddb2803b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7a4cd51c-9f24-4905-bbdd-c540777a4e23","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7d1c0aab-5385-4d42-805c-7be2b6cdfe4b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7dbc4275-2472-4eba-a8b1-6e4fe5cab5bf","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?81437733-9a56-42b3-ab28-fb58bfbb0f9d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?83b8c92a-84fd-4992-8d79-5ce34cee7453","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?842b5778-c796-420c-a9ea-168ac930fb03","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?91bfbccd-2cd2-4ff7-9b3e-70dbdded1e2b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9508cb1b-3f9f-48bd-8f34-a6fbb68c9a4a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?98bb408d-c402-4da6-8f9d-5de4833dedc4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?99adb2c7-4725-4768-a2d9-856a87f33192","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a2109f51-f1e5-4ba5-b3b1-3e3ebee6cf1d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a4c5d9e0-1de0-4de6-a382-5e5f56bf16e3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a99cffb0-4504-4e61-b8a7-69aa35c04b01","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?aa2e353f-860b-4d10-9a62-aad1c533b8aa","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?aacc7c2b-efdc-49b6-869f-107b48cc60a5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?aaf4d420-13a9-412e-b0ea-64234b49a57e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b033c169-4943-4ad9-ace0-7e4a1f0dc100","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b11dbff5-ceee-4a63-a093-f6efebdc2f6f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b1a9ef34-092b-409b-a6b0-59cb079bad0a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b2df0e0e-43ba-47ab-b8f9-22c8010772ba","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b452453b-add6-48a0-9ae8-9db6c48eec17","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b53c69ca-3f9d-285d-7568-aba4a6c87b05","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b5f455c0-d2f1-4e12-bdfe-cd4a50debb30","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b846004f-a71d-4ebe-a1aa-1f9b6ac89ee0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bbe6bcf4-f7d3-4067-93af-218c641059dc","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bdef074d-a8b5-4891-a9a9-52e1ac0ddc53","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?be462235-9fa6-457d-b4bb-31277eab1387","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c375ec41-b099-4bb0-a23a-76f3f7a858b7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c78f5574-a2e3-400a-9fad-a73727f0ef74","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c79d94ec-117d-4fb6-845d-1954e3472bb0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c8369a3f-6155-f4b5-a1e2-ba392b1d2442","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c9a05f0c-b5f0-422c-9d67-6d0efc921a74","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cd2d3b9d-09cc-4342-9888-9b2e792a51ee","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cd606ad3-9c12-473a-948c-1ad7759a7727","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cfeb2b37-c295-46d0-be1e-68334c0a7f90","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cff7de45-148b-4e96-88fd-6052bf75b5f7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d08562ff-7ebf-4669-a824-933bf66b6328","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d576364c-9aa6-4356-a31b-321b0292a8fe","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d65099f2-b10d-47a8-ba7e-fe113fdb98d1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dab71f43-6644-410b-a5c0-362da371e7e7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?de7207ad-2c50-4c9d-87af-a262ac5e962f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dee07488-7a2b-4d45-89e1-d65ab895fd52","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?df12230c-09ea-b03b-c32e-800390ce3e33","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e116597c-1782-4fc1-9550-4a08777d1056","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e2c1bea3-3c6d-4fe9-9bfd-09dbbce0fd7c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e312d01f-570f-2eb8-e877-c13c2cddc088","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e4832536-fe56-40b2-b6c1-6edd3511e2ff","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e5462645-2b46-4764-87ef-bccb1a64067a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e9f2d8a6-fabe-436d-8fba-4976229692f9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ea6016be-2f5d-4bd0-a228-fa8f455abeae","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ee629b60-a461-457d-a9c4-97428a7fc274","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f08849b1-a914-4e94-bbce-ebd72e785986","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f3e0e02b-7762-42c7-b144-3714fb31c22b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f6d93c20-6a77-4e88-8ec1-3607c48dde19"]},{"source":"FDA","ids":["05f88e8a-7504-4074-bca1-c050b9b881a7","09567287-2cc1-4918-94e2-913634117a3b","0a12003c-1972-4606-aa82-ab09ad3992df","0bab4e6e-2c08-48e7-bad5-0b3341ac1340","0ce15e26-f289-406c-8d5a-de95d790ed1d","0ce67440-8b75-4a10-a70e-9c5286449783","0d543ed4-ff0d-407c-9c78-c416bd0c4eee","161f2ca3-e746-40f2-95c7-f37ee62dfe2d","1c245363-51bb-452c-a2bb-e43811e98894","2fdaf80d-66dc-453d-b3d6-390ec952ce6a","30a70882-b40a-4782-b227-cd0d35e50a26","326cf698-0719-4bfd-b0c5-1dfc95cbbbc7","330d6f3e-dab9-4a83-9ef1-3f6ea04421a8","38055bf9-bcf0-439c-a650-35a6ccc40575","3be172f9-acdc-4df8-b745-3884cdd1063e","424f78e1-2546-4451-a75e-586084480bbf","43372910-b0a1-4b2d-9d37-7984a6e4cf7f","43fb50c1-e6d0-4e59-aa57-640b939899a4","454f2f4c-5bdd-4aff-b49e-792962dd1a94","49f2afe4-9220-4b9d-a261-5017166f518a","4e054319-5d50-49c3-9fe1-681234d81dc1","4f4e77f5-5421-4482-82b6-c84b49dcdbea","579fcb4d-1b2c-4a76-9ff7-0ee76ddd1041","57d438aa-eee7-4403-9ecf-04730fa32f2f","5a205e32-ce63-491c-a1e4-0e45635090af","5b6f93c9-43b2-40a9-9f10-054c1145b4cc","5cae6b8d-be87-42a7-ad95-1b24cb2e2c8e","63f09089-f5f0-4723-9d34-57e0e81a0843","66e3f3fd-5e5e-4db6-a32e-40a88fef42fc","67ebb302-d044-430c-a98e-1785806c90e8","73866965-6eda-43f9-8f2f-8b5df159f72a","749ade13-082b-40de-be54-541627075d74","76635b0d-0a20-44b7-a076-b8f3c689c2ce","78edc5af-9a37-45f7-893a-414eb890f07b","7c50bb9c-7c49-4ba7-a3e5-c28ff0719ce5","82262fea-91ef-4905-9e25-10b287cd6456","8362b919-efa6-4451-8c44-49380f81b5db","84dba679-a118-47c1-8c44-7a3a1e1ed725","857f774c-ebd1-4332-860e-0c8647cbd70a","971e48af-6aa6-42c3-af9b-50ad373190a3","9f136e44-ac86-4476-b1f2-9fb650ea7fd3","a7baa9ea-6cd5-4a86-8936-8e47ed794db5","a806ba79-f8f0-4fe7-b754-59921a93d5ed"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A05f88e8a-7504-4074-bca1-c050b9b881a7","https://api.fda.gov/drug/label.json?search=set_id%3A09567287-2cc1-4918-94e2-913634117a3b","https://api.fda.gov/drug/label.json?search=set_id%3A0a12003c-1972-4606-aa82-ab09ad3992df","https://api.fda.gov/drug/label.json?search=set_id%3A0bab4e6e-2c08-48e7-bad5-0b3341ac1340","https://api.fda.gov/drug/label.json?search=set_id%3A0ce15e26-f289-406c-8d5a-de95d790ed1d","https://api.fda.gov/drug/label.json?search=set_id%3A0ce67440-8b75-4a10-a70e-9c5286449783","https://api.fda.gov/drug/label.json?search=set_id%3A0d543ed4-ff0d-407c-9c78-c416bd0c4eee","https://api.fda.gov/drug/label.json?search=set_id%3A161f2ca3-e746-40f2-95c7-f37ee62dfe2d","https://api.fda.gov/drug/label.json?search=set_id%3A1c245363-51bb-452c-a2bb-e43811e98894","https://api.fda.gov/drug/label.json?search=set_id%3A2fdaf80d-66dc-453d-b3d6-390ec952ce6a","https://api.fda.gov/drug/label.json?search=set_id%3A30a70882-b40a-4782-b227-cd0d35e50a26","https://api.fda.gov/drug/label.json?search=set_id%3A326cf698-0719-4bfd-b0c5-1dfc95cbbbc7","https://api.fda.gov/drug/label.json?search=set_id%3A330d6f3e-dab9-4a83-9ef1-3f6ea04421a8","https://api.fda.gov/drug/label.json?search=set_id%3A38055bf9-bcf0-439c-a650-35a6ccc40575","https://api.fda.gov/drug/label.json?search=set_id%3A3be172f9-acdc-4df8-b745-3884cdd1063e","https://api.fda.gov/drug/label.json?search=set_id%3A424f78e1-2546-4451-a75e-586084480bbf","https://api.fda.gov/drug/label.json?search=set_id%3A43372910-b0a1-4b2d-9d37-7984a6e4cf7f","https://api.fda.gov/drug/label.json?search=set_id%3A43fb50c1-e6d0-4e59-aa57-640b939899a4","https://api.fda.gov/drug/label.json?search=set_id%3A454f2f4c-5bdd-4aff-b49e-792962dd1a94","https://api.fda.gov/drug/label.json?search=set_id%3A49f2afe4-9220-4b9d-a261-5017166f518a","https://api.fda.gov/drug/label.json?search=set_id%3A4e054319-5d50-49c3-9fe1-681234d81dc1","https://api.fda.gov/drug/label.json?search=set_id%3A4f4e77f5-5421-4482-82b6-c84b49dcdbea","https://api.fda.gov/drug/label.json?search=set_id%3A579fcb4d-1b2c-4a76-9ff7-0ee76ddd1041","https://api.fda.gov/drug/label.json?search=set_id%3A57d438aa-eee7-4403-9ecf-04730fa32f2f","https://api.fda.gov/drug/label.json?search=set_id%3A5a205e32-ce63-491c-a1e4-0e45635090af","https://api.fda.gov/drug/label.json?search=set_id%3A5b6f93c9-43b2-40a9-9f10-054c1145b4cc","https://api.fda.gov/drug/label.json?search=set_id%3A5cae6b8d-be87-42a7-ad95-1b24cb2e2c8e","https://api.fda.gov/drug/label.json?search=set_id%3A63f09089-f5f0-4723-9d34-57e0e81a0843","https://api.fda.gov/drug/label.json?search=set_id%3A66e3f3fd-5e5e-4db6-a32e-40a88fef42fc","https://api.fda.gov/drug/label.json?search=set_id%3A67ebb302-d044-430c-a98e-1785806c90e8","https://api.fda.gov/drug/label.json?search=set_id%3A73866965-6eda-43f9-8f2f-8b5df159f72a","https://api.fda.gov/drug/label.json?search=set_id%3A749ade13-082b-40de-be54-541627075d74","https://api.fda.gov/drug/label.json?search=set_id%3A76635b0d-0a20-44b7-a076-b8f3c689c2ce","https://api.fda.gov/drug/label.json?search=set_id%3A78edc5af-9a37-45f7-893a-414eb890f07b","https://api.fda.gov/drug/label.json?search=set_id%3A7c50bb9c-7c49-4ba7-a3e5-c28ff0719ce5","https://api.fda.gov/drug/label.json?search=set_id%3A82262fea-91ef-4905-9e25-10b287cd6456","https://api.fda.gov/drug/label.json?search=set_id%3A8362b919-efa6-4451-8c44-49380f81b5db","https://api.fda.gov/drug/label.json?search=set_id%3A84dba679-a118-47c1-8c44-7a3a1e1ed725","https://api.fda.gov/drug/label.json?search=set_id%3A857f774c-ebd1-4332-860e-0c8647cbd70a","https://api.fda.gov/drug/label.json?search=set_id%3A971e48af-6aa6-42c3-af9b-50ad373190a3","https://api.fda.gov/drug/label.json?search=set_id%3A9f136e44-ac86-4476-b1f2-9fb650ea7fd3","https://api.fda.gov/drug/label.json?search=set_id%3Aa7baa9ea-6cd5-4a86-8936-8e47ed794db5","https://api.fda.gov/drug/label.json?search=set_id%3Aa806ba79-f8f0-4fe7-b754-59921a93d5ed"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01533753"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01533753%22"]}]},{"efo_id":"EFO_0003829","efo_label":"alcohol dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003829","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00011297","NCT00183196","NCT00262639","NCT00391716","NCT01141049","NCT02349477"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00011297%22OR%22NCT00183196%22OR%22NCT00262639%22OR%22NCT00391716%22OR%22NCT01141049%22OR%22NCT02349477%22"]}]},{"efo_id":"EFO_0004143","efo_label":"carpal tunnel syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004143","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00137735","NCT01632215"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00137735%22OR%22NCT01632215%22"]}]},{"efo_id":"EFO_0005762","efo_label":"neuropathic pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005762","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00967707","NCT01485185","NCT02219373"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00967707%22OR%22NCT01485185%22OR%22NCT02219373%22"]}]},{"efo_id":"EFO_0003917","efo_label":"premature birth","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003917","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02056899"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02056899%22"]}]},{"efo_id":"EFO_0005687","efo_label":"fibromyalgia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005687","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00057278","NCT01107574"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00057278%22OR%22NCT01107574%22"]}]},{"efo_id":"EFO_0004994","efo_label":"lumbar disc degeneration","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004994","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02120703"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02120703%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02306278"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02306278%22"]}]},{"efo_id":"EFO_0004263","efo_label":"partial epilepsy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004263","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00603473","NCT00620555"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00603473%22OR%22NCT00620555%22"]}]},{"efo_id":"EFO_0004777","efo_label":"alcohol withdrawal","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004777","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00229125","NCT02349477"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00229125%22OR%22NCT02349477%22"]}]},{"efo_id":"EFO_0001422","efo_label":"cirrhosis of liver","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001422","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02642484"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02642484%22"]}]},{"efo_id":"EFO_0003768","efo_label":"nicotine dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003768","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00578552"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00578552%22"]}]},{"efo_id":"EFO_0003890","efo_label":"drug dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003890","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00593463","NCT01893632","NCT02490345","NCT02543944"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00593463%22OR%22NCT01893632%22OR%22NCT02490345%22OR%22NCT02543944%22"]}]},{"efo_id":"EFO_0005611","efo_label":"opioid dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005611","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00420771","NCT01210079"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00420771%22OR%22NCT01210079%22"]}]},{"efo_id":"EFO_0005407","efo_label":"psychosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005407","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02557945"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02557945%22"]}]},{"efo_id":"EFO_0004888","efo_label":"post operative nausea and vomiting","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004888","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02384187","NCT02525848"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02384187%22OR%22NCT02525848%22"]}]},{"efo_id":"EFO_1000783","efo_label":"diabetic neuropathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000783","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00712439","NCT01263132","NCT03749642"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00712439%22OR%22NCT01263132%22OR%22NCT03749642%22"]}]},{"efo_id":"EFO_0000292","efo_label":"bladder carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000292","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02355886"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02355886%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03084536"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03084536%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00250744"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00250744%22"]}]},{"efo_id":"EFO_0000512","efo_label":"reproductive system disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000512","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02099006"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02099006%22"]}]},{"efo_id":"EFO_0000692","efo_label":"schizophrenia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000692","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02374567"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02374567%22"]}]},{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02374567"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02374567%22"]}]},{"efo_id":"EFO_0003885","efo_label":"multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003885","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01744444"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01744444%22"]}]},{"efo_id":"EFO_0004329","efo_label":"alcohol drinking","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004329","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03274167"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03274167%22"]}]},{"efo_id":"EFO_0004710","efo_label":"pelvic organ prolapse","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004710","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02999724"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02999724%22"]}]},{"efo_id":"EFO_0005230","efo_label":"anxiety","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005230","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02374567"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02374567%22"]}]},{"efo_id":"EFO_0005323","efo_label":"post-operative sign or symptom","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005323","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03023501"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03023501%22"]}]},{"efo_id":"EFO_1000971","efo_label":"hyperemesis gravidarum","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000971","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02163434"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02163434%22"]}]},{"efo_id":"EFO_1001800","efo_label":"Intervertebral Disc Displacement","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001800","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01014520"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01014520%22"]}]},{"efo_id":"EFO_1001898","efo_label":"mucositis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001898","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02252926"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02252926%22"]}]},{"efo_id":"EFO_1001931","efo_label":"oropharynx cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001931","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03269344"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03269344%22"]}]},{"efo_id":"HP_0000726","efo_label":"Dementia","efo_uri":"http://purl.obolibrary.org/obo/HP_0000726","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02374567"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02374567%22"]}]},{"efo_id":"HP_0001250","efo_label":"Seizure","efo_uri":"http://purl.obolibrary.org/obo/HP_0001250","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00007670"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00007670%22"]}]},{"efo_id":"EFO_0000546","efo_label":"injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000546","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03818932"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03818932%22"]}]},{"efo_id":"EFO_0003756","efo_label":"autism spectrum disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003756","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT03589898"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03589898%22"]}]},{"efo_id":"EFO_0006859","efo_label":"head and neck malignant neoplasia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006859","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03682367"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03682367%22"]}]},{"efo_id":"EFO_0007191","efo_label":"cannabis dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007191","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00395044"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00395044%22"]}]},{"efo_id":"EFO_0008533","efo_label":"dyspepsia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008533","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01052896"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01052896%22"]}]},{"efo_id":"EFO_1001250","efo_label":"rotator cuff tear","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001250","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03818919"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03818919%22"]}]},{"efo_id":"EFO_1002028","efo_label":"cicatricial alopecia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1002028","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT03346668"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03346668%22"]}]},{"efo_id":"HP_0000360","efo_label":"Tinnitus","efo_uri":"http://purl.obolibrary.org/obo/HP_0000360","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00257270","NCT00317850","NCT00555776"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00257270%22OR%22NCT00317850%22OR%22NCT00555776%22"]}]},{"efo_id":"HP_0012532","efo_label":"Chronic pain","efo_uri":"http://purl.obolibrary.org/obo/HP_0012532","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00414466","NCT02722603","NCT03158376","NCT03275012"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00414466%22OR%22NCT02722603%22OR%22NCT03158376%22OR%22NCT03275012%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000196557","approved_name":"calcium voltage-gated channel subunit alpha1 H","approved_symbol":"CACNA1H"},{"ensembl":"ENSG00000153956","approved_name":"calcium voltage-gated channel auxiliary subunit alpha2delta 1","approved_symbol":"CACNA2D1"},{"ensembl":"ENSG00000151067","approved_name":"calcium voltage-gated channel subunit alpha1 C","approved_symbol":"CACNA1C"},{"ensembl":"ENSG00000157445","approved_name":"calcium voltage-gated channel auxiliary subunit alpha2delta 3","approved_symbol":"CACNA2D3"},{"ensembl":"ENSG00000081248","approved_name":"calcium voltage-gated channel subunit alpha1 S","approved_symbol":"CACNA1S"},{"ensembl":"ENSG00000007402","approved_name":"calcium voltage-gated channel auxiliary subunit alpha2delta 2","approved_symbol":"CACNA2D2"},{"ensembl":"ENSG00000157388","approved_name":"calcium voltage-gated channel subunit alpha1 D","approved_symbol":"CACNA1D"},{"ensembl":"ENSG00000141837","approved_name":"calcium voltage-gated channel subunit alpha1 A","approved_symbol":"CACNA1A"},{"ensembl":"ENSG00000148408","approved_name":"calcium voltage-gated channel subunit alpha1 B","approved_symbol":"CACNA1B"},{"ensembl":"ENSG00000006283","approved_name":"calcium voltage-gated channel subunit alpha1 G","approved_symbol":"CACNA1G"},{"ensembl":"ENSG00000151062","approved_name":"calcium voltage-gated channel auxiliary subunit alpha2delta 4","approved_symbol":"CACNA2D4"},{"ensembl":"ENSG00000100346","approved_name":"calcium voltage-gated channel subunit alpha1 I","approved_symbol":"CACNA1I"},{"ensembl":"ENSG00000102001","approved_name":"calcium voltage-gated channel subunit alpha1 F","approved_symbol":"CACNA1F"},{"ensembl":"ENSG00000198216","approved_name":"calcium voltage-gated channel subunit alpha1 E","approved_symbol":"CACNA1E"},{"ensembl":"ENSG00000182389","approved_name":"calcium voltage-gated channel auxiliary subunit beta 4","approved_symbol":"CACNB4"},{"ensembl":"ENSG00000165995","approved_name":"calcium voltage-gated channel auxiliary subunit beta 2","approved_symbol":"CACNB2"},{"ensembl":"ENSG00000067191","approved_name":"calcium voltage-gated channel auxiliary subunit beta 1","approved_symbol":"CACNB1"},{"ensembl":"ENSG00000167535","approved_name":"calcium voltage-gated channel auxiliary subunit beta 3","approved_symbol":"CACNB3"},{"ensembl":"ENSG00000105605","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 7","approved_symbol":"CACNG7"},{"ensembl":"ENSG00000075429","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 5","approved_symbol":"CACNG5"},{"ensembl":"ENSG00000166862","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 2","approved_symbol":"CACNG2"},{"ensembl":"ENSG00000075461","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 4","approved_symbol":"CACNG4"},{"ensembl":"ENSG00000142408","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 8","approved_symbol":"CACNG8"},{"ensembl":"ENSG00000006116","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 3","approved_symbol":"CACNG3"},{"ensembl":"ENSG00000130433","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 6","approved_symbol":"CACNG6"},{"ensembl":"ENSG00000108878","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 1","approved_symbol":"CACNG1"}],"target_type":"protein complex group","target_name":"Voltage-gated calcium channel","action_type":"modulator","description":"Voltage-gated calcium channel modulator","references":[{"source":"FDA","ids":["label/2012/022544s008lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2012%2F022544s008lbl.pdf"]},{"source":"ISBN","ids":["0-12-184453-6 PP. 124"],"urls":[]},{"source":"PubMed","ids":["18299583"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18299583"]},{"source":"Wikipedia","ids":["Gabapentin"],"urls":["https://www.wikipedia.org/Gabapentin"]}]}],"adverse_events":{"significant":[{"event":"drug hypersensitivity","count":71246,"llr":9004.026509},{"event":"somnolence","count":38949,"llr":1127.189096},{"event":"myoclonus","count":4355,"llr":896.8406847},{"event":"drug abuse","count":14574,"llr":521.616491},{"event":"confusional state","count":40628,"llr":516.2250744},{"event":"drug titration error","count":357,"llr":476.3253246},{"event":"sedation","count":6964,"llr":434.1869419},{"event":"dizziness","count":99375,"llr":334.5284952},{"event":"suicidal ideation","count":21218,"llr":307.7724461},{"event":"feeling abnormal","count":36538,"llr":297.9505692}],"critval":296.6515063},"child_chembl_ids":["CHEMBL542620"],"number_of_indications":49,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":17},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":12},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":11},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":8},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":7},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":6},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":5},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":5},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":4},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":3},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":2},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":2},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":2},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":1},{"therapeutic_code":"OTAR_0000014","therapeutic_label":"pregnancy or perinatal disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1527608","_score":1,"_source":{"id":"CHEMBL1527608","internal_compound":false,"type":"Small molecule","pref_name":"DOXOFYLLINE","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["ABC 12/3","Doxofylline"],"trade_names":["Maxivent"],"cross_references":[{"source":"PubChem","ids":["144205130","170466312","29215238","49645880"]},{"source":"drugbank","ids":["DB09273"]}],"canonical_smiles":"Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O","indications":[{"efo_id":"HP_0006536","efo_label":"Obstructive lung disease","efo_uri":"http://purl.obolibrary.org/obo/HP_0006536","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["R03DA11"],"urls":["https://www.whocc.no/atc_ddd_index/?code=R03DA11"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL431651","_score":1,"_source":{"id":"CHEMBL431651","internal_compound":false,"type":"Small molecule","pref_name":"ENRASENTAN","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Enrasentan","SB-217242"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB06460"]}],"canonical_smiles":"CCCOc1ccc2c(c1)[C@@H](c1ccc(OC)cc1OCCO)[C@H](C(=O)O)[C@H]2c1ccc2c(c1)OCO2","mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000151617","approved_name":"endothelin receptor type A","approved_symbol":"EDNRA"}],"target_type":"single protein","target_name":"Endothelin receptor ET-A","action_type":"antagonist","description":"Endothelin receptor ET-A antagonist","references":[{"source":"PubMed","ids":["8632328"],"urls":["https://europepmc.org/search?query=EXT_ID%3A8632328"]}]},{"target_components":[{"ensembl":"ENSG00000136160","approved_name":"endothelin receptor type B","approved_symbol":"EDNRB"}],"target_type":"single protein","target_name":"Endothelin receptor ET-B","action_type":"antagonist","description":"Endothelin receptor ET-B antagonist","references":[{"source":"PubMed","ids":["8632328"],"urls":["https://europepmc.org/search?query=EXT_ID%3A8632328"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3127326","_score":1,"_source":{"id":"CHEMBL3127326","internal_compound":false,"type":"Small molecule","pref_name":"OMBITASVIR","year_first_approved":2014,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["ABT-267","Ombitasvir"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[85183]},{"source":"drugbank","ids":["DB09296"]}],"canonical_smiles":"COC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1ccc([C@@H]2CC[C@@H](c3ccc(NC(=O)[C@@H]4CCCN4C(=O)[C@@H](NC(=O)OC)C(C)C)cc3)N2c2ccc(C(C)(C)C)cc2)cc1)C(C)C","indications":[{"efo_id":"EFO_0004220","efo_label":"chronic hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004220","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT01314261","NCT01464827","NCT01563536","NCT01609933","NCT01674725","NCT01685203","NCT01715415","NCT01716585","NCT01767116","NCT01782495","NCT01833533","NCT01854528","NCT01854697","NCT01911845","NCT02023099","NCT02167945","NCT02216422","NCT02219490","NCT02356562","NCT02399345","NCT02442271","NCT02476617","NCT02486406","NCT02493855","NCT02504099","NCT02517528","NCT02555943","NCT02806362","NCT03067883"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01314261%22OR%22NCT01464827%22OR%22NCT01563536%22OR%22NCT01609933%22OR%22NCT01674725%22OR%22NCT01685203%22OR%22NCT01715415%22OR%22NCT01716585%22OR%22NCT01767116%22OR%22NCT01782495%22OR%22NCT01833533%22OR%22NCT01854528%22OR%22NCT01854697%22OR%22NCT01911845%22OR%22NCT02023099%22OR%22NCT02167945%22OR%22NCT02216422%22OR%22NCT02219490%22OR%22NCT02356562%22OR%22NCT02399345%22OR%22NCT02442271%22OR%22NCT02476617%22OR%22NCT02486406%22OR%22NCT02493855%22OR%22NCT02504099%22OR%22NCT02517528%22OR%22NCT02555943%22OR%22NCT02806362%22OR%22NCT03067883%22"]},{"source":"DailyMed","ids":["ab74e474-9fd6-902c-9bd9-16dc9541edd0"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ab74e474-9fd6-902c-9bd9-16dc9541edd0"]}]},{"efo_id":"EFO_0000544","efo_label":"infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000544","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01181427"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01181427%22"]}]},{"efo_id":"EFO_0003047","efo_label":"hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003047","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT01458535","NCT01773070","NCT02023112","NCT02194998","NCT02265237","NCT02487199","NCT02517515","NCT02582632","NCT02609659","NCT02634008","NCT03341988"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01458535%22OR%22NCT01773070%22OR%22NCT02023112%22OR%22NCT02194998%22OR%22NCT02265237%22OR%22NCT02487199%22OR%22NCT02517515%22OR%22NCT02582632%22OR%22NCT02609659%22OR%22NCT02634008%22OR%22NCT03341988%22"]},{"source":"DailyMed","ids":["ab74e474-9fd6-902c-9bd9-16dc9541edd0"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ab74e474-9fd6-902c-9bd9-16dc9541edd0"]}]},{"efo_id":"EFO_0004197","efo_label":"hepatitis B virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004197","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02555943"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02555943%22"]}]}],"mechanisms_of_action":[{"target_type":"single protein","target_name":"Nonstructural protein 5A","action_type":"inhibitor","description":"Nonstructural protein 5A inhibitor","references":[{"source":"FDA","ids":["label/2015/206619s003lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F206619s003lbl.pdf"]}]}],"adverse_events":{"significant":[{"event":"hyperbilirubinaemia","count":3507,"llr":102.1087992},{"event":"virologic failure","count":2156,"llr":45.61199426},{"event":"gilbert's syndrome","count":150,"llr":41.3433759},{"event":"hepatitis b reactivation","count":747,"llr":41.04442807},{"event":"anaemia","count":61405,"llr":39.97213139},{"event":"hepatotoxicity","count":5998,"llr":26.08870794},{"event":"hepatic encephalopathy","count":2810,"llr":25.0182237},{"event":"hepatitis c","count":4688,"llr":24.69303262},{"event":"jaundice","count":9877,"llr":24.436273},{"event":"hepatic failure","count":5407,"llr":23.44149044},{"event":"hepatocellular carcinoma","count":2310,"llr":22.30192747},{"event":"disease recurrence","count":6331,"llr":22.06358834},{"event":"psychiatric decompensation","count":541,"llr":21.42695421},{"event":"fatigue","count":147738,"llr":17.4904297},{"event":"alanine aminotransferase increased","count":24852,"llr":17.29099185},{"event":"insomnia","count":44658,"llr":16.87674282},{"event":"blood bilirubin increased","count":9989,"llr":12.40511695},{"event":"sense of oppression","count":405,"llr":12.17959732},{"event":"drug interaction","count":53526,"llr":11.0203225},{"event":"blood glucose abnormal","count":2337,"llr":10.47405235},{"event":"glomerulonephritis","count":938,"llr":9.685020735},{"event":"aspartate aminotransferase increased","count":21532,"llr":9.58410975},{"event":"hepatic cirrhosis","count":3807,"llr":8.590800993},{"event":"liver injury","count":4415,"llr":8.026534104},{"event":"renal impairment","count":20843,"llr":7.756329622},{"event":"headache","count":120638,"llr":7.533927546},{"event":"varicella zoster virus infection","count":474,"llr":6.998341736},{"event":"hepatitis e","count":502,"llr":6.884877331},{"event":"haemoglobin decreased","count":33686,"llr":6.56220198},{"event":"treatment failure","count":12895,"llr":6.145275609},{"event":"pruritus","count":57095,"llr":5.879116136}],"critval":5.856332019},"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":3},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":3},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":3},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2105420","_score":1,"_source":{"id":"CHEMBL2105420","internal_compound":false,"type":"Small molecule","pref_name":"TAUROLIDINE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Taurolidine","W-3100M"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12473"]}],"canonical_smiles":"O=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1","indications":[{"efo_id":"EFO_0000544","efo_label":"infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000544","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02036255"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02036255%22"]}]},{"efo_id":"EFO_0000326","efo_label":"central nervous system cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000326","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00022360"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00022360%22"]}]},{"efo_id":"EFO_0001075","efo_label":"ovarian carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001075","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00021034"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00021034%22"]}]},{"efo_id":"EFO_1000251","efo_label":"Fallopian Tube Carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000251","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00021034"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00021034%22"]}]},{"efo_id":"EFO_1001100","efo_label":"peritoneal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001100","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00021034"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00021034%22"]}]}],"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":4},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":2},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":2},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2107011","_score":1,"_source":{"id":"CHEMBL2107011","internal_compound":false,"type":"Small molecule","pref_name":"OXYPERTINE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Oxipertine","Oxypertine","WIN-185012"],"trade_names":["Forit","Integrin"],"cross_references":[{"source":"drugbank","ids":["DB13403"]},{"source":"PubChem","ids":["144206763"]}],"canonical_smiles":"COc1cc2[nH]c(C)c(CCN3CCN(c4ccccc4)CC3)c2cc1OC","indications":[{"efo_id":"EFO_0005407","efo_label":"psychosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005407","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N05AE01"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N05AE01"]}]}],"adverse_events":{"significant":[{"event":"ileus paralytic","count":1414,"llr":12.44779281},{"event":"haemolytic anaemia","count":3565,"llr":10.59999297}],"critval":10.28665372},"child_chembl_ids":["CHEMBL2360489"],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2360841","_score":1,"_source":{"id":"CHEMBL2360841","internal_compound":false,"type":"Small molecule","pref_name":"RO-24-7429","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["RO 24-7429","RO-24-7429","Ro 24-7429","Ro-24-7429"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["109967254"]}],"canonical_smiles":"CNC1=Nc2ccc(Cl)cc2C(c2ccc[nH]2)=NC1","indications":[{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00000760"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000760%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL404849","_score":1,"_source":{"id":"CHEMBL404849","internal_compound":false,"type":"Small molecule","pref_name":"SULOCTIDIL","year_first_approved":1979,"max_clinical_trial_phase":4,"withdrawn_flag":true,"withdrawn_reason":["Hepatotoxicity"],"withdrawn_year":1985,"withdrawn_country":["France","Germany","Spain"],"withdrawn_class":["Hepatotoxicity"],"black_box_warning":false,"synonyms":["CP-556S","MJF-12637","Suloctidil"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["104171389","144204409","170466521","26748521"]}],"canonical_smiles":"CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1","indications":[{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["C04AX19"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C04AX19"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000196557","approved_name":"calcium voltage-gated channel subunit alpha1 H","approved_symbol":"CACNA1H"},{"ensembl":"ENSG00000153956","approved_name":"calcium voltage-gated channel auxiliary subunit alpha2delta 1","approved_symbol":"CACNA2D1"},{"ensembl":"ENSG00000151067","approved_name":"calcium voltage-gated channel subunit alpha1 C","approved_symbol":"CACNA1C"},{"ensembl":"ENSG00000157445","approved_name":"calcium voltage-gated channel auxiliary subunit alpha2delta 3","approved_symbol":"CACNA2D3"},{"ensembl":"ENSG00000081248","approved_name":"calcium voltage-gated channel subunit alpha1 S","approved_symbol":"CACNA1S"},{"ensembl":"ENSG00000007402","approved_name":"calcium voltage-gated channel auxiliary subunit alpha2delta 2","approved_symbol":"CACNA2D2"},{"ensembl":"ENSG00000157388","approved_name":"calcium voltage-gated channel subunit alpha1 D","approved_symbol":"CACNA1D"},{"ensembl":"ENSG00000141837","approved_name":"calcium voltage-gated channel subunit alpha1 A","approved_symbol":"CACNA1A"},{"ensembl":"ENSG00000148408","approved_name":"calcium voltage-gated channel subunit alpha1 B","approved_symbol":"CACNA1B"},{"ensembl":"ENSG00000006283","approved_name":"calcium voltage-gated channel subunit alpha1 G","approved_symbol":"CACNA1G"},{"ensembl":"ENSG00000151062","approved_name":"calcium voltage-gated channel auxiliary subunit alpha2delta 4","approved_symbol":"CACNA2D4"},{"ensembl":"ENSG00000100346","approved_name":"calcium voltage-gated channel subunit alpha1 I","approved_symbol":"CACNA1I"},{"ensembl":"ENSG00000102001","approved_name":"calcium voltage-gated channel subunit alpha1 F","approved_symbol":"CACNA1F"},{"ensembl":"ENSG00000198216","approved_name":"calcium voltage-gated channel subunit alpha1 E","approved_symbol":"CACNA1E"},{"ensembl":"ENSG00000182389","approved_name":"calcium voltage-gated channel auxiliary subunit beta 4","approved_symbol":"CACNB4"},{"ensembl":"ENSG00000165995","approved_name":"calcium voltage-gated channel auxiliary subunit beta 2","approved_symbol":"CACNB2"},{"ensembl":"ENSG00000067191","approved_name":"calcium voltage-gated channel auxiliary subunit beta 1","approved_symbol":"CACNB1"},{"ensembl":"ENSG00000167535","approved_name":"calcium voltage-gated channel auxiliary subunit beta 3","approved_symbol":"CACNB3"},{"ensembl":"ENSG00000105605","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 7","approved_symbol":"CACNG7"},{"ensembl":"ENSG00000075429","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 5","approved_symbol":"CACNG5"},{"ensembl":"ENSG00000166862","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 2","approved_symbol":"CACNG2"},{"ensembl":"ENSG00000075461","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 4","approved_symbol":"CACNG4"},{"ensembl":"ENSG00000142408","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 8","approved_symbol":"CACNG8"},{"ensembl":"ENSG00000006116","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 3","approved_symbol":"CACNG3"},{"ensembl":"ENSG00000130433","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 6","approved_symbol":"CACNG6"},{"ensembl":"ENSG00000108878","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 1","approved_symbol":"CACNG1"}],"target_type":"protein complex group","target_name":"Voltage-gated calcium channel","action_type":"blocker","description":"Voltage-gated calcium channel blocker","references":[{"source":"PubMed","ids":["1338656","2464117","2839389","3023210","3030204","3036152","8383582"],"urls":["https://europepmc.org/search?query=EXT_ID%3A1338656+OR+EXT_ID%3A2464117+OR+EXT_ID%3A2839389+OR+EXT_ID%3A3023210+OR+EXT_ID%3A3030204+OR+EXT_ID%3A3036152+OR+EXT_ID%3A8383582"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1743036","_score":1,"_source":{"id":"CHEMBL1743036","internal_compound":false,"type":"Antibody","pref_name":"LEXATUMUMAB","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["ETR2-ST01","HGS-ETR2","HGS1018","Lexatumumab"],"trade_names":[],"indications":[{"efo_id":"EFO_0000174","efo_label":"Ewing sarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000174","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00428272"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00428272%22"]}]},{"efo_id":"EFO_0000621","efo_label":"neuroblastoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000621","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00428272"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00428272%22"]}]},{"efo_id":"EFO_0000637","efo_label":"osteosarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000637","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00428272"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00428272%22"]}]},{"efo_id":"EFO_0002918","efo_label":"rhabdomyosarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002918","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00428272"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00428272%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000120889","approved_name":"TNF receptor superfamily member 10b","approved_symbol":"TNFRSF10B"}],"target_type":"single protein","target_name":"Tumor necrosis factor receptor superfamily member 10B","action_type":"agonist","description":"Tumor necrosis factor receptor superfamily member 10B agonist","references":[{"source":"Other","ids":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=528015"],"urls":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=528015"]},{"source":"PMC","ids":["PMC3494837"],"urls":["https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494837"]}]}],"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":4},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":2},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297387","_score":1,"_source":{"id":"CHEMBL4297387","internal_compound":false,"type":"Small molecule","pref_name":"GSK-424887","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["GSK424887","Gsk-424887","Gsk424887"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12219"]}],"canonical_smiles":"C[C@@H](c1cc(Cl)cc2ccccc12)N(C)C(=O)CC1(c2ccc(F)cc2)CCN(C)CC1","indications":[{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01059591","NCT01424384"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01059591%22OR%22NCT01424384%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201202","_score":1,"_source":{"id":"CHEMBL1201202","internal_compound":false,"type":"Oligosaccharide","pref_name":"FONDAPARINUX","year_first_approved":2001,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["Fondaparinux","Fondaparinux Sodium","Fondaparinux sodium for assay","Fondaparinux sodium identification","IC-851589","ORG-31540","SR-90107A"],"trade_names":["Arixtra","Fondaparinux Sodium"],"cross_references":[{"source":"ChEBI","ids":[61033]},{"source":"DailyMed","ids":["fondaparinux%20sodium"]},{"source":"Wikipedia","ids":["Fondaparinux"]},{"source":"drugbank","ids":["DB00569"]}],"canonical_smiles":"CO[C@H]1O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]2O[C@@H](C(=O)O)[C@@H](O[C@H]3O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]4O[C@H](C(=O)O)[C@@H](O[C@H]5O[C@H](COS(=O)(=O)O)[C@@H](O)[C@H](O)[C@H]5NS(=O)(=O)O)[C@H](O)[C@H]4O)[C@H](OS(=O)(=O)O)[C@H]3NS(=O)(=O)O)[C@H](O)[C@H]2OS(=O)(=O)O)[C@H](O)[C@H]1NS(=O)(=O)O","indications":[{"efo_id":"EFO_0000275","efo_label":"atrial fibrillation","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000275","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00911300"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00911300%22"]}]},{"efo_id":"EFO_0001074","efo_label":"morbid obesity","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001074","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00346879"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00346879%22"]}]},{"efo_id":"EFO_0001075","efo_label":"ovarian carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001075","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00659399"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00659399%22"]}]},{"efo_id":"EFO_0004286","efo_label":"venous thromboembolism","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004286","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00064428","NCT00139815","NCT00320424","NCT00493896","NCT01857583"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00064428%22OR%22NCT00139815%22OR%22NCT00320424%22OR%22NCT00493896%22OR%22NCT01857583%22"]}]},{"efo_id":"EFO_0005672","efo_label":"acute coronary syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005672","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00464087"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00464087%22"]}]},{"efo_id":"HP_0004419","efo_label":"Recurrent thrombophlebitis","efo_uri":"http://purl.obolibrary.org/obo/HP_0004419","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["B01AX05"],"urls":["https://www.whocc.no/atc_ddd_index/?code=B01AX05"]}]},{"efo_id":"HP_0004936","efo_label":"Venous thrombosis","efo_uri":"http://purl.obolibrary.org/obo/HP_0004936","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00320398","NCT00443053","NCT00539942","NCT01499953"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00320398%22OR%22NCT00443053%22OR%22NCT00539942%22OR%22NCT01499953%22"]}]},{"efo_id":"EFO_0004286","efo_label":"venous thromboembolism","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004286","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00038961","NCT00328939","NCT00333021","NCT00531843"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00038961%22OR%22NCT00328939%22OR%22NCT00333021%22OR%22NCT00531843%22"]}]},{"efo_id":"HP_0004936","efo_label":"Venous thrombosis","efo_uri":"http://purl.obolibrary.org/obo/HP_0004936","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00539942","NCT00843492"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00539942%22OR%22NCT00843492%22"]}]},{"efo_id":"EFO_0003827","efo_label":"pulmonary embolism","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003827","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00981409"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00981409%22"]}]},{"efo_id":"EFO_0003907","efo_label":"deep vein thrombosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003907","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00911157"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00911157%22"]}]}],"adverse_events":{"significant":[{"event":"haematoma","count":8376,"llr":845.0867468},{"event":"muscle haemorrhage","count":1334,"llr":358.1456094},{"event":"anaemia","count":61405,"llr":278.4877776},{"event":"heparin-induced thrombocytopenia","count":1115,"llr":257.0321759},{"event":"post procedural haemorrhage","count":3009,"llr":238.2556561},{"event":"haemoglobin decreased","count":33686,"llr":223.9667014},{"event":"melaena","count":7928,"llr":216.3087585},{"event":"haemorrhage","count":20448,"llr":215.9740406},{"event":"shock haemorrhagic","count":1482,"llr":211.3228504},{"event":"post procedural haematoma","count":629,"llr":202.988414},{"event":"pulmonary embolism","count":25452,"llr":167.7067341},{"event":"haematemesis","count":6588,"llr":155.5877552},{"event":"deep vein thrombosis","count":21525,"llr":129.5704168},{"event":"intra-abdominal haematoma","count":419,"llr":119.313008},{"event":"abdominal wall haematoma","count":730,"llr":114.407487},{"event":"retroperitoneal haematoma","count":714,"llr":102.4563474},{"event":"incision site haematoma","count":92,"llr":101.1235742},{"event":"haemorrhagic anaemia","count":1864,"llr":89.06806849},{"event":"cerebral haemorrhage","count":6313,"llr":87.111894},{"event":"subdural haematoma","count":3943,"llr":84.61405976},{"event":"haemorrhage subcutaneous","count":1081,"llr":70.96134014},{"event":"subcutaneous haematoma","count":479,"llr":66.73852402},{"event":"skin necrosis","count":1769,"llr":64.42940775},{"event":"fatigue","count":147738,"llr":63.08039399},{"event":"thrombocythaemia","count":384,"llr":58.38069327},{"event":"haematuria","count":11307,"llr":57.0499911},{"event":"haematocrit decreased","count":6949,"llr":56.66508228},{"event":"platelet count increased","count":3955,"llr":54.89415099},{"event":"compartment syndrome","count":919,"llr":49.86407476},{"event":"gastrointestinal haemorrhage","count":25270,"llr":48.49227696},{"event":"thrombosis","count":17096,"llr":43.70106304},{"event":"thrombocytopenia","count":35327,"llr":42.89522881},{"event":"incision site haemorrhage","count":262,"llr":42.88070906},{"event":"red blood cell count decreased","count":7305,"llr":42.21269835},{"event":"extradural haematoma","count":497,"llr":42.15881064},{"event":"shock","count":5269,"llr":41.58337077},{"event":"intra-abdominal haemorrhage","count":561,"llr":40.38546077},{"event":"hepatic function abnormal","count":12036,"llr":39.85821881},{"event":"diarrhoea","count":126514,"llr":39.74861777},{"event":"gastric ulcer haemorrhage","count":1601,"llr":39.22607687},{"event":"pallor","count":6405,"llr":38.11873775},{"event":"haemarthrosis","count":1142,"llr":36.16498705},{"event":"gastric haemorrhage","count":3864,"llr":36.14460476},{"event":"peritoneal haemorrhage","count":664,"llr":34.46051637},{"event":"catheter thrombosis","count":65,"llr":33.58255919},{"event":"retroperitoneal haemorrhage","count":718,"llr":33.40270687},{"event":"drug hypersensitivity","count":71246,"llr":32.7992846},{"event":"rectal haemorrhage","count":10551,"llr":32.46506873},{"event":"postoperative wound complication","count":320,"llr":32.30934904},{"event":"wound haemorrhage","count":629,"llr":31.74576233}],"critval":30.93848159},"child_chembl_ids":["CHEMBL1200644"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000117601","approved_name":"serpin family C member 1","approved_symbol":"SERPINC1"}],"target_type":"single protein","target_name":"Antithrombin-III","action_type":"activator","description":"Antithrombin-III activator","references":[{"source":"FDA","ids":["label/2014/021345s032lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2014%2F021345s032lbl.pdf"]}]}],"number_of_indications":11,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":5},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":4},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":2},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1213460","_score":1,"_source":{"id":"CHEMBL1213460","internal_compound":false,"type":"Small molecule","pref_name":"ETHYL LOFLAZEPATE","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Ethyl Loflazepate"],"trade_names":[],"cross_references":[{"source":"Wikipedia","ids":["Ethyl_loflazepate"]},{"source":"drugbank","ids":["DB01545"]}],"canonical_smiles":"CCOC(=O)C1N=C(c2ccccc2F)c2cc(Cl)ccc2NC1=O","indications":[{"efo_id":"EFO_0005230","efo_label":"anxiety","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005230","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["N05BA18"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N05BA18"]}]}],"adverse_events":{"significant":[{"event":"lung disorder","count":9520,"llr":15.28015727},{"event":"oedema","count":15307,"llr":12.95552034},{"event":"altered state of consciousness","count":6397,"llr":12.85576567},{"event":"suicide attempt","count":20244,"llr":11.60044388},{"event":"disinhibition","count":679,"llr":9.449932866}],"critval":8.851702997},"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3787344","_score":1,"_source":{"id":"CHEMBL3787344","internal_compound":false,"type":"Small molecule","pref_name":"NAZARTINIB","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["EGF-816","NVP-EGF816-AGA","NVP-EGF816-NX","Nazartinib","Nazartinib mesylate"],"trade_names":[],"canonical_smiles":"Cc1cc(C(=O)Nc2nc3cccc(Cl)c3n2[C@@H]2CCCCN(C(=O)/C=C/CN(C)C)C2)ccn1","indications":[{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02108964","NCT02323126","NCT02335944","NCT03333343"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02108964%22OR%22NCT02323126%22OR%22NCT02335944%22OR%22NCT03333343%22"]}]},{"efo_id":"EFO_0001071","efo_label":"lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001071","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03292133"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03292133%22"]}]},{"efo_id":"EFO_1000849","efo_label":"bronchial neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000849","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03516214"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03516214%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000146648","approved_name":"epidermal growth factor receptor","approved_symbol":"EGFR"}],"target_type":"single protein","target_name":"Epidermal growth factor receptor erbB1","action_type":"inhibitor","description":"Epidermal growth factor receptor erbB1 inhibitor","references":[{"source":"ClinicalTrials","ids":["NCT02108964"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02108964%22"]},{"source":"DOI","ids":["10.1158/1538-7445.AM2014-1734"],"urls":["http://dx.doi.org/10.1158/1538-7445.AM2014-1734"]},{"source":"Other","ids":["http://www.novartisoncology.com/ct/pipelineDetails?compound=EGF816&diseaseAcr=NSCLC"],"urls":["http://www.novartisoncology.com/ct/pipelineDetails?compound=EGF816&diseaseAcr=NSCLC"]}]}],"child_chembl_ids":["CHEMBL3984979","CHEMBL4297222"],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":3}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4292264","_score":1,"_source":{"id":"CHEMBL4292264","internal_compound":false,"type":"Small molecule","pref_name":"MILADEMETAN","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["DS-3032","DS-3032 TOSYLATE","DS-3032B","Ds 3032b","Ds-3032","Ds-3032b","Milademetan","Milademetan tosylate"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB15257"]}],"canonical_smiles":"CC1(C)CCC2(CC1)N[C@@H](C(=O)N[C@@H]1CC[C@@H](C(N)=O)OC1)[C@H](c1ccnc(Cl)c1F)[C@]21C(=O)Nc2cc(Cl)ccc21","indications":[{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03552029","NCT03671564"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03552029%22OR%22NCT03671564%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01877382"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01877382%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02579824"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02579824%22"]}]}],"child_chembl_ids":["CHEMBL4297374"],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":3},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":3},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":2},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297788","_score":1,"_source":{"id":"CHEMBL4297788","internal_compound":false,"type":"Antibody","pref_name":"MOSUNETUZUMAB","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["BTCT-4465A","BTCT4465A","Mosunetuzumab","RG-7828","RG7828","RO-7030816","RO7030816"],"trade_names":[],"indications":[{"efo_id":"EFO_0000096","efo_label":"neoplasm of mature B-cells","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000096","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03671018","NCT03677141"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03671018%22OR%22NCT03677141%22"]}]},{"efo_id":"EFO_0000403","efo_label":"diffuse large B-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000403","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03677154"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03677154%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":2}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL139","_score":1,"_source":{"id":"CHEMBL139","internal_compound":false,"type":"Small molecule","pref_name":"DICLOFENAC","year_first_approved":1988,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["Arthrotec","CGP-45840B","Cataflam","Diclofenac","Diclofenac Epolamine","Diclofenac Potassium","Diclofenac Sodium","Diclofenac potassium salt","Diclofenac sod","Diclofenac sodium salt","GP-45840","Solaraze","Voltaren","Voltaren-XR"],"trade_names":["Acoflam","Acoflam Ret","Acoflam SR","Arthronac","Arthrotec 50","Arthrotec 75","Cambia","Cataflam","Closteril 100","Defanac","Defanac Retard","Defanac SR","Dexomon Ret","Dexomon SR","Diclofenac Potassium","Diclofenac Sodium","Dicloflex","Dicloflex Ret","Dicloflex SR","Diclomax Ret","Diclomax SR","Diclotard 100 MR","Diclotard 75 MR","Diclovol","Diclovol Ret","Diclovol SR","Diclozip 25","Diclozip 50","Difenor XL","Digenac XL 100","Dyloject","Econac","Econac SR","Econac XL","Enstar SR","Enstar XL","Enzed","Fenactol","Fenactol Ret","Fenactol SR","Flamatak MR","Flamrase","Flamrase SR","Flector","Flector Patch","Flexotard MR","Isclofen","Licart","Lofensaid 25","Lofensaid 50","Lofensaid Ret 100","Lofensaid Ret 75","Masidemen","Misofen","Mobigel","Mobigel Paineze","Motifene","Pennsaid","Rheumatac Ret 75","Rhumalgan","Rhumalgan CR 100","Rhumalgan CR 75","Rhumalgan SR","Rhumalgan XL","Slofenac","Solaraze","Valdic 100 Ret","Valdic 75 Ret","Valenac","Volraman","Volsaid Ret 100","Volsaid Ret 75","Voltaren","Voltaren Emulgel","Voltaren Ophthalmic","Voltaren Ret","Voltaren Xr","Voltaren-Xr","Voltarene","Voltarene Emulgel","Voltarene L.P.","Voltarene Ret","Voltarol","Voltarol 12 Hour Emulgel P","Voltarol Active","Voltarol Emulgel","Voltarol Emulgel P","Voltarol Gel Patch","Voltarol Joint Pain","Voltarol Ophtha","Voltarol Pain-eze","Voltarol Pain-eze Emulgel","Voltarol Pain-eze Extra Strgh","Voltarol Rapid","Voltarol Ret","Voltarol SR","Zipsor","Zorvolex","Zorvolex Capsules"],"cross_references":[{"source":"ChEBI","ids":[47381]},{"source":"DailyMed","ids":["diclofenac","diclofenac%20epolamine","diclofenac%20potassium","diclofenac%20sodium"]},{"source":"PubChem","ids":["24424557"]},{"source":"TG-GATEs","ids":["19"]},{"source":"Wikipedia","ids":["Diclofenac"]},{"source":"drugbank","ids":["DB00586"]},{"source":"ChEBI","ids":[4509]},{"source":"DailyMed","ids":["diclofenac%20sodium"]},{"source":"PubChem","ids":["11111091","11112998","144204321","144210585","170464642","26747983","50106220","56422389","85231008","855544","90341049"]},{"source":"ChEBI","ids":[4508]},{"source":"DailyMed","ids":["diclofenac%20potassium"]},{"source":"ChEBI","ids":[48296]},{"source":"DailyMed","ids":["diclofenac%20epolamine"]}],"canonical_smiles":"O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl","indications":[{"efo_id":"EFO_0005752","efo_label":"eye inflammation","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005752","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["S01BC03"],"urls":["https://www.whocc.no/atc_ddd_index/?code=S01BC03"]}]},{"efo_id":"EFO_0002506","efo_label":"osteoarthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002506","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00108992","NCT00171626","NCT00171665","NCT00171678","NCT00171691","NCT00242489","NCT00371696","NCT00864097","NCT01461369","NCT01510912","NCT01967550","NCT02088411","NCT02286453"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00108992%22OR%22NCT00171626%22OR%22NCT00171665%22OR%22NCT00171678%22OR%22NCT00171691%22OR%22NCT00242489%22OR%22NCT00371696%22OR%22NCT00864097%22OR%22NCT01461369%22OR%22NCT01510912%22OR%22NCT01967550%22OR%22NCT02088411%22OR%22NCT02286453%22"]},{"source":"DailyMed","ids":["dff10e66-a577-451d-ba75-1889458ca833"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff10e66-a577-451d-ba75-1889458ca833"]}]},{"efo_id":"EFO_0004616","efo_label":"osteoarthritis, knee","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004616","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00484120","NCT01456611"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00484120%22OR%22NCT01456611%22"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00140933","NCT00448110","NCT00507026","NCT00942448","NCT00943098","NCT00985439","NCT01462435","NCT02192203","NCT02194088","NCT02332057","NCT02419651","NCT02424578","NCT02425709","NCT02428777","NCT02666846","NCT02700815","NCT02714842","NCT02752971","NCT02760888","NCT03178539","NCT03497039","NCT04052620"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00140933%22OR%22NCT00448110%22OR%22NCT00507026%22OR%22NCT00942448%22OR%22NCT00943098%22OR%22NCT00985439%22OR%22NCT01462435%22OR%22NCT02192203%22OR%22NCT02194088%22OR%22NCT02332057%22OR%22NCT02419651%22OR%22NCT02424578%22OR%22NCT02425709%22OR%22NCT02428777%22OR%22NCT02666846%22OR%22NCT02700815%22OR%22NCT02714842%22OR%22NCT02752971%22OR%22NCT02760888%22OR%22NCT03178539%22OR%22NCT03497039%22OR%22NCT04052620%22"]}]},{"efo_id":"EFO_0003898","efo_label":"ankylosing spondylitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003898","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00648141","NCT00762463"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00648141%22OR%22NCT00762463%22"]}]},{"efo_id":"EFO_0004193","efo_label":"basal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004193","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01358045"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01358045%22"]}]},{"efo_id":"EFO_0000685","efo_label":"rheumatoid arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000685","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00264147"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00264147%22"]}]},{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01413854"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01413854%22"]}]},{"efo_id":"HP_0002829","efo_label":"Arthralgia","efo_uri":"http://purl.obolibrary.org/obo/HP_0002829","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["M02AA15"],"urls":["https://www.whocc.no/atc_ddd_index/?code=M02AA15"]}]},{"efo_id":"HP_0003326","efo_label":"Myalgia","efo_uri":"http://purl.obolibrary.org/obo/HP_0003326","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["M02AA15"],"urls":["https://www.whocc.no/atc_ddd_index/?code=M02AA15"]}]},{"efo_id":"EFO_0003827","efo_label":"pulmonary embolism","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003827","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01590342"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01590342%22"]}]},{"efo_id":"EFO_0005755","efo_label":"rheumatic disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005755","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["M01AB05","M01AB55"],"urls":["https://www.whocc.no/atc_ddd_index/?code=M01AB05","https://www.whocc.no/atc_ddd_index/?code=M01AB55"]}]},{"efo_id":"EFO_0000545","efo_label":"infertility","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000545","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02433418"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02433418%22"]}]},{"efo_id":"EFO_1000786","efo_label":"osteoarthritis, hip","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000786","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03304379"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03304379%22"]}]},{"efo_id":"EFO_0000313","efo_label":"carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000313","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01939743"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01939743%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01596647"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01596647%22"]}]},{"efo_id":"EFO_1001366","efo_label":"Mastodynia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001366","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00276419"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00276419%22"]}]},{"efo_id":"EFO_1001412","efo_label":"Renal Colic","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001412","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00139646","NCT03199924"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00139646%22OR%22NCT03199924%22"]}]},{"efo_id":"GO_0007568","efo_label":"aging","efo_uri":"http://purl.obolibrary.org/obo/GO_0007568","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03072485"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03072485%22"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff10e66-a577-451d-ba75-1889458ca833"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff10e66-a577-451d-ba75-1889458ca833"]}]},{"efo_id":"EFO_0000649","efo_label":"periodontitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000649","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03519152"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03519152%22"]}]},{"efo_id":"EFO_0009454","efo_label":"gastric ulcer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009454","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00594854"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00594854%22"]}]},{"efo_id":"EFO_0009582","efo_label":"sprain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009582","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00573768","NCT00955513","NCT01066520"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00573768%22OR%22NCT00955513%22OR%22NCT01066520%22"]}]},{"efo_id":"EFO_0002496","efo_label":"actinic keratosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002496","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01742663","NCT01962987","NCT02611804","NCT02952898","NCT03826550"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01742663%22OR%22NCT01962987%22OR%22NCT02611804%22OR%22NCT02952898%22OR%22NCT03826550%22"]}]},{"efo_id":"EFO_0002970","efo_label":"muscular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002970","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02271854"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02271854%22"]}]},{"efo_id":"EFO_0002506","efo_label":"osteoarthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002506","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00092703","NCT00171652","NCT00542087","NCT00546507","NCT00546832","NCT02121002","NCT02596451","NCT02769572","NCT02913521","NCT03172780"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00092703%22OR%22NCT00171652%22OR%22NCT00542087%22OR%22NCT00546507%22OR%22NCT00546832%22OR%22NCT02121002%22OR%22NCT02596451%22OR%22NCT02769572%22OR%22NCT02913521%22OR%22NCT03172780%22"]},{"source":"DailyMed","ids":["0055edbf-f1f6-4b50-8e41-202c5a2a7883","01e92b73-8271-4028-8a74-c236e3b55db8","05a94f49-3f12-462c-9180-ae75719d3441","0c4281ab-1cd8-4e45-904c-9b9f5940c3bb","137c4e7a-e671-413e-b687-89490ef98974","1877c2fb-39f7-45e3-b7f0-eb834ee273e4","1940300f-2b4a-4016-a1bb-21f821797a89","19b4ff5c-adb7-a0d0-7ef2-4ae05047fd94","1b291d0a-1350-4637-bab3-f0bf43ab2a13","1cdede45-4e2b-490a-bd22-eca5315af316","1eb7a7bb-c524-4168-8ade-4601dc11533b","1f5a4b8e-458d-43f1-a1e9-fac0df45954e","206c072d-a6a9-49eb-9741-5d08353d557b","24845e58-5bfe-4a74-beec-696a564fb68c","253ee985-e0a0-4674-a114-cfea96304c79","26b2d99e-d471-4758-8aa0-a26ef464eb35","2ae3c1e2-f053-4efb-9597-eeac4998d23f","2d92077c-75d2-4b34-8704-71660f77a63b","3330ea92-fc9d-4541-b378-be399b0995d3","3643ab1b-9f8f-b2f4-e02d-950d0a02e587","36ce096d-625f-4907-bfaa-49ac04dc7df1","381a14e5-65d3-487c-b0d2-b483b0d2824d","40879600-ba6c-43a8-aa5d-d0d41503d593","42fcf2b5-3466-4493-8a47-c4675538ece3","4616cae3-c91b-477c-94b0-d3f4468a59d9","4732a181-9fe0-49b4-b486-e2da9ad66e31","4b0d7319-a587-4648-bded-5b35b8efa1cb","4c1e3237-288d-4d30-b8e9-8a935602ee17","4c9f995c-d687-483a-b6bb-11c8b263681b","4f0a7109-2915-4daa-a752-8f78cf040b37","5d260623-1e56-cacc-5df8-0841d52e6872","60045fc6-f0d9-4f67-ba91-c3b317596437","600fe842-45d9-4d68-9ef2-456dbbebaa11","663a3dbc-a631-4046-8852-ec619c41c81d","688fa1d0-6e17-4191-8618-8f62bc7765d3","6b7fb6b7-2f58-4cb6-b48f-e9b4cf292365","70c96b78-3702-4216-819f-1071770494bf","73a46413-ecbc-4453-814d-bec955b375d2","74bb5cb3-03e0-4dbf-9b8a-f67417538e4f","758c886c-decb-41a3-a147-b6565014eaa5","770b5db0-3565-409d-a274-caa132fb8d89","7a7ee8e2-5137-4abf-9d75-5db51a69b88b","802cd382-443d-48e3-9c9d-fd946c73c79f","807a0f13-93e5-4388-b3e9-5edc2a319640","87d5a720-f154-4c4b-b2d4-0ae58455dda0","93879f33-d484-471d-94e2-a5ba37eb44d5","9a22cb4b-e49a-4bd7-b235-47405c302658","9c4c44f5-33fd-4829-829f-caa132e90475","a1339d2d-066e-459c-93b7-1ba839b15e2e","a388be87-4a3e-4501-8895-46101fdda1f3","a57b897e-0cbe-4ac3-969f-b00357a0cfa8","a65aa738-8ce2-4276-8e54-5ecf4f461d3a","a7701e8c-4e16-4165-8b83-de2c08d5ded3","ab5dc1b9-dc3f-4c06-9839-46515a9a05f5","b04009ca-7545-4cd4-af63-f15aebf20f18","b3d2ceba-34b3-419f-808b-e10cf0c15a3a","bd27460e-46ff-4450-a4f2-a41420c1f93d","bdf17a90-9444-4dba-aff6-df27e07f23d5","bfa8cb40-3528-4d41-ae77-444e521e30c0","bfcd5d3b-30f8-4483-89e2-c67b41b22811","cbdc93dd-860a-4bf7-b86f-5c9c9e2e553b","cc715a60-32e0-4d31-a1df-2a591a56d4e5","d207da6e-d074-4dab-95f1-265b1df41aea","d349b4ca-3aec-44a8-a4d5-87be4c822190","d44134d1-2ca9-4249-872c-65a7186870c8","d512ea2e-a4b5-4ff9-b972-a9bf86ea9937","d77f1654-4423-464f-a846-6767a2377ce1","d81dc6f5-7e4e-4fff-81e7-ee83c850c5f7","df63e944-bfb7-453d-bbd8-63f545826784","df8b8660-0c24-4848-8bea-c1b935090c66","e1685937-3980-40e3-8f04-998174fef3a2","e424b30d-8f40-48b7-bb99-415f92d84ed0","e780534f-5b33-42f8-ae35-ccf8ee652035","e8527a76-4efc-4ead-a11d-87252693fa36","ea23fc47-3b7b-4fad-ae34-b6eb6913d957","eff16712-d4c4-4e7b-bf38-c467de1095f4","f0e00d55-02b7-4642-a60e-6a5841932ca5","f32c0225-fd21-468a-90f5-6083071e80fb","f674ad5c-b022-463a-af41-05bb03ee171b","f940aa00-2a88-44ce-b36f-fd51552b2c2b","fae53d24-acf1-4250-888d-b8d965ffc3d3","fdda600c-3fa1-4515-922e-aff6e89b4d2c","ffbf7573-c726-42f6-bbd5-5d2533d8288f"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0055edbf-f1f6-4b50-8e41-202c5a2a7883","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?01e92b73-8271-4028-8a74-c236e3b55db8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?05a94f49-3f12-462c-9180-ae75719d3441","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0c4281ab-1cd8-4e45-904c-9b9f5940c3bb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?137c4e7a-e671-413e-b687-89490ef98974","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1877c2fb-39f7-45e3-b7f0-eb834ee273e4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1940300f-2b4a-4016-a1bb-21f821797a89","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?19b4ff5c-adb7-a0d0-7ef2-4ae05047fd94","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1b291d0a-1350-4637-bab3-f0bf43ab2a13","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1cdede45-4e2b-490a-bd22-eca5315af316","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1eb7a7bb-c524-4168-8ade-4601dc11533b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1f5a4b8e-458d-43f1-a1e9-fac0df45954e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?206c072d-a6a9-49eb-9741-5d08353d557b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?24845e58-5bfe-4a74-beec-696a564fb68c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?253ee985-e0a0-4674-a114-cfea96304c79","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?26b2d99e-d471-4758-8aa0-a26ef464eb35","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2ae3c1e2-f053-4efb-9597-eeac4998d23f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2d92077c-75d2-4b34-8704-71660f77a63b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3330ea92-fc9d-4541-b378-be399b0995d3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3643ab1b-9f8f-b2f4-e02d-950d0a02e587","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?36ce096d-625f-4907-bfaa-49ac04dc7df1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?381a14e5-65d3-487c-b0d2-b483b0d2824d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?40879600-ba6c-43a8-aa5d-d0d41503d593","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?42fcf2b5-3466-4493-8a47-c4675538ece3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4616cae3-c91b-477c-94b0-d3f4468a59d9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4732a181-9fe0-49b4-b486-e2da9ad66e31","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4b0d7319-a587-4648-bded-5b35b8efa1cb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4c1e3237-288d-4d30-b8e9-8a935602ee17","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4c9f995c-d687-483a-b6bb-11c8b263681b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4f0a7109-2915-4daa-a752-8f78cf040b37","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5d260623-1e56-cacc-5df8-0841d52e6872","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?60045fc6-f0d9-4f67-ba91-c3b317596437","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?600fe842-45d9-4d68-9ef2-456dbbebaa11","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?663a3dbc-a631-4046-8852-ec619c41c81d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?688fa1d0-6e17-4191-8618-8f62bc7765d3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6b7fb6b7-2f58-4cb6-b48f-e9b4cf292365","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?70c96b78-3702-4216-819f-1071770494bf","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?73a46413-ecbc-4453-814d-bec955b375d2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?74bb5cb3-03e0-4dbf-9b8a-f67417538e4f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?758c886c-decb-41a3-a147-b6565014eaa5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?770b5db0-3565-409d-a274-caa132fb8d89","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7a7ee8e2-5137-4abf-9d75-5db51a69b88b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?802cd382-443d-48e3-9c9d-fd946c73c79f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?807a0f13-93e5-4388-b3e9-5edc2a319640","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?87d5a720-f154-4c4b-b2d4-0ae58455dda0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?93879f33-d484-471d-94e2-a5ba37eb44d5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9a22cb4b-e49a-4bd7-b235-47405c302658","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9c4c44f5-33fd-4829-829f-caa132e90475","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a1339d2d-066e-459c-93b7-1ba839b15e2e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a388be87-4a3e-4501-8895-46101fdda1f3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a57b897e-0cbe-4ac3-969f-b00357a0cfa8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a65aa738-8ce2-4276-8e54-5ecf4f461d3a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a7701e8c-4e16-4165-8b83-de2c08d5ded3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ab5dc1b9-dc3f-4c06-9839-46515a9a05f5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b04009ca-7545-4cd4-af63-f15aebf20f18","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b3d2ceba-34b3-419f-808b-e10cf0c15a3a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bd27460e-46ff-4450-a4f2-a41420c1f93d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bdf17a90-9444-4dba-aff6-df27e07f23d5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bfa8cb40-3528-4d41-ae77-444e521e30c0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bfcd5d3b-30f8-4483-89e2-c67b41b22811","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cbdc93dd-860a-4bf7-b86f-5c9c9e2e553b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cc715a60-32e0-4d31-a1df-2a591a56d4e5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d207da6e-d074-4dab-95f1-265b1df41aea","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d349b4ca-3aec-44a8-a4d5-87be4c822190","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d44134d1-2ca9-4249-872c-65a7186870c8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d512ea2e-a4b5-4ff9-b972-a9bf86ea9937","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d77f1654-4423-464f-a846-6767a2377ce1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d81dc6f5-7e4e-4fff-81e7-ee83c850c5f7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?df63e944-bfb7-453d-bbd8-63f545826784","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?df8b8660-0c24-4848-8bea-c1b935090c66","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e1685937-3980-40e3-8f04-998174fef3a2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e424b30d-8f40-48b7-bb99-415f92d84ed0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e780534f-5b33-42f8-ae35-ccf8ee652035","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e8527a76-4efc-4ead-a11d-87252693fa36","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ea23fc47-3b7b-4fad-ae34-b6eb6913d957","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?eff16712-d4c4-4e7b-bf38-c467de1095f4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f0e00d55-02b7-4642-a60e-6a5841932ca5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f32c0225-fd21-468a-90f5-6083071e80fb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f674ad5c-b022-463a-af41-05bb03ee171b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f940aa00-2a88-44ce-b36f-fd51552b2c2b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?fae53d24-acf1-4250-888d-b8d965ffc3d3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?fdda600c-3fa1-4515-922e-aff6e89b4d2c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ffbf7573-c726-42f6-bbd5-5d2533d8288f"]},{"source":"FDA","ids":["1bc60f67-86a4-4047-8a3b-ec1d16ebabca","1d1d442c-b423-4843-a15b-197dbfeb5df1","217f6c23-9a2e-4647-b4d2-ea9f9eb413c0","2280a305-34bd-4f9c-8f31-d6bb6fad90d5","27ccf64c-fc2b-44d3-bf57-397417b406f8","2840012a-3466-4a86-a316-d555f421e23b","29d4e5e9-cfe7-44d4-9bd6-e4d376f65972","2b0c2fc7-800c-4d5e-914c-9e67a54b1e2a","43d7d5d1-a593-4b97-ae24-f3e92be90004","4a9f22fe-7f2e-4597-beb1-e1f950d2de33","5aaa3f1d-9792-4ce1-8895-9d5f3e871a2a","636dfa0a-0a93-4f22-9f0c-4131bd523df3","69d6802e-86b1-43f7-86ef-982ffd24511d","6fcb75a2-095d-424b-b9ac-f843a8e1d9b1","716bf76f-ae98-498d-8960-0b35aa90c92b","7a7e69c1-6eea-4f27-b2ed-3e5fb176fdae","8a33def9-169d-4370-ba72-9d7a4117530e","8c7a84ca-915f-4e71-9bb0-3ca70a5ae517","97532b47-41c4-41e5-a89b-fc788528204b","9d522742-7f29-47eb-9e96-c08482975bee","9e2244cb-f50f-4fbb-b6b8-acbba8459081","a8c96721-fc32-41a1-ac15-05c984210784","afff07ab-9440-4448-8768-359a5dda202e","b5e8af50-ddf8-826e-f167-34026fd35d59","bb530269-5c2e-4821-8fca-2fea108f8f26","c1888b7a-0a14-4e24-9ba7-1458154d07d9","c1cdbca7-8ea7-42c4-a8b5-c04ce0aadd09","c5855fad-0acb-4e4c-b186-bc759aa503f2","d99ef8e0-1cb2-42ea-8b38-837ce8c8e672"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A1bc60f67-86a4-4047-8a3b-ec1d16ebabca","https://api.fda.gov/drug/label.json?search=set_id%3A1d1d442c-b423-4843-a15b-197dbfeb5df1","https://api.fda.gov/drug/label.json?search=set_id%3A217f6c23-9a2e-4647-b4d2-ea9f9eb413c0","https://api.fda.gov/drug/label.json?search=set_id%3A2280a305-34bd-4f9c-8f31-d6bb6fad90d5","https://api.fda.gov/drug/label.json?search=set_id%3A27ccf64c-fc2b-44d3-bf57-397417b406f8","https://api.fda.gov/drug/label.json?search=set_id%3A2840012a-3466-4a86-a316-d555f421e23b","https://api.fda.gov/drug/label.json?search=set_id%3A29d4e5e9-cfe7-44d4-9bd6-e4d376f65972","https://api.fda.gov/drug/label.json?search=set_id%3A2b0c2fc7-800c-4d5e-914c-9e67a54b1e2a","https://api.fda.gov/drug/label.json?search=set_id%3A43d7d5d1-a593-4b97-ae24-f3e92be90004","https://api.fda.gov/drug/label.json?search=set_id%3A4a9f22fe-7f2e-4597-beb1-e1f950d2de33","https://api.fda.gov/drug/label.json?search=set_id%3A5aaa3f1d-9792-4ce1-8895-9d5f3e871a2a","https://api.fda.gov/drug/label.json?search=set_id%3A636dfa0a-0a93-4f22-9f0c-4131bd523df3","https://api.fda.gov/drug/label.json?search=set_id%3A69d6802e-86b1-43f7-86ef-982ffd24511d","https://api.fda.gov/drug/label.json?search=set_id%3A6fcb75a2-095d-424b-b9ac-f843a8e1d9b1","https://api.fda.gov/drug/label.json?search=set_id%3A716bf76f-ae98-498d-8960-0b35aa90c92b","https://api.fda.gov/drug/label.json?search=set_id%3A7a7e69c1-6eea-4f27-b2ed-3e5fb176fdae","https://api.fda.gov/drug/label.json?search=set_id%3A8a33def9-169d-4370-ba72-9d7a4117530e","https://api.fda.gov/drug/label.json?search=set_id%3A8c7a84ca-915f-4e71-9bb0-3ca70a5ae517","https://api.fda.gov/drug/label.json?search=set_id%3A97532b47-41c4-41e5-a89b-fc788528204b","https://api.fda.gov/drug/label.json?search=set_id%3A9d522742-7f29-47eb-9e96-c08482975bee","https://api.fda.gov/drug/label.json?search=set_id%3A9e2244cb-f50f-4fbb-b6b8-acbba8459081","https://api.fda.gov/drug/label.json?search=set_id%3Aa8c96721-fc32-41a1-ac15-05c984210784","https://api.fda.gov/drug/label.json?search=set_id%3Aafff07ab-9440-4448-8768-359a5dda202e","https://api.fda.gov/drug/label.json?search=set_id%3Ab5e8af50-ddf8-826e-f167-34026fd35d59","https://api.fda.gov/drug/label.json?search=set_id%3Abb530269-5c2e-4821-8fca-2fea108f8f26","https://api.fda.gov/drug/label.json?search=set_id%3Ac1888b7a-0a14-4e24-9ba7-1458154d07d9","https://api.fda.gov/drug/label.json?search=set_id%3Ac1cdbca7-8ea7-42c4-a8b5-c04ce0aadd09","https://api.fda.gov/drug/label.json?search=set_id%3Ac5855fad-0acb-4e4c-b186-bc759aa503f2","https://api.fda.gov/drug/label.json?search=set_id%3Ad99ef8e0-1cb2-42ea-8b38-837ce8c8e672"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00092378","NCT00726388","NCT00869063","NCT00943098","NCT01202799","NCT01706588","NCT02100670","NCT02169154","NCT02201238","NCT02598102","NCT03825016"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00092378%22OR%22NCT00726388%22OR%22NCT00869063%22OR%22NCT00943098%22OR%22NCT01202799%22OR%22NCT01706588%22OR%22NCT02100670%22OR%22NCT02169154%22OR%22NCT02201238%22OR%22NCT02598102%22OR%22NCT03825016%22"]},{"source":"FDA","ids":["dd089777-5479-457a-bc22-3e49d8ae15b1"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Add089777-5479-457a-bc22-3e49d8ae15b1"]}]},{"efo_id":"EFO_0004616","efo_label":"osteoarthritis, knee","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004616","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00426621","NCT01119898","NCT01511939","NCT03277066"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00426621%22OR%22NCT01119898%22OR%22NCT01511939%22OR%22NCT03277066%22"]}]},{"efo_id":"EFO_0004198","efo_label":"skin neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004198","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00601640"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00601640%22"]}]},{"efo_id":"EFO_0000685","efo_label":"rheumatoid arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000685","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00092742","NCT00250445"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00092742%22OR%22NCT00250445%22"]},{"source":"DailyMed","ids":["ffbf7573-c726-42f6-bbd5-5d2533d8288f"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ffbf7573-c726-42f6-bbd5-5d2533d8288f"]}]},{"efo_id":"MP_0001845","efo_label":"inflammation","efo_uri":"http://purl.obolibrary.org/obo/MP_0001845","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00913224","NCT00913887","NCT00914160"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00913224%22OR%22NCT00913887%22OR%22NCT00914160%22"]}]},{"efo_id":"EFO_0004274","efo_label":"gout","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004274","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02545777"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02545777%22"]}]},{"efo_id":"EFO_0000546","efo_label":"injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000546","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03041779"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03041779%22"]}]},{"efo_id":"EFO_0003958","efo_label":"sunburn","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003958","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00441051"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00441051%22"]}]},{"efo_id":"EFO_0004272","efo_label":"anemia (phenotype)","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004272","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02339428"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02339428%22"]}]},{"efo_id":"MP_0001914","efo_label":"hemorrhage","efo_uri":"http://purl.obolibrary.org/obo/MP_0001914","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["1cdede45-4e2b-490a-bd22-eca5315af316","253ee985-e0a0-4674-a114-cfea96304c79","3643ab1b-9f8f-b2f4-e02d-950d0a02e587","4616cae3-c91b-477c-94b0-d3f4468a59d9","4f0a7109-2915-4daa-a752-8f78cf040b37","600fe842-45d9-4d68-9ef2-456dbbebaa11","758c886c-decb-41a3-a147-b6565014eaa5","9a22cb4b-e49a-4bd7-b235-47405c302658","a388be87-4a3e-4501-8895-46101fdda1f3","a7701e8c-4e16-4165-8b83-de2c08d5ded3","ab5dc1b9-dc3f-4c06-9839-46515a9a05f5","bdf17a90-9444-4dba-aff6-df27e07f23d5","df8b8660-0c24-4848-8bea-c1b935090c66"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1cdede45-4e2b-490a-bd22-eca5315af316","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?253ee985-e0a0-4674-a114-cfea96304c79","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3643ab1b-9f8f-b2f4-e02d-950d0a02e587","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4616cae3-c91b-477c-94b0-d3f4468a59d9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4f0a7109-2915-4daa-a752-8f78cf040b37","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?600fe842-45d9-4d68-9ef2-456dbbebaa11","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?758c886c-decb-41a3-a147-b6565014eaa5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9a22cb4b-e49a-4bd7-b235-47405c302658","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a388be87-4a3e-4501-8895-46101fdda1f3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a7701e8c-4e16-4165-8b83-de2c08d5ded3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ab5dc1b9-dc3f-4c06-9839-46515a9a05f5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bdf17a90-9444-4dba-aff6-df27e07f23d5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?df8b8660-0c24-4848-8bea-c1b935090c66"]},{"source":"FDA","ids":["27ccf64c-fc2b-44d3-bf57-397417b406f8","8c7a84ca-915f-4e71-9bb0-3ca70a5ae517","b5e8af50-ddf8-826e-f167-34026fd35d59"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A27ccf64c-fc2b-44d3-bf57-397417b406f8","https://api.fda.gov/drug/label.json?search=set_id%3A8c7a84ca-915f-4e71-9bb0-3ca70a5ae517","https://api.fda.gov/drug/label.json?search=set_id%3Ab5e8af50-ddf8-826e-f167-34026fd35d59"]}]},{"efo_id":"EFO_0000292","efo_label":"bladder carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000292","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01542567"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01542567%22"]}]},{"efo_id":"EFO_0009560","efo_label":"otitis externa","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009560","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00523120"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00523120%22"]}]},{"efo_id":"EFO_0009582","efo_label":"sprain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009582","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00640705","NCT01255423","NCT01272934"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00640705%22OR%22NCT01255423%22OR%22NCT01272934%22"]}]},{"efo_id":"HP_0012532","efo_label":"Chronic pain","efo_uri":"http://purl.obolibrary.org/obo/HP_0012532","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03471507"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03471507%22"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00366444","NCT00375934","NCT02192203","NCT02476422","NCT02709590"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00366444%22OR%22NCT00375934%22OR%22NCT02192203%22OR%22NCT02476422%22OR%22NCT02709590%22"]},{"source":"DailyMed","ids":["0c3ac260-586d-4203-855b-f7518e89484e","1728cd89-1bb4-4b55-8e1c-9181702e4c51","236678af-b766-41e7-98f4-bf13c0f39a28","2cc4fc25-1948-445d-aa50-81fc7a5222a5","61c5becd-0295-4e86-9b5b-f8388207da49","645c97bc-5197-45a1-9802-2b4d43bd7496","717341fc-e067-0005-215c-053f6d12e0d1","77b60a0c-e49a-4ad4-abb1-b662c24ab782","7dfb36a4-3064-4639-9167-23d1c7d1bee9","85da6c5c-a1ec-4ea0-9fbb-2012f63931be","a0a86ecf-e6fe-4c85-ac60-f62fd63e2590","a697e731-8d19-4845-8f31-16c4b19bb338","ae0257c5-c16e-4c95-83b6-f9ae02792884","d751e65a-5086-4303-864b-bd9ed895a239","fac1f8e7-f2b4-4de3-bd5c-d798d12273c1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0c3ac260-586d-4203-855b-f7518e89484e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1728cd89-1bb4-4b55-8e1c-9181702e4c51","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?236678af-b766-41e7-98f4-bf13c0f39a28","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2cc4fc25-1948-445d-aa50-81fc7a5222a5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?61c5becd-0295-4e86-9b5b-f8388207da49","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?645c97bc-5197-45a1-9802-2b4d43bd7496","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?717341fc-e067-0005-215c-053f6d12e0d1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?77b60a0c-e49a-4ad4-abb1-b662c24ab782","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7dfb36a4-3064-4639-9167-23d1c7d1bee9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?85da6c5c-a1ec-4ea0-9fbb-2012f63931be","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a0a86ecf-e6fe-4c85-ac60-f62fd63e2590","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a697e731-8d19-4845-8f31-16c4b19bb338","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ae0257c5-c16e-4c95-83b6-f9ae02792884","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d751e65a-5086-4303-864b-bd9ed895a239","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?fac1f8e7-f2b4-4de3-bd5c-d798d12273c1"]},{"source":"FDA","ids":["1582c050-925a-4af8-a44f-948017946ae6","31eaf8b6-5e2a-424c-8830-2c561044cdf8","8e6e1aea-d1c9-f6bf-2a8c-0504437be95c","ac52a142-bf15-4c1c-b6a6-ab2c1b65726b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A1582c050-925a-4af8-a44f-948017946ae6","https://api.fda.gov/drug/label.json?search=set_id%3A31eaf8b6-5e2a-424c-8830-2c561044cdf8","https://api.fda.gov/drug/label.json?search=set_id%3A8e6e1aea-d1c9-f6bf-2a8c-0504437be95c","https://api.fda.gov/drug/label.json?search=set_id%3Aac52a142-bf15-4c1c-b6a6-ab2c1b65726b"]}]},{"efo_id":"EFO_0003821","efo_label":"migraine disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003821","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["c5856c21-f322-11e3-ac10-0800200c9a66","d7335594-50c9-4ae2-a3e3-b9a375187b62"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c5856c21-f322-11e3-ac10-0800200c9a66","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d7335594-50c9-4ae2-a3e3-b9a375187b62"]}]},{"efo_id":"EFO_1001139","efo_label":"pulpitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001139","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03163420","NCT03174860","NCT03341260"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03163420%22OR%22NCT03174860%22OR%22NCT03341260%22"]}]},{"efo_id":"EFO_0000685","efo_label":"rheumatoid arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000685","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["0c3ac260-586d-4203-855b-f7518e89484e","1728cd89-1bb4-4b55-8e1c-9181702e4c51","236678af-b766-41e7-98f4-bf13c0f39a28","2cc4fc25-1948-445d-aa50-81fc7a5222a5","61c5becd-0295-4e86-9b5b-f8388207da49","645c97bc-5197-45a1-9802-2b4d43bd7496","717341fc-e067-0005-215c-053f6d12e0d1","77b60a0c-e49a-4ad4-abb1-b662c24ab782","7dfb36a4-3064-4639-9167-23d1c7d1bee9","85da6c5c-a1ec-4ea0-9fbb-2012f63931be","a0a86ecf-e6fe-4c85-ac60-f62fd63e2590","a697e731-8d19-4845-8f31-16c4b19bb338","ae0257c5-c16e-4c95-83b6-f9ae02792884","d751e65a-5086-4303-864b-bd9ed895a239","fac1f8e7-f2b4-4de3-bd5c-d798d12273c1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0c3ac260-586d-4203-855b-f7518e89484e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1728cd89-1bb4-4b55-8e1c-9181702e4c51","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?236678af-b766-41e7-98f4-bf13c0f39a28","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2cc4fc25-1948-445d-aa50-81fc7a5222a5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?61c5becd-0295-4e86-9b5b-f8388207da49","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?645c97bc-5197-45a1-9802-2b4d43bd7496","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?717341fc-e067-0005-215c-053f6d12e0d1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?77b60a0c-e49a-4ad4-abb1-b662c24ab782","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7dfb36a4-3064-4639-9167-23d1c7d1bee9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?85da6c5c-a1ec-4ea0-9fbb-2012f63931be","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a0a86ecf-e6fe-4c85-ac60-f62fd63e2590","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a697e731-8d19-4845-8f31-16c4b19bb338","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ae0257c5-c16e-4c95-83b6-f9ae02792884","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d751e65a-5086-4303-864b-bd9ed895a239","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?fac1f8e7-f2b4-4de3-bd5c-d798d12273c1"]},{"source":"FDA","ids":["1582c050-925a-4af8-a44f-948017946ae6","31eaf8b6-5e2a-424c-8830-2c561044cdf8","8e6e1aea-d1c9-f6bf-2a8c-0504437be95c","ac52a142-bf15-4c1c-b6a6-ab2c1b65726b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A1582c050-925a-4af8-a44f-948017946ae6","https://api.fda.gov/drug/label.json?search=set_id%3A31eaf8b6-5e2a-424c-8830-2c561044cdf8","https://api.fda.gov/drug/label.json?search=set_id%3A8e6e1aea-d1c9-f6bf-2a8c-0504437be95c","https://api.fda.gov/drug/label.json?search=set_id%3Aac52a142-bf15-4c1c-b6a6-ab2c1b65726b"]}]},{"efo_id":"EFO_0002506","efo_label":"osteoarthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002506","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["0c3ac260-586d-4203-855b-f7518e89484e","1728cd89-1bb4-4b55-8e1c-9181702e4c51","236678af-b766-41e7-98f4-bf13c0f39a28","2cc4fc25-1948-445d-aa50-81fc7a5222a5","61c5becd-0295-4e86-9b5b-f8388207da49","645c97bc-5197-45a1-9802-2b4d43bd7496","717341fc-e067-0005-215c-053f6d12e0d1","77b60a0c-e49a-4ad4-abb1-b662c24ab782","7dfb36a4-3064-4639-9167-23d1c7d1bee9","85da6c5c-a1ec-4ea0-9fbb-2012f63931be","a0a86ecf-e6fe-4c85-ac60-f62fd63e2590","a697e731-8d19-4845-8f31-16c4b19bb338","ae0257c5-c16e-4c95-83b6-f9ae02792884","d751e65a-5086-4303-864b-bd9ed895a239","fac1f8e7-f2b4-4de3-bd5c-d798d12273c1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0c3ac260-586d-4203-855b-f7518e89484e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1728cd89-1bb4-4b55-8e1c-9181702e4c51","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?236678af-b766-41e7-98f4-bf13c0f39a28","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2cc4fc25-1948-445d-aa50-81fc7a5222a5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?61c5becd-0295-4e86-9b5b-f8388207da49","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?645c97bc-5197-45a1-9802-2b4d43bd7496","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?717341fc-e067-0005-215c-053f6d12e0d1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?77b60a0c-e49a-4ad4-abb1-b662c24ab782","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7dfb36a4-3064-4639-9167-23d1c7d1bee9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?85da6c5c-a1ec-4ea0-9fbb-2012f63931be","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a0a86ecf-e6fe-4c85-ac60-f62fd63e2590","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a697e731-8d19-4845-8f31-16c4b19bb338","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ae0257c5-c16e-4c95-83b6-f9ae02792884","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d751e65a-5086-4303-864b-bd9ed895a239","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?fac1f8e7-f2b4-4de3-bd5c-d798d12273c1"]},{"source":"FDA","ids":["1582c050-925a-4af8-a44f-948017946ae6","31eaf8b6-5e2a-424c-8830-2c561044cdf8","8e6e1aea-d1c9-f6bf-2a8c-0504437be95c","ac52a142-bf15-4c1c-b6a6-ab2c1b65726b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A1582c050-925a-4af8-a44f-948017946ae6","https://api.fda.gov/drug/label.json?search=set_id%3A31eaf8b6-5e2a-424c-8830-2c561044cdf8","https://api.fda.gov/drug/label.json?search=set_id%3A8e6e1aea-d1c9-f6bf-2a8c-0504437be95c","https://api.fda.gov/drug/label.json?search=set_id%3Aac52a142-bf15-4c1c-b6a6-ab2c1b65726b"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["c982eca0-fc41-11e1-a9c8-0002a5d5c51b"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c982eca0-fc41-11e1-a9c8-0002a5d5c51b"]},{"source":"FDA","ids":["61420046-b04b-4532-a21d-65986966f681","b20c6938-cf96-4175-9eb3-d6ae3a43059c"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A61420046-b04b-4532-a21d-65986966f681","https://api.fda.gov/drug/label.json?search=set_id%3Ab20c6938-cf96-4175-9eb3-d6ae3a43059c"]}]},{"efo_id":"HP_0100607","efo_label":"Dysmenorrhea","efo_uri":"http://purl.obolibrary.org/obo/HP_0100607","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02255045"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02255045%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT01380353"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01380353%22"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["4bca1472-9a43-4510-a2de-5a2d80edbfbc","56caa44c-cc65-4500-ae05-ed508e52075d","f103f7e8-1253-43cb-9667-cd0d8f4d5500","f8b489ee-b48f-41b6-a759-c910e531576f"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4bca1472-9a43-4510-a2de-5a2d80edbfbc","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?56caa44c-cc65-4500-ae05-ed508e52075d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f103f7e8-1253-43cb-9667-cd0d8f4d5500","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f8b489ee-b48f-41b6-a759-c910e531576f"]}]},{"efo_id":"EFO_0009582","efo_label":"sprain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009582","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02324270"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02324270%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000073756","approved_name":"prostaglandin-endoperoxide synthase 2","approved_symbol":"PTGS2"},{"ensembl":"ENSG00000095303","approved_name":"prostaglandin-endoperoxide synthase 1","approved_symbol":"PTGS1"}],"target_type":"protein family","target_name":"Cyclooxygenase","action_type":"inhibitor","description":"Cyclooxygenase inhibitor","references":[{"source":"FDA","ids":["label/2013/204592s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2013%2F204592s000lbl.pdf"]},{"source":"PubMed","ids":["12534640","12713596","12925531"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12534640+OR+EXT_ID%3A12713596+OR+EXT_ID%3A12925531"]}]},{"target_components":[{"ensembl":"ENSG00000073756","approved_name":"prostaglandin-endoperoxide synthase 2","approved_symbol":"PTGS2"},{"ensembl":"ENSG00000095303","approved_name":"prostaglandin-endoperoxide synthase 1","approved_symbol":"PTGS1"}],"target_type":"protein family","target_name":"Cyclooxygenase","action_type":"inhibitor","description":"Cyclooxygenase inhibitor","references":[{"source":"PubMed","ids":["12534640","12713596","12925531"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12534640+OR+EXT_ID%3A12713596+OR+EXT_ID%3A12925531"]},{"source":"Wikipedia","ids":["Diclofenac#Mechanism_of_action"],"urls":["https://www.wikipedia.org/Diclofenac#Mechanism_of_action"]}]}],"adverse_events":{"significant":[{"event":"melaena","count":7928,"llr":635.8749868},{"event":"gastric ulcer","count":5425,"llr":516.4919633},{"event":"drug hypersensitivity","count":71246,"llr":394.4128303},{"event":"renal failure acute","count":23893,"llr":392.5930139},{"event":"embolia cutis medicamentosa","count":234,"llr":369.9259042},{"event":"ductus arteriosus stenosis foetal","count":165,"llr":340.7365985},{"event":"duodenal ulcer","count":2784,"llr":300.3163092},{"event":"haematemesis","count":6588,"llr":291.7458201},{"event":"deafness transitory","count":270,"llr":276.1024907},{"event":"angioedema","count":18080,"llr":266.4072522},{"event":"pharyngitis","count":3297,"llr":261.060974},{"event":"rheumatoid arthritis","count":23147,"llr":233.0554975},{"event":"anaphylactic reaction","count":16695,"llr":231.5219854},{"event":"abdominal pain upper","count":34037,"llr":230.5962295},{"event":"drug interaction","count":53526,"llr":224.0194084},{"event":"anaphylactic shock","count":6651,"llr":211.729094},{"event":"gastrointestinal haemorrhage","count":25270,"llr":211.522495}],"critval":210.9716058},"child_chembl_ids":["CHEMBL1034","CHEMBL1200804","CHEMBL1201180","CHEMBL3350449"],"number_of_indications":50,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":17},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":15},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":7},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":6},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":5},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":4},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":3},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":3},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":2},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":2},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":2},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1},{"therapeutic_code":"MONDO_0021205","therapeutic_label":"disease of ear","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3989914","_score":1,"_source":{"id":"CHEMBL3989914","internal_compound":false,"type":"Small molecule","pref_name":"GLESATINIB","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Glesatinib","MG-90265","MG-90265X","MG90265","MG90265H9","MG90265X","MG90265gly","MGCD-265","MGCD265","Mgcd-265"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB06302"]}],"canonical_smiles":"COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccc(F)cc5)cc4F)c3s2)nc1","indications":[{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00679133","NCT00697632","NCT01930006"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00679133%22OR%22NCT00697632%22OR%22NCT01930006%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00975767","NCT02544633","NCT02954991"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00975767%22OR%22NCT02544633%22OR%22NCT02954991%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000105976","approved_name":"MET proto-oncogene, receptor tyrosine kinase","approved_symbol":"MET"}],"target_type":"single protein","target_name":"Hepatocyte growth factor receptor","action_type":"inhibitor","description":"Hepatocyte growth factor receptor inhibitor"},{"target_components":[{"ensembl":"ENSG00000164078","approved_name":"macrophage stimulating 1 receptor","approved_symbol":"MST1R"}],"target_type":"single protein","target_name":"Macrophage-stimulating protein receptor","action_type":"inhibitor","description":"Macrophage-stimulating protein receptor inhibitor"},{"target_components":[{"ensembl":"ENSG00000102755","approved_name":"fms related receptor tyrosine kinase 1","approved_symbol":"FLT1"},{"ensembl":"ENSG00000037280","approved_name":"fms related receptor tyrosine kinase 4","approved_symbol":"FLT4"},{"ensembl":"ENSG00000128052","approved_name":"kinase insert domain receptor","approved_symbol":"KDR"}],"target_type":"protein family","target_name":"Vascular endothelial growth factor receptor","action_type":"inhibitor","description":"Vascular endothelial growth factor receptor inhibitor"},{"target_components":[{"ensembl":"ENSG00000120156","approved_name":"TEK receptor tyrosine kinase","approved_symbol":"TEK"}],"target_type":"single protein","target_name":"Tyrosine-protein kinase TIE-2","action_type":"inhibitor","description":"Tyrosine-protein kinase TIE-2 inhibitor"}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":4}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1027","_score":1,"_source":{"id":"CHEMBL1027","internal_compound":false,"type":"Small molecule","pref_name":"TIAGABINE","year_first_approved":1997,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["A-70569-1","ABBOTT-70569","ABBOTT-70569 FREE BASE","ABBOTT-70569 HYDROCHLORIDE","ABBOTT-70569-1","ABBOTT-70569.1","ABBOTT-70569.HCl","ABBOTT-705691","ABBOTT-705691 FREE BASE","ABT-569","ABT-569 FREE BASE","Abbott-70569","Abbott-70569.1","Gabitril","NNC-05-0328","NNC-050328","NNC-050328 FREE BASE","NO-05-0328","NO-050328","NO-050328 FREE BASE","Tiagabine","Tiagabine HCl"],"trade_names":["Gabitril","Tiagabine HCl"],"cross_references":[{"source":"ChEBI","ids":[9586]},{"source":"DailyMed","ids":["tiagabine%20hydrochloride"]},{"source":"PubChem","ids":["26758048"]},{"source":"Wikipedia","ids":["Tiagabine"]},{"source":"drugbank","ids":["DB00906"]},{"source":"ChEBI","ids":[85388]},{"source":"PubChem","ids":["144205798","170465153","49681547"]}],"canonical_smiles":"Cc1ccsc1C(=CCCN1CCC[C@@H](C(=O)O)C1)c1sccc1C","indications":[{"efo_id":"EFO_0000474","efo_label":"epilepsy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000474","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N03AG06"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N03AG06"]}]},{"efo_id":"EFO_0000692","efo_label":"schizophrenia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000692","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00179465"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00179465%22"]}]},{"efo_id":"EFO_0003829","efo_label":"alcohol dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003829","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01904487"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01904487%22"]}]},{"efo_id":"EFO_0003918","efo_label":"obstructive sleep apnea","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003918","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02387710"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02387710%22"]}]},{"efo_id":"EFO_0002610","efo_label":"cocaine dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002610","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00086255","NCT00129298"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00086255%22OR%22NCT00129298%22"]}]},{"efo_id":"EFO_0005230","efo_label":"anxiety","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005230","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00233675"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00233675%22"]}]},{"efo_id":"EFO_0005230","efo_label":"anxiety","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005230","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00214994","NCT00233675","NCT00236015"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00214994%22OR%22NCT00233675%22OR%22NCT00236015%22"]}]}],"adverse_events":{"significant":[{"event":"convulsion","count":26614,"llr":230.8240628},{"event":"status epilepticus","count":3754,"llr":94.85080715},{"event":"grand mal convulsion","count":4865,"llr":92.63211175},{"event":"confusional state","count":40628,"llr":88.3376527},{"event":"unresponsive to verbal stimuli","count":104,"llr":48.10024242},{"event":"loss of consciousness","count":30434,"llr":42.14408178},{"event":"agitation","count":21093,"llr":39.60041024},{"event":"complex partial seizures","count":625,"llr":39.08413142},{"event":"aphasia","count":8046,"llr":28.59509159},{"event":"aggression","count":12814,"llr":28.44853006},{"event":"encephalopathy","count":8151,"llr":25.30711786},{"event":"abnormal behaviour","count":10841,"llr":24.90670714},{"event":"dyskinesia","count":7974,"llr":22.49747696},{"event":"encephalocele","count":81,"llr":22.2492881},{"event":"tremor","count":36500,"llr":22.10324041},{"event":"muscle twitching","count":4905,"llr":20.8331906},{"event":"refusal of treatment by patient","count":2091,"llr":20.26990629},{"event":"mental status changes","count":10001,"llr":20.14315554},{"event":"drug interaction","count":53526,"llr":17.66107706},{"event":"dizziness","count":99375,"llr":17.24665072},{"event":"amnesia","count":13293,"llr":17.23600058},{"event":"coordination abnormal","count":3529,"llr":16.70495358},{"event":"diplopia","count":6509,"llr":15.44563362},{"event":"oscillopsia","count":95,"llr":15.34243214},{"event":"suicide attempt","count":20244,"llr":15.20678176},{"event":"speech disorder","count":10086,"llr":14.69831619},{"event":"pupillary reflex impaired","count":632,"llr":14.06973453},{"event":"delirium","count":11053,"llr":13.94030299},{"event":"clavicle fracture","count":718,"llr":13.56537773},{"event":"drug screen positive","count":1833,"llr":13.46001493},{"event":"post-traumatic stress disorder","count":747,"llr":13.40900637},{"event":"communication disorder","count":792,"llr":13.17814227},{"event":"panic attack","count":6167,"llr":12.97864082},{"event":"congenital ectopic bladder","count":17,"llr":12.85173801},{"event":"coma","count":13175,"llr":12.50455163},{"event":"psychomotor retardation","count":1073,"llr":11.98302087},{"event":"cerebral disorder","count":1115,"llr":11.83235002},{"event":"disorientation","count":10841,"llr":11.66095336},{"event":"electroencephalogram abnormal","count":1335,"llr":11.12730115},{"event":"petit mal epilepsy","count":1413,"llr":10.905576},{"event":"laceration","count":3403,"llr":10.47501929},{"event":"eye movement disorder","count":1601,"llr":10.41896287},{"event":"ligament sprain","count":1614,"llr":10.38751606},{"event":"conversion disorder","count":564,"llr":10.03154345},{"event":"urinary incontinence","count":6744,"llr":9.753533791},{"event":"disturbance in attention","count":10609,"llr":9.486391244},{"event":"staring","count":686,"llr":9.452565427},{"event":"psychotic disorder","count":11057,"llr":9.227663071},{"event":"nightmare","count":7702,"llr":9.022621199},{"event":"incontinence","count":2356,"llr":8.925990821},{"event":"insomnia","count":44658,"llr":8.784535161},{"event":"metabolic encephalopathy","count":868,"llr":8.759292225},{"event":"dysphemia","count":873,"llr":8.742408761},{"event":"spinal compression fracture","count":2481,"llr":8.727877464},{"event":"facial bones fracture","count":907,"llr":8.630154895},{"event":"faecal fat increased","count":1,"llr":8.563552759},{"event":"suicidal behaviour","count":944,"llr":8.512779425},{"event":"mood altered","count":5179,"llr":8.498060535},{"event":"food allergy","count":950,"llr":8.494189649},{"event":"lethargy","count":17134,"llr":8.430456405},{"event":"lower limb fracture","count":2751,"llr":8.333399703},{"event":"retrograde amnesia","count":187,"llr":8.067823428},{"event":"anterograde amnesia","count":205,"llr":7.885278189},{"event":"meningomyelocele","count":225,"llr":7.700494557},{"event":"cognitive disorder","count":9869,"llr":7.684572736},{"event":"alcohol use","count":1293,"llr":7.593292915},{"event":"congenital cystic kidney disease","count":244,"llr":7.539686271},{"event":"skin laceration","count":1318,"llr":7.537582401},{"event":"muscle rigidity","count":3651,"llr":7.26370724},{"event":"vision blurred","count":26101,"llr":7.235587933},{"event":"ammonia increased","count":1465,"llr":7.230597323},{"event":"fall","count":67604,"llr":7.182027619},{"event":"anorectal agenesis","count":4,"llr":7.177468751},{"event":"mucopolysaccharidosis","count":4,"llr":7.177468751},{"event":"foot fracture","count":3763,"llr":7.150618687},{"event":"sedation","count":6964,"llr":7.140844317},{"event":"eye rolling","count":304,"llr":7.104159024},{"event":"joint injury","count":3850,"llr":7.065230316},{"event":"major depression","count":1649,"llr":6.888466804},{"event":"rib fracture","count":4118,"llr":6.814653693},{"event":"catatonia","count":1881,"llr":6.509717014},{"event":"foaming at mouth","count":416,"llr":6.4846686},{"event":"tonic clonic movements","count":430,"llr":6.419446805},{"event":"dystonia","count":4697,"llr":6.328619503},{"event":"postictal state","count":451,"llr":6.325549705},{"event":"ophthalmoplegia","count":459,"llr":6.290942884},{"event":"epilepsy","count":8950,"llr":6.023814432},{"event":"caesarean section","count":5212,"llr":5.948214828},{"event":"eyes sunken","count":14,"llr":5.925406958},{"event":"psychomotor seizures","count":15,"llr":5.856484205},{"event":"irritability","count":14353,"llr":5.746749841}],"critval":5.699967312},"child_chembl_ids":["CHEMBL1695"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000157103","approved_name":"solute carrier family 6 member 1","approved_symbol":"SLC6A1"}],"target_type":"single protein","target_name":"GABA transporter 1","action_type":"inhibitor","description":"GABA transporter 1 inhibitor","references":[{"source":"DailyMed","ids":["setid=cf97a72e-951e-a7db-a574-adac12a6b189"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cf97a72e-951e-a7db-a574-adac12a6b189"]},{"source":"PubMed","ids":["20512624"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20512624"]},{"source":"Wikipedia","ids":["Tiagabine#Pharmacology"],"urls":["https://www.wikipedia.org/Tiagabine#Pharmacology"]}]}],"number_of_indications":7,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":5},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":4},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":2},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":2},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4298089","_score":1,"_source":{"id":"CHEMBL4298089","internal_compound":false,"type":"Antibody","pref_name":"CODRITUZUMAB","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Codrituzumab","GC-33","GC33","RO5137382","Ro5137382"],"trade_names":[],"indications":[{"efo_id":"EFO_0000182","efo_label":"hepatocellular carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000182","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01507168"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01507168%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201129","_score":1,"_source":{"id":"CHEMBL1201129","internal_compound":false,"type":"Small molecule","pref_name":"DECITABINE","year_first_approved":2006,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["DAC","Decitabine","NSC-127716"],"trade_names":["Dacogen","Decitabine"],"cross_references":[{"source":"ChEBI","ids":[50131]},{"source":"DailyMed","ids":["decitabine"]},{"source":"PubChem","ids":["144205864","170465126","47211573","56324652","57260149"]},{"source":"Wikipedia","ids":["Decitabine"]},{"source":"drugbank","ids":["DB01262"]}],"canonical_smiles":"Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1","indications":[{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00260832","NCT00358644","NCT00398983","NCT00414310","NCT00479232","NCT00492401","NCT00538876","NCT00671697","NCT00691938","NCT00703300","NCT00760084","NCT00778375","NCT00861874","NCT00866073","NCT00867672","NCT00882102","NCT00943553","NCT00968071","NCT00986804","NCT01001143","NCT01130662","NCT01149408","NCT01177540","NCT01277484","NCT01303796","NCT01352650","NCT01420926","NCT01455506","NCT01546038","NCT01633099","NCT01687400","NCT01690507","NCT01729845","NCT01758367","NCT01809392","NCT01829503","NCT01846624","NCT01853228","NCT01861314","NCT02003573","NCT02073838","NCT02088541","NCT02093403","NCT02109744","NCT02172872","NCT02203773","NCT02204085","NCT02252107","NCT02272478","NCT02316964","NCT02323607","NCT02343939","NCT02412475","NCT02472145","NCT02488408","NCT02532010","NCT02632721","NCT02634827","NCT02662647","NCT02785900","NCT02878785","NCT02886559","NCT02921061","NCT02954653","NCT02985372","NCT02996474","NCT03009240","NCT03013998","NCT03021395","NCT03041688","NCT03063203","NCT03063944","NCT03080766","NCT03092674","NCT03113071","NCT03132454","NCT03164057","NCT03256071","NCT03263936","NCT03303339","NCT03356080","NCT03381781","NCT03530085","NCT03679650","NCT03752138","NCT03793517","NCT03844815","NCT03926624","NCT03941964","NCT04051996","NCT04113616"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00260832%22OR%22NCT00358644%22OR%22NCT00398983%22OR%22NCT00414310%22OR%22NCT00479232%22OR%22NCT00492401%22OR%22NCT00538876%22OR%22NCT00671697%22OR%22NCT00691938%22OR%22NCT00703300%22OR%22NCT00760084%22OR%22NCT00778375%22OR%22NCT00861874%22OR%22NCT00866073%22OR%22NCT00867672%22OR%22NCT00882102%22OR%22NCT00943553%22OR%22NCT00968071%22OR%22NCT00986804%22OR%22NCT01001143%22OR%22NCT01130662%22OR%22NCT01149408%22OR%22NCT01177540%22OR%22NCT01277484%22OR%22NCT01303796%22OR%22NCT01352650%22OR%22NCT01420926%22OR%22NCT01455506%22OR%22NCT01546038%22OR%22NCT01633099%22OR%22NCT01687400%22OR%22NCT01690507%22OR%22NCT01729845%22OR%22NCT01758367%22OR%22NCT01809392%22OR%22NCT01829503%22OR%22NCT01846624%22OR%22NCT01853228%22OR%22NCT01861314%22OR%22NCT02003573%22OR%22NCT02073838%22OR%22NCT02088541%22OR%22NCT02093403%22OR%22NCT02109744%22OR%22NCT02172872%22OR%22NCT02203773%22OR%22NCT02204085%22OR%22NCT02252107%22OR%22NCT02272478%22OR%22NCT02316964%22OR%22NCT02323607%22OR%22NCT02343939%22OR%22NCT02412475%22OR%22NCT02472145%22OR%22NCT02488408%22OR%22NCT02532010%22OR%22NCT02632721%22OR%22NCT02634827%22OR%22NCT02662647%22OR%22NCT02785900%22OR%22NCT02878785%22OR%22NCT02886559%22OR%22NCT02921061%22OR%22NCT02954653%22OR%22NCT02985372%22OR%22NCT02996474%22OR%22NCT03009240%22OR%22NCT03013998%22OR%22NCT03021395%22OR%22NCT03041688%22OR%22NCT03063203%22OR%22NCT03063944%22OR%22NCT03080766%22OR%22NCT03092674%22OR%22NCT03113071%22OR%22NCT03132454%22OR%22NCT03164057%22OR%22NCT03256071%22OR%22NCT03263936%22OR%22NCT03303339%22OR%22NCT03356080%22OR%22NCT03381781%22OR%22NCT03530085%22OR%22NCT03679650%22OR%22NCT03752138%22OR%22NCT03793517%22OR%22NCT03844815%22OR%22NCT03926624%22OR%22NCT03941964%22OR%22NCT04051996%22OR%22NCT04113616%22"]}]},{"efo_id":"EFO_0000198","efo_label":"myelodysplastic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000198","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00002832","NCT00002980","NCT00003361","NCT00043381","NCT00260065","NCT00282399","NCT00382200","NCT00414310","NCT00479232","NCT00619099","NCT00621023","NCT00671697","NCT00691938","NCT00744757","NCT00760084","NCT00778375","NCT00828802","NCT00882102","NCT00903760","NCT00941109","NCT00968071","NCT00986804","NCT01277484","NCT01333449","NCT01417767","NCT01455506","NCT01593670","NCT01687400","NCT01690507","NCT01729845","NCT01751867","NCT01809392","NCT01993641","NCT02214407","NCT02272478","NCT02488408","NCT02744742","NCT02850822","NCT02921061","NCT03045510","NCT03092674","NCT03113071","NCT03164057","NCT03184935","NCT03356080","NCT03377725"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002832%22OR%22NCT00002980%22OR%22NCT00003361%22OR%22NCT00043381%22OR%22NCT00260065%22OR%22NCT00282399%22OR%22NCT00382200%22OR%22NCT00414310%22OR%22NCT00479232%22OR%22NCT00619099%22OR%22NCT00621023%22OR%22NCT00671697%22OR%22NCT00691938%22OR%22NCT00744757%22OR%22NCT00760084%22OR%22NCT00778375%22OR%22NCT00828802%22OR%22NCT00882102%22OR%22NCT00903760%22OR%22NCT00941109%22OR%22NCT00968071%22OR%22NCT00986804%22OR%22NCT01277484%22OR%22NCT01333449%22OR%22NCT01417767%22OR%22NCT01455506%22OR%22NCT01593670%22OR%22NCT01687400%22OR%22NCT01690507%22OR%22NCT01729845%22OR%22NCT01751867%22OR%22NCT01809392%22OR%22NCT01993641%22OR%22NCT02214407%22OR%22NCT02272478%22OR%22NCT02488408%22OR%22NCT02744742%22OR%22NCT02850822%22OR%22NCT02921061%22OR%22NCT03045510%22OR%22NCT03092674%22OR%22NCT03113071%22OR%22NCT03164057%22OR%22NCT03184935%22OR%22NCT03356080%22OR%22NCT03377725%22"]},{"source":"DailyMed","ids":["0b9599e8-9018-42ee-b247-e2a944c36510","358764ca-4c69-d516-af0c-bf8a348d26ca","4e1f4eb4-19b2-eee8-3402-bd2ccf622791","99cea19b-cabf-8a6d-b2ef-f04920952b93","acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2","c155d6ba-9a16-406c-919e-65a149689ab9","deb4a13c-855b-4372-9778-6e81da598df6"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0b9599e8-9018-42ee-b247-e2a944c36510","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?358764ca-4c69-d516-af0c-bf8a348d26ca","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4e1f4eb4-19b2-eee8-3402-bd2ccf622791","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?99cea19b-cabf-8a6d-b2ef-f04920952b93","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c155d6ba-9a16-406c-919e-65a149689ab9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?deb4a13c-855b-4372-9778-6e81da598df6"]}]},{"efo_id":"EFO_0000565","efo_label":"leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000565","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002831","NCT00002832","NCT00002980","NCT00003361","NCT00882206","NCT01041703","NCT01378416","NCT01498445","NCT01515527","NCT01720225","NCT01786343","NCT01794702","NCT01893320","NCT02010645","NCT02141477","NCT02188706","NCT02234037","NCT02269280","NCT02441803","NCT02469415","NCT03417427","NCT03596892","NCT03799224"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002831%22OR%22NCT00002832%22OR%22NCT00002980%22OR%22NCT00003361%22OR%22NCT00882206%22OR%22NCT01041703%22OR%22NCT01378416%22OR%22NCT01498445%22OR%22NCT01515527%22OR%22NCT01720225%22OR%22NCT01786343%22OR%22NCT01794702%22OR%22NCT01893320%22OR%22NCT02010645%22OR%22NCT02141477%22OR%22NCT02188706%22OR%22NCT02234037%22OR%22NCT02269280%22OR%22NCT02441803%22OR%22NCT02469415%22OR%22NCT03417427%22OR%22NCT03596892%22OR%22NCT03799224%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["L01BC08"],"urls":["https://www.whocc.no/atc_ddd_index/?code=L01BC08"]},{"source":"ClinicalTrials","ids":["NCT00701298","NCT03875287"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00701298%22OR%22NCT03875287%22"]}]},{"efo_id":"EFO_0000220","efo_label":"acute lymphoblastic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000220","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00042796","NCT00349596","NCT01483690","NCT03132454"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00042796%22OR%22NCT00349596%22OR%22NCT01483690%22OR%22NCT03132454%22"]}]},{"efo_id":"EFO_0001075","efo_label":"ovarian carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001075","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00477386","NCT00748527","NCT02159820","NCT03467178"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00477386%22OR%22NCT00748527%22OR%22NCT02159820%22OR%22NCT03467178%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00002980","NCT00882206","NCT01799083","NCT03346642","NCT03445858"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002980%22OR%22NCT00882206%22OR%22NCT01799083%22OR%22NCT03346642%22OR%22NCT03445858%22"]}]},{"efo_id":"EFO_0001642","efo_label":"lymphoid neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001642","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00089089"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00089089%22"]}]},{"efo_id":"HP_0001873","efo_label":"Thrombocytopenia","efo_uri":"http://purl.obolibrary.org/obo/HP_0001873","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02487563"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02487563%22"]}]},{"efo_id":"EFO_0007160","efo_label":"autoimmune thrombocytopenic purpura","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007160","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01568333","NCT03252457"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01568333%22OR%22NCT03252457%22"]}]},{"efo_id":"EFO_1001779","efo_label":"chronic myelomonocytic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001779","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT01098084","NCT01251627"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01098084%22OR%22NCT01251627%22"]},{"source":"DailyMed","ids":["0b9599e8-9018-42ee-b247-e2a944c36510","358764ca-4c69-d516-af0c-bf8a348d26ca","4e1f4eb4-19b2-eee8-3402-bd2ccf622791","99cea19b-cabf-8a6d-b2ef-f04920952b93","acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2","c155d6ba-9a16-406c-919e-65a149689ab9","deb4a13c-855b-4372-9778-6e81da598df6"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0b9599e8-9018-42ee-b247-e2a944c36510","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?358764ca-4c69-d516-af0c-bf8a348d26ca","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4e1f4eb4-19b2-eee8-3402-bd2ccf622791","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?99cea19b-cabf-8a6d-b2ef-f04920952b93","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c155d6ba-9a16-406c-919e-65a149689ab9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?deb4a13c-855b-4372-9778-6e81da598df6"]}]},{"efo_id":"EFO_0003811","efo_label":"refractory anemia with excess blasts","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003811","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["0b9599e8-9018-42ee-b247-e2a944c36510","358764ca-4c69-d516-af0c-bf8a348d26ca","4e1f4eb4-19b2-eee8-3402-bd2ccf622791","99cea19b-cabf-8a6d-b2ef-f04920952b93","acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2","c155d6ba-9a16-406c-919e-65a149689ab9","deb4a13c-855b-4372-9778-6e81da598df6"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0b9599e8-9018-42ee-b247-e2a944c36510","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?358764ca-4c69-d516-af0c-bf8a348d26ca","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4e1f4eb4-19b2-eee8-3402-bd2ccf622791","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?99cea19b-cabf-8a6d-b2ef-f04920952b93","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c155d6ba-9a16-406c-919e-65a149689ab9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?deb4a13c-855b-4372-9778-6e81da598df6"]}]},{"efo_id":"EFO_0000096","efo_label":"neoplasm of mature B-cells","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000096","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT02846935"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02846935%22"]}]},{"efo_id":"EFO_0000183","efo_label":"Hodgkins lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000183","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03250962"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03250962%22"]}]},{"efo_id":"EFO_0000224","efo_label":"acute promyelocytic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000224","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00042796","NCT01130506"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00042796%22OR%22NCT01130506%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01194908","NCT03282825"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01194908%22OR%22NCT03282825%22"]}]},{"efo_id":"EFO_0000309","efo_label":"Burkitts lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000309","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00109824"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00109824%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00886457","NCT02499861","NCT02961101"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00886457%22OR%22NCT02499861%22OR%22NCT02961101%22"]}]},{"efo_id":"EFO_0000339","efo_label":"chronic myelogenous leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000339","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00041990","NCT00042003","NCT00042016","NCT00054431"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00041990%22OR%22NCT00042003%22OR%22NCT00042016%22OR%22NCT00054431%22"]}]},{"efo_id":"EFO_0000403","efo_label":"diffuse large B-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000403","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00109824","NCT02951728","NCT04025593"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00109824%22OR%22NCT02951728%22OR%22NCT04025593%22"]}]},{"efo_id":"EFO_0000501","efo_label":"follicular thyroid carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000501","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00085293"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00085293%22"]}]},{"efo_id":"EFO_0000621","efo_label":"neuroblastoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000621","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00075634"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00075634%22"]}]},{"efo_id":"EFO_0000641","efo_label":"papillary thyroid carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000641","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00085293"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00085293%22"]}]},{"efo_id":"EFO_0000681","efo_label":"renal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000681","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00561912"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00561912%22"]}]},{"efo_id":"EFO_0000756","efo_label":"melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000756","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00715793","NCT00791271","NCT02605473"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00715793%22OR%22NCT00791271%22OR%22NCT02605473%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00002980"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002980%22"]}]},{"efo_id":"EFO_0002617","efo_label":"metastatic melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002617","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00925132","NCT01876641"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00925132%22OR%22NCT01876641%22"]}]},{"efo_id":"EFO_0002913","efo_label":"Cutaneous T-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002913","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03240211"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03240211%22"]}]},{"efo_id":"EFO_0002939","efo_label":"medulloblastoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002939","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02332889"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02332889%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00084981","NCT01628471","NCT02664181","NCT03233724"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00084981%22OR%22NCT01628471%22OR%22NCT02664181%22OR%22NCT03233724%22"]}]},{"efo_id":"EFO_0003869","efo_label":"breast neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003869","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01194908","NCT03295552"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01194908%22OR%22NCT03295552%22"]}]},{"efo_id":"EFO_0004251","efo_label":"myeloproliferative disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004251","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02076191"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02076191%22"]}]},{"efo_id":"EFO_0005952","efo_label":"non-Hodgkins lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005952","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02846935","NCT03535753"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02846935%22OR%22NCT03535753%22"]}]},{"efo_id":"EFO_1001469","efo_label":"Mantle cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001469","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00109824"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00109824%22"]}]},{"efo_id":"EFO_1001830","efo_label":"precursor T-cell lymphoblastic leukemia-lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001830","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01483690"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01483690%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00879385"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00879385%22"]}]},{"efo_id":"EFO_1001996","efo_label":"Thalassemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001996","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00661726"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00661726%22"]}]},{"efo_id":"Orphanet_232","efo_label":"Sickle cell anemia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_232","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01685515"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01685515%22"]}]},{"efo_id":"EFO_0000196","efo_label":"metastatic prostate cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000196","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03709550"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03709550%22"]}]},{"efo_id":"EFO_0000211","efo_label":"unspecified peripheral T-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000211","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03553537"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03553537%22"]}]},{"efo_id":"EFO_1000251","efo_label":"Fallopian Tube Carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000251","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00748527"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00748527%22"]}]},{"efo_id":"EFO_1001100","efo_label":"peritoneal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001100","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00748527"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00748527%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000119772","approved_name":"DNA methyltransferase 3 alpha","approved_symbol":"DNMT3A"}],"target_type":"single protein","target_name":"DNA (cytosine-5)-methyltransferase 3A","action_type":"inhibitor","description":"DNA (cytosine-5)-methyltransferase 3A inhibitor","references":[{"source":"DailyMed","ids":["setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13"]},{"source":"Wikipedia","ids":["DNA_methylation"],"urls":["https://www.wikipedia.org/DNA_methylation"]}]},{"target_components":[{"ensembl":"ENSG00000130816","approved_name":"DNA methyltransferase 1","approved_symbol":"DNMT1"}],"target_type":"single protein","target_name":"DNA (cytosine-5)-methyltransferase 1","action_type":"inhibitor","description":"DNA (cytosine-5)-methyltransferase 1 inhibitor","references":[{"source":"DailyMed","ids":["setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13"]},{"source":"Wikipedia","ids":["DNA_methylation"],"urls":["https://www.wikipedia.org/DNA_methylation"]}]}],"adverse_events":{"significant":[{"event":"febrile neutropenia","count":19204,"llr":380.6813515},{"event":"bone marrow failure","count":8717,"llr":203.716469},{"event":"haematotoxicity","count":2676,"llr":126.4162618},{"event":"acute myeloid leukaemia","count":3032,"llr":76.62217084},{"event":"chronic graft versus host disease","count":1026,"llr":55.9607271},{"event":"thrombocytopenia","count":35327,"llr":52.95241009},{"event":"pancytopenia","count":17598,"llr":49.45534015},{"event":"chimerism","count":24,"llr":48.26585942},{"event":"lung infection","count":5755,"llr":44.15316463},{"event":"colitis","count":8859,"llr":38.90120406},{"event":"pyrexia","count":87334,"llr":36.52251537},{"event":"systemic inflammatory response syndrome","count":1392,"llr":35.88475772},{"event":"lichenification","count":134,"llr":34.53982895},{"event":"neutropenia","count":41585,"llr":33.12088089},{"event":"sepsis","count":19258,"llr":32.84153128},{"event":"extravasation","count":1902,"llr":31.66327581},{"event":"bacterial infection","count":3360,"llr":29.57732411},{"event":"myelodysplastic syndrome","count":4118,"llr":29.16451695},{"event":"escherichia bacteraemia","count":521,"llr":27.80860111},{"event":"acute myeloid leukaemia recurrent","count":175,"llr":27.43288544},{"event":"infection","count":26803,"llr":25.27199002},{"event":"organising pneumonia","count":1476,"llr":24.99586097},{"event":"pneumonia","count":65209,"llr":24.75694841},{"event":"white blood cell count decreased","count":28818,"llr":21.89290131},{"event":"neutrophil count decreased","count":11062,"llr":21.48104897},{"event":"headache","count":120638,"llr":21.2327602},{"event":"pneumonia fungal","count":489,"llr":20.33201766},{"event":"cardiomyopathy","count":4877,"llr":19.34904516},{"event":"platelet count decreased","count":29394,"llr":17.36275804},{"event":"hypophosphataemia","count":2382,"llr":17.2848938},{"event":"neutropenic colitis","count":437,"llr":17.17981188},{"event":"mucosal inflammation","count":9134,"llr":17.08336279},{"event":"refractory cytopenia with unilineage dysplasia","count":93,"llr":15.9589223},{"event":"failure to thrive","count":1438,"llr":15.93694505},{"event":"cardiac failure","count":15275,"llr":15.9296723},{"event":"proctalgia","count":1441,"llr":15.92115265},{"event":"culture wound positive","count":132,"llr":14.56959002}],"critval":14.56508821},"number_of_indications":42,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":38},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":23},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":21},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":13},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":8},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":6},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":6},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":6},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":5},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":3},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":3},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108660","_score":1,"_source":{"id":"CHEMBL2108660","internal_compound":false,"type":"Antibody","pref_name":"TUCOTUZUMAB CELMOLEUKIN","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["EMD-273066","HUKS-IL2","KSA-Interleukin-2","Tucotuzumab celmoleukin"],"trade_names":[],"indications":[{"efo_id":"EFO_0001075","efo_label":"ovarian carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001075","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00408967"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00408967%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000119888","approved_name":"epithelial cell adhesion molecule","approved_symbol":"EPCAM"}],"target_type":"single protein","target_name":"Epithelial cell adhesion molecule","action_type":"other","description":"Epithelial cell adhesion molecule other","references":[{"source":"PubMed","ids":["23320927"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23320927"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297948","_score":1,"_source":{"id":"CHEMBL4297948","internal_compound":false,"type":"Unknown","pref_name":"ERY-974","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["ERY-974","ERY974","Ery-974","Ery974"],"trade_names":[],"indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02748837"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02748837%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4093031","_score":1,"_source":{"id":"CHEMBL4093031","internal_compound":false,"type":"Small molecule","pref_name":"BMS-929075","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Bms-929075"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB14950"]}],"canonical_smiles":"CNC(=O)c1c(-c2ccc(F)cc2)oc2ccc(-c3cc(C(=O)NC4(c5ncccn5)CC4)ccc3C)c(F)c12","indications":[{"efo_id":"EFO_0004220","efo_label":"chronic hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004220","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01525212"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01525212%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297538","_score":1,"_source":{"id":"CHEMBL4297538","internal_compound":false,"type":"Small molecule","pref_name":"MK-0812","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Mk-0812","Mk0812"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB11990"]}],"canonical_smiles":"CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](CN2CCc3ncc(C(F)(F)F)cc3C2)(C(C)C)C1","indications":[{"efo_id":"EFO_0003929","efo_label":"relapsing-remitting multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003929","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00239655"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00239655%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2178570","_score":1,"_source":{"id":"CHEMBL2178570","internal_compound":false,"type":"Small molecule","pref_name":"AZD4818","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AZD-4818","Azd 4818"],"trade_names":[],"canonical_smiles":"CC(=O)Nc1ccc(O)cc1OC[C@@](C)(O)CNC1CCN(Cc2ccc(Cl)cc2)CC1","indications":[{"efo_id":"EFO_0000341","efo_label":"chronic obstructive pulmonary disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000341","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00629239"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00629239%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000163823","approved_name":"C-C motif chemokine receptor 1","approved_symbol":"CCR1"}],"target_type":"single protein","target_name":"C-C chemokine receptor type 1","action_type":"antagonist","description":"C-C chemokine receptor type 1 antagonist","references":[{"source":"PubMed","ids":["20466530"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20466530"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2107909","_score":1,"_source":{"id":"CHEMBL2107909","internal_compound":false,"type":"Unknown","pref_name":"RABIES VACCINE","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Rabies Vaccine"],"trade_names":[],"indications":[{"efo_id":"EFO_0001068","efo_label":"malaria","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001068","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00308061","NCT00380393","NCT00703066","NCT00866619","NCT01148459","NCT01635647","NCT01658696","NCT01666925","NCT03276962"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00308061%22OR%22NCT00380393%22OR%22NCT00703066%22OR%22NCT00866619%22OR%22NCT01148459%22OR%22NCT01635647%22OR%22NCT01658696%22OR%22NCT01666925%22OR%22NCT03276962%22"]}]},{"efo_id":"EFO_0000544","efo_label":"infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000544","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02177032"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02177032%22"]}]},{"efo_id":"EFO_0007444","efo_label":"Plasmodium falciparum malaria","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007444","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00317473","NCT00349713","NCT00358332","NCT00460525","NCT03435874","NCT03896724"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00317473%22OR%22NCT00349713%22OR%22NCT00358332%22OR%22NCT00460525%22OR%22NCT03435874%22OR%22NCT03896724%22"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00031070"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00031070%22"]}]}],"adverse_events":{"significant":[{"event":"laryngeal oedema","count":2237,"llr":15.59870615},{"event":"urticaria","count":39524,"llr":10.74622434},{"event":"angioedema","count":18080,"llr":9.36695953}],"critval":7.774074261},"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":3},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1200376","_score":1,"_source":{"id":"CHEMBL1200376","internal_compound":false,"type":"Small molecule","pref_name":"BETAMETHASONE BENZOATE","year_first_approved":1982,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Betamethasone Benzoate","W-5975"],"trade_names":["Uticort"],"canonical_smiles":"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccccc1)C(=O)CO","indications":[{"efo_id":"HP_0001742","efo_label":"Nasal obstruction","efo_uri":"http://purl.obolibrary.org/obo/HP_0001742","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["R01AD06"],"urls":["https://www.whocc.no/atc_ddd_index/?code=R01AD06"]}]},{"efo_id":"HP_0006536","efo_label":"Obstructive lung disease","efo_uri":"http://purl.obolibrary.org/obo/HP_0006536","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["R03BA04"],"urls":["https://www.whocc.no/atc_ddd_index/?code=R03BA04"]}]},{"efo_id":"EFO_0005752","efo_label":"eye inflammation","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005752","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["S01BA06","S01CB04"],"urls":["https://www.whocc.no/atc_ddd_index/?code=S01BA06","https://www.whocc.no/atc_ddd_index/?code=S01CB04"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000113580","approved_name":"nuclear receptor subfamily 3 group C member 1","approved_symbol":"NR3C1"}],"target_type":"single protein","target_name":"Glucocorticoid receptor","action_type":"agonist","description":"Glucocorticoid receptor agonist","references":[{"source":"PubMed","ids":["12188035","15336699","15866114"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12188035+OR+EXT_ID%3A15336699+OR+EXT_ID%3A15866114"]}]}],"adverse_events":{"significant":[{"event":"toxic anterior segment syndrome","count":602,"llr":20.98765778}],"critval":11.10957907},"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":3}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL604710","_score":1,"_source":{"id":"CHEMBL604710","internal_compound":false,"type":"Small molecule","pref_name":"Z160","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["MK-6721","NMED-160","NP-118809","Z-160"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12743"]}],"canonical_smiles":"O=C(CC(c1ccccc1)c1ccccc1)N1CCN(C(c2ccccc2)c2ccccc2)CC1","mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000148408","approved_name":"calcium voltage-gated channel subunit alpha1 B","approved_symbol":"CACNA1B"}],"target_type":"single protein","target_name":"Voltage-gated N-type calcium channel alpha-1B subunit","action_type":"blocker","description":"Voltage-gated N-type calcium channel alpha-1B subunit blocker","references":[{"source":"PubMed","ids":["19815411"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19815411"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL710","_score":1,"_source":{"id":"CHEMBL710","internal_compound":false,"type":"Small molecule","pref_name":"FINASTERIDE","year_first_approved":1992,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["Finasteride","MK-906"],"trade_names":["Aindeem","Finasteride","Propecia","Proscar","Prostide"],"cross_references":[{"source":"ChEBI","ids":[5062]},{"source":"DailyMed","ids":["finasteride"]},{"source":"PubChem","ids":["144204268","144208704","144213061","170464818","26719811","26753508","26753509","49666458"]},{"source":"Wikipedia","ids":["Finasteride"]},{"source":"drugbank","ids":["DB01216"]}],"canonical_smiles":"CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C","indications":[{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02055170"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02055170%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00736645"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00736645%22"]},{"source":"DailyMed","ids":["1c1bf77c-f99a-44e4-b71e-ce766afa99b6","278e7dd6-7f56-479c-87d1-5a6f1a596010","32266029-c710-44dd-943f-7e31d0afa622","77589cc3-c440-4695-800c-82a0e5128a6c","7c01f541-1c88-400c-41a9-7cbb9dee50c0","8330011c-7e20-4a1c-954f-b98bb0ad78b7","9cb6a9f1-f7a6-46be-9b2b-8f228c821b4d","a4dd6d6c-c8c7-16a9-aa68-aa46283dfae1","ac8ecb07-237a-eac2-e613-e5fe8e3429c7","adfb8f6b-a7bb-4ac2-b2aa-fec6d56630ad","be37d74f-2c78-41bc-8a17-cd53d1a92d2e","c8ed59a3-c5b2-3156-b781-5e514b79011b","d089b70b-7961-488a-8f65-83038e169983","db499a51-42f2-40bd-afe6-b2a715e723be","e9ea2f77-11c3-4dbf-bdc4-d1b0e7437990"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1c1bf77c-f99a-44e4-b71e-ce766afa99b6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?278e7dd6-7f56-479c-87d1-5a6f1a596010","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?32266029-c710-44dd-943f-7e31d0afa622","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?77589cc3-c440-4695-800c-82a0e5128a6c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7c01f541-1c88-400c-41a9-7cbb9dee50c0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8330011c-7e20-4a1c-954f-b98bb0ad78b7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9cb6a9f1-f7a6-46be-9b2b-8f228c821b4d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a4dd6d6c-c8c7-16a9-aa68-aa46283dfae1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ac8ecb07-237a-eac2-e613-e5fe8e3429c7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?adfb8f6b-a7bb-4ac2-b2aa-fec6d56630ad","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?be37d74f-2c78-41bc-8a17-cd53d1a92d2e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c8ed59a3-c5b2-3156-b781-5e514b79011b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d089b70b-7961-488a-8f65-83038e169983","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?db499a51-42f2-40bd-afe6-b2a715e723be","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e9ea2f77-11c3-4dbf-bdc4-d1b0e7437990"]},{"source":"FDA","ids":["220cd180-8a71-4530-b8ca-8864bee9caa0","23aa3ad8-93f9-4cbb-9979-e0c38b7f7c84","44620606-85cc-4ec9-892d-4730341cb824","4da84c09-c022-499f-9446-7a7f3c898839","63ed2cec-c677-45bd-a802-64a9ec54046f","bfb5d609-f9e7-4dac-aa7e-6dbb27b4a510","c663d1f3-32e3-464b-b299-a377a1296e02","f149569c-05d1-4dba-b35a-4ed6a633f776","fde9c9e4-5275-4aa5-8f56-56037b3db0c7"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A220cd180-8a71-4530-b8ca-8864bee9caa0","https://api.fda.gov/drug/label.json?search=set_id%3A23aa3ad8-93f9-4cbb-9979-e0c38b7f7c84","https://api.fda.gov/drug/label.json?search=set_id%3A44620606-85cc-4ec9-892d-4730341cb824","https://api.fda.gov/drug/label.json?search=set_id%3A4da84c09-c022-499f-9446-7a7f3c898839","https://api.fda.gov/drug/label.json?search=set_id%3A63ed2cec-c677-45bd-a802-64a9ec54046f","https://api.fda.gov/drug/label.json?search=set_id%3Abfb5d609-f9e7-4dac-aa7e-6dbb27b4a510","https://api.fda.gov/drug/label.json?search=set_id%3Ac663d1f3-32e3-464b-b299-a377a1296e02","https://api.fda.gov/drug/label.json?search=set_id%3Af149569c-05d1-4dba-b35a-4ed6a633f776","https://api.fda.gov/drug/label.json?search=set_id%3Afde9c9e4-5275-4aa5-8f56-56037b3db0c7"]}]},{"efo_id":"EFO_0000284","efo_label":"benign prostatic hyperplasia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000284","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["G04CB01"],"urls":["https://www.whocc.no/atc_ddd_index/?code=G04CB01"]},{"source":"ClinicalTrials","ids":["NCT00021814","NCT00064649","NCT00127179","NCT00564460","NCT00759135","NCT01139762","NCT01534351","NCT01829893"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00021814%22OR%22NCT00064649%22OR%22NCT00127179%22OR%22NCT00564460%22OR%22NCT00759135%22OR%22NCT01139762%22OR%22NCT01534351%22OR%22NCT01829893%22"]},{"source":"DailyMed","ids":["0c3b40ab-0dd9-4e1c-a8bc-bf2b36066314","1c1bf77c-f99a-44e4-b71e-ce766afa99b6","278e7dd6-7f56-479c-87d1-5a6f1a596010","32266029-c710-44dd-943f-7e31d0afa622","344a2e9e-24fa-4550-863e-ff56df0bf15c","77589cc3-c440-4695-800c-82a0e5128a6c","7813e1fc-0081-0e69-136e-a7c7dc4ed589","7c01f541-1c88-400c-41a9-7cbb9dee50c0","8330011c-7e20-4a1c-954f-b98bb0ad78b7","9783a5b0-c856-4cbd-8536-53bd805c3a63","9cb6a9f1-f7a6-46be-9b2b-8f228c821b4d","a4dd6d6c-c8c7-16a9-aa68-aa46283dfae1","ac8ecb07-237a-eac2-e613-e5fe8e3429c7","adfb8f6b-a7bb-4ac2-b2aa-fec6d56630ad","be37d74f-2c78-41bc-8a17-cd53d1a92d2e","be68c512-7985-47fa-a64b-6bac80bd9751","c59f8018-fff8-4884-a3c8-bc306e2c8f64","c8ed59a3-c5b2-3156-b781-5e514b79011b","cc9709ce-2d29-48bd-b46b-3f72114f2527","d089b70b-7961-488a-8f65-83038e169983","db499a51-42f2-40bd-afe6-b2a715e723be","e3469758-5111-4c30-a7fc-12444e914515","e9ea2f77-11c3-4dbf-bdc4-d1b0e7437990"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0c3b40ab-0dd9-4e1c-a8bc-bf2b36066314","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1c1bf77c-f99a-44e4-b71e-ce766afa99b6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?278e7dd6-7f56-479c-87d1-5a6f1a596010","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?32266029-c710-44dd-943f-7e31d0afa622","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?344a2e9e-24fa-4550-863e-ff56df0bf15c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?77589cc3-c440-4695-800c-82a0e5128a6c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7813e1fc-0081-0e69-136e-a7c7dc4ed589","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7c01f541-1c88-400c-41a9-7cbb9dee50c0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8330011c-7e20-4a1c-954f-b98bb0ad78b7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9783a5b0-c856-4cbd-8536-53bd805c3a63","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9cb6a9f1-f7a6-46be-9b2b-8f228c821b4d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a4dd6d6c-c8c7-16a9-aa68-aa46283dfae1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ac8ecb07-237a-eac2-e613-e5fe8e3429c7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?adfb8f6b-a7bb-4ac2-b2aa-fec6d56630ad","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?be37d74f-2c78-41bc-8a17-cd53d1a92d2e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?be68c512-7985-47fa-a64b-6bac80bd9751","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c59f8018-fff8-4884-a3c8-bc306e2c8f64","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c8ed59a3-c5b2-3156-b781-5e514b79011b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cc9709ce-2d29-48bd-b46b-3f72114f2527","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d089b70b-7961-488a-8f65-83038e169983","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?db499a51-42f2-40bd-afe6-b2a715e723be","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e3469758-5111-4c30-a7fc-12444e914515","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e9ea2f77-11c3-4dbf-bdc4-d1b0e7437990"]},{"source":"FDA","ids":["0e47fe83-9650-4643-803d-0592fec4defa","1cfbda56-d700-4049-8a51-e24af8a622c4","220cd180-8a71-4530-b8ca-8864bee9caa0","23aa3ad8-93f9-4cbb-9979-e0c38b7f7c84","44620606-85cc-4ec9-892d-4730341cb824","4c303c07-ddee-43bf-a277-d40e7ef724c5","4da84c09-c022-499f-9446-7a7f3c898839","5e2ea873-f8a4-4b19-b79f-93f957114352","63ed2cec-c677-45bd-a802-64a9ec54046f","87b26764-074f-40f2-8d4b-446c03bf4d68","bfb5d609-f9e7-4dac-aa7e-6dbb27b4a510","c663d1f3-32e3-464b-b299-a377a1296e02","c9a3cb34-9a8e-4538-ab90-32e08d8acc3a","f149569c-05d1-4dba-b35a-4ed6a633f776","fde9c9e4-5275-4aa5-8f56-56037b3db0c7"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A0e47fe83-9650-4643-803d-0592fec4defa","https://api.fda.gov/drug/label.json?search=set_id%3A1cfbda56-d700-4049-8a51-e24af8a622c4","https://api.fda.gov/drug/label.json?search=set_id%3A220cd180-8a71-4530-b8ca-8864bee9caa0","https://api.fda.gov/drug/label.json?search=set_id%3A23aa3ad8-93f9-4cbb-9979-e0c38b7f7c84","https://api.fda.gov/drug/label.json?search=set_id%3A44620606-85cc-4ec9-892d-4730341cb824","https://api.fda.gov/drug/label.json?search=set_id%3A4c303c07-ddee-43bf-a277-d40e7ef724c5","https://api.fda.gov/drug/label.json?search=set_id%3A4da84c09-c022-499f-9446-7a7f3c898839","https://api.fda.gov/drug/label.json?search=set_id%3A5e2ea873-f8a4-4b19-b79f-93f957114352","https://api.fda.gov/drug/label.json?search=set_id%3A63ed2cec-c677-45bd-a802-64a9ec54046f","https://api.fda.gov/drug/label.json?search=set_id%3A87b26764-074f-40f2-8d4b-446c03bf4d68","https://api.fda.gov/drug/label.json?search=set_id%3Abfb5d609-f9e7-4dac-aa7e-6dbb27b4a510","https://api.fda.gov/drug/label.json?search=set_id%3Ac663d1f3-32e3-464b-b299-a377a1296e02","https://api.fda.gov/drug/label.json?search=set_id%3Ac9a3cb34-9a8e-4538-ab90-32e08d8acc3a","https://api.fda.gov/drug/label.json?search=set_id%3Af149569c-05d1-4dba-b35a-4ed6a633f776","https://api.fda.gov/drug/label.json?search=set_id%3Afde9c9e4-5275-4aa5-8f56-56037b3db0c7"]}]},{"efo_id":"EFO_0003839","efo_label":"retinopathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003839","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00837252","NCT01227993","NCT01585441"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00837252%22OR%22NCT01227993%22OR%22NCT01585441%22"]}]},{"efo_id":"EFO_0004191","efo_label":"androgenetic alopecia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004191","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00396175","NCT01052870","NCT01231607","NCT01391156","NCT02791243","NCT03004469"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00396175%22OR%22NCT01052870%22OR%22NCT01231607%22OR%22NCT01391156%22OR%22NCT02791243%22OR%22NCT03004469%22"]},{"source":"DailyMed","ids":["00e934bb-c15b-490a-a852-839689a1231a","01b88593-99d3-4dd6-a7b6-5438c15bd7b7","142b1561-4310-494e-8a82-662c12de2cd1","1a11f437-a2aa-4f2b-b368-d1075cf857a9","3444ec5f-cc70-488a-9462-61945ef77148","4e07adb4-7807-47d3-b9a9-2332a3047410","7d140366-2388-488e-bd86-67e6edf44345","81b424d3-8418-4497-9395-59eae6755230","8bb21853-dc5b-4991-bf9a-fafbe1e685fe","9acbe693-8448-b443-9f78-1f9972520798","9e7329eb-39f1-4f84-a0bb-91daffaba1c3","bf7e2ff0-8cd8-48a9-bbb8-94f1236f87c7","e3728709-e805-4b46-9954-2c433a865987","fa19372d-027d-a91b-f58e-1bdb8fd7e2b6"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?00e934bb-c15b-490a-a852-839689a1231a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?01b88593-99d3-4dd6-a7b6-5438c15bd7b7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?142b1561-4310-494e-8a82-662c12de2cd1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1a11f437-a2aa-4f2b-b368-d1075cf857a9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3444ec5f-cc70-488a-9462-61945ef77148","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4e07adb4-7807-47d3-b9a9-2332a3047410","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7d140366-2388-488e-bd86-67e6edf44345","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?81b424d3-8418-4497-9395-59eae6755230","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8bb21853-dc5b-4991-bf9a-fafbe1e685fe","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9acbe693-8448-b443-9f78-1f9972520798","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9e7329eb-39f1-4f84-a0bb-91daffaba1c3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bf7e2ff0-8cd8-48a9-bbb8-94f1236f87c7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e3728709-e805-4b46-9954-2c433a865987","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?fa19372d-027d-a91b-f58e-1bdb8fd7e2b6"]},{"source":"FDA","ids":["8c02066b-e2fe-4d84-8210-6ab77ee9fdbc","abd87058-923f-4767-986c-278201c0e688"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A8c02066b-e2fe-4d84-8210-6ab77ee9fdbc","https://api.fda.gov/drug/label.json?search=set_id%3Aabd87058-923f-4767-986c-278201c0e688"]}]},{"efo_id":"EFO_0000673","efo_label":"prostate adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000673","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00438464"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00438464%22"]}]},{"efo_id":"EFO_0003894","efo_label":"acne","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003894","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02502669"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02502669%22"]}]},{"efo_id":"Orphanet_79364","efo_label":"Alopecia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_79364","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT02781311"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02781311%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000277893","approved_name":"steroid 5 alpha-reductase 2","approved_symbol":"SRD5A2"}],"target_type":"single protein","target_name":"Steroid 5-alpha-reductase 2","action_type":"inhibitor","description":"Steroid 5-alpha-reductase 2 inhibitor","references":[{"source":"DailyMed","ids":["setid=c8ed59a3-c5b2-3156-b781-5e514b79011b"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c8ed59a3-c5b2-3156-b781-5e514b79011b"]}]}],"adverse_events":{"significant":[{"event":"erectile dysfunction","count":4685,"llr":4864.417492},{"event":"sexual dysfunction","count":2461,"llr":4677.966272},{"event":"libido decreased","count":2070,"llr":2212.379395},{"event":"cognitive disorder","count":9869,"llr":1677.163082},{"event":"loss of libido","count":1529,"llr":1589.723038},{"event":"depression","count":45027,"llr":1529.61662},{"event":"anxiety","count":45966,"llr":1225.208062},{"event":"ejaculation disorder","count":516,"llr":1199.247258},{"event":"semen volume decreased","count":242,"llr":1162.34816},{"event":"gynaecomastia","count":2425,"llr":1061.086913},{"event":"testicular pain","count":690,"llr":810.7058428},{"event":"ejaculation failure","count":397,"llr":769.859589},{"event":"hypogonadism","count":405,"llr":754.6690186},{"event":"blood testosterone decreased","count":1272,"llr":730.9365006},{"event":"penile size reduced","count":178,"llr":620.0304141},{"event":"organic erectile dysfunction","count":134,"llr":569.5828485},{"event":"testicular atrophy","count":159,"llr":416.621416},{"event":"penis injury","count":111,"llr":397.9681022},{"event":"hormone level abnormal","count":698,"llr":386.2925793},{"event":"testicular disorder","count":211,"llr":334.5977162},{"event":"peyronie's disease","count":213,"llr":328.0468037},{"event":"benign prostatic hyperplasia","count":1191,"llr":304.4448216},{"event":"brain injury","count":1133,"llr":295.3087496},{"event":"penis disorder","count":394,"llr":292.2892983},{"event":"prostatitis","count":990,"llr":283.7567899},{"event":"painful ejaculation","count":71,"llr":278.2108847},{"event":"genital hypoaesthesia","count":110,"llr":275.62187},{"event":"varicocele","count":76,"llr":274.8805816},{"event":"hypogonadism male","count":114,"llr":236.5097213},{"event":"suicidal ideation","count":21218,"llr":235.1300995},{"event":"testicular failure","count":55,"llr":222.4298963},{"event":"prostate cancer","count":3761,"llr":218.7823682},{"event":"hyperlipidaemia","count":5013,"llr":212.0223011},{"event":"nocturia","count":1917,"llr":201.0114712},{"event":"endocrine disorder","count":259,"llr":193.5715743},{"event":"male orgasmic disorder","count":87,"llr":192.1272493},{"event":"epididymal cyst","count":48,"llr":187.1611623},{"event":"insomnia","count":44658,"llr":183.0187634},{"event":"orgasm abnormal","count":155,"llr":182.1089045},{"event":"disturbance in attention","count":10609,"llr":172.6412837},{"event":"androgen deficiency","count":92,"llr":171.7697118},{"event":"semen analysis abnormal","count":37,"llr":168.2542102},{"event":"hair transplant","count":31,"llr":166.4155597},{"event":"emotional distress","count":5209,"llr":160.331587},{"event":"infertility male","count":182,"llr":159.4557135},{"event":"panic attack","count":6167,"llr":155.5922829},{"event":"anorgasmia","count":456,"llr":149.5223102},{"event":"dysuria","count":8090,"llr":144.2934809},{"event":"sperm concentration decreased","count":87,"llr":143.5029208},{"event":"premature ejaculation","count":103,"llr":138.6210122},{"event":"urine flow decreased","count":386,"llr":137.2589463},{"event":"muscle atrophy","count":2516,"llr":134.3345261},{"event":"epididymitis","count":382,"llr":128.2635091},{"event":"major depression","count":1649,"llr":125.456507},{"event":"genital disorder male","count":56,"llr":124.7608143},{"event":"sleep apnoea syndrome","count":4137,"llr":123.9281488},{"event":"orgasmic sensation decreased","count":60,"llr":123.1084647},{"event":"gastrooesophageal reflux disease","count":14790,"llr":120.525613},{"event":"pollakiuria","count":7029,"llr":119.3500293},{"event":"attention deficit/hyperactivity disorder","count":1098,"llr":114.0491377},{"event":"penile pain","count":615,"llr":111.7984776},{"event":"infertility","count":379,"llr":110.1041284},{"event":"breast cancer male","count":118,"llr":106.926754},{"event":"male genital atrophy","count":21,"llr":106.0128925},{"event":"azoospermia","count":222,"llr":101.5761862},{"event":"vasectomy","count":45,"llr":98.47183586},{"event":"hypercholesterolaemia","count":2955,"llr":98.00150905},{"event":"prostatomegaly","count":660,"llr":97.15926267},{"event":"breast enlargement","count":521,"llr":96.1518007},{"event":"stress","count":9267,"llr":96.08043143},{"event":"hydrocele","count":394,"llr":95.54475998},{"event":"melanocytic naevus","count":1171,"llr":93.29518391},{"event":"fatigue","count":147738,"llr":92.55892521},{"event":"tonsillectomy","count":451,"llr":91.81102576},{"event":"male sexual dysfunction","count":87,"llr":91.53300621},{"event":"reproductive tract disorder","count":106,"llr":87.59893353},{"event":"prostatic pain","count":59,"llr":87.45173534},{"event":"generalised anxiety disorder","count":355,"llr":85.07228458},{"event":"prostatic specific antigen increased","count":2393,"llr":83.22897167},{"event":"amnesia","count":13293,"llr":82.64561254},{"event":"disturbance in sexual arousal","count":187,"llr":81.15142878},{"event":"lower urinary tract symptoms","count":113,"llr":81.03729229},{"event":"back pain","count":46032,"llr":79.94217585},{"event":"spermatocele","count":22,"llr":78.28139312},{"event":"sleep disorder","count":11647,"llr":77.49378822},{"event":"penile curvature","count":37,"llr":77.12362622},{"event":"urinary retention","count":9378,"llr":76.06286429},{"event":"haematospermia","count":150,"llr":75.68782296},{"event":"knee operation","count":1335,"llr":75.20284115},{"event":"dihydrotestosterone decreased","count":12,"llr":72.51260271},{"event":"rhinitis allergic","count":1191,"llr":71.92970699},{"event":"perineal pain","count":150,"llr":70.73527224},{"event":"granulomatous rosacea","count":24,"llr":70.59649645},{"event":"apathy","count":2732,"llr":69.64729143},{"event":"hypertension","count":52519,"llr":68.94329875},{"event":"oligospermia","count":45,"llr":68.28277863},{"event":"haemorrhoids","count":4658,"llr":67.34817404},{"event":"secondary hypogonadism","count":104,"llr":66.82089524},{"event":"vitamin d deficiency","count":2136,"llr":66.61615804},{"event":"essential hypertension","count":714,"llr":64.24046353},{"event":"haematuria","count":11307,"llr":63.87953589},{"event":"self esteem decreased","count":351,"llr":63.86536527},{"event":"breast tenderness","count":1034,"llr":62.28084374},{"event":"orchitis","count":316,"llr":61.67540693},{"event":"breast mass","count":1449,"llr":59.99775657},{"event":"libido disorder","count":162,"llr":59.78018059},{"event":"seborrhoeic dermatitis","count":367,"llr":58.87706517},{"event":"anogenital warts","count":298,"llr":58.5079973},{"event":"genital atrophy","count":13,"llr":57.8031701},{"event":"back injury","count":1579,"llr":57.70503634},{"event":"hernia repair","count":583,"llr":57.61757224},{"event":"groin pain","count":2009,"llr":56.95492382},{"event":"acne","count":6076,"llr":56.61631691},{"event":"wisdom teeth removal","count":199,"llr":56.52110681},{"event":"anhedonia","count":1332,"llr":55.95555829},{"event":"nipple pain","count":359,"llr":55.2090361},{"event":"testicular cyst","count":35,"llr":53.75722501},{"event":"muscle strain","count":1837,"llr":53.69170304},{"event":"marital problem","count":129,"llr":53.61196541},{"event":"arterial insufficiency","count":59,"llr":53.44206217},{"event":"blood oestrogen increased","count":93,"llr":53.04761925},{"event":"soft tissue injury","count":187,"llr":52.95159453},{"event":"radical prostatectomy","count":38,"llr":52.85522558},{"event":"obesity","count":2349,"llr":52.55972043},{"event":"inguinal hernia","count":1398,"llr":51.71244007},{"event":"eczema","count":5580,"llr":51.27755866},{"event":"tinnitus","count":8558,"llr":50.74084915},{"event":"stress at work","count":219,"llr":50.61005866},{"event":"feeling abnormal","count":36538,"llr":50.14624431},{"event":"ejaculation delayed","count":120,"llr":49.75758324},{"event":"dark circles under eyes","count":187,"llr":48.46442133},{"event":"emotional poverty","count":187,"llr":48.46442133},{"event":"dermal cyst","count":530,"llr":48.34607709},{"event":"nasal septum deviation","count":426,"llr":48.33452822},{"event":"ligament sprain","count":1614,"llr":48.30851573},{"event":"psychosexual disorder","count":60,"llr":47.85009401},{"event":"blood cholesterol increased","count":8813,"llr":47.67292838},{"event":"scrotal pain","count":147,"llr":47.14291567},{"event":"semen viscosity decreased","count":10,"llr":46.5535731},{"event":"alopecia","count":25428,"llr":46.35923066},{"event":"lipoma","count":726,"llr":46.22826822},{"event":"soft tissue mass","count":109,"llr":46.11998532},{"event":"arthroscopy","count":222,"llr":46.09299522},{"event":"prostatic disorder","count":497,"llr":45.77586095}],"critval":45.46942235},"number_of_indications":8,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":4},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":3},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":3},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":3},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":3},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109298","_score":1,"_source":{"id":"CHEMBL2109298","internal_compound":false,"type":"Antibody","pref_name":"MEDI-3617","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["MEDI-3617"],"trade_names":[],"indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01248949"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01248949%22"]}]},{"efo_id":"EFO_0002617","efo_label":"metastatic melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002617","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02141542"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02141542%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000091879","approved_name":"angiopoietin 2","approved_symbol":"ANGPT2"}],"target_type":"single protein","target_name":"Angiopoietin-2","action_type":"inhibitor","description":"Angiopoietin-2 inhibitor","references":[{"source":"PubMed","ids":["22327175"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22327175"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545378","_score":1,"_source":{"id":"CHEMBL3545378","internal_compound":false,"type":"Small molecule","pref_name":"MK-6592","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["MK-6592","VX-667"],"trade_names":[],"canonical_smiles":"Cc1cc(Nc2cc(N3CC(F)(C4CC4)C3)nc(O[C@H]3CCN(C(=O)c4cc(Cl)ccc4F)C3)n2)n[nH]1","indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00359671"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00359671%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000178999","approved_name":"aurora kinase B","approved_symbol":"AURKB"},{"ensembl":"ENSG00000105146","approved_name":"aurora kinase C","approved_symbol":"AURKC"},{"ensembl":"ENSG00000087586","approved_name":"aurora kinase A","approved_symbol":"AURKA"}],"target_type":"protein family","target_name":"Serine/threonine-protein kinase Aurora","action_type":"inhibitor","description":"Serine/threonine-protein kinase Aurora inhibitor","references":[{"source":"Other","ids":["http://investors.vrtx.com/releasedetail.cfm?ReleaseID=276543"],"urls":["http://investors.vrtx.com/releasedetail.cfm?ReleaseID=276543"]},{"source":"PubMed","ids":["19684075"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19684075"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL809","_score":1,"_source":{"id":"CHEMBL809","internal_compound":false,"type":"Small molecule","pref_name":"SERTRALINE","year_first_approved":1991,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["CP-51974-1","CP-519741","Sertraline","Sertraline HCl"],"trade_names":["Aremis","Besitron","Lustral","Sertraline HCl","Zoloft"],"cross_references":[{"source":"ChEBI","ids":[9123]},{"source":"DailyMed","ids":["sertraline%20hydrochloride"]},{"source":"PubChem","ids":["26753299","29215139","49665783","50105682","50105683","50105684","50105685","90341218"]},{"source":"Wikipedia","ids":["Sertraline"]},{"source":"drugbank","ids":["DB01104"]},{"source":"ChEBI","ids":[9124]},{"source":"PubChem","ids":["144204750","170465121","26719805","26753298","26753614","49681568"]}],"canonical_smiles":"CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21","indications":[{"efo_id":"EFO_0000198","efo_label":"myelodysplastic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000198","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02452983"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02452983%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02891278"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02891278%22"]}]},{"efo_id":"EFO_0000289","efo_label":"bipolar disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000289","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00001483","NCT00158990","NCT00276965","NCT00581009","NCT00857584"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00001483%22OR%22NCT00158990%22OR%22NCT00276965%22OR%22NCT00581009%22OR%22NCT00857584%22"]}]},{"efo_id":"EFO_0000519","efo_label":"glioblastoma multiforme","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000519","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02770378"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02770378%22"]}]},{"efo_id":"EFO_0000546","efo_label":"injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000546","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00704379"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00704379%22"]}]},{"efo_id":"EFO_0000692","efo_label":"schizophrenia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000692","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02374567"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02374567%22"]}]},{"efo_id":"EFO_0001073","efo_label":"obesity","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001073","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01155531"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01155531%22"]}]},{"efo_id":"EFO_0001358","efo_label":"post-traumatic stress disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001358","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000446","NCT00078767","NCT00127673","NCT00133822","NCT00215241","NCT00262223","NCT03033069","NCT04124614"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000446%22OR%22NCT00078767%22OR%22NCT00127673%22OR%22NCT00133822%22OR%22NCT00215241%22OR%22NCT00262223%22OR%22NCT03033069%22OR%22NCT04124614%22"]}]},{"efo_id":"EFO_0002610","efo_label":"cocaine dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002610","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00015132"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00015132%22"]}]},{"efo_id":"EFO_0003047","efo_label":"hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003047","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02175602"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02175602%22"]}]},{"efo_id":"EFO_0003756","efo_label":"autism spectrum disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003756","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02385799"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02385799%22"]}]},{"efo_id":"EFO_0003758","efo_label":"autism","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003758","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00655174"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00655174%22"]}]},{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N06AB06"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N06AB06"]},{"source":"ClinicalTrials","ids":["NCT00001483","NCT00043550","NCT00056472","NCT00143091","NCT00158990","NCT00179257","NCT00179283","NCT00232167","NCT00232284","NCT00233103","NCT00275197","NCT00276900","NCT00276965","NCT00331305","NCT00351910","NCT00581009","NCT00612807","NCT00636246","NCT00742573","NCT00744406","NCT01033084","NCT01098318","NCT01250873","NCT01254305","NCT01360866","NCT01407094","NCT01703039","NCT02269540","NCT02374567","NCT02417064","NCT02418585","NCT02422186","NCT02493868","NCT02497287","NCT03414931","NCT03434041","NCT03538691","NCT03852160"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00001483%22OR%22NCT00043550%22OR%22NCT00056472%22OR%22NCT00143091%22OR%22NCT00158990%22OR%22NCT00179257%22OR%22NCT00179283%22OR%22NCT00232167%22OR%22NCT00232284%22OR%22NCT00233103%22OR%22NCT00275197%22OR%22NCT00276900%22OR%22NCT00276965%22OR%22NCT00331305%22OR%22NCT00351910%22OR%22NCT00581009%22OR%22NCT00612807%22OR%22NCT00636246%22OR%22NCT00742573%22OR%22NCT00744406%22OR%22NCT01033084%22OR%22NCT01098318%22OR%22NCT01250873%22OR%22NCT01254305%22OR%22NCT01360866%22OR%22NCT01407094%22OR%22NCT01703039%22OR%22NCT02269540%22OR%22NCT02374567%22OR%22NCT02417064%22OR%22NCT02418585%22OR%22NCT02422186%22OR%22NCT02493868%22OR%22NCT02497287%22OR%22NCT03414931%22OR%22NCT03434041%22OR%22NCT03538691%22OR%22NCT03852160%22"]}]},{"efo_id":"EFO_0003829","efo_label":"alcohol dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003829","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00000440","NCT00000446","NCT00000451","NCT00262223"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000440%22OR%22NCT00000446%22OR%22NCT00000451%22OR%22NCT00262223%22"]}]},{"efo_id":"EFO_0003890","efo_label":"drug dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003890","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00232284"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00232284%22"]}]},{"efo_id":"EFO_0004242","efo_label":"obsessive-compulsive disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004242","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000384","NCT00074815","NCT00299611","NCT02797808"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000384%22OR%22NCT00074815%22OR%22NCT00299611%22OR%22NCT02797808%22"]}]},{"efo_id":"EFO_0004247","efo_label":"mood disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004247","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00340379"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00340379%22"]}]},{"efo_id":"EFO_0004262","efo_label":"panic disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004262","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00118417"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00118417%22"]}]},{"efo_id":"EFO_0004698","efo_label":"insomnia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004698","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00232167"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00232167%22"]}]},{"efo_id":"EFO_0005230","efo_label":"anxiety","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005230","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00052078","NCT01977729","NCT02374567"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00052078%22OR%22NCT01977729%22OR%22NCT02374567%22"]}]},{"efo_id":"EFO_0007211","efo_label":"coccidioidomycosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007211","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02908334"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02908334%22"]}]},{"efo_id":"EFO_0007228","efo_label":"cryptococcal meningitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007228","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01802385"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01802385%22"]}]},{"efo_id":"EFO_0007453","efo_label":"postpartum depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007453","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00602355"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00602355%22"]}]},{"efo_id":"EFO_1000942","efo_label":"fungal meningitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000942","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01802385"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01802385%22"]}]},{"efo_id":"EFO_1001917","efo_label":"social anxiety disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001917","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00052078","NCT00215150"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00052078%22OR%22NCT00215150%22"]}]},{"efo_id":"HP_0000726","efo_label":"Dementia","efo_uri":"http://purl.obolibrary.org/obo/HP_0000726","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00001777","NCT02374567"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00001777%22OR%22NCT02374567%22"]}]},{"efo_id":"HP_0000989","efo_label":"Pruritus","efo_uri":"http://purl.obolibrary.org/obo/HP_0000989","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00058903"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00058903%22"]}]},{"efo_id":"Orphanet_908","efo_label":"Fragile X syndrome","efo_uri":"http://www.orpha.net/ORDO/Orphanet_908","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01474746"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01474746%22"]}]},{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02473783"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02473783%22"]}]},{"efo_id":"EFO_0001358","efo_label":"post-traumatic stress disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001358","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00150306"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00150306%22"]}]},{"efo_id":"EFO_0003847","efo_label":"mental retardation","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003847","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00004300"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004300%22"]}]},{"efo_id":"EFO_0004262","efo_label":"panic disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004262","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03199625"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03199625%22"]}]},{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["050dfd68-07f6-482f-a2f1-ec0fe4fdc3d2","1743d408-6eac-41ae-8f80-0053f9d24e85","1b92d9ce-ba64-47da-8d3d-40a2ee12e5f4","27259b83-277e-4891-b5d0-896f07a66cda","31fd504e-5955-49f9-a77e-2720a126fbc7","347db8a2-b214-4bb7-953a-2dad1076ab37","3923bb17-cc93-4410-bf94-76c4600f63ee","39a85db1-9e59-4ab0-9e18-36757f019faa","3ee3a687-bbbf-4d17-8faf-33bc37328259","42120ff8-b353-4632-9ea9-54de9a698724","478b6915-9d73-4681-bee0-0f4540fd4839","5213ff08-ba1f-4f22-99e0-9604dd13a63f","5365e9a7-ad09-4a85-95a1-a86f40c890a5","65b94cce-bf02-42b3-ab57-1e4fcc8725ff","7e7a5675-ccf7-4d98-bb4f-3435e1c87f6b","80adf27d-60fb-4394-8881-e75d3acb2774","8bebc624-a1db-4ef5-9ab0-05c567917851","966d728e-87ca-4491-9411-2ec253eca632","983f8b2c-89ff-4519-b0f6-db3d17b3a3e7","99400099-eae2-4061-a2c7-f56314973dc0","9ba5b9bd-9a6f-4e64-a9d9-1b2b03658ea4","9bc362d4-489c-4e7f-915a-3076ff8d132a","aa1026ed-fcaa-4442-a3f8-b5e0b600b51f","b03b5595-b1ae-415d-8398-00405302b17b","c0724513-693c-42cf-9b25-d5394cc32d7c","c25f968b-7037-4f60-9a02-2189769b0cbf","c3162f51-f3d1-4269-8d56-e56dc9da43fd","d17d767b-08c4-4a25-ad73-03a36d56902a","dfce609d-c63f-4528-b205-3473d053074c","e2a70629-cd46-270a-48b1-8122600b603d","e5fe446b-1118-4208-bf57-3a91d6fc78ae","e6d920ee-80bc-4247-8b50-77f463130d38","ecc38d95-880f-43ea-aa8b-41472803c780","fc9b20f5-44f1-048f-14d1-7e7d08949490"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?050dfd68-07f6-482f-a2f1-ec0fe4fdc3d2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1743d408-6eac-41ae-8f80-0053f9d24e85","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1b92d9ce-ba64-47da-8d3d-40a2ee12e5f4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?27259b83-277e-4891-b5d0-896f07a66cda","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?31fd504e-5955-49f9-a77e-2720a126fbc7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?347db8a2-b214-4bb7-953a-2dad1076ab37","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3923bb17-cc93-4410-bf94-76c4600f63ee","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?39a85db1-9e59-4ab0-9e18-36757f019faa","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3ee3a687-bbbf-4d17-8faf-33bc37328259","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?42120ff8-b353-4632-9ea9-54de9a698724","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?478b6915-9d73-4681-bee0-0f4540fd4839","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5213ff08-ba1f-4f22-99e0-9604dd13a63f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5365e9a7-ad09-4a85-95a1-a86f40c890a5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?65b94cce-bf02-42b3-ab57-1e4fcc8725ff","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7e7a5675-ccf7-4d98-bb4f-3435e1c87f6b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?80adf27d-60fb-4394-8881-e75d3acb2774","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8bebc624-a1db-4ef5-9ab0-05c567917851","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?966d728e-87ca-4491-9411-2ec253eca632","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?983f8b2c-89ff-4519-b0f6-db3d17b3a3e7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?99400099-eae2-4061-a2c7-f56314973dc0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9ba5b9bd-9a6f-4e64-a9d9-1b2b03658ea4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9bc362d4-489c-4e7f-915a-3076ff8d132a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?aa1026ed-fcaa-4442-a3f8-b5e0b600b51f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b03b5595-b1ae-415d-8398-00405302b17b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c0724513-693c-42cf-9b25-d5394cc32d7c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c25f968b-7037-4f60-9a02-2189769b0cbf","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c3162f51-f3d1-4269-8d56-e56dc9da43fd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d17d767b-08c4-4a25-ad73-03a36d56902a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dfce609d-c63f-4528-b205-3473d053074c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e2a70629-cd46-270a-48b1-8122600b603d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e5fe446b-1118-4208-bf57-3a91d6fc78ae","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e6d920ee-80bc-4247-8b50-77f463130d38","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ecc38d95-880f-43ea-aa8b-41472803c780","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?fc9b20f5-44f1-048f-14d1-7e7d08949490"]},{"source":"FDA","ids":["097d95e4-707e-47aa-b18e-aad18fecd42a","12016940-1156-44ce-b18d-eee811267eea","1290cfce-73b5-4978-8cf6-35a4dc414432","1de51edc-4b90-4828-afca-0ff77ffad667","22cb97e4-02b9-4e7b-8540-14659739dad4","25ca06cc-2c74-4bf8-a052-718729288852","34d6090d-f833-4890-b3b9-c7a9c2fc4630","3796bad0-85ff-409f-be43-28884bbc115e","38499dc1-612e-4bf2-bfab-3814f3562bd0","63e5ec33-11ad-40fc-b5c6-059cba25f9f6","6601bf07-5971-4b35-bd32-dcd9017bebac","80413939-4a2c-4f37-886d-fa80731bde11","8da17719-a671-4b2c-b2bb-263bca1c49d9","8e9c8e1b-cdb2-4ea1-99e1-b2a58fe0184e","98b03c2a-cd9f-494d-86f9-500340bd99d9","9c689329-217a-4820-95c1-bc7f6749069a","b840b7ec-311f-4731-bb56-539eb9804adc","b93d1bcd-91b6-42fe-a668-2e0dcfc78bfe","b981ff68-e4d4-4a04-ad58-fdb3d9bc91d2","cf937a8d-6fd9-4cb2-b335-283070ebb126","e48d4ca0-c718-4dd1-b82e-a16e57d46360","f759810c-2f9e-4cbf-80ca-73de0618217d","fbe7e73c-5d82-4da7-b4de-3e53334066f3"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A097d95e4-707e-47aa-b18e-aad18fecd42a","https://api.fda.gov/drug/label.json?search=set_id%3A12016940-1156-44ce-b18d-eee811267eea","https://api.fda.gov/drug/label.json?search=set_id%3A1290cfce-73b5-4978-8cf6-35a4dc414432","https://api.fda.gov/drug/label.json?search=set_id%3A1de51edc-4b90-4828-afca-0ff77ffad667","https://api.fda.gov/drug/label.json?search=set_id%3A22cb97e4-02b9-4e7b-8540-14659739dad4","https://api.fda.gov/drug/label.json?search=set_id%3A25ca06cc-2c74-4bf8-a052-718729288852","https://api.fda.gov/drug/label.json?search=set_id%3A34d6090d-f833-4890-b3b9-c7a9c2fc4630","https://api.fda.gov/drug/label.json?search=set_id%3A3796bad0-85ff-409f-be43-28884bbc115e","https://api.fda.gov/drug/label.json?search=set_id%3A38499dc1-612e-4bf2-bfab-3814f3562bd0","https://api.fda.gov/drug/label.json?search=set_id%3A63e5ec33-11ad-40fc-b5c6-059cba25f9f6","https://api.fda.gov/drug/label.json?search=set_id%3A6601bf07-5971-4b35-bd32-dcd9017bebac","https://api.fda.gov/drug/label.json?search=set_id%3A80413939-4a2c-4f37-886d-fa80731bde11","https://api.fda.gov/drug/label.json?search=set_id%3A8da17719-a671-4b2c-b2bb-263bca1c49d9","https://api.fda.gov/drug/label.json?search=set_id%3A8e9c8e1b-cdb2-4ea1-99e1-b2a58fe0184e","https://api.fda.gov/drug/label.json?search=set_id%3A98b03c2a-cd9f-494d-86f9-500340bd99d9","https://api.fda.gov/drug/label.json?search=set_id%3A9c689329-217a-4820-95c1-bc7f6749069a","https://api.fda.gov/drug/label.json?search=set_id%3Ab840b7ec-311f-4731-bb56-539eb9804adc","https://api.fda.gov/drug/label.json?search=set_id%3Ab93d1bcd-91b6-42fe-a668-2e0dcfc78bfe","https://api.fda.gov/drug/label.json?search=set_id%3Ab981ff68-e4d4-4a04-ad58-fdb3d9bc91d2","https://api.fda.gov/drug/label.json?search=set_id%3Acf937a8d-6fd9-4cb2-b335-283070ebb126","https://api.fda.gov/drug/label.json?search=set_id%3Ae48d4ca0-c718-4dd1-b82e-a16e57d46360","https://api.fda.gov/drug/label.json?search=set_id%3Af759810c-2f9e-4cbf-80ca-73de0618217d","https://api.fda.gov/drug/label.json?search=set_id%3Afbe7e73c-5d82-4da7-b4de-3e53334066f3"]}]},{"efo_id":"Orphanet_399","efo_label":"Huntington disease","efo_uri":"http://www.orpha.net/ORDO/Orphanet_399","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT04071639"],"urls":["https://clinicaltrials.gov/search?id=%22NCT04071639%22"]}]}],"adverse_events":{"significant":[{"event":"serotonin syndrome","count":6002,"llr":1758.609559},{"event":"suicide attempt","count":20244,"llr":827.0989845},{"event":"drug hypersensitivity","count":71246,"llr":731.7299587},{"event":"hyponatraemia","count":21598,"llr":699.1605837},{"event":"drug interaction","count":53526,"llr":662.4026852},{"event":"suicidal ideation","count":21218,"llr":633.1426792},{"event":"anxiety","count":45966,"llr":578.9183671},{"event":"drug abuse","count":14574,"llr":575.2900477},{"event":"agitation","count":21093,"llr":474.52587},{"event":"depression","count":45027,"llr":412.2702974},{"event":"tremor","count":36500,"llr":373.7271387},{"event":"confusional state","count":40628,"llr":331.3157632},{"event":"injection site pain","count":56727,"llr":290.9577503},{"event":"somnolence","count":38949,"llr":279.0740845}],"critval":270.7861764},"child_chembl_ids":["CHEMBL1709"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000108576","approved_name":"solute carrier family 6 member 4","approved_symbol":"SLC6A4"}],"target_type":"single protein","target_name":"Serotonin transporter","action_type":"inhibitor","description":"Serotonin transporter inhibitor","references":[{"source":"FDA","ids":["label/2014/019839s084,020990s043lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2014%2F019839s084%2C020990s043lbl.pdf"]},{"source":"Wikipedia","ids":["Sertraline#Mechanism_of_action"],"urls":["https://www.wikipedia.org/Sertraline#Mechanism_of_action"]}]}],"number_of_indications":34,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":24},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":21},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":5},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":4},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":4},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":4},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":2},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"OTAR_0000014","therapeutic_label":"pregnancy or perinatal disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL607","_score":1,"_source":{"id":"CHEMBL607","internal_compound":false,"type":"Small molecule","pref_name":"MEPERIDINE","year_first_approved":1942,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["IDS-NP-001","Meperidine","Meperidine HCl","Meperidine hydrochloride cii","NIH 10522","NSC-400479","Pethidine","Pethidine HCl","meperidine oxalate"],"trade_names":["Demerol","Meperidine HCl","Meperidine Hydrochloride Preservative Free","Pamergan","Pethidine","Pethilorfan","Spasmodlin"],"cross_references":[{"source":"ChEBI","ids":[6754]},{"source":"DailyMed","ids":["meperidine%20hydrochloride"]},{"source":"Wikipedia","ids":["Pethidine"]},{"source":"drugbank","ids":["DB00454"]}],"canonical_smiles":"CCOC(=O)C1(c2ccccc2)CCN(C)CC1","indications":[{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N02AB02","N02AB52","N02AB72"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N02AB02","https://www.whocc.no/atc_ddd_index/?code=N02AB52","https://www.whocc.no/atc_ddd_index/?code=N02AB72"]},{"source":"ClinicalTrials","ids":["NCT02549118","NCT02557087","NCT02578251","NCT02707250"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02549118%22OR%22NCT02557087%22OR%22NCT02578251%22OR%22NCT02707250%22"]}]},{"efo_id":"HP_0011868","efo_label":"Sciatica","efo_uri":"http://purl.obolibrary.org/obo/HP_0011868","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00163553"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00163553%22"]}]},{"efo_id":"EFO_0004273","efo_label":"scoliosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004273","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03968146"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03968146%22"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT02707250"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02707250%22"]},{"source":"DailyMed","ids":["0084d5bc-17d5-4c58-a791-7ab3bb4590b7","15bc51a8-1e24-4d33-9a2f-05a41c29acf0","53ddfe26-5a7e-4f39-8904-829a03538f63","7df4e964-2a34-4f38-4d8b-62bb637323c7","b31d1308-28c3-43f4-e0a6-2f3ed76b8975","cca1bdfb-3e40-4401-a2e2-78403c7237ba","d714a877-5fce-4dd2-ba64-7f88004da0a5","e0e998da-f056-4fce-be8e-ed60cf3b461b","e89f69d8-e3f0-4e83-b512-fa8f67c6feb5","fa1b3118-9c7b-4767-9212-85140b10dafd","fae5cc34-5917-4445-9516-25f97ffca8db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0084d5bc-17d5-4c58-a791-7ab3bb4590b7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?15bc51a8-1e24-4d33-9a2f-05a41c29acf0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?53ddfe26-5a7e-4f39-8904-829a03538f63","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7df4e964-2a34-4f38-4d8b-62bb637323c7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b31d1308-28c3-43f4-e0a6-2f3ed76b8975","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cca1bdfb-3e40-4401-a2e2-78403c7237ba","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d714a877-5fce-4dd2-ba64-7f88004da0a5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e0e998da-f056-4fce-be8e-ed60cf3b461b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e89f69d8-e3f0-4e83-b512-fa8f67c6feb5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?fa1b3118-9c7b-4767-9212-85140b10dafd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?fae5cc34-5917-4445-9516-25f97ffca8db"]},{"source":"FDA","ids":["6c2b41c3-732c-477f-8790-0eecea43b2da","8f9e0a64-cae4-4a56-8a3e-3dec2e705759","987a91b8-dd9e-47ce-bd43-f8189a54838e","c550b809-fbea-4070-824d-2aeda4150fb5","d97ea8ca-755e-44de-b9d4-40a6c8f4465e","dc578720-0447-4e99-ad63-75253a751297","df4b24fc-db03-4ebf-a8ba-542f60e6d857"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A6c2b41c3-732c-477f-8790-0eecea43b2da","https://api.fda.gov/drug/label.json?search=set_id%3A8f9e0a64-cae4-4a56-8a3e-3dec2e705759","https://api.fda.gov/drug/label.json?search=set_id%3A987a91b8-dd9e-47ce-bd43-f8189a54838e","https://api.fda.gov/drug/label.json?search=set_id%3Ac550b809-fbea-4070-824d-2aeda4150fb5","https://api.fda.gov/drug/label.json?search=set_id%3Ad97ea8ca-755e-44de-b9d4-40a6c8f4465e","https://api.fda.gov/drug/label.json?search=set_id%3Adc578720-0447-4e99-ad63-75253a751297","https://api.fda.gov/drug/label.json?search=set_id%3Adf4b24fc-db03-4ebf-a8ba-542f60e6d857"]}]},{"efo_id":"EFO_0005251","efo_label":"hypotension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005251","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01567657"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01567657%22"]}]}],"adverse_events":{"significant":[{"event":"drug hypersensitivity","count":71246,"llr":6189.402768},{"event":"international normalised ratio fluctuation","count":596,"llr":261.6054203},{"event":"drug intolerance","count":21687,"llr":222.6464728},{"event":"contrast media allergy","count":331,"llr":159.7778064},{"event":"vomiting","count":103943,"llr":110.0615073},{"event":"serotonin syndrome","count":6002,"llr":96.70840706},{"event":"urticaria","count":39524,"llr":96.39943493},{"event":"bloody discharge","count":230,"llr":75.83773729},{"event":"nausea","count":165652,"llr":59.56798827},{"event":"obliterative bronchiolitis","count":437,"llr":59.03116316},{"event":"treatment failure","count":12895,"llr":53.6578445},{"event":"therapeutic product effect incomplete","count":2974,"llr":48.46692835},{"event":"lyme disease","count":718,"llr":46.23083369},{"event":"upper respiratory tract infection","count":12359,"llr":43.2189343},{"event":"fatigue","count":147738,"llr":41.91438677},{"event":"diarrhoea","count":126514,"llr":39.71065042},{"event":"injection site pain","count":56727,"llr":36.98766259},{"event":"infection","count":26803,"llr":34.19527306},{"event":"respiratory arrest","count":3162,"llr":29.97486145},{"event":"anaemia","count":61405,"llr":29.15125747},{"event":"respiratory depression","count":3384,"llr":28.64302812}],"critval":28.02839364},"child_chembl_ids":["CHEMBL1701","CHEMBL429713"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000112038","approved_name":"opioid receptor mu 1","approved_symbol":"OPRM1"}],"target_type":"single protein","target_name":"Mu opioid receptor","action_type":"agonist","description":"Mu opioid receptor agonist","references":[{"source":"PubMed","ids":["21215785"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21215785"]}]}],"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":3},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545273","_score":1,"_source":{"id":"CHEMBL3545273","internal_compound":false,"type":"Small molecule","pref_name":"CR-3465","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["CR-3465"],"trade_names":[],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000173198","approved_name":"cysteinyl leukotriene receptor 1","approved_symbol":"CYSLTR1"}],"target_type":"single protein","target_name":"Cysteinyl leukotriene receptor 1","action_type":"antagonist","description":"Cysteinyl leukotriene receptor 1 antagonist","references":[{"source":"Other","ids":["http://www.rottapharm.fr/rph-fr/media/pdf/RD_pipeline_May_2013_clean.pdf"],"urls":["http://www.rottapharm.fr/rph-fr/media/pdf/RD_pipeline_May_2013_clean.pdf"]},{"source":"PubMed","ids":["15541426"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15541426"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL16503","_score":1,"_source":{"id":"CHEMBL16503","internal_compound":false,"type":"Small molecule","pref_name":"SALCAPROZIC ACID","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["E-414","E414","SNAC","Salcaprozate Sodium","Salcaprozic Acid"],"trade_names":[],"canonical_smiles":"O=C(O)CCCCCCCNC(=O)c1ccccc1O","child_chembl_ids":["CHEMBL2107027"],"indications":[{"efo_id":"EFO_0000400","efo_label":"diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000400","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02920385","NCT03010475"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02920385%22OR%22NCT03010475%22"]}]},{"efo_id":"EFO_0001360","efo_label":"type II diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001360","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02845219"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02845219%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":2},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":2}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL530","_score":1,"_source":{"id":"CHEMBL530","internal_compound":false,"type":"Small molecule","pref_name":"AMDINOCILLIN","year_first_approved":1984,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Amdinocillin","FL 1060","FL-1060","Mecillinam","RO-10-9070","Ro-109070"],"trade_names":["Coactin","Selexidin"],"cross_references":[{"source":"PubChem","ids":["144205762","170465354"]},{"source":"Wikipedia","ids":["Mecillinam"]}],"canonical_smiles":"CC1(C)S[C@@H]2[C@H](/N=C/N3CCCCCC3)C(=O)N2[C@H]1C(=O)O","mechanisms_of_action":[{"target_type":"single protein","target_name":"Bacterial penicillin-binding protein 2","action_type":"inhibitor","description":"Bacterial penicillin-binding protein 2 inhibitor","references":[{"source":"PubMed","ids":["7447421"],"urls":["https://europepmc.org/search?query=EXT_ID%3A7447421"]},{"source":"Wikipedia","ids":["Amdinocillin"],"urls":["https://www.wikipedia.org/Amdinocillin"]}]}],"adverse_events":{"significant":[{"event":"congenital pulmonary hypertension","count":66,"llr":62.95157728},{"event":"ductus arteriosus premature closure","count":149,"llr":58.06584953},{"event":"foetal heart rate abnormal","count":305,"llr":53.76769737},{"event":"right ventricular failure","count":1708,"llr":43.43146358},{"event":"tricuspid valve incompetence","count":2442,"llr":41.28668933},{"event":"generalised oedema","count":3459,"llr":39.1979817},{"event":"cyanosis","count":4608,"llr":37.47739515},{"event":"ascites","count":7879,"llr":34.25980675},{"event":"live birth","count":1539,"llr":26.50549627}],"critval":19.47100172},"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2110737","_score":1,"_source":{"id":"CHEMBL2110737","internal_compound":false,"type":"Small molecule","pref_name":"CELGOSIVIR","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Celgosivir","Celgosivir HCl","MDL-28574A"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB06580"]}],"canonical_smiles":"CCCC(=O)O[C@H]1CN2CC[C@H](O)[C@@H]2[C@@H](O)[C@@H]1O","indications":[{"efo_id":"EFO_0004220","efo_label":"chronic hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004220","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00157534","NCT00217139","NCT00292084","NCT00332176"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00157534%22OR%22NCT00217139%22OR%22NCT00292084%22OR%22NCT00332176%22"]}]},{"efo_id":"EFO_0005547","efo_label":"dengue disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005547","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01619969","NCT02569827"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01619969%22OR%22NCT02569827%22"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00002150","NCT00002151","NCT00002329"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002150%22OR%22NCT00002151%22OR%22NCT00002329%22"]}]}],"child_chembl_ids":["CHEMBL2105801"],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":3},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108506","_score":1,"_source":{"id":"CHEMBL2108506","internal_compound":false,"type":"Protein","pref_name":"INTERFERON ALFA","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Interferon Alfa","Interferon alfa natural","Interferon alpha"],"trade_names":["Interf","Roferon-A","Viraferon","Wellferon"],"indications":[{"efo_id":"EFO_0000389","efo_label":"cutaneous melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000389","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002669","NCT00002763","NCT00002767","NCT00002892","NCT00003027","NCT00003444","NCT00003715","NCT00004104","NCT00004196","NCT00004244","NCT00005615","NCT00006237","NCT00006385","NCT00014092","NCT00026221","NCT00026520","NCT00447356"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002669%22OR%22NCT00002763%22OR%22NCT00002767%22OR%22NCT00002892%22OR%22NCT00003027%22OR%22NCT00003444%22OR%22NCT00003715%22OR%22NCT00004104%22OR%22NCT00004196%22OR%22NCT00004244%22OR%22NCT00005615%22OR%22NCT00006237%22OR%22NCT00006385%22OR%22NCT00014092%22OR%22NCT00026221%22OR%22NCT00026520%22OR%22NCT00447356%22"]}]},{"efo_id":"EFO_0000681","efo_label":"renal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000681","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00059813","NCT00065468","NCT00291369","NCT00445523","NCT00485563","NCT00591188","NCT00619268","NCT00631371","NCT00862303","NCT01176552"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00059813%22OR%22NCT00065468%22OR%22NCT00291369%22OR%22NCT00445523%22OR%22NCT00485563%22OR%22NCT00591188%22OR%22NCT00619268%22OR%22NCT00631371%22OR%22NCT00862303%22OR%22NCT01176552%22"]}]},{"efo_id":"EFO_0000756","efo_label":"melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000756","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002882","NCT00026143","NCT01341158"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002882%22OR%22NCT00026143%22OR%22NCT01341158%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002504","NCT00002548","NCT00002599","NCT00002657","NCT00002849","NCT00003007","NCT00003195","NCT00003451","NCT00004040","NCT00004088","NCT00004903","NCT00005987","NCT00006244","NCT00007995","NCT00028886","NCT00470093","NCT00633542"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002504%22OR%22NCT00002548%22OR%22NCT00002599%22OR%22NCT00002657%22OR%22NCT00002849%22OR%22NCT00003007%22OR%22NCT00003195%22OR%22NCT00003451%22OR%22NCT00004040%22OR%22NCT00004088%22OR%22NCT00004903%22OR%22NCT00005987%22OR%22NCT00006244%22OR%22NCT00007995%22OR%22NCT00028886%22OR%22NCT00470093%22OR%22NCT00633542%22"]}]},{"efo_id":"EFO_0004220","efo_label":"chronic hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004220","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00695019"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00695019%22"]}]},{"efo_id":"EFO_0002890","efo_label":"renal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002890","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002737","NCT00002847","NCT00003585","NCT00003656","NCT00003664","NCT00004244","NCT00005966","NCT00006384","NCT00027664","NCT00045370","NCT00053807","NCT00053820","NCT00072046","NCT00085436","NCT00278174","NCT00416871"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002737%22OR%22NCT00002847%22OR%22NCT00003585%22OR%22NCT00003656%22OR%22NCT00003664%22OR%22NCT00004244%22OR%22NCT00005966%22OR%22NCT00006384%22OR%22NCT00027664%22OR%22NCT00045370%22OR%22NCT00053807%22OR%22NCT00053820%22OR%22NCT00072046%22OR%22NCT00085436%22OR%22NCT00278174%22OR%22NCT00416871%22"]}]},{"efo_id":"EFO_0000326","efo_label":"central nervous system cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000326","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00002965"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002965%22"]}]},{"efo_id":"EFO_0000096","efo_label":"neoplasm of mature B-cells","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000096","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00015912","NCT03069248"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00015912%22OR%22NCT03069248%22"]}]},{"efo_id":"EFO_0000178","efo_label":"gastric carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000178","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00003172"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003172%22"]}]},{"efo_id":"EFO_0000182","efo_label":"hepatocellular carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000182","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00006006","NCT01681446","NCT01834963"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00006006%22OR%22NCT01681446%22OR%22NCT01834963%22"]}]},{"efo_id":"EFO_0000198","efo_label":"myelodysplastic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000198","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00002504","NCT00003451"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002504%22OR%22NCT00003451%22"]}]},{"efo_id":"EFO_0000292","efo_label":"bladder carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000292","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00004122","NCT00330707","NCT01094964"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004122%22OR%22NCT00330707%22OR%22NCT01094964%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00095862"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00095862%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00250796","NCT00329368"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00250796%22OR%22NCT00329368%22"]}]},{"efo_id":"EFO_0000339","efo_label":"chronic myelogenous leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000339","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00333840","NCT01220648","NCT03117816"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00333840%22OR%22NCT01220648%22OR%22NCT03117816%22"]}]},{"efo_id":"EFO_0000349","efo_label":"clear cell renal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000349","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00098618"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00098618%22"]}]},{"efo_id":"EFO_0000565","efo_label":"leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000565","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002504","NCT00002574","NCT00002598","NCT00002621","NCT00002771","NCT00002868","NCT00002869","NCT00003239","NCT00003405","NCT00003451","NCT00003561","NCT00003727","NCT00004040","NCT00004905","NCT00005948","NCT00005984","NCT00005986","NCT00006343","NCT00011934","NCT00015847","NCT00025402","NCT00045422","NCT00055874","NCT00110058","NCT00363649"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002504%22OR%22NCT00002574%22OR%22NCT00002598%22OR%22NCT00002621%22OR%22NCT00002771%22OR%22NCT00002868%22OR%22NCT00002869%22OR%22NCT00003239%22OR%22NCT00003405%22OR%22NCT00003451%22OR%22NCT00003561%22OR%22NCT00003727%22OR%22NCT00004040%22OR%22NCT00004905%22OR%22NCT00005948%22OR%22NCT00005984%22OR%22NCT00005986%22OR%22NCT00006343%22OR%22NCT00011934%22OR%22NCT00015847%22OR%22NCT00025402%22OR%22NCT00045422%22OR%22NCT00055874%22OR%22NCT00110058%22OR%22NCT00363649%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002504","NCT00002621","NCT00002657","NCT00002829","NCT00002835","NCT00003152","NCT00003416","NCT00003451","NCT00003639","NCT00003924","NCT00004039","NCT00004231","NCT00016887","NCT00030849","NCT00041327","NCT00637117"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002504%22OR%22NCT00002621%22OR%22NCT00002657%22OR%22NCT00002829%22OR%22NCT00002835%22OR%22NCT00003152%22OR%22NCT00003416%22OR%22NCT00003451%22OR%22NCT00003639%22OR%22NCT00003924%22OR%22NCT00004039%22OR%22NCT00004231%22OR%22NCT00016887%22OR%22NCT00030849%22OR%22NCT00041327%22OR%22NCT00637117%22"]}]},{"efo_id":"EFO_0000588","efo_label":"mesothelioma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000588","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00003263"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003263%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00004063"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004063%22"]}]},{"efo_id":"EFO_0000637","efo_label":"osteosarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000637","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00504140"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00504140%22"]}]},{"efo_id":"EFO_0000640","efo_label":"papillary renal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000640","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00098618"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00098618%22"]}]},{"efo_id":"EFO_0000691","efo_label":"sarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000691","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00026416"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00026416%22"]}]},{"efo_id":"EFO_0001071","efo_label":"lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001071","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00062010"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00062010%22"]}]},{"efo_id":"EFO_0001359","efo_label":"type I diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001359","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00005665"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00005665%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00005847"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00005847%22"]}]},{"efo_id":"EFO_0002429","efo_label":"polycythemia vera","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002429","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02218047","NCT04116502"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02218047%22OR%22NCT04116502%22"]}]},{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00002773","NCT00068575","NCT00082862","NCT00262951","NCT00660270","NCT00761241"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002773%22OR%22NCT00068575%22OR%22NCT00082862%22OR%22NCT00262951%22OR%22NCT00660270%22OR%22NCT00761241%22"]}]},{"efo_id":"EFO_0002916","efo_label":"esophageal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002916","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00004897"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004897%22"]}]},{"efo_id":"EFO_0003047","efo_label":"hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003047","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00004804","NCT00324389"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004804%22OR%22NCT00324389%22"]}]},{"efo_id":"EFO_0003885","efo_label":"multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003885","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01171209"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01171209%22"]}]},{"efo_id":"EFO_0006859","efo_label":"head and neck malignant neoplasia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006859","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00054561"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00054561%22"]}]},{"efo_id":"EFO_1000657","efo_label":"rectum cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000657","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01060501"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01060501%22"]}]},{"efo_id":"EFO_1001051","efo_label":"mycosis fungoides","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001051","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00038376"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00038376%22"]}]},{"efo_id":"EFO_1001469","efo_label":"Mantle cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001469","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00209209"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00209209%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00003063"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003063%22"]}]},{"efo_id":"EFO_0001075","efo_label":"ovarian carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001075","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00002734"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002734%22"]}]},{"efo_id":"EFO_1001100","efo_label":"peritoneal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001100","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00002734"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002734%22"]}]}],"adverse_events":{"significant":[{"event":"anaemia","count":61405,"llr":59.57709862},{"event":"retinopathy","count":1268,"llr":37.06269636},{"event":"leukopenia","count":17226,"llr":32.88193039},{"event":"depression","count":45027,"llr":32.61451501},{"event":"mitochondrial toxicity","count":279,"llr":28.34327249},{"event":"basedow's disease","count":873,"llr":24.43027615},{"event":"hyperthyroidism","count":3841,"llr":24.1745927},{"event":"thrombocytopenia","count":35327,"llr":24.09560149},{"event":"hypothyroidism","count":7054,"llr":22.28254391},{"event":"type 1 diabetes mellitus","count":1280,"llr":21.43431269},{"event":"parkinsonism","count":3067,"llr":20.53657158},{"event":"porphyria non-acute","count":255,"llr":14.32342402},{"event":"sudden visual loss","count":72,"llr":13.65161997},{"event":"hepatic steatosis","count":5106,"llr":13.31767709},{"event":"nephrotic syndrome","count":2560,"llr":13.19499412},{"event":"natural killer-cell lymphoblastic lymphoma","count":8,"llr":12.67651144},{"event":"haemolytic uraemic syndrome","count":1065,"llr":11.9972242},{"event":"pain","count":94786,"llr":11.87446693},{"event":"periproctitis","count":20,"llr":10.84587868},{"event":"coeliac disease","count":1393,"llr":10.70782444},{"event":"sarcoidosis","count":1486,"llr":10.39971846},{"event":"influenza like illness","count":19494,"llr":10.03948999}],"critval":10.00245609},"number_of_indications":38,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":34},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":9},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":9},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":8},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":8},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":8},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":7},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":4},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":4},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":3},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":3},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":2},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":2},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3950712","_score":1,"_source":{"id":"CHEMBL3950712","internal_compound":false,"type":"Small molecule","pref_name":"DA-6886","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Da-6886"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12853"]}],"canonical_smiles":"COc1cc(N)c(Cl)cc1C(=O)NCC1CCN(CCCn2ccnn2)CC1","indications":[{"efo_id":"EFO_0000555","efo_label":"irritable bowel syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000555","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01633723"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01633723%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2104986","_score":1,"_source":{"id":"CHEMBL2104986","internal_compound":false,"type":"Small molecule","pref_name":"TEDATIOXETINE","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Lu-AA24530","Lu-AA24530-(HBr)","Tedatioxetine","Tedatioxetine Hydrobromide"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12641"]}],"canonical_smiles":"Cc1ccc(Sc2ccccc2C2CCNCC2)cc1","indications":[{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00599911"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00599911%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000108576","approved_name":"solute carrier family 6 member 4","approved_symbol":"SLC6A4"}],"target_type":"single protein","target_name":"Serotonin transporter","action_type":"inhibitor","description":"Serotonin transporter inhibitor","references":[{"source":"Other","ids":["http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788"],"urls":["http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788"]},{"source":"Wikipedia","ids":["Tedatioxetine"],"urls":["https://www.wikipedia.org/Tedatioxetine"]}]},{"target_components":[{"ensembl":"ENSG00000103546","approved_name":"solute carrier family 6 member 2","approved_symbol":"SLC6A2"}],"target_type":"single protein","target_name":"Norepinephrine transporter","action_type":"inhibitor","description":"Norepinephrine transporter inhibitor","references":[{"source":"Other","ids":["http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788"],"urls":["http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788"]},{"source":"Wikipedia","ids":["Tedatioxetine"],"urls":["https://www.wikipedia.org/Tedatioxetine"]}]},{"target_components":[{"ensembl":"ENSG00000142319","approved_name":"solute carrier family 6 member 3","approved_symbol":"SLC6A3"}],"target_type":"single protein","target_name":"Dopamine transporter","action_type":"inhibitor","description":"Dopamine transporter inhibitor","references":[{"source":"Other","ids":["http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788"],"urls":["http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788"]},{"source":"Wikipedia","ids":["Tedatioxetine"],"urls":["https://www.wikipedia.org/Tedatioxetine"]}]},{"target_components":[{"ensembl":"ENSG00000102468","approved_name":"5-hydroxytryptamine receptor 2A","approved_symbol":"HTR2A"}],"target_type":"single protein","target_name":"Serotonin 2a (5-HT2a) receptor","action_type":"antagonist","description":"Serotonin 2a (5-HT2a) receptor antagonist","references":[{"source":"Other","ids":["http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788"],"urls":["http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788"]},{"source":"Wikipedia","ids":["Tedatioxetine"],"urls":["https://www.wikipedia.org/Tedatioxetine"]}]},{"target_components":[{"ensembl":"ENSG00000147246","approved_name":"5-hydroxytryptamine receptor 2C","approved_symbol":"HTR2C"}],"target_type":"single protein","target_name":"Serotonin 2c (5-HT2c) receptor","action_type":"antagonist","description":"Serotonin 2c (5-HT2c) receptor antagonist","references":[{"source":"Other","ids":["http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788"],"urls":["http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788"]},{"source":"Wikipedia","ids":["Tedatioxetine"],"urls":["https://www.wikipedia.org/Tedatioxetine"]}]},{"target_components":[{"ensembl":"ENSG00000120907","approved_name":"adrenoceptor alpha 1A","approved_symbol":"ADRA1A"}],"target_type":"single protein","target_name":"Alpha-1a adrenergic receptor","action_type":"antagonist","description":"Alpha-1a adrenergic receptor antagonist","references":[{"source":"Other","ids":["http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788"],"urls":["http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788"]},{"source":"Wikipedia","ids":["Tedatioxetine"],"urls":["https://www.wikipedia.org/Tedatioxetine"]}]},{"target_components":[{"ensembl":"ENSG00000166736","approved_name":"5-hydroxytryptamine receptor 3A","approved_symbol":"HTR3A"},{"ensembl":"ENSG00000186038","approved_name":"5-hydroxytryptamine receptor 3E","approved_symbol":"HTR3E"},{"ensembl":"ENSG00000149305","approved_name":"5-hydroxytryptamine receptor 3B","approved_symbol":"HTR3B"},{"ensembl":"ENSG00000186090","approved_name":"5-hydroxytryptamine receptor 3D","approved_symbol":"HTR3D"},{"ensembl":"ENSG00000178084","approved_name":"5-hydroxytryptamine receptor 3C","approved_symbol":"HTR3C"}],"target_type":"protein complex group","target_name":"Serotonin 3 (5-HT3) receptor","action_type":"antagonist","description":"Serotonin 3 (5-HT3) receptor antagonist","references":[{"source":"Other","ids":["http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788"],"urls":["http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788"]},{"source":"Wikipedia","ids":["Tedatioxetine"],"urls":["https://www.wikipedia.org/Tedatioxetine"]}]}],"child_chembl_ids":["CHEMBL2107377"],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":7}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL14762","_score":1,"_source":{"id":"CHEMBL14762","internal_compound":false,"type":"Small molecule","pref_name":"SELICICLIB","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AL-39256","CYC-202","NSC-701554","Seliciclib"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[45307]},{"source":"PubChem","ids":["124891685","26753649","26753650","50100113","50107006","527377"]},{"source":"Wikipedia","ids":["Seliciclib"]},{"source":"drugbank","ids":["DB06195"]}],"canonical_smiles":"CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1","indications":[{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00372073"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00372073%22"]}]},{"efo_id":"Orphanet_586","efo_label":"Cystic fibrosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_586","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02649751"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02649751%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01333423"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01333423%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00999401"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00999401%22"]}]},{"efo_id":"EFO_1001110","efo_label":"pituitary-dependent Cushing's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001110","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02160730","NCT03774446"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02160730%22OR%22NCT03774446%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000123374","approved_name":"cyclin dependent kinase 2","approved_symbol":"CDK2"}],"target_type":"single protein","target_name":"Cyclin-dependent kinase 2","action_type":"inhibitor","description":"Cyclin-dependent kinase 2 inhibitor","references":[{"source":"PubMed","ids":["25747275","26207228","9030781"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25747275+OR+EXT_ID%3A26207228+OR+EXT_ID%3A9030781"]}]},{"target_components":[{"ensembl":"ENSG00000134058","approved_name":"cyclin dependent kinase 7","approved_symbol":"CDK7"}],"target_type":"single protein","target_name":"Cyclin-dependent kinase 7","action_type":"inhibitor","description":"Cyclin-dependent kinase 7 inhibitor","references":[{"source":"PubMed","ids":["25747275","26207228","9030781"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25747275+OR+EXT_ID%3A26207228+OR+EXT_ID%3A9030781"]}]},{"target_components":[{"ensembl":"ENSG00000136807","approved_name":"cyclin dependent kinase 9","approved_symbol":"CDK9"}],"target_type":"single protein","target_name":"Cyclin-dependent kinase 9","action_type":"inhibitor","description":"Cyclin-dependent kinase 9 inhibitor","references":[{"source":"PubMed","ids":["25747275","26207228","9030781"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25747275+OR+EXT_ID%3A26207228+OR+EXT_ID%3A9030781"]}]},{"target_components":[{"ensembl":"ENSG00000170312","approved_name":"cyclin dependent kinase 1","approved_symbol":"CDK1"}],"target_type":"single protein","target_name":"Cyclin-dependent kinase 1","action_type":"inhibitor","description":"Cyclin-dependent kinase 1 inhibitor","references":[{"source":"PubMed","ids":["25747275","26207228","9030781"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25747275+OR+EXT_ID%3A26207228+OR+EXT_ID%3A9030781"]}]},{"target_components":[{"ensembl":"ENSG00000164885","approved_name":"cyclin dependent kinase 5","approved_symbol":"CDK5"}],"target_type":"single protein","target_name":"Cyclin-dependent kinase 5","action_type":"inhibitor","description":"Cyclin-dependent kinase 5 inhibitor","references":[{"source":"PubMed","ids":["25747275","26207228","9030781"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25747275+OR+EXT_ID%3A26207228+OR+EXT_ID%3A9030781"]}]}],"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1}],"number_of_mechanisms_of_action":5}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545369","_score":1,"_source":{"id":"CHEMBL3545369","internal_compound":false,"type":"Small molecule","pref_name":"EPACADOSTAT","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Epacadostat","INCB-024360"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB11717"]}],"canonical_smiles":"NS(=O)(=O)NCCNc1nonc1/C(=N/O)Nc1ccc(F)c(Br)c1","indications":[{"efo_id":"EFO_0000198","efo_label":"myelodysplastic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000198","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01822691"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01822691%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01195311","NCT02959437","NCT03277352"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01195311%22OR%22NCT02959437%22OR%22NCT03277352%22"]}]},{"efo_id":"EFO_0000181","efo_label":"head and neck squamous cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000181","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03325465","NCT03823131"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03325465%22OR%22NCT03823131%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03444649","NCT03491579"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03444649%22OR%22NCT03491579%22"]}]},{"efo_id":"EFO_0000389","efo_label":"cutaneous melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000389","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01961115"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01961115%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03322384"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03322384%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":3,"references":[{"source":"ATC","ids":["L01XX58"],"urls":["https://www.whocc.no/atc_ddd_index/?code=L01XX58"]},{"source":"ClinicalTrials","ids":["NCT02559492","NCT03347123","NCT03361228","NCT03471286","NCT03589651"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02559492%22OR%22NCT03347123%22OR%22NCT03361228%22OR%22NCT03471286%22OR%22NCT03589651%22"]}]},{"efo_id":"EFO_0000681","efo_label":"renal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000681","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03260894"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03260894%22"]}]},{"efo_id":"EFO_0000691","efo_label":"sarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000691","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03414229"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03414229%22"]}]},{"efo_id":"EFO_0000702","efo_label":"small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000702","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03402880"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03402880%22"]}]},{"efo_id":"EFO_0000756","efo_label":"melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000756","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01604889","NCT02752074"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01604889%22OR%22NCT02752074%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02862457","NCT03217669"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02862457%22OR%22NCT03217669%22"]}]},{"efo_id":"EFO_0006859","efo_label":"head and neck malignant neoplasia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006859","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03238638","NCT03342352","NCT03358472"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03238638%22OR%22NCT03342352%22OR%22NCT03358472%22"]}]},{"efo_id":"EFO_1000576","efo_label":"Thymic Carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000576","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02364076"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02364076%22"]}]},{"efo_id":"EFO_1001512","efo_label":"endometrial carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001512","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03310567"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03310567%22"]}]},{"efo_id":"Orphanet_44890","efo_label":"Gastrointestinal stromal tumor","efo_uri":"http://www.orpha.net/ORDO/Orphanet_44890","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03291054"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03291054%22"]}]},{"efo_id":"EFO_0000196","efo_label":"metastatic prostate cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000196","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03493945"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03493945%22"]}]},{"efo_id":"EFO_0000292","efo_label":"bladder carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000292","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03832673"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03832673%22"]}]},{"efo_id":"EFO_0000519","efo_label":"glioblastoma multiforme","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000519","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03532295","NCT03707457"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03532295%22OR%22NCT03707457%22"]}]},{"efo_id":"EFO_0001071","efo_label":"lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001071","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03322540","NCT03322566","NCT03348904"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03322540%22OR%22NCT03322566%22OR%22NCT03348904%22"]}]},{"efo_id":"EFO_0001075","efo_label":"ovarian carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001075","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01685255","NCT02042430","NCT02575807","NCT02785250","NCT03602586"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01685255%22OR%22NCT02042430%22OR%22NCT02575807%22OR%22NCT02785250%22OR%22NCT03602586%22"]}]},{"efo_id":"EFO_0002517","efo_label":"pancreatic ductal adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002517","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03432676"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03432676%22"]}]},{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03432676"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03432676%22"]}]},{"efo_id":"EFO_0003863","efo_label":"urogenital neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003863","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03361865","NCT03374488"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03361865%22OR%22NCT03374488%22"]}]},{"efo_id":"EFO_1000251","efo_label":"Fallopian Tube Carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000251","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02042430","NCT02575807","NCT02785250"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02042430%22OR%22NCT02575807%22OR%22NCT02785250%22"]}]},{"efo_id":"EFO_1000657","efo_label":"rectum cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000657","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03516708"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03516708%22"]}]},{"efo_id":"EFO_1001100","efo_label":"peritoneal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001100","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02042430","NCT02575807","NCT02785250"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02042430%22OR%22NCT02575807%22OR%22NCT02785250%22"]}]},{"efo_id":"Orphanet_145","efo_label":"Hereditary breast and ovarian cancer syndrome","efo_uri":"http://www.orpha.net/ORDO/Orphanet_145","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03432676"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03432676%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000131203","approved_name":"indoleamine 2,3-dioxygenase 1","approved_symbol":"IDO1"}],"target_type":"single protein","target_name":"Indoleamine 2,3-dioxygenase","action_type":"inhibitor","description":"Indoleamine 2,3-dioxygenase inhibitor","references":[{"source":"PubMed","ids":["27192116"],"urls":["https://europepmc.org/search?query=EXT_ID%3A27192116"]}]}],"adverse_events":{"significant":[{"event":"febrile neutropenia","count":19204,"llr":22.34673219},{"event":"exfoliative rash","count":760,"llr":10.08878654}],"critval":6.907493942},"number_of_indications":28,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":28},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":8},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":8},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":5},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":5},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":5},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":5},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":4},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":4},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":2},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":2},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108232","_score":1,"_source":{"id":"CHEMBL2108232","internal_compound":false,"type":"Unknown","pref_name":"COAL TAR","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Coal Tar","Coal tar solution","Coal tar, prepared"],"trade_names":["Alphosyl","AquaTar","Capasal","Clinitar","Cocois Co","Denorex","Fototar","Gelcotar","Genisol","Ionil T","Ionil-T","Ionil-T-Plus","Neutrogena","Patterson's","Pentrax","Polytar Af","Polytar Plus","Pomade U.B.H.","Psoriderm","St Johns","Stantar","Vanseb-T","Zetar"],"indications":[{"efo_id":"EFO_0000676","efo_label":"psoriasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000676","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02644954"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02644954%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297825","_score":1,"_source":{"id":"CHEMBL4297825","internal_compound":false,"type":"Oligosaccharide","pref_name":"SEVUPARIN","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["DF-02","DF02","Sevuparin"],"trade_names":[],"indications":[{"efo_id":"Orphanet_232","efo_label":"Sickle cell anemia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_232","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02515838"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02515838%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108063","_score":1,"_source":{"id":"CHEMBL2108063","internal_compound":false,"type":"Antibody","pref_name":"ZANOLIMUMAB","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["HuMax-CD4","MDX-016","Zanolimumab"],"trade_names":["HuMax-CD4"],"indications":[{"efo_id":"EFO_0000685","efo_label":"rheumatoid arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000685","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00042406"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00042406%22"]}]},{"efo_id":"EFO_0002913","efo_label":"Cutaneous T-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002913","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00071071","NCT00071084"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00071071%22OR%22NCT00071084%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00877656"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00877656%22"]}]},{"efo_id":"EFO_1000785","efo_label":"Sezary's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000785","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00127881"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00127881%22"]}]},{"efo_id":"EFO_1001051","efo_label":"mycosis fungoides","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001051","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00127881"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00127881%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000010610","approved_name":"CD4 molecule","approved_symbol":"CD4"}],"target_type":"single protein","target_name":"T-cell surface antigen CD4","action_type":"other","description":"T-cell surface antigen CD4 other"}],"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":4},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":4},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":4},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":3},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545264","_score":1,"_source":{"id":"CHEMBL3545264","internal_compound":false,"type":"Small molecule","pref_name":"LY-2874455","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["LY-2874455","LY2874455"],"trade_names":[],"canonical_smiles":"CC(Oc1ccc2[nH]nc(/C=C/c3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl","mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000068078","approved_name":"fibroblast growth factor receptor 3","approved_symbol":"FGFR3"},{"ensembl":"ENSG00000077782","approved_name":"fibroblast growth factor receptor 1","approved_symbol":"FGFR1"},{"ensembl":"ENSG00000160867","approved_name":"fibroblast growth factor receptor 4","approved_symbol":"FGFR4"},{"ensembl":"ENSG00000066468","approved_name":"fibroblast growth factor receptor 2","approved_symbol":"FGFR2"}],"target_type":"protein family","target_name":"Fibroblast growth factor receptor","action_type":"inhibitor","description":"Fibroblast growth factor receptor inhibitor","references":[{"source":"Other","ids":["http://www.lillyoncologypipeline.com/fgfr-inhibitor.aspx"],"urls":["http://www.lillyoncologypipeline.com/fgfr-inhibitor.aspx"]},{"source":"PubMed","ids":["21900693"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21900693"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3039564","_score":1,"_source":{"id":"CHEMBL3039564","internal_compound":false,"type":"Small molecule","pref_name":"IRINOTECAN SUCROSOFATE","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Irinotecan Sucrosofate","MM-398","PEP-02"],"trade_names":[],"indications":[{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01494506"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01494506%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02640365"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02640365%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000198900","approved_name":"DNA topoisomerase I","approved_symbol":"TOP1"}],"target_type":"single protein","target_name":"DNA topoisomerase I","action_type":"inhibitor","description":"DNA topoisomerase I inhibitor","references":[{"source":"PubMed","ids":["14648715","25733708"],"urls":["https://europepmc.org/search?query=EXT_ID%3A14648715+OR+EXT_ID%3A25733708"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1200358","_score":1,"_source":{"id":"CHEMBL1200358","internal_compound":false,"type":"Small molecule","pref_name":"SODIUM PHENYLACETATE","year_first_approved":1987,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["NSC-3039","Sodium Phenylacetate"],"trade_names":[],"cross_references":[{"source":"DailyMed","ids":["sodium%20phenylacetate"]},{"source":"PubChem","ids":["538568"]}],"canonical_smiles":"O=C([O-])Cc1ccccc1.[Na+]","indications":[{"efo_id":"EFO_0000326","efo_label":"central nervous system cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000326","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00003241"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003241%22"]}]}],"mechanisms_of_action":[],"adverse_events":{"significant":[{"event":"hyperammonaemia","count":1794,"llr":20.89999551},{"event":"respiratory syncytial virus test positive","count":255,"llr":12.84528443},{"event":"product odour abnormal","count":797,"llr":10.56850421},{"event":"metabolic acidosis","count":8683,"llr":10.02195404},{"event":"ammonia increased","count":1465,"llr":9.353953448},{"event":"ornithine transcarbamoylase deficiency","count":10,"llr":8.939863322},{"event":"ammonia decreased","count":15,"llr":8.534421674}],"critval":8.018225292},"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201302","_score":1,"_source":{"id":"CHEMBL1201302","internal_compound":false,"type":"Small molecule","pref_name":"DEXAMETHASONE PHOSPHORIC ACID","year_first_approved":1959,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Dexamethasone 21-phosphate disodium salt","Dexamethasone Sodium Phosphate","Dexamethasone phosphate","Dexamethasone phosphoric acid"],"trade_names":["Decadron","Dexacen-4","Dexacort","Dexair","Dexamethasone","Dexamethasone Sodium Phosphate","Hexadrol","Maxidex"],"cross_references":[{"source":"ChEBI","ids":[68637]},{"source":"DailyMed","ids":["dexamethasone%20sodium%20phosphate"]},{"source":"PubChem","ids":["26663018","855520"]},{"source":"ChEBI","ids":[4462]},{"source":"PubChem","ids":["144206732","144212903"]}],"canonical_smiles":"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O","indications":[{"efo_id":"EFO_0001059","efo_label":"cataract","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001059","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01515826","NCT01602068","NCT02571556"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01515826%22OR%22NCT01602068%22OR%22NCT02571556%22"]}]},{"efo_id":"EFO_1000811","efo_label":"anterior uveitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000811","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00694135","NCT02517619"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00694135%22OR%22NCT02517619%22"]}]},{"efo_id":"EFO_1000906","efo_label":"dry eye syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000906","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00765804","NCT01129856"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00765804%22OR%22NCT01129856%22"]}]},{"efo_id":"EFO_0009560","efo_label":"otitis externa","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009560","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00750633"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00750633%22"]}]},{"efo_id":"EFO_0005752","efo_label":"eye inflammation","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005752","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["S01BA01","S01CB01"],"urls":["https://www.whocc.no/atc_ddd_index/?code=S01BA01","https://www.whocc.no/atc_ddd_index/?code=S01CB01"]}]},{"efo_id":"EFO_0000270","efo_label":"asthma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000270","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT02192827"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02192827%22"]},{"source":"DailyMed","ids":["2b626a48-c7aa-4443-9164-a08ff069ccd1","6d3cbd54-93ef-40fe-b15a-7a4f52dc5f71","cca2c160-9188-48e8-9505-49a52388dcb7","dff598e8-e662-411f-978d-4ba3fb8ef7db","ff045cba-f55a-4368-8045-d783694adb85"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2b626a48-c7aa-4443-9164-a08ff069ccd1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6d3cbd54-93ef-40fe-b15a-7a4f52dc5f71","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cca2c160-9188-48e8-9505-49a52388dcb7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ff045cba-f55a-4368-8045-d783694adb85"]},{"source":"FDA","ids":["49476f92-e4ea-4594-9d2c-274115c1ab40","5aa947fa-af28-483e-8104-0f1fadb8879a","836f8017-d023-410b-8515-ec776e73ca59","92e9aa9f-06f8-4be3-9273-1f11cde13c5a","a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A49476f92-e4ea-4594-9d2c-274115c1ab40","https://api.fda.gov/drug/label.json?search=set_id%3A5aa947fa-af28-483e-8104-0f1fadb8879a","https://api.fda.gov/drug/label.json?search=set_id%3A836f8017-d023-410b-8515-ec776e73ca59","https://api.fda.gov/drug/label.json?search=set_id%3A92e9aa9f-06f8-4be3-9273-1f11cde13c5a","https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"HP_0001742","efo_label":"Nasal obstruction","efo_uri":"http://purl.obolibrary.org/obo/HP_0001742","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["R01AD03","R01AD53"],"urls":["https://www.whocc.no/atc_ddd_index/?code=R01AD03","https://www.whocc.no/atc_ddd_index/?code=R01AD53"]}]},{"efo_id":"EFO_0003894","efo_label":"acne","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003894","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["D10AA03"],"urls":["https://www.whocc.no/atc_ddd_index/?code=D10AA03"]}]},{"efo_id":"EFO_0000685","efo_label":"rheumatoid arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000685","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0000729","efo_label":"ulcerative colitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000729","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["2b626a48-c7aa-4443-9164-a08ff069ccd1","65428186-5fbb-4e1a-ae60-8824f3d62179","6d3cbd54-93ef-40fe-b15a-7a4f52dc5f71","94472ddb-ae1d-4a11-a673-81254d562e6b","b7d58d9b-e1fa-4a7f-afca-beb06d028057","cca2c160-9188-48e8-9505-49a52388dcb7","d3fd1d51-7749-4e1e-a8b5-8a151392f66d","dff598e8-e662-411f-978d-4ba3fb8ef7db","ff045cba-f55a-4368-8045-d783694adb85"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2b626a48-c7aa-4443-9164-a08ff069ccd1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?65428186-5fbb-4e1a-ae60-8824f3d62179","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6d3cbd54-93ef-40fe-b15a-7a4f52dc5f71","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?94472ddb-ae1d-4a11-a673-81254d562e6b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b7d58d9b-e1fa-4a7f-afca-beb06d028057","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cca2c160-9188-48e8-9505-49a52388dcb7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d3fd1d51-7749-4e1e-a8b5-8a151392f66d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ff045cba-f55a-4368-8045-d783694adb85"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0002609","efo_label":"juvenile idiopathic arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002609","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0003106","efo_label":"pneumonia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003106","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0003898","efo_label":"ankylosing spondylitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003898","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0004719","efo_label":"pemphigus vulgaris","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004719","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0005558","efo_label":"hemolytic anemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005558","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0007257","efo_label":"eosinophilic pneumonia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007257","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_1000039","efo_label":"meningeal tuberculosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000039","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_1000694","efo_label":"erythema multiforme","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000694","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_1000997","efo_label":"iritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000997","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_1001205","efo_label":"sympathetic ophthalmia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001205","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_1001435","efo_label":"Tenosynovitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001435","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"HP_0001873","efo_label":"Thrombocytopenia","efo_uri":"http://purl.obolibrary.org/obo/HP_0001873","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"MP_0001845","efo_label":"inflammation","efo_uri":"http://purl.obolibrary.org/obo/MP_0001845","max_phase_for_indication":4,"references":[{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"Orphanet_797","efo_label":"Sarcoidosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_797","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"Orphanet_90794","efo_label":"Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","efo_uri":"http://www.orpha.net/ORDO/Orphanet_90794","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0003956","efo_label":"seasonal allergic rhinitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003956","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]}]},{"efo_id":"EFO_0004274","efo_label":"gout","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004274","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0007520","efo_label":"trichinosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007520","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_1000049","efo_label":"pulmonary tuberculosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000049","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_1000845","efo_label":"brain edema","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000845","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_1000941","efo_label":"frozen shoulder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000941","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0000676","efo_label":"psoriasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000676","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0003778","efo_label":"psoriatic arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003778","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0004276","efo_label":"Stevens-Johnson syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004276","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0005319","efo_label":"contact dermatitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005319","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0005854","efo_label":"allergic rhinitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005854","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0007160","efo_label":"autoimmune thrombocytopenic purpura","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007160","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_1000764","efo_label":"seborrheic dermatitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000764","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_1001194","efo_label":"subacute thyroiditis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001194","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"HP_0001915","efo_label":"Aplastic anemia","efo_uri":"http://purl.obolibrary.org/obo/HP_0001915","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"HP_0004398","efo_label":"Peptic ulcer","efo_uri":"http://purl.obolibrary.org/obo/HP_0004398","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0002506","efo_label":"osteoarthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002506","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["2b626a48-c7aa-4443-9164-a08ff069ccd1","65428186-5fbb-4e1a-ae60-8824f3d62179","6d3cbd54-93ef-40fe-b15a-7a4f52dc5f71","94472ddb-ae1d-4a11-a673-81254d562e6b","b7d58d9b-e1fa-4a7f-afca-beb06d028057","cca2c160-9188-48e8-9505-49a52388dcb7","d3fd1d51-7749-4e1e-a8b5-8a151392f66d","dff598e8-e662-411f-978d-4ba3fb8ef7db","ff045cba-f55a-4368-8045-d783694adb85"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2b626a48-c7aa-4443-9164-a08ff069ccd1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?65428186-5fbb-4e1a-ae60-8824f3d62179","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6d3cbd54-93ef-40fe-b15a-7a4f52dc5f71","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?94472ddb-ae1d-4a11-a673-81254d562e6b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b7d58d9b-e1fa-4a7f-afca-beb06d028057","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cca2c160-9188-48e8-9505-49a52388dcb7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d3fd1d51-7749-4e1e-a8b5-8a151392f66d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ff045cba-f55a-4368-8045-d783694adb85"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0002690","efo_label":"systemic lupus erythematosus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002690","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0007403","efo_label":"ophthalmic herpes zoster","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007403","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_1001119","efo_label":"posterior uveitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001119","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0000565","efo_label":"leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000565","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0004255","efo_label":"nephrotic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004255","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0007405","efo_label":"optic neuritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007405","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0000384","efo_label":"Crohn's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000384","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["2b626a48-c7aa-4443-9164-a08ff069ccd1","65428186-5fbb-4e1a-ae60-8824f3d62179","6d3cbd54-93ef-40fe-b15a-7a4f52dc5f71","94472ddb-ae1d-4a11-a673-81254d562e6b","b7d58d9b-e1fa-4a7f-afca-beb06d028057","cca2c160-9188-48e8-9505-49a52388dcb7","d3fd1d51-7749-4e1e-a8b5-8a151392f66d","dff598e8-e662-411f-978d-4ba3fb8ef7db","ff045cba-f55a-4368-8045-d783694adb85"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2b626a48-c7aa-4443-9164-a08ff069ccd1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?65428186-5fbb-4e1a-ae60-8824f3d62179","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6d3cbd54-93ef-40fe-b15a-7a4f52dc5f71","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?94472ddb-ae1d-4a11-a673-81254d562e6b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b7d58d9b-e1fa-4a7f-afca-beb06d028057","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cca2c160-9188-48e8-9505-49a52388dcb7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d3fd1d51-7749-4e1e-a8b5-8a151392f66d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ff045cba-f55a-4368-8045-d783694adb85"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_1001051","efo_label":"mycosis fungoides","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001051","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0000274","efo_label":"atopic eczema","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000274","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["2b626a48-c7aa-4443-9164-a08ff069ccd1","65428186-5fbb-4e1a-ae60-8824f3d62179","6d3cbd54-93ef-40fe-b15a-7a4f52dc5f71","94472ddb-ae1d-4a11-a673-81254d562e6b","b7d58d9b-e1fa-4a7f-afca-beb06d028057","cca2c160-9188-48e8-9505-49a52388dcb7","d3fd1d51-7749-4e1e-a8b5-8a151392f66d","dff598e8-e662-411f-978d-4ba3fb8ef7db","ff045cba-f55a-4368-8045-d783694adb85"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2b626a48-c7aa-4443-9164-a08ff069ccd1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?65428186-5fbb-4e1a-ae60-8824f3d62179","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6d3cbd54-93ef-40fe-b15a-7a4f52dc5f71","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?94472ddb-ae1d-4a11-a673-81254d562e6b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b7d58d9b-e1fa-4a7f-afca-beb06d028057","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cca2c160-9188-48e8-9505-49a52388dcb7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d3fd1d51-7749-4e1e-a8b5-8a151392f66d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ff045cba-f55a-4368-8045-d783694adb85"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0007141","efo_label":"allergic conjunctivitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007141","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_1000684","efo_label":"dermatitis herpetiformis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000684","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"HP_0003072","efo_label":"Hypercalcemia","efo_uri":"http://purl.obolibrary.org/obo/HP_0003072","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dff598e8-e662-411f-978d-4ba3fb8ef7db"]},{"source":"FDA","ids":["a760c03f-c675-4d63-a20e-0600a980130b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aa760c03f-c675-4d63-a20e-0600a980130b"]}]},{"efo_id":"EFO_0000556","efo_label":"ischemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000556","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02479555","NCT02479620"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02479555%22OR%22NCT02479620%22"]}]},{"efo_id":"EFO_0003929","efo_label":"relapsing-remitting multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003929","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00674141"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00674141%22"]}]},{"efo_id":"EFO_1000811","efo_label":"anterior uveitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000811","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02309385"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02309385%22"]}]},{"efo_id":"EFO_1001250","efo_label":"rotator cuff tear","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001250","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01688362"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01688362%22"]}]},{"efo_id":"EFO_1000999","efo_label":"joint disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000999","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT04084912"],"urls":["https://clinicaltrials.gov/search?id=%22NCT04084912%22"]}]}],"adverse_events":{"significant":[{"event":"febrile neutropenia","count":19204,"llr":1396.730105},{"event":"plasma cell myeloma","count":7205,"llr":1333.658256},{"event":"neutropenia","count":41585,"llr":1332.507685},{"event":"thrombocytopenia","count":35327,"llr":1297.510451},{"event":"febrile bone marrow aplasia","count":1608,"llr":1070.641444},{"event":"neuropathy peripheral","count":20261,"llr":1017.917988},{"event":"pneumonia","count":65209,"llr":557.1192318},{"event":"hyperglycaemia","count":9767,"llr":475.5900658}],"critval":473.7803149},"child_chembl_ids":["CHEMBL1200637","CHEMBL2021430"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000113580","approved_name":"nuclear receptor subfamily 3 group C member 1","approved_symbol":"NR3C1"}],"target_type":"single protein","target_name":"Glucocorticoid receptor","action_type":"agonist","description":"Glucocorticoid receptor agonist","references":[{"source":"DailyMed","ids":["setid=5564ee46-7bd7-4b2a-ad51-d01f7fda0461#nlm34090-1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5564ee46-7bd7-4b2a-ad51-d01f7fda0461#nlm34090-1"]}]}],"number_of_indications":60,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":19},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":13},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":12},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":9},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":9},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":8},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":7},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":7},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":7},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":6},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":4},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":2},{"therapeutic_code":"MONDO_0021205","therapeutic_label":"disease of ear","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1972860","_score":1,"_source":{"id":"CHEMBL1972860","internal_compound":false,"type":"Small molecule","pref_name":"ELESCLOMOL","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Elesclomol","GSK-842879","GSK-842879A","STA-4783"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[79369]},{"source":"PubChem","ids":["137275831","445356"]},{"source":"Wikipedia","ids":["Elesclomol"]},{"source":"drugbank","ids":["DB05719"]}],"canonical_smiles":"CN(NC(=O)CC(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1","indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00827203"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00827203%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01280786"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01280786%22"]}]},{"efo_id":"EFO_0000756","efo_label":"melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000756","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00084214","NCT00522834"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00084214%22OR%22NCT00522834%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00808418"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00808418%22"]}]},{"efo_id":"EFO_1001968","efo_label":"soft tissue sarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001968","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00087997"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00087997%22"]}]}],"adverse_events":{"significant":[{"event":"abdominal wall abscess","count":233,"llr":8.32277838}],"critval":6.296047617},"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":5},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2106978","_score":1,"_source":{"id":"CHEMBL2106978","internal_compound":false,"type":"Small molecule","pref_name":"POTASSIUM GLUCONATE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["E-577","Gluconic acid potassium salt","INS NO.577","INS-577","Potassium Gluconate"],"trade_names":["Kaon","Katorin"],"cross_references":[{"source":"DrugCentral","ids":["4524"]},{"source":"PubChem","ids":["144209972"]},{"source":"drugbank","ids":["DB13620"]}],"canonical_smiles":"O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[K+]","indications":[{"efo_id":"EFO_0003888","efo_label":"attention deficit hyperactivity disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003888","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03563573"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03563573%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3833357","_score":1,"_source":{"id":"CHEMBL3833357","internal_compound":false,"type":"Antibody","pref_name":"BEGELOMAB","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["BT 5/9","Begelomab","SAND-26"],"trade_names":["Begedina"],"indications":[{"efo_id":"EFO_0004599","efo_label":"acute graft vs. host disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004599","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02411084"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02411084%22"]}]},{"efo_id":"EFO_0000540","efo_label":"immune system disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000540","max_phase_for_indication":3,"references":[{"source":"ATC","ids":["L04AA35"],"urls":["https://www.whocc.no/atc_ddd_index/?code=L04AA35"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000197635","approved_name":"dipeptidyl peptidase 4","approved_symbol":"DPP4"}],"target_type":"single protein","target_name":"Dipeptidyl peptidase IV","action_type":"inhibitor","description":"Dipeptidyl peptidase IV inhibitor","references":[{"source":"Other","ids":["http://www.ema.europa.eu/docs/en_GB/document_library/Application_withdrawal_assessment_report/human/004144/WC500219766.pdf","https://www.karger.com/Article/Pdf/206319"],"urls":["http://www.ema.europa.eu/docs/en_GB/document_library/Application_withdrawal_assessment_report/human/004144/WC500219766.pdf","https://www.karger.com/Article/Pdf/206319"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":2}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3234681","_score":1,"_source":{"id":"CHEMBL3234681","internal_compound":false,"type":"Small molecule","pref_name":"TEDALINAB","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["GRC-10693","Tedalinab"],"trade_names":[],"canonical_smiles":"CC(C)(C)NC(=O)c1nn(-c2ccc(F)cc2F)c2c1[C@H]1CC[C@@H]2C1","mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000188822","approved_name":"cannabinoid receptor 2","approved_symbol":"CNR2"}],"target_type":"single protein","target_name":"Cannabinoid CB2 receptor","action_type":"agonist","description":"Cannabinoid CB2 receptor agonist","references":[{"source":"Other","ids":["http://www.glenmarkpharma.com/gln_nws/pdf/glenmark_molecule_GRC_10693.pdf"],"urls":["http://www.glenmarkpharma.com/gln_nws/pdf/glenmark_molecule_GRC_10693.pdf"]},{"source":"PubMed","ids":["14638775"],"urls":["https://europepmc.org/search?query=EXT_ID%3A14638775"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109480","_score":1,"_source":{"id":"CHEMBL2109480","internal_compound":false,"type":"Antibody","pref_name":"AHN-12","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AHN-12"],"trade_names":[],"indications":[{"efo_id":"EFO_0000198","efo_label":"myelodysplastic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000198","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00618696","NCT01207076"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00618696%22OR%22NCT01207076%22"]}]},{"efo_id":"EFO_0000220","efo_label":"acute lymphoblastic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000220","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01207076"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01207076%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01207076"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01207076%22"]}]},{"efo_id":"EFO_0000339","efo_label":"chronic myelogenous leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000339","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01207076"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01207076%22"]}]},{"efo_id":"EFO_0000565","efo_label":"leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000565","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00618696"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00618696%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000081237","approved_name":"protein tyrosine phosphatase receptor type C","approved_symbol":"PTPRC"}],"target_type":"single protein","target_name":"Leukocyte common antigen","action_type":"binding agent","description":"Leukocyte common antigen binding agent","references":[{"source":"PubMed","ids":["12804039"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12804039"]}]}],"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":5},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":5},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":4},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":4},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":4}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL290960","_score":1,"_source":{"id":"CHEMBL290960","internal_compound":false,"type":"Small molecule","pref_name":"NIFURTIMOX","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["BAY-2502","BAY-A2502","BAYER-2502","DNDI1613515","Nifurtimox"],"trade_names":["Lampit"],"cross_references":[{"source":"ChEBI","ids":[7566]},{"source":"Wikipedia","ids":["Nifurtimox"]},{"source":"drugbank","ids":["DB11820"]}],"canonical_smiles":"CC1CS(=O)(=O)CCN1/N=C/c1ccc([N+](=O)[O-])o1","indications":[{"efo_id":"DOID_10113","efo_label":"trypanosomiasis","efo_uri":"http://purl.obolibrary.org/obo/DOID_10113","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00146627","NCT00330148","NCT00489658"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00146627%22OR%22NCT00330148%22OR%22NCT00489658%22"]}]},{"efo_id":"EFO_0000621","efo_label":"neuroblastoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000621","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00486564"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00486564%22"]}]},{"efo_id":"EFO_0005225","efo_label":"human african trypanosomiasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005225","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01685827"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01685827%22"]}]},{"efo_id":"EFO_0008559","efo_label":"American trypanosomiasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008559","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01927224","NCT02369978","NCT02606864","NCT02625974","NCT03334838","NCT03350295","NCT03981523"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01927224%22OR%22NCT02369978%22OR%22NCT02606864%22OR%22NCT02625974%22OR%22NCT03334838%22OR%22NCT03350295%22OR%22NCT03981523%22"]}]}],"adverse_events":{"significant":[{"event":"neuroblastoma","count":70,"llr":8.662269377},{"event":"fungal sepsis","count":113,"llr":8.183410426}],"critval":8.020019131},"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":3},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297888","_score":1,"_source":{"id":"CHEMBL4297888","internal_compound":false,"type":"Unknown","pref_name":"APX-005M","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["APX-005","APX-005M","APX005M","Apx-005m","Apx005m","EPI-0050"],"trade_names":[],"indications":[{"efo_id":"EFO_0000756","efo_label":"melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000756","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02706353"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02706353%22"]}]},{"efo_id":"EFO_0002617","efo_label":"metastatic melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002617","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03597282"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03597282%22"]}]},{"efo_id":"EFO_0002916","efo_label":"esophageal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002916","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03165994"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03165994%22"]}]},{"efo_id":"EFO_1001968","efo_label":"soft tissue sarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001968","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03719430"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03719430%22"]}]}],"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":4},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1200928","_score":1,"_source":{"id":"CHEMBL1200928","internal_compound":false,"type":"Small molecule","pref_name":"ZINC ACETATE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["E650","NPC-02","NSC-75801","Npc-02","Zinc Acetate","Zinc acetate","Zinc acetate dihydrate","Zinc acetate hydrate"],"trade_names":["Galzin","Wilzin"],"cross_references":[{"source":"ChEBI","ids":[62984]},{"source":"DailyMed","ids":["zinc%20acetate"]},{"source":"DrugCentral","ids":["4269"]},{"source":"PubChem","ids":["144212333"]},{"source":"Wikipedia","ids":["Zinc_acetate"]},{"source":"drugbank","ids":["DB14487"]},{"source":"PubChem","ids":["144208062"]}],"canonical_smiles":"CC(=O)[O-].CC(=O)[O-].[Zn+2]","indications":[{"efo_id":"EFO_0003106","efo_label":"pneumonia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003106","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00373100"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00373100%22"]}]},{"efo_id":"EFO_1001904","efo_label":"oral mucositis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001904","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02868151"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02868151%22"]}]},{"efo_id":"HP_0012735","efo_label":"Cough","efo_uri":"http://purl.obolibrary.org/obo/HP_0012735","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03135522"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03135522%22"]}]},{"efo_id":"Orphanet_905","efo_label":"Wilson disease","efo_uri":"http://www.orpha.net/ORDO/Orphanet_905","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00212355","NCT00212368"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00212355%22OR%22NCT00212368%22"]}]}],"adverse_events":{"significant":[{"event":"toxicity to various agents","count":31033,"llr":274.8533611},{"event":"electrocardiogram qt prolonged","count":12378,"llr":227.8617289},{"event":"anticholinergic syndrome","count":527,"llr":176.9443082},{"event":"compartment syndrome","count":919,"llr":145.4350942},{"event":"temperature regulation disorder","count":351,"llr":134.627892},{"event":"somnolence","count":38949,"llr":126.1623061},{"event":"suicide attempt","count":20244,"llr":117.1286458},{"event":"mydriasis","count":3319,"llr":113.4502387},{"event":"tachycardia","count":26994,"llr":109.5221154},{"event":"drug abuse","count":14574,"llr":98.01607622},{"event":"agitation","count":21093,"llr":89.99441245},{"event":"delirium","count":11053,"llr":87.56313026},{"event":"sinus tachycardia","count":5084,"llr":86.58671009},{"event":"mental status changes","count":10001,"llr":80.97006726},{"event":"cardiac arrest","count":9359,"llr":75.41849689},{"event":"unresponsive to stimuli","count":6342,"llr":72.53433674},{"event":"serotonin syndrome","count":6002,"llr":71.40063256},{"event":"food allergy","count":950,"llr":69.93096561},{"event":"infusion related reaction","count":15012,"llr":68.86753121},{"event":"tachypnoea","count":3857,"llr":62.90069809},{"event":"coeliac disease","count":1393,"llr":62.02263672},{"event":"immunodeficiency","count":1426,"llr":61.54059668},{"event":"generalised tonic-clonic seizure","count":4083,"llr":61.37200545},{"event":"hallucination","count":16074,"llr":59.09364429},{"event":"torsade de pointes","count":3618,"llr":58.13348526},{"event":"seizure","count":19835,"llr":57.15628935},{"event":"hypotension","count":55121,"llr":55.37290379},{"event":"mucosal dryness","count":541,"llr":53.27005761},{"event":"hyperhidrosis","count":28377,"llr":51.80071215},{"event":"bursitis","count":2524,"llr":49.87119282},{"event":"gastrointestinal sounds abnormal","count":756,"llr":48.31389595},{"event":"muscle rigidity","count":3651,"llr":45.45126197},{"event":"blood pressure fluctuation","count":3754,"llr":44.86930233},{"event":"electrocardiogram qrs complex prolonged","count":1553,"llr":44.86398312},{"event":"metabolic acidosis","count":8683,"llr":44.00622512},{"event":"rheumatoid arthritis","count":23147,"llr":43.20781867},{"event":"heart rate increased","count":16145,"llr":37.70522175},{"event":"flushing","count":18642,"llr":37.27585969},{"event":"myoclonus","count":4355,"llr":36.17387894},{"event":"fatigue","count":147738,"llr":35.87768007},{"event":"loss of consciousness","count":30434,"llr":35.1408826},{"event":"acute hepatic failure","count":3420,"llr":34.84987084},{"event":"vitamin k deficiency","count":166,"llr":32.77289792},{"event":"vanishing twin syndrome","count":33,"llr":32.514157},{"event":"sedation","count":6964,"llr":32.21323084},{"event":"hypertension","count":52519,"llr":31.81801132},{"event":"rash erythematous","count":9868,"llr":31.6859337},{"event":"rhabdomyolysis","count":16457,"llr":31.39554049},{"event":"coma","count":13175,"llr":31.21635167},{"event":"lethargy","count":17134,"llr":30.3427268},{"event":"pneumonia aspiration","count":5215,"llr":30.27503203},{"event":"pupil fixed","count":403,"llr":30.01479955},{"event":"infusion site streaking","count":16,"llr":29.79751994},{"event":"adrenergic syndrome","count":18,"llr":29.20919751},{"event":"cardiogenic shock","count":2837,"llr":29.08858808},{"event":"hyperthermia","count":2914,"llr":28.70953155},{"event":"clonus","count":1049,"llr":28.54242602},{"event":"ventricular tachycardia","count":5901,"llr":28.12805775},{"event":"confusional state","count":40628,"llr":28.06112661},{"event":"defect conduction intraventricular","count":88,"llr":26.64546776},{"event":"hypersensitivity","count":35921,"llr":26.59043117},{"event":"drug hypersensitivity","count":71246,"llr":26.47030774},{"event":"anxiety","count":45966,"llr":26.45286592},{"event":"dry mouth","count":12994,"llr":25.71904702},{"event":"pulseless electrical activity","count":675,"llr":25.45315472},{"event":"microcephaly","count":428,"llr":25.27326471},{"event":"reduced facial expression","count":114,"llr":25.099997},{"event":"fluid retention","count":10070,"llr":25.00826315},{"event":"electric shock","count":147,"llr":23.58436411},{"event":"abdominal compartment syndrome","count":149,"llr":23.50387403},{"event":"poisoning","count":1688,"llr":23.49809655},{"event":"foetal growth restriction","count":1834,"llr":22.62865324},{"event":"dystonia","count":4697,"llr":22.07287225},{"event":"salivary hypersecretion","count":2562,"llr":21.88867341},{"event":"corneal neovascularisation","count":81,"llr":21.70748207},{"event":"psychomotor hyperactivity","count":4158,"llr":21.27032916},{"event":"upper respiratory tract infection","count":12359,"llr":21.17234573},{"event":"tremor","count":36500,"llr":20.77042236},{"event":"drug dependence","count":7072,"llr":20.71297633},{"event":"postural tremor","count":99,"llr":20.70946338},{"event":"hepatic enzyme increased","count":17239,"llr":19.8927333},{"event":"hallucination, visual","count":5602,"llr":19.69609039},{"event":"exposure via ingestion","count":124,"llr":19.59106427},{"event":"dysarthria","count":11020,"llr":19.55929579},{"event":"scratch","count":1371,"llr":19.28151047},{"event":"erythema","count":35163,"llr":19.22755064},{"event":"dry throat","count":1427,"llr":18.93774939},{"event":"hypoxia","count":9218,"llr":18.70406412},{"event":"feeding disorder neonatal","count":618,"llr":18.67689708},{"event":"respiratory disorder neonatal","count":618,"llr":18.67689708},{"event":"hypoglycaemia","count":14252,"llr":18.59162965},{"event":"pupillary reflex impaired","count":632,"llr":18.52423308},{"event":"urinary retention","count":9378,"llr":18.44130335},{"event":"cough","count":52232,"llr":17.68158992},{"event":"prothrombin time prolonged","count":2966,"llr":17.67471899},{"event":"corneal perforation","count":186,"llr":17.58211441}],"critval":17.15116847},"child_chembl_ids":["CHEMBL3184986"],"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":2},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL17350","_score":1,"_source":{"id":"CHEMBL17350","internal_compound":false,"type":"Small molecule","pref_name":"TRAXOPRODIL","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["CP-101,606","CP-101606","CP-101606-27","Traxoprodil","Traxoprodil Mesylate"],"trade_names":[],"cross_references":[{"source":"Wikipedia","ids":["Traxoprodil"]}],"canonical_smiles":"C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(O)(c2ccccc2)CC1","indications":[{"efo_id":"EFO_0000712","efo_label":"stroke","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000712","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00073476"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00073476%22"]}]},{"efo_id":"EFO_0002508","efo_label":"Parkinson's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002508","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00163085"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00163085%22"]}]},{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00163059"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00163059%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000176884","approved_name":"glutamate ionotropic receptor NMDA type subunit 1","approved_symbol":"GRIN1"},{"ensembl":"ENSG00000273079","approved_name":"glutamate ionotropic receptor NMDA type subunit 2B","approved_symbol":"GRIN2B"}],"target_type":"protein complex","target_name":"Glutamate NMDA receptor; GRIN1/GRIN2B","action_type":"antagonist","description":"Glutamate NMDA receptor; GRIN1/GRIN2B antagonist","references":[{"source":"DOI","ids":["10.1111/j.1527-3458.1998.tb00073.x"],"urls":["http://dx.doi.org/10.1111/j.1527-3458.1998.tb00073.x"]},{"source":"PubMed","ids":["11897110","21699507"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11897110+OR+EXT_ID%3A21699507"]}]}],"child_chembl_ids":["CHEMBL3989673"],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":3},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3546271","_score":1,"_source":{"id":"CHEMBL3546271","internal_compound":false,"type":"Small molecule","pref_name":"FLORTAUCIPIR","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["(F-18)T807","18F-AV-1451","AV-1451 F-18","Flortaucipir","Flortaucipir (18f)","Flortaucipir F-18","LY-3191748","T-807","T-807 F-18","T807","T807 F-18","[F-18]T807"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB15033"]},{"source":"drugbank","ids":["DB14914"]}],"canonical_smiles":"Fc1ccc(-c2ccc3c(c2)[nH]c2ccncc23)cn1","indications":[{"efo_id":"EFO_0000249","efo_label":"Alzheimer's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000249","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03019536"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03019536%22"]}]}],"child_chembl_ids":["CHEMBL3545253"],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL20684","_score":1,"_source":{"id":"CHEMBL20684","internal_compound":false,"type":"Small molecule","pref_name":"ABT-751","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["ABT-751","Abt-751","E 7010","E-7010"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12254"]}],"canonical_smiles":"COc1ccc(S(=O)(=O)Nc2cccnc2Nc2ccc(O)cc2)cc1","indications":[{"efo_id":"EFO_0000220","efo_label":"acute lymphoblastic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000220","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00439296"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00439296%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00063102"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00063102%22"]}]},{"efo_id":"EFO_0000621","efo_label":"neuroblastoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000621","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00436852"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00436852%22"]}]},{"efo_id":"EFO_0000681","efo_label":"renal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000681","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00073112"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00073112%22"]}]},{"efo_id":"EFO_0001642","efo_label":"lymphoid neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001642","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00047489"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00047489%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00471718"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00471718%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00073151","NCT00297089","NCT00354562"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00073151%22OR%22NCT00297089%22OR%22NCT00354562%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00073138"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00073138%22"]}]}],"adverse_events":{"significant":[{"event":"neuropathy peripheral","count":20261,"llr":18.67065631},{"event":"hypokalaemia","count":14556,"llr":15.11347773}],"critval":11.49602786},"child_chembl_ids":["CHEMBL1830238"],"number_of_indications":8,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":8},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":2},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":2},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL345237","_score":1,"_source":{"id":"CHEMBL345237","internal_compound":false,"type":"Small molecule","pref_name":"PICLOZOTAN","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Piclozotan","SUN-N-4057","SUN-N4057"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12361"]}],"canonical_smiles":"O=C1c2ccccc2OC=C(Cl)N1CCCCN1CC=C(c2ccccn2)CC1","indications":[{"efo_id":"EFO_0000712","efo_label":"stroke","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000712","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00272909"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00272909%22"]}]},{"efo_id":"EFO_0002508","efo_label":"Parkinson's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002508","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00623363"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00623363%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000178394","approved_name":"5-hydroxytryptamine receptor 1A","approved_symbol":"HTR1A"}],"target_type":"single protein","target_name":"Serotonin 1a (5-HT1a) receptor","action_type":"agonist","description":"Serotonin 1a (5-HT1a) receptor agonist","references":[{"source":"PubMed","ids":["11229779","16290165"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11229779+OR+EXT_ID%3A16290165"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":2},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1191","_score":1,"_source":{"id":"CHEMBL1191","internal_compound":false,"type":"Small molecule","pref_name":"SULFAMETHIZOLE","year_first_approved":1953,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Sulfamethizole","Sulphamethizole"],"trade_names":["Methazol","Microsul","Proklar","Sulphamethylthiadiazole","Tetracid","Thiosulfil","Urolucosil"],"cross_references":[{"source":"ChEBI","ids":[9331]},{"source":"PubChem","ids":["11112301","144203976","144208233","170465369","17389528","856011"]},{"source":"Wikipedia","ids":["Sulfamethizole"]},{"source":"drugbank","ids":["DB00576"]}],"canonical_smiles":"Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1","indications":[{"efo_id":"EFO_0003102","efo_label":"osteomyelitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003102","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT02099240"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02099240%22"]}]}],"mechanisms_of_action":[{"target_type":"single protein","target_name":"Bacterial dihydropteroate synthase","action_type":"inhibitor","description":"Bacterial dihydropteroate synthase inhibitor","references":[{"source":"KEGG","ids":["D00870"],"urls":["https://www.genome.jp/dbget-bin/www_bget?dr:D00870"]},{"source":"PubMed","ids":["2372557"],"urls":["https://europepmc.org/search?query=EXT_ID%3A2372557"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL170","_score":1,"_source":{"id":"CHEMBL170","internal_compound":false,"type":"Small molecule","pref_name":"QUININE","year_first_approved":2005,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["FEMA NO. 2977","GNF-Pf-506","NSC-192949","Quinine","Quinine Ascorbate","Quinine Biascorbate","Quinine Bisulfate","Quinine Dihydrochloride","Quinine Glycerophosphate","Quinine HCl","Quinine Hydrobromide","Quinine Phosphate","Quinine Salicylate","Quinine Sulfate","Quinine sulfate","Quinine sulfate dihydrate","Quinine sulfate hydrate","TCMDC-123939","WR297608"],"trade_names":["Qualaquin","Quinate","Quinine Sulfate"],"cross_references":[{"source":"ChEBI","ids":[15854]},{"source":"DailyMed","ids":["quinine%20sulfate"]},{"source":"Wikipedia","ids":["Quinine"]},{"source":"drugbank","ids":["DB00468"]},{"source":"PubChem","ids":["56320921"]},{"source":"ChEBI","ids":[52251]},{"source":"PubChem","ids":["144206988"]},{"source":"PubChem","ids":["56320740","56323657"]}],"canonical_smiles":"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12","indications":[{"efo_id":"EFO_0001068","efo_label":"malaria","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001068","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00124267","NCT00322907","NCT00329134","NCT01374581","NCT02492178","NCT02563704","NCT02974348"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00124267%22OR%22NCT00322907%22OR%22NCT00329134%22OR%22NCT01374581%22OR%22NCT02492178%22OR%22NCT02563704%22OR%22NCT02974348%22"]}]},{"efo_id":"EFO_0007444","efo_label":"Plasmodium falciparum malaria","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007444","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00299208","NCT01047436","NCT01258049"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00299208%22OR%22NCT01047436%22OR%22NCT01258049%22"]}]},{"efo_id":"HP_0012532","efo_label":"Chronic pain","efo_uri":"http://purl.obolibrary.org/obo/HP_0012532","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02276989"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02276989%22"]}]}],"adverse_events":{"significant":[{"event":"thrombotic microangiopathy","count":2397,"llr":181.5946416},{"event":"somatic symptom disorder","count":145,"llr":106.0307367},{"event":"drug hypersensitivity","count":71246,"llr":89.77355203},{"event":"sacroiliitis","count":502,"llr":83.72144008},{"event":"retinal toxicity","count":392,"llr":82.2755957},{"event":"electrocardiogram qt prolonged","count":12378,"llr":72.73119369},{"event":"acute kidney injury","count":33030,"llr":67.15253717},{"event":"toxicity to various agents","count":31033,"llr":59.88928755},{"event":"purpura senile","count":29,"llr":53.42608884},{"event":"microangiopathic haemolytic anaemia","count":279,"llr":52.12469865},{"event":"atrioventricular block","count":2594,"llr":50.42468023},{"event":"electrocardiogram u wave present","count":19,"llr":48.76514574},{"event":"tarsal tunnel syndrome","count":54,"llr":48.45575015},{"event":"fibromyalgia","count":3651,"llr":48.39754792},{"event":"therapeutic product effect incomplete","count":2974,"llr":44.3516916},{"event":"optic atrophy","count":629,"llr":43.22665415},{"event":"cinchonism","count":14,"llr":42.69966899},{"event":"mood altered","count":5179,"llr":42.29435546},{"event":"thrombocytopenia","count":35327,"llr":39.84336824},{"event":"agitated depression","count":87,"llr":38.12349389},{"event":"vestibular disorder","count":419,"llr":37.18727649},{"event":"bradycardia","count":20091,"llr":37.15104579},{"event":"resorption bone increased","count":293,"llr":34.95651968},{"event":"hypokalaemia","count":14556,"llr":34.4731416},{"event":"drug abuse","count":14574,"llr":34.44817613},{"event":"blood sodium decreased","count":4728,"llr":33.88537018},{"event":"blindness","count":7374,"llr":33.25886632},{"event":"cognitive disorder","count":9869,"llr":31.27124816},{"event":"thrombotic thrombocytopenic purpura","count":1292,"llr":31.22646324},{"event":"plasmodium falciparum infection","count":35,"llr":30.08787462},{"event":"renal failure","count":27897,"llr":29.57485569},{"event":"haemolytic uraemic syndrome","count":1065,"llr":28.87322713},{"event":"impaired quality of life","count":377,"llr":27.89594959},{"event":"vertigo positional","count":497,"llr":25.9767704},{"event":"retinal degeneration","count":386,"llr":22.84631032},{"event":"long qt syndrome","count":841,"llr":22.33843436},{"event":"compartment syndrome","count":919,"llr":21.72747681},{"event":"thrombophlebitis superficial","count":932,"llr":21.6308006},{"event":"coma","count":13175,"llr":19.57021321},{"event":"retinitis pigmentosa","count":98,"llr":19.06412255},{"event":"disseminated intravascular coagulation","count":3330,"llr":18.8997548},{"event":"body mass index decreased","count":114,"llr":18.4612423},{"event":"back injury","count":1579,"llr":18.02245907},{"event":"vasculitis","count":3695,"llr":18.0098661},{"event":"tinnitus","count":8558,"llr":17.87695167},{"event":"blood chloride decreased","count":1115,"llr":16.57442475},{"event":"tachycardia","count":26994,"llr":15.29438636},{"event":"torsade de pointes","count":3618,"llr":15.26991496},{"event":"glaucoma","count":3701,"llr":15.09898615},{"event":"electrocardiogram u-wave abnormality","count":57,"llr":15.05565083},{"event":"retinal artery occlusion","count":821,"llr":14.41219612},{"event":"phlebitis","count":1786,"llr":13.83306504},{"event":"cerebral malaria","count":6,"llr":13.72262883},{"event":"macular dystrophy congenital","count":6,"llr":13.72262883},{"event":"increased bronchial secretion","count":401,"llr":13.4668494},{"event":"haemolysis","count":2108,"llr":12.87947795},{"event":"retinal depigmentation","count":129,"llr":12.61458248},{"event":"deafness","count":5329,"llr":12.38898073},{"event":"chronic kidney disease","count":5505,"llr":12.1513627},{"event":"ventricular tachycardia","count":5901,"llr":11.64588242},{"event":"electrocardiogram qrs complex prolonged","count":1553,"llr":11.31842402},{"event":"retinal pigment epitheliopathy","count":217,"llr":11.06559072},{"event":"retinal vascular disorder","count":223,"llr":10.98453542},{"event":"cholinergic syndrome","count":233,"llr":10.85421528},{"event":"blood amylase decreased","count":29,"llr":10.57450575},{"event":"night blindness","count":272,"llr":10.39491615},{"event":"mydriasis","count":3319,"llr":10.31008506},{"event":"sinus tachycardia","count":5084,"llr":10.28262849},{"event":"carnitine decreased","count":35,"llr":10.19917076},{"event":"fibrin d dimer increased","count":963,"llr":10.03427467},{"event":"electrocardiogram qt interval","count":39,"llr":9.983256572},{"event":"insulin c-peptide increased","count":45,"llr":9.69782436},{"event":"metabolic function test abnormal","count":49,"llr":9.528021728},{"event":"drug interaction","count":53526,"llr":9.49502258},{"event":"cholelithiasis","count":8088,"llr":9.401361645},{"event":"injection site granuloma","count":56,"llr":9.261856666},{"event":"chills","count":26715,"llr":9.204749004},{"event":"fatigue","count":147738,"llr":9.021196887},{"event":"retinopathy","count":1268,"llr":8.972670688},{"event":"aplastic anaemia","count":1397,"llr":8.60160781},{"event":"tonic convulsion","count":508,"llr":8.551085266},{"event":"atrioventricular dissociation","count":92,"llr":8.273599786},{"event":"retinal oedema","count":564,"llr":8.244534952},{"event":"hypotension","count":55121,"llr":7.98940322},{"event":"administration site calcification","count":1,"llr":7.958656276},{"event":"hyperinsulinaemia","count":109,"llr":7.93666139},{"event":"blood alkaline phosphatase increased","count":10095,"llr":7.88294334},{"event":"purpura","count":3290,"llr":7.7864712}],"critval":7.763545194},"child_chembl_ids":["CHEMBL1201100","CHEMBL1899143","CHEMBL2146083","CHEMBL2146084","CHEMBL2146088","CHEMBL2146105","CHEMBL2359966","CHEMBL3229759","CHEMBL3229764","CHEMBL3706390","CHEMBL3707252","CHEMBL3707329","CHEMBL3707332","CHEMBL588046","CHEMBL589001"],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1477036","_score":1,"_source":{"id":"CHEMBL1477036","internal_compound":false,"type":"Small molecule","pref_name":"DOCUSATE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Dioctyl Calcium Sulfosuccinate","Dioctyl Disodium Sulfosuccinate","Dioctyl Sodium Sulfosuccinate","Docusate","Docusate Calcium","Docusate Potassium","Docusate Sodium","E480","Sodium Dioctyl Sulfosuccinate"],"trade_names":["Audinorm","Clear Ear","Colace","Correctol Stool Softener Laxative","D-S-S","Dialose","Dioctyl","Docusol","Docusol 100","Doxinate","Dulcoease","Fletchers' Enemette","Klyx","Modane Soft","Molcer","Molofac","Norgalax","Rectalad Enema","Soliwax","Surfak","Waxsol"],"cross_references":[{"source":"ChEBI","ids":[534]},{"source":"PubChem","ids":["104171408","29216456"]},{"source":"Wikipedia","ids":["Dioctyl_sodium_sulfosuccinate"]},{"source":"drugbank","ids":["DB11089"]},{"source":"PubChem","ids":["144205640","144207018","144208540","144210814","26757557"]}],"canonical_smiles":"CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)O","indications":[{"efo_id":"EFO_1000948","efo_label":"gastroparesis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000948","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03342157"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03342157%22"]}]},{"efo_id":"HP_0002019","efo_label":"Constipation","efo_uri":"http://purl.obolibrary.org/obo/HP_0002019","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00571896"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00571896%22"]}]},{"efo_id":"HP_0001891","efo_label":"Iron deficiency anemia","efo_uri":"http://purl.obolibrary.org/obo/HP_0001891","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["47e3ae30-64ac-462c-95eb-2e29506d9a7b"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?47e3ae30-64ac-462c-95eb-2e29506d9a7b"]},{"source":"FDA","ids":["002df203-be22-41aa-a52c-d14ecbc00dbe"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A002df203-be22-41aa-a52c-d14ecbc00dbe"]}]},{"efo_id":"HP_0002019","efo_label":"Constipation","efo_uri":"http://purl.obolibrary.org/obo/HP_0002019","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01335386","NCT01474499"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01335386%22OR%22NCT01474499%22"]}]},{"efo_id":"EFO_0004272","efo_label":"anemia (phenotype)","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004272","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["2c9fd33d-4b38-42be-ad36-b1521ded47e1","50fa1766-1db6-4360-97b1-c1550695c75c","878e22cc-9f69-3074-3212-2b36763b2a65"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2c9fd33d-4b38-42be-ad36-b1521ded47e1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?50fa1766-1db6-4360-97b1-c1550695c75c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?878e22cc-9f69-3074-3212-2b36763b2a65"]}]}],"adverse_events":{"significant":[{"event":"pneumonia aspiration","count":5215,"llr":442.3727751},{"event":"gastrooesophageal reflux disease","count":14790,"llr":401.4641259},{"event":"coma","count":13175,"llr":372.211761},{"event":"somnolence","count":38949,"llr":292.281201},{"event":"muscle spasticity","count":3045,"llr":110.0775071},{"event":"salpingo-oophorectomy unilateral","count":28,"llr":83.77929491},{"event":"exposure via breast milk","count":444,"llr":72.20647785},{"event":"sputum increased","count":343,"llr":70.57300606},{"event":"pulmonary malformation","count":106,"llr":67.81578439},{"event":"respiratory symptom","count":428,"llr":67.26436837},{"event":"female genital tract fistula","count":437,"llr":66.95351583},{"event":"nasal polyps","count":447,"llr":66.61557645},{"event":"embolism venous","count":679,"llr":60.37808495},{"event":"diastolic dysfunction","count":1012,"llr":59.10647093},{"event":"sinusitis fungal","count":150,"llr":57.38606615},{"event":"gangrene neonatal","count":9,"llr":53.01093045},{"event":"chronic sinusitis","count":774,"llr":48.76888339},{"event":"emphysema","count":1683,"llr":46.90716986},{"event":"burkholderia test positive","count":11,"llr":43.30417314},{"event":"obstructive airways disorder","count":2421,"llr":41.55956418},{"event":"tricuspid valve incompetence","count":2442,"llr":41.43304268},{"event":"hypertonia","count":2565,"llr":40.71366752},{"event":"diverticulum","count":2754,"llr":39.67449095},{"event":"candida infection","count":2791,"llr":39.47964485},{"event":"iron deficiency anaemia","count":3027,"llr":38.2961077},{"event":"weight decrease neonatal","count":79,"llr":37.81560374},{"event":"sleep apnoea syndrome","count":4137,"llr":37.02773366},{"event":"hiatus hernia","count":3438,"llr":36.445633},{"event":"no therapeutic response","count":5658,"llr":35.24558215},{"event":"hysterectomy","count":1755,"llr":34.37340607},{"event":"osteoarthritis","count":9922,"llr":33.99845912},{"event":"burkholderia infection","count":14,"llr":33.96567454},{"event":"skin turgor decreased","count":142,"llr":33.72016207},{"event":"osteoporosis","count":5957,"llr":31.45640991},{"event":"peripheral artery thrombosis","count":414,"llr":31.08907585},{"event":"constipation","count":39620,"llr":30.53406226},{"event":"fungal infection","count":6516,"llr":30.10187301},{"event":"moaning","count":252,"llr":29.72103399},{"event":"eczema","count":5580,"llr":29.49027137},{"event":"dyspnoea exertional","count":8279,"llr":29.15162506},{"event":"disease recurrence","count":6331,"llr":27.70465101},{"event":"peritonitis","count":3134,"llr":27.61529203},{"event":"mucosal disorder","count":55,"llr":27.13031212},{"event":"pulmonary embolism","count":25452,"llr":26.47924425},{"event":"muscle spasms","count":35356,"llr":24.65490325},{"event":"chest discomfort","count":21346,"llr":24.16585576},{"event":"weight increased","count":33631,"llr":24.06077327},{"event":"hyporesponsive to stimuli","count":286,"llr":23.79588041},{"event":"hypovolaemic shock","count":1161,"llr":22.9487693},{"event":"lower respiratory tract infection","count":8977,"llr":22.8487073},{"event":"performance status decreased","count":1191,"llr":22.74905703},{"event":"wheezing","count":9665,"llr":21.84044},{"event":"respiratory tract malformation","count":47,"llr":21.43733049},{"event":"colonic pseudo-obstruction","count":179,"llr":21.24824674},{"event":"asthma","count":16236,"llr":20.86051157},{"event":"hypernatraemia","count":1567,"llr":20.60900387},{"event":"urinary retention","count":9378,"llr":19.88196642},{"event":"bladder dilatation","count":265,"llr":19.29914799},{"event":"abdominal distension","count":15793,"llr":19.25484989},{"event":"acidosis","count":2021,"llr":18.63986917},{"event":"livedo reticularis","count":702,"llr":18.46917883},{"event":"disseminated intravascular coagulation","count":3330,"llr":17.69693748},{"event":"heart rate increased","count":16145,"llr":16.97384232},{"event":"necrosis","count":1632,"llr":16.84595387},{"event":"diabetic neuropathy","count":944,"llr":16.72748062},{"event":"abdominal pain","count":57904,"llr":16.56618569},{"event":"deep vein thrombosis","count":21525,"llr":16.54679461},{"event":"hypokalaemia","count":14556,"llr":16.40530221},{"event":"wrong product administered","count":484,"llr":16.31951427},{"event":"gangrene","count":1124,"llr":15.70671886},{"event":"oedema peripheral","count":40474,"llr":15.58561997},{"event":"sudden death","count":43,"llr":15.48029292},{"event":"dyspnoea","count":124409,"llr":15.2243447},{"event":"thyroid disorder","count":2102,"llr":15.14313434},{"event":"faecaloma","count":1343,"llr":14.67073765},{"event":"obesity","count":2349,"llr":14.40157109},{"event":"sinusitis","count":19686,"llr":14.31296928},{"event":"urinary incontinence","count":6744,"llr":14.1113706},{"event":"lung cyst","count":74,"llr":13.85626351},{"event":"musculoskeletal stiffness","count":18205,"llr":13.57814691},{"event":"partial seizures","count":1707,"llr":13.28509231},{"event":"nephrolithiasis","count":9413,"llr":13.20128731},{"event":"hypokinesia","count":2834,"llr":13.15864456},{"event":"dehydration","count":36809,"llr":12.9947057},{"event":"muscle tightness","count":2932,"llr":12.93501638},{"event":"pallor","count":6405,"llr":12.25860134},{"event":"cholestasis of pregnancy","count":138,"llr":11.99612345},{"event":"hepatic necrosis","count":1234,"llr":11.74994595},{"event":"skin discolouration","count":8819,"llr":11.73123609},{"event":"autoimmune hepatitis","count":2284,"llr":11.62251635},{"event":"respiratory distress","count":7103,"llr":11.42954074},{"event":"vomiting","count":103943,"llr":11.27563913},{"event":"femoral nerve injury","count":21,"llr":10.93973104},{"event":"lethargy","count":17134,"llr":10.8769343},{"event":"subcutaneous abscess","count":1565,"llr":10.61041389},{"event":"pre-eclampsia","count":1582,"llr":10.55888946}],"critval":10.45943262},"child_chembl_ids":["CHEMBL1905872","CHEMBL2106608","CHEMBL2107648"],"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":4},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2110686","_score":1,"_source":{"id":"CHEMBL2110686","internal_compound":false,"type":"Small molecule","pref_name":"GEMCABENE","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["CI-1027","Gemcabene","Gemcabene Calcium","PD-0072953"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB05123"]}],"canonical_smiles":"CC(C)(CCCCOCCCCC(C)(C)C(=O)O)C(=O)O","indications":[{"efo_id":"EFO_0003095","efo_label":"non-alcoholic fatty liver disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003095","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03436420"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03436420%22"]}]},{"efo_id":"HP_0003124","efo_label":"Hypercholesterolemia","efo_uri":"http://purl.obolibrary.org/obo/HP_0003124","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02571257","NCT02587364","NCT02587390","NCT02591836"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02571257%22OR%22NCT02587364%22OR%22NCT02587390%22OR%22NCT02591836%22"]}]},{"efo_id":"Orphanet_309005","efo_label":"Disorder of lipid metabolism","efo_uri":"http://www.orpha.net/ORDO/Orphanet_309005","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02587416","NCT02634151","NCT02722408"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02587416%22OR%22NCT02634151%22OR%22NCT02722408%22"]}]}],"child_chembl_ids":["CHEMBL2105057"],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108286","_score":1,"_source":{"id":"CHEMBL2108286","internal_compound":false,"type":"Protein","pref_name":"TUROCTOCOG ALFA","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Turoctocog Alfa"],"trade_names":[],"cross_references":[{"source":"DrugCentral","ids":["5019"]}],"indications":[{"efo_id":"Orphanet_98878","efo_label":"Hemophilia A","efo_uri":"http://www.orpha.net/ORDO/Orphanet_98878","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00837356","NCT00840086","NCT00984126","NCT01138501","NCT01205724","NCT01238367","NCT01365520","NCT01480180","NCT01489111","NCT01493778","NCT01692925","NCT01731600","NCT02137850","NCT02920398","NCT02938585","NCT02941354","NCT02994407","NCT03196297","NCT03528551","NCT03588741"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00837356%22OR%22NCT00840086%22OR%22NCT00984126%22OR%22NCT01138501%22OR%22NCT01205724%22OR%22NCT01238367%22OR%22NCT01365520%22OR%22NCT01480180%22OR%22NCT01489111%22OR%22NCT01493778%22OR%22NCT01692925%22OR%22NCT01731600%22OR%22NCT02137850%22OR%22NCT02920398%22OR%22NCT02938585%22OR%22NCT02941354%22OR%22NCT02994407%22OR%22NCT03196297%22OR%22NCT03528551%22OR%22NCT03588741%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2110581","_score":1,"_source":{"id":"CHEMBL2110581","internal_compound":false,"type":"Oligonucleotide","pref_name":"BEVASIRANIB","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Bevasiranib","Bevasiranib Sodium","CAND5"],"trade_names":[],"canonical_smiles":"Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@@H]3[C@@H](COP(=O)(O)O[C@@H]4[C@@H](COP(=O)(O)O[C@@H]5[C@@H](COP(=O)(O)O[C@@H]6[C@@H](COP(=O)(O)O[C@@H]7[C@@H](COP(=O)(O)O[C@@H]8[C@@H](COP(=O)(O)O[C@@H]9[C@@H](COP(=O)(O)O[C@@H]%10[C@@H](COP(=O)(O)O[C@@H]%11[C@@H](COP(=O)(O)O[C@@H]%12[C@@H](COP(=O)(O)O[C@@H]%13[C@@H](COP(=O)(O)O[C@@H]%14[C@@H](COP(=O)(O)O[C@@H]%15[C@@H](COP(=O)(O)O[C@@H]%16[C@@H](COP(=O)(O)O[C@@H]%17[C@@H](COP(=O)(O)O[C@@H]%18[C@@H](COP(=O)(O)O[C@@H]%19[C@@H](COP(=O)(O)O[C@@H]%20[C@@H](COP(=O)(O)O[C@@H]%21[C@@H](CO)O[C@@H](n%22cnc%23c(N)ncnc%23%22)[C@@H]%21O)O[C@@H](n%21ccc(N)nc%21=O)[C@@H]%20O)O[C@@H](n%20ccc(N)nc%20=O)[C@@H]%19O)O[C@@H](n%19ccc(=O)[nH]c%19=O)[C@@H]%18O)O[C@@H](n%18ccc(N)nc%18=O)[C@@H]%17O)O[C@@H](n%17cnc%18c(N)ncnc%18%17)[C@@H]%16O)O[C@@H](n%16ccc(N)nc%16=O)[C@@H]%15O)O[C@@H](n%15ccc(N)nc%15=O)[C@@H]%14O)O[C@@H](n%14cnc%15c(N)ncnc%15%14)[C@@H]%13O)O[C@@H](n%13cnc%14c(N)ncnc%14%13)[C@@H]%12O)O[C@@H](n%12cnc%13c(=O)[nH]c(N)nc%13%12)[C@@H]%11O)O[C@@H](n%11cnc%12c(=O)[nH]c(N)nc%12%11)[C@@H]%10O)O[C@@H](n%10ccc(N)nc%10=O)[C@@H]9O)O[C@@H](n9ccc(N)nc9=O)[C@@H]8O)O[C@@H](n8cnc9c(N)ncnc98)[C@@H]7O)O[C@@H](n7cnc8c(=O)[nH]c(N)nc87)[C@@H]6O)O[C@@H](n6ccc(N)nc6=O)[C@@H]5O)O[C@@H](n5cnc6c(N)ncnc65)[C@@H]4O)O[C@@H](n4ccc(N)nc4=O)[C@@H]3O)O2)c(=O)[nH]c1=O","indications":[{"efo_id":"EFO_0001365","efo_label":"age-related macular degeneration","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001365","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00557791"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00557791%22"]}]},{"efo_id":"EFO_0009606","efo_label":"macular degeneration","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009606","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00259753","NCT00499590","NCT00722384"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00259753%22OR%22NCT00499590%22OR%22NCT00722384%22"]}]}],"child_chembl_ids":["CHEMBL2103797"],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":2},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":2}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL54893","_score":1,"_source":{"id":"CHEMBL54893","internal_compound":false,"type":"Small molecule","pref_name":"UC 781","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["UC-781","Uc 781"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["515904"]},{"source":"drugbank","ids":["DB05871"]}],"canonical_smiles":"CC(C)=CCOc1cc(NC(=S)c2ccoc2C)ccc1Cl","indications":[{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00132444","NCT00408538","NCT00441909"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00132444%22OR%22NCT00408538%22OR%22NCT00441909%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545382","_score":1,"_source":{"id":"CHEMBL3545382","internal_compound":false,"type":"Small molecule","pref_name":"R-348","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["R-348"],"trade_names":[],"indications":[{"efo_id":"EFO_0004599","efo_label":"acute graft vs. host disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004599","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02040623"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02040623%22"]}]},{"efo_id":"EFO_1001001","efo_label":"keratoconjunctivitis sicca","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001001","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01733992","NCT01900249"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01733992%22OR%22NCT01900249%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000105639","approved_name":"Janus kinase 3","approved_symbol":"JAK3"}],"target_type":"single protein","target_name":"Tyrosine-protein kinase JAK3","action_type":"inhibitor","description":"Tyrosine-protein kinase JAK3 inhibitor","references":[{"source":"PubMed","ids":["18360272","19596999"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18360272+OR+EXT_ID%3A19596999"]}]},{"target_components":[{"ensembl":"ENSG00000165025","approved_name":"spleen associated tyrosine kinase","approved_symbol":"SYK"}],"target_type":"single protein","target_name":"Tyrosine-protein kinase SYK","action_type":"inhibitor","description":"Tyrosine-protein kinase SYK inhibitor","references":[{"source":"PubMed","ids":["18360272","19596999"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18360272+OR+EXT_ID%3A19596999"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2219640","_score":1,"_source":{"id":"CHEMBL2219640","internal_compound":false,"type":"Small molecule","pref_name":"STRONTIUM CHLORIDE","year_first_approved":1993,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["85SR","89SR","SMS-2PA","SMS2PA","Strontium (89 sr) chloride","Strontium (89Sr) Chloride","Strontium (89sr) chloride","Strontium Chloride (85Sr)","Strontium Chloride (89Sr)","Strontium Chloride Hexahydrate","Strontium chloride"],"trade_names":["Metastron","Stronscan-85","Strontium Chloride (89Sr)"],"cross_references":[{"source":"ChEBI","ids":[36383]},{"source":"DailyMed","ids":["strontium%20chloride%20sr-89"]},{"source":"drugbank","ids":["DB13987"]},{"source":"drugbank","ids":["DB09498"]},{"source":"ChEBI","ids":[36385]}],"canonical_smiles":"[Cl-].[Cl-].[Sr+2]","adverse_events":{"significant":[{"event":"anaemia","count":61405,"llr":65.65307805},{"event":"disease progression","count":21531,"llr":37.09309165},{"event":"platelet count decreased","count":29394,"llr":35.39357378},{"event":"disseminated intravascular coagulation","count":3330,"llr":31.96832387},{"event":"bone marrow failure","count":8717,"llr":27.1335426},{"event":"neoplasm progression","count":5699,"llr":23.21612511},{"event":"prostate cancer","count":3761,"llr":14.17877692},{"event":"acute promyelocytic leukaemia","count":386,"llr":13.72442436},{"event":"metastatic pain","count":47,"llr":12.5351132},{"event":"rectal cancer metastatic","count":56,"llr":12.18497012},{"event":"general physical health deterioration","count":17224,"llr":11.95225739},{"event":"haematotoxicity","count":2676,"llr":11.78517548},{"event":"blood albumin decreased","count":2695,"llr":11.75742535},{"event":"metastases to bone","count":3280,"llr":10.9885836},{"event":"white blood cell count decreased","count":28818,"llr":10.89816741},{"event":"protein total decreased","count":1201,"llr":10.34300493},{"event":"pancytopenia","count":17598,"llr":9.248483585},{"event":"condition aggravated","count":52909,"llr":8.457911441},{"event":"malignant pleural effusion","count":363,"llr":8.455910865},{"event":"electrocardiogram st-t change","count":365,"llr":8.444980741},{"event":"malignant neoplasm progression","count":14458,"llr":7.753402397},{"event":"anorectal disorder","count":592,"llr":7.484449192},{"event":"myoglobin blood increased","count":675,"llr":7.22448221},{"event":"glossopharyngeal nerve paralysis","count":19,"llr":6.475604425}],"critval":6.450286998},"child_chembl_ids":["CHEMBL1200625","CHEMBL1909080","CHEMBL2105878"],"indications":[{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00592098"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00592098%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL286398","_score":1,"_source":{"id":"CHEMBL286398","internal_compound":false,"type":"Small molecule","pref_name":"PROPYLENE GLYCOL","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["E1520","E490","FEMA NO. 2940","NSC-69860","Propylene Glycol","Propylene Glycol Cefatrizine","Propylene glycol dl-form"],"trade_names":["Sentry Propylene Glycol","Sirlene"],"cross_references":[{"source":"ChEBI","ids":[16997]},{"source":"PubChem","ids":["144209010","144210326","144211758","17389749","49816670"]},{"source":"Wikipedia","ids":["Propylene_glycol"]},{"source":"drugbank","ids":["DB01839"]}],"canonical_smiles":"CC(O)CO","indications":[{"efo_id":"EFO_1000906","efo_label":"dry eye syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000906","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00607776","NCT00779987","NCT01541891","NCT01657253","NCT02455050"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00607776%22OR%22NCT00779987%22OR%22NCT01541891%22OR%22NCT01657253%22OR%22NCT02455050%22"]}]},{"efo_id":"EFO_1001518","efo_label":"heavy metal poisoning","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001518","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02352987"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02352987%22"]}]},{"efo_id":"EFO_0009536","efo_label":"blepharitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009536","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00796926"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00796926%22"]}]}],"adverse_events":{"significant":[{"event":"ocular hyperaemia","count":6875,"llr":73.74259136},{"event":"eye irritation","count":5686,"llr":57.36308153},{"event":"eye pain","count":7341,"llr":31.04088964},{"event":"pharmaceutical product complaint","count":7517,"llr":30.74351094},{"event":"eye allergy","count":178,"llr":25.51535528},{"event":"dry eye","count":6029,"llr":23.18710934},{"event":"product odour abnormal","count":797,"llr":22.76655347},{"event":"eye discharge","count":1453,"llr":19.20407576},{"event":"vision blurred","count":26101,"llr":15.6849396},{"event":"hyponatraemic seizure","count":110,"llr":15.20847133},{"event":"eye pruritus","count":3799,"llr":13.58306929},{"event":"eye swelling","count":6631,"llr":13.17634767},{"event":"fibrinolysis","count":24,"llr":12.36568429},{"event":"intraocular pressure increased","count":2955,"llr":11.64107463},{"event":"metabolic acidosis","count":8683,"llr":11.41608593},{"event":"eyelid skin dryness","count":49,"llr":10.93972836},{"event":"hepatitis b core antibody positive","count":57,"llr":10.63777107},{"event":"hepatitis b surface antibody positive","count":58,"llr":10.60305066},{"event":"product package associated injury","count":65,"llr":10.37560371},{"event":"eye oedema","count":612,"llr":10.09125367},{"event":"foreign body sensation in eyes","count":698,"llr":9.702196561},{"event":"linear iga disease","count":698,"llr":9.702196561},{"event":"product packaging issue","count":816,"llr":9.241024905},{"event":"coagulation factor v level decreased","count":135,"llr":8.918244379},{"event":"lactic acidosis","count":8744,"llr":8.888565286},{"event":"erythema of eyelid","count":950,"llr":8.793301696},{"event":"ocular discomfort","count":963,"llr":8.753344264},{"event":"corneal infiltrates","count":158,"llr":8.605054757},{"event":"blood culture positive","count":1081,"llr":8.41399366},{"event":"acute generalised exanthematous pustulosis","count":3030,"llr":8.354028877},{"event":"scleral hyperaemia","count":180,"llr":8.345718934},{"event":"atrial fibrillation","count":25339,"llr":8.205413436},{"event":"retching","count":3162,"llr":8.191724766},{"event":"conjunctival hyperaemia","count":1201,"llr":8.105730165},{"event":"product name confusion","count":239,"llr":7.782427433},{"event":"streptococcal infection","count":1353,"llr":7.757772409},{"event":"hyponatraemia","count":21598,"llr":7.560716404},{"event":"eyelid oedema","count":4197,"llr":7.12387379},{"event":"pseudomonas infection","count":1686,"llr":7.118595882},{"event":"hypopyon","count":361,"llr":6.965294937},{"event":"prothrombin level decreased","count":384,"llr":6.84321672},{"event":"shock","count":5269,"llr":6.281136705},{"event":"dysgeusia","count":15051,"llr":6.022589725},{"event":"hypertonia","count":2565,"llr":5.915045506},{"event":"oral candidiasis","count":2639,"llr":5.834372528},{"event":"infective keratitis","count":17,"llr":5.832797662},{"event":"renal replacement therapy","count":18,"llr":5.775702589},{"event":"hypersensitivity","count":35921,"llr":5.718034895},{"event":"pneumonia viral","count":702,"llr":5.656697178},{"event":"unresponsive to stimuli","count":6342,"llr":5.60694916},{"event":"chemical burns of eye","count":22,"llr":5.575285256},{"event":"corneal exfoliation","count":22,"llr":5.575285256}],"critval":5.534344176},"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":2},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545141","_score":1,"_source":{"id":"CHEMBL3545141","internal_compound":false,"type":"Small molecule","pref_name":"RP-6530","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["RP-6530"],"trade_names":[],"indications":[{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02017613"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02017613%22"]}]},{"efo_id":"EFO_0002913","efo_label":"Cutaneous T-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002913","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02567656"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02567656%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000171608","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta","approved_symbol":"PIK3CD"}],"target_type":"single protein","target_name":"PI3-kinase p110-delta subunit","action_type":"inhibitor","description":"PI3-kinase p110-delta subunit inhibitor","references":[{"source":"DOI","ids":["10.1158/1538-7445.AM2015-2704"],"urls":["http://dx.doi.org/10.1158/1538-7445.AM2015-2704"]},{"source":"Other","ids":["http://www.bloodjournal.org/content/122/21/4411?sso-checked=true"],"urls":["http://www.bloodjournal.org/content/122/21/4411?sso-checked=true"]}]},{"target_components":[{"ensembl":"ENSG00000105851","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma","approved_symbol":"PIK3CG"}],"target_type":"single protein","target_name":"PI3-kinase p110-gamma subunit","action_type":"inhibitor","description":"PI3-kinase p110-gamma subunit inhibitor","references":[{"source":"DOI","ids":["10.1158/1538-7445.AM2015-2704"],"urls":["http://dx.doi.org/10.1158/1538-7445.AM2015-2704"]},{"source":"Other","ids":["http://www.bloodjournal.org/content/122/21/4411?sso-checked=true"],"urls":["http://www.bloodjournal.org/content/122/21/4411?sso-checked=true"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL561057","_score":1,"_source":{"id":"CHEMBL561057","internal_compound":false,"type":"Small molecule","pref_name":"SQ109","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["NSC-722041","SQ-109","SQ109","Sq109"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB05186"]}],"canonical_smiles":"CC(C)=CCC/C(C)=C/CNCCNC1C2CC3CC(C2)CC1C3","indications":[{"efo_id":"EFO_1000961","efo_label":"Helicobacter pylori infectious disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000961","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01252108"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01252108%22"]}]},{"efo_id":"Orphanet_3389","efo_label":"Tuberculosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_3389","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00866190","NCT01218217","NCT01358162","NCT01585636","NCT01785186","NCT01874314"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00866190%22OR%22NCT01218217%22OR%22NCT01358162%22OR%22NCT01585636%22OR%22NCT01785186%22OR%22NCT01874314%22"]}]}],"child_chembl_ids":["CHEMBL3140371","CHEMBL570170"],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1743013","_score":1,"_source":{"id":"CHEMBL1743013","internal_compound":false,"type":"Antibody","pref_name":"ENSITUXIMAB","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Ensituximab","NEO-102","NPC-1C"],"trade_names":[],"indications":[{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01834235"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01834235%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000215182","approved_name":"mucin 5AC, oligomeric mucus/gel-forming","approved_symbol":"MUC5AC"}],"target_type":"single protein","target_name":"Mucin-5AC","action_type":"other","description":"Mucin-5AC other","references":[{"source":"PubMed","ids":["23591984","27449137"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23591984+OR+EXT_ID%3A27449137"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297364","_score":1,"_source":{"id":"CHEMBL4297364","internal_compound":false,"type":"Small molecule","pref_name":"OXITROPIUM","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Oxitropium","Oxitropium Bromide"],"trade_names":["Oxivent"],"canonical_smiles":"CC[N+]1(C)[C@H]2CC(OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21","indications":[{"efo_id":"EFO_0000341","efo_label":"chronic obstructive pulmonary disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000341","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02172807"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02172807%22"]}]},{"efo_id":"HP_0006536","efo_label":"Obstructive lung disease","efo_uri":"http://purl.obolibrary.org/obo/HP_0006536","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["R03BB02"],"urls":["https://www.whocc.no/atc_ddd_index/?code=R03BB02"]}]}],"child_chembl_ids":["CHEMBL4297109"],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL33986","_score":1,"_source":{"id":"CHEMBL33986","internal_compound":false,"type":"Small molecule","pref_name":"BUTORPHANOL","year_first_approved":1978,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["Butorphanol","Butorphanol Tartrate","Butorphanol tartrate civ","LEVO-BC-2627","LEVO-BC-2627 Tartrate"],"trade_names":["Butorphanol Tartrate","Butorphanol tartrate preservative free","Stadol","Stadol NS","Stadol preservative free","Torbugesic","Torbutrol"],"cross_references":[{"source":"ChEBI","ids":[3242]},{"source":"DailyMed","ids":["butorphanol%20tartrate"]},{"source":"Wikipedia","ids":["Butorphanol"]}],"canonical_smiles":"Oc1ccc2c(c1)[C@@]13CCCC[C@@]1(O)[C@@H](C2)N(CC1CCC1)CC3","indications":[{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N02AF01"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N02AF01"]}]},{"efo_id":"EFO_0005230","efo_label":"anxiety","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005230","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03429179","NCT03810391"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03429179%22OR%22NCT03810391%22"]}]}],"adverse_events":{"significant":[{"event":"dependence","count":1115,"llr":2025.402704},{"event":"drug addict","count":52,"llr":345.5594082},{"event":"drug hypersensitivity","count":71246,"llr":227.9634788},{"event":"drug withdrawal syndrome","count":13453,"llr":102.6546796},{"event":"drug dependence","count":7072,"llr":25.56049909},{"event":"fatigue","count":147738,"llr":15.11782786},{"event":"analgesic drug level above therapeutic","count":15,"llr":11.9238909},{"event":"pain","count":94786,"llr":8.648845597},{"event":"malaise","count":82447,"llr":7.19153135},{"event":"areflexia","count":950,"llr":6.77687326},{"event":"paraplegia","count":990,"llr":6.658181601},{"event":"dyspnoea","count":124409,"llr":6.421272996},{"event":"arthralgia","count":75397,"llr":6.370938977},{"event":"heart rate irregular","count":4688,"llr":6.266528968},{"event":"asthenia","count":74334,"llr":6.248079021},{"event":"nasal discomfort","count":1152,"llr":6.223933174}],"critval":5.836444591},"child_chembl_ids":["CHEMBL299400"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000112038","approved_name":"opioid receptor mu 1","approved_symbol":"OPRM1"}],"target_type":"single protein","target_name":"Mu opioid receptor","action_type":"partial agonist","description":"Mu opioid receptor partial agonist","references":[{"source":"DailyMed","ids":["setid=b8e48063-0b40-ee43-85c1-4ef2de80c404#nlm34090-1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b8e48063-0b40-ee43-85c1-4ef2de80c404#nlm34090-1"]}]},{"target_components":[{"ensembl":"ENSG00000082556","approved_name":"opioid receptor kappa 1","approved_symbol":"OPRK1"}],"target_type":"single protein","target_name":"Kappa opioid receptor","action_type":"partial agonist","description":"Kappa opioid receptor partial agonist","references":[{"source":"DailyMed","ids":["setid=b8e48063-0b40-ee43-85c1-4ef2de80c404#nlm34090-1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b8e48063-0b40-ee43-85c1-4ef2de80c404#nlm34090-1"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":2}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109398","_score":1,"_source":{"id":"CHEMBL2109398","internal_compound":false,"type":"Antibody","pref_name":"KB-004","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["KB-004"],"trade_names":[],"indications":[{"efo_id":"EFO_0000198","efo_label":"myelodysplastic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000198","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01211691"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01211691%22"]}]},{"efo_id":"EFO_0000519","efo_label":"glioblastoma multiforme","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000519","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03374943"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03374943%22"]}]},{"efo_id":"EFO_0002430","efo_label":"primary myelofibrosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002430","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01211691"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01211691%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000044524","approved_name":"EPH receptor A3","approved_symbol":"EPHA3"}],"target_type":"single protein","target_name":"Ephrin type-A receptor 3","action_type":"inhibitor","description":"Ephrin type-A receptor 3 inhibitor","references":[{"source":"Other","ids":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=686621"],"urls":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=686621"]},{"source":"PubMed","ids":["27736729"],"urls":["https://europepmc.org/search?query=EXT_ID%3A27736729"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3590674","_score":1,"_source":{"id":"CHEMBL3590674","internal_compound":false,"type":"Small molecule","pref_name":"ABT-639","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Abt-639"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB15055"]}],"canonical_smiles":"O=C(c1cc(S(=O)(=O)Nc2ccccc2F)c(F)cc1Cl)N1CCN2CCC[C@@H]2C1","indications":[{"efo_id":"EFO_0005762","efo_label":"neuropathic pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005762","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01345045","NCT01589432"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01345045%22OR%22NCT01589432%22"]}]}],"child_chembl_ids":["CHEMBL3589557"],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2106991","_score":1,"_source":{"id":"CHEMBL2106991","internal_compound":false,"type":"Small molecule","pref_name":"RALURIDINE","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["935-U-83","935U83","Raluridine"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12894"]}],"canonical_smiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](F)[C@@H](CO)O2)cc1Cl","indications":[{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00002338"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002338%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1297","_score":1,"_source":{"id":"CHEMBL1297","internal_compound":false,"type":"Small molecule","pref_name":"FENOPROFEN","year_first_approved":1976,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["53858","69323","Fenoprofen","Fenoprofen Calcium","Fenoprofen Sodium","Nalfon"],"trade_names":["Fenoprofen Calcium","Nalfon","Progesic"],"cross_references":[{"source":"ChEBI","ids":[5004]},{"source":"DailyMed","ids":["fenoprofen%20calcium"]},{"source":"Wikipedia","ids":["Fenoprofen"]},{"source":"drugbank","ids":["DB00573"]},{"source":"PubChem","ids":["93576614"]},{"source":"ChEBI","ids":[5005]}],"canonical_smiles":"CC(C(=O)O)c1cccc(Oc2ccccc2)c1","indications":[{"efo_id":"EFO_0005755","efo_label":"rheumatic disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005755","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["M01AE04"],"urls":["https://www.whocc.no/atc_ddd_index/?code=M01AE04"]}]}],"adverse_events":{"significant":[{"event":"drug hypersensitivity","count":71246,"llr":42.28563972},{"event":"intestinal diaphragm disease","count":116,"llr":21.9217701},{"event":"nephritis","count":857,"llr":9.767663227}],"critval":9.671296625},"child_chembl_ids":["CHEMBL138241","CHEMBL2068720","CHEMBL2103736"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000073756","approved_name":"prostaglandin-endoperoxide synthase 2","approved_symbol":"PTGS2"},{"ensembl":"ENSG00000095303","approved_name":"prostaglandin-endoperoxide synthase 1","approved_symbol":"PTGS1"}],"target_type":"protein family","target_name":"Cyclooxygenase","action_type":"inhibitor","description":"Cyclooxygenase inhibitor","references":[{"source":"DailyMed","ids":["setid=f90becaa-a4f3-44aa-ac8c-c69935c5ddb2"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f90becaa-a4f3-44aa-ac8c-c69935c5ddb2"]},{"source":"PubMed","ids":["17050798"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17050798"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2103838","_score":1,"_source":{"id":"CHEMBL2103838","internal_compound":false,"type":"Small molecule","pref_name":"DILMAPIMOD","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Dilmapimod","Dilmapimod Tosylate","GW681323","SB-681323","SB-681323-T","SB681323"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12140"]}],"canonical_smiles":"Cc1cc(F)ccc1-c1nc(NC(CO)CO)nc2c1ccc(=O)n2-c1c(F)cccc1F","indications":[{"efo_id":"EFO_0000341","efo_label":"chronic obstructive pulmonary disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000341","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00144859","NCT00380133","NCT00564746"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00144859%22OR%22NCT00380133%22OR%22NCT00564746%22"]}]},{"efo_id":"EFO_0004610","efo_label":"acute lung injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004610","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00996840"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00996840%22"]}]},{"efo_id":"EFO_0000685","efo_label":"rheumatoid arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000685","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00134693","NCT00320450","NCT00419809"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00134693%22OR%22NCT00320450%22OR%22NCT00419809%22"]}]},{"efo_id":"EFO_0001645","efo_label":"coronary heart disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001645","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00291902"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00291902%22"]}]},{"efo_id":"EFO_0005762","efo_label":"neuropathic pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005762","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00390845"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00390845%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000112062","approved_name":"mitogen-activated protein kinase 14","approved_symbol":"MAPK14"}],"target_type":"single protein","target_name":"MAP kinase p38 alpha","action_type":"inhibitor","description":"MAP kinase p38 alpha inhibitor","references":[{"source":"Other","ids":["http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7815"],"urls":["http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7815"]},{"source":"PubMed","ids":["19880675","9808629"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19880675+OR+EXT_ID%3A9808629"]}]}],"child_chembl_ids":["CHEMBL2105674"],"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":3},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL570015","_score":1,"_source":{"id":"CHEMBL570015","internal_compound":false,"type":"Small molecule","pref_name":"GSK-256066","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["GSK256066","Gsk-256066"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12137"]}],"canonical_smiles":"COc1cccc(Nc2c(C(N)=O)cnc3c(C)cc(S(=O)(=O)c4cccc(C(=O)N(C)C)c4)cc23)c1","indications":[{"efo_id":"EFO_0000270","efo_label":"asthma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000270","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00380354","NCT00445510","NCT00549744"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00380354%22OR%22NCT00445510%22OR%22NCT00549744%22"]}]},{"efo_id":"EFO_0000341","efo_label":"chronic obstructive pulmonary disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000341","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00549679"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00549679%22"]}]},{"efo_id":"EFO_0003956","efo_label":"seasonal allergic rhinitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003956","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00377728","NCT00430157","NCT00464568","NCT00612118","NCT00612820"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00377728%22OR%22NCT00430157%22OR%22NCT00464568%22OR%22NCT00612118%22OR%22NCT00612820%22"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":3},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545373","_score":1,"_source":{"id":"CHEMBL3545373","internal_compound":false,"type":"Antibody","pref_name":"ENOBLITUZUMAB","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Enoblituzumab","Inc.","MGA-271","MGA271","MacroGenics"],"trade_names":[],"indications":[{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02923180"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02923180%22"]}]},{"efo_id":"EFO_0000756","efo_label":"melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000756","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01918930"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01918930%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000103855","approved_name":"CD276 molecule","approved_symbol":"CD276"}],"target_type":"single protein","target_name":"CD276 antigen","action_type":"cross-linking agent","description":"CD276 antigen cross-linking agent","references":[{"source":"Other","ids":["https://www.macrogenics.com/enoblituzumab-anti-b7-h3/"],"urls":["https://www.macrogenics.com/enoblituzumab-anti-b7-h3/"]},{"source":"PubMed","ids":["28401653"],"urls":["https://europepmc.org/search?query=EXT_ID%3A28401653"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL483254","_score":1,"_source":{"id":"CHEMBL483254","internal_compound":false,"type":"Small molecule","pref_name":"PANOBINOSTAT","year_first_approved":2015,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["LBH589","Panobinostat","Panobinostat lactate"],"trade_names":["Farydak"],"cross_references":[{"source":"ChEBI","ids":[85990]},{"source":"DailyMed","ids":["panobinostat%20lactate"]},{"source":"drugbank","ids":["DB06603"]},{"source":"ChEBI","ids":[85991]}],"canonical_smiles":"Cc1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1","indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["L01XX42"],"urls":["https://www.whocc.no/atc_ddd_index/?code=L01XX42"]},{"source":"ClinicalTrials","ids":["NCT00472368","NCT00878904","NCT00997399","NCT01007968","NCT01159418"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00472368%22OR%22NCT00878904%22OR%22NCT00997399%22OR%22NCT01007968%22OR%22NCT01159418%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00570284","NCT00739414"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00570284%22OR%22NCT00739414%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00445068","NCT00532389","NCT00532675","NCT00621244","NCT00743288","NCT00891033","NCT00962507","NCT01023308","NCT01083602","NCT01301807","NCT01440582","NCT01496118","NCT01549431","NCT01651039","NCT01965353","NCT02057640","NCT02145715","NCT02290431","NCT02506959","NCT02654990","NCT02720510","NCT02722941","NCT02756663","NCT02802163","NCT03256045"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00445068%22OR%22NCT00532389%22OR%22NCT00532675%22OR%22NCT00621244%22OR%22NCT00743288%22OR%22NCT00891033%22OR%22NCT00962507%22OR%22NCT01023308%22OR%22NCT01083602%22OR%22NCT01301807%22OR%22NCT01440582%22OR%22NCT01496118%22OR%22NCT01549431%22OR%22NCT01651039%22OR%22NCT01965353%22OR%22NCT02057640%22OR%22NCT02145715%22OR%22NCT02290431%22OR%22NCT02506959%22OR%22NCT02654990%22OR%22NCT02720510%22OR%22NCT02722941%22OR%22NCT02756663%22OR%22NCT02802163%22OR%22NCT03256045%22"]}]},{"efo_id":"EFO_0002913","efo_label":"Cutaneous T-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002913","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00412997","NCT00425555","NCT00490776"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00412997%22OR%22NCT00425555%22OR%22NCT00490776%22"]}]},{"efo_id":"EFO_0000403","efo_label":"diffuse large B-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000403","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00978432","NCT01238692","NCT01282476","NCT01523834"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00978432%22OR%22NCT01238692%22OR%22NCT01282476%22OR%22NCT01523834%22"]}]},{"efo_id":"EFO_0000183","efo_label":"Hodgkins lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000183","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00742027","NCT01032148","NCT01034163","NCT01169636","NCT01321346","NCT01884428"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00742027%22OR%22NCT01032148%22OR%22NCT01034163%22OR%22NCT01169636%22OR%22NCT01321346%22OR%22NCT01884428%22"]}]},{"efo_id":"EFO_0000339","efo_label":"chronic myelogenous leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000339","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00449761","NCT00451035"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00449761%22OR%22NCT00451035%22"]}]},{"efo_id":"EFO_0000519","efo_label":"glioblastoma multiforme","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000519","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01115036"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01115036%22"]}]},{"efo_id":"EFO_0000756","efo_label":"melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000756","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01065467","NCT02032810"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01065467%22OR%22NCT02032810%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00419536","NCT00493766","NCT00663832","NCT00667862"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00419536%22OR%22NCT00493766%22OR%22NCT00663832%22OR%22NCT00667862%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00691938","NCT00840346","NCT00880269","NCT00946647","NCT01055483","NCT01242774","NCT01321346","NCT01451268","NCT01463046","NCT02676323"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00691938%22OR%22NCT00840346%22OR%22NCT00880269%22OR%22NCT00946647%22OR%22NCT01055483%22OR%22NCT01242774%22OR%22NCT01321346%22OR%22NCT01451268%22OR%22NCT01463046%22OR%22NCT02676323%22"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01680094","NCT02471430"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01680094%22OR%22NCT02471430%22"]}]},{"efo_id":"EFO_0002892","efo_label":"thyroid carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002892","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01013597"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01013597%22"]}]},{"efo_id":"EFO_0005952","efo_label":"non-Hodgkins lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005952","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00503451","NCT01032148","NCT01090973","NCT01321346"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00503451%22OR%22NCT01032148%22OR%22NCT01090973%22OR%22NCT01321346%22"]}]},{"efo_id":"EFO_0001642","efo_label":"lymphoid neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001642","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01802879"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01802879%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00567879","NCT00632489","NCT00777049","NCT00777335","NCT00788931","NCT00993642","NCT01105312"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00567879%22OR%22NCT00632489%22OR%22NCT00777049%22OR%22NCT00777335%22OR%22NCT00788931%22OR%22NCT00993642%22OR%22NCT01105312%22"]}]},{"efo_id":"EFO_0000681","efo_label":"renal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000681","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00550277"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00550277%22"]}]},{"efo_id":"EFO_0000565","efo_label":"leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000565","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00621244","NCT00686218","NCT00723203"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00621244%22OR%22NCT00686218%22OR%22NCT00723203%22"]}]},{"efo_id":"EFO_0004599","efo_label":"acute graft vs. host disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004599","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01028313","NCT01111526","NCT02588339"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01028313%22OR%22NCT01111526%22OR%22NCT02588339%22"]}]},{"efo_id":"EFO_0000178","efo_label":"gastric carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000178","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01528501"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01528501%22"]}]},{"efo_id":"EFO_0000198","efo_label":"myelodysplastic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000198","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00594230","NCT00691938","NCT00939159","NCT00946647","NCT01034657","NCT01451268","NCT01463046","NCT02676323"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00594230%22OR%22NCT00691938%22OR%22NCT00939159%22OR%22NCT00946647%22OR%22NCT01034657%22OR%22NCT01451268%22OR%22NCT01463046%22OR%22NCT02676323%22"]}]},{"efo_id":"Orphanet_232","efo_label":"Sickle cell anemia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_232","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01245179"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01245179%22"]}]},{"efo_id":"EFO_0000326","efo_label":"central nervous system cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000326","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00848523","NCT00859222","NCT02717455"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00848523%22OR%22NCT00859222%22OR%22NCT02717455%22"]}]},{"efo_id":"EFO_0000182","efo_label":"hepatocellular carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000182","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00823290","NCT00873002"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00823290%22OR%22NCT00873002%22"]}]},{"efo_id":"EFO_0000220","efo_label":"acute lymphoblastic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000220","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01321346","NCT02518750"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01321346%22OR%22NCT02518750%22"]}]},{"efo_id":"EFO_0000349","efo_label":"clear cell renal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000349","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01582009"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01582009%22"]}]},{"efo_id":"EFO_0000479","efo_label":"essential thrombocythemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000479","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01298934","NCT01433445"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01298934%22OR%22NCT01433445%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00621244","NCT00962507","NCT00967044","NCT02518750","NCT02961816"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00621244%22OR%22NCT00962507%22OR%22NCT00967044%22OR%22NCT02518750%22OR%22NCT02961816%22"]}]},{"efo_id":"EFO_0000673","efo_label":"prostate adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000673","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00878436"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00878436%22"]}]},{"efo_id":"EFO_0001071","efo_label":"lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001071","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01160731"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01160731%22"]}]},{"efo_id":"EFO_0002429","efo_label":"polycythemia vera","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002429","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01298934"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01298934%22"]}]},{"efo_id":"EFO_0002430","efo_label":"primary myelofibrosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002430","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01298934","NCT01433445","NCT01693601"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01298934%22OR%22NCT01433445%22OR%22NCT01693601%22"]}]},{"efo_id":"EFO_0002617","efo_label":"metastatic melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002617","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00925132"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00925132%22"]}]},{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01056601"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01056601%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01336842"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01336842%22"]}]},{"efo_id":"EFO_0004252","efo_label":"nasopharyngeal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004252","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01341834"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01341834%22"]}]},{"efo_id":"EFO_1001469","efo_label":"Mantle cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001469","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01504776"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01504776%22"]}]},{"efo_id":"EFO_1001779","efo_label":"chronic myelomonocytic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001779","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00946647"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00946647%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00690677"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00690677%22"]}]},{"efo_id":"EFO_1001968","efo_label":"soft tissue sarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001968","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01136499"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01136499%22"]}]},{"efo_id":"EFO_0006475","efo_label":"plasma cell leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006475","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02506959"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02506959%22"]}]},{"efo_id":"EFO_0006738","efo_label":"plasmacytoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006738","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02506959"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02506959%22"]}]},{"efo_id":"EFO_0009441","efo_label":"Waldenstrom macroglobulinemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009441","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00936611"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00936611%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["7774972a-eeaa-4b9a-9e56-3fc1b968e86a"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7774972a-eeaa-4b9a-9e56-3fc1b968e86a"]}]}],"adverse_events":{"significant":[{"event":"diarrhoea","count":126514,"llr":193.3868153},{"event":"platelet count decreased","count":29394,"llr":115.054446},{"event":"thrombocytopenia","count":35327,"llr":91.23419532},{"event":"plasma cell myeloma","count":7205,"llr":89.40313437},{"event":"malignant neoplasm progression","count":14458,"llr":56.11058222},{"event":"febrile neutropenia","count":19204,"llr":38.2677751},{"event":"autonomic neuropathy","count":333,"llr":34.66748064},{"event":"morganella infection","count":64,"llr":30.52999662},{"event":"pneumomediastinum","count":388,"llr":28.66504016},{"event":"pneumoperitoneum","count":440,"llr":27.66990589},{"event":"pneumatosis intestinalis","count":831,"llr":26.54251538},{"event":"vomiting","count":103943,"llr":25.88892794},{"event":"neutrophil count decreased","count":11062,"llr":21.03281078},{"event":"disease progression","count":21531,"llr":20.44780397},{"event":"lung consolidation","count":778,"llr":19.36599404},{"event":"fatigue","count":147738,"llr":19.05520292},{"event":"lung infection","count":5755,"llr":18.9529395},{"event":"concomitant disease aggravated","count":1624,"llr":17.47389991},{"event":"neuropathy peripheral","count":20261,"llr":16.63659971},{"event":"pneumonia","count":65209,"llr":15.42923815},{"event":"hypokalaemia","count":14556,"llr":15.08223611},{"event":"bacteraemia","count":3187,"llr":14.94358759},{"event":"pleocytosis","count":189,"llr":14.42630908},{"event":"atrial fibrillation","count":25339,"llr":14.40255027},{"event":"dehydration","count":36809,"llr":14.36422625},{"event":"nausea","count":165652,"llr":13.84743858},{"event":"electrocardiogram qt prolonged","count":12378,"llr":13.7511124},{"event":"candida infection","count":2791,"llr":13.38928687},{"event":"blood creatinine increased","count":21684,"llr":12.55053888},{"event":"subdural haemorrhage","count":730,"llr":12.50014447},{"event":"white blood cell count decreased","count":28818,"llr":12.30184123},{"event":"drug hypersensitivity","count":71246,"llr":11.64760171},{"event":"tumour lysis syndrome","count":1936,"llr":10.47080636},{"event":"bone marrow failure","count":8717,"llr":10.4348878},{"event":"klebsiella infection","count":1124,"llr":10.42594535},{"event":"encephalitis toxic","count":19,"llr":10.40296527},{"event":"ileus","count":4225,"llr":10.37649847},{"event":"brain stem glioma","count":20,"llr":10.30059216},{"event":"spinal pain","count":2016,"llr":10.24486195}],"critval":10.08277771},"child_chembl_ids":["CHEMBL3545368"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000116478","approved_name":"histone deacetylase 1","approved_symbol":"HDAC1"},{"ensembl":"ENSG00000171720","approved_name":"histone deacetylase 3","approved_symbol":"HDAC3"},{"ensembl":"ENSG00000094631","approved_name":"histone deacetylase 6","approved_symbol":"HDAC6"},{"ensembl":"ENSG00000196591","approved_name":"histone deacetylase 2","approved_symbol":"HDAC2"},{"ensembl":"ENSG00000108840","approved_name":"histone deacetylase 5","approved_symbol":"HDAC5"},{"ensembl":"ENSG00000061273","approved_name":"histone deacetylase 7","approved_symbol":"HDAC7"},{"ensembl":"ENSG00000147099","approved_name":"histone deacetylase 8","approved_symbol":"HDAC8"},{"ensembl":"ENSG00000163517","approved_name":"histone deacetylase 11","approved_symbol":"HDAC11"},{"ensembl":"ENSG00000068024","approved_name":"histone deacetylase 4","approved_symbol":"HDAC4"},{"ensembl":"ENSG00000048052","approved_name":"histone deacetylase 9","approved_symbol":"HDAC9"},{"ensembl":"ENSG00000100429","approved_name":"histone deacetylase 10","approved_symbol":"HDAC10"}],"target_type":"protein family","target_name":"Histone deacetylase","action_type":"inhibitor","description":"Histone deacetylase inhibitor","references":[{"source":"FDA","ids":["label/2015/205353s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F205353s000lbl.pdf"]}]}],"number_of_indications":44,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":41},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":22},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":20},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":16},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":10},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":6},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":6},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":5},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":5},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":4},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":4},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":3},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":2},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1200877","_score":1,"_source":{"id":"CHEMBL1200877","internal_compound":false,"type":"Small molecule","pref_name":"FLUMETHASONE PIVALATE","year_first_approved":1982,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Flumetasone Pivalate","Flumethasone Pivalate"],"trade_names":["Locorten","Locorten-Vioform"],"cross_references":[{"source":"ChEBI","ids":[31620]},{"source":"PubChem","ids":["56423133","855730"]}],"canonical_smiles":"C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C","mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000113580","approved_name":"nuclear receptor subfamily 3 group C member 1","approved_symbol":"NR3C1"}],"target_type":"single protein","target_name":"Glucocorticoid receptor","action_type":"agonist","description":"Glucocorticoid receptor agonist","references":[{"source":"ISBN","ids":["9780702034718 PP. 402"],"urls":[]},{"source":"PubMed","ids":["3212030"],"urls":["https://europepmc.org/search?query=EXT_ID%3A3212030"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL236687","_score":1,"_source":{"id":"CHEMBL236687","internal_compound":false,"type":"Small molecule","pref_name":"PERILLYL ALCOHOL","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["FEMA NO. 2664","NSC-641066","Perillyl alcohol"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[10782]},{"source":"PubChem","ids":["500472","93576954"]},{"source":"drugbank","ids":["DB15289"]}],"canonical_smiles":"C=C(C)[C@@H]1CC=C(CO)CC1","indications":[{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00003219","NCT00022425"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003219%22OR%22NCT00022425%22"]}]},{"efo_id":"EFO_0000519","efo_label":"glioblastoma multiforme","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000519","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02704858"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02704858%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00002862"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002862%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00003238"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003238%22"]}]},{"efo_id":"EFO_0002496","efo_label":"actinic keratosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002496","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00608634"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00608634%22"]}]},{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00003769"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003769%22"]}]}],"number_of_indications":6,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":6},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":2},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":2},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2070241","_score":1,"_source":{"id":"CHEMBL2070241","internal_compound":false,"type":"Protein","pref_name":"BREMELANOTIDE","year_first_approved":2019,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Bremelanotide","Bremelanotide acetate","PT-141"],"trade_names":["Bremelanotide","Vyleesi (autoinjector)"],"cross_references":[{"source":"drugbank","ids":["DB11653"]}],"canonical_smiles":"CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O","indications":[{"efo_id":"EFO_0004714","efo_label":"sexual dysfunction","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004714","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01382719","NCT02333071","NCT02338960"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01382719%22OR%22NCT02333071%22OR%22NCT02338960%22"]}]},{"efo_id":"HP_0002018","efo_label":"Nausea","efo_uri":"http://purl.obolibrary.org/obo/HP_0002018","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03973047"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03973047%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000166603","approved_name":"melanocortin 4 receptor","approved_symbol":"MC4R"}],"target_type":"single protein","target_name":"Melanocortin receptor 4","action_type":"agonist","description":"Melanocortin receptor 4 agonist","references":[{"source":"FDA","ids":["label/2019/210557s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2019%2F210557s000lbl.pdf"]},{"source":"PubMed","ids":["12851303","17584130"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12851303+OR+EXT_ID%3A17584130"]},{"source":"Wikipedia","ids":["Bremelanotide"],"urls":["https://www.wikipedia.org/Bremelanotide"]}]}],"adverse_events":{"significant":[{"event":"libido increased","count":476,"llr":7.608462325},{"event":"injection site warmth","count":8324,"llr":4.749029998}],"critval":4.456846131},"child_chembl_ids":["CHEMBL4297533"],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":2}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL383322","_score":1,"_source":{"id":"CHEMBL383322","internal_compound":false,"type":"Small molecule","pref_name":"RESIQUIMOD","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["CD-11301","CD11301","Resiquimod"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[36706]},{"source":"Wikipedia","ids":["Resiquimod"]},{"source":"drugbank","ids":["DB06530"]}],"canonical_smiles":"CCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)O","indications":[{"efo_id":"EFO_0000389","efo_label":"cutaneous melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000389","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00470379"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00470379%22"]}]},{"efo_id":"EFO_0000756","efo_label":"melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000756","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00960752","NCT01748747"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00960752%22OR%22NCT01748747%22"]}]},{"efo_id":"EFO_0002617","efo_label":"metastatic melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002617","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02126579"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02126579%22"]}]},{"efo_id":"EFO_0004193","efo_label":"basal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004193","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01808950"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01808950%22"]}]},{"efo_id":"EFO_0002913","efo_label":"Cutaneous T-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002913","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01676831"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01676831%22"]}]},{"efo_id":"EFO_0002496","efo_label":"actinic keratosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002496","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01583816"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01583816%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00948961"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00948961%22"]}]},{"efo_id":"EFO_0000519","efo_label":"glioblastoma multiforme","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000519","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01204684"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01204684%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00821652"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00821652%22"]}]},{"efo_id":"EFO_0000632","efo_label":"oligodendroglioma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000632","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01204684"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01204684%22"]}]},{"efo_id":"EFO_0002499","efo_label":"anaplastic astrocytoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002499","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01204684"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01204684%22"]}]},{"efo_id":"EFO_0004197","efo_label":"hepatitis B virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004197","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00175435"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00175435%22"]}]}],"number_of_indications":12,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":11},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":6},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":4},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":3},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3319236","_score":1,"_source":{"id":"CHEMBL3319236","internal_compound":false,"type":"Small molecule","pref_name":"GLPG-0187","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["GLPG0187","Glpg-0187","Glpg0187"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12297"]}],"canonical_smiles":"COc1ccc(S(=O)(=O)N[C@@H](CNc2nc(C)nc(N3CCC(c4ccc5c(n4)NCCC5)CC3)c2C)C(=O)O)cc1","indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01313598"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01313598%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL19019","_score":1,"_source":{"id":"CHEMBL19019","internal_compound":false,"type":"Small molecule","pref_name":"NALTREXONE","year_first_approved":1984,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["EN-1639A","EN-1639A (AS HYDROCHLORIDE)","EN-1639A FREE BASE","EN-1639A [As Hydrochloride]","Naltrexone","Naltrexone HCl","Revia"],"trade_names":["Adepend","Celupan","Depade","Nalorex","Naltrexone HCl","Opizone","Revia","Trexal","Trexan","Vivitrol"],"cross_references":[{"source":"ChEBI","ids":[7465]},{"source":"DailyMed","ids":["naltrexone","naltrexone%20hydrochloride"]},{"source":"PubChem","ids":["144205560","170465207"]},{"source":"drugbank","ids":["DB00704"]},{"source":"DailyMed","ids":["naltrexone%20hydrochloride"]},{"source":"PubChem","ids":["56422210","855955"]}],"canonical_smiles":"O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5","indications":[{"efo_id":"EFO_0003829","efo_label":"alcohol dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003829","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N07BB04"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N07BB04"]},{"source":"ClinicalTrials","ids":["NCT00000307","NCT00000440","NCT00000451","NCT00006206","NCT00027079","NCT00142818","NCT00142844","NCT00156923","NCT00156936","NCT00167232","NCT00183196","NCT00183222","NCT00218569","NCT00218660","NCT00338962","NCT00501631","NCT00523133","NCT00614328","NCT00656630","NCT00667771","NCT00667875","NCT00768508","NCT00769158","NCT00777062","NCT01115894","NCT01211769","NCT01214083","NCT01218958","NCT01218971","NCT01218997","NCT01296646","NCT01342549","NCT01723384","NCT01738867","NCT01856712","NCT01908062","NCT02026011","NCT02652585","NCT02689674","NCT02698215","NCT03479086","NCT03854942"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000307%22OR%22NCT00000440%22OR%22NCT00000451%22OR%22NCT00006206%22OR%22NCT00027079%22OR%22NCT00142818%22OR%22NCT00142844%22OR%22NCT00156923%22OR%22NCT00156936%22OR%22NCT00167232%22OR%22NCT00183196%22OR%22NCT00183222%22OR%22NCT00218569%22OR%22NCT00218660%22OR%22NCT00338962%22OR%22NCT00501631%22OR%22NCT00523133%22OR%22NCT00614328%22OR%22NCT00656630%22OR%22NCT00667771%22OR%22NCT00667875%22OR%22NCT00768508%22OR%22NCT00769158%22OR%22NCT00777062%22OR%22NCT01115894%22OR%22NCT01211769%22OR%22NCT01214083%22OR%22NCT01218958%22OR%22NCT01218971%22OR%22NCT01218997%22OR%22NCT01296646%22OR%22NCT01342549%22OR%22NCT01723384%22OR%22NCT01738867%22OR%22NCT01856712%22OR%22NCT01908062%22OR%22NCT02026011%22OR%22NCT02652585%22OR%22NCT02689674%22OR%22NCT02698215%22OR%22NCT03479086%22OR%22NCT03854942%22"]}]},{"efo_id":"EFO_0004699","efo_label":"gambling behaviour","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004699","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00053677","NCT01057862","NCT02537197"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00053677%22OR%22NCT01057862%22OR%22NCT02537197%22"]}]},{"efo_id":"EFO_0005611","efo_label":"opioid dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005611","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000195","NCT00000196","NCT00125515","NCT00156936","NCT00182572","NCT00204243","NCT00269607","NCT00332228","NCT00383045","NCT00521157","NCT00678418","NCT00719095","NCT00734461","NCT00781898","NCT00834080","NCT01024335","NCT01180647","NCT01218984","NCT01377610","NCT01389167","NCT01556425","NCT01587196","NCT01690546","NCT01717963","NCT01895036","NCT01908062","NCT02437344","NCT02593474","NCT02617628","NCT02696434","NCT02750748","NCT03113409","NCT03232346","NCT03766893","NCT03810495","NCT03851731"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000195%22OR%22NCT00000196%22OR%22NCT00125515%22OR%22NCT00156936%22OR%22NCT00182572%22OR%22NCT00204243%22OR%22NCT00269607%22OR%22NCT00332228%22OR%22NCT00383045%22OR%22NCT00521157%22OR%22NCT00678418%22OR%22NCT00719095%22OR%22NCT00734461%22OR%22NCT00781898%22OR%22NCT00834080%22OR%22NCT01024335%22OR%22NCT01180647%22OR%22NCT01218984%22OR%22NCT01377610%22OR%22NCT01389167%22OR%22NCT01556425%22OR%22NCT01587196%22OR%22NCT01690546%22OR%22NCT01717963%22OR%22NCT01895036%22OR%22NCT01908062%22OR%22NCT02437344%22OR%22NCT02593474%22OR%22NCT02617628%22OR%22NCT02696434%22OR%22NCT02750748%22OR%22NCT03113409%22OR%22NCT03232346%22OR%22NCT03766893%22OR%22NCT03810495%22OR%22NCT03851731%22"]}]},{"efo_id":"EFO_0004329","efo_label":"alcohol drinking","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004329","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01625611"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01625611%22"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01174914","NCT01227044","NCT01625091","NCT02046252","NCT02330419"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01174914%22OR%22NCT01227044%22OR%22NCT01625091%22OR%22NCT02046252%22OR%22NCT02330419%22"]}]},{"efo_id":"EFO_0001073","efo_label":"obesity","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001073","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00364871","NCT00456521","NCT00532779","NCT00567255","NCT00711477","NCT00976066","NCT03374956"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00364871%22OR%22NCT00456521%22OR%22NCT00532779%22OR%22NCT00567255%22OR%22NCT00711477%22OR%22NCT00976066%22OR%22NCT03374956%22"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00398957","NCT00399295","NCT01557257","NCT01750060","NCT01780233","NCT02401750"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00398957%22OR%22NCT00399295%22OR%22NCT01557257%22OR%22NCT01750060%22OR%22NCT01780233%22OR%22NCT02401750%22"]}]},{"efo_id":"EFO_0004701","efo_label":"methamphetamine dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004701","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00332605","NCT00984360","NCT01723384","NCT01982643"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00332605%22OR%22NCT00984360%22OR%22NCT01723384%22OR%22NCT01982643%22"]}]},{"efo_id":"EFO_0000384","efo_label":"Crohn's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000384","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00715117","NCT01810185"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00715117%22OR%22NCT01810185%22"]}]},{"efo_id":"EFO_0004240","efo_label":"heroin dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004240","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00135759","NCT00142948","NCT00218426","NCT00238914","NCT00476242","NCT00577408"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00135759%22OR%22NCT00142948%22OR%22NCT00218426%22OR%22NCT00238914%22OR%22NCT00476242%22OR%22NCT00577408%22"]}]},{"efo_id":"EFO_0004242","efo_label":"obsessive-compulsive disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004242","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00758966"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00758966%22"]}]},{"efo_id":"EFO_0003768","efo_label":"nicotine dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003768","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00105482","NCT00129246","NCT00218153","NCT00270231","NCT00419731","NCT00502216","NCT00773422","NCT00938886","NCT02698215"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00105482%22OR%22NCT00129246%22OR%22NCT00218153%22OR%22NCT00270231%22OR%22NCT00419731%22OR%22NCT00502216%22OR%22NCT00773422%22OR%22NCT00938886%22OR%22NCT02698215%22"]}]},{"efo_id":"EFO_0003885","efo_label":"multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003885","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00501696"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00501696%22"]}]},{"efo_id":"EFO_0002610","efo_label":"cocaine dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002610","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000307","NCT00015080","NCT00142818","NCT00142844","NCT00167232","NCT00218023","NCT00218569","NCT00218660","NCT00777062","NCT01402492"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000307%22OR%22NCT00015080%22OR%22NCT00142818%22OR%22NCT00142844%22OR%22NCT00167232%22OR%22NCT00218023%22OR%22NCT00218569%22OR%22NCT00218660%22OR%22NCT00777062%22OR%22NCT01402492%22"]}]},{"efo_id":"EFO_0003890","efo_label":"drug dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003890","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01100853","NCT02543944"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01100853%22OR%22NCT02543944%22"]}]},{"efo_id":"EFO_0000692","efo_label":"schizophrenia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000692","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00567034"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00567034%22"]}]},{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00338962","NCT00624858","NCT01874951","NCT02911597"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00338962%22OR%22NCT00624858%22OR%22NCT01874951%22OR%22NCT02911597%22"]}]},{"efo_id":"EFO_0000274","efo_label":"atopic eczema","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000274","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02268448"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02268448%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00379197"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00379197%22"]}]},{"efo_id":"EFO_0000677","efo_label":"mental or behavioural disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000677","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00318162"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00318162%22"]}]},{"efo_id":"EFO_0000729","efo_label":"ulcerative colitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000729","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01810185"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01810185%22"]}]},{"efo_id":"EFO_0001358","efo_label":"post-traumatic stress disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001358","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00338962"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00338962%22"]}]},{"efo_id":"HP_0012076","efo_label":"Borderline personality disorder","efo_uri":"http://purl.obolibrary.org/obo/HP_0012076","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00124839","NCT01133301"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00124839%22OR%22NCT01133301%22"]}]},{"efo_id":"EFO_0001065","efo_label":"endometriosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001065","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03970330"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03970330%22"]}]},{"efo_id":"EFO_0007191","efo_label":"cannabis dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007191","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00403117","NCT00743145","NCT02088177"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00403117%22OR%22NCT00743145%22OR%22NCT02088177%22"]}]},{"efo_id":"EFO_1000906","efo_label":"dry eye syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000906","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03660475"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03660475%22"]}]},{"efo_id":"HP_0012532","efo_label":"Chronic pain","efo_uri":"http://purl.obolibrary.org/obo/HP_0012532","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00650182","NCT01428583"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00650182%22OR%22NCT01428583%22"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00415597"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00415597%22"]},{"source":"DailyMed","ids":["a7658a2d-b7a9-4fb5-8d65-a20ca1b9ad1f","dfe97a3d-247d-4dda-a641-1a95196cd8d8"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a7658a2d-b7a9-4fb5-8d65-a20ca1b9ad1f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dfe97a3d-247d-4dda-a641-1a95196cd8d8"]}]},{"efo_id":"EFO_0005611","efo_label":"opioid dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005611","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01380093","NCT03715634"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01380093%22OR%22NCT03715634%22"]}]},{"efo_id":"EFO_0005203","efo_label":"eating disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005203","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03539900"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03539900%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000082556","approved_name":"opioid receptor kappa 1","approved_symbol":"OPRK1"},{"ensembl":"ENSG00000116329","approved_name":"opioid receptor delta 1","approved_symbol":"OPRD1"},{"ensembl":"ENSG00000112038","approved_name":"opioid receptor mu 1","approved_symbol":"OPRM1"}],"target_type":"protein family","target_name":"Opioid receptors; mu/kappa/delta","action_type":"antagonist","description":"Opioid receptors; mu/kappa/delta antagonist","references":[{"source":"DailyMed","ids":["setid=49aa3d6d-2270-4615-aafa-b440859ab870#nlm34090-1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=49aa3d6d-2270-4615-aafa-b440859ab870#nlm34090-1"]}]}],"adverse_events":{"significant":[{"event":"injection site reaction","count":22116,"llr":4754.591298},{"event":"alcoholism","count":1201,"llr":2814.336712},{"event":"injection site mass","count":6387,"llr":2455.421084},{"event":"injection site pain","count":56727,"llr":1972.288192},{"event":"drug dependence","count":7072,"llr":1187.934042},{"event":"injection site induration","count":4525,"llr":959.339786},{"event":"therapeutic response shortened","count":1275,"llr":539.5593152},{"event":"feeling abnormal","count":36538,"llr":506.5963514},{"event":"alcohol use","count":1293,"llr":437.5335672},{"event":"drug use disorder","count":913,"llr":403.5802648},{"event":"withdrawal syndrome","count":6642,"llr":307.1618967},{"event":"needle issue","count":3041,"llr":265.7333573},{"event":"insomnia","count":44658,"llr":245.2886979},{"event":"depression","count":45027,"llr":243.0274773},{"event":"product administered at inappropriate site","count":535,"llr":240.1956638},{"event":"injection site abscess","count":797,"llr":239.1010246},{"event":"injection site swelling","count":20326,"llr":221.0602263},{"event":"anxiety","count":45966,"llr":220.2739708},{"event":"drug screen positive","count":1833,"llr":190.2908859},{"event":"substance abuse","count":1041,"llr":188.9475118},{"event":"euphoric mood","count":1822,"llr":174.886001},{"event":"decreased appetite","count":40807,"llr":162.0381504},{"event":"apathy","count":2732,"llr":130.6406218},{"event":"drug withdrawal syndrome","count":13453,"llr":125.9684618},{"event":"dependence","count":1115,"llr":123.0363715},{"event":"nausea","count":165652,"llr":119.5887605},{"event":"headache","count":120638,"llr":108.6017764},{"event":"alcohol abuse","count":821,"llr":107.869213},{"event":"injection site nodule","count":2274,"llr":107.5521971},{"event":"anaemia","count":61405,"llr":103.8789074},{"event":"tremor","count":36500,"llr":99.86475651},{"event":"drug abuse","count":14574,"llr":97.63172276},{"event":"lack of injection site rotation","count":168,"llr":97.57636261},{"event":"pain","count":94786,"llr":97.22418933},{"event":"alcohol poisoning","count":639,"llr":87.22999286}],"critval":83.23919932},"child_chembl_ids":["CHEMBL1201149","CHEMBL4303313"],"number_of_indications":30,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":16},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":15},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":9},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":4},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":4},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":3},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":3},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":2},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":2},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":2},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3301593","_score":1,"_source":{"id":"CHEMBL3301593","internal_compound":false,"type":"Small molecule","pref_name":"DECOGLURANT","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Decoglurant","RG-1578","RO-4995819"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB11923"]}],"canonical_smiles":"Nc1ccc(C#Cc2cnn3c(C(F)(F)F)cc(-c4ccc(C(F)(F)F)cc4)nc23)cn1","indications":[{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01457677","NCT01733654"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01457677%22OR%22NCT01733654%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000164082","approved_name":"glutamate metabotropic receptor 2","approved_symbol":"GRM2"}],"target_type":"single protein","target_name":"Metabotropic glutamate receptor 2","action_type":"modulator","description":"Metabotropic glutamate receptor 2 modulator","references":[{"source":"Wikipedia","ids":["Decoglurant"],"urls":["https://www.wikipedia.org/Decoglurant"]}]},{"target_components":[{"ensembl":"ENSG00000198822","approved_name":"glutamate metabotropic receptor 3","approved_symbol":"GRM3"}],"target_type":"single protein","target_name":"Metabotropic glutamate receptor 3","action_type":"modulator","description":"Metabotropic glutamate receptor 3 modulator","references":[{"source":"Wikipedia","ids":["Decoglurant"],"urls":["https://www.wikipedia.org/Decoglurant"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL93645","_score":1,"_source":{"id":"CHEMBL93645","internal_compound":false,"type":"Small molecule","pref_name":"ACECLOFENAC","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Aceclofenac","Aceclofenac betadex"],"trade_names":["Gerbin","Preservex"],"cross_references":[{"source":"ChEBI","ids":[31159]},{"source":"PubChem","ids":["11112873","144204261","170465979","50085951"]},{"source":"Wikipedia","ids":["Aceclofenac"]},{"source":"drugbank","ids":["DB06736"]}],"canonical_smiles":"O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl","indications":[{"efo_id":"EFO_0005755","efo_label":"rheumatic disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005755","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["M01AB16"],"urls":["https://www.whocc.no/atc_ddd_index/?code=M01AB16"]}]},{"efo_id":"HP_0003326","efo_label":"Myalgia","efo_uri":"http://purl.obolibrary.org/obo/HP_0003326","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["M02AA25"],"urls":["https://www.whocc.no/atc_ddd_index/?code=M02AA25"]}]},{"efo_id":"HP_0002829","efo_label":"Arthralgia","efo_uri":"http://purl.obolibrary.org/obo/HP_0002829","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["M02AA25"],"urls":["https://www.whocc.no/atc_ddd_index/?code=M02AA25"]}]},{"efo_id":"EFO_1001139","efo_label":"pulpitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001139","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03146481","NCT03335007"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03146481%22OR%22NCT03335007%22"]}]},{"efo_id":"EFO_0002506","efo_label":"osteoarthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002506","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["8a023942-01e8-4849-aa3c-1a640ffc7fd3"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8a023942-01e8-4849-aa3c-1a640ffc7fd3"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000073756","approved_name":"prostaglandin-endoperoxide synthase 2","approved_symbol":"PTGS2"}],"target_type":"single protein","target_name":"Cyclooxygenase-2","action_type":"inhibitor","description":"Cyclooxygenase-2 inhibitor","references":[{"source":"Other","ids":["http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con2030967.pdf"],"urls":["http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con2030967.pdf"]},{"source":"PubMed","ids":["11511027","24633464","24639945"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11511027+OR+EXT_ID%3A24633464+OR+EXT_ID%3A24639945"]}]}],"adverse_events":{"significant":[{"event":"hyperreflexia","count":1491,"llr":35.95154835},{"event":"macular degeneration","count":1967,"llr":28.55626551},{"event":"apraxia","count":505,"llr":25.43568181},{"event":"hyperkalaemia","count":12419,"llr":19.22445092},{"event":"coma","count":13175,"llr":18.7677178},{"event":"lactic acidosis","count":8744,"llr":18.25831275},{"event":"ataxia","count":4833,"llr":14.23718991},{"event":"cognitive disorder","count":9869,"llr":14.01685867},{"event":"metabolic syndrome","count":571,"llr":13.33185209},{"event":"tetany","count":730,"llr":12.59845098},{"event":"pachymeningitis","count":81,"llr":11.96470327},{"event":"acute kidney injury","count":33030,"llr":11.83670442},{"event":"drug abuse","count":14574,"llr":11.77993195},{"event":"potentiating drug interaction","count":1142,"llr":11.26521336},{"event":"myoclonus","count":4355,"llr":10.9023241},{"event":"disorientation","count":10841,"llr":10.32966757},{"event":"suicide attempt","count":20244,"llr":9.931444175},{"event":"pallor","count":6405,"llr":9.404790518},{"event":"vision blurred","count":26101,"llr":8.534237895},{"event":"hypomagnesaemia","count":4347,"llr":7.326995879},{"event":"gait disturbance","count":34050,"llr":7.11243298}],"critval":6.727959751},"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":3},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":2},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3989794","_score":1,"_source":{"id":"CHEMBL3989794","internal_compound":false,"type":"Small molecule","pref_name":"DAGLUTRIL","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Daglutril"],"trade_names":[],"canonical_smiles":"CCOC(=O)[C@H](CCCc1ccccc1)C1(C(=O)N[C@H]2CCc3ccccc3N(CC(=O)O)C2=O)CCCC1","indications":[{"efo_id":"EFO_0000537","efo_label":"hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000537","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00160212","NCT00160225"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00160212%22OR%22NCT00160225%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109389","_score":1,"_source":{"id":"CHEMBL2109389","internal_compound":false,"type":"Antibody","pref_name":"IMGATUZUMAB","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["GA-201","GA201","HUMA-B","HUMAB","HuMAB<EGFR>","Imgatuzumab","RG-7160","Ro-5083945"],"trade_names":[],"indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00721266"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00721266%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01185847","NCT01702714"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01185847%22OR%22NCT01702714%22"]}]},{"efo_id":"EFO_0006859","efo_label":"head and neck malignant neoplasia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006859","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01046266"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01046266%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01326000"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01326000%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000146648","approved_name":"epidermal growth factor receptor","approved_symbol":"EGFR"}],"target_type":"single protein","target_name":"Epidermal growth factor receptor erbB1","action_type":"inhibitor","description":"Epidermal growth factor receptor erbB1 inhibitor","references":[{"source":"PubMed","ids":["28467975"],"urls":["https://europepmc.org/search?query=EXT_ID%3A28467975"]}]},{"target_components":[{"ensembl":"ENSG00000203747","approved_name":"Fc fragment of IgG receptor IIIa","approved_symbol":"FCGR3A"}],"target_type":"single protein","target_name":"Low affinity immunoglobulin gamma Fc region receptor III-A","action_type":"cross-linking agent","description":"Low affinity immunoglobulin gamma Fc region receptor III-A cross-linking agent","references":[{"source":"PubMed","ids":["26581243","28467975"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26581243+OR+EXT_ID%3A28467975"]}]}],"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":4},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL563646","_score":1,"_source":{"id":"CHEMBL563646","internal_compound":false,"type":"Small molecule","pref_name":"EVATANEPAG","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["C-533,536-02","CP-533536","CP-533536-02","Evatanepag","Evatanepag Sodium"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12022"]}],"canonical_smiles":"CC(C)(C)c1ccc(CN(Cc2cccc(OCC(=O)O)c2)S(=O)(=O)c2cccnc2)cc1","indications":[{"efo_id":"EFO_0003944","efo_label":"tibia fracture","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003944","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00533377"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00533377%22"]}]}],"child_chembl_ids":["CHEMBL2105672"],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL939","_score":1,"_source":{"id":"CHEMBL939","internal_compound":false,"type":"Small molecule","pref_name":"GEFITINIB","year_first_approved":2003,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Gefitinib","Iressa","ZD-1839"],"trade_names":["Iressa"],"cross_references":[{"source":"ChEBI","ids":[49668]},{"source":"DailyMed","ids":["gefitinib"]},{"source":"PubChem","ids":["103905343","103905344","124892204","124892206","137275808","144205236","170464828","29215403","50100103"]},{"source":"Wikipedia","ids":["Gefitinib"]},{"source":"drugbank","ids":["DB00317"]}],"canonical_smiles":"COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1","indications":[{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00049062","NCT00057941","NCT00066339","NCT00066378","NCT00077025","NCT00080743","NCT00082667","NCT00086957","NCT00206414","NCT00206492","NCT00234403","NCT00239343","NCT00247481","NCT00252811","NCT00255463","NCT00319618","NCT00357734","NCT00428896","NCT00632723","NCT00637026","NCT01732276"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00049062%22OR%22NCT00057941%22OR%22NCT00066339%22OR%22NCT00066378%22OR%22NCT00077025%22OR%22NCT00080743%22OR%22NCT00082667%22OR%22NCT00086957%22OR%22NCT00206414%22OR%22NCT00206492%22OR%22NCT00234403%22OR%22NCT00239343%22OR%22NCT00247481%22OR%22NCT00252811%22OR%22NCT00255463%22OR%22NCT00319618%22OR%22NCT00357734%22OR%22NCT00428896%22OR%22NCT00632723%22OR%22NCT00637026%22OR%22NCT01732276%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00020709","NCT00029003","NCT00034879","NCT00048087","NCT00059722","NCT00076388","NCT00080340","NCT00090675","NCT00162318","NCT00173875","NCT00198393","NCT00231465","NCT00234468","NCT00242801","NCT00252707","NCT00252798","NCT00255489","NCT00256711","NCT00259064","NCT00264498","NCT00268255","NCT00319800","NCT00322452","NCT00328562","NCT00333294","NCT00372515","NCT00409006","NCT00478049","NCT00497250","NCT00588445","NCT00683306","NCT00807066","NCT00809237","NCT00824746","NCT00891579","NCT00986284","NCT01017679","NCT01017874","NCT01037998","NCT01040780","NCT01066195","NCT01158170","NCT01192243","NCT01196234","NCT01312337","NCT01391260","NCT01404260","NCT01405079","NCT01469000","NCT01498562","NCT01510990","NCT01513174","NCT01544179","NCT01570296","NCT01579630","NCT01749072","NCT01755923","NCT01769066","NCT01774721","NCT01783834","NCT01784549","NCT01833572","NCT01864681","NCT01871480","NCT01933347","NCT01955421","NCT01982955","NCT02039674","NCT02040064","NCT02088112","NCT02151721","NCT02179671","NCT02296125","NCT02319577","NCT02326285","NCT02374645","NCT02387086","NCT02411448","NCT02588261","NCT02804776","NCT02824458","NCT02856893","NCT02882984","NCT02893332","NCT02930954","NCT02976116","NCT03050411","NCT03122717","NCT03123484","NCT03267654","NCT03333343","NCT03374280","NCT03381066","NCT03399669","NCT03457337","NCT03529084","NCT03599518","NCT03656393","NCT03758287","NCT03787992","NCT03849768","NCT03856697","NCT03866499","NCT03944772","NCT04028778"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00020709%22OR%22NCT00029003%22OR%22NCT00034879%22OR%22NCT00048087%22OR%22NCT00059722%22OR%22NCT00076388%22OR%22NCT00080340%22OR%22NCT00090675%22OR%22NCT00162318%22OR%22NCT00173875%22OR%22NCT00198393%22OR%22NCT00231465%22OR%22NCT00234468%22OR%22NCT00242801%22OR%22NCT00252707%22OR%22NCT00252798%22OR%22NCT00255489%22OR%22NCT00256711%22OR%22NCT00259064%22OR%22NCT00264498%22OR%22NCT00268255%22OR%22NCT00319800%22OR%22NCT00322452%22OR%22NCT00328562%22OR%22NCT00333294%22OR%22NCT00372515%22OR%22NCT00409006%22OR%22NCT00478049%22OR%22NCT00497250%22OR%22NCT00588445%22OR%22NCT00683306%22OR%22NCT00807066%22OR%22NCT00809237%22OR%22NCT00824746%22OR%22NCT00891579%22OR%22NCT00986284%22OR%22NCT01017679%22OR%22NCT01017874%22OR%22NCT01037998%22OR%22NCT01040780%22OR%22NCT01066195%22OR%22NCT01158170%22OR%22NCT01192243%22OR%22NCT01196234%22OR%22NCT01312337%22OR%22NCT01391260%22OR%22NCT01404260%22OR%22NCT01405079%22OR%22NCT01469000%22OR%22NCT01498562%22OR%22NCT01510990%22OR%22NCT01513174%22OR%22NCT01544179%22OR%22NCT01570296%22OR%22NCT01579630%22OR%22NCT01749072%22OR%22NCT01755923%22OR%22NCT01769066%22OR%22NCT01774721%22OR%22NCT01783834%22OR%22NCT01784549%22OR%22NCT01833572%22OR%22NCT01864681%22OR%22NCT01871480%22OR%22NCT01933347%22OR%22NCT01955421%22OR%22NCT01982955%22OR%22NCT02039674%22OR%22NCT02040064%22OR%22NCT02088112%22OR%22NCT02151721%22OR%22NCT02179671%22OR%22NCT02296125%22OR%22NCT02319577%22OR%22NCT02326285%22OR%22NCT02374645%22OR%22NCT02387086%22OR%22NCT02411448%22OR%22NCT02588261%22OR%22NCT02804776%22OR%22NCT02824458%22OR%22NCT02856893%22OR%22NCT02882984%22OR%22NCT02893332%22OR%22NCT02930954%22OR%22NCT02976116%22OR%22NCT03050411%22OR%22NCT03122717%22OR%22NCT03123484%22OR%22NCT03267654%22OR%22NCT03333343%22OR%22NCT03374280%22OR%22NCT03381066%22OR%22NCT03399669%22OR%22NCT03457337%22OR%22NCT03529084%22OR%22NCT03599518%22OR%22NCT03656393%22OR%22NCT03758287%22OR%22NCT03787992%22OR%22NCT03849768%22OR%22NCT03856697%22OR%22NCT03866499%22OR%22NCT03944772%22OR%22NCT04028778%22"]},{"source":"DailyMed","ids":["827d60e8-7e07-41b7-c28b-49ef1c4a5a41"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?827d60e8-7e07-41b7-c28b-49ef1c4a5a41"]}]},{"efo_id":"EFO_0004284","efo_label":"upper aerodigestive tract neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004284","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00239304","NCT00519077"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00239304%22OR%22NCT00519077%22"]}]},{"efo_id":"EFO_0001071","efo_label":"lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001071","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00005806","NCT00006048","NCT00006049","NCT00062062","NCT00062270","NCT00068653","NCT00091156","NCT00096486","NCT00098462","NCT00103051","NCT00144066","NCT00188617","NCT00193336","NCT00217698","NCT00238251","NCT00238628","NCT00310154","NCT00344773","NCT00357734","NCT00411047","NCT00452244","NCT00455936","NCT00616499","NCT00955695","NCT01024712","NCT01039948","NCT01466660","NCT01530334","NCT01556191","NCT02025218","NCT02321293","NCT02518802","NCT03292133"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00005806%22OR%22NCT00006048%22OR%22NCT00006049%22OR%22NCT00062062%22OR%22NCT00062270%22OR%22NCT00068653%22OR%22NCT00091156%22OR%22NCT00096486%22OR%22NCT00098462%22OR%22NCT00103051%22OR%22NCT00144066%22OR%22NCT00188617%22OR%22NCT00193336%22OR%22NCT00217698%22OR%22NCT00238251%22OR%22NCT00238628%22OR%22NCT00310154%22OR%22NCT00344773%22OR%22NCT00357734%22OR%22NCT00411047%22OR%22NCT00452244%22OR%22NCT00455936%22OR%22NCT00616499%22OR%22NCT00955695%22OR%22NCT01024712%22OR%22NCT01039948%22OR%22NCT01466660%22OR%22NCT01530334%22OR%22NCT01556191%22OR%22NCT02025218%22OR%22NCT02321293%22OR%22NCT02518802%22OR%22NCT03292133%22"]}]},{"efo_id":"EFO_0000707","efo_label":"squamous cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000707","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00126555","NCT01485809"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00126555%22OR%22NCT01485809%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00130702"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00130702%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["L01XE02"],"urls":["https://www.whocc.no/atc_ddd_index/?code=L01XE02"]},{"source":"ClinicalTrials","ids":["NCT00039390","NCT00040781","NCT00084708","NCT00084786","NCT00127829","NCT00186979","NCT00229723","NCT00502060","NCT01024413","NCT02447419","NCT03239015"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00039390%22OR%22NCT00040781%22OR%22NCT00084708%22OR%22NCT00084786%22OR%22NCT00127829%22OR%22NCT00186979%22OR%22NCT00229723%22OR%22NCT00502060%22OR%22NCT01024413%22OR%22NCT02447419%22OR%22NCT03239015%22"]}]},{"efo_id":"EFO_0000326","efo_label":"central nervous system cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000326","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00016991","NCT00025675","NCT00027625"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00016991%22OR%22NCT00025675%22OR%22NCT00027625%22"]}]},{"efo_id":"EFO_0003826","efo_label":"salivary gland neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003826","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00509002"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00509002%22"]}]},{"efo_id":"EFO_0002916","efo_label":"esophageal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002916","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00093652","NCT00100945","NCT00258297","NCT00258323","NCT00268346","NCT00290719","NCT00493025","NCT01291823"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00093652%22OR%22NCT00100945%22OR%22NCT00258297%22OR%22NCT00258323%22OR%22NCT00268346%22OR%22NCT00290719%22OR%22NCT00493025%22OR%22NCT01291823%22"]}]},{"efo_id":"EFO_0000588","efo_label":"mesothelioma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000588","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00025207","NCT00787410"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00025207%22OR%22NCT00787410%22"]}]},{"efo_id":"EFO_0000182","efo_label":"hepatocellular carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000182","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00071994"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00071994%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00177242","NCT00635973","NCT02889692","NCT02929693"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00177242%22OR%22NCT00635973%22OR%22NCT02889692%22OR%22NCT02929693%22"]}]},{"efo_id":"EFO_1001465","efo_label":"gliosarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001465","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00014170","NCT00052208"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00014170%22OR%22NCT00052208%22"]}]},{"efo_id":"EFO_0003859","efo_label":"uterine neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003859","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00027690"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00027690%22"]}]},{"efo_id":"EFO_0000178","efo_label":"gastric carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000178","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00237900"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00237900%22"]}]},{"efo_id":"EFO_0000181","efo_label":"head and neck squamous cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000181","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00206219"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00206219%22"]}]},{"efo_id":"EFO_0000196","efo_label":"metastatic prostate cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000196","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00239291"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00239291%22"]}]},{"efo_id":"EFO_0000292","efo_label":"bladder carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000292","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00014144","NCT00246974","NCT00352079","NCT00479089"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00014144%22OR%22NCT00246974%22OR%22NCT00352079%22OR%22NCT00479089%22"]}]},{"efo_id":"EFO_0000514","efo_label":"germ cell tumor","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000514","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00198159"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00198159%22"]}]},{"efo_id":"EFO_0000519","efo_label":"glioblastoma multiforme","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000519","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00238797","NCT00250887","NCT01310855"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00238797%22OR%22NCT00250887%22OR%22NCT01310855%22"]}]},{"efo_id":"EFO_0000621","efo_label":"neuroblastoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000621","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00135135"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00135135%22"]}]},{"efo_id":"EFO_0000681","efo_label":"renal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000681","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00113529"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00113529%22"]}]},{"efo_id":"EFO_0000691","efo_label":"sarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000691","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00052754"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00052754%22"]}]},{"efo_id":"EFO_0000702","efo_label":"small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000702","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00298688"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00298688%22"]}]},{"efo_id":"EFO_0000708","efo_label":"squamous cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000708","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00020709"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00020709%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00025116","NCT00241475","NCT00242918","NCT00265070","NCT00319787","NCT00483561","NCT00635856"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00025116%22OR%22NCT00241475%22OR%22NCT00242918%22OR%22NCT00265070%22OR%22NCT00319787%22OR%22NCT00483561%22OR%22NCT00635856%22"]}]},{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00234416"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00234416%22"]}]},{"efo_id":"EFO_0002890","efo_label":"renal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002890","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00012337","NCT00014183","NCT00467077"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00012337%22OR%22NCT00014183%22OR%22NCT00467077%22"]}]},{"efo_id":"EFO_0003846","efo_label":"urethral neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003846","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00014144"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00014144%22"]}]},{"efo_id":"EFO_0003869","efo_label":"breast neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003869","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00229697"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00229697%22"]}]},{"efo_id":"EFO_0003897","efo_label":"stomach neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003897","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03170180"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03170180%22"]}]},{"efo_id":"EFO_0004252","efo_label":"nasopharyngeal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004252","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00212108"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00212108%22"]}]},{"efo_id":"EFO_0006859","efo_label":"head and neck malignant neoplasia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006859","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00015964","NCT00024089","NCT00083057","NCT00088907","NCT00095836","NCT00169221","NCT00193284","NCT00195078","NCT00228488","NCT00242749","NCT00242762","NCT00352105","NCT00681967","NCT01185158"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00015964%22OR%22NCT00024089%22OR%22NCT00083057%22OR%22NCT00088907%22OR%22NCT00095836%22OR%22NCT00169221%22OR%22NCT00193284%22OR%22NCT00195078%22OR%22NCT00228488%22OR%22NCT00242749%22OR%22NCT00242762%22OR%22NCT00352105%22OR%22NCT00681967%22OR%22NCT01185158%22"]}]},{"efo_id":"EFO_0006861","efo_label":"male breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006861","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00024154"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00024154%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00025142","NCT00025350","NCT00026299","NCT00026364","NCT00030524","NCT00087334","NCT00234429","NCT00242788"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00025142%22OR%22NCT00025350%22OR%22NCT00026299%22OR%22NCT00026364%22OR%22NCT00030524%22OR%22NCT00087334%22OR%22NCT00234429%22OR%22NCT00242788%22"]}]},{"efo_id":"EFO_0000571","efo_label":"lung adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000571","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00020709","NCT02951637","NCT03486496"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00020709%22OR%22NCT02951637%22OR%22NCT03486496%22"]}]},{"efo_id":"EFO_0001061","efo_label":"cervical carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001061","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00049556"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00049556%22"]}]},{"efo_id":"EFO_0001075","efo_label":"ovarian carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001075","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00023699","NCT00049556","NCT00181688","NCT00189358","NCT00317772"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00023699%22OR%22NCT00049556%22OR%22NCT00181688%22OR%22NCT00189358%22OR%22NCT00317772%22"]}]},{"efo_id":"EFO_0009259","efo_label":"skin carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009259","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00054691"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00054691%22"]}]},{"efo_id":"EFO_1000251","efo_label":"Fallopian Tube Carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000251","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00049556","NCT00189358","NCT00317772"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00049556%22OR%22NCT00189358%22OR%22NCT00317772%22"]}]},{"efo_id":"EFO_1001100","efo_label":"peritoneal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001100","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00023699","NCT00049556","NCT00181688","NCT00189358","NCT00317772"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00023699%22OR%22NCT00049556%22OR%22NCT00181688%22OR%22NCT00189358%22OR%22NCT00317772%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000146648","approved_name":"epidermal growth factor receptor","approved_symbol":"EGFR"}],"target_type":"single protein","target_name":"Epidermal growth factor receptor erbB1","action_type":"inhibitor","description":"Epidermal growth factor receptor erbB1 inhibitor","references":[{"source":"DailyMed","ids":["setid=827d60e8-7e07-41b7-c28b-49ef1c4a5a41"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=827d60e8-7e07-41b7-c28b-49ef1c4a5a41"]}]}],"adverse_events":{"significant":[{"event":"malignant neoplasm progression","count":14458,"llr":883.6627815},{"event":"drug resistance","count":7341,"llr":290.0085342},{"event":"hepatic function abnormal","count":12036,"llr":252.1426966},{"event":"interstitial lung disease","count":12888,"llr":240.4265691},{"event":"disease progression","count":21531,"llr":209.8742944},{"event":"liver disorder","count":11122,"llr":176.8055497},{"event":"metastases to central nervous system","count":2595,"llr":171.7887733},{"event":"diarrhoea","count":126514,"llr":161.8525619},{"event":"lung disorder","count":9520,"llr":145.6803256},{"event":"acquired gene mutation","count":335,"llr":126.1543223},{"event":"dermatitis acneiform","count":1635,"llr":105.1261376},{"event":"paronychia","count":1339,"llr":91.66584242},{"event":"metastases to meninges","count":426,"llr":82.72799965},{"event":"malignant transformation","count":87,"llr":71.05066905},{"event":"egfr gene mutation","count":80,"llr":66.89647667},{"event":"metastases to bone","count":3280,"llr":58.34255016},{"event":"rash","count":97330,"llr":51.80497171},{"event":"anorexia","count":4812,"llr":50.62988985},{"event":"metastases to lung","count":2171,"llr":48.82561196},{"event":"small cell lung cancer","count":269,"llr":44.6463306},{"event":"oral intake reduced","count":1057,"llr":44.10019424},{"event":"dehydration","count":36809,"llr":41.50439114},{"event":"drug hypersensitivity","count":71246,"llr":40.47832592}],"critval":39.45588597},"number_of_indications":42,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":42},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":10},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":9},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":9},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":9},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":7},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":4},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":4},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL501174","_score":1,"_source":{"id":"CHEMBL501174","internal_compound":false,"type":"Small molecule","pref_name":"LYCOPENE","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["E-160D(III)","E160d","FEMA NO. 4110","INS NO.160D(III)","INS-160D(III)","Lycopene","NSC-407322"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[15948]},{"source":"PubChem","ids":["144205948","29218049"]},{"source":"Wikipedia","ids":["Lycopene"]},{"source":"drugbank","ids":["DB11231"]}],"canonical_smiles":"CC(C)=CCC/C(C)=C/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C=C(\\C)CCC=C(C)C","indications":[{"efo_id":"EFO_0000284","efo_label":"benign prostatic hyperplasia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000284","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00154843"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00154843%22"]}]},{"efo_id":"EFO_0000649","efo_label":"periodontitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000649","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03203746"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03203746%22"]}]},{"efo_id":"EFO_0000673","efo_label":"prostate adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000673","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00450749","NCT01443026","NCT01882985","NCT01949519"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00450749%22OR%22NCT01443026%22OR%22NCT01882985%22OR%22NCT01949519%22"]}]},{"efo_id":"EFO_0001645","efo_label":"coronary heart disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001645","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00939237"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00939237%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00006078","NCT00068731","NCT00093561","NCT00416325","NCT00450957"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00006078%22OR%22NCT00068731%22OR%22NCT00093561%22OR%22NCT00416325%22OR%22NCT00450957%22"]}]},{"efo_id":"EFO_0002621","efo_label":"prostate intraepithelial neoplasia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002621","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00178113"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00178113%22"]}]},{"efo_id":"EFO_0003914","efo_label":"atherosclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003914","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01287182"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01287182%22"]}]},{"efo_id":"EFO_1000726","efo_label":"lichen planus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000726","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00656214"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00656214%22"]}]},{"efo_id":"EFO_1001393","efo_label":"Periodontal Pocket","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001393","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03964935"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03964935%22"]}]}],"number_of_indications":9,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":4},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":4},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":4},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":2},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL9967","_score":1,"_source":{"id":"CHEMBL9967","internal_compound":false,"type":"Small molecule","pref_name":"PIRENZEPINE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["LS-519-C12","Pirenzepine","Pirenzepine Dihydrochloride","Pirenzepine HCl"],"trade_names":["Gastri P","Gastrozepin"],"cross_references":[{"source":"ChEBI","ids":[8247]},{"source":"PubChem","ids":["104171218","11111661","11111662","11113363","144203790","170465793","26751604","90341394"]},{"source":"Wikipedia","ids":["Pirenzepine"]},{"source":"drugbank","ids":["DB00670"]},{"source":"PubChem","ids":["855667"]},{"source":"ChEBI","ids":[32014]},{"source":"PubChem","ids":["50106842"]}],"canonical_smiles":"CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1","indications":[{"efo_id":"HP_0004398","efo_label":"Peptic ulcer","efo_uri":"http://purl.obolibrary.org/obo/HP_0004398","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["A02BX03"],"urls":["https://www.whocc.no/atc_ddd_index/?code=A02BX03"]}]},{"efo_id":"EFO_0003948","efo_label":"gastroesophageal reflux disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003948","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["A02BX03"],"urls":["https://www.whocc.no/atc_ddd_index/?code=A02BX03"]}]}],"adverse_events":{"significant":[{"event":"hepatitis c virus test positive","count":150,"llr":58.70695376},{"event":"eosinophil count decreased","count":426,"llr":50.35975898},{"event":"salivary hypersecretion","count":2562,"llr":41.68684991},{"event":"intestinal strangulation","count":59,"llr":38.85266994},{"event":"differential white blood cell count abnormal","count":783,"llr":38.8012176},{"event":"neutrophil count abnormal","count":816,"llr":38.51264175},{"event":"mental impairment","count":4700,"llr":31.20289763},{"event":"psychotic disorder","count":11057,"llr":24.43360706},{"event":"hypogammaglobulinaemia","count":1358,"llr":23.18777126},{"event":"ileus paralytic","count":1414,"llr":22.98642448},{"event":"intestinal obstruction","count":7554,"llr":18.75596571},{"event":"hepatitis","count":8668,"llr":17.94427708},{"event":"thrombocytopenia","count":35327,"llr":15.42734817},{"event":"neutropenia","count":41585,"llr":14.19675994},{"event":"generalised tonic-clonic seizure","count":4083,"llr":13.25293046},{"event":"platelet count decreased","count":29394,"llr":10.87254289},{"event":"restlessness","count":8148,"llr":10.5411709}],"critval":10.40826026},"child_chembl_ids":["CHEMBL1257024","CHEMBL1531864"],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201233","_score":1,"_source":{"id":"CHEMBL1201233","internal_compound":false,"type":"Small molecule","pref_name":"METHYLDOPATE","year_first_approved":1962,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Methyldopate","Methyldopate HCl"],"trade_names":["Aldomet","Methyldopate HCl"],"cross_references":[{"source":"DailyMed","ids":["methyldopate%20hydrochloride"]},{"source":"PubChem","ids":["144204076","170466856"]}],"canonical_smiles":"CCOC(=O)[C@@](C)(N)Cc1ccc(O)c(O)c1","adverse_events":{"significant":[{"event":"premature baby","count":8946,"llr":39.17188383},{"event":"caesarean section","count":5212,"llr":31.07806813},{"event":"pre-eclampsia","count":1582,"llr":29.4263813},{"event":"hellp syndrome","count":244,"llr":25.31219421},{"event":"foetal arrhythmia","count":99,"llr":22.94993224},{"event":"alanine aminotransferase increased","count":24852,"llr":19.51087097},{"event":"gamma-glutamyltransferase increased","count":9889,"llr":18.06932728},{"event":"aspartate aminotransferase increased","count":21532,"llr":16.22077501},{"event":"hepatitis","count":8668,"llr":16.14800752},{"event":"blood pressure inadequately controlled","count":1635,"llr":15.86668753},{"event":"oligohydramnios","count":1057,"llr":13.52310611},{"event":"foetal growth retardation","count":382,"llr":12.30503365},{"event":"hypertension","count":52519,"llr":11.04412608},{"event":"hypotonia neonatal","count":625,"llr":10.83963332},{"event":"caudal regression syndrome","count":76,"llr":10.60787179},{"event":"abortion spontaneous","count":14396,"llr":9.944915486},{"event":"tricuspid valve disease","count":124,"llr":9.631077542},{"event":"blood alkaline phosphatase increased","count":10095,"llr":9.609707069},{"event":"proteinuria","count":6145,"llr":9.459702878},{"event":"pulmonary arterial hypertension","count":3314,"llr":9.05935449},{"event":"ventricular hypertrophy","count":1181,"llr":8.957065662},{"event":"coombs positive haemolytic anaemia","count":182,"llr":8.86640917},{"event":"haemolytic anaemia","count":3565,"llr":8.779240088},{"event":"renal aplasia","count":213,"llr":8.553325092},{"event":"superior sagittal sinus thrombosis","count":241,"llr":8.307658554},{"event":"threatened labour","count":242,"llr":8.299424933},{"event":"neonatal respiratory distress syndrome","count":1535,"llr":8.187451161},{"event":"glomerulonephritis rapidly progressive","count":282,"llr":7.995404829},{"event":"bronchopulmonary dysplasia","count":296,"llr":7.899171572},{"event":"complications of maternal exposure to therapeutic drugs","count":302,"llr":7.859324236},{"event":"uterine spasm","count":305,"llr":7.839698614},{"event":"aplasia pure red cell","count":1777,"llr":7.759811213},{"event":"foetal growth restriction","count":1834,"llr":7.66781296},{"event":"rhinitis","count":1896,"llr":7.571030752},{"event":"small for dates baby","count":1938,"llr":7.507304855},{"event":"autophony","count":5,"llr":7.327799985},{"event":"blood bilirubin increased","count":9989,"llr":7.212213895},{"event":"drug rash with eosinophilia and systemic symptoms","count":2240,"llr":7.08726026},{"event":"colitis ulcerative","count":5663,"llr":7.027730226},{"event":"late developer","count":7,"llr":6.991424193},{"event":"congenital skin disorder","count":8,"llr":6.857941022},{"event":"low birth weight baby","count":2450,"llr":6.828447059},{"event":"le cells present","count":9,"llr":6.740206209},{"event":"moderate mental retardation","count":9,"llr":6.740206209},{"event":"renal artery stenosis","count":532,"llr":6.737923606},{"event":"liver disorder","count":11122,"llr":6.728612416},{"event":"jaundice neonatal","count":574,"llr":6.58796646},{"event":"rheumatoid factor positive","count":586,"llr":6.547161297},{"event":"blood pressure increased","count":25616,"llr":6.437296304},{"event":"hepatic function abnormal","count":12036,"llr":6.376979772},{"event":"evacuation of retained products of conception","count":15,"llr":6.229669918},{"event":"hepatocellular damage","count":734,"llr":6.103882323},{"event":"solitary kidney","count":21,"llr":5.893487015},{"event":"foetal distress syndrome","count":821,"llr":5.884027646}],"critval":5.866190813},"child_chembl_ids":["CHEMBL1200432"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000150594","approved_name":"adrenoceptor alpha 2A","approved_symbol":"ADRA2A"},{"ensembl":"ENSG00000184160","approved_name":"adrenoceptor alpha 2C","approved_symbol":"ADRA2C"},{"ensembl":"ENSG00000274286","approved_name":"adrenoceptor alpha 2B","approved_symbol":"ADRA2B"}],"target_type":"protein family","target_name":"Adrenergic receptor alpha-2","action_type":"agonist","description":"Adrenergic receptor alpha-2 agonist","references":[{"source":"DailyMed","ids":["setid=f5f25053-a9f3-48b9-a412-078f5ee942fd#nlm34090-1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5f25053-a9f3-48b9-a412-078f5ee942fd#nlm34090-1"]},{"source":"Wikipedia","ids":["Methyldopa"],"urls":["https://www.wikipedia.org/Methyldopa"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2068884","_score":1,"_source":{"id":"CHEMBL2068884","internal_compound":false,"type":"Small molecule","pref_name":"SODIUM GLUCONATE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["E-576-","E576","Gluconate sodium","Gluconic acid sodium salt","INS NO.576","INS-576","Sodium Gluconate"],"trade_names":[],"cross_references":[{"source":"DailyMed","ids":["sodium%20gluconate"]},{"source":"DrugCentral","ids":["4214"]}],"canonical_smiles":"O=C([O-])[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O.[Na+]","indications":[{"efo_id":"EFO_0003833","efo_label":"brain neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003833","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02707549"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02707549%22"]}]},{"efo_id":"MP_0001914","efo_label":"hemorrhage","efo_uri":"http://purl.obolibrary.org/obo/MP_0001914","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["36e56b56-33c0-49e5-ddab-b55da19cae58","50265baf-0232-45cf-7388-31c0bbfbc2a3","c3335a21-20c9-46a5-5d9f-12227d67fd11"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?36e56b56-33c0-49e5-ddab-b55da19cae58","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?50265baf-0232-45cf-7388-31c0bbfbc2a3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c3335a21-20c9-46a5-5d9f-12227d67fd11"]},{"source":"FDA","ids":["38b56b76-33c0-69d5-ddab-b25fa19cae52","3f404549-daf0-4795-98fe-77dbf6ca357d"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A38b56b76-33c0-69d5-ddab-b25fa19cae52","https://api.fda.gov/drug/label.json?search=set_id%3A3f404549-daf0-4795-98fe-77dbf6ca357d"]}]}],"adverse_events":{"significant":[{"event":"renal failure acute","count":23893,"llr":85.39242212},{"event":"confusion postoperative","count":44,"llr":67.1658449},{"event":"mental status changes postoperative","count":65,"llr":64.04455941},{"event":"metabolic alkalosis","count":568,"llr":46.70976684}],"critval":27.61944078},"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL360328","_score":1,"_source":{"id":"CHEMBL360328","internal_compound":false,"type":"Small molecule","pref_name":"LORCASERIN","year_first_approved":2012,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["APD-356","Lorcaserin","Lorcaserin HCl"],"trade_names":["Belviq","Belviq XR"],"cross_references":[{"source":"ChEBI","ids":[65353]},{"source":"DailyMed","ids":["lorcaserin%20hydrochloride"]},{"source":"PubChem","ids":["144206569","170466882"]},{"source":"Wikipedia","ids":["Lorcaserin"]},{"source":"drugbank","ids":["DB04871"]},{"source":"ChEBI","ids":[65350]}],"canonical_smiles":"C[C@H]1CNCCc2ccc(Cl)cc21","indications":[{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03011645"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03011645%22"]}]},{"efo_id":"EFO_0001073","efo_label":"obesity","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001073","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["A08AA11"],"urls":["https://www.whocc.no/atc_ddd_index/?code=A08AA11"]},{"source":"ClinicalTrials","ids":["NCT00395135","NCT00828581","NCT00828724","NCT00829140","NCT02022956","NCT02129608","NCT03720574"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00395135%22OR%22NCT00828581%22OR%22NCT00828724%22OR%22NCT00829140%22OR%22NCT02022956%22OR%22NCT02129608%22OR%22NCT03720574%22"]}]},{"efo_id":"EFO_0001421","efo_label":"liver disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001421","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00828932"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00828932%22"]}]},{"efo_id":"EFO_0002610","efo_label":"cocaine dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002610","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02537873","NCT02680288","NCT03007394","NCT03192995","NCT03266939"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02537873%22OR%22NCT02680288%22OR%22NCT03007394%22OR%22NCT03192995%22OR%22NCT03266939%22"]}]},{"efo_id":"EFO_0003768","efo_label":"nicotine dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003768","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02906644"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02906644%22"]}]},{"efo_id":"EFO_0003890","efo_label":"drug dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003890","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00828659"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00828659%22"]}]},{"efo_id":"EFO_0005611","efo_label":"opioid dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005611","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03143855","NCT03169816"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03143855%22OR%22NCT03169816%22"]}]},{"efo_id":"EFO_0003100","efo_label":"peripheral neuropathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003100","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03812523"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03812523%22"]}]},{"efo_id":"EFO_0007191","efo_label":"cannabis dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007191","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02932215","NCT03253926","NCT03637842"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02932215%22OR%22NCT03253926%22OR%22NCT03637842%22"]}]},{"efo_id":"EFO_0001073","efo_label":"obesity","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001073","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00104507","NCT00116740","NCT02398669"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00104507%22OR%22NCT00116740%22OR%22NCT02398669%22"]}]},{"efo_id":"EFO_0004319","efo_label":"smoking cessation","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004319","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02044874"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02044874%22"]}]}],"adverse_events":{"significant":[{"event":"headache","count":120638,"llr":94.80233962},{"event":"dizziness","count":99375,"llr":51.42205153},{"event":"fatigue","count":147738,"llr":45.03814817},{"event":"hunger","count":1089,"llr":24.63837699},{"event":"weight increased","count":33631,"llr":21.61158061},{"event":"feeling jittery","count":3123,"llr":21.10412387},{"event":"feeling abnormal","count":36538,"llr":18.28581883},{"event":"abnormal dreams","count":4584,"llr":17.17495242},{"event":"aortic valve incompetence","count":1435,"llr":15.58222739},{"event":"migraine","count":14792,"llr":13.89450262},{"event":"mitral valve incompetence","count":3884,"llr":13.75453904},{"event":"somnolence","count":38949,"llr":10.74096774},{"event":"dry mouth","count":12994,"llr":10.45307709},{"event":"serotonin syndrome","count":6002,"llr":10.26258925},{"event":"fall","count":67604,"llr":10.19662669},{"event":"pyrexia","count":87334,"llr":9.525471523},{"event":"suicidal ideation","count":21218,"llr":9.404656128},{"event":"anaemia","count":61405,"llr":9.015832617},{"event":"increased appetite","count":2669,"llr":8.994209174}],"critval":8.895318495},"child_chembl_ids":["CHEMBL2095211","CHEMBL3527027"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000147246","approved_name":"5-hydroxytryptamine receptor 2C","approved_symbol":"HTR2C"}],"target_type":"single protein","target_name":"Serotonin 2c (5-HT2c) receptor","action_type":"agonist","description":"Serotonin 2c (5-HT2c) receptor agonist","references":[{"source":"Expert","ids":["LORCASERIN"]}]}],"number_of_indications":11,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":6},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":5},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":5},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":2},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1742998","_score":1,"_source":{"id":"CHEMBL1742998","internal_compound":false,"type":"Antibody","pref_name":"CANTUZUMAB RAVTANSINE","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Cantuzumab Ravtansine","IMGN242","huC242-DM4"],"trade_names":[],"indications":[{"efo_id":"EFO_0000178","efo_label":"gastric carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000178","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00620607"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00620607%22"]}]},{"efo_id":"EFO_0000365","efo_label":"colorectal adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000365","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00352131"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00352131%22"]}]},{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00352131"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00352131%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000185499","approved_name":"mucin 1, cell surface associated","approved_symbol":"MUC1"}],"target_type":"single protein","target_name":"Mucin-1","action_type":"binding agent","description":"Mucin-1 binding agent","references":[{"source":"Other","ids":["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=492706"],"urls":["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=492706"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":3},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3039519","_score":1,"_source":{"id":"CHEMBL3039519","internal_compound":false,"type":"Small molecule","pref_name":"SAMATASVIR","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["IDX-18719","IDX18719","Samatasvir"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12660"]}],"canonical_smiles":"COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2cc(-c3csc4c(-c5ccc(-c6c[nH]c([C@@H]7CCCN7C(=O)[C@H](NC(=O)OC)c7ccccc7)n6)cc5)csc34)ccc2[nH]1)C(C)C","indications":[{"efo_id":"EFO_0003047","efo_label":"hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003047","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01335607"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01335607%22"]}]},{"efo_id":"EFO_0004220","efo_label":"chronic hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004220","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01813552","NCT01852604"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01813552%22OR%22NCT01852604%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3301608","_score":1,"_source":{"id":"CHEMBL3301608","internal_compound":false,"type":"Small molecule","pref_name":"LANOPEPDEN","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["GSK-1322322 MESYLATE SALT","GSK-1322322B","GSK-1322322J","GSK1322322","GSK1322322 MESYLATE SALT","GSK1322322B","GSK1322322J","Lanopepden","Lanopepden mesilate","Lanopepden mesylate"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB11912"]}],"canonical_smiles":"Cc1nc(NNC(=O)[C@H](CC2CCCC2)CN(O)C=O)c(F)c(N2CCN3CCOC[C@@H]3C2)n1","indications":[{"efo_id":"EFO_0000544","efo_label":"infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000544","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00924911","NCT01209078","NCT01648179","NCT01663389","NCT01803399","NCT01818011","NCT01953809"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00924911%22OR%22NCT01209078%22OR%22NCT01648179%22OR%22NCT01663389%22OR%22NCT01803399%22OR%22NCT01818011%22OR%22NCT01953809%22"]}]},{"efo_id":"EFO_0000544","efo_label":"infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000544","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01610388"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01610388%22"]}]}],"child_chembl_ids":["CHEMBL3301616"],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":2}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1851805","_score":1,"_source":{"id":"CHEMBL1851805","internal_compound":false,"type":"Small molecule","pref_name":"PROPACETAMOL","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["4-Acetamidophenyl 2-(Diethylamino)Acetate HCl","Propacetamol"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["170466215"]},{"source":"drugbank","ids":["DB09288"]}],"canonical_smiles":"CCN(CC)CC(=O)Oc1ccc(NC(C)=O)cc1","indications":[{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["N02BE05"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N02BE05"]}]},{"efo_id":"HP_0001945","efo_label":"Fever","efo_uri":"http://purl.obolibrary.org/obo/HP_0001945","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["N02BE05"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N02BE05"]}]}],"child_chembl_ids":["CHEMBL1795480"],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":2}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1222250","_score":1,"_source":{"id":"CHEMBL1222250","internal_compound":false,"type":"Small molecule","pref_name":"DEXTROSE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Dextrose","Glucose","Glucose injection","Glucose, Liquid"],"trade_names":["Capd","Clintec","Dextro Energy","Dextrogel","GSF-Syrup","Gambrosol","Glucose-40","Insta-Glucose","Rapilose","Yourgluco"],"cross_references":[{"source":"ChEBI","ids":[4167]},{"source":"DailyMed","ids":["dextrose"]},{"source":"PubChem","ids":["144206716","144207343","29218051"]},{"source":"Wikipedia","ids":["Glucose"]}],"canonical_smiles":"OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O","indications":[{"efo_id":"EFO_0004238","efo_label":"hearing loss","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004238","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00552786"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00552786%22"]}]},{"efo_id":"EFO_0000612","efo_label":"myocardial infarction","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000612","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00091507","NCT02591927"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00091507%22OR%22NCT02591927%22"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00337597","NCT02374281","NCT02728037","NCT03577730"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00337597%22OR%22NCT02374281%22OR%22NCT02728037%22OR%22NCT03577730%22"]}]},{"efo_id":"EFO_0003144","efo_label":"heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003144","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02596477"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02596477%22"]}]},{"efo_id":"HP_0002902","efo_label":"Hyponatremia","efo_uri":"http://purl.obolibrary.org/obo/HP_0002902","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00632775","NCT01251770","NCT01909336"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00632775%22OR%22NCT01251770%22OR%22NCT01909336%22"]}]},{"efo_id":"EFO_0000400","efo_label":"diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000400","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT01307904"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01307904%22"]}]},{"efo_id":"HP_0001943","efo_label":"Hypoglycemia","efo_uri":"http://purl.obolibrary.org/obo/HP_0001943","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02866435","NCT03241706"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02866435%22OR%22NCT03241706%22"]}]},{"efo_id":"EFO_0001359","efo_label":"type I diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001359","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00800085","NCT02269735","NCT02910518"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00800085%22OR%22NCT02269735%22OR%22NCT02910518%22"]}]},{"efo_id":"EFO_0001073","efo_label":"obesity","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001073","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00686608"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00686608%22"]}]},{"efo_id":"EFO_0001360","efo_label":"type II diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001360","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00609154","NCT01300260"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00609154%22OR%22NCT01300260%22"]}]},{"efo_id":"EFO_0003917","efo_label":"premature birth","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003917","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01783041","NCT02103998"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01783041%22OR%22NCT02103998%22"]}]},{"efo_id":"EFO_0000546","efo_label":"injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000546","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02776488"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02776488%22"]}]},{"efo_id":"MP_0001914","efo_label":"hemorrhage","efo_uri":"http://purl.obolibrary.org/obo/MP_0001914","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT03024814"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03024814%22"]},{"source":"DailyMed","ids":["50265baf-0232-45cf-7388-31c0bbfbc2a3"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?50265baf-0232-45cf-7388-31c0bbfbc2a3"]}]},{"efo_id":"EFO_0001421","efo_label":"liver disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001421","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02710266"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02710266%22"]}]},{"efo_id":"EFO_0000692","efo_label":"schizophrenia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000692","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01548612"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01548612%22"]}]},{"efo_id":"EFO_1000948","efo_label":"gastroparesis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000948","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00612014","NCT00639808","NCT01557296"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00612014%22OR%22NCT00639808%22OR%22NCT01557296%22"]}]},{"efo_id":"EFO_0000182","efo_label":"hepatocellular carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000182","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00617981"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00617981%22"]}]},{"efo_id":"EFO_0000253","efo_label":"amyotrophic lateral sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000253","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03039673"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03039673%22"]}]},{"efo_id":"EFO_0000373","efo_label":"congestive heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000373","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00091507"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00091507%22"]}]},{"efo_id":"EFO_0000474","efo_label":"epilepsy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000474","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02325583"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02325583%22"]}]},{"efo_id":"EFO_0000544","efo_label":"infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000544","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01075984","NCT01121354"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01075984%22OR%22NCT01121354%22"]}]},{"efo_id":"EFO_0000589","efo_label":"metabolic disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000589","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02185729"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02185729%22"]}]},{"efo_id":"EFO_0002506","efo_label":"osteoarthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002506","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01210183","NCT04022057"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01210183%22OR%22NCT04022057%22"]}]},{"efo_id":"EFO_0003885","efo_label":"multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003885","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00062972"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00062972%22"]}]},{"efo_id":"EFO_0003932","efo_label":"bacterial vaginosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003932","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03357666"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03357666%22"]}]},{"efo_id":"EFO_0004209","efo_label":"hypospadias","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004209","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02752308"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02752308%22"]}]},{"efo_id":"EFO_0006834","efo_label":"septic shock","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006834","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00823108","NCT01223690","NCT01485315"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00823108%22OR%22NCT01223690%22OR%22NCT01485315%22"]}]},{"efo_id":"EFO_0007214","efo_label":"common cold","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007214","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01883440"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01883440%22"]}]},{"efo_id":"EFO_1000985","efo_label":"intermediate coronary syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000985","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00091507"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00091507%22"]}]},{"efo_id":"EFO_1001919","efo_label":"Spinal cord injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001919","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01753882","NCT01788969"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01753882%22OR%22NCT01788969%22"]}]},{"efo_id":"HP_0100806","efo_label":"Sepsis","efo_uri":"http://purl.obolibrary.org/obo/HP_0100806","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01223690","NCT04088591"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01223690%22OR%22NCT04088591%22"]}]},{"efo_id":"Orphanet_738","efo_label":"Porphyria","efo_uri":"http://www.orpha.net/ORDO/Orphanet_738","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02180412"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02180412%22"]}]},{"efo_id":"EFO_0003106","efo_label":"pneumonia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003106","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03690583"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03690583%22"]}]},{"efo_id":"EFO_0003774","efo_label":"hyperlipidemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003774","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03860688"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03860688%22"]}]},{"efo_id":"EFO_0008572","efo_label":"malnutrition","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008572","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02632630"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02632630%22"]}]},{"efo_id":"EFO_0009579","efo_label":"postpartum hemorrhage","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009579","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02678208"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02678208%22"]}]}],"adverse_events":{"significant":[{"event":"acute kidney injury","count":33030,"llr":675.6657138},{"event":"hypoglycaemia","count":14252,"llr":83.61384203},{"event":"neonatal infection","count":98,"llr":52.52873506},{"event":"premature baby","count":8946,"llr":40.64103195},{"event":"metabolic acidosis","count":8683,"llr":33.51209515},{"event":"foetal death","count":1161,"llr":31.85018664},{"event":"low birth weight baby","count":2450,"llr":30.33091724},{"event":"pulmonary oedema","count":9905,"llr":28.61191132},{"event":"ataxia","count":4833,"llr":27.36152196},{"event":"endometritis","count":307,"llr":26.31315662},{"event":"pantoea agglomerans infection","count":14,"llr":25.10917989},{"event":"hyperkalaemia","count":12419,"llr":24.57448948},{"event":"neonatal hypocalcaemia","count":17,"llr":24.33314701},{"event":"hyperglycaemia","count":9767,"llr":24.2524042},{"event":"electrocardiogram u wave present","count":19,"llr":23.88863859},{"event":"pre-eclampsia","count":1582,"llr":21.58085303},{"event":"bone marrow failure","count":8717,"llr":21.48267858},{"event":"chronic kidney disease-mineral and bone disorder","count":44,"llr":20.53456247},{"event":"extravasation","count":1902,"llr":19.98557835},{"event":"small for dates baby","count":1938,"llr":19.82387413},{"event":"hyperdynamic left ventricle","count":63,"llr":19.10252627},{"event":"lactobacillus test positive","count":10,"llr":18.97617972},{"event":"cytotoxic oedema","count":73,"llr":18.51519803},{"event":"stillbirth","count":1542,"llr":18.46727536},{"event":"fatigue","count":147738,"llr":17.73830275},{"event":"bronchopulmonary dysplasia","count":296,"llr":17.30379043},{"event":"electrocardiogram p wave abnormal","count":110,"llr":16.88240568},{"event":"csf pressure increased","count":111,"llr":16.8464034},{"event":"reversible cerebral vasoconstriction syndrome","count":363,"llr":16.29676013},{"event":"shock","count":5269,"llr":16.01473309},{"event":"electrocardiogram t wave amplitude decreased","count":145,"llr":15.78428945},{"event":"tongue oedema","count":1455,"llr":15.64713998},{"event":"bacteraemia","count":3187,"llr":15.59172431},{"event":"lactic acidosis","count":8744,"llr":15.01859353},{"event":"blindness cortical","count":186,"llr":14.79631748},{"event":"haemodynamic instability","count":1660,"llr":14.76471113},{"event":"lactobacillus infection","count":41,"llr":14.74933574},{"event":"optic nerve injury","count":202,"llr":14.46938649},{"event":"anaemia neonatal","count":217,"llr":14.1858239},{"event":"retinal ischaemia","count":250,"llr":13.62607298},{"event":"optic atrophy","count":629,"llr":13.60047306},{"event":"blood aldosterone abnormal","count":5,"llr":13.22450438},{"event":"colour blindness","count":282,"llr":13.15059468},{"event":"hypokalaemia","count":14556,"llr":12.71639105},{"event":"embolism arterial","count":316,"llr":12.70195463},{"event":"cardiac arrest","count":9359,"llr":12.33276414},{"event":"neonatal respiratory distress syndrome","count":1535,"llr":12.21872699},{"event":"product container seal issue","count":101,"llr":12.05652976},{"event":"hypoglycaemic coma","count":1073,"llr":11.01745833},{"event":"bacillus bacteraemia","count":16,"llr":10.90037614},{"event":"product commingling","count":150,"llr":10.8796544},{"event":"product label confusion","count":510,"llr":10.82551407},{"event":"stupor","count":1152,"llr":10.67780439},{"event":"tachycardia","count":26994,"llr":10.56001272},{"event":"pain","count":94786,"llr":10.44186564},{"event":"paraesthesia oral","count":3231,"llr":10.4114399}],"critval":9.932432222},"number_of_indications":36,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":9},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":7},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":6},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":6},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":4},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":4},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":3},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":3},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":3},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":2},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":2},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":2},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000014","therapeutic_label":"pregnancy or perinatal disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2110786","_score":1,"_source":{"id":"CHEMBL2110786","internal_compound":false,"type":"Small molecule","pref_name":"STRONTIUM","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["85SR","Strontium","Strontium (85Sr)"],"trade_names":[],"canonical_smiles":"[SrH2]","indications":[{"efo_id":"EFO_0003882","efo_label":"osteoporosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003882","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00409032"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00409032%22"]}]}],"adverse_events":{"significant":[{"event":"oesophagitis","count":3670,"llr":70.24063632},{"event":"dehydration","count":36809,"llr":45.46430427},{"event":"radiation oesophagitis","count":132,"llr":40.24986269},{"event":"dysphagia","count":22741,"llr":26.98011697},{"event":"gastric outlet obstruction","count":21,"llr":20.19558836},{"event":"vomiting","count":103943,"llr":18.68558148},{"event":"radiation skin injury","count":388,"llr":16.44292009},{"event":"mediastinitis","count":151,"llr":14.28541504},{"event":"pharyngeal fistula","count":20,"llr":12.74659377},{"event":"oral pain","count":4982,"llr":12.07738587},{"event":"lymphopenia","count":5118,"llr":11.9241691},{"event":"metastases to liver","count":3380,"llr":11.03550665},{"event":"febrile neutropenia","count":19204,"llr":10.38789914},{"event":"radiation pneumonitis","count":571,"llr":10.3212544},{"event":"nausea","count":165652,"llr":9.686628714},{"event":"oesophageal fistula","count":98,"llr":9.573002986},{"event":"oral intake reduced","count":1057,"llr":8.504135152},{"event":"pyrexia","count":87334,"llr":7.948928583},{"event":"candidiasis","count":1415,"llr":7.651360424},{"event":"anastomotic leak","count":265,"llr":7.593926022},{"event":"oesophageal stent insertion","count":3,"llr":7.574757868},{"event":"skin toxicity","count":1598,"llr":7.297895423},{"event":"odynophagia","count":1729,"llr":7.069688877},{"event":"epiglottic erythema","count":5,"llr":7.064057883},{"event":"delayed effects of radiation","count":6,"llr":6.881799145},{"event":"weight decreased","count":46078,"llr":6.68522644},{"event":"gastrostomy","count":459,"llr":6.507422711},{"event":"mucosal inflammation","count":9134,"llr":6.420908369},{"event":"biliary abscess","count":10,"llr":6.371224798},{"event":"peripheral motor neuropathy","count":527,"llr":6.235376546},{"event":"skin infection","count":2334,"llr":6.207277941},{"event":"soft tissue infection","count":547,"llr":6.162131379},{"event":"neutropenia","count":41585,"llr":6.120047665},{"event":"bilevel positive airway pressure","count":13,"llr":6.109048991},{"event":"large intestinal stricture","count":13,"llr":6.109048991},{"event":"cognitive disorder","count":9869,"llr":6.079452621},{"event":"gastric perforation","count":577,"llr":6.057221475},{"event":"mental status changes","count":10001,"llr":6.021195484},{"event":"lung infection","count":5755,"llr":5.988863512},{"event":"migration of implant","count":16,"llr":5.901598083}],"critval":5.841036281},"child_chembl_ids":["CHEMBL2106034"],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1742989","_score":1,"_source":{"id":"CHEMBL1742989","internal_compound":false,"type":"Antibody","pref_name":"BAVITUXIMAB","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Bavituximab","Ch3G4","Tarvacin"],"trade_names":[],"indications":[{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01272791"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01272791%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00669591","NCT02651610"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00669591%22OR%22NCT02651610%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00687817","NCT01138163","NCT01160601","NCT01323062","NCT01999673","NCT02673814"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00687817%22OR%22NCT01138163%22OR%22NCT01160601%22OR%22NCT01323062%22OR%22NCT01999673%22OR%22NCT02673814%22"]}]},{"efo_id":"EFO_0003047","efo_label":"hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003047","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00128271","NCT00343525","NCT01273948"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00128271%22OR%22NCT00343525%22OR%22NCT01273948%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00129337"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00129337%22"]}]},{"efo_id":"EFO_0000182","efo_label":"hepatocellular carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000182","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01264705","NCT02989870","NCT03519997"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01264705%22OR%22NCT02989870%22OR%22NCT03519997%22"]}]},{"efo_id":"EFO_0000313","efo_label":"carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000313","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00669565"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00669565%22"]}]},{"efo_id":"EFO_0000519","efo_label":"glioblastoma multiforme","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000519","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03139916"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03139916%22"]}]},{"efo_id":"EFO_0000673","efo_label":"prostate adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000673","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01335204"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01335204%22"]}]},{"efo_id":"EFO_0000756","efo_label":"melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000756","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01984255"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01984255%22"]}]},{"efo_id":"EFO_0006861","efo_label":"male breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006861","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01288261"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01288261%22"]}]},{"efo_id":"EFO_1000657","efo_label":"rectum cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000657","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01634685"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01634685%22"]}]},{"efo_id":"EFO_0003869","efo_label":"breast neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003869","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02685306"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02685306%22"]}]},{"efo_id":"EFO_0005537","efo_label":"triple-negative breast cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005537","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02685306"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02685306%22"]}]}],"mechanisms_of_action":[],"adverse_events":{"significant":[{"event":"embolism","count":2402,"llr":11.98065079}],"critval":11.41617156},"number_of_indications":14,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":13},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":5},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":5},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":5},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":4},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":4},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3707398","_score":1,"_source":{"id":"CHEMBL3707398","internal_compound":false,"type":"Small molecule","pref_name":"PAC-14028","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Asivatrep","PAC-14028"],"trade_names":[],"indications":[{"efo_id":"EFO_0000274","efo_label":"atopic eczema","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000274","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02583022","NCT02748993","NCT02757729","NCT02965118"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02583022%22OR%22NCT02748993%22OR%22NCT02757729%22OR%22NCT02965118%22"]}]},{"efo_id":"EFO_1000760","efo_label":"rosacea","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000760","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02052999","NCT02583009"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02052999%22OR%22NCT02583009%22"]}]},{"efo_id":"HP_0000989","efo_label":"Pruritus","efo_uri":"http://purl.obolibrary.org/obo/HP_0000989","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02052531","NCT02565134"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02052531%22OR%22NCT02565134%22"]}]},{"efo_id":"EFO_1000764","efo_label":"seborrheic dermatitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000764","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02749383"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02749383%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000196689","approved_name":"transient receptor potential cation channel subfamily V member 1","approved_symbol":"TRPV1"}],"target_type":"single protein","target_name":"Vanilloid receptor","action_type":"antagonist","description":"Vanilloid receptor antagonist","references":[{"source":"PubMed","ids":["22477184"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22477184"]}]}],"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":3},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1413176","_score":1,"_source":{"id":"CHEMBL1413176","internal_compound":false,"type":"Small molecule","pref_name":"NIFENAZONE","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Nifenazone"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["11112511","144204070","170466050","26666234","26748748"]},{"source":"drugbank","ids":["DB13407"]}],"canonical_smiles":"Cc1c(NC(=O)c2cccnc2)c(=O)n(-c2ccccc2)n1C","indications":[{"efo_id":"HP_0003326","efo_label":"Myalgia","efo_uri":"http://purl.obolibrary.org/obo/HP_0003326","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["M02AA24"],"urls":["https://www.whocc.no/atc_ddd_index/?code=M02AA24"]}]},{"efo_id":"HP_0002829","efo_label":"Arthralgia","efo_uri":"http://purl.obolibrary.org/obo/HP_0002829","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["M02AA24"],"urls":["https://www.whocc.no/atc_ddd_index/?code=M02AA24"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":2}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108314","_score":1,"_source":{"id":"CHEMBL2108314","internal_compound":false,"type":"Protein","pref_name":"NEPIDERMIN","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Nepidermin"],"trade_names":[],"indications":[{"efo_id":"EFO_1001904","efo_label":"oral mucositis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001904","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00845819"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00845819%22"]}]},{"efo_id":"EFO_0009688","efo_label":"stomatitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009688","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01099891"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01099891%22"]}]},{"efo_id":"EFO_1001459","efo_label":"diabetic foot","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001459","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01629199","NCT02554851"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01629199%22OR%22NCT02554851%22"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL175","_score":1,"_source":{"id":"CHEMBL175","internal_compound":false,"type":"Small molecule","pref_name":"DEXIBUPROFEN","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["(S)-[11C]-Ibuprofen","Dexibuprofen","IBU-TAB","Neoprofen","Rufen"],"trade_names":["Seractil"],"cross_references":[{"source":"ChEBI","ids":[43415]},{"source":"PubChem","ids":["11111293","11111294","11112775","144206692","47193724","50100253","50106464","85231335","90340840"]},{"source":"Wikipedia","ids":["Dexibuprofen"]},{"source":"drugbank","ids":["DB09213"]}],"canonical_smiles":"CC(C)Cc1ccc([C@H](C)C(=O)O)cc1","indications":[{"efo_id":"EFO_0005755","efo_label":"rheumatic disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005755","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["M01AE14"],"urls":["https://www.whocc.no/atc_ddd_index/?code=M01AE14"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03852459"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03852459%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000073756","approved_name":"prostaglandin-endoperoxide synthase 2","approved_symbol":"PTGS2"},{"ensembl":"ENSG00000095303","approved_name":"prostaglandin-endoperoxide synthase 1","approved_symbol":"PTGS1"}],"target_type":"protein family","target_name":"Cyclooxygenase","action_type":"inhibitor","description":"Cyclooxygenase inhibitor","references":[{"source":"PubMed","ids":["19032727","28115830"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19032727+OR+EXT_ID%3A28115830"]}]}],"adverse_events":{"significant":[{"event":"bronchopulmonary dysplasia","count":296,"llr":678.3019668},{"event":"necrotising colitis","count":347,"llr":76.18910861},{"event":"gastrointestinal perforation","count":1318,"llr":73.28846731},{"event":"intestinal perforation","count":2470,"llr":58.00144924},{"event":"neonatal intestinal perforation","count":7,"llr":32.28452048},{"event":"pulmonary hypertension","count":5222,"llr":27.632425},{"event":"sopor","count":6099,"llr":25.98036863},{"event":"intraventricular haemorrhage","count":583,"llr":24.38685175},{"event":"drug abuse","count":14574,"llr":19.45665151},{"event":"retinopathy of prematurity","count":254,"llr":17.93492029},{"event":"posthaemorrhagic hydrocephalus","count":7,"llr":14.74826101},{"event":"perforation","count":170,"llr":13.78549942},{"event":"meconium ileus","count":15,"llr":13.2245064},{"event":"anaemia neonatal","count":217,"llr":13.05627783},{"event":"pulmonary haemorrhage","count":1470,"llr":10.99144497},{"event":"renal failure neonatal","count":83,"llr":9.807392308},{"event":"haemorrhage intracranial","count":4344,"llr":9.609658719},{"event":"suicide attempt","count":20244,"llr":9.596546816},{"event":"necrotising enterocolitis neonatal","count":94,"llr":9.559206525},{"event":"infantile apnoea","count":202,"llr":8.03635508}],"critval":8.025996281},"child_chembl_ids":["CHEMBL1778537"],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297738","_score":1,"_source":{"id":"CHEMBL4297738","internal_compound":false,"type":"Protein","pref_name":"DALAZATIDE","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Dalazatide","SHK-186"],"trade_names":[],"indications":[{"efo_id":"EFO_0000676","efo_label":"psoriasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000676","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02435342"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02435342%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545177","_score":1,"_source":{"id":"CHEMBL3545177","internal_compound":false,"type":"Small molecule","pref_name":"AZD-0424","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AZD-0424","AZD0424"],"trade_names":[],"indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01668550"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01668550%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000097007","approved_name":"ABL proto-oncogene 1, non-receptor tyrosine kinase","approved_symbol":"ABL1"}],"target_type":"single protein","target_name":"Tyrosine-protein kinase ABL","action_type":"inhibitor","description":"Tyrosine-protein kinase ABL inhibitor","references":[{"source":"ClinicalTrials","ids":["NCT01668550"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01668550%22"]},{"source":"PubMed","ids":["25662515"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25662515"]}]},{"target_components":[{"ensembl":"ENSG00000197122","approved_name":"SRC proto-oncogene, non-receptor tyrosine kinase","approved_symbol":"SRC"}],"target_type":"single protein","target_name":"Tyrosine-protein kinase SRC","action_type":"inhibitor","description":"Tyrosine-protein kinase SRC inhibitor","references":[{"source":"ClinicalTrials","ids":["NCT01668550"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01668550%22"]},{"source":"PubMed","ids":["25662515"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25662515"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1697851","_score":1,"_source":{"id":"CHEMBL1697851","internal_compound":false,"type":"Small molecule","pref_name":"THIOPROPAZATE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Thiopropazate","Thiopropazate HCl"],"trade_names":["Dartalan"],"cross_references":[{"source":"ChEBI","ids":[59119]},{"source":"drugbank","ids":["DB13557"]}],"canonical_smiles":"CC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1","indications":[{"efo_id":"EFO_0005407","efo_label":"psychosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005407","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N05AB05"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N05AB05"]}]}],"child_chembl_ids":["CHEMBL3989786"],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4279455","_score":1,"_source":{"id":"CHEMBL4279455","internal_compound":false,"type":"Small molecule","pref_name":"LAROTAXEL","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Larotaxel","XRP-9881","XRP9881","Xrp9881"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12984"]}],"canonical_smiles":"CC(=O)O[C@H]1C(=O)[C@]23C[C@H]2C[C@H]2OC[C@@]2(OC(C)=O)[C@H]3[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C","indications":[{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00087958","NCT00327743"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00087958%22OR%22NCT00327743%22"]}]}],"adverse_events":{"significant":[{"event":"cardiotoxicity","count":2240,"llr":6.060109001}],"critval":4.459978956},"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2218860","_score":1,"_source":{"id":"CHEMBL2218860","internal_compound":false,"type":"Small molecule","pref_name":"GADOBUTROL","year_first_approved":2011,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["BAY86-4875","Gadobutrol","ZK 135079","ZK-135079"],"trade_names":["Gadavist"],"cross_references":[{"source":"DailyMed","ids":["gadobutrol"]},{"source":"DrugCentral","ids":["4179"]}],"indications":[{"efo_id":"EFO_0000373","efo_label":"congestive heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000373","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02135861"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02135861%22"]}]},{"efo_id":"EFO_0000685","efo_label":"rheumatoid arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000685","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02350426"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02350426%22"]}]}],"adverse_events":{"significant":[{"event":"urticaria","count":39524,"llr":1661.391942},{"event":"vomiting","count":103943,"llr":466.6786257},{"event":"pruritus","count":57095,"llr":424.5227869},{"event":"nausea","count":165652,"llr":328.3518817},{"event":"erythema","count":35163,"llr":210.1791831},{"event":"sneezing","count":3545,"llr":178.9690834},{"event":"contrast media reaction","count":544,"llr":157.3351926},{"event":"throat irritation","count":6709,"llr":144.4801195},{"event":"contrast media allergy","count":331,"llr":127.9461472},{"event":"feeling hot","count":10305,"llr":106.4009234},{"event":"eye swelling","count":6631,"llr":100.4651801},{"event":"throat tightness","count":6159,"llr":84.18439133},{"event":"contrast media deposition","count":31,"llr":82.07256194},{"event":"eye pruritus","count":3799,"llr":50.77164874},{"event":"anaphylactic reaction","count":16695,"llr":48.64179147},{"event":"dyspnoea","count":124409,"llr":46.38877597},{"event":"diarrhoea","count":126514,"llr":46.12974088},{"event":"fatigue","count":147738,"llr":45.88297492},{"event":"lip swelling","count":7601,"llr":41.65862543},{"event":"gadolinium deposition disease","count":15,"llr":41.25210279},{"event":"oropharyngeal discomfort","count":769,"llr":37.46494465},{"event":"cough","count":52232,"llr":36.95947443},{"event":"flushing","count":18642,"llr":35.74497554},{"event":"pruritus generalised","count":7747,"llr":34.72960645},{"event":"pyrexia","count":87334,"llr":33.84727682},{"event":"nontherapeutic agent urine positive","count":12,"llr":28.89700853},{"event":"swelling face","count":15924,"llr":27.95735383},{"event":"rash macular","count":5296,"llr":26.17509265},{"event":"drug hypersensitivity","count":71246,"llr":23.83188063},{"event":"ocular hyperaemia","count":6875,"llr":23.33254535},{"event":"arthralgia","count":75397,"llr":23.3217494},{"event":"pharyngeal oedema","count":5370,"llr":21.78102336},{"event":"hyperhidrosis","count":28377,"llr":20.60888193},{"event":"condition aggravated","count":52909,"llr":18.21419965},{"event":"fall","count":67604,"llr":18.01271972},{"event":"nephrogenic systemic fibrosis","count":464,"llr":17.44169623},{"event":"retching","count":3162,"llr":16.59663753},{"event":"chest discomfort","count":21346,"llr":16.23072508},{"event":"blood heavy metal increased","count":12,"llr":15.80635892},{"event":"nasal congestion","count":9898,"llr":15.20678013},{"event":"depression","count":45027,"llr":14.74925146},{"event":"oral pruritus","count":412,"llr":14.74350303},{"event":"somnolence","count":38949,"llr":14.66469056},{"event":"insomnia","count":44658,"llr":14.58858504},{"event":"rash","count":97330,"llr":14.06565741},{"event":"unresponsive to stimuli","count":6342,"llr":13.77842824},{"event":"dehydration","count":36809,"llr":13.6952971},{"event":"sensation of foreign body","count":1257,"llr":13.3745915},{"event":"salivary hypersecretion","count":2562,"llr":12.30198843},{"event":"lacrimation increased","count":4647,"llr":12.29235533},{"event":"nasal pruritus","count":150,"llr":12.18755505},{"event":"pallor","count":6405,"llr":12.01491345},{"event":"pain","count":94786,"llr":11.68098104},{"event":"nuclear magnetic resonance imaging brain abnormal","count":730,"llr":11.46192612},{"event":"skin tightness","count":743,"llr":11.36217189},{"event":"back pain","count":46032,"llr":11.15617419},{"event":"nasopharyngitis","count":30974,"llr":11.07355744},{"event":"hypoaesthesia oral","count":2951,"llr":11.07229223},{"event":"cerebrovascular accident","count":35770,"llr":10.77129341},{"event":"burning sensation","count":12178,"llr":10.65350945},{"event":"injection site pain","count":56727,"llr":10.61709564}],"critval":10.59179319},"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108956","_score":1,"_source":{"id":"CHEMBL2108956","internal_compound":false,"type":"Unknown","pref_name":"HYPROMELLOSE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Hydroxypropylmethylcellulose","Hypromellose","Methylcellulose, Propylene Glycol Ether Of","Propylene Glycol Ether Of Methylcellulose"],"trade_names":["Artelac","Artelac SDU","Brolene","Dacriosol","GenTeal","Goniosol","Isopto Tears","Methocel E, F, J, K","Moisture-Eyes","Tearisol","Tears Naturale","Ultra Tears"],"indications":[{"efo_id":"EFO_1000906","efo_label":"dry eye syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000906","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02455050","NCT03693183","NCT03697876"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02455050%22OR%22NCT03693183%22OR%22NCT03697876%22"]}]},{"efo_id":"EFO_0007403","efo_label":"ophthalmic herpes zoster","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007403","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02382588"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02382588%22"]}]},{"efo_id":"EFO_0000662","efo_label":"polyp","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000662","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00583466"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00583466%22"]}]},{"efo_id":"EFO_0003047","efo_label":"hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003047","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01308606"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01308606%22"]}]},{"efo_id":"EFO_0007126","efo_label":"Acanthamoeba keratitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007126","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03484507"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03484507%22"]}]}],"adverse_events":{"significant":[{"event":"cholangiocarcinoma","count":226,"llr":33.12162469},{"event":"eye irritation","count":5686,"llr":31.30557112},{"event":"dry eye","count":6029,"llr":30.84020149},{"event":"eye pain","count":7341,"llr":24.60359807},{"event":"hepatic cirrhosis","count":3807,"llr":19.03773851},{"event":"conjunctival granuloma","count":10,"llr":17.57911465},{"event":"ocular hyperaemia","count":6875,"llr":16.1137196},{"event":"pinguecula","count":34,"llr":15.13182653},{"event":"corneal disorder","count":653,"llr":15.09034693},{"event":"foreign body sensation in eyes","count":698,"llr":14.89090201},{"event":"lacrimation increased","count":4647,"llr":13.50878581},{"event":"eye inflammation","count":1429,"llr":12.74918318},{"event":"corneal erosion","count":196,"llr":11.63009184},{"event":"corneal abrasion","count":279,"llr":10.92480631}],"critval":10.64108235},"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":3},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":3},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":2},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297295","_score":1,"_source":{"id":"CHEMBL4297295","internal_compound":false,"type":"Small molecule","pref_name":"JTK-853","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Jtk-853"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB13095"]}],"canonical_smiles":"O=C(NCc1ccc(OC(F)(F)F)c(F)c1)[C@H]1CN(c2nc3nc(C4CC4)ncc3s2)CCN1S(=O)(=O)c1ccc(C(F)(F)F)cc1","indications":[{"efo_id":"EFO_0000544","efo_label":"infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000544","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01473056"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01473056%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109667","_score":1,"_source":{"id":"CHEMBL2109667","internal_compound":false,"type":"Antibody","pref_name":"SIMTUZUMAB","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AB-0024","GS-6624","Simtuzumab"],"trade_names":[],"indications":[{"efo_id":"EFO_0001422","efo_label":"cirrhosis of liver","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001422","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01452308"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01452308%22"]}]},{"efo_id":"EFO_0000768","efo_label":"idiopathic pulmonary fibrosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000768","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01362231","NCT01759511","NCT01769196"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01362231%22OR%22NCT01759511%22OR%22NCT01769196%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01323933"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01323933%22"]}]},{"efo_id":"EFO_0004268","efo_label":"sclerosing cholangitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004268","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01672853"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01672853%22"]}]},{"efo_id":"EFO_0002430","efo_label":"primary myelofibrosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002430","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01369498"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01369498%22"]}]},{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01472198"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01472198%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01479465"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01479465%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000134013","approved_name":"lysyl oxidase like 2","approved_symbol":"LOXL2"}],"target_type":"single protein","target_name":"Lysyl oxidase homolog 2","action_type":"inhibitor","description":"Lysyl oxidase homolog 2 inhibitor","references":[{"source":"PubMed","ids":["27232579"],"urls":["https://europepmc.org/search?query=EXT_ID%3A27232579"]}]}],"number_of_indications":7,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":6},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":4},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":3},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL24","_score":1,"_source":{"id":"CHEMBL24","internal_compound":false,"type":"Small molecule","pref_name":"ATENOLOL","year_first_approved":1981,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["Atenolol","C07AB03","Esatenolol","ICI 66082","ICI-66082"],"trade_names":["Antipressan","Atenamin","Atenix-100","Atenix-25","Atenix-50","Atenolol","Ibinolo","Kentol","Tenormin","Tenormin 25","Tenormin L.S.","Totamol","Unibloc","Vasaten"],"cross_references":[{"source":"ChEBI","ids":[2904]},{"source":"DailyMed","ids":["atenolol"]},{"source":"PubChem","ids":["144212743","26751696","50085956","50104387","855957","90340978"]},{"source":"Wikipedia","ids":["Atenolol"]},{"source":"drugbank","ids":["DB00335"]}],"canonical_smiles":"CC(C)NCC(O)COc1ccc(CC(N)=O)cc1","indications":[{"efo_id":"EFO_0003913","efo_label":"angina pectoris","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003913","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["18a6026b-a790-44b6-bf03-a17a1a7dac7a","1998fa54-018e-45d2-826d-cc3eb570fd0b","1b8a4689-3916-4f4b-b54a-bbb4e322d79b","1eb4f6dd-0f94-0130-5aca-ed0a0defb503","2339e482-333c-4dcf-881e-8b65181810ef","2492d5f6-00b0-42c9-a793-2be83ea81ad1","27522eb0-9e11-45cb-9137-fc50dc78ba80","2c34488c-e22b-46c6-80dd-b24c2bae8d7b","2cc8b659-bd69-4ecc-9b7f-9968ece05357","32066d3f-dd94-4db6-943f-581a2f7104e7","500ca21e-571b-4fa9-8b62-4914b226bf3e","59f296ff-48d4-4f26-b2a1-98cc82fc3c0c","5a0f3359-ea19-4f12-a7f7-48b7f7185571","73705d59-49fa-4e5d-8e3b-13bc2ac8796b","75e4f9de-ab9c-4b15-bdc0-05e4cda1737c","793b6b1d-54fd-4856-ab0b-899bb046a239","86bac633-4f6f-4ecf-b3b4-317591666129","87ecfffe-4b46-4e06-84eb-d2eaed45062e","8c137b74-6a28-4760-b8d5-f453efa95a9e","95762713-18df-424c-8c50-13aded4bbd8c","994244cf-6198-41f0-a9b0-75ee9bbd629e","99ae0271-47d8-4321-96e0-55124811df1a","a6794dfa-adbb-491b-9d48-f89a44e866c5","a990373a-fad0-4ed5-aa56-7a065d092caa","aae36822-9c1b-4600-81d6-da022d56c03e","afa4e524-0d4d-4223-91f7-d22ed7c507ff","b002421f-8120-4e76-a9e2-cc356fbc4cff","b4cfa459-c1c3-4fe2-ac2d-afeea2b96cca","b68595c6-d772-4b25-a42c-5c911bf67d36","b90fcfe1-15f5-4dec-8294-6db4aee5a4d7","bcad40fe-36ea-4d10-af2d-de7c54c63349","c289e59d-0ca8-4db6-9016-b03974611e43","db801706-1362-44c7-92ab-f584f96c7e1c","dc429f91-5de5-4a4a-9943-422ec2331694","f23be9b8-5dd0-4025-99b1-6dcf8e14b185","f36d4ed3-dcbb-4465-9fa6-1da811f555e6","f4414ed2-068f-47d3-bd6d-6a2e501304a7","ff24761a-002a-b445-fd5b-446913d6231e"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?18a6026b-a790-44b6-bf03-a17a1a7dac7a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1998fa54-018e-45d2-826d-cc3eb570fd0b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1b8a4689-3916-4f4b-b54a-bbb4e322d79b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1eb4f6dd-0f94-0130-5aca-ed0a0defb503","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2339e482-333c-4dcf-881e-8b65181810ef","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2492d5f6-00b0-42c9-a793-2be83ea81ad1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?27522eb0-9e11-45cb-9137-fc50dc78ba80","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2c34488c-e22b-46c6-80dd-b24c2bae8d7b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2cc8b659-bd69-4ecc-9b7f-9968ece05357","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?32066d3f-dd94-4db6-943f-581a2f7104e7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?500ca21e-571b-4fa9-8b62-4914b226bf3e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?59f296ff-48d4-4f26-b2a1-98cc82fc3c0c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5a0f3359-ea19-4f12-a7f7-48b7f7185571","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?73705d59-49fa-4e5d-8e3b-13bc2ac8796b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?75e4f9de-ab9c-4b15-bdc0-05e4cda1737c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?793b6b1d-54fd-4856-ab0b-899bb046a239","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?86bac633-4f6f-4ecf-b3b4-317591666129","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?87ecfffe-4b46-4e06-84eb-d2eaed45062e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8c137b74-6a28-4760-b8d5-f453efa95a9e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?95762713-18df-424c-8c50-13aded4bbd8c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?994244cf-6198-41f0-a9b0-75ee9bbd629e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?99ae0271-47d8-4321-96e0-55124811df1a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a6794dfa-adbb-491b-9d48-f89a44e866c5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a990373a-fad0-4ed5-aa56-7a065d092caa","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?aae36822-9c1b-4600-81d6-da022d56c03e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?afa4e524-0d4d-4223-91f7-d22ed7c507ff","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b002421f-8120-4e76-a9e2-cc356fbc4cff","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b4cfa459-c1c3-4fe2-ac2d-afeea2b96cca","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b68595c6-d772-4b25-a42c-5c911bf67d36","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b90fcfe1-15f5-4dec-8294-6db4aee5a4d7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bcad40fe-36ea-4d10-af2d-de7c54c63349","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c289e59d-0ca8-4db6-9016-b03974611e43","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?db801706-1362-44c7-92ab-f584f96c7e1c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dc429f91-5de5-4a4a-9943-422ec2331694","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f23be9b8-5dd0-4025-99b1-6dcf8e14b185","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f36d4ed3-dcbb-4465-9fa6-1da811f555e6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f4414ed2-068f-47d3-bd6d-6a2e501304a7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ff24761a-002a-b445-fd5b-446913d6231e"]},{"source":"FDA","ids":["00e9960b-bb7c-4cf1-bfeb-5c7071f62bbe","0186ea57-212f-42a1-85c3-1dd56cf96793","0bcd32df-eaf7-468d-abe7-d2615e83f67a","0ebcca1e-ca16-4483-429a-aec5dcacd1dc","1203ed3a-7a1f-4598-818e-7c2e7a6d1ce7","3658041f-d6a3-4199-932b-a27a98ce6ce7","707e110b-0635-0c8e-9eae-63a6fade79e6","c6095ce4-119e-41b5-8cbd-6f7c65f4788b","fcfc9676-4edc-460e-6199-8161b824908f"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A00e9960b-bb7c-4cf1-bfeb-5c7071f62bbe","https://api.fda.gov/drug/label.json?search=set_id%3A0186ea57-212f-42a1-85c3-1dd56cf96793","https://api.fda.gov/drug/label.json?search=set_id%3A0bcd32df-eaf7-468d-abe7-d2615e83f67a","https://api.fda.gov/drug/label.json?search=set_id%3A0ebcca1e-ca16-4483-429a-aec5dcacd1dc","https://api.fda.gov/drug/label.json?search=set_id%3A1203ed3a-7a1f-4598-818e-7c2e7a6d1ce7","https://api.fda.gov/drug/label.json?search=set_id%3A3658041f-d6a3-4199-932b-a27a98ce6ce7","https://api.fda.gov/drug/label.json?search=set_id%3A707e110b-0635-0c8e-9eae-63a6fade79e6","https://api.fda.gov/drug/label.json?search=set_id%3Ac6095ce4-119e-41b5-8cbd-6f7c65f4788b","https://api.fda.gov/drug/label.json?search=set_id%3Afcfc9676-4edc-460e-6199-8161b824908f"]}]},{"efo_id":"EFO_0000537","efo_label":"hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000537","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00000513","NCT00000514","NCT00145210","NCT00158093","NCT00200421","NCT00389168","NCT00396656","NCT00541684","NCT00913965","NCT01522950","NCT03147092"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000513%22OR%22NCT00000514%22OR%22NCT00145210%22OR%22NCT00158093%22OR%22NCT00200421%22OR%22NCT00389168%22OR%22NCT00396656%22OR%22NCT00541684%22OR%22NCT00913965%22OR%22NCT01522950%22OR%22NCT03147092%22"]},{"source":"DailyMed","ids":["18a6026b-a790-44b6-bf03-a17a1a7dac7a","1998fa54-018e-45d2-826d-cc3eb570fd0b","1b8a4689-3916-4f4b-b54a-bbb4e322d79b","1e528336-c1a6-4657-96a6-5eb5121e757b","1eb4f6dd-0f94-0130-5aca-ed0a0defb503","2339e482-333c-4dcf-881e-8b65181810ef","2492d5f6-00b0-42c9-a793-2be83ea81ad1","27522eb0-9e11-45cb-9137-fc50dc78ba80","2c34488c-e22b-46c6-80dd-b24c2bae8d7b","2cc8b659-bd69-4ecc-9b7f-9968ece05357","32066d3f-dd94-4db6-943f-581a2f7104e7","500ca21e-571b-4fa9-8b62-4914b226bf3e","59f296ff-48d4-4f26-b2a1-98cc82fc3c0c","5a0f3359-ea19-4f12-a7f7-48b7f7185571","73705d59-49fa-4e5d-8e3b-13bc2ac8796b","75e4f9de-ab9c-4b15-bdc0-05e4cda1737c","78b374f8-0e16-4c15-85c1-16609ac3aca2","793b6b1d-54fd-4856-ab0b-899bb046a239","84e9de8f-27c3-4177-827a-6992495511ac","86bac633-4f6f-4ecf-b3b4-317591666129","87ecfffe-4b46-4e06-84eb-d2eaed45062e","8c137b74-6a28-4760-b8d5-f453efa95a9e","95762713-18df-424c-8c50-13aded4bbd8c","994244cf-6198-41f0-a9b0-75ee9bbd629e","99ae0271-47d8-4321-96e0-55124811df1a","a6794dfa-adbb-491b-9d48-f89a44e866c5","a990373a-fad0-4ed5-aa56-7a065d092caa","aae36822-9c1b-4600-81d6-da022d56c03e","afa4e524-0d4d-4223-91f7-d22ed7c507ff","b002421f-8120-4e76-a9e2-cc356fbc4cff","b4cfa459-c1c3-4fe2-ac2d-afeea2b96cca","b68595c6-d772-4b25-a42c-5c911bf67d36","b90fcfe1-15f5-4dec-8294-6db4aee5a4d7","bcad40fe-36ea-4d10-af2d-de7c54c63349","c289e59d-0ca8-4db6-9016-b03974611e43","cd4f6a14-a2eb-4157-83a7-91ab4e9926e5","db801706-1362-44c7-92ab-f584f96c7e1c","dc429f91-5de5-4a4a-9943-422ec2331694","e5929809-f517-4383-a754-ba8afc00e5c4","f23be9b8-5dd0-4025-99b1-6dcf8e14b185","f36d4ed3-dcbb-4465-9fa6-1da811f555e6","f4414ed2-068f-47d3-bd6d-6a2e501304a7","ff24761a-002a-b445-fd5b-446913d6231e"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?18a6026b-a790-44b6-bf03-a17a1a7dac7a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1998fa54-018e-45d2-826d-cc3eb570fd0b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1b8a4689-3916-4f4b-b54a-bbb4e322d79b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1e528336-c1a6-4657-96a6-5eb5121e757b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1eb4f6dd-0f94-0130-5aca-ed0a0defb503","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2339e482-333c-4dcf-881e-8b65181810ef","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2492d5f6-00b0-42c9-a793-2be83ea81ad1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?27522eb0-9e11-45cb-9137-fc50dc78ba80","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2c34488c-e22b-46c6-80dd-b24c2bae8d7b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2cc8b659-bd69-4ecc-9b7f-9968ece05357","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?32066d3f-dd94-4db6-943f-581a2f7104e7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?500ca21e-571b-4fa9-8b62-4914b226bf3e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?59f296ff-48d4-4f26-b2a1-98cc82fc3c0c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5a0f3359-ea19-4f12-a7f7-48b7f7185571","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?73705d59-49fa-4e5d-8e3b-13bc2ac8796b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?75e4f9de-ab9c-4b15-bdc0-05e4cda1737c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?78b374f8-0e16-4c15-85c1-16609ac3aca2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?793b6b1d-54fd-4856-ab0b-899bb046a239","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?84e9de8f-27c3-4177-827a-6992495511ac","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?86bac633-4f6f-4ecf-b3b4-317591666129","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?87ecfffe-4b46-4e06-84eb-d2eaed45062e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8c137b74-6a28-4760-b8d5-f453efa95a9e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?95762713-18df-424c-8c50-13aded4bbd8c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?994244cf-6198-41f0-a9b0-75ee9bbd629e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?99ae0271-47d8-4321-96e0-55124811df1a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a6794dfa-adbb-491b-9d48-f89a44e866c5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a990373a-fad0-4ed5-aa56-7a065d092caa","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?aae36822-9c1b-4600-81d6-da022d56c03e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?afa4e524-0d4d-4223-91f7-d22ed7c507ff","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b002421f-8120-4e76-a9e2-cc356fbc4cff","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b4cfa459-c1c3-4fe2-ac2d-afeea2b96cca","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b68595c6-d772-4b25-a42c-5c911bf67d36","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b90fcfe1-15f5-4dec-8294-6db4aee5a4d7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bcad40fe-36ea-4d10-af2d-de7c54c63349","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c289e59d-0ca8-4db6-9016-b03974611e43","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cd4f6a14-a2eb-4157-83a7-91ab4e9926e5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?db801706-1362-44c7-92ab-f584f96c7e1c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dc429f91-5de5-4a4a-9943-422ec2331694","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e5929809-f517-4383-a754-ba8afc00e5c4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f23be9b8-5dd0-4025-99b1-6dcf8e14b185","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f36d4ed3-dcbb-4465-9fa6-1da811f555e6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f4414ed2-068f-47d3-bd6d-6a2e501304a7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ff24761a-002a-b445-fd5b-446913d6231e"]},{"source":"FDA","ids":["00e9960b-bb7c-4cf1-bfeb-5c7071f62bbe","0186ea57-212f-42a1-85c3-1dd56cf96793","0bcd32df-eaf7-468d-abe7-d2615e83f67a","0ebcca1e-ca16-4483-429a-aec5dcacd1dc","1203ed3a-7a1f-4598-818e-7c2e7a6d1ce7","1c3c2cbf-e307-4327-a044-69451aef66ae","3658041f-d6a3-4199-932b-a27a98ce6ce7","424a34e0-9100-4232-8de6-bc90c21e6b3f","707e110b-0635-0c8e-9eae-63a6fade79e6","b5de77fc-8b73-44eb-ab0f-27422a8d60b4","c6095ce4-119e-41b5-8cbd-6f7c65f4788b","fcfc9676-4edc-460e-6199-8161b824908f"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A00e9960b-bb7c-4cf1-bfeb-5c7071f62bbe","https://api.fda.gov/drug/label.json?search=set_id%3A0186ea57-212f-42a1-85c3-1dd56cf96793","https://api.fda.gov/drug/label.json?search=set_id%3A0bcd32df-eaf7-468d-abe7-d2615e83f67a","https://api.fda.gov/drug/label.json?search=set_id%3A0ebcca1e-ca16-4483-429a-aec5dcacd1dc","https://api.fda.gov/drug/label.json?search=set_id%3A1203ed3a-7a1f-4598-818e-7c2e7a6d1ce7","https://api.fda.gov/drug/label.json?search=set_id%3A1c3c2cbf-e307-4327-a044-69451aef66ae","https://api.fda.gov/drug/label.json?search=set_id%3A3658041f-d6a3-4199-932b-a27a98ce6ce7","https://api.fda.gov/drug/label.json?search=set_id%3A424a34e0-9100-4232-8de6-bc90c21e6b3f","https://api.fda.gov/drug/label.json?search=set_id%3A707e110b-0635-0c8e-9eae-63a6fade79e6","https://api.fda.gov/drug/label.json?search=set_id%3Ab5de77fc-8b73-44eb-ab0f-27422a8d60b4","https://api.fda.gov/drug/label.json?search=set_id%3Ac6095ce4-119e-41b5-8cbd-6f7c65f4788b","https://api.fda.gov/drug/label.json?search=set_id%3Afcfc9676-4edc-460e-6199-8161b824908f"]}]},{"efo_id":"EFO_0000612","efo_label":"myocardial infarction","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000612","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["1998fa54-018e-45d2-826d-cc3eb570fd0b","1b8a4689-3916-4f4b-b54a-bbb4e322d79b","1eb4f6dd-0f94-0130-5aca-ed0a0defb503","2339e482-333c-4dcf-881e-8b65181810ef","2492d5f6-00b0-42c9-a793-2be83ea81ad1","27522eb0-9e11-45cb-9137-fc50dc78ba80","2c34488c-e22b-46c6-80dd-b24c2bae8d7b","2cc8b659-bd69-4ecc-9b7f-9968ece05357","32066d3f-dd94-4db6-943f-581a2f7104e7","500ca21e-571b-4fa9-8b62-4914b226bf3e","59f296ff-48d4-4f26-b2a1-98cc82fc3c0c","5a0f3359-ea19-4f12-a7f7-48b7f7185571","75e4f9de-ab9c-4b15-bdc0-05e4cda1737c","793b6b1d-54fd-4856-ab0b-899bb046a239","86bac633-4f6f-4ecf-b3b4-317591666129","87ecfffe-4b46-4e06-84eb-d2eaed45062e","8c137b74-6a28-4760-b8d5-f453efa95a9e","95762713-18df-424c-8c50-13aded4bbd8c","994244cf-6198-41f0-a9b0-75ee9bbd629e","a990373a-fad0-4ed5-aa56-7a065d092caa","aae36822-9c1b-4600-81d6-da022d56c03e","afa4e524-0d4d-4223-91f7-d22ed7c507ff","b002421f-8120-4e76-a9e2-cc356fbc4cff","b68595c6-d772-4b25-a42c-5c911bf67d36","b90fcfe1-15f5-4dec-8294-6db4aee5a4d7","bcad40fe-36ea-4d10-af2d-de7c54c63349","c289e59d-0ca8-4db6-9016-b03974611e43","db801706-1362-44c7-92ab-f584f96c7e1c","dc429f91-5de5-4a4a-9943-422ec2331694","f23be9b8-5dd0-4025-99b1-6dcf8e14b185","f36d4ed3-dcbb-4465-9fa6-1da811f555e6","f4414ed2-068f-47d3-bd6d-6a2e501304a7","ff24761a-002a-b445-fd5b-446913d6231e"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1998fa54-018e-45d2-826d-cc3eb570fd0b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1b8a4689-3916-4f4b-b54a-bbb4e322d79b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1eb4f6dd-0f94-0130-5aca-ed0a0defb503","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2339e482-333c-4dcf-881e-8b65181810ef","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2492d5f6-00b0-42c9-a793-2be83ea81ad1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?27522eb0-9e11-45cb-9137-fc50dc78ba80","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2c34488c-e22b-46c6-80dd-b24c2bae8d7b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2cc8b659-bd69-4ecc-9b7f-9968ece05357","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?32066d3f-dd94-4db6-943f-581a2f7104e7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?500ca21e-571b-4fa9-8b62-4914b226bf3e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?59f296ff-48d4-4f26-b2a1-98cc82fc3c0c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5a0f3359-ea19-4f12-a7f7-48b7f7185571","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?75e4f9de-ab9c-4b15-bdc0-05e4cda1737c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?793b6b1d-54fd-4856-ab0b-899bb046a239","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?86bac633-4f6f-4ecf-b3b4-317591666129","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?87ecfffe-4b46-4e06-84eb-d2eaed45062e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8c137b74-6a28-4760-b8d5-f453efa95a9e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?95762713-18df-424c-8c50-13aded4bbd8c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?994244cf-6198-41f0-a9b0-75ee9bbd629e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a990373a-fad0-4ed5-aa56-7a065d092caa","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?aae36822-9c1b-4600-81d6-da022d56c03e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?afa4e524-0d4d-4223-91f7-d22ed7c507ff","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b002421f-8120-4e76-a9e2-cc356fbc4cff","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b68595c6-d772-4b25-a42c-5c911bf67d36","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b90fcfe1-15f5-4dec-8294-6db4aee5a4d7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bcad40fe-36ea-4d10-af2d-de7c54c63349","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c289e59d-0ca8-4db6-9016-b03974611e43","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?db801706-1362-44c7-92ab-f584f96c7e1c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dc429f91-5de5-4a4a-9943-422ec2331694","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f23be9b8-5dd0-4025-99b1-6dcf8e14b185","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f36d4ed3-dcbb-4465-9fa6-1da811f555e6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f4414ed2-068f-47d3-bd6d-6a2e501304a7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ff24761a-002a-b445-fd5b-446913d6231e"]},{"source":"FDA","ids":["00e9960b-bb7c-4cf1-bfeb-5c7071f62bbe","0bcd32df-eaf7-468d-abe7-d2615e83f67a","707e110b-0635-0c8e-9eae-63a6fade79e6","c6095ce4-119e-41b5-8cbd-6f7c65f4788b","fcfc9676-4edc-460e-6199-8161b824908f"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A00e9960b-bb7c-4cf1-bfeb-5c7071f62bbe","https://api.fda.gov/drug/label.json?search=set_id%3A0bcd32df-eaf7-468d-abe7-d2615e83f67a","https://api.fda.gov/drug/label.json?search=set_id%3A707e110b-0635-0c8e-9eae-63a6fade79e6","https://api.fda.gov/drug/label.json?search=set_id%3Ac6095ce4-119e-41b5-8cbd-6f7c65f4788b","https://api.fda.gov/drug/label.json?search=set_id%3Afcfc9676-4edc-460e-6199-8161b824908f"]}]},{"efo_id":"Orphanet_558","efo_label":"Marfan syndrome","efo_uri":"http://www.orpha.net/ORDO/Orphanet_558","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00429364","NCT00593710","NCT00651235","NCT00723801","NCT01145612","NCT01715207"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00429364%22OR%22NCT00593710%22OR%22NCT00651235%22OR%22NCT00723801%22OR%22NCT01145612%22OR%22NCT01715207%22"]}]},{"efo_id":"EFO_0003777","efo_label":"heart disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003777","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000513","NCT00000514","NCT01202721"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000513%22OR%22NCT00000514%22OR%22NCT01202721%22"]}]},{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["C07AB03"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C07AB03"]},{"source":"ClinicalTrials","ids":["NCT01313702"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01313702%22"]}]},{"efo_id":"EFO_1000635","efo_label":"hemangioma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000635","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02342275","NCT03237637"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02342275%22OR%22NCT03237637%22"]}]},{"efo_id":"EFO_0003913","efo_label":"angina pectoris","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003913","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02623569"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02623569%22"]}]},{"efo_id":"EFO_0000275","efo_label":"atrial fibrillation","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000275","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00589303"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00589303%22"]}]},{"efo_id":"EFO_0000378","efo_label":"coronary artery disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000378","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000478"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000478%22"]}]},{"efo_id":"EFO_0001358","efo_label":"post-traumatic stress disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001358","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02560805"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02560805%22"]}]},{"efo_id":"EFO_0003144","efo_label":"heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003144","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00589303"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00589303%22"]}]},{"efo_id":"EFO_0003763","efo_label":"cerebrovascular disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003763","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000514"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000514%22"]}]},{"efo_id":"EFO_0003882","efo_label":"osteoporosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003882","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT02467400"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02467400%22"]}]},{"efo_id":"EFO_0003896","efo_label":"left ventricular hypertrophy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003896","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00108082"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00108082%22"]}]},{"efo_id":"EFO_0004264","efo_label":"vascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004264","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000513"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000513%22"]}]},{"efo_id":"EFO_0007372","efo_label":"mitral valve stenosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007372","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01022463"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01022463%22"]}]},{"efo_id":"EFO_1001375","efo_label":"Myocardial Ischemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001375","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000478"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000478%22"]}]},{"efo_id":"EFO_1002032","efo_label":"primary hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1002032","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00185185"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00185185%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000043591","approved_name":"adrenoceptor beta 1","approved_symbol":"ADRB1"}],"target_type":"single protein","target_name":"Beta-1 adrenergic receptor","action_type":"antagonist","description":"Beta-1 adrenergic receptor antagonist","references":[{"source":"DailyMed","ids":["setid=f36d4ed3-dcbb-4465-9fa6-1da811f555e6"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f36d4ed3-dcbb-4465-9fa6-1da811f555e6"]}]}],"adverse_events":{"significant":[{"event":"bradycardia","count":20091,"llr":2391.956846},{"event":"hypotension","count":55121,"llr":876.2097953},{"event":"sinus bradycardia","count":4115,"llr":572.4986698},{"event":"syncope","count":31191,"llr":453.8698126},{"event":"shock","count":5269,"llr":296.1959233},{"event":"orthostatic hypotension","count":6478,"llr":227.0803622},{"event":"drug interaction","count":53526,"llr":224.8452965},{"event":"heart rate decreased","count":5985,"llr":200.9797817},{"event":"hyperkalaemia","count":12419,"llr":200.6158662},{"event":"suicide attempt","count":20244,"llr":193.9093249},{"event":"circulatory collapse","count":4559,"llr":157.437784},{"event":"presyncope","count":6977,"llr":137.5043378},{"event":"atrioventricular block first degree","count":1707,"llr":131.6313725},{"event":"toxicity to various agents","count":31033,"llr":129.4676658},{"event":"loss of consciousness","count":30434,"llr":110.5534119},{"event":"atrioventricular block","count":2594,"llr":107.165087},{"event":"atrioventricular block complete","count":2688,"llr":105.1148143},{"event":"blood pressure increased","count":25616,"llr":104.9167348},{"event":"dizziness","count":99375,"llr":98.63480935},{"event":"cardiac arrest","count":9359,"llr":97.47512545},{"event":"hypokalaemia","count":14556,"llr":86.46353943}],"critval":84.11508324},"number_of_indications":19,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":14},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":7},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":4},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":3},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":2},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL441765","_score":1,"_source":{"id":"CHEMBL441765","internal_compound":false,"type":"Small molecule","pref_name":"U-50488 METHANE SULFONATE","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["(+)-Trans-(1R,2R0-U-50488 HCl","NCG-C00093883-01","NCG-C00094496-01","U-50488","U-50488 methane sulfonate","U-50488H"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[73358]},{"source":"PubChem","ids":["11111942","11111943","26756547"]},{"source":"Wikipedia","ids":["U-50488"]},{"source":"PubChem","ids":["50107208"]},{"source":"PubChem","ids":["11112023","11532953","56422173"]}],"canonical_smiles":"CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@@H]1CCCC[C@H]1N1CCCC1","child_chembl_ids":["CHEMBL1256834","CHEMBL1793845","CHEMBL2062342","CHEMBL482811"],"indications":[{"efo_id":"EFO_0002506","efo_label":"osteoarthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002506","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01836757"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01836757%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108546","_score":1,"_source":{"id":"CHEMBL2108546","internal_compound":false,"type":"Enzyme","pref_name":"PEGASPARGASE","year_first_approved":1994,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Pegaspargase"],"trade_names":["Oncaspar"],"cross_references":[{"source":"DailyMed","ids":["pegaspargase"]},{"source":"DrugCentral","ids":["5082"]}],"indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["L01XX24"],"urls":["https://www.whocc.no/atc_ddd_index/?code=L01XX24"]}]},{"efo_id":"EFO_0000220","efo_label":"acute lymphoblastic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000220","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00022737","NCT00098839","NCT00720109","NCT00819351","NCT00890656","NCT00905034","NCT01251809","NCT01483690","NCT02003222","NCT02101853","NCT02419755","NCT02553460","NCT02716233","NCT02828358","NCT02883049","NCT03020030","NCT03318419","NCT03553238","NCT03564704","NCT03571321","NCT03643276","NCT04067518"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00022737%22OR%22NCT00098839%22OR%22NCT00720109%22OR%22NCT00819351%22OR%22NCT00890656%22OR%22NCT00905034%22OR%22NCT01251809%22OR%22NCT01483690%22OR%22NCT02003222%22OR%22NCT02101853%22OR%22NCT02419755%22OR%22NCT02553460%22OR%22NCT02716233%22OR%22NCT02828358%22OR%22NCT02883049%22OR%22NCT03020030%22OR%22NCT03318419%22OR%22NCT03553238%22OR%22NCT03564704%22OR%22NCT03571321%22OR%22NCT03643276%22OR%22NCT04067518%22"]},{"source":"FDA","ids":["d933e1d1-06b7-4d70-981f-3e8984b0683f"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Ad933e1d1-06b7-4d70-981f-3e8984b0683f"]}]},{"efo_id":"EFO_0000094","efo_label":"B-cell acute lymphoblastic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000094","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03962465"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03962465%22"]}]},{"efo_id":"EFO_0000209","efo_label":"T-cell acute lymphoblastic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000209","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00501826","NCT03808610"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00501826%22OR%22NCT03808610%22"]}]},{"efo_id":"EFO_0000565","efo_label":"leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000565","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002744","NCT00002766","NCT00002785","NCT00002812","NCT00002816","NCT00003437","NCT00005585","NCT00005596","NCT00005945","NCT00022126","NCT00075725","NCT00400946","NCT00558519","NCT00882206","NCT00967057","NCT01005758","NCT01005914","NCT01117441","NCT01228331","NCT02660762","NCT02723994"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002744%22OR%22NCT00002766%22OR%22NCT00002785%22OR%22NCT00002812%22OR%22NCT00002816%22OR%22NCT00003437%22OR%22NCT00005585%22OR%22NCT00005596%22OR%22NCT00005945%22OR%22NCT00022126%22OR%22NCT00075725%22OR%22NCT00400946%22OR%22NCT00558519%22OR%22NCT00882206%22OR%22NCT00967057%22OR%22NCT01005758%22OR%22NCT01005914%22OR%22NCT01117441%22OR%22NCT01228331%22OR%22NCT02660762%22OR%22NCT02723994%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002590","NCT00002766","NCT00363610","NCT00882206","NCT01878708","NCT01921790","NCT01991158","NCT02085655","NCT02359162","NCT02533323","NCT02631239","NCT02918747"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002590%22OR%22NCT00002766%22OR%22NCT00363610%22OR%22NCT00882206%22OR%22NCT01878708%22OR%22NCT01921790%22OR%22NCT01991158%22OR%22NCT02085655%22OR%22NCT02359162%22OR%22NCT02533323%22OR%22NCT02631239%22OR%22NCT02918747%22"]}]},{"efo_id":"EFO_0004289","efo_label":"lymphoid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004289","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00408005","NCT00501826","NCT00873093","NCT03564704"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00408005%22OR%22NCT00501826%22OR%22NCT00873093%22OR%22NCT03564704%22"]}]},{"efo_id":"EFO_1001830","efo_label":"precursor T-cell lymphoblastic leukemia-lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001830","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01483690"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01483690%22"]}]},{"efo_id":"Orphanet_158038","efo_label":"Primary hemophagocytic lymphohistiocytosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_158038","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02631109","NCT02912702"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02631109%22OR%22NCT02912702%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02419755"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02419755%22"]}]}],"mechanisms_of_action":[],"adverse_events":{"significant":[{"event":"febrile bone marrow aplasia","count":1608,"llr":2346.985324},{"event":"hypofibrinogenaemia","count":397,"llr":1200.663862},{"event":"febrile neutropenia","count":19204,"llr":980.183664},{"event":"hypertriglyceridaemia","count":2168,"llr":745.0484046},{"event":"hyperbilirubinaemia","count":3507,"llr":503.1166537},{"event":"hepatocellular injury","count":6669,"llr":349.5946456},{"event":"pancreatitis","count":15810,"llr":190.8324091},{"event":"sepsis","count":19258,"llr":175.2200751},{"event":"mucosal inflammation","count":9134,"llr":169.8672617},{"event":"septic shock","count":5712,"llr":146.3872159},{"event":"antithrombin iii decreased","count":109,"llr":142.1371584},{"event":"anaphylactic reaction","count":16695,"llr":136.4201623},{"event":"blood culture positive","count":1081,"llr":116.7170982},{"event":"hypoalbuminaemia","count":2309,"llr":114.8791116},{"event":"superior sagittal sinus thrombosis","count":241,"llr":107.6846808},{"event":"cholestasis","count":6825,"llr":104.1220044},{"event":"potentiating drug interaction","count":1142,"llr":103.9993276},{"event":"blood bilirubin increased","count":9989,"llr":100.9160661},{"event":"fatigue","count":147738,"llr":92.6875777},{"event":"alanine aminotransferase increased","count":24852,"llr":91.47205402},{"event":"neutropenia","count":41585,"llr":87.91417774},{"event":"pyrexia","count":87334,"llr":86.95607757},{"event":"respiratory distress","count":7103,"llr":84.3425855},{"event":"gamma-glutamyltransferase increased","count":9889,"llr":80.54803232},{"event":"coagulopathy","count":4025,"llr":78.22055115},{"event":"antithrombin iii","count":13,"llr":73.611218},{"event":"lipase increased","count":3060,"llr":71.36631637},{"event":"blood fibrinogen decreased","count":277,"llr":69.19282202},{"event":"bacterial infection","count":3360,"llr":67.4452603},{"event":"venoocclusive liver disease","count":1475,"llr":66.24661129},{"event":"aplasia","count":702,"llr":65.81496088},{"event":"bacteraemia","count":3187,"llr":64.84124815},{"event":"cerebral venous thrombosis","count":561,"llr":64.50281209},{"event":"perineal necrosis","count":17,"llr":63.77430823},{"event":"hypersensitivity","count":35921,"llr":61.54472203},{"event":"escherichia sepsis","count":841,"llr":61.11436031},{"event":"staphylococcal sepsis","count":1291,"llr":58.67094614},{"event":"perineal infection","count":42,"llr":58.40291728},{"event":"pancreatitis acute","count":7957,"llr":56.79001958},{"event":"arthralgia","count":75397,"llr":54.36100371},{"event":"pseudomonal sepsis","count":330,"llr":53.75579083},{"event":"hepatic steatosis","count":5106,"llr":52.3834701},{"event":"intracranial venous sinus thrombosis","count":388,"llr":50.75349085},{"event":"cerebral thrombosis","count":561,"llr":50.62739786}],"critval":50.24594008},"number_of_indications":10,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":9},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":9},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":8},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":7},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":7}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL278315","_score":1,"_source":{"id":"CHEMBL278315","internal_compound":false,"type":"Small molecule","pref_name":"GELDANAMYCIN","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Geldanamycin","NSC-122750"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[5292]},{"source":"PubChem","ids":["26756833","26756834"]},{"source":"Wikipedia","ids":["Geldanamycin"]},{"source":"drugbank","ids":["DB02424"]}],"canonical_smiles":"COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\\C=C(/C)C(=O)NC(=CC1=O)C2=O","indications":[{"efo_id":"EFO_0002890","efo_label":"renal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002890","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00088374"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00088374%22"]}]},{"efo_id":"Orphanet_892","efo_label":"Von Hippel-Lindau disease","efo_uri":"http://www.orpha.net/ORDO/Orphanet_892","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00088374"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00088374%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1189025","_score":1,"_source":{"id":"CHEMBL1189025","internal_compound":false,"type":"Small molecule","pref_name":"BROSTALLICIN","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Brostallicin"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB06598"]}],"canonical_smiles":"C=C(Br)C(=O)Nc1cc(C(=O)Nc2cc(C(=O)Nc3cc(C(=O)Nc4cc(C(=O)NCCN=C(N)N)n(C)c4)n(C)c3)n(C)c2)n(C)c1","indications":[{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00060203"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00060203%22"]}]},{"efo_id":"EFO_0000613","efo_label":"myxoid liposarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000613","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00633165"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00633165%22"]}]},{"efo_id":"EFO_0005537","efo_label":"triple-negative breast cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005537","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01091454"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01091454%22"]}]}],"child_chembl_ids":["CHEMBL537929"],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109152","_score":1,"_source":{"id":"CHEMBL2109152","internal_compound":false,"type":"Small molecule","pref_name":"MINERAL OIL","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["E-905D","INS NO.905D","INS-905D","Liquid Paraffin","Mineral Oil","Paraffin, Liquid","Petrolatum, liquid"],"trade_names":["Alpha Keri","Ashbourne Emollient","Aveeno","Balneol","Dermalo","Doublebase","Emmolate","Emulsiderm","Gppe Emollient","Lacri-Lube","Liq Paraf Light","Lubri-Tears","Neo-Cultol","Nujol","Oilatum Jnr","Petrolagar","Rae's","Zerolatum","Zerolatum Plus"],"indications":[{"efo_id":"EFO_0000701","efo_label":"skin disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000701","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02379793"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02379793%22"]}]}],"adverse_events":{"significant":[{"event":"eye irritation","count":5686,"llr":26.75200972},{"event":"foreign body in eye","count":154,"llr":17.77637274},{"event":"corneal infiltrates","count":158,"llr":17.69952052},{"event":"cataract","count":9235,"llr":15.43436096},{"event":"eye swelling","count":6631,"llr":13.55404083},{"event":"product container seal issue","count":101,"llr":11.8700068},{"event":"corneal transplant","count":134,"llr":11.30519618},{"event":"eye discharge","count":1453,"llr":11.06745764},{"event":"dark circles under eyes","count":187,"llr":10.63966708},{"event":"corneal epithelium defect","count":223,"llr":10.28822583},{"event":"eye pain","count":7341,"llr":9.55510943},{"event":"vision blurred","count":26101,"llr":9.505270497},{"event":"corneal opacity","count":440,"llr":8.93314938},{"event":"drug reaction with eosinophilia and systemic symptoms","count":9050,"llr":8.749646579},{"event":"corneal disorder","count":653,"llr":8.147598149},{"event":"propionibacterium test positive","count":6,"llr":8.057615104},{"event":"foreign body sensation in eyes","count":698,"llr":8.01517062},{"event":"eyelid oedema","count":4197,"llr":7.936774786},{"event":"blepharitis","count":760,"llr":7.846151928},{"event":"lacrimation increased","count":4647,"llr":7.639674306},{"event":"keratitis","count":884,"llr":7.546234666}],"critval":7.456778959},"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108200","_score":1,"_source":{"id":"CHEMBL2108200","internal_compound":false,"type":"Unknown","pref_name":"DIMETHICONE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Dimethicone","Dimeticone","Dimeticone ","E-900A","INS NO.900A","INS-900A"],"trade_names":["Conotrane","Cymex","Hedrin","Johnson's","Rikospray","Sentry Dimethicone","Sentry Dimethicone Dispension","Siopel","Sprilon","Superderm","Vasogen"],"cross_references":[{"source":"DrugCentral","ids":["3152"]}],"indications":[{"efo_id":"EFO_0000676","efo_label":"psoriasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000676","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01914627"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01914627%22"]}]}],"mechanisms_of_action":[],"adverse_events":{"significant":[{"event":"milk-alkali syndrome","count":222,"llr":856.1168434},{"event":"hypercalcaemia","count":3877,"llr":447.7873431},{"event":"pneumonia aspiration","count":5215,"llr":300.8125815},{"event":"gastrooesophageal reflux disease","count":14790,"llr":248.0430789},{"event":"coma","count":13175,"llr":228.2997097},{"event":"somnolence","count":38949,"llr":160.965104},{"event":"metabolic alkalosis","count":568,"llr":137.9588795},{"event":"constipation","count":39620,"llr":86.091711},{"event":"diarrhoea","count":126514,"llr":83.90240265},{"event":"calciphylaxis","count":556,"llr":71.11595135},{"event":"nephrocalcinosis","count":365,"llr":44.80219226},{"event":"intestinal obstruction","count":7554,"llr":42.0213},{"event":"salivary gland calculus","count":110,"llr":40.53446554},{"event":"acute kidney injury","count":33030,"llr":36.08788796},{"event":"infrequent bowel movements","count":300,"llr":34.70675797}],"critval":34.06153704},"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL110691","_score":1,"_source":{"id":"CHEMBL110691","internal_compound":false,"type":"Small molecule","pref_name":"CHLORMADINONE ACETATE","max_clinical_trial_phase":4,"withdrawn_flag":true,"withdrawn_reason":["Animal carcinogenicity (dogs)"],"withdrawn_year":1970,"withdrawn_country":["United Kingdom","United States"],"withdrawn_class":["Carcinogenicity"],"black_box_warning":false,"synonyms":["Chlormadinone","Chlormadinone Acetate","NSC-92338"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[31394]},{"source":"PubChem","ids":["144204432","144207863","170465776","29215009","56422443","855775"]}],"canonical_smiles":"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C","mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000082175","approved_name":"progesterone receptor","approved_symbol":"PGR"}],"target_type":"single protein","target_name":"Progesterone receptor","action_type":"modulator","description":"Progesterone receptor modulator","references":[{"source":"PubMed","ids":["16356876","19272496"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16356876+OR+EXT_ID%3A19272496"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297696","_score":1,"_source":{"id":"CHEMBL4297696","internal_compound":false,"type":"Unknown","pref_name":"AR-105","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AR-105","Ar-105"],"trade_names":[],"indications":[{"efo_id":"EFO_0003106","efo_label":"pneumonia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003106","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03027609"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03027609%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545232","_score":1,"_source":{"id":"CHEMBL3545232","internal_compound":false,"type":"Small molecule","pref_name":"AQW051","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AQW051"],"trade_names":[],"canonical_smiles":"Cc1ccc(-c2ccc(OC3CN4CCC3CC4)cn2)cc1","indications":[{"efo_id":"EFO_0000692","efo_label":"schizophrenia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000692","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00825539","NCT01163227","NCT01730768"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00825539%22OR%22NCT01163227%22OR%22NCT01730768%22"]}]},{"efo_id":"EFO_0000249","efo_label":"Alzheimer's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000249","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00582855"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00582855%22"]}]},{"efo_id":"HP_0100543","efo_label":"Cognitive impairment","efo_uri":"http://purl.obolibrary.org/obo/HP_0100543","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00582855"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00582855%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000175344","approved_name":"cholinergic receptor nicotinic alpha 7 subunit","approved_symbol":"CHRNA7"}],"target_type":"single protein","target_name":"Neuronal acetylcholine receptor protein alpha-7 subunit","action_type":"partial agonist","description":"Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist","references":[{"source":"PubMed","ids":["25172125","25363835"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25172125+OR+EXT_ID%3A25363835"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":2},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":2},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3989927","_score":1,"_source":{"id":"CHEMBL3989927","internal_compound":false,"type":"Small molecule","pref_name":"IBERDOMIDE","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["CC-220","Iberdomide","Iberdomide hydrochloride"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12101"]}],"canonical_smiles":"O=C1CC[C@H](N2Cc3c(OCc4ccc(CN5CCOCC5)cc4)cccc3C2=O)C(=O)N1","child_chembl_ids":["CHEMBL3989912"],"indications":[{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02773030"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02773030%22"]}]},{"efo_id":"EFO_0001421","efo_label":"liver disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001421","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03824678"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03824678%22"]}]},{"efo_id":"EFO_0002690","efo_label":"systemic lupus erythematosus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002690","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02185040","NCT03161483"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02185040%22OR%22NCT03161483%22"]}]},{"efo_id":"Orphanet_797","efo_label":"Sarcoidosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_797","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02192489"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02192489%22"]}]}],"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":2},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":2},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2435707","_score":1,"_source":{"id":"CHEMBL2435707","internal_compound":false,"type":"Small molecule","pref_name":"SQUARIC ACID DIBUTYL ESTER","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["NSC-113489","Squaric acid dibutyl ester","Squaric acid dibutylester"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[53612]},{"source":"drugbank","ids":["DB12223"]}],"canonical_smiles":"CCCCOc1c(OCCCC)c(=O)c1=O","indications":[{"efo_id":"EFO_1001347","efo_label":"Herpes Labialis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001347","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03521479","NCT03661541"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03521479%22OR%22NCT03661541%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201752","_score":1,"_source":{"id":"CHEMBL1201752","internal_compound":false,"type":"Small molecule","pref_name":"IXABEPILONE","year_first_approved":2007,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["BMS-247550","BMS-247550-01","Ixabepilone"],"trade_names":["Ixempra","Ixempra Kit"],"cross_references":[{"source":"ChEBI","ids":[63605]},{"source":"DailyMed","ids":["ixabepilone"]},{"source":"Wikipedia","ids":["Ixabepilone"]},{"source":"drugbank","ids":["DB04845"]}],"canonical_smiles":"C/C(=C\\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)N1","indications":[{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00020904","NCT00045097","NCT00049244","NCT00079326","NCT00080262","NCT00080301","NCT00082433","NCT00322374","NCT00370552","NCT00448591","NCT00455533","NCT00490646","NCT00568022","NCT00593827","NCT00627978","NCT00630032","NCT00633464","NCT00634088","NCT00637897","NCT00751868","NCT00765765","NCT00785291","NCT00789581","NCT00790894","NCT00821886","NCT00825734","NCT00866905","NCT00877500","NCT00879086","NCT00924352","NCT01019577","NCT01027208","NCT01075100","NCT01097642","NCT01349088","NCT01416389","NCT01446016","NCT01818999","NCT02067416"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00020904%22OR%22NCT00045097%22OR%22NCT00049244%22OR%22NCT00079326%22OR%22NCT00080262%22OR%22NCT00080301%22OR%22NCT00082433%22OR%22NCT00322374%22OR%22NCT00370552%22OR%22NCT00448591%22OR%22NCT00455533%22OR%22NCT00490646%22OR%22NCT00568022%22OR%22NCT00593827%22OR%22NCT00627978%22OR%22NCT00630032%22OR%22NCT00633464%22OR%22NCT00634088%22OR%22NCT00637897%22OR%22NCT00751868%22OR%22NCT00765765%22OR%22NCT00785291%22OR%22NCT00789581%22OR%22NCT00790894%22OR%22NCT00821886%22OR%22NCT00825734%22OR%22NCT00866905%22OR%22NCT00877500%22OR%22NCT00879086%22OR%22NCT00924352%22OR%22NCT01019577%22OR%22NCT01027208%22OR%22NCT01075100%22OR%22NCT01097642%22OR%22NCT01349088%22OR%22NCT01416389%22OR%22NCT01446016%22OR%22NCT01818999%22OR%22NCT02067416%22"]},{"source":"FDA","ids":["label/2007/022065lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2007%2F022065lbl.pdf"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00162136","NCT00309049","NCT00362830","NCT00422097","NCT00798252"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00162136%22OR%22NCT00309049%22OR%22NCT00362830%22OR%22NCT00422097%22OR%22NCT00798252%22"]}]},{"efo_id":"EFO_0004230","efo_label":"endometrial neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004230","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00883116"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00883116%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00016393","NCT00025194","NCT00828308","NCT01079793"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00016393%22OR%22NCT00025194%22OR%22NCT00828308%22OR%22NCT01079793%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["L01DC04"],"urls":["https://www.whocc.no/atc_ddd_index/?code=L01DC04"]},{"source":"ClinicalTrials","ids":["NCT00004927","NCT00028561","NCT00043095","NCT00096317","NCT00207090","NCT00207129","NCT00632424","NCT00717704","NCT00804310","NCT00884676","NCT01018966","NCT01170871","NCT01375829"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004927%22OR%22NCT00028561%22OR%22NCT00043095%22OR%22NCT00096317%22OR%22NCT00207090%22OR%22NCT00207129%22OR%22NCT00632424%22OR%22NCT00717704%22OR%22NCT00804310%22OR%22NCT00884676%22OR%22NCT01018966%22OR%22NCT01170871%22OR%22NCT01375829%22"]}]},{"efo_id":"EFO_0003897","efo_label":"stomach neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003897","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00983801"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00983801%22"]}]},{"efo_id":"EFO_0000756","efo_label":"melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000756","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00036764"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00036764%22"]}]},{"efo_id":"EFO_0000673","efo_label":"prostate adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000673","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00058084","NCT00087139","NCT00331344","NCT00672009"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00058084%22OR%22NCT00087139%22OR%22NCT00331344%22OR%22NCT00672009%22"]}]},{"efo_id":"EFO_0000349","efo_label":"clear cell renal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000349","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00182702"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00182702%22"]}]},{"efo_id":"EFO_0000691","efo_label":"sarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000691","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00022542"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00022542%22"]}]},{"efo_id":"EFO_0000292","efo_label":"bladder carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000292","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00021099"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00021099%22"]}]},{"efo_id":"EFO_0000309","efo_label":"Burkitts lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000309","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00058019"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00058019%22"]}]},{"efo_id":"EFO_0000403","efo_label":"diffuse large B-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000403","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00058019"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00058019%22"]}]},{"efo_id":"EFO_0000565","efo_label":"leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000565","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00052572"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00052572%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00052572"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00052572%22"]}]},{"efo_id":"EFO_0000681","efo_label":"renal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000681","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00030992","NCT00923130"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00030992%22OR%22NCT00923130%22"]}]},{"efo_id":"EFO_0001071","efo_label":"lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001071","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00998101"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00998101%22"]}]},{"efo_id":"EFO_0002499","efo_label":"anaplastic astrocytoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002499","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00045708"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00045708%22"]}]},{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00016965","NCT00383149"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00016965%22OR%22NCT00383149%22"]}]},{"efo_id":"EFO_0003032","efo_label":"anaplastic large cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003032","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00058019"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00058019%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00683904","NCT00723957","NCT00741988","NCT00832117","NCT01057212"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00683904%22OR%22NCT00723957%22OR%22NCT00741988%22OR%22NCT00832117%22OR%22NCT01057212%22"]}]},{"efo_id":"EFO_0003844","efo_label":"ureteral neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003844","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00021099"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00021099%22"]}]},{"efo_id":"EFO_0003846","efo_label":"urethral neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003846","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00021099"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00021099%22"]}]},{"efo_id":"EFO_0003869","efo_label":"breast neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003869","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00546364","NCT01446016"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00546364%22OR%22NCT01446016%22"]}]},{"efo_id":"EFO_0003871","efo_label":"tongue neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003871","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00033618"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00033618%22"]}]},{"efo_id":"EFO_0006859","efo_label":"head and neck malignant neoplasia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006859","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00057850"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00057850%22"]}]},{"efo_id":"EFO_0006861","efo_label":"male breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006861","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00077376","NCT01084057"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00077376%22OR%22NCT01084057%22"]}]},{"efo_id":"EFO_0007535","efo_label":"verrucous carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007535","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00033618"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00033618%22"]}]},{"efo_id":"EFO_1001465","efo_label":"gliosarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001465","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00045708"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00045708%22"]}]},{"efo_id":"EFO_1001469","efo_label":"Mantle cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001469","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00058019"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00058019%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00022477","NCT00033306"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00022477%22OR%22NCT00033306%22"]}]},{"efo_id":"EFO_0001075","efo_label":"ovarian carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001075","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00030706","NCT03093155"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00030706%22OR%22NCT03093155%22"]}]},{"efo_id":"EFO_1000251","efo_label":"Fallopian Tube Carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000251","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03093155"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03093155%22"]}]},{"efo_id":"EFO_1001100","efo_label":"peritoneal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001100","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00030706","NCT03093155"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00030706%22OR%22NCT03093155%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000188229","approved_name":"tubulin beta 4B class IVb","approved_symbol":"TUBB4B"},{"ensembl":"ENSG00000101162","approved_name":"tubulin beta 1 class VI","approved_symbol":"TUBB1"},{"ensembl":"ENSG00000198033","approved_name":"tubulin alpha 3c","approved_symbol":"TUBA3C"},{"ensembl":"ENSG00000127824","approved_name":"tubulin alpha 4a","approved_symbol":"TUBA4A"},{"ensembl":"ENSG00000258947","approved_name":"tubulin beta 3 class III","approved_symbol":"TUBB3"},{"ensembl":"ENSG00000167552","approved_name":"tubulin alpha 1a","approved_symbol":"TUBA1A"},{"ensembl":"ENSG00000104833","approved_name":"tubulin beta 4A class IVa","approved_symbol":"TUBB4A"},{"ensembl":"ENSG00000261456","approved_name":"tubulin beta 8 class VIII","approved_symbol":"TUBB8"},{"ensembl":"ENSG00000196230","approved_name":"tubulin beta class I","approved_symbol":"TUBB"},{"ensembl":"ENSG00000123416","approved_name":"tubulin alpha 1b","approved_symbol":"TUBA1B"},{"ensembl":"ENSG00000167553","approved_name":"tubulin alpha 1c","approved_symbol":"TUBA1C"},{"ensembl":"ENSG00000152086","approved_name":"tubulin alpha 3e","approved_symbol":"TUBA3E"},{"ensembl":"ENSG00000137267","approved_name":"tubulin beta 2A class IIa","approved_symbol":"TUBB2A"},{"ensembl":"ENSG00000137285","approved_name":"tubulin beta 2B class IIb","approved_symbol":"TUBB2B"},{"ensembl":"ENSG00000176014","approved_name":"tubulin beta 6 class V","approved_symbol":"TUBB6"}],"target_type":"protein complex group","target_name":"Tubulin","action_type":"inhibitor","description":"Tubulin inhibitor","references":[{"source":"DailyMed","ids":["setid=e7992f6b-279b-46a7-b9c3-fea4e17718dc#nlm34090-1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e7992f6b-279b-46a7-b9c3-fea4e17718dc#nlm34090-1"]},{"source":"PubMed","ids":["22113255"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22113255"]}]}],"adverse_events":{"significant":[{"event":"neutrophil count decreased","count":11062,"llr":125.0455438},{"event":"pseudocirrhosis","count":98,"llr":91.24025212},{"event":"white blood cell count decreased","count":28818,"llr":73.44979159},{"event":"neuropathy peripheral","count":20261,"llr":49.13604879},{"event":"portal hypertension","count":1106,"llr":48.40857085},{"event":"hypoalbuminaemia","count":2309,"llr":48.35167043},{"event":"febrile neutropenia","count":19204,"llr":46.38086849},{"event":"dehydration","count":36809,"llr":44.23606398},{"event":"mucosal inflammation","count":9134,"llr":42.26199181},{"event":"anaemia","count":61405,"llr":41.90730027},{"event":"neutropenia","count":41585,"llr":41.40301724},{"event":"malignant neoplasm progression","count":14458,"llr":38.52452118},{"event":"peripheral sensory neuropathy","count":2329,"llr":37.48157773},{"event":"hypokalaemia","count":14556,"llr":33.86521497},{"event":"platelet count decreased","count":29394,"llr":33.4684279},{"event":"vomiting","count":103943,"llr":30.57596172},{"event":"extravasation","count":1902,"llr":29.72371409},{"event":"palmar-plantar erythrodysaesthesia syndrome","count":7553,"llr":25.6030369},{"event":"lymphopenia","count":5118,"llr":23.57269706},{"event":"hypophosphataemia","count":2382,"llr":20.84366979},{"event":"recall phenomenon","count":412,"llr":19.75046717},{"event":"hypocalcaemia","count":7012,"llr":17.2763619},{"event":"fatigue","count":147738,"llr":14.52646704},{"event":"pleural effusion","count":17395,"llr":13.37963935},{"event":"stomatitis","count":13596,"llr":11.5870015},{"event":"peripheral motor neuropathy","count":527,"llr":10.60630127},{"event":"hyponatraemia","count":21598,"llr":10.53850885}],"critval":10.42738428},"number_of_indications":34,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":34},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":9},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":8},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":6},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":5},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":5},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":5},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":5},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":4},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":3},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":2},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL114","_score":1,"_source":{"id":"CHEMBL114","internal_compound":false,"type":"Small molecule","pref_name":"SAQUINAVIR","year_first_approved":1995,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["Invirase","Ro-31-8959","Ro-31-8959-003","Ro-318959000","Ro-318959003","SCH-52852","Saquinavir","Saquinavir Mesylate","Saquinavir mesilate","Saquinavir methanesulfonate salt"],"trade_names":["Fortovase","Invirase"],"cross_references":[{"source":"ChEBI","ids":[63621]},{"source":"DailyMed","ids":["saquinavir%20mesylate"]},{"source":"PubChem","ids":["49666064","50105601"]},{"source":"Wikipedia","ids":["Saquinavir"]},{"source":"drugbank","ids":["DB01232"]},{"source":"ChEBI","ids":[32121]},{"source":"PubChem","ids":["144204688","144209731","17388741","49681831"]}],"canonical_smiles":"CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1","indications":[{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000848","NCT00000891","NCT00000906","NCT00000912","NCT00000913","NCT00000918","NCT00000941","NCT00001040","NCT00001087","NCT00001094","NCT00001108","NCT00002111","NCT00002162","NCT00002178","NCT00002184","NCT00002190","NCT00002333","NCT00002334","NCT00002347","NCT00002367","NCT00002372","NCT00002374","NCT00002378","NCT00002380","NCT00002382","NCT00002383","NCT00002440","NCT00002447","NCT00002448","NCT00004584","NCT00035932","NCT00038519","NCT00038532","NCT00046033","NCT00056641","NCT00084058","NCT00102206","NCT00105079","NCT00122603","NCT00145561","NCT00307502","NCT00400738","NCT00435929","NCT00622141","NCT00622206","NCT00623597","NCT00624195","NCT01638650","NCT02184286","NCT02239835","NCT02302547"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000848%22OR%22NCT00000891%22OR%22NCT00000906%22OR%22NCT00000912%22OR%22NCT00000913%22OR%22NCT00000918%22OR%22NCT00000941%22OR%22NCT00001040%22OR%22NCT00001087%22OR%22NCT00001094%22OR%22NCT00001108%22OR%22NCT00002111%22OR%22NCT00002162%22OR%22NCT00002178%22OR%22NCT00002184%22OR%22NCT00002190%22OR%22NCT00002333%22OR%22NCT00002334%22OR%22NCT00002347%22OR%22NCT00002367%22OR%22NCT00002372%22OR%22NCT00002374%22OR%22NCT00002378%22OR%22NCT00002380%22OR%22NCT00002382%22OR%22NCT00002383%22OR%22NCT00002440%22OR%22NCT00002447%22OR%22NCT00002448%22OR%22NCT00004584%22OR%22NCT00035932%22OR%22NCT00038519%22OR%22NCT00038532%22OR%22NCT00046033%22OR%22NCT00056641%22OR%22NCT00084058%22OR%22NCT00102206%22OR%22NCT00105079%22OR%22NCT00122603%22OR%22NCT00145561%22OR%22NCT00307502%22OR%22NCT00400738%22OR%22NCT00435929%22OR%22NCT00622141%22OR%22NCT00622206%22OR%22NCT00623597%22OR%22NCT00624195%22OR%22NCT01638650%22OR%22NCT02184286%22OR%22NCT02239835%22OR%22NCT02302547%22"]}]},{"efo_id":"EFO_0000765","efo_label":"AIDS","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000765","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00433056"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00433056%22"]}]},{"efo_id":"EFO_0001361","efo_label":"pulmonary arterial hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001361","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT02023450"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02023450%22"]}]},{"efo_id":"EFO_0007313","efo_label":"HIV-associated nephropathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007313","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002397"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002397%22"]}]},{"efo_id":"EFO_0000691","efo_label":"sarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000691","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00003008"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003008%22"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00043953","NCT00285883","NCT00622141"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00043953%22OR%22NCT00285883%22OR%22NCT00622141%22"]}]}],"mechanisms_of_action":[{"target_type":"single protein","target_name":"Human immunodeficiency virus type 1 protease","action_type":"inhibitor","description":"Human immunodeficiency virus type 1 protease inhibitor","references":[{"source":"DailyMed","ids":["setid=c00d1607-ac36-457b-a34b-75ad74f9cf0a"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c00d1607-ac36-457b-a34b-75ad74f9cf0a"]}]}],"adverse_events":{"significant":[{"event":"mitochondrial toxicity","count":279,"llr":456.3968399},{"event":"lipodystrophy acquired","count":879,"llr":412.669916},{"event":"progressive external ophthalmoplegia","count":60,"llr":286.9209335},{"event":"eyelid ptosis","count":2847,"llr":258.9006713},{"event":"diplopia","count":6509,"llr":194.0385139},{"event":"viral mutation identified","count":1049,"llr":149.4041806},{"event":"drug resistance","count":7341,"llr":128.2399539},{"event":"hypertriglyceridaemia","count":2168,"llr":114.2009202},{"event":"blood lactic acid increased","count":1442,"llr":70.40055535},{"event":"premature baby","count":8946,"llr":57.7162715},{"event":"hyperlactacidaemia","count":751,"llr":56.42211384},{"event":"portal hypertension","count":1106,"llr":54.4788383},{"event":"virologic failure","count":2156,"llr":54.22235986},{"event":"immune reconstitution syndrome","count":646,"llr":49.59046612},{"event":"ophthalmoplegia","count":459,"llr":49.48785893},{"event":"lipoatrophy","count":316,"llr":44.11421978},{"event":"hepatic fibrosis","count":1098,"llr":42.26886676},{"event":"pathogen resistance","count":2318,"llr":42.17931953},{"event":"plagiocephaly","count":170,"llr":39.83638063},{"event":"alpha 1 foetoprotein increased","count":219,"llr":37.56832726},{"event":"hepatomegaly","count":2754,"llr":32.90253435},{"event":"normal newborn","count":1776,"llr":32.20323824},{"event":"extraocular muscle paresis","count":154,"llr":29.91391423},{"event":"pregnancy","count":9039,"llr":29.428297},{"event":"dysphagia","count":22741,"llr":29.1997203},{"event":"treatment failure","count":12895,"llr":28.93174642},{"event":"spastic paraplegia","count":25,"llr":28.74971921},{"event":"hepatotoxicity","count":5998,"llr":26.86689418},{"event":"maternal drugs affecting foetus","count":3468,"llr":26.71653919},{"event":"trisomy 21","count":497,"llr":25.96170496},{"event":"osteonecrosis","count":10916,"llr":25.89815518},{"event":"subacute combined cord degeneration","count":47,"llr":25.59850423},{"event":"lactic acidosis","count":8744,"llr":25.46765411},{"event":"congenital musculoskeletal anomaly","count":199,"llr":23.1898214},{"event":"joint hyperextension","count":91,"llr":22.30523261},{"event":"aspartate aminotransferase increased","count":21532,"llr":20.21115256},{"event":"alpha 1 foetoprotein abnormal","count":47,"llr":19.58621458},{"event":"hypophosphataemia","count":2382,"llr":19.43289813},{"event":"blood triglycerides increased","count":5126,"llr":19.20071485},{"event":"congenital foot malformation","count":175,"llr":19.05524113},{"event":"glycosuria","count":497,"llr":17.76771471},{"event":"hypercholesterolaemia","count":2955,"llr":17.41063636},{"event":"alanine aminotransferase increased","count":24852,"llr":17.38976467},{"event":"gamma-glutamyltransferase increased","count":9889,"llr":17.29105294},{"event":"cushing's syndrome","count":1514,"llr":17.28739503},{"event":"multiple-drug resistance","count":550,"llr":17.17212509},{"event":"live birth","count":1539,"llr":17.16220149},{"event":"transaminases increased","count":8955,"llr":16.65106401},{"event":"premature labour","count":2380,"llr":16.59945526},{"event":"anogenital warts","count":298,"llr":16.42246418},{"event":"mitochondrial myopathy","count":105,"llr":16.38454005},{"event":"mycobacterium avium complex infection","count":664,"llr":16.06857089},{"event":"aids encephalopathy","count":29,"llr":15.27204733},{"event":"thrombocythaemia","count":384,"llr":15.17482844},{"event":"spinal cord disorder","count":392,"llr":15.07360268},{"event":"proteinuria","count":6145,"llr":14.91026512},{"event":"atypical mycobacterial infection","count":410,"llr":14.85333513},{"event":"non-hodgkin's lymphoma","count":1386,"llr":14.8208136},{"event":"renal tubular disorder","count":1390,"llr":14.80157418},{"event":"hepatic function abnormal","count":12036,"llr":14.64464543},{"event":"diaphragmatic hernia","count":172,"llr":14.42608695},{"event":"patent ductus arteriosus","count":1500,"llr":14.29411626},{"event":"varices oesophageal","count":938,"llr":14.05977044},{"event":"cd4 lymphocytes abnormal","count":45,"llr":13.95769671},{"event":"premature delivery","count":4411,"llr":13.74346616},{"event":"cytomegalovirus chorioretinitis","count":535,"llr":13.55201726},{"event":"pain","count":94786,"llr":13.47948808},{"event":"pneumocystis jiroveci pneumonia","count":1065,"llr":13.32755838},{"event":"optic neuritis retrobulbar","count":58,"llr":13.19940152},{"event":"congenital nail disorder","count":60,"llr":13.09816554},{"event":"drug hypersensitivity","count":71246,"llr":13.07184591},{"event":"fat tissue increased","count":270,"llr":12.64531744},{"event":"hyperlipidaemia","count":5013,"llr":12.60427715}],"critval":12.52153004},"child_chembl_ids":["CHEMBL282042"],"number_of_indications":6,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":4},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":4},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":4},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":2},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2105825","_score":1,"_source":{"id":"CHEMBL2105825","internal_compound":false,"type":"Small molecule","pref_name":"PROGLUMETACIN","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Proglumetacin","Proglumetacin Maleate"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[76263]},{"source":"PubChem","ids":["144206876"]},{"source":"drugbank","ids":["DB13527"]}],"canonical_smiles":"CCCN(CCC)C(=O)C(CCC(=O)OCCCN1CCN(CCOC(=O)Cc2c(C)n(C(=O)c3ccc(Cl)cc3)c3ccc(OC)cc23)CC1)NC(=O)c1ccccc1","indications":[{"efo_id":"EFO_0005755","efo_label":"rheumatic disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005755","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["M01AB14"],"urls":["https://www.whocc.no/atc_ddd_index/?code=M01AB14"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2106841","_score":1,"_source":{"id":"CHEMBL2106841","internal_compound":false,"type":"Small molecule","pref_name":"NONABINE","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["BRL-4664","Nonabine"],"trade_names":[],"canonical_smiles":"CCCCCC(C)C(C)c1cc(O)c2c(c1)OC(C)(C)C=C2c1ccncc1","mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000118432","approved_name":"cannabinoid receptor 1","approved_symbol":"CNR1"}],"target_type":"single protein","target_name":"Cannabinoid CB1 receptor","action_type":"agonist","description":"Cannabinoid CB1 receptor agonist","references":[{"source":"PubMed","ids":["6402096"],"urls":["https://europepmc.org/search?query=EXT_ID%3A6402096"]},{"source":"Wikipedia","ids":["Nonabine"],"urls":["https://www.wikipedia.org/Nonabine"]}]},{"target_components":[{"ensembl":"ENSG00000188822","approved_name":"cannabinoid receptor 2","approved_symbol":"CNR2"}],"target_type":"single protein","target_name":"Cannabinoid CB2 receptor","action_type":"agonist","description":"Cannabinoid CB2 receptor agonist","references":[{"source":"PubMed","ids":["6402096"],"urls":["https://europepmc.org/search?query=EXT_ID%3A6402096"]},{"source":"Wikipedia","ids":["Nonabine"],"urls":["https://www.wikipedia.org/Nonabine"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1331216","_score":1,"_source":{"id":"CHEMBL1331216","internal_compound":false,"type":"Small molecule","pref_name":"HYOSCYAMINE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Daturine Hydrobromide","Hyoscyamine","Hyoscyamine Hydrobromide","Hyoscyamine Sulfate","Hyoscyamine Sulphate"],"trade_names":["Anaspaz","Levsin","Levsin SL","Levsinex","Levsinex Timecaps","Neoquess","Peptard"],"cross_references":[{"source":"ChEBI","ids":[17486]},{"source":"PubChem","ids":["50085944"]},{"source":"drugbank","ids":["DB00424"]},{"source":"Wikipedia","ids":["Hyoscyamine"]}],"canonical_smiles":"CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)[C@H](CO)c1ccccc1)C2","indications":[{"efo_id":"EFO_0003103","efo_label":"urinary tract infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003103","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["1d80a11c-6f86-403b-85d4-32ec1924dbe9","1e1b0dee-1a3b-4846-a212-c9febb3fc17d","2c1f0f4c-e57b-4df5-9a58-41d39c3d8893","4c386261-5f80-4317-a5e9-852a76f06f11","6368bb69-43e9-4304-a30d-03d593c1c05f","a39b46a2-f7e1-444f-b992-6f81b5e306ef","bda27303-2ee9-4a80-b049-7ad514f894e8","bf66622c-faa4-4ce9-a0e9-f99cb5c6981b","d801fc5b-f0df-4347-9b9b-8f439328cdde","d820e42d-ad2b-4e11-907b-a94d698ca285","dc773b57-378b-4650-9bb0-34e6f8c067ab","f650dd78-615c-42d3-9b2d-3a989039d80c","fa2cc334-bd86-46cc-bc6a-12c71303f963"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1d80a11c-6f86-403b-85d4-32ec1924dbe9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1e1b0dee-1a3b-4846-a212-c9febb3fc17d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2c1f0f4c-e57b-4df5-9a58-41d39c3d8893","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4c386261-5f80-4317-a5e9-852a76f06f11","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6368bb69-43e9-4304-a30d-03d593c1c05f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a39b46a2-f7e1-444f-b992-6f81b5e306ef","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bda27303-2ee9-4a80-b049-7ad514f894e8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bf66622c-faa4-4ce9-a0e9-f99cb5c6981b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d801fc5b-f0df-4347-9b9b-8f439328cdde","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d820e42d-ad2b-4e11-907b-a94d698ca285","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dc773b57-378b-4650-9bb0-34e6f8c067ab","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f650dd78-615c-42d3-9b2d-3a989039d80c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?fa2cc334-bd86-46cc-bc6a-12c71303f963"]},{"source":"FDA","ids":["206ac12b-a081-4e37-aa0e-73b8794608d8","263ed7eb-a390-4a26-9985-16ac883f4bfc","36527dcb-dc17-469c-8286-b752b0d8badf","bf3cabc3-9ae8-45e6-9bc9-005954a80fe1"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A206ac12b-a081-4e37-aa0e-73b8794608d8","https://api.fda.gov/drug/label.json?search=set_id%3A263ed7eb-a390-4a26-9985-16ac883f4bfc","https://api.fda.gov/drug/label.json?search=set_id%3A36527dcb-dc17-469c-8286-b752b0d8badf","https://api.fda.gov/drug/label.json?search=set_id%3Abf3cabc3-9ae8-45e6-9bc9-005954a80fe1"]}]}],"adverse_events":{"significant":[{"event":"drug hypersensitivity","count":71246,"llr":128.3321795},{"event":"anticholinergic syndrome","count":527,"llr":63.50609813},{"event":"apparent life threatening event","count":154,"llr":48.82859986},{"event":"vision blurred","count":26101,"llr":42.50289417},{"event":"dry mouth","count":12994,"llr":38.68592916},{"event":"infantile apnoea","count":202,"llr":33.2344412},{"event":"serotonin syndrome","count":6002,"llr":30.6895332},{"event":"mydriasis","count":3319,"llr":24.396928},{"event":"clonus","count":1049,"llr":18.5693885},{"event":"mental status changes","count":10001,"llr":15.85191665},{"event":"disorientation","count":10841,"llr":15.24184348},{"event":"dementia","count":4361,"llr":14.9770334},{"event":"hallucination","count":16074,"llr":14.84825437},{"event":"dizziness","count":99375,"llr":12.49380628},{"event":"heart rate increased","count":16145,"llr":12.27762914},{"event":"toxicity to various agents","count":31033,"llr":11.54562494},{"event":"anxiety","count":45966,"llr":9.942268222},{"event":"disorganised speech","count":219,"llr":8.701752436},{"event":"cystitis interstitial","count":270,"llr":8.285258863},{"event":"heart rate irregular","count":4688,"llr":8.12700557},{"event":"balance disorder","count":15453,"llr":7.856016053},{"event":"confusional state","count":40628,"llr":7.528181928},{"event":"choking","count":2352,"llr":7.243166771},{"event":"dysarthria","count":11020,"llr":7.234326818},{"event":"le cells present","count":9,"llr":6.842235787},{"event":"urinary incontinence","count":6744,"llr":6.760438294},{"event":"amnesia","count":13293,"llr":6.393579047},{"event":"ovulation pain","count":22,"llr":5.948983805},{"event":"gastrooesophageal reflux disease","count":14790,"llr":5.923848029},{"event":"photophobia","count":3837,"llr":5.838812107},{"event":"platelet count increased","count":3955,"llr":5.753022939},{"event":"thyroid function test abnormal","count":977,"llr":5.743725982},{"event":"neutrophil count increased","count":4046,"llr":5.688696416},{"event":"psychogenic pain disorder","count":29,"llr":5.673035142},{"event":"urinary retention","count":9378,"llr":5.554420882},{"event":"anal incontinence","count":1106,"llr":5.501272203},{"event":"malabsorption from administration site","count":38,"llr":5.403136587},{"event":"positive rombergism","count":38,"llr":5.403136587},{"event":"sticky skin","count":41,"llr":5.327281272},{"event":"cyanosis","count":4608,"llr":5.32269912},{"event":"prominent epicanthal folds","count":47,"llr":5.190966921}],"critval":5.113836616},"child_chembl_ids":["CHEMBL1697729","CHEMBL2106364","CHEMBL3989570"],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL343633","_score":1,"_source":{"id":"CHEMBL343633","internal_compound":false,"type":"Small molecule","pref_name":"ESATENOLOL","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Esatenolol","S-Atenolol","S-atenolol"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[31556]},{"source":"PubChem","ids":["11110679","11110681","11112794","11112795","11113477","11113481","124882641","26751699","26753528","50104390","50104391","50105883","50105884","56463525","85231336","90341383"]},{"source":"drugbank","ids":["DB13443"]}],"canonical_smiles":"CC(C)NC[C@H](O)COc1ccc(CC(N)=O)cc1","indications":[{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["C07AB11"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C07AB11"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL100116","_score":1,"_source":{"id":"CHEMBL100116","internal_compound":false,"type":"Small molecule","pref_name":"PENTAZOCINE","year_first_approved":1967,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["NSC-107430","Pentazocine","Pentazocine HCl","Pentazocine civ","Pentazocine lactate","WIN-20228"],"trade_names":["Fortral","Sosegon","Talwin","Talwin 50"],"cross_references":[{"source":"DailyMed","ids":["pentazocine%20hydrochloride","pentazocine%20lactate"]},{"source":"DailyMed","ids":["pentazocine%20lactate"]},{"source":"DailyMed","ids":["pentazocine%20hydrochloride"]}],"canonical_smiles":"CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C","indications":[{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N02AD01"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N02AD01"]}]},{"efo_id":"EFO_0000289","efo_label":"bipolar disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000289","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00125931"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00125931%22"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["017ef042-40aa-44c9-baa8-037f06356845","05a17f16-c982-4a54-80cd-079959ab49a7","0967a6ed-138c-4465-9d81-fea67c00749b","1e2de757-cfe1-4731-93d1-36f80175ef33","62a055f3-a58b-446d-9476-af6d36956eaf","911500d0-8894-4c08-a92e-85c834bc2b9a","a28450a0-ac93-4235-b9a6-58cdf24773cb","fbb6a064-59a6-4e1c-bbb6-5934c1505c4f"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?017ef042-40aa-44c9-baa8-037f06356845","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?05a17f16-c982-4a54-80cd-079959ab49a7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0967a6ed-138c-4465-9d81-fea67c00749b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1e2de757-cfe1-4731-93d1-36f80175ef33","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?62a055f3-a58b-446d-9476-af6d36956eaf","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?911500d0-8894-4c08-a92e-85c834bc2b9a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a28450a0-ac93-4235-b9a6-58cdf24773cb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?fbb6a064-59a6-4e1c-bbb6-5934c1505c4f"]},{"source":"FDA","ids":["643af9ce-549e-4102-932e-f4d995816cf1","e6aa52f1-0ebd-4312-8a18-99ea77928c51","ffa4a9b6-5770-4dc9-8151-78065bfc9e94"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A643af9ce-549e-4102-932e-f4d995816cf1","https://api.fda.gov/drug/label.json?search=set_id%3Ae6aa52f1-0ebd-4312-8a18-99ea77928c51","https://api.fda.gov/drug/label.json?search=set_id%3Affa4a9b6-5770-4dc9-8151-78065bfc9e94"]}]}],"adverse_events":{"significant":[{"event":"drug hypersensitivity","count":71246,"llr":691.8899393},{"event":"drug abuse","count":14574,"llr":235.7923054},{"event":"scleroderma","count":932,"llr":68.2574952},{"event":"skin fibrosis","count":135,"llr":41.43447041},{"event":"skin ulcer","count":6795,"llr":23.56325917},{"event":"porphyria acute","count":147,"llr":23.11259022},{"event":"drug dependence","count":7072,"llr":23.07731795},{"event":"gangrene","count":1124,"llr":16.74615472},{"event":"hallucination","count":16074,"llr":11.63568993},{"event":"injection site necrosis","count":675,"llr":11.56476456},{"event":"muscle fibrosis","count":20,"llr":11.39077366},{"event":"arteritis","count":207,"llr":11.31657414},{"event":"fatigue","count":147738,"llr":10.15452847},{"event":"headache","count":120638,"llr":9.123194329},{"event":"muscle contracture","count":589,"llr":8.226554394},{"event":"injection site thrombosis","count":109,"llr":8.010538814},{"event":"extremity contracture","count":172,"llr":7.106029727},{"event":"administration site ulcer","count":4,"llr":6.609884653},{"event":"pain","count":94786,"llr":6.319174989},{"event":"neonatal asphyxia","count":270,"llr":6.216283621},{"event":"arthralgia","count":75397,"llr":6.19326499},{"event":"injection site ulcer","count":335,"llr":5.792898031}],"critval":5.760471604},"child_chembl_ids":["CHEMBL3989509","CHEMBL3989510"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000147955","approved_name":"sigma non-opioid intracellular receptor 1","approved_symbol":"SIGMAR1"}],"target_type":"single protein","target_name":"Sigma opioid receptor","action_type":"modulator","description":"Sigma opioid receptor modulator","references":[{"source":"DailyMed","ids":["setid=3107d8eb-ebe8-4114-9db0-2d278612f186#nlm34090-1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3107d8eb-ebe8-4114-9db0-2d278612f186#nlm34090-1"]},{"source":"PubMed","ids":["19587856"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19587856"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":2},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL441","_score":1,"_source":{"id":"CHEMBL441","internal_compound":false,"type":"Small molecule","pref_name":"THIOPENTAL","year_first_approved":1982,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Thiomebumal Sodium","Thiopental","Thiopental Sodium","Thiopental ciii","Thiopental sodium"],"trade_names":["Intraval","Intraval Sod","Penthiobarbital","Pentothal","Thiomebumal","Thionembutal","Thiopentone","Trapanal"],"cross_references":[{"source":"ChEBI","ids":[102166]},{"source":"PubChem","ids":["29215503"]},{"source":"drugbank","ids":["DB00599"]},{"source":"ChEBI","ids":[9561]},{"source":"PubChem","ids":["144205294","170464734","26749790"]},{"source":"Wikipedia","ids":["Sodium_thiopental"]}],"canonical_smiles":"CCCC(C)C1(CC)C(=O)NC(=S)NC1=O","indications":[{"efo_id":"EFO_0000546","efo_label":"injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000546","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00622570"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00622570%22"]}]},{"efo_id":"EFO_0006834","efo_label":"septic shock","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006834","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03104140"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03104140%22"]}]},{"efo_id":"EFO_0008526","efo_label":"status epilepticus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008526","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00265616"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00265616%22"]}]},{"efo_id":"HP_0000486","efo_label":"Strabismus","efo_uri":"http://purl.obolibrary.org/obo/HP_0000486","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00478907"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00478907%22"]}]},{"efo_id":"EFO_1001454","efo_label":"amnesia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001454","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00142493"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00142493%22"]}]}],"adverse_events":{"significant":[{"event":"mental status changes postoperative","count":65,"llr":230.8945611},{"event":"hypotension","count":55121,"llr":101.9044106},{"event":"anaesthetic complication","count":778,"llr":64.48841184},{"event":"status epilepticus","count":3754,"llr":57.76214643},{"event":"premature baby","count":8946,"llr":52.09364461},{"event":"laryngospasm","count":1171,"llr":44.41700665},{"event":"diabetes insipidus","count":747,"llr":40.63756947},{"event":"cardiac arrest","count":9359,"llr":36.51251419},{"event":"anaphylactic reaction","count":16695,"llr":35.101608},{"event":"lung infiltration","count":3570,"llr":33.58743315},{"event":"bronchospasm","count":4962,"llr":32.2482122},{"event":"periventricular haemorrhage neonatal","count":4,"llr":31.58716376},{"event":"foetal malpresentation","count":34,"llr":29.90805723},{"event":"caesarean section","count":5212,"llr":28.50967743},{"event":"neonatal respiratory depression","count":141,"llr":28.46853156},{"event":"circulatory collapse","count":4559,"llr":27.20107909},{"event":"hyperthermia malignant","count":513,"llr":25.30562448},{"event":"premature rupture of membranes","count":1019,"llr":24.56461703},{"event":"pco2 increased","count":286,"llr":24.24483267},{"event":"oxygen saturation decreased","count":10498,"llr":24.14957714},{"event":"therapeutic agent toxicity","count":1191,"llr":23.34012001},{"event":"renal ischaemia","count":145,"llr":22.67129464},{"event":"oxygen saturation abnormal","count":401,"llr":22.23263379},{"event":"brain oedema","count":2176,"llr":22.01465979},{"event":"po2 increased","count":186,"llr":21.43180886},{"event":"tachycardia","count":26994,"llr":21.2030879},{"event":"uterine inversion","count":8,"llr":20.74570981},{"event":"blood pressure decreased","count":13298,"llr":20.74082701},{"event":"torsade de pointes","count":3618,"llr":20.60086131},{"event":"encephalopathy","count":8151,"llr":20.12964521},{"event":"foetal death","count":1161,"llr":19.67614756},{"event":"bradycardia","count":20091,"llr":18.73705356},{"event":"left ventricular dysfunction","count":2183,"llr":18.62712483},{"event":"premature labour","count":2380,"llr":17.96258803},{"event":"procedural complication","count":2098,"llr":15.66128566},{"event":"cyanosis","count":4608,"llr":15.59057276},{"event":"blood ph decreased","count":625,"llr":15.43152253},{"event":"hypocoagulable state","count":289,"llr":14.50548855},{"event":"blood bicarbonate decreased","count":787,"llr":14.30118601},{"event":"congenital bladder anomaly","count":71,"llr":14.20459978},{"event":"nausea","count":165652,"llr":14.05869959},{"event":"labile blood pressure","count":333,"llr":13.94462413},{"event":"pulmonary oedema","count":9905,"llr":13.43900921},{"event":"premature delivery","count":4411,"llr":13.30158239},{"event":"renal impairment","count":20843,"llr":12.84667026},{"event":"hypotonia","count":3254,"llr":12.74577925},{"event":"pulse absent","count":1181,"llr":12.32536626},{"event":"heart rate increased","count":16145,"llr":12.31896901},{"event":"premature recovery from anaesthesia","count":13,"llr":12.04767435},{"event":"erythema","count":35163,"llr":12.0455226},{"event":"electromechanical dissociation","count":157,"llr":11.83564871},{"event":"electroencephalogram abnormal","count":1335,"llr":11.73347827},{"event":"apgar score low","count":615,"llr":11.52915341},{"event":"toxic epidermal necrolysis","count":4052,"llr":11.3187666},{"event":"cyanosis neonatal","count":220,"llr":10.83210881},{"event":"agitation postoperative","count":25,"llr":10.74146358},{"event":"decerebration","count":29,"llr":10.44517096},{"event":"hysterectomy","count":1755,"llr":10.42296048},{"event":"peritoneal dialysis","count":288,"llr":10.03339844},{"event":"blood magnesium decreased","count":1961,"llr":9.896074859},{"event":"acidosis","count":2021,"llr":9.753553501},{"event":"activated partial thromboplastin time prolonged","count":2063,"llr":9.656427267},{"event":"vascular compression","count":59,"llr":9.028793164},{"event":"coma","count":13175,"llr":8.967600896},{"event":"ventricular tachycardia","count":5901,"llr":8.938332437},{"event":"urinoma","count":62,"llr":8.930009827},{"event":"pancreatic steatosis","count":66,"llr":8.805516507},{"event":"fatigue","count":147738,"llr":8.518412735},{"event":"akinesia","count":510,"llr":8.349372872},{"event":"cerebral atrophy","count":1406,"llr":8.329487662},{"event":"hypoxia","count":9218,"llr":8.056588449},{"event":"dystonia","count":4697,"llr":8.052127095},{"event":"malaise","count":82447,"llr":8.00117971},{"event":"multi-organ failure","count":1564,"llr":7.925043954},{"event":"uterine atony","count":103,"llr":7.920431439},{"event":"anorectal disorder","count":592,"llr":7.913286776},{"event":"anaesthetic complication foetal","count":1,"llr":7.893936384},{"event":"vater syndrome","count":1,"llr":7.893936384},{"event":"intra-uterine death","count":618,"llr":7.787893095},{"event":"refusal of treatment by relative","count":111,"llr":7.771923814},{"event":"unwanted awareness during anaesthesia","count":114,"llr":7.71899787},{"event":"petechiae","count":3194,"llr":7.62485744},{"event":"retained placenta or membranes","count":123,"llr":7.568257711},{"event":"pain","count":94786,"llr":7.391080071},{"event":"nuclear magnetic resonance imaging brain abnormal","count":730,"llr":7.303525144},{"event":"blood calcium decreased","count":3465,"llr":7.254569984},{"event":"maternal drugs affecting foetus","count":3468,"llr":7.250651415},{"event":"respiratory disorder","count":5504,"llr":7.210559983},{"event":"muscle rigidity","count":3651,"llr":7.01845909},{"event":"carotid pulse increased","count":3,"llr":6.79559831},{"event":"traumatic amputation","count":3,"llr":6.79559831},{"event":"vomiting","count":103943,"llr":6.721141209},{"event":"anaesthetic complication neurological","count":189,"llr":6.718164615},{"event":"anaesthetic complication vascular","count":4,"llr":6.508053344},{"event":"foetal heart rate deceleration abnormality","count":217,"llr":6.445695837}],"critval":6.404527273},"child_chembl_ids":["CHEMBL738"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000022355","approved_name":"gamma-aminobutyric acid type A receptor subunit alpha1","approved_symbol":"GABRA1"},{"ensembl":"ENSG00000145864","approved_name":"gamma-aminobutyric acid type A receptor subunit beta2","approved_symbol":"GABRB2"},{"ensembl":"ENSG00000113327","approved_name":"gamma-aminobutyric acid type A receptor subunit gamma2","approved_symbol":"GABRG2"},{"ensembl":"ENSG00000166206","approved_name":"gamma-aminobutyric acid type A receptor subunit beta3","approved_symbol":"GABRB3"},{"ensembl":"ENSG00000109158","approved_name":"gamma-aminobutyric acid type A receptor subunit alpha4","approved_symbol":"GABRA4"},{"ensembl":"ENSG00000182256","approved_name":"gamma-aminobutyric acid type A receptor subunit gamma3","approved_symbol":"GABRG3"},{"ensembl":"ENSG00000268089","approved_name":"gamma-aminobutyric acid type A receptor subunit theta","approved_symbol":"GABRQ"},{"ensembl":"ENSG00000011677","approved_name":"gamma-aminobutyric acid type A receptor subunit alpha3","approved_symbol":"GABRA3"},{"ensembl":"ENSG00000094755","approved_name":"gamma-aminobutyric acid type A receptor subunit pi","approved_symbol":"GABRP"},{"ensembl":"ENSG00000187730","approved_name":"gamma-aminobutyric acid type A receptor subunit delta","approved_symbol":"GABRD"},{"ensembl":"ENSG00000163285","approved_name":"gamma-aminobutyric acid type A receptor subunit gamma1","approved_symbol":"GABRG1"},{"ensembl":"ENSG00000163288","approved_name":"gamma-aminobutyric acid type A receptor subunit beta1","approved_symbol":"GABRB1"},{"ensembl":"ENSG00000102287","approved_name":"gamma-aminobutyric acid type A receptor subunit epsilon","approved_symbol":"GABRE"},{"ensembl":"ENSG00000151834","approved_name":"gamma-aminobutyric acid type A receptor subunit alpha2","approved_symbol":"GABRA2"},{"ensembl":"ENSG00000186297","approved_name":"gamma-aminobutyric acid type A receptor subunit alpha5","approved_symbol":"GABRA5"},{"ensembl":"ENSG00000145863","approved_name":"gamma-aminobutyric acid type A receptor subunit alpha6","approved_symbol":"GABRA6"}],"target_type":"protein complex group","target_name":"GABA-A receptor; anion channel","action_type":"positive allosteric modulator","description":"GABA-A receptor; anion channel positive allosteric modulator","references":[{"source":"ISBN","ids":["0721603246 PP. 113"],"urls":[]},{"source":"PubMed","ids":["11264449"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11264449"]}]}],"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":2},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":2},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL23330","_score":1,"_source":{"id":"CHEMBL23330","internal_compound":false,"type":"Small molecule","pref_name":"TRETAZICAR","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["CB-1954","NSC-115829","Tretazicar"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["11110923","17404763","411933","46500339","50105941","50105942","85230965","90341816"]},{"source":"drugbank","ids":["DB04253"]}],"canonical_smiles":"NC(=O)c1cc(N2CC2)c([N+](=O)[O-])cc1[N+](=O)[O-]","indications":[{"efo_id":"EFO_0000182","efo_label":"hepatocellular carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000182","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00746590"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00746590%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1172928","_score":1,"_source":{"id":"CHEMBL1172928","internal_compound":false,"type":"Small molecule","pref_name":"RADAFAXINE","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["GW353162A","Radafaxine","Radafaxine HCl"],"trade_names":[],"cross_references":[{"source":"Wikipedia","ids":["Radafaxine"]},{"source":"drugbank","ids":["DB11790"]}],"canonical_smiles":"C[C@@H]1NC(C)(C)CO[C@@]1(O)c1cccc(Cl)c1","indications":[{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00057213","NCT00057226","NCT00057239"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00057213%22OR%22NCT00057226%22OR%22NCT00057239%22"]}]}],"child_chembl_ids":["CHEMBL2107365"],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL18901","_score":1,"_source":{"id":"CHEMBL18901","internal_compound":false,"type":"Small molecule","pref_name":"EFAPROXIRAL","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Efaproxiral","Efaproxiral Sodium","RSR-13","RSR13","RSR13 Sodium"],"trade_names":[],"cross_references":[{"source":"Wikipedia","ids":["Efaproxiral"]},{"source":"drugbank","ids":["DB08486"]}],"canonical_smiles":"Cc1cc(C)cc(NC(=O)Cc2ccc(OC(C)(C)C(=O)O)cc2)c1","indications":[{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00083304"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00083304%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00005887"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00005887%22"]}]},{"efo_id":"EFO_0000326","efo_label":"central nervous system cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000326","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00005855"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00005855%22"]}]},{"efo_id":"EFO_0001071","efo_label":"lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001071","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00004202","NCT00055887"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004202%22OR%22NCT00055887%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000244734","approved_name":"hemoglobin subunit beta","approved_symbol":"HBB"}],"target_type":"protein complex","target_name":"Hemoglobin HbA","action_type":"negative modulator","description":"Hemoglobin HbA negative modulator","references":[{"source":"PubMed","ids":["11316875","8770102"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11316875+OR+EXT_ID%3A8770102"]}]}],"child_chembl_ids":["CHEMBL2107744"],"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":4},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":2},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297205","_score":1,"_source":{"id":"CHEMBL4297205","internal_compound":false,"type":"Small molecule","pref_name":"PADOPORFIN","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Padoporfin","WST-09","WST09","Wst09"],"trade_names":[],"indications":[{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00308919"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00308919%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3039113","_score":1,"_source":{"id":"CHEMBL3039113","internal_compound":false,"type":"Small molecule","pref_name":"THEANINE","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["L-theanine","NSC-21308","Theanine"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[17394]},{"source":"drugbank","ids":["DB12444"]}],"canonical_smiles":"CCNC(=O)CC[C@H](N)C(=O)O","indications":[{"efo_id":"EFO_0000692","efo_label":"schizophrenia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000692","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00372151"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00372151%22"]}]},{"efo_id":"EFO_0003888","efo_label":"attention deficit hyperactivity disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003888","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00291070","NCT03533556"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00291070%22OR%22NCT03533556%22"]}]}],"adverse_events":{"significant":[{"event":"blood thyroid stimulating hormone increased","count":1855,"llr":6.248599763},{"event":"dry eye","count":6029,"llr":5.070992412}],"critval":4.495386387},"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":2},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":2}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL203125","_score":1,"_source":{"id":"CHEMBL203125","internal_compound":false,"type":"Small molecule","pref_name":"FOSMIDOMYCIN","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Fosmidomycin","Fosmidomycin Sodium"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[443725]},{"source":"PubChem","ids":["174006643"]},{"source":"Wikipedia","ids":["Fosmidomycin"]},{"source":"drugbank","ids":["DB02948"]}],"canonical_smiles":"O=CN(O)CCCP(=O)(O)O","indications":[{"efo_id":"EFO_0001068","efo_label":"malaria","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001068","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00214643","NCT00217451","NCT01002183","NCT01361269","NCT01464125","NCT01464138"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00214643%22OR%22NCT00217451%22OR%22NCT01002183%22OR%22NCT01361269%22OR%22NCT01464125%22OR%22NCT01464138%22"]}]},{"efo_id":"EFO_0007444","efo_label":"Plasmodium falciparum malaria","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007444","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02198807"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02198807%22"]}]}],"child_chembl_ids":["CHEMBL2164257"],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL292707","_score":1,"_source":{"id":"CHEMBL292707","internal_compound":false,"type":"Small molecule","pref_name":"IBUPROXAM","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Ibuproxam"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[76160]},{"source":"drugbank","ids":["DB08955"]}],"canonical_smiles":"CC(C)Cc1ccc(C(C)C(=O)NO)cc1","indications":[{"efo_id":"EFO_0005755","efo_label":"rheumatic disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005755","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["M01AE13"],"urls":["https://www.whocc.no/atc_ddd_index/?code=M01AE13"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1200453","_score":1,"_source":{"id":"CHEMBL1200453","internal_compound":false,"type":"Small molecule","pref_name":"DOCOSANOL","year_first_approved":2000,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Behenyl Alcohol","Docosanol","Lidakol","N-Docosanol","NSC-8407"],"trade_names":["Abreva"],"cross_references":[{"source":"ChEBI","ids":[31000]},{"source":"DailyMed","ids":["docosanol"]},{"source":"PubChem","ids":["174006877","29215293"]},{"source":"Wikipedia","ids":["Docosanol"]},{"source":"drugbank","ids":["DB00632"]}],"canonical_smiles":"CCCCCCCCCCCCCCCCCCCCCCO","indications":[{"efo_id":"EFO_0000763","efo_label":"viral disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000763","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["D06BB11"],"urls":["https://www.whocc.no/atc_ddd_index/?code=D06BB11"]}]}],"mechanisms_of_action":[{"target_type":"protein family","target_name":"Envelope glycoprotein","action_type":"inhibitor","description":"Envelope glycoprotein inhibitor","references":[{"source":"Other","ids":["http://libsta28.lib.cam.ac.uk:2113/protocol/10.1385/0-89603-347-3:9/fulltext.html"],"urls":["http://libsta28.lib.cam.ac.uk:2113/protocol/10.1385/0-89603-347-3:9/fulltext.html"]},{"source":"PubMed","ids":["15571473","20210688","9864049"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15571473+OR+EXT_ID%3A20210688+OR+EXT_ID%3A9864049"]},{"source":"Wikipedia","ids":["Docosanol#Mechanism_and_history_of_antiviral_drug_usage"],"urls":["https://www.wikipedia.org/Docosanol#Mechanism_and_history_of_antiviral_drug_usage"]}]}],"adverse_events":{"significant":[{"event":"oral herpes","count":3043,"llr":62.38006591},{"event":"sjogren's syndrome","count":1287,"llr":44.69272887},{"event":"appetite disorder","count":997,"llr":39.84822489},{"event":"haemorrhagic diathesis","count":963,"llr":33.34796212},{"event":"dysphoria","count":2634,"llr":33.06047516},{"event":"skin warm","count":1057,"llr":32.78990243},{"event":"arthritis infective","count":1081,"llr":32.65538543},{"event":"tenderness","count":2901,"llr":32.38670123},{"event":"thinking abnormal","count":3137,"llr":31.84106819},{"event":"ear pain","count":3480,"llr":31.11739514},{"event":"sneezing","count":3545,"llr":30.98836283},{"event":"photophobia","count":3837,"llr":30.43657985},{"event":"oral pain","count":4982,"llr":28.61755957},{"event":"rhinorrhoea","count":11157,"llr":27.48943331},{"event":"skin disorder","count":5986,"llr":27.34027793},{"event":"hypoaesthesia","count":31062,"llr":26.79208151},{"event":"anaphylactic reaction","count":16695,"llr":24.30711093},{"event":"wheezing","count":9665,"llr":24.01549181},{"event":"osteoarthritis","count":9922,"llr":23.83380283},{"event":"dry skin","count":10734,"llr":23.28953732},{"event":"neck pain","count":10926,"llr":23.16694},{"event":"blister","count":11140,"llr":23.03283951},{"event":"interstitial lung disease","count":12888,"llr":22.02627056},{"event":"erythema","count":35163,"llr":21.9613112},{"event":"dysphagia","count":22741,"llr":21.88056803},{"event":"intestinal obstruction","count":7554,"llr":21.042605},{"event":"oedema","count":15307,"llr":20.84116123},{"event":"hallucination","count":16074,"llr":20.5049339},{"event":"visual impairment","count":16617,"llr":20.27663576},{"event":"wound","count":3694,"llr":20.10552907},{"event":"contusion","count":18117,"llr":19.68344759},{"event":"musculoskeletal stiffness","count":18205,"llr":19.6502201},{"event":"drug intolerance","count":21687,"llr":18.45247386},{"event":"condition aggravated","count":52909,"llr":18.41512243},{"event":"joint swelling","count":23084,"llr":18.02647508},{"event":"rheumatoid arthritis","count":23147,"llr":18.0078926},{"event":"abdominal discomfort","count":25125,"llr":17.44947078},{"event":"chills","count":26715,"llr":17.03245594},{"event":"gait disturbance","count":34050,"llr":15.39203819},{"event":"pruritus","count":57095,"llr":14.7786099},{"event":"constipation","count":39620,"llr":14.37548861},{"event":"myalgia","count":42953,"llr":13.83642833},{"event":"back pain","count":46032,"llr":13.37617579},{"event":"weight decreased","count":46078,"llr":13.36954823},{"event":"drug hypersensitivity","count":71246,"llr":13.11602189},{"event":"loss of consciousness","count":30434,"llr":12.86750701},{"event":"abdominal pain","count":57904,"llr":11.8641396},{"event":"pain","count":94786,"llr":11.01403567},{"event":"rash","count":97330,"llr":10.82187558},{"event":"asthenia","count":74334,"llr":10.24639815},{"event":"arthralgia","count":75397,"llr":10.15548278},{"event":"dyspnoea","count":124409,"llr":9.068923612},{"event":"facial palsy","count":1124,"llr":8.500572453},{"event":"dizziness","count":99375,"llr":8.414425202},{"event":"vomiting","count":103943,"llr":8.136523615},{"event":"cheilitis","count":1482,"llr":7.950842077},{"event":"herpes simplex","count":1665,"llr":7.719647094},{"event":"headache","count":120638,"llr":7.228350031},{"event":"diarrhoea","count":126514,"llr":6.94291792},{"event":"application site injury","count":39,"llr":6.899573797},{"event":"application site erythema","count":2671,"llr":6.783574487}],"critval":6.100773261},"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4298052","_score":1,"_source":{"id":"CHEMBL4298052","internal_compound":false,"type":"Small molecule","pref_name":"DEMPLATIN PEGRAGLUMER","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Demplatin pegraglumer","NC-6004","NC-6004 NANOPLATIN","Nc-6004"],"trade_names":[],"indications":[{"efo_id":"EFO_0000181","efo_label":"head and neck squamous cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000181","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03771820"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03771820%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02240238"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02240238%22"]}]},{"efo_id":"EFO_0000707","efo_label":"squamous cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000707","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03109158"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03109158%22"]}]},{"efo_id":"EFO_0003860","efo_label":"pancreatic neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003860","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02043288"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02043288%22"]}]},{"efo_id":"EFO_0004284","efo_label":"upper aerodigestive tract neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004284","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02817113"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02817113%22"]}]}],"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":5},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":2},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109408","_score":1,"_source":{"id":"CHEMBL2109408","internal_compound":false,"type":"Antibody","pref_name":"LAMPALIZUMAB","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AFD","Anti-Factor-D","Anti-fD","FCFD-4514S","FCFD4514S","Lampalizumab","RG-7417"],"trade_names":[],"indications":[{"efo_id":"EFO_0001365","efo_label":"age-related macular degeneration","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001365","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00973011","NCT01229215","NCT01602120","NCT02247479","NCT02247531","NCT02288559","NCT02745119"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00973011%22OR%22NCT01229215%22OR%22NCT01602120%22OR%22NCT02247479%22OR%22NCT02247531%22OR%22NCT02288559%22OR%22NCT02745119%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000197766","approved_name":"complement factor D","approved_symbol":"CFD"}],"target_type":"single protein","target_name":"Complement factor D","action_type":"inhibitor","description":"Complement factor D inhibitor","references":[{"source":"PubMed","ids":["26535160","28491291"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26535160+OR+EXT_ID%3A28491291"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1289601","_score":1,"_source":{"id":"CHEMBL1289601","internal_compound":false,"type":"Small molecule","pref_name":"LENVATINIB","year_first_approved":2015,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["E-7080","E-7080 MESYLATE","E7080","E7080 MESYLATE","ER-203492-00","Lenvatinib","Lenvatinib Mesylate","Lenvatinib mesilate","Lenvatinib methanesulfonate"],"trade_names":["Kisplyx","Lenvima"],"cross_references":[{"source":"ChEBI","ids":[85994]},{"source":"DailyMed","ids":["lenvatinib%20mesylate"]},{"source":"PubChem","ids":["137276042"]},{"source":"Wikipedia","ids":["Lenvatinib"]},{"source":"drugbank","ids":["DB09078"]},{"source":"ChEBI","ids":[85995]}],"canonical_smiles":"COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O","indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["L01XE29"],"urls":["https://www.whocc.no/atc_ddd_index/?code=L01XE29"]},{"source":"ClinicalTrials","ids":["NCT01433991","NCT02501096","NCT02686164","NCT03006887","NCT03009292","NCT03245151"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01433991%22OR%22NCT02501096%22OR%22NCT02686164%22OR%22NCT03006887%22OR%22NCT03009292%22OR%22NCT03245151%22"]}]},{"efo_id":"EFO_0002892","efo_label":"thyroid carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002892","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT01321554","NCT02702388","NCT02726503","NCT02966093","NCT03139747"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01321554%22OR%22NCT02702388%22OR%22NCT02726503%22OR%22NCT02966093%22OR%22NCT03139747%22"]},{"source":"DailyMed","ids":["f4bedd21-efde-44c6-9d9c-b48b78d7ed1e"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f4bedd21-efde-44c6-9d9c-b48b78d7ed1e"]}]},{"efo_id":"EFO_0001421","efo_label":"liver disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001421","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02421042"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02421042%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01529112","NCT03516981","NCT03829319","NCT03829332","NCT03976375"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01529112%22OR%22NCT03516981%22OR%22NCT03829319%22OR%22NCT03829332%22OR%22NCT03976375%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00121719","NCT01525394","NCT02578316"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00121719%22OR%22NCT01525394%22OR%22NCT02578316%22"]}]},{"efo_id":"EFO_0003891","efo_label":"biliary tract neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003891","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02579616"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02579616%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT02640508","NCT02846766"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02640508%22OR%22NCT02846766%22"]}]},{"efo_id":"EFO_0000326","efo_label":"central nervous system cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000326","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01137604"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01137604%22"]}]},{"efo_id":"EFO_0000231","efo_label":"adenoid cystic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000231","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02780310"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02780310%22"]}]},{"efo_id":"EFO_0000681","efo_label":"renal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000681","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01136733","NCT02454478","NCT02811861","NCT03173560","NCT03324373"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01136733%22OR%22NCT02454478%22OR%22NCT02811861%22OR%22NCT03173560%22OR%22NCT03324373%22"]}]},{"efo_id":"EFO_0000182","efo_label":"hepatocellular carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000182","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00946153","NCT01761266","NCT02953743","NCT03006926","NCT03418922","NCT03433703","NCT03713593","NCT03744247","NCT03746249","NCT03775395","NCT03775707","NCT03791918","NCT03803254","NCT03841201","NCT03899428","NCT03905967","NCT03919383","NCT04008797","NCT04039607","NCT04042805","NCT04044313","NCT04044651","NCT04053972","NCT04053985"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00946153%22OR%22NCT01761266%22OR%22NCT02953743%22OR%22NCT03006926%22OR%22NCT03418922%22OR%22NCT03433703%22OR%22NCT03713593%22OR%22NCT03744247%22OR%22NCT03746249%22OR%22NCT03775395%22OR%22NCT03775707%22OR%22NCT03791918%22OR%22NCT03803254%22OR%22NCT03841201%22OR%22NCT03899428%22OR%22NCT03905967%22OR%22NCT03919383%22OR%22NCT04008797%22OR%22NCT04039607%22OR%22NCT04042805%22OR%22NCT04044313%22OR%22NCT04044651%22OR%22NCT04053972%22OR%22NCT04053985%22"]}]},{"efo_id":"EFO_0000756","efo_label":"melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000756","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01133977","NCT01136967","NCT03776136","NCT03820986"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01133977%22OR%22NCT01136967%22OR%22NCT03776136%22OR%22NCT03820986%22"]}]},{"efo_id":"EFO_0004230","efo_label":"endometrial neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004230","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01111461","NCT03005015","NCT03517449","NCT03884101"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01111461%22OR%22NCT03005015%22OR%22NCT03517449%22OR%22NCT03884101%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02562118","NCT03168074"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02562118%22OR%22NCT03168074%22"]}]},{"efo_id":"EFO_0000349","efo_label":"clear cell renal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000349","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02915783"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02915783%22"]}]},{"efo_id":"EFO_0000501","efo_label":"follicular thyroid carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000501","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02973997","NCT03506048","NCT03630120"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02973997%22OR%22NCT03506048%22OR%22NCT03630120%22"]}]},{"efo_id":"EFO_0000641","efo_label":"papillary thyroid carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000641","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT02973997","NCT03506048","NCT03630120"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02973997%22OR%22NCT03506048%22OR%22NCT03630120%22"]}]},{"efo_id":"EFO_0002916","efo_label":"esophageal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002916","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03321630"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03321630%22"]}]},{"efo_id":"EFO_0003826","efo_label":"salivary gland neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003826","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02860936"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02860936%22"]}]},{"efo_id":"EFO_1000657","efo_label":"rectum cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000657","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02935309"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02935309%22"]}]},{"efo_id":"EFO_0000178","efo_label":"gastric carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000178","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03609359"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03609359%22"]}]},{"efo_id":"EFO_0000571","efo_label":"lung adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000571","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01877083"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01877083%22"]}]},{"efo_id":"EFO_0001075","efo_label":"ovarian carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001075","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01133756"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01133756%22"]}]},{"efo_id":"EFO_0008528","efo_label":"urothelial carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008528","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03898180"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03898180%22"]}]},{"efo_id":"EFO_1001961","efo_label":"intrahepatic cholangiocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001961","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03779100","NCT03801499"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03779100%22OR%22NCT03801499%22"]}]},{"efo_id":"EFO_0002617","efo_label":"metastatic melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002617","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00121680"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00121680%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00280397","NCT01268293"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00280397%22OR%22NCT01268293%22"]}]},{"efo_id":"EFO_0002892","efo_label":"thyroid carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002892","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT01728623"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01728623%22"]},{"source":"FDA","ids":["label/2015/206947s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F206947s000lbl.pdf"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00832819"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00832819%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03477175"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03477175%22"]}]}],"adverse_events":{"significant":[{"event":"decreased appetite","count":40807,"llr":668.7639559},{"event":"hypertension","count":52519,"llr":605.5642195},{"event":"hepatic encephalopathy","count":2810,"llr":564.1296675},{"event":"proteinuria","count":6145,"llr":443.2780446},{"event":"palmar-plantar erythrodysaesthesia syndrome","count":7553,"llr":368.9030357},{"event":"diarrhoea","count":126514,"llr":324.0978195},{"event":"blood pressure increased","count":25616,"llr":146.5113168},{"event":"fatigue","count":147738,"llr":136.3917707},{"event":"tumour haemorrhage","count":710,"llr":127.4043961},{"event":"hypothyroidism","count":7054,"llr":126.6698647},{"event":"stomatitis","count":13596,"llr":122.8776763},{"event":"cholecystitis","count":3428,"llr":117.2572236},{"event":"ascites","count":7879,"llr":95.36045792},{"event":"platelet count decreased","count":29394,"llr":93.9545049},{"event":"malignant neoplasm progression","count":14458,"llr":93.90748144},{"event":"ammonia increased","count":1465,"llr":85.14918417},{"event":"dysphonia","count":9978,"llr":80.59596386},{"event":"dehydration","count":36809,"llr":74.79309974},{"event":"renal cancer","count":1530,"llr":64.77885876},{"event":"oral pain","count":4982,"llr":60.40772211},{"event":"weight decreased","count":46078,"llr":59.92658173},{"event":"oesophageal varices haemorrhage","count":596,"llr":58.67130716},{"event":"epistaxis","count":16532,"llr":57.13153597},{"event":"blood thyroid stimulating hormone increased","count":1855,"llr":56.28415315},{"event":"drug hypersensitivity","count":71246,"llr":54.37056275},{"event":"pneumothorax","count":3795,"llr":49.87185194},{"event":"malaise","count":82447,"llr":48.94430928},{"event":"condition aggravated","count":52909,"llr":46.79066705},{"event":"liver carcinoma ruptured","count":38,"llr":46.06982705},{"event":"cholecystitis acute","count":1659,"llr":45.23147983}],"critval":42.10899234},"child_chembl_ids":["CHEMBL2105704","CHEMBL3527309"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000102755","approved_name":"fms related receptor tyrosine kinase 1","approved_symbol":"FLT1"},{"ensembl":"ENSG00000037280","approved_name":"fms related receptor tyrosine kinase 4","approved_symbol":"FLT4"},{"ensembl":"ENSG00000128052","approved_name":"kinase insert domain receptor","approved_symbol":"KDR"}],"target_type":"protein family","target_name":"Vascular endothelial growth factor receptor","action_type":"inhibitor","description":"Vascular endothelial growth factor receptor inhibitor","references":[{"source":"DailyMed","ids":["setid=f4bedd21-efde-44c6-9d9c-b48b78d7ed1e"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f4bedd21-efde-44c6-9d9c-b48b78d7ed1e"]}]}],"number_of_indications":30,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":29},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":11},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":8},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":5},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":5},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":3},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":3},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109680","_score":1,"_source":{"id":"CHEMBL2109680","internal_compound":false,"type":"Antibody","pref_name":"IDEC-159 90Y","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["IDEC-159","IDEC-159 (90Y)","IDEC-159 90Y"],"trade_names":[],"indications":[{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00102024"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00102024%22"]}]}],"mechanisms_of_action":[],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297606","_score":1,"_source":{"id":"CHEMBL4297606","internal_compound":false,"type":"Small molecule","pref_name":"RECOFLAVONE","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["DA 6034","DA-6034","Da-6034","Recoflavone"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12058"]}],"canonical_smiles":"COc1ccc(-c2cc(=O)c3c(OC)cc(OCC(=O)O)cc3o2)cc1OC","indications":[{"efo_id":"EFO_0000337","efo_label":"chronic gastritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000337","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01813812"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01813812%22"]}]},{"efo_id":"EFO_1000906","efo_label":"dry eye syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000906","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01162954"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01162954%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1200854","_score":1,"_source":{"id":"CHEMBL1200854","internal_compound":false,"type":"Small molecule","pref_name":"FLUPHENAZINE DECANOATE","year_first_approved":1972,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["Fluphenazine Decanoate","NSC-169510","QD-10733","SQ-10733"],"trade_names":["Decazate","Fluphenazine Decanoate","Modecate","Modecate Conc","Prolixin Decanoate"],"cross_references":[{"source":"DailyMed","ids":["fluphenazine%20decanoate"]}],"canonical_smiles":"CCCCCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1","indications":[{"efo_id":"EFO_0000676","efo_label":"psoriasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000676","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00356200"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00356200%22"]}]},{"efo_id":"EFO_0005407","efo_label":"psychosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005407","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N05AB02"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N05AB02"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000149295","approved_name":"dopamine receptor D2","approved_symbol":"DRD2"}],"target_type":"single protein","target_name":"Dopamine D2 receptor","action_type":"antagonist","description":"Dopamine D2 receptor antagonist","references":[{"source":"PubMed","ids":["11873706","7508675","7828655"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11873706+OR+EXT_ID%3A7508675+OR+EXT_ID%3A7828655"]},{"source":"Wikipedia","ids":["Antipsychotic#Mechanism_of_action"],"urls":["https://www.wikipedia.org/Antipsychotic#Mechanism_of_action"]}]}],"adverse_events":{"significant":[{"event":"sedation","count":6964,"llr":56.14047479},{"event":"neuroleptic malignant syndrome","count":4739,"llr":48.71068962},{"event":"parkinsonism","count":3067,"llr":44.999824},{"event":"dystonia","count":4697,"llr":39.93829773},{"event":"accommodation disorder","count":324,"llr":38.02959081},{"event":"akathisia","count":3469,"llr":34.39940112},{"event":"blood prolactin increased","count":1776,"llr":30.99712993},{"event":"extrapyramidal disorder","count":5088,"llr":30.62287138},{"event":"orthostatic hypertension","count":134,"llr":29.85532043},{"event":"hypercholesterolaemia","count":2955,"llr":26.96371831},{"event":"dyskinesia","count":7974,"llr":26.22555756},{"event":"hostility","count":561,"llr":22.71060805},{"event":"anosognosia","count":145,"llr":22.66251844},{"event":"blunted affect","count":168,"llr":22.07439488},{"event":"emotional poverty","count":187,"llr":21.64647505},{"event":"blood prolactin abnormal","count":208,"llr":21.22148526},{"event":"tremor","count":36500,"llr":21.15368607},{"event":"constipation","count":39620,"llr":17.75761155},{"event":"dyslipidaemia","count":1671,"llr":17.29152789},{"event":"hallucination","count":16074,"llr":16.61076372},{"event":"flatulence","count":7191,"llr":16.56361839},{"event":"musculoskeletal stiffness","count":18205,"llr":15.56174339},{"event":"aggression","count":12814,"llr":15.55959359},{"event":"gynaecomastia","count":2425,"llr":15.4554383},{"event":"salivary hypersecretion","count":2562,"llr":15.18537174},{"event":"suicidal ideation","count":21218,"llr":14.28440723},{"event":"social avoidant behaviour","count":1250,"llr":14.08417289},{"event":"schizophrenia","count":3472,"llr":13.69699385},{"event":"non-hodgkin's lymphoma","count":1386,"llr":13.67577593},{"event":"delusion","count":4266,"llr":12.69461153},{"event":"central pontine myelinolysis","count":43,"llr":12.36021644},{"event":"hyponatraemia","count":21598,"llr":11.679788},{"event":"hyperammonaemic encephalopathy","count":664,"llr":11.57748261},{"event":"conduction disorder","count":671,"llr":11.54626618},{"event":"sexual dysfunction","count":2461,"llr":11.41647895},{"event":"camptocormia","count":76,"llr":11.22231124},{"event":"rhabdomyolysis","count":16457,"llr":11.08312988},{"event":"apathy","count":2732,"llr":11.00801558},{"event":"abnormal behaviour","count":10841,"llr":10.94848418},{"event":"tension","count":932,"llr":10.56969337},{"event":"drug interaction","count":53526,"llr":10.47472494},{"event":"muscle rigidity","count":3651,"llr":9.880033108},{"event":"urinary retention","count":9378,"llr":8.93236431},{"event":"weight increased","count":33631,"llr":8.544552192},{"event":"hyperkalaemia","count":12419,"llr":7.632989109},{"event":"wrong drug administered","count":2846,"llr":7.287568342},{"event":"blood creatine phosphokinase increased","count":14851,"llr":6.822767337},{"event":"lung disorder","count":9520,"llr":6.250272923},{"event":"cognitive disorder","count":9869,"llr":6.118387882}],"critval":6.038931225},"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297573","_score":1,"_source":{"id":"CHEMBL4297573","internal_compound":false,"type":"Unknown","pref_name":"TAGRAXOFUSP","year_first_approved":2018,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["DT-3881L3","DT388IL3","MOLECULE-129","Molecule 129","SL-401","Sl-401","Tagraxofusp","Tagraxofusp-erzs"],"trade_names":["Elzonris"],"cross_references":[{"source":"DailyMed","ids":["tagraxofusp-erzs"]}],"indications":[{"efo_id":"EFO_0000198","efo_label":"myelodysplastic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000198","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03113643"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03113643%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT02270463","NCT03113643"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02270463%22OR%22NCT03113643%22"]},{"source":"FDA","ids":["label/2018/761116s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2018%2F761116s000lbl.pdf"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000185291","approved_name":"interleukin 3 receptor subunit alpha","approved_symbol":"IL3RA"}],"target_type":"single protein","target_name":"Interleukin-3 receptor subunit alpha","action_type":"binding agent","description":"Interleukin-3 receptor subunit alpha binding agent","references":[{"source":"FDA","ids":["label/2018/761116s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2018%2F761116s000lbl.pdf"]},{"source":"PubMed","ids":["30621282"],"urls":["https://europepmc.org/search?query=EXT_ID%3A30621282"]}]},{"target_components":[{"ensembl":"ENSG00000167658","approved_name":"eukaryotic translation elongation factor 2","approved_symbol":"EEF2"}],"target_type":"single protein","target_name":"Elongation factor 2","action_type":"inhibitor","description":"Elongation factor 2 inhibitor","references":[{"source":"FDA","ids":["label/2018/761116s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2018%2F761116s000lbl.pdf"]},{"source":"PubMed","ids":["30621282"],"urls":["https://europepmc.org/search?query=EXT_ID%3A30621282"]}]}],"adverse_events":{"significant":[{"event":"capillary leak syndrome","count":550,"llr":26.40488688},{"event":"blood albumin decreased","count":2695,"llr":14.0705853}],"critval":11.42906304},"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297268","_score":1,"_source":{"id":"CHEMBL4297268","internal_compound":false,"type":"Small molecule","pref_name":"BMS-275183","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Bms-275183"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12144"]}],"canonical_smiles":"COC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](OC(C)=O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C","indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00207025"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00207025%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00099879"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00099879%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3301570","_score":1,"_source":{"id":"CHEMBL3301570","internal_compound":false,"type":"Unknown","pref_name":"NECUPARANIB","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["M-402 FREE ACID","Necuparanib"],"trade_names":[],"indications":[{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01621243"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01621243%22"]}]}],"adverse_events":{"significant":[{"event":"administration site cellulitis","count":6,"llr":9.347996548}],"critval":8.503150364},"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL206815","_score":1,"_source":{"id":"CHEMBL206815","internal_compound":false,"type":"Small molecule","pref_name":"APRATASTAT","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Apratastat","TMI-005","TMI-05"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB13020"]}],"canonical_smiles":"CC1(C)SCCN(S(=O)(=O)c2ccc(OCC#CCO)cc2)[C@H]1C(=O)NO","indications":[{"efo_id":"EFO_0000685","efo_label":"rheumatoid arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000685","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00095342"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00095342%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL189676","_score":1,"_source":{"id":"CHEMBL189676","internal_compound":false,"type":"Small molecule","pref_name":"SURINABANT","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["SR-147778","Surinabant"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["144210559"]},{"source":"Wikipedia","ids":["Surinabant"]},{"source":"drugbank","ids":["DB13070"]}],"canonical_smiles":"CCc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Br)cc1","indications":[{"efo_id":"EFO_0004319","efo_label":"smoking cessation","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004319","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00432575"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00432575%22"]}]},{"efo_id":"EFO_0001073","efo_label":"obesity","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001073","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00239174"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00239174%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000118432","approved_name":"cannabinoid receptor 1","approved_symbol":"CNR1"}],"target_type":"single protein","target_name":"Cannabinoid CB1 receptor","action_type":"antagonist","description":"Cannabinoid CB1 receptor antagonist","references":[{"source":"PubMed","ids":["15131245"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15131245"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3707257","_score":1,"_source":{"id":"CHEMBL3707257","internal_compound":false,"type":"Small molecule","pref_name":"TENITRAMINE","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Tenitramine"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB13637"]}],"canonical_smiles":"O=[N+]([O-])OCCN(CCO[N+](=O)[O-])CCN(CCO[N+](=O)[O-])CCO[N+](=O)[O-]","indications":[{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["C01DA38"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C01DA38"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2219776","_score":1,"_source":{"id":"CHEMBL2219776","internal_compound":false,"type":"Oligonucleotide","pref_name":"CENERSEN SODIUM","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Cenersen Sodium","EL-625","OL(1)P53"],"trade_names":[],"indications":[{"efo_id":"EFO_0000095","efo_label":"chronic lymphocytic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000095","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00636155"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00636155%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL562967","_score":1,"_source":{"id":"CHEMBL562967","internal_compound":false,"type":"Small molecule","pref_name":"MERICITABINE","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["3',5'-DIISOBUTYRYL PSI 6130","Mericitabine","PSI 6130 DIISOBUTYRATE","R 7128","R-7128","R7128","RG 7128","RO-5024048","RO5024048"],"trade_names":["RO5024048; R7128"],"cross_references":[{"source":"drugbank","ids":["DB12045"]}],"canonical_smiles":"CC(C)C(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@](C)(F)[C@@H]1OC(=O)C(C)C","indications":[{"efo_id":"EFO_0003047","efo_label":"hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003047","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00382798","NCT01482390"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00382798%22OR%22NCT01482390%22"]}]},{"efo_id":"EFO_0004220","efo_label":"chronic hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004220","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00377182","NCT00801255","NCT00869661","NCT01057667","NCT01278134","NCT01331850","NCT01482403","NCT01483742","NCT01579019","NCT01628094"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00377182%22OR%22NCT00801255%22OR%22NCT00869661%22OR%22NCT01057667%22OR%22NCT01278134%22OR%22NCT01331850%22OR%22NCT01482403%22OR%22NCT01483742%22OR%22NCT01579019%22OR%22NCT01628094%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL169","_score":1,"_source":{"id":"CHEMBL169","internal_compound":false,"type":"Small molecule","pref_name":"URSOLIC ACID","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["NSC-167406","NSC-4060","Ursolic Acid Glutaryl Hemi Ester","Ursolic Acid Hydrogen Malonate","Ursolic acid"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[9908]},{"source":"PubChem","ids":["124882839","26725260","26754242","56463656"]},{"source":"Wikipedia","ids":["Ursolic_acid"]},{"source":"drugbank","ids":["DB15588"]}],"canonical_smiles":"C[C@@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@]2(C(=O)O)CC[C@H]1C","indications":[{"efo_id":"EFO_0000195","efo_label":"metabolic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000195","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02337933"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02337933%22"]}]},{"efo_id":"EFO_0004268","efo_label":"sclerosing cholangitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004268","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03216876"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03216876%22"]}]}],"child_chembl_ids":["CHEMBL1783810","CHEMBL1783814","CHEMBL520029"],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297669","_score":1,"_source":{"id":"CHEMBL4297669","internal_compound":false,"type":"Small molecule","pref_name":"PHOSPHATIDYL SERINE","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Phosphatidyl serine","Phosphatidylserine"],"trade_names":[],"canonical_smiles":"CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCCCCCCCCCCCCCCCC","indications":[{"efo_id":"Orphanet_1764","efo_label":"Familial dysautonomia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_1764","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02276716"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02276716%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1652","_score":1,"_source":{"id":"CHEMBL1652","internal_compound":false,"type":"Small molecule","pref_name":"AMBENONIUM","year_first_approved":1956,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Ambenonium","Ambenonium Chloride"],"trade_names":["Mytelase"],"cross_references":[{"source":"ChEBI","ids":[2627]},{"source":"PubChem","ids":["11113478","26756578"]},{"source":"Wikipedia","ids":["Ambenonium_chloride"]},{"source":"drugbank","ids":["DB01122"]},{"source":"ChEBI","ids":[2628]},{"source":"PubChem","ids":["144205583","170465386"]}],"canonical_smiles":"CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc1ccccc1Cl","adverse_events":{"significant":[{"event":"cholinergic syndrome","count":233,"llr":48.68632117},{"event":"myasthenia gravis crisis","count":121,"llr":20.1420206},{"event":"creatinine renal clearance abnormal","count":195,"llr":11.64031109},{"event":"miosis","count":2714,"llr":10.83857747},{"event":"myasthenia gravis neonatal","count":2,"llr":9.694186777},{"event":"diarrhoea","count":126514,"llr":7.640599177}],"critval":7.527205552},"child_chembl_ids":["CHEMBL1200541"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000087085","approved_name":"acetylcholinesterase (Cartwright blood group)","approved_symbol":"ACHE"}],"target_type":"single protein","target_name":"Acetylcholinesterase","action_type":"inhibitor","description":"Acetylcholinesterase inhibitor","references":[{"source":"FDA","ids":["label/2014/010155s024lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2014%2F010155s024lbl.pdf"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4296717","_score":1,"_source":{"id":"CHEMBL4296717","internal_compound":false,"type":"Small molecule","pref_name":"RESMINOSTAT","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["4SC-201","4sc-201","BYK-408740","BYK408740","RAS-2410","RAS2410","Resminostat"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12392"]}],"canonical_smiles":"CN(C)Cc1ccc(S(=O)(=O)n2ccc(/C=C/C(=O)NO)c2)cc1","indications":[{"efo_id":"EFO_0000182","efo_label":"hepatocellular carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000182","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00943449","NCT02400788"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00943449%22OR%22NCT02400788%22"]}]},{"efo_id":"EFO_1000785","efo_label":"Sezary's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000785","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02953301"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02953301%22"]}]},{"efo_id":"EFO_1001051","efo_label":"mycosis fungoides","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001051","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02953301"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02953301%22"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL46102","_score":1,"_source":{"id":"CHEMBL46102","internal_compound":false,"type":"Small molecule","pref_name":"ROXATIDINE ACETATE","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["HOE-760","Roxatidine","Roxatidine Acetate","Roxatidine Acetate HCl"],"trade_names":[],"cross_references":[{"source":"Wikipedia","ids":["Roxatidine"]},{"source":"drugbank","ids":["DB08806"]},{"source":"PubChem","ids":["144206053","144206507","170465941","49681593"]}],"canonical_smiles":"CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1","indications":[{"efo_id":"EFO_0003948","efo_label":"gastroesophageal reflux disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003948","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["A02BA06"],"urls":["https://www.whocc.no/atc_ddd_index/?code=A02BA06"]}]},{"efo_id":"HP_0004398","efo_label":"Peptic ulcer","efo_uri":"http://purl.obolibrary.org/obo/HP_0004398","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["A02BA06"],"urls":["https://www.whocc.no/atc_ddd_index/?code=A02BA06"]}]}],"adverse_events":{"significant":[{"event":"heparin-induced thrombocytopenia","count":1115,"llr":31.17239813},{"event":"disseminated intravascular coagulation","count":3330,"llr":25.70758559},{"event":"snoring","count":765,"llr":11.15282476}],"critval":10.7738416},"child_chembl_ids":["CHEMBL2104871"],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1743044","_score":1,"_source":{"id":"CHEMBL1743044","internal_compound":false,"type":"Antibody","pref_name":"NAMILUMAB","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["MT-203","MT203","Namilumab"],"trade_names":[],"indications":[{"efo_id":"EFO_0000676","efo_label":"psoriasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000676","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02129777"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02129777%22"]}]},{"efo_id":"EFO_0000685","efo_label":"rheumatoid arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000685","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01317797","NCT02379091","NCT02393378"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01317797%22OR%22NCT02379091%22OR%22NCT02393378%22"]}]},{"efo_id":"EFO_0003898","efo_label":"ankylosing spondylitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003898","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03622658"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03622658%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000164400","approved_name":"colony stimulating factor 2","approved_symbol":"CSF2"}],"target_type":"single protein","target_name":"Granulocyte-macrophage colony-stimulating factor","action_type":"inhibitor","description":"Granulocyte-macrophage colony-stimulating factor inhibitor","references":[{"source":"PubMed","ids":["26633290"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26633290"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":3},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":2},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL77101","_score":1,"_source":{"id":"CHEMBL77101","internal_compound":false,"type":"Small molecule","pref_name":"DIETHYLHOMOSPERMINE","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Diethylhomospermine"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB13011"]}],"canonical_smiles":"CCNCCCCNCCCCNCCCCNCC","indications":[{"efo_id":"HP_0002014","efo_label":"Diarrhea","efo_uri":"http://purl.obolibrary.org/obo/HP_0002014","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00002121"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002121%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108887","_score":1,"_source":{"id":"CHEMBL2108887","internal_compound":false,"type":"Antibody","pref_name":"AFELIMOMAB","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Afelimomab","LU-54107","MAK-195F"],"trade_names":["Segard"],"indications":[{"efo_id":"EFO_0000540","efo_label":"immune system disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000540","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["L04AB03"],"urls":["https://www.whocc.no/atc_ddd_index/?code=L04AB03"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000232810","approved_name":"tumor necrosis factor","approved_symbol":"TNF"}],"target_type":"single protein","target_name":"TNF-alpha","action_type":"inhibitor","description":"TNF-alpha inhibitor","references":[{"source":"PubMed","ids":["11373466"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11373466"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL496","_score":1,"_source":{"id":"CHEMBL496","internal_compound":false,"type":"Small molecule","pref_name":"HEXACHLOROPHENE","year_first_approved":1949,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Hexachlorophene"],"trade_names":["\"germa-medica \"\"mg\"\"\"","E-Z Scrub","Gamophen","Germa-Medica","Germa-Medica \"Mg\"","Hexa-Germ","Hexascrub","Phiso-Scrub","Phisohex","Pre-Op","Pre-Op ii","Scrubteam Surgical Spongebrush","Septi-Soft","Septisol","Soy-Dome","Turgex"],"cross_references":[{"source":"ChEBI","ids":[5693]},{"source":"DailyMed","ids":["hexachlorophene"]},{"source":"PubChem","ids":["144204650","144208548","144213058","170464690","17389858","26747319","26747320","26752933","50105541","56422370","56436644","8139957","99234229"]},{"source":"Wikipedia","ids":["Hexachlorophene"]},{"source":"drugbank","ids":["DB00756"]}],"canonical_smiles":"Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl","mechanisms_of_action":[{"target_type":"single protein","target_name":"Bacterial enoyl-[acyl-carrier-protein] reductase","action_type":"inhibitor","description":"Bacterial enoyl-[acyl-carrier-protein] reductase inhibitor","references":[{"source":"PubMed","ids":["10671494"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10671494"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1762","_score":1,"_source":{"id":"CHEMBL1762","internal_compound":false,"type":"Small molecule","pref_name":"TOCAINIDE","year_first_approved":1984,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["Tocainide","Tocainide HCl","W-36095"],"trade_names":["Tonocard","Xylotocan"],"cross_references":[{"source":"ChEBI","ids":[9611]},{"source":"PubChem","ids":["90341559"]},{"source":"Wikipedia","ids":["Tocainide"]},{"source":"drugbank","ids":["DB01056"]},{"source":"PubChem","ids":["144204283","170465114"]}],"canonical_smiles":"Cc1cccc(C)c1NC(=O)C(C)N","indications":[{"efo_id":"EFO_0004269","efo_label":"cardiac arrhythmia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004269","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["C01BB03"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C01BB03"]}]}],"child_chembl_ids":["CHEMBL1200773"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000144285","approved_name":"sodium voltage-gated channel alpha subunit 1","approved_symbol":"SCN1A"},{"ensembl":"ENSG00000183873","approved_name":"sodium voltage-gated channel alpha subunit 5","approved_symbol":"SCN5A"},{"ensembl":"ENSG00000007314","approved_name":"sodium voltage-gated channel alpha subunit 4","approved_symbol":"SCN4A"},{"ensembl":"ENSG00000136546","approved_name":"sodium voltage-gated channel alpha subunit 7","approved_symbol":"SCN7A"},{"ensembl":"ENSG00000136531","approved_name":"sodium voltage-gated channel alpha subunit 2","approved_symbol":"SCN2A"},{"ensembl":"ENSG00000169432","approved_name":"sodium voltage-gated channel alpha subunit 9","approved_symbol":"SCN9A"},{"ensembl":"ENSG00000153253","approved_name":"sodium voltage-gated channel alpha subunit 3","approved_symbol":"SCN3A"},{"ensembl":"ENSG00000168356","approved_name":"sodium voltage-gated channel alpha subunit 11","approved_symbol":"SCN11A"},{"ensembl":"ENSG00000196876","approved_name":"sodium voltage-gated channel alpha subunit 8","approved_symbol":"SCN8A"},{"ensembl":"ENSG00000185313","approved_name":"sodium voltage-gated channel alpha subunit 10","approved_symbol":"SCN10A"}],"target_type":"protein family","target_name":"Sodium channel alpha subunit","action_type":"blocker","description":"Sodium channel alpha subunit blocker","references":[{"source":"ISBN","ids":["9780702034718 PP. 521, 255"],"urls":[]},{"source":"Wikipedia","ids":["Antiarrhythmic_agent","Sodium_channel","Tocainide"],"urls":["https://www.wikipedia.org/Antiarrhythmic_agent","https://www.wikipedia.org/Sodium_channel","https://www.wikipedia.org/Tocainide"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109357","_score":1,"_source":{"id":"CHEMBL2109357","internal_compound":false,"type":"Antibody","pref_name":"AVE-1642","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AVE-1642"],"trade_names":[],"indications":[{"efo_id":"EFO_0000313","efo_label":"carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000313","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00791544"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00791544%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01233895"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01233895%22"]}]},{"efo_id":"EFO_0003869","efo_label":"breast neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003869","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00774878"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00774878%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000140443","approved_name":"insulin like growth factor 1 receptor","approved_symbol":"IGF1R"}],"target_type":"single protein","target_name":"Insulin-like growth factor I receptor","action_type":"antagonist","description":"Insulin-like growth factor I receptor antagonist","references":[{"source":"PubMed","ids":["19165200","21875414"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19165200+OR+EXT_ID%3A21875414"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2105765","_score":1,"_source":{"id":"CHEMBL2105765","internal_compound":false,"type":"Small molecule","pref_name":"LIPEGFILGRASTIM","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Lipegfilgrastim","XM-22","XM22"],"trade_names":["Lonquex"],"cross_references":[{"source":"DrugCentral","ids":["4991"]}],"canonical_smiles":"COCCOC(=O)NCC(=O)N[C@@H]1[C@@H](O)C[C@](OC[C@H]2O[C@H](O[C@H](C)[C@H](N)C(=O)O)[C@H](NC(C)=O)[C@@H](O)[C@H]2O)(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CO","indications":[{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02044276"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02044276%22"]}]},{"efo_id":"EFO_0000174","efo_label":"Ewing sarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000174","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01585649"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01585649%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000119535","approved_name":"colony stimulating factor 3 receptor","approved_symbol":"CSF3R"}],"target_type":"single protein","target_name":"Granulocyte colony stimulating factor receptor","action_type":"agonist","description":"Granulocyte colony stimulating factor receptor agonist","references":[{"source":"PubMed","ids":["26858523"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26858523"]}]}],"adverse_events":{"significant":[{"event":"febrile neutropenia","count":19204,"llr":93.11130694},{"event":"neutropenia","count":41585,"llr":79.12427159},{"event":"testicular germ cell cancer metastatic","count":15,"llr":75.27290971},{"event":"lymphopenia","count":5118,"llr":67.40737675},{"event":"seminoma","count":97,"llr":58.47708797},{"event":"thrombocytopenia","count":35327,"llr":48.74047373},{"event":"post-traumatic pain","count":104,"llr":43.20111325},{"event":"leukopenia","count":17226,"llr":40.54540527},{"event":"platelet count increased","count":3955,"llr":37.20712727},{"event":"anal fissure","count":797,"llr":28.98109517},{"event":"vascular device infection","count":347,"llr":28.87303801},{"event":"large intestinal obstruction","count":416,"llr":27.78840063},{"event":"neutrophil count decreased","count":11062,"llr":25.21737157},{"event":"ileus","count":4225,"llr":24.71830154},{"event":"polyneuropathy","count":3403,"llr":22.72320174},{"event":"skin candida","count":165,"llr":20.57691052},{"event":"hypokinesia","count":2834,"llr":20.20455391},{"event":"anaemia","count":61405,"llr":13.23825064},{"event":"haematoma","count":8376,"llr":12.90088902},{"event":"platelet count decreased","count":29394,"llr":12.34659282},{"event":"bone pain","count":13854,"llr":12.02154633},{"event":"jejunal stenosis","count":48,"llr":11.35989404},{"event":"odynophagia","count":1729,"llr":11.26023739},{"event":"hot flush","count":10860,"llr":11.20945377},{"event":"alopecia","count":25428,"llr":9.635623353},{"event":"lymphocyte count decreased","count":5692,"llr":9.426917664},{"event":"leukocytosis","count":6078,"llr":9.118699122},{"event":"pneumonitis","count":6754,"llr":8.626173697},{"event":"epistaxis","count":16532,"llr":8.557305616},{"event":"general physical health deterioration","count":17224,"llr":8.305593406},{"event":"atrial fibrillation","count":25339,"llr":7.775135977},{"event":"hypomagnesaemia","count":4347,"llr":7.707690049}],"critval":7.053895962},"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297829","_score":1,"_source":{"id":"CHEMBL4297829","internal_compound":false,"type":"Antibody","pref_name":"SINTILIMAB","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["ANTI-PD-1 MONOCLONAL ANTIBODY IBI308","IBI-308","IBI308","Ibi308","Sintilimab"],"trade_names":[],"indications":[{"efo_id":"EFO_0000178","efo_label":"gastric carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000178","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03745170","NCT04065282","NCT04089657"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03745170%22OR%22NCT04065282%22OR%22NCT04089657%22"]}]},{"efo_id":"EFO_0000182","efo_label":"hepatocellular carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000182","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03794440","NCT04042805","NCT04104074"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03794440%22OR%22NCT04042805%22OR%22NCT04104074%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02937116","NCT03568539","NCT03732430"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02937116%22OR%22NCT03568539%22OR%22NCT03732430%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03936452"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03936452%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03545971","NCT03758001"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03545971%22OR%22NCT03758001%22"]}]},{"efo_id":"EFO_0000702","efo_label":"small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000702","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT04055792","NCT04056949"],"urls":["https://clinicaltrials.gov/search?id=%22NCT04055792%22OR%22NCT04056949%22"]}]},{"efo_id":"EFO_0000708","efo_label":"squamous cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000708","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03150875"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03150875%22"]}]},{"efo_id":"EFO_0001071","efo_label":"lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001071","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03607539"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03607539%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03629925","NCT03765775","NCT03802240","NCT03812549","NCT03830411","NCT03863483","NCT03874000","NCT03987867","NCT04106180"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03629925%22OR%22NCT03765775%22OR%22NCT03802240%22OR%22NCT03812549%22OR%22NCT03830411%22OR%22NCT03863483%22OR%22NCT03874000%22OR%22NCT03987867%22OR%22NCT04106180%22"]}]},{"efo_id":"EFO_0004252","efo_label":"nasopharyngeal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004252","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03619824","NCT03700476","NCT04072107"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03619824%22OR%22NCT03700476%22OR%22NCT04072107%22"]}]},{"efo_id":"EFO_0005922","efo_label":"esophageal squamous cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005922","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03748134","NCT03940001","NCT03946969"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03748134%22OR%22NCT03940001%22OR%22NCT03946969%22"]}]}],"number_of_indications":11,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":11},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":6},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":4},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545268","_score":1,"_source":{"id":"CHEMBL3545268","internal_compound":false,"type":"Small molecule","pref_name":"MLN3126","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["MLN-3126"],"trade_names":[],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000173585","approved_name":"C-C motif chemokine receptor 9","approved_symbol":"CCR9"}],"target_type":"single protein","target_name":"C-C chemokine receptor type 9","action_type":"antagonist","description":"C-C chemokine receptor type 9 antagonist","references":[{"source":"Other","ids":["https://www.takeda.com/research/files/pipeline_20150205_en.pdf"],"urls":["https://www.takeda.com/research/files/pipeline_20150205_en.pdf"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL615","_score":1,"_source":{"id":"CHEMBL615","internal_compound":false,"type":"Small molecule","pref_name":"PENICILLIN V","year_first_approved":1958,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Benzathine phenoxymethylpenicillin","Bicillin V2","Penapar-VK","Penicillin Benzathine Phenoxymethyl","Penicillin Phenoxymethyl","Penicillin Potassium Phenoxymethyl","Penicillin V","Penicillin V Benzathine","Penicillin V Potassium","Penicillin-VK","Phenomycilline","Phenoxymethylpenicillin","Phenoxymethylpenicillin Potassium","Veetids"],"trade_names":["Beepen VK","Beepen-Vk","Betapen-Vk","Ledercillin Vk","Pen-Vee K","Penapar-Vk","Penicillin V Potassium","Penicillin Vk","Penicillin-Vk","Pfizerpen Vk","Phenoxymethylpenicillin K","Uticillin Vk","V-Cillin","V-Cillin K","V-Cillin-K","Veetids","Veetids '125'","Veetids '250'","Veetids '500'"],"cross_references":[{"source":"ChEBI","ids":[27446]},{"source":"DailyMed","ids":["penicillin%20v%20potassium"]},{"source":"PubChem","ids":["29215255"]},{"source":"Wikipedia","ids":["Phenoxymethylpenicillin"]},{"source":"drugbank","ids":["DB00417"]},{"source":"ChEBI","ids":[7967]},{"source":"PubChem","ids":["144209374","144213231","26757422"]},{"source":"ChEBI","ids":[31973]},{"source":"DrugCentral","ids":["4440"]},{"source":"PubChem","ids":["11112967"]}],"canonical_smiles":"CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O","indications":[{"efo_id":"EFO_0003102","efo_label":"osteomyelitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003102","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT02099240"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02099240%22"]}]},{"efo_id":"EFO_0003106","efo_label":"pneumonia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003106","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03208361"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03208361%22"]}]}],"mechanisms_of_action":[{"target_type":"protein family","target_name":"Bacterial penicillin-binding protein","action_type":"inhibitor","description":"Bacterial penicillin-binding protein inhibitor","references":[{"source":"DailyMed","ids":["setid=2bfee83c-4f38-440e-9061-58036490d009"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2bfee83c-4f38-440e-9061-58036490d009"]},{"source":"Wikipedia","ids":["Penicillin_binding_proteins#Function"],"urls":["https://www.wikipedia.org/Penicillin_binding_proteins#Function"]}]}],"adverse_events":{"significant":[{"event":"drug hypersensitivity","count":71246,"llr":382.7383542},{"event":"rash","count":97330,"llr":118.9187},{"event":"myocardial depression","count":113,"llr":99.08132987},{"event":"swelling face","count":15924,"llr":88.62867107},{"event":"decorticate posture","count":55,"llr":83.58727709},{"event":"lip swelling","count":7601,"llr":79.75928294},{"event":"rash generalised","count":11944,"llr":60.98704902},{"event":"hypersensitivity","count":35921,"llr":52.75934997},{"event":"ventricular hypokinesia","count":1161,"llr":45.11676469},{"event":"hypothermia","count":3713,"llr":40.12066755},{"event":"swelling","count":18005,"llr":34.67195138},{"event":"respiratory depression","count":3384,"llr":32.55784816},{"event":"swollen tongue","count":8894,"llr":31.57925603},{"event":"liver injury","count":4415,"llr":31.30473948},{"event":"pharyngeal oedema","count":5370,"llr":30.82355303},{"event":"acute respiratory distress syndrome","count":3118,"llr":30.76257358},{"event":"vomiting projectile","count":500,"llr":29.97917516},{"event":"eye swelling","count":6631,"llr":29.79231225},{"event":"plagiocephaly","count":170,"llr":29.04981203},{"event":"encephalopathy","count":8151,"llr":28.54449506},{"event":"toxic epidermal necrolysis","count":4052,"llr":27.05404359},{"event":"clostridium difficile infection","count":4220,"llr":26.48456812},{"event":"urticaria","count":39524,"llr":24.53782306},{"event":"lactose intolerance","count":502,"llr":21.54965},{"event":"rash macular","count":5296,"llr":20.88944365},{"event":"coma scale abnormal","count":1223,"llr":18.73215779},{"event":"monocytosis","count":214,"llr":17.93345112},{"event":"hepatitis e","count":502,"llr":17.56025815},{"event":"dandy-walker syndrome","count":82,"llr":17.26767423},{"event":"stevens-johnson syndrome","count":7437,"llr":16.64547243},{"event":"rash pruritic","count":11632,"llr":16.54764615},{"event":"drug reaction with eosinophilia and systemic symptoms","count":9050,"llr":16.18828586},{"event":"abnormal faeces","count":1115,"llr":16.11029599},{"event":"neurodevelopmental disorder","count":126,"llr":15.55998685},{"event":"unresponsive to stimuli","count":6342,"llr":14.31127576},{"event":"epigastric discomfort","count":890,"llr":14.21749087},{"event":"psychomotor hyperactivity","count":4158,"llr":14.04700889},{"event":"blister","count":11140,"llr":13.56868017},{"event":"fall","count":67604,"llr":12.63693229},{"event":"skin swelling","count":660,"llr":12.40909805},{"event":"livedo reticularis","count":702,"llr":12.11070388},{"event":"skin exfoliation","count":9496,"llr":11.92752657},{"event":"congenital central nervous system anomaly","count":330,"llr":11.75772054},{"event":"wheezing","count":9665,"llr":11.73847617},{"event":"beta haemolytic streptococcal infection","count":333,"llr":11.72224146}],"critval":11.6757828},"child_chembl_ids":["CHEMBL1200852","CHEMBL1396177","CHEMBL2103963"],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL574738","_score":1,"_source":{"id":"CHEMBL574738","internal_compound":false,"type":"Small molecule","pref_name":"AST-487","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AST-487","NVP-AST487"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["103905682","50100088"]}],"canonical_smiles":"CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1","mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000122025","approved_name":"fms related receptor tyrosine kinase 3","approved_symbol":"FLT3"}],"target_type":"single protein","target_name":"Tyrosine-protein kinase receptor FLT3","action_type":"inhibitor","description":"Tyrosine-protein kinase receptor FLT3 inhibitor","references":[{"source":"PubMed","ids":["18820131"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18820131"]}]},{"target_components":[{"ensembl":"ENSG00000165731","approved_name":"ret proto-oncogene","approved_symbol":"RET"}],"target_type":"single protein","target_name":"Tyrosine-protein kinase receptor RET","action_type":"inhibitor","description":"Tyrosine-protein kinase receptor RET inhibitor","references":[{"source":"PubMed","ids":["17638907"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17638907"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1743035","_score":1,"_source":{"id":"CHEMBL1743035","internal_compound":false,"type":"Antibody","pref_name":"LEBRIKIZUMAB","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Lebrikizumab","MILR1444A","PRO-301444","PRO-301444 RG-3637","RG-3637"],"trade_names":[],"indications":[{"efo_id":"EFO_0000270","efo_label":"asthma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000270","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00781443","NCT00930163","NCT00971035","NCT01545440","NCT01545453","NCT01867125","NCT01868061","NCT01875003","NCT01987492","NCT02099656","NCT02104674","NCT02546869"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00781443%22OR%22NCT00930163%22OR%22NCT00971035%22OR%22NCT01545440%22OR%22NCT01545453%22OR%22NCT01867125%22OR%22NCT01868061%22OR%22NCT01875003%22OR%22NCT01987492%22OR%22NCT02099656%22OR%22NCT02104674%22OR%22NCT02546869%22"]}]},{"efo_id":"EFO_0000274","efo_label":"atopic eczema","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000274","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02340234","NCT02465606","NCT03443024"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02340234%22OR%22NCT02465606%22OR%22NCT03443024%22"]}]},{"efo_id":"EFO_0000341","efo_label":"chronic obstructive pulmonary disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000341","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02546700"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02546700%22"]}]},{"efo_id":"EFO_0000768","efo_label":"idiopathic pulmonary fibrosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000768","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01872689"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01872689%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000169194","approved_name":"interleukin 13","approved_symbol":"IL13"}],"target_type":"single protein","target_name":"Interleukin-13","action_type":"inhibitor","description":"Interleukin-13 inhibitor","references":[{"source":"PubMed","ids":["23357170"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23357170"]}]}],"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":3},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108878","_score":1,"_source":{"id":"CHEMBL2108878","internal_compound":false,"type":"Unknown","pref_name":"THYROID","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["Dried Thyroid","NSC-26492","Thyroid","Thyroid gland preparations"],"trade_names":["Nature"],"indications":[{"efo_id":"EFO_0001064","efo_label":"Down syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001064","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01576705"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01576705%22"]}]},{"efo_id":"EFO_0001360","efo_label":"type II diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001360","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01557504"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01557504%22"]}]},{"efo_id":"EFO_0002892","efo_label":"thyroid carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002892","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00435851"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00435851%22"]}]},{"efo_id":"EFO_0003144","efo_label":"heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003144","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02656329"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02656329%22"]}]}],"adverse_events":{"significant":[{"event":"butterfly rash","count":257,"llr":14.21846045},{"event":"periorbital oedema","count":1853,"llr":10.27081918},{"event":"head discomfort","count":2326,"llr":9.817117841}],"critval":9.549154004},"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL403989","_score":1,"_source":{"id":"CHEMBL403989","internal_compound":false,"type":"Small molecule","pref_name":"TG100-801","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["TG100-801"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB05075"]}],"canonical_smiles":"Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12","indications":[{"efo_id":"EFO_0003770","efo_label":"diabetic retinopathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003770","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00414999"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00414999%22"]}]},{"efo_id":"EFO_0009606","efo_label":"macular degeneration","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009606","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00414999","NCT00509548"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00414999%22OR%22NCT00509548%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000010810","approved_name":"FYN proto-oncogene, Src family tyrosine kinase","approved_symbol":"FYN"},{"ensembl":"ENSG00000197122","approved_name":"SRC proto-oncogene, non-receptor tyrosine kinase","approved_symbol":"SRC"},{"ensembl":"ENSG00000182866","approved_name":"LCK proto-oncogene, Src family tyrosine kinase","approved_symbol":"LCK"},{"ensembl":"ENSG00000176105","approved_name":"YES proto-oncogene 1, Src family tyrosine kinase","approved_symbol":"YES1"},{"ensembl":"ENSG00000136573","approved_name":"BLK proto-oncogene, Src family tyrosine kinase","approved_symbol":"BLK"},{"ensembl":"ENSG00000101336","approved_name":"HCK proto-oncogene, Src family tyrosine kinase","approved_symbol":"HCK"},{"ensembl":"ENSG00000254087","approved_name":"LYN proto-oncogene, Src family tyrosine kinase","approved_symbol":"LYN"},{"ensembl":"ENSG00000111816","approved_name":"fyn related Src family tyrosine kinase","approved_symbol":"FRK"},{"ensembl":"ENSG00000000938","approved_name":"FGR proto-oncogene, Src family tyrosine kinase","approved_symbol":"FGR"},{"ensembl":"ENSG00000125508","approved_name":"src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites","approved_symbol":"SRMS"}],"target_type":"protein family","target_name":"SRC","action_type":"inhibitor","description":"SRC inhibitor","references":[{"source":"PubMed","ids":["18311895","18330892","18483622"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18311895+OR+EXT_ID%3A18330892+OR+EXT_ID%3A18483622"]}]},{"target_components":[{"ensembl":"ENSG00000196411","approved_name":"EPH receptor B4","approved_symbol":"EPHB4"}],"target_type":"single protein","target_name":"Ephrin type-B receptor 4","action_type":"inhibitor","description":"Ephrin type-B receptor 4 inhibitor","references":[{"source":"PubMed","ids":["18483622"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18483622"]}]},{"target_components":[{"ensembl":"ENSG00000077782","approved_name":"fibroblast growth factor receptor 1","approved_symbol":"FGFR1"}],"target_type":"single protein","target_name":"Fibroblast growth factor receptor 1","action_type":"inhibitor","description":"Fibroblast growth factor receptor 1 inhibitor","references":[{"source":"PubMed","ids":["18311895","18330892","18483622"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18311895+OR+EXT_ID%3A18330892+OR+EXT_ID%3A18483622"]}]},{"target_components":[{"ensembl":"ENSG00000066468","approved_name":"fibroblast growth factor receptor 2","approved_symbol":"FGFR2"}],"target_type":"single protein","target_name":"Fibroblast growth factor receptor 2","action_type":"inhibitor","description":"Fibroblast growth factor receptor 2 inhibitor","references":[{"source":"PubMed","ids":["18311895","18330892","18483622"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18311895+OR+EXT_ID%3A18330892+OR+EXT_ID%3A18483622"]}]},{"target_components":[{"ensembl":"ENSG00000113721","approved_name":"platelet derived growth factor receptor beta","approved_symbol":"PDGFRB"}],"target_type":"single protein","target_name":"Platelet-derived growth factor receptor beta","action_type":"inhibitor","description":"Platelet-derived growth factor receptor beta inhibitor","references":[{"source":"PubMed","ids":["18311895","18330892","18483622"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18311895+OR+EXT_ID%3A18330892+OR+EXT_ID%3A18483622"]}]},{"target_components":[{"ensembl":"ENSG00000102755","approved_name":"fms related receptor tyrosine kinase 1","approved_symbol":"FLT1"}],"target_type":"single protein","target_name":"Vascular endothelial growth factor receptor 1","action_type":"inhibitor","description":"Vascular endothelial growth factor receptor 1 inhibitor","references":[{"source":"PubMed","ids":["18311895","18330892","18483622"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18311895+OR+EXT_ID%3A18330892+OR+EXT_ID%3A18483622"]}]},{"target_components":[{"ensembl":"ENSG00000128052","approved_name":"kinase insert domain receptor","approved_symbol":"KDR"}],"target_type":"single protein","target_name":"Vascular endothelial growth factor receptor 2","action_type":"inhibitor","description":"Vascular endothelial growth factor receptor 2 inhibitor","references":[{"source":"PubMed","ids":["18311895","18330892","18483622"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18311895+OR+EXT_ID%3A18330892+OR+EXT_ID%3A18483622"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":2},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":2},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1}],"number_of_mechanisms_of_action":7}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297281","_score":1,"_source":{"id":"CHEMBL4297281","internal_compound":false,"type":"Protein","pref_name":"FOXY-5","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Foxy-5"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB13034"]}],"canonical_smiles":"CSCC[C@H](NC=O)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O","indications":[{"efo_id":"EFO_1001950","efo_label":"colon carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001950","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03883802"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03883802%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL626","_score":1,"_source":{"id":"CHEMBL626","internal_compound":false,"type":"Small molecule","pref_name":"NAFTIFINE","year_first_approved":1988,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AW-105-843","AW-105843","Naftifine","Naftifine HCl"],"trade_names":["Exoderil","Naftifine HCl","Naftin"],"cross_references":[{"source":"ChEBI","ids":[7451]},{"source":"DailyMed","ids":["naftifine%20hydrochloride"]},{"source":"Wikipedia","ids":["Naftifine"]},{"source":"ChEBI","ids":[7452]},{"source":"PubChem","ids":["144204228","170464903","56463179"]}],"canonical_smiles":"CN(C/C=C/c1ccccc1)Cc1cccc2ccccc12","indications":[{"efo_id":"EFO_0007512","efo_label":"tinea pedis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007512","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00750139","NCT00750152","NCT01580891","NCT02335255","NCT02633813","NCT02658292"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00750139%22OR%22NCT00750152%22OR%22NCT01580891%22OR%22NCT02335255%22OR%22NCT02633813%22OR%22NCT02658292%22"]}]},{"efo_id":"EFO_0007512","efo_label":"tinea pedis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007512","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00750139","NCT01289015","NCT01290341","NCT01580891","NCT01885156","NCT02132260","NCT02335255","NCT02633813"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00750139%22OR%22NCT01289015%22OR%22NCT01290341%22OR%22NCT01580891%22OR%22NCT01885156%22OR%22NCT02132260%22OR%22NCT02335255%22OR%22NCT02633813%22"]},{"source":"DailyMed","ids":["29c570d7-9483-42dd-a7a4-d466256e8259","c8c13708-b35c-40bf-a911-12e4cffef2a7","f4b6c5d8-615c-47d6-8ad9-523c7ab146af"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?29c570d7-9483-42dd-a7a4-d466256e8259","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c8c13708-b35c-40bf-a911-12e4cffef2a7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f4b6c5d8-615c-47d6-8ad9-523c7ab146af"]},{"source":"FDA","ids":["394000b0-f55b-49f7-a9cb-1c16b02a8e30","4658d068-0e0c-4358-bea0-71c7d4ed0e59","e516fb5a-5c9b-4a74-9beb-423f2b345dde"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A394000b0-f55b-49f7-a9cb-1c16b02a8e30","https://api.fda.gov/drug/label.json?search=set_id%3A4658d068-0e0c-4358-bea0-71c7d4ed0e59","https://api.fda.gov/drug/label.json?search=set_id%3Ae516fb5a-5c9b-4a74-9beb-423f2b345dde"]}]}],"adverse_events":{"significant":[{"event":"blister","count":11140,"llr":47.151749},{"event":"skin exfoliation","count":9496,"llr":32.38179071},{"event":"erythema","count":35163,"llr":14.5517554}],"critval":12.65241851},"child_chembl_ids":["CHEMBL1200493"],"mechanisms_of_action":[{"target_type":"single protein","target_name":"Squalene monooxygenase","action_type":"inhibitor","description":"Squalene monooxygenase inhibitor","references":[{"source":"DailyMed","ids":["setid=f4b6c5d8-615c-47d6-8ad9-523c7ab146af"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f4b6c5d8-615c-47d6-8ad9-523c7ab146af"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":2},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL252518","_score":1,"_source":{"id":"CHEMBL252518","internal_compound":false,"type":"Small molecule","pref_name":"ARTENIMOL","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Artemether related compound a","Artenimol","Dihydroartemisinin","GNF-PF-5634"],"trade_names":[],"canonical_smiles":"C[C@@H]1CC[C@H]2[C@@H](C)[C@@H](O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@@]23OO4","indications":[{"efo_id":"EFO_0001068","efo_label":"malaria","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001068","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00529620","NCT00852371","NCT00941785","NCT00948896","NCT01054248","NCT01165372","NCT01231880","NCT01743820","NCT01838902","NCT01845701","NCT01899820","NCT02163447","NCT02511353","NCT02605720","NCT02831023","NCT02974348","NCT03576313"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00529620%22OR%22NCT00852371%22OR%22NCT00941785%22OR%22NCT00948896%22OR%22NCT01054248%22OR%22NCT01165372%22OR%22NCT01231880%22OR%22NCT01743820%22OR%22NCT01838902%22OR%22NCT01845701%22OR%22NCT01899820%22OR%22NCT02163447%22OR%22NCT02511353%22OR%22NCT02605720%22OR%22NCT02831023%22OR%22NCT02974348%22OR%22NCT03576313%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03402464"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03402464%22"]}]},{"efo_id":"EFO_0007444","efo_label":"Plasmodium falciparum malaria","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007444","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00682578","NCT01082705","NCT02259426","NCT02614404","NCT02987270","NCT03697668","NCT04009343","NCT04049916"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00682578%22OR%22NCT01082705%22OR%22NCT02259426%22OR%22NCT02614404%22OR%22NCT02987270%22OR%22NCT03697668%22OR%22NCT04009343%22OR%22NCT04049916%22"]}]},{"efo_id":"EFO_0007445","efo_label":"Plasmodium vivax malaria","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007445","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00682578","NCT01288820","NCT01640574","NCT02184637","NCT03208907"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00682578%22OR%22NCT01288820%22OR%22NCT01640574%22OR%22NCT02184637%22OR%22NCT03208907%22"]}]}],"mechanisms_of_action":[],"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":3},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":3},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":3},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":3},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109653","_score":1,"_source":{"id":"CHEMBL2109653","internal_compound":false,"type":"Antibody","pref_name":"BERMEKIMAB","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Bermekimab","CA-18C3","CV-18C3","MABp1","RA-18C3","Ra-18c3","T2-18C3"],"trade_names":["Xilonix"],"indications":[{"efo_id":"EFO_0003894","efo_label":"acne","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003894","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01474798"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01474798%22"]}]},{"efo_id":"HP_0000999","efo_label":"Pyoderma","efo_uri":"http://purl.obolibrary.org/obo/HP_0000999","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01965613"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01965613%22"]}]},{"efo_id":"EFO_0000676","efo_label":"psoriasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000676","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01384630"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01384630%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01021072","NCT01260545"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01021072%22OR%22NCT01260545%22"]}]},{"efo_id":"EFO_0001360","efo_label":"type II diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001360","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01427699"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01427699%22"]}]},{"efo_id":"EFO_1000710","efo_label":"hidradenitis suppurativa","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000710","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02643654"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02643654%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":3,"references":[{"source":"ATC","ids":["L01XC29"],"urls":["https://www.whocc.no/atc_ddd_index/?code=L01XC29"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000115008","approved_name":"interleukin 1 alpha","approved_symbol":"IL1A"}],"target_type":"single protein","target_name":"Interleukin-1 alpha","action_type":"inhibitor","description":"Interleukin-1 alpha inhibitor","references":[{"source":"PubMed","ids":["24746841"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24746841"]}]}],"number_of_indications":7,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":3},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3990694","_score":1,"_source":{"id":"CHEMBL3990694","internal_compound":false,"type":"Small molecule","pref_name":"PIPERAZINE CITRATE","year_first_approved":1954,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"canonical_smiles":"C1CNCCN1.C1CNCCN1.C1CNCCN1.O=C(O)CC(O)(CC(=O)O)C(=O)O.O=C(O)CC(O)(CC(=O)O)C(=O)O","child_chembl_ids":["CHEMBL3989678"],"synonyms":["Piperazine citrate"],"trade_names":["Antepar","Bryrel","Multifuge","Piperazine Citrate","Vermidol"],"mechanisms_of_action":[{"target_type":"protein complex group","target_name":"Nematode GABA-A receptor","action_type":"positive modulator","description":"Nematode GABA-A receptor positive modulator","references":[{"source":"ISBN","ids":["9780702034718 PP. 670"],"urls":[]},{"source":"PubMed","ids":["12421359","13678839"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12421359+OR+EXT_ID%3A13678839"]},{"source":"Wikipedia","ids":["Anthelmintic","Piperazine"],"urls":["https://www.wikipedia.org/Anthelmintic","https://www.wikipedia.org/Piperazine"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2110627","_score":1,"_source":{"id":"CHEMBL2110627","internal_compound":false,"type":"Small molecule","pref_name":"TEMOCAPRIL","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["CS-622","Temocapril","Temocapril HCl"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB08836"]},{"source":"PubChem","ids":["144206356","170465944"]}],"canonical_smiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CS[C@H](c2cccs2)CN(CC(=O)O)C1=O","indications":[{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["C09AA14"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C09AA14"]}]}],"child_chembl_ids":["CHEMBL2104499"],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1795072","_score":1,"_source":{"id":"CHEMBL1795072","internal_compound":false,"type":"Protein","pref_name":"ZICONOTIDE ACETATE","year_first_approved":2004,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["Ziconotide Acetate"],"trade_names":["Prialt"],"cross_references":[{"source":"DailyMed","ids":["ziconotide%20acetate"]}],"indications":[{"efo_id":"HP_0001945","efo_label":"Fever","efo_uri":"http://purl.obolibrary.org/obo/HP_0001945","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N02BG08"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N02BG08"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N02BG08"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N02BG08"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000148408","approved_name":"calcium voltage-gated channel subunit alpha1 B","approved_symbol":"CACNA1B"}],"target_type":"single protein","target_name":"Voltage-gated N-type calcium channel alpha-1B subunit","action_type":"blocker","description":"Voltage-gated N-type calcium channel alpha-1B subunit blocker","references":[{"source":"FDA","ids":["label/2011/021060s006lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2011%2F021060s006lbl.pdf"]},{"source":"PubMed","ids":["19300539"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19300539"]}]}],"adverse_events":{"significant":[{"event":"hallucination, auditory","count":4322,"llr":161.6405054},{"event":"confusional state","count":40628,"llr":148.3568363},{"event":"pain","count":94786,"llr":123.3387545},{"event":"hallucination","count":16074,"llr":98.44649624},{"event":"mental status changes","count":10001,"llr":84.32192685},{"event":"psychotic disorder","count":11057,"llr":71.73792232},{"event":"urinary retention","count":9378,"llr":49.0076008},{"event":"drug withdrawal syndrome","count":13453,"llr":46.89466832},{"event":"hallucination, visual","count":5602,"llr":44.10486956},{"event":"hyperaesthesia","count":1976,"llr":39.52117317},{"event":"catheter related complication","count":489,"llr":36.05750255},{"event":"dysgeusia","count":15051,"llr":34.69687878},{"event":"burning sensation","count":12178,"llr":32.81940319},{"event":"memory impairment","count":20326,"llr":27.64819385},{"event":"aphasia","count":8046,"llr":26.61976608},{"event":"delirium","count":11053,"llr":23.62337814},{"event":"somnolence","count":38949,"llr":21.87684952},{"event":"disorientation","count":10841,"llr":21.82181899},{"event":"suicidal ideation","count":21218,"llr":21.32358314},{"event":"muscle spasticity","count":3045,"llr":21.11454752},{"event":"gait disturbance","count":34050,"llr":20.75394081},{"event":"muscle spasms","count":35356,"llr":18.46951274},{"event":"dizziness","count":99375,"llr":18.29860058},{"event":"paranoia","count":4316,"llr":17.53808848},{"event":"granuloma","count":1057,"llr":17.48193086},{"event":"aggression","count":12814,"llr":17.31220435},{"event":"sedation","count":6964,"llr":17.07430597},{"event":"narcissistic personality disorder","count":18,"llr":17.07168756},{"event":"depression","count":45027,"llr":17.04013113},{"event":"blood creatine phosphokinase increased","count":14851,"llr":16.97362527},{"event":"hypoaesthesia","count":31062,"llr":16.9290204},{"event":"mental impairment","count":4700,"llr":16.67928629},{"event":"vasoplegia syndrome","count":330,"llr":16.53155083},{"event":"agitation","count":21093,"llr":16.46487308},{"event":"insomnia","count":44658,"llr":15.97803441},{"event":"nausea","count":165652,"llr":15.72594094},{"event":"cerebrospinal fluid leakage","count":432,"llr":15.20594538},{"event":"delusion","count":4266,"llr":15.17209941},{"event":"amnesia","count":13293,"llr":14.98117785},{"event":"feeling cold","count":4597,"llr":14.49280601},{"event":"acute psychosis","count":1019,"llr":14.29903799},{"event":"disturbance in attention","count":10609,"llr":14.17507819},{"event":"anxiety","count":45966,"llr":14.15920698},{"event":"allodynia","count":226,"llr":13.83659131},{"event":"hallucinations, mixed","count":1124,"llr":13.73226114},{"event":"meningitis","count":1890,"llr":13.58553418},{"event":"mood altered","count":5179,"llr":13.42026858},{"event":"muscular weakness","count":25474,"llr":13.3933782},{"event":"mental disorder","count":6617,"llr":13.30974298},{"event":"withdrawal syndrome","count":6642,"llr":13.27339251},{"event":"balance disorder","count":15453,"llr":13.01350454},{"event":"back pain","count":46032,"llr":12.97742671},{"event":"speech disorder","count":10086,"llr":12.89860394},{"event":"tinnitus","count":8558,"llr":12.75763832},{"event":"thinking abnormal","count":3137,"llr":12.74662718},{"event":"implant site swelling","count":355,"llr":12.05692687},{"event":"paraesthesia","count":35881,"llr":11.69159115}],"critval":11.68439919},"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":2}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2106467","_score":1,"_source":{"id":"CHEMBL2106467","internal_compound":false,"type":"Small molecule","pref_name":"TYMAZOLINE","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Tymazoline"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB08803"]}],"canonical_smiles":"Cc1ccc(C(C)C)c(OCC2=NCCN2)c1","indications":[{"efo_id":"HP_0001742","efo_label":"Nasal obstruction","efo_uri":"http://purl.obolibrary.org/obo/HP_0001742","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["R01AA13"],"urls":["https://www.whocc.no/atc_ddd_index/?code=R01AA13"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545395","_score":1,"_source":{"id":"CHEMBL3545395","internal_compound":false,"type":"Small molecule","pref_name":"BI-811283","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["BI-811283"],"trade_names":[],"indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00701324"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00701324%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00632749"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00632749%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000178999","approved_name":"aurora kinase B","approved_symbol":"AURKB"}],"target_type":"single protein","target_name":"Serine/threonine-protein kinase Aurora-B","action_type":"inhibitor","description":"Serine/threonine-protein kinase Aurora-B inhibitor","references":[{"source":"Other","ids":["http://meetinglibrary.asco.org/content/47733-74"],"urls":["http://meetinglibrary.asco.org/content/47733-74"]},{"source":"PubMed","ids":["25529193"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25529193"]},{"source":"Wikipedia","ids":["BI811283"],"urls":["https://www.wikipedia.org/BI811283"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL953","_score":1,"_source":{"id":"CHEMBL953","internal_compound":false,"type":"Small molecule","pref_name":"ENTACAPONE","year_first_approved":1999,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Entacapone","OR-611"],"trade_names":["Comtan","Comtess","Entacapone"],"cross_references":[{"source":"ChEBI","ids":[4798]},{"source":"DailyMed","ids":["entacapone"]},{"source":"PubChem","ids":["144205737","170464850","26757974"]},{"source":"Wikipedia","ids":["Entacapone"]},{"source":"drugbank","ids":["DB00494"]}],"canonical_smiles":"CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1","indications":[{"efo_id":"EFO_0002508","efo_label":"Parkinson's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002508","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N04BX02"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N04BX02"]},{"source":"ClinicalTrials","ids":["NCT00099268","NCT00134966","NCT00200447","NCT00237263","NCT00360308","NCT00491998","NCT00562198","NCT01070628","NCT01227655","NCT01515891","NCT01519284","NCT01520727","NCT01520987","NCT01532115","NCT01532128","NCT01532141","NCT01533077","NCT01533116","NCT01536366","NCT01568034","NCT01568047","NCT01568073","NCT02071810","NCT02071823","NCT02092168","NCT02101190","NCT02169414","NCT02169440","NCT02169453","NCT02169466","NCT02169479","NCT02169895","NCT02170376","NCT02305017","NCT02305030","NCT02305277","NCT02305316","NCT02554734","NCT02834507","NCT03091868","NCT03094156","NCT03103399","NCT03119194","NCT03820037"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00099268%22OR%22NCT00134966%22OR%22NCT00200447%22OR%22NCT00237263%22OR%22NCT00360308%22OR%22NCT00491998%22OR%22NCT00562198%22OR%22NCT01070628%22OR%22NCT01227655%22OR%22NCT01515891%22OR%22NCT01519284%22OR%22NCT01520727%22OR%22NCT01520987%22OR%22NCT01532115%22OR%22NCT01532128%22OR%22NCT01532141%22OR%22NCT01533077%22OR%22NCT01533116%22OR%22NCT01536366%22OR%22NCT01568034%22OR%22NCT01568047%22OR%22NCT01568073%22OR%22NCT02071810%22OR%22NCT02071823%22OR%22NCT02092168%22OR%22NCT02101190%22OR%22NCT02169414%22OR%22NCT02169440%22OR%22NCT02169453%22OR%22NCT02169466%22OR%22NCT02169479%22OR%22NCT02169895%22OR%22NCT02170376%22OR%22NCT02305017%22OR%22NCT02305030%22OR%22NCT02305277%22OR%22NCT02305316%22OR%22NCT02554734%22OR%22NCT02834507%22OR%22NCT03091868%22OR%22NCT03094156%22OR%22NCT03103399%22OR%22NCT03119194%22OR%22NCT03820037%22"]},{"source":"DailyMed","ids":["3b19e8e3-336c-4aef-8721-ed121e216155","5edfc3e7-f80d-47ee-897a-c02ff4eb3e74","b1aceb59-9be8-43b8-83d6-81e05e4b51e4"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3b19e8e3-336c-4aef-8721-ed121e216155","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5edfc3e7-f80d-47ee-897a-c02ff4eb3e74","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b1aceb59-9be8-43b8-83d6-81e05e4b51e4"]},{"source":"FDA","ids":["95976f1d-1b36-4f08-a98f-36d5d7883d7b"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A95976f1d-1b36-4f08-a98f-36d5d7883d7b"]}]},{"efo_id":"EFO_0004701","efo_label":"methamphetamine dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004701","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT02058966"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02058966%22"]}]},{"efo_id":"EFO_0000474","efo_label":"epilepsy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000474","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02305329"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02305329%22"]}]},{"efo_id":"EFO_0001073","efo_label":"obesity","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001073","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02349243"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02349243%22"]}]},{"efo_id":"EFO_0002610","efo_label":"cocaine dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002610","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01437293","NCT01468012"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01437293%22OR%22NCT01468012%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000093010","approved_name":"catechol-O-methyltransferase","approved_symbol":"COMT"}],"target_type":"single protein","target_name":"Catechol O-methyltransferase","action_type":"inhibitor","description":"Catechol O-methyltransferase inhibitor","references":[{"source":"DailyMed","ids":["setid=95976f1d-1b36-4f08-a98f-36d5d7883d7b#nlm34090-1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=95976f1d-1b36-4f08-a98f-36d5d7883d7b#nlm34090-1"]}]}],"adverse_events":{"significant":[{"event":"parkinson's disease","count":2639,"llr":878.3300783},{"event":"dyskinesia","count":7974,"llr":499.3908012},{"event":"hallucination","count":16074,"llr":318.7054537},{"event":"dysphagia","count":22741,"llr":290.5993315},{"event":"on and off phenomenon","count":228,"llr":288.3990385},{"event":"hallucination, visual","count":5602,"llr":249.3396759},{"event":"akinesia","count":510,"llr":190.7303431},{"event":"muscle rigidity","count":3651,"llr":180.5010336},{"event":"hypersexuality","count":568,"llr":145.5830565},{"event":"dopamine dysregulation syndrome","count":182,"llr":134.0491302},{"event":"confusional state","count":40628,"llr":122.9626104},{"event":"delusion","count":4266,"llr":122.5518459},{"event":"fall","count":67604,"llr":121.6866902},{"event":"impulse-control disorder","count":530,"llr":118.6113352},{"event":"pathological gambling","count":410,"llr":96.64555869},{"event":"therapeutic response shortened","count":1275,"llr":95.71282561},{"event":"delirium","count":11053,"llr":92.04384851},{"event":"neuroleptic malignant syndrome","count":4739,"llr":89.38175636},{"event":"freezing phenomenon","count":222,"llr":85.04604759},{"event":"compulsive shopping","count":279,"llr":80.50223874},{"event":"pneumonia aspiration","count":5215,"llr":76.81011053},{"event":"wrong technique in product usage process","count":27855,"llr":76.35702925},{"event":"stereotypy","count":279,"llr":75.50397375},{"event":"jealous delusion","count":113,"llr":75.22321785},{"event":"tremor","count":36500,"llr":73.42506964},{"event":"psychotic disorder","count":11057,"llr":72.90064638},{"event":"hyperkinesia","count":313,"llr":63.73120292},{"event":"bradykinesia","count":1223,"llr":58.58012068},{"event":"orthostatic hypotension","count":6478,"llr":58.28647721},{"event":"gambling disorder","count":284,"llr":51.12860763},{"event":"ileus","count":4225,"llr":50.55890649},{"event":"sudden onset of sleep","count":419,"llr":50.04038356},{"event":"gait disturbance","count":34050,"llr":49.33908318},{"event":"parkinson's disease psychosis","count":31,"llr":48.74275478},{"event":"psychomotor hyperactivity","count":4158,"llr":48.31079393},{"event":"illusion","count":479,"llr":48.06131191},{"event":"fracture","count":4291,"llr":47.49170207},{"event":"blood creatine phosphokinase increased","count":14851,"llr":43.84008064},{"event":"soft tissue mass","count":109,"llr":42.67669949},{"event":"tricuspid valve sclerosis","count":14,"llr":41.70771175},{"event":"abnormal behaviour","count":10841,"llr":41.2768874},{"event":"depressed level of consciousness","count":10912,"llr":41.06861517},{"event":"hypokinesia","count":2834,"llr":40.85091205},{"event":"hyperthermia","count":2914,"llr":40.27619479},{"event":"aggression","count":12814,"llr":39.70552082},{"event":"movement disorder","count":4278,"llr":37.34016823},{"event":"cognitive disorder","count":9869,"llr":36.20560834},{"event":"agitation","count":21093,"llr":35.90667161},{"event":"oesophageal achalasia","count":137,"llr":35.41909884},{"event":"dystonia","count":4697,"llr":35.29501314},{"event":"camptocormia","count":76,"llr":35.23146816},{"event":"persecutory delusion","count":997,"llr":33.88511081},{"event":"psychiatric symptom","count":1814,"llr":31.61284236},{"event":"parkinsonian crisis","count":25,"llr":31.35018855},{"event":"posture abnormal","count":797,"llr":29.84789869},{"event":"product difficult to swallow","count":151,"llr":29.77469683},{"event":"mitral valve sclerosis","count":79,"llr":29.62584838},{"event":"restlessness","count":8148,"llr":29.38007521},{"event":"gastric fistula","count":88,"llr":28.87490003},{"event":"dementia","count":4361,"llr":27.44330455},{"event":"musculoskeletal stiffness","count":18205,"llr":27.0296852},{"event":"thunderclap headache","count":58,"llr":26.31646663},{"event":"choking","count":2352,"llr":25.07745096},{"event":"pleurothotonus","count":447,"llr":24.92297517},{"event":"teeth brittle","count":178,"llr":23.98651733},{"event":"drug hypersensitivity","count":71246,"llr":23.95158637},{"event":"anticholinergic syndrome","count":527,"llr":23.47915444},{"event":"blood pressure fluctuation","count":3754,"llr":23.12294314},{"event":"disorientation","count":10841,"llr":22.93794472},{"event":"headache","count":120638,"llr":22.86024036},{"event":"speech disorder","count":10086,"llr":22.81272174}],"critval":22.67567204},"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":4},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":2},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":2},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1200963","_score":1,"_source":{"id":"CHEMBL1200963","internal_compound":false,"type":"Small molecule","pref_name":"BIMATOPROST","year_first_approved":2001,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AGN-192024","Bimatoprost"],"trade_names":["Bimatoprost","Latisse","Lumigan"],"cross_references":[{"source":"ChEBI","ids":[51230]},{"source":"DailyMed","ids":["bimatoprost"]},{"source":"Wikipedia","ids":["Bimatoprost"]},{"source":"drugbank","ids":["DB00905"]}],"canonical_smiles":"CCNC(=O)CCC/C=C\\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCc1ccccc1","indications":[{"efo_id":"Orphanet_55654","efo_label":"Hypotrichosis simplex","efo_uri":"http://www.orpha.net/ORDO/Orphanet_55654","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00907426","NCT01064882","NCT01200251","NCT01391273","NCT01391286","NCT01698554","NCT01765764"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00907426%22OR%22NCT01064882%22OR%22NCT01200251%22OR%22NCT01391273%22OR%22NCT01391286%22OR%22NCT01698554%22OR%22NCT01765764%22"]},{"source":"DailyMed","ids":["34f83d9d-2c64-463e-8a90-9a460fedfead"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?34f83d9d-2c64-463e-8a90-9a460fedfead"]}]},{"efo_id":"EFO_0004190","efo_label":"open-angle glaucoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004190","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["6094c742-7cea-429d-8d21-b7cbf8bfe1bd","a5e67c75-db88-4372-bb07-c8dd15c97631","ac853f64-50bd-4bff-9cbe-aac93ef5550f"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6094c742-7cea-429d-8d21-b7cbf8bfe1bd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a5e67c75-db88-4372-bb07-c8dd15c97631","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ac853f64-50bd-4bff-9cbe-aac93ef5550f"]}]},{"efo_id":"EFO_0000516","efo_label":"glaucoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000516","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["S01EE03"],"urls":["https://www.whocc.no/atc_ddd_index/?code=S01EE03"]},{"source":"ClinicalTrials","ids":["NCT01426113","NCT02154217","NCT02390284"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01426113%22OR%22NCT02154217%22OR%22NCT02390284%22"]}]},{"efo_id":"EFO_1001069","efo_label":"ocular hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001069","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00300443","NCT00332059","NCT00332072","NCT00332540"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00300443%22OR%22NCT00332059%22OR%22NCT00332072%22OR%22NCT00332540%22"]},{"source":"DailyMed","ids":["6094c742-7cea-429d-8d21-b7cbf8bfe1bd","a5e67c75-db88-4372-bb07-c8dd15c97631","ac853f64-50bd-4bff-9cbe-aac93ef5550f"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6094c742-7cea-429d-8d21-b7cbf8bfe1bd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a5e67c75-db88-4372-bb07-c8dd15c97631","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ac853f64-50bd-4bff-9cbe-aac93ef5550f"]}]},{"efo_id":"EFO_0004191","efo_label":"androgenetic alopecia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004191","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01189279","NCT01325337","NCT01904721","NCT02676310","NCT02848300"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01189279%22OR%22NCT01325337%22OR%22NCT01904721%22OR%22NCT02676310%22OR%22NCT02848300%22"]}]},{"efo_id":"Orphanet_79364","efo_label":"Alopecia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_79364","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01325350"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01325350%22"]}]},{"efo_id":"EFO_1001466","efo_label":"Graves ophthalmopathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001466","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02155049"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02155049%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000122420","approved_name":"prostaglandin F receptor","approved_symbol":"PTGFR"}],"target_type":"single protein","target_name":"Prostanoid FP receptor","action_type":"agonist","description":"Prostanoid FP receptor agonist","references":[{"source":"KEGG","ids":["D02724"],"urls":["https://www.genome.jp/dbget-bin/www_bget?dr:D02724"]},{"source":"PubMed","ids":["11740958","12222762","14733708","19627411"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11740958+OR+EXT_ID%3A12222762+OR+EXT_ID%3A14733708+OR+EXT_ID%3A19627411"]}]}],"adverse_events":{"significant":[{"event":"ocular hyperaemia","count":6875,"llr":2111.175391},{"event":"madarosis","count":816,"llr":1694.957197},{"event":"eye irritation","count":5686,"llr":1621.119008},{"event":"erythema of eyelid","count":950,"llr":1480.894022},{"event":"eye pruritus","count":3799,"llr":1312.653287},{"event":"eyelids pruritus","count":384,"llr":929.0757211},{"event":"eyelid oedema","count":4197,"llr":583.0629061},{"event":"eye swelling","count":6631,"llr":557.4045476},{"event":"eyelid irritation","count":267,"llr":548.4393042},{"event":"intraocular pressure increased","count":2955,"llr":313.4974884},{"event":"eye pain","count":7341,"llr":278.7119203},{"event":"skin hyperpigmentation","count":1558,"llr":264.1204789},{"event":"trichorrhexis","count":341,"llr":243.2982842},{"event":"blepharal pigmentation","count":68,"llr":211.389916},{"event":"eye discharge","count":1453,"llr":198.7884323},{"event":"growth of eyelashes","count":125,"llr":194.2721797},{"event":"dry eye","count":6029,"llr":188.866882},{"event":"scleral hyperaemia","count":180,"llr":168.9059508},{"event":"lacrimation increased","count":4647,"llr":167.5802948},{"event":"eyelid pain","count":168,"llr":149.1312984},{"event":"blepharitis","count":760,"llr":120.2084608},{"event":"eyelid exfoliation","count":95,"llr":97.33125045},{"event":"foreign body sensation in eyes","count":698,"llr":94.41797794},{"event":"vision blurred","count":26101,"llr":93.85494039},{"event":"eyelash discolouration","count":37,"llr":91.18735029},{"event":"iris hyperpigmentation","count":29,"llr":88.74411898},{"event":"erythema","count":35163,"llr":88.70088673},{"event":"nausea","count":165652,"llr":76.11087843},{"event":"hypersensitivity","count":35921,"llr":73.58458242},{"event":"hair growth abnormal","count":902,"llr":71.79684877},{"event":"enophthalmos","count":64,"llr":70.38238741},{"event":"fatigue","count":147738,"llr":69.2965507},{"event":"eyelid disorder","count":451,"llr":64.90294656},{"event":"diarrhoea","count":126514,"llr":64.38459435},{"event":"abnormal sensation in eye","count":787,"llr":64.24298962},{"event":"skin irritation","count":2331,"llr":64.03993177},{"event":"eyelid margin crusting","count":265,"llr":62.32298095},{"event":"pyrexia","count":87334,"llr":61.0942611},{"event":"skin discolouration","count":8819,"llr":59.53957092},{"event":"vomiting","count":103943,"llr":56.88674879},{"event":"eyelid thickening","count":31,"llr":56.15609477},{"event":"ocular discomfort","count":963,"llr":52.71884305},{"event":"conjunctival hyperaemia","count":1201,"llr":48.04790301},{"event":"eye colour change","count":166,"llr":46.83065372},{"event":"eyelid rash","count":89,"llr":44.60089905},{"event":"hordeolum","count":592,"llr":44.49215022},{"event":"pneumonia","count":65209,"llr":43.74383481},{"event":"fat tissue decreased","count":50,"llr":39.85412177},{"event":"visual acuity reduced","count":9897,"llr":39.82333272},{"event":"eye infection","count":1876,"llr":38.76915816},{"event":"abdominal pain","count":57904,"llr":38.08306053},{"event":"dyspnoea","count":124409,"llr":36.41651992},{"event":"anaemia","count":61405,"llr":35.14349149},{"event":"drug interaction","count":53526,"llr":34.71076043},{"event":"arthralgia","count":75397,"llr":34.30770458},{"event":"lid sulcus deepened","count":55,"llr":33.72820782},{"event":"pain","count":94786,"llr":33.61151964},{"event":"eye inflammation","count":1429,"llr":32.91311017},{"event":"dark circles under eyes","count":187,"llr":32.25089543},{"event":"swelling of eyelid","count":217,"llr":30.78678147},{"event":"blepharopachynsis","count":6,"llr":29.78302302},{"event":"periorbital fat atrophy","count":6,"llr":29.78302302},{"event":"eyelid skin dryness","count":49,"llr":29.38560944},{"event":"neutropenia","count":41585,"llr":28.73197605},{"event":"trichiasis","count":56,"llr":28.45644208},{"event":"iris disorder","count":300,"llr":27.61370432},{"event":"pain in extremity","count":62441,"llr":27.32591222},{"event":"application site discolouration","count":456,"llr":26.91921592},{"event":"corneal oedema","count":836,"llr":26.34477984},{"event":"visual impairment","count":16617,"llr":26.04801639},{"event":"malaise","count":82447,"llr":25.99680413},{"event":"eyelash changes","count":15,"llr":25.20871276},{"event":"oedema peripheral","count":40474,"llr":24.77146088}],"critval":24.59709776},"number_of_indications":7,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":4},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":3},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":3},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":2},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL376756","_score":1,"_source":{"id":"CHEMBL376756","internal_compound":false,"type":"Protein","pref_name":"KISSPEPTIN-10","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Kisspeptin-10"],"trade_names":[],"canonical_smiles":"CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O","indications":[{"efo_id":"EFO_0000545","efo_label":"infertility","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000545","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03315325"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03315325%22"]}]},{"efo_id":"HP_0000044","efo_label":"Hypogonadotropic hypogonadism","efo_uri":"http://purl.obolibrary.org/obo/HP_0000044","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01952782"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01952782%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL488280","_score":1,"_source":{"id":"CHEMBL488280","internal_compound":false,"type":"Small molecule","pref_name":"PROPATYL NITRATE","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["ETT-N","ETTN","Propatylnitrate","WIN-9317"],"trade_names":["Etrynit"],"cross_references":[{"source":"Wikipedia","ids":["Propatylnitrate"]},{"source":"drugbank","ids":["DB13255"]}],"canonical_smiles":"CCC(CO[N+](=O)[O-])(CO[N+](=O)[O-])CO[N+](=O)[O-]","indications":[{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":3,"references":[{"source":"ATC","ids":["C01DA07","C01DA57"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C01DA07","https://www.whocc.no/atc_ddd_index/?code=C01DA57"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297441","_score":1,"_source":{"id":"CHEMBL4297441","internal_compound":false,"type":"Small molecule","pref_name":"PACLITAXEL DOCOSAHEXAENOIC ACID","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Dha paclitaxel","Paclitaxel docosahexaenoic acid","Taxoprexin"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB05297"]}],"canonical_smiles":"CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCC(=O)O[C@@H](C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@H]3[C@](C)(C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C)[C@@H](O)C[C@H]1OC[C@]13OC(C)=O)[C@@H](NC(=O)c1ccccc1)c1ccccc1","indications":[{"efo_id":"EFO_0000182","efo_label":"hepatocellular carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000182","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00422877"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00422877%22"]}]},{"efo_id":"EFO_0002617","efo_label":"metastatic melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002617","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00244816","NCT00249262"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00244816%22OR%22NCT00249262%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00243867"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00243867%22"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4298016","_score":1,"_source":{"id":"CHEMBL4298016","internal_compound":false,"type":"Antibody","pref_name":"FROVOCIMAB","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Frovocimab","LY-3015014","LY3015014","Ly3015014"],"trade_names":[],"indications":[{"efo_id":"HP_0003124","efo_label":"Hypercholesterolemia","efo_uri":"http://purl.obolibrary.org/obo/HP_0003124","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01671085","NCT01890967"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01671085%22OR%22NCT01890967%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1200384","_score":1,"_source":{"id":"CHEMBL1200384","internal_compound":false,"type":"Small molecule","pref_name":"BETAMETHASONE DIPROPIONATE","year_first_approved":1975,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Betamethasone 17,21-dipropionate","Betamethasone Dipropionate","SCH-11460"],"trade_names":["Alphatrex","Betamethasone Dipropionate","Diprolene","Diprolene Af","Diprosone","Sernivo"],"cross_references":[{"source":"ChEBI","ids":[31276]},{"source":"DailyMed","ids":["betamethasone%20dipropionate"]},{"source":"PubChem","ids":["144206894","29215385"]},{"source":"Wikipedia","ids":["Betamethasone_dipropionate"]}],"canonical_smiles":"CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","indications":[{"efo_id":"EFO_0005752","efo_label":"eye inflammation","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005752","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["S01BA06","S01CB04"],"urls":["https://www.whocc.no/atc_ddd_index/?code=S01BA06","https://www.whocc.no/atc_ddd_index/?code=S01CB04"]}]},{"efo_id":"HP_0006536","efo_label":"Obstructive lung disease","efo_uri":"http://purl.obolibrary.org/obo/HP_0006536","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["R03BA04"],"urls":["https://www.whocc.no/atc_ddd_index/?code=R03BA04"]}]},{"efo_id":"EFO_0000676","efo_label":"psoriasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000676","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00216827","NCT00216840","NCT00216879","NCT00243464","NCT00820950","NCT01422434","NCT03331523","NCT03399526"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00216827%22OR%22NCT00216840%22OR%22NCT00216879%22OR%22NCT00243464%22OR%22NCT00820950%22OR%22NCT01422434%22OR%22NCT03331523%22OR%22NCT03399526%22"]},{"source":"DailyMed","ids":["757c914f-dd8d-43cc-a973-212d591af4af","ef43ba2d-20ce-4415-b5c2-e486b836812e"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?757c914f-dd8d-43cc-a973-212d591af4af","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ef43ba2d-20ce-4415-b5c2-e486b836812e"]}]},{"efo_id":"HP_0001742","efo_label":"Nasal obstruction","efo_uri":"http://purl.obolibrary.org/obo/HP_0001742","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["R01AD06"],"urls":["https://www.whocc.no/atc_ddd_index/?code=R01AD06"]}]},{"efo_id":"EFO_0000701","efo_label":"skin disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000701","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT02355639","NCT02416258","NCT02518048"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02355639%22OR%22NCT02416258%22OR%22NCT02518048%22"]},{"source":"DailyMed","ids":["000ae256-a337-4903-845b-003777a4efa8"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?000ae256-a337-4903-845b-003777a4efa8"]}]},{"efo_id":"EFO_0000274","efo_label":"atopic eczema","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000274","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02376049"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02376049%22"]}]},{"efo_id":"EFO_0000544","efo_label":"infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000544","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["030a1460-3522-43af-a75d-29c99570698f","20ad6d8a-117a-4b9d-a14c-24234437e211","3d235926-6f17-4aa5-be82-7f1b4357e247","55db730a-df6d-4950-9c26-91b06bdcef36","a6ac4020-2c67-426a-8289-7e54ce43d0c9","b844e453-78ff-4c5f-b541-37d33f355a3a","e4e9f244-4a85-4c0d-9917-93182c4a6e87","e947a6be-90ae-40d8-b9dd-afa14a66bb9d"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?030a1460-3522-43af-a75d-29c99570698f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?20ad6d8a-117a-4b9d-a14c-24234437e211","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3d235926-6f17-4aa5-be82-7f1b4357e247","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?55db730a-df6d-4950-9c26-91b06bdcef36","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a6ac4020-2c67-426a-8289-7e54ce43d0c9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b844e453-78ff-4c5f-b541-37d33f355a3a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e4e9f244-4a85-4c0d-9917-93182c4a6e87","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e947a6be-90ae-40d8-b9dd-afa14a66bb9d"]},{"source":"FDA","ids":["07232f6e-adec-48be-b232-7b3011b0cddd","e4cb9989-da6e-4e82-ba4e-e97f4f246ecc"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A07232f6e-adec-48be-b232-7b3011b0cddd","https://api.fda.gov/drug/label.json?search=set_id%3Ae4cb9989-da6e-4e82-ba4e-e97f4f246ecc"]}]},{"efo_id":"EFO_0008517","efo_label":"oral lichen planus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008517","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03026478"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03026478%22"]}]},{"efo_id":"EFO_1001494","efo_label":"psoriasis vulgaris","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001494","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00263718","NCT00817219","NCT01347255","NCT01466478","NCT01536886","NCT01536938","NCT01600222","NCT01768013","NCT01866163","NCT01935869","NCT01946386","NCT02132936","NCT02310646","NCT02387853","NCT02899962","NCT02973776","NCT03442244","NCT03806790"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00263718%22OR%22NCT00817219%22OR%22NCT01347255%22OR%22NCT01466478%22OR%22NCT01536886%22OR%22NCT01536938%22OR%22NCT01600222%22OR%22NCT01768013%22OR%22NCT01866163%22OR%22NCT01935869%22OR%22NCT01946386%22OR%22NCT02132936%22OR%22NCT02310646%22OR%22NCT02387853%22OR%22NCT02899962%22OR%22NCT02973776%22OR%22NCT03442244%22OR%22NCT03806790%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000113580","approved_name":"nuclear receptor subfamily 3 group C member 1","approved_symbol":"NR3C1"}],"target_type":"single protein","target_name":"Glucocorticoid receptor","action_type":"agonist","description":"Glucocorticoid receptor agonist","references":[{"source":"DailyMed","ids":["setid=892bf494-0b95-4314-a253-79350fdd7238#nlm34090-1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=892bf494-0b95-4314-a253-79350fdd7238#nlm34090-1"]},{"source":"PubMed","ids":["12188035"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12188035"]},{"source":"Wikipedia","ids":["Betamethasone"],"urls":["https://www.wikipedia.org/Betamethasone"]}]}],"adverse_events":{"significant":[{"event":"hepatic function abnormal","count":12036,"llr":210.3018113},{"event":"stomatitis","count":13596,"llr":205.5661357},{"event":"epistaxis","count":16532,"llr":191.6210802},{"event":"urticaria","count":39524,"llr":147.6461041},{"event":"hypersensitivity","count":35921,"llr":145.9013049},{"event":"muscle spasms","count":35356,"llr":138.2380663},{"event":"pain in extremity","count":62441,"llr":118.9538529},{"event":"pneumonia","count":65209,"llr":94.63627553},{"event":"cushing's syndrome","count":1514,"llr":54.7781484},{"event":"erythrodermic psoriasis","count":357,"llr":49.28902384},{"event":"steroid withdrawal syndrome","count":208,"llr":49.2321343},{"event":"purpura senile","count":29,"llr":30.96674775},{"event":"adrenal insufficiency","count":2809,"llr":30.3797892},{"event":"skin atrophy","count":990,"llr":29.41286875},{"event":"tarsal tunnel syndrome","count":54,"llr":27.86153236},{"event":"theft","count":116,"llr":24.04650146},{"event":"glaucoma","count":3701,"llr":20.89029637},{"event":"resorption bone increased","count":293,"llr":19.43642828},{"event":"skin striae","count":335,"llr":18.77205822},{"event":"reaction to excipient","count":129,"llr":17.92041843},{"event":"vestibular disorder","count":419,"llr":17.66419558},{"event":"shared psychotic disorder","count":31,"llr":16.84323639},{"event":"cushingoid","count":1073,"llr":16.72825847},{"event":"hyperadrenocorticism","count":34,"llr":16.56650507},{"event":"meningoencephalitis viral","count":41,"llr":16.00577729},{"event":"perioral dermatitis","count":46,"llr":15.66121705},{"event":"chorioretinopathy","count":739,"llr":14.86835528},{"event":"hypothalamo-pituitary disorder","count":298,"llr":14.59314485},{"event":"erysipelas","count":1652,"llr":14.21367112},{"event":"nausea","count":165652,"llr":13.0251943},{"event":"vertigo positional","count":497,"llr":12.5728895},{"event":"rhinovirus infection","count":521,"llr":12.38735274},{"event":"vasculitis","count":3695,"llr":12.26060249},{"event":"electrocardiogram ambulatory abnormal","count":19,"llr":11.39477283},{"event":"lipohypertrophy","count":219,"llr":11.0023386},{"event":"diarrhoea","count":126514,"llr":10.48444765},{"event":"psoriasis","count":30767,"llr":10.2972949},{"event":"drug dependence","count":7072,"llr":10.26000873},{"event":"thrombophlebitis superficial","count":932,"llr":10.11416874},{"event":"blood cortisol decreased","count":296,"llr":10.10845127},{"event":"headache","count":120638,"llr":9.791423069},{"event":"hyperplasia","count":343,"llr":9.67242755},{"event":"prescription drug used without a prescription","count":343,"llr":9.67242755},{"event":"secondary adrenocortical insufficiency","count":375,"llr":9.408986732},{"event":"toxic skin eruption","count":3870,"llr":9.391872471},{"event":"growth retardation","count":1124,"llr":9.389733669},{"event":"pityriasis rubra pilaris","count":57,"llr":9.202481029},{"event":"osteonecrosis","count":10916,"llr":9.082692195},{"event":"hypertrichosis","count":428,"llr":9.019261977},{"event":"pustular psoriasis","count":1381,"llr":8.59931483},{"event":"hypothalamic pituitary adrenal axis suppression","count":88,"llr":8.337934074},{"event":"skin exfoliation","count":9496,"llr":8.213727521}],"critval":8.158018535},"number_of_indications":9,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":5},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":3},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":3},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL964","_score":1,"_source":{"id":"CHEMBL964","internal_compound":false,"type":"Small molecule","pref_name":"DISULFIRAM","year_first_approved":1951,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["Disulfiram","NSC-25953","ORA-102","ORA102"],"trade_names":["Antabuse","Disulfiram","Esperal"],"cross_references":[{"source":"ChEBI","ids":[4659]},{"source":"DailyMed","ids":["disulfiram"]},{"source":"PubChem","ids":["104171249","11111859","11111860","11533044","123060006","124881563","124881565","124881567","124881570","144203831","144210721","144214033","170464767","26747681","26747682","26753660","26753661","50107088","50107089","56422197","85231246","90340564"]},{"source":"TG-GATEs","ids":["109"]},{"source":"Wikipedia","ids":["Disulfiram"]},{"source":"drugbank","ids":["DB00822"]}],"canonical_smiles":"CCN(CC)C(=S)SSC(=S)N(CC)CC","indications":[{"efo_id":"EFO_0002610","efo_label":"cocaine dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002610","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00000278","NCT00094289","NCT00142844","NCT00149630","NCT00218608","NCT00350870","NCT00395850","NCT00729300","NCT00913484"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000278%22OR%22NCT00094289%22OR%22NCT00142844%22OR%22NCT00149630%22OR%22NCT00218608%22OR%22NCT00350870%22OR%22NCT00395850%22OR%22NCT00729300%22OR%22NCT00913484%22"]}]},{"efo_id":"EFO_0000756","efo_label":"melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000756","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00256230","NCT02101008"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00256230%22OR%22NCT02101008%22"]}]},{"efo_id":"EFO_0001067","efo_label":"parasitic infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001067","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["P03AA04","P03AA54"],"urls":["https://www.whocc.no/atc_ddd_index/?code=P03AA04","https://www.whocc.no/atc_ddd_index/?code=P03AA54"]}]},{"efo_id":"EFO_0003829","efo_label":"alcohol dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003829","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N07BB01"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N07BB01"]},{"source":"ClinicalTrials","ids":["NCT00000278","NCT00094289","NCT00142844"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000278%22OR%22NCT00094289%22OR%22NCT00142844%22"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01944371","NCT03198559"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01944371%22OR%22NCT03198559%22"]}]},{"efo_id":"EFO_0004701","efo_label":"methamphetamine dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004701","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00731133"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00731133%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00742911"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00742911%22"]}]},{"efo_id":"EFO_0000519","efo_label":"glioblastoma multiforme","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000519","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01777919","NCT01907165","NCT02678975","NCT02715609","NCT02770378","NCT03034135","NCT03151772","NCT03363659"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01777919%22OR%22NCT01907165%22OR%22NCT02678975%22OR%22NCT02715609%22OR%22NCT02770378%22OR%22NCT03034135%22OR%22NCT03151772%22OR%22NCT03363659%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02963051"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02963051%22"]}]},{"efo_id":"EFO_0002617","efo_label":"metastatic melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002617","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00571116"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00571116%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00312819"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00312819%22"]}]},{"efo_id":"EFO_0005611","efo_label":"opioid dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005611","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00149630"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00149630%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03323346"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03323346%22"]}]},{"efo_id":"EFO_0000514","efo_label":"germ cell tumor","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000514","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03950830"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03950830%22"]}]},{"efo_id":"EFO_0003869","efo_label":"breast neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003869","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03323346"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03323346%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000111275","approved_name":"aldehyde dehydrogenase 2 family member","approved_symbol":"ALDH2"}],"target_type":"single protein","target_name":"Aldehyde dehydrogenase","action_type":"inhibitor","description":"Aldehyde dehydrogenase inhibitor","references":[{"source":"DailyMed","ids":["archiveid=146982"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?archiveid=146982"]},{"source":"Wikipedia","ids":["Disulfiram"],"urls":["https://www.wikipedia.org/Disulfiram"]}]}],"adverse_events":{"significant":[{"event":"alcohol intolerance","count":157,"llr":50.58454411},{"event":"drug interaction","count":53526,"llr":45.39953368},{"event":"delusion","count":4266,"llr":42.88750817},{"event":"coma","count":13175,"llr":38.08386448},{"event":"drug abuse","count":14574,"llr":33.41463503},{"event":"psychotic disorder","count":11057,"llr":32.04698751},{"event":"encephalopathy","count":8151,"llr":30.28382979},{"event":"generalised tonic-clonic seizure","count":4083,"llr":28.52008885},{"event":"alcohol interaction","count":574,"llr":28.52007252},{"event":"sopor","count":6099,"llr":27.48375699},{"event":"toxic encephalopathy","count":1425,"llr":22.21955548},{"event":"hypomania","count":1498,"llr":21.87538128},{"event":"confabulation","count":89,"llr":21.47624692},{"event":"toxicity to various agents","count":31033,"llr":21.0184582},{"event":"hepatitis acute","count":2333,"llr":18.83758054},{"event":"suicide attempt","count":20244,"llr":18.44631858},{"event":"ileus paralytic","count":1414,"llr":18.17168684},{"event":"illogical thinking","count":44,"llr":17.35067386},{"event":"catatonia","count":1881,"llr":16.4949608},{"event":"psychotic behaviour","count":337,"llr":16.16946694},{"event":"alanine aminotransferase increased","count":24852,"llr":15.91833638},{"event":"epilepsy","count":8950,"llr":14.85924668},{"event":"concussion","count":1308,"llr":14.62279792},{"event":"neurotoxicity","count":4628,"llr":14.21703012},{"event":"jaundice","count":9877,"llr":14.04225233},{"event":"grand mal convulsion","count":4865,"llr":13.88543596},{"event":"aspartate aminotransferase increased","count":21532,"llr":13.50144144},{"event":"polyneuropathy","count":3403,"llr":13.05376095},{"event":"cognitive disorder","count":9869,"llr":11.6172858},{"event":"gamma-glutamyltransferase increased","count":9889,"llr":11.60260555},{"event":"depersonalisation","count":322,"llr":11.40096584},{"event":"optic neuritis","count":2718,"llr":11.07355545},{"event":"alcohol poisoning","count":639,"llr":9.369285753},{"event":"coagulopathy","count":4025,"llr":9.210320133},{"event":"psychomotor hyperactivity","count":4158,"llr":9.057942229},{"event":"toxicologic test abnormal","count":113,"llr":8.872877813},{"event":"abnormal behaviour","count":10841,"llr":8.730777363},{"event":"confusional state","count":40628,"llr":8.726056569},{"event":"delirium","count":11053,"llr":8.6113375},{"event":"metabolic encephalopathy","count":868,"llr":8.468036291},{"event":"repetitive speech","count":146,"llr":8.362986416},{"event":"areflexia","count":950,"llr":8.203532332},{"event":"dysphoria","count":2634,"llr":8.120859454},{"event":"hepatomegaly","count":2754,"llr":7.951858799},{"event":"hepatic failure","count":5407,"llr":7.840150396},{"event":"metabolic acidosis","count":8683,"llr":7.836011413},{"event":"attention deficit/hyperactivity disorder","count":1098,"llr":7.780564856},{"event":"urine barbiturates","count":2,"llr":7.771644356},{"event":"alcoholism","count":1201,"llr":7.519494772},{"event":"mydriasis","count":3319,"llr":7.248754735},{"event":"mental status changes","count":10001,"llr":7.088664722},{"event":"stereotypy","count":279,"llr":7.078038312},{"event":"diplopia","count":6509,"llr":6.996987524},{"event":"disturbance in attention","count":10609,"llr":6.780960168},{"event":"memory impairment","count":20326,"llr":6.630848782},{"event":"idiosyncratic drug reaction","count":357,"llr":6.59100892},{"event":"bradyphrenia","count":1686,"llr":6.539189734},{"event":"myocardial ischaemia","count":4035,"llr":6.52230619},{"event":"slow response to stimuli","count":379,"llr":6.473105652},{"event":"foetal growth retardation","count":382,"llr":6.457568333},{"event":"ischaemic cerebral infarction","count":410,"llr":6.318255801},{"event":"self injurious behaviour","count":1911,"llr":6.180695713},{"event":"biliary fibrosis","count":10,"llr":6.162825772},{"event":"asterixis","count":447,"llr":6.148307994},{"event":"renal infarct","count":449,"llr":6.139533736},{"event":"blood thromboplastin decreased","count":12,"llr":5.980659047}],"critval":5.959922125},"number_of_indications":15,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":9},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":5},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":4},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":4},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":4},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":4},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":3},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":2}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4303060","_score":1,"_source":{"id":"CHEMBL4303060","internal_compound":false,"type":"Small molecule","pref_name":"MELPHALAN FLUFENAMIDE","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"canonical_smiles":"CCOC(=O)[C@H](Cc1ccc(F)cc1)NC(=O)[C@@H](N)Cc1ccc(N(CCCl)CCCl)cc1","child_chembl_ids":["CHEMBL4297403"],"synonyms":["J-1 HYDROCHLORIDE","Melflufen","Melphalan flufenamide hydrochloride"],"indications":[{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01897714","NCT02963493","NCT03151811","NCT03481556"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01897714%22OR%22NCT02963493%22OR%22NCT03151811%22OR%22NCT03481556%22"]}]},{"efo_id":"Orphanet_85443","efo_label":"AL amyloidosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_85443","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT04115956"],"urls":["https://clinicaltrials.gov/search?id=%22NCT04115956%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108628","_score":1,"_source":{"id":"CHEMBL2108628","internal_compound":false,"type":"Unknown","pref_name":"PACLITAXEL POLIGLUMEX","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["CT-2103","PG-TXL","Paclitaxel Poliglumex"],"trade_names":["Xyotax"],"indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":3,"references":[{"source":"ATC","ids":["L01CD03"],"urls":["https://www.whocc.no/atc_ddd_index/?code=L01CD03"]}]},{"efo_id":"EFO_0005842","efo_label":"colorectal cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005842","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00598247"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00598247%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00148707","NCT00265733","NCT00270907","NCT01227408"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00148707%22OR%22NCT00265733%22OR%22NCT00270907%22OR%22NCT01227408%22"]}]},{"efo_id":"EFO_0000673","efo_label":"prostate adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000673","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00446836"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00446836%22"]}]},{"efo_id":"EFO_0000707","efo_label":"squamous cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000707","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00660218"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00660218%22"]}]},{"efo_id":"EFO_0001071","efo_label":"lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001071","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00054184","NCT00054197","NCT00054210","NCT00551733"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00054184%22OR%22NCT00054197%22OR%22NCT00054210%22OR%22NCT00551733%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00459810"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00459810%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00269828","NCT00352690","NCT00487669"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00269828%22OR%22NCT00352690%22OR%22NCT00487669%22"]}]},{"efo_id":"EFO_0003833","efo_label":"brain neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003833","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00763750"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00763750%22"]}]},{"efo_id":"EFO_0000466","efo_label":"endometrioid carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000466","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00108745"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00108745%22"]}]},{"efo_id":"EFO_0001075","efo_label":"ovarian carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001075","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00017017"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00017017%22"]}]},{"efo_id":"EFO_0006772","efo_label":"undifferentiated carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006772","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00108745"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00108745%22"]}]},{"efo_id":"EFO_1000251","efo_label":"Fallopian Tube Carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000251","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00017017","NCT00108745"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00017017%22OR%22NCT00108745%22"]}]},{"efo_id":"EFO_1001100","efo_label":"peritoneal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001100","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00017017","NCT00108745"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00017017%22OR%22NCT00108745%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000188229","approved_name":"tubulin beta 4B class IVb","approved_symbol":"TUBB4B"},{"ensembl":"ENSG00000101162","approved_name":"tubulin beta 1 class VI","approved_symbol":"TUBB1"},{"ensembl":"ENSG00000198033","approved_name":"tubulin alpha 3c","approved_symbol":"TUBA3C"},{"ensembl":"ENSG00000127824","approved_name":"tubulin alpha 4a","approved_symbol":"TUBA4A"},{"ensembl":"ENSG00000258947","approved_name":"tubulin beta 3 class III","approved_symbol":"TUBB3"},{"ensembl":"ENSG00000167552","approved_name":"tubulin alpha 1a","approved_symbol":"TUBA1A"},{"ensembl":"ENSG00000104833","approved_name":"tubulin beta 4A class IVa","approved_symbol":"TUBB4A"},{"ensembl":"ENSG00000261456","approved_name":"tubulin beta 8 class VIII","approved_symbol":"TUBB8"},{"ensembl":"ENSG00000196230","approved_name":"tubulin beta class I","approved_symbol":"TUBB"},{"ensembl":"ENSG00000123416","approved_name":"tubulin alpha 1b","approved_symbol":"TUBA1B"},{"ensembl":"ENSG00000167553","approved_name":"tubulin alpha 1c","approved_symbol":"TUBA1C"},{"ensembl":"ENSG00000152086","approved_name":"tubulin alpha 3e","approved_symbol":"TUBA3E"},{"ensembl":"ENSG00000137267","approved_name":"tubulin beta 2A class IIa","approved_symbol":"TUBB2A"},{"ensembl":"ENSG00000137285","approved_name":"tubulin beta 2B class IIb","approved_symbol":"TUBB2B"},{"ensembl":"ENSG00000176014","approved_name":"tubulin beta 6 class V","approved_symbol":"TUBB6"}],"target_type":"protein complex group","target_name":"Tubulin","action_type":"stabiliser","description":"Tubulin stabiliser","references":[{"source":"PubMed","ids":["17722272"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17722272"]}]}],"adverse_events":{"significant":[{"event":"urogenital fistula","count":63,"llr":18.21481214}],"critval":8.523034634},"number_of_indications":14,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":14},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":6},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":5},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":3},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":2},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109644","_score":1,"_source":{"id":"CHEMBL2109644","internal_compound":false,"type":"Antibody","pref_name":"TNT-1B","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["TNT-1B"],"trade_names":["Cotara"],"indications":[{"efo_id":"EFO_0000519","efo_label":"glioblastoma multiforme","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000519","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00677716"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00677716%22"]}]}],"mechanisms_of_action":[],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2107884","_score":1,"_source":{"id":"CHEMBL2107884","internal_compound":false,"type":"Antibody","pref_name":"RESLIZUMAB","year_first_approved":2016,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["CEP-38072","DCP 835","DCP-835","Reslizumab","SCH-55700","SCH55700"],"trade_names":["Cinqaero","Cinqair","Cinquil"],"cross_references":[{"source":"DailyMed","ids":["reslizumab"]},{"source":"DrugCentral","ids":["5093"]}],"indications":[{"efo_id":"HP_0006536","efo_label":"Obstructive lung disease","efo_uri":"http://purl.obolibrary.org/obo/HP_0006536","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["R03DX08"],"urls":["https://www.whocc.no/atc_ddd_index/?code=R03DX08"]}]},{"efo_id":"EFO_0004232","efo_label":"eosinophilic esophagitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004232","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00538434","NCT00635089"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00538434%22OR%22NCT00635089%22"]}]},{"efo_id":"EFO_0000270","efo_label":"asthma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000270","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00587288","NCT01270464","NCT01285323","NCT01287039","NCT01290887","NCT01508936","NCT02452190","NCT02501629","NCT02559791","NCT02947945","NCT03052725","NCT03074942"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00587288%22OR%22NCT01270464%22OR%22NCT01285323%22OR%22NCT01287039%22OR%22NCT01290887%22OR%22NCT01508936%22OR%22NCT02452190%22OR%22NCT02501629%22OR%22NCT02559791%22OR%22NCT02947945%22OR%22NCT03052725%22OR%22NCT03074942%22"]},{"source":"FDA","ids":["label/2016/761033lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2016%2F761033lbl.pdf"]}]},{"efo_id":"EFO_0007486","efo_label":"sinusitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007486","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02799446"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02799446%22"]}]},{"efo_id":"EFO_1000729","efo_label":"loiasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000729","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01111305"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01111305%22"]}]},{"efo_id":"EFO_0009661","efo_label":"bronchitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009661","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02559791"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02559791%22"]}]},{"efo_id":"EFO_1001467","efo_label":"Hypereosinophilic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001467","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00017862"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00017862%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000113525","approved_name":"interleukin 5","approved_symbol":"IL5"}],"target_type":"single protein","target_name":"Interleukin-5","action_type":"inhibitor","description":"Interleukin-5 inhibitor","references":[{"source":"FDA","ids":["label/2016/761033lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2016%2F761033lbl.pdf"]}]}],"adverse_events":{"significant":[{"event":"asthma","count":16236,"llr":20.21339643},{"event":"throat tightness","count":6159,"llr":14.6771333},{"event":"myalgia","count":42953,"llr":13.38141298},{"event":"infusion site extravasation","count":1461,"llr":9.489364677},{"event":"wheezing","count":9665,"llr":9.190462553},{"event":"dyspnoea","count":124409,"llr":9.097104598},{"event":"hepatitis viral","count":265,"llr":8.898895056},{"event":"genital herpes","count":440,"llr":7.890462088},{"event":"chest discomfort","count":21346,"llr":7.696179775},{"event":"encapsulation reaction","count":13,"llr":6.763221561},{"event":"oropharyngeal pain","count":17252,"llr":6.533512775},{"event":"aspergillus infection","count":963,"llr":6.340812107}],"critval":6.190114063},"number_of_indications":7,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":5},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":2},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108459","_score":1,"_source":{"id":"CHEMBL2108459","internal_compound":false,"type":"Antibody","pref_name":"FONTOLIZUMAB","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Fontolizumab","HuZAF"],"trade_names":[],"indications":[{"efo_id":"EFO_0000685","efo_label":"rheumatoid arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000685","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00281294"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00281294%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000111537","approved_name":"interferon gamma","approved_symbol":"IFNG"}],"target_type":"single protein","target_name":"Interferon gamma","action_type":"inhibitor","description":"Interferon gamma inhibitor","references":[{"source":"PubMed","ids":["16507585"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16507585"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1908391","_score":1,"_source":{"id":"CHEMBL1908391","internal_compound":false,"type":"Small molecule","pref_name":"MASITINIB","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AB-1010","Masitinib"],"trade_names":["Kinavet","Masivet"],"cross_references":[{"source":"ChEBI","ids":[63450]},{"source":"PubChem","ids":["124950163","99460877"]},{"source":"drugbank","ids":["DB11526"]}],"canonical_smiles":"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1","indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":3,"references":[{"source":"ATC","ids":["L01XE22"],"urls":["https://www.whocc.no/atc_ddd_index/?code=L01XE22"]},{"source":"ClinicalTrials","ids":["NCT00998751","NCT01506336","NCT02009423"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00998751%22OR%22NCT01506336%22OR%22NCT02009423%22"]}]},{"efo_id":"EFO_0003885","efo_label":"multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003885","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01450488"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01450488%22"]}]},{"efo_id":"EFO_0000685","efo_label":"rheumatoid arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000685","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00831922","NCT00913432","NCT01410695"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00831922%22OR%22NCT00913432%22OR%22NCT01410695%22"]}]},{"efo_id":"EFO_0003840","efo_label":"chronic progressive multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003840","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01433497"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01433497%22"]}]},{"efo_id":"EFO_0000249","efo_label":"Alzheimer's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000249","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00976118","NCT01872598"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00976118%22OR%22NCT01872598%22"]}]},{"efo_id":"EFO_0000270","efo_label":"asthma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000270","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00842270","NCT01449162","NCT03771040"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00842270%22OR%22NCT01449162%22OR%22NCT03771040%22"]}]},{"efo_id":"Orphanet_44890","efo_label":"Gastrointestinal stromal tumor","efo_uri":"http://www.orpha.net/ORDO/Orphanet_44890","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00812240","NCT01694277"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00812240%22OR%22NCT01694277%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00866138","NCT01470131"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00866138%22OR%22NCT01470131%22"]}]},{"efo_id":"EFO_0002617","efo_label":"metastatic melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002617","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01280565"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01280565%22"]}]},{"efo_id":"EFO_0000676","efo_label":"psoriasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000676","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01045577"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01045577%22"]}]},{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00789633","NCT03766295"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00789633%22OR%22NCT03766295%22"]}]},{"efo_id":"EFO_0001075","efo_label":"ovarian carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001075","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02490488"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02490488%22"]}]},{"efo_id":"EFO_0000253","efo_label":"amyotrophic lateral sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000253","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02588677","NCT03127267"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02588677%22OR%22NCT03127267%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03761225"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03761225%22"]}]},{"efo_id":"EFO_0009001","efo_label":"Mastocytosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009001","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00814073","NCT00831974","NCT01266369"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00814073%22OR%22NCT00831974%22OR%22NCT01266369%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000068078","approved_name":"fibroblast growth factor receptor 3","approved_symbol":"FGFR3"}],"target_type":"single protein","target_name":"Fibroblast growth factor receptor 3","action_type":"inhibitor","description":"Fibroblast growth factor receptor 3 inhibitor","references":[{"source":"Other","ids":["http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/veterinary/000128/WC500064717.pdf"],"urls":["http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/veterinary/000128/WC500064717.pdf"]},{"source":"PubMed","ids":["19541476","19789626"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19541476+OR+EXT_ID%3A19789626"]}]},{"target_components":[{"ensembl":"ENSG00000157404","approved_name":"KIT proto-oncogene, receptor tyrosine kinase","approved_symbol":"KIT"}],"target_type":"single protein","target_name":"Stem cell growth factor receptor","action_type":"inhibitor","description":"Stem cell growth factor receptor inhibitor","references":[{"source":"Other","ids":["http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/veterinary/000128/WC500064717.pdf"],"urls":["http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/veterinary/000128/WC500064717.pdf"]},{"source":"PubMed","ids":["19541476","19789626"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19541476+OR+EXT_ID%3A19789626"]}]},{"target_components":[{"ensembl":"ENSG00000113721","approved_name":"platelet derived growth factor receptor beta","approved_symbol":"PDGFRB"},{"ensembl":"ENSG00000134853","approved_name":"platelet derived growth factor receptor alpha","approved_symbol":"PDGFRA"}],"target_type":"protein complex","target_name":"Platelet-derived growth factor receptor","action_type":"inhibitor","description":"Platelet-derived growth factor receptor inhibitor","references":[{"source":"Other","ids":["http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/veterinary/000128/WC500064717.pdf"],"urls":["http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/veterinary/000128/WC500064717.pdf"]},{"source":"PubMed","ids":["19541476","19789626"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19541476+OR+EXT_ID%3A19789626"]}]}],"adverse_events":{"significant":[{"event":"acute lymphocytic leukaemia","count":714,"llr":15.26897862},{"event":"second primary malignancy","count":2158,"llr":13.05724678}],"critval":7.441810953},"number_of_indications":15,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":8},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":6},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":4},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":3},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":3},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":2},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":2},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":2},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1}],"number_of_mechanisms_of_action":3}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL773","_score":1,"_source":{"id":"CHEMBL773","internal_compound":false,"type":"Small molecule","pref_name":"GLYCINE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Aluminium glycinate","Aminoacetic Acid","FEMA NO. 3287","Glycine","Glycocoll","NSC-25936"],"trade_names":["Glycolixir"],"cross_references":[{"source":"ChEBI","ids":[15428]},{"source":"DailyMed","ids":["glycine"]},{"source":"PubChem","ids":["11113413","144207124","170466831"]},{"source":"Wikipedia","ids":["Glycine"]},{"source":"drugbank","ids":["DB00145"]},{"source":"DrugCentral","ids":["4763"]}],"canonical_smiles":"NCC(=O)O","indications":[{"efo_id":"EFO_0000289","efo_label":"bipolar disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000289","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01720316"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01720316%22"]}]},{"efo_id":"EFO_0000692","efo_label":"schizophrenia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000692","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000372","NCT00005658","NCT00222235","NCT00268749","NCT00276263","NCT00291226","NCT00929370"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000372%22OR%22NCT00005658%22OR%22NCT00222235%22OR%22NCT00268749%22OR%22NCT00276263%22OR%22NCT00291226%22OR%22NCT00929370%22"]}]},{"efo_id":"Orphanet_586","efo_label":"Cystic fibrosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_586","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01417481"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01417481%22"]}]},{"efo_id":"HP_0002014","efo_label":"Diarrhea","efo_uri":"http://purl.obolibrary.org/obo/HP_0002014","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00133406"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00133406%22"]}]},{"efo_id":"EFO_0000270","efo_label":"asthma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000270","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01501942"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01501942%22"]}]},{"efo_id":"EFO_0000537","efo_label":"hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000537","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03166228"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03166228%22"]}]},{"efo_id":"EFO_0004242","efo_label":"obsessive-compulsive disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004242","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01031927"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01031927%22"]}]},{"efo_id":"EFO_0005411","efo_label":"schizoaffective disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005411","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00222235"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00222235%22"]}]},{"efo_id":"EFO_1001347","efo_label":"Herpes Labialis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001347","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00913692"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00913692%22"]}]},{"efo_id":"EFO_0008572","efo_label":"malnutrition","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008572","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00133562","NCT00338221"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00133562%22OR%22NCT00338221%22"]}]}],"adverse_events":{"significant":[{"event":"foetal growth restriction","count":1834,"llr":64.87796606},{"event":"apnoea neonatal","count":145,"llr":49.65874812},{"event":"feeding disorder neonatal","count":618,"llr":38.07957595},{"event":"cerebral haemorrhage","count":6313,"llr":34.46237481},{"event":"hyperpyrexia","count":1089,"llr":18.59808879},{"event":"extravasation","count":1902,"llr":15.84293002},{"event":"maternal exposure timing unspecified","count":718,"llr":15.63337555},{"event":"product colour issue","count":510,"llr":11.87767387},{"event":"chills","count":26715,"llr":11.06454512},{"event":"bladder perforation","count":126,"llr":9.888718996},{"event":"anaphylactoid reaction","count":1507,"llr":8.668348912},{"event":"lymphangitis","count":304,"llr":8.134605008},{"event":"caesarean section","count":5212,"llr":7.888430809},{"event":"systemic candida","count":416,"llr":7.511932153},{"event":"breast swelling","count":428,"llr":7.455553675},{"event":"food craving","count":432,"llr":7.437114688},{"event":"lactescent serum","count":6,"llr":7.290248898},{"event":"infusion site reaction","count":492,"llr":7.179495424},{"event":"anaphylactic shock","count":6651,"llr":6.97219676},{"event":"mosaicism","count":9,"llr":6.884908907},{"event":"transurethral resection syndrome","count":9,"llr":6.884908907},{"event":"staphylococcus test positive","count":706,"llr":6.466092971},{"event":"pantoea agglomerans infection","count":14,"llr":6.443284683},{"event":"administration site necrosis","count":15,"llr":6.374333517},{"event":"renal colic","count":802,"llr":6.21508572},{"event":"infusion related reaction","count":15012,"llr":6.047479305}],"critval":5.993029229},"child_chembl_ids":["CHEMBL3707233"],"number_of_indications":10,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":4},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":4},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL514201","_score":1,"_source":{"id":"CHEMBL514201","internal_compound":false,"type":"Small molecule","pref_name":"TALMAPIMOD","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["SCIO-469","Talmapimod"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[90683]},{"source":"drugbank","ids":["DB05412"]}],"canonical_smiles":"C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1","indications":[{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00087867","NCT00095680"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00087867%22OR%22NCT00095680%22"]}]},{"efo_id":"EFO_0000685","efo_label":"rheumatoid arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000685","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00043732","NCT00089921","NCT00508768"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00043732%22OR%22NCT00089921%22OR%22NCT00508768%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000112062","approved_name":"mitogen-activated protein kinase 14","approved_symbol":"MAPK14"}],"target_type":"single protein","target_name":"MAP kinase p38 alpha","action_type":"inhibitor","description":"MAP kinase p38 alpha inhibitor","references":[{"source":"PubMed","ids":["19195885","19950901","21659629"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19195885+OR+EXT_ID%3A19950901+OR+EXT_ID%3A21659629"]}]}],"adverse_events":{"significant":[{"event":"blood culture positive","count":1081,"llr":6.788396093},{"event":"duodenal ulcer","count":2784,"llr":5.842838016}],"critval":4.241044533},"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL409153","_score":1,"_source":{"id":"CHEMBL409153","internal_compound":false,"type":"Small molecule","pref_name":"ISAVUCONAZOLE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["BAL-4815","Isavuconazole"],"trade_names":["Cresemba"],"cross_references":[{"source":"ChEBI","ids":[85979]},{"source":"Wikipedia","ids":["Isavuconazole"]},{"source":"drugbank","ids":["DB11633"]}],"canonical_smiles":"C[C@@H](c1nc(-c2ccc(C#N)cc2)cs1)[C@](O)(Cn1cncn1)c1cc(F)ccc1F","indications":[{"efo_id":"EFO_0003086","efo_label":"kidney disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003086","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01555866"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01555866%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00413439"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00413439%22"]}]},{"efo_id":"EFO_0007157","efo_label":"aspergillosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007157","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03327727"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03327727%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02203526"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02203526%22"]}]}],"adverse_events":{"significant":[{"event":"dysphagia","count":22741,"llr":35.5396467},{"event":"febrile neutropenia","count":19204,"llr":33.61563052},{"event":"aspergillus infection","count":963,"llr":29.39979579},{"event":"mucormycosis","count":447,"llr":24.8876692},{"event":"dermatitis bullous","count":2761,"llr":24.79903269},{"event":"artery dissection","count":145,"llr":19.44810439},{"event":"cerebral aspergillosis","count":109,"llr":14.57426516},{"event":"electrocardiogram qt shortened","count":114,"llr":14.44010577},{"event":"wrong technique in product usage process","count":27855,"llr":14.30308332},{"event":"vascular graft occlusion","count":123,"llr":14.21285419},{"event":"neuropsychiatric symptoms","count":132,"llr":14.00170764},{"event":"venoocclusive liver disease","count":1475,"llr":13.93656224},{"event":"hepatotoxicity","count":5998,"llr":12.37418269},{"event":"agranulocytosis","count":6607,"llr":11.74448127},{"event":"infection","count":26803,"llr":11.06715103},{"event":"epistaxis","count":16532,"llr":9.753273796},{"event":"tachypnoea","count":3857,"llr":9.316179361},{"event":"drug-induced liver injury","count":7265,"llr":8.688211098},{"event":"mycoplasmal postpartum fever","count":1,"llr":8.44474828},{"event":"fusarium infection","count":142,"llr":8.378457517},{"event":"nervous system disorder","count":5276,"llr":7.860511299},{"event":"candida infection","count":2791,"llr":7.825409233},{"event":"electrocardiogram qt prolonged","count":12378,"llr":7.797819645},{"event":"hyperthermia","count":2914,"llr":7.662527716},{"event":"pulse absent","count":1181,"llr":7.510080059},{"event":"drug level below therapeutic","count":1234,"llr":7.382541506},{"event":"heart transplant rejection","count":247,"llr":7.279600894},{"event":"fungal infection","count":6516,"llr":6.901839931},{"event":"anaphylactic shock","count":6651,"llr":6.8098469},{"event":"leukaemia recurrent","count":357,"llr":6.551565797},{"event":"drug resistance","count":7341,"llr":6.37018256},{"event":"gastrostomy","count":459,"llr":6.056967154},{"event":"activated partial thromboplastin time prolonged","count":2063,"llr":5.905910673},{"event":"liver function test increased","count":4754,"llr":5.848717116}],"critval":5.679188694},"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201496","_score":1,"_source":{"id":"CHEMBL1201496","internal_compound":false,"type":"Protein","pref_name":"INSULIN ASPART","year_first_approved":2000,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["B28-ASP-INSULIN","INA-X14","Insulin Aspart Recombinant","Insulin X14","Insulin aspart"],"trade_names":["Fiasp","Fiasp flextouch","Fiasp penfill","Ins NovoRapid","Novolog","Novolog Flexpen","Novolog Innolet","Novolog Penfill","Novolog flextouch"],"cross_references":[{"source":"DailyMed","ids":["insulin%20aspart","insulin%20aspart%20recombinant"]},{"source":"DrugCentral","ids":["4981"]},{"source":"Wikipedia","ids":["Insulin_aspart"]}],"indications":[{"efo_id":"EFO_0001360","efo_label":"type II diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001360","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00082407","NCT00097084","NCT00097279","NCT00097877","NCT00106366","NCT00115973","NCT00184574","NCT00184600","NCT00184613","NCT00267683","NCT00280046","NCT00313001","NCT00318786","NCT00331604","NCT00434954","NCT00476437","NCT00504673","NCT00564668","NCT00598793","NCT00600626","NCT00605020","NCT00612599","NCT00613951","NCT00614055","NCT00617565","NCT00627445","NCT00824668","NCT00825253","NCT00842361","NCT00972283","NCT01009580","NCT01045447","NCT01045707","NCT01059812","NCT01121276","NCT01134224","NCT01159353","NCT01194258","NCT01196104","NCT01272193","NCT01365507","NCT01388361","NCT01467323","NCT01467375","NCT01474538","NCT01513590","NCT01520753","NCT01520818","NCT01526980","NCT01527539","NCT01527630","NCT01538511","NCT01620424","NCT01650129","NCT01680341","NCT01697618","NCT01713530","NCT01814137","NCT01819129","NCT01850615","NCT01865305","NCT02100475","NCT02420262","NCT02648217","NCT02762578","NCT02906917","NCT02933853","NCT03268005","NCT03689374"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00082407%22OR%22NCT00097084%22OR%22NCT00097279%22OR%22NCT00097877%22OR%22NCT00106366%22OR%22NCT00115973%22OR%22NCT00184574%22OR%22NCT00184600%22OR%22NCT00184613%22OR%22NCT00267683%22OR%22NCT00280046%22OR%22NCT00313001%22OR%22NCT00318786%22OR%22NCT00331604%22OR%22NCT00434954%22OR%22NCT00476437%22OR%22NCT00504673%22OR%22NCT00564668%22OR%22NCT00598793%22OR%22NCT00600626%22OR%22NCT00605020%22OR%22NCT00612599%22OR%22NCT00613951%22OR%22NCT00614055%22OR%22NCT00617565%22OR%22NCT00627445%22OR%22NCT00824668%22OR%22NCT00825253%22OR%22NCT00842361%22OR%22NCT00972283%22OR%22NCT01009580%22OR%22NCT01045447%22OR%22NCT01045707%22OR%22NCT01059812%22OR%22NCT01121276%22OR%22NCT01134224%22OR%22NCT01159353%22OR%22NCT01194258%22OR%22NCT01196104%22OR%22NCT01272193%22OR%22NCT01365507%22OR%22NCT01388361%22OR%22NCT01467323%22OR%22NCT01467375%22OR%22NCT01474538%22OR%22NCT01513590%22OR%22NCT01520753%22OR%22NCT01520818%22OR%22NCT01526980%22OR%22NCT01527539%22OR%22NCT01527630%22OR%22NCT01538511%22OR%22NCT01620424%22OR%22NCT01650129%22OR%22NCT01680341%22OR%22NCT01697618%22OR%22NCT01713530%22OR%22NCT01814137%22OR%22NCT01819129%22OR%22NCT01850615%22OR%22NCT01865305%22OR%22NCT02100475%22OR%22NCT02420262%22OR%22NCT02648217%22OR%22NCT02762578%22OR%22NCT02906917%22OR%22NCT02933853%22OR%22NCT03268005%22OR%22NCT03689374%22"]}]},{"efo_id":"EFO_0000400","efo_label":"diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000400","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["A10AB05","A10AD05"],"urls":["https://www.whocc.no/atc_ddd_index/?code=A10AB05","https://www.whocc.no/atc_ddd_index/?code=A10AD05"]},{"source":"ClinicalTrials","ids":["NCT00309244","NCT00353990","NCT00513643","NCT00624767","NCT00969592","NCT01125553","NCT01242826","NCT01486914","NCT01487811","NCT01520831","NCT01523041","NCT01527552","NCT01527565","NCT01527643","NCT01527656","NCT01530048","NCT01620333","NCT01620437","NCT01698697","NCT01707160","NCT01865331","NCT01868555","NCT01868581","NCT02089451","NCT02491528","NCT02594033","NCT03430856","NCT03737240"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00309244%22OR%22NCT00353990%22OR%22NCT00513643%22OR%22NCT00624767%22OR%22NCT00969592%22OR%22NCT01125553%22OR%22NCT01242826%22OR%22NCT01486914%22OR%22NCT01487811%22OR%22NCT01520831%22OR%22NCT01523041%22OR%22NCT01527552%22OR%22NCT01527565%22OR%22NCT01527643%22OR%22NCT01527656%22OR%22NCT01530048%22OR%22NCT01620333%22OR%22NCT01620437%22OR%22NCT01698697%22OR%22NCT01707160%22OR%22NCT01865331%22OR%22NCT01868555%22OR%22NCT01868581%22OR%22NCT02089451%22OR%22NCT02491528%22OR%22NCT02594033%22OR%22NCT03430856%22OR%22NCT03737240%22"]},{"source":"DailyMed","ids":["1861fcee-7673-4afe-a206-08fa05c0add2","3a1e73a2-3009-40d0-876c-b4cb2be56fc5","66472b3d-32c1-4803-aff4-b621aa5430b3","973a9333-fec7-46dd-8eb5-25738f06ee54","cd88e313-6193-4413-beff-7d955580060d"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1861fcee-7673-4afe-a206-08fa05c0add2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3a1e73a2-3009-40d0-876c-b4cb2be56fc5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?66472b3d-32c1-4803-aff4-b621aa5430b3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?973a9333-fec7-46dd-8eb5-25738f06ee54","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cd88e313-6193-4413-beff-7d955580060d"]}]},{"efo_id":"EFO_0001359","efo_label":"type I diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001359","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00071448","NCT00095082","NCT00097071","NCT00184665","NCT00312104","NCT00312156","NCT00322257","NCT00410033","NCT00435019","NCT00447382","NCT00474045","NCT00595374","NCT00604656","NCT00612040","NCT00617565","NCT00623194","NCT00652288","NCT00725036","NCT00797823","NCT00832182","NCT00841087","NCT00850161","NCT00888732","NCT00978627","NCT00982228","NCT00992537","NCT00993096","NCT01051102","NCT01074268","NCT01079234","NCT01109316","NCT01121276","NCT01121289","NCT01134107","NCT01138488","NCT01173926","NCT01174303","NCT01190956","NCT01194245","NCT01269606","NCT01275131","NCT01296438","NCT01399346","NCT01445951","NCT01455142","NCT01464099","NCT01467323","NCT01469143","NCT01486381","NCT01486940","NCT01513473","NCT01520818","NCT01524809","NCT01526941","NCT01536028","NCT01590836","NCT01618188","NCT01682902","NCT01697657","NCT01707134","NCT01773798","NCT01831765","NCT01835431","NCT01865305","NCT01868568","NCT01924637","NCT01934712","NCT01992588","NCT01999322","NCT02003677","NCT02033239","NCT02034513","NCT02035371","NCT02059174","NCT02101229","NCT02131246","NCT02269735","NCT02328040","NCT02500706","NCT02546401","NCT02568280","NCT02612844","NCT02670915","NCT02825251","NCT02910518","NCT02938572","NCT03179332","NCT03202875","NCT03215498","NCT03262116","NCT03377699","NCT03407599","NCT03436498","NCT03449433","NCT03565666","NCT03760068","NCT03816761","NCT03874715","NCT03916601","NCT03959514","NCT03977727","NCT03981627","NCT04031599"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00071448%22OR%22NCT00095082%22OR%22NCT00097071%22OR%22NCT00184665%22OR%22NCT00312104%22OR%22NCT00312156%22OR%22NCT00322257%22OR%22NCT00410033%22OR%22NCT00435019%22OR%22NCT00447382%22OR%22NCT00474045%22OR%22NCT00595374%22OR%22NCT00604656%22OR%22NCT00612040%22OR%22NCT00617565%22OR%22NCT00623194%22OR%22NCT00652288%22OR%22NCT00725036%22OR%22NCT00797823%22OR%22NCT00832182%22OR%22NCT00841087%22OR%22NCT00850161%22OR%22NCT00888732%22OR%22NCT00978627%22OR%22NCT00982228%22OR%22NCT00992537%22OR%22NCT00993096%22OR%22NCT01051102%22OR%22NCT01074268%22OR%22NCT01079234%22OR%22NCT01109316%22OR%22NCT01121276%22OR%22NCT01121289%22OR%22NCT01134107%22OR%22NCT01138488%22OR%22NCT01173926%22OR%22NCT01174303%22OR%22NCT01190956%22OR%22NCT01194245%22OR%22NCT01269606%22OR%22NCT01275131%22OR%22NCT01296438%22OR%22NCT01399346%22OR%22NCT01445951%22OR%22NCT01455142%22OR%22NCT01464099%22OR%22NCT01467323%22OR%22NCT01469143%22OR%22NCT01486381%22OR%22NCT01486940%22OR%22NCT01513473%22OR%22NCT01520818%22OR%22NCT01524809%22OR%22NCT01526941%22OR%22NCT01536028%22OR%22NCT01590836%22OR%22NCT01618188%22OR%22NCT01682902%22OR%22NCT01697657%22OR%22NCT01707134%22OR%22NCT01773798%22OR%22NCT01831765%22OR%22NCT01835431%22OR%22NCT01865305%22OR%22NCT01868568%22OR%22NCT01924637%22OR%22NCT01934712%22OR%22NCT01992588%22OR%22NCT01999322%22OR%22NCT02003677%22OR%22NCT02033239%22OR%22NCT02034513%22OR%22NCT02035371%22OR%22NCT02059174%22OR%22NCT02101229%22OR%22NCT02131246%22OR%22NCT02269735%22OR%22NCT02328040%22OR%22NCT02500706%22OR%22NCT02546401%22OR%22NCT02568280%22OR%22NCT02612844%22OR%22NCT02670915%22OR%22NCT02825251%22OR%22NCT02910518%22OR%22NCT02938572%22OR%22NCT03179332%22OR%22NCT03202875%22OR%22NCT03215498%22OR%22NCT03262116%22OR%22NCT03377699%22OR%22NCT03407599%22OR%22NCT03436498%22OR%22NCT03449433%22OR%22NCT03565666%22OR%22NCT03760068%22OR%22NCT03816761%22OR%22NCT03874715%22OR%22NCT03916601%22OR%22NCT03959514%22OR%22NCT03977727%22OR%22NCT03981627%22OR%22NCT04031599%22"]}]},{"efo_id":"EFO_0000249","efo_label":"Alzheimer's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000249","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00581867"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00581867%22"]}]},{"efo_id":"Orphanet_586","efo_label":"Cystic fibrosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_586","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02496780"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02496780%22"]}]},{"efo_id":"EFO_0000565","efo_label":"leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000565","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00500240"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00500240%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00500240"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00500240%22"]}]},{"efo_id":"EFO_0004593","efo_label":"gestational diabetes","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004593","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00065130"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00065130%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000171105","approved_name":"insulin receptor","approved_symbol":"INSR"}],"target_type":"single protein","target_name":"Insulin receptor","action_type":"agonist","description":"Insulin receptor agonist","references":[{"source":"DailyMed","ids":["setid=3a1e73a2-3009-40d0-876c-b4cb2be56fc5"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a1e73a2-3009-40d0-876c-b4cb2be56fc5"]}]}],"adverse_events":{"significant":[{"event":"blood glucose increased","count":20555,"llr":1000.157508},{"event":"hypoglycaemia","count":14252,"llr":687.2895838},{"event":"blood glucose decreased","count":5278,"llr":488.8092385},{"event":"diabetic ketoacidosis","count":6771,"llr":431.3015745},{"event":"hypoglycaemic unconsciousness","count":382,"llr":252.9980017},{"event":"blood glucose fluctuation","count":1474,"llr":154.8811197},{"event":"diabetes mellitus inadequate control","count":3519,"llr":138.0646695},{"event":"hyperglycaemia","count":9767,"llr":126.6318801},{"event":"hypoglycaemic seizure","count":282,"llr":110.553799},{"event":"diabetic retinopathy","count":664,"llr":92.88872908},{"event":"wrong drug administered","count":2846,"llr":92.78051753},{"event":"hypoglycaemic coma","count":1073,"llr":80.12763555},{"event":"glycosylated haemoglobin increased","count":4131,"llr":75.89673411},{"event":"congenital bladder anomaly","count":71,"llr":70.08773439},{"event":"conjoined twins","count":42,"llr":64.50996049},{"event":"diabetic neuropathy","count":944,"llr":59.75403647},{"event":"genitalia external ambiguous","count":81,"llr":50.97014482},{"event":"diabetic metabolic decompensation","count":341,"llr":43.84847648},{"event":"foetal hypokinesia","count":210,"llr":40.55358223},{"event":"liquid product physical issue","count":466,"llr":39.84921035},{"event":"pharmaceutical product complaint","count":7517,"llr":38.9896197},{"event":"blood glucose abnormal","count":2337,"llr":38.49329606},{"event":"hypoglycaemia neonatal","count":649,"llr":35.6318299},{"event":"neonatal respiratory depression","count":141,"llr":34.93957788},{"event":"infusion site pain","count":1662,"llr":32.5619575},{"event":"fine motor skill dysfunction","count":464,"llr":31.95645669},{"event":"diabetic macroangiopathy","count":18,"llr":26.7292098},{"event":"wrong technique in product usage process","count":27855,"llr":25.15109939},{"event":"persistent cloaca","count":25,"llr":25.09010152},{"event":"diarrhoea","count":126514,"llr":24.7771512},{"event":"insulin resistance","count":328,"llr":23.45763513}],"critval":23.42976326},"number_of_indications":8,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":4},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":4},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"OTAR_0000014","therapeutic_label":"pregnancy or perinatal disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1684","_score":1,"_source":{"id":"CHEMBL1684","internal_compound":false,"type":"Small molecule","pref_name":"BENDROFLUMETHIAZIDE","year_first_approved":1959,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Bendrofluazide","Bendroflumethiazide","Benzydroflumethiazide"],"trade_names":["Aprinox","Berkozide","Centyl","Naturetin","Naturetin-10","Naturetin-2.5","Naturetin-5","Neo-Bendromax 2.5","Neo-Bendromax 5","Neo-Naclex","Urizide"],"cross_references":[{"source":"ChEBI","ids":[3013]},{"source":"DailyMed","ids":["bendroflumethiazide"]},{"source":"PubChem","ids":["124883448","144203916","170465156","26747201","56422088","855628"]},{"source":"Wikipedia","ids":["Bendroflumethiazide"]},{"source":"drugbank","ids":["DB00436"]}],"canonical_smiles":"NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O","indications":[{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["C03AA01"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C03AA01"]}]},{"efo_id":"EFO_0000537","efo_label":"hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000537","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["3f11df27-710b-4903-a985-74ee4674a844","d2d226ea-1624-47ee-82bf-e9660b75029f"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3f11df27-710b-4903-a985-74ee4674a844","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d2d226ea-1624-47ee-82bf-e9660b75029f"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000070915","approved_name":"solute carrier family 12 member 3","approved_symbol":"SLC12A3"}],"target_type":"single protein","target_name":"Thiazide-sensitive sodium-chloride cotransporter","action_type":"inhibitor","description":"Thiazide-sensitive sodium-chloride cotransporter inhibitor","references":[{"source":"DOI","ids":["10.1056/NEJMra0907219"],"urls":["http://dx.doi.org/10.1056/NEJMra0907219"]}]}],"adverse_events":{"significant":[{"event":"hyponatraemia","count":21598,"llr":921.2091089},{"event":"confusional state","count":40628,"llr":156.860354},{"event":"acute kidney injury","count":33030,"llr":145.4202977},{"event":"hypokalaemia","count":14556,"llr":126.511977},{"event":"orthostatic hypotension","count":6478,"llr":85.6980821},{"event":"hypophagia","count":5291,"llr":82.17841758},{"event":"dehydration","count":36809,"llr":68.56830167},{"event":"renal failure acute","count":23893,"llr":66.31411891},{"event":"hypotension","count":55121,"llr":57.73917926},{"event":"hypomagnesaemia","count":4347,"llr":56.8016292},{"event":"monoclonal b-cell lymphocytosis","count":34,"llr":55.73201982},{"event":"extravasation blood","count":58,"llr":50.93003194},{"event":"neutrophilic dermatosis","count":119,"llr":44.47399205},{"event":"acanthosis","count":126,"llr":43.96095308},{"event":"delirium","count":11053,"llr":43.12963711},{"event":"drug interaction","count":53526,"llr":41.94380713},{"event":"drug dispensed to wrong patient","count":164,"llr":41.59622053},{"event":"circulatory collapse","count":4559,"llr":39.784726},{"event":"fall","count":67604,"llr":36.75736774},{"event":"lethargy","count":17134,"llr":36.73578962},{"event":"skin oedema","count":361,"llr":34.53414538},{"event":"renal tubular necrosis","count":3219,"llr":32.97292864},{"event":"daydreaming","count":254,"llr":32.54867726},{"event":"diabetes mellitus inadequate control","count":3519,"llr":31.69535007},{"event":"thirst","count":2942,"llr":31.0478274},{"event":"urine oxalate increased","count":24,"llr":29.75278755},{"event":"mucous membrane disorder","count":657,"llr":29.2035366},{"event":"vomiting","count":103943,"llr":28.75548429},{"event":"osmotic demyelination syndrome","count":267,"llr":27.20033761},{"event":"narcotic intoxication","count":48,"llr":26.29183114},{"event":"syncope","count":31191,"llr":25.29096035},{"event":"chronic lymphocytic leukaemia","count":1098,"llr":24.66886483},{"event":"livedo reticularis","count":702,"llr":24.50476139},{"event":"feeding disorder of infancy or early childhood","count":94,"llr":22.94052308},{"event":"dysarthria","count":11020,"llr":22.1342097},{"event":"jaundice","count":9877,"llr":21.68140179},{"event":"viith nerve paralysis","count":1573,"llr":21.52754719},{"event":"blood electrolytes abnormal","count":324,"llr":21.2437617},{"event":"malaise","count":82447,"llr":20.37385242},{"event":"polyuria","count":2563,"llr":20.25864677},{"event":"faeces soft","count":765,"llr":19.93087476},{"event":"blood magnesium decreased","count":1961,"llr":19.62021661},{"event":"agitation","count":21093,"llr":18.72086625},{"event":"atrial fibrillation","count":25339,"llr":18.58532832},{"event":"supraventricular tachycardia","count":3329,"llr":17.79537405},{"event":"atrioventricular block first degree","count":1707,"llr":17.59570323},{"event":"rash pustular","count":2776,"llr":16.65376045},{"event":"lower respiratory tract infection","count":8977,"llr":16.61928561},{"event":"hepatic cancer metastatic","count":123,"llr":16.39122634},{"event":"abnormal loss of weight","count":1300,"llr":16.3254605},{"event":"urine flow decreased","count":386,"llr":15.93596381},{"event":"biliary sepsis","count":141,"llr":15.84851361},{"event":"nodule","count":3063,"llr":15.82520476},{"event":"lid lag","count":30,"llr":15.64897255},{"event":"pain","count":94786,"llr":15.26945721},{"event":"headache","count":120638,"llr":15.21899175},{"event":"hypocalcaemia","count":7012,"llr":15.21284273},{"event":"neonatal respiratory distress syndrome","count":1535,"llr":15.20899125},{"event":"dizziness","count":99375,"llr":14.66869402},{"event":"blood sodium decreased","count":4728,"llr":14.56414084},{"event":"pleuritic pain","count":1019,"llr":14.50700867},{"event":"productive cough","count":7770,"llr":14.13093312},{"event":"dermatitis exfoliative","count":2700,"llr":14.12467522},{"event":"rash vesicular","count":1171,"llr":13.70302958},{"event":"diarrhoea","count":126514,"llr":13.53825362},{"event":"mastication disorder","count":694,"llr":13.06413582},{"event":"abscess","count":4306,"llr":13.00615025},{"event":"hemianopia homonymous","count":320,"llr":12.60596476},{"event":"glucose urine present","count":367,"llr":12.0671742},{"event":"bradycardia","count":20091,"llr":11.62028778},{"event":"loss of consciousness","count":30434,"llr":11.206355},{"event":"arcus lipoides","count":17,"llr":10.75578844},{"event":"growth retardation","count":1124,"llr":10.73890266},{"event":"weight fluctuation","count":1133,"llr":10.70081933},{"event":"blood phosphorus decreased","count":1181,"llr":10.50291835},{"event":"retching","count":3162,"llr":10.47362771},{"event":"seizure","count":19835,"llr":10.34838159},{"event":"neutropenic sepsis","count":2129,"llr":10.30687594},{"event":"obesity","count":2349,"llr":9.760631892},{"event":"chronic obstructive pulmonary disease","count":10053,"llr":9.737442232},{"event":"milk-alkali syndrome","count":222,"llr":9.682869538},{"event":"skin lesion","count":6560,"llr":9.664473011},{"event":"cerebral infarction","count":8424,"llr":9.520790505},{"event":"skin ulcer","count":6795,"llr":9.394339986},{"event":"water intoxication","count":247,"llr":9.367728611},{"event":"cerebral haematoma","count":811,"llr":8.984098617},{"event":"miosis","count":2714,"llr":8.966669088}],"critval":8.857239939},"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":2}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297263","_score":1,"_source":{"id":"CHEMBL4297263","internal_compound":false,"type":"Small molecule","pref_name":"AROPLATIN","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Aroplatin"],"trade_names":[],"indications":[{"efo_id":"EFO_0000096","efo_label":"neoplasm of mature B-cells","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000096","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00316511"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00316511%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL468","_score":1,"_source":{"id":"CHEMBL468","internal_compound":false,"type":"Small molecule","pref_name":"THALIDOMIDE","year_first_approved":1998,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["K-17","NSC-527179","NSC-66847","Thalidomide","Thalidomide "],"trade_names":["Talidex","Thalomid"],"cross_references":[{"source":"ChEBI","ids":[74947]},{"source":"DailyMed","ids":["thalidomide"]},{"source":"PubChem","ids":["111716","11532929","124881523","144210897","170465323","174007312","26747126","26751823","50104514","90341724"]},{"source":"Wikipedia","ids":["Thalidomide"]},{"source":"drugbank","ids":["DB01041"]}],"canonical_smiles":"O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1","indications":[{"efo_id":"EFO_0000540","efo_label":"immune system disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000540","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["L04AX02"],"urls":["https://www.whocc.no/atc_ddd_index/?code=L04AX02"]}]},{"efo_id":"EFO_0000384","efo_label":"Crohn's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000384","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00720538","NCT02501291","NCT02956538","NCT03221166"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00720538%22OR%22NCT02501291%22OR%22NCT02956538%22OR%22NCT03221166%22"]}]},{"efo_id":"EFO_0000717","efo_label":"systemic scleroderma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000717","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00418132"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00418132%22"]}]},{"efo_id":"EFO_0000691","efo_label":"sarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000691","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00019123","NCT00025506","NCT00026416","NCT00033709","NCT00089544"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00019123%22OR%22NCT00025506%22OR%22NCT00026416%22OR%22NCT00033709%22OR%22NCT00089544%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00004088","NCT00005834","NCT00006890","NCT00008242","NCT00022607","NCT00028886","NCT00033332","NCT00038090","NCT00038233","NCT00040937","NCT00049374","NCT00049673","NCT00054158","NCT00057564","NCT00064337","NCT00075829","NCT00081757","NCT00081939","NCT00083382","NCT00083408","NCT00083460","NCT00083538","NCT00083551","NCT00083577","NCT00083681","NCT00083876","NCT00083902","NCT00083915","NCT00089167","NCT00097981","NCT00098475","NCT00111748","NCT00112879","NCT00124579","NCT00124813","NCT00182663","NCT00193544","NCT00205751","NCT00215943","NCT00218855","NCT00222053","NCT00222105","NCT00227682","NCT00232934","NCT00256776","NCT00258245","NCT00263484","NCT00287872","NCT00319865","NCT00349115","NCT00358020","NCT00367185","NCT00406978","NCT00432458","NCT00438841","NCT00443235","NCT00452569","NCT00458705","NCT00461747","NCT00507416","NCT00523848","NCT00531453","NCT00538733","NCT00538824","NCT00572169","NCT00573391","NCT00574080","NCT00577668","NCT00602511","NCT00602641","NCT00633542","NCT00644306","NCT00657488","NCT00689936","NCT00734877","NCT00792142","NCT00869232","NCT00871013","NCT00910897","NCT00934154","NCT00961467","NCT00966693","NCT01055301","NCT01057225","NCT01063179","NCT01070862","NCT01114048","NCT01134484","NCT01242267","NCT01274403","NCT01296503","NCT01341262","NCT01526694","NCT01532856","NCT01537861","NCT01539083","NCT01548573","NCT01554852","NCT01632150","NCT01937442","NCT01971658","NCT01998971","NCT02145715","NCT02248428","NCT02410694","NCT02467647","NCT02541383","NCT02586038","NCT02891811","NCT03004287","NCT03140943","NCT03143036","NCT03402295","NCT03562169","NCT03608501"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004088%22OR%22NCT00005834%22OR%22NCT00006890%22OR%22NCT00008242%22OR%22NCT00022607%22OR%22NCT00028886%22OR%22NCT00033332%22OR%22NCT00038090%22OR%22NCT00038233%22OR%22NCT00040937%22OR%22NCT00049374%22OR%22NCT00049673%22OR%22NCT00054158%22OR%22NCT00057564%22OR%22NCT00064337%22OR%22NCT00075829%22OR%22NCT00081757%22OR%22NCT00081939%22OR%22NCT00083382%22OR%22NCT00083408%22OR%22NCT00083460%22OR%22NCT00083538%22OR%22NCT00083551%22OR%22NCT00083577%22OR%22NCT00083681%22OR%22NCT00083876%22OR%22NCT00083902%22OR%22NCT00083915%22OR%22NCT00089167%22OR%22NCT00097981%22OR%22NCT00098475%22OR%22NCT00111748%22OR%22NCT00112879%22OR%22NCT00124579%22OR%22NCT00124813%22OR%22NCT00182663%22OR%22NCT00193544%22OR%22NCT00205751%22OR%22NCT00215943%22OR%22NCT00218855%22OR%22NCT00222053%22OR%22NCT00222105%22OR%22NCT00227682%22OR%22NCT00232934%22OR%22NCT00256776%22OR%22NCT00258245%22OR%22NCT00263484%22OR%22NCT00287872%22OR%22NCT00319865%22OR%22NCT00349115%22OR%22NCT00358020%22OR%22NCT00367185%22OR%22NCT00406978%22OR%22NCT00432458%22OR%22NCT00438841%22OR%22NCT00443235%22OR%22NCT00452569%22OR%22NCT00458705%22OR%22NCT00461747%22OR%22NCT00507416%22OR%22NCT00523848%22OR%22NCT00531453%22OR%22NCT00538733%22OR%22NCT00538824%22OR%22NCT00572169%22OR%22NCT00573391%22OR%22NCT00574080%22OR%22NCT00577668%22OR%22NCT00602511%22OR%22NCT00602641%22OR%22NCT00633542%22OR%22NCT00644306%22OR%22NCT00657488%22OR%22NCT00689936%22OR%22NCT00734877%22OR%22NCT00792142%22OR%22NCT00869232%22OR%22NCT00871013%22OR%22NCT00910897%22OR%22NCT00934154%22OR%22NCT00961467%22OR%22NCT00966693%22OR%22NCT01055301%22OR%22NCT01057225%22OR%22NCT01063179%22OR%22NCT01070862%22OR%22NCT01114048%22OR%22NCT01134484%22OR%22NCT01242267%22OR%22NCT01274403%22OR%22NCT01296503%22OR%22NCT01341262%22OR%22NCT01526694%22OR%22NCT01532856%22OR%22NCT01537861%22OR%22NCT01539083%22OR%22NCT01548573%22OR%22NCT01554852%22OR%22NCT01632150%22OR%22NCT01937442%22OR%22NCT01971658%22OR%22NCT01998971%22OR%22NCT02145715%22OR%22NCT02248428%22OR%22NCT02410694%22OR%22NCT02467647%22OR%22NCT02541383%22OR%22NCT02586038%22OR%22NCT02891811%22OR%22NCT03004287%22OR%22NCT03140943%22OR%22NCT03143036%22OR%22NCT03402295%22OR%22NCT03562169%22OR%22NCT03608501%22"]},{"source":"DailyMed","ids":["2eda833b-1357-4ed4-a093-194524fcb061"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2eda833b-1357-4ed4-a093-194524fcb061"]}]},{"efo_id":"Orphanet_797","efo_label":"Sarcoidosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_797","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00305552"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00305552%22"]}]},{"efo_id":"EFO_0002430","efo_label":"primary myelofibrosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002430","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00015821","NCT03069326"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00015821%22OR%22NCT03069326%22"]}]},{"efo_id":"EFO_0000249","efo_label":"Alzheimer's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000249","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01094340"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01094340%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00049296","NCT00250796","NCT00251797","NCT00379353"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00049296%22OR%22NCT00250796%22OR%22NCT00251797%22OR%22NCT00379353%22"]}]},{"efo_id":"EFO_0000474","efo_label":"epilepsy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000474","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01061866"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01061866%22"]}]},{"efo_id":"EFO_0002916","efo_label":"esophageal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002916","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01551641"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01551641%22"]}]},{"efo_id":"EFO_0000365","efo_label":"colorectal adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000365","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00165217"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00165217%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00003754","NCT00033254","NCT00062127","NCT02203253"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003754%22OR%22NCT00033254%22OR%22NCT00062127%22OR%22NCT02203253%22"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00000812","NCT00053430"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000812%22OR%22NCT00053430%22"]}]},{"efo_id":"EFO_0003898","efo_label":"ankylosing spondylitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003898","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02201043"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02201043%22"]}]},{"efo_id":"EFO_0000095","efo_label":"chronic lymphocytic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000095","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00006226","NCT00009984","NCT00022581","NCT01125176"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00006226%22OR%22NCT00009984%22OR%22NCT00022581%22OR%22NCT01125176%22"]}]},{"efo_id":"EFO_0000182","efo_label":"hepatocellular carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000182","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00006006","NCT00006016","NCT00006198","NCT00058487","NCT00155272","NCT00225290","NCT00276705","NCT00384800","NCT00519688","NCT00728078","NCT00921531","NCT00971126"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00006006%22OR%22NCT00006016%22OR%22NCT00006198%22OR%22NCT00058487%22OR%22NCT00155272%22OR%22NCT00225290%22OR%22NCT00276705%22OR%22NCT00384800%22OR%22NCT00519688%22OR%22NCT00728078%22OR%22NCT00921531%22OR%22NCT00971126%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00193102","NCT02649101"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00193102%22OR%22NCT02649101%22"]}]},{"efo_id":"EFO_0001065","efo_label":"endometriosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001065","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01028781"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01028781%22"]}]},{"efo_id":"EFO_0003047","efo_label":"hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003047","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00856804"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00856804%22"]}]},{"efo_id":"EFO_0004268","efo_label":"sclerosing cholangitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004268","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00953615"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00953615%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02387086","NCT03062800","NCT03341494"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02387086%22OR%22NCT03062800%22OR%22NCT03341494%22"]}]},{"efo_id":"EFO_0000096","efo_label":"neoplasm of mature B-cells","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000096","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00015912","NCT00209014"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00015912%22OR%22NCT00209014%22"]}]},{"efo_id":"EFO_0000183","efo_label":"Hodgkins lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000183","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00209014"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00209014%22"]}]},{"efo_id":"EFO_0000191","efo_label":"MALT lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000191","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00373646"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00373646%22"]}]},{"efo_id":"EFO_0000198","efo_label":"myelodysplastic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000198","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00050843","NCT00455910","NCT00704704"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00050843%22OR%22NCT00455910%22OR%22NCT00704704%22"]}]},{"efo_id":"EFO_0000253","efo_label":"amyotrophic lateral sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000253","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00140452","NCT00231140"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00140452%22OR%22NCT00231140%22"]}]},{"efo_id":"EFO_0000313","efo_label":"carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000313","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00310076"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00310076%22"]}]},{"efo_id":"EFO_0000326","efo_label":"central nervous system cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000326","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00006358","NCT00014443","NCT00039468","NCT00047281","NCT00047294","NCT00047879","NCT00049361","NCT00079092","NCT00112502"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00006358%22OR%22NCT00014443%22OR%22NCT00039468%22OR%22NCT00047281%22OR%22NCT00047294%22OR%22NCT00047879%22OR%22NCT00049361%22OR%22NCT00079092%22OR%22NCT00112502%22"]}]},{"efo_id":"EFO_0000342","efo_label":"chronic pancreatitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000342","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00469703"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00469703%22"]}]},{"efo_id":"EFO_0000389","efo_label":"cutaneous melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000389","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00005815","NCT00017316","NCT00026520","NCT00072345","NCT00104988","NCT00238329"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00005815%22OR%22NCT00017316%22OR%22NCT00026520%22OR%22NCT00072345%22OR%22NCT00104988%22OR%22NCT00238329%22"]}]},{"efo_id":"EFO_0000403","efo_label":"diffuse large B-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000403","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02733380","NCT03016000"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02733380%22OR%22NCT03016000%22"]}]},{"efo_id":"EFO_0000519","efo_label":"glioblastoma multiforme","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000519","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00412542","NCT00521482"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00412542%22OR%22NCT00521482%22"]}]},{"efo_id":"EFO_0000565","efo_label":"leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000565","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00052416","NCT00083694","NCT00096018"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00052416%22OR%22NCT00083694%22OR%22NCT00096018%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00052416","NCT00450801","NCT00723658","NCT00958854","NCT02085655"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00052416%22OR%22NCT00450801%22OR%22NCT00723658%22OR%22NCT00958854%22OR%22NCT02085655%22"]}]},{"efo_id":"EFO_0000673","efo_label":"prostate adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000673","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00001446","NCT00020046","NCT00089609","NCT00450008"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00001446%22OR%22NCT00020046%22OR%22NCT00089609%22OR%22NCT00450008%22"]}]},{"efo_id":"EFO_0000676","efo_label":"psoriasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000676","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01891019"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01891019%22"]}]},{"efo_id":"EFO_0000681","efo_label":"renal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000681","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00019539","NCT00277017"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00019539%22OR%22NCT00277017%22"]}]},{"efo_id":"EFO_0000729","efo_label":"ulcerative colitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000729","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00720538"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00720538%22"]}]},{"efo_id":"EFO_0000756","efo_label":"melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000756","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00006200","NCT00072163","NCT00505635"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00006200%22OR%22NCT00072163%22OR%22NCT00505635%22"]}]},{"efo_id":"EFO_0000765","efo_label":"AIDS","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000765","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00001475"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00001475%22"]}]},{"efo_id":"EFO_0000768","efo_label":"idiopathic pulmonary fibrosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000768","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00162760","NCT00600028"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00162760%22OR%22NCT00600028%22"]}]},{"efo_id":"EFO_0001071","efo_label":"lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001071","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00004859","NCT00025285","NCT00053300","NCT00061919","NCT00114192","NCT00281827"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004859%22OR%22NCT00025285%22OR%22NCT00053300%22OR%22NCT00061919%22OR%22NCT00114192%22OR%22NCT00281827%22"]}]},{"efo_id":"EFO_0001075","efo_label":"ovarian carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001075","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00004876","NCT00016224"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004876%22OR%22NCT00016224%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00004635","NCT00038181","NCT00038246","NCT00046826","NCT00083005","NCT00201357","NCT00307294","NCT00400517"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004635%22OR%22NCT00038181%22OR%22NCT00038246%22OR%22NCT00046826%22OR%22NCT00083005%22OR%22NCT00201357%22OR%22NCT00307294%22OR%22NCT00400517%22"]}]},{"efo_id":"EFO_0002690","efo_label":"systemic lupus erythematosus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002690","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00001680"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00001680%22"]}]},{"efo_id":"EFO_0002890","efo_label":"renal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002890","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00005966","NCT00025519","NCT00027664","NCT00090870"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00005966%22OR%22NCT00025519%22OR%22NCT00027664%22OR%22NCT00090870%22"]}]},{"efo_id":"EFO_0002939","efo_label":"medulloblastoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002939","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01356290"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01356290%22"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00121563"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00121563%22"]}]},{"efo_id":"EFO_0003865","efo_label":"kidney neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003865","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00226980"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00226980%22"]}]},{"efo_id":"EFO_0004142","efo_label":"colorectal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004142","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02748772"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02748772%22"]}]},{"efo_id":"EFO_0004289","efo_label":"lymphoid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004289","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00006226","NCT00009984"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00006226%22OR%22NCT00009984%22"]}]},{"efo_id":"EFO_0005543","efo_label":"glioma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005543","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01756989"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01756989%22"]}]},{"efo_id":"EFO_0005952","efo_label":"non-Hodgkins lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005952","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00151281"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00151281%22"]}]},{"efo_id":"EFO_0006859","efo_label":"head and neck malignant neoplasia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006859","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00003850","NCT00026533"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003850%22OR%22NCT00026533%22"]}]},{"efo_id":"EFO_0006888","efo_label":"vascular malformation","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006888","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02707484"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02707484%22"]}]},{"efo_id":"EFO_0007160","efo_label":"autoimmune thrombocytopenic purpura","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007160","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01976195"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01976195%22"]}]},{"efo_id":"EFO_0007312","efo_label":"HIV wasting syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007312","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00002127"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002127%22"]}]},{"efo_id":"EFO_1000045","efo_label":"pancreatic neuroendocrine tumor","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000045","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03204019"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03204019%22"]}]},{"efo_id":"EFO_1001332","efo_label":"Giant Lymph Node Hyperplasia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001332","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03043105"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03043105%22"]}]},{"efo_id":"EFO_1001767","efo_label":"brain stem neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001767","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00179881"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00179881%22"]}]},{"efo_id":"EFO_1001875","efo_label":"amyloidosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001875","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02545907"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02545907%22"]}]},{"efo_id":"EFO_1001901","efo_label":"neuroendocrine neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001901","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00165230","NCT03204032"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00165230%22OR%22NCT03204032%22"]}]},{"efo_id":"EFO_1001950","efo_label":"colon carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001950","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00890188"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00890188%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00019747","NCT00310076"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00019747%22OR%22NCT00310076%22"]}]},{"efo_id":"EFO_1001996","efo_label":"Thalassemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001996","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02995707","NCT03184844"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02995707%22OR%22NCT03184844%22"]}]},{"efo_id":"HP_0012735","efo_label":"Cough","efo_uri":"http://purl.obolibrary.org/obo/HP_0012735","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00600028"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00600028%22"]}]},{"efo_id":"Orphanet_314701","efo_label":"Primary systemic amyloidosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_314701","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01527032"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01527032%22"]}]},{"efo_id":"Orphanet_85443","efo_label":"AL amyloidosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_85443","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01659658"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01659658%22"]}]},{"efo_id":"EFO_0009441","efo_label":"Waldenstrom macroglobulinemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009441","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00083707","NCT00142116","NCT01779167"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00083707%22OR%22NCT00142116%22OR%22NCT01779167%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000113851","approved_name":"cereblon","approved_symbol":"CRBN"},{"ensembl":"ENSG00000167986","approved_name":"damage specific DNA binding protein 1","approved_symbol":"DDB1"},{"ensembl":"ENSG00000139842","approved_name":"cullin 4A","approved_symbol":"CUL4A"},{"ensembl":"ENSG00000100387","approved_name":"ring-box 1","approved_symbol":"RBX1"}],"target_type":"protein complex","target_name":"CRL4(CRBN) E3 ubiquitin ligase","action_type":"inhibitor","description":"CRL4(CRBN) E3 ubiquitin ligase inhibitor","references":[{"source":"PubMed","ids":["22552008","25043012"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22552008+OR+EXT_ID%3A25043012"]}]}],"adverse_events":{"significant":[{"event":"neuropathy peripheral","count":20261,"llr":1181.498842},{"event":"plasma cell myeloma","count":7205,"llr":957.1355321},{"event":"deep vein thrombosis","count":21525,"llr":562.9819864},{"event":"blood human chorionic gonadotropin increased","count":201,"llr":475.1485978},{"event":"disease progression","count":21531,"llr":407.9339147},{"event":"pneumonia","count":65209,"llr":383.4284983},{"event":"multiple myeloma","count":1081,"llr":321.4814415},{"event":"pulmonary embolism","count":25452,"llr":306.2976628},{"event":"neuropathy","count":896,"llr":228.5185487},{"event":"constipation","count":39620,"llr":211.1199799},{"event":"plasma cell myeloma recurrent","count":726,"llr":186.6866972},{"event":"injection site pain","count":56727,"llr":180.3022608}],"critval":162.4583483},"number_of_indications":70,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":43},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":20},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":17},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":17},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":15},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":12},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":10},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":10},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":9},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":8},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":8},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":5},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":5},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":3},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":3},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":3},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":2},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL172513","_score":1,"_source":{"id":"CHEMBL172513","internal_compound":false,"type":"Small molecule","pref_name":"CARNITINE","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Carnitine","Carnitine Chloride","Carnitine dl-form"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[17126]},{"source":"Wikipedia","ids":["Carnitine"]}],"canonical_smiles":"C[N+](C)(C)CC(O)CC(=O)[O-]","indications":[{"efo_id":"Orphanet_1480","efo_label":"Ventricular septal defect","efo_uri":"http://www.orpha.net/ORDO/Orphanet_1480","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01825369"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01825369%22"]}]},{"efo_id":"EFO_0003876","efo_label":"intermittent vascular claudication","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003876","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00399919"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00399919%22"]}]},{"efo_id":"EFO_0000729","efo_label":"ulcerative colitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000729","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01026857","NCT01538251","NCT01567956"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01026857%22OR%22NCT01538251%22OR%22NCT01567956%22"]}]},{"efo_id":"EFO_0006834","efo_label":"septic shock","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006834","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01665092"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01665092%22"]}]},{"efo_id":"EFO_0003888","efo_label":"attention deficit hyperactivity disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003888","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01099072"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01099072%22"]}]},{"efo_id":"EFO_0007454","efo_label":"postpoliomyelitis syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007454","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01549847"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01549847%22"]}]},{"efo_id":"Orphanet_683","efo_label":"Progressive supranuclear palsy","efo_uri":"http://www.orpha.net/ORDO/Orphanet_683","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01537549"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01537549%22"]}]}],"adverse_events":{"significant":[{"event":"parenteral nutrition associated liver disease","count":50,"llr":282.1063551}],"critval":32.98677839},"number_of_indications":7,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":3},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":2},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":2},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2106618","_score":1,"_source":{"id":"CHEMBL2106618","internal_compound":false,"type":"Small molecule","pref_name":"GLISOXEPIDE","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["BAY-B-4231","FBB-4231","Glisoxepide","RP-22410"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["144205252"]},{"source":"drugbank","ids":["DB01289"]}],"canonical_smiles":"Cc1cc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NN3CCCCCC3)cc2)no1","indications":[{"efo_id":"EFO_0000400","efo_label":"diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000400","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["A10BB11"],"urls":["https://www.whocc.no/atc_ddd_index/?code=A10BB11"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL997","_score":1,"_source":{"id":"CHEMBL997","internal_compound":false,"type":"Small molecule","pref_name":"IBANDRONIC ACID","year_first_approved":2003,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["BM 21.0955","BM-21.0955","BM-210955","Boniva","Ibandronate","Ibandronate Sodium","Ibandronate monosodium monohydrate","Ibandronate sodium hydrate","Ibandronic Acid","Ibandronic acid sodium salt","Ibandronic acid sodium salt monohydrate"],"trade_names":["Bondronat","Boniva","Bonviva","Iasibon","Ibandronate Sodium","Quodixor"],"cross_references":[{"source":"DailyMed","ids":["ibandronate%20sodium"]},{"source":"PubChem","ids":["90340689"]},{"source":"Wikipedia","ids":["Ibandronic_acid"]},{"source":"drugbank","ids":["DB00710"]},{"source":"PubChem","ids":["144205985"]}],"canonical_smiles":"CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O","indications":[{"efo_id":"EFO_0003854","efo_label":"postmenopausal osteoporosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003854","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00092053","NCT00545779","NCT00666627","NCT00936897","NCT01581320"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00092053%22OR%22NCT00545779%22OR%22NCT00666627%22OR%22NCT00936897%22OR%22NCT01581320%22"]}]},{"efo_id":"EFO_0003882","efo_label":"osteoporosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003882","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00397839","NCT00447915","NCT00683163","NCT03186131"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00397839%22OR%22NCT00447915%22OR%22NCT00683163%22OR%22NCT03186131%22"]}]},{"efo_id":"HP_0002027","efo_label":"Abdominal pain","efo_uri":"http://purl.obolibrary.org/obo/HP_0002027","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02586558"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02586558%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00196859","NCT00381368","NCT02616744"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00196859%22OR%22NCT00381368%22OR%22NCT02616744%22"]}]},{"efo_id":"EFO_0004260","efo_label":"bone disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004260","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["M05BA06"],"urls":["https://www.whocc.no/atc_ddd_index/?code=M05BA06"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02739594"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02739594%22"]}]},{"efo_id":"EFO_0004259","efo_label":"osteonecrosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004259","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02114489"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02114489%22"]}]},{"efo_id":"EFO_0001642","efo_label":"lymphoid neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001642","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00824993"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00824993%22"]}]},{"efo_id":"EFO_0003882","efo_label":"osteoporosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003882","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00048061","NCT00048074","NCT00493623","NCT01290094"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00048061%22OR%22NCT00048074%22OR%22NCT00493623%22OR%22NCT01290094%22"]},{"source":"DailyMed","ids":["5500be0f-8b29-450c-9857-755029965157","8c556975-1d94-43a8-b259-a8780046c2da","9531b609-61df-4b77-be09-7469fc30ee2d","a70566e1-cbe5-472a-85ae-08a14117552a","be514be6-727a-4d6c-993b-52144f8e6de8"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5500be0f-8b29-450c-9857-755029965157","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8c556975-1d94-43a8-b259-a8780046c2da","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9531b609-61df-4b77-be09-7469fc30ee2d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a70566e1-cbe5-472a-85ae-08a14117552a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?be514be6-727a-4d6c-993b-52144f8e6de8"]}]},{"efo_id":"EFO_0003854","efo_label":"postmenopausal osteoporosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003854","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["841bf769-0148-42a8-a4d0-ff062b4734e8","a70566e1-cbe5-472a-85ae-08a14117552a","bcac6719-ad8c-e4a5-c32a-af1c0511c591","d6d7711f-541b-47d1-b937-2c6a021eb6c3","dd674424-b151-d7eb-3acf-b1589347f2f7","f94d9c49-245a-8081-42c4-785113fce498"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?841bf769-0148-42a8-a4d0-ff062b4734e8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a70566e1-cbe5-472a-85ae-08a14117552a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bcac6719-ad8c-e4a5-c32a-af1c0511c591","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d6d7711f-541b-47d1-b937-2c6a021eb6c3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dd674424-b151-d7eb-3acf-b1589347f2f7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f94d9c49-245a-8081-42c4-785113fce498"]},{"source":"FDA","ids":["0c3577ec-2a55-40ee-75f3-74347f83a728","cb78606d-683f-456e-bcf3-a64b9855d033"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A0c3577ec-2a55-40ee-75f3-74347f83a728","https://api.fda.gov/drug/label.json?search=set_id%3Acb78606d-683f-456e-bcf3-a64b9855d033"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00127205","NCT00326820"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00127205%22OR%22NCT00326820%22"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00082927"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00082927%22"]}]},{"efo_id":"HP_0000938","efo_label":"Osteopenia","efo_uri":"http://purl.obolibrary.org/obo/HP_0000938","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00545207"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00545207%22"]}]}],"adverse_events":{"significant":[{"event":"femur fracture","count":7800,"llr":1577.88492},{"event":"osteonecrosis of jaw","count":11946,"llr":967.0915449},{"event":"osteonecrosis","count":10916,"llr":775.7625972},{"event":"bone pain","count":13854,"llr":683.5346889},{"event":"low turnover osteopathy","count":1335,"llr":623.6019837},{"event":"arthralgia","count":75397,"llr":459.802071},{"event":"stress fracture","count":1561,"llr":432.3841535},{"event":"myalgia","count":42953,"llr":301.3325944},{"event":"osteoarthritis","count":9922,"llr":297.3933535},{"event":"back pain","count":46032,"llr":266.6461251},{"event":"pain in extremity","count":62441,"llr":265.4329763},{"event":"fracture nonunion","count":612,"llr":265.0006863},{"event":"pain in jaw","count":7746,"llr":261.1683253},{"event":"impaired healing","count":7834,"llr":256.9650219},{"event":"atypical femur fracture","count":1191,"llr":252.439885},{"event":"osteomyelitis","count":5427,"llr":251.0011856},{"event":"influenza like illness","count":19494,"llr":242.5177522},{"event":"osteoporosis","count":5957,"llr":241.0509434},{"event":"gastrooesophageal reflux disease","count":14790,"llr":234.1425787},{"event":"tooth disorder","count":5727,"llr":228.1821035},{"event":"intramedullary rod insertion","count":694,"llr":226.3227742},{"event":"bone disorder","count":5209,"llr":224.5236279},{"event":"injection site extravasation","count":3270,"llr":208.1713066},{"event":"vitamin d deficiency","count":2136,"llr":203.6046566},{"event":"tooth extraction","count":3855,"llr":194.2013496},{"event":"anaemia postoperative","count":625,"llr":193.1523621},{"event":"dental caries","count":2993,"llr":185.1727152},{"event":"fall","count":67604,"llr":183.3297319},{"event":"foot fracture","count":3763,"llr":180.3533656},{"event":"jaw disorder","count":1782,"llr":171.0868166},{"event":"tooth fracture","count":2370,"llr":158.6105074},{"event":"spinal osteoarthritis","count":2421,"llr":156.9810411},{"event":"fracture delayed union","count":399,"llr":152.4154326},{"event":"bursitis","count":2524,"llr":148.1321385},{"event":"pain","count":94786,"llr":124.5978987},{"event":"chest pain","count":46262,"llr":119.0441494},{"event":"hyperlipidaemia","count":5013,"llr":116.0312984},{"event":"dyspepsia","count":15285,"llr":114.2421691},{"event":"fracture","count":4291,"llr":114.1087968},{"event":"acute phase reaction","count":141,"llr":112.125884},{"event":"osteopenia","count":2685,"llr":111.4169028},{"event":"pathological fracture","count":1695,"llr":110.6577717},{"event":"open reduction of fracture","count":416,"llr":110.3614689},{"event":"exostosis","count":1891,"llr":104.7872416},{"event":"rib fracture","count":4118,"llr":103.2155886},{"event":"bone density decreased","count":1977,"llr":102.4130344},{"event":"musculoskeletal pain","count":15494,"llr":97.09300387}],"critval":96.42957113},"child_chembl_ids":["CHEMBL1201008","CHEMBL3989569"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000160752","approved_name":"farnesyl diphosphate synthase","approved_symbol":"FDPS"}],"target_type":"single protein","target_name":"Farnesyl diphosphate synthase","action_type":"inhibitor","description":"Farnesyl diphosphate synthase inhibitor","references":[{"source":"DailyMed","ids":["setid=5500be0f-8b29-450c-9857-755029965157"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5500be0f-8b29-450c-9857-755029965157"]},{"source":"PubMed","ids":["11160603","15028820","16892359"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11160603+OR+EXT_ID%3A15028820+OR+EXT_ID%3A16892359"]}]}],"number_of_indications":13,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":6},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":4},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":3},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":2},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":2},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL593","_score":1,"_source":{"id":"CHEMBL593","internal_compound":false,"type":"Small molecule","pref_name":"DELAVIRDINE","year_first_approved":1997,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Delavirdine","Delavirdine mesilate","Delavirdine mesylate","Delavirdine methanesulfonate","Rescriptor","U-90152","U-90152S","U-90152T"],"trade_names":["Rescriptor"],"cross_references":[{"source":"ChEBI","ids":[119573]},{"source":"DailyMed","ids":["delavirdine%20mesylate"]},{"source":"PubChem","ids":["144206190","170464664"]},{"source":"Wikipedia","ids":["Delavirdine"]},{"source":"drugbank","ids":["DB00705"]},{"source":"ChEBI","ids":[4379]}],"canonical_smiles":"CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1","indications":[{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00624195","NCT02249130"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00624195%22OR%22NCT02249130%22"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000803","NCT00000810","NCT00000882","NCT00000891","NCT00001094","NCT00002123","NCT00002124","NCT00002178","NCT00002210","NCT00002378","NCT00002420"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000803%22OR%22NCT00000810%22OR%22NCT00000882%22OR%22NCT00000891%22OR%22NCT00001094%22OR%22NCT00002123%22OR%22NCT00002124%22OR%22NCT00002178%22OR%22NCT00002210%22OR%22NCT00002378%22OR%22NCT00002420%22"]}]}],"adverse_events":{"significant":[{"event":"progressive external ophthalmoplegia","count":60,"llr":319.0288064},{"event":"mitochondrial toxicity","count":279,"llr":312.9991055},{"event":"lipodystrophy acquired","count":879,"llr":268.2509492},{"event":"eyelid ptosis","count":2847,"llr":215.4238622},{"event":"diplopia","count":6509,"llr":177.9048078},{"event":"ophthalmoplegia","count":459,"llr":66.60216493},{"event":"extraocular muscle paresis","count":154,"llr":46.68411882},{"event":"campylobacter gastroenteritis","count":187,"llr":23.58991785},{"event":"virologic failure","count":2156,"llr":23.26023259},{"event":"lactic acidosis","count":8744,"llr":22.33031174},{"event":"drug resistance","count":7341,"llr":16.01581249},{"event":"weight decreased","count":46078,"llr":9.789290151},{"event":"low birth weight baby","count":2450,"llr":9.142463049}],"critval":8.805527121},"child_chembl_ids":["CHEMBL929"],"mechanisms_of_action":[{"target_type":"single protein","target_name":"Human immunodeficiency virus type 1 reverse transcriptase","action_type":"inhibitor","description":"Human immunodeficiency virus type 1 reverse transcriptase inhibitor","references":[{"source":"DailyMed","ids":["setid=992306f0-c612-41dd-a4df-35d1fd360033#nlm34090-1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=992306f0-c612-41dd-a4df-35d1fd360033#nlm34090-1"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":2},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":2}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2104207","_score":1,"_source":{"id":"CHEMBL2104207","internal_compound":false,"type":"Small molecule","pref_name":"CAFEDRINE","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Cafedrine"],"trade_names":[],"canonical_smiles":"CC(NCCn1cnc2c1c(=O)n(C)c(=O)n2C)C(O)c1ccccc1","indications":[{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["C01CA21"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C01CA21"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545200","_score":1,"_source":{"id":"CHEMBL3545200","internal_compound":false,"type":"Small molecule","pref_name":"S-222611","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["S-222611"],"trade_names":[],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000146648","approved_name":"epidermal growth factor receptor","approved_symbol":"EGFR"}],"target_type":"single protein","target_name":"Epidermal growth factor receptor erbB1","action_type":"inhibitor","description":"Epidermal growth factor receptor erbB1 inhibitor","references":[{"source":"PubMed","ids":["24837299","25434923"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24837299+OR+EXT_ID%3A25434923"]}]},{"target_components":[{"ensembl":"ENSG00000141736","approved_name":"erb-b2 receptor tyrosine kinase 2","approved_symbol":"ERBB2"}],"target_type":"single protein","target_name":"Receptor protein-tyrosine kinase erbB-2","action_type":"inhibitor","description":"Receptor protein-tyrosine kinase erbB-2 inhibitor","references":[{"source":"PubMed","ids":["24837299","25434923"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24837299+OR+EXT_ID%3A25434923"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1267","_score":1,"_source":{"id":"CHEMBL1267","internal_compound":false,"type":"Small molecule","pref_name":"LERIGLITAZONE","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Leriglitazone","Leriglitazone hydrochloride","MIN-102","MIN-102 HCl","Min-102"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[82937]},{"source":"drugbank","ids":["DB15021"]}],"canonical_smiles":"CC(O)c1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1","indications":[{"efo_id":"Orphanet_95","efo_label":"Friedreich ataxia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_95","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03917225"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03917225%22"]}]}],"child_chembl_ids":["CHEMBL4298170"],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL105060","_score":1,"_source":{"id":"CHEMBL105060","internal_compound":false,"type":"Small molecule","pref_name":"DNK333","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["DNK-333"],"trade_names":[],"canonical_smiles":"CN(C(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@@H](/C=C/C(=O)N[C@@H]1CCCCNC1=O)Cc1ccc(Cl)c(Cl)c1","indications":[{"efo_id":"EFO_0000341","efo_label":"chronic obstructive pulmonary disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000341","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01287325"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01287325%22"]}]},{"efo_id":"EFO_0000274","efo_label":"atopic eczema","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000274","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01033097"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01033097%22"]}]},{"efo_id":"EFO_0000555","efo_label":"irritable bowel syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000555","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00394173","NCT00699166"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00394173%22OR%22NCT00699166%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000115353","approved_name":"tachykinin receptor 1","approved_symbol":"TACR1"}],"target_type":"single protein","target_name":"Neurokinin 1 receptor","action_type":"antagonist","description":"Neurokinin 1 receptor antagonist","references":[{"source":"PubMed","ids":["12877589","17169559"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12877589+OR+EXT_ID%3A17169559"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3623004","_score":1,"_source":{"id":"CHEMBL3623004","internal_compound":false,"type":"Small molecule","pref_name":"AZD-9496","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AZD9496","Azd 9496","Azd-9496","Azd9496"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB15138"]}],"canonical_smiles":"C[C@@H]1Cc2c([nH]c3ccccc23)[C@@H](c2c(F)cc(/C=C/C(=O)O)cc2F)N1CC(C)(C)F","indications":[{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02248090"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02248090%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3989862","_score":1,"_source":{"id":"CHEMBL3989862","internal_compound":false,"type":"Small molecule","pref_name":"PEFCALCITOL","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["M-5181","M-518101","M5181","M518101","Pefcalcitol"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB11786"]}],"canonical_smiles":"C=C1/C(=C\\C=C2/CCC[C@]3(C)C([C@H](C)OCC(=O)NCC(F)(F)C(F)(F)F)=CC[C@@H]23)C[C@@H](O)C[C@@H]1O","indications":[{"efo_id":"EFO_0000676","efo_label":"psoriasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000676","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00884169","NCT01301157","NCT01844973","NCT01873677","NCT01878461","NCT01908595","NCT01989429","NCT02970331"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00884169%22OR%22NCT01301157%22OR%22NCT01844973%22OR%22NCT01873677%22OR%22NCT01878461%22OR%22NCT01908595%22OR%22NCT01989429%22OR%22NCT02970331%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000111424","approved_name":"vitamin D receptor","approved_symbol":"VDR"}],"target_type":"single protein","target_name":"Vitamin D receptor","action_type":"agonist","description":"Vitamin D receptor agonist","references":[{"source":"Other","ids":["http://clinicaltrials.gov/ct2/show/NCT01989429","http://www.maruho.co.jp/english/aboutmaruho/activities/randd/pipeline.html"],"urls":["http://clinicaltrials.gov/ct2/show/NCT01989429","http://www.maruho.co.jp/english/aboutmaruho/activities/randd/pipeline.html"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1200430","_score":1,"_source":{"id":"CHEMBL1200430","internal_compound":false,"type":"Small molecule","pref_name":"ESTRADIOL ACETATE","year_first_approved":2003,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["E3A","Estradiol 3-acetate","Estradiol Acetate","Estradiol-3-Acetate"],"trade_names":["Femring","Femtrace"],"cross_references":[{"source":"DailyMed","ids":["estradiol%20acetate"]},{"source":"PubChem","ids":["144204912","170465258"]},{"source":"drugbank","ids":["DB13952"]}],"canonical_smiles":"CC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12","mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000091831","approved_name":"estrogen receptor 1","approved_symbol":"ESR1"}],"target_type":"single protein","target_name":"Estrogen receptor alpha","action_type":"agonist","description":"Estrogen receptor alpha agonist","references":[{"source":"DailyMed","ids":["setid=86b90d68-bfb6-47f6-aa5b-a6642391ff13#nlm34090-1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=86b90d68-bfb6-47f6-aa5b-a6642391ff13#nlm34090-1"]},{"source":"Wikipedia","ids":["Estrogen_receptor"],"urls":["https://www.wikipedia.org/Estrogen_receptor"]}]}],"adverse_events":{"significant":[{"event":"hot flush","count":10860,"llr":51.5233669},{"event":"vulvovaginal dryness","count":518,"llr":16.15870121},{"event":"bartholin's cyst","count":62,"llr":14.17778304},{"event":"vaginal haemorrhage","count":7630,"llr":12.0539632},{"event":"menopausal symptoms","count":414,"llr":10.3837149},{"event":"vulvovaginal discomfort","count":577,"llr":9.721334555},{"event":"mood swings","count":5761,"llr":8.981267169},{"event":"night sweats","count":6010,"llr":8.856666278},{"event":"dyspareunia","count":913,"llr":8.806788476},{"event":"fungal infection","count":6516,"llr":8.618914391}],"critval":8.537853959},"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL914","_score":1,"_source":{"id":"CHEMBL914","internal_compound":false,"type":"Small molecule","pref_name":"FEXOFENADINE","year_first_approved":1996,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Allegra","Fexofenadine","Fexofenadine HCl","MDL-16455A"],"trade_names":["Allegra","Allegra Allergy","Allegra Hives","Children's allegra allergy","Children's allegra hives","Fexofenadine HCl","Fexofenadine Hydrochloride Allergy","Fexofenadine Hydrochloride Hives","Telfast 120","Telfast 180","Telfast 30"],"cross_references":[{"source":"ChEBI","ids":[5050]},{"source":"DailyMed","ids":["fexofenadine%20hydrochloride"]},{"source":"PubChem","ids":["50105687","90341422"]},{"source":"Wikipedia","ids":["Fexofenadine"]},{"source":"drugbank","ids":["DB00950"]},{"source":"PubChem","ids":["144206676","170464669","26749923","26753303","50085984"]}],"canonical_smiles":"CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1","indications":[{"efo_id":"EFO_0000270","efo_label":"asthma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000270","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00044811","NCT00044824","NCT00045955"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00044811%22OR%22NCT00044824%22OR%22NCT00045955%22"]}]},{"efo_id":"EFO_0000274","efo_label":"atopic eczema","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000274","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01244230"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01244230%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02908750"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02908750%22"]}]},{"efo_id":"EFO_0003785","efo_label":"allergy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003785","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["R06AX26"],"urls":["https://www.whocc.no/atc_ddd_index/?code=R06AX26"]}]},{"efo_id":"EFO_0003948","efo_label":"gastroesophageal reflux disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003948","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03425097"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03425097%22"]}]},{"efo_id":"EFO_0003956","efo_label":"seasonal allergic rhinitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003956","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00420082","NCT01306721"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00420082%22OR%22NCT01306721%22"]}]},{"efo_id":"EFO_1001417","efo_label":"Rhinitis, Allergic, Perennial","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001417","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01244217"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01244217%22"]}]},{"efo_id":"EFO_0009373","efo_label":"edema","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009373","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01172522"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01172522%22"]}]},{"efo_id":"EFO_0005854","efo_label":"allergic rhinitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005854","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00562120","NCT01033396"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00562120%22OR%22NCT01033396%22"]},{"source":"DailyMed","ids":["4021a77c-36ad-4f3a-bb4b-b44de96173b2"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4021a77c-36ad-4f3a-bb4b-b44de96173b2"]},{"source":"FDA","ids":["14710a71-e2e9-4e4e-bd65-1c296f70c166"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A14710a71-e2e9-4e4e-bd65-1c296f70c166"]}]},{"efo_id":"EFO_1001417","efo_label":"Rhinitis, Allergic, Perennial","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001417","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01228630"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01228630%22"]}]},{"efo_id":"EFO_0003956","efo_label":"seasonal allergic rhinitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003956","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT01306721"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01306721%22"]},{"source":"DailyMed","ids":["107ea1b7-5fbd-46a3-bc42-da620674f350","164e3ec3-b07e-41a5-814e-c462cdc57946","286343b7-96a9-49db-80de-adeaa15647fe","593917d0-1d47-c63c-0c21-ac90182e57bb","6cf8da77-4272-4f88-9e5c-e83cfd80e9e9","741e8b74-2bb5-4153-9727-92ad91e9e9a0","7c25b695-bbed-4ad1-aa47-de47091bc808","8c563f3e-3d21-00ca-b75e-0d052837c1bd","9738127d-7308-454c-94c8-3229d507370f","a3d17e8d-a8ce-4e1a-9ec2-13736af1d7b5","cf6676ff-1122-4495-b64d-f70771a09633","e4020ca3-82d0-4668-b4bc-92e4a53c1f4e","e5a207e4-472b-4bf9-8cd3-a018ef3a82bb","f7036088-40c5-444a-80d4-cead603d2f2e"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?107ea1b7-5fbd-46a3-bc42-da620674f350","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?164e3ec3-b07e-41a5-814e-c462cdc57946","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?286343b7-96a9-49db-80de-adeaa15647fe","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?593917d0-1d47-c63c-0c21-ac90182e57bb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6cf8da77-4272-4f88-9e5c-e83cfd80e9e9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?741e8b74-2bb5-4153-9727-92ad91e9e9a0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7c25b695-bbed-4ad1-aa47-de47091bc808","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8c563f3e-3d21-00ca-b75e-0d052837c1bd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9738127d-7308-454c-94c8-3229d507370f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a3d17e8d-a8ce-4e1a-9ec2-13736af1d7b5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cf6676ff-1122-4495-b64d-f70771a09633","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e4020ca3-82d0-4668-b4bc-92e4a53c1f4e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e5a207e4-472b-4bf9-8cd3-a018ef3a82bb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f7036088-40c5-444a-80d4-cead603d2f2e"]},{"source":"FDA","ids":["00fc4909-d33f-4e73-a63d-10058624915b","5b0cb8a4-61f3-4b0b-a312-58b1b1a5f017","6bbd920a-851b-4fb0-9c09-64642fa410b5","7aa00c0d-ec38-4b45-80d3-3dbba7f1b265","7badf70a-90ec-4c3e-b58a-ba0fbc18e952","ce6d4fc1-7b86-4737-960b-124c52ebaac4","f4a41d2b-9f00-4768-b375-5749793e7de3","f6c3d4ca-0c82-4d74-b147-d3dede8e68f7","f9a15b63-f48e-4802-bd4d-53fdb65ca6a2","ff8b8d50-2ae5-40ca-aa4d-ad426823bceb"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A00fc4909-d33f-4e73-a63d-10058624915b","https://api.fda.gov/drug/label.json?search=set_id%3A5b0cb8a4-61f3-4b0b-a312-58b1b1a5f017","https://api.fda.gov/drug/label.json?search=set_id%3A6bbd920a-851b-4fb0-9c09-64642fa410b5","https://api.fda.gov/drug/label.json?search=set_id%3A7aa00c0d-ec38-4b45-80d3-3dbba7f1b265","https://api.fda.gov/drug/label.json?search=set_id%3A7badf70a-90ec-4c3e-b58a-ba0fbc18e952","https://api.fda.gov/drug/label.json?search=set_id%3Ace6d4fc1-7b86-4737-960b-124c52ebaac4","https://api.fda.gov/drug/label.json?search=set_id%3Af4a41d2b-9f00-4768-b375-5749793e7de3","https://api.fda.gov/drug/label.json?search=set_id%3Af6c3d4ca-0c82-4d74-b147-d3dede8e68f7","https://api.fda.gov/drug/label.json?search=set_id%3Af9a15b63-f48e-4802-bd4d-53fdb65ca6a2","https://api.fda.gov/drug/label.json?search=set_id%3Aff8b8d50-2ae5-40ca-aa4d-ad426823bceb"]}]}],"adverse_events":{"significant":[{"event":"chronic spontaneous urticaria","count":138,"llr":132.3654252},{"event":"urticaria","count":39524,"llr":70.97750763},{"event":"angioedema","count":18080,"llr":70.62188525},{"event":"palpitations","count":23550,"llr":58.13201562},{"event":"drug hypersensitivity","count":71246,"llr":55.78075874},{"event":"hepatic function abnormal","count":12036,"llr":53.66354368},{"event":"pruritus","count":57095,"llr":36.54494186},{"event":"haemoglobin abnormal","count":1301,"llr":34.94622702},{"event":"liver disorder","count":11122,"llr":34.23113872},{"event":"chest discomfort","count":21346,"llr":31.01772633},{"event":"hearing impaired","count":1437,"llr":30.26611988},{"event":"neutrophil count abnormal","count":816,"llr":29.85498042},{"event":"arrhythmia","count":9500,"llr":29.68099486},{"event":"electrocardiogram qt prolonged","count":12378,"llr":29.60838215},{"event":"white blood cell count abnormal","count":1318,"llr":28.00760003},{"event":"condition aggravated","count":52909,"llr":27.52132268},{"event":"skin infection","count":2334,"llr":27.10981782},{"event":"therapeutic response unexpected with drug substitution","count":2352,"llr":27.00829092},{"event":"oesophagitis","count":3670,"llr":26.22379323},{"event":"lip swelling","count":7601,"llr":23.71281497},{"event":"neurosis","count":135,"llr":23.32708547},{"event":"persistent depressive disorder","count":76,"llr":21.38613301},{"event":"alanine aminotransferase increased","count":24852,"llr":20.76470108},{"event":"alopecia universalis","count":93,"llr":20.38253193}],"critval":18.68163955},"child_chembl_ids":["CHEMBL1200618"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000196639","approved_name":"histamine receptor H1","approved_symbol":"HRH1"}],"target_type":"single protein","target_name":"Histamine H1 receptor","action_type":"antagonist","description":"Histamine H1 receptor antagonist","references":[{"source":"DailyMed","ids":["setid=ac0c0247-3b20-445a-84c0-cb7f3939c823"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ac0c0247-3b20-445a-84c0-cb7f3939c823"]}]}],"number_of_indications":11,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":8},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":7},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":2},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108505","_score":1,"_source":{"id":"CHEMBL2108505","internal_compound":false,"type":"Enzyme","pref_name":"LACTASE","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Lactase"],"trade_names":[],"indications":[{"efo_id":"EFO_1000062","efo_label":"lactose intolerance","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000062","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01145586"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01145586%22"]}]}],"adverse_events":{"significant":[{"event":"drug hypersensitivity","count":71246,"llr":28.76850872}],"critval":18.19281279},"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL577294","_score":1,"_source":{"id":"CHEMBL577294","internal_compound":false,"type":"Unknown","pref_name":"2-hydroxypropyl-beta-cyclodextrin","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["2-hydroxypropyl-beta-cyclodextrin","Hydroxypropyl betadex","Hydroxypropyl-Beta-Cyclodextrin"],"trade_names":[],"canonical_smiles":"CC(O)COC[C@H]1O[C@@H]2O[C@@H]3[C@@H](COCC(C)O)O[C@H](O[C@@H]4[C@@H](COCC(C)O)O[C@H](O[C@@H]5[C@@H](COCC(C)O)O[C@H](O[C@@H]6[C@@H](COCC(C)O)O[C@H](O[C@@H]7[C@@H](COCC(C)O)O[C@H](O[C@@H]8[C@@H](COCC(C)O)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O","indications":[{"efo_id":"EFO_1001347","efo_label":"Herpes Labialis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001347","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00914745"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00914745%22"]}]},{"efo_id":"Orphanet_646","efo_label":"Niemann-Pick disease type C","efo_uri":"http://www.orpha.net/ORDO/Orphanet_646","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02912793","NCT02939547","NCT03471143"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02912793%22OR%22NCT02939547%22OR%22NCT03471143%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3301588","_score":1,"_source":{"id":"CHEMBL3301588","internal_compound":false,"type":"Antibody","pref_name":"TAREXTUMAB","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["OMP-59R5","Tarextumab"],"trade_names":[],"indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01277146"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01277146%22"]}]},{"efo_id":"EFO_0000702","efo_label":"small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000702","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01859741"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01859741%22"]}]},{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01647828"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01647828%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000074181","approved_name":"notch receptor 3","approved_symbol":"NOTCH3"}],"target_type":"single protein","target_name":"Neurogenic locus notch homolog protein 3","action_type":"inhibitor","description":"Neurogenic locus notch homolog protein 3 inhibitor","references":[{"source":"Other","ids":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=693946"],"urls":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=693946"]}]},{"target_components":[{"ensembl":"ENSG00000134250","approved_name":"notch receptor 2","approved_symbol":"NOTCH2"}],"target_type":"single protein","target_name":"Neurogenic locus notch homolog protein 2","action_type":"inhibitor","description":"Neurogenic locus notch homolog protein 2 inhibitor","references":[{"source":"Other","ids":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=693946"],"urls":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=693946"]},{"source":"PubMed","ids":["25934888"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25934888"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2111101","_score":1,"_source":{"id":"CHEMBL2111101","internal_compound":false,"type":"Small molecule","pref_name":"PIMAVANSERIN","year_first_approved":2016,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["ACP-103","Pimavanserin","Pimavanserin Tartrate","Pimavanserin tartrate"],"trade_names":["Nuplazid"],"cross_references":[{"source":"DailyMed","ids":["pimavanserin%20tartrate"]},{"source":"drugbank","ids":["DB05316"]}],"canonical_smiles":"CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1","indications":[{"efo_id":"EFO_0000692","efo_label":"schizophrenia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000692","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02970292","NCT02970305","NCT03121586"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02970292%22OR%22NCT02970305%22OR%22NCT03121586%22"]}]},{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03018340","NCT03968159","NCT03999918","NCT04000009"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03018340%22OR%22NCT03968159%22OR%22NCT03999918%22OR%22NCT04000009%22"]}]},{"efo_id":"EFO_0005407","efo_label":"psychosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005407","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N05AX17"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N05AX17"]}]},{"efo_id":"EFO_0005772","efo_label":"neurodegenerative disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005772","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03575052","NCT03623321"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03575052%22OR%22NCT03623321%22"]}]},{"efo_id":"EFO_0002508","efo_label":"Parkinson's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002508","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00086294","NCT00477672","NCT00550238","NCT00658567","NCT01174004","NCT01518309"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00086294%22OR%22NCT00477672%22OR%22NCT00550238%22OR%22NCT00658567%22OR%22NCT01174004%22OR%22NCT01518309%22"]},{"source":"FDA","ids":["label/2016/207318lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2016%2F207318lbl.pdf"]}]},{"efo_id":"EFO_0000249","efo_label":"Alzheimer's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000249","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02035553"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02035553%22"]}]},{"efo_id":"EFO_0000692","efo_label":"schizophrenia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000692","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00361166"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00361166%22"]}]}],"adverse_events":{"significant":[{"event":"hallucination","count":16074,"llr":5200.139915},{"event":"nonspecific reaction","count":802,"llr":1075.40784},{"event":"confusional state","count":40628,"llr":896.4685445},{"event":"delusion","count":4266,"llr":830.3376093},{"event":"abnormal behaviour","count":10841,"llr":495.6010203},{"event":"gait disturbance","count":34050,"llr":372.2317753},{"event":"hospitalisation","count":28436,"llr":363.6540116},{"event":"peripheral swelling","count":26462,"llr":316.6774463},{"event":"somnolence","count":38949,"llr":286.2769363},{"event":"fall","count":67604,"llr":272.5369833},{"event":"hallucination, visual","count":5602,"llr":249.5567505},{"event":"therapeutic response unexpected","count":4551,"llr":226.9213253},{"event":"aggression","count":12814,"llr":218.3820165},{"event":"hypersomnia","count":4153,"llr":155.5553404},{"event":"paranoia","count":4316,"llr":136.3944639},{"event":"gait inability","count":2567,"llr":129.7691346},{"event":"insomnia","count":44658,"llr":128.6179671},{"event":"posture abnormal","count":797,"llr":109.7351346},{"event":"freezing phenomenon","count":222,"llr":108.7557458},{"event":"agitation","count":21093,"llr":108.5328238},{"event":"nightmare","count":7702,"llr":107.1266002},{"event":"dementia","count":4361,"llr":100.1272526},{"event":"urinary tract infection","count":38069,"llr":96.90255257},{"event":"dysstasia","count":4610,"llr":94.42112659},{"event":"psychotic disorder","count":11057,"llr":93.14907115},{"event":"balance disorder","count":15453,"llr":85.13416286},{"event":"drug hypersensitivity","count":71246,"llr":73.76490163},{"event":"restlessness","count":8148,"llr":73.12748147},{"event":"abnormal dreams","count":4584,"llr":71.8815861},{"event":"constipation","count":39620,"llr":71.72415033},{"event":"pyrexia","count":87334,"llr":70.32288603},{"event":"drooling","count":1621,"llr":64.52477234},{"event":"anger","count":5808,"llr":64.45506786},{"event":"anaemia","count":61405,"llr":61.23733566},{"event":"feeling abnormal","count":36538,"llr":59.98988267},{"event":"parkinson's disease","count":2639,"llr":58.23524559},{"event":"tremor","count":36500,"llr":57.92254184},{"event":"unresponsive to stimuli","count":6342,"llr":54.49793967},{"event":"speech disorder","count":10086,"llr":53.98885736},{"event":"disorientation","count":10841,"llr":50.1548018},{"event":"arthralgia","count":75397,"llr":49.38469858},{"event":"lethargy","count":17134,"llr":45.61435332}],"critval":45.54723268},"child_chembl_ids":["CHEMBL2448613"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000102468","approved_name":"5-hydroxytryptamine receptor 2A","approved_symbol":"HTR2A"}],"target_type":"single protein","target_name":"Serotonin 2a (5-HT2a) receptor","action_type":"inverse agonist","description":"Serotonin 2a (5-HT2a) receptor inverse agonist","references":[{"source":"Other","ids":["http://www.acadia-pharm.com/pipeline/nuplazid-pdp/"],"urls":["http://www.acadia-pharm.com/pipeline/nuplazid-pdp/"]},{"source":"PubMed","ids":["16469866","7806373"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16469866+OR+EXT_ID%3A7806373"]},{"source":"Wikipedia","ids":["Pimavanserin"],"urls":["https://www.wikipedia.org/Pimavanserin"]}]}],"number_of_indications":7,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":7},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":5}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1079593","_score":1,"_source":{"id":"CHEMBL1079593","internal_compound":false,"type":"Small molecule","pref_name":"VS-5584","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["VS-5584","Vs 5584"],"trade_names":[],"canonical_smiles":"O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1[C@@H]1CCOc2c(F)cccc21","indications":[{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01991938"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01991938%22"]}]},{"efo_id":"EFO_0000588","efo_label":"mesothelioma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000588","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02372227"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02372227%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000198793","approved_name":"mechanistic target of rapamycin kinase","approved_symbol":"MTOR"}],"target_type":"single protein","target_name":"Serine/threonine-protein kinase mTOR","action_type":"inhibitor","description":"Serine/threonine-protein kinase mTOR inhibitor","references":[{"source":"PubMed","ids":["23270925"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23270925"]}]},{"target_components":[{"ensembl":"ENSG00000145675","approved_name":"phosphoinositide-3-kinase regulatory subunit 1","approved_symbol":"PIK3R1"},{"ensembl":"ENSG00000051382","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta","approved_symbol":"PIK3CB"},{"ensembl":"ENSG00000105851","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma","approved_symbol":"PIK3CG"},{"ensembl":"ENSG00000121879","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha","approved_symbol":"PIK3CA"},{"ensembl":"ENSG00000105647","approved_name":"phosphoinositide-3-kinase regulatory subunit 2","approved_symbol":"PIK3R2"},{"ensembl":"ENSG00000171608","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta","approved_symbol":"PIK3CD"},{"ensembl":"ENSG00000141506","approved_name":"phosphoinositide-3-kinase regulatory subunit 5","approved_symbol":"PIK3R5"},{"ensembl":"ENSG00000117461","approved_name":"phosphoinositide-3-kinase regulatory subunit 3","approved_symbol":"PIK3R3"}],"target_type":"protein complex group","target_name":"PI3-kinase class I","action_type":"inhibitor","description":"PI3-kinase class I inhibitor","references":[{"source":"PubMed","ids":["23270925"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23270925"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1487","_score":1,"_source":{"id":"CHEMBL1487","internal_compound":false,"type":"Small molecule","pref_name":"ATORVASTATIN","year_first_approved":1996,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Atorvastatin","Atorvastatin Acid","Atorvastatin Calcium","Atorvastatin calcium hydrate","Atorvastatin calcium salt anhydrous","Atorvastatin calcium salt trihydrate","Atorvastatin calcium trihydrate","CI-981"],"trade_names":["Atorvastatin Calcium","Cardyl","Lipitor","Prevencor","Sortis","Tahor","Zarator"],"cross_references":[{"source":"ChEBI","ids":[39548]},{"source":"DailyMed","ids":["atorvastatin%20calcium"]},{"source":"PubChem","ids":["124892211","144212734","29215408"]},{"source":"Wikipedia","ids":["Atorvastatin"]},{"source":"drugbank","ids":["DB01076"]},{"source":"PubChem","ids":["99355609"]},{"source":"ChEBI","ids":[50686]},{"source":"PubChem","ids":["144205238","144212690","170465113"]}],"canonical_smiles":"CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O","indications":[{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["C10AA05"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C10AA05"]}]},{"efo_id":"EFO_0000195","efo_label":"metabolic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000195","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02503865"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02503865%22"]}]},{"efo_id":"HP_0003124","efo_label":"Hypercholesterolemia","efo_uri":"http://purl.obolibrary.org/obo/HP_0003124","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00092716","NCT00758004","NCT00777517"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00092716%22OR%22NCT00758004%22OR%22NCT00777517%22"]},{"source":"FDA","ids":["9658deb6-9ee3-4345-95ed-1acd8dca7fed"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A9658deb6-9ee3-4345-95ed-1acd8dca7fed"]}]},{"efo_id":"EFO_0000649","efo_label":"periodontitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000649","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02386033","NCT02455869"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02386033%22OR%22NCT02455869%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02958852"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02958852%22"]}]},{"efo_id":"EFO_0000378","efo_label":"coronary artery disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000378","max_phase_for_indication":4,"references":[{"source":"FDA","ids":["9658deb6-9ee3-4345-95ed-1acd8dca7fed"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A9658deb6-9ee3-4345-95ed-1acd8dca7fed"]}]},{"efo_id":"EFO_0001360","efo_label":"type II diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001360","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00541697"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00541697%22"]}]},{"efo_id":"EFO_0003047","efo_label":"hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003047","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00403533"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00403533%22"]}]},{"efo_id":"EFO_0003774","efo_label":"hyperlipidemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003774","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00137462","NCT00138762","NCT00139061"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00137462%22OR%22NCT00138762%22OR%22NCT00139061%22"]}]},{"efo_id":"EFO_0003914","efo_label":"atherosclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003914","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00150722"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00150722%22"]}]},{"efo_id":"EFO_0004911","efo_label":"familial hypercholesterolemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004911","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00134511"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00134511%22"]}]},{"efo_id":"EFO_0007243","efo_label":"Ebola hemorrhagic fever","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007243","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02380625"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02380625%22"]}]},{"efo_id":"HP_0001258","efo_label":"Spastic paraplegia","efo_uri":"http://purl.obolibrary.org/obo/HP_0001258","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02314208"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02314208%22"]}]},{"efo_id":"Orphanet_412","efo_label":"Hyperlipoproteinemia type 3","efo_uri":"http://www.orpha.net/ORDO/Orphanet_412","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00145431"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00145431%22"]}]},{"efo_id":"Orphanet_79211","efo_label":"Combined hyperlipidemia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_79211","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00134238"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00134238%22"]}]},{"efo_id":"EFO_0000270","efo_label":"asthma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000270","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00126048","NCT00292201"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00126048%22OR%22NCT00292201%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01259284","NCT01525407"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01259284%22OR%22NCT01525407%22"]}]},{"efo_id":"Orphanet_79211","efo_label":"Combined hyperlipidemia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_79211","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00134238","NCT00289900","NCT00491530","NCT01956201","NCT02035215","NCT02166593"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00134238%22OR%22NCT00289900%22OR%22NCT00491530%22OR%22NCT01956201%22OR%22NCT02035215%22OR%22NCT02166593%22"]}]},{"efo_id":"Orphanet_309005","efo_label":"Disorder of lipid metabolism","efo_uri":"http://www.orpha.net/ORDO/Orphanet_309005","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00239330","NCT00329173","NCT00487994","NCT00504829","NCT00689442","NCT00728910","NCT00977288","NCT00990808","NCT01105975","NCT01218204","NCT01375075","NCT01970215","NCT02066207","NCT02364258","NCT02587416","NCT02651753","NCT02714569","NCT02977065","NCT03346187","NCT03415178","NCT03482180","NCT03510884","NCT03696940"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00239330%22OR%22NCT00329173%22OR%22NCT00487994%22OR%22NCT00504829%22OR%22NCT00689442%22OR%22NCT00728910%22OR%22NCT00977288%22OR%22NCT00990808%22OR%22NCT01105975%22OR%22NCT01218204%22OR%22NCT01375075%22OR%22NCT01970215%22OR%22NCT02066207%22OR%22NCT02364258%22OR%22NCT02587416%22OR%22NCT02651753%22OR%22NCT02714569%22OR%22NCT02977065%22OR%22NCT03346187%22OR%22NCT03415178%22OR%22NCT03482180%22OR%22NCT03510884%22OR%22NCT03696940%22"]}]},{"efo_id":"HP_0003124","efo_label":"Hypercholesterolemia","efo_uri":"http://purl.obolibrary.org/obo/HP_0003124","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00092690","NCT00132717","NCT00133380","NCT00143676","NCT00150371","NCT00249899","NCT00276458","NCT00276484","NCT00418834","NCT00462748","NCT00474240","NCT00496730","NCT00532311","NCT00535405","NCT00654095","NCT00654173","NCT00654407","NCT00654537","NCT00664469","NCT00683618","NCT00687271","NCT00690443","NCT00741715","NCT00758004","NCT00777517","NCT00782184","NCT00864643","NCT01154036","NCT01288443","NCT01288469","NCT01370590","NCT01370603","NCT01516879","NCT01709513","NCT01710007","NCT01730040","NCT01779453","NCT01812707","NCT01859455","NCT01964326","NCT02260648","NCT02374047","NCT02550288","NCT02584504","NCT02591836","NCT02608697","NCT02715726","NCT03051100","NCT03464682","NCT03510715","NCT03590496","NCT03768427","NCT03867110","NCT03867318","NCT03882996","NCT03885921"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00092690%22OR%22NCT00132717%22OR%22NCT00133380%22OR%22NCT00143676%22OR%22NCT00150371%22OR%22NCT00249899%22OR%22NCT00276458%22OR%22NCT00276484%22OR%22NCT00418834%22OR%22NCT00462748%22OR%22NCT00474240%22OR%22NCT00496730%22OR%22NCT00532311%22OR%22NCT00535405%22OR%22NCT00654095%22OR%22NCT00654173%22OR%22NCT00654407%22OR%22NCT00654537%22OR%22NCT00664469%22OR%22NCT00683618%22OR%22NCT00687271%22OR%22NCT00690443%22OR%22NCT00741715%22OR%22NCT00758004%22OR%22NCT00777517%22OR%22NCT00782184%22OR%22NCT00864643%22OR%22NCT01154036%22OR%22NCT01288443%22OR%22NCT01288469%22OR%22NCT01370590%22OR%22NCT01370603%22OR%22NCT01516879%22OR%22NCT01709513%22OR%22NCT01710007%22OR%22NCT01730040%22OR%22NCT01779453%22OR%22NCT01812707%22OR%22NCT01859455%22OR%22NCT01964326%22OR%22NCT02260648%22OR%22NCT02374047%22OR%22NCT02550288%22OR%22NCT02584504%22OR%22NCT02591836%22OR%22NCT02608697%22OR%22NCT02715726%22OR%22NCT03051100%22OR%22NCT03464682%22OR%22NCT03510715%22OR%22NCT03590496%22OR%22NCT03768427%22OR%22NCT03867110%22OR%22NCT03867318%22OR%22NCT03882996%22OR%22NCT03885921%22"]},{"source":"DailyMed","ids":["00966aac-118a-4ee5-9230-a53a3ce5142e","00b6912b-d195-4d7d-8333-e9b0fa20fcc1","09c6c750-ae05-459f-83e8-4a9e4fd85212","10a7ba02-42d6-4cae-8904-b256e2da5496","1667b9d6-26cb-4cb1-8d59-0b341afa45e8","17a163ef-b349-4e32-bc8c-b02bac7f65d6","194218c4-3f18-4b6b-a0d9-acc8c862d4b7","194ee30e-c063-4bc8-be30-ac91ce329b61","1b1faadc-b8b5-4545-a12b-060a90881aec","263f60b2-355e-4389-b47f-146854184da8","28e28cc3-349a-427a-b19c-77503ef43db4","2a8de5aa-936a-493e-a0e3-813cbc969c6d","2b5f69aa-2dd9-4eb8-b8b8-def1a1ec1433","3d29ce1f-a9cf-4883-a320-712c6d21a297","4053ed16-9219-4657-b86f-52ef6b66d005","5412835b-27c6-461f-97b9-b5bf03afe7f2","56550295-7074-43f0-9f46-4b2dc852f881","595ab888-6b55-4642-a32f-e8521821ed81","59b924d0-e27f-4567-a0c4-467f9a61df3e","59e8d9ff-a6a5-4384-907e-749a5c64dee9","5cc454ee-3013-4d10-859e-ad8c5ca16c85","6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d","6d203e05-1fe6-4262-9d66-b461f84c4672","786a6f14-1e2d-4c2a-93dd-c45315aff4fd","7ba5c4ab-e385-4803-9a5c-ea7eafad550f","7c1083b9-7a20-475d-ba12-4f5d0b53e601","7fcb451e-4834-4905-852b-ec1efe9115f0","7fe85155-bc00-406b-b097-e8aece187a8a","84ceda02-d704-478e-b18c-3bad66120a15","865f4e70-ead8-4480-96a4-6ca7b7d8ed69","87f1e55a-6876-41d0-9f2b-d8c90d857968","8f71bea6-2fd0-44ae-afd9-727d365293a0","901550e6-22be-68c9-eb86-f85a9c9dd998","909fad96-a941-443a-a39f-4f93607410fb","912bef4c-97f8-4d43-8844-960a88724503","9d6a052b-b032-4d72-9bd1-e6c895b12472","a0bd00e9-9813-4ea7-b640-1eb59202751b","a25666a6-6e45-46c9-8c9e-e693756f940a","a3c08a6d-f986-4efc-9f96-3f0e652704dc","afd5c7b3-4886-4250-9a12-b61451f65eb5","afe34ac2-1403-4754-9beb-f76393cdc3ca","bc8b9bf5-74d7-422e-bab9-e5aa63cfa0ab","bd7cb86a-9800-4ffc-942b-e2b5ec34000e","c6e131fe-e7df-4876-83f7-9156fc4e8228","cc710d44-d515-4b17-a3c6-4d3ba9b049f8","d0a0feb6-84f0-4693-a11f-eb4f7ae0a87d","d9adb9e4-c495-9530-e5e3-7e3b01d53e4c","da09f66e-9093-4e07-9820-e7d8ccd594f3","df64ffb8-f40f-479f-8c7b-a4b2011664e8","e10ae715-81e6-4089-9fc3-fa2d10171ed6","f12f81e5-634d-480c-b607-53ec5cbad03f","f394be03-fefc-4679-b001-4168a204a136","f60a672d-8d6d-4d67-9a47-5547357e7b5b","f9a92bf9-0bb2-4963-90d0-f610fe0a34f2"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?00966aac-118a-4ee5-9230-a53a3ce5142e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?00b6912b-d195-4d7d-8333-e9b0fa20fcc1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?09c6c750-ae05-459f-83e8-4a9e4fd85212","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?10a7ba02-42d6-4cae-8904-b256e2da5496","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1667b9d6-26cb-4cb1-8d59-0b341afa45e8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?17a163ef-b349-4e32-bc8c-b02bac7f65d6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?194218c4-3f18-4b6b-a0d9-acc8c862d4b7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?194ee30e-c063-4bc8-be30-ac91ce329b61","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1b1faadc-b8b5-4545-a12b-060a90881aec","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?263f60b2-355e-4389-b47f-146854184da8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?28e28cc3-349a-427a-b19c-77503ef43db4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2a8de5aa-936a-493e-a0e3-813cbc969c6d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2b5f69aa-2dd9-4eb8-b8b8-def1a1ec1433","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3d29ce1f-a9cf-4883-a320-712c6d21a297","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4053ed16-9219-4657-b86f-52ef6b66d005","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5412835b-27c6-461f-97b9-b5bf03afe7f2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?56550295-7074-43f0-9f46-4b2dc852f881","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?595ab888-6b55-4642-a32f-e8521821ed81","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?59b924d0-e27f-4567-a0c4-467f9a61df3e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?59e8d9ff-a6a5-4384-907e-749a5c64dee9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5cc454ee-3013-4d10-859e-ad8c5ca16c85","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6d203e05-1fe6-4262-9d66-b461f84c4672","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?786a6f14-1e2d-4c2a-93dd-c45315aff4fd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7ba5c4ab-e385-4803-9a5c-ea7eafad550f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7c1083b9-7a20-475d-ba12-4f5d0b53e601","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7fcb451e-4834-4905-852b-ec1efe9115f0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7fe85155-bc00-406b-b097-e8aece187a8a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?84ceda02-d704-478e-b18c-3bad66120a15","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?865f4e70-ead8-4480-96a4-6ca7b7d8ed69","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?87f1e55a-6876-41d0-9f2b-d8c90d857968","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8f71bea6-2fd0-44ae-afd9-727d365293a0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?901550e6-22be-68c9-eb86-f85a9c9dd998","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?909fad96-a941-443a-a39f-4f93607410fb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?912bef4c-97f8-4d43-8844-960a88724503","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9d6a052b-b032-4d72-9bd1-e6c895b12472","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a0bd00e9-9813-4ea7-b640-1eb59202751b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a25666a6-6e45-46c9-8c9e-e693756f940a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a3c08a6d-f986-4efc-9f96-3f0e652704dc","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?afd5c7b3-4886-4250-9a12-b61451f65eb5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?afe34ac2-1403-4754-9beb-f76393cdc3ca","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bc8b9bf5-74d7-422e-bab9-e5aa63cfa0ab","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bd7cb86a-9800-4ffc-942b-e2b5ec34000e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c6e131fe-e7df-4876-83f7-9156fc4e8228","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cc710d44-d515-4b17-a3c6-4d3ba9b049f8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d0a0feb6-84f0-4693-a11f-eb4f7ae0a87d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d9adb9e4-c495-9530-e5e3-7e3b01d53e4c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?da09f66e-9093-4e07-9820-e7d8ccd594f3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?df64ffb8-f40f-479f-8c7b-a4b2011664e8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e10ae715-81e6-4089-9fc3-fa2d10171ed6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f12f81e5-634d-480c-b607-53ec5cbad03f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f394be03-fefc-4679-b001-4168a204a136","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f60a672d-8d6d-4d67-9a47-5547357e7b5b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f9a92bf9-0bb2-4963-90d0-f610fe0a34f2"]},{"source":"FDA","ids":["044ea3a4-e289-4446-bb6d-0486533ab728","200601d6-2c98-42dd-bece-76fc350c5356","20c51638-3ce0-4c4a-b4d9-49dfb574d90d","2e90b6a9-fc55-4124-9699-b5142a92888d","54bcef51-511d-458f-8034-4dde11779ab7","8a201c80-a51d-4c1c-963b-488c071908c0","97337771-dd37-4cdf-9eac-e0d60803cf6a","c387354c-607b-474d-b2e5-d35c789ce09b","c67cebe8-bb1e-4bd5-b06f-2a730319ba50","cc249aa8-e6fe-40b4-a6b3-de62c00658a2","d385e07a-c16f-4aef-8e55-af95bd1c7526","e480e538-4ea7-47e6-9e5d-dc0f8179e06c","f1793d84-68fd-3ab9-c4e2-09f9a1be6425","label/2015/020702s065lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A044ea3a4-e289-4446-bb6d-0486533ab728","https://api.fda.gov/drug/label.json?search=set_id%3A200601d6-2c98-42dd-bece-76fc350c5356","https://api.fda.gov/drug/label.json?search=set_id%3A20c51638-3ce0-4c4a-b4d9-49dfb574d90d","https://api.fda.gov/drug/label.json?search=set_id%3A2e90b6a9-fc55-4124-9699-b5142a92888d","https://api.fda.gov/drug/label.json?search=set_id%3A54bcef51-511d-458f-8034-4dde11779ab7","https://api.fda.gov/drug/label.json?search=set_id%3A8a201c80-a51d-4c1c-963b-488c071908c0","https://api.fda.gov/drug/label.json?search=set_id%3A97337771-dd37-4cdf-9eac-e0d60803cf6a","https://api.fda.gov/drug/label.json?search=set_id%3Ac387354c-607b-474d-b2e5-d35c789ce09b","https://api.fda.gov/drug/label.json?search=set_id%3Ac67cebe8-bb1e-4bd5-b06f-2a730319ba50","https://api.fda.gov/drug/label.json?search=set_id%3Acc249aa8-e6fe-40b4-a6b3-de62c00658a2","https://api.fda.gov/drug/label.json?search=set_id%3Ad385e07a-c16f-4aef-8e55-af95bd1c7526","https://api.fda.gov/drug/label.json?search=set_id%3Ae480e538-4ea7-47e6-9e5d-dc0f8179e06c","https://api.fda.gov/drug/label.json?search=set_id%3Af1793d84-68fd-3ab9-c4e2-09f9a1be6425","https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F020702s065lbl.pdf"]}]},{"efo_id":"EFO_0003774","efo_label":"hyperlipidemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003774","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00136942","NCT00137462","NCT00138762","NCT00195793","NCT00296400","NCT00362934","NCT00559962","NCT00701883","NCT01236430","NCT01332747","NCT01386853","NCT01763866","NCT01953328","NCT01984424","NCT02135029","NCT02189837","NCT02227784","NCT02451098","NCT02659397","NCT02979704","NCT02994745"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00136942%22OR%22NCT00137462%22OR%22NCT00138762%22OR%22NCT00195793%22OR%22NCT00296400%22OR%22NCT00362934%22OR%22NCT00559962%22OR%22NCT00701883%22OR%22NCT01236430%22OR%22NCT01332747%22OR%22NCT01386853%22OR%22NCT01763866%22OR%22NCT01953328%22OR%22NCT01984424%22OR%22NCT02135029%22OR%22NCT02189837%22OR%22NCT02227784%22OR%22NCT02451098%22OR%22NCT02659397%22OR%22NCT02979704%22OR%22NCT02994745%22"]},{"source":"DailyMed","ids":["00966aac-118a-4ee5-9230-a53a3ce5142e","00b6912b-d195-4d7d-8333-e9b0fa20fcc1","062bf1a0-9a29-4dee-a8cb-f0d051f4c0b1","09c6c750-ae05-459f-83e8-4a9e4fd85212","10a7ba02-42d6-4cae-8904-b256e2da5496","1667b9d6-26cb-4cb1-8d59-0b341afa45e8","17a163ef-b349-4e32-bc8c-b02bac7f65d6","194218c4-3f18-4b6b-a0d9-acc8c862d4b7","194ee30e-c063-4bc8-be30-ac91ce329b61","1b1faadc-b8b5-4545-a12b-060a90881aec","263f60b2-355e-4389-b47f-146854184da8","28e28cc3-349a-427a-b19c-77503ef43db4","2a8de5aa-936a-493e-a0e3-813cbc969c6d","2b5f69aa-2dd9-4eb8-b8b8-def1a1ec1433","3d29ce1f-a9cf-4883-a320-712c6d21a297","4053ed16-9219-4657-b86f-52ef6b66d005","4be76756-4114-4d50-a36c-fd410f6c773d","5412835b-27c6-461f-97b9-b5bf03afe7f2","56550295-7074-43f0-9f46-4b2dc852f881","595ab888-6b55-4642-a32f-e8521821ed81","59b924d0-e27f-4567-a0c4-467f9a61df3e","59e8d9ff-a6a5-4384-907e-749a5c64dee9","5cc454ee-3013-4d10-859e-ad8c5ca16c85","6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d","6d203e05-1fe6-4262-9d66-b461f84c4672","6f1a9bd8-ee30-4c7d-932f-3fa8c4e087b6","786a6f14-1e2d-4c2a-93dd-c45315aff4fd","7ba5c4ab-e385-4803-9a5c-ea7eafad550f","7c1083b9-7a20-475d-ba12-4f5d0b53e601","7fcb451e-4834-4905-852b-ec1efe9115f0","7fe85155-bc00-406b-b097-e8aece187a8a","84ceda02-d704-478e-b18c-3bad66120a15","865f4e70-ead8-4480-96a4-6ca7b7d8ed69","87f1e55a-6876-41d0-9f2b-d8c90d857968","8f71bea6-2fd0-44ae-afd9-727d365293a0","901550e6-22be-68c9-eb86-f85a9c9dd998","909fad96-a941-443a-a39f-4f93607410fb","912bef4c-97f8-4d43-8844-960a88724503","9d6a052b-b032-4d72-9bd1-e6c895b12472","a0bd00e9-9813-4ea7-b640-1eb59202751b","a25666a6-6e45-46c9-8c9e-e693756f940a","a3c08a6d-f986-4efc-9f96-3f0e652704dc","abee4a34-89cc-d886-192c-32582ab8f024","afd5c7b3-4886-4250-9a12-b61451f65eb5","afe34ac2-1403-4754-9beb-f76393cdc3ca","bc8b9bf5-74d7-422e-bab9-e5aa63cfa0ab","bd7cb86a-9800-4ffc-942b-e2b5ec34000e","c6e131fe-e7df-4876-83f7-9156fc4e8228","cc710d44-d515-4b17-a3c6-4d3ba9b049f8","d0a0feb6-84f0-4693-a11f-eb4f7ae0a87d","d9adb9e4-c495-9530-e5e3-7e3b01d53e4c","da09f66e-9093-4e07-9820-e7d8ccd594f3","df64ffb8-f40f-479f-8c7b-a4b2011664e8","e10ae715-81e6-4089-9fc3-fa2d10171ed6","f12f81e5-634d-480c-b607-53ec5cbad03f","f394be03-fefc-4679-b001-4168a204a136","f60a672d-8d6d-4d67-9a47-5547357e7b5b","f9a92bf9-0bb2-4963-90d0-f610fe0a34f2"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?00966aac-118a-4ee5-9230-a53a3ce5142e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?00b6912b-d195-4d7d-8333-e9b0fa20fcc1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?062bf1a0-9a29-4dee-a8cb-f0d051f4c0b1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?09c6c750-ae05-459f-83e8-4a9e4fd85212","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?10a7ba02-42d6-4cae-8904-b256e2da5496","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1667b9d6-26cb-4cb1-8d59-0b341afa45e8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?17a163ef-b349-4e32-bc8c-b02bac7f65d6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?194218c4-3f18-4b6b-a0d9-acc8c862d4b7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?194ee30e-c063-4bc8-be30-ac91ce329b61","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1b1faadc-b8b5-4545-a12b-060a90881aec","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?263f60b2-355e-4389-b47f-146854184da8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?28e28cc3-349a-427a-b19c-77503ef43db4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2a8de5aa-936a-493e-a0e3-813cbc969c6d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2b5f69aa-2dd9-4eb8-b8b8-def1a1ec1433","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3d29ce1f-a9cf-4883-a320-712c6d21a297","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4053ed16-9219-4657-b86f-52ef6b66d005","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4be76756-4114-4d50-a36c-fd410f6c773d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5412835b-27c6-461f-97b9-b5bf03afe7f2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?56550295-7074-43f0-9f46-4b2dc852f881","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?595ab888-6b55-4642-a32f-e8521821ed81","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?59b924d0-e27f-4567-a0c4-467f9a61df3e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?59e8d9ff-a6a5-4384-907e-749a5c64dee9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5cc454ee-3013-4d10-859e-ad8c5ca16c85","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6d203e05-1fe6-4262-9d66-b461f84c4672","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6f1a9bd8-ee30-4c7d-932f-3fa8c4e087b6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?786a6f14-1e2d-4c2a-93dd-c45315aff4fd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7ba5c4ab-e385-4803-9a5c-ea7eafad550f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7c1083b9-7a20-475d-ba12-4f5d0b53e601","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7fcb451e-4834-4905-852b-ec1efe9115f0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7fe85155-bc00-406b-b097-e8aece187a8a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?84ceda02-d704-478e-b18c-3bad66120a15","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?865f4e70-ead8-4480-96a4-6ca7b7d8ed69","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?87f1e55a-6876-41d0-9f2b-d8c90d857968","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8f71bea6-2fd0-44ae-afd9-727d365293a0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?901550e6-22be-68c9-eb86-f85a9c9dd998","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?909fad96-a941-443a-a39f-4f93607410fb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?912bef4c-97f8-4d43-8844-960a88724503","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9d6a052b-b032-4d72-9bd1-e6c895b12472","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a0bd00e9-9813-4ea7-b640-1eb59202751b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a25666a6-6e45-46c9-8c9e-e693756f940a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a3c08a6d-f986-4efc-9f96-3f0e652704dc","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?abee4a34-89cc-d886-192c-32582ab8f024","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?afd5c7b3-4886-4250-9a12-b61451f65eb5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?afe34ac2-1403-4754-9beb-f76393cdc3ca","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bc8b9bf5-74d7-422e-bab9-e5aa63cfa0ab","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bd7cb86a-9800-4ffc-942b-e2b5ec34000e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c6e131fe-e7df-4876-83f7-9156fc4e8228","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cc710d44-d515-4b17-a3c6-4d3ba9b049f8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d0a0feb6-84f0-4693-a11f-eb4f7ae0a87d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d9adb9e4-c495-9530-e5e3-7e3b01d53e4c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?da09f66e-9093-4e07-9820-e7d8ccd594f3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?df64ffb8-f40f-479f-8c7b-a4b2011664e8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e10ae715-81e6-4089-9fc3-fa2d10171ed6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f12f81e5-634d-480c-b607-53ec5cbad03f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f394be03-fefc-4679-b001-4168a204a136","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f60a672d-8d6d-4d67-9a47-5547357e7b5b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f9a92bf9-0bb2-4963-90d0-f610fe0a34f2"]},{"source":"FDA","ids":["044ea3a4-e289-4446-bb6d-0486533ab728","200601d6-2c98-42dd-bece-76fc350c5356","20c51638-3ce0-4c4a-b4d9-49dfb574d90d","2e90b6a9-fc55-4124-9699-b5142a92888d","2f568859-64e6-454f-801b-c0a0a647dc3d","54bcef51-511d-458f-8034-4dde11779ab7","8a201c80-a51d-4c1c-963b-488c071908c0","97337771-dd37-4cdf-9eac-e0d60803cf6a","c387354c-607b-474d-b2e5-d35c789ce09b","c67cebe8-bb1e-4bd5-b06f-2a730319ba50","cc249aa8-e6fe-40b4-a6b3-de62c00658a2","d2d28679-a01b-4e63-90e2-d5c23b393c94","d385e07a-c16f-4aef-8e55-af95bd1c7526","e480e538-4ea7-47e6-9e5d-dc0f8179e06c","f1793d84-68fd-3ab9-c4e2-09f9a1be6425"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A044ea3a4-e289-4446-bb6d-0486533ab728","https://api.fda.gov/drug/label.json?search=set_id%3A200601d6-2c98-42dd-bece-76fc350c5356","https://api.fda.gov/drug/label.json?search=set_id%3A20c51638-3ce0-4c4a-b4d9-49dfb574d90d","https://api.fda.gov/drug/label.json?search=set_id%3A2e90b6a9-fc55-4124-9699-b5142a92888d","https://api.fda.gov/drug/label.json?search=set_id%3A2f568859-64e6-454f-801b-c0a0a647dc3d","https://api.fda.gov/drug/label.json?search=set_id%3A54bcef51-511d-458f-8034-4dde11779ab7","https://api.fda.gov/drug/label.json?search=set_id%3A8a201c80-a51d-4c1c-963b-488c071908c0","https://api.fda.gov/drug/label.json?search=set_id%3A97337771-dd37-4cdf-9eac-e0d60803cf6a","https://api.fda.gov/drug/label.json?search=set_id%3Ac387354c-607b-474d-b2e5-d35c789ce09b","https://api.fda.gov/drug/label.json?search=set_id%3Ac67cebe8-bb1e-4bd5-b06f-2a730319ba50","https://api.fda.gov/drug/label.json?search=set_id%3Acc249aa8-e6fe-40b4-a6b3-de62c00658a2","https://api.fda.gov/drug/label.json?search=set_id%3Ad2d28679-a01b-4e63-90e2-d5c23b393c94","https://api.fda.gov/drug/label.json?search=set_id%3Ad385e07a-c16f-4aef-8e55-af95bd1c7526","https://api.fda.gov/drug/label.json?search=set_id%3Ae480e538-4ea7-47e6-9e5d-dc0f8179e06c","https://api.fda.gov/drug/label.json?search=set_id%3Af1793d84-68fd-3ab9-c4e2-09f9a1be6425"]}]},{"efo_id":"EFO_0003885","efo_label":"multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003885","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00094172","NCT00942591"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00094172%22OR%22NCT00942591%22"]}]},{"efo_id":"EFO_0000660","efo_label":"polycystic ovary syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000660","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00529542"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00529542%22"]}]},{"efo_id":"EFO_0000673","efo_label":"prostate adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000673","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01759836","NCT01821404"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01759836%22OR%22NCT01821404%22"]}]},{"efo_id":"EFO_0001361","efo_label":"pulmonary arterial hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001361","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00615823"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00615823%22"]}]},{"efo_id":"EFO_0004264","efo_label":"vascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004264","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00570752","NCT00703261"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00570752%22OR%22NCT00703261%22"]}]},{"efo_id":"EFO_0003884","efo_label":"chronic kidney disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003884","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00143741","NCT01820767"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00143741%22OR%22NCT01820767%22"]}]},{"efo_id":"EFO_0000378","efo_label":"coronary artery disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000378","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00469326","NCT00620542","NCT00911339","NCT00965055","NCT01058057","NCT01946815","NCT02205775","NCT02245087","NCT02586155"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00469326%22OR%22NCT00620542%22OR%22NCT00911339%22OR%22NCT00965055%22OR%22NCT01058057%22OR%22NCT01946815%22OR%22NCT02205775%22OR%22NCT02245087%22OR%22NCT02586155%22"]},{"source":"DailyMed","ids":["062bf1a0-9a29-4dee-a8cb-f0d051f4c0b1","4be76756-4114-4d50-a36c-fd410f6c773d","6f1a9bd8-ee30-4c7d-932f-3fa8c4e087b6","786a6f14-1e2d-4c2a-93dd-c45315aff4fd","909fad96-a941-443a-a39f-4f93607410fb","abee4a34-89cc-d886-192c-32582ab8f024"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?062bf1a0-9a29-4dee-a8cb-f0d051f4c0b1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4be76756-4114-4d50-a36c-fd410f6c773d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6f1a9bd8-ee30-4c7d-932f-3fa8c4e087b6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?786a6f14-1e2d-4c2a-93dd-c45315aff4fd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?909fad96-a941-443a-a39f-4f93607410fb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?abee4a34-89cc-d886-192c-32582ab8f024"]},{"source":"FDA","ids":["2f568859-64e6-454f-801b-c0a0a647dc3d","d2d28679-a01b-4e63-90e2-d5c23b393c94"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A2f568859-64e6-454f-801b-c0a0a647dc3d","https://api.fda.gov/drug/label.json?search=set_id%3Ad2d28679-a01b-4e63-90e2-d5c23b393c94"]}]},{"efo_id":"EFO_0000400","efo_label":"diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000400","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00296374","NCT02243098"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00296374%22OR%22NCT02243098%22"]}]},{"efo_id":"EFO_0000668","efo_label":"preeclampsia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000668","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01278459"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01278459%22"]}]},{"efo_id":"EFO_0006818","efo_label":"stricture","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006818","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01617538"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01617538%22"]}]},{"efo_id":"EFO_0000180","efo_label":"HIV-1 infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000180","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01351025","NCT03709355"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01351025%22OR%22NCT03709355%22"]}]},{"efo_id":"EFO_0003086","efo_label":"kidney disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003086","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02113540","NCT02114346","NCT03867994"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02113540%22OR%22NCT02114346%22OR%22NCT03867994%22"]}]},{"efo_id":"EFO_0000685","efo_label":"rheumatoid arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000685","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01059864"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01059864%22"]}]},{"efo_id":"Orphanet_797","efo_label":"Sarcoidosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_797","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00279708"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00279708%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00816244","NCT00914017","NCT01980823","NCT01988571","NCT03358017"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00816244%22OR%22NCT00914017%22OR%22NCT01980823%22OR%22NCT01988571%22OR%22NCT03358017%22"]}]},{"efo_id":"EFO_0000365","efo_label":"colorectal adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000365","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01605344"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01605344%22"]}]},{"efo_id":"EFO_0001645","efo_label":"coronary heart disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001645","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00973986"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00973986%22"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000941","NCT00367458","NCT01138072","NCT02081638","NCT03037372"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000941%22OR%22NCT00367458%22OR%22NCT01138072%22OR%22NCT02081638%22OR%22NCT03037372%22"]}]},{"efo_id":"EFO_0004211","efo_label":"Hypertriglyceridemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004211","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00435045","NCT00973271"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00435045%22OR%22NCT00973271%22"]}]},{"efo_id":"EFO_0000676","efo_label":"psoriasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000676","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01527097","NCT02432040"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01527097%22OR%22NCT02432040%22"]}]},{"efo_id":"EFO_0005672","efo_label":"acute coronary syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005672","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00214630","NCT00296387","NCT02089061"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00214630%22OR%22NCT00296387%22OR%22NCT02089061%22"]}]},{"efo_id":"EFO_0004599","efo_label":"acute graft vs. host disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004599","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01175148","NCT01665677"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01175148%22OR%22NCT01665677%22"]}]},{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00343655","NCT00770575","NCT03837925"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00343655%22OR%22NCT00770575%22OR%22NCT03837925%22"]}]},{"efo_id":"EFO_0000195","efo_label":"metabolic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000195","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00654485","NCT00666029","NCT01785615"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00654485%22OR%22NCT00666029%22OR%22NCT01785615%22"]}]},{"efo_id":"EFO_0000249","efo_label":"Alzheimer's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000249","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00024531","NCT00151502","NCT00751907"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00024531%22OR%22NCT00151502%22OR%22NCT00751907%22"]}]},{"efo_id":"EFO_0000538","efo_label":"hypertrophic cardiomyopathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000538","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00317967"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00317967%22"]}]},{"efo_id":"EFO_0002690","efo_label":"systemic lupus erythematosus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002690","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00065806","NCT00432354","NCT00519363"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00065806%22OR%22NCT00432354%22OR%22NCT00519363%22"]}]},{"efo_id":"EFO_0004911","efo_label":"familial hypercholesterolemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004911","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00739999","NCT00827606","NCT01709500","NCT03884452"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00739999%22OR%22NCT00827606%22OR%22NCT01709500%22OR%22NCT03884452%22"]},{"source":"DailyMed","ids":["00966aac-118a-4ee5-9230-a53a3ce5142e","00b6912b-d195-4d7d-8333-e9b0fa20fcc1","09c6c750-ae05-459f-83e8-4a9e4fd85212","10a7ba02-42d6-4cae-8904-b256e2da5496","1667b9d6-26cb-4cb1-8d59-0b341afa45e8","17a163ef-b349-4e32-bc8c-b02bac7f65d6","194218c4-3f18-4b6b-a0d9-acc8c862d4b7","194ee30e-c063-4bc8-be30-ac91ce329b61","1b1faadc-b8b5-4545-a12b-060a90881aec","263f60b2-355e-4389-b47f-146854184da8","28e28cc3-349a-427a-b19c-77503ef43db4","2a8de5aa-936a-493e-a0e3-813cbc969c6d","2b5f69aa-2dd9-4eb8-b8b8-def1a1ec1433","3d29ce1f-a9cf-4883-a320-712c6d21a297","4053ed16-9219-4657-b86f-52ef6b66d005","5412835b-27c6-461f-97b9-b5bf03afe7f2","56550295-7074-43f0-9f46-4b2dc852f881","595ab888-6b55-4642-a32f-e8521821ed81","59b924d0-e27f-4567-a0c4-467f9a61df3e","59e8d9ff-a6a5-4384-907e-749a5c64dee9","5cc454ee-3013-4d10-859e-ad8c5ca16c85","6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d","6d203e05-1fe6-4262-9d66-b461f84c4672","786a6f14-1e2d-4c2a-93dd-c45315aff4fd","7ba5c4ab-e385-4803-9a5c-ea7eafad550f","7c1083b9-7a20-475d-ba12-4f5d0b53e601","7fcb451e-4834-4905-852b-ec1efe9115f0","7fe85155-bc00-406b-b097-e8aece187a8a","84ceda02-d704-478e-b18c-3bad66120a15","865f4e70-ead8-4480-96a4-6ca7b7d8ed69","87f1e55a-6876-41d0-9f2b-d8c90d857968","8f71bea6-2fd0-44ae-afd9-727d365293a0","901550e6-22be-68c9-eb86-f85a9c9dd998","909fad96-a941-443a-a39f-4f93607410fb","912bef4c-97f8-4d43-8844-960a88724503","9d6a052b-b032-4d72-9bd1-e6c895b12472","a0bd00e9-9813-4ea7-b640-1eb59202751b","a25666a6-6e45-46c9-8c9e-e693756f940a","a3c08a6d-f986-4efc-9f96-3f0e652704dc","afd5c7b3-4886-4250-9a12-b61451f65eb5","afe34ac2-1403-4754-9beb-f76393cdc3ca","bc8b9bf5-74d7-422e-bab9-e5aa63cfa0ab","bd7cb86a-9800-4ffc-942b-e2b5ec34000e","c6e131fe-e7df-4876-83f7-9156fc4e8228","cc710d44-d515-4b17-a3c6-4d3ba9b049f8","d0a0feb6-84f0-4693-a11f-eb4f7ae0a87d","d9adb9e4-c495-9530-e5e3-7e3b01d53e4c","da09f66e-9093-4e07-9820-e7d8ccd594f3","df64ffb8-f40f-479f-8c7b-a4b2011664e8","e10ae715-81e6-4089-9fc3-fa2d10171ed6","f12f81e5-634d-480c-b607-53ec5cbad03f","f394be03-fefc-4679-b001-4168a204a136","f60a672d-8d6d-4d67-9a47-5547357e7b5b","f9a92bf9-0bb2-4963-90d0-f610fe0a34f2"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?00966aac-118a-4ee5-9230-a53a3ce5142e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?00b6912b-d195-4d7d-8333-e9b0fa20fcc1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?09c6c750-ae05-459f-83e8-4a9e4fd85212","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?10a7ba02-42d6-4cae-8904-b256e2da5496","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1667b9d6-26cb-4cb1-8d59-0b341afa45e8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?17a163ef-b349-4e32-bc8c-b02bac7f65d6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?194218c4-3f18-4b6b-a0d9-acc8c862d4b7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?194ee30e-c063-4bc8-be30-ac91ce329b61","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1b1faadc-b8b5-4545-a12b-060a90881aec","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?263f60b2-355e-4389-b47f-146854184da8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?28e28cc3-349a-427a-b19c-77503ef43db4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2a8de5aa-936a-493e-a0e3-813cbc969c6d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2b5f69aa-2dd9-4eb8-b8b8-def1a1ec1433","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3d29ce1f-a9cf-4883-a320-712c6d21a297","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4053ed16-9219-4657-b86f-52ef6b66d005","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5412835b-27c6-461f-97b9-b5bf03afe7f2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?56550295-7074-43f0-9f46-4b2dc852f881","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?595ab888-6b55-4642-a32f-e8521821ed81","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?59b924d0-e27f-4567-a0c4-467f9a61df3e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?59e8d9ff-a6a5-4384-907e-749a5c64dee9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5cc454ee-3013-4d10-859e-ad8c5ca16c85","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6d203e05-1fe6-4262-9d66-b461f84c4672","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?786a6f14-1e2d-4c2a-93dd-c45315aff4fd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7ba5c4ab-e385-4803-9a5c-ea7eafad550f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7c1083b9-7a20-475d-ba12-4f5d0b53e601","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7fcb451e-4834-4905-852b-ec1efe9115f0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7fe85155-bc00-406b-b097-e8aece187a8a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?84ceda02-d704-478e-b18c-3bad66120a15","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?865f4e70-ead8-4480-96a4-6ca7b7d8ed69","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?87f1e55a-6876-41d0-9f2b-d8c90d857968","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8f71bea6-2fd0-44ae-afd9-727d365293a0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?901550e6-22be-68c9-eb86-f85a9c9dd998","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?909fad96-a941-443a-a39f-4f93607410fb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?912bef4c-97f8-4d43-8844-960a88724503","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9d6a052b-b032-4d72-9bd1-e6c895b12472","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a0bd00e9-9813-4ea7-b640-1eb59202751b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a25666a6-6e45-46c9-8c9e-e693756f940a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a3c08a6d-f986-4efc-9f96-3f0e652704dc","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?afd5c7b3-4886-4250-9a12-b61451f65eb5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?afe34ac2-1403-4754-9beb-f76393cdc3ca","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bc8b9bf5-74d7-422e-bab9-e5aa63cfa0ab","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bd7cb86a-9800-4ffc-942b-e2b5ec34000e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c6e131fe-e7df-4876-83f7-9156fc4e8228","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cc710d44-d515-4b17-a3c6-4d3ba9b049f8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d0a0feb6-84f0-4693-a11f-eb4f7ae0a87d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d9adb9e4-c495-9530-e5e3-7e3b01d53e4c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?da09f66e-9093-4e07-9820-e7d8ccd594f3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?df64ffb8-f40f-479f-8c7b-a4b2011664e8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e10ae715-81e6-4089-9fc3-fa2d10171ed6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f12f81e5-634d-480c-b607-53ec5cbad03f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f394be03-fefc-4679-b001-4168a204a136","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f60a672d-8d6d-4d67-9a47-5547357e7b5b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f9a92bf9-0bb2-4963-90d0-f610fe0a34f2"]},{"source":"FDA","ids":["044ea3a4-e289-4446-bb6d-0486533ab728","200601d6-2c98-42dd-bece-76fc350c5356","2e90b6a9-fc55-4124-9699-b5142a92888d","54bcef51-511d-458f-8034-4dde11779ab7","97337771-dd37-4cdf-9eac-e0d60803cf6a","c67cebe8-bb1e-4bd5-b06f-2a730319ba50","cc249aa8-e6fe-40b4-a6b3-de62c00658a2","d385e07a-c16f-4aef-8e55-af95bd1c7526","e480e538-4ea7-47e6-9e5d-dc0f8179e06c","f1793d84-68fd-3ab9-c4e2-09f9a1be6425","label/2015/020702s065lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A044ea3a4-e289-4446-bb6d-0486533ab728","https://api.fda.gov/drug/label.json?search=set_id%3A200601d6-2c98-42dd-bece-76fc350c5356","https://api.fda.gov/drug/label.json?search=set_id%3A2e90b6a9-fc55-4124-9699-b5142a92888d","https://api.fda.gov/drug/label.json?search=set_id%3A54bcef51-511d-458f-8034-4dde11779ab7","https://api.fda.gov/drug/label.json?search=set_id%3A97337771-dd37-4cdf-9eac-e0d60803cf6a","https://api.fda.gov/drug/label.json?search=set_id%3Ac67cebe8-bb1e-4bd5-b06f-2a730319ba50","https://api.fda.gov/drug/label.json?search=set_id%3Acc249aa8-e6fe-40b4-a6b3-de62c00658a2","https://api.fda.gov/drug/label.json?search=set_id%3Ad385e07a-c16f-4aef-8e55-af95bd1c7526","https://api.fda.gov/drug/label.json?search=set_id%3Ae480e538-4ea7-47e6-9e5d-dc0f8179e06c","https://api.fda.gov/drug/label.json?search=set_id%3Af1793d84-68fd-3ab9-c4e2-09f9a1be6425","https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F020702s065lbl.pdf"]}]},{"efo_id":"EFO_0004246","efo_label":"mucocutaneous lymph node syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004246","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01431105"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01431105%22"]}]},{"efo_id":"EFO_0000649","efo_label":"periodontitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000649","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01929135","NCT02060032","NCT02119520","NCT02800902"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01929135%22OR%22NCT02060032%22OR%22NCT02119520%22OR%22NCT02800902%22"]}]},{"efo_id":"EFO_0001359","efo_label":"type I diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001359","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00529191","NCT00974740","NCT01581476"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00529191%22OR%22NCT00974740%22OR%22NCT01581476%22"]}]},{"efo_id":"EFO_0003869","efo_label":"breast neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003869","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01980823","NCT02416427"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01980823%22OR%22NCT02416427%22"]}]},{"efo_id":"HP_0003119","efo_label":"Abnormal circulating lipid concentration","efo_uri":"http://purl.obolibrary.org/obo/HP_0003119","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["00966aac-118a-4ee5-9230-a53a3ce5142e","09c6c750-ae05-459f-83e8-4a9e4fd85212","10a7ba02-42d6-4cae-8904-b256e2da5496","1667b9d6-26cb-4cb1-8d59-0b341afa45e8","194218c4-3f18-4b6b-a0d9-acc8c862d4b7","194ee30e-c063-4bc8-be30-ac91ce329b61","263f60b2-355e-4389-b47f-146854184da8","28e28cc3-349a-427a-b19c-77503ef43db4","2a8de5aa-936a-493e-a0e3-813cbc969c6d","2b5f69aa-2dd9-4eb8-b8b8-def1a1ec1433","3d29ce1f-a9cf-4883-a320-712c6d21a297","4053ed16-9219-4657-b86f-52ef6b66d005","5412835b-27c6-461f-97b9-b5bf03afe7f2","56550295-7074-43f0-9f46-4b2dc852f881","5cc454ee-3013-4d10-859e-ad8c5ca16c85","6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d","6d203e05-1fe6-4262-9d66-b461f84c4672","786a6f14-1e2d-4c2a-93dd-c45315aff4fd","7ba5c4ab-e385-4803-9a5c-ea7eafad550f","7fe85155-bc00-406b-b097-e8aece187a8a","84ceda02-d704-478e-b18c-3bad66120a15","87f1e55a-6876-41d0-9f2b-d8c90d857968","901550e6-22be-68c9-eb86-f85a9c9dd998","912bef4c-97f8-4d43-8844-960a88724503","a0bd00e9-9813-4ea7-b640-1eb59202751b","a3c08a6d-f986-4efc-9f96-3f0e652704dc","afd5c7b3-4886-4250-9a12-b61451f65eb5","afe34ac2-1403-4754-9beb-f76393cdc3ca","bc8b9bf5-74d7-422e-bab9-e5aa63cfa0ab","bd7cb86a-9800-4ffc-942b-e2b5ec34000e","d9adb9e4-c495-9530-e5e3-7e3b01d53e4c","df64ffb8-f40f-479f-8c7b-a4b2011664e8","f12f81e5-634d-480c-b607-53ec5cbad03f","f394be03-fefc-4679-b001-4168a204a136","f60a672d-8d6d-4d67-9a47-5547357e7b5b","f9a92bf9-0bb2-4963-90d0-f610fe0a34f2"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?00966aac-118a-4ee5-9230-a53a3ce5142e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?09c6c750-ae05-459f-83e8-4a9e4fd85212","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?10a7ba02-42d6-4cae-8904-b256e2da5496","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1667b9d6-26cb-4cb1-8d59-0b341afa45e8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?194218c4-3f18-4b6b-a0d9-acc8c862d4b7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?194ee30e-c063-4bc8-be30-ac91ce329b61","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?263f60b2-355e-4389-b47f-146854184da8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?28e28cc3-349a-427a-b19c-77503ef43db4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2a8de5aa-936a-493e-a0e3-813cbc969c6d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2b5f69aa-2dd9-4eb8-b8b8-def1a1ec1433","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3d29ce1f-a9cf-4883-a320-712c6d21a297","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4053ed16-9219-4657-b86f-52ef6b66d005","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5412835b-27c6-461f-97b9-b5bf03afe7f2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?56550295-7074-43f0-9f46-4b2dc852f881","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5cc454ee-3013-4d10-859e-ad8c5ca16c85","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6d203e05-1fe6-4262-9d66-b461f84c4672","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?786a6f14-1e2d-4c2a-93dd-c45315aff4fd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7ba5c4ab-e385-4803-9a5c-ea7eafad550f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7fe85155-bc00-406b-b097-e8aece187a8a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?84ceda02-d704-478e-b18c-3bad66120a15","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?87f1e55a-6876-41d0-9f2b-d8c90d857968","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?901550e6-22be-68c9-eb86-f85a9c9dd998","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?912bef4c-97f8-4d43-8844-960a88724503","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a0bd00e9-9813-4ea7-b640-1eb59202751b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a3c08a6d-f986-4efc-9f96-3f0e652704dc","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?afd5c7b3-4886-4250-9a12-b61451f65eb5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?afe34ac2-1403-4754-9beb-f76393cdc3ca","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bc8b9bf5-74d7-422e-bab9-e5aa63cfa0ab","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bd7cb86a-9800-4ffc-942b-e2b5ec34000e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d9adb9e4-c495-9530-e5e3-7e3b01d53e4c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?df64ffb8-f40f-479f-8c7b-a4b2011664e8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f12f81e5-634d-480c-b607-53ec5cbad03f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f394be03-fefc-4679-b001-4168a204a136","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f60a672d-8d6d-4d67-9a47-5547357e7b5b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f9a92bf9-0bb2-4963-90d0-f610fe0a34f2"]},{"source":"FDA","ids":["044ea3a4-e289-4446-bb6d-0486533ab728","200601d6-2c98-42dd-bece-76fc350c5356","2e90b6a9-fc55-4124-9699-b5142a92888d","54bcef51-511d-458f-8034-4dde11779ab7","97337771-dd37-4cdf-9eac-e0d60803cf6a","c67cebe8-bb1e-4bd5-b06f-2a730319ba50","cc249aa8-e6fe-40b4-a6b3-de62c00658a2","d385e07a-c16f-4aef-8e55-af95bd1c7526","e480e538-4ea7-47e6-9e5d-dc0f8179e06c","f1793d84-68fd-3ab9-c4e2-09f9a1be6425","label/2015/020702s065lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A044ea3a4-e289-4446-bb6d-0486533ab728","https://api.fda.gov/drug/label.json?search=set_id%3A200601d6-2c98-42dd-bece-76fc350c5356","https://api.fda.gov/drug/label.json?search=set_id%3A2e90b6a9-fc55-4124-9699-b5142a92888d","https://api.fda.gov/drug/label.json?search=set_id%3A54bcef51-511d-458f-8034-4dde11779ab7","https://api.fda.gov/drug/label.json?search=set_id%3A97337771-dd37-4cdf-9eac-e0d60803cf6a","https://api.fda.gov/drug/label.json?search=set_id%3Ac67cebe8-bb1e-4bd5-b06f-2a730319ba50","https://api.fda.gov/drug/label.json?search=set_id%3Acc249aa8-e6fe-40b4-a6b3-de62c00658a2","https://api.fda.gov/drug/label.json?search=set_id%3Ad385e07a-c16f-4aef-8e55-af95bd1c7526","https://api.fda.gov/drug/label.json?search=set_id%3Ae480e538-4ea7-47e6-9e5d-dc0f8179e06c","https://api.fda.gov/drug/label.json?search=set_id%3Af1793d84-68fd-3ab9-c4e2-09f9a1be6425","https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F020702s065lbl.pdf"]}]},{"efo_id":"EFO_0000612","efo_label":"myocardial infarction","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000612","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00979758","NCT03047772"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00979758%22OR%22NCT03047772%22"]},{"source":"DailyMed","ids":["062bf1a0-9a29-4dee-a8cb-f0d051f4c0b1","1667b9d6-26cb-4cb1-8d59-0b341afa45e8","4be76756-4114-4d50-a36c-fd410f6c773d","56550295-7074-43f0-9f46-4b2dc852f881","6f1a9bd8-ee30-4c7d-932f-3fa8c4e087b6","7c1083b9-7a20-475d-ba12-4f5d0b53e601","7fcb451e-4834-4905-852b-ec1efe9115f0","7fe85155-bc00-406b-b097-e8aece187a8a","909fad96-a941-443a-a39f-4f93607410fb","abee4a34-89cc-d886-192c-32582ab8f024","bc8b9bf5-74d7-422e-bab9-e5aa63cfa0ab","f12f81e5-634d-480c-b607-53ec5cbad03f"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?062bf1a0-9a29-4dee-a8cb-f0d051f4c0b1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1667b9d6-26cb-4cb1-8d59-0b341afa45e8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4be76756-4114-4d50-a36c-fd410f6c773d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?56550295-7074-43f0-9f46-4b2dc852f881","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6f1a9bd8-ee30-4c7d-932f-3fa8c4e087b6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7c1083b9-7a20-475d-ba12-4f5d0b53e601","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7fcb451e-4834-4905-852b-ec1efe9115f0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7fe85155-bc00-406b-b097-e8aece187a8a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?909fad96-a941-443a-a39f-4f93607410fb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?abee4a34-89cc-d886-192c-32582ab8f024","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bc8b9bf5-74d7-422e-bab9-e5aa63cfa0ab","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f12f81e5-634d-480c-b607-53ec5cbad03f"]},{"source":"FDA","ids":["54bcef51-511d-458f-8034-4dde11779ab7","8a201c80-a51d-4c1c-963b-488c071908c0","f1793d84-68fd-3ab9-c4e2-09f9a1be6425"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A54bcef51-511d-458f-8034-4dde11779ab7","https://api.fda.gov/drug/label.json?search=set_id%3A8a201c80-a51d-4c1c-963b-488c071908c0","https://api.fda.gov/drug/label.json?search=set_id%3Af1793d84-68fd-3ab9-c4e2-09f9a1be6425"]}]},{"efo_id":"EFO_0001360","efo_label":"type II diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001360","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00251680","NCT01477853","NCT01495013"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00251680%22OR%22NCT01477853%22OR%22NCT01495013%22"]}]},{"efo_id":"EFO_0004208","efo_label":"Vitiligo","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004208","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02432534","NCT03247400"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02432534%22OR%22NCT03247400%22"]}]},{"efo_id":"EFO_0003144","efo_label":"heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003144","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT02943590"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02943590%22"]}]},{"efo_id":"EFO_0000537","efo_label":"hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000537","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT02397590","NCT02791958","NCT03338426"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02397590%22OR%22NCT02791958%22OR%22NCT03338426%22"]},{"source":"DailyMed","ids":["062bf1a0-9a29-4dee-a8cb-f0d051f4c0b1","4be76756-4114-4d50-a36c-fd410f6c773d","6f1a9bd8-ee30-4c7d-932f-3fa8c4e087b6","786a6f14-1e2d-4c2a-93dd-c45315aff4fd","909fad96-a941-443a-a39f-4f93607410fb","abee4a34-89cc-d886-192c-32582ab8f024"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?062bf1a0-9a29-4dee-a8cb-f0d051f4c0b1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4be76756-4114-4d50-a36c-fd410f6c773d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6f1a9bd8-ee30-4c7d-932f-3fa8c4e087b6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?786a6f14-1e2d-4c2a-93dd-c45315aff4fd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?909fad96-a941-443a-a39f-4f93607410fb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?abee4a34-89cc-d886-192c-32582ab8f024"]},{"source":"FDA","ids":["2f568859-64e6-454f-801b-c0a0a647dc3d","d2d28679-a01b-4e63-90e2-d5c23b393c94"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A2f568859-64e6-454f-801b-c0a0a647dc3d","https://api.fda.gov/drug/label.json?search=set_id%3Ad2d28679-a01b-4e63-90e2-d5c23b393c94"]}]},{"efo_id":"EFO_0003095","efo_label":"non-alcoholic fatty liver disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003095","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01617772"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01617772%22"]}]},{"efo_id":"EFO_0003914","efo_label":"atherosclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003914","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00115817","NCT00115830"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00115817%22OR%22NCT00115830%22"]}]},{"efo_id":"EFO_0004252","efo_label":"nasopharyngeal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004252","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02022293"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02022293%22"]}]},{"efo_id":"EFO_0000712","efo_label":"stroke","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000712","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT01518231"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01518231%22"]},{"source":"DailyMed","ids":["00966aac-118a-4ee5-9230-a53a3ce5142e","00b6912b-d195-4d7d-8333-e9b0fa20fcc1","09c6c750-ae05-459f-83e8-4a9e4fd85212","10a7ba02-42d6-4cae-8904-b256e2da5496","1667b9d6-26cb-4cb1-8d59-0b341afa45e8","17a163ef-b349-4e32-bc8c-b02bac7f65d6","194218c4-3f18-4b6b-a0d9-acc8c862d4b7","194ee30e-c063-4bc8-be30-ac91ce329b61","1b1faadc-b8b5-4545-a12b-060a90881aec","263f60b2-355e-4389-b47f-146854184da8","28e28cc3-349a-427a-b19c-77503ef43db4","2a8de5aa-936a-493e-a0e3-813cbc969c6d","2b5f69aa-2dd9-4eb8-b8b8-def1a1ec1433","3d29ce1f-a9cf-4883-a320-712c6d21a297","4053ed16-9219-4657-b86f-52ef6b66d005","5412835b-27c6-461f-97b9-b5bf03afe7f2","56550295-7074-43f0-9f46-4b2dc852f881","595ab888-6b55-4642-a32f-e8521821ed81","59b924d0-e27f-4567-a0c4-467f9a61df3e","59e8d9ff-a6a5-4384-907e-749a5c64dee9","5cc454ee-3013-4d10-859e-ad8c5ca16c85","6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d","6d203e05-1fe6-4262-9d66-b461f84c4672","786a6f14-1e2d-4c2a-93dd-c45315aff4fd","7ba5c4ab-e385-4803-9a5c-ea7eafad550f","7c1083b9-7a20-475d-ba12-4f5d0b53e601","7fcb451e-4834-4905-852b-ec1efe9115f0","7fe85155-bc00-406b-b097-e8aece187a8a","84ceda02-d704-478e-b18c-3bad66120a15","865f4e70-ead8-4480-96a4-6ca7b7d8ed69","87f1e55a-6876-41d0-9f2b-d8c90d857968","8f71bea6-2fd0-44ae-afd9-727d365293a0","901550e6-22be-68c9-eb86-f85a9c9dd998","909fad96-a941-443a-a39f-4f93607410fb","912bef4c-97f8-4d43-8844-960a88724503","9d6a052b-b032-4d72-9bd1-e6c895b12472","a0bd00e9-9813-4ea7-b640-1eb59202751b","a25666a6-6e45-46c9-8c9e-e693756f940a","a3c08a6d-f986-4efc-9f96-3f0e652704dc","afd5c7b3-4886-4250-9a12-b61451f65eb5","afe34ac2-1403-4754-9beb-f76393cdc3ca","bc8b9bf5-74d7-422e-bab9-e5aa63cfa0ab","bd7cb86a-9800-4ffc-942b-e2b5ec34000e","c6e131fe-e7df-4876-83f7-9156fc4e8228","cc710d44-d515-4b17-a3c6-4d3ba9b049f8","d0a0feb6-84f0-4693-a11f-eb4f7ae0a87d","d9adb9e4-c495-9530-e5e3-7e3b01d53e4c","da09f66e-9093-4e07-9820-e7d8ccd594f3","df64ffb8-f40f-479f-8c7b-a4b2011664e8","e10ae715-81e6-4089-9fc3-fa2d10171ed6","f12f81e5-634d-480c-b607-53ec5cbad03f","f394be03-fefc-4679-b001-4168a204a136","f60a672d-8d6d-4d67-9a47-5547357e7b5b","f9a92bf9-0bb2-4963-90d0-f610fe0a34f2"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?00966aac-118a-4ee5-9230-a53a3ce5142e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?00b6912b-d195-4d7d-8333-e9b0fa20fcc1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?09c6c750-ae05-459f-83e8-4a9e4fd85212","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?10a7ba02-42d6-4cae-8904-b256e2da5496","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1667b9d6-26cb-4cb1-8d59-0b341afa45e8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?17a163ef-b349-4e32-bc8c-b02bac7f65d6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?194218c4-3f18-4b6b-a0d9-acc8c862d4b7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?194ee30e-c063-4bc8-be30-ac91ce329b61","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1b1faadc-b8b5-4545-a12b-060a90881aec","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?263f60b2-355e-4389-b47f-146854184da8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?28e28cc3-349a-427a-b19c-77503ef43db4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2a8de5aa-936a-493e-a0e3-813cbc969c6d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2b5f69aa-2dd9-4eb8-b8b8-def1a1ec1433","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3d29ce1f-a9cf-4883-a320-712c6d21a297","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4053ed16-9219-4657-b86f-52ef6b66d005","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5412835b-27c6-461f-97b9-b5bf03afe7f2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?56550295-7074-43f0-9f46-4b2dc852f881","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?595ab888-6b55-4642-a32f-e8521821ed81","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?59b924d0-e27f-4567-a0c4-467f9a61df3e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?59e8d9ff-a6a5-4384-907e-749a5c64dee9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5cc454ee-3013-4d10-859e-ad8c5ca16c85","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6d203e05-1fe6-4262-9d66-b461f84c4672","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?786a6f14-1e2d-4c2a-93dd-c45315aff4fd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7ba5c4ab-e385-4803-9a5c-ea7eafad550f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7c1083b9-7a20-475d-ba12-4f5d0b53e601","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7fcb451e-4834-4905-852b-ec1efe9115f0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7fe85155-bc00-406b-b097-e8aece187a8a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?84ceda02-d704-478e-b18c-3bad66120a15","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?865f4e70-ead8-4480-96a4-6ca7b7d8ed69","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?87f1e55a-6876-41d0-9f2b-d8c90d857968","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8f71bea6-2fd0-44ae-afd9-727d365293a0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?901550e6-22be-68c9-eb86-f85a9c9dd998","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?909fad96-a941-443a-a39f-4f93607410fb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?912bef4c-97f8-4d43-8844-960a88724503","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9d6a052b-b032-4d72-9bd1-e6c895b12472","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a0bd00e9-9813-4ea7-b640-1eb59202751b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a25666a6-6e45-46c9-8c9e-e693756f940a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a3c08a6d-f986-4efc-9f96-3f0e652704dc","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?afd5c7b3-4886-4250-9a12-b61451f65eb5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?afe34ac2-1403-4754-9beb-f76393cdc3ca","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bc8b9bf5-74d7-422e-bab9-e5aa63cfa0ab","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bd7cb86a-9800-4ffc-942b-e2b5ec34000e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c6e131fe-e7df-4876-83f7-9156fc4e8228","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cc710d44-d515-4b17-a3c6-4d3ba9b049f8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d0a0feb6-84f0-4693-a11f-eb4f7ae0a87d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d9adb9e4-c495-9530-e5e3-7e3b01d53e4c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?da09f66e-9093-4e07-9820-e7d8ccd594f3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?df64ffb8-f40f-479f-8c7b-a4b2011664e8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e10ae715-81e6-4089-9fc3-fa2d10171ed6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f12f81e5-634d-480c-b607-53ec5cbad03f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f394be03-fefc-4679-b001-4168a204a136","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f60a672d-8d6d-4d67-9a47-5547357e7b5b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f9a92bf9-0bb2-4963-90d0-f610fe0a34f2"]},{"source":"FDA","ids":["044ea3a4-e289-4446-bb6d-0486533ab728","200601d6-2c98-42dd-bece-76fc350c5356","20c51638-3ce0-4c4a-b4d9-49dfb574d90d","2e90b6a9-fc55-4124-9699-b5142a92888d","54bcef51-511d-458f-8034-4dde11779ab7","8a201c80-a51d-4c1c-963b-488c071908c0","97337771-dd37-4cdf-9eac-e0d60803cf6a","c67cebe8-bb1e-4bd5-b06f-2a730319ba50","cc249aa8-e6fe-40b4-a6b3-de62c00658a2","d385e07a-c16f-4aef-8e55-af95bd1c7526","e480e538-4ea7-47e6-9e5d-dc0f8179e06c","f1793d84-68fd-3ab9-c4e2-09f9a1be6425"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A044ea3a4-e289-4446-bb6d-0486533ab728","https://api.fda.gov/drug/label.json?search=set_id%3A200601d6-2c98-42dd-bece-76fc350c5356","https://api.fda.gov/drug/label.json?search=set_id%3A20c51638-3ce0-4c4a-b4d9-49dfb574d90d","https://api.fda.gov/drug/label.json?search=set_id%3A2e90b6a9-fc55-4124-9699-b5142a92888d","https://api.fda.gov/drug/label.json?search=set_id%3A54bcef51-511d-458f-8034-4dde11779ab7","https://api.fda.gov/drug/label.json?search=set_id%3A8a201c80-a51d-4c1c-963b-488c071908c0","https://api.fda.gov/drug/label.json?search=set_id%3A97337771-dd37-4cdf-9eac-e0d60803cf6a","https://api.fda.gov/drug/label.json?search=set_id%3Ac67cebe8-bb1e-4bd5-b06f-2a730319ba50","https://api.fda.gov/drug/label.json?search=set_id%3Acc249aa8-e6fe-40b4-a6b3-de62c00658a2","https://api.fda.gov/drug/label.json?search=set_id%3Ad385e07a-c16f-4aef-8e55-af95bd1c7526","https://api.fda.gov/drug/label.json?search=set_id%3Ae480e538-4ea7-47e6-9e5d-dc0f8179e06c","https://api.fda.gov/drug/label.json?search=set_id%3Af1793d84-68fd-3ab9-c4e2-09f9a1be6425"]}]},{"efo_id":"EFO_0004230","efo_label":"endometrial neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004230","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT02767362"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02767362%22"]}]},{"efo_id":"EFO_0003913","efo_label":"angina pectoris","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003913","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT02029118"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02029118%22"]},{"source":"DailyMed","ids":["909fad96-a941-443a-a39f-4f93607410fb"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?909fad96-a941-443a-a39f-4f93607410fb"]}]},{"efo_id":"EFO_0000384","efo_label":"Crohn's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000384","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00454545"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00454545%22"]}]},{"efo_id":"EFO_0000474","efo_label":"epilepsy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000474","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00627575"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00627575%22"]}]},{"efo_id":"EFO_0000519","efo_label":"glioblastoma multiforme","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000519","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02029573"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02029573%22"]}]},{"efo_id":"EFO_0000565","efo_label":"leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000565","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00185731"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00185731%22"]}]},{"efo_id":"EFO_0000681","efo_label":"renal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000681","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00490698"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00490698%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00164086"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00164086%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01220973","NCT02497638","NCT03819101"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01220973%22OR%22NCT02497638%22OR%22NCT03819101%22"]}]},{"efo_id":"EFO_0003047","efo_label":"hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003047","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00446940"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00446940%22"]}]},{"efo_id":"EFO_0003781","efo_label":"carotid artery disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003781","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00804843"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00804843%22"]}]},{"efo_id":"EFO_0003918","efo_label":"obstructive sleep apnea","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003918","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00669695","NCT03122639","NCT03308578"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00669695%22OR%22NCT03122639%22OR%22NCT03308578%22"]}]},{"efo_id":"EFO_0003929","efo_label":"relapsing-remitting multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003929","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00616187","NCT01111656"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00616187%22OR%22NCT01111656%22"]}]},{"efo_id":"EFO_0004194","efo_label":"IGA glomerulonephritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004194","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00396721"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00396721%22"]}]},{"efo_id":"EFO_0004236","efo_label":"focal segmental glomerulosclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004236","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00814255"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00814255%22"]}]},{"efo_id":"EFO_0004277","efo_label":"brain infarction","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004277","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03176498"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03176498%22"]}]},{"efo_id":"EFO_0004286","efo_label":"venous thromboembolism","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004286","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02331095"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02331095%22"]}]},{"efo_id":"EFO_0004616","efo_label":"osteoarthritis, knee","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004616","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01645176"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01645176%22"]}]},{"efo_id":"EFO_0005952","efo_label":"non-Hodgkins lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005952","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00185731"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00185731%22"]}]},{"efo_id":"EFO_1001249","efo_label":"non-alcoholic steatohepatitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001249","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02633956"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02633956%22"]}]},{"efo_id":"EFO_1001801","efo_label":"intracranial subdural hematoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001801","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02024373","NCT02192320","NCT03956368"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02024373%22OR%22NCT02192320%22OR%22NCT03956368%22"]}]},{"efo_id":"EFO_1001993","efo_label":"scleroderma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001993","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02370784"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02370784%22"]}]},{"efo_id":"EFO_1002032","efo_label":"primary hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1002032","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00991705","NCT02579356"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00991705%22OR%22NCT02579356%22"]}]},{"efo_id":"HP_0000863","efo_label":"Central diabetes insipidus","efo_uri":"http://purl.obolibrary.org/obo/HP_0000863","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02967653"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02967653%22"]}]},{"efo_id":"HP_0100806","efo_label":"Sepsis","efo_uri":"http://purl.obolibrary.org/obo/HP_0100806","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00452608"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00452608%22"]}]},{"efo_id":"EFO_0003913","efo_label":"angina pectoris","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003913","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["00966aac-118a-4ee5-9230-a53a3ce5142e","00b6912b-d195-4d7d-8333-e9b0fa20fcc1","09c6c750-ae05-459f-83e8-4a9e4fd85212","10a7ba02-42d6-4cae-8904-b256e2da5496","1667b9d6-26cb-4cb1-8d59-0b341afa45e8","17a163ef-b349-4e32-bc8c-b02bac7f65d6","194218c4-3f18-4b6b-a0d9-acc8c862d4b7","194ee30e-c063-4bc8-be30-ac91ce329b61","1b1faadc-b8b5-4545-a12b-060a90881aec","263f60b2-355e-4389-b47f-146854184da8","28e28cc3-349a-427a-b19c-77503ef43db4","2a8de5aa-936a-493e-a0e3-813cbc969c6d","2b5f69aa-2dd9-4eb8-b8b8-def1a1ec1433","3d29ce1f-a9cf-4883-a320-712c6d21a297","4053ed16-9219-4657-b86f-52ef6b66d005","5412835b-27c6-461f-97b9-b5bf03afe7f2","56550295-7074-43f0-9f46-4b2dc852f881","595ab888-6b55-4642-a32f-e8521821ed81","59b924d0-e27f-4567-a0c4-467f9a61df3e","59e8d9ff-a6a5-4384-907e-749a5c64dee9","5cc454ee-3013-4d10-859e-ad8c5ca16c85","6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d","6d203e05-1fe6-4262-9d66-b461f84c4672","786a6f14-1e2d-4c2a-93dd-c45315aff4fd","7ba5c4ab-e385-4803-9a5c-ea7eafad550f","7c1083b9-7a20-475d-ba12-4f5d0b53e601","7fcb451e-4834-4905-852b-ec1efe9115f0","7fe85155-bc00-406b-b097-e8aece187a8a","84ceda02-d704-478e-b18c-3bad66120a15","865f4e70-ead8-4480-96a4-6ca7b7d8ed69","87f1e55a-6876-41d0-9f2b-d8c90d857968","8f71bea6-2fd0-44ae-afd9-727d365293a0","901550e6-22be-68c9-eb86-f85a9c9dd998","909fad96-a941-443a-a39f-4f93607410fb","912bef4c-97f8-4d43-8844-960a88724503","9d6a052b-b032-4d72-9bd1-e6c895b12472","a0bd00e9-9813-4ea7-b640-1eb59202751b","a25666a6-6e45-46c9-8c9e-e693756f940a","a3c08a6d-f986-4efc-9f96-3f0e652704dc","afd5c7b3-4886-4250-9a12-b61451f65eb5","afe34ac2-1403-4754-9beb-f76393cdc3ca","bc8b9bf5-74d7-422e-bab9-e5aa63cfa0ab","bd7cb86a-9800-4ffc-942b-e2b5ec34000e","c6e131fe-e7df-4876-83f7-9156fc4e8228","cc710d44-d515-4b17-a3c6-4d3ba9b049f8","d0a0feb6-84f0-4693-a11f-eb4f7ae0a87d","d9adb9e4-c495-9530-e5e3-7e3b01d53e4c","da09f66e-9093-4e07-9820-e7d8ccd594f3","df64ffb8-f40f-479f-8c7b-a4b2011664e8","e10ae715-81e6-4089-9fc3-fa2d10171ed6","f12f81e5-634d-480c-b607-53ec5cbad03f","f394be03-fefc-4679-b001-4168a204a136","f60a672d-8d6d-4d67-9a47-5547357e7b5b","f9a92bf9-0bb2-4963-90d0-f610fe0a34f2"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?00966aac-118a-4ee5-9230-a53a3ce5142e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?00b6912b-d195-4d7d-8333-e9b0fa20fcc1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?09c6c750-ae05-459f-83e8-4a9e4fd85212","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?10a7ba02-42d6-4cae-8904-b256e2da5496","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1667b9d6-26cb-4cb1-8d59-0b341afa45e8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?17a163ef-b349-4e32-bc8c-b02bac7f65d6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?194218c4-3f18-4b6b-a0d9-acc8c862d4b7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?194ee30e-c063-4bc8-be30-ac91ce329b61","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1b1faadc-b8b5-4545-a12b-060a90881aec","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?263f60b2-355e-4389-b47f-146854184da8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?28e28cc3-349a-427a-b19c-77503ef43db4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2a8de5aa-936a-493e-a0e3-813cbc969c6d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2b5f69aa-2dd9-4eb8-b8b8-def1a1ec1433","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3d29ce1f-a9cf-4883-a320-712c6d21a297","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4053ed16-9219-4657-b86f-52ef6b66d005","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5412835b-27c6-461f-97b9-b5bf03afe7f2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?56550295-7074-43f0-9f46-4b2dc852f881","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?595ab888-6b55-4642-a32f-e8521821ed81","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?59b924d0-e27f-4567-a0c4-467f9a61df3e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?59e8d9ff-a6a5-4384-907e-749a5c64dee9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5cc454ee-3013-4d10-859e-ad8c5ca16c85","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6d203e05-1fe6-4262-9d66-b461f84c4672","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?786a6f14-1e2d-4c2a-93dd-c45315aff4fd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7ba5c4ab-e385-4803-9a5c-ea7eafad550f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7c1083b9-7a20-475d-ba12-4f5d0b53e601","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7fcb451e-4834-4905-852b-ec1efe9115f0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7fe85155-bc00-406b-b097-e8aece187a8a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?84ceda02-d704-478e-b18c-3bad66120a15","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?865f4e70-ead8-4480-96a4-6ca7b7d8ed69","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?87f1e55a-6876-41d0-9f2b-d8c90d857968","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8f71bea6-2fd0-44ae-afd9-727d365293a0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?901550e6-22be-68c9-eb86-f85a9c9dd998","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?909fad96-a941-443a-a39f-4f93607410fb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?912bef4c-97f8-4d43-8844-960a88724503","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9d6a052b-b032-4d72-9bd1-e6c895b12472","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a0bd00e9-9813-4ea7-b640-1eb59202751b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a25666a6-6e45-46c9-8c9e-e693756f940a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a3c08a6d-f986-4efc-9f96-3f0e652704dc","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?afd5c7b3-4886-4250-9a12-b61451f65eb5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?afe34ac2-1403-4754-9beb-f76393cdc3ca","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bc8b9bf5-74d7-422e-bab9-e5aa63cfa0ab","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bd7cb86a-9800-4ffc-942b-e2b5ec34000e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c6e131fe-e7df-4876-83f7-9156fc4e8228","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cc710d44-d515-4b17-a3c6-4d3ba9b049f8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d0a0feb6-84f0-4693-a11f-eb4f7ae0a87d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d9adb9e4-c495-9530-e5e3-7e3b01d53e4c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?da09f66e-9093-4e07-9820-e7d8ccd594f3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?df64ffb8-f40f-479f-8c7b-a4b2011664e8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e10ae715-81e6-4089-9fc3-fa2d10171ed6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f12f81e5-634d-480c-b607-53ec5cbad03f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f394be03-fefc-4679-b001-4168a204a136","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f60a672d-8d6d-4d67-9a47-5547357e7b5b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f9a92bf9-0bb2-4963-90d0-f610fe0a34f2"]},{"source":"FDA","ids":["044ea3a4-e289-4446-bb6d-0486533ab728","200601d6-2c98-42dd-bece-76fc350c5356","20c51638-3ce0-4c4a-b4d9-49dfb574d90d","2e90b6a9-fc55-4124-9699-b5142a92888d","54bcef51-511d-458f-8034-4dde11779ab7","8a201c80-a51d-4c1c-963b-488c071908c0","97337771-dd37-4cdf-9eac-e0d60803cf6a","c67cebe8-bb1e-4bd5-b06f-2a730319ba50","cc249aa8-e6fe-40b4-a6b3-de62c00658a2","d385e07a-c16f-4aef-8e55-af95bd1c7526","e480e538-4ea7-47e6-9e5d-dc0f8179e06c","f1793d84-68fd-3ab9-c4e2-09f9a1be6425"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A044ea3a4-e289-4446-bb6d-0486533ab728","https://api.fda.gov/drug/label.json?search=set_id%3A200601d6-2c98-42dd-bece-76fc350c5356","https://api.fda.gov/drug/label.json?search=set_id%3A20c51638-3ce0-4c4a-b4d9-49dfb574d90d","https://api.fda.gov/drug/label.json?search=set_id%3A2e90b6a9-fc55-4124-9699-b5142a92888d","https://api.fda.gov/drug/label.json?search=set_id%3A54bcef51-511d-458f-8034-4dde11779ab7","https://api.fda.gov/drug/label.json?search=set_id%3A8a201c80-a51d-4c1c-963b-488c071908c0","https://api.fda.gov/drug/label.json?search=set_id%3A97337771-dd37-4cdf-9eac-e0d60803cf6a","https://api.fda.gov/drug/label.json?search=set_id%3Ac67cebe8-bb1e-4bd5-b06f-2a730319ba50","https://api.fda.gov/drug/label.json?search=set_id%3Acc249aa8-e6fe-40b4-a6b3-de62c00658a2","https://api.fda.gov/drug/label.json?search=set_id%3Ad385e07a-c16f-4aef-8e55-af95bd1c7526","https://api.fda.gov/drug/label.json?search=set_id%3Ae480e538-4ea7-47e6-9e5d-dc0f8179e06c","https://api.fda.gov/drug/label.json?search=set_id%3Af1793d84-68fd-3ab9-c4e2-09f9a1be6425"]}]},{"efo_id":"EFO_0000373","efo_label":"congestive heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000373","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["00966aac-118a-4ee5-9230-a53a3ce5142e","00b6912b-d195-4d7d-8333-e9b0fa20fcc1","09c6c750-ae05-459f-83e8-4a9e4fd85212","10a7ba02-42d6-4cae-8904-b256e2da5496","1667b9d6-26cb-4cb1-8d59-0b341afa45e8","17a163ef-b349-4e32-bc8c-b02bac7f65d6","194218c4-3f18-4b6b-a0d9-acc8c862d4b7","194ee30e-c063-4bc8-be30-ac91ce329b61","1b1faadc-b8b5-4545-a12b-060a90881aec","263f60b2-355e-4389-b47f-146854184da8","28e28cc3-349a-427a-b19c-77503ef43db4","2a8de5aa-936a-493e-a0e3-813cbc969c6d","2b5f69aa-2dd9-4eb8-b8b8-def1a1ec1433","3d29ce1f-a9cf-4883-a320-712c6d21a297","4053ed16-9219-4657-b86f-52ef6b66d005","5412835b-27c6-461f-97b9-b5bf03afe7f2","56550295-7074-43f0-9f46-4b2dc852f881","595ab888-6b55-4642-a32f-e8521821ed81","59b924d0-e27f-4567-a0c4-467f9a61df3e","59e8d9ff-a6a5-4384-907e-749a5c64dee9","5cc454ee-3013-4d10-859e-ad8c5ca16c85","6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d","6d203e05-1fe6-4262-9d66-b461f84c4672","7ba5c4ab-e385-4803-9a5c-ea7eafad550f","7c1083b9-7a20-475d-ba12-4f5d0b53e601","7fcb451e-4834-4905-852b-ec1efe9115f0","7fe85155-bc00-406b-b097-e8aece187a8a","84ceda02-d704-478e-b18c-3bad66120a15","865f4e70-ead8-4480-96a4-6ca7b7d8ed69","87f1e55a-6876-41d0-9f2b-d8c90d857968","8f71bea6-2fd0-44ae-afd9-727d365293a0","901550e6-22be-68c9-eb86-f85a9c9dd998","909fad96-a941-443a-a39f-4f93607410fb","912bef4c-97f8-4d43-8844-960a88724503","9d6a052b-b032-4d72-9bd1-e6c895b12472","a0bd00e9-9813-4ea7-b640-1eb59202751b","a25666a6-6e45-46c9-8c9e-e693756f940a","a3c08a6d-f986-4efc-9f96-3f0e652704dc","afd5c7b3-4886-4250-9a12-b61451f65eb5","afe34ac2-1403-4754-9beb-f76393cdc3ca","bc8b9bf5-74d7-422e-bab9-e5aa63cfa0ab","bd7cb86a-9800-4ffc-942b-e2b5ec34000e","c6e131fe-e7df-4876-83f7-9156fc4e8228","cc710d44-d515-4b17-a3c6-4d3ba9b049f8","d0a0feb6-84f0-4693-a11f-eb4f7ae0a87d","d9adb9e4-c495-9530-e5e3-7e3b01d53e4c","da09f66e-9093-4e07-9820-e7d8ccd594f3","df64ffb8-f40f-479f-8c7b-a4b2011664e8","e10ae715-81e6-4089-9fc3-fa2d10171ed6","f12f81e5-634d-480c-b607-53ec5cbad03f","f394be03-fefc-4679-b001-4168a204a136","f60a672d-8d6d-4d67-9a47-5547357e7b5b","f9a92bf9-0bb2-4963-90d0-f610fe0a34f2"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?00966aac-118a-4ee5-9230-a53a3ce5142e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?00b6912b-d195-4d7d-8333-e9b0fa20fcc1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?09c6c750-ae05-459f-83e8-4a9e4fd85212","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?10a7ba02-42d6-4cae-8904-b256e2da5496","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1667b9d6-26cb-4cb1-8d59-0b341afa45e8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?17a163ef-b349-4e32-bc8c-b02bac7f65d6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?194218c4-3f18-4b6b-a0d9-acc8c862d4b7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?194ee30e-c063-4bc8-be30-ac91ce329b61","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1b1faadc-b8b5-4545-a12b-060a90881aec","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?263f60b2-355e-4389-b47f-146854184da8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?28e28cc3-349a-427a-b19c-77503ef43db4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2a8de5aa-936a-493e-a0e3-813cbc969c6d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2b5f69aa-2dd9-4eb8-b8b8-def1a1ec1433","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3d29ce1f-a9cf-4883-a320-712c6d21a297","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4053ed16-9219-4657-b86f-52ef6b66d005","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5412835b-27c6-461f-97b9-b5bf03afe7f2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?56550295-7074-43f0-9f46-4b2dc852f881","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?595ab888-6b55-4642-a32f-e8521821ed81","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?59b924d0-e27f-4567-a0c4-467f9a61df3e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?59e8d9ff-a6a5-4384-907e-749a5c64dee9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5cc454ee-3013-4d10-859e-ad8c5ca16c85","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6d203e05-1fe6-4262-9d66-b461f84c4672","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7ba5c4ab-e385-4803-9a5c-ea7eafad550f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7c1083b9-7a20-475d-ba12-4f5d0b53e601","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7fcb451e-4834-4905-852b-ec1efe9115f0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7fe85155-bc00-406b-b097-e8aece187a8a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?84ceda02-d704-478e-b18c-3bad66120a15","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?865f4e70-ead8-4480-96a4-6ca7b7d8ed69","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?87f1e55a-6876-41d0-9f2b-d8c90d857968","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8f71bea6-2fd0-44ae-afd9-727d365293a0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?901550e6-22be-68c9-eb86-f85a9c9dd998","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?909fad96-a941-443a-a39f-4f93607410fb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?912bef4c-97f8-4d43-8844-960a88724503","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9d6a052b-b032-4d72-9bd1-e6c895b12472","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a0bd00e9-9813-4ea7-b640-1eb59202751b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a25666a6-6e45-46c9-8c9e-e693756f940a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a3c08a6d-f986-4efc-9f96-3f0e652704dc","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?afd5c7b3-4886-4250-9a12-b61451f65eb5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?afe34ac2-1403-4754-9beb-f76393cdc3ca","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bc8b9bf5-74d7-422e-bab9-e5aa63cfa0ab","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bd7cb86a-9800-4ffc-942b-e2b5ec34000e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c6e131fe-e7df-4876-83f7-9156fc4e8228","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cc710d44-d515-4b17-a3c6-4d3ba9b049f8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d0a0feb6-84f0-4693-a11f-eb4f7ae0a87d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d9adb9e4-c495-9530-e5e3-7e3b01d53e4c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?da09f66e-9093-4e07-9820-e7d8ccd594f3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?df64ffb8-f40f-479f-8c7b-a4b2011664e8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e10ae715-81e6-4089-9fc3-fa2d10171ed6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f12f81e5-634d-480c-b607-53ec5cbad03f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f394be03-fefc-4679-b001-4168a204a136","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f60a672d-8d6d-4d67-9a47-5547357e7b5b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f9a92bf9-0bb2-4963-90d0-f610fe0a34f2"]},{"source":"FDA","ids":["044ea3a4-e289-4446-bb6d-0486533ab728","200601d6-2c98-42dd-bece-76fc350c5356","20c51638-3ce0-4c4a-b4d9-49dfb574d90d","2e90b6a9-fc55-4124-9699-b5142a92888d","54bcef51-511d-458f-8034-4dde11779ab7","8a201c80-a51d-4c1c-963b-488c071908c0","97337771-dd37-4cdf-9eac-e0d60803cf6a","c67cebe8-bb1e-4bd5-b06f-2a730319ba50","cc249aa8-e6fe-40b4-a6b3-de62c00658a2","d385e07a-c16f-4aef-8e55-af95bd1c7526","e480e538-4ea7-47e6-9e5d-dc0f8179e06c","f1793d84-68fd-3ab9-c4e2-09f9a1be6425"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A044ea3a4-e289-4446-bb6d-0486533ab728","https://api.fda.gov/drug/label.json?search=set_id%3A200601d6-2c98-42dd-bece-76fc350c5356","https://api.fda.gov/drug/label.json?search=set_id%3A20c51638-3ce0-4c4a-b4d9-49dfb574d90d","https://api.fda.gov/drug/label.json?search=set_id%3A2e90b6a9-fc55-4124-9699-b5142a92888d","https://api.fda.gov/drug/label.json?search=set_id%3A54bcef51-511d-458f-8034-4dde11779ab7","https://api.fda.gov/drug/label.json?search=set_id%3A8a201c80-a51d-4c1c-963b-488c071908c0","https://api.fda.gov/drug/label.json?search=set_id%3A97337771-dd37-4cdf-9eac-e0d60803cf6a","https://api.fda.gov/drug/label.json?search=set_id%3Ac67cebe8-bb1e-4bd5-b06f-2a730319ba50","https://api.fda.gov/drug/label.json?search=set_id%3Acc249aa8-e6fe-40b4-a6b3-de62c00658a2","https://api.fda.gov/drug/label.json?search=set_id%3Ad385e07a-c16f-4aef-8e55-af95bd1c7526","https://api.fda.gov/drug/label.json?search=set_id%3Ae480e538-4ea7-47e6-9e5d-dc0f8179e06c","https://api.fda.gov/drug/label.json?search=set_id%3Af1793d84-68fd-3ab9-c4e2-09f9a1be6425"]}]},{"efo_id":"EFO_0000196","efo_label":"metastatic prostate cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000196","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT04026230"],"urls":["https://clinicaltrials.gov/search?id=%22NCT04026230%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03560882"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03560882%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03275376"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03275376%22"]}]},{"efo_id":"EFO_0007129","efo_label":"acute chest syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007129","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03820466"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03820466%22"]}]},{"efo_id":"EFO_0007160","efo_label":"autoimmune thrombocytopenic purpura","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007160","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03460808"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03460808%22"]}]},{"efo_id":"EFO_0008568","efo_label":"Sleep Disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008568","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01299597"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01299597%22"]}]},{"efo_id":"EFO_0008585","efo_label":"ST Elevation Myocardial Infarction","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008585","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01334671"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01334671%22"]}]},{"efo_id":"EFO_0009426","efo_label":"necrosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009426","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01228227"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01228227%22"]}]},{"efo_id":"EFO_1000984","efo_label":"inflammatory breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000984","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03872388"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03872388%22"]}]},{"efo_id":"EFO_1001771","efo_label":"cardiac edema","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001771","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02901379"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02901379%22"]}]}],"adverse_events":{"significant":[{"event":"myalgia","count":42953,"llr":5172.95843},{"event":"rhabdomyolysis","count":16457,"llr":3624.140141},{"event":"drug hypersensitivity","count":71246,"llr":2845.230094},{"event":"blood creatine phosphokinase increased","count":14851,"llr":2413.110011},{"event":"myopathy","count":3383,"llr":1285.184089},{"event":"immune-mediated necrotising myopathy","count":481,"llr":1198.867573},{"event":"muscular weakness","count":25474,"llr":738.2943234},{"event":"muscle spasms","count":35356,"llr":620.4323064},{"event":"blood cholesterol increased","count":8813,"llr":530.8271335},{"event":"drug interaction","count":53526,"llr":523.6290434},{"event":"myositis","count":2909,"llr":428.6431447}],"critval":419.1637686},"child_chembl_ids":["CHEMBL1790017","CHEMBL3349878","CHEMBL393220"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000113161","approved_name":"3-hydroxy-3-methylglutaryl-CoA reductase","approved_symbol":"HMGCR"}],"target_type":"single protein","target_name":"HMG-CoA reductase","action_type":"inhibitor","description":"HMG-CoA reductase inhibitor","references":[{"source":"DailyMed","ids":["setid=6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d#section-13"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d#section-13"]}]}],"number_of_indications":100,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":25},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":20},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":18},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":15},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":14},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":13},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":13},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":13},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":12},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":11},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":11},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":9},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":9},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":7},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":6},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":5},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":4},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":3},{"therapeutic_code":"OTAR_0000014","therapeutic_label":"pregnancy or perinatal disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201301","_score":1,"_source":{"id":"CHEMBL1201301","internal_compound":false,"type":"Small molecule","pref_name":"MANGAFODIPIR","year_first_approved":1997,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Mangafodipir","Mangafodipir Trisodium","Mangafodipir trisodium salt","WIN-59010"],"trade_names":["Teslascan"],"cross_references":[{"source":"DrugCentral","ids":["4532"]}],"indications":[{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00727922"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00727922%22"]}]},{"efo_id":"EFO_0000612","efo_label":"myocardial infarction","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000612","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00966563"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00966563%22"]}]},{"efo_id":"EFO_1001950","efo_label":"colon carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001950","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00671996"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00671996%22"]}]}],"child_chembl_ids":["CHEMBL2096651"],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL734","_score":1,"_source":{"id":"CHEMBL734","internal_compound":false,"type":"Small molecule","pref_name":"ACETOHYDROXAMIC ACID","year_first_approved":1983,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Acetohydroxamic acid","NSC-176136"],"trade_names":["Lithostat"],"cross_references":[{"source":"ChEBI","ids":[27777]},{"source":"DailyMed","ids":["acetohydroxamic%20acid"]},{"source":"PubChem","ids":["144204853","170465439","26747835"]},{"source":"Wikipedia","ids":["Acetohydroxamic_acid"]},{"source":"drugbank","ids":["DB00551"]}],"canonical_smiles":"CC(=O)NO","indications":[{"efo_id":"Orphanet_23","efo_label":"Argininosuccinic aciduria","efo_uri":"http://www.orpha.net/ORDO/Orphanet_23","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02670889"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02670889%22"]}]},{"efo_id":"Orphanet_247525","efo_label":"Citrullinemia type I","efo_uri":"http://www.orpha.net/ORDO/Orphanet_247525","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02670889"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02670889%22"]}]},{"efo_id":"Orphanet_664","efo_label":"Ornithine transcarbamylase deficiency","efo_uri":"http://www.orpha.net/ORDO/Orphanet_664","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02670889"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02670889%22"]}]}],"mechanisms_of_action":[{"target_type":"protein complex","target_name":"Bacterial urease","action_type":"inhibitor","description":"Bacterial urease inhibitor","references":[{"source":"DailyMed","ids":["setid=6660b616-a82d-9109-19ce-2bdf9747acea#nlm34090-1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6660b616-a82d-9109-19ce-2bdf9747acea#nlm34090-1"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":3},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":3},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108568","_score":1,"_source":{"id":"CHEMBL2108568","internal_compound":false,"type":"Protein","pref_name":"TREBANANIB","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AMG-386","Tovasanib","Trebananib"],"trade_names":[],"indications":[{"efo_id":"EFO_0000681","efo_label":"renal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000681","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00467025","NCT00853372","NCT01664182"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00467025%22OR%22NCT00853372%22OR%22NCT01664182%22"]}]},{"efo_id":"EFO_0000182","efo_label":"hepatocellular carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000182","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00872014"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00872014%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00511459"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00511459%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00102830","NCT00861419","NCT01992341","NCT02525536","NCT03239145"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00102830%22OR%22NCT00861419%22OR%22NCT01992341%22OR%22NCT02525536%22OR%22NCT03239145%22"]}]},{"efo_id":"EFO_0000632","efo_label":"oligodendroglioma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000632","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01609790"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01609790%22"]}]},{"efo_id":"EFO_0000673","efo_label":"prostate adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000673","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01553188"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01553188%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01666977"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01666977%22"]}]},{"efo_id":"EFO_0003968","efo_label":"angiosarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003968","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01623869"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01623869%22"]}]},{"efo_id":"EFO_1001465","efo_label":"gliosarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001465","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01609790"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01609790%22"]}]},{"efo_id":"EFO_0001075","efo_label":"ovarian carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001075","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00479817","NCT01204749","NCT01493505"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00479817%22OR%22NCT01204749%22OR%22NCT01493505%22"]}]},{"efo_id":"EFO_0008528","efo_label":"urothelial carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008528","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01907308"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01907308%22"]}]},{"efo_id":"EFO_1000251","efo_label":"Fallopian Tube Carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000251","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00479817","NCT01204749","NCT01493505"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00479817%22OR%22NCT01204749%22OR%22NCT01493505%22"]}]},{"efo_id":"EFO_1001100","efo_label":"peritoneal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001100","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00479817","NCT01204749","NCT01493505"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00479817%22OR%22NCT01204749%22OR%22NCT01493505%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000154188","approved_name":"angiopoietin 1","approved_symbol":"ANGPT1"}],"target_type":"single protein","target_name":"Angiopoietin-1","action_type":"inhibitor","description":"Angiopoietin-1 inhibitor","references":[{"source":"PubMed","ids":["20677100"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20677100"]}]},{"target_components":[{"ensembl":"ENSG00000091879","approved_name":"angiopoietin 2","approved_symbol":"ANGPT2"}],"target_type":"single protein","target_name":"Angiopoietin-2","action_type":"inhibitor","description":"Angiopoietin-2 inhibitor","references":[{"source":"PubMed","ids":["20677100"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20677100"]}]}],"adverse_events":{"significant":[{"event":"peripheral artery stenosis","count":175,"llr":7.746060756}],"critval":7.560494074},"number_of_indications":13,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":13},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":5},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":4},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":2},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":2},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2068237","_score":1,"_source":{"id":"CHEMBL2068237","internal_compound":false,"type":"Small molecule","pref_name":"CISPLATIN","year_first_approved":1978,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"cross_references":[{"source":"PubChem","ids":["144204562","144207019","144209698","170464726"]},{"source":"TG-GATEs","ids":["132"]},{"source":"DailyMed","ids":["cisplatin"]},{"source":"DrugCentral","ids":["4392"]},{"source":"PubChem","ids":["17389100","301178","50105439","557830","90340859"]}],"adverse_events":{"significant":[{"event":"febrile neutropenia","count":19204,"llr":2388.706073},{"event":"neutropenia","count":41585,"llr":1289.228791},{"event":"mucosal inflammation","count":9134,"llr":1136.97014},{"event":"dehydration","count":36809,"llr":892.9083587},{"event":"thrombocytopenia","count":35327,"llr":876.1219462},{"event":"vomiting","count":103943,"llr":730.4815938},{"event":"leukopenia","count":17226,"llr":697.8088984},{"event":"anaemia","count":61405,"llr":473.705403},{"event":"nausea","count":165652,"llr":471.1191016},{"event":"bone marrow failure","count":8717,"llr":466.2527619},{"event":"haematotoxicity","count":2676,"llr":421.5135869},{"event":"disease progression","count":21531,"llr":411.5166649},{"event":"nephropathy toxic","count":3566,"llr":391.6085771},{"event":"hypokalaemia","count":14556,"llr":371.9224044},{"event":"hyponatraemia","count":21598,"llr":366.6167427},{"event":"hypomagnesaemia","count":4347,"llr":365.7088546},{"event":"stomatitis","count":13596,"llr":356.7742904},{"event":"pancytopenia","count":17598,"llr":345.7673633},{"event":"neutropenic sepsis","count":2129,"llr":326.5208405},{"event":"injection site pain","count":56727,"llr":308.3546821},{"event":"neutrophil count decreased","count":11062,"llr":286.1660398},{"event":"pulmonary embolism","count":25452,"llr":279.6717569}],"critval":272.3795225},"child_chembl_ids":["CHEMBL11359"],"synonyms":["CIS-DDP","Cis-Platinum II","Cisplatin","Cisplatinum","INT-230-6 COMPONENT CISPLATIN","INT230-6 COMPONENT CISPLATIN","NSC-119875","cis-diamminedichloroplatinum(II)"],"trade_names":["Cisplatin","Platinol","Platinol-Aq"],"indications":[{"efo_id":"EFO_0000181","efo_label":"head and neck squamous cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000181","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002774","NCT00049166","NCT00139269","NCT00174837","NCT00442455","NCT00454779","NCT00513383","NCT00736944","NCT00756444","NCT00971932","NCT00999700","NCT01015664","NCT01064921","NCT01086826","NCT01154920","NCT01177956","NCT01218048","NCT01360827","NCT01689194","NCT01732640","NCT01737008","NCT01953952","NCT02022098","NCT02031250","NCT02047201","NCT02061631","NCT02158234","NCT02268695","NCT02350712","NCT02508246","NCT02537223","NCT02551159","NCT02624128","NCT02624999","NCT02764593","NCT02777385","NCT02882308","NCT02901483","NCT02923258","NCT03117257","NCT03169764","NCT03196869","NCT03330249","NCT03340896","NCT03349710","NCT03383094","NCT03389477","NCT03576417","NCT03673735","NCT03830385","NCT03855384"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002774%22OR%22NCT00049166%22OR%22NCT00139269%22OR%22NCT00174837%22OR%22NCT00442455%22OR%22NCT00454779%22OR%22NCT00513383%22OR%22NCT00736944%22OR%22NCT00756444%22OR%22NCT00971932%22OR%22NCT00999700%22OR%22NCT01015664%22OR%22NCT01064921%22OR%22NCT01086826%22OR%22NCT01154920%22OR%22NCT01177956%22OR%22NCT01218048%22OR%22NCT01360827%22OR%22NCT01689194%22OR%22NCT01732640%22OR%22NCT01737008%22OR%22NCT01953952%22OR%22NCT02022098%22OR%22NCT02031250%22OR%22NCT02047201%22OR%22NCT02061631%22OR%22NCT02158234%22OR%22NCT02268695%22OR%22NCT02350712%22OR%22NCT02508246%22OR%22NCT02537223%22OR%22NCT02551159%22OR%22NCT02624128%22OR%22NCT02624999%22OR%22NCT02764593%22OR%22NCT02777385%22OR%22NCT02882308%22OR%22NCT02901483%22OR%22NCT02923258%22OR%22NCT03117257%22OR%22NCT03169764%22OR%22NCT03196869%22OR%22NCT03330249%22OR%22NCT03340896%22OR%22NCT03349710%22OR%22NCT03383094%22OR%22NCT03389477%22OR%22NCT03576417%22OR%22NCT03673735%22OR%22NCT03830385%22OR%22NCT03855384%22"]}]},{"efo_id":"EFO_0000313","efo_label":"carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000313","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00001569","NCT00022178","NCT00094497","NCT00126269","NCT00490399","NCT01171781","NCT01593306","NCT01608464","NCT01828034","NCT02254278","NCT02695459","NCT03256916","NCT03976323","NCT04003636"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00001569%22OR%22NCT00022178%22OR%22NCT00094497%22OR%22NCT00126269%22OR%22NCT00490399%22OR%22NCT01171781%22OR%22NCT01593306%22OR%22NCT01608464%22OR%22NCT01828034%22OR%22NCT02254278%22OR%22NCT02695459%22OR%22NCT03256916%22OR%22NCT03976323%22OR%22NCT04003636%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00003004","NCT00003108","NCT00003132","NCT00003144","NCT00003242","NCT00003742","NCT00004063","NCT00004090","NCT00004913","NCT00004919","NCT00005791","NCT00005819","NCT00005996","NCT00006000","NCT00006464","NCT00009932","NCT00012194","NCT00016874","NCT00024323","NCT00046917","NCT00047047","NCT00084734","NCT00084812","NCT00087698","NCT00116896","NCT00190801","NCT00210041","NCT00215501","NCT00229723","NCT00251407","NCT00415324","NCT00423865","NCT00454649","NCT00458315","NCT00483093","NCT00528619","NCT00550901","NCT00573690","NCT00648648","NCT00653068","NCT00678132","NCT00782574","NCT00878449","NCT00954512","NCT01021150","NCT01047007","NCT01093092","NCT01095302","NCT01099358","NCT01284335","NCT01303926","NCT01460537","NCT01525927","NCT01606748","NCT01687413","NCT01868022","NCT01920061","NCT01980667","NCT02120118","NCT02157792","NCT02278250","NCT02403531","NCT02516813","NCT02620839","NCT02648425","NCT02715531","NCT02723955","NCT02797977","NCT02825940","NCT02937272","NCT03102320","NCT03421353","NCT03577704"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003004%22OR%22NCT00003108%22OR%22NCT00003132%22OR%22NCT00003144%22OR%22NCT00003242%22OR%22NCT00003742%22OR%22NCT00004063%22OR%22NCT00004090%22OR%22NCT00004913%22OR%22NCT00004919%22OR%22NCT00005791%22OR%22NCT00005819%22OR%22NCT00005996%22OR%22NCT00006000%22OR%22NCT00006464%22OR%22NCT00009932%22OR%22NCT00012194%22OR%22NCT00016874%22OR%22NCT00024323%22OR%22NCT00046917%22OR%22NCT00047047%22OR%22NCT00084734%22OR%22NCT00084812%22OR%22NCT00087698%22OR%22NCT00116896%22OR%22NCT00190801%22OR%22NCT00210041%22OR%22NCT00215501%22OR%22NCT00229723%22OR%22NCT00251407%22OR%22NCT00415324%22OR%22NCT00423865%22OR%22NCT00454649%22OR%22NCT00458315%22OR%22NCT00483093%22OR%22NCT00528619%22OR%22NCT00550901%22OR%22NCT00573690%22OR%22NCT00648648%22OR%22NCT00653068%22OR%22NCT00678132%22OR%22NCT00782574%22OR%22NCT00878449%22OR%22NCT00954512%22OR%22NCT01021150%22OR%22NCT01047007%22OR%22NCT01093092%22OR%22NCT01095302%22OR%22NCT01099358%22OR%22NCT01284335%22OR%22NCT01303926%22OR%22NCT01460537%22OR%22NCT01525927%22OR%22NCT01606748%22OR%22NCT01687413%22OR%22NCT01868022%22OR%22NCT01920061%22OR%22NCT01980667%22OR%22NCT02120118%22OR%22NCT02157792%22OR%22NCT02278250%22OR%22NCT02403531%22OR%22NCT02516813%22OR%22NCT02620839%22OR%22NCT02648425%22OR%22NCT02715531%22OR%22NCT02723955%22OR%22NCT02797977%22OR%22NCT02825940%22OR%22NCT02937272%22OR%22NCT03102320%22OR%22NCT03421353%22OR%22NCT03577704%22"]}]},{"efo_id":"EFO_0000707","efo_label":"squamous cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000707","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00443261","NCT00627835","NCT00705016","NCT00816634","NCT01051765","NCT01181401","NCT01232374","NCT01301612","NCT01474642","NCT01491139","NCT01588431","NCT01596868","NCT01627379","NCT01688700","NCT01836029","NCT01880359","NCT01914900","NCT02014831","NCT02051868","NCT02128906","NCT02277184","NCT02298595","NCT02305654","NCT02383966","NCT02394652","NCT02459457","NCT02485548","NCT02585973","NCT02753140","NCT03107182","NCT03387111","NCT03908372"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00443261%22OR%22NCT00627835%22OR%22NCT00705016%22OR%22NCT00816634%22OR%22NCT01051765%22OR%22NCT01181401%22OR%22NCT01232374%22OR%22NCT01301612%22OR%22NCT01474642%22OR%22NCT01491139%22OR%22NCT01588431%22OR%22NCT01596868%22OR%22NCT01627379%22OR%22NCT01688700%22OR%22NCT01836029%22OR%22NCT01880359%22OR%22NCT01914900%22OR%22NCT02014831%22OR%22NCT02051868%22OR%22NCT02128906%22OR%22NCT02277184%22OR%22NCT02298595%22OR%22NCT02305654%22OR%22NCT02383966%22OR%22NCT02394652%22OR%22NCT02459457%22OR%22NCT02485548%22OR%22NCT02585973%22OR%22NCT02753140%22OR%22NCT03107182%22OR%22NCT03387111%22OR%22NCT03908372%22"]}]},{"efo_id":"EFO_0000756","efo_label":"melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000756","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002882","NCT00083252","NCT00498979","NCT00505635","NCT00707161","NCT00779714","NCT00885534","NCT00970996","NCT01409174","NCT02285413","NCT03167177","NCT03435302"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002882%22OR%22NCT00083252%22OR%22NCT00498979%22OR%22NCT00505635%22OR%22NCT00707161%22OR%22NCT00779714%22OR%22NCT00885534%22OR%22NCT00970996%22OR%22NCT01409174%22OR%22NCT02285413%22OR%22NCT03167177%22OR%22NCT03435302%22"]}]},{"efo_id":"EFO_0001061","efo_label":"cervical carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001061","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002536","NCT00002813","NCT00003078","NCT00003209","NCT00003369","NCT00003377","NCT00003379","NCT00003624","NCT00003945","NCT00005965","NCT00006482","NCT00008112","NCT00012012","NCT00023660","NCT00039338","NCT00054067","NCT00057928","NCT00085631","NCT00098995","NCT00101192","NCT00137358","NCT00191100","NCT00193739","NCT00251888","NCT00257816","NCT00257829","NCT00276796","NCT00287911","NCT00320983","NCT00322920","NCT00428194","NCT00462397","NCT00510250","NCT00548418","NCT00548821","NCT00590967","NCT00691301","NCT00770874","NCT00826891","NCT00846508","NCT00957411","NCT00967928","NCT00980954","NCT01019278","NCT01076400","NCT01088347","NCT01097252","NCT01158248","NCT01230996","NCT01276730","NCT01405235","NCT01461772","NCT01485731","NCT01487226","NCT01554397","NCT01554410","NCT01561586","NCT01566240","NCT01594099","NCT01755845","NCT01756170","NCT01793701","NCT01958658","NCT01973101","NCT01999933","NCT02309658","NCT02363829","NCT02422563","NCT02432365","NCT02433626","NCT02595554","NCT02635360","NCT02703961","NCT02705612","NCT02957266","NCT03071289","NCT03255252","NCT03298893","NCT03332069","NCT03367871","NCT03527264","NCT03534713","NCT03556839","NCT03612791","NCT03635567","NCT03830866","NCT03912402","NCT03912415","NCT04121975"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002536%22OR%22NCT00002813%22OR%22NCT00003078%22OR%22NCT00003209%22OR%22NCT00003369%22OR%22NCT00003377%22OR%22NCT00003379%22OR%22NCT00003624%22OR%22NCT00003945%22OR%22NCT00005965%22OR%22NCT00006482%22OR%22NCT00008112%22OR%22NCT00012012%22OR%22NCT00023660%22OR%22NCT00039338%22OR%22NCT00054067%22OR%22NCT00057928%22OR%22NCT00085631%22OR%22NCT00098995%22OR%22NCT00101192%22OR%22NCT00137358%22OR%22NCT00191100%22OR%22NCT00193739%22OR%22NCT00251888%22OR%22NCT00257816%22OR%22NCT00257829%22OR%22NCT00276796%22OR%22NCT00287911%22OR%22NCT00320983%22OR%22NCT00322920%22OR%22NCT00428194%22OR%22NCT00462397%22OR%22NCT00510250%22OR%22NCT00548418%22OR%22NCT00548821%22OR%22NCT00590967%22OR%22NCT00691301%22OR%22NCT00770874%22OR%22NCT00826891%22OR%22NCT00846508%22OR%22NCT00957411%22OR%22NCT00967928%22OR%22NCT00980954%22OR%22NCT01019278%22OR%22NCT01076400%22OR%22NCT01088347%22OR%22NCT01097252%22OR%22NCT01158248%22OR%22NCT01230996%22OR%22NCT01276730%22OR%22NCT01405235%22OR%22NCT01461772%22OR%22NCT01485731%22OR%22NCT01487226%22OR%22NCT01554397%22OR%22NCT01554410%22OR%22NCT01561586%22OR%22NCT01566240%22OR%22NCT01594099%22OR%22NCT01755845%22OR%22NCT01756170%22OR%22NCT01793701%22OR%22NCT01958658%22OR%22NCT01973101%22OR%22NCT01999933%22OR%22NCT02309658%22OR%22NCT02363829%22OR%22NCT02422563%22OR%22NCT02432365%22OR%22NCT02433626%22OR%22NCT02595554%22OR%22NCT02635360%22OR%22NCT02703961%22OR%22NCT02705612%22OR%22NCT02957266%22OR%22NCT03071289%22OR%22NCT03255252%22OR%22NCT03298893%22OR%22NCT03332069%22OR%22NCT03367871%22OR%22NCT03527264%22OR%22NCT03534713%22OR%22NCT03556839%22OR%22NCT03612791%22OR%22NCT03635567%22OR%22NCT03830866%22OR%22NCT03912402%22OR%22NCT03912415%22OR%22NCT04121975%22"]}]},{"efo_id":"EFO_0001416","efo_label":"cervical adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001416","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00295789","NCT00421096","NCT00916500","NCT00950261","NCT02036164","NCT02095119","NCT02394652","NCT02501278"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00295789%22OR%22NCT00421096%22OR%22NCT00916500%22OR%22NCT00950261%22OR%22NCT02036164%22OR%22NCT02095119%22OR%22NCT02394652%22OR%22NCT02501278%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00001450","NCT00001499","NCT00005838","NCT00020709","NCT00042835","NCT00055757","NCT00069875","NCT00070629","NCT00077883","NCT00082472","NCT00087711","NCT00130780","NCT00148395","NCT00148798","NCT00154739","NCT00167401","NCT00173888","NCT00190476","NCT00191126","NCT00191139","NCT00191230","NCT00191308","NCT00191490","NCT00191620","NCT00191763","NCT00191841","NCT00192036","NCT00193921","NCT00198354","NCT00198367","NCT00198432","NCT00199758","NCT00216125","NCT00232206","NCT00254384","NCT00254904","NCT00259285","NCT00269152","NCT00270582","NCT00271323","NCT00291850","NCT00324805","NCT00326378","NCT00329472","NCT00333294","NCT00347412","NCT00349089","NCT00349219","NCT00379665","NCT00379717","NCT00385606","NCT00401492","NCT00402051","NCT00409006","NCT00417248","NCT00424853","NCT00425191","NCT00434668","NCT00446225","NCT00449033","NCT00455572","NCT00478699","NCT00482014","NCT00489996","NCT00490659","NCT00496275","NCT00497315","NCT00509366","NCT00526643","NCT00529100","NCT00535275","NCT00536640","NCT00545948","NCT00560573","NCT00577707","NCT00582634","NCT00614965","NCT00620269","NCT00620971","NCT00622349","NCT00633568","NCT00661778","NCT00678977","NCT00680940","NCT00682383","NCT00686959","NCT00705549","NCT00735904","NCT00771563","NCT00773188","NCT00776698","NCT00789373","NCT00794417","NCT00799240","NCT00806923","NCT00828841","NCT00832117","NCT00842712","NCT00867009","NCT00870870","NCT00871403","NCT00874328","NCT00883779","NCT00887315","NCT00887549","NCT00907504","NCT00924209","NCT00942825","NCT00961415","NCT00963807","NCT00966914","NCT00974584","NCT00981058","NCT00982111","NCT00985855","NCT00994097","NCT00995761","NCT00998166","NCT01000480","NCT01003964","NCT01004250","NCT01005680","NCT01017874","NCT01019798","NCT01029678","NCT01076231","NCT01077713","NCT01086254","NCT01088620","NCT01088906","NCT01109524","NCT01110226","NCT01131429","NCT01139775","NCT01160744","NCT01165021","NCT01185847","NCT01192243","NCT01194453","NCT01204307","NCT01222312","NCT01222572","NCT01232452","NCT01336842","NCT01356303","NCT01356368","NCT01368848","NCT01373463","NCT01383148","NCT01401192","NCT01405079","NCT01405586","NCT01407822","NCT01410214","NCT01411098","NCT01424709","NCT01454102","NCT01496742","NCT01519804","NCT01544179","NCT01562210","NCT01565772","NCT01631136","NCT01633645","NCT01639001","NCT01641575","NCT01655225","NCT01656551","NCT01674738","NCT01683175","NCT01687439","NCT01702714","NCT01705184","NCT01714037","NCT01731626","NCT01733589","NCT01742767","NCT01752023","NCT01763788","NCT01771289","NCT01783197","NCT01784549","NCT01788566","NCT01809210","NCT01810367","NCT01820754","NCT01822496","NCT01828099","NCT01836341","NCT01843647","NCT01860040","NCT01899989","NCT01928160","NCT01933568","NCT01971489","NCT01982955","NCT01993810","NCT01998919","NCT02001168","NCT02001896"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00001450%22OR%22NCT00001499%22OR%22NCT00005838%22OR%22NCT00020709%22OR%22NCT00042835%22OR%22NCT00055757%22OR%22NCT00069875%22OR%22NCT00070629%22OR%22NCT00077883%22OR%22NCT00082472%22OR%22NCT00087711%22OR%22NCT00130780%22OR%22NCT00148395%22OR%22NCT00148798%22OR%22NCT00154739%22OR%22NCT00167401%22OR%22NCT00173888%22OR%22NCT00190476%22OR%22NCT00191126%22OR%22NCT00191139%22OR%22NCT00191230%22OR%22NCT00191308%22OR%22NCT00191490%22OR%22NCT00191620%22OR%22NCT00191763%22OR%22NCT00191841%22OR%22NCT00192036%22OR%22NCT00193921%22OR%22NCT00198354%22OR%22NCT00198367%22OR%22NCT00198432%22OR%22NCT00199758%22OR%22NCT00216125%22OR%22NCT00232206%22OR%22NCT00254384%22OR%22NCT00254904%22OR%22NCT00259285%22OR%22NCT00269152%22OR%22NCT00270582%22OR%22NCT00271323%22OR%22NCT00291850%22OR%22NCT00324805%22OR%22NCT00326378%22OR%22NCT00329472%22OR%22NCT00333294%22OR%22NCT00347412%22OR%22NCT00349089%22OR%22NCT00349219%22OR%22NCT00379665%22OR%22NCT00379717%22OR%22NCT00385606%22OR%22NCT00401492%22OR%22NCT00402051%22OR%22NCT00409006%22OR%22NCT00417248%22OR%22NCT00424853%22OR%22NCT00425191%22OR%22NCT00434668%22OR%22NCT00446225%22OR%22NCT00449033%22OR%22NCT00455572%22OR%22NCT00478699%22OR%22NCT00482014%22OR%22NCT00489996%22OR%22NCT00490659%22OR%22NCT00496275%22OR%22NCT00497315%22OR%22NCT00509366%22OR%22NCT00526643%22OR%22NCT00529100%22OR%22NCT00535275%22OR%22NCT00536640%22OR%22NCT00545948%22OR%22NCT00560573%22OR%22NCT00577707%22OR%22NCT00582634%22OR%22NCT00614965%22OR%22NCT00620269%22OR%22NCT00620971%22OR%22NCT00622349%22OR%22NCT00633568%22OR%22NCT00661778%22OR%22NCT00678977%22OR%22NCT00680940%22OR%22NCT00682383%22OR%22NCT00686959%22OR%22NCT00705549%22OR%22NCT00735904%22OR%22NCT00771563%22OR%22NCT00773188%22OR%22NCT00776698%22OR%22NCT00789373%22OR%22NCT00794417%22OR%22NCT00799240%22OR%22NCT00806923%22OR%22NCT00828841%22OR%22NCT00832117%22OR%22NCT00842712%22OR%22NCT00867009%22OR%22NCT00870870%22OR%22NCT00871403%22OR%22NCT00874328%22OR%22NCT00883779%22OR%22NCT00887315%22OR%22NCT00887549%22OR%22NCT00907504%22OR%22NCT00924209%22OR%22NCT00942825%22OR%22NCT00961415%22OR%22NCT00963807%22OR%22NCT00966914%22OR%22NCT00974584%22OR%22NCT00981058%22OR%22NCT00982111%22OR%22NCT00985855%22OR%22NCT00994097%22OR%22NCT00995761%22OR%22NCT00998166%22OR%22NCT01000480%22OR%22NCT01003964%22OR%22NCT01004250%22OR%22NCT01005680%22OR%22NCT01017874%22OR%22NCT01019798%22OR%22NCT01029678%22OR%22NCT01076231%22OR%22NCT01077713%22OR%22NCT01086254%22OR%22NCT01088620%22OR%22NCT01088906%22OR%22NCT01109524%22OR%22NCT01110226%22OR%22NCT01131429%22OR%22NCT01139775%22OR%22NCT01160744%22OR%22NCT01165021%22OR%22NCT01185847%22OR%22NCT01192243%22OR%22NCT01194453%22OR%22NCT01204307%22OR%22NCT01222312%22OR%22NCT01222572%22OR%22NCT01232452%22OR%22NCT01336842%22OR%22NCT01356303%22OR%22NCT01356368%22OR%22NCT01368848%22OR%22NCT01373463%22OR%22NCT01383148%22OR%22NCT01401192%22OR%22NCT01405079%22OR%22NCT01405586%22OR%22NCT01407822%22OR%22NCT01410214%22OR%22NCT01411098%22OR%22NCT01424709%22OR%22NCT01454102%22OR%22NCT01496742%22OR%22NCT01519804%22OR%22NCT01544179%22OR%22NCT01562210%22OR%22NCT01565772%22OR%22NCT01631136%22OR%22NCT01633645%22OR%22NCT01639001%22OR%22NCT01641575%22OR%22NCT01655225%22OR%22NCT01656551%22OR%22NCT01674738%22OR%22NCT01683175%22OR%22NCT01687439%22OR%22NCT01702714%22OR%22NCT01705184%22OR%22NCT01714037%22OR%22NCT01731626%22OR%22NCT01733589%22OR%22NCT01742767%22OR%22NCT01752023%22OR%22NCT01763788%22OR%22NCT01771289%22OR%22NCT01783197%22OR%22NCT01784549%22OR%22NCT01788566%22OR%22NCT01809210%22OR%22NCT01810367%22OR%22NCT01820754%22OR%22NCT01822496%22OR%22NCT01828099%22OR%22NCT01836341%22OR%22NCT01843647%22OR%22NCT01860040%22OR%22NCT01899989%22OR%22NCT01928160%22OR%22NCT01933568%22OR%22NCT01971489%22OR%22NCT01982955%22OR%22NCT01993810%22OR%22NCT01998919%22OR%22NCT02001168%22OR%22NCT02001896%22"]}]},{"efo_id":"EFO_0004230","efo_label":"endometrial neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004230","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00003624","NCT00003691","NCT00005583","NCT00006027","NCT00016341","NCT00052312","NCT00388154","NCT00411138","NCT00448643","NCT01461746","NCT01461759","NCT02433626"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003624%22OR%22NCT00003691%22OR%22NCT00005583%22OR%22NCT00006027%22OR%22NCT00016341%22OR%22NCT00052312%22OR%22NCT00388154%22OR%22NCT00411138%22OR%22NCT00448643%22OR%22NCT01461746%22OR%22NCT01461759%22OR%22NCT02433626%22"]}]},{"efo_id":"EFO_0004252","efo_label":"nasopharyngeal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004252","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00201344","NCT00201396","NCT00370890","NCT00436293","NCT00592501","NCT00603915","NCT00677118","NCT00697905","NCT00747799","NCT00778908","NCT00816816","NCT00816855","NCT00817258","NCT00817583","NCT01187238","NCT01245959","NCT01265147","NCT01309633","NCT01312311","NCT01326559","NCT01417390","NCT01462474","NCT01479504","NCT01528618","NCT01534585","NCT01536223","NCT01540136","NCT01614938","NCT01616849","NCT01655628","NCT01797900","NCT01817023","NCT01854203","NCT01872962","NCT01915134","NCT02012062","NCT02016417","NCT02143388","NCT02187315","NCT02301208","NCT02360501","NCT02421640","NCT02434614","NCT02444949","NCT02460887","NCT02500940","NCT02512315","NCT02562599","NCT02608073","NCT02610010","NCT02610556","NCT02621970","NCT02633176","NCT02633202","NCT02786641","NCT02871518","NCT02973386","NCT03015727","NCT03020329","NCT03047265","NCT03068936","NCT03121716","NCT03175939","NCT03267498","NCT03306121","NCT03366415","NCT03427359","NCT03503136","NCT03557112","NCT03574324","NCT03601975","NCT03604965","NCT03612219","NCT03619824","NCT03668730","NCT03700476","NCT03707509","NCT03932266","NCT03984357","NCT04136886"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00201344%22OR%22NCT00201396%22OR%22NCT00370890%22OR%22NCT00436293%22OR%22NCT00592501%22OR%22NCT00603915%22OR%22NCT00677118%22OR%22NCT00697905%22OR%22NCT00747799%22OR%22NCT00778908%22OR%22NCT00816816%22OR%22NCT00816855%22OR%22NCT00817258%22OR%22NCT00817583%22OR%22NCT01187238%22OR%22NCT01245959%22OR%22NCT01265147%22OR%22NCT01309633%22OR%22NCT01312311%22OR%22NCT01326559%22OR%22NCT01417390%22OR%22NCT01462474%22OR%22NCT01479504%22OR%22NCT01528618%22OR%22NCT01534585%22OR%22NCT01536223%22OR%22NCT01540136%22OR%22NCT01614938%22OR%22NCT01616849%22OR%22NCT01655628%22OR%22NCT01797900%22OR%22NCT01817023%22OR%22NCT01854203%22OR%22NCT01872962%22OR%22NCT01915134%22OR%22NCT02012062%22OR%22NCT02016417%22OR%22NCT02143388%22OR%22NCT02187315%22OR%22NCT02301208%22OR%22NCT02360501%22OR%22NCT02421640%22OR%22NCT02434614%22OR%22NCT02444949%22OR%22NCT02460887%22OR%22NCT02500940%22OR%22NCT02512315%22OR%22NCT02562599%22OR%22NCT02608073%22OR%22NCT02610010%22OR%22NCT02610556%22OR%22NCT02621970%22OR%22NCT02633176%22OR%22NCT02633202%22OR%22NCT02786641%22OR%22NCT02871518%22OR%22NCT02973386%22OR%22NCT03015727%22OR%22NCT03020329%22OR%22NCT03047265%22OR%22NCT03068936%22OR%22NCT03121716%22OR%22NCT03175939%22OR%22NCT03267498%22OR%22NCT03306121%22OR%22NCT03366415%22OR%22NCT03427359%22OR%22NCT03503136%22OR%22NCT03557112%22OR%22NCT03574324%22OR%22NCT03601975%22OR%22NCT03604965%22OR%22NCT03612219%22OR%22NCT03619824%22OR%22NCT03668730%22OR%22NCT03700476%22OR%22NCT03707509%22OR%22NCT03932266%22OR%22NCT03984357%22OR%22NCT04136886%22"]}]},{"efo_id":"EFO_0004284","efo_label":"upper aerodigestive tract neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004284","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00094081","NCT00239304","NCT00261703","NCT00357149","NCT00402545","NCT00415194","NCT00521521","NCT00982436","NCT00995293","NCT01057589","NCT01087970","NCT01566435","NCT02283489","NCT02397486","NCT02555644","NCT02630264","NCT02633800","NCT02918955","NCT03040999","NCT03326947","NCT03765918"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00094081%22OR%22NCT00239304%22OR%22NCT00261703%22OR%22NCT00357149%22OR%22NCT00402545%22OR%22NCT00415194%22OR%22NCT00521521%22OR%22NCT00982436%22OR%22NCT00995293%22OR%22NCT01057589%22OR%22NCT01087970%22OR%22NCT01566435%22OR%22NCT02283489%22OR%22NCT02397486%22OR%22NCT02555644%22OR%22NCT02630264%22OR%22NCT02633800%22OR%22NCT02918955%22OR%22NCT03040999%22OR%22NCT03326947%22OR%22NCT03765918%22"]}]},{"efo_id":"EFO_0000292","efo_label":"bladder carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000292","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002919","NCT00003105","NCT00003133","NCT00003376","NCT00003640","NCT00003642","NCT00003930","NCT00005047","NCT00005086","NCT00006105","NCT00006111","NCT00006118","NCT00014534","NCT00022191","NCT00028756","NCT00054626","NCT00055601","NCT00080795","NCT00234494","NCT00237575","NCT00246974","NCT00268450","NCT00310011","NCT00330499","NCT00490880","NCT00506155","NCT00516750","NCT00556621","NCT00623064","NCT00635726","NCT00645593","NCT00714948","NCT00808639","NCT00847015","NCT00859339","NCT00981656","NCT01089088","NCT01090466","NCT01126749","NCT01222676","NCT01496534","NCT01589094","NCT01734798","NCT01812369","NCT01828736","NCT01938573","NCT02030574","NCT02074189","NCT02177695","NCT02202772","NCT02662062","NCT02690558","NCT02710734","NCT02723838","NCT02845050","NCT02885974","NCT03294304","NCT03472274","NCT03558087","NCT03661320","NCT03732677"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002919%22OR%22NCT00003105%22OR%22NCT00003133%22OR%22NCT00003376%22OR%22NCT00003640%22OR%22NCT00003642%22OR%22NCT00003930%22OR%22NCT00005047%22OR%22NCT00005086%22OR%22NCT00006105%22OR%22NCT00006111%22OR%22NCT00006118%22OR%22NCT00014534%22OR%22NCT00022191%22OR%22NCT00028756%22OR%22NCT00054626%22OR%22NCT00055601%22OR%22NCT00080795%22OR%22NCT00234494%22OR%22NCT00237575%22OR%22NCT00246974%22OR%22NCT00268450%22OR%22NCT00310011%22OR%22NCT00330499%22OR%22NCT00490880%22OR%22NCT00506155%22OR%22NCT00516750%22OR%22NCT00556621%22OR%22NCT00623064%22OR%22NCT00635726%22OR%22NCT00645593%22OR%22NCT00714948%22OR%22NCT00808639%22OR%22NCT00847015%22OR%22NCT00859339%22OR%22NCT00981656%22OR%22NCT01089088%22OR%22NCT01090466%22OR%22NCT01126749%22OR%22NCT01222676%22OR%22NCT01496534%22OR%22NCT01589094%22OR%22NCT01734798%22OR%22NCT01812369%22OR%22NCT01828736%22OR%22NCT01938573%22OR%22NCT02030574%22OR%22NCT02074189%22OR%22NCT02177695%22OR%22NCT02202772%22OR%22NCT02662062%22OR%22NCT02690558%22OR%22NCT02710734%22OR%22NCT02723838%22OR%22NCT02845050%22OR%22NCT02885974%22OR%22NCT03294304%22OR%22NCT03472274%22OR%22NCT03558087%22OR%22NCT03661320%22OR%22NCT03732677%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002772","NCT00002836","NCT00002998","NCT00003032","NCT00003042","NCT00003086","NCT00003690","NCT00004900","NCT00004906","NCT00006123","NCT00006260","NCT00148694","NCT00154882","NCT00155259","NCT00191789","NCT00191815","NCT00191854","NCT00192101","NCT00201760","NCT00480597","NCT00483223","NCT00499122","NCT00580333","NCT00601159","NCT00603408","NCT00680758","NCT00717951","NCT00776724","NCT00930930","NCT00998036","NCT01025349","NCT01031446","NCT01074970","NCT01149798","NCT01194869","NCT01287624","NCT01483300","NCT01611727","NCT01630226","NCT01655225","NCT01670500","NCT01672671","NCT01674842","NCT01910844","NCT01910870","NCT01928680","NCT01939418","NCT01982448","NCT02341911","NCT02365805","NCT02422498","NCT02445391","NCT02499367","NCT02544243","NCT02546934","NCT02595905","NCT02641847","NCT03012477","NCT03175666","NCT03193853","NCT03201861","NCT03387085","NCT03423849","NCT03580395","NCT03644589","NCT03982485"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002772%22OR%22NCT00002836%22OR%22NCT00002998%22OR%22NCT00003032%22OR%22NCT00003042%22OR%22NCT00003086%22OR%22NCT00003690%22OR%22NCT00004900%22OR%22NCT00004906%22OR%22NCT00006123%22OR%22NCT00006260%22OR%22NCT00148694%22OR%22NCT00154882%22OR%22NCT00155259%22OR%22NCT00191789%22OR%22NCT00191815%22OR%22NCT00191854%22OR%22NCT00192101%22OR%22NCT00201760%22OR%22NCT00480597%22OR%22NCT00483223%22OR%22NCT00499122%22OR%22NCT00580333%22OR%22NCT00601159%22OR%22NCT00603408%22OR%22NCT00680758%22OR%22NCT00717951%22OR%22NCT00776724%22OR%22NCT00930930%22OR%22NCT00998036%22OR%22NCT01025349%22OR%22NCT01031446%22OR%22NCT01074970%22OR%22NCT01149798%22OR%22NCT01194869%22OR%22NCT01287624%22OR%22NCT01483300%22OR%22NCT01611727%22OR%22NCT01630226%22OR%22NCT01655225%22OR%22NCT01670500%22OR%22NCT01672671%22OR%22NCT01674842%22OR%22NCT01910844%22OR%22NCT01910870%22OR%22NCT01928680%22OR%22NCT01939418%22OR%22NCT01982448%22OR%22NCT02341911%22OR%22NCT02365805%22OR%22NCT02422498%22OR%22NCT02445391%22OR%22NCT02499367%22OR%22NCT02544243%22OR%22NCT02546934%22OR%22NCT02595905%22OR%22NCT02641847%22OR%22NCT03012477%22OR%22NCT03175666%22OR%22NCT03193853%22OR%22NCT03201861%22OR%22NCT03387085%22OR%22NCT03423849%22OR%22NCT03580395%22OR%22NCT03644589%22OR%22NCT03982485%22"]}]},{"efo_id":"EFO_0000178","efo_label":"gastric carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000178","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002615","NCT00002722","NCT00002783","NCT00003157","NCT00003298","NCT00003862","NCT00004099","NCT00004103","NCT00004873","NCT00005049","NCT00005060","NCT00005638","NCT00006389","NCT00062374","NCT00072787","NCT00088816","NCT00123318","NCT00142350","NCT00150670","NCT00182611","NCT00215514","NCT00323830","NCT00400179","NCT00407186","NCT00415168","NCT00450203","NCT00454636","NCT00477711","NCT00565370","NCT00568971","NCT00601510","NCT00632268","NCT00674167","NCT00675194","NCT00678535","NCT00718913","NCT00743964","NCT00842244","NCT00842491","NCT00845884","NCT00857246","NCT00887822","NCT00915382","NCT00952497","NCT00960349","NCT00976976","NCT00980603","NCT00992199","NCT01015339","NCT01041404","NCT01045538","NCT01100801","NCT01198392","NCT01216644","NCT01228045","NCT01269255","NCT01283204","NCT01285557","NCT01286766","NCT01348009","NCT01355302","NCT01388790","NCT01406249","NCT01412294","NCT01426646","NCT01444521","NCT01450696","NCT01461057","NCT01471470","NCT01517009","NCT01558947","NCT01611506","NCT01671449","NCT01679340","NCT01697072","NCT01736410","NCT01774786","NCT01783951","NCT01824459","NCT01854255","NCT01924819","NCT02114359","NCT02137343","NCT02291211","NCT02322593","NCT02563054","NCT02901301","NCT03067792","NCT03322969","NCT03382600","NCT03588533"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002615%22OR%22NCT00002722%22OR%22NCT00002783%22OR%22NCT00003157%22OR%22NCT00003298%22OR%22NCT00003862%22OR%22NCT00004099%22OR%22NCT00004103%22OR%22NCT00004873%22OR%22NCT00005049%22OR%22NCT00005060%22OR%22NCT00005638%22OR%22NCT00006389%22OR%22NCT00062374%22OR%22NCT00072787%22OR%22NCT00088816%22OR%22NCT00123318%22OR%22NCT00142350%22OR%22NCT00150670%22OR%22NCT00182611%22OR%22NCT00215514%22OR%22NCT00323830%22OR%22NCT00400179%22OR%22NCT00407186%22OR%22NCT00415168%22OR%22NCT00450203%22OR%22NCT00454636%22OR%22NCT00477711%22OR%22NCT00565370%22OR%22NCT00568971%22OR%22NCT00601510%22OR%22NCT00632268%22OR%22NCT00674167%22OR%22NCT00675194%22OR%22NCT00678535%22OR%22NCT00718913%22OR%22NCT00743964%22OR%22NCT00842244%22OR%22NCT00842491%22OR%22NCT00845884%22OR%22NCT00857246%22OR%22NCT00887822%22OR%22NCT00915382%22OR%22NCT00952497%22OR%22NCT00960349%22OR%22NCT00976976%22OR%22NCT00980603%22OR%22NCT00992199%22OR%22NCT01015339%22OR%22NCT01041404%22OR%22NCT01045538%22OR%22NCT01100801%22OR%22NCT01198392%22OR%22NCT01216644%22OR%22NCT01228045%22OR%22NCT01269255%22OR%22NCT01283204%22OR%22NCT01285557%22OR%22NCT01286766%22OR%22NCT01348009%22OR%22NCT01355302%22OR%22NCT01388790%22OR%22NCT01406249%22OR%22NCT01412294%22OR%22NCT01426646%22OR%22NCT01444521%22OR%22NCT01450696%22OR%22NCT01461057%22OR%22NCT01471470%22OR%22NCT01517009%22OR%22NCT01558947%22OR%22NCT01611506%22OR%22NCT01671449%22OR%22NCT01679340%22OR%22NCT01697072%22OR%22NCT01736410%22OR%22NCT01774786%22OR%22NCT01783951%22OR%22NCT01824459%22OR%22NCT01854255%22OR%22NCT01924819%22OR%22NCT02114359%22OR%22NCT02137343%22OR%22NCT02291211%22OR%22NCT02322593%22OR%22NCT02563054%22OR%22NCT02901301%22OR%22NCT03067792%22OR%22NCT03322969%22OR%22NCT03382600%22OR%22NCT03588533%22"]}]},{"efo_id":"EFO_0000294","efo_label":"bladder tumor","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000294","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00625664","NCT02560038"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00625664%22OR%22NCT02560038%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002854","NCT00010023","NCT00106626","NCT00226239","NCT00249977","NCT00460265","NCT00490360","NCT00507962","NCT00551512","NCT00705874","NCT01096199","NCT01165385","NCT01192165","NCT01285037","NCT01301716","NCT01312324","NCT01375972","NCT01604863","NCT01711658","NCT01903018","NCT01909856","NCT01969877","NCT02240017","NCT02250872","NCT02711553","NCT02777788","NCT02937116","NCT03143153","NCT03308604","NCT03498521"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002854%22OR%22NCT00010023%22OR%22NCT00106626%22OR%22NCT00226239%22OR%22NCT00249977%22OR%22NCT00460265%22OR%22NCT00490360%22OR%22NCT00507962%22OR%22NCT00551512%22OR%22NCT00705874%22OR%22NCT01096199%22OR%22NCT01165385%22OR%22NCT01192165%22OR%22NCT01285037%22OR%22NCT01301716%22OR%22NCT01312324%22OR%22NCT01375972%22OR%22NCT01604863%22OR%22NCT01711658%22OR%22NCT01903018%22OR%22NCT01909856%22OR%22NCT01969877%22OR%22NCT02240017%22OR%22NCT02250872%22OR%22NCT02711553%22OR%22NCT02777788%22OR%22NCT02937116%22OR%22NCT03143153%22OR%22NCT03308604%22OR%22NCT03498521%22"]}]},{"efo_id":"EFO_0003897","efo_label":"stomach neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003897","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00188266","NCT00296322","NCT00296335","NCT00320294","NCT00320515","NCT00343239","NCT00384878","NCT00510107","NCT00553696","NCT00555620","NCT00555672","NCT00811447","NCT00909402","NCT01187212","NCT01967875","NCT02359058","NCT02370849","NCT03023436","NCT03061058","NCT03675737"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00188266%22OR%22NCT00296322%22OR%22NCT00296335%22OR%22NCT00320294%22OR%22NCT00320515%22OR%22NCT00343239%22OR%22NCT00384878%22OR%22NCT00510107%22OR%22NCT00553696%22OR%22NCT00555620%22OR%22NCT00555672%22OR%22NCT00811447%22OR%22NCT00909402%22OR%22NCT01187212%22OR%22NCT01967875%22OR%22NCT02359058%22OR%22NCT02370849%22OR%22NCT03023436%22OR%22NCT03061058%22OR%22NCT03675737%22"]}]},{"efo_id":"EFO_0002617","efo_label":"metastatic melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002617","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00527761","NCT01029873"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00527761%22OR%22NCT01029873%22"]}]},{"efo_id":"EFO_0002916","efo_label":"esophageal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002916","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002631","NCT00002711","NCT00002884","NCT00002897","NCT00002984","NCT00003087","NCT00003118","NCT00004897","NCT00005638","NCT00021320","NCT00030862","NCT00041262","NCT00047112","NCT00069953","NCT00072033","NCT00075738","NCT00101907","NCT00109850","NCT00137852","NCT00154700","NCT00154804","NCT00160030","NCT00160875","NCT00183807","NCT00193882","NCT00220129","NCT00230451","NCT00238407","NCT00258323","NCT00259402","NCT00290719","NCT00316862","NCT00354679","NCT00400114","NCT00416858","NCT00445861","NCT00493025","NCT00509561","NCT00520091","NCT00522795","NCT00525200","NCT00544362","NCT00570531","NCT00590031","NCT00601692","NCT00632333","NCT00655876","NCT00659113","NCT00686114","NCT00701857","NCT00733889","NCT00735345","NCT00759226","NCT00815308","NCT00861094","NCT00909402","NCT00915850","NCT01034189","NCT01372202","NCT01444547","NCT01704690","NCT01787006","NCT01843049","NCT01998347","NCT02133612","NCT02188615","NCT02279134","NCT02395705","NCT02446574","NCT02461043","NCT02741856","NCT02879227","NCT02891083","NCT02937519","NCT03002064","NCT03126708","NCT03189719","NCT03691090","NCT03881111","NCT04006041"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002631%22OR%22NCT00002711%22OR%22NCT00002884%22OR%22NCT00002897%22OR%22NCT00002984%22OR%22NCT00003087%22OR%22NCT00003118%22OR%22NCT00004897%22OR%22NCT00005638%22OR%22NCT00021320%22OR%22NCT00030862%22OR%22NCT00041262%22OR%22NCT00047112%22OR%22NCT00069953%22OR%22NCT00072033%22OR%22NCT00075738%22OR%22NCT00101907%22OR%22NCT00109850%22OR%22NCT00137852%22OR%22NCT00154700%22OR%22NCT00154804%22OR%22NCT00160030%22OR%22NCT00160875%22OR%22NCT00183807%22OR%22NCT00193882%22OR%22NCT00220129%22OR%22NCT00230451%22OR%22NCT00238407%22OR%22NCT00258323%22OR%22NCT00259402%22OR%22NCT00290719%22OR%22NCT00316862%22OR%22NCT00354679%22OR%22NCT00400114%22OR%22NCT00416858%22OR%22NCT00445861%22OR%22NCT00493025%22OR%22NCT00509561%22OR%22NCT00520091%22OR%22NCT00522795%22OR%22NCT00525200%22OR%22NCT00544362%22OR%22NCT00570531%22OR%22NCT00590031%22OR%22NCT00601692%22OR%22NCT00632333%22OR%22NCT00655876%22OR%22NCT00659113%22OR%22NCT00686114%22OR%22NCT00701857%22OR%22NCT00733889%22OR%22NCT00735345%22OR%22NCT00759226%22OR%22NCT00815308%22OR%22NCT00861094%22OR%22NCT00909402%22OR%22NCT00915850%22OR%22NCT01034189%22OR%22NCT01372202%22OR%22NCT01444547%22OR%22NCT01704690%22OR%22NCT01787006%22OR%22NCT01843049%22OR%22NCT01998347%22OR%22NCT02133612%22OR%22NCT02188615%22OR%22NCT02279134%22OR%22NCT02395705%22OR%22NCT02446574%22OR%22NCT02461043%22OR%22NCT02741856%22OR%22NCT02879227%22OR%22NCT02891083%22OR%22NCT02937519%22OR%22NCT03002064%22OR%22NCT03126708%22OR%22NCT03189719%22OR%22NCT03691090%22OR%22NCT03881111%22OR%22NCT04006041%22"]}]},{"efo_id":"EFO_0000182","efo_label":"hepatocellular carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000182","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00003044","NCT00003907","NCT00003912","NCT00077389","NCT00109954","NCT00183885","NCT00238160","NCT00276705","NCT00524498","NCT00808145","NCT00843934","NCT00875615","NCT00933816","NCT01004978","NCT01042041","NCT01327521","NCT01834963","NCT02821533","NCT02967887","NCT03192644","NCT03268499"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003044%22OR%22NCT00003907%22OR%22NCT00003912%22OR%22NCT00077389%22OR%22NCT00109954%22OR%22NCT00183885%22OR%22NCT00238160%22OR%22NCT00276705%22OR%22NCT00524498%22OR%22NCT00808145%22OR%22NCT00843934%22OR%22NCT00875615%22OR%22NCT00933816%22OR%22NCT01004978%22OR%22NCT01042041%22OR%22NCT01327521%22OR%22NCT01834963%22OR%22NCT02821533%22OR%22NCT02967887%22OR%22NCT03192644%22OR%22NCT03268499%22"]}]},{"efo_id":"EFO_0000637","efo_label":"osteosarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000637","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00023998","NCT00102531","NCT00134030","NCT00586846","NCT01258634","NCT01650090"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00023998%22OR%22NCT00102531%22OR%22NCT00134030%22OR%22NCT00586846%22OR%22NCT01258634%22OR%22NCT01650090%22"]}]},{"efo_id":"EFO_0000702","efo_label":"small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000702","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00043927","NCT00057837","NCT00066742","NCT00079040","NCT00118235","NCT00143455","NCT00320359","NCT00349492","NCT00359359","NCT00388960","NCT00401609","NCT00447421","NCT00452634","NCT00453154","NCT00475657","NCT00526396","NCT00537511","NCT00544596","NCT00546130","NCT00613626","NCT00658580","NCT00717938","NCT00791154","NCT00812266","NCT00826644","NCT00887159","NCT00916669","NCT00977561","NCT01187615","NCT01441349","NCT01450761","NCT01487499","NCT01573338","NCT01859741","NCT01977235","NCT02194049","NCT02323737","NCT02337712","NCT02815592","NCT02819999","NCT02875457","NCT02899728","NCT02934503","NCT02949895","NCT03043872","NCT03066778","NCT03116971","NCT03382561","NCT03699956","NCT03781869","NCT03850067"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00043927%22OR%22NCT00057837%22OR%22NCT00066742%22OR%22NCT00079040%22OR%22NCT00118235%22OR%22NCT00143455%22OR%22NCT00320359%22OR%22NCT00349492%22OR%22NCT00359359%22OR%22NCT00388960%22OR%22NCT00401609%22OR%22NCT00447421%22OR%22NCT00452634%22OR%22NCT00453154%22OR%22NCT00475657%22OR%22NCT00526396%22OR%22NCT00537511%22OR%22NCT00544596%22OR%22NCT00546130%22OR%22NCT00613626%22OR%22NCT00658580%22OR%22NCT00717938%22OR%22NCT00791154%22OR%22NCT00812266%22OR%22NCT00826644%22OR%22NCT00887159%22OR%22NCT00916669%22OR%22NCT00977561%22OR%22NCT01187615%22OR%22NCT01441349%22OR%22NCT01450761%22OR%22NCT01487499%22OR%22NCT01573338%22OR%22NCT01859741%22OR%22NCT01977235%22OR%22NCT02194049%22OR%22NCT02323737%22OR%22NCT02337712%22OR%22NCT02815592%22OR%22NCT02819999%22OR%22NCT02875457%22OR%22NCT02899728%22OR%22NCT02934503%22OR%22NCT02949895%22OR%22NCT03043872%22OR%22NCT03066778%22OR%22NCT03116971%22OR%22NCT03382561%22OR%22NCT03699956%22OR%22NCT03781869%22OR%22NCT03850067%22"]}]},{"efo_id":"EFO_0000691","efo_label":"sarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000691","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002492","NCT00002539","NCT00002546","NCT00002601","NCT00002993","NCT00003141","NCT00003624","NCT00003776","NCT00003937","NCT00014313","NCT00019864","NCT00033644","NCT00470223","NCT00652860","NCT00742924","NCT00989651","NCT01277744","NCT03809637"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002492%22OR%22NCT00002539%22OR%22NCT00002546%22OR%22NCT00002601%22OR%22NCT00002993%22OR%22NCT00003141%22OR%22NCT00003624%22OR%22NCT00003776%22OR%22NCT00003937%22OR%22NCT00014313%22OR%22NCT00019864%22OR%22NCT00033644%22OR%22NCT00470223%22OR%22NCT00652860%22OR%22NCT00742924%22OR%22NCT00989651%22OR%22NCT01277744%22OR%22NCT03809637%22"]}]},{"efo_id":"EFO_0002892","efo_label":"thyroid carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002892","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01240590"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01240590%22"]}]},{"efo_id":"EFO_0003869","efo_label":"breast neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003869","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00270569","NCT00463788","NCT01167192"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00270569%22OR%22NCT00463788%22OR%22NCT01167192%22"]}]},{"efo_id":"EFO_1001469","efo_label":"Mantle cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001469","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00209222","NCT01345357","NCT02858258","NCT02896582"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00209222%22OR%22NCT01345357%22OR%22NCT02858258%22OR%22NCT02896582%22"]}]},{"efo_id":"EFO_0001071","efo_label":"lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001071","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002550","NCT00002583","NCT00002623","NCT00002642","NCT00002822","NCT00002823","NCT00002858","NCT00002887","NCT00003037","NCT00003053","NCT00003111","NCT00003159","NCT00003202","NCT00003231","NCT00003240","NCT00003299","NCT00003364","NCT00003583","NCT00003587","NCT00003589","NCT00003606","NCT00003803","NCT00004100","NCT00004160","NCT00004176","NCT00004199","NCT00004201","NCT00004209","NCT00004264","NCT00004887","NCT00005022","NCT00005825","NCT00005868","NCT00006004","NCT00006012","NCT00006048","NCT00006116","NCT00006212","NCT00006374","NCT00006487","NCT00014196","NCT00016367","NCT00017459","NCT00021112","NCT00022308","NCT00030771","NCT00030810","NCT00039039","NCT00041015","NCT00045162","NCT00045604","NCT00045617","NCT00051506","NCT00052494","NCT00055887","NCT00055965","NCT00059761","NCT00062270","NCT00062322","NCT00062439","NCT00066222","NCT00072527","NCT00083161","NCT00101907","NCT00103051","NCT00112710","NCT00113386","NCT00118131","NCT00128037","NCT00132639","NCT00144053","NCT00144989","NCT00174629","NCT00174772","NCT00217698","NCT00227539","NCT00248482","NCT00248495","NCT00253591","NCT00281970","NCT00301808","NCT00309972","NCT00313690","NCT00346801","NCT00354549","NCT00387699","NCT00389688","NCT00398385","NCT00433498","NCT00452803","NCT00452881","NCT00514293","NCT00530634","NCT00538681","NCT00554463","NCT00589056","NCT00616785","NCT00617656","NCT00621361","NCT00632853","NCT00657423","NCT00660504","NCT00726986","NCT00744900","NCT00754858","NCT00792701","NCT00801736","NCT00863512","NCT00869752","NCT00945451","NCT00984997","NCT01038661","NCT01059188","NCT01116219","NCT01134861","NCT01160731","NCT01266512","NCT01443078","NCT01553942","NCT01579929","NCT01623102","NCT01839032","NCT01998529","NCT02281708","NCT02283476","NCT02644252","NCT02709720","NCT03348904","NCT03380468","NCT03432598","NCT03811002","NCT03823625","NCT03912389"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002550%22OR%22NCT00002583%22OR%22NCT00002623%22OR%22NCT00002642%22OR%22NCT00002822%22OR%22NCT00002823%22OR%22NCT00002858%22OR%22NCT00002887%22OR%22NCT00003037%22OR%22NCT00003053%22OR%22NCT00003111%22OR%22NCT00003159%22OR%22NCT00003202%22OR%22NCT00003231%22OR%22NCT00003240%22OR%22NCT00003299%22OR%22NCT00003364%22OR%22NCT00003583%22OR%22NCT00003587%22OR%22NCT00003589%22OR%22NCT00003606%22OR%22NCT00003803%22OR%22NCT00004100%22OR%22NCT00004160%22OR%22NCT00004176%22OR%22NCT00004199%22OR%22NCT00004201%22OR%22NCT00004209%22OR%22NCT00004264%22OR%22NCT00004887%22OR%22NCT00005022%22OR%22NCT00005825%22OR%22NCT00005868%22OR%22NCT00006004%22OR%22NCT00006012%22OR%22NCT00006048%22OR%22NCT00006116%22OR%22NCT00006212%22OR%22NCT00006374%22OR%22NCT00006487%22OR%22NCT00014196%22OR%22NCT00016367%22OR%22NCT00017459%22OR%22NCT00021112%22OR%22NCT00022308%22OR%22NCT00030771%22OR%22NCT00030810%22OR%22NCT00039039%22OR%22NCT00041015%22OR%22NCT00045162%22OR%22NCT00045604%22OR%22NCT00045617%22OR%22NCT00051506%22OR%22NCT00052494%22OR%22NCT00055887%22OR%22NCT00055965%22OR%22NCT00059761%22OR%22NCT00062270%22OR%22NCT00062322%22OR%22NCT00062439%22OR%22NCT00066222%22OR%22NCT00072527%22OR%22NCT00083161%22OR%22NCT00101907%22OR%22NCT00103051%22OR%22NCT00112710%22OR%22NCT00113386%22OR%22NCT00118131%22OR%22NCT00128037%22OR%22NCT00132639%22OR%22NCT00144053%22OR%22NCT00144989%22OR%22NCT00174629%22OR%22NCT00174772%22OR%22NCT00217698%22OR%22NCT00227539%22OR%22NCT00248482%22OR%22NCT00248495%22OR%22NCT00253591%22OR%22NCT00281970%22OR%22NCT00301808%22OR%22NCT00309972%22OR%22NCT00313690%22OR%22NCT00346801%22OR%22NCT00354549%22OR%22NCT00387699%22OR%22NCT00389688%22OR%22NCT00398385%22OR%22NCT00433498%22OR%22NCT00452803%22OR%22NCT00452881%22OR%22NCT00514293%22OR%22NCT00530634%22OR%22NCT00538681%22OR%22NCT00554463%22OR%22NCT00589056%22OR%22NCT00616785%22OR%22NCT00617656%22OR%22NCT00621361%22OR%22NCT00632853%22OR%22NCT00657423%22OR%22NCT00660504%22OR%22NCT00726986%22OR%22NCT00744900%22OR%22NCT00754858%22OR%22NCT00792701%22OR%22NCT00801736%22OR%22NCT00863512%22OR%22NCT00869752%22OR%22NCT00945451%22OR%22NCT00984997%22OR%22NCT01038661%22OR%22NCT01059188%22OR%22NCT01116219%22OR%22NCT01134861%22OR%22NCT01160731%22OR%22NCT01266512%22OR%22NCT01443078%22OR%22NCT01553942%22OR%22NCT01579929%22OR%22NCT01623102%22OR%22NCT01839032%22OR%22NCT01998529%22OR%22NCT02281708%22OR%22NCT02283476%22OR%22NCT02644252%22OR%22NCT02709720%22OR%22NCT03348904%22OR%22NCT03380468%22OR%22NCT03432598%22OR%22NCT03811002%22OR%22NCT03823625%22OR%22NCT03912389%22"]}]},{"efo_id":"EFO_0000096","efo_label":"neoplasm of mature B-cells","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000096","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02741388"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02741388%22"]}]},{"efo_id":"EFO_0000183","efo_label":"Hodgkins lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000183","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00025259","NCT01453504","NCT02243436","NCT02280993","NCT03418038"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00025259%22OR%22NCT01453504%22OR%22NCT02243436%22OR%22NCT02280993%22OR%22NCT03418038%22"]}]},{"efo_id":"EFO_0000209","efo_label":"T-cell acute lymphoblastic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000209","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01626664"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01626664%22"]}]},{"efo_id":"EFO_0000211","efo_label":"unspecified peripheral T-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000211","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00970385","NCT01719835","NCT02520219"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00970385%22OR%22NCT01719835%22OR%22NCT02520219%22"]}]},{"efo_id":"EFO_0000228","efo_label":"adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000228","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00548548","NCT01301612"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00548548%22OR%22NCT01301612%22"]}]},{"efo_id":"EFO_0000255","efo_label":"angioimmunoblastic T-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000255","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01719835"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01719835%22"]}]},{"efo_id":"EFO_0000326","efo_label":"central nervous system cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000326","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002876","NCT00003141","NCT00003211","NCT00003309","NCT00003621","NCT00003996","NCT00006258","NCT00014573","NCT00053872","NCT00084838","NCT00085202","NCT00147160","NCT00274911","NCT00276666","NCT00278278","NCT00293358","NCT00360945","NCT00392886","NCT01574092","NCT01670890","NCT02263105"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002876%22OR%22NCT00003141%22OR%22NCT00003211%22OR%22NCT00003309%22OR%22NCT00003621%22OR%22NCT00003996%22OR%22NCT00006258%22OR%22NCT00014573%22OR%22NCT00053872%22OR%22NCT00084838%22OR%22NCT00085202%22OR%22NCT00147160%22OR%22NCT00274911%22OR%22NCT00276666%22OR%22NCT00278278%22OR%22NCT00293358%22OR%22NCT00360945%22OR%22NCT00392886%22OR%22NCT01574092%22OR%22NCT01670890%22OR%22NCT02263105%22"]}]},{"efo_id":"EFO_0000389","efo_label":"cutaneous melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000389","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002669","NCT00003027","NCT00003690","NCT00004141","NCT00006237","NCT00072124","NCT00492505","NCT01196416"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002669%22OR%22NCT00003027%22OR%22NCT00003690%22OR%22NCT00004141%22OR%22NCT00006237%22OR%22NCT00072124%22OR%22NCT00492505%22OR%22NCT01196416%22"]}]},{"efo_id":"EFO_0000403","efo_label":"diffuse large B-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000403","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00137995","NCT01453205","NCT01805557","NCT02060656","NCT02542111","NCT03356054","NCT03418038","NCT03837873"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00137995%22OR%22NCT01453205%22OR%22NCT01805557%22OR%22NCT02060656%22OR%22NCT02542111%22OR%22NCT03356054%22OR%22NCT03418038%22OR%22NCT03837873%22"]}]},{"efo_id":"EFO_0000503","efo_label":"gastric adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000503","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00062374","NCT01283217","NCT01565109","NCT02494583","NCT03814759"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00062374%22OR%22NCT01283217%22OR%22NCT01565109%22OR%22NCT02494583%22OR%22NCT03814759%22"]}]},{"efo_id":"EFO_0000514","efo_label":"germ cell tumor","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000514","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00127049","NCT00198172","NCT01873326","NCT02104986","NCT02414685","NCT02582697"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00127049%22OR%22NCT00198172%22OR%22NCT01873326%22OR%22NCT02104986%22OR%22NCT02414685%22OR%22NCT02582697%22"]}]},{"efo_id":"EFO_0000565","efo_label":"leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000565","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00003402","NCT00004086","NCT00960726"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003402%22OR%22NCT00004086%22OR%22NCT00960726%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002461","NCT00002481","NCT00002488","NCT00002521","NCT00002522","NCT00002565","NCT00002835","NCT00003143","NCT00003397","NCT00003402","NCT00004086","NCT00004189","NCT00005601","NCT00012051","NCT00014209","NCT00025064","NCT00025636","NCT00028665","NCT00053105","NCT00069966","NCT00078949","NCT00090909","NCT00109928","NCT00418535","NCT00568607","NCT00577993","NCT00723658","NCT00732498","NCT00920153","NCT00933673","NCT01055496","NCT02276248","NCT02371161","NCT02404571","NCT02436707","NCT02532192","NCT02750670"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002461%22OR%22NCT00002481%22OR%22NCT00002488%22OR%22NCT00002521%22OR%22NCT00002522%22OR%22NCT00002565%22OR%22NCT00002835%22OR%22NCT00003143%22OR%22NCT00003397%22OR%22NCT00003402%22OR%22NCT00004086%22OR%22NCT00004189%22OR%22NCT00005601%22OR%22NCT00012051%22OR%22NCT00014209%22OR%22NCT00025064%22OR%22NCT00025636%22OR%22NCT00028665%22OR%22NCT00053105%22OR%22NCT00069966%22OR%22NCT00078949%22OR%22NCT00090909%22OR%22NCT00109928%22OR%22NCT00418535%22OR%22NCT00568607%22OR%22NCT00577993%22OR%22NCT00723658%22OR%22NCT00732498%22OR%22NCT00920153%22OR%22NCT00933673%22OR%22NCT01055496%22OR%22NCT02276248%22OR%22NCT02371161%22OR%22NCT02404571%22OR%22NCT02436707%22OR%22NCT02532192%22OR%22NCT02750670%22"]}]},{"efo_id":"EFO_0000588","efo_label":"mesothelioma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000588","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00003263","NCT00004920","NCT00005636","NCT00024271","NCT00027703","NCT00030459","NCT00030745","NCT00075699","NCT00227630","NCT00295503","NCT00334594","NCT00354393","NCT00402766","NCT00458913","NCT00541073","NCT00651456","NCT00668499","NCT00715611","NCT00859495","NCT00895648","NCT01105390","NCT01445392","NCT01569919","NCT01655225","NCT01907100","NCT02357147","NCT02707666","NCT02784171","NCT02838745","NCT02899299","NCT03319537","NCT03760575"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003263%22OR%22NCT00004920%22OR%22NCT00005636%22OR%22NCT00024271%22OR%22NCT00027703%22OR%22NCT00030459%22OR%22NCT00030745%22OR%22NCT00075699%22OR%22NCT00227630%22OR%22NCT00295503%22OR%22NCT00334594%22OR%22NCT00354393%22OR%22NCT00402766%22OR%22NCT00458913%22OR%22NCT00541073%22OR%22NCT00651456%22OR%22NCT00668499%22OR%22NCT00715611%22OR%22NCT00859495%22OR%22NCT00895648%22OR%22NCT01105390%22OR%22NCT01445392%22OR%22NCT01569919%22OR%22NCT01655225%22OR%22NCT01907100%22OR%22NCT02357147%22OR%22NCT02707666%22OR%22NCT02784171%22OR%22NCT02838745%22OR%22NCT02899299%22OR%22NCT03319537%22OR%22NCT03760575%22"]}]},{"efo_id":"EFO_0000621","efo_label":"neuroblastoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000621","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002634","NCT00002802","NCT00003141","NCT00004188","NCT00017225","NCT00017368","NCT00024193","NCT00040872","NCT00070200","NCT00135135","NCT00186849","NCT00276731","NCT00365755","NCT00410631","NCT00416676","NCT00567567","NCT00578864","NCT00808899","NCT01704716","NCT01857934","NCT02771743"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002634%22OR%22NCT00002802%22OR%22NCT00003141%22OR%22NCT00004188%22OR%22NCT00017225%22OR%22NCT00017368%22OR%22NCT00024193%22OR%22NCT00040872%22OR%22NCT00070200%22OR%22NCT00135135%22OR%22NCT00186849%22OR%22NCT00276731%22OR%22NCT00365755%22OR%22NCT00410631%22OR%22NCT00416676%22OR%22NCT00567567%22OR%22NCT00578864%22OR%22NCT00808899%22OR%22NCT01704716%22OR%22NCT01857934%22OR%22NCT02771743%22"]}]},{"efo_id":"EFO_0000681","efo_label":"renal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000681","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01762150"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01762150%22"]}]},{"efo_id":"EFO_0000708","efo_label":"squamous cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000708","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00005838","NCT00020709","NCT00042835","NCT01947062","NCT02787473","NCT03574818"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00005838%22OR%22NCT00020709%22OR%22NCT00042835%22OR%22NCT01947062%22OR%22NCT02787473%22OR%22NCT03574818%22"]}]},{"efo_id":"EFO_0000770","efo_label":"malignant pleural mesothelioma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000770","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00165516","NCT00165555","NCT00251550","NCT00386815","NCT00571298","NCT00700336","NCT00738582","NCT00886028","NCT01064648","NCT01211275","NCT01353482","NCT01869023","NCT02397928","NCT02436733","NCT02611037","NCT02639767","NCT03228537"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00165516%22OR%22NCT00165555%22OR%22NCT00251550%22OR%22NCT00386815%22OR%22NCT00571298%22OR%22NCT00700336%22OR%22NCT00738582%22OR%22NCT00886028%22OR%22NCT01064648%22OR%22NCT01211275%22OR%22NCT01353482%22OR%22NCT01869023%22OR%22NCT02397928%22OR%22NCT02436733%22OR%22NCT02611037%22OR%22NCT02639767%22OR%22NCT03228537%22"]}]},{"efo_id":"EFO_0001068","efo_label":"malaria","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001068","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02315690"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02315690%22"]}]},{"efo_id":"EFO_0001075","efo_label":"ovarian carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001075","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002477","NCT00002568","NCT00002717","NCT00002894","NCT00003214","NCT00003322","NCT00003345","NCT00003358","NCT00003386","NCT00003413","NCT00003624","NCT00003636","NCT00003896","NCT00004083","NCT00005049","NCT00005051","NCT00006028","NCT00006356","NCT00020696","NCT00028743","NCT00091377","NCT00191334","NCT00314678","NCT00345540","NCT00550784","NCT00702299","NCT00889733","NCT00942838","NCT00964626","NCT00993655","NCT01083537","NCT01809379","NCT01936974","NCT01970722","NCT02121990","NCT02432378","NCT02433626","NCT02475772","NCT02567253","NCT02608684","NCT03025477","NCT03734692","NCT03772028","NCT03989336"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002477%22OR%22NCT00002568%22OR%22NCT00002717%22OR%22NCT00002894%22OR%22NCT00003214%22OR%22NCT00003322%22OR%22NCT00003345%22OR%22NCT00003358%22OR%22NCT00003386%22OR%22NCT00003413%22OR%22NCT00003624%22OR%22NCT00003636%22OR%22NCT00003896%22OR%22NCT00004083%22OR%22NCT00005049%22OR%22NCT00005051%22OR%22NCT00006028%22OR%22NCT00006356%22OR%22NCT00020696%22OR%22NCT00028743%22OR%22NCT00091377%22OR%22NCT00191334%22OR%22NCT00314678%22OR%22NCT00345540%22OR%22NCT00550784%22OR%22NCT00702299%22OR%22NCT00889733%22OR%22NCT00942838%22OR%22NCT00964626%22OR%22NCT00993655%22OR%22NCT01083537%22OR%22NCT01809379%22OR%22NCT01936974%22OR%22NCT01970722%22OR%22NCT02121990%22OR%22NCT02432378%22OR%22NCT02433626%22OR%22NCT02475772%22OR%22NCT02567253%22OR%22NCT02608684%22OR%22NCT03025477%22OR%22NCT03734692%22OR%22NCT03772028%22OR%22NCT03989336%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00003399","NCT00003401","NCT00004903","NCT00005834","NCT00083538","NCT00083551","NCT00083681","NCT00083915","NCT00572169","NCT00574080","NCT00734877","NCT00869232","NCT00871013","NCT01055301","NCT01548573","NCT03004287"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003399%22OR%22NCT00003401%22OR%22NCT00004903%22OR%22NCT00005834%22OR%22NCT00083538%22OR%22NCT00083551%22OR%22NCT00083681%22OR%22NCT00083915%22OR%22NCT00572169%22OR%22NCT00574080%22OR%22NCT00734877%22OR%22NCT00869232%22OR%22NCT00871013%22OR%22NCT01055301%22OR%22NCT01548573%22OR%22NCT03004287%22"]}]},{"efo_id":"EFO_0001421","efo_label":"liver disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001421","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00398424"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00398424%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00003400","NCT00003690","NCT03275857"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003400%22OR%22NCT00003690%22OR%22NCT03275857%22"]}]},{"efo_id":"EFO_0002517","efo_label":"pancreatic ductal adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002517","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02754726"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02754726%22"]}]},{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00003029","NCT00003157","NCT00003332","NCT00004003","NCT00004884","NCT00012220","NCT00026403","NCT00049348","NCT00059826","NCT00068575","NCT00082862","NCT00101907","NCT00112697","NCT00126633","NCT00176813","NCT00262951","NCT00303758","NCT00335543","NCT00416507","NCT00660270","NCT00758381","NCT00785421","NCT00813696","NCT00922896","NCT00960284","NCT00966706","NCT01150630","NCT01167738","NCT01188109","NCT01296763","NCT01396668","NCT01396681","NCT01459614","NCT01730222","NCT01893801","NCT03403049","NCT03649321","NCT03797443","NCT04054362"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003029%22OR%22NCT00003157%22OR%22NCT00003332%22OR%22NCT00004003%22OR%22NCT00004884%22OR%22NCT00012220%22OR%22NCT00026403%22OR%22NCT00049348%22OR%22NCT00059826%22OR%22NCT00068575%22OR%22NCT00082862%22OR%22NCT00101907%22OR%22NCT00112697%22OR%22NCT00126633%22OR%22NCT00176813%22OR%22NCT00262951%22OR%22NCT00303758%22OR%22NCT00335543%22OR%22NCT00416507%22OR%22NCT00660270%22OR%22NCT00758381%22OR%22NCT00785421%22OR%22NCT00813696%22OR%22NCT00922896%22OR%22NCT00960284%22OR%22NCT00966706%22OR%22NCT01150630%22OR%22NCT01167738%22OR%22NCT01188109%22OR%22NCT01296763%22OR%22NCT01396668%22OR%22NCT01396681%22OR%22NCT01459614%22OR%22NCT01730222%22OR%22NCT01893801%22OR%22NCT03403049%22OR%22NCT03649321%22OR%22NCT03797443%22OR%22NCT04054362%22"]}]},{"efo_id":"EFO_0002626","efo_label":"thymus neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002626","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02633514"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02633514%22"]}]},{"efo_id":"EFO_0002890","efo_label":"renal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002890","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00003928"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003928%22"]}]},{"efo_id":"EFO_0002921","efo_label":"vulvar carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002921","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00006096"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00006096%22"]}]},{"efo_id":"EFO_0002939","efo_label":"medulloblastoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002939","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00006461","NCT00031590","NCT00085735","NCT00180791","NCT00336024","NCT00392327","NCT01614132","NCT01878617","NCT02724579"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00006461%22OR%22NCT00031590%22OR%22NCT00085735%22OR%22NCT00180791%22OR%22NCT00336024%22OR%22NCT00392327%22OR%22NCT01614132%22OR%22NCT01878617%22OR%22NCT02724579%22"]}]},{"efo_id":"EFO_0003032","efo_label":"anaplastic large cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003032","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00310128","NCT01719835"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00310128%22OR%22NCT01719835%22"]}]},{"efo_id":"EFO_0003817","efo_label":"laryngeal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003817","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00169182","NCT00599131","NCT01073683","NCT01633541"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00169182%22OR%22NCT00599131%22OR%22NCT01073683%22OR%22NCT01633541%22"]}]},{"efo_id":"EFO_0003826","efo_label":"salivary gland neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003826","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01488838","NCT01969578"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01488838%22OR%22NCT01969578%22"]}]},{"efo_id":"EFO_0003835","efo_label":"anal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003835","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00003596","NCT00003652","NCT00025090","NCT00068744","NCT00316888","NCT00324415","NCT00955240","NCT02402842"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003596%22OR%22NCT00003652%22OR%22NCT00025090%22OR%22NCT00068744%22OR%22NCT00316888%22OR%22NCT00324415%22OR%22NCT00955240%22OR%22NCT02402842%22"]}]},{"efo_id":"EFO_0003846","efo_label":"urethral neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003846","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00003376","NCT00006111","NCT00022191","NCT00080795","NCT01089088","NCT01090466"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003376%22OR%22NCT00006111%22OR%22NCT00022191%22OR%22NCT00080795%22OR%22NCT01089088%22OR%22NCT01090466%22"]}]},{"efo_id":"EFO_0003859","efo_label":"uterine neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003859","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00063999","NCT00231842","NCT00505492","NCT01970722"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00063999%22OR%22NCT00231842%22OR%22NCT00505492%22OR%22NCT01970722%22"]}]},{"efo_id":"EFO_0003863","efo_label":"urogenital neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003863","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00374868","NCT00821327","NCT02006667","NCT02516241","NCT03036098"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00374868%22OR%22NCT00821327%22OR%22NCT02006667%22OR%22NCT02516241%22OR%22NCT03036098%22"]}]},{"efo_id":"EFO_0003868","efo_label":"mouth neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003868","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00933387","NCT03383094"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00933387%22OR%22NCT03383094%22"]}]},{"efo_id":"EFO_0003871","efo_label":"tongue neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003871","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01953952"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01953952%22"]}]},{"efo_id":"EFO_0003891","efo_label":"biliary tract neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003891","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00380588","NCT00939848","NCT01096745","NCT01242605","NCT01284413","NCT01297998","NCT01821248","NCT01859728","NCT01917617","NCT01949870","NCT02182778","NCT02392637","NCT02632305","NCT02711553","NCT02992340","NCT03046862","NCT03101566","NCT03311789","NCT03406299"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00380588%22OR%22NCT00939848%22OR%22NCT01096745%22OR%22NCT01242605%22OR%22NCT01284413%22OR%22NCT01297998%22OR%22NCT01821248%22OR%22NCT01859728%22OR%22NCT01917617%22OR%22NCT01949870%22OR%22NCT02182778%22OR%22NCT02392637%22OR%22NCT02632305%22OR%22NCT02711553%22OR%22NCT02992340%22OR%22NCT03046862%22OR%22NCT03101566%22OR%22NCT03311789%22OR%22NCT03406299%22"]}]},{"efo_id":"EFO_0003893","efo_label":"ovarian neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003893","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00001426","NCT00772863","NCT00919984"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00001426%22OR%22NCT00772863%22OR%22NCT00919984%22"]}]},{"efo_id":"EFO_0004142","efo_label":"colorectal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004142","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02124148"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02124148%22"]}]},{"efo_id":"EFO_0004281","efo_label":"testicular neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004281","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00004077","NCT00324298","NCT02341989"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004077%22OR%22NCT00324298%22OR%22NCT02341989%22"]}]},{"efo_id":"EFO_0004606","efo_label":"gallbladder neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004606","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00949949","NCT01053390","NCT01242605","NCT02631590"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00949949%22OR%22NCT01053390%22OR%22NCT01242605%22OR%22NCT02631590%22"]}]},{"efo_id":"EFO_0005088","efo_label":"testicular carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005088","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00531687","NCT03937843"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00531687%22OR%22NCT03937843%22"]}]},{"efo_id":"EFO_0005221","efo_label":"cholangiocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005221","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01073839","NCT01242605","NCT01320254","NCT01692704","NCT01900158","NCT02128282","NCT02452970","NCT02631590","NCT02994251","NCT03656536","NCT03773302","NCT04088188","NCT04093362"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01073839%22OR%22NCT01242605%22OR%22NCT01320254%22OR%22NCT01692704%22OR%22NCT01900158%22OR%22NCT02128282%22OR%22NCT02452970%22OR%22NCT02631590%22OR%22NCT02994251%22OR%22NCT03656536%22OR%22NCT03773302%22OR%22NCT04088188%22OR%22NCT04093362%22"]}]},{"efo_id":"EFO_0005235","efo_label":"primitive neuroectodermal tumor","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005235","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00006461","NCT00336024"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00006461%22OR%22NCT00336024%22"]}]},{"efo_id":"EFO_0005537","efo_label":"triple-negative breast cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005537","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01091454","NCT01918306","NCT02393794"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01091454%22OR%22NCT01918306%22OR%22NCT02393794%22"]}]},{"efo_id":"EFO_0005842","efo_label":"colorectal cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005842","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02830139","NCT03100955","NCT03769935"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02830139%22OR%22NCT03100955%22OR%22NCT03769935%22"]}]},{"efo_id":"EFO_0005922","efo_label":"esophageal squamous cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005922","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00165490","NCT01225523","NCT01248299","NCT01258192","NCT01391572","NCT01551589","NCT01591135","NCT01854749","NCT02017600","NCT02272699","NCT02325986","NCT02465736","NCT02611700","NCT02677597","NCT02976909","NCT03600831","NCT03748134","NCT03783442","NCT04138212"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00165490%22OR%22NCT01225523%22OR%22NCT01248299%22OR%22NCT01258192%22OR%22NCT01391572%22OR%22NCT01551589%22OR%22NCT01591135%22OR%22NCT01854749%22OR%22NCT02017600%22OR%22NCT02272699%22OR%22NCT02325986%22OR%22NCT02465736%22OR%22NCT02611700%22OR%22NCT02677597%22OR%22NCT02976909%22OR%22NCT03600831%22OR%22NCT03748134%22OR%22NCT03783442%22OR%22NCT04138212%22"]}]},{"efo_id":"EFO_0005952","efo_label":"non-Hodgkins lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005952","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00367497","NCT00384553","NCT00491127","NCT00504751","NCT01655225","NCT03535753","NCT03623087"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00367497%22OR%22NCT00384553%22OR%22NCT00491127%22OR%22NCT00504751%22OR%22NCT01655225%22OR%22NCT03535753%22OR%22NCT03623087%22"]}]},{"efo_id":"EFO_0006859","efo_label":"head and neck malignant neoplasia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006859","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002496","NCT00002555","NCT00002654","NCT00002659","NCT00002670","NCT00002735","NCT00002747","NCT00002839","NCT00002888","NCT00002932","NCT00002999","NCT00003182","NCT00003251","NCT00003264","NCT00003576","NCT00003580","NCT00003627","NCT00003637","NCT00003777","NCT00003809","NCT00003888","NCT00004164","NCT00004865","NCT00005087","NCT00005088","NCT00005814","NCT00006051","NCT00006248","NCT00011999","NCT00017173","NCT00022217","NCT00025298","NCT00030576","NCT00047008","NCT00052429","NCT00054054","NCT00057850","NCT00076310","NCT00077051","NCT00077103","NCT00079079","NCT00084318","NCT00084435","NCT00093665","NCT00095875","NCT00096174","NCT00113399","NCT00122460","NCT00195078","NCT00242749","NCT00242762","NCT00265941","NCT00268372","NCT00304278","NCT00337532","NCT00352105","NCT00352118","NCT00423930","NCT00450138","NCT00468169","NCT00498953","NCT00544414","NCT00559156","NCT00566540","NCT00608205","NCT00623558","NCT00625937","NCT00629226","NCT00639769","NCT00646659","NCT00665392","NCT00702481","NCT00720083","NCT00721513","NCT00820248","NCT00833261","NCT00851877","NCT00858663","NCT00868491","NCT00875849","NCT00881114","NCT00882583","NCT00910117","NCT00935961","NCT00959387","NCT00997906","NCT01009346","NCT01058408","NCT01081041","NCT01084083","NCT01126008","NCT01126216","NCT01142414","NCT01220583","NCT01275183","NCT01291095","NCT01302834","NCT01372111","NCT01384799","NCT01437449","NCT01467115","NCT01472653","NCT01504815","NCT01587820","NCT01911598","NCT02075112","NCT02308072","NCT02325401","NCT02353260","NCT02358031","NCT02429037","NCT02433626","NCT02567383","NCT02641093","NCT02741570","NCT02759575","NCT02760667","NCT02990468","NCT02997332","NCT03342352","NCT03358472","NCT03383094","NCT03386838","NCT03727061","NCT03894891"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002496%22OR%22NCT00002555%22OR%22NCT00002654%22OR%22NCT00002659%22OR%22NCT00002670%22OR%22NCT00002735%22OR%22NCT00002747%22OR%22NCT00002839%22OR%22NCT00002888%22OR%22NCT00002932%22OR%22NCT00002999%22OR%22NCT00003182%22OR%22NCT00003251%22OR%22NCT00003264%22OR%22NCT00003576%22OR%22NCT00003580%22OR%22NCT00003627%22OR%22NCT00003637%22OR%22NCT00003777%22OR%22NCT00003809%22OR%22NCT00003888%22OR%22NCT00004164%22OR%22NCT00004865%22OR%22NCT00005087%22OR%22NCT00005088%22OR%22NCT00005814%22OR%22NCT00006051%22OR%22NCT00006248%22OR%22NCT00011999%22OR%22NCT00017173%22OR%22NCT00022217%22OR%22NCT00025298%22OR%22NCT00030576%22OR%22NCT00047008%22OR%22NCT00052429%22OR%22NCT00054054%22OR%22NCT00057850%22OR%22NCT00076310%22OR%22NCT00077051%22OR%22NCT00077103%22OR%22NCT00079079%22OR%22NCT00084318%22OR%22NCT00084435%22OR%22NCT00093665%22OR%22NCT00095875%22OR%22NCT00096174%22OR%22NCT00113399%22OR%22NCT00122460%22OR%22NCT00195078%22OR%22NCT00242749%22OR%22NCT00242762%22OR%22NCT00265941%22OR%22NCT00268372%22OR%22NCT00304278%22OR%22NCT00337532%22OR%22NCT00352105%22OR%22NCT00352118%22OR%22NCT00423930%22OR%22NCT00450138%22OR%22NCT00468169%22OR%22NCT00498953%22OR%22NCT00544414%22OR%22NCT00559156%22OR%22NCT00566540%22OR%22NCT00608205%22OR%22NCT00623558%22OR%22NCT00625937%22OR%22NCT00629226%22OR%22NCT00639769%22OR%22NCT00646659%22OR%22NCT00665392%22OR%22NCT00702481%22OR%22NCT00720083%22OR%22NCT00721513%22OR%22NCT00820248%22OR%22NCT00833261%22OR%22NCT00851877%22OR%22NCT00858663%22OR%22NCT00868491%22OR%22NCT00875849%22OR%22NCT00881114%22OR%22NCT00882583%22OR%22NCT00910117%22OR%22NCT00935961%22OR%22NCT00959387%22OR%22NCT00997906%22OR%22NCT01009346%22OR%22NCT01058408%22OR%22NCT01081041%22OR%22NCT01084083%22OR%22NCT01126008%22OR%22NCT01126216%22OR%22NCT01142414%22OR%22NCT01220583%22OR%22NCT01275183%22OR%22NCT01291095%22OR%22NCT01302834%22OR%22NCT01372111%22OR%22NCT01384799%22OR%22NCT01437449%22OR%22NCT01467115%22OR%22NCT01472653%22OR%22NCT01504815%22OR%22NCT01587820%22OR%22NCT01911598%22OR%22NCT02075112%22OR%22NCT02308072%22OR%22NCT02325401%22OR%22NCT02353260%22OR%22NCT02358031%22OR%22NCT02429037%22OR%22NCT02433626%22OR%22NCT02567383%22OR%22NCT02641093%22OR%22NCT02741570%22OR%22NCT02759575%22OR%22NCT02760667%22OR%22NCT02990468%22OR%22NCT02997332%22OR%22NCT03342352%22OR%22NCT03358472%22OR%22NCT03383094%22OR%22NCT03386838%22OR%22NCT03727061%22OR%22NCT03894891%22"]}]},{"efo_id":"EFO_0006911","efo_label":"Chemotherapy-induced nausea and vomiting","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006911","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00895245"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00895245%22"]}]},{"efo_id":"EFO_0007206","efo_label":"choroid plexus cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007206","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01014767"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01014767%22"]}]},{"efo_id":"EFO_1000028","efo_label":"ependymoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000028","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02265770"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02265770%22"]}]},{"efo_id":"EFO_1000292","efo_label":"Hepatoblastoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000292","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00980460"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00980460%22"]}]},{"efo_id":"EFO_1000581","efo_label":"Thymoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000581","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00387868","NCT00818090","NCT01100944"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00387868%22OR%22NCT00818090%22OR%22NCT01100944%22"]}]},{"efo_id":"EFO_1000984","efo_label":"inflammatory breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000984","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02199418","NCT02221999","NCT02879513"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02199418%22OR%22NCT02221999%22OR%22NCT02879513%22"]}]},{"efo_id":"EFO_1001094","efo_label":"penile neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001094","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00066391","NCT00512096"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00066391%22OR%22NCT00512096%22"]}]},{"efo_id":"EFO_1001365","efo_label":"Lymphoma, AIDS-Related","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001365","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00002524","NCT00310128"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002524%22OR%22NCT00310128%22"]}]},{"efo_id":"EFO_1001471","efo_label":"Merkel cell skin cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001471","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03167164"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03167164%22"]}]},{"efo_id":"EFO_1001931","efo_label":"oropharynx cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001931","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02298595","NCT02908477","NCT03215719","NCT03383094","NCT03822897","NCT04019548","NCT04116047"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02298595%22OR%22NCT02908477%22OR%22NCT03215719%22OR%22NCT03383094%22OR%22NCT03822897%22OR%22NCT04019548%22OR%22NCT04116047%22"]}]},{"efo_id":"EFO_1001956","efo_label":"gallbladder carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001956","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02151084","NCT02867865"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02151084%22OR%22NCT02867865%22"]}]},{"efo_id":"EFO_1001961","efo_label":"intrahepatic cholangiocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001961","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02254681","NCT02807181","NCT03081039","NCT03579771","NCT03898895"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02254681%22OR%22NCT02807181%22OR%22NCT03081039%22OR%22NCT03579771%22OR%22NCT03898895%22"]}]},{"efo_id":"EFO_1001968","efo_label":"soft tissue sarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001968","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02784015"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02784015%22"]}]},{"efo_id":"Orphanet_59305","efo_label":"Gestational trophoblastic neoplasm","efo_uri":"http://www.orpha.net/ORDO/Orphanet_59305","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02639650"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02639650%22"]}]},{"efo_id":"Orphanet_790","efo_label":"Retinoblastoma","efo_uri":"http://www.orpha.net/ORDO/Orphanet_790","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002675","NCT00554788"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002675%22OR%22NCT00554788%22"]}]},{"efo_id":"EFO_0000198","efo_label":"myelodysplastic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000198","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00960726"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00960726%22"]}]},{"efo_id":"EFO_0000466","efo_label":"endometrioid carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000466","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002913","NCT00951496","NCT00989651"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002913%22OR%22NCT00951496%22OR%22NCT00989651%22"]}]},{"efo_id":"EFO_0000571","efo_label":"lung adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000571","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00005838","NCT00020709","NCT00042835","NCT01218516","NCT02120807","NCT02980991","NCT03351842","NCT03544814","NCT03709147","NCT03891173"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00005838%22OR%22NCT00020709%22OR%22NCT00042835%22OR%22NCT01218516%22OR%22NCT02120807%22OR%22NCT02980991%22OR%22NCT03351842%22OR%22NCT03544814%22OR%22NCT03709147%22OR%22NCT03891173%22"]}]},{"efo_id":"EFO_0003833","efo_label":"brain neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003833","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00003141"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003141%22"]}]},{"efo_id":"EFO_0004193","efo_label":"basal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004193","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03541252"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03541252%22"]}]},{"efo_id":"EFO_0004243","efo_label":"carcinoid tumor","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004243","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00005049"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00005049%22"]}]},{"efo_id":"EFO_0005577","efo_label":"pharynx cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005577","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00169182"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00169182%22"]}]},{"efo_id":"EFO_0006772","efo_label":"undifferentiated carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006772","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00989651"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00989651%22"]}]},{"efo_id":"EFO_0008528","efo_label":"urothelial carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008528","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01261728","NCT01490437","NCT01524991","NCT01616875","NCT02807636","NCT02853305","NCT02969083","NCT03093922","NCT03197571"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01261728%22OR%22NCT01490437%22OR%22NCT01524991%22OR%22NCT01616875%22OR%22NCT02807636%22OR%22NCT02853305%22OR%22NCT02969083%22OR%22NCT03093922%22OR%22NCT03197571%22"]}]},{"efo_id":"EFO_0008549","efo_label":"digestive system neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008549","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02631590"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02631590%22"]}]},{"efo_id":"EFO_0009637","efo_label":"pleural effusion","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009637","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01661790","NCT02429726","NCT02657460","NCT02702700"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01661790%22OR%22NCT02429726%22OR%22NCT02657460%22OR%22NCT02702700%22"]}]},{"efo_id":"EFO_0009708","efo_label":"metastasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009708","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02124148","NCT03383094"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02124148%22OR%22NCT03383094%22"]}]},{"efo_id":"EFO_1000251","efo_label":"Fallopian Tube Carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000251","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00003345","NCT00003358","NCT00003624","NCT00003636","NCT00003896","NCT00028743","NCT00091377","NCT00550784","NCT00702299","NCT00951496","NCT00993655","NCT01083537","NCT01936974","NCT01970722","NCT02121990","NCT02433626"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003345%22OR%22NCT00003358%22OR%22NCT00003624%22OR%22NCT00003636%22OR%22NCT00003896%22OR%22NCT00028743%22OR%22NCT00091377%22OR%22NCT00550784%22OR%22NCT00702299%22OR%22NCT00951496%22OR%22NCT00993655%22OR%22NCT01083537%22OR%22NCT01936974%22OR%22NCT01970722%22OR%22NCT02121990%22OR%22NCT02433626%22"]}]},{"efo_id":"EFO_1000576","efo_label":"Thymic Carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000576","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00818090","NCT01100944"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00818090%22OR%22NCT01100944%22"]}]},{"efo_id":"EFO_1000796","efo_label":"adrenal cortex carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000796","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00304070","NCT00324012","NCT03583710"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00304070%22OR%22NCT00324012%22OR%22NCT03583710%22"]}]},{"efo_id":"EFO_1001100","efo_label":"peritoneal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001100","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00001569","NCT00002717","NCT00002894","NCT00003322","NCT00003345","NCT00003358","NCT00003624","NCT00003636","NCT00003896","NCT00005049","NCT00006028","NCT00020696","NCT00028743","NCT00091377","NCT00314678","NCT00550784","NCT00702299","NCT00951496","NCT00989651","NCT00993655","NCT01083537","NCT01936974","NCT01970722","NCT02121990","NCT02433626","NCT02567253"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00001569%22OR%22NCT00002717%22OR%22NCT00002894%22OR%22NCT00003322%22OR%22NCT00003345%22OR%22NCT00003358%22OR%22NCT00003624%22OR%22NCT00003636%22OR%22NCT00003896%22OR%22NCT00005049%22OR%22NCT00006028%22OR%22NCT00020696%22OR%22NCT00028743%22OR%22NCT00091377%22OR%22NCT00314678%22OR%22NCT00550784%22OR%22NCT00702299%22OR%22NCT00951496%22OR%22NCT00989651%22OR%22NCT00993655%22OR%22NCT01083537%22OR%22NCT01936974%22OR%22NCT01970722%22OR%22NCT02121990%22OR%22NCT02433626%22OR%22NCT02567253%22"]}]},{"efo_id":"EFO_1001904","efo_label":"oral mucositis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001904","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02508389","NCT03515538"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02508389%22OR%22NCT03515538%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00005049"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00005049%22"]}]},{"efo_id":"HP_0002017","efo_label":"Nausea and vomiting","efo_uri":"http://purl.obolibrary.org/obo/HP_0002017","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02116530"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02116530%22"]}]},{"efo_id":"Orphanet_44890","efo_label":"Gastrointestinal stromal tumor","efo_uri":"http://www.orpha.net/ORDO/Orphanet_44890","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00005049"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00005049%22"]}]}],"number_of_indications":113,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":106},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":30},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":22},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":21},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":19},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":18},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":17},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":15},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":13},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":9},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":8},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":4},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":3},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":2},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":2},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"OTAR_0000014","therapeutic_label":"pregnancy or perinatal disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545359","_score":1,"_source":{"id":"CHEMBL3545359","internal_compound":false,"type":"Small molecule","pref_name":"ARRY-300","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["ARRY-300","MET-300"],"trade_names":[],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000105976","approved_name":"MET proto-oncogene, receptor tyrosine kinase","approved_symbol":"MET"}],"target_type":"single protein","target_name":"Hepatocyte growth factor receptor","action_type":"inhibitor","description":"Hepatocyte growth factor receptor inhibitor","references":[{"source":"PubMed","ids":["24434059"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24434059"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545423","_score":1,"_source":{"id":"CHEMBL3545423","internal_compound":false,"type":"Small molecule","pref_name":"AZD-1208","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AZD-1208","Azd 1208"],"trade_names":[],"canonical_smiles":"NC1CCCN(c2c(/C=C3/SC(=O)NC3=O)cccc2-c2ccccc2)C1","indications":[{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01588548"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01588548%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01489722"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01489722%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000137193","approved_name":"Pim-1 proto-oncogene, serine/threonine kinase","approved_symbol":"PIM1"},{"ensembl":"ENSG00000102096","approved_name":"Pim-2 proto-oncogene, serine/threonine kinase","approved_symbol":"PIM2"},{"ensembl":"ENSG00000198355","approved_name":"Pim-3 proto-oncogene, serine/threonine kinase","approved_symbol":"PIM3"}],"target_type":"protein family","target_name":"Serine/threonine-protein kinase PIM","action_type":"inhibitor","description":"Serine/threonine-protein kinase PIM inhibitor","references":[{"source":"PubMed","ids":["24363397"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24363397"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL113178","_score":1,"_source":{"id":"CHEMBL113178","internal_compound":false,"type":"Small molecule","pref_name":"SELENOMETHIONINE","year_first_approved":1973,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["75SE","Radioselenomethionine (75Se)","Selenomethionine","Selenomethionine (75Se)","Selenomethionine (75Se) Injection"],"trade_names":["Selenomethionine (75Se)","Sethotope"],"cross_references":[{"source":"ChEBI","ids":[30021]},{"source":"PubChem","ids":["144206245","50125779"]},{"source":"drugbank","ids":["DB11142"]},{"source":"drugbank","ids":["DB09400"]}],"canonical_smiles":"C[Se]CC[C@H](N)C(=O)O","indications":[{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00030901"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00030901%22"]}]},{"efo_id":"EFO_0000096","efo_label":"neoplasm of mature B-cells","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000096","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00455416"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00455416%22"]}]},{"efo_id":"EFO_0000349","efo_label":"clear cell renal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000349","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02535533"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02535533%22"]}]},{"efo_id":"EFO_0000365","efo_label":"colorectal adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000365","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT01211561"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01211561%22"]}]}],"child_chembl_ids":["CHEMBL1201054"],"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":4},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":2},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2104325","_score":1,"_source":{"id":"CHEMBL2104325","internal_compound":false,"type":"Small molecule","pref_name":"ISOBROMINDIONE","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Isobromindione"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB13545"]}],"canonical_smiles":"O=C1c2ccc(Br)cc2C(=O)C1c1ccccc1","indications":[{"efo_id":"EFO_0004274","efo_label":"gout","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004274","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["M04AB04"],"urls":["https://www.whocc.no/atc_ddd_index/?code=M04AB04"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3334824","_score":1,"_source":{"id":"CHEMBL3334824","internal_compound":false,"type":"Small molecule","pref_name":"BMS-817399","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["BMS-817399","Bms-817399"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB14941"]}],"canonical_smiles":"CC(C)[C@@H](NC(=O)NCC(C)(C)O)C(=O)N1CC[C@](O)(c2ccc(Cl)cc2)C(C)(C)C1","indications":[{"efo_id":"EFO_0000685","efo_label":"rheumatoid arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000685","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01404585"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01404585%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1236682","_score":1,"_source":{"id":"CHEMBL1236682","internal_compound":false,"type":"Small molecule","pref_name":"REFAMETINIB","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["BAY 869766","BAY 8697661","BAY-86-9766","BAY-869766","BAY-8697661","BAY86-9766","RDEA 119","RDEA-119","Refametinib"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB06309"]}],"canonical_smiles":"COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1","indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01179295","NCT01392521","NCT01764828","NCT02168777"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01179295%22OR%22NCT01392521%22OR%22NCT01764828%22OR%22NCT02168777%22"]}]},{"efo_id":"EFO_0003891","efo_label":"biliary tract neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003891","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02346032"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02346032%22"]}]},{"efo_id":"EFO_0000182","efo_label":"hepatocellular carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000182","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01915589","NCT01915602"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01915589%22OR%22NCT01915602%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00610194","NCT00785226"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00610194%22OR%22NCT00785226%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000169032","approved_name":"mitogen-activated protein kinase kinase 1","approved_symbol":"MAP2K1"}],"target_type":"single protein","target_name":"Dual specificity mitogen-activated protein kinase kinase 1","action_type":"inhibitor","description":"Dual specificity mitogen-activated protein kinase kinase 1 inhibitor","references":[{"source":"PubMed","ids":["19706763"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19706763"]}]},{"target_components":[{"ensembl":"ENSG00000126934","approved_name":"mitogen-activated protein kinase kinase 2","approved_symbol":"MAP2K2"}],"target_type":"single protein","target_name":"Dual specificity mitogen-activated protein kinase kinase 2","action_type":"inhibitor","description":"Dual specificity mitogen-activated protein kinase kinase 2 inhibitor","references":[{"source":"PubMed","ids":["19706763"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19706763"]}]}],"adverse_events":{"significant":[{"event":"blood creatine phosphokinase increased","count":14851,"llr":16.68724873}],"critval":13.73613877},"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":4},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1614702","_score":1,"_source":{"id":"CHEMBL1614702","internal_compound":false,"type":"Small molecule","pref_name":"SCIO-323","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["SCIO-323"],"trade_names":[],"canonical_smiles":"COc1cc2c(cc1C(=O)N1CCC(Cc3ccc(F)cc3)CC1)c(C(=O)C(=O)N(C)C)cn2C","mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000112062","approved_name":"mitogen-activated protein kinase 14","approved_symbol":"MAPK14"}],"target_type":"single protein","target_name":"MAP kinase p38 alpha","action_type":"inhibitor","description":"MAP kinase p38 alpha inhibitor","references":[{"source":"PubMed","ids":["18431764"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18431764"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL515966","_score":1,"_source":{"id":"CHEMBL515966","internal_compound":false,"type":"Small molecule","pref_name":"EZLOPITANT","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["CJ-11974","Ezlopitant"],"trade_names":[],"cross_references":[{"source":"Wikipedia","ids":["Ezlopitant"]}],"canonical_smiles":"COc1ccc(C(C)C)cc1CN[C@H]1C2CCN(CC2)[C@H]1C(c1ccccc1)c1ccccc1","mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000115353","approved_name":"tachykinin receptor 1","approved_symbol":"TACR1"}],"target_type":"single protein","target_name":"Neurokinin 1 receptor","action_type":"antagonist","description":"Neurokinin 1 receptor antagonist","references":[{"source":"PubMed","ids":["12372904"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12372904"]},{"source":"Wikipedia","ids":["Ezlopitant"],"urls":["https://www.wikipedia.org/Ezlopitant"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL254328","_score":1,"_source":{"id":"CHEMBL254328","internal_compound":false,"type":"Small molecule","pref_name":"ABIRATERONE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Abiraterone","CB 7598","CB-7598"],"trade_names":["Zytiga"],"cross_references":[{"source":"ChEBI","ids":[68642]},{"source":"Wikipedia","ids":["Abiraterone"]},{"source":"drugbank","ids":["DB05812"]}],"canonical_smiles":"C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2c1cccnc1","indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["L02BX03"],"urls":["https://www.whocc.no/atc_ddd_index/?code=L02BX03"]},{"source":"ClinicalTrials","ids":["NCT01771458","NCT02711137","NCT03150056"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01771458%22OR%22NCT02711137%22OR%22NCT03150056%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00268476","NCT00924469","NCT01424930","NCT01485861","NCT01574937","NCT01741753","NCT01756638","NCT01795703","NCT01828476","NCT01972217","NCT02403505","NCT02429193","NCT02758132","NCT02772588","NCT02789878","NCT02867020","NCT02883166","NCT03141671","NCT03414034","NCT03418324","NCT03480646","NCT03556904","NCT03770455","NCT03860987","NCT03934840","NCT04087174"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00268476%22OR%22NCT00924469%22OR%22NCT01424930%22OR%22NCT01485861%22OR%22NCT01574937%22OR%22NCT01741753%22OR%22NCT01756638%22OR%22NCT01795703%22OR%22NCT01828476%22OR%22NCT01972217%22OR%22NCT02403505%22OR%22NCT02429193%22OR%22NCT02758132%22OR%22NCT02772588%22OR%22NCT02789878%22OR%22NCT02867020%22OR%22NCT02883166%22OR%22NCT03141671%22OR%22NCT03414034%22OR%22NCT03418324%22OR%22NCT03480646%22OR%22NCT03556904%22OR%22NCT03770455%22OR%22NCT03860987%22OR%22NCT03934840%22OR%22NCT04087174%22"]}]},{"efo_id":"EFO_0000673","efo_label":"prostate adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000673","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01553188","NCT01780220","NCT01949337","NCT01995058","NCT02043678","NCT02254785","NCT03173859","NCT03511196","NCT03649841"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01553188%22OR%22NCT01780220%22OR%22NCT01949337%22OR%22NCT01995058%22OR%22NCT02043678%22OR%22NCT02254785%22OR%22NCT03173859%22OR%22NCT03511196%22OR%22NCT03649841%22"]}]},{"efo_id":"EFO_0000196","efo_label":"metastatic prostate cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000196","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02036060","NCT02049190","NCT03072238","NCT03110588","NCT03298087","NCT03649841"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02036060%22OR%22NCT02049190%22OR%22NCT03072238%22OR%22NCT03110588%22OR%22NCT03298087%22OR%22NCT03649841%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT02380313"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02380313%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000148795","approved_name":"cytochrome P450 family 17 subfamily A member 1","approved_symbol":"CYP17A1"}],"target_type":"single protein","target_name":"Cytochrome P450 17A1","action_type":"inhibitor","description":"Cytochrome P450 17A1 inhibitor","references":[{"source":"PubMed","ids":["16287438","24276076","26030522","27083183","27225130"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16287438+OR+EXT_ID%3A24276076+OR+EXT_ID%3A26030522+OR+EXT_ID%3A27083183+OR+EXT_ID%3A27225130"]}]},{"target_components":[{"ensembl":"ENSG00000169083","approved_name":"androgen receptor","approved_symbol":"AR"}],"target_type":"single protein","target_name":"Androgen Receptor","action_type":"antagonist","description":"Androgen Receptor antagonist","references":[{"source":"PubMed","ids":["16287438","24276076","26030522","27083183","27225130"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16287438+OR+EXT_ID%3A24276076+OR+EXT_ID%3A26030522+OR+EXT_ID%3A27083183+OR+EXT_ID%3A27225130"]}]},{"target_components":[{"ensembl":"ENSG00000145545","approved_name":"steroid 5 alpha-reductase 1","approved_symbol":"SRD5A1"},{"ensembl":"ENSG00000277893","approved_name":"steroid 5 alpha-reductase 2","approved_symbol":"SRD5A2"},{"ensembl":"ENSG00000128039","approved_name":"steroid 5 alpha-reductase 3","approved_symbol":"SRD5A3"}],"target_type":"protein family","target_name":"Steroid 5-alpha-reductase","action_type":"inhibitor","description":"Steroid 5-alpha-reductase inhibitor","references":[{"source":"PubMed","ids":["16287438","24276076","26030522","27083183","27225130"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16287438+OR+EXT_ID%3A24276076+OR+EXT_ID%3A26030522+OR+EXT_ID%3A27083183+OR+EXT_ID%3A27225130"]}]}],"adverse_events":{"significant":[{"event":"prostatic specific antigen increased","count":2393,"llr":1373.667914},{"event":"disease progression","count":21531,"llr":391.0949319},{"event":"hot flush","count":10860,"llr":344.9697703},{"event":"prostate cancer metastatic","count":513,"llr":337.4783678},{"event":"hypokalaemia","count":14556,"llr":288.3789279},{"event":"prostate cancer","count":3761,"llr":240.6013551},{"event":"drug hypersensitivity","count":71246,"llr":149.1639284},{"event":"injection site pain","count":56727,"llr":130.6795948}],"critval":107.815055},"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":5},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":3},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":3}],"number_of_mechanisms_of_action":3}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2365940","_score":1,"_source":{"id":"CHEMBL2365940","internal_compound":false,"type":"Small molecule","pref_name":"DAROTROPIUM","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"canonical_smiles":"C[N+]1(C)[C@H]2CC[C@@H]1C[C@@H](CC(C#N)(c1ccccc1)c1ccccc1)C2","child_chembl_ids":["CHEMBL2308782"],"synonyms":["Darotropium Bromide","GSK-233705","GSK-233705B","GSK233705","GSK233705B"],"indications":[{"efo_id":"EFO_0000341","efo_label":"chronic obstructive pulmonary disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000341","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00279019","NCT00376714","NCT00422604","NCT00453687","NCT00500461","NCT00671216","NCT00676052","NCT00749411","NCT00783003","NCT00964405"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00279019%22OR%22NCT00376714%22OR%22NCT00422604%22OR%22NCT00453687%22OR%22NCT00500461%22OR%22NCT00671216%22OR%22NCT00676052%22OR%22NCT00749411%22OR%22NCT00783003%22OR%22NCT00964405%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000133019","approved_name":"cholinergic receptor muscarinic 3","approved_symbol":"CHRM3"},{"ensembl":"ENSG00000180720","approved_name":"cholinergic receptor muscarinic 4","approved_symbol":"CHRM4"},{"ensembl":"ENSG00000168539","approved_name":"cholinergic receptor muscarinic 1","approved_symbol":"CHRM1"},{"ensembl":"ENSG00000181072","approved_name":"cholinergic receptor muscarinic 2","approved_symbol":"CHRM2"},{"ensembl":"ENSG00000184984","approved_name":"cholinergic receptor muscarinic 5","approved_symbol":"CHRM5"}],"target_type":"protein family","target_name":"Muscarinic acetylcholine receptor","action_type":"antagonist","description":"Muscarinic acetylcholine receptor antagonist","references":[{"source":"PubMed","ids":["22419863"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22419863"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL315838","_score":1,"_source":{"id":"CHEMBL315838","internal_compound":false,"type":"Small molecule","pref_name":"ENCAINIDE","year_first_approved":1986,"max_clinical_trial_phase":4,"withdrawn_flag":true,"withdrawn_reason":["Cardiotoxicity and Excess Mortality","Ventricular arrhythmias"],"withdrawn_year":1991,"withdrawn_country":["United Kingdom","United States"],"withdrawn_class":["Cardiotoxicity"],"black_box_warning":false,"synonyms":["Encainide","Encainide HCl","MJ-9067-1"],"trade_names":["Enkaid"],"cross_references":[{"source":"ChEBI","ids":[4788]},{"source":"drugbank","ids":["DB01228"]},{"source":"ChEBI","ids":[59880]},{"source":"PubChem","ids":["144207047"]}],"canonical_smiles":"COc1ccc(C(=O)Nc2ccccc2CCC2CCCCN2C)cc1","indications":[{"efo_id":"EFO_0004269","efo_label":"cardiac arrhythmia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004269","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["C01BC08"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C01BC08"]}]}],"child_chembl_ids":["CHEMBL2106155"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000144285","approved_name":"sodium voltage-gated channel alpha subunit 1","approved_symbol":"SCN1A"},{"ensembl":"ENSG00000183873","approved_name":"sodium voltage-gated channel alpha subunit 5","approved_symbol":"SCN5A"},{"ensembl":"ENSG00000007314","approved_name":"sodium voltage-gated channel alpha subunit 4","approved_symbol":"SCN4A"},{"ensembl":"ENSG00000136546","approved_name":"sodium voltage-gated channel alpha subunit 7","approved_symbol":"SCN7A"},{"ensembl":"ENSG00000136531","approved_name":"sodium voltage-gated channel alpha subunit 2","approved_symbol":"SCN2A"},{"ensembl":"ENSG00000169432","approved_name":"sodium voltage-gated channel alpha subunit 9","approved_symbol":"SCN9A"},{"ensembl":"ENSG00000153253","approved_name":"sodium voltage-gated channel alpha subunit 3","approved_symbol":"SCN3A"},{"ensembl":"ENSG00000168356","approved_name":"sodium voltage-gated channel alpha subunit 11","approved_symbol":"SCN11A"},{"ensembl":"ENSG00000196876","approved_name":"sodium voltage-gated channel alpha subunit 8","approved_symbol":"SCN8A"},{"ensembl":"ENSG00000185313","approved_name":"sodium voltage-gated channel alpha subunit 10","approved_symbol":"SCN10A"}],"target_type":"protein family","target_name":"Sodium channel alpha subunit","action_type":"blocker","description":"Sodium channel alpha subunit blocker","references":[{"source":"PubMed","ids":["1900101","2106401","2518680","6206322","6780234"],"urls":["https://europepmc.org/search?query=EXT_ID%3A1900101+OR+EXT_ID%3A2106401+OR+EXT_ID%3A2518680+OR+EXT_ID%3A6206322+OR+EXT_ID%3A6780234"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2103846","_score":1,"_source":{"id":"CHEMBL2103846","internal_compound":false,"type":"Small molecule","pref_name":"ULIPRISTAL","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Uliprisnil","Ulipristal","Ulipristal acetate ulipristal"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB08867"]}],"canonical_smiles":"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C","indications":[{"efo_id":"EFO_0000731","efo_label":"uterine fibroid","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000731","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02465814","NCT03342859"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02465814%22OR%22NCT03342859%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000082175","approved_name":"progesterone receptor","approved_symbol":"PGR"}],"target_type":"single protein","target_name":"Progesterone receptor","action_type":"modulator","description":"Progesterone receptor modulator","references":[{"source":"PubMed","ids":["18216291"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18216291"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109060","_score":1,"_source":{"id":"CHEMBL2109060","internal_compound":false,"type":"Unknown","pref_name":"LICORICE","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["B2048","FEMA NO. 2628","FEMA NO. 2629","FEMA NO. 2630","Glycyrrhiza glabra extract","Glycyrrhiza glabra rhizome","Glycyrrhiza glabra root","Glycyrrhiza glabra root powder","Glycyrrhiza glabra root with rhizome","Licorice","NDI 329"],"trade_names":[],"indications":[{"efo_id":"EFO_0000712","efo_label":"stroke","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000712","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02473458"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02473458%22"]}]},{"efo_id":"EFO_1001898","efo_label":"mucositis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001898","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02075749"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02075749%22"]}]},{"efo_id":"EFO_0003819","efo_label":"dental caries","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003819","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03684993"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03684993%22"]}]},{"efo_id":"EFO_0008517","efo_label":"oral lichen planus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008517","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02453503"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02453503%22"]}]}],"adverse_events":{"significant":[{"event":"hypokalaemia","count":14556,"llr":50.34378725},{"event":"metabolic alkalosis","count":568,"llr":44.59069647},{"event":"rhabdomyolysis","count":16457,"llr":30.03198515},{"event":"hyperparathyroidism","count":765,"llr":26.44412388},{"event":"hypocalcaemia","count":7012,"llr":17.59515417},{"event":"emphysema","count":1683,"llr":16.45107914},{"event":"hypophosphataemia","count":2382,"llr":15.41063215},{"event":"ventricular tachycardia","count":5901,"llr":12.69735235},{"event":"hypertension","count":52519,"llr":9.636583851}],"critval":9.224045053},"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4302409","_score":1,"_source":{"id":"CHEMBL4302409","internal_compound":false,"type":"Unknown","pref_name":"LUTETIUM OXODOTREOTIDE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"child_chembl_ids":["CHEMBL4297545"],"synonyms":["177lu-dotatate","Lutetium (177lu) oxodotreotide","Lutetium oxodotreotide lu-177"],"indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01860742"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01860742%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3183740","_score":1,"_source":{"id":"CHEMBL3183740","internal_compound":false,"type":"Small molecule","pref_name":"TRELANSERIN","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["SL65.0472","Trelanserin"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["144210557"]}],"canonical_smiles":"NC(=O)Cn1c(=O)cc(CCN2CCN(c3nccc4sccc34)CC2)c2ccc(F)cc21","mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000135312","approved_name":"5-hydroxytryptamine receptor 1B","approved_symbol":"HTR1B"}],"target_type":"single protein","target_name":"Serotonin 1b (5-HT1b) receptor","action_type":"antagonist","description":"Serotonin 1b (5-HT1b) receptor antagonist","references":[{"source":"PubMed","ids":["10996601","11504649"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10996601+OR+EXT_ID%3A11504649"]}]},{"target_components":[{"ensembl":"ENSG00000102468","approved_name":"5-hydroxytryptamine receptor 2A","approved_symbol":"HTR2A"}],"target_type":"single protein","target_name":"Serotonin 2a (5-HT2a) receptor","action_type":"antagonist","description":"Serotonin 2a (5-HT2a) receptor antagonist","references":[{"source":"PubMed","ids":["10996601","11504649"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10996601+OR+EXT_ID%3A11504649"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297773","_score":1,"_source":{"id":"CHEMBL4297773","internal_compound":false,"type":"Unknown","pref_name":"ITI-214","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Iti-214"],"trade_names":[],"indications":[{"efo_id":"EFO_0002508","efo_label":"Parkinson's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002508","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03257046"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03257046%22"]}]},{"efo_id":"EFO_1001207","efo_label":"systolic heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001207","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03387215"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03387215%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3337527","_score":1,"_source":{"id":"CHEMBL3337527","internal_compound":false,"type":"Small molecule","pref_name":"JNJ-40411813","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["ADX-71149","Jnj-40411813"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12059"]}],"canonical_smiles":"CCCCn1ccc(N2CCC(c3ccccc3)CC2)c(Cl)c1=O","indications":[{"efo_id":"EFO_0000692","efo_label":"schizophrenia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000692","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01101659","NCT01323205"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01101659%22OR%22NCT01323205%22"]}]},{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01582815"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01582815%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":2},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":2}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL12713","_score":1,"_source":{"id":"CHEMBL12713","internal_compound":false,"type":"Small molecule","pref_name":"SERTINDOLE","max_clinical_trial_phase":4,"withdrawn_flag":true,"withdrawn_reason":["Arrhythmias and Sudden Cardiac Death (Arrhythmias and Sudden)"],"withdrawn_year":1998,"withdrawn_country":["European Union","Germany","Ireland","Italy","Netherlands","United Kingdom"],"withdrawn_class":["Cardiotoxicity"],"black_box_warning":false,"synonyms":["LU 23-174","LU-23-174","Sertindole"],"trade_names":["SerLect"],"cross_references":[{"source":"ChEBI","ids":[9122]},{"source":"PubChem","ids":["144206958","144206971","170465613"]},{"source":"Wikipedia","ids":["Sertindole"]},{"source":"drugbank","ids":["DB06144"]}],"canonical_smiles":"O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1","indications":[{"efo_id":"EFO_0005407","efo_label":"psychosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005407","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N05AE03"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N05AE03"]}]},{"efo_id":"EFO_0000692","efo_label":"schizophrenia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000692","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00654706","NCT00759421","NCT00759460","NCT00856583","NCT00864045","NCT02374567"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00654706%22OR%22NCT00759421%22OR%22NCT00759460%22OR%22NCT00856583%22OR%22NCT00864045%22OR%22NCT02374567%22"]}]},{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02374567"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02374567%22"]}]},{"efo_id":"EFO_0005230","efo_label":"anxiety","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005230","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02374567"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02374567%22"]}]},{"efo_id":"HP_0000726","efo_label":"Dementia","efo_uri":"http://purl.obolibrary.org/obo/HP_0000726","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02374567"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02374567%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000149295","approved_name":"dopamine receptor D2","approved_symbol":"DRD2"}],"target_type":"single protein","target_name":"Dopamine D2 receptor","action_type":"antagonist","description":"Dopamine D2 receptor antagonist","references":[{"source":"PubMed","ids":["16925508","22791154","22992213","25830594"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16925508+OR+EXT_ID%3A22791154+OR+EXT_ID%3A22992213+OR+EXT_ID%3A25830594"]}]},{"target_components":[{"ensembl":"ENSG00000120907","approved_name":"adrenoceptor alpha 1A","approved_symbol":"ADRA1A"},{"ensembl":"ENSG00000171873","approved_name":"adrenoceptor alpha 1D","approved_symbol":"ADRA1D"},{"ensembl":"ENSG00000170214","approved_name":"adrenoceptor alpha 1B","approved_symbol":"ADRA1B"}],"target_type":"protein family","target_name":"Adrenergic receptor alpha-1","action_type":"antagonist","description":"Adrenergic receptor alpha-1 antagonist","references":[{"source":"PubMed","ids":["16925508","22791154","22992213","25830594"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16925508+OR+EXT_ID%3A22791154+OR+EXT_ID%3A22992213+OR+EXT_ID%3A25830594"]}]},{"target_components":[{"ensembl":"ENSG00000102468","approved_name":"5-hydroxytryptamine receptor 2A","approved_symbol":"HTR2A"},{"ensembl":"ENSG00000147246","approved_name":"5-hydroxytryptamine receptor 2C","approved_symbol":"HTR2C"}],"target_type":"selectivity group","target_name":"Serotonin 2 receptors; 5-HT2a & 5-HT2c","action_type":"antagonist","description":"Serotonin 2 receptors; 5-HT2a & 5-HT2c antagonist","references":[{"source":"PubMed","ids":["16925508","22791154","22992213","25830594"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16925508+OR+EXT_ID%3A22791154+OR+EXT_ID%3A22992213+OR+EXT_ID%3A25830594"]}]}],"adverse_events":{"significant":[{"event":"pleurothotonus","count":447,"llr":25.41882888},{"event":"long qt syndrome","count":841,"llr":22.89275096},{"event":"ventricular tachycardia","count":5901,"llr":20.13335239},{"event":"electrocardiogram qt prolonged","count":12378,"llr":16.46151218}],"critval":15.65645489},"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":3},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":3},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":2}],"number_of_mechanisms_of_action":3}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297299","_score":1,"_source":{"id":"CHEMBL4297299","internal_compound":false,"type":"Small molecule","pref_name":"KX2-361","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["KX-02","KX-2361","Kx2-361"],"trade_names":[],"canonical_smiles":"O=C(Cc1ccc(-c2ccc(N3CCOCC3)cc2)cn1)NCc1cccc(F)c1","indications":[{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02326441"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02326441%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201355","_score":1,"_source":{"id":"CHEMBL1201355","internal_compound":false,"type":"Protein","pref_name":"CERULETIDE","year_first_approved":1982,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Ceruletide","Ceruletide Diethylamine"],"trade_names":["Tymtran"],"cross_references":[{"source":"ChEBI","ids":[59219]},{"source":"Wikipedia","ids":["Ceruletide"]},{"source":"drugbank","ids":["DB00403"]},{"source":"ChEBI","ids":[59223]}],"canonical_smiles":"CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O","child_chembl_ids":["CHEMBL1200755"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000163394","approved_name":"cholecystokinin A receptor","approved_symbol":"CCKAR"}],"target_type":"single protein","target_name":"Cholecystokinin A receptor","action_type":"agonist","description":"Cholecystokinin A receptor agonist","references":[{"source":"PubMed","ids":["7491953"],"urls":["https://europepmc.org/search?query=EXT_ID%3A7491953"]},{"source":"Wikipedia","ids":["Ceruletide"],"urls":["https://www.wikipedia.org/Ceruletide"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1214598","_score":1,"_source":{"id":"CHEMBL1214598","internal_compound":false,"type":"Small molecule","pref_name":"UMIFENOVIR","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Arbidol","Umifenovir"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["26662180"]},{"source":"drugbank","ids":["DB13609"]}],"canonical_smiles":"CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12","indications":[{"efo_id":"EFO_0000763","efo_label":"viral disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000763","max_phase_for_indication":3,"references":[{"source":"ATC","ids":["J05AX13"],"urls":["https://www.whocc.no/atc_ddd_index/?code=J05AX13"]}]}],"mechanisms_of_action":[{"target_type":"single protein","target_name":"Hemagglutinin","action_type":"negative modulator","description":"Hemagglutinin negative modulator","references":[{"source":"PubMed","ids":["23770981","28003465"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23770981+OR+EXT_ID%3A28003465"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1980391","_score":1,"_source":{"id":"CHEMBL1980391","internal_compound":false,"type":"Small molecule","pref_name":"RG-1530","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["R-1530","RG-1530"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["103905607"]}],"canonical_smiles":"COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2","indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00493155"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00493155%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000077782","approved_name":"fibroblast growth factor receptor 1","approved_symbol":"FGFR1"}],"target_type":"single protein","target_name":"Fibroblast growth factor receptor 1","action_type":"inhibitor","description":"Fibroblast growth factor receptor 1 inhibitor","references":[{"source":"PubMed","ids":["21553286","24900658"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21553286+OR+EXT_ID%3A24900658"]}]},{"target_components":[{"ensembl":"ENSG00000066468","approved_name":"fibroblast growth factor receptor 2","approved_symbol":"FGFR2"}],"target_type":"single protein","target_name":"Fibroblast growth factor receptor 2","action_type":"inhibitor","description":"Fibroblast growth factor receptor 2 inhibitor","references":[{"source":"PubMed","ids":["21553286","24900658"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21553286+OR+EXT_ID%3A24900658"]}]},{"target_components":[{"ensembl":"ENSG00000122025","approved_name":"fms related receptor tyrosine kinase 3","approved_symbol":"FLT3"}],"target_type":"single protein","target_name":"Tyrosine-protein kinase receptor FLT3","action_type":"inhibitor","description":"Tyrosine-protein kinase receptor FLT3 inhibitor","references":[{"source":"PubMed","ids":["21553286","24900658"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21553286+OR+EXT_ID%3A24900658"]}]},{"target_components":[{"ensembl":"ENSG00000113721","approved_name":"platelet derived growth factor receptor beta","approved_symbol":"PDGFRB"}],"target_type":"single protein","target_name":"Platelet-derived growth factor receptor beta","action_type":"inhibitor","description":"Platelet-derived growth factor receptor beta inhibitor","references":[{"source":"PubMed","ids":["21553286","24900658"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21553286+OR+EXT_ID%3A24900658"]}]},{"target_components":[{"ensembl":"ENSG00000102755","approved_name":"fms related receptor tyrosine kinase 1","approved_symbol":"FLT1"},{"ensembl":"ENSG00000037280","approved_name":"fms related receptor tyrosine kinase 4","approved_symbol":"FLT4"},{"ensembl":"ENSG00000128052","approved_name":"kinase insert domain receptor","approved_symbol":"KDR"}],"target_type":"protein family","target_name":"Vascular endothelial growth factor receptor","action_type":"inhibitor","description":"Vascular endothelial growth factor receptor inhibitor","references":[{"source":"PubMed","ids":["21553286","24900658"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21553286+OR+EXT_ID%3A24900658"]}]},{"target_components":[{"ensembl":"ENSG00000087586","approved_name":"aurora kinase A","approved_symbol":"AURKA"}],"target_type":"single protein","target_name":"Serine/threonine-protein kinase Aurora-A","action_type":"inhibitor","description":"Serine/threonine-protein kinase Aurora-A inhibitor","references":[{"source":"PubMed","ids":["21553286","24900658"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21553286+OR+EXT_ID%3A24900658"]}]},{"target_components":[{"ensembl":"ENSG00000142731","approved_name":"polo like kinase 4","approved_symbol":"PLK4"}],"target_type":"single protein","target_name":"Serine/threonine-protein kinase PLK4","action_type":"inhibitor","description":"Serine/threonine-protein kinase PLK4 inhibitor","references":[{"source":"PubMed","ids":["21553286","24900658"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21553286+OR+EXT_ID%3A24900658"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":7}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL152452","_score":1,"_source":{"id":"CHEMBL152452","internal_compound":false,"type":"Small molecule","pref_name":"SIALIC ACID","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Aceneuramic Acid","N-acetylneuraminic acid","NSC-111756","Sialic acid","Sialic acids n-acetylneuraminic acid","UX-001"],"trade_names":[],"canonical_smiles":"CC(=O)N[C@@H]1[C@@H](O)C[C@](O)(C(=O)O)O[C@H]1[C@@H](O)[C@@H](O)CO","indications":[{"efo_id":"EFO_0004145","efo_label":"myopathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004145","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01359319"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01359319%22"]}]},{"efo_id":"HP_0001873","efo_label":"Thrombocytopenia","efo_uri":"http://purl.obolibrary.org/obo/HP_0001873","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02845609"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02845609%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1200370","_score":1,"_source":{"id":"CHEMBL1200370","internal_compound":false,"type":"Small molecule","pref_name":"BENZOYL PEROXIDE","year_first_approved":1984,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Benzoyl Peroxide","E928","NSC-671","NSC-675"],"trade_names":["Acetoxyl 2.5","Acetoxyl 5","Acne-Aid Cream","Acnecide","Acnecide 10","Acnegel","Acnegel Fte","Acnidazil","Benoxyl","Benoxyl 10","Benoxyl 20","Benoxyl 5","Benzac","Benzac W","Benzagel 10","Benzagel 5","Benzamycin","Brevoxyl","Clear By Design","Clearasil Max 10","Dermoxyl","Dry Clear","Dry and Clear","Epi-Clear","Fostex BPO Bar, Gel, and Wash","Gppe Lotio Gel","Loroxide","Mediclear","Mediclear Acne 10","Mediclear Acne 5","Nericur","Oxy-10","Oxy-10 Cover-Up","Oxy-5","PanOxyl","PanOxyl 10","PanOxyl 10 Acnegel","PanOxyl 10 Aquagel","PanOxyl 2.5 Aquagel","PanOxyl 5 Acnegel","PanOxyl 5 Aquagel","PanOxyl Crm 5","PanOxyl Lot 10","PanOxyl Lot 5","Persa-Gel","Quinoderm 5","Quinoped","Theraderm 10","Theraderm 5","Topex","Ultra Clearasil","Valderma","Vanair","Vanoxide"],"cross_references":[{"source":"ChEBI","ids":[82405]},{"source":"DailyMed","ids":["benzoyl%20peroxide"]},{"source":"PubChem","ids":["170464986","26754472","29215306"]},{"source":"Wikipedia","ids":["Benzoyl_peroxide"]},{"source":"drugbank","ids":["DB09096"]}],"canonical_smiles":"O=C(OOC(=O)c1ccccc1)c1ccccc1","indications":[{"efo_id":"EFO_0003894","efo_label":"acne","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003894","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00151541","NCT00421993","NCT00422240","NCT00441415","NCT00446043","NCT00663286","NCT00664248","NCT00687908","NCT00713609","NCT00776919","NCT00869492","NCT00877409","NCT00891982","NCT01106807","NCT01132443","NCT01138514","NCT01400932","NCT01428466","NCT01445301","NCT01527123","NCT01742637","NCT01769235","NCT01769664","NCT01788384","NCT01796665","NCT01880320","NCT01910064","NCT01915732","NCT02005666","NCT02073448","NCT02073461","NCT02465632","NCT02515305","NCT02525549","NCT02578043","NCT02595034","NCT02616614","NCT02651220","NCT02716090","NCT03034460","NCT03393494"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00151541%22OR%22NCT00421993%22OR%22NCT00422240%22OR%22NCT00441415%22OR%22NCT00446043%22OR%22NCT00663286%22OR%22NCT00664248%22OR%22NCT00687908%22OR%22NCT00713609%22OR%22NCT00776919%22OR%22NCT00869492%22OR%22NCT00877409%22OR%22NCT00891982%22OR%22NCT01106807%22OR%22NCT01132443%22OR%22NCT01138514%22OR%22NCT01400932%22OR%22NCT01428466%22OR%22NCT01445301%22OR%22NCT01527123%22OR%22NCT01742637%22OR%22NCT01769235%22OR%22NCT01769664%22OR%22NCT01788384%22OR%22NCT01796665%22OR%22NCT01880320%22OR%22NCT01910064%22OR%22NCT01915732%22OR%22NCT02005666%22OR%22NCT02073448%22OR%22NCT02073461%22OR%22NCT02465632%22OR%22NCT02515305%22OR%22NCT02525549%22OR%22NCT02578043%22OR%22NCT02595034%22OR%22NCT02616614%22OR%22NCT02651220%22OR%22NCT02716090%22OR%22NCT03034460%22OR%22NCT03393494%22"]},{"source":"DailyMed","ids":["059323b0-1034-4cc3-96b8-31af3c0c6d22","375bf717-5d70-457e-8b74-1f66f4f08b79","3dcd2c96-72b1-4a9f-b65c-08198d63b7df","4c6b2aca-d940-42af-a068-418f015d277a","67002593-3bd3-4e91-a48f-9f7483e579a0","697e760a-c206-4565-8f4e-a8085e215827","80397ecd-6069-43dc-b8ae-8703f4b66308","890ed265-1217-4fa6-b7f1-a7246dbe137e","96b3e35a-e174-49cd-8695-acd7d23e7710","9dfc4f2d-3945-40a8-b260-f11eb1b2c742","a0610f87-3b39-458a-afa3-66be1fefd1de","a3061440-9f66-4539-9db3-4f13bd662b70","ad3c5d77-52b4-4654-917c-f53697f79277","b4cd760f-2ebd-4789-9e53-42141e3def1f","c1adf643-ee59-4251-bbf8-49f54265f833","c8c05e98-ec28-4636-8e5c-9a2557483e3c","de96e1f5-402c-492f-b0d1-04fc1bc4fd51","f5f9b9dd-0005-4e2e-9c46-7686c4697687"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?059323b0-1034-4cc3-96b8-31af3c0c6d22","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?375bf717-5d70-457e-8b74-1f66f4f08b79","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3dcd2c96-72b1-4a9f-b65c-08198d63b7df","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4c6b2aca-d940-42af-a068-418f015d277a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?67002593-3bd3-4e91-a48f-9f7483e579a0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?697e760a-c206-4565-8f4e-a8085e215827","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?80397ecd-6069-43dc-b8ae-8703f4b66308","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?890ed265-1217-4fa6-b7f1-a7246dbe137e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?96b3e35a-e174-49cd-8695-acd7d23e7710","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9dfc4f2d-3945-40a8-b260-f11eb1b2c742","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a0610f87-3b39-458a-afa3-66be1fefd1de","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a3061440-9f66-4539-9db3-4f13bd662b70","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ad3c5d77-52b4-4654-917c-f53697f79277","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b4cd760f-2ebd-4789-9e53-42141e3def1f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c1adf643-ee59-4251-bbf8-49f54265f833","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c8c05e98-ec28-4636-8e5c-9a2557483e3c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?de96e1f5-402c-492f-b0d1-04fc1bc4fd51","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f5f9b9dd-0005-4e2e-9c46-7686c4697687"]},{"source":"FDA","ids":["11c49c9d-0164-4e91-881f-34e02987a45d","31fd4347-fade-4bee-99d3-25a2de1e307d","4e02ed63-884d-494b-ab64-34cafe744d28","67823063-91a6-4867-a855-7ce0a4a09bd6","764ef37b-7ead-4a64-89eb-67321320138f","907ddb7d-813b-47dc-9565-73ee5f3ce507","92af7521-c836-40f0-af3f-ef96509c6f5e","a683409c-5130-4037-96b0-4ed274450e4a","b51c625c-8d13-4b9f-b247-249344a02ffb","ce91cbf5-5364-4b7e-9e9b-a655b8f50739","d2777f5a-458c-49a0-8907-a95c4b23fd9d"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A11c49c9d-0164-4e91-881f-34e02987a45d","https://api.fda.gov/drug/label.json?search=set_id%3A31fd4347-fade-4bee-99d3-25a2de1e307d","https://api.fda.gov/drug/label.json?search=set_id%3A4e02ed63-884d-494b-ab64-34cafe744d28","https://api.fda.gov/drug/label.json?search=set_id%3A67823063-91a6-4867-a855-7ce0a4a09bd6","https://api.fda.gov/drug/label.json?search=set_id%3A764ef37b-7ead-4a64-89eb-67321320138f","https://api.fda.gov/drug/label.json?search=set_id%3A907ddb7d-813b-47dc-9565-73ee5f3ce507","https://api.fda.gov/drug/label.json?search=set_id%3A92af7521-c836-40f0-af3f-ef96509c6f5e","https://api.fda.gov/drug/label.json?search=set_id%3Aa683409c-5130-4037-96b0-4ed274450e4a","https://api.fda.gov/drug/label.json?search=set_id%3Ab51c625c-8d13-4b9f-b247-249344a02ffb","https://api.fda.gov/drug/label.json?search=set_id%3Ace91cbf5-5364-4b7e-9e9b-a655b8f50739","https://api.fda.gov/drug/label.json?search=set_id%3Ad2777f5a-458c-49a0-8907-a95c4b23fd9d"]}]},{"efo_id":"EFO_0000544","efo_label":"infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000544","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02219776","NCT03257202"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02219776%22OR%22NCT03257202%22"]}]},{"efo_id":"EFO_0002496","efo_label":"actinic keratosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002496","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03122457"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03122457%22"]}]}],"adverse_events":{"significant":[{"event":"methaemoglobinaemia","count":657,"llr":382.6268798},{"event":"erythema","count":35163,"llr":154.6934699},{"event":"swelling face","count":15924,"llr":118.8654964},{"event":"skin burning sensation","count":3095,"llr":79.20815258},{"event":"dry skin","count":10734,"llr":66.02360752},{"event":"application site erythema","count":2671,"llr":56.78753866},{"event":"cyanosis","count":4608,"llr":50.81832136},{"event":"skin irritation","count":2331,"llr":42.51668295},{"event":"drug hypersensitivity","count":71246,"llr":36.12883712},{"event":"eye swelling","count":6631,"llr":34.45651305},{"event":"acquired methaemoglobinaemia","count":19,"llr":33.94395251},{"event":"pruritus","count":57095,"llr":32.49500248},{"event":"dermatitis contact","count":2314,"llr":30.84672637},{"event":"application site burn","count":599,"llr":30.55376496},{"event":"hypersensitivity","count":35921,"llr":29.54416619},{"event":"skin exfoliation","count":9496,"llr":23.6139543},{"event":"acne","count":6076,"llr":23.5036133},{"event":"application site swelling","count":497,"llr":22.30024816},{"event":"eyelid oedema","count":4197,"llr":21.34836641},{"event":"application site pain","count":3142,"llr":20.79270206},{"event":"pain of skin","count":2246,"llr":20.15797797},{"event":"dermatitis allergic","count":3411,"llr":20.08230147},{"event":"application site rash","count":1422,"llr":19.83655801},{"event":"application site pruritus","count":1896,"llr":17.87395643},{"event":"polyarteritis nodosa","count":259,"llr":15.83475151},{"event":"burning sensation","count":12178,"llr":15.81228412},{"event":"skin hyperpigmentation","count":1558,"llr":15.55964204},{"event":"rash","count":97330,"llr":15.52517785},{"event":"burns second degree","count":330,"llr":14.87341108},{"event":"chemical burn of skin","count":87,"llr":14.27055896},{"event":"application site irritation","count":1049,"llr":13.99988734},{"event":"dermatitis","count":4087,"llr":12.73412489},{"event":"fatigue","count":147738,"llr":12.70898563},{"event":"pharyngeal paraesthesia","count":182,"llr":12.06661441},{"event":"lip discolouration","count":198,"llr":11.81557675},{"event":"application site dryness","count":204,"llr":11.72667163},{"event":"angioedema","count":18080,"llr":11.70188259},{"event":"skin tightness","count":743,"llr":11.67189486},{"event":"swelling of eyelid","count":217,"llr":11.54275606},{"event":"application site exfoliation","count":272,"llr":10.87103486},{"event":"oxygen saturation decreased","count":10498,"llr":10.72715592},{"event":"sunburn","count":997,"llr":10.52329077},{"event":"rash pustular","count":2776,"llr":9.321378382},{"event":"skin swelling","count":660,"llr":8.254001512},{"event":"diarrhoea","count":126514,"llr":8.180036712},{"event":"blepharitis","count":760,"llr":7.841663305},{"event":"po2 increased","count":186,"llr":7.194709137},{"event":"erythema of eyelid","count":950,"llr":7.192938852},{"event":"rash papular","count":4428,"llr":7.165995494},{"event":"application site inflammation","count":204,"llr":7.011928491},{"event":"acne cystic","count":214,"llr":6.917308672},{"event":"skin warm","count":1057,"llr":6.88441616},{"event":"product residue present","count":223,"llr":6.835900163},{"event":"red blood cell poikilocytes present","count":4,"llr":6.732749762},{"event":"wound contamination","count":4,"llr":6.732749762},{"event":"swelling","count":18005,"llr":6.681169497},{"event":"pigmentation disorder","count":1337,"llr":6.209952509},{"event":"depilation","count":7,"llr":6.173462406},{"event":"paraesthesia oral","count":3231,"llr":6.063064625}],"critval":6.031592988},"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109630","_score":1,"_source":{"id":"CHEMBL2109630","internal_compound":false,"type":"Antibody","pref_name":"BC8 131I","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["BC8","BC8 131I"],"trade_names":[],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000081237","approved_name":"protein tyrosine phosphatase receptor type C","approved_symbol":"PTPRC"}],"target_type":"single protein","target_name":"Leukocyte common antigen","action_type":"binding agent","description":"Leukocyte common antigen binding agent","references":[{"source":"Other","ids":["https://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=443020"],"urls":["https://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=443020"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4204794","_score":1,"_source":{"id":"CHEMBL4204794","internal_compound":false,"type":"Small molecule","pref_name":"AVAPRITINIB","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["70C366","Avapritinib","BLU-285","C-366","X-720776","X720776"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB15233"]}],"canonical_smiles":"Cn1cc(-c2cc3c(N4CCN(c5ncc([C@@](C)(N)c6ccc(F)cc6)cn5)CC4)ncnn3c2)cn1","indications":[{"efo_id":"EFO_0009001","efo_label":"Mastocytosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009001","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03731260"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03731260%22"]}]},{"efo_id":"Orphanet_44890","efo_label":"Gastrointestinal stromal tumor","efo_uri":"http://www.orpha.net/ORDO/Orphanet_44890","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02508532","NCT03465722"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02508532%22OR%22NCT03465722%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000157404","approved_name":"KIT proto-oncogene, receptor tyrosine kinase","approved_symbol":"KIT"}],"target_type":"single protein","target_name":"Stem cell growth factor receptor","action_type":"inhibitor","description":"Stem cell growth factor receptor inhibitor","references":[{"source":"FDA","ids":["label/2020/212608s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2020%2F212608s000lbl.pdf"]}]},{"target_components":[{"ensembl":"ENSG00000134853","approved_name":"platelet derived growth factor receptor alpha","approved_symbol":"PDGFRA"}],"target_type":"single protein","target_name":"Platelet-derived growth factor receptor alpha","action_type":"inhibitor","description":"Platelet-derived growth factor receptor alpha inhibitor","references":[{"source":"FDA","ids":["label/2020/212608s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2020%2F212608s000lbl.pdf"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109220","_score":1,"_source":{"id":"CHEMBL2109220","internal_compound":false,"type":"Unknown","pref_name":"PERTUSSIS VACCINE ADSORBED","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Pertussis Vaccine Adsorbed"],"trade_names":[],"indications":[{"efo_id":"EFO_0000095","efo_label":"chronic lymphocytic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000095","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02518555"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02518555%22"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00006066"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00006066%22"]}]},{"efo_id":"EFO_0004227","efo_label":"Dengue Hemorrhagic Fever","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004227","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01187433","NCT02992418"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01187433%22OR%22NCT02992418%22"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545236","_score":1,"_source":{"id":"CHEMBL3545236","internal_compound":false,"type":"Small molecule","pref_name":"BPI-9016","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["BPI-9016","BPI-9016M"],"trade_names":[],"indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02478866"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02478866%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02929290"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02929290%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000167601","approved_name":"AXL receptor tyrosine kinase","approved_symbol":"AXL"}],"target_type":"single protein","target_name":"Tyrosine-protein kinase receptor UFO","action_type":"inhibitor","description":"Tyrosine-protein kinase receptor UFO inhibitor","references":[{"source":"ClinicalTrials","ids":["NCT02478866"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02478866%22"]}]},{"target_components":[{"ensembl":"ENSG00000105976","approved_name":"MET proto-oncogene, receptor tyrosine kinase","approved_symbol":"MET"}],"target_type":"single protein","target_name":"Hepatocyte growth factor receptor","action_type":"inhibitor","description":"Hepatocyte growth factor receptor inhibitor","references":[{"source":"ClinicalTrials","ids":["NCT02478866"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02478866%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108171","_score":1,"_source":{"id":"CHEMBL2108171","internal_compound":false,"type":"Oligonucleotide","pref_name":"ABETIMUS","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Abetimus"],"trade_names":[],"indications":[{"efo_id":"EFO_0000540","efo_label":"immune system disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000540","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["L04AA22"],"urls":["https://www.whocc.no/atc_ddd_index/?code=L04AA22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3","_score":1,"_source":{"id":"CHEMBL3","internal_compound":false,"type":"Small molecule","pref_name":"NICOTINE","year_first_approved":1984,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["(-)-Nicotine Hydrogen Tartrate Salt","NSC-97238","Nicotine","Nicotine Bitartrate","Nicotine HCl","Nicotine Polacrilex","Nicotine bitartrate dihydrate","Nicotine polacrilex"],"trade_names":["Commit","Habitrol","NiQuitin Clr","NiQuitin Minis Cherry","NiQuitin Minis Mint","NiQuitin Minis Orange","NiQuitin Mint","NiQuitin Pre-Quit","NiQuitin Strips Mint","Nicabate","Nicoderm","Nicoderm CQ","Nicopass","Nicopatch","Nicorette","Nicorette Invisi","Nicotine","Nicotine Polacrilex","Nicotinell Classic","Nicotinell Support","Nicotinell TTS 10","Nicotinell TTS 20","Nicotinell TTS 30","Nicotrol","Nicotrol Inhaler","Nicotrol NS","Niquitin","Prostep","Stoppers","Stubit","Thrive"],"cross_references":[{"source":"ChEBI","ids":[17688]},{"source":"DailyMed","ids":["nicotine"]},{"source":"PubChem","ids":["144209012","144210494","17389805","26752744","26752745","26752746","50105392","50105393","56314824","90341453"]},{"source":"Wikipedia","ids":["Nicotine"]},{"source":"drugbank","ids":["DB00184"]},{"source":"DailyMed","ids":["nicotine%20polacrilex"]},{"source":"PubChem","ids":["56463314"]},{"source":"PubChem","ids":["144212671"]}],"canonical_smiles":"CN1CCC[C@H]1c1cccnc1","indications":[{"efo_id":"EFO_0003768","efo_label":"nicotine dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003768","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N07BA01"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N07BA01"]},{"source":"ClinicalTrials","ids":["NCT00018148","NCT00018161","NCT00018187","NCT00061074","NCT00067158","NCT00086411","NCT00105482","NCT00108537","NCT00218283","NCT00218296","NCT00258479","NCT00364156","NCT00392379","NCT00469079","NCT00507975","NCT00664755","NCT00710034","NCT00715871","NCT00734617","NCT00755716","NCT00777569","NCT00831155","NCT00879918","NCT00888459","NCT00939029","NCT00956943","NCT00960778","NCT00969137","NCT00985985","NCT01018394","NCT01034020","NCT01050569","NCT01056926","NCT01058876","NCT01065506","NCT01091363","NCT01136642","NCT01199380","NCT01208935","NCT01292642","NCT01296698","NCT01303861","NCT01314001","NCT01321931","NCT01329614","NCT01351766","NCT01372254","NCT01406223","NCT01417429","NCT01438944","NCT01444131","NCT01457469","NCT01478230","NCT01484717","NCT01506908","NCT01560507","NCT01592695","NCT01654107","NCT01702519","NCT01806779","NCT01867411","NCT01892813","NCT01907594","NCT01926626","NCT01989507","NCT02019459","NCT02081144","NCT02179034","NCT02232737","NCT02250534","NCT02250664","NCT02355665","NCT02439944","NCT02487953","NCT02501265","NCT02511704","NCT02587312","NCT02840435","NCT02896400","NCT02906644","NCT02927847","NCT03000387","NCT03168191","NCT03243630","NCT03272685","NCT03442413","NCT03492463","NCT03521141","NCT03541044","NCT03543137","NCT03580525","NCT03634839","NCT03635333","NCT03860077","NCT03972137","NCT04003805","NCT04033237","NCT04063267","NCT04126135"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00018148%22OR%22NCT00018161%22OR%22NCT00018187%22OR%22NCT00061074%22OR%22NCT00067158%22OR%22NCT00086411%22OR%22NCT00105482%22OR%22NCT00108537%22OR%22NCT00218283%22OR%22NCT00218296%22OR%22NCT00258479%22OR%22NCT00364156%22OR%22NCT00392379%22OR%22NCT00469079%22OR%22NCT00507975%22OR%22NCT00664755%22OR%22NCT00710034%22OR%22NCT00715871%22OR%22NCT00734617%22OR%22NCT00755716%22OR%22NCT00777569%22OR%22NCT00831155%22OR%22NCT00879918%22OR%22NCT00888459%22OR%22NCT00939029%22OR%22NCT00956943%22OR%22NCT00960778%22OR%22NCT00969137%22OR%22NCT00985985%22OR%22NCT01018394%22OR%22NCT01034020%22OR%22NCT01050569%22OR%22NCT01056926%22OR%22NCT01058876%22OR%22NCT01065506%22OR%22NCT01091363%22OR%22NCT01136642%22OR%22NCT01199380%22OR%22NCT01208935%22OR%22NCT01292642%22OR%22NCT01296698%22OR%22NCT01303861%22OR%22NCT01314001%22OR%22NCT01321931%22OR%22NCT01329614%22OR%22NCT01351766%22OR%22NCT01372254%22OR%22NCT01406223%22OR%22NCT01417429%22OR%22NCT01438944%22OR%22NCT01444131%22OR%22NCT01457469%22OR%22NCT01478230%22OR%22NCT01484717%22OR%22NCT01506908%22OR%22NCT01560507%22OR%22NCT01592695%22OR%22NCT01654107%22OR%22NCT01702519%22OR%22NCT01806779%22OR%22NCT01867411%22OR%22NCT01892813%22OR%22NCT01907594%22OR%22NCT01926626%22OR%22NCT01989507%22OR%22NCT02019459%22OR%22NCT02081144%22OR%22NCT02179034%22OR%22NCT02232737%22OR%22NCT02250534%22OR%22NCT02250664%22OR%22NCT02355665%22OR%22NCT02439944%22OR%22NCT02487953%22OR%22NCT02501265%22OR%22NCT02511704%22OR%22NCT02587312%22OR%22NCT02840435%22OR%22NCT02896400%22OR%22NCT02906644%22OR%22NCT02927847%22OR%22NCT03000387%22OR%22NCT03168191%22OR%22NCT03243630%22OR%22NCT03272685%22OR%22NCT03442413%22OR%22NCT03492463%22OR%22NCT03521141%22OR%22NCT03541044%22OR%22NCT03543137%22OR%22NCT03580525%22OR%22NCT03634839%22OR%22NCT03635333%22OR%22NCT03860077%22OR%22NCT03972137%22OR%22NCT04003805%22OR%22NCT04033237%22OR%22NCT04063267%22OR%22NCT04126135%22"]}]},{"efo_id":"EFO_0004319","efo_label":"smoking cessation","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004319","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00297492","NCT00622752","NCT00738595","NCT00744913","NCT00764439","NCT00833404","NCT00840242","NCT00851357","NCT00894166","NCT00931021","NCT00965913","NCT00966901","NCT00967070","NCT00967174","NCT01075659","NCT01085032","NCT01287377","NCT01443858","NCT01476202","NCT01502306","NCT01536704","NCT01669122","NCT01702532","NCT01736085","NCT01838460","NCT01847443","NCT01857531","NCT02050308","NCT02356913","NCT02521662","NCT02796391","NCT02942212","NCT02997657","NCT03059940","NCT03091699","NCT03178422","NCT03290430","NCT03404596","NCT03432273","NCT03432312","NCT03897439"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00297492%22OR%22NCT00622752%22OR%22NCT00738595%22OR%22NCT00744913%22OR%22NCT00764439%22OR%22NCT00833404%22OR%22NCT00840242%22OR%22NCT00851357%22OR%22NCT00894166%22OR%22NCT00931021%22OR%22NCT00965913%22OR%22NCT00966901%22OR%22NCT00967070%22OR%22NCT00967174%22OR%22NCT01075659%22OR%22NCT01085032%22OR%22NCT01287377%22OR%22NCT01443858%22OR%22NCT01476202%22OR%22NCT01502306%22OR%22NCT01536704%22OR%22NCT01669122%22OR%22NCT01702532%22OR%22NCT01736085%22OR%22NCT01838460%22OR%22NCT01847443%22OR%22NCT01857531%22OR%22NCT02050308%22OR%22NCT02356913%22OR%22NCT02521662%22OR%22NCT02796391%22OR%22NCT02942212%22OR%22NCT02997657%22OR%22NCT03059940%22OR%22NCT03091699%22OR%22NCT03178422%22OR%22NCT03290430%22OR%22NCT03404596%22OR%22NCT03432273%22OR%22NCT03432312%22OR%22NCT03897439%22"]}]},{"efo_id":"EFO_0001072","efo_label":"memory impairment","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001072","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00091468"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00091468%22"]}]},{"efo_id":"EFO_0002508","efo_label":"Parkinson's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002508","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00873392","NCT00957918","NCT01560754","NCT03865121"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00873392%22OR%22NCT00957918%22OR%22NCT01560754%22OR%22NCT03865121%22"]}]},{"efo_id":"EFO_0004888","efo_label":"post operative nausea and vomiting","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004888","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00553709"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00553709%22"]}]},{"efo_id":"Orphanet_797","efo_label":"Sarcoidosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_797","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02265874"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02265874%22"]}]},{"efo_id":"EFO_0004329","efo_label":"alcohol drinking","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004329","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00616746","NCT00699556"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00616746%22OR%22NCT00699556%22"]}]},{"efo_id":"EFO_0000692","efo_label":"schizophrenia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000692","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00527020"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00527020%22"]}]},{"efo_id":"EFO_0003144","efo_label":"heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003144","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00543881"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00543881%22"]}]},{"efo_id":"EFO_0000341","efo_label":"chronic obstructive pulmonary disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000341","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01539434"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01539434%22"]}]},{"efo_id":"EFO_0001061","efo_label":"cervical carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001061","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01172561"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01172561%22"]}]},{"efo_id":"HP_0100543","efo_label":"Cognitive impairment","efo_uri":"http://purl.obolibrary.org/obo/HP_0100543","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02720445"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02720445%22"]}]},{"efo_id":"EFO_0001071","efo_label":"lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001071","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00032084"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00032084%22"]}]},{"efo_id":"EFO_0003888","efo_label":"attention deficit hyperactivity disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003888","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01819259"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01819259%22"]}]},{"efo_id":"EFO_0000546","efo_label":"injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000546","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02893345"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02893345%22"]}]},{"efo_id":"EFO_0003890","efo_label":"drug dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003890","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00793468"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00793468%22"]}]},{"efo_id":"EFO_0000691","efo_label":"sarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000691","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00295984"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00295984%22"]}]},{"efo_id":"GO_0007568","efo_label":"aging","efo_uri":"http://purl.obolibrary.org/obo/GO_0007568","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03408574"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03408574%22"]}]},{"efo_id":"Orphanet_3389","efo_label":"Tuberculosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_3389","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01517022"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01517022%22"]}]},{"efo_id":"EFO_0000313","efo_label":"carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000313","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03808818"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03808818%22"]}]},{"efo_id":"EFO_0002610","efo_label":"cocaine dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002610","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02018263"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02018263%22"]}]},{"efo_id":"EFO_0007191","efo_label":"cannabis dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007191","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01292642","NCT02955329","NCT04124432"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01292642%22OR%22NCT02955329%22OR%22NCT04124432%22"]}]},{"efo_id":"EFO_0003768","efo_label":"nicotine dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003768","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N07BA01"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N07BA01"]},{"source":"ClinicalTrials","ids":["NCT00086385","NCT00115687","NCT01341938","NCT01451814","NCT02792426","NCT02906995","NCT03259607","NCT03541044","NCT03543137"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00086385%22OR%22NCT00115687%22OR%22NCT01341938%22OR%22NCT01451814%22OR%22NCT02792426%22OR%22NCT02906995%22OR%22NCT03259607%22OR%22NCT03541044%22OR%22NCT03543137%22"]}]},{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02346539"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02346539%22"]}]},{"efo_id":"EFO_0003768","efo_label":"nicotine dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003768","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00996034"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00996034%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000160716","approved_name":"cholinergic receptor nicotinic beta 2 subunit","approved_symbol":"CHRNB2"},{"ensembl":"ENSG00000101204","approved_name":"cholinergic receptor nicotinic alpha 4 subunit","approved_symbol":"CHRNA4"}],"target_type":"protein complex","target_name":"Neuronal acetylcholine receptor; alpha4/beta2","action_type":"agonist","description":"Neuronal acetylcholine receptor; alpha4/beta2 agonist","references":[{"source":"PubMed","ids":["11006350","16636791","16754836","17146052","17226798","17360707","17590520","17613539","19560048","20081230","20400469"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11006350+OR+EXT_ID%3A16636791+OR+EXT_ID%3A16754836+OR+EXT_ID%3A17146052+OR+EXT_ID%3A17226798+OR+EXT_ID%3A17360707+OR+EXT_ID%3A17590520+OR+EXT_ID%3A17613539+OR+EXT_ID%3A19560048+OR+EXT_ID%3A20081230+OR+EXT_ID%3A20400469"]}]}],"adverse_events":{"significant":[{"event":"nicotine dependence","count":316,"llr":1080.034576},{"event":"drug dependence","count":7072,"llr":605.1519465},{"event":"drug withdrawal syndrome neonatal","count":2590,"llr":425.9170649},{"event":"premature baby","count":8946,"llr":201.9113105},{"event":"dependence","count":1115,"llr":193.2199791},{"event":"low birth weight baby","count":2450,"llr":170.0306908},{"event":"premature delivery","count":4411,"llr":165.0375611},{"event":"application site erythema","count":2671,"llr":157.5757904},{"event":"application site pruritus","count":1896,"llr":151.651251},{"event":"myocardial stunning","count":58,"llr":110.3216873},{"event":"foetal disorder","count":259,"llr":108.3833886},{"event":"application site rash","count":1422,"llr":90.77831522},{"event":"alcohol abuse","count":821,"llr":81.50066378},{"event":"neutropenia neonatal","count":87,"llr":78.83809381},{"event":"jaundice neonatal","count":574,"llr":74.64020957},{"event":"maternal drugs affecting foetus","count":3468,"llr":71.93331193},{"event":"application site irritation","count":1049,"llr":67.57017063},{"event":"rhesus incompatibility","count":25,"llr":66.39860683},{"event":"tobacco abuse","count":145,"llr":65.09834947},{"event":"drug abuse","count":14574,"llr":56.92795389},{"event":"tobacco poisoning","count":11,"llr":54.58820875},{"event":"palpitations","count":23550,"llr":54.17410856},{"event":"exposure via breast milk","count":444,"llr":51.37808266},{"event":"application site vesicles","count":841,"llr":51.15228642},{"event":"application site reaction","count":739,"llr":50.03161876},{"event":"poor feeding infant","count":193,"llr":46.52090227},{"event":"application site dermatitis","count":186,"llr":42.42846128},{"event":"caesarean section","count":5212,"llr":39.09333785},{"event":"fatigue","count":147738,"llr":38.67737868},{"event":"drug screen positive","count":1833,"llr":36.26005149},{"event":"injection site pain","count":56727,"llr":35.34550548}],"critval":34.92667831},"child_chembl_ids":["CHEMBL1201536","CHEMBL1448280","CHEMBL151515","CHEMBL225057","CHEMBL3137669","CHEMBL3182465","CHEMBL3989563"],"number_of_indications":25,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":10},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":9},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":7},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":4},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":4},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":3},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":3},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":3},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201587","_score":1,"_source":{"id":"CHEMBL1201587","internal_compound":false,"type":"Antibody","pref_name":"ALEMTUZUMAB","year_first_approved":2001,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["Alemtuzumab","Alemtuzumab (genetical recombination)","Campath-1H","GZ-402673","GZ402673","LDP-03"],"trade_names":["Campath","Campath Mabcampath, Lemtrada","Campath mabcampath","Lemtrada","Mabcampath"],"cross_references":[{"source":"DailyMed","ids":["alemtuzumab"]},{"source":"DrugCentral","ids":["4909"]},{"source":"Wikipedia","ids":["Alemtuzumab"]}],"indications":[{"efo_id":"EFO_0003885","efo_label":"multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003885","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT01333358","NCT01624714","NCT01679041","NCT01712945","NCT02583594","NCT03368664","NCT03477500"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01333358%22OR%22NCT01624714%22OR%22NCT01679041%22OR%22NCT01712945%22OR%22NCT02583594%22OR%22NCT03368664%22OR%22NCT03477500%22"]},{"source":"DailyMed","ids":["6236b0bc-82e9-4447-9a78-f57d94770269"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6236b0bc-82e9-4447-9a78-f57d94770269"]}]},{"efo_id":"EFO_0004599","efo_label":"acute graft vs. host disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004599","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00048399","NCT00495755","NCT00775632","NCT00781781","NCT00986557"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00048399%22OR%22NCT00495755%22OR%22NCT00775632%22OR%22NCT00781781%22OR%22NCT00986557%22"]}]},{"efo_id":"EFO_0000095","efo_label":"chronic lymphocytic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000095","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00046683","NCT00071396","NCT00086580","NCT00098670","NCT00102661","NCT00143065","NCT00162851","NCT00206726","NCT00230282","NCT00276809","NCT00281983","NCT00292760","NCT00328198","NCT00330252","NCT00337519","NCT00504491","NCT00525603","NCT00565981","NCT00634881","NCT00771602","NCT00800943","NCT00923182","NCT00947388","NCT01013961","NCT01082939","NCT01269385","NCT01361711","NCT01392079","NCT01465334","NCT01982175"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00046683%22OR%22NCT00071396%22OR%22NCT00086580%22OR%22NCT00098670%22OR%22NCT00102661%22OR%22NCT00143065%22OR%22NCT00162851%22OR%22NCT00206726%22OR%22NCT00230282%22OR%22NCT00276809%22OR%22NCT00281983%22OR%22NCT00292760%22OR%22NCT00328198%22OR%22NCT00330252%22OR%22NCT00337519%22OR%22NCT00504491%22OR%22NCT00525603%22OR%22NCT00565981%22OR%22NCT00634881%22OR%22NCT00771602%22OR%22NCT00800943%22OR%22NCT00923182%22OR%22NCT00947388%22OR%22NCT01013961%22OR%22NCT01082939%22OR%22NCT01269385%22OR%22NCT01361711%22OR%22NCT01392079%22OR%22NCT01465334%22OR%22NCT01982175%22"]},{"source":"DailyMed","ids":["4f5f7255-7abc-4328-bd1a-ceaf139ef3e0"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4f5f7255-7abc-4328-bd1a-ceaf139ef3e0"]}]},{"efo_id":"EFO_0000220","efo_label":"acute lymphoblastic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000220","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00089349","NCT00262925","NCT00458250","NCT00773149","NCT00983528","NCT01256398","NCT03821610"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00089349%22OR%22NCT00262925%22OR%22NCT00458250%22OR%22NCT00773149%22OR%22NCT00983528%22OR%22NCT01256398%22OR%22NCT03821610%22"]}]},{"efo_id":"EFO_0000211","efo_label":"unspecified peripheral T-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000211","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00441025","NCT00453427","NCT00725231","NCT00930605","NCT01806337"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00441025%22OR%22NCT00453427%22OR%22NCT00725231%22OR%22NCT00930605%22OR%22NCT01806337%22"]}]},{"efo_id":"EFO_0000565","efo_label":"leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000565","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00004857","NCT00006390","NCT00057005","NCT00069992","NCT00074282","NCT00086775","NCT00274976","NCT00416884","NCT00436904","NCT00453193","NCT00458523","NCT00462332","NCT00536978","NCT00562328","NCT00564512","NCT00586547","NCT00669318","NCT00801931","NCT00858117","NCT00943319","NCT01191749","NCT02385110"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004857%22OR%22NCT00006390%22OR%22NCT00057005%22OR%22NCT00069992%22OR%22NCT00074282%22OR%22NCT00086775%22OR%22NCT00274976%22OR%22NCT00416884%22OR%22NCT00436904%22OR%22NCT00453193%22OR%22NCT00458523%22OR%22NCT00462332%22OR%22NCT00536978%22OR%22NCT00562328%22OR%22NCT00564512%22OR%22NCT00586547%22OR%22NCT00669318%22OR%22NCT00801931%22OR%22NCT00858117%22OR%22NCT00943319%22OR%22NCT01191749%22OR%22NCT02385110%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00057967","NCT00069238","NCT00081068","NCT00161590","NCT00363090","NCT00453193","NCT00536978","NCT00646854","NCT00669318","NCT00720447","NCT00801931","NCT00907036","NCT00908180","NCT00943319","NCT01679860"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00057967%22OR%22NCT00069238%22OR%22NCT00081068%22OR%22NCT00161590%22OR%22NCT00363090%22OR%22NCT00453193%22OR%22NCT00536978%22OR%22NCT00646854%22OR%22NCT00669318%22OR%22NCT00720447%22OR%22NCT00801931%22OR%22NCT00907036%22OR%22NCT00908180%22OR%22NCT00943319%22OR%22NCT01679860%22"]}]},{"efo_id":"EFO_0000540","efo_label":"immune system disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000540","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["L04AA34"],"urls":["https://www.whocc.no/atc_ddd_index/?code=L04AA34"]},{"source":"ClinicalTrials","ids":["NCT00801931","NCT01050855"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00801931%22OR%22NCT01050855%22"]}]},{"efo_id":"EFO_0003929","efo_label":"relapsing-remitting multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003929","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00050778","NCT00530348","NCT00548405","NCT00930553","NCT01307332"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00050778%22OR%22NCT00530348%22OR%22NCT00548405%22OR%22NCT00930553%22OR%22NCT01307332%22"]}]},{"efo_id":"EFO_0000183","efo_label":"Hodgkins lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000183","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00129753","NCT01030900"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00129753%22OR%22NCT01030900%22"]}]},{"efo_id":"EFO_0000209","efo_label":"T-cell acute lymphoblastic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000209","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00061048"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00061048%22"]}]},{"efo_id":"HP_0001915","efo_label":"Aplastic anemia","efo_uri":"http://purl.obolibrary.org/obo/HP_0001915","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00065260","NCT00578266","NCT00578903"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00065260%22OR%22NCT00578266%22OR%22NCT00578903%22"]}]},{"efo_id":"EFO_0000198","efo_label":"myelodysplastic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000198","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00069992","NCT00217594","NCT00226512","NCT02497404"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00069992%22OR%22NCT00217594%22OR%22NCT00226512%22OR%22NCT02497404%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00226512","NCT00458250"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00226512%22OR%22NCT00458250%22"]}]},{"efo_id":"EFO_0000255","efo_label":"angioimmunoblastic T-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000255","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00725231"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00725231%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00056966","NCT00058825","NCT00113048"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00056966%22OR%22NCT00058825%22OR%22NCT00113048%22"]}]},{"efo_id":"EFO_0000384","efo_label":"Crohn's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000384","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00692939"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00692939%22"]}]},{"efo_id":"EFO_0000403","efo_label":"diffuse large B-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000403","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01030900","NCT03132584"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01030900%22OR%22NCT03132584%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00895739","NCT02653196"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00895739%22OR%22NCT02653196%22"]}]},{"efo_id":"EFO_0000621","efo_label":"neuroblastoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000621","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00801931"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00801931%22"]}]},{"efo_id":"EFO_0001359","efo_label":"type I diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001359","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00175253","NCT00175266","NCT00214214","NCT03182426"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00175253%22OR%22NCT00175266%22OR%22NCT00214214%22OR%22NCT03182426%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00943319"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00943319%22"]}]},{"efo_id":"EFO_0001421","efo_label":"liver disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001421","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00105235"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00105235%22"]}]},{"efo_id":"EFO_0001642","efo_label":"lymphoid neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001642","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02701517"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02701517%22"]}]},{"efo_id":"EFO_0002890","efo_label":"renal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002890","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00073879"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00073879%22"]}]},{"efo_id":"EFO_0003086","efo_label":"kidney disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003086","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00078559"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00078559%22"]}]},{"efo_id":"EFO_0004272","efo_label":"anemia (phenotype)","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004272","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00801931"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00801931%22"]}]},{"efo_id":"EFO_0004289","efo_label":"lymphoid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004289","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00278213","NCT00935792","NCT00947388","NCT01186640","NCT01269385"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00278213%22OR%22NCT00935792%22OR%22NCT00947388%22OR%22NCT01186640%22OR%22NCT01269385%22"]}]},{"efo_id":"EFO_0005952","efo_label":"non-Hodgkins lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005952","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00051701","NCT00077961","NCT00323323"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00051701%22OR%22NCT00077961%22OR%22NCT00323323%22"]}]},{"efo_id":"EFO_0006927","efo_label":"severe aplastic anemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006927","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00195624"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00195624%22"]}]},{"efo_id":"EFO_0007323","efo_label":"inclusion body myositis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007323","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00079768"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00079768%22"]}]},{"efo_id":"EFO_1000785","efo_label":"Sezary's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000785","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00047060","NCT00157274"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00047060%22OR%22NCT00157274%22"]}]},{"efo_id":"EFO_1001051","efo_label":"mycosis fungoides","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001051","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00047060","NCT00157274"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00047060%22OR%22NCT00157274%22"]}]},{"efo_id":"EFO_1001257","efo_label":"acute erythroblastic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001257","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02497404"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02497404%22"]}]},{"efo_id":"EFO_1001996","efo_label":"Thalassemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001996","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00040417","NCT00040469","NCT01005576"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00040417%22OR%22NCT00040469%22OR%22NCT01005576%22"]}]},{"efo_id":"HP_0100727","efo_label":"Histiocytosis","efo_uri":"http://purl.obolibrary.org/obo/HP_0100727","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00618540"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00618540%22"]}]},{"efo_id":"Orphanet_158038","efo_label":"Primary hemophagocytic lymphohistiocytosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_158038","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02472054"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02472054%22"]}]},{"efo_id":"Orphanet_183660","efo_label":"Severe combined immunodeficiency","efo_uri":"http://www.orpha.net/ORDO/Orphanet_183660","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00152100","NCT01182675"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00152100%22OR%22NCT01182675%22"]}]},{"efo_id":"Orphanet_232","efo_label":"Sickle cell anemia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_232","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00040417","NCT00040469","NCT00408447","NCT00977691","NCT01499888","NCT01877837","NCT02013375","NCT02435901","NCT02678143","NCT03077542","NCT03421756","NCT03587272","NCT04018937"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00040417%22OR%22NCT00040469%22OR%22NCT00408447%22OR%22NCT00977691%22OR%22NCT01499888%22OR%22NCT01877837%22OR%22NCT02013375%22OR%22NCT02435901%22OR%22NCT02678143%22OR%22NCT03077542%22OR%22NCT03421756%22OR%22NCT03587272%22OR%22NCT04018937%22"]}]},{"efo_id":"Orphanet_2781","efo_label":"Osteopetrosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_2781","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00775931"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00775931%22"]}]},{"efo_id":"Orphanet_379","efo_label":"Chronic granulomatous disease","efo_uri":"http://www.orpha.net/ORDO/Orphanet_379","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00578643","NCT03910452"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00578643%22OR%22NCT03910452%22"]}]},{"efo_id":"Orphanet_84","efo_label":"Fanconi anemia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_84","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00586274"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00586274%22"]}]},{"efo_id":"Orphanet_848","efo_label":"Beta-thalassemia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_848","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00408447","NCT02435901"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00408447%22OR%22NCT02435901%22"]}]},{"efo_id":"EFO_0000685","efo_label":"rheumatoid arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000685","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00282412"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00282412%22"]}]},{"efo_id":"EFO_0001075","efo_label":"ovarian carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001075","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00637390"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00637390%22"]}]},{"efo_id":"EFO_0003884","efo_label":"chronic kidney disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003884","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00240994"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00240994%22"]}]},{"efo_id":"EFO_0006803","efo_label":"vasculitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006803","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00278512"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00278512%22"]}]},{"efo_id":"EFO_0009441","efo_label":"Waldenstrom macroglobulinemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009441","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00142181"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00142181%22"]}]},{"efo_id":"EFO_1000251","efo_label":"Fallopian Tube Carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000251","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00637390"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00637390%22"]}]},{"efo_id":"EFO_1000560","efo_label":"T-Cell Prolymphocytic Leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000560","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03989466"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03989466%22"]}]},{"efo_id":"EFO_1001100","efo_label":"peritoneal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001100","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00637390"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00637390%22"]}]},{"efo_id":"EFO_1002048","efo_label":"kidney failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1002048","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00183248"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00183248%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000169442","approved_name":"CD52 molecule","approved_symbol":"CD52"}],"target_type":"single protein","target_name":"CAMPATH-1 antigen","action_type":"inhibitor","description":"CAMPATH-1 antigen inhibitor","references":[{"source":"DailyMed","ids":["setid=4f5f7255-7abc-4328-bd1a-ceaf139ef3e0"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4f5f7255-7abc-4328-bd1a-ceaf139ef3e0"]}]}],"adverse_events":{"significant":[{"event":"immune thrombocytopenic purpura","count":1610,"llr":1189.873492},{"event":"lymphocyte count decreased","count":5692,"llr":1013.914754},{"event":"cytomegalovirus infection","count":5010,"llr":872.3184259},{"event":"urine abnormality","count":821,"llr":685.0079994},{"event":"red blood cells urine positive","count":375,"llr":516.8036531},{"event":"white blood cells urine positive","count":568,"llr":514.382039},{"event":"pyrexia","count":87334,"llr":499.3228001},{"event":"urinary sediment present","count":234,"llr":473.7889809},{"event":"lymphocyte percentage decreased","count":596,"llr":427.2296718},{"event":"lymphopenia","count":5118,"llr":427.0613723},{"event":"crystal urine present","count":176,"llr":423.3759179},{"event":"urine leukocyte esterase positive","count":277,"llr":418.9665239},{"event":"multiple sclerosis relapse","count":13404,"llr":411.0359928},{"event":"bacterial test","count":126,"llr":359.3785301},{"event":"basedow's disease","count":873,"llr":349.3380371},{"event":"neutrophil percentage increased","count":599,"llr":348.4773422},{"event":"urine analysis abnormal","count":950,"llr":327.9618177},{"event":"blood urine present","count":3895,"llr":303.1861991},{"event":"haematocrit decreased","count":6949,"llr":282.4621527},{"event":"adenovirus infection","count":524,"llr":270.7901338},{"event":"red cell distribution width increased","count":1026,"llr":268.3839695},{"event":"blood thyroid stimulating hormone decreased","count":1034,"llr":263.7937904},{"event":"white blood cell count decreased","count":28818,"llr":262.5628451},{"event":"platelet count decreased","count":29394,"llr":261.2734659},{"event":"nitrite urine present","count":151,"llr":257.9022573},{"event":"monocyte percentage increased","count":291,"llr":248.0359681},{"event":"urine ketone body present","count":541,"llr":246.5156472},{"event":"hyperthyroidism","count":3841,"llr":245.5493672},{"event":"headache","count":120638,"llr":239.4045265},{"event":"bacterial test positive","count":547,"llr":237.1135757},{"event":"autoimmune thyroiditis","count":944,"llr":228.88799},{"event":"leukocyturia","count":284,"llr":202.0577805},{"event":"graft versus host disease","count":1579,"llr":182.2493123},{"event":"herpes zoster","count":15237,"llr":181.2698124},{"event":"chest discomfort","count":21346,"llr":180.7453736},{"event":"leukopenia","count":17226,"llr":177.1866665},{"event":"autoimmune haemolytic anaemia","count":792,"llr":176.2745239},{"event":"neutropenia","count":41585,"llr":168.9650395},{"event":"transplant rejection","count":2524,"llr":167.5351638},{"event":"culture urine positive","count":556,"llr":165.603685},{"event":"chills","count":26715,"llr":164.7370336},{"event":"haemoglobin urine present","count":76,"llr":164.2070742},{"event":"nuclear magnetic resonance imaging abnormal","count":1293,"llr":162.9456746},{"event":"blood thyroid stimulating hormone increased","count":1855,"llr":160.8119672},{"event":"specific gravity urine decreased","count":53,"llr":159.5089352},{"event":"red blood cell count decreased","count":7305,"llr":152.9942234},{"event":"monocyte count decreased","count":384,"llr":151.3322857},{"event":"tachycardia","count":26994,"llr":150.8682398},{"event":"cytomegalovirus viraemia","count":913,"llr":149.5566356},{"event":"listeriosis","count":371,"llr":148.6954447},{"event":"flushing","count":18642,"llr":146.4889513},{"event":"protein urine present","count":1333,"llr":144.457827},{"event":"acute graft versus host disease in skin","count":622,"llr":140.3695629},{"event":"bradycardia","count":20091,"llr":135.9915927},{"event":"transplant failure","count":618,"llr":133.1364572},{"event":"mean cell haemoglobin decreased","count":497,"llr":127.6622191},{"event":"thyroxine free increased","count":201,"llr":124.8490742},{"event":"anti-thyroid antibody positive","count":183,"llr":123.4614908},{"event":"thrombocytopenia","count":35327,"llr":123.1703427},{"event":"hypothyroidism","count":7054,"llr":120.1248302},{"event":"neutrophil count increased","count":4046,"llr":118.0825536},{"event":"goodpasture's syndrome","count":60,"llr":116.2700512},{"event":"human herpesvirus 6 infection","count":718,"llr":111.8780169},{"event":"rash","count":97330,"llr":111.8687861},{"event":"mean cell haemoglobin concentration decreased","count":331,"llr":111.7021161},{"event":"haemoglobin decreased","count":33686,"llr":111.6840744},{"event":"lymphocyte count abnormal","count":262,"llr":111.4043776},{"event":"post transplant lymphoproliferative disorder","count":944,"llr":110.0760365},{"event":"monocyte count increased","count":1019,"llr":109.8621514},{"event":"urinary casts","count":104,"llr":106.9877297},{"event":"cd4 lymphocytes decreased","count":811,"llr":106.6882673},{"event":"varicella zoster virus infection","count":474,"llr":106.5493396},{"event":"fatigue","count":147738,"llr":103.232733},{"event":"graft versus host disease in skin","count":530,"llr":102.4079668},{"event":"muscular weakness","count":25474,"llr":101.4566105},{"event":"petechiae","count":3194,"llr":100.0114965},{"event":"red cell distribution width decreased","count":114,"llr":99.68043801},{"event":"neutrophil count decreased","count":11062,"llr":98.60094411},{"event":"urinary tract infection","count":38069,"llr":96.00340126}],"critval":95.84637458},"number_of_indications":52,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":28},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":26},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":25},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":22},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":13},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":9},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":5},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":4},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":4},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":4},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":4},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":3},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":3},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":2},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545131","_score":1,"_source":{"id":"CHEMBL3545131","internal_compound":false,"type":"Antibody","pref_name":"ISATUXIMAB","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Isatuximab","SAR-650984"],"trade_names":[],"indications":[{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01749969","NCT02283775","NCT02332850","NCT02513186","NCT02514668","NCT02812706","NCT02990338","NCT03104842","NCT03194867","NCT03275285","NCT03319667","NCT03617731","NCT03733717","NCT04045795","NCT04083898"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01749969%22OR%22NCT02283775%22OR%22NCT02332850%22OR%22NCT02513186%22OR%22NCT02514668%22OR%22NCT02812706%22OR%22NCT02990338%22OR%22NCT03104842%22OR%22NCT03194867%22OR%22NCT03275285%22OR%22NCT03319667%22OR%22NCT03617731%22OR%22NCT03733717%22OR%22NCT04045795%22OR%22NCT04083898%22"]}]},{"efo_id":"EFO_0001642","efo_label":"lymphoid neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001642","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01084252"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01084252%22"]}]},{"efo_id":"EFO_0004289","efo_label":"lymphoid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004289","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02999633"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02999633%22"]}]},{"efo_id":"EFO_0000220","efo_label":"acute lymphoblastic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000220","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03860844"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03860844%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03860844"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03860844%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03769181"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03769181%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03637764"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03637764%22"]}]},{"efo_id":"EFO_0003073","efo_label":"asymptomatic myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003073","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02960555"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02960555%22"]}]},{"efo_id":"EFO_0008528","efo_label":"urothelial carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008528","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03869190"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03869190%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03555149"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03555149%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000004468","approved_name":"CD38 molecule","approved_symbol":"CD38"}],"target_type":"single protein","target_name":"Lymphocyte differentiation antigen CD38","action_type":"inhibitor","description":"Lymphocyte differentiation antigen CD38 inhibitor","references":[{"source":"PubMed","ids":["28249894"],"urls":["https://europepmc.org/search?query=EXT_ID%3A28249894"]}]}],"number_of_indications":10,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":10},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":7},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":5},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":5},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":3},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2096654","_score":1,"_source":{"id":"CHEMBL2096654","internal_compound":false,"type":"Small molecule","pref_name":"HEMIN","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Hemin","NSC-122707"],"trade_names":["Panhematin"],"cross_references":[{"source":"DrugCentral","ids":["5117"]}],"indications":[{"efo_id":"EFO_0000198","efo_label":"myelodysplastic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000198","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00467610"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00467610%22"]}]},{"efo_id":"Orphanet_738","efo_label":"Porphyria","efo_uri":"http://www.orpha.net/ORDO/Orphanet_738","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02180412"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02180412%22"]}]},{"efo_id":"Orphanet_79273","efo_label":"Hereditary coproporphyria","efo_uri":"http://www.orpha.net/ORDO/Orphanet_79273","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02922413"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02922413%22"]}]},{"efo_id":"Orphanet_79276","efo_label":"Acute intermittent porphyria","efo_uri":"http://www.orpha.net/ORDO/Orphanet_79276","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02922413"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02922413%22"]}]}],"adverse_events":{"significant":[{"event":"phlebitis","count":1786,"llr":50.50504124},{"event":"serum ferritin increased","count":1549,"llr":29.82360153},{"event":"iron overload","count":274,"llr":28.20708537},{"event":"infusion site extravasation","count":1461,"llr":19.86588693},{"event":"extravasation","count":1902,"llr":18.55719789},{"event":"stenotrophomonas sepsis","count":16,"llr":15.09644108},{"event":"injection site phlebitis","count":108,"llr":11.27956233},{"event":"infusion related reaction","count":15012,"llr":8.532285546},{"event":"low income","count":3,"llr":8.523554224},{"event":"catheter related complication","count":489,"llr":8.268237157},{"event":"renal and liver transplant","count":4,"llr":8.235896393},{"event":"culture urine positive","count":556,"llr":8.013032472},{"event":"free haemoglobin present","count":6,"llr":7.830479768}],"critval":7.825050299},"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":4},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":3},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":3},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":3},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":2},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297354","_score":1,"_source":{"id":"CHEMBL4297354","internal_compound":false,"type":"Small molecule","pref_name":"AZD-7687","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AZD7687","Azd 7687","Azd-7687","Azd7687"],"trade_names":[],"canonical_smiles":"Cc1nc(C)c(-c2ccc(C3CCC(CC(=O)O)CC3)cc2)nc1C(N)=O","indications":[{"efo_id":"EFO_0001073","efo_label":"obesity","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001073","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01119352"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01119352%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201482","_score":1,"_source":{"id":"CHEMBL1201482","internal_compound":false,"type":"Enzyme","pref_name":"PROTEASE (PANCRELIPASE)","year_first_approved":1996,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Pancrelipase","Protease"],"trade_names":[],"indications":[{"efo_id":"EFO_0000180","efo_label":"HIV-1 infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000180","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02397096"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02397096%22"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02269917","NCT02556268"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02269917%22OR%22NCT02556268%22"]}]},{"efo_id":"EFO_0003047","efo_label":"hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003047","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01309932"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01309932%22"]}]},{"efo_id":"Orphanet_586","efo_label":"Cystic fibrosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_586","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00432861"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00432861%22"]}]}],"mechanisms_of_action":[],"adverse_events":{"significant":[{"event":"abdominal pain","count":57904,"llr":177.7539454},{"event":"diarrhoea","count":126514,"llr":172.9524707},{"event":"pancreaticoduodenectomy","count":80,"llr":167.180307},{"event":"pancreatic failure","count":139,"llr":158.1774724},{"event":"steatorrhoea","count":237,"llr":148.6835041},{"event":"pancreatitis chronic","count":561,"llr":117.8524906},{"event":"cystic fibrosis","count":743,"llr":114.5687876},{"event":"cholecystectomy","count":1971,"llr":93.46007957},{"event":"abdominal distension","count":15793,"llr":87.66076862},{"event":"pancreatic carcinoma","count":2052,"llr":84.51785717},{"event":"weight decreased","count":46078,"llr":77.903125},{"event":"pancreatectomy","count":65,"llr":70.27649972},{"event":"flatulence","count":7191,"llr":64.45306525},{"event":"adenocarcinoma pancreas","count":333,"llr":63.77828735},{"event":"distal intestinal obstruction syndrome","count":73,"llr":50.27028406},{"event":"constipation","count":39620,"llr":48.14767128},{"event":"intestinal obstruction","count":7554,"llr":44.72468391},{"event":"pancreatic disorder","count":668,"llr":44.30352241},{"event":"abnormal faeces","count":1115,"llr":40.95514094},{"event":"pancreatitis","count":15810,"llr":38.88601118},{"event":"pancreatic mass","count":259,"llr":37.66797959},{"event":"malabsorption","count":1223,"llr":36.01930055},{"event":"hospitalisation","count":28436,"llr":35.15302174},{"event":"colonoscopy","count":464,"llr":31.90507005},{"event":"fibrosing colonopathy","count":11,"llr":31.11399152},{"event":"female sterilisation","count":133,"llr":28.51211205},{"event":"hysterectomy","count":1755,"llr":27.98712259},{"event":"essential hypertension","count":714,"llr":27.67759738},{"event":"gastrooesophageal reflux disease","count":14790,"llr":27.59921412},{"event":"frequent bowel movements","count":3405,"llr":27.58999588},{"event":"abdominal pain upper","count":34037,"llr":26.10703954},{"event":"sjogren's syndrome","count":1287,"llr":25.18229167},{"event":"pancreatic cyst","count":388,"llr":25.16938736},{"event":"appetite disorder","count":997,"llr":24.43232874},{"event":"appendicectomy","count":769,"llr":23.33209423},{"event":"large intestine polyp","count":1583,"llr":23.0028432},{"event":"hernia","count":2679,"llr":22.79281984},{"event":"dysphagia","count":22741,"llr":21.9566392},{"event":"pancreatic enzymes decreased","count":19,"llr":21.8142573},{"event":"diabetes mellitus","count":14312,"llr":21.38685893},{"event":"haemorrhagic diathesis","count":963,"llr":21.37151633},{"event":"surgery","count":8983,"llr":21.12610605},{"event":"skin warm","count":1057,"llr":20.56433938},{"event":"arthritis infective","count":1081,"llr":20.37020124},{"event":"tonsillectomy","count":451,"llr":20.06947968},{"event":"osteochondritis","count":30,"llr":19.99087086},{"event":"hyperlipidaemia","count":5013,"llr":19.68970365},{"event":"pancreatitis relapsing","count":254,"llr":19.67615629},{"event":"nausea","count":165652,"llr":19.53449504},{"event":"osteoarthritis","count":9922,"llr":19.44587091},{"event":"microcytic anaemia","count":852,"llr":19.03012226},{"event":"polyp","count":1287,"llr":18.86840841},{"event":"spinal operation","count":1299,"llr":18.78884553}],"critval":18.69467969},"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":3},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":2},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":2},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3544926","_score":1,"_source":{"id":"CHEMBL3544926","internal_compound":false,"type":"Antibody","pref_name":"OBILTOXAXIMAB","year_first_approved":2016,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["ETI-204","Obiltoxaximab"],"trade_names":["Anthim"],"cross_references":[{"source":"DailyMed","ids":["obiltoxaximab"]},{"source":"DrugCentral","ids":["5094"]}],"indications":[{"efo_id":"EFO_0000778","efo_label":"anthrax infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000778","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00138411","NCT01453907","NCT01929226","NCT01932242","NCT01932437","NCT01952444"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00138411%22OR%22NCT01453907%22OR%22NCT01929226%22OR%22NCT01932242%22OR%22NCT01932437%22OR%22NCT01952444%22"]},{"source":"FDA","ids":["label/2016/125509lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2016%2F125509lbl.pdf"]}]}],"mechanisms_of_action":[{"target_type":"single protein","target_name":"Protective antigen","action_type":"binding agent","description":"Protective antigen binding agent","references":[{"source":"FDA","ids":["label/2016/125509lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2016%2F125509lbl.pdf"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109621","_score":1,"_source":{"id":"CHEMBL2109621","internal_compound":false,"type":"Antibody","pref_name":"ABITUZUMAB","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["ALD403","Abituzumab","DI 17E6","DI-17E6","DI17E6","EMD 525797","EMD-525797"],"trade_names":[],"indications":[{"efo_id":"EFO_0000717","efo_label":"systemic scleroderma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000717","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02745145"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02745145%22"]}]},{"efo_id":"EFO_0001075","efo_label":"ovarian carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001075","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00848510"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00848510%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00958477","NCT01360840"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00958477%22OR%22NCT01360840%22"]}]},{"efo_id":"EFO_0004244","efo_label":"interstitial lung disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004244","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02745145"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02745145%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00848510"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00848510%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000150093","approved_name":"integrin subunit beta 1","approved_symbol":"ITGB1"},{"ensembl":"ENSG00000138448","approved_name":"integrin subunit alpha V","approved_symbol":"ITGAV"}],"target_type":"protein complex","target_name":"Integrin alpha-V/beta-1","action_type":"inhibitor","description":"Integrin alpha-V/beta-1 inhibitor","references":[{"source":"PubMed","ids":["23791392"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23791392"]}]},{"target_components":[{"ensembl":"ENSG00000259207","approved_name":"integrin subunit beta 3","approved_symbol":"ITGB3"},{"ensembl":"ENSG00000138448","approved_name":"integrin subunit alpha V","approved_symbol":"ITGAV"}],"target_type":"protein complex","target_name":"Integrin alpha-V/beta-3","action_type":"inhibitor","description":"Integrin alpha-V/beta-3 inhibitor","references":[{"source":"PubMed","ids":["23791392"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23791392"]}]},{"target_components":[{"ensembl":"ENSG00000138448","approved_name":"integrin subunit alpha V","approved_symbol":"ITGAV"},{"ensembl":"ENSG00000082781","approved_name":"integrin subunit beta 5","approved_symbol":"ITGB5"}],"target_type":"protein complex","target_name":"Integrin alpha-V/beta-5","action_type":"inhibitor","description":"Integrin alpha-V/beta-5 inhibitor","references":[{"source":"PubMed","ids":["23791392"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23791392"]}]},{"target_components":[{"ensembl":"ENSG00000138448","approved_name":"integrin subunit alpha V","approved_symbol":"ITGAV"},{"ensembl":"ENSG00000115221","approved_name":"integrin subunit beta 6","approved_symbol":"ITGB6"}],"target_type":"protein complex","target_name":"Integrin alpha-V/beta-6","action_type":"inhibitor","description":"Integrin alpha-V/beta-6 inhibitor","references":[{"source":"PubMed","ids":["23791392"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23791392"]}]},{"target_components":[{"ensembl":"ENSG00000138448","approved_name":"integrin subunit alpha V","approved_symbol":"ITGAV"},{"ensembl":"ENSG00000105855","approved_name":"integrin subunit beta 8","approved_symbol":"ITGB8"}],"target_type":"protein complex","target_name":"Integrin alpha-V/beta-8","action_type":"inhibitor","description":"Integrin alpha-V/beta-8 inhibitor","references":[{"source":"PubMed","ids":["23791392"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23791392"]}]}],"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":3},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":2},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":2},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1}],"number_of_mechanisms_of_action":5}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2107861","_score":1,"_source":{"id":"CHEMBL2107861","internal_compound":false,"type":"Antibody","pref_name":"ZALUTUMUMAB","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["2F8","HUMAX-EGFR, 2F8","HUMAX-EGFR-2F8","HuMax-EGFr","Zalutumumab"],"trade_names":[],"indications":[{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00460551","NCT01449357"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00460551%22OR%22NCT01449357%22"]}]},{"efo_id":"EFO_0004284","efo_label":"upper aerodigestive tract neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004284","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00093041"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00093041%22"]}]},{"efo_id":"EFO_0000707","efo_label":"squamous cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000707","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00382031"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00382031%22"]}]},{"efo_id":"EFO_0006859","efo_label":"head and neck malignant neoplasia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006859","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00382031","NCT00496652","NCT01054625"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00382031%22OR%22NCT00496652%22OR%22NCT01054625%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00677924"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00677924%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000146648","approved_name":"epidermal growth factor receptor","approved_symbol":"EGFR"}],"target_type":"single protein","target_name":"Epidermal growth factor receptor erbB1","action_type":"antagonist","description":"Epidermal growth factor receptor erbB1 antagonist","references":[{"source":"PubMed","ids":["15383606"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15383606"]}]}],"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":5},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108162","_score":1,"_source":{"id":"CHEMBL2108162","internal_compound":false,"type":"Antibody","pref_name":"TUVIRUMAB","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["OST-577","PE1-1","SDZ OST 577","Tuvirumab"],"trade_names":["Ostavir"],"mechanisms_of_action":[{"target_type":"single protein","target_name":"Major surface antigen","action_type":"inhibitor","description":"Major surface antigen inhibitor","references":[{"source":"PubMed","ids":["11468726"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11468726"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201747","_score":1,"_source":{"id":"CHEMBL1201747","internal_compound":false,"type":"Small molecule","pref_name":"ALCAFTADINE","year_first_approved":2010,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Alcaftadine","R-89674"],"trade_names":["Lastacaft"],"cross_references":[{"source":"ChEBI","ids":[71023]},{"source":"DailyMed","ids":["alcaftadine"]},{"source":"Wikipedia","ids":["Alcaftadine"]},{"source":"drugbank","ids":["DB06766"]}],"canonical_smiles":"CN1CCC(=C2c3ccccc3CCn3c(C=O)cnc32)CC1","indications":[{"efo_id":"EFO_0005751","efo_label":"eye allergy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005751","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["S01GX11"],"urls":["https://www.whocc.no/atc_ddd_index/?code=S01GX11"]}]},{"efo_id":"EFO_0007141","efo_label":"allergic conjunctivitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007141","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00889330"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00889330%22"]},{"source":"DailyMed","ids":["17d37e8d-7825-424b-b6ca-0a85d0bf4694","4b8c6afe-2d76-46c7-a23e-99db5e180ff6","c192fecc-046d-4905-868f-b8200320309c"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?17d37e8d-7825-424b-b6ca-0a85d0bf4694","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4b8c6afe-2d76-46c7-a23e-99db5e180ff6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c192fecc-046d-4905-868f-b8200320309c"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000196639","approved_name":"histamine receptor H1","approved_symbol":"HRH1"}],"target_type":"single protein","target_name":"Histamine H1 receptor","action_type":"antagonist","description":"Histamine H1 receptor antagonist","references":[{"source":"DailyMed","ids":["setid=17d37e8d-7825-424b-b6ca-0a85d0bf4694"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17d37e8d-7825-424b-b6ca-0a85d0bf4694"]}]}],"adverse_events":{"significant":[{"event":"ocular hyperaemia","count":6875,"llr":489.269187},{"event":"eye irritation","count":5686,"llr":255.2706159},{"event":"scleral hyperaemia","count":180,"llr":141.3687551},{"event":"eye pruritus","count":3799,"llr":122.0437134},{"event":"eye swelling","count":6631,"llr":110.0671901},{"event":"eye pain","count":7341,"llr":106.9465186},{"event":"eyelid oedema","count":4197,"llr":80.09282434},{"event":"erythema of eyelid","count":950,"llr":76.57757224},{"event":"eye discharge","count":1453,"llr":53.93216581},{"event":"conjunctivitis","count":4335,"llr":35.82835301},{"event":"lacrimation increased","count":4647,"llr":35.01022725},{"event":"eyelid exfoliation","count":95,"llr":29.48034419},{"event":"conjunctival hyperaemia","count":1201,"llr":25.95865884},{"event":"eye inflammation","count":1429,"llr":24.75380651},{"event":"instillation site pain","count":679,"llr":24.71420683},{"event":"conjunctivitis allergic","count":316,"llr":23.48265457},{"event":"conjunctival oedema","count":394,"llr":22.38371842},{"event":"eyelid margin crusting","count":265,"llr":18.58850618},{"event":"blepharitis","count":760,"llr":14.40034763},{"event":"hypersensitivity","count":35921,"llr":13.98369372},{"event":"chemical burns of eye","count":22,"llr":12.86974147},{"event":"eyelids pruritus","count":384,"llr":11.96816918},{"event":"conjunctival haemorrhage","count":1420,"llr":11.93490586},{"event":"conjunctivitis viral","count":67,"llr":10.64484575},{"event":"foreign body sensation in eyes","count":698,"llr":10.19213869},{"event":"conjunctivitis infective","count":119,"llr":9.4987627},{"event":"reaction to preservatives","count":132,"llr":9.292100521}],"critval":9.231597612},"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":2},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":2}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL717","_score":1,"_source":{"id":"CHEMBL717","internal_compound":false,"type":"Small molecule","pref_name":"MEDROXYPROGESTERONE ACETATE","year_first_approved":1959,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["Amen","Medroxiprogesterone Acetate","Medroxyprogesterone","Medroxyprogesterone 17-acetate","Medroxyprogesterone Acetate","Medroxyprogesterone acetate","NSC-21171","NSC-26386","Prempro","Provera","TV-46046"],"trade_names":["Adgyn Medro","Amen","Climanor","Curretab","Cycrin","Depo-Progevera","Depo-Provera","Depo-Provera Oncology","Depo-Subq Provera 104","Farlutal","Farlutal 100","Farlutal 200","Farlutal 250","Farlutal 500","Lunelle","Medroxyprogesterone Acetate","Provera","Sayana Press"],"cross_references":[{"source":"ChEBI","ids":[6716]},{"source":"DailyMed","ids":["medroxyprogesterone%20acetate"]},{"source":"PubChem","ids":["144204872","144207339","170464622","17388931","26751478","56422500","855664"]},{"source":"Wikipedia","ids":["Medroxyprogesterone_acetate"]},{"source":"drugbank","ids":["DB00603"]}],"canonical_smiles":"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C","indications":[{"efo_id":"EFO_0001065","efo_label":"endometriosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001065","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00437658","NCT01791413"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00437658%22OR%22NCT01791413%22"]}]},{"efo_id":"EFO_0003922","efo_label":"menopause","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003922","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00543634","NCT00745108"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00543634%22OR%22NCT00745108%22"]}]},{"efo_id":"MP_0001914","efo_label":"hemorrhage","efo_uri":"http://purl.obolibrary.org/obo/MP_0001914","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02103764","NCT02943655"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02103764%22OR%22NCT02943655%22"]}]},{"efo_id":"EFO_0003877","efo_label":"sleep apnea","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003877","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01472315"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01472315%22"]}]},{"efo_id":"EFO_0000180","efo_label":"HIV-1 infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000180","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01296152"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01296152%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["L02AB02"],"urls":["https://www.whocc.no/atc_ddd_index/?code=L02AB02"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00044837","NCT00807625","NCT01421368"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00044837%22OR%22NCT00807625%22OR%22NCT01421368%22"]}]},{"efo_id":"EFO_0000545","efo_label":"infertility","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000545","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03300960"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03300960%22"]}]},{"efo_id":"EFO_0004230","efo_label":"endometrial neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004230","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00003179","NCT00033358","NCT00739830","NCT02228681","NCT03567655"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003179%22OR%22NCT00033358%22OR%22NCT00739830%22OR%22NCT02228681%22OR%22NCT03567655%22"]}]},{"efo_id":"EFO_0000249","efo_label":"Alzheimer's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000249","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00066157"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00066157%22"]}]},{"efo_id":"EFO_0000673","efo_label":"prostate adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000673","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01011751"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01011751%22"]}]},{"efo_id":"EFO_0000681","efo_label":"renal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000681","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00291369"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00291369%22"]}]},{"efo_id":"EFO_0001645","efo_label":"coronary heart disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001645","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00319566"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00319566%22"]}]},{"efo_id":"EFO_0002690","efo_label":"systemic lupus erythematosus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002690","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000419"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000419%22"]}]},{"efo_id":"EFO_0002890","efo_label":"renal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002890","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00416429"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00416429%22"]}]},{"efo_id":"EFO_0003777","efo_label":"heart disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003777","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03097120"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03097120%22"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02894151"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02894151%22"]}]},{"efo_id":"EFO_0003882","efo_label":"osteoporosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003882","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00004650"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004650%22"]}]},{"efo_id":"EFO_0004266","efo_label":"primary ovarian insufficiency","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004266","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00370019"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00370019%22"]}]},{"efo_id":"HP_0000132","efo_label":"Menorrhagia","efo_uri":"http://purl.obolibrary.org/obo/HP_0000132","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00360490"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00360490%22"]}]},{"efo_id":"Orphanet_881","efo_label":"Turner syndrome","efo_uri":"http://www.orpha.net/ORDO/Orphanet_881","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00191113"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00191113%22"]}]},{"efo_id":"EFO_0000378","efo_label":"coronary artery disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000378","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00083824"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00083824%22"]}]},{"efo_id":"EFO_0000536","efo_label":"hyperplasia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000536","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03675139"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03675139%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000082175","approved_name":"progesterone receptor","approved_symbol":"PGR"}],"target_type":"single protein","target_name":"Progesterone receptor","action_type":"agonist","description":"Progesterone receptor agonist","references":[{"source":"DailyMed","ids":["setid=199cf13e-0859-4a73-9b45-e700d0cd1049#nlm34090-1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=199cf13e-0859-4a73-9b45-e700d0cd1049#nlm34090-1"]}]}],"adverse_events":{"significant":[{"event":"unintended pregnancy","count":3593,"llr":1901.945777},{"event":"pregnancy with injectable contraceptive","count":133,"llr":675.5339134},{"event":"metrorrhagia","count":3244,"llr":448.2708939},{"event":"breast cancer","count":9611,"llr":334.3286161},{"event":"menorrhagia","count":5436,"llr":250.082204},{"event":"osteopenia","count":2685,"llr":236.5107846},{"event":"injection site abscess","count":797,"llr":215.8544206},{"event":"amenorrhoea","count":3571,"llr":195.050617},{"event":"vaginal haemorrhage","count":7630,"llr":164.1611667},{"event":"injection site reaction","count":22116,"llr":140.9080761},{"event":"breast cancer female","count":1620,"llr":132.1417172},{"event":"injection site atrophy","count":330,"llr":129.9701234},{"event":"oestrogen receptor assay positive","count":192,"llr":122.9193807},{"event":"progesterone receptor assay positive","count":158,"llr":97.64258143},{"event":"osteoporosis","count":5957,"llr":96.44861981},{"event":"fibrocystic breast disease","count":302,"llr":82.23267576},{"event":"breast cancer metastatic","count":1438,"llr":79.51238095},{"event":"hot flush","count":10860,"llr":75.819798},{"event":"breast tenderness","count":1034,"llr":69.82027736},{"event":"depression","count":45027,"llr":67.34818222},{"event":"uterine leiomyoma","count":1986,"llr":65.83667511},{"event":"breast mass","count":1449,"llr":63.48875861},{"event":"injection site inflammation","count":1309,"llr":63.24461092},{"event":"abortion spontaneous","count":14396,"llr":62.48762885},{"event":"breast cancer in situ","count":435,"llr":61.64164211},{"event":"dysmenorrhoea","count":1201,"llr":59.25477071},{"event":"uterine haemorrhage","count":977,"llr":54.70247899},{"event":"suppressed lactation","count":223,"llr":53.19031118},{"event":"menstruation irregular","count":2560,"llr":52.55312104}],"critval":48.77980989},"number_of_indications":23,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":11},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":8},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":6},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":4},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":4},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":4},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":3},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":2},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201642","_score":1,"_source":{"id":"CHEMBL1201642","internal_compound":false,"type":"Protein","pref_name":"INSULIN ZINC SUSP PROMPT BEEF","year_first_approved":1982,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Insulin Zinc Susp Prompt Beef","Insulin zinc susp prompt beef"],"trade_names":["Semilente Insulin"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000171105","approved_name":"insulin receptor","approved_symbol":"INSR"}],"target_type":"single protein","target_name":"Insulin receptor","action_type":"agonist","description":"Insulin receptor agonist","references":[{"source":"FDA","ids":["label/2015/022472s006s008lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F022472s006s008lbl.pdf"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL27","_score":1,"_source":{"id":"CHEMBL27","internal_compound":false,"type":"Small molecule","pref_name":"PROPRANOLOL","year_first_approved":1967,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["AY-64043","AY-64043-","ICI-45520","Inderal","Inderide-40/25","Inderide-80/25","NSC-91523","Propranolol","Propranolol HCl"],"trade_names":["Angilol","Apsolol","Avlocardyl","Bedranol","Bedranol S.R.","Berkolol","Beta-Prograne MR","Betadur CR","Cardinol","Dupromex","Half Beta-Prograne MR","Half Propanix LA","Half Propatard LA","Half-Beprane CR","Half-Betadur CR","Half-Inderal LA","Hemangeol","Inderal","Inderal La","Innopran","Innopran Xl","Lederpronol","Lopranol LA","Probeta LA","Propanix LA","Propanix-10","Propanix-160","Propanix-160 SR","Propanix-40","Propanix-80","Propatard LA","Propranolol HCl","Propranolol Hydrochloride Intensol","Rapranol SR","Sagittol","Slo-Blok","Slo-Pro","Sloprolol","Syprol","Tesnol"],"cross_references":[{"source":"ChEBI","ids":[8499]},{"source":"DailyMed","ids":["propranolol%20hydrochloride"]},{"source":"PubChem","ids":["124881056","26751802","26755283","50104497","90341556"]},{"source":"Wikipedia","ids":["Propranolol"]},{"source":"drugbank","ids":["DB00571"]},{"source":"ChEBI","ids":[8500]},{"source":"PubChem","ids":["144209084","144213222","17389750","26732618","26747603","26747604","26751803","46500341","50106744","50106745","50106746"]}],"canonical_smiles":"CC(C)NCC(O)COc1cccc2ccccc12","indications":[{"efo_id":"EFO_0000182","efo_label":"hepatocellular carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000182","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01265576"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01265576%22"]}]},{"efo_id":"EFO_0000270","efo_label":"asthma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000270","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01074853","NCT01544634"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01074853%22OR%22NCT01544634%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01847001","NCT02596867"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01847001%22OR%22NCT02596867%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02897986"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02897986%22"]}]},{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["C07AA05"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C07AA05"]}]},{"efo_id":"EFO_0000341","efo_label":"chronic obstructive pulmonary disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000341","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00549120","NCT00687700"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00549120%22OR%22NCT00687700%22"]}]},{"efo_id":"EFO_0000537","efo_label":"hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000537","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01007994"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01007994%22"]}]},{"efo_id":"EFO_0000546","efo_label":"injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000546","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00069355","NCT00356187","NCT01007084","NCT01202110","NCT01322048"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00069355%22OR%22NCT00356187%22OR%22NCT01007084%22OR%22NCT01202110%22OR%22NCT01322048%22"]}]},{"efo_id":"EFO_0000666","efo_label":"portal hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000666","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01000779"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01000779%22"]}]},{"efo_id":"EFO_0000681","efo_label":"renal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000681","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03323710"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03323710%22"]}]},{"efo_id":"EFO_0000712","efo_label":"stroke","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000712","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01061190"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01061190%22"]}]},{"efo_id":"EFO_0000756","efo_label":"melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000756","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01705392","NCT02962947"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01705392%22OR%22NCT02962947%22"]}]},{"efo_id":"EFO_0001072","efo_label":"memory impairment","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001072","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00889096"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00889096%22"]}]},{"efo_id":"EFO_0001358","efo_label":"post-traumatic stress disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001358","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00465608","NCT00611871","NCT01127568","NCT01349439","NCT01713556","NCT02789982","NCT03151681"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00465608%22OR%22NCT00611871%22OR%22NCT01127568%22OR%22NCT01349439%22OR%22NCT01713556%22OR%22NCT02789982%22OR%22NCT03151681%22"]}]},{"efo_id":"EFO_0001359","efo_label":"type I diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001359","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03161964"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03161964%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02420223"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02420223%22"]}]},{"efo_id":"EFO_0001422","efo_label":"cirrhosis of liver","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001422","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01134692","NCT01205074"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01134692%22OR%22NCT01205074%22"]}]},{"efo_id":"EFO_0002610","efo_label":"cocaine dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002610","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00000197","NCT00158132","NCT00688805","NCT00830362","NCT01822587","NCT01978457"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000197%22OR%22NCT00158132%22OR%22NCT00688805%22OR%22NCT00830362%22OR%22NCT01822587%22OR%22NCT01978457%22"]}]},{"efo_id":"EFO_0003086","efo_label":"kidney disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003086","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01087749"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01087749%22"]}]},{"efo_id":"EFO_0003756","efo_label":"autism spectrum disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003756","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT02871349"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02871349%22"]}]},{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01263197"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01263197%22"]}]},{"efo_id":"EFO_0003821","efo_label":"migraine disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003821","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00772031","NCT01080677"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00772031%22OR%22NCT01080677%22"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02511483"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02511483%22"]}]},{"efo_id":"EFO_0003882","efo_label":"osteoporosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003882","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT02467400"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02467400%22"]}]},{"efo_id":"EFO_0003890","efo_label":"drug dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003890","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01634347"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01634347%22"]}]},{"efo_id":"EFO_0003918","efo_label":"obstructive sleep apnea","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003918","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03049306"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03049306%22"]}]},{"efo_id":"EFO_0003968","efo_label":"angiosarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003968","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02732678"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02732678%22"]}]},{"efo_id":"EFO_0004142","efo_label":"colorectal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004142","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00888797","NCT03919461"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00888797%22OR%22NCT03919461%22"]}]},{"efo_id":"EFO_0004262","efo_label":"panic disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004262","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02631694"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02631694%22"]}]},{"efo_id":"EFO_0004319","efo_label":"smoking cessation","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004319","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00916721"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00916721%22"]}]},{"efo_id":"EFO_0005230","efo_label":"anxiety","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005230","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01784250","NCT02153944"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01784250%22OR%22NCT02153944%22"]}]},{"efo_id":"EFO_0005252","efo_label":"orthostatic hypotension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005252","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00748059","NCT01988883"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00748059%22OR%22NCT01988883%22"]}]},{"efo_id":"EFO_0005295","efo_label":"migraine with aura","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005295","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00884663"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00884663%22"]}]},{"efo_id":"EFO_0005296","efo_label":"migraine without aura","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005296","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00884663"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00884663%22"]}]},{"efo_id":"EFO_0005687","efo_label":"fibromyalgia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005687","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03029845"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03029845%22"]}]},{"efo_id":"EFO_1000635","efo_label":"hemangioma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000635","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00744185","NCT00967226","NCT01056341","NCT01072045","NCT01074437","NCT01512173","NCT01743885","NCT02342275","NCT02505971","NCT03237637"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00744185%22OR%22NCT00967226%22OR%22NCT01056341%22OR%22NCT01072045%22OR%22NCT01074437%22OR%22NCT01512173%22OR%22NCT01743885%22OR%22NCT02342275%22OR%22NCT02505971%22OR%22NCT03237637%22"]}]},{"efo_id":"EFO_1000911","efo_label":"dystocia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000911","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00315913"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00315913%22"]}]},{"efo_id":"EFO_1001158","efo_label":"retinopathy of prematurity","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001158","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01079715","NCT01238471","NCT02014454","NCT02504944","NCT03038295","NCT03083431"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01079715%22OR%22NCT01238471%22OR%22NCT02014454%22OR%22NCT02504944%22OR%22NCT03038295%22OR%22NCT03083431%22"]}]},{"efo_id":"HP_0001541","efo_label":"Ascites","efo_uri":"http://purl.obolibrary.org/obo/HP_0001541","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02649335"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02649335%22"]}]},{"efo_id":"Orphanet_232","efo_label":"Sickle cell anemia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_232","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01077921","NCT02012777"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01077921%22OR%22NCT02012777%22"]}]},{"efo_id":"Orphanet_558","efo_label":"Marfan syndrome","efo_uri":"http://www.orpha.net/ORDO/Orphanet_558","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00651235"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00651235%22"]}]},{"efo_id":"Orphanet_79383","efo_label":"Lymphedema","efo_uri":"http://www.orpha.net/ORDO/Orphanet_79383","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02595996"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02595996%22"]}]},{"efo_id":"EFO_0000178","efo_label":"gastric carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000178","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT04005365"],"urls":["https://clinicaltrials.gov/search?id=%22NCT04005365%22"]}]},{"efo_id":"EFO_0000378","efo_label":"coronary artery disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000378","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000492","NCT00000493"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000492%22OR%22NCT00000493%22"]}]},{"efo_id":"EFO_0000612","efo_label":"myocardial infarction","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000612","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000492","NCT00000493"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000492%22OR%22NCT00000493%22"]}]},{"efo_id":"EFO_0003860","efo_label":"pancreatic neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003860","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03838029"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03838029%22"]}]},{"efo_id":"EFO_0004278","efo_label":"sudden cardiac arrest","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004278","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000492"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000492%22"]}]},{"efo_id":"EFO_0004287","efo_label":"ventricular fibrillation","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004287","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000492"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000492%22"]}]},{"efo_id":"EFO_0004329","efo_label":"alcohol drinking","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004329","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03588754"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03588754%22"]}]},{"efo_id":"EFO_0009516","efo_label":"burn","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009516","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00673309","NCT00675714","NCT01902810","NCT01957449","NCT02452255"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00673309%22OR%22NCT00675714%22OR%22NCT01902810%22OR%22NCT01957449%22OR%22NCT02452255%22"]}]},{"efo_id":"EFO_1000645","efo_label":"orthostatic intolerance","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000645","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00748059"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00748059%22"]}]},{"efo_id":"EFO_1001375","efo_label":"Myocardial Ischemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001375","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000492","NCT00000493"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000492%22OR%22NCT00000493%22"]}]},{"efo_id":"HP_0001279","efo_label":"Syncope","efo_uri":"http://purl.obolibrary.org/obo/HP_0001279","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00093860"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00093860%22"]}]},{"efo_id":"HP_0001943","efo_label":"Hypoglycemia","efo_uri":"http://purl.obolibrary.org/obo/HP_0001943","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT03079921"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03079921%22"]}]},{"efo_id":"HP_0004755","efo_label":"Supraventricular tachycardia","efo_uri":"http://purl.obolibrary.org/obo/HP_0004755","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00390546"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00390546%22"]}]},{"efo_id":"HP_0030834","efo_label":"Shoulder pain","efo_uri":"http://purl.obolibrary.org/obo/HP_0030834","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02620579"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02620579%22"]}]},{"efo_id":"Orphanet_774","efo_label":"Hereditary hemorrhagic telangiectasia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_774","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT04113187"],"urls":["https://clinicaltrials.gov/search?id=%22NCT04113187%22"]}]},{"efo_id":"EFO_0001360","efo_label":"type II diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001360","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00902161"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00902161%22"]}]},{"efo_id":"EFO_0000537","efo_label":"hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000537","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT01007994"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01007994%22"]},{"source":"DailyMed","ids":["4d15bb34-f5d0-4cd0-8b08-27a0c265d9a5","84050954-e94c-4d90-b3b3-6f47fd14e492","90656b7e-c3b6-46f9-9428-421b7d61d0cc"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4d15bb34-f5d0-4cd0-8b08-27a0c265d9a5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?84050954-e94c-4d90-b3b3-6f47fd14e492","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?90656b7e-c3b6-46f9-9428-421b7d61d0cc"]}]},{"efo_id":"EFO_0000389","efo_label":"cutaneous melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000389","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01988831","NCT03384836"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01988831%22OR%22NCT03384836%22"]}]},{"efo_id":"EFO_0001358","efo_label":"post-traumatic stress disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001358","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01239173"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01239173%22"]}]},{"efo_id":"EFO_0001422","efo_label":"cirrhosis of liver","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001422","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01134692"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01134692%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03152786"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03152786%22"]}]},{"efo_id":"EFO_0002610","efo_label":"cocaine dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002610","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01822587"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01822587%22"]}]},{"efo_id":"EFO_0003821","efo_label":"migraine disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003821","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00772031"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00772031%22"]},{"source":"DailyMed","ids":["0d5ac315-df2b-4b3a-bc7e-ad04752865c4","0d5e8db9-32e6-4947-a510-3d957d5de595","0fc60597-a43b-1a0f-e054-00144ff88e88","164d9c0a-9501-4088-a43a-377933557721","16d3417d-9080-4fc8-99cb-beb904120565","2169e9dd-7541-44e1-bf75-048331bc75e8","23af21f4-cba8-485b-943c-1163b3910ab5","2b26c3aa-2762-471c-9140-c5084d695da4","5a7858eb-9d2d-44d9-9f81-c78ba3ce1815","5ea127c8-b9b9-42fa-9a09-8e8107163d37","7b7b39ae-8c19-4696-a16c-716a73287d0e","7cd94137-98d5-4c59-9924-44fe2f78790d","976077df-038b-4b01-bc4e-751cd70d4441","9ab4058c-86fa-41c8-8291-e073fd28257f","aa627be5-7fa9-4d12-8891-c8e058aebb79","ab9e5678-db53-4354-998a-ed8bf1d33e90","c5091cd2-81c8-4ffe-b2aa-d053de5d6e12","db15690c-6f65-4ad1-845c-d337b8ab5f54","dc49f7e4-f011-4d08-bcae-19aced7c5443","e27c2424-0e18-4c10-aa3a-34bc28b5d681","e2f24efe-ff12-45f2-a4af-4f8ab3c9e835","ee09b4db-4d28-4748-a471-0f7b8c491f54","fa1ec93e-35b0-43c9-81ee-69f7e8abea87","fc3c4c5e-b21f-428e-9ee9-88b478f39998","ff1404ea-430b-4c79-8ada-576a351c9dc6"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0d5ac315-df2b-4b3a-bc7e-ad04752865c4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0d5e8db9-32e6-4947-a510-3d957d5de595","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0fc60597-a43b-1a0f-e054-00144ff88e88","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?164d9c0a-9501-4088-a43a-377933557721","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?16d3417d-9080-4fc8-99cb-beb904120565","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2169e9dd-7541-44e1-bf75-048331bc75e8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?23af21f4-cba8-485b-943c-1163b3910ab5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2b26c3aa-2762-471c-9140-c5084d695da4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5a7858eb-9d2d-44d9-9f81-c78ba3ce1815","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5ea127c8-b9b9-42fa-9a09-8e8107163d37","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7b7b39ae-8c19-4696-a16c-716a73287d0e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7cd94137-98d5-4c59-9924-44fe2f78790d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?976077df-038b-4b01-bc4e-751cd70d4441","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9ab4058c-86fa-41c8-8291-e073fd28257f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?aa627be5-7fa9-4d12-8891-c8e058aebb79","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ab9e5678-db53-4354-998a-ed8bf1d33e90","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c5091cd2-81c8-4ffe-b2aa-d053de5d6e12","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?db15690c-6f65-4ad1-845c-d337b8ab5f54","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dc49f7e4-f011-4d08-bcae-19aced7c5443","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e27c2424-0e18-4c10-aa3a-34bc28b5d681","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e2f24efe-ff12-45f2-a4af-4f8ab3c9e835","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ee09b4db-4d28-4748-a471-0f7b8c491f54","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?fa1ec93e-35b0-43c9-81ee-69f7e8abea87","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?fc3c4c5e-b21f-428e-9ee9-88b478f39998","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ff1404ea-430b-4c79-8ada-576a351c9dc6"]},{"source":"FDA","ids":["0edd2792-281e-463f-a564-ab8969e812d9","1431ca79-5995-46c2-a16f-882ed7bc43ca","1eee14d3-acfc-4002-b457-6bd69afbd2c7","2159a4fd-7d90-48c9-b34b-0edee70c304f","42c535b9-c55e-4fe4-be69-0fc76831bc92","44146b18-78ee-406e-be8d-89a6afa15454","46942e6e-73bb-4687-853a-e3ec2734cc70","53132901-2adb-48b9-9158-5ae585c759bd","5c8e044f-cd83-446e-80da-505e23a3b5cd","6112d957-e39e-470d-9f66-0bce4b3455ee","70e029d2-0a8d-4a6b-bdf6-59bbe58bd659","719412fc-b212-4c63-9b80-376293a70b4f","7242ad8c-548d-47c6-bdd0-3bdc081208d1","76622d52-a8f5-439e-b983-b9ba712e02e4","7dbc22e1-b4c7-4794-8277-7d3814b924d2","888d7d37-f581-4b27-bf9a-40f05a5ceb86","9d73278f-c9c0-4e02-9879-8952a024421c","c67fe5f7-8441-4f19-b027-c8febeb6de1b","e5f93bf7-6f27-4963-a508-11f317f030a0"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A0edd2792-281e-463f-a564-ab8969e812d9","https://api.fda.gov/drug/label.json?search=set_id%3A1431ca79-5995-46c2-a16f-882ed7bc43ca","https://api.fda.gov/drug/label.json?search=set_id%3A1eee14d3-acfc-4002-b457-6bd69afbd2c7","https://api.fda.gov/drug/label.json?search=set_id%3A2159a4fd-7d90-48c9-b34b-0edee70c304f","https://api.fda.gov/drug/label.json?search=set_id%3A42c535b9-c55e-4fe4-be69-0fc76831bc92","https://api.fda.gov/drug/label.json?search=set_id%3A44146b18-78ee-406e-be8d-89a6afa15454","https://api.fda.gov/drug/label.json?search=set_id%3A46942e6e-73bb-4687-853a-e3ec2734cc70","https://api.fda.gov/drug/label.json?search=set_id%3A53132901-2adb-48b9-9158-5ae585c759bd","https://api.fda.gov/drug/label.json?search=set_id%3A5c8e044f-cd83-446e-80da-505e23a3b5cd","https://api.fda.gov/drug/label.json?search=set_id%3A6112d957-e39e-470d-9f66-0bce4b3455ee","https://api.fda.gov/drug/label.json?search=set_id%3A70e029d2-0a8d-4a6b-bdf6-59bbe58bd659","https://api.fda.gov/drug/label.json?search=set_id%3A719412fc-b212-4c63-9b80-376293a70b4f","https://api.fda.gov/drug/label.json?search=set_id%3A7242ad8c-548d-47c6-bdd0-3bdc081208d1","https://api.fda.gov/drug/label.json?search=set_id%3A76622d52-a8f5-439e-b983-b9ba712e02e4","https://api.fda.gov/drug/label.json?search=set_id%3A7dbc22e1-b4c7-4794-8277-7d3814b924d2","https://api.fda.gov/drug/label.json?search=set_id%3A888d7d37-f581-4b27-bf9a-40f05a5ceb86","https://api.fda.gov/drug/label.json?search=set_id%3A9d73278f-c9c0-4e02-9879-8952a024421c","https://api.fda.gov/drug/label.json?search=set_id%3Ac67fe5f7-8441-4f19-b027-c8febeb6de1b","https://api.fda.gov/drug/label.json?search=set_id%3Ae5f93bf7-6f27-4963-a508-11f317f030a0"]}]},{"efo_id":"EFO_0004280","efo_label":"movement disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004280","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03254186"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03254186%22"]}]},{"efo_id":"EFO_1001968","efo_label":"soft tissue sarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001968","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03108300"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03108300%22"]}]},{"efo_id":"EFO_1000635","efo_label":"hemangioma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000635","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03633747"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03633747%22"]}]}],"adverse_events":{"significant":[{"event":"bradycardia","count":20091,"llr":700.8868588},{"event":"hypotension","count":55121,"llr":479.185749},{"event":"toxicity to various agents","count":31033,"llr":288.0193911},{"event":"hypoglycaemia","count":14252,"llr":277.2119186},{"event":"cardiogenic shock","count":2837,"llr":206.4123553},{"event":"cardiac arrest","count":9359,"llr":189.8593106},{"event":"coma","count":13175,"llr":172.9475031},{"event":"circulatory collapse","count":4559,"llr":160.5955603},{"event":"peripheral coldness","count":2946,"llr":158.8216008},{"event":"sinus bradycardia","count":4115,"llr":154.6616359},{"event":"heart rate decreased","count":5985,"llr":138.5846395},{"event":"hypoglycaemic seizure","count":282,"llr":123.4906263},{"event":"poisoning deliberate","count":1558,"llr":107.0325994},{"event":"sleep disorder","count":11647,"llr":102.4747619},{"event":"shock","count":5269,"llr":91.33196866},{"event":"suicide attempt","count":20244,"llr":89.79240145},{"event":"premature baby","count":8946,"llr":84.51984776},{"event":"sclerosing encapsulating peritonitis","count":86,"llr":80.40104998},{"event":"sleep terror","count":541,"llr":70.88227664},{"event":"electrocardiogram qrs complex prolonged","count":1553,"llr":69.92077653},{"event":"somnolence","count":38949,"llr":69.00654155},{"event":"granulomatous rosacea","count":24,"llr":66.61988901},{"event":"depressed level of consciousness","count":10912,"llr":66.4453644},{"event":"cyanosis","count":4608,"llr":66.22847786},{"event":"bronchial hyperreactivity","count":373,"llr":64.37304638}],"critval":60.81850645},"child_chembl_ids":["CHEMBL1671"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000043591","approved_name":"adrenoceptor beta 1","approved_symbol":"ADRB1"}],"target_type":"single protein","target_name":"Beta-1 adrenergic receptor","action_type":"antagonist","description":"Beta-1 adrenergic receptor antagonist","references":[{"source":"DailyMed","ids":["setid=fce692df-1e68-465e-8dda-0cb01320608c"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fce692df-1e68-465e-8dda-0cb01320608c"]},{"source":"Wikipedia","ids":["Propranolol"],"urls":["https://www.wikipedia.org/Propranolol"]}]},{"target_components":[{"ensembl":"ENSG00000169252","approved_name":"adrenoceptor beta 2","approved_symbol":"ADRB2"}],"target_type":"single protein","target_name":"Beta-2 adrenergic receptor","action_type":"antagonist","description":"Beta-2 adrenergic receptor antagonist","references":[{"source":"DailyMed","ids":["setid=fce692df-1e68-465e-8dda-0cb01320608c"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fce692df-1e68-465e-8dda-0cb01320608c"]},{"source":"Wikipedia","ids":["Propranolol"],"urls":["https://www.wikipedia.org/Propranolol"]}]}],"number_of_indications":68,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":23},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":19},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":17},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":11},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":9},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":9},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":8},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":7},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":6},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":6},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":5},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":5},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":4},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":4},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":3},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":3},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":3},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":3},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":2},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":2},{"therapeutic_code":"OTAR_0000014","therapeutic_label":"pregnancy or perinatal disease","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109548","_score":1,"_source":{"id":"CHEMBL2109548","internal_compound":false,"type":"Antibody","pref_name":"MK-4721","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AGS-PSCA","MK-4721"],"trade_names":[],"indications":[{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00519233"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00519233%22"]}]},{"efo_id":"EFO_0002517","efo_label":"pancreatic ductal adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002517","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00902291","NCT01608711"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00902291%22OR%22NCT01608711%22"]}]},{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00902291","NCT01608711"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00902291%22OR%22NCT01608711%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000167653","approved_name":"prostate stem cell antigen","approved_symbol":"PSCA"}],"target_type":"single protein","target_name":"Prostate stem cell antigen","action_type":"inhibitor","description":"Prostate stem cell antigen inhibitor","references":[{"source":"Other","ids":["http://en.pharmacodia.com/web/drug/1_18234.html"],"urls":["http://en.pharmacodia.com/web/drug/1_18234.html"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":2},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL31634","_score":1,"_source":{"id":"CHEMBL31634","internal_compound":false,"type":"Small molecule","pref_name":"BRIVUDINE","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["BVDU","Brivudine","Bromovinyldeoxyuridine","NSC-633770","RP-101","RP101"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["144204764","50105913"]},{"source":"Wikipedia","ids":["Brivudine"]},{"source":"drugbank","ids":["DB03312"]}],"canonical_smiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1/C=C/Br","indications":[{"efo_id":"EFO_0000763","efo_label":"viral disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000763","max_phase_for_indication":2,"references":[{"source":"ATC","ids":["J05AB15"],"urls":["https://www.whocc.no/atc_ddd_index/?code=J05AB15"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00031616"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00031616%22"]}]},{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00550004"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00550004%22"]}]}],"adverse_events":{"significant":[{"event":"rash maculovesicular","count":22,"llr":30.09842114},{"event":"lip erythema","count":65,"llr":26.84846515},{"event":"nasal mucosal disorder","count":129,"llr":24.79230652},{"event":"genital ulceration","count":216,"llr":23.24606726},{"event":"enanthema","count":244,"llr":22.8804489},{"event":"oral mucosa erosion","count":442,"llr":21.09838524},{"event":"conjunctival hyperaemia","count":1201,"llr":18.1009706},{"event":"eye discharge","count":1453,"llr":17.53000304},{"event":"lip oedema","count":1550,"llr":17.33630645},{"event":"lung infiltration","count":3570,"llr":14.83706265},{"event":"coagulopathy","count":4025,"llr":14.47801573},{"event":"rash papular","count":4428,"llr":14.19248255},{"event":"stevens-johnson syndrome","count":7437,"llr":12.64242274}],"critval":11.5679546},"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1569545","_score":1,"_source":{"id":"CHEMBL1569545","internal_compound":false,"type":"Small molecule","pref_name":"CRIDANIMOD","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Cridanimod"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["144205901","170466071","29217965","50086600","56422767"]},{"source":"drugbank","ids":["DB13674"]}],"canonical_smiles":"O=C(O)Cn1c2ccccc2c(=O)c2ccccc21","indications":[{"efo_id":"EFO_0004230","efo_label":"endometrial neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004230","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03077698"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03077698%22"]}]},{"efo_id":"EFO_1001512","efo_label":"endometrial carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001512","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02064725"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02064725%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":2},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":2}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109379","_score":1,"_source":{"id":"CHEMBL2109379","internal_compound":false,"type":"Antibody","pref_name":"NI-0801","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["NI-0801"],"trade_names":[],"indications":[{"efo_id":"EFO_1000668","efo_label":"allergic contact dermatitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000668","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01244607"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01244607%22"]}]},{"efo_id":"EFO_1001486","efo_label":"primary biliary cirrhosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001486","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01430429"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01430429%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000169245","approved_name":"C-X-C motif chemokine ligand 10","approved_symbol":"CXCL10"}],"target_type":"single protein","target_name":"C-X-C motif chemokine 10","action_type":"inhibitor","description":"C-X-C motif chemokine 10 inhibitor","references":[{"source":"Other","ids":["http://novimmune.com/pipeline/ni-1801.html"],"urls":["http://novimmune.com/pipeline/ni-1801.html"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL651","_score":1,"_source":{"id":"CHEMBL651","internal_compound":false,"type":"Small molecule","pref_name":"METHADONE","year_first_approved":1947,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["AN-148","Amidone","Dolophine","Heptadon","IDS-NM-002","Methadone","Methadone HCl","Methadone hydrochloride cii","Methadonium Chloride","Methadose","NSC-19600","Phy","Physeptone","Symoron","Westadone"],"trade_names":["Dolophine HCl","Eptadone","Martindale","Methadone HCl","Methadone Hydrochloride Intensol","Methadose","Metharose","Methex","Physeptone","Pinadone","Synastone","Westadone"],"cross_references":[{"source":"ChEBI","ids":[6807]},{"source":"DailyMed","ids":["methadone%20hydrochloride"]},{"source":"Wikipedia","ids":["Methadone"]},{"source":"drugbank","ids":["DB00333"]},{"source":"ChEBI","ids":[50140]},{"source":"PubChem","ids":["144206448","144209224","144210950"]}],"canonical_smiles":"CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1","indications":[{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00184496","NCT00634010"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00184496%22OR%22NCT00634010%22"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01131273","NCT01467518","NCT02666001","NCT02715700"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01131273%22OR%22NCT01467518%22OR%22NCT02666001%22OR%22NCT02715700%22"]}]},{"efo_id":"EFO_0002610","efo_label":"cocaine dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002610","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000200","NCT00000311","NCT00149630","NCT00292110","NCT00292123","NCT00838981"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000200%22OR%22NCT00000311%22OR%22NCT00149630%22OR%22NCT00292110%22OR%22NCT00292123%22OR%22NCT00838981%22"]}]},{"efo_id":"EFO_0003047","efo_label":"hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003047","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00915564","NCT01396005","NCT02045693"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00915564%22OR%22NCT01396005%22OR%22NCT02045693%22"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N02AC52"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N02AC52"]},{"source":"ClinicalTrials","ids":["NCT00142519","NCT00558870","NCT00715988","NCT01094522","NCT01836328","NCT02687347","NCT02774499","NCT03908944","NCT04027166"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00142519%22OR%22NCT00558870%22OR%22NCT00715988%22OR%22NCT01094522%22OR%22NCT01836328%22OR%22NCT02687347%22OR%22NCT02774499%22OR%22NCT03908944%22OR%22NCT04027166%22"]}]},{"efo_id":"EFO_0003890","efo_label":"drug dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003890","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N07BC02"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N07BC02"]},{"source":"ClinicalTrials","ids":["NCT00504413"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00504413%22"]}]},{"efo_id":"EFO_0003917","efo_label":"premature birth","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003917","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01327079"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01327079%22"]}]},{"efo_id":"EFO_0004240","efo_label":"heroin dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004240","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00378079"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00378079%22"]}]},{"efo_id":"EFO_0004273","efo_label":"scoliosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004273","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01205256","NCT01677650"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01205256%22OR%22NCT01677650%22"]}]},{"efo_id":"EFO_0005611","efo_label":"opioid dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005611","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000311","NCT00142727","NCT00149630","NCT00175357","NCT00204243","NCT00268814","NCT00292123","NCT00344812","NCT00351026","NCT00367302","NCT01021566","NCT01082679","NCT02502175","NCT03948464"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000311%22OR%22NCT00142727%22OR%22NCT00149630%22OR%22NCT00175357%22OR%22NCT00204243%22OR%22NCT00268814%22OR%22NCT00292123%22OR%22NCT00344812%22OR%22NCT00351026%22OR%22NCT00367302%22OR%22NCT01021566%22OR%22NCT01082679%22OR%22NCT02502175%22OR%22NCT03948464%22"]}]},{"efo_id":"EFO_0005762","efo_label":"neuropathic pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005762","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01429181"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01429181%22"]}]},{"efo_id":"EFO_0005799","efo_label":"neonatal abstinence syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005799","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03134703"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03134703%22"]}]},{"efo_id":"HP_0012532","efo_label":"Chronic pain","efo_uri":"http://purl.obolibrary.org/obo/HP_0012532","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00356083"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00356083%22"]}]},{"efo_id":"EFO_0004273","efo_label":"scoliosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004273","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01795495"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01795495%22"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00000800","NCT00000906"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000800%22OR%22NCT00000906%22"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT03525509"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03525509%22"]},{"source":"DailyMed","ids":["092d78eb-6423-495c-bf0d-e6532bea7138","1deb3865-48b5-4860-880f-625f912d7ed4","3c926b78-999e-4d26-9498-7f1bcaf0b992","5e23b861-c635-4749-9c2a-be9d4a501823","7a4840d6-98e3-4523-81a0-ef0b3a47d0c2","7ff89589-149c-4007-8144-5f60131b8c33","802ab399-479b-4271-a2a7-07aadde91cff","8c363f90-c378-48ae-abbc-aeb25c9bf5cb","9bbe219f-3bf1-44f4-a709-cd108c4fa9ef","a36705c4-867f-41f1-94c9-78b8b31836ce","aa8e14c1-fbfd-4e4d-b59e-2d4ae1ca815f","cf10ec82-1f41-45c0-b438-5ade38b5625a","d0e6a966-179a-45e0-8444-4c1b8523f8d2","d3b7a707-78af-4fd5-9b66-b63050bbd6f6","db37a292-5685-4f10-92fc-57631e1a25f9","ec41ab86-a948-44e4-b21c-c65a22cdf294","eddf7077-02fb-4771-9823-31984f4ff2bb"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?092d78eb-6423-495c-bf0d-e6532bea7138","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1deb3865-48b5-4860-880f-625f912d7ed4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3c926b78-999e-4d26-9498-7f1bcaf0b992","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5e23b861-c635-4749-9c2a-be9d4a501823","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7a4840d6-98e3-4523-81a0-ef0b3a47d0c2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7ff89589-149c-4007-8144-5f60131b8c33","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?802ab399-479b-4271-a2a7-07aadde91cff","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8c363f90-c378-48ae-abbc-aeb25c9bf5cb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9bbe219f-3bf1-44f4-a709-cd108c4fa9ef","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a36705c4-867f-41f1-94c9-78b8b31836ce","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?aa8e14c1-fbfd-4e4d-b59e-2d4ae1ca815f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cf10ec82-1f41-45c0-b438-5ade38b5625a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d0e6a966-179a-45e0-8444-4c1b8523f8d2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d3b7a707-78af-4fd5-9b66-b63050bbd6f6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?db37a292-5685-4f10-92fc-57631e1a25f9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ec41ab86-a948-44e4-b21c-c65a22cdf294","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?eddf7077-02fb-4771-9823-31984f4ff2bb"]},{"source":"FDA","ids":["04d04496-36bb-46df-a6e9-5c8aa8578222","052cc172-e3f8-436a-ad92-234c3b7b4e38","0b72a120-ca4e-4b90-7d89-52967a39adb3","20127592-3a20-e280-2c70-f3d4e1ce009f","6059a68d-5434-4a0e-9f53-b793c3dc8630","cf106b94-9c17-4a22-a1ba-ad45d32b41ce"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A04d04496-36bb-46df-a6e9-5c8aa8578222","https://api.fda.gov/drug/label.json?search=set_id%3A052cc172-e3f8-436a-ad92-234c3b7b4e38","https://api.fda.gov/drug/label.json?search=set_id%3A0b72a120-ca4e-4b90-7d89-52967a39adb3","https://api.fda.gov/drug/label.json?search=set_id%3A20127592-3a20-e280-2c70-f3d4e1ce009f","https://api.fda.gov/drug/label.json?search=set_id%3A6059a68d-5434-4a0e-9f53-b793c3dc8630","https://api.fda.gov/drug/label.json?search=set_id%3Acf106b94-9c17-4a22-a1ba-ad45d32b41ce"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["db37a292-5685-4f10-92fc-57631e1a25f9"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?db37a292-5685-4f10-92fc-57631e1a25f9"]}]},{"efo_id":"EFO_0004994","efo_label":"lumbar disc degeneration","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004994","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT04112550"],"urls":["https://clinicaltrials.gov/search?id=%22NCT04112550%22"]}]}],"adverse_events":{"significant":[{"event":"drug withdrawal syndrome neonatal","count":2590,"llr":4448.203919},{"event":"electrocardiogram qt prolonged","count":12378,"llr":762.9604798},{"event":"torsade de pointes","count":3618,"llr":707.7651833},{"event":"premature delivery","count":4411,"llr":459.3690008},{"event":"congenital nystagmus","count":128,"llr":453.3238255},{"event":"toxicity to various agents","count":31033,"llr":418.1937827},{"event":"drug abuse","count":14574,"llr":402.8577893},{"event":"premature baby","count":8946,"llr":367.245171},{"event":"premature labour","count":2380,"llr":353.1029337},{"event":"coma","count":13175,"llr":325.6769307},{"event":"strabismus","count":831,"llr":313.4092154},{"event":"respiratory depression","count":3384,"llr":302.0132564},{"event":"unresponsive to stimuli","count":6342,"llr":255.8387669},{"event":"miosis","count":2714,"llr":243.1278415},{"event":"suicide attempt","count":20244,"llr":228.6106117},{"event":"nystagmus","count":2028,"llr":215.5399188},{"event":"drug withdrawal syndrome","count":13453,"llr":200.8652692},{"event":"developmental delay","count":1019,"llr":193.7412692},{"event":"somnolence","count":38949,"llr":191.9148287},{"event":"delirium","count":11053,"llr":182.732296},{"event":"hyperaesthesia","count":1976,"llr":176.8560793},{"event":"strabismus congenital","count":87,"llr":175.3138324},{"event":"hepatic fibrosis","count":1098,"llr":155.2658725},{"event":"drug dependence","count":7072,"llr":155.152356},{"event":"withdrawal syndrome","count":6642,"llr":151.4052144},{"event":"leukoencephalopathy","count":1566,"llr":148.6537727},{"event":"sedation","count":6964,"llr":144.6945972},{"event":"drug-induced liver injury","count":7265,"llr":133.963412},{"event":"mental status changes","count":10001,"llr":133.08969},{"event":"substance abuse","count":1041,"llr":125.6376104},{"event":"drug interaction","count":53526,"llr":115.8738946},{"event":"visual evoked potentials abnormal","count":89,"llr":113.4404831},{"event":"depressed level of consciousness","count":10912,"llr":99.45263774},{"event":"ventricular tachycardia","count":5901,"llr":95.70306443},{"event":"rhabdomyolysis","count":16457,"llr":95.1398063},{"event":"serotonin syndrome","count":6002,"llr":94.60174673},{"event":"drug diversion","count":556,"llr":92.0182145},{"event":"bradypnoea","count":642,"llr":87.39001732},{"event":"visual acuity reduced","count":9897,"llr":86.45723517},{"event":"respiratory acidosis","count":1152,"llr":81.18848505},{"event":"optic nerve hypoplasia","count":39,"llr":80.93513588},{"event":"respiratory failure","count":13025,"llr":76.77723661},{"event":"rash","count":97330,"llr":75.48903766},{"event":"pneumonia aspiration","count":5215,"llr":72.62427182},{"event":"maternal drugs affecting foetus","count":3468,"llr":72.33430505},{"event":"fatigue","count":147738,"llr":67.51443081},{"event":"injection site pain","count":56727,"llr":65.97773063},{"event":"drug screen positive","count":1833,"llr":64.9364907},{"event":"diarrhoea","count":126514,"llr":64.75383576}],"critval":64.50856139},"child_chembl_ids":["CHEMBL1200825"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000112038","approved_name":"opioid receptor mu 1","approved_symbol":"OPRM1"}],"target_type":"single protein","target_name":"Mu opioid receptor","action_type":"agonist","description":"Mu opioid receptor agonist","references":[{"source":"DailyMed","ids":["setid=e6af84de-cbfc-4a3b-bd73-6bcf77337168#nlm34090-1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e6af84de-cbfc-4a3b-bd73-6bcf77337168#nlm34090-1"]}]}],"number_of_indications":18,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":6},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":5},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":5},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":4},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":3},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":3},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":2},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":2},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL75133","_score":1,"_source":{"id":"CHEMBL75133","internal_compound":false,"type":"Small molecule","pref_name":"IRX-4204","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AGN-194204","IRX-4204","KB-145960","NRX-194204"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB11806"]}],"canonical_smiles":"CC(/C=C/[C@@H]1C[C@]1(C)c1ccc2c(c1)C(C)(C)CCC2(C)C)=C\\C(=O)O","indications":[{"efo_id":"EFO_0002508","efo_label":"Parkinson's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002508","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02438215"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02438215%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00964132","NCT02991651"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00964132%22OR%22NCT02991651%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00630760"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00630760%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01540071"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01540071%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000204231","approved_name":"retinoid X receptor beta","approved_symbol":"RXRB"},{"ensembl":"ENSG00000143171","approved_name":"retinoid X receptor gamma","approved_symbol":"RXRG"},{"ensembl":"ENSG00000186350","approved_name":"retinoid X receptor alpha","approved_symbol":"RXRA"}],"target_type":"protein family","target_name":"Retinoid X receptor","action_type":"agonist","description":"Retinoid X receptor agonist","references":[{"source":"Other","ids":["http://io-therapeutics.com/programs/4204-2/","http://www.neurology.org/content/82/10_Supplement/S14.005"],"urls":["http://io-therapeutics.com/programs/4204-2/","http://www.neurology.org/content/82/10_Supplement/S14.005"]},{"source":"PubMed","ids":["17947492"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17947492"]}]}],"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL428690","_score":1,"_source":{"id":"CHEMBL428690","internal_compound":false,"type":"Small molecule","pref_name":"ALVOCIDIB","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Alvocidib","Alvocidib HCl","Flavopiridol","Flavopiridol hydrochloride","HL-275","HMR-1275","L-86-8275","L-868275","MDL-107826A","NSC-649890"],"trade_names":[],"cross_references":[{"source":"Wikipedia","ids":["Alvocidib"]},{"source":"drugbank","ids":["DB03496"]},{"source":"PubChem","ids":["144206947","170466414"]}],"canonical_smiles":"CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1","indications":[{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00003039","NCT00005074","NCT00019344","NCT00445341"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003039%22OR%22NCT00005074%22OR%22NCT00019344%22OR%22NCT00445341%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00003256","NCT00003690","NCT00019344"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003256%22OR%22NCT00003690%22OR%22NCT00019344%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00003004","NCT00006485","NCT00007917","NCT00016185","NCT00021073","NCT00042874","NCT00045448","NCT00046917","NCT00072436","NCT00079352","NCT00080990","NCT00112684","NCT00324480"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003004%22OR%22NCT00006485%22OR%22NCT00007917%22OR%22NCT00016185%22OR%22NCT00021073%22OR%22NCT00042874%22OR%22NCT00045448%22OR%22NCT00046917%22OR%22NCT00072436%22OR%22NCT00079352%22OR%22NCT00080990%22OR%22NCT00112684%22OR%22NCT00324480%22"]}]},{"efo_id":"EFO_0001642","efo_label":"lymphoid neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001642","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00070239"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00070239%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00047203"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00047203%22"]}]},{"efo_id":"EFO_0000095","efo_label":"chronic lymphocytic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000095","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00003620","NCT00058240","NCT00098371","NCT00377104","NCT00464633"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003620%22OR%22NCT00058240%22OR%22NCT00098371%22OR%22NCT00377104%22OR%22NCT00464633%22"]}]},{"efo_id":"EFO_0000182","efo_label":"hepatocellular carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000182","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00087282"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00087282%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00016016","NCT02520011","NCT03298984","NCT03441555","NCT03563560"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00016016%22OR%22NCT02520011%22OR%22NCT03298984%22OR%22NCT03441555%22OR%22NCT03563560%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00003690","NCT00020332"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003690%22OR%22NCT00020332%22"]}]},{"efo_id":"EFO_0000389","efo_label":"cutaneous melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000389","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00003690","NCT00005971"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003690%22OR%22NCT00005971%22"]}]},{"efo_id":"EFO_0000565","efo_label":"leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000565","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00064285"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00064285%22"]}]},{"efo_id":"EFO_0000691","efo_label":"sarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000691","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00005974"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00005974%22"]}]},{"efo_id":"EFO_0002890","efo_label":"renal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002890","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00016939"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00016939%22"]}]},{"efo_id":"EFO_0002916","efo_label":"esophageal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002916","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00006245"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00006245%22"]}]},{"efo_id":"EFO_0004230","efo_label":"endometrial neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004230","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00023894"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00023894%22"]}]},{"efo_id":"EFO_0004289","efo_label":"lymphoid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004289","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00003620","NCT00058240","NCT00098371"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003620%22OR%22NCT00058240%22OR%22NCT00098371%22"]}]},{"efo_id":"EFO_0006861","efo_label":"male breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006861","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00039455"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00039455%22"]}]},{"efo_id":"EFO_0000220","efo_label":"acute lymphoblastic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000220","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00016016"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00016016%22"]}]},{"efo_id":"EFO_0000095","efo_label":"chronic lymphocytic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000095","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01076556"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01076556%22"]}]},{"efo_id":"EFO_0000191","efo_label":"MALT lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000191","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00082784"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00082784%22"]}]},{"efo_id":"EFO_0000403","efo_label":"diffuse large B-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000403","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00082784"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00082784%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00082784"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00082784%22"]}]},{"efo_id":"EFO_0004289","efo_label":"lymphoid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004289","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01076556"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01076556%22"]}]},{"efo_id":"EFO_1001469","efo_label":"Mantle cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001469","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00082784"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00082784%22"]}]},{"efo_id":"EFO_0009441","efo_label":"Waldenstrom macroglobulinemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009441","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00082784"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00082784%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000123374","approved_name":"cyclin dependent kinase 2","approved_symbol":"CDK2"}],"target_type":"single protein","target_name":"Cyclin-dependent kinase 2","action_type":"inhibitor","description":"Cyclin-dependent kinase 2 inhibitor","references":[{"source":"PubMed","ids":["15217973","25215591"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15217973+OR+EXT_ID%3A25215591"]}]},{"target_components":[{"ensembl":"ENSG00000135446","approved_name":"cyclin dependent kinase 4","approved_symbol":"CDK4"}],"target_type":"single protein","target_name":"Cyclin-dependent kinase 4","action_type":"inhibitor","description":"Cyclin-dependent kinase 4 inhibitor","references":[{"source":"PubMed","ids":["15217973","25215591"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15217973+OR+EXT_ID%3A25215591"]}]},{"target_components":[{"ensembl":"ENSG00000105810","approved_name":"cyclin dependent kinase 6","approved_symbol":"CDK6"}],"target_type":"single protein","target_name":"Cyclin-dependent kinase 6","action_type":"inhibitor","description":"Cyclin-dependent kinase 6 inhibitor","references":[{"source":"PubMed","ids":["15217973","25215591"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15217973+OR+EXT_ID%3A25215591"]}]},{"target_components":[{"ensembl":"ENSG00000136807","approved_name":"cyclin dependent kinase 9","approved_symbol":"CDK9"}],"target_type":"single protein","target_name":"Cyclin-dependent kinase 9","action_type":"inhibitor","description":"Cyclin-dependent kinase 9 inhibitor","references":[{"source":"PubMed","ids":["15217973","25215591"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15217973+OR+EXT_ID%3A25215591"]}]},{"target_components":[{"ensembl":"ENSG00000170312","approved_name":"cyclin dependent kinase 1","approved_symbol":"CDK1"}],"target_type":"single protein","target_name":"Cyclin-dependent kinase 1","action_type":"inhibitor","description":"Cyclin-dependent kinase 1 inhibitor","references":[{"source":"PubMed","ids":["15217973","25215591"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15217973+OR+EXT_ID%3A25215591"]}]},{"target_components":[{"ensembl":"ENSG00000134058","approved_name":"cyclin dependent kinase 7","approved_symbol":"CDK7"}],"target_type":"single protein","target_name":"Cyclin-dependent kinase 7","action_type":"inhibitor","description":"Cyclin-dependent kinase 7 inhibitor","references":[{"source":"PubMed","ids":["15217973","25215591"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15217973+OR+EXT_ID%3A25215591"]}]}],"adverse_events":{"significant":[{"event":"vaccination failure","count":101,"llr":32.17209253},{"event":"lymphopenia","count":5118,"llr":16.49143644},{"event":"tumour lysis syndrome","count":1936,"llr":14.32941281}],"critval":9.816961078},"child_chembl_ids":["CHEMBL2105698"],"number_of_indications":25,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":25},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":15},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":13},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":11},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":7},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":4},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":3},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":3},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":3},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":3},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2}],"number_of_mechanisms_of_action":6}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2178578","_score":1,"_source":{"id":"CHEMBL2178578","internal_compound":false,"type":"Small molecule","pref_name":"VERCIRNON","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["CCX-282","CCX-282-B","GSK-1605786","GSK-1605786A","GSK1605786","GSK1605786A","Vercirnon","Vercirnon Sodium","Verecimon"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB15250"]}],"canonical_smiles":"CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(Cl)cc2C(=O)c2cc[n+]([O-])cc2)cc1","indications":[{"efo_id":"EFO_0000729","efo_label":"ulcerative colitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000729","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01658605"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01658605%22"]}]},{"efo_id":"EFO_0000384","efo_label":"Crohn's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000384","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00102921","NCT00306215","NCT01114607","NCT01489943","NCT01611805","NCT01827631"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00102921%22OR%22NCT00306215%22OR%22NCT01114607%22OR%22NCT01489943%22OR%22NCT01611805%22OR%22NCT01827631%22"]}]},{"efo_id":"EFO_0001060","efo_label":"celiac disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001060","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00540657"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00540657%22"]}]},{"efo_id":"EFO_0000384","efo_label":"Crohn's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000384","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01277666","NCT01316939","NCT01318993","NCT01536418"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01277666%22OR%22NCT01316939%22OR%22NCT01318993%22OR%22NCT01536418%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000173585","approved_name":"C-C motif chemokine receptor 9","approved_symbol":"CCR9"}],"target_type":"single protein","target_name":"C-C chemokine receptor type 9","action_type":"antagonist","description":"C-C chemokine receptor type 9 antagonist","references":[{"source":"PubMed","ids":["20582872"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20582872"]}]}],"adverse_events":{"significant":[{"event":"adenocarcinoma of colon","count":653,"llr":7.292349194},{"event":"inguinal hernia","count":1398,"llr":6.531322643}],"critval":5.785642564},"child_chembl_ids":["CHEMBL3039505"],"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":4},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":4}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1082723","_score":1,"_source":{"id":"CHEMBL1082723","internal_compound":false,"type":"Small molecule","pref_name":"CIPARGAMIN","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Cipargamin","KAE-609","KAE609","Kae609","NITD-609","NITD609"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12306"]}],"canonical_smiles":"C[C@H]1Cc2c([nH]c3cc(Cl)c(F)cc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc12","indications":[{"efo_id":"EFO_0001068","efo_label":"malaria","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001068","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01524341","NCT01836458","NCT03334747"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01524341%22OR%22NCT01836458%22OR%22NCT03334747%22"]}]},{"efo_id":"EFO_0007444","efo_label":"Plasmodium falciparum malaria","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007444","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02543086"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02543086%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3301574","_score":1,"_source":{"id":"CHEMBL3301574","internal_compound":false,"type":"Cell","pref_name":"TISAGENLECLEUCEL","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["CART-19","CART19","CTL-019","Tisagenlecleucel","Tisagenlecleucel-T"],"trade_names":[],"indications":[{"efo_id":"EFO_0000183","efo_label":"Hodgkins lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000183","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT02624258"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02624258%22"]}]},{"efo_id":"EFO_0000094","efo_label":"B-cell acute lymphoblastic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000094","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02030847","NCT02167360","NCT02228096","NCT02924753","NCT03876769"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02030847%22OR%22NCT02167360%22OR%22NCT02228096%22OR%22NCT02924753%22OR%22NCT03876769%22"]}]},{"efo_id":"EFO_0000403","efo_label":"diffuse large B-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000403","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02445248","NCT03630159","NCT03876028"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02445248%22OR%22NCT03630159%22OR%22NCT03876028%22"]}]},{"efo_id":"EFO_0004289","efo_label":"lymphoid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004289","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02435849","NCT03321123"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02435849%22OR%22NCT03321123%22"]}]},{"efo_id":"EFO_0000095","efo_label":"chronic lymphocytic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000095","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01747486","NCT02529813"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01747486%22OR%22NCT02529813%22"]}]},{"efo_id":"EFO_0000096","efo_label":"neoplasm of mature B-cells","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000096","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03391726","NCT03568461"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03391726%22OR%22NCT03568461%22"]}]},{"efo_id":"EFO_0000220","efo_label":"acute lymphoblastic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000220","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01551043","NCT02529813","NCT02810223","NCT03027739","NCT03123939","NCT03391739","NCT03544021","NCT03628053"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01551043%22OR%22NCT02529813%22OR%22NCT02810223%22OR%22NCT03027739%22OR%22NCT03123939%22OR%22NCT03391739%22OR%22NCT03544021%22OR%22NCT03628053%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03896854"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03896854%22"]}]},{"efo_id":"EFO_0000565","efo_label":"leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000565","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01626495","NCT02799550","NCT03614858"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01626495%22OR%22NCT02799550%22OR%22NCT03614858%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01626495","NCT02476734","NCT03101709","NCT04134117"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01626495%22OR%22NCT02476734%22OR%22NCT03101709%22OR%22NCT04134117%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02135406","NCT02794246"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02135406%22OR%22NCT02794246%22"]}]},{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT03497819"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03497819%22"]}]},{"efo_id":"EFO_0005952","efo_label":"non-Hodgkins lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005952","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02030834","NCT02529813","NCT03570892","NCT03610724"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02030834%22OR%22NCT02529813%22OR%22NCT03570892%22OR%22NCT03610724%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000177455","approved_name":"CD19 molecule","approved_symbol":"CD19"}],"target_type":"single protein","target_name":"B-lymphocyte antigen CD19","action_type":"binding agent","description":"B-lymphocyte antigen CD19 binding agent","references":[{"source":"FDA","ids":["https://www.fda.gov/media/107296/download"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Ahttps%3A%2F%2Fwww.fda.gov%2Fmedia%2F107296%2Fdownload"]}]}],"adverse_events":{"significant":[{"event":"proteus infection","count":190,"llr":8.526781552},{"event":"staphylococcal bacteraemia","count":1019,"llr":6.847444712},{"event":"enterococcal infection","count":1106,"llr":6.765539247}],"critval":6.564029204},"number_of_indications":13,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":13},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":12},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":10},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":9},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":6},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1234886","_score":1,"_source":{"id":"CHEMBL1234886","internal_compound":false,"type":"Small molecule","pref_name":"OXYGEN","year_first_approved":2015,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["E-948","E948","INS NO.948","INS-948","Oxygen","Oxygen (93%)"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[15379]},{"source":"drugbank","ids":["DB09140"]}],"canonical_smiles":"O=O","indications":[{"efo_id":"EFO_0000546","efo_label":"injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000546","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00301483","NCT00594503","NCT01220713","NCT01306968","NCT01847755","NCT01986205","NCT02407028","NCT02468752","NCT03900182"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00301483%22OR%22NCT00594503%22OR%22NCT01220713%22OR%22NCT01306968%22OR%22NCT01847755%22OR%22NCT01986205%22OR%22NCT02407028%22OR%22NCT02468752%22OR%22NCT03900182%22"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00219713","NCT01298921","NCT01990404","NCT03088306"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00219713%22OR%22NCT01298921%22OR%22NCT01990404%22OR%22NCT03088306%22"]}]},{"efo_id":"EFO_0000341","efo_label":"chronic obstructive pulmonary disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000341","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00692198","NCT01155310","NCT01261377","NCT01355809"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00692198%22OR%22NCT01155310%22OR%22NCT01261377%22OR%22NCT01355809%22"]}]},{"efo_id":"EFO_0000544","efo_label":"infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000544","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00315822","NCT02563678"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00315822%22OR%22NCT02563678%22"]}]},{"efo_id":"EFO_0003103","efo_label":"urinary tract infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003103","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01659723"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01659723%22"]}]},{"efo_id":"EFO_0004278","efo_label":"sudden cardiac arrest","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004278","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02499042"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02499042%22"]}]},{"efo_id":"EFO_0004234","efo_label":"erectile dysfunction","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004234","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02619383"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02619383%22"]}]},{"efo_id":"EFO_0005762","efo_label":"neuropathic pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005762","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT02246517"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02246517%22"]}]},{"efo_id":"HP_0001919","efo_label":"Acute kidney injury","efo_uri":"http://purl.obolibrary.org/obo/HP_0001919","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02743754"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02743754%22"]}]},{"efo_id":"EFO_0000768","efo_label":"idiopathic pulmonary fibrosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000768","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01214187"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01214187%22"]}]},{"efo_id":"EFO_0003821","efo_label":"migraine disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003821","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01542307"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01542307%22"]}]},{"efo_id":"EFO_0000400","efo_label":"diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000400","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02042339"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02042339%22"]}]},{"efo_id":"EFO_0000556","efo_label":"ischemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000556","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00899587"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00899587%22"]}]},{"efo_id":"EFO_0004264","efo_label":"vascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004264","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02562781"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02562781%22"]}]},{"efo_id":"EFO_0000729","efo_label":"ulcerative colitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000729","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02144350","NCT03494764"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02144350%22OR%22NCT03494764%22"]}]},{"efo_id":"EFO_0004259","efo_label":"osteonecrosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004259","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00462098"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00462098%22"]}]},{"efo_id":"Orphanet_232","efo_label":"Sickle cell anemia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_232","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00142051","NCT02813850"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00142051%22OR%22NCT02813850%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02357134"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02357134%22"]}]},{"efo_id":"EFO_0003144","efo_label":"heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003144","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02949531","NCT03102827"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02949531%22OR%22NCT03102827%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01799161"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01799161%22"]}]},{"efo_id":"EFO_1000637","efo_label":"acute respiratory distress syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000637","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02713451","NCT03621293"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02713451%22OR%22NCT03621293%22"]}]},{"efo_id":"EFO_1000809","efo_label":"anterior ischemic optic neuropathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000809","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02439866"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02439866%22"]}]},{"efo_id":"EFO_1001158","efo_label":"retinopathy of prematurity","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001158","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00623220"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00623220%22"]}]},{"efo_id":"EFO_0003913","efo_label":"angina pectoris","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003913","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01413841"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01413841%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03916068"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03916068%22"]}]},{"efo_id":"EFO_0000326","efo_label":"central nervous system cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000326","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00006460"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00006460%22"]}]},{"efo_id":"EFO_0000378","efo_label":"coronary artery disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000378","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03369184"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03369184%22"]}]},{"efo_id":"EFO_0000692","efo_label":"schizophrenia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000692","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00525863"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00525863%22"]}]},{"efo_id":"EFO_0001360","efo_label":"type II diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001360","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01786707"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01786707%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03398200"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03398200%22"]}]},{"efo_id":"EFO_0002950","efo_label":"pregnancy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002950","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01948115"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01948115%22"]}]},{"efo_id":"EFO_0003758","efo_label":"autism","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003758","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00406159"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00406159%22"]}]},{"efo_id":"EFO_0003817","efo_label":"laryngeal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003817","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00026975"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00026975%22"]}]},{"efo_id":"EFO_0003827","efo_label":"pulmonary embolism","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003827","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT04003116"],"urls":["https://clinicaltrials.gov/search?id=%22NCT04003116%22"]}]},{"efo_id":"EFO_0003918","efo_label":"obstructive sleep apnea","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003918","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03189173"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03189173%22"]}]},{"efo_id":"EFO_0005230","efo_label":"anxiety","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005230","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT03165500"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03165500%22"]}]},{"efo_id":"EFO_0005611","efo_label":"opioid dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005611","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00000251"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000251%22"]}]},{"efo_id":"EFO_0005774","efo_label":"brain disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005774","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00592891"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00592891%22"]}]},{"efo_id":"EFO_0007512","efo_label":"tinea pedis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007512","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00893880"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00893880%22"]}]},{"efo_id":"EFO_1001465","efo_label":"gliosarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001465","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00936052"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00936052%22"]}]},{"efo_id":"EFO_1001821","efo_label":"osteoradionecrosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001821","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00760682","NCT00989820"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00760682%22OR%22NCT00989820%22"]}]},{"efo_id":"Orphanet_791","efo_label":"Retinitis pigmentosa","efo_uri":"http://www.orpha.net/ORDO/Orphanet_791","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT02465749"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02465749%22"]}]},{"efo_id":"Orphanet_79383","efo_label":"Lymphedema","efo_uri":"http://www.orpha.net/ORDO/Orphanet_79383","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02895724"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02895724%22"]}]},{"efo_id":"EFO_0000181","efo_label":"head and neck squamous cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000181","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03843671"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03843671%22"]}]},{"efo_id":"EFO_0000373","efo_label":"congestive heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000373","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03841084"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03841084%22"]}]},{"efo_id":"EFO_0001645","efo_label":"coronary heart disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001645","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03660657"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03660657%22"]}]},{"efo_id":"EFO_0003756","efo_label":"autism spectrum disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003756","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03887754"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03887754%22"]}]},{"efo_id":"EFO_0003818","efo_label":"lung disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003818","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT03532334"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03532334%22"]}]},{"efo_id":"EFO_0007167","efo_label":"Bell's palsy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007167","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT03457025"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03457025%22"]}]},{"efo_id":"EFO_0008590","efo_label":"Status Asthmaticus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008590","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00410150"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00410150%22"]}]},{"efo_id":"EFO_0009448","efo_label":"pulmonary fibrosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009448","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02668029"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02668029%22"]}]},{"efo_id":"EFO_0009516","efo_label":"burn","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009516","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00643357","NCT00824551"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00643357%22OR%22NCT00824551%22"]}]},{"efo_id":"EFO_0009686","efo_label":"respiratory failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009686","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02424773"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02424773%22"]}]},{"efo_id":"HP_0011110","efo_label":"Tonsillitis","efo_uri":"http://purl.obolibrary.org/obo/HP_0011110","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01691690"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01691690%22"]}]}],"adverse_events":{"significant":[{"event":"retinopathy of prematurity","count":254,"llr":238.5414543},{"event":"thermal burn","count":1276,"llr":121.7756206},{"event":"premature baby","count":8946,"llr":85.62715401},{"event":"accident","count":1430,"llr":68.12107418},{"event":"tachypnoea","count":3857,"llr":43.02300607},{"event":"oxygen saturation decreased","count":10498,"llr":33.18009082},{"event":"low birth weight baby","count":2450,"llr":30.36304274},{"event":"hypoxia","count":9218,"llr":29.64262411},{"event":"subcutaneous emphysema","count":239,"llr":26.73698829},{"event":"burns second degree","count":330,"llr":24.81093961},{"event":"dyspnoea","count":124409,"llr":23.96846995},{"event":"epistaxis","count":16532,"llr":23.31721365},{"event":"apgar score low","count":615,"llr":21.10622376},{"event":"pneumomediastinum","count":388,"llr":18.96072702},{"event":"burns third degree","count":145,"llr":18.19056807},{"event":"barotrauma","count":26,"llr":17.92328522},{"event":"oliguria","count":1950,"llr":17.76500417},{"event":"blood creatine increased","count":1383,"llr":16.32599325},{"event":"pulmonary mycosis","count":234,"llr":16.28577692},{"event":"frostbite","count":57,"llr":15.5717583},{"event":"shoulder dystocia","count":64,"llr":15.22501643},{"event":"pneumoperitoneum","count":440,"llr":13.78208712},{"event":"pneumothorax","count":3795,"llr":13.30086133},{"event":"airway burns","count":10,"llr":13.04574912},{"event":"generalised tonic-clonic seizure","count":4083,"llr":12.8195633},{"event":"gastric perforation","count":577,"llr":12.71253158},{"event":"myopia","count":629,"llr":12.37296087},{"event":"hypercapnia","count":783,"llr":11.51349649},{"event":"infective exacerbation of chronic obstructive airways disease","count":222,"llr":11.51064325},{"event":"pulmonary oedema","count":9905,"llr":11.28238395},{"event":"chronic obstructive pulmonary disease","count":10053,"llr":11.16464323},{"event":"underweight","count":293,"llr":10.6858014},{"event":"abdominal pain lower","count":5970,"llr":10.36159548},{"event":"laryngospasm","count":1171,"llr":9.945252434},{"event":"respiratory fume inhalation disorder","count":53,"llr":9.714975779},{"event":"respiratory distress","count":7103,"llr":9.266198391},{"event":"respiratory failure","count":13025,"llr":9.149893932},{"event":"reticulocytosis","count":75,"llr":9.022957506},{"event":"atelectasis","count":3009,"llr":8.999853323},{"event":"migraine with aura","count":541,"llr":8.872762095},{"event":"acute respiratory distress syndrome","count":3118,"llr":8.83362008},{"event":"vaginal haemorrhage","count":7630,"llr":8.821495526},{"event":"respiratory arrest","count":3162,"llr":8.768272869},{"event":"atrioventricular dissociation","count":92,"llr":8.616191142},{"event":"respiratory muscle weakness","count":92,"llr":8.616191142},{"event":"bronchopleural fistula","count":94,"llr":8.573394563},{"event":"anaemia heinz body","count":1,"llr":8.13067626},{"event":"cold burn","count":1,"llr":8.13067626},{"event":"sputum retention","count":121,"llr":8.071316771},{"event":"nasal dryness","count":802,"llr":7.719796308},{"event":"procedural complication","count":2098,"llr":7.712341326},{"event":"respiratory tract haemorrhage","count":149,"llr":7.658026923}],"critval":7.476238697},"number_of_indications":54,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":16},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":14},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":10},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":9},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":7},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":5},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":4},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":4},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":4},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":3},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":3},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":3},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":3},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":3},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":3},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":3},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":2},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":2},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":2},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201328","_score":1,"_source":{"id":"CHEMBL1201328","internal_compound":false,"type":"Small molecule","pref_name":"CARPHENAZINE","year_first_approved":1982,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Carfenazine","Carphenazine","Carphenazine Maleate","WY-2445"],"trade_names":["Proketazine"],"cross_references":[{"source":"PubChem","ids":["50125832"]},{"source":"Wikipedia","ids":["Carfenazine"]},{"source":"drugbank","ids":["DB01038"]},{"source":"PubChem","ids":["144206284"]}],"canonical_smiles":"CCC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2","child_chembl_ids":["CHEMBL2358147"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000102468","approved_name":"5-hydroxytryptamine receptor 2A","approved_symbol":"HTR2A"}],"target_type":"single protein","target_name":"Serotonin 2a (5-HT2a) receptor","action_type":"antagonist","description":"Serotonin 2a (5-HT2a) receptor antagonist","references":[{"source":"ISBN","ids":["0443-059748 PP. 544"],"urls":[]},{"source":"PubMed","ids":["4889058"],"urls":["https://europepmc.org/search?query=EXT_ID%3A4889058"]},{"source":"Wikipedia","ids":["Carphenazine"],"urls":["https://www.wikipedia.org/Carphenazine"]}]},{"target_components":[{"ensembl":"ENSG00000147246","approved_name":"5-hydroxytryptamine receptor 2C","approved_symbol":"HTR2C"}],"target_type":"single protein","target_name":"Serotonin 2c (5-HT2c) receptor","action_type":"antagonist","description":"Serotonin 2c (5-HT2c) receptor antagonist","references":[{"source":"ISBN","ids":["0443-059748 PP. 544"],"urls":[]},{"source":"PubMed","ids":["4889058"],"urls":["https://europepmc.org/search?query=EXT_ID%3A4889058"]},{"source":"Wikipedia","ids":["Carphenazine"],"urls":["https://www.wikipedia.org/Carphenazine"]}]},{"target_components":[{"ensembl":"ENSG00000149295","approved_name":"dopamine receptor D2","approved_symbol":"DRD2"}],"target_type":"single protein","target_name":"Dopamine D2 receptor","action_type":"antagonist","description":"Dopamine D2 receptor antagonist","references":[{"source":"ISBN","ids":["0443-059748 PP. 544"],"urls":[]},{"source":"PubMed","ids":["4889058"],"urls":["https://europepmc.org/search?query=EXT_ID%3A4889058"]},{"source":"Wikipedia","ids":["Carphenazine"],"urls":["https://www.wikipedia.org/Carphenazine"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":3}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1371937","_score":1,"_source":{"id":"CHEMBL1371937","internal_compound":false,"type":"Small molecule","pref_name":"PANTHENOL","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Panthenol","Panthenol, racemic"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["144212977","56320906"]}],"canonical_smiles":"CC(C)(CO)C(O)C(=O)NCCCO","indications":[{"efo_id":"EFO_1001459","efo_label":"diabetic foot","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001459","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01531517","NCT02379468"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01531517%22OR%22NCT02379468%22"]}]},{"efo_id":"EFO_0007214","efo_label":"common cold","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007214","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01533220"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01533220%22"]}]}],"adverse_events":{"significant":[{"event":"drug hypersensitivity","count":71246,"llr":27.49966073},{"event":"unresponsive to stimuli","count":6342,"llr":18.37261748},{"event":"respiratory failure","count":13025,"llr":14.81964174},{"event":"heart rate increased","count":16145,"llr":10.07577378},{"event":"throat irritation","count":6709,"llr":9.239503919},{"event":"accidental exposure to product by child","count":1142,"llr":8.831932039}],"critval":8.356626036},"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL356359","_score":1,"_source":{"id":"CHEMBL356359","internal_compound":false,"type":"Small molecule","pref_name":"PIBOSEROD","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Piboserod","Piboserod HCl","SB-207266","SB-207266-A"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["137275879"]},{"source":"Wikipedia","ids":["Piboserod"]},{"source":"drugbank","ids":["DB04873"]}],"canonical_smiles":"CCCCN1CCC(CNC(=O)c2c3n(c4ccccc24)CCCO3)CC1","indications":[{"efo_id":"EFO_0000275","efo_label":"atrial fibrillation","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000275","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00041496"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00041496%22"]}]},{"efo_id":"EFO_0000373","efo_label":"congestive heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000373","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00421746"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00421746%22"]}]}],"child_chembl_ids":["CHEMBL2106927"],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":2},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":2}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1503","_score":1,"_source":{"id":"CHEMBL1503","internal_compound":false,"type":"Small molecule","pref_name":"OMEPRAZOLE","year_first_approved":1989,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["H 168/68","H 168/68 Magnesium","H 168/68 Sodium","H-168/68","Omeprazole","Omeprazole Magnesium","Omeprazole Sodium","Omeprazole magnesium","Omeprazole magnesium salt"],"trade_names":["Antra","Losec","Losec MUPS","Losec Sodium","Mezzopram","Mopral","Omeprazole","Omeprazole Magnesium","Omeran","Prilosec","Prilosec Otc","Zanprol"],"cross_references":[{"source":"ChEBI","ids":[77260]},{"source":"DailyMed","ids":["omeprazole","omeprazole%20magnesium"]},{"source":"PubChem","ids":["104171331","11112840","124882676","124882677","144204237","144207707","170465443","174007234","26751452","26751453","50103932","56422106","855576"]},{"source":"TG-GATEs","ids":["12"]},{"source":"Wikipedia","ids":["Omeprazole"]},{"source":"drugbank","ids":["DB00338"]},{"source":"DailyMed","ids":["omeprazole%20magnesium"]},{"source":"PubChem","ids":["49665950","49681830"]}],"canonical_smiles":"COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1","indications":[{"efo_id":"EFO_0004234","efo_label":"erectile dysfunction","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004234","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01415128"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01415128%22"]}]},{"efo_id":"EFO_0003948","efo_label":"gastroesophageal reflux disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003948","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["A02BC01"],"urls":["https://www.whocc.no/atc_ddd_index/?code=A02BC01"]},{"source":"ClinicalTrials","ids":["NCT00256737","NCT00259051","NCT00259077","NCT00426595","NCT00564590","NCT00818870","NCT00857597","NCT01136317","NCT01269788","NCT01493089","NCT01499368","NCT01657578","NCT01710995","NCT01824199","NCT02584751","NCT03367195"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00256737%22OR%22NCT00259051%22OR%22NCT00259077%22OR%22NCT00426595%22OR%22NCT00564590%22OR%22NCT00818870%22OR%22NCT00857597%22OR%22NCT01136317%22OR%22NCT01269788%22OR%22NCT01493089%22OR%22NCT01499368%22OR%22NCT01657578%22OR%22NCT01710995%22OR%22NCT01824199%22OR%22NCT02584751%22OR%22NCT03367195%22"]},{"source":"DailyMed","ids":["03ac077f-3873-4087-96d0-89049161dea9","04d9fe8b-6d44-f46f-732a-5583a7118b91","08b0a9cc-208a-45ff-96a6-50109a325388","0dc9682c-a4ae-4786-8dd9-31e33ce9861b","0f560bc9-9f40-0f96-e054-00144ff88e88","0f82d42d-e19e-463c-9000-e590cc7c9360","11a46141-f466-0131-e054-00144ff88e88","11a810ca-72e8-1d9b-e054-00144ff88e88","1577bc9c-24d3-450e-b438-d4f1b5db6485","15b91de7-1954-4055-aef6-fb57d8568a80","181e6f96-4a1d-49af-b906-b9aa2bbf0061","18b22092-605b-4ae7-8bc8-7f213d7d02eb","276c3f70-890e-4afa-af48-8630f9689785","2aaaf0fd-7f2a-4533-b3ad-f35c6c19cca2","2c40d64b-5e7b-4381-9ebf-df3a4bf0edfe","2f381ecb-1e71-4f2f-acf0-d4918e0f3a1c","2f6e74e5-929c-4a74-a9e4-f56c2a7d575e","2ffbec78-5bd4-4647-b282-d6edf8e22ccc","3660ed71-6268-4491-a4a3-4d5aeabbb489","3817cb8f-78f0-49cd-b55c-27f44a66d446","4349207c-5253-49fb-95ef-15f5ed371442","44260509-a91c-4906-bcc7-4eb5d3465ded","456ca6dc-1d19-4750-998f-406e84173959","48bd690b-8ce5-4adf-a76a-2e4702a160e5","4b188d97-f1b3-468d-9818-b8333bf24b5a","4e0c7ad7-3b44-4db8-b144-a1ad6d152315","5397bbb7-74a4-4751-b491-c2e14cf8a076","581d1c3d-457a-41f2-8db0-5b6219cdcb09","5a09ce48-7139-4fc7-9b6e-439459c8e866","5aba19da-663f-4901-94e2-f438dba4841f","603d2d06-c5e8-4378-a422-8dca1a410af7","60752a58-1d6c-4b4d-98dd-d49c76d2f443","615a4d38-a235-bb1f-a0ef-1909dcfe7b2a","61b34d13-3b8b-4491-b5a3-e9740b2aaccb","665307df-4c80-44f5-b924-e9efb8680205","72fb11b6-b08c-2f02-d82b-f60f52394903","76704e78-335a-45a0-88fe-9889d8bcea35","78a623e8-47be-44b6-b7e0-5b13b2bcecf9","7b891df0-add4-4f0c-a3ab-d53e864eced7","80cbc57e-d864-4c17-bd64-b5206ee55aab","83a0bb34-405b-4aea-9557-4f8b8fd811d7","8750bc89-340d-4abf-b0b8-b83012ab7cae","8752e76c-1220-48b2-b394-7536245707e1","8772b002-c446-4581-8a14-d7a9bca62385","878064ef-6a81-4999-8902-9da151e9c22d","8809c12d-06de-4ccb-95d3-5108d2a955fb","8e3b29b0-d3a8-409a-b397-53dbbbcda094","92201fb1-4570-42db-8da3-3b8c0e291d32","93ec1327-22b1-4a5d-a793-e014f6dffd33","9a77cf66-e110-4d51-ae8a-bea6207bba75","9c22ceb2-2c34-43c3-9a35-2589c9078741","a17e415e-a559-4a8d-a455-699184a01523","a4d91dd8-10be-42e7-9088-abef4f9a3fff","a5df1698-884f-4f48-833e-0647962154c6","a9c5d6d3-1e82-48ce-9d0a-853ef1104744","ab5f9512-335f-4490-a6a9-12f611646991","b43f6b44-9de3-4efb-a467-487aee28f6a0","b83329ac-a65e-b3af-a3fb-c5a6c740e5e7","b92afca2-4526-474d-a023-858f1d1f166f","bced816b-6927-49fb-851f-f83a678dac97","c07b1c7a-510c-48cd-8eda-42397c41f893","c10af03b-cea2-4929-bcbb-b973bf3c5704","c22dfa61-ca2e-419c-9ff6-484023793699","c43b7c1e-1eb6-48b4-ba73-56e274239ae2","c63b2dd4-ac8a-47a1-889b-94d68137bd01","c6bc8fb7-2862-464a-b7c9-e409034f072a","cc12443a-26f3-4a6d-8569-62494c0841c4","cd6868b9-5824-442b-8d65-4db29ecb70a4","d44ae7a1-c7f4-4af5-a250-40083a104e55","d58c0b66-475f-46b3-949d-cda5343e7239","d8b466e0-a35e-4fba-9d43-4e6c0122e7ad","e2350006-09e9-4883-9c62-c1434f85a714","ed5e0d81-0c1a-4548-bde3-03fff123f12e","f1e576fc-3bce-40e2-bfba-de48e341b722","f26025f6-d093-4aad-8c3b-be0bde1d8032","f30c4317-bb6a-452d-b1aa-78dbd09c3833"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?03ac077f-3873-4087-96d0-89049161dea9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?04d9fe8b-6d44-f46f-732a-5583a7118b91","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?08b0a9cc-208a-45ff-96a6-50109a325388","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0dc9682c-a4ae-4786-8dd9-31e33ce9861b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0f560bc9-9f40-0f96-e054-00144ff88e88","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0f82d42d-e19e-463c-9000-e590cc7c9360","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?11a46141-f466-0131-e054-00144ff88e88","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?11a810ca-72e8-1d9b-e054-00144ff88e88","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1577bc9c-24d3-450e-b438-d4f1b5db6485","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?15b91de7-1954-4055-aef6-fb57d8568a80","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?181e6f96-4a1d-49af-b906-b9aa2bbf0061","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?18b22092-605b-4ae7-8bc8-7f213d7d02eb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?276c3f70-890e-4afa-af48-8630f9689785","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2aaaf0fd-7f2a-4533-b3ad-f35c6c19cca2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2c40d64b-5e7b-4381-9ebf-df3a4bf0edfe","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2f381ecb-1e71-4f2f-acf0-d4918e0f3a1c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2f6e74e5-929c-4a74-a9e4-f56c2a7d575e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2ffbec78-5bd4-4647-b282-d6edf8e22ccc","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3660ed71-6268-4491-a4a3-4d5aeabbb489","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3817cb8f-78f0-49cd-b55c-27f44a66d446","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4349207c-5253-49fb-95ef-15f5ed371442","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?44260509-a91c-4906-bcc7-4eb5d3465ded","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?456ca6dc-1d19-4750-998f-406e84173959","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?48bd690b-8ce5-4adf-a76a-2e4702a160e5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4b188d97-f1b3-468d-9818-b8333bf24b5a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4e0c7ad7-3b44-4db8-b144-a1ad6d152315","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5397bbb7-74a4-4751-b491-c2e14cf8a076","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?581d1c3d-457a-41f2-8db0-5b6219cdcb09","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5a09ce48-7139-4fc7-9b6e-439459c8e866","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5aba19da-663f-4901-94e2-f438dba4841f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?603d2d06-c5e8-4378-a422-8dca1a410af7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?60752a58-1d6c-4b4d-98dd-d49c76d2f443","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?615a4d38-a235-bb1f-a0ef-1909dcfe7b2a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?61b34d13-3b8b-4491-b5a3-e9740b2aaccb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?665307df-4c80-44f5-b924-e9efb8680205","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?72fb11b6-b08c-2f02-d82b-f60f52394903","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?76704e78-335a-45a0-88fe-9889d8bcea35","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?78a623e8-47be-44b6-b7e0-5b13b2bcecf9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7b891df0-add4-4f0c-a3ab-d53e864eced7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?80cbc57e-d864-4c17-bd64-b5206ee55aab","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?83a0bb34-405b-4aea-9557-4f8b8fd811d7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8750bc89-340d-4abf-b0b8-b83012ab7cae","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8752e76c-1220-48b2-b394-7536245707e1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8772b002-c446-4581-8a14-d7a9bca62385","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?878064ef-6a81-4999-8902-9da151e9c22d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8809c12d-06de-4ccb-95d3-5108d2a955fb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8e3b29b0-d3a8-409a-b397-53dbbbcda094","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?92201fb1-4570-42db-8da3-3b8c0e291d32","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?93ec1327-22b1-4a5d-a793-e014f6dffd33","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9a77cf66-e110-4d51-ae8a-bea6207bba75","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9c22ceb2-2c34-43c3-9a35-2589c9078741","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a17e415e-a559-4a8d-a455-699184a01523","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a4d91dd8-10be-42e7-9088-abef4f9a3fff","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a5df1698-884f-4f48-833e-0647962154c6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a9c5d6d3-1e82-48ce-9d0a-853ef1104744","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ab5f9512-335f-4490-a6a9-12f611646991","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b43f6b44-9de3-4efb-a467-487aee28f6a0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b83329ac-a65e-b3af-a3fb-c5a6c740e5e7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b92afca2-4526-474d-a023-858f1d1f166f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bced816b-6927-49fb-851f-f83a678dac97","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c07b1c7a-510c-48cd-8eda-42397c41f893","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c10af03b-cea2-4929-bcbb-b973bf3c5704","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c22dfa61-ca2e-419c-9ff6-484023793699","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c43b7c1e-1eb6-48b4-ba73-56e274239ae2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c63b2dd4-ac8a-47a1-889b-94d68137bd01","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c6bc8fb7-2862-464a-b7c9-e409034f072a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cc12443a-26f3-4a6d-8569-62494c0841c4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cd6868b9-5824-442b-8d65-4db29ecb70a4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d44ae7a1-c7f4-4af5-a250-40083a104e55","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d58c0b66-475f-46b3-949d-cda5343e7239","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d8b466e0-a35e-4fba-9d43-4e6c0122e7ad","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e2350006-09e9-4883-9c62-c1434f85a714","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ed5e0d81-0c1a-4548-bde3-03fff123f12e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f1e576fc-3bce-40e2-bfba-de48e341b722","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f26025f6-d093-4aad-8c3b-be0bde1d8032","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f30c4317-bb6a-452d-b1aa-78dbd09c3833"]},{"source":"FDA","ids":["00b0e183-eddc-4613-b506-94ef07db2c05","1fbadc58-db1c-4068-b728-7b10a52956b9","325f598d-8cfc-4fb4-87e6-03dfd2b17e00","346a77ce-d326-4cda-b7da-0d51c6d11307","34f6e21e-f6fc-4426-b5fb-1abe97faa7ac","5574738c-0d5f-41bb-867e-8edad315c606","64e27197-b9f6-44e6-9c45-9e276b527273","79ae25f4-c7c8-4e0b-9c9f-432fb8e66202","7c055b8b-f6f1-46ea-8c73-73bd7392ba8f","7d2e7d26-3693-4178-b884-83bc0a67f9c3","7f052e0f-8d78-45d8-a6cb-568b201b7e1a","a30ea420-a02f-4566-875b-140ed97edf65","abf3db95-913b-432a-984f-caaef72088b8","b04c23ee-3165-4eb7-86a9-ca457747539e","ba1b1d02-21f8-40b0-a6ef-0c0e0cb89ff0","e0ac4b70-bfd2-49b5-b7ca-f95a22f5beaf","e41e7bf5-86b4-4b25-b061-407c88449372","eb2dc01a-099f-486a-be40-e19788f37105","f88abaf8-066b-4015-adb9-92d343a2f468"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A00b0e183-eddc-4613-b506-94ef07db2c05","https://api.fda.gov/drug/label.json?search=set_id%3A1fbadc58-db1c-4068-b728-7b10a52956b9","https://api.fda.gov/drug/label.json?search=set_id%3A325f598d-8cfc-4fb4-87e6-03dfd2b17e00","https://api.fda.gov/drug/label.json?search=set_id%3A346a77ce-d326-4cda-b7da-0d51c6d11307","https://api.fda.gov/drug/label.json?search=set_id%3A34f6e21e-f6fc-4426-b5fb-1abe97faa7ac","https://api.fda.gov/drug/label.json?search=set_id%3A5574738c-0d5f-41bb-867e-8edad315c606","https://api.fda.gov/drug/label.json?search=set_id%3A64e27197-b9f6-44e6-9c45-9e276b527273","https://api.fda.gov/drug/label.json?search=set_id%3A79ae25f4-c7c8-4e0b-9c9f-432fb8e66202","https://api.fda.gov/drug/label.json?search=set_id%3A7c055b8b-f6f1-46ea-8c73-73bd7392ba8f","https://api.fda.gov/drug/label.json?search=set_id%3A7d2e7d26-3693-4178-b884-83bc0a67f9c3","https://api.fda.gov/drug/label.json?search=set_id%3A7f052e0f-8d78-45d8-a6cb-568b201b7e1a","https://api.fda.gov/drug/label.json?search=set_id%3Aa30ea420-a02f-4566-875b-140ed97edf65","https://api.fda.gov/drug/label.json?search=set_id%3Aabf3db95-913b-432a-984f-caaef72088b8","https://api.fda.gov/drug/label.json?search=set_id%3Ab04c23ee-3165-4eb7-86a9-ca457747539e","https://api.fda.gov/drug/label.json?search=set_id%3Aba1b1d02-21f8-40b0-a6ef-0c0e0cb89ff0","https://api.fda.gov/drug/label.json?search=set_id%3Ae0ac4b70-bfd2-49b5-b7ca-f95a22f5beaf","https://api.fda.gov/drug/label.json?search=set_id%3Ae41e7bf5-86b4-4b25-b061-407c88449372","https://api.fda.gov/drug/label.json?search=set_id%3Aeb2dc01a-099f-486a-be40-e19788f37105","https://api.fda.gov/drug/label.json?search=set_id%3Af88abaf8-066b-4015-adb9-92d343a2f468"]}]},{"efo_id":"MP_0001914","efo_label":"hemorrhage","efo_uri":"http://purl.obolibrary.org/obo/MP_0001914","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00164931","NCT00519519","NCT02262169","NCT03362268","NCT03362281"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00164931%22OR%22NCT00519519%22OR%22NCT02262169%22OR%22NCT03362268%22OR%22NCT03362281%22"]}]},{"efo_id":"EFO_0004607","efo_label":"duodenal ulcer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004607","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00952978","NCT00953381"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00952978%22OR%22NCT00953381%22"]},{"source":"FDA","ids":["bef579d1-ee3f-459f-ba2b-8bb2f8a2067d"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Abef579d1-ee3f-459f-ba2b-8bb2f8a2067d"]}]},{"efo_id":"EFO_0000768","efo_label":"idiopathic pulmonary fibrosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000768","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02085018"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02085018%22"]}]},{"efo_id":"HP_0004398","efo_label":"Peptic ulcer","efo_uri":"http://purl.obolibrary.org/obo/HP_0004398","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["A02BC01"],"urls":["https://www.whocc.no/atc_ddd_index/?code=A02BC01"]}]},{"efo_id":"EFO_0000280","efo_label":"Barrett's esophagus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000280","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01465113","NCT01566474"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01465113%22OR%22NCT01566474%22"]}]},{"efo_id":"EFO_0000516","efo_label":"glaucoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000516","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01000220"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01000220%22"]}]},{"efo_id":"EFO_0000546","efo_label":"injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000546","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01661101"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01661101%22"]}]},{"efo_id":"EFO_0000342","efo_label":"chronic pancreatitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000342","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00559364"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00559364%22"]}]},{"efo_id":"EFO_0000544","efo_label":"infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000544","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT01470690"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01470690%22"]},{"source":"FDA","ids":["bef579d1-ee3f-459f-ba2b-8bb2f8a2067d"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Abef579d1-ee3f-459f-ba2b-8bb2f8a2067d"]}]},{"efo_id":"HP_0002239","efo_label":"Gastrointestinal hemorrhage","efo_uri":"http://purl.obolibrary.org/obo/HP_0002239","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00402259"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00402259%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02595372","NCT02950259"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02595372%22OR%22NCT02950259%22"]}]},{"efo_id":"EFO_0001359","efo_label":"type I diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001359","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01762644"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01762644%22"]}]},{"efo_id":"EFO_1001095","efo_label":"peptic esophagitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001095","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00633932","NCT00634114","NCT01599858"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00633932%22OR%22NCT00634114%22OR%22NCT01599858%22"]}]},{"efo_id":"EFO_0000178","efo_label":"gastric carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000178","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00003617"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003617%22"]}]},{"efo_id":"EFO_0000180","efo_label":"HIV-1 infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000180","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01000818","NCT03709355"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01000818%22OR%22NCT03709355%22"]}]},{"efo_id":"EFO_0000181","efo_label":"head and neck squamous cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000181","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00210470"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00210470%22"]}]},{"efo_id":"EFO_0000191","efo_label":"MALT lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000191","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00201422"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00201422%22"]}]},{"efo_id":"EFO_0000249","efo_label":"Alzheimer's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000249","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00692510","NCT00726726"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00692510%22OR%22NCT00726726%22"]}]},{"efo_id":"EFO_0000274","efo_label":"atopic eczema","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000274","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02647086","NCT03556592"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02647086%22OR%22NCT03556592%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00559182"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00559182%22"]}]},{"efo_id":"EFO_0000341","efo_label":"chronic obstructive pulmonary disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000341","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02453022","NCT03457727"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02453022%22OR%22NCT03457727%22"]}]},{"efo_id":"EFO_0000384","efo_label":"Crohn's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000384","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01489943","NCT02272868","NCT03358706"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01489943%22OR%22NCT02272868%22OR%22NCT03358706%22"]}]},{"efo_id":"EFO_0000400","efo_label":"diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000400","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02249871"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02249871%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00002682","NCT00003151","NCT00298779"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002682%22OR%22NCT00003151%22OR%22NCT00298779%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00420615","NCT00442741","NCT01218620","NCT01287598","NCT01517399","NCT01596647","NCT02740712","NCT03333824","NCT04108676"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00420615%22OR%22NCT00442741%22OR%22NCT01218620%22OR%22NCT01287598%22OR%22NCT01517399%22OR%22NCT01596647%22OR%22NCT02740712%22OR%22NCT03333824%22OR%22NCT04108676%22"]}]},{"efo_id":"EFO_0000676","efo_label":"psoriasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000676","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02397382","NCT02772601"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02397382%22OR%22NCT02772601%22"]}]},{"efo_id":"EFO_0000685","efo_label":"rheumatoid arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000685","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00367211","NCT01636557","NCT02762123","NCT03131973"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00367211%22OR%22NCT01636557%22OR%22NCT02762123%22OR%22NCT03131973%22"]}]},{"efo_id":"EFO_0000729","efo_label":"ulcerative colitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000729","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01287195"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01287195%22"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00357240","NCT01001247"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00357240%22OR%22NCT01001247%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01911728"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01911728%22"]}]},{"efo_id":"EFO_0002506","efo_label":"osteoarthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002506","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00367211"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00367211%22"]}]},{"efo_id":"EFO_0002892","efo_label":"thyroid carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002892","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01539655"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01539655%22"]}]},{"efo_id":"EFO_0003047","efo_label":"hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003047","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01458054"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01458054%22"]}]},{"efo_id":"EFO_0003756","efo_label":"autism spectrum disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003756","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02504554"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02504554%22"]}]},{"efo_id":"EFO_0003839","efo_label":"retinopathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003839","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00817245"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00817245%22"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00971581"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00971581%22"]}]},{"efo_id":"EFO_0003898","efo_label":"ankylosing spondylitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003898","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00367211"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00367211%22"]}]},{"efo_id":"EFO_0003929","efo_label":"relapsing-remitting multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003929","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01462318"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01462318%22"]}]},{"efo_id":"EFO_0004220","efo_label":"chronic hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004220","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01813552"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01813552%22"]}]},{"efo_id":"EFO_0004272","efo_label":"anemia (phenotype)","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004272","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00443170"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00443170%22"]}]},{"efo_id":"EFO_0005741","efo_label":"infectious disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005741","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01275170"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01275170%22"]}]},{"efo_id":"EFO_0006859","efo_label":"head and neck malignant neoplasia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006859","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02013453"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02013453%22"]}]},{"efo_id":"EFO_0007231","efo_label":"cysticercosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007231","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00290823"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00290823%22"]}]},{"efo_id":"EFO_0007549","efo_label":"Zollinger-Ellison Syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007549","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00001191"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00001191%22"]}]},{"efo_id":"EFO_1000961","efo_label":"Helicobacter pylori infectious disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000961","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00669955","NCT00719420","NCT02422706"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00669955%22OR%22NCT00719420%22OR%22NCT02422706%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02518373"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02518373%22"]}]},{"efo_id":"HP_0012735","efo_label":"Cough","efo_uri":"http://purl.obolibrary.org/obo/HP_0012735","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00668317"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00668317%22"]}]},{"efo_id":"EFO_0002617","efo_label":"metastatic melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002617","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03864042"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03864042%22"]}]},{"efo_id":"EFO_0003869","efo_label":"breast neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003869","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02950259"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02950259%22"]}]},{"efo_id":"EFO_0008533","efo_label":"dyspepsia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008533","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00404534","NCT01408849","NCT02621359"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00404534%22OR%22NCT01408849%22OR%22NCT02621359%22"]}]},{"efo_id":"EFO_0009130","efo_label":"clostridium difficile infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009130","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01822977"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01822977%22"]}]},{"efo_id":"EFO_0009454","efo_label":"gastric ulcer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009454","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01150162","NCT02299687"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01150162%22OR%22NCT02299687%22"]}]},{"efo_id":"EFO_0009462","efo_label":"granuloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009462","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01678053"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01678053%22"]}]},{"efo_id":"HP_0012532","efo_label":"Chronic pain","efo_uri":"http://purl.obolibrary.org/obo/HP_0012532","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00930306"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00930306%22"]}]},{"efo_id":"Orphanet_586","efo_label":"Cystic fibrosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_586","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03551691"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03551691%22"]}]},{"efo_id":"EFO_0003948","efo_label":"gastroesophageal reflux disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003948","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00857597"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00857597%22"]}]},{"efo_id":"HP_0002239","efo_label":"Gastrointestinal hemorrhage","efo_uri":"http://purl.obolibrary.org/obo/HP_0002239","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00045799"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00045799%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000105675","approved_name":"ATPase H+/K+ transporting subunit alpha","approved_symbol":"ATP4A"},{"ensembl":"ENSG00000186009","approved_name":"ATPase H+/K+ transporting subunit beta","approved_symbol":"ATP4B"}],"target_type":"protein complex","target_name":"Potassium-transporting ATPase","action_type":"inhibitor","description":"Potassium-transporting ATPase inhibitor","references":[{"source":"FDA","ids":["label/2012/019810s095,022056s011lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2012%2F019810s095%2C022056s011lbl.pdf"]},{"source":"PubMed","ids":["10411559","18925391","19120905"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10411559+OR+EXT_ID%3A18925391+OR+EXT_ID%3A19120905"]}]}],"adverse_events":{"significant":[{"event":"chronic kidney disease","count":5505,"llr":6880.501521},{"event":"hypomagnesaemia","count":4347,"llr":2706.281717},{"event":"acute kidney injury","count":33030,"llr":1926.890318},{"event":"end stage renal disease","count":1304,"llr":1661.538245},{"event":"renal injury","count":2203,"llr":1608.327521},{"event":"tubulointerstitial nephritis","count":4806,"llr":1478.887593},{"event":"hyponatraemia","count":21598,"llr":1176.056165},{"event":"hypocalcaemia","count":7012,"llr":1073.071473},{"event":"drug interaction","count":53526,"llr":503.5885933},{"event":"renal failure","count":27897,"llr":494.444967},{"event":"gastrooesophageal reflux disease","count":14790,"llr":454.6576208},{"event":"tetany","count":730,"llr":388.3907939},{"event":"subacute cutaneous lupus erythematosus","count":608,"llr":320.5025035},{"event":"hypokalaemia","count":14556,"llr":298.8394944},{"event":"rebound acid hypersecretion","count":81,"llr":263.4586718},{"event":"renal haemangioma","count":54,"llr":228.4905981}],"critval":224.1664587},"child_chembl_ids":["CHEMBL1567328","CHEMBL2105294"],"number_of_indications":59,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":16},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":15},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":9},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":9},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":9},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":8},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":6},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":6},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":6},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":5},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":5},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":4},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":4},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":4},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":3},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":2},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":2},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":2}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL23832","_score":1,"_source":{"id":"CHEMBL23832","internal_compound":false,"type":"Small molecule","pref_name":"FENAMIC ACID ","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["2-(Phenylamino)Benzoic Acid","2-Phenylamino-Benzoic Acid","Fenamic acid ","N-Phenylanthranilic Acid"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[34756]},{"source":"PubChem","ids":["11110659","124878982","124878985","26747414","26753504","26753505","50105728","50105729","56463797","85230871","90341494"]},{"source":"TG-GATEs","ids":["140"]},{"source":"Wikipedia","ids":["Fenamic_acid"]}],"canonical_smiles":"O=C(O)c1ccccc1Nc1ccccc1","indications":[{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02159248"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02159248%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109570","_score":1,"_source":{"id":"CHEMBL2109570","internal_compound":false,"type":"Antibody","pref_name":"SONEPCIZUMAB","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["LT-1009","LT1009","Sonepcizumab"],"trade_names":[],"indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00661414"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00661414%22"]}]},{"efo_id":"EFO_0000681","efo_label":"renal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000681","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01762033"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01762033%22"]}]},{"efo_id":"EFO_0001365","efo_label":"age-related macular degeneration","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001365","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00767949","NCT01414153"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00767949%22OR%22NCT01414153%22"]}]}],"mechanisms_of_action":[],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545209","_score":1,"_source":{"id":"CHEMBL3545209","internal_compound":false,"type":"Small molecule","pref_name":"NKTR-171","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["NKTR-171"],"trade_names":[],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000144285","approved_name":"sodium voltage-gated channel alpha subunit 1","approved_symbol":"SCN1A"},{"ensembl":"ENSG00000183873","approved_name":"sodium voltage-gated channel alpha subunit 5","approved_symbol":"SCN5A"},{"ensembl":"ENSG00000007314","approved_name":"sodium voltage-gated channel alpha subunit 4","approved_symbol":"SCN4A"},{"ensembl":"ENSG00000136546","approved_name":"sodium voltage-gated channel alpha subunit 7","approved_symbol":"SCN7A"},{"ensembl":"ENSG00000136531","approved_name":"sodium voltage-gated channel alpha subunit 2","approved_symbol":"SCN2A"},{"ensembl":"ENSG00000169432","approved_name":"sodium voltage-gated channel alpha subunit 9","approved_symbol":"SCN9A"},{"ensembl":"ENSG00000153253","approved_name":"sodium voltage-gated channel alpha subunit 3","approved_symbol":"SCN3A"},{"ensembl":"ENSG00000168356","approved_name":"sodium voltage-gated channel alpha subunit 11","approved_symbol":"SCN11A"},{"ensembl":"ENSG00000196876","approved_name":"sodium voltage-gated channel alpha subunit 8","approved_symbol":"SCN8A"},{"ensembl":"ENSG00000185313","approved_name":"sodium voltage-gated channel alpha subunit 10","approved_symbol":"SCN10A"}],"target_type":"protein family","target_name":"Sodium channel alpha subunit","action_type":"blocker","description":"Sodium channel alpha subunit blocker","references":[{"source":"Other","ids":["http://www.nektar.com/product_pipeline/cns_pain_nktr-171.html"],"urls":["http://www.nektar.com/product_pipeline/cns_pain_nktr-171.html"]},{"source":"PubMed","ids":["25060923"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25060923"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL31601","_score":1,"_source":{"id":"CHEMBL31601","internal_compound":false,"type":"Small molecule","pref_name":"REMIKIREN","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Remikiren"],"trade_names":[],"cross_references":[{"source":"Wikipedia","ids":["Remikiren"]},{"source":"drugbank","ids":["DB00212"]}],"canonical_smiles":"CC(C)(C)S(=O)(=O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1","indications":[{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["C09XA01"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C09XA01"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2111086","_score":1,"_source":{"id":"CHEMBL2111086","internal_compound":false,"type":"Small molecule","pref_name":"CANFOSFAMIDE","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Canfosfamide","Canfosfamide HCl","Canfosfamidhydrochloride","TER-286","TER286","TLK-286","TLK286"],"trade_names":["Telcyta"],"cross_references":[{"source":"drugbank","ids":["DB04972"]}],"canonical_smiles":"N[C@@H](CCC(=O)N[C@@H](CS(=O)(=O)CCOP(=O)(N(CCCl)CCCl)N(CCCl)CCCl)C(=O)N[C@@H](C(=O)O)c1ccccc1)C(=O)O","child_chembl_ids":["CHEMBL2107319"],"indications":[{"efo_id":"EFO_0001071","efo_label":"lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001071","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00036920"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00036920%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00040638","NCT00047801","NCT00077883","NCT00080340","NCT00088556"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00040638%22OR%22NCT00047801%22OR%22NCT00077883%22OR%22NCT00080340%22OR%22NCT00088556%22"]}]},{"efo_id":"EFO_0003869","efo_label":"breast neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003869","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00035841"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00035841%22"]}]},{"efo_id":"EFO_0003893","efo_label":"ovarian neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003893","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00038428","NCT00051948","NCT00052065","NCT00057720","NCT00350948"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00038428%22OR%22NCT00051948%22OR%22NCT00052065%22OR%22NCT00057720%22OR%22NCT00350948%22"]}]},{"efo_id":"EFO_0001075","efo_label":"ovarian carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001075","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00022347"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00022347%22"]}]},{"efo_id":"EFO_1000251","efo_label":"Fallopian Tube Carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000251","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00022347"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00022347%22"]}]},{"efo_id":"EFO_1001100","efo_label":"peritoneal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001100","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00022347"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00022347%22"]}]}],"number_of_indications":7,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":7},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":4},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":3},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":3},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545176","_score":1,"_source":{"id":"CHEMBL3545176","internal_compound":false,"type":"Small molecule","pref_name":"DB959","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["DB-959","T3D-959"],"trade_names":[],"indications":[{"efo_id":"EFO_0000249","efo_label":"Alzheimer's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000249","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02560753"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02560753%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000112033","approved_name":"peroxisome proliferator activated receptor delta","approved_symbol":"PPARD"}],"target_type":"single protein","target_name":"Peroxisome proliferator-activated receptor delta","action_type":"agonist","description":"Peroxisome proliferator-activated receptor delta agonist","references":[{"source":"Other","ids":["http://www.darabio.com/media-center/press-releases?detail=134","http://www.t3dtherapeutics.com/product-portfolio/"],"urls":["http://www.darabio.com/media-center/press-releases?detail=134","http://www.t3dtherapeutics.com/product-portfolio/"]}]},{"target_components":[{"ensembl":"ENSG00000132170","approved_name":"peroxisome proliferator activated receptor gamma","approved_symbol":"PPARG"}],"target_type":"single protein","target_name":"Peroxisome proliferator-activated receptor gamma","action_type":"agonist","description":"Peroxisome proliferator-activated receptor gamma agonist","references":[{"source":"Other","ids":["http://www.darabio.com/media-center/press-releases?detail=134","http://www.t3dtherapeutics.com/product-portfolio/"],"urls":["http://www.darabio.com/media-center/press-releases?detail=134","http://www.t3dtherapeutics.com/product-portfolio/"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297873","_score":1,"_source":{"id":"CHEMBL4297873","internal_compound":false,"type":"Unknown","pref_name":"ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Advate","Antihemophilic factor, human recombinant","BAY 14-2222","BAY 81-8973","BAY-14-2222","BAY-81-8973","BAY-W-6240","BAY81-8973","Bay81-8973","Factor viii octocog alfa","Factor viii, recombinant","Octocog Alfa"],"trade_names":[],"indications":[{"efo_id":"Orphanet_98878","efo_label":"Hemophilia A","efo_uri":"http://www.orpha.net/ORDO/Orphanet_98878","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02483208"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02483208%22"]}]}],"adverse_events":{"significant":[{"event":"factor viii inhibition","count":296,"llr":1463.829336},{"event":"haemarthrosis","count":1142,"llr":446.0966184},{"event":"haemorrhage","count":20448,"llr":309.9992481},{"event":"muscle haemorrhage","count":1334,"llr":111.1945299},{"event":"inhibiting antibodies","count":16,"llr":88.2593209},{"event":"haematoma","count":8376,"llr":68.30179977},{"event":"coagulation factor viii level decreased","count":32,"llr":64.78322784},{"event":"anti factor viii antibody positive","count":41,"llr":55.1216355},{"event":"traumatic haemorrhage","count":239,"llr":50.23578504},{"event":"anti factor viii antibody test","count":20,"llr":46.12565278},{"event":"haemophilic arthropathy","count":25,"llr":44.56452896},{"event":"spontaneous haemorrhage","count":94,"llr":35.30575465},{"event":"inhibiting antibodies positive","count":9,"llr":35.24878165},{"event":"soft tissue haemorrhage","count":82,"llr":30.15247717},{"event":"head injury","count":6131,"llr":28.21617613},{"event":"arthropathy","count":10920,"llr":19.81483636},{"event":"anti factor viii antibody increased","count":12,"llr":18.75050895},{"event":"haemorrhage intracranial","count":4344,"llr":13.91122944},{"event":"fatigue","count":147738,"llr":13.34267812},{"event":"contusion","count":18117,"llr":12.97078408},{"event":"product reconstitution quality issue","count":88,"llr":12.78668952},{"event":"periprosthetic fracture","count":128,"llr":11.66969931},{"event":"renal haematoma","count":164,"llr":10.93257201},{"event":"myositis ossificans","count":22,"llr":10.47815699},{"event":"rash maculovesicular","count":22,"llr":10.47815699},{"event":"nausea","count":165652,"llr":10.12728053},{"event":"device deposit issue","count":28,"llr":9.996897935},{"event":"mouth haemorrhage","count":1515,"llr":9.885255013},{"event":"haematuria","count":11307,"llr":9.753564038},{"event":"tongue haemorrhage","count":249,"llr":9.694879539},{"event":"coagulation factor viii level increased","count":50,"llr":8.841166186},{"event":"diarrhoea","count":126514,"llr":8.791575886},{"event":"bleeding time prolonged","count":359,"llr":8.616769947},{"event":"haemorrhage subcutaneous","count":1081,"llr":8.339919387},{"event":"pneumonia","count":65209,"llr":8.240778739},{"event":"catheter related infection","count":476,"llr":7.791223885},{"event":"application site purpura","count":1,"llr":7.634465791},{"event":"plasmin inhibitor","count":1,"llr":7.634465791},{"event":"gastroenteritis rotavirus","count":98,"llr":7.503797845}],"critval":7.498296484},"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201760","_score":1,"_source":{"id":"CHEMBL1201760","internal_compound":false,"type":"Small molecule","pref_name":"BESIFLOXACIN","year_first_approved":2009,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["BOL-303224-A","Besifloxacin","Besifloxacin HCl","ISV-403","SS-734"],"trade_names":["Besivance"],"cross_references":[{"source":"DailyMed","ids":["besifloxacin%20hydrochloride"]},{"source":"Wikipedia","ids":["Besifloxacin"]},{"source":"drugbank","ids":["DB06771"]}],"canonical_smiles":"N[C@@H]1CCCCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1","indications":[{"efo_id":"EFO_1000829","efo_label":"bacterial conjunctivitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000829","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00347932","NCT00348348","NCT00622908","NCT00972777","NCT01740388"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00347932%22OR%22NCT00348348%22OR%22NCT00622908%22OR%22NCT00972777%22OR%22NCT01740388%22"]}]},{"efo_id":"EFO_1000829","efo_label":"bacterial conjunctivitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000829","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00407589","NCT01175590","NCT01330355"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00407589%22OR%22NCT01175590%22OR%22NCT01330355%22"]}]},{"efo_id":"EFO_0001059","efo_label":"cataract","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001059","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00824070"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00824070%22"]}]}],"adverse_events":{"significant":[{"event":"impaired healing","count":7834,"llr":117.5274313},{"event":"corneal infiltrates","count":158,"llr":117.0429194},{"event":"corneal oedema","count":836,"llr":82.50574585},{"event":"corneal opacity","count":440,"llr":72.54540657},{"event":"diffuse lamellar keratitis","count":13,"llr":68.79631273},{"event":"eye irritation","count":5686,"llr":65.1791797},{"event":"eye pain","count":7341,"llr":60.38794473},{"event":"corneal epithelium defect","count":223,"llr":59.87619624},{"event":"endophthalmitis","count":2022,"llr":57.91799429},{"event":"corneal striae","count":21,"llr":55.88342386},{"event":"ulcerative keratitis","count":1034,"llr":55.73792252},{"event":"punctate keratitis","count":300,"llr":50.24635316},{"event":"corneal disorder","count":653,"llr":49.14940552},{"event":"corneal abrasion","count":279,"llr":44.27703008},{"event":"foreign body sensation in eyes","count":698,"llr":42.66250569},{"event":"ocular hyperaemia","count":6875,"llr":37.06358882},{"event":"photophobia","count":3837,"llr":35.79250353},{"event":"corneal deposits","count":260,"llr":31.8693991},{"event":"hypopyon","count":361,"llr":29.90438108},{"event":"chemical eye injury","count":34,"llr":27.73107145},{"event":"vision blurred","count":26101,"llr":25.70266384}],"critval":24.59699901},"child_chembl_ids":["CHEMBL1201761"],"mechanisms_of_action":[{"target_type":"protein complex","target_name":"Topoisomerase IV","action_type":"inhibitor","description":"Topoisomerase IV inhibitor","references":[{"source":"FDA","ids":["label/2012/022308s003lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2012%2F022308s003lbl.pdf"]}]},{"target_type":"protein complex","target_name":"Bacterial DNA gyrase","action_type":"inhibitor","description":"Bacterial DNA gyrase inhibitor","references":[{"source":"FDA","ids":["label/2012/022308s003lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2012%2F022308s003lbl.pdf"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":3},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201286","_score":1,"_source":{"id":"CHEMBL1201286","internal_compound":false,"type":"Small molecule","pref_name":"OXYPHENONIUM","year_first_approved":1982,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Oxyphenonium","Oxyphenonium Bromide"],"trade_names":["Antrenyl"],"cross_references":[{"source":"drugbank","ids":["DB00219"]},{"source":"PubChem","ids":["144204402","170465282","56422900","855750"]},{"source":"Wikipedia","ids":["Oxyphenonium_bromide"]}],"canonical_smiles":"CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)C1CCCCC1","child_chembl_ids":["CHEMBL1200906"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000133019","approved_name":"cholinergic receptor muscarinic 3","approved_symbol":"CHRM3"}],"target_type":"single protein","target_name":"Muscarinic acetylcholine receptor M3","action_type":"antagonist","description":"Muscarinic acetylcholine receptor M3 antagonist","references":[{"source":"ISBN","ids":["9780702034718 PP. 153"],"urls":[]},{"source":"PubMed","ids":["1907331"],"urls":["https://europepmc.org/search?query=EXT_ID%3A1907331"]}]},{"target_components":[{"ensembl":"ENSG00000168539","approved_name":"cholinergic receptor muscarinic 1","approved_symbol":"CHRM1"}],"target_type":"single protein","target_name":"Muscarinic acetylcholine receptor M1","action_type":"antagonist","description":"Muscarinic acetylcholine receptor M1 antagonist","references":[{"source":"ISBN","ids":["9780702034718 PP. 153"],"urls":[]},{"source":"PubMed","ids":["1907331"],"urls":["https://europepmc.org/search?query=EXT_ID%3A1907331"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2110809","_score":1,"_source":{"id":"CHEMBL2110809","internal_compound":false,"type":"Small molecule","pref_name":"CAPTODIAME","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Captodiame","Captodiame HCl","Captodiamine HCl"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB09014"]}],"canonical_smiles":"CCCCSc1ccc(C(SCCN(C)C)c2ccccc2)cc1","indications":[{"efo_id":"EFO_0005230","efo_label":"anxiety","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005230","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["N05BB02"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N05BB02"]}]}],"child_chembl_ids":["CHEMBL2106143"],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL368347","_score":1,"_source":{"id":"CHEMBL368347","internal_compound":false,"type":"Small molecule","pref_name":"(+)-SECOISOLARICIRESINOL","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["(+)-secoisolariciresinol","Secoisolariciresinol"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[65004]},{"source":"Wikipedia","ids":["Secoisolariciresinol"]},{"source":"drugbank","ids":["DB12179"]}],"canonical_smiles":"COc1cc(C[C@@H](CO)[C@H](CO)Cc2ccc(O)c(OC)c2)ccc1O","indications":[{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01276704"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01276704%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109425","_score":1,"_source":{"id":"CHEMBL2109425","internal_compound":false,"type":"Antibody","pref_name":"14G2A","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["14G2A"],"trade_names":[],"indications":[{"efo_id":"EFO_0000621","efo_label":"neuroblastoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000621","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00085930"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00085930%22"]}]}],"mechanisms_of_action":[],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL99946","_score":1,"_source":{"id":"CHEMBL99946","internal_compound":false,"type":"Small molecule","pref_name":"LEVOMILNACIPRAN","year_first_approved":2013,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["F 2695","F 2695 HYDROCHLORIDE","F-2695","F-2695 HYDROCHLORIDE","F2695 HYDROCHLORIDE","Levomilnacipran","Levomilnacipran HCl"],"trade_names":["Fetzima"],"cross_references":[{"source":"DailyMed","ids":["levomilnacipran%20hydrochloride"]},{"source":"drugbank","ids":["DB08918"]}],"canonical_smiles":"CCN(CC)C(=O)[C@@]1(c2ccccc2)C[C@H]1CN","indications":[{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00969150","NCT00969709","NCT01034462","NCT01254305","NCT01377194","NCT02431806","NCT02720198","NCT03569475"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00969150%22OR%22NCT00969709%22OR%22NCT01034462%22OR%22NCT01254305%22OR%22NCT01377194%22OR%22NCT02431806%22OR%22NCT02720198%22OR%22NCT03569475%22"]}]},{"efo_id":"EFO_0003768","efo_label":"nicotine dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003768","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT02265367"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02265367%22"]}]},{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["f371258d-91b3-4b6a-ac99-434a1964c3af"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f371258d-91b3-4b6a-ac99-434a1964c3af"]}]},{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01034267","NCT01085812"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01034267%22OR%22NCT01085812%22"]}]}],"adverse_events":{"significant":[{"event":"suicidal ideation","count":21218,"llr":61.71206992},{"event":"painful ejaculation","count":71,"llr":23.45671755},{"event":"serotonin syndrome","count":6002,"llr":20.57563771},{"event":"urinary hesitation","count":599,"llr":19.81445635},{"event":"urinary retention","count":9378,"llr":16.75227795},{"event":"suicide attempt","count":20244,"llr":14.76067022},{"event":"blood pressure increased","count":25616,"llr":14.54422947},{"event":"suicidal behaviour","count":944,"llr":13.15791165},{"event":"agitation","count":21093,"llr":12.19040209},{"event":"hyperhidrosis","count":28377,"llr":11.50870651},{"event":"testicular pain","count":690,"llr":9.938171588},{"event":"feeling abnormal","count":36538,"llr":9.193744728},{"event":"anger","count":5808,"llr":8.758843671},{"event":"homicidal ideation","count":1191,"llr":8.329990732},{"event":"malignant hypertension","count":377,"llr":7.014221149},{"event":"tachycardia","count":26994,"llr":6.549679269},{"event":"sleep inertia","count":12,"llr":6.248704413},{"event":"heart rate increased","count":16145,"llr":6.014465774},{"event":"feeling of despair","count":686,"llr":5.835161694},{"event":"palpitations","count":23550,"llr":5.737507098}],"critval":5.538764041},"child_chembl_ids":["CHEMBL2105732"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000108576","approved_name":"solute carrier family 6 member 4","approved_symbol":"SLC6A4"}],"target_type":"single protein","target_name":"Serotonin transporter","action_type":"inhibitor","description":"Serotonin transporter inhibitor","references":[{"source":"DailyMed","ids":["setid=f371258d-91b3-4b6a-ac99-434a1964c3af"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f371258d-91b3-4b6a-ac99-434a1964c3af"]}]},{"target_components":[{"ensembl":"ENSG00000103546","approved_name":"solute carrier family 6 member 2","approved_symbol":"SLC6A2"}],"target_type":"single protein","target_name":"Norepinephrine transporter","action_type":"inhibitor","description":"Norepinephrine transporter inhibitor","references":[{"source":"DailyMed","ids":["setid=f371258d-91b3-4b6a-ac99-434a1964c3af"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f371258d-91b3-4b6a-ac99-434a1964c3af"]}]}],"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":4},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":4},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109256","_score":1,"_source":{"id":"CHEMBL2109256","internal_compound":false,"type":"Antibody","pref_name":"SGN-30","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["SGN-30"],"trade_names":[],"indications":[{"efo_id":"EFO_0000183","efo_label":"Hodgkins lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000183","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00051597"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00051597%22"]}]},{"efo_id":"EFO_0000558","efo_label":"Kaposi's sarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000558","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00051597"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00051597%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00079755"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00079755%22"]}]},{"efo_id":"EFO_0001642","efo_label":"lymphoid neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001642","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00099255"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00099255%22"]}]},{"efo_id":"EFO_0002913","efo_label":"Cutaneous T-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002913","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00051597"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00051597%22"]}]},{"efo_id":"EFO_0003032","efo_label":"anaplastic large cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003032","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00354107","NCT00365274"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00354107%22OR%22NCT00365274%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000120949","approved_name":"TNF receptor superfamily member 8","approved_symbol":"TNFRSF8"}],"target_type":"single protein","target_name":"Tumor necrosis factor receptor superfamily member 8","action_type":"agonist","description":"Tumor necrosis factor receptor superfamily member 8 agonist"}],"number_of_indications":6,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":6},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":5},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":4},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":2},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297969","_score":1,"_source":{"id":"CHEMBL4297969","internal_compound":false,"type":"Unknown","pref_name":"GSK-3359609","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["GSK-3359609","GSK3359609","Gsk-3359609","Gsk3359609"],"trade_names":[],"indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03447314","NCT03693612"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03447314%22OR%22NCT03693612%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT04126200"],"urls":["https://clinicaltrials.gov/search?id=%22NCT04126200%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL206031","_score":1,"_source":{"id":"CHEMBL206031","internal_compound":false,"type":"Small molecule","pref_name":"BRECANAVIR","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Brecanavir","GW-640385","GW-640385X","GW-64085X","GW640385","GW64085X"],"trade_names":[],"cross_references":[{"source":"Wikipedia","ids":["Brecanavir"]},{"source":"drugbank","ids":["DB04887"]}],"canonical_smiles":"Cc1nc(COc2ccc(C[C@H](NC(=O)O[C@H]3CO[C@H]4OCC[C@@H]34)[C@H](O)CN(CC(C)C)S(=O)(=O)c3ccc4c(c3)OCO4)cc2)cs1","indications":[{"efo_id":"EFO_0000180","efo_label":"HIV-1 infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000180","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00242879"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00242879%22"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00257621"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00257621%22"]}]}],"mechanisms_of_action":[{"target_type":"single protein","target_name":"HIV-1 protease","action_type":"inhibitor","description":"HIV-1 protease inhibitor","references":[{"source":"PubMed","ids":["17620375","17635930"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17620375+OR+EXT_ID%3A17635930"]}]}],"child_chembl_ids":["CHEMBL2377050","CHEMBL2377051"],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":2},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":2}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL462018","_score":1,"_source":{"id":"CHEMBL462018","internal_compound":false,"type":"Small molecule","pref_name":"TRICIRIBINE PHOSPHATE","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["NSC-280594","Phosphate Salt Of Tricyclic Nucleoside","Triciribine","Triciribine Phosphate","VQD-002"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB14636"]}],"canonical_smiles":"Cn1nc(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23","indications":[{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00363454"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00363454%22"]}]},{"efo_id":"EFO_0000565","efo_label":"leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000565","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00642031"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00642031%22"]}]},{"efo_id":"EFO_0001075","efo_label":"ovarian carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001075","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01690468"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01690468%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000105221","approved_name":"AKT serine/threonine kinase 2","approved_symbol":"AKT2"},{"ensembl":"ENSG00000117020","approved_name":"AKT serine/threonine kinase 3","approved_symbol":"AKT3"},{"ensembl":"ENSG00000142208","approved_name":"AKT serine/threonine kinase 1","approved_symbol":"AKT1"}],"target_type":"protein family","target_name":"Serine/threonine-protein kinase AKT","action_type":"inhibitor","description":"Serine/threonine-protein kinase AKT inhibitor","references":[{"source":"PubMed","ids":["15231645","19422047"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15231645+OR+EXT_ID%3A19422047"]}]}],"adverse_events":{"significant":[{"event":"pelvic mass","count":225,"llr":7.834524852},{"event":"constipation","count":39620,"llr":7.246760803}],"critval":6.492683217},"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL8809","_score":1,"_source":{"id":"CHEMBL8809","internal_compound":false,"type":"Small molecule","pref_name":"RACLOPRIDE","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Raclopride","Raclopride (11C)","S(+)-Raclopride L-Tartrate"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["11114224","144204512","170466218","26719717","26752250","90340860"]},{"source":"Wikipedia","ids":["Raclopride"]},{"source":"drugbank","ids":["DB12518"]},{"source":"PubChem","ids":["46500331","50106984"]}],"canonical_smiles":"CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC","indications":[{"efo_id":"EFO_0003888","efo_label":"attention deficit hyperactivity disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003888","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03103750"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03103750%22"]}]},{"efo_id":"EFO_0002610","efo_label":"cocaine dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002610","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT02233829"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02233829%22"]}]},{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00832221"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00832221%22"]}]}],"child_chembl_ids":["CHEMBL1369632","CHEMBL2104769"],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":3},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":3},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL249420","_score":1,"_source":{"id":"CHEMBL249420","internal_compound":false,"type":"Small molecule","pref_name":"DEXPRAMIPEXOLE","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Dexpramipexole","Dexpramipexole Dihydrochloride","KNS-760704","KNS-760704 ANHYDROUS","Pramipexole related compound d","SND 919CL2X","SND-919CL2X","SND-919CL2X MONOHYDRATE"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB15130"]}],"canonical_smiles":"CCCN[C@@H]1CCc2nc(N)sc2C1","indications":[{"efo_id":"EFO_0000253","efo_label":"amyotrophic lateral sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000253","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01281189","NCT01449578","NCT01511029","NCT01536249","NCT01622088"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01281189%22OR%22NCT01449578%22OR%22NCT01511029%22OR%22NCT01536249%22OR%22NCT01622088%22"]}]},{"efo_id":"EFO_1001467","efo_label":"Hypereosinophilic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001467","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02101138"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02101138%22"]}]},{"efo_id":"EFO_0000253","efo_label":"amyotrophic lateral sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000253","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00647296","NCT00931944"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00647296%22OR%22NCT00931944%22"]}]}],"child_chembl_ids":["CHEMBL2105687","CHEMBL3216394"],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545231","_score":1,"_source":{"id":"CHEMBL3545231","internal_compound":false,"type":"Small molecule","pref_name":"ABT-126","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["ABT-126"],"trade_names":[],"canonical_smiles":"c1ccc(-c2nnc(O[C@@H]3C4CC5C[C@H]3CN(C5)C4)s2)cc1","indications":[{"efo_id":"EFO_0000692","efo_label":"schizophrenia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000692","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01043458","NCT01095562","NCT01655680","NCT01678755","NCT01834638"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01043458%22OR%22NCT01095562%22OR%22NCT01655680%22OR%22NCT01678755%22OR%22NCT01834638%22"]}]},{"efo_id":"EFO_0000249","efo_label":"Alzheimer's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000249","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00867399","NCT00948909","NCT01482845","NCT01527916","NCT01549834","NCT01676935","NCT01690195"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00867399%22OR%22NCT00948909%22OR%22NCT01482845%22OR%22NCT01527916%22OR%22NCT01549834%22OR%22NCT01676935%22OR%22NCT01690195%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000175344","approved_name":"cholinergic receptor nicotinic alpha 7 subunit","approved_symbol":"CHRNA7"}],"target_type":"single protein","target_name":"Neuronal acetylcholine receptor protein alpha-7 subunit","action_type":"agonist","description":"Neuronal acetylcholine receptor protein alpha-7 subunit agonist","references":[{"source":"DOI","ids":["10.1016/j.trci.2015.06.001"],"urls":["http://dx.doi.org/10.1016/j.trci.2015.06.001"]},{"source":"PubMed","ids":["26044974"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26044974"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":2},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":2}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2105085","_score":1,"_source":{"id":"CHEMBL2105085","internal_compound":false,"type":"Small molecule","pref_name":"GEFARNATE","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["DA-688","Gefarnate"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["144206536","170465908"]},{"source":"drugbank","ids":["DB12079"]}],"canonical_smiles":"CC(C)=CCC/C(C)=C/CC/C(C)=C/CCC(=O)OC/C=C(\\C)CCC=C(C)C","indications":[{"efo_id":"EFO_0003948","efo_label":"gastroesophageal reflux disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003948","max_phase_for_indication":3,"references":[{"source":"ATC","ids":["A02BX07","A02BX77"],"urls":["https://www.whocc.no/atc_ddd_index/?code=A02BX07","https://www.whocc.no/atc_ddd_index/?code=A02BX77"]}]},{"efo_id":"HP_0004398","efo_label":"Peptic ulcer","efo_uri":"http://purl.obolibrary.org/obo/HP_0004398","max_phase_for_indication":3,"references":[{"source":"ATC","ids":["A02BX07","A02BX77"],"urls":["https://www.whocc.no/atc_ddd_index/?code=A02BX07","https://www.whocc.no/atc_ddd_index/?code=A02BX77"]}]},{"efo_id":"EFO_0003763","efo_label":"cerebrovascular disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003763","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01051388"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01051388%22"]}]},{"efo_id":"EFO_0000378","efo_label":"coronary artery disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000378","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03610321"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03610321%22"]}]}],"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":2},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":2},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL19236","_score":1,"_source":{"id":"CHEMBL19236","internal_compound":false,"type":"Small molecule","pref_name":"MOXONIDINE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["BDF-5896","BDF5896","BE-5895","BE5895","LY-326869","LY326869","Moxonidine","Moxonidine HCl"],"trade_names":["Cynt","Fisiotens","Norcynt","Normatens","Nucynt","Physiotens"],"cross_references":[{"source":"ChEBI","ids":[7009]},{"source":"PubChem","ids":["11111430","11111431","144203741","170466534","85148350","90341434"]},{"source":"Wikipedia","ids":["Moxonidine"]},{"source":"drugbank","ids":["DB09242"]},{"source":"PubChem","ids":["26753262","49681826","50106578"]}],"canonical_smiles":"COc1nc(C)nc(Cl)c1NC1=NCCN1","indications":[{"efo_id":"EFO_0000537","efo_label":"hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000537","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["C02AC05"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C02AC05"]},{"source":"ClinicalTrials","ids":["NCT00160277"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00160277%22"]}]},{"efo_id":"EFO_0003777","efo_label":"heart disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003777","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00244504"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00244504%22"]}]},{"efo_id":"EFO_0005252","efo_label":"orthostatic hypotension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005252","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT04050410"],"urls":["https://clinicaltrials.gov/search?id=%22NCT04050410%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000010322","approved_name":"nischarin","approved_symbol":"NISCH"}],"target_type":"single protein","target_name":"Nischarin","action_type":"agonist","description":"Nischarin agonist","references":[{"source":"PubMed","ids":["21884003","22483786","24302832"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21884003+OR+EXT_ID%3A22483786+OR+EXT_ID%3A24302832"]}]}],"adverse_events":{"significant":[{"event":"hypotension","count":55121,"llr":75.68249246},{"event":"hyperammonaemia","count":1794,"llr":68.25476186},{"event":"bradycardia","count":20091,"llr":67.49889324},{"event":"renal impairment","count":20843,"llr":60.39507316},{"event":"hyperkalaemia","count":12419,"llr":52.50340255},{"event":"hyperkaliuria","count":17,"llr":52.37038343},{"event":"cranial sutures widening","count":32,"llr":47.94399233},{"event":"cardiac septal hypertrophy","count":68,"llr":42.67063009},{"event":"abnormal palmar/plantar creases","count":88,"llr":40.86751543},{"event":"linear iga disease","count":698,"llr":36.24450896},{"event":"cognitive disorder","count":9869,"llr":35.15087513},{"event":"fall","count":67604,"llr":33.02715999},{"event":"orthostatic hypotension","count":6478,"llr":31.92757342},{"event":"coagulopathy","count":4025,"llr":31.06575867},{"event":"spinal pain","count":2016,"llr":30.83779405},{"event":"sinus bradycardia","count":4115,"llr":30.80788308},{"event":"disorientation","count":10841,"llr":30.71536798},{"event":"syncope","count":31191,"llr":27.49435974},{"event":"bradyarrhythmia","count":690,"llr":26.50287824},{"event":"general physical health deterioration","count":17224,"llr":26.28760514},{"event":"circulatory collapse","count":4559,"llr":26.20599229},{"event":"dysmorphism","count":797,"llr":25.50277497},{"event":"strabismus","count":831,"llr":25.2132212},{"event":"hypertension","count":52519,"llr":24.67770931},{"event":"atrial septal defect","count":3155,"llr":22.87411241},{"event":"foot deformity","count":2223,"llr":18.44294574},{"event":"suicide attempt","count":20244,"llr":17.11676923},{"event":"haemodynamic instability","count":1660,"llr":16.60608058},{"event":"peripheral artery occlusion","count":272,"llr":16.60114958},{"event":"balance disorder","count":15453,"llr":15.87508174},{"event":"rash scarlatiniform","count":94,"llr":14.76142195},{"event":"peripheral embolism","count":481,"llr":14.33870477},{"event":"mixed liver injury","count":632,"llr":13.25948873},{"event":"acute kidney injury","count":33030,"llr":12.98970323},{"event":"somnolence","count":38949,"llr":12.57565219},{"event":"hyponatraemia","count":21598,"llr":12.37094977},{"event":"subileus","count":932,"llr":11.73129097},{"event":"musculoskeletal pain","count":15494,"llr":11.57472729},{"event":"cryoglobulinaemia","count":274,"llr":11.56731206},{"event":"hypertensive crisis","count":4011,"llr":11.51205348},{"event":"orthostatic intolerance","count":307,"llr":11.22897473},{"event":"dizziness","count":99375,"llr":10.75341868},{"event":"dehydration","count":36809,"llr":10.12540127},{"event":"blood pressure increased","count":25616,"llr":8.982065968},{"event":"blood urea increased","count":6508,"llr":8.819926058},{"event":"listless","count":706,"llr":8.764789809},{"event":"blood creatinine increased","count":21684,"llr":8.733959134},{"event":"activated partial thromboplastin time prolonged","count":2063,"llr":8.649395389},{"event":"international normalised ratio increased","count":13854,"llr":8.474341636},{"event":"albuminuria","count":166,"llr":7.898473426},{"event":"pemphigus","count":997,"llr":7.754268173},{"event":"premature rupture of membranes","count":1019,"llr":7.690670797},{"event":"lid margin discharge","count":2,"llr":7.666469036},{"event":"leukocytoclastic vasculitis","count":1057,"llr":7.58408168},{"event":"intention tremor","count":236,"llr":7.200788698},{"event":"colitis ulcerative","count":5663,"llr":7.147829724},{"event":"blood pressure systolic decreased","count":1335,"llr":6.907367323},{"event":"gingival bleeding","count":3507,"llr":6.650166196},{"event":"venous thrombosis","count":1476,"llr":6.618213424},{"event":"blood pressure ambulatory abnormal","count":6,"llr":6.568200818},{"event":"gastrointestinal disorder","count":14216,"llr":6.469401457},{"event":"viith nerve paralysis","count":1573,"llr":6.435563173},{"event":"renal failure acute","count":23893,"llr":6.399490959},{"event":"malignant hypertension","count":377,"llr":6.276054638},{"event":"continuous haemodiafiltration","count":408,"llr":6.120669403},{"event":"breech presentation","count":444,"llr":5.954642222},{"event":"therapeutic response decreased","count":15645,"llr":5.920074323}],"critval":5.725807744},"child_chembl_ids":["CHEMBL1256287"],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":3},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3137345","_score":1,"_source":{"id":"CHEMBL3137345","internal_compound":false,"type":"Antibody","pref_name":"DULIGOTUZUMAB","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Duligotumab","Duligotuzumab","MEHD-7945A","MEHD7945A","RG-7597","RG7597"],"trade_names":[],"indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01207323","NCT01986166"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01207323%22OR%22NCT01986166%22"]}]},{"efo_id":"EFO_0006859","efo_label":"head and neck malignant neoplasia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006859","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01577173","NCT01911598"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01577173%22OR%22NCT01911598%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01652482"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01652482%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000146648","approved_name":"epidermal growth factor receptor","approved_symbol":"EGFR"}],"target_type":"single protein","target_name":"Epidermal growth factor receptor erbB1","action_type":"inhibitor","description":"Epidermal growth factor receptor erbB1 inhibitor","references":[{"source":"PubMed","ids":["27843803"],"urls":["https://europepmc.org/search?query=EXT_ID%3A27843803"]}]},{"target_components":[{"ensembl":"ENSG00000065361","approved_name":"erb-b2 receptor tyrosine kinase 3","approved_symbol":"ERBB3"}],"target_type":"single protein","target_name":"Receptor tyrosine-protein kinase erbB-3","action_type":"inhibitor","description":"Receptor tyrosine-protein kinase erbB-3 inhibitor","references":[{"source":"PubMed","ids":["27843803"],"urls":["https://europepmc.org/search?query=EXT_ID%3A27843803"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL206468","_score":1,"_source":{"id":"CHEMBL206468","internal_compound":false,"type":"Small molecule","pref_name":"AFEGOSTAT","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AT-2101","Afegostat","Afegostat Tartrate","HGT-3410","Isofagomine","Isofagomine tartrate"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["85267413"]},{"source":"drugbank","ids":["DB04545"]}],"canonical_smiles":"OC[C@H]1CNC[C@@H](O)[C@@H]1O","child_chembl_ids":["CHEMBL2105671"],"indications":[{"efo_id":"Orphanet_355","efo_label":"Gaucher disease","efo_uri":"http://www.orpha.net/ORDO/Orphanet_355","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00433147","NCT00446550","NCT00813865","NCT00875160"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00433147%22OR%22NCT00446550%22OR%22NCT00813865%22OR%22NCT00875160%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000177628","approved_name":"glucosylceramidase beta","approved_symbol":"GBA"}],"target_type":"single protein","target_name":"Beta-glucocerebrosidase","action_type":"stabiliser","description":"Beta-glucocerebrosidase stabiliser","references":[{"source":"PubMed","ids":["20148966","25037721"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20148966+OR+EXT_ID%3A25037721"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1214","_score":1,"_source":{"id":"CHEMBL1214","internal_compound":false,"type":"Small molecule","pref_name":"CARBENICILLIN","year_first_approved":1982,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["BRL-2064","CP-15-639-2","Carbenicillin","Carbenicillin Disodium","Carbenicillin Potassium","Carbenicillin Sodium","Carbenicillin disodium salt","GS-3159","Geocillin","Geopen","NSC-111071","Pyopen"],"trade_names":["Geopen","Pyopen"],"cross_references":[{"source":"ChEBI","ids":[3393]},{"source":"Wikipedia","ids":["Carbenicillin"]},{"source":"drugbank","ids":["DB00578"]},{"source":"ChEBI","ids":[34609]},{"source":"PubChem","ids":["144204857","170465106","855754"]}],"canonical_smiles":"CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)O)c3ccccc3)C(=O)N2[C@H]1C(=O)O","indications":[{"efo_id":"EFO_0003102","efo_label":"osteomyelitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003102","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT02099240"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02099240%22"]}]}],"adverse_events":{"significant":[{"event":"megacolon","count":369,"llr":7.863055642}],"critval":7.117232387},"child_chembl_ids":["CHEMBL2105992","CHEMBL606260"],"mechanisms_of_action":[{"target_type":"protein family","target_name":"Bacterial penicillin-binding protein","action_type":"inhibitor","description":"Bacterial penicillin-binding protein inhibitor","references":[{"source":"PubMed","ids":["2112536"],"urls":["https://europepmc.org/search?query=EXT_ID%3A2112536"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL623","_score":1,"_source":{"id":"CHEMBL623","internal_compound":false,"type":"Small molecule","pref_name":"NEFAZODONE","year_first_approved":1994,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["BMY-13754","MJ-13754-1","Nefazodone","Nefazodone HCl"],"trade_names":["Dutonin","Nefazodone HCl","Serzone"],"cross_references":[{"source":"ChEBI","ids":[7494]},{"source":"DailyMed","ids":["nefazodone%20hydrochloride"]},{"source":"PubChem","ids":["29217604","49666410","50111710"]},{"source":"Wikipedia","ids":["Nefazodone"]},{"source":"drugbank","ids":["DB01149"]},{"source":"ChEBI","ids":[7495]},{"source":"PubChem","ids":["144205288","144207123","170465078","26719737","49681554"]}],"canonical_smiles":"CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1","indications":[{"efo_id":"EFO_0002610","efo_label":"cocaine dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002610","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000286","NCT00000293","NCT00015210"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000286%22OR%22NCT00000293%22OR%22NCT00015210%22"]}]},{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N06AX06"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N06AX06"]}]},{"efo_id":"EFO_0007191","efo_label":"cannabis dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007191","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00249509"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00249509%22"]}]}],"adverse_events":{"significant":[{"event":"hepatocellular damage","count":734,"llr":671.3630394},{"event":"alanine aminotransferase increased","count":24852,"llr":78.67652273},{"event":"hepatic steatosis","count":5106,"llr":60.5211177},{"event":"aspartate aminotransferase increased","count":21532,"llr":48.49683298},{"event":"hepatitis c","count":4688,"llr":35.2992578},{"event":"hepatitis","count":8668,"llr":31.279693},{"event":"chromaturia","count":5181,"llr":24.8451949},{"event":"adrenal suppression","count":341,"llr":22.82277316},{"event":"visual disturbance","count":2241,"llr":21.2110101},{"event":"hepatic enzyme increased","count":17239,"llr":20.12127593},{"event":"hepatic cirrhosis","count":3807,"llr":19.51988572},{"event":"hepatic failure","count":5407,"llr":18.84479084},{"event":"hypogammaglobulinaemia","count":1358,"llr":18.17729184},{"event":"secondary adrenocortical insufficiency","count":375,"llr":17.64090552},{"event":"hepatic fibrosis","count":1098,"llr":15.91612706},{"event":"feeling hot and cold","count":71,"llr":14.01714853},{"event":"liver function test abnormal","count":13429,"llr":13.64477628},{"event":"genital hypoaesthesia","count":110,"llr":12.70941967},{"event":"blood alkaline phosphatase increased","count":10095,"llr":12.65043201},{"event":"drug hypersensitivity","count":71246,"llr":12.49971407},{"event":"gamma-glutamyltransferase increased","count":9889,"llr":10.8491502},{"event":"serotonin syndrome","count":6002,"llr":10.60253298},{"event":"suicidal ideation","count":21218,"llr":10.30478021},{"event":"anxiety","count":45966,"llr":9.830206964},{"event":"muscle twitching","count":4905,"llr":9.700221898},{"event":"pharmaceutical product complaint","count":7517,"llr":9.020702746},{"event":"depression","count":45027,"llr":8.968826057},{"event":"dizziness","count":99375,"llr":8.913246183},{"event":"hepatic necrosis","count":1234,"llr":8.587915178},{"event":"dry mouth","count":12994,"llr":8.565788138}],"critval":8.31745086},"child_chembl_ids":["CHEMBL1200492"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000108576","approved_name":"solute carrier family 6 member 4","approved_symbol":"SLC6A4"}],"target_type":"single protein","target_name":"Serotonin transporter","action_type":"inhibitor","description":"Serotonin transporter inhibitor","references":[{"source":"DailyMed","ids":["setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1"]}]},{"target_components":[{"ensembl":"ENSG00000102468","approved_name":"5-hydroxytryptamine receptor 2A","approved_symbol":"HTR2A"}],"target_type":"single protein","target_name":"Serotonin 2a (5-HT2a) receptor","action_type":"antagonist","description":"Serotonin 2a (5-HT2a) receptor antagonist","references":[{"source":"DailyMed","ids":["setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1"]}]},{"target_components":[{"ensembl":"ENSG00000147246","approved_name":"5-hydroxytryptamine receptor 2C","approved_symbol":"HTR2C"}],"target_type":"single protein","target_name":"Serotonin 2c (5-HT2c) receptor","action_type":"antagonist","description":"Serotonin 2c (5-HT2c) receptor antagonist","references":[{"source":"DailyMed","ids":["setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1"]}]},{"target_components":[{"ensembl":"ENSG00000103546","approved_name":"solute carrier family 6 member 2","approved_symbol":"SLC6A2"}],"target_type":"single protein","target_name":"Norepinephrine transporter","action_type":"inhibitor","description":"Norepinephrine transporter inhibitor","references":[{"source":"DailyMed","ids":["setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":3},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":3},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":2}],"number_of_mechanisms_of_action":4}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1159662","_score":1,"_source":{"id":"CHEMBL1159662","internal_compound":false,"type":"Small molecule","pref_name":"RIBOSE (PYRANOSE)","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["D-Ribose","Ribose","Ribose (pyranose)"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[27476]},{"source":"Wikipedia","ids":["Ribose"]},{"source":"drugbank","ids":["DB04286"]}],"canonical_smiles":"O[C@@H]1CO[C@@H](O)[C@H](O)[C@@H]1O","indications":[{"efo_id":"EFO_0000373","efo_label":"congestive heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000373","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01858480"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01858480%22"]}]},{"efo_id":"EFO_0005687","efo_label":"fibromyalgia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005687","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01315210"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01315210%22"]}]},{"efo_id":"EFO_1000899","efo_label":"diastolic heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000899","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03133793"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03133793%22"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":2},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":2},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297581","_score":1,"_source":{"id":"CHEMBL4297581","internal_compound":false,"type":"Oligonucleotide","pref_name":"IONIS HTTRX","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Ionis httrx","Isis 443139","Rg6042","Ro7234292"],"trade_names":[],"indications":[{"efo_id":"Orphanet_399","efo_label":"Huntington disease","efo_uri":"http://www.orpha.net/ORDO/Orphanet_399","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03761849"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03761849%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000197386","approved_name":"huntingtin","approved_symbol":"HTT"}],"target_type":"nucleic-acid","target_name":"Huntingtin mRNA","action_type":"antisense inhibitor","description":"Huntingtin mRNA antisense inhibitor","references":[{"source":"Other","ids":["https://n.neurology.org/content/86/16_Supplement/PL01.002.short"],"urls":["https://n.neurology.org/content/86/16_Supplement/PL01.002.short"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2362016","_score":1,"_source":{"id":"CHEMBL2362016","internal_compound":false,"type":"Small molecule","pref_name":"ARSENIC TRIOXIDE","year_first_approved":2000,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["Arsenic Trioxide"],"trade_names":["Trisenox"],"cross_references":[{"source":"ChEBI","ids":[30621]},{"source":"DailyMed","ids":["arsenic%20trioxide"]},{"source":"PubChem","ids":["144205808"]}],"canonical_smiles":"O1[As]2O[As]3O[As]1O[As](O2)O3","indications":[{"efo_id":"EFO_0000565","efo_label":"leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000565","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00003395","NCT00003885","NCT00005618","NCT00005795","NCT00006008","NCT00006090","NCT00006091","NCT00006092","NCT00006220","NCT00008697","NCT00016159","NCT00020111","NCT00053248","NCT00081133","NCT00093483","NCT00250042","NCT00276601","NCT00482833","NCT00528450","NCT00551460","NCT02188706"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003395%22OR%22NCT00003885%22OR%22NCT00005618%22OR%22NCT00005795%22OR%22NCT00006008%22OR%22NCT00006090%22OR%22NCT00006091%22OR%22NCT00006092%22OR%22NCT00006220%22OR%22NCT00008697%22OR%22NCT00016159%22OR%22NCT00020111%22OR%22NCT00053248%22OR%22NCT00081133%22OR%22NCT00093483%22OR%22NCT00250042%22OR%22NCT00276601%22OR%22NCT00482833%22OR%22NCT00528450%22OR%22NCT00551460%22OR%22NCT02188706%22"]}]},{"efo_id":"EFO_0000339","efo_label":"chronic myelogenous leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000339","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01397734"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01397734%22"]}]},{"efo_id":"EFO_0000182","efo_label":"hepatocellular carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000182","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00128596","NCT00582400","NCT01861912","NCT02956772"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00128596%22OR%22NCT00582400%22OR%22NCT01861912%22OR%22NCT02956772%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT01428128"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01428128%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00184054","NCT00513305","NCT00671697","NCT00850304","NCT03031249","NCT03381781"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00184054%22OR%22NCT00513305%22OR%22NCT00671697%22OR%22NCT00850304%22OR%22NCT03031249%22OR%22NCT03381781%22"]}]},{"efo_id":"EFO_0000224","efo_label":"acute promyelocytic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000224","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00378365","NCT00413166","NCT00517712","NCT00670150","NCT00866918","NCT00985530","NCT01404949","NCT01409161","NCT02339740","NCT02688140","NCT02899169","NCT03624270"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00378365%22OR%22NCT00413166%22OR%22NCT00517712%22OR%22NCT00670150%22OR%22NCT00866918%22OR%22NCT00985530%22OR%22NCT01404949%22OR%22NCT01409161%22OR%22NCT02339740%22OR%22NCT02688140%22OR%22NCT02899169%22OR%22NCT03624270%22"]},{"source":"DailyMed","ids":["dec51fab-3784-deb7-752f-2d4d5692a20f"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dec51fab-3784-deb7-752f-2d4d5692a20f"]}]},{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00053222"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00053222%22"]}]},{"efo_id":"EFO_0002690","efo_label":"systemic lupus erythematosus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002690","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01738360"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01738360%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["L01XX27"],"urls":["https://www.whocc.no/atc_ddd_index/?code=L01XX27"]},{"source":"ClinicalTrials","ids":["NCT00003630"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003630%22"]}]},{"efo_id":"EFO_0000702","efo_label":"small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000702","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01470248"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01470248%22"]}]},{"efo_id":"EFO_0004599","efo_label":"acute graft vs. host disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004599","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02966301"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02966301%22"]}]},{"efo_id":"EFO_1001465","efo_label":"gliosarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001465","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00045565"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00045565%22"]}]},{"efo_id":"EFO_0000095","efo_label":"chronic lymphocytic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000095","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00193518"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00193518%22"]}]},{"efo_id":"EFO_0000198","efo_label":"myelodysplastic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000198","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00003885","NCT00006220","NCT00195104","NCT00225992","NCT00251511","NCT00621023","NCT00671697","NCT03377725"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003885%22OR%22NCT00006220%22OR%22NCT00195104%22OR%22NCT00225992%22OR%22NCT00251511%22OR%22NCT00621023%22OR%22NCT00671697%22OR%22NCT03377725%22"]}]},{"efo_id":"EFO_0000292","efo_label":"bladder carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000292","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00009867"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00009867%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00075413"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00075413%22"]}]},{"efo_id":"EFO_0000326","efo_label":"central nervous system cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000326","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00095771","NCT00275067","NCT00720564"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00095771%22OR%22NCT00275067%22OR%22NCT00720564%22"]}]},{"efo_id":"EFO_0000479","efo_label":"essential thrombocythemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000479","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01014546"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01014546%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00003395","NCT00003885","NCT00005040","NCT00005595","NCT00006220","NCT00020111"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003395%22OR%22NCT00003885%22OR%22NCT00005040%22OR%22NCT00005595%22OR%22NCT00006220%22OR%22NCT00020111%22"]}]},{"efo_id":"EFO_0001061","efo_label":"cervical carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001061","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00005999"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00005999%22"]}]},{"efo_id":"EFO_0001071","efo_label":"lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001071","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00075426"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00075426%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00003395","NCT00003885","NCT00006021","NCT00006220","NCT00017069","NCT00017433","NCT00085345","NCT00112879","NCT00124605","NCT00193544","NCT00201695","NCT00227682","NCT00258245","NCT00469209","NCT00504101","NCT00590603","NCT00661544"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003395%22OR%22NCT00003885%22OR%22NCT00006021%22OR%22NCT00006220%22OR%22NCT00017069%22OR%22NCT00017433%22OR%22NCT00085345%22OR%22NCT00112879%22OR%22NCT00124605%22OR%22NCT00193544%22OR%22NCT00201695%22OR%22NCT00227682%22OR%22NCT00258245%22OR%22NCT00469209%22OR%22NCT00504101%22OR%22NCT00590603%22OR%22NCT00661544%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00004149"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004149%22"]}]},{"efo_id":"EFO_0002429","efo_label":"polycythemia vera","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002429","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01014546"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01014546%22"]}]},{"efo_id":"EFO_0002430","efo_label":"primary myelofibrosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002430","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00572065","NCT01014546"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00572065%22OR%22NCT01014546%22"]}]},{"efo_id":"EFO_0002617","efo_label":"metastatic melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002617","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00571116"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00571116%22"]}]},{"efo_id":"EFO_0002890","efo_label":"renal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002890","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00005069"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00005069%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02066870"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02066870%22"]}]},{"efo_id":"EFO_0003833","efo_label":"brain neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003833","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00185861"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00185861%22"]}]},{"efo_id":"EFO_0003844","efo_label":"ureteral neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003844","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00009867"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00009867%22"]}]},{"efo_id":"EFO_0003846","efo_label":"urethral neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003846","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00009867"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00009867%22"]}]},{"efo_id":"EFO_1001512","efo_label":"endometrial carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001512","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01184053"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01184053%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00449137"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00449137%22"]}]},{"efo_id":"EFO_0000621","efo_label":"neuroblastoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000621","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03503864"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03503864%22"]}]},{"efo_id":"EFO_0000765","efo_label":"AIDS","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000765","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03980665"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03980665%22"]}]},{"efo_id":"EFO_0004193","efo_label":"basal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004193","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01791894","NCT02699723"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01791894%22OR%22NCT02699723%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000198431","approved_name":"thioredoxin reductase 1","approved_symbol":"TXNRD1"}],"target_type":"single protein","target_name":"Thioredoxin reductase 1","action_type":"inhibitor","description":"Thioredoxin reductase 1 inhibitor","references":[{"source":"PubMed","ids":["17640917"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17640917"]}]}],"adverse_events":{"significant":[{"event":"electrocardiogram qt prolonged","count":12378,"llr":350.6705904},{"event":"acute promyelocytic leukaemia differentiation syndrome","count":150,"llr":314.5863055},{"event":"hyperleukocytosis","count":190,"llr":163.9272215},{"event":"febrile neutropenia","count":19204,"llr":126.1330699},{"event":"myelodysplastic syndrome transformation","count":120,"llr":118.8111043},{"event":"alanine aminotransferase increased","count":24852,"llr":108.1749592},{"event":"leukaemia recurrent","count":357,"llr":105.6232408},{"event":"differentiation syndrome","count":72,"llr":102.753208},{"event":"aspartate aminotransferase increased","count":21532,"llr":84.57268686},{"event":"retinoic acid syndrome","count":104,"llr":77.37116735},{"event":"hepatic function abnormal","count":12036,"llr":71.80024091},{"event":"haematopoietic neoplasm","count":22,"llr":70.37874804},{"event":"pleural effusion","count":17395,"llr":63.41127104},{"event":"pancytopenia","count":17598,"llr":62.91457953},{"event":"pericardial effusion","count":6325,"llr":62.75544705},{"event":"white blood cell count decreased","count":28818,"llr":58.90629571},{"event":"electrocardiogram qt corrected interval prolonged","count":502,"llr":58.50008297},{"event":"acute promyelocytic leukaemia","count":386,"llr":57.78518378},{"event":"disseminated intravascular coagulation","count":3330,"llr":46.67010754},{"event":"hypokalaemia","count":14556,"llr":46.04495954},{"event":"leukocytosis","count":6078,"llr":44.54120615},{"event":"gamma-glutamyltransferase increased","count":9889,"llr":41.99360288},{"event":"pyrexia","count":87334,"llr":38.83585369},{"event":"neutropenia","count":41585,"llr":38.75045533},{"event":"lower respiratory tract infection fungal","count":113,"llr":35.56560667},{"event":"sepsis","count":19258,"llr":35.25222172},{"event":"platelet count decreased","count":29394,"llr":35.16446764},{"event":"activated partial thromboplastin time prolonged","count":2063,"llr":33.15384848},{"event":"neutrophil count decreased","count":11062,"llr":30.47521496},{"event":"hypomagnesaemia","count":4347,"llr":30.23955689},{"event":"blood lactate dehydrogenase increased","count":5771,"llr":27.92860404},{"event":"second primary malignancy","count":2158,"llr":26.39029849},{"event":"hepatotoxicity","count":5998,"llr":24.94580621},{"event":"catheter related infection","count":476,"llr":24.17236351},{"event":"chromosomal deletion","count":52,"llr":23.74717837},{"event":"ventricular extrasystoles","count":4152,"llr":23.29783741},{"event":"hyperglycaemia","count":9767,"llr":22.96230911},{"event":"pneumonia","count":65209,"llr":21.03986664},{"event":"blood alkaline phosphatase increased","count":10095,"llr":20.46675385},{"event":"lymphopenia","count":5118,"llr":20.45418418},{"event":"long qt syndrome","count":841,"llr":19.73059233},{"event":"ventricular tachycardia","count":5901,"llr":18.55713157},{"event":"thrombocytopenia","count":35327,"llr":18.24051345},{"event":"hypoxia","count":9218,"llr":18.18870337}],"critval":17.9800252},"number_of_indications":36,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":33},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":12},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":12},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":11},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":9},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":8},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":5},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":4},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":4},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":4},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":3},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":3},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1672635","_score":1,"_source":{"id":"CHEMBL1672635","internal_compound":false,"type":"Small molecule","pref_name":"RAD-140","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["RAD-140","RAD140","Rad-140","Rad140"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB13939"]}],"canonical_smiles":"Cc1c(N[C@@H](c2nnc(-c3ccc(C#N)cc3)o2)[C@H](C)O)ccc(C#N)c1Cl","indications":[{"efo_id":"EFO_0003869","efo_label":"breast neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003869","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03088527"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03088527%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3686884","_score":1,"_source":{"id":"CHEMBL3686884","internal_compound":false,"type":"Small molecule","pref_name":"E-7090","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["E-7090","E7090"],"trade_names":[],"canonical_smiles":"CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(CCO)CC5)cc4)c3)c(OCCOC)cc21","indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02275910"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02275910%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL358150","_score":1,"_source":{"id":"CHEMBL358150","internal_compound":false,"type":"Small molecule","pref_name":"ETOFIBRATE","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Etofibrate"],"trade_names":[],"cross_references":[{"source":"Wikipedia","ids":["Etofibrate"]},{"source":"drugbank","ids":["DB08983"]}],"canonical_smiles":"CC(C)(Oc1ccc(Cl)cc1)C(=O)OCCOC(=O)c1cccnc1","indications":[{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["C10AB09"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C10AB09"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1742992","_score":1,"_source":{"id":"CHEMBL1742992","internal_compound":false,"type":"Antibody","pref_name":"BLINATUMOMAB","year_first_approved":2014,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["Blinatumomab","MEDI-538","MT-103"],"trade_names":[],"cross_references":[{"source":"DailyMed","ids":["blinatumomab"]},{"source":"DrugCentral","ids":["4915"]}],"indications":[{"efo_id":"EFO_0000220","efo_label":"acute lymphoblastic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000220","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00560794","NCT01371630","NCT01466179","NCT01471782","NCT02000427","NCT02003222","NCT02013167","NCT02101853","NCT02143414","NCT02393859","NCT02412306","NCT02458014","NCT02744768","NCT02807883","NCT02877303","NCT02879695","NCT03367299","NCT03476239","NCT03480438","NCT03512405","NCT03518112","NCT03523429","NCT03541083","NCT03628053","NCT03643276","NCT03739814"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00560794%22OR%22NCT01371630%22OR%22NCT01466179%22OR%22NCT01471782%22OR%22NCT02000427%22OR%22NCT02003222%22OR%22NCT02013167%22OR%22NCT02101853%22OR%22NCT02143414%22OR%22NCT02393859%22OR%22NCT02412306%22OR%22NCT02458014%22OR%22NCT02744768%22OR%22NCT02807883%22OR%22NCT02877303%22OR%22NCT02879695%22OR%22NCT03367299%22OR%22NCT03476239%22OR%22NCT03480438%22OR%22NCT03512405%22OR%22NCT03518112%22OR%22NCT03523429%22OR%22NCT03541083%22OR%22NCT03628053%22OR%22NCT03643276%22OR%22NCT03739814%22"]}]},{"efo_id":"EFO_0000094","efo_label":"B-cell acute lymphoblastic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000094","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01207388","NCT01209286","NCT03160079","NCT03751709"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01207388%22OR%22NCT01209286%22OR%22NCT03160079%22OR%22NCT03751709%22"]}]},{"efo_id":"EFO_0000095","efo_label":"chronic lymphocytic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000095","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00676871"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00676871%22"]}]},{"efo_id":"EFO_0000403","efo_label":"diffuse large B-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000403","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01741792","NCT03023878","NCT03072771","NCT03298412","NCT03340766"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01741792%22OR%22NCT03023878%22OR%22NCT03072771%22OR%22NCT03298412%22OR%22NCT03340766%22"]}]},{"efo_id":"EFO_0005952","efo_label":"non-Hodgkins lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005952","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00274742","NCT00538096","NCT02811679","NCT02910063","NCT02961881"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00274742%22OR%22NCT00538096%22OR%22NCT02811679%22OR%22NCT02910063%22OR%22NCT02961881%22"]}]},{"efo_id":"EFO_0000220","efo_label":"acute lymphoblastic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000220","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["38b482a8-960b-4591-9857-5031ecb830aa"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?38b482a8-960b-4591-9857-5031ecb830aa"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["L01XC19"],"urls":["https://www.whocc.no/atc_ddd_index/?code=L01XC19"]}]},{"efo_id":"EFO_0000209","efo_label":"T-cell acute lymphoblastic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000209","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03109093"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03109093%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT03173430"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03173430%22"]}]},{"efo_id":"EFO_0001642","efo_label":"lymphoid neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001642","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03121534"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03121534%22"]}]},{"efo_id":"EFO_0000565","efo_label":"leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000565","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03605589"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03605589%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03605589"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03605589%22"]}]},{"efo_id":"EFO_0004289","efo_label":"lymphoid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004289","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02877303"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02877303%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000198851","approved_name":"CD3e molecule","approved_symbol":"CD3E"},{"ensembl":"ENSG00000160654","approved_name":"CD3g molecule","approved_symbol":"CD3G"},{"ensembl":"ENSG00000167286","approved_name":"CD3d molecule","approved_symbol":"CD3D"}],"target_type":"protein complex","target_name":"T cell surface glycoprotein CD3","action_type":"cross-linking agent","description":"T cell surface glycoprotein CD3 cross-linking agent","references":[{"source":"FDA","ids":["label/2014/125557lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2014%2F125557lbl.pdf"]}]},{"target_components":[{"ensembl":"ENSG00000177455","approved_name":"CD19 molecule","approved_symbol":"CD19"}],"target_type":"single protein","target_name":"B-lymphocyte antigen CD19","action_type":"cross-linking agent","description":"B-lymphocyte antigen CD19 cross-linking agent","references":[{"source":"FDA","ids":["label/2014/125557lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2014%2F125557lbl.pdf"]}]}],"adverse_events":{"significant":[{"event":"acute lymphocytic leukaemia recurrent","count":361,"llr":402.3508706},{"event":"cytokine release syndrome","count":668,"llr":322.7651644},{"event":"neurotoxicity","count":4628,"llr":125.0883039},{"event":"acute lymphocytic leukaemia refractory","count":41,"llr":121.1032914},{"event":"pyrexia","count":87334,"llr":89.31297166},{"event":"leukaemic infiltration extramedullary","count":22,"llr":67.57299914},{"event":"neoplasm recurrence","count":811,"llr":67.52589881},{"event":"cytopenia","count":2040,"llr":66.91078396},{"event":"acute lymphocytic leukaemia","count":714,"llr":64.94707497},{"event":"leukaemia recurrent","count":357,"llr":55.11800867},{"event":"metastases to retroperitoneum","count":38,"llr":54.94604344},{"event":"febrile neutropenia","count":19204,"llr":54.46362471},{"event":"therapy non-responder","count":8416,"llr":53.43923957},{"event":"metastases to muscle","count":47,"llr":53.03473116},{"event":"nervous system disorder","count":5276,"llr":52.88673096},{"event":"metastases to bone marrow","count":100,"llr":52.44678766},{"event":"metastases to spleen","count":82,"llr":48.0323558},{"event":"neutropenic sepsis","count":2129,"llr":46.64497906},{"event":"transformation to acute myeloid leukaemia","count":88,"llr":41.1858014},{"event":"transplant evaluation","count":185,"llr":40.72954846},{"event":"neoplasm progression","count":5699,"llr":39.08203645},{"event":"cytomegalovirus infection","count":5010,"llr":38.51290529},{"event":"end stage renal disease","count":1304,"llr":38.45929198},{"event":"philadelphia chromosome positive","count":87,"llr":35.18012503},{"event":"acute graft versus host disease","count":1251,"llr":35.03963852},{"event":"central nervous system leukaemia","count":42,"llr":33.58859616},{"event":"hypoproteinaemia","count":550,"llr":30.99408759},{"event":"trichosporon infection","count":70,"llr":30.52907986},{"event":"tubulointerstitial nephritis","count":4806,"llr":30.4308065},{"event":"encephalopathy","count":8151,"llr":29.8658574},{"event":"seizure","count":19835,"llr":29.60471417},{"event":"personality change due to a general medical condition","count":30,"llr":28.75694181},{"event":"graft versus host disease in skin","count":530,"llr":26.90708894},{"event":"malignant neoplasm progression","count":14458,"llr":26.19299178},{"event":"jaw operation","count":355,"llr":25.38863377},{"event":"minimal residual disease","count":17,"llr":24.38088485},{"event":"aphasia","count":8046,"llr":22.80762383},{"event":"escherichia urinary tract infection","count":1570,"llr":21.75120615},{"event":"epilepsy","count":8950,"llr":21.27754565},{"event":"meningitis bacterial","count":373,"llr":20.54942418},{"event":"aspiration bone marrow abnormal","count":54,"llr":19.76500647},{"event":"diffuse large b-cell lymphoma","count":1375,"llr":19.44412478},{"event":"metastases to lung","count":2171,"llr":18.95049148},{"event":"apraxia","count":505,"llr":18.75718033},{"event":"escherichia bacteraemia","count":521,"llr":18.57313813},{"event":"hepatotoxicity","count":5998,"llr":17.14511167},{"event":"thrombocytopenia","count":35327,"llr":16.96511519},{"event":"glomerular filtration rate decreased","count":2869,"llr":16.57659918},{"event":"therapeutic response delayed","count":367,"llr":16.30165322},{"event":"diarrhoea","count":126514,"llr":15.75619921},{"event":"dizziness","count":99375,"llr":15.71598576},{"event":"lymphocyte count decreased","count":5692,"llr":15.36664422},{"event":"acute biphenotypic leukaemia","count":35,"llr":15.25855121},{"event":"metastases to liver","count":3380,"llr":15.2003024},{"event":"graft versus host disease","count":1579,"llr":15.17906028},{"event":"acute lymphocytic leukaemia (in remission)","count":2,"llr":15.08034557},{"event":"fatigue","count":147738,"llr":13.84374414},{"event":"fungaemia","count":272,"llr":13.34018357},{"event":"adenoviral haemorrhagic cystitis","count":71,"llr":13.1435749},{"event":"bacteraemia","count":3187,"llr":13.07025333},{"event":"confusional state","count":40628,"llr":12.97184598},{"event":"leukaemic infiltration renal","count":6,"llr":12.88390192},{"event":"hypoxia","count":9218,"llr":12.60982042},{"event":"leukoencephalopathy","count":1566,"llr":12.17294436},{"event":"hyperglycaemia","count":9767,"llr":12.02162006},{"event":"lower respiratory tract infection fungal","count":113,"llr":11.75764015},{"event":"graft versus host disease in gastrointestinal tract","count":412,"llr":11.70656065},{"event":"dyspnoea","count":124409,"llr":11.6929725},{"event":"facial paralysis","count":1715,"llr":11.65656036},{"event":"chronic graft versus host disease","count":1026,"llr":11.28951451},{"event":"disease progression","count":21531,"llr":11.03323692},{"event":"transaminases increased","count":8955,"llr":11.01258803},{"event":"nausea","count":165652,"llr":11.00952394},{"event":"pancytopenia","count":17598,"llr":10.60198835},{"event":"device related thrombosis","count":179,"llr":10.39051493},{"event":"hypertriglyceridaemia","count":2168,"llr":10.33822159},{"event":"secondary hyperthyroidism","count":22,"llr":10.28845971},{"event":"stem cell transplant","count":635,"llr":10.01958092},{"event":"bone marrow failure","count":8717,"llr":9.434463714},{"event":"lung consolidation","count":778,"llr":9.235023867}],"critval":9.130143555},"number_of_indications":13,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":13},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":12},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":9},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":9},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":7}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1183349","_score":1,"_source":{"id":"CHEMBL1183349","internal_compound":false,"type":"Small molecule","pref_name":"ISAVUCONAZONIUM","year_first_approved":2015,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["BAL-8557-002","BAL8557-000","BAL8557-002","Isavuconazonium","Isavuconazonium Sulfate"],"trade_names":["Cresemba"],"cross_references":[{"source":"ChEBI","ids":[85978]},{"source":"DailyMed","ids":["isavuconazonium%20sulfate"]},{"source":"drugbank","ids":["DB06636"]},{"source":"ChEBI","ids":[85977]}],"canonical_smiles":"CNCC(=O)OCc1cccnc1N(C)C(=O)OC(C)[n+]1cnn(C[C@](O)(c2cc(F)ccc2F)[C@@H](C)c2nc(-c3ccc(C#N)cc3)cs2)c1","adverse_events":{"significant":[{"event":"dysphagia","count":22741,"llr":44.27284251},{"event":"artery dissection","count":145,"llr":21.64881217},{"event":"wrong technique in product usage process","count":27855,"llr":21.26670353},{"event":"agranulocytosis","count":6607,"llr":15.40952814},{"event":"febrile neutropenia","count":19204,"llr":12.98744641},{"event":"tachypnoea","count":3857,"llr":11.95050584},{"event":"drug-induced liver injury","count":7265,"llr":11.76870214},{"event":"epistaxis","count":16532,"llr":11.75779008},{"event":"hyperthermia","count":2914,"llr":9.770812541},{"event":"anaphylactic shock","count":6651,"llr":9.350825318},{"event":"heart transplant rejection","count":247,"llr":8.369260531},{"event":"transaminases increased","count":8955,"llr":7.966506257},{"event":"gastrostomy","count":459,"llr":7.139552881},{"event":"endotracheal intubation","count":568,"llr":6.718354795},{"event":"pancreatitis acute","count":7957,"llr":5.979127119}],"critval":5.848324794},"child_chembl_ids":["CHEMBL1688829","CHEMBL291921","CHEMBL3137333"],"indications":[{"efo_id":"EFO_0007157","efo_label":"aspergillosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007157","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["8f7f73b8-586a-4df0-935f-fecd4696c16c"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8f7f73b8-586a-4df0-935f-fecd4696c16c"]}]},{"efo_id":"EFO_0007380","efo_label":"mucormycosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007380","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["8f7f73b8-586a-4df0-935f-fecd4696c16c"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8f7f73b8-586a-4df0-935f-fecd4696c16c"]}]},{"efo_id":"EFO_0001642","efo_label":"lymphoid neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001642","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03241550"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03241550%22"]}]}],"mechanisms_of_action":[{"target_type":"single protein","target_name":"Lanosterol 14-alpha demethylase","action_type":"inhibitor","description":"Lanosterol 14-alpha demethylase inhibitor","references":[{"source":"FDA","ids":["label/2015/207500s001,207501s001lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F207500s001%2C207501s001lbl.pdf"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1957038","_score":1,"_source":{"id":"CHEMBL1957038","internal_compound":false,"type":"Small molecule","pref_name":"IDRONOXIL","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Dehydroequol","Idronoxil","NV-06"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["174006673"]},{"source":"drugbank","ids":["DB04915"]}],"canonical_smiles":"Oc1ccc(C2=Cc3ccc(O)cc3OC2)cc1","indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00022295"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00022295%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03041285"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03041285%22"]}]},{"efo_id":"EFO_0001075","efo_label":"ovarian carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001075","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00303888"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00303888%22"]}]},{"efo_id":"EFO_1000251","efo_label":"Fallopian Tube Carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000251","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00303888"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00303888%22"]}]},{"efo_id":"EFO_1001100","efo_label":"peritoneal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001100","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00303888"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00303888%22"]}]}],"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":5},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":3},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":3},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL277100","_score":1,"_source":{"id":"CHEMBL277100","internal_compound":false,"type":"Small molecule","pref_name":"TEMAFLOXACIN","year_first_approved":1992,"max_clinical_trial_phase":4,"withdrawn_flag":true,"withdrawn_reason":["Low blood sugar","allergic reactions","hemolytic anemia","kidney, liver dysfunction"],"withdrawn_year":1992,"withdrawn_country":["Germany","United Kingdom","United States"],"withdrawn_class":["Hematological toxicity","Hepatotoxicity","Immune system toxicity","Nephrotoxicity"],"black_box_warning":false,"synonyms":["ABBOTT-62254","Omniflox","Temafloxacin","Temafloxacin HCl"],"trade_names":["Omnifiox","Teflox","Teflox 400"],"cross_references":[{"source":"ChEBI","ids":[77796]},{"source":"PubChem","ids":["144206857"]},{"source":"Wikipedia","ids":["Temafloxacin"]},{"source":"drugbank","ids":["DB01405"]}],"canonical_smiles":"CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1","child_chembl_ids":["CHEMBL2107495"],"mechanisms_of_action":[{"target_type":"protein complex","target_name":"Bacterial DNA gyrase","action_type":"inhibitor","description":"Bacterial DNA gyrase inhibitor","references":[{"source":"PubMed","ids":["1662892","1846917","2039194","3145851","8031064"],"urls":["https://europepmc.org/search?query=EXT_ID%3A1662892+OR+EXT_ID%3A1846917+OR+EXT_ID%3A2039194+OR+EXT_ID%3A3145851+OR+EXT_ID%3A8031064"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1544","_score":1,"_source":{"id":"CHEMBL1544","internal_compound":false,"type":"Small molecule","pref_name":"LIOTHYRONINE","year_first_approved":1956,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["Euthroid-0.5","Euthroid-1","Euthroid-2","Euthroid-3","Liothyronine","Liothyronine (125I)","Liothyronine (131I)","Liothyronine Sodium","Liothyronine sodium salt","NSC-80203","NSC-80774","Rathyronine","T3 (Liotrix)","Thyrolar-0.25","Thyrolar-0.5","Thyrolar-1","Thyrolar-2","Thyrolar-3","Thyrolar-5","Triiodothyronine (T3 Or Liothyronine, Active) (6-11%)","Triiodothyronine Sodium, Levo","Triostat"],"trade_names":["Cynomel","Cytomel","Liothyronine Sodium","Tertroxin","Thybon","Tri-Thyrotope","Triiodothyronine","Triiodothyronine,evans","Triomet-125","Triomet-131","Triostat"],"cross_references":[{"source":"ChEBI","ids":[18258]},{"source":"DailyMed","ids":["liothyronine%20sodium"]},{"source":"PubChem","ids":["11532858","124877498","144203580","144212260","26753840","4253003"]},{"source":"Wikipedia","ids":["Triiodothyronine"]},{"source":"drugbank","ids":["DB00279"]},{"source":"ChEBI","ids":[6484]},{"source":"PubChem","ids":["144212831","855617"]},{"source":"Wikipedia","ids":["Liothyronine"]},{"source":"PubChem","ids":["56422785"]},{"source":"drugbank","ids":["DB12425"]}],"canonical_smiles":"N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O","indications":[{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00158990","NCT00790738"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00158990%22OR%22NCT00790738%22"]}]},{"efo_id":"EFO_0000275","efo_label":"atrial fibrillation","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000275","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00289367"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00289367%22"]}]},{"efo_id":"EFO_0000289","efo_label":"bipolar disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000289","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00158990","NCT00790738"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00158990%22OR%22NCT00790738%22"]}]},{"efo_id":"EFO_0003840","efo_label":"chronic progressive multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003840","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02506751"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02506751%22"]}]},{"efo_id":"EFO_0003929","efo_label":"relapsing-remitting multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003929","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02506751"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02506751%22"]}]},{"efo_id":"EFO_0004705","efo_label":"hypothyroidism","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004705","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01800617","NCT03053115","NCT03627611"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01800617%22OR%22NCT03053115%22OR%22NCT03627611%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03787303"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03787303%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00788307"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00788307%22"]}]},{"efo_id":"EFO_0005207","efo_label":"congenital heart disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005207","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02320669"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02320669%22"]}]},{"efo_id":"EFO_0003885","efo_label":"multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003885","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02760056"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02760056%22"]}]},{"efo_id":"EFO_0003841","efo_label":"thyroid neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003841","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01182285"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01182285%22"]}]},{"efo_id":"EFO_0006859","efo_label":"head and neck malignant neoplasia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006859","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00004062"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004062%22"]}]},{"efo_id":"EFO_0004705","efo_label":"hypothyroidism","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004705","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01800617"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01800617%22"]}]},{"efo_id":"HP_0030680","efo_label":"Abnormality of cardiovascular system morphology","efo_uri":"http://purl.obolibrary.org/obo/HP_0030680","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00027417"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00027417%22"]}]},{"efo_id":"HP_0030680","efo_label":"Abnormality of cardiovascular system morphology","efo_uri":"http://purl.obolibrary.org/obo/HP_0030680","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00004828"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004828%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000126351","approved_name":"thyroid hormone receptor alpha","approved_symbol":"THRA"},{"ensembl":"ENSG00000151090","approved_name":"thyroid hormone receptor beta","approved_symbol":"THRB"}],"target_type":"protein complex","target_name":"Thyroid hormone receptor","action_type":"agonist","description":"Thyroid hormone receptor agonist","references":[{"source":"DailyMed","ids":["setid=51452b31-ff68-4e0c-b982-c15502ebf1d3#nlm34090-1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=51452b31-ff68-4e0c-b982-c15502ebf1d3#nlm34090-1"]},{"source":"Wikipedia","ids":["Thyroid_hormone","Thyroid_hormone_receptor"],"urls":["https://www.wikipedia.org/Thyroid_hormone","https://www.wikipedia.org/Thyroid_hormone_receptor"]}]}],"adverse_events":{"significant":[{"event":"hyperthyroidism","count":3841,"llr":105.0509746},{"event":"performance enhancing product use","count":19,"llr":59.56770183},{"event":"hypothyroidism","count":7054,"llr":49.8630378},{"event":"secondary hypogonadism","count":104,"llr":45.97568613},{"event":"glucose tolerance decreased","count":20,"llr":42.62512392},{"event":"loose associations","count":31,"llr":39.99658355},{"event":"autoimmune thyroiditis","count":944,"llr":37.74497187},{"event":"thyrotoxic periodic paralysis","count":46,"llr":37.63000732},{"event":"thyroid function test abnormal","count":977,"llr":37.40430095},{"event":"palpitations","count":23550,"llr":36.70385482},{"event":"feelings of worthlessness","count":216,"llr":28.36547346},{"event":"rhinovirus infection","count":521,"llr":28.04295929},{"event":"alopecia","count":25428,"llr":28.03945015},{"event":"haematocrit increased","count":532,"llr":27.89769163},{"event":"pressure of speech","count":262,"llr":27.21121381},{"event":"tri-iodothyronine increased","count":98,"llr":26.66329475},{"event":"acute respiratory distress syndrome","count":3118,"llr":25.99010122},{"event":"drug abuse","count":14574,"llr":25.40311943},{"event":"feeling abnormal","count":36538,"llr":23.30510785},{"event":"blood thyroid stimulating hormone abnormal","count":293,"llr":21.2048567},{"event":"tri-iodothyronine decreased","count":99,"llr":20.39358864},{"event":"psychomotor hyperactivity","count":4158,"llr":19.96054611},{"event":"incoherent","count":1729,"llr":19.75446958},{"event":"insomnia","count":44658,"llr":19.59392854},{"event":"atrial fibrillation","count":25339,"llr":19.50225068},{"event":"rebound effect","count":983,"llr":19.34247441},{"event":"psychomotor retardation","count":1073,"llr":18.82494233},{"event":"inhibitory drug interaction","count":481,"llr":18.74334049},{"event":"anhedonia","count":1332,"llr":17.55090222},{"event":"major depression","count":1649,"llr":16.29849551},{"event":"blood thyroid stimulating hormone decreased","count":1034,"llr":14.96661051},{"event":"asthenia","count":74334,"llr":14.83617611},{"event":"bipolar disorder","count":2203,"llr":14.61043425},{"event":"weight increased","count":33631,"llr":13.6983731},{"event":"delusion","count":4266,"llr":13.66019851},{"event":"malaise","count":82447,"llr":12.9502791},{"event":"hepatic neoplasm","count":706,"llr":12.59051532},{"event":"speech disorder","count":10086,"llr":12.5149569},{"event":"mood altered","count":5179,"llr":12.38461773},{"event":"congestive cardiomyopathy","count":1939,"llr":11.90457449},{"event":"thyrotoxic crisis","count":236,"llr":11.83639946},{"event":"myocarditis","count":2475,"llr":10.7326031},{"event":"arrhythmia","count":9500,"llr":10.69955102},{"event":"fatigue","count":147738,"llr":10.545324},{"event":"feeling cold","count":4597,"llr":10.41240872},{"event":"mania","count":4633,"llr":10.36884588},{"event":"sinus tachycardia","count":5084,"llr":9.852092157},{"event":"myxoedema","count":59,"llr":9.840824086},{"event":"diabetes mellitus","count":14312,"llr":9.743337726},{"event":"enlarged clitoris","count":62,"llr":9.741903119},{"event":"heart rate decreased","count":5985,"llr":8.954286036},{"event":"throat tightness","count":6159,"llr":8.798009711},{"event":"sluggishness","count":1894,"llr":8.750680878},{"event":"abdominal discomfort","count":25125,"llr":8.629151565},{"event":"allergic reaction to excipient","count":115,"llr":8.511129164},{"event":"overweight","count":769,"llr":8.34097649},{"event":"endocrine ophthalmopathy","count":133,"llr":8.221932681},{"event":"urine output decreased","count":2326,"llr":7.967940061},{"event":"thyroxine increased","count":164,"llr":7.805718267},{"event":"thyroxine decreased","count":175,"llr":7.676879892},{"event":"blood selenium abnormal","count":2,"llr":7.607725373},{"event":"reverse tri-iodothyronine increased","count":2,"llr":7.607725373},{"event":"anti-thyroid antibody positive","count":183,"llr":7.588207329},{"event":"systolic hypertension","count":189,"llr":7.524231453},{"event":"urticaria","count":39524,"llr":7.378164479},{"event":"anger","count":5808,"llr":6.768545921},{"event":"liver induration","count":5,"llr":6.691708334},{"event":"tri-iodothyronine uptake decreased","count":5,"llr":6.691708334},{"event":"coeliac disease","count":1393,"llr":6.615223187},{"event":"liver function test abnormal","count":13429,"llr":6.456536455},{"event":"pituitary hyperplasia","count":7,"llr":6.355418559},{"event":"product dispensing error","count":1584,"llr":6.247074639}],"critval":6.234934771},"child_chembl_ids":["CHEMBL1201119","CHEMBL1356342","CHEMBL2106622","CHEMBL2107398"],"number_of_indications":15,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":5},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":4},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":3},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":3},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":3},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":2},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":2},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":2},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":2},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL284092","_score":1,"_source":{"id":"CHEMBL284092","internal_compound":false,"type":"Small molecule","pref_name":"GEPIRONE","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Ariza","BMY-13805","BMY-13805-1","Gepirone","Gepirone HCl","ORG-13011","Variza"],"trade_names":[],"cross_references":[{"source":"Wikipedia","ids":["Gepirone"]},{"source":"drugbank","ids":["DB12184"]}],"canonical_smiles":"CC1(C)CC(=O)N(CCCCN2CCN(c3ncccn3)CC2)C(=O)C1","indications":[{"efo_id":"EFO_0002610","efo_label":"cocaine dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002610","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00000189"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000189%22"]}]},{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":2,"references":[{"source":"ATC","ids":["N06AX19"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N06AX19"]}]}],"child_chembl_ids":["CHEMBL1204187"],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":2},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":2},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL656","_score":1,"_source":{"id":"CHEMBL656","internal_compound":false,"type":"Small molecule","pref_name":"OXYCODONE","year_first_approved":1950,"max_clinical_trial_phase":4,"withdrawn_flag":true,"withdrawn_country":["United States"],"black_box_warning":true,"synonyms":["IDS-NO-002","N02AA05","NSC-19043","Oxicone","Oxycodone","Oxycodone HCl","Oxycodone cii","Oxycodone hydrochloride cii","Oxycodone terephthalate","PF-00345439","PTI-821"],"trade_names":["Abtard","Candox","Carexil","Dolocodon PR","Leveraxo","Longtec","Lynlor","Oxaydo","Oxecta","Oxeltra","Oxycodone HCl","Oxycontin","Oxylan","Oxynorm","Proladone","Reltebon","Roxicodone","Roxybond","Shortec","Xtampza ER","Zomestine"],"cross_references":[{"source":"ChEBI","ids":[7852]},{"source":"DailyMed","ids":["oxycodone","oxycodone%20hydrochloride","oxycodone%20terephthalate"]},{"source":"Wikipedia","ids":["Oxycodone"]},{"source":"drugbank","ids":["DB00497"]},{"source":"ChEBI","ids":[7859]},{"source":"DailyMed","ids":["oxycodone%20hydrochloride"]},{"source":"DailyMed","ids":["oxycodone%20terephthalate"]}],"canonical_smiles":"COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314","indications":[{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N02AA05"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N02AA05"]},{"source":"ClinicalTrials","ids":["NCT00092313","NCT00092326","NCT00261495","NCT00412100","NCT00412152","NCT00685295","NCT00814580","NCT00818493","NCT00941304","NCT01165281","NCT01167127","NCT01167699","NCT01192295","NCT01270659","NCT01304134","NCT01402375","NCT01482936","NCT01552850","NCT01552863","NCT01557257","NCT01559701","NCT01871285","NCT02240602","NCT02321397","NCT02401750","NCT02541396","NCT02732262","NCT02862691","NCT03011905","NCT03088826","NCT03173456","NCT03579446"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00092313%22OR%22NCT00092326%22OR%22NCT00261495%22OR%22NCT00412100%22OR%22NCT00412152%22OR%22NCT00685295%22OR%22NCT00814580%22OR%22NCT00818493%22OR%22NCT00941304%22OR%22NCT01165281%22OR%22NCT01167127%22OR%22NCT01167699%22OR%22NCT01192295%22OR%22NCT01270659%22OR%22NCT01304134%22OR%22NCT01402375%22OR%22NCT01482936%22OR%22NCT01552850%22OR%22NCT01552863%22OR%22NCT01557257%22OR%22NCT01559701%22OR%22NCT01871285%22OR%22NCT02240602%22OR%22NCT02321397%22OR%22NCT02401750%22OR%22NCT02541396%22OR%22NCT02732262%22OR%22NCT02862691%22OR%22NCT03011905%22OR%22NCT03088826%22OR%22NCT03173456%22OR%22NCT03579446%22"]},{"source":"DailyMed","ids":["0d0dbb74-4a2c-4a95-b81e-6d008cd88808","2137ced5-791a-4ac1-80bc-30161ea52143","26c17ac7-64f4-436b-a56d-38d4584959e8","9396ebdb-1ccb-40d1-8c7a-1ce4bf7e0ffc"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0d0dbb74-4a2c-4a95-b81e-6d008cd88808","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2137ced5-791a-4ac1-80bc-30161ea52143","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?26c17ac7-64f4-436b-a56d-38d4584959e8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9396ebdb-1ccb-40d1-8c7a-1ce4bf7e0ffc"]},{"source":"FDA","ids":["189ab0e3-ba5c-4889-b58a-079bf783772e"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A189ab0e3-ba5c-4889-b58a-079bf783772e"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00478101","NCT01675622","NCT01918098"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00478101%22OR%22NCT01675622%22OR%22NCT01918098%22"]}]},{"efo_id":"EFO_0002506","efo_label":"osteoarthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002506","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00312221","NCT00483977","NCT00743587","NCT00902837","NCT00985621"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00312221%22OR%22NCT00483977%22OR%22NCT00743587%22OR%22NCT00902837%22OR%22NCT00985621%22"]}]},{"efo_id":"EFO_0004616","efo_label":"osteoarthritis, knee","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004616","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00979953","NCT01709214"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00979953%22OR%22NCT01709214%22"]}]},{"efo_id":"EFO_0002508","efo_label":"Parkinson's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002508","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01439100","NCT02601586"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01439100%22OR%22NCT02601586%22"]}]},{"efo_id":"EFO_1000783","efo_label":"diabetic neuropathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000783","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00944697","NCT01063868"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00944697%22OR%22NCT01063868%22"]}]},{"efo_id":"EFO_0003845","efo_label":"kidney stone","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003845","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00784472"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00784472%22"]}]},{"efo_id":"HP_0000989","efo_label":"Pruritus","efo_uri":"http://purl.obolibrary.org/obo/HP_0000989","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02277678"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02277678%22"]}]},{"efo_id":"EFO_0005611","efo_label":"opioid dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005611","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00158184","NCT00699010","NCT00734461","NCT01986283","NCT03415581","NCT03475862","NCT03837860","NCT03958474"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00158184%22OR%22NCT00699010%22OR%22NCT00734461%22OR%22NCT01986283%22OR%22NCT03415581%22OR%22NCT03475862%22OR%22NCT03837860%22OR%22NCT03958474%22"]}]},{"efo_id":"EFO_0004270","efo_label":"restless legs syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004270","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01112644"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01112644%22"]}]},{"efo_id":"EFO_0005762","efo_label":"neuropathic pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005762","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02307305"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02307305%22"]}]},{"efo_id":"EFO_0007486","efo_label":"sinusitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007486","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03055507"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03055507%22"]}]},{"efo_id":"EFO_1000999","efo_label":"joint disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000999","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02604446"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02604446%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03253133"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03253133%22"]}]},{"efo_id":"EFO_0000668","efo_label":"preeclampsia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000668","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03978767"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03978767%22"]}]},{"efo_id":"EFO_0001069","efo_label":"nutritional disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001069","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02309437"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02309437%22"]}]},{"efo_id":"EFO_0003890","efo_label":"drug dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003890","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03765346"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03765346%22"]}]},{"efo_id":"EFO_0004253","efo_label":"nephrolithiasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004253","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03584373"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03584373%22"]}]},{"efo_id":"EFO_1001919","efo_label":"Spinal cord injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001919","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03906721"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03906721%22"]}]},{"efo_id":"HP_0003418","efo_label":"Back pain","efo_uri":"http://purl.obolibrary.org/obo/HP_0003418","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00315445","NCT00771758","NCT00986180","NCT02892591"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00315445%22OR%22NCT00771758%22OR%22NCT00986180%22OR%22NCT02892591%22"]}]},{"efo_id":"HP_0012532","efo_label":"Chronic pain","efo_uri":"http://purl.obolibrary.org/obo/HP_0012532","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00463047","NCT00813488","NCT01428583","NCT01971632","NCT02603705","NCT03398278","NCT03398330","NCT03403504"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00463047%22OR%22NCT00813488%22OR%22NCT01428583%22OR%22NCT01971632%22OR%22NCT02603705%22OR%22NCT03398278%22OR%22NCT03398330%22OR%22NCT03403504%22"]}]},{"efo_id":"HP_0030833","efo_label":"Neck pain","efo_uri":"http://purl.obolibrary.org/obo/HP_0030833","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02892591"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02892591%22"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00560183","NCT00626600","NCT00801788","NCT00818493","NCT00831051","NCT01016808","NCT01055015","NCT01205126","NCT01280331","NCT01369615","NCT01643772","NCT01675635","NCT03254459"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00560183%22OR%22NCT00626600%22OR%22NCT00801788%22OR%22NCT00818493%22OR%22NCT00831051%22OR%22NCT01016808%22OR%22NCT01055015%22OR%22NCT01205126%22OR%22NCT01280331%22OR%22NCT01369615%22OR%22NCT01643772%22OR%22NCT01675635%22OR%22NCT03254459%22"]},{"source":"DailyMed","ids":["00109d18-397a-4c10-a28b-836d56d71829","03a90b9f-e4d9-48c7-8bb2-745f86cf0634","03c9ff0d-46e8-448c-944a-7ad59d1afd6d","04c8ab3f-b026-4009-bf0f-d6eb71517d23","0525087e-271c-47a1-8d4a-06b5ecac34b3","056f088d-cff1-4b46-8539-ff85880586bf","094b64b3-cd32-4de5-afb6-ea00d9caad74","0a1d47b5-0215-4636-acac-191e51df8754","0a446947-2cda-4a32-aa6a-53e09245825a","0b46314b-604d-48ed-9d31-83a18ef4134c","0d1017df-f9b5-4165-978c-f8dd58df2ca0","0ffab497-1988-426b-8c9e-3be653a203dd","11eddb9e-1cd6-4205-a3ce-c595c88e9d55","205be197-5ad5-4849-bc78-5fda9927b531","20bb6bb4-230a-c9c2-01d8-a6e9341e96ba","23a60947-6058-4bf7-a3ee-ae396e55d939","2426980d-f1b4-45d3-9d1a-156548a2c872","243254d5-afd7-474f-b5d7-182b471bda06","25c2a91c-dfc2-4596-8a24-63acf04a2568","28156b13-0ba9-4dc4-be24-9c3070a7e1cc","281a38ef-c755-4a37-8dca-4776a9dfeb7f","29a8d7c5-288e-4305-8d64-42d8158ae4cd","29d70f34-6f64-415a-a051-0e5cd1ee39d5","2cb9090d-76dd-44a2-9590-37c6e7ed495b","2daac07a-7b11-4e90-bc56-20a4f54fbbf8","3132ab0a-53ee-4f46-ad5f-2e4af77bc54c","32664ae8-78dd-408c-a49f-e0bdf01752dc","346fd641-7fe2-44e6-adf9-a9fc32126b81","35b99e65-32d3-43bc-89d9-2e7c7838aa14","3af57f54-117e-43fc-b0ae-21ef772d854e","3efb2cf8-9b0e-4d76-afb1-c4ecd514d534","3f2b939c-2206-469b-85a4-b0ee9ba25be8","3f5814b3-4ffd-44b6-840e-ebd3474b3564","444d5f08-e491-4ff7-bf35-c26ae972f3ff","46ff6f79-385d-4c47-ae0e-78930642da13","4dd36cf5-8f73-404a-8b1d-3bd53bd90c25","5243e601-42c2-48c7-8600-8806cea4185d","5721945b-269b-428d-9e99-b9da8dfb534f","5747157d-7bcd-4021-83f1-289f348e9c3f","5803313b-e7f3-4c2f-b646-516c9b2a616a","5999f3c3-3225-4d24-82cd-0b8d7a309587","5a8157d3-ba20-4abf-b0d4-6ad141b31d63","5d7df029-54b5-419f-b0a4-2a1322a00718","5e7bb2c8-9ae2-4ea0-a084-6ea1323ffbb4","603741db-1545-4c6f-ab7c-be9f5f42e49d","60d2b60f-cbc1-4716-9c2a-ffc8292e3c85","616098ee-42dd-4d10-badb-be628e7763fb","66a32123-df98-43fe-8c8a-e153bc3b0c07","683d563f-0686-4964-8183-cf08758cae71","69df20d9-b1d5-47dc-9ff0-29987284f8c7","6a30d67a-49ae-4d5c-8b60-5bc8453e9341","6b6b766a-9618-4134-9187-2a8e7bdf3665","6eda7c38-6193-4005-9476-fe0137c36098","6fa888fc-a9d5-47f3-b28f-660d169875ae","72274f64-50eb-4725-bf20-5c05e2784154","72e126d5-afe4-4dd2-ab69-da135414791a","77a4aae7-a0cc-4f86-b91f-ec4112c6d3be","81bfe460-07f8-4044-8858-b6435f6268af","824f98e1-620b-41e5-8453-864bb67b4358","83a2a183-7354-4ba8-bd8d-9b6fd1d1a351","86817b05-450c-4af0-aeea-acba2ac00601","86b99b2c-a270-4390-b386-496fddbb2702","88603d5f-4ad0-46ab-999f-740312dc35dc","8c3e312d-c7e7-49f2-9e6c-776f3a387d86","8c9cb953-0995-4f47-83ee-c8c9dfd1b533","8f0eccce-728f-4039-959b-4887ae32325f","8f84a572-a5a9-4c7b-adc5-ad209393befa","900ec197-720e-5428-b526-055b7756aa4a","928227bf-89c5-4c64-9823-0e84cc669388","944d3e60-7eee-11de-a413-0002a5d5c51b","94679f29-d63a-41a5-bdda-3aa3fc2db531","946b4df5-f1dc-42a7-acb9-1d2543c9bb44","94b95304-8d3b-496a-8d2c-22ae89688427","96ad4352-fff3-46a7-85de-466cc161045e","97081243-cc59-4025-a5a7-4a71a260ac4c","9709f2b9-092e-4175-ae1e-a6253c0f658f","994dfdaa-6cf7-4177-8cea-b20b56f1512a","9cfea43d-ed03-4ab9-aa16-9d738ea00378","9ee2fa21-b80d-449a-8e36-260cc79ef600","a113fda0-0637-4645-b05e-8a401bb0a063","a1b2e514-b75d-4f01-a9fd-83151f0ce813","a1df89be-8dbe-465b-9d52-a4e767ab7dc3","a3185171-0581-4e49-9be0-ec2dce877aa4","a33e88ea-3761-4b1e-bcb3-0a2ddf6794c6","a4c772dc-32d8-4a53-a7c4-80114df47642","a4cd874d-65a7-4159-adcf-a694642dc24e","a5162476-1217-41c0-bc7e-0a0f123f069f","a598f735-d2e2-43ad-be77-8627ea4a9b78","a6cce10a-23ba-4eb1-9b1b-0f962f42df81","a7203c66-9a88-4669-860b-9bc3a0c854cb","a7a7ba28-78c5-453e-a101-61c6afa40216","a95425ac-6ab7-45e4-820d-bddffde30a0f","a996e110-4b51-4ad7-aee1-979a80363915","aa4940e0-9983-4b53-8278-78c5fcaceba5","aa4d77fb-8d49-4212-8535-9ab8ea7e30d5","aa7ac2bf-d9ed-445d-b394-4d3fe39780ca","ac0f82eb-6b88-491d-bf61-2d3e93fc78c6","acfe4393-bbda-4355-914b-d0c175189468","ae0de7f7-defe-41ec-8635-ee08948541f0","b43d7ece-d41f-4955-944c-416f479c5cc6"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?00109d18-397a-4c10-a28b-836d56d71829","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?03a90b9f-e4d9-48c7-8bb2-745f86cf0634","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?03c9ff0d-46e8-448c-944a-7ad59d1afd6d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?04c8ab3f-b026-4009-bf0f-d6eb71517d23","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0525087e-271c-47a1-8d4a-06b5ecac34b3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?056f088d-cff1-4b46-8539-ff85880586bf","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?094b64b3-cd32-4de5-afb6-ea00d9caad74","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0a1d47b5-0215-4636-acac-191e51df8754","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0a446947-2cda-4a32-aa6a-53e09245825a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0b46314b-604d-48ed-9d31-83a18ef4134c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0d1017df-f9b5-4165-978c-f8dd58df2ca0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0ffab497-1988-426b-8c9e-3be653a203dd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?11eddb9e-1cd6-4205-a3ce-c595c88e9d55","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?205be197-5ad5-4849-bc78-5fda9927b531","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?20bb6bb4-230a-c9c2-01d8-a6e9341e96ba","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?23a60947-6058-4bf7-a3ee-ae396e55d939","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2426980d-f1b4-45d3-9d1a-156548a2c872","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?243254d5-afd7-474f-b5d7-182b471bda06","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?25c2a91c-dfc2-4596-8a24-63acf04a2568","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?28156b13-0ba9-4dc4-be24-9c3070a7e1cc","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?281a38ef-c755-4a37-8dca-4776a9dfeb7f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?29a8d7c5-288e-4305-8d64-42d8158ae4cd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?29d70f34-6f64-415a-a051-0e5cd1ee39d5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2cb9090d-76dd-44a2-9590-37c6e7ed495b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2daac07a-7b11-4e90-bc56-20a4f54fbbf8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3132ab0a-53ee-4f46-ad5f-2e4af77bc54c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?32664ae8-78dd-408c-a49f-e0bdf01752dc","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?346fd641-7fe2-44e6-adf9-a9fc32126b81","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?35b99e65-32d3-43bc-89d9-2e7c7838aa14","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3af57f54-117e-43fc-b0ae-21ef772d854e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3efb2cf8-9b0e-4d76-afb1-c4ecd514d534","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3f2b939c-2206-469b-85a4-b0ee9ba25be8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3f5814b3-4ffd-44b6-840e-ebd3474b3564","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?444d5f08-e491-4ff7-bf35-c26ae972f3ff","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?46ff6f79-385d-4c47-ae0e-78930642da13","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4dd36cf5-8f73-404a-8b1d-3bd53bd90c25","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5243e601-42c2-48c7-8600-8806cea4185d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5721945b-269b-428d-9e99-b9da8dfb534f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5747157d-7bcd-4021-83f1-289f348e9c3f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5803313b-e7f3-4c2f-b646-516c9b2a616a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5999f3c3-3225-4d24-82cd-0b8d7a309587","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5a8157d3-ba20-4abf-b0d4-6ad141b31d63","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5d7df029-54b5-419f-b0a4-2a1322a00718","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5e7bb2c8-9ae2-4ea0-a084-6ea1323ffbb4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?603741db-1545-4c6f-ab7c-be9f5f42e49d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?60d2b60f-cbc1-4716-9c2a-ffc8292e3c85","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?616098ee-42dd-4d10-badb-be628e7763fb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?66a32123-df98-43fe-8c8a-e153bc3b0c07","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?683d563f-0686-4964-8183-cf08758cae71","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?69df20d9-b1d5-47dc-9ff0-29987284f8c7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6a30d67a-49ae-4d5c-8b60-5bc8453e9341","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6b6b766a-9618-4134-9187-2a8e7bdf3665","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6eda7c38-6193-4005-9476-fe0137c36098","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6fa888fc-a9d5-47f3-b28f-660d169875ae","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?72274f64-50eb-4725-bf20-5c05e2784154","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?72e126d5-afe4-4dd2-ab69-da135414791a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?77a4aae7-a0cc-4f86-b91f-ec4112c6d3be","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?81bfe460-07f8-4044-8858-b6435f6268af","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?824f98e1-620b-41e5-8453-864bb67b4358","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?83a2a183-7354-4ba8-bd8d-9b6fd1d1a351","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?86817b05-450c-4af0-aeea-acba2ac00601","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?86b99b2c-a270-4390-b386-496fddbb2702","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?88603d5f-4ad0-46ab-999f-740312dc35dc","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8c3e312d-c7e7-49f2-9e6c-776f3a387d86","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8c9cb953-0995-4f47-83ee-c8c9dfd1b533","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8f0eccce-728f-4039-959b-4887ae32325f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8f84a572-a5a9-4c7b-adc5-ad209393befa","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?900ec197-720e-5428-b526-055b7756aa4a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?928227bf-89c5-4c64-9823-0e84cc669388","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?944d3e60-7eee-11de-a413-0002a5d5c51b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?94679f29-d63a-41a5-bdda-3aa3fc2db531","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?946b4df5-f1dc-42a7-acb9-1d2543c9bb44","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?94b95304-8d3b-496a-8d2c-22ae89688427","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?96ad4352-fff3-46a7-85de-466cc161045e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?97081243-cc59-4025-a5a7-4a71a260ac4c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9709f2b9-092e-4175-ae1e-a6253c0f658f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?994dfdaa-6cf7-4177-8cea-b20b56f1512a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9cfea43d-ed03-4ab9-aa16-9d738ea00378","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9ee2fa21-b80d-449a-8e36-260cc79ef600","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a113fda0-0637-4645-b05e-8a401bb0a063","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a1b2e514-b75d-4f01-a9fd-83151f0ce813","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a1df89be-8dbe-465b-9d52-a4e767ab7dc3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a3185171-0581-4e49-9be0-ec2dce877aa4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a33e88ea-3761-4b1e-bcb3-0a2ddf6794c6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a4c772dc-32d8-4a53-a7c4-80114df47642","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a4cd874d-65a7-4159-adcf-a694642dc24e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a5162476-1217-41c0-bc7e-0a0f123f069f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a598f735-d2e2-43ad-be77-8627ea4a9b78","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a6cce10a-23ba-4eb1-9b1b-0f962f42df81","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a7203c66-9a88-4669-860b-9bc3a0c854cb","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a7a7ba28-78c5-453e-a101-61c6afa40216","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a95425ac-6ab7-45e4-820d-bddffde30a0f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a996e110-4b51-4ad7-aee1-979a80363915","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?aa4940e0-9983-4b53-8278-78c5fcaceba5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?aa4d77fb-8d49-4212-8535-9ab8ea7e30d5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?aa7ac2bf-d9ed-445d-b394-4d3fe39780ca","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ac0f82eb-6b88-491d-bf61-2d3e93fc78c6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?acfe4393-bbda-4355-914b-d0c175189468","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ae0de7f7-defe-41ec-8635-ee08948541f0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b43d7ece-d41f-4955-944c-416f479c5cc6"]},{"source":"FDA","ids":["000dde4b-1d94-442f-94c0-26e283e04d88","02029af4-f821-4a13-b195-f3fe0f67cb07","07458304-ebc7-4c3f-9920-e6acca76d074","0ad893bd-5e2e-4ea4-b11c-80ed34a85b35","0f55e641-862e-4445-b8e2-7fa5e2e155f3","1174649e-e6eb-47ec-a8d4-379e186f8a64","1affabf4-d808-4dc4-ad48-ea4fc9b3c28d","206a6da0-2411-48e7-94e6-8a115fc9ff07","215fc8cf-92a0-98d6-c084-3575882f0a66","240118ae-2cf5-4e48-a182-7c37026d59b5","28e157c7-6b3b-4dc2-adf3-e6c212515118","2c896e29-a2c6-49b2-a99f-9131e09fbaa7","2dc39f78-95a8-4c2b-8bbb-8ed9156a0f0e","3bfe9f12-5af5-404e-9ba5-98ed8d7d644d","46345ce2-4038-4928-916d-f3764bddf456","486db2f4-1233-4327-8b56-9faecdae2951","5493b9ac-aabc-4858-8c8e-8febf8d2aedf","599803dc-7595-482f-aa7e-70d349fbe699","59c12ad6-478c-445b-90ab-0ca513e4d3fa","5d1e0e59-f3af-496d-a878-547b5467cd99","61b0c7d6-21ff-4a07-b737-1edd105bb74d","6beb5fe9-ff58-4fa6-bd69-7790412bdb06","6c428e0d-2882-45e6-976b-5ae1f8aa1867","6c87f781-b347-4651-b244-33a6813d34ae","6d577d77-fcd2-498f-b76e-3097e76c959b","6dbf24ce-1200-49ea-95ad-9a06f6db3c1b","72260dc5-08eb-4b91-ae54-c7be35242b70","73f5c8ea-a8d8-447f-b323-613a4af747c2","79b4518f-9360-443a-b63c-d8e3ade1ef12","7a804956-0d78-4d51-8129-17c925931794","7c7fdf76-4562-4267-9ba3-8a6eb85a4388","7d2d79e4-33ae-4436-98e3-14e91753886c","7e593aec-4ef2-445c-b4e9-13dfc99296f2","7ff22143-2093-4233-ac99-0116ee2fb7c5","82b39e9b-0241-43c6-90f2-97543a2c7010","8b91ade4-5fcc-473e-b3e5-77f9b4810d24","b82495ce-8d77-4e12-a064-274a88448ba3","bbb6aa31-8f6a-47f7-8d75-757e35443695"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A000dde4b-1d94-442f-94c0-26e283e04d88","https://api.fda.gov/drug/label.json?search=set_id%3A02029af4-f821-4a13-b195-f3fe0f67cb07","https://api.fda.gov/drug/label.json?search=set_id%3A07458304-ebc7-4c3f-9920-e6acca76d074","https://api.fda.gov/drug/label.json?search=set_id%3A0ad893bd-5e2e-4ea4-b11c-80ed34a85b35","https://api.fda.gov/drug/label.json?search=set_id%3A0f55e641-862e-4445-b8e2-7fa5e2e155f3","https://api.fda.gov/drug/label.json?search=set_id%3A1174649e-e6eb-47ec-a8d4-379e186f8a64","https://api.fda.gov/drug/label.json?search=set_id%3A1affabf4-d808-4dc4-ad48-ea4fc9b3c28d","https://api.fda.gov/drug/label.json?search=set_id%3A206a6da0-2411-48e7-94e6-8a115fc9ff07","https://api.fda.gov/drug/label.json?search=set_id%3A215fc8cf-92a0-98d6-c084-3575882f0a66","https://api.fda.gov/drug/label.json?search=set_id%3A240118ae-2cf5-4e48-a182-7c37026d59b5","https://api.fda.gov/drug/label.json?search=set_id%3A28e157c7-6b3b-4dc2-adf3-e6c212515118","https://api.fda.gov/drug/label.json?search=set_id%3A2c896e29-a2c6-49b2-a99f-9131e09fbaa7","https://api.fda.gov/drug/label.json?search=set_id%3A2dc39f78-95a8-4c2b-8bbb-8ed9156a0f0e","https://api.fda.gov/drug/label.json?search=set_id%3A3bfe9f12-5af5-404e-9ba5-98ed8d7d644d","https://api.fda.gov/drug/label.json?search=set_id%3A46345ce2-4038-4928-916d-f3764bddf456","https://api.fda.gov/drug/label.json?search=set_id%3A486db2f4-1233-4327-8b56-9faecdae2951","https://api.fda.gov/drug/label.json?search=set_id%3A5493b9ac-aabc-4858-8c8e-8febf8d2aedf","https://api.fda.gov/drug/label.json?search=set_id%3A599803dc-7595-482f-aa7e-70d349fbe699","https://api.fda.gov/drug/label.json?search=set_id%3A59c12ad6-478c-445b-90ab-0ca513e4d3fa","https://api.fda.gov/drug/label.json?search=set_id%3A5d1e0e59-f3af-496d-a878-547b5467cd99","https://api.fda.gov/drug/label.json?search=set_id%3A61b0c7d6-21ff-4a07-b737-1edd105bb74d","https://api.fda.gov/drug/label.json?search=set_id%3A6beb5fe9-ff58-4fa6-bd69-7790412bdb06","https://api.fda.gov/drug/label.json?search=set_id%3A6c428e0d-2882-45e6-976b-5ae1f8aa1867","https://api.fda.gov/drug/label.json?search=set_id%3A6c87f781-b347-4651-b244-33a6813d34ae","https://api.fda.gov/drug/label.json?search=set_id%3A6d577d77-fcd2-498f-b76e-3097e76c959b","https://api.fda.gov/drug/label.json?search=set_id%3A6dbf24ce-1200-49ea-95ad-9a06f6db3c1b","https://api.fda.gov/drug/label.json?search=set_id%3A72260dc5-08eb-4b91-ae54-c7be35242b70","https://api.fda.gov/drug/label.json?search=set_id%3A73f5c8ea-a8d8-447f-b323-613a4af747c2","https://api.fda.gov/drug/label.json?search=set_id%3A79b4518f-9360-443a-b63c-d8e3ade1ef12","https://api.fda.gov/drug/label.json?search=set_id%3A7a804956-0d78-4d51-8129-17c925931794","https://api.fda.gov/drug/label.json?search=set_id%3A7c7fdf76-4562-4267-9ba3-8a6eb85a4388","https://api.fda.gov/drug/label.json?search=set_id%3A7d2d79e4-33ae-4436-98e3-14e91753886c","https://api.fda.gov/drug/label.json?search=set_id%3A7e593aec-4ef2-445c-b4e9-13dfc99296f2","https://api.fda.gov/drug/label.json?search=set_id%3A7ff22143-2093-4233-ac99-0116ee2fb7c5","https://api.fda.gov/drug/label.json?search=set_id%3A82b39e9b-0241-43c6-90f2-97543a2c7010","https://api.fda.gov/drug/label.json?search=set_id%3A8b91ade4-5fcc-473e-b3e5-77f9b4810d24","https://api.fda.gov/drug/label.json?search=set_id%3Ab82495ce-8d77-4e12-a064-274a88448ba3","https://api.fda.gov/drug/label.json?search=set_id%3Abbb6aa31-8f6a-47f7-8d75-757e35443695"]}]},{"efo_id":"EFO_0004616","efo_label":"osteoarthritis, knee","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004616","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01366014"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01366014%22"]}]},{"efo_id":"EFO_1000786","efo_label":"osteoarthritis, hip","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000786","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00399048"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00399048%22"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["061cf52b-4432-422d-a97b-c3e1f8c4bab6","566ef74d-5c0b-49bf-9619-e757d16431ef","6869fec9-1837-4221-afd8-5cc6fadd025d","6eaff86d-3b90-499e-b46f-316a35f5d811","6fcb8041-c9c7-4a31-8f1a-35e54d33f46f","7290eb06-641a-43df-9a23-74288ca1e25d","75a36759-c970-4689-b373-a6a15b6a1a3c","7c686a46-1f5f-46e3-945b-2ade3931718f","a22b4011-322d-4b61-9349-1b32e1f3a361","c0d7293d-5203-4fbe-b944-3960810cb24c","d46fcd26-a828-4b9f-af88-1f62a7cb9598","d57345c9-19cf-4d12-a7b1-e0c5f78d5198","d7dceba3-96dc-4593-bc8f-318052bdb520","d8e87c66-f872-4e1d-9ade-ef11490af63b","edf94500-97e2-4782-8371-e1f12c78457f"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?061cf52b-4432-422d-a97b-c3e1f8c4bab6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?566ef74d-5c0b-49bf-9619-e757d16431ef","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6869fec9-1837-4221-afd8-5cc6fadd025d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6eaff86d-3b90-499e-b46f-316a35f5d811","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6fcb8041-c9c7-4a31-8f1a-35e54d33f46f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7290eb06-641a-43df-9a23-74288ca1e25d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?75a36759-c970-4689-b373-a6a15b6a1a3c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7c686a46-1f5f-46e3-945b-2ade3931718f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a22b4011-322d-4b61-9349-1b32e1f3a361","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c0d7293d-5203-4fbe-b944-3960810cb24c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d46fcd26-a828-4b9f-af88-1f62a7cb9598","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d57345c9-19cf-4d12-a7b1-e0c5f78d5198","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d7dceba3-96dc-4593-bc8f-318052bdb520","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d8e87c66-f872-4e1d-9ade-ef11490af63b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?edf94500-97e2-4782-8371-e1f12c78457f"]},{"source":"FDA","ids":["72260dc5-08eb-4b91-ae54-c7be35242b70"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A72260dc5-08eb-4b91-ae54-c7be35242b70"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["3f5814b3-4ffd-44b6-840e-ebd3474b3564"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3f5814b3-4ffd-44b6-840e-ebd3474b3564"]},{"source":"FDA","ids":["59c12ad6-478c-445b-90ab-0ca513e4d3fa"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A59c12ad6-478c-445b-90ab-0ca513e4d3fa"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["946b4df5-f1dc-42a7-acb9-1d2543c9bb44"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?946b4df5-f1dc-42a7-acb9-1d2543c9bb44"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000112038","approved_name":"opioid receptor mu 1","approved_symbol":"OPRM1"}],"target_type":"single protein","target_name":"Mu opioid receptor","action_type":"agonist","description":"Mu opioid receptor agonist","references":[{"source":"DailyMed","ids":["setid=dd9f9d6d-9a59-4f74-8fe7-685e0c3c5fd4#nlm34090-1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd9f9d6d-9a59-4f74-8fe7-685e0c3c5fd4#nlm34090-1"]}]}],"adverse_events":{"significant":[{"event":"drug abuser","count":2112,"llr":4259.410798},{"event":"drug dependence","count":7072,"llr":3138.066221},{"event":"drug withdrawal syndrome","count":13453,"llr":1542.747631},{"event":"inadequate analgesia","count":1325,"llr":1204.658848},{"event":"somnolence","count":38949,"llr":939.009596},{"event":"polysubstance abuse","count":267,"llr":861.3514872},{"event":"constipation","count":39620,"llr":677.0881448},{"event":"drug hypersensitivity","count":71246,"llr":628.6637568},{"event":"delirium","count":11053,"llr":601.2170979},{"event":"coma","count":13175,"llr":598.5455156},{"event":"confusional state","count":40628,"llr":549.6001057},{"event":"miosis","count":2714,"llr":542.931175},{"event":"respiratory depression","count":3384,"llr":540.6573537},{"event":"pain","count":94786,"llr":431.305113},{"event":"drug abuse","count":14574,"llr":427.3538253},{"event":"drug tolerance","count":884,"llr":417.8157989},{"event":"depressed level of consciousness","count":10912,"llr":385.8370368},{"event":"drug screen positive","count":1833,"llr":297.522771},{"event":"mental status changes","count":10001,"llr":293.1310764},{"event":"sedation","count":6964,"llr":279.4156404},{"event":"agitation","count":21093,"llr":274.1768114},{"event":"vomiting","count":103943,"llr":273.084683},{"event":"hyperhidrosis","count":28377,"llr":265.9072569},{"event":"respiratory rate decreased","count":970,"llr":264.9307974},{"event":"lethargy","count":17134,"llr":258.3424327},{"event":"unresponsive to stimuli","count":6342,"llr":253.1850914},{"event":"presbyacusis","count":106,"llr":222.8639777},{"event":"pharmaceutical product complaint","count":7517,"llr":213.2643789},{"event":"deafness neurosensory","count":1280,"llr":211.5821622},{"event":"delusional disorder, unspecified type","count":234,"llr":208.036021},{"event":"hyperaesthesia","count":1976,"llr":205.3267167},{"event":"depression","count":45027,"llr":196.0434054},{"event":"anxiety","count":45966,"llr":190.2966204},{"event":"pleural thickening","count":118,"llr":186.9996985},{"event":"loss of consciousness","count":30434,"llr":184.6756893},{"event":"hallucination","count":16074,"llr":180.9108777},{"event":"nausea","count":165652,"llr":180.4968647},{"event":"sinus tachycardia","count":5084,"llr":178.2813018},{"event":"substance abuse","count":1041,"llr":162.8629093},{"event":"therapeutic response unexpected with drug substitution","count":2352,"llr":158.550339},{"event":"pleural fibrosis","count":357,"llr":155.2192053},{"event":"oxygen saturation decreased","count":10498,"llr":149.8000258},{"event":"serotonin syndrome","count":6002,"llr":146.5179135},{"event":"blood magnesium increased","count":289,"llr":145.3708472}],"critval":143.2192894},"child_chembl_ids":["CHEMBL1200890","CHEMBL3989826"],"number_of_indications":28,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":10},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":6},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":6},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":3},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":2},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":2},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"OTAR_0000014","therapeutic_label":"pregnancy or perinatal disease","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108518","_score":1,"_source":{"id":"CHEMBL2108518","internal_compound":false,"type":"Unknown","pref_name":"GELATIN","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Gelatin"],"trade_names":["Gelofusine","Gppe Inf","Haemaccel","Isoplex","Volplex"],"indications":[{"efo_id":"EFO_0003047","efo_label":"hepatitis C virus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003047","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01308606"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01308606%22"]}]},{"efo_id":"EFO_0000224","efo_label":"acute promyelocytic leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000224","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00675870"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00675870%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02040480"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02040480%22"]}]},{"efo_id":"EFO_0001360","efo_label":"type II diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001360","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02541734"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02541734%22"]}]},{"efo_id":"EFO_0002892","efo_label":"thyroid carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002892","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03246659"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03246659%22"]}]},{"efo_id":"EFO_0003932","efo_label":"bacterial vaginosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003932","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT02139839"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02139839%22"]}]},{"efo_id":"Orphanet_44890","efo_label":"Gastrointestinal stromal tumor","efo_uri":"http://www.orpha.net/ORDO/Orphanet_44890","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01907607"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01907607%22"]}]},{"efo_id":"EFO_0009472","efo_label":"tympanic membrane perforation","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009472","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02550314"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02550314%22"]}]}],"adverse_events":{"significant":[{"event":"hepatic artery stenosis","count":63,"llr":81.77513137},{"event":"anaphylactic reaction","count":16695,"llr":50.12132631},{"event":"anaphylactic shock","count":6651,"llr":30.74333202},{"event":"stridor","count":1098,"llr":22.950211},{"event":"hypotension","count":55121,"llr":22.77304214},{"event":"breath sounds abnormal","count":1171,"llr":22.62957143},{"event":"erythema","count":35163,"llr":22.04440163},{"event":"oxygen saturation decreased","count":10498,"llr":18.9330752},{"event":"wheezing","count":9665,"llr":15.76546128},{"event":"hepatic artery occlusion","count":28,"llr":14.63315698},{"event":"liver abscess","count":841,"llr":12.99511237},{"event":"swelling face","count":15924,"llr":12.87105306},{"event":"hypernatraemia","count":1567,"llr":11.14043701}],"critval":9.837348007},"number_of_indications":8,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":4},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1342","_score":1,"_source":{"id":"CHEMBL1342","internal_compound":false,"type":"Small molecule","pref_name":"OXYBATE","year_first_approved":2002,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":[".gamma.-hydroxybutyrate sodium salt","NSC-84223","Oxybate","Oxybate sodium","Sodium Oxybate","Sodium oxybate","WY-3478","Xyrem"],"trade_names":["Xyrem"],"cross_references":[{"source":"ChEBI","ids":[30830]},{"source":"DailyMed","ids":["sodium%20oxybate"]},{"source":"Wikipedia","ids":["Gamma-Hydroxybutyric_acid"]},{"source":"drugbank","ids":["DB01440"]},{"source":"DrugCentral","ids":["4566"]},{"source":"PubChem","ids":["144206424"]},{"source":"Wikipedia","ids":["Sodium_oxybate"]},{"source":"drugbank","ids":["DB09072"]}],"canonical_smiles":"O=C(O)CCCO","adverse_events":{"significant":[{"event":"cataplexy","count":343,"llr":1089.350844},{"event":"sleep apnoea syndrome","count":4137,"llr":945.7506587},{"event":"somnolence","count":38949,"llr":884.6610486},{"event":"insomnia","count":44658,"llr":627.320944},{"event":"somnambulism","count":1422,"llr":611.3254788},{"event":"feeling abnormal","count":36538,"llr":595.2859626},{"event":"unevaluable event","count":14822,"llr":594.065457},{"event":"anxiety","count":45966,"llr":564.519147},{"event":"depression","count":45027,"llr":477.0272366},{"event":"initial insomnia","count":1234,"llr":373.4313198},{"event":"condition aggravated","count":52909,"llr":363.6850218},{"event":"pre-existing condition improved","count":938,"llr":347.3460761},{"event":"poor quality sleep","count":3130,"llr":344.6089334},{"event":"suicidal ideation","count":21218,"llr":336.3819803},{"event":"enuresis","count":884,"llr":333.8162567},{"event":"snoring","count":765,"llr":276.0178639},{"event":"nasopharyngitis","count":30974,"llr":270.5716052},{"event":"weight decreased","count":46078,"llr":252.3812626},{"event":"hunger","count":1089,"llr":222.6529779},{"event":"feeling drunk","count":1316,"llr":217.0574047},{"event":"migraine","count":14792,"llr":207.8021081},{"event":"sleep paralysis","count":198,"llr":200.7564497},{"event":"lethargy","count":17134,"llr":196.1869392},{"event":"parasomnia","count":214,"llr":191.9785011},{"event":"sleep-related eating disorder","count":249,"llr":188.7239308},{"event":"fall","count":67604,"llr":180.4128251},{"event":"therapeutic response unexpected","count":4551,"llr":164.124768},{"event":"hangover","count":508,"llr":163.118572},{"event":"stress","count":9267,"llr":161.5663347},{"event":"abnormal dreams","count":4584,"llr":158.6441046},{"event":"suicide attempt","count":20244,"llr":154.5939212},{"event":"narcolepsy","count":339,"llr":147.459586},{"event":"nausea","count":165652,"llr":146.8388421},{"event":"middle insomnia","count":2446,"llr":145.1658738},{"event":"fibromyalgia","count":3651,"llr":143.5448249},{"event":"tremor","count":36500,"llr":139.9559724},{"event":"dizziness","count":99375,"llr":136.6265528},{"event":"confusional state","count":40628,"llr":127.6149949},{"event":"blood pressure increased","count":25616,"llr":125.415012},{"event":"injection site pain","count":56727,"llr":123.0359595},{"event":"abnormal sleep-related event","count":279,"llr":122.6573081},{"event":"bipolar disorder","count":2203,"llr":120.3855934},{"event":"restless legs syndrome","count":3502,"llr":115.7563054},{"event":"irritability","count":14353,"llr":107.0422677},{"event":"drug tolerance","count":884,"llr":106.8107853}],"critval":106.5162525},"child_chembl_ids":["CHEMBL1200682"],"indications":[{"efo_id":"EFO_0005203","efo_label":"eating disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005203","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00514995"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00514995%22"]}]},{"efo_id":"EFO_0005687","efo_label":"fibromyalgia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005687","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00087555","NCT00371137","NCT00423605","NCT00423813","NCT00803023"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00087555%22OR%22NCT00371137%22OR%22NCT00423605%22OR%22NCT00423813%22OR%22NCT00803023%22"]}]},{"efo_id":"Orphanet_2131","efo_label":"Alternating hemiplegia of childhood","efo_uri":"http://www.orpha.net/ORDO/Orphanet_2131","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00931164"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00931164%22"]}]},{"efo_id":"EFO_0000614","efo_label":"narcolepsy with cataplexy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000614","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00049803","NCT00066170","NCT00132873","NCT02221869"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00049803%22OR%22NCT00066170%22OR%22NCT00132873%22OR%22NCT02221869%22"]},{"source":"DailyMed","ids":["926eb076-a4a8-45e4-91ef-411f0aa4f3ca"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?926eb076-a4a8-45e4-91ef-411f0aa4f3ca"]}]},{"efo_id":"EFO_0002508","efo_label":"Parkinson's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002508","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02111122"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02111122%22"]}]},{"efo_id":"EFO_0003108","efo_label":"essential tremor","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003108","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00598078"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00598078%22"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02637648"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02637648%22"]}]},{"efo_id":"EFO_0004698","efo_label":"insomnia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004698","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00383643"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00383643%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000204681","approved_name":"gamma-aminobutyric acid type B receptor subunit 1","approved_symbol":"GABBR1"},{"ensembl":"ENSG00000136928","approved_name":"gamma-aminobutyric acid type B receptor subunit 2","approved_symbol":"GABBR2"}],"target_type":"protein complex","target_name":"GABA-B receptor","action_type":"agonist","description":"GABA-B receptor agonist","references":[{"source":"DailyMed","ids":["setid=926eb076-a4a8-45e4-91ef-411f0aa4f3ca#nlm34090-1"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=926eb076-a4a8-45e4-91ef-411f0aa4f3ca#nlm34090-1"]},{"source":"PubMed","ids":["23065655"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23065655"]}]}],"number_of_indications":8,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":5},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":3},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":2},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1140","_score":1,"_source":{"id":"CHEMBL1140","internal_compound":false,"type":"Small molecule","pref_name":"NIACINAMIDE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["NSC-13128","NSC-27452","Niacinamide","Nicotinamide","Nicotinic Acid Amide","Nicotylamide"],"trade_names":["Freederm","Niatin","Nicam","Nicobion","Papulex"],"cross_references":[{"source":"ChEBI","ids":[17154]},{"source":"DailyMed","ids":["niacinamide"]},{"source":"PubChem","ids":["144204753","144208914","144213093","170464905","174007286","29215143","8139965"]},{"source":"Wikipedia","ids":["Nicotinamide"]},{"source":"drugbank","ids":["DB02701"]}],"canonical_smiles":"NC(=O)c1cccnc1","indications":[{"efo_id":"EFO_0003884","efo_label":"chronic kidney disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003884","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01011699","NCT02258074"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01011699%22OR%22NCT02258074%22"]}]},{"efo_id":"EFO_0000249","efo_label":"Alzheimer's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000249","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00580931"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00580931%22"]}]},{"efo_id":"EFO_0000676","efo_label":"psoriasis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000676","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01368887"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01368887%22"]}]},{"efo_id":"EFO_0000668","efo_label":"preeclampsia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000668","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02213094","NCT03419364"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02213094%22OR%22NCT03419364%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02416739"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02416739%22"]}]},{"efo_id":"EFO_0004272","efo_label":"anemia (phenotype)","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004272","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["4d4d823b-ff2f-4746-9bd7-44def2b81347"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4d4d823b-ff2f-4746-9bd7-44def2b81347"]},{"source":"FDA","ids":["2d207dad-c8bf-44d9-9065-692a3ea5217b","3c2df670-f894-48e5-b08a-6ad5d293429b","d68362a4-05ca-4062-8863-62c5a2d8177a"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A2d207dad-c8bf-44d9-9065-692a3ea5217b","https://api.fda.gov/drug/label.json?search=set_id%3A3c2df670-f894-48e5-b08a-6ad5d293429b","https://api.fda.gov/drug/label.json?search=set_id%3Ad68362a4-05ca-4062-8863-62c5a2d8177a"]}]},{"efo_id":"HP_0001891","efo_label":"Iron deficiency anemia","efo_uri":"http://purl.obolibrary.org/obo/HP_0001891","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["56e912df-3a49-4405-8df1-7b80d12bd920","578a7991-b26a-4544-9836-d5018eaeff37","bf9624d8-b2ef-45a4-9ad6-a3b8701e76b7","e174c804-fe33-4cd8-809a-d107b5200064"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?56e912df-3a49-4405-8df1-7b80d12bd920","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?578a7991-b26a-4544-9836-d5018eaeff37","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bf9624d8-b2ef-45a4-9ad6-a3b8701e76b7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e174c804-fe33-4cd8-809a-d107b5200064"]}]},{"efo_id":"EFO_0000183","efo_label":"Hodgkins lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000183","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00691210"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00691210%22"]}]},{"efo_id":"EFO_0000292","efo_label":"bladder carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000292","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00033436"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00033436%22"]}]},{"efo_id":"EFO_0003885","efo_label":"multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003885","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01381354"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01381354%22"]}]},{"efo_id":"EFO_0003963","efo_label":"freckles","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003963","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT03392623"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03392623%22"]}]},{"efo_id":"EFO_0005772","efo_label":"neurodegenerative disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005772","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01589809"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01589809%22"]}]},{"efo_id":"EFO_0005952","efo_label":"non-Hodgkins lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005952","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00691210"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00691210%22"]}]},{"efo_id":"EFO_1001068","efo_label":"obstructive jaundice","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001068","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03418935"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03418935%22"]}]},{"efo_id":"HP_0001919","efo_label":"Acute kidney injury","efo_uri":"http://purl.obolibrary.org/obo/HP_0001919","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT02701127"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02701127%22"]}]},{"efo_id":"EFO_0000707","efo_label":"squamous cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000707","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03769285"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03769285%22"]}]},{"efo_id":"EFO_0003894","efo_label":"acne","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003894","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["e25686be-d652-4ac5-8d52-4d9de03eec3b"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e25686be-d652-4ac5-8d52-4d9de03eec3b"]}]},{"efo_id":"EFO_0004193","efo_label":"basal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004193","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03769285"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03769285%22"]}]},{"efo_id":"EFO_0008572","efo_label":"malnutrition","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008572","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03268902"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03268902%22"]}]},{"efo_id":"EFO_0008620","efo_label":"Polycystic Kidney Disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008620","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02140814","NCT02558595"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02140814%22OR%22NCT02558595%22"]}]},{"efo_id":"Orphanet_232","efo_label":"Sickle cell anemia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_232","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT04055818"],"urls":["https://clinicaltrials.gov/search?id=%22NCT04055818%22"]}]},{"efo_id":"Orphanet_95","efo_label":"Friedreich ataxia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_95","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03761511"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03761511%22"]}]}],"adverse_events":{"significant":[{"event":"pneumonia aspiration","count":5215,"llr":312.2220742},{"event":"coma","count":13175,"llr":241.1362856},{"event":"gastrooesophageal reflux disease","count":14790,"llr":231.7312203},{"event":"somnolence","count":38949,"llr":162.9462784},{"event":"bronchospasm","count":4962,"llr":99.97561758},{"event":"arteriospasm coronary","count":1404,"llr":54.79458231},{"event":"ventricular tachycardia","count":5901,"llr":38.53934362},{"event":"supraventricular tachycardia","count":3329,"llr":37.71232453},{"event":"pemphigus","count":997,"llr":28.69518661},{"event":"cardiac arrest","count":9359,"llr":25.52628452},{"event":"respiratory arrest","count":3162,"llr":24.87016206},{"event":"product compounding quality issue","count":98,"llr":24.52023364},{"event":"cardio-respiratory arrest","count":2972,"llr":22.28057363},{"event":"chronic kidney disease-mineral and bone disorder","count":44,"llr":21.91821787},{"event":"scrotal disorder","count":87,"llr":19.1973293},{"event":"pulmonary valve stenosis","count":286,"llr":19.19123243},{"event":"multiple congenital abnormalities","count":430,"llr":17.17227345},{"event":"haemodynamic instability","count":1660,"llr":17.10025274},{"event":"nonalcoholic fatty liver disease","count":27,"llr":17.03704711},{"event":"toxic skin eruption","count":3870,"llr":16.88526184},{"event":"hypoxia","count":9218,"llr":16.13843007},{"event":"tachycardia","count":26994,"llr":15.65620077},{"event":"tachycardia induced cardiomyopathy","count":46,"llr":15.44128315},{"event":"hypotension","count":55121,"llr":14.85439953},{"event":"bradycardia","count":20091,"llr":14.76921794},{"event":"respiratory distress","count":7103,"llr":14.13704258},{"event":"atrioventricular block complete","count":2688,"llr":13.86876041},{"event":"ventricular fibrillation","count":2934,"llr":13.2898495},{"event":"procedural complication","count":2098,"llr":12.41586295},{"event":"toxic epidermal necrolysis","count":4052,"llr":11.18482584},{"event":"epiglottitis","count":208,"llr":10.93718521},{"event":"heart rate abnormal","count":879,"llr":10.05607632},{"event":"respiratory depression","count":3384,"llr":9.725877657},{"event":"flushing","count":18642,"llr":8.984127282},{"event":"treatment failure","count":12895,"llr":8.973044649},{"event":"heart valve insufficiency","count":62,"llr":8.888793785}],"critval":8.846609242},"number_of_indications":22,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":6},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":5},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":5},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":4},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":4},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":4},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":3},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":3},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":2},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":2},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":2},{"therapeutic_code":"OTAR_0000014","therapeutic_label":"pregnancy or perinatal disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL75094","_score":1,"_source":{"id":"CHEMBL75094","internal_compound":false,"type":"Small molecule","pref_name":"PRINOMASTAT","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AG-3340","KB-R-9896","Prinomastat"],"trade_names":[],"cross_references":[{"source":"Wikipedia","ids":["Prinomastat"]},{"source":"drugbank","ids":["DB05100"]}],"canonical_smiles":"CC1(C)SCCN(S(=O)(=O)c2ccc(Oc3ccncc3)cc2)[C@H]1C(=O)NO","indications":[{"efo_id":"EFO_0000326","efo_label":"central nervous system cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000326","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00004200"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004200%22"]}]},{"efo_id":"EFO_0001071","efo_label":"lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001071","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00004199"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004199%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00003343"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003343%22"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1200539","_score":1,"_source":{"id":"CHEMBL1200539","internal_compound":false,"type":"Small molecule","pref_name":"CALCIUM CARBONATE","year_first_approved":2000,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Calcium Carbonate","Chalk","Chalk, Precipitated","E-170(I)","E170","INS NO.170(I)","INS-170(I)","NDI 443","Precipitated Calcium Carbonate","Precpitated calcium carbonate"],"trade_names":["Adcal","Albacar","Cacit","Cal-Sup","Calc 500","Calcette","Calcichew","Calcichew Fte","Calcidrink","Children's Mylanta Upset Stomach Relief","Chooz","Citrical","Mylanta Soothing Lozenges","Os-Cal","Precipitated Calcium Carbonate","Purecal","Remegel","Rennie","Rennie Fruit","Rennie Gold","Setlers","Titralac","Tums"],"cross_references":[{"source":"ChEBI","ids":[3311]},{"source":"DailyMed","ids":["calcium%20carbonate"]},{"source":"DrugCentral","ids":["4239"]},{"source":"Wikipedia","ids":["Calcium_carbonate"]},{"source":"drugbank","ids":["DB06724"]}],"canonical_smiles":"O=C([O-])[O-].[Ca+2]","indications":[{"efo_id":"EFO_0000401","efo_label":"diabetic nephropathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000401","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00967629","NCT01493050"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00967629%22OR%22NCT01493050%22"]}]},{"efo_id":"EFO_0001422","efo_label":"cirrhosis of liver","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001422","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02642484","NCT02642861","NCT02642874"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02642484%22OR%22NCT02642861%22OR%22NCT02642874%22"]}]},{"efo_id":"EFO_0004288","efo_label":"colonic neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004288","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02647671"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02647671%22"]}]},{"efo_id":"EFO_0003884","efo_label":"chronic kidney disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003884","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01994733"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01994733%22"]}]},{"efo_id":"EFO_0004272","efo_label":"anemia (phenotype)","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004272","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["0722734e-5a30-47af-99a3-2512848b45cd"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0722734e-5a30-47af-99a3-2512848b45cd"]},{"source":"FDA","ids":["3c2df670-f894-48e5-b08a-6ad5d293429b","d68362a4-05ca-4062-8863-62c5a2d8177a"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A3c2df670-f894-48e5-b08a-6ad5d293429b","https://api.fda.gov/drug/label.json?search=set_id%3Ad68362a4-05ca-4062-8863-62c5a2d8177a"]}]},{"efo_id":"EFO_0000180","efo_label":"HIV-1 infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000180","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01403051"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01403051%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01052051","NCT03057314"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01052051%22OR%22NCT03057314%22"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00061256","NCT01622673","NCT01762995","NCT02473367"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00061256%22OR%22NCT01622673%22OR%22NCT01762995%22OR%22NCT02473367%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02864784"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02864784%22"]}]},{"efo_id":"EFO_0002609","efo_label":"juvenile idiopathic arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002609","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00000429"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000429%22"]}]},{"efo_id":"EFO_0003762","efo_label":"vitamin D deficiency","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003762","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01190683","NCT01349127"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01190683%22OR%22NCT01349127%22"]}]},{"efo_id":"EFO_0003854","efo_label":"postmenopausal osteoporosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003854","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00620113","NCT00996801","NCT01552122"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00620113%22OR%22NCT00996801%22OR%22NCT01552122%22"]}]},{"efo_id":"EFO_0003869","efo_label":"breast neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003869","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00073073","NCT00263185"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00073073%22OR%22NCT00263185%22"]}]},{"efo_id":"EFO_0003882","efo_label":"osteoporosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003882","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00112437","NCT00421343","NCT00960934","NCT01120600"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00112437%22OR%22NCT00421343%22OR%22NCT00960934%22OR%22NCT01120600%22"]},{"source":"DailyMed","ids":["9f89cb91-bd3b-4103-a8a1-c1c1512fe514"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9f89cb91-bd3b-4103-a8a1-c1c1512fe514"]}]},{"efo_id":"EFO_0003957","efo_label":"radius fracture","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003957","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01859468"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01859468%22"]}]},{"efo_id":"EFO_0005952","efo_label":"non-Hodgkins lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005952","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00352846"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00352846%22"]}]},{"efo_id":"HP_0000938","efo_label":"Osteopenia","efo_uri":"http://purl.obolibrary.org/obo/HP_0000938","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02186600"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02186600%22"]}]},{"efo_id":"HP_0002014","efo_label":"Diarrhea","efo_uri":"http://purl.obolibrary.org/obo/HP_0002014","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00650637"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00650637%22"]}]},{"efo_id":"EFO_0001073","efo_label":"obesity","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001073","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03198767"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03198767%22"]}]},{"efo_id":"EFO_0009451","efo_label":"hypoparathyroidism","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009451","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01815021"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01815021%22"]}]}],"adverse_events":{"significant":[{"event":"gastrointestinal haemorrhage","count":25270,"llr":3192.517689},{"event":"melaena","count":7928,"llr":1406.647444},{"event":"gastric haemorrhage","count":3864,"llr":1180.823791},{"event":"upper gastrointestinal haemorrhage","count":4147,"llr":1068.938651},{"event":"gastric ulcer","count":5425,"llr":888.4009439},{"event":"haematemesis","count":6588,"llr":826.9391875},{"event":"anaemia","count":61405,"llr":762.6956023},{"event":"haemorrhage","count":20448,"llr":687.7453183},{"event":"haemoglobin decreased","count":33686,"llr":667.2291381},{"event":"milk-alkali syndrome","count":222,"llr":666.6866325},{"event":"rectal haemorrhage","count":10551,"llr":566.557249},{"event":"duodenal ulcer","count":2784,"llr":531.215322},{"event":"haemorrhage intracranial","count":4344,"llr":509.1377799},{"event":"faeces discoloured","count":4657,"llr":436.2575335},{"event":"international normalised ratio increased","count":13854,"llr":415.4914421},{"event":"drug hypersensitivity","count":71246,"llr":398.3933264},{"event":"labelled drug-drug interaction medication error","count":2483,"llr":386.0370754},{"event":"haematochezia","count":10052,"llr":377.7682933},{"event":"subdural haematoma","count":3943,"llr":370.9218858},{"event":"cerebral haemorrhage","count":6313,"llr":354.5440041},{"event":"gastritis erosive","count":1726,"llr":340.3848865},{"event":"gastric ulcer haemorrhage","count":1601,"llr":330.7032102},{"event":"haematoma","count":8376,"llr":327.448221},{"event":"gastritis","count":7597,"llr":322.9582438},{"event":"epistaxis","count":16532,"llr":321.8971102},{"event":"haemorrhagic anaemia","count":1864,"llr":307.9016482},{"event":"aspirin-exacerbated respiratory disease","count":295,"llr":299.4767053},{"event":"haematuria","count":11307,"llr":276.8042915},{"event":"lower gastrointestinal haemorrhage","count":1873,"llr":270.1326004},{"event":"haematocrit decreased","count":6949,"llr":257.9723603},{"event":"angioedema","count":18080,"llr":256.2397202}],"critval":241.6473319},"number_of_indications":20,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":6},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":5},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":4},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":4},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":4},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":3},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL476","_score":1,"_source":{"id":"CHEMBL476","internal_compound":false,"type":"Small molecule","pref_name":"DACARBAZINE","year_first_approved":1975,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["DIC","DTIC","Dacarbazine","NCI C04717","NSC-45388"],"trade_names":["Dacarbazine","Dtic-Dome"],"cross_references":[{"source":"DailyMed","ids":["dacarbazine"]},{"source":"PubChem","ids":["17389952","26747399","99125"]},{"source":"Wikipedia","ids":["Dacarbazine"]},{"source":"drugbank","ids":["DB00851"]}],"canonical_smiles":"CN(C)/N=N/c1[nH]cnc1C(N)=O","indications":[{"efo_id":"EFO_0002617","efo_label":"metastatic melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002617","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00066196","NCT00308607","NCT00395070","NCT00553618","NCT00597038","NCT01055522","NCT01280565","NCT01542255","NCT01721746","NCT02076646","NCT03430297"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00066196%22OR%22NCT00308607%22OR%22NCT00395070%22OR%22NCT00553618%22OR%22NCT00597038%22OR%22NCT01055522%22OR%22NCT01280565%22OR%22NCT01542255%22OR%22NCT01721746%22OR%22NCT02076646%22OR%22NCT03430297%22"]},{"source":"DailyMed","ids":["26e91082-7698-4680-beab-07c47802f0f9","4c7e5795-feba-425d-7ca3-6cb2c3a1c43c","b6b97e41-5f15-498c-abfb-d8443ea4d216"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?26e91082-7698-4680-beab-07c47802f0f9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4c7e5795-feba-425d-7ca3-6cb2c3a1c43c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b6b97e41-5f15-498c-abfb-d8443ea4d216"]}]},{"efo_id":"EFO_0000756","efo_label":"melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000756","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00002882","NCT00003647","NCT00006200","NCT00070642","NCT00091572","NCT00099970","NCT00110994","NCT00130442","NCT00246012","NCT00257205","NCT00324155","NCT00327600","NCT00412581","NCT00492297","NCT00496223","NCT00498979","NCT00518895","NCT00533702","NCT00542893","NCT00600496","NCT00615160","NCT00779714","NCT00794235","NCT00796991","NCT00813449","NCT00849875","NCT00864253","NCT00911443","NCT00936221","NCT00991250","NCT01006980","NCT01028222","NCT01100528","NCT01133977","NCT01152788","NCT01164007","NCT01359956","NCT01376713","NCT01614301","NCT01681212","NCT01692691","NCT01704287","NCT01705392","NCT01721772","NCT02190838","NCT02545075"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002882%22OR%22NCT00003647%22OR%22NCT00006200%22OR%22NCT00070642%22OR%22NCT00091572%22OR%22NCT00099970%22OR%22NCT00110994%22OR%22NCT00130442%22OR%22NCT00246012%22OR%22NCT00257205%22OR%22NCT00324155%22OR%22NCT00327600%22OR%22NCT00412581%22OR%22NCT00492297%22OR%22NCT00496223%22OR%22NCT00498979%22OR%22NCT00518895%22OR%22NCT00533702%22OR%22NCT00542893%22OR%22NCT00600496%22OR%22NCT00615160%22OR%22NCT00779714%22OR%22NCT00794235%22OR%22NCT00796991%22OR%22NCT00813449%22OR%22NCT00849875%22OR%22NCT00864253%22OR%22NCT00911443%22OR%22NCT00936221%22OR%22NCT00991250%22OR%22NCT01006980%22OR%22NCT01028222%22OR%22NCT01100528%22OR%22NCT01133977%22OR%22NCT01152788%22OR%22NCT01164007%22OR%22NCT01359956%22OR%22NCT01376713%22OR%22NCT01614301%22OR%22NCT01681212%22OR%22NCT01692691%22OR%22NCT01704287%22OR%22NCT01705392%22OR%22NCT01721772%22OR%22NCT02190838%22OR%22NCT02545075%22"]}]},{"efo_id":"EFO_0000389","efo_label":"cutaneous melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000389","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00002669","NCT00003027","NCT00004141","NCT00006237","NCT00016263","NCT00072124","NCT01693068","NCT01763164","NCT02288897"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002669%22OR%22NCT00003027%22OR%22NCT00004141%22OR%22NCT00006237%22OR%22NCT00016263%22OR%22NCT00072124%22OR%22NCT01693068%22OR%22NCT01763164%22OR%22NCT02288897%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01227889"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01227889%22"]}]},{"efo_id":"EFO_0000691","efo_label":"sarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000691","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002791","NCT00023738","NCT00033644","NCT00089544","NCT00802880","NCT01710176","NCT02049905"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002791%22OR%22NCT00023738%22OR%22NCT00033644%22OR%22NCT00089544%22OR%22NCT00802880%22OR%22NCT01710176%22OR%22NCT02049905%22"]}]},{"efo_id":"EFO_0000183","efo_label":"Hodgkins lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000183","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00002561","NCT00038558","NCT00443677","NCT00654732","NCT00736320","NCT00784537","NCT00795613","NCT00797472","NCT00816959","NCT01056679","NCT01060904","NCT01251107","NCT01356680","NCT01358747","NCT01468740","NCT01523847","NCT01534078","NCT01569204","NCT01652261","NCT01712490","NCT01716806","NCT01920932","NCT02181738","NCT02247869","NCT02275598","NCT02292979","NCT02505269","NCT02661503","NCT02684708","NCT02979522","NCT03004833","NCT03033914","NCT03159897","NCT03226249","NCT03233347","NCT03331341","NCT03407144","NCT03517137","NCT03527628","NCT03646123","NCT03712202","NCT03755804","NCT03907488","NCT04067037"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002561%22OR%22NCT00038558%22OR%22NCT00443677%22OR%22NCT00654732%22OR%22NCT00736320%22OR%22NCT00784537%22OR%22NCT00795613%22OR%22NCT00797472%22OR%22NCT00816959%22OR%22NCT01056679%22OR%22NCT01060904%22OR%22NCT01251107%22OR%22NCT01356680%22OR%22NCT01358747%22OR%22NCT01468740%22OR%22NCT01523847%22OR%22NCT01534078%22OR%22NCT01569204%22OR%22NCT01652261%22OR%22NCT01712490%22OR%22NCT01716806%22OR%22NCT01920932%22OR%22NCT02181738%22OR%22NCT02247869%22OR%22NCT02275598%22OR%22NCT02292979%22OR%22NCT02505269%22OR%22NCT02661503%22OR%22NCT02684708%22OR%22NCT02979522%22OR%22NCT03004833%22OR%22NCT03033914%22OR%22NCT03159897%22OR%22NCT03226249%22OR%22NCT03233347%22OR%22NCT03331341%22OR%22NCT03407144%22OR%22NCT03517137%22OR%22NCT03527628%22OR%22NCT03646123%22OR%22NCT03712202%22OR%22NCT03755804%22OR%22NCT03907488%22OR%22NCT04067037%22"]},{"source":"DailyMed","ids":["26e91082-7698-4680-beab-07c47802f0f9"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?26e91082-7698-4680-beab-07c47802f0f9"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00003389","NCT00003421","NCT00004010","NCT00005090","NCT00005584","NCT00025064","NCT00041210","NCT00049595","NCT00264953","NCT00265018","NCT00369681","NCT00416832","NCT00433433","NCT00433459","NCT00504504","NCT00678327","NCT00822120","NCT00920153","NCT01118026","NCT01132807","NCT01390584","NCT01404936"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003389%22OR%22NCT00003421%22OR%22NCT00004010%22OR%22NCT00005090%22OR%22NCT00005584%22OR%22NCT00025064%22OR%22NCT00041210%22OR%22NCT00049595%22OR%22NCT00264953%22OR%22NCT00265018%22OR%22NCT00369681%22OR%22NCT00416832%22OR%22NCT00433433%22OR%22NCT00433459%22OR%22NCT00504504%22OR%22NCT00678327%22OR%22NCT00822120%22OR%22NCT00920153%22OR%22NCT01118026%22OR%22NCT01132807%22OR%22NCT01390584%22OR%22NCT01404936%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00516802","NCT01845675","NCT03023124"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00516802%22OR%22NCT01845675%22OR%22NCT03023124%22"]}]},{"efo_id":"EFO_0000621","efo_label":"neuroblastoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000621","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002802","NCT00017225","NCT00410631"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002802%22OR%22NCT00017225%22OR%22NCT00410631%22"]}]},{"efo_id":"EFO_0002892","efo_label":"thyroid carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002892","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00354523"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00354523%22"]}]},{"efo_id":"EFO_1001968","efo_label":"soft tissue sarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001968","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01327885"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01327885%22"]}]},{"efo_id":"EFO_0000211","efo_label":"unspecified peripheral T-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000211","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00970385","NCT01716806"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00970385%22OR%22NCT01716806%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00600496"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00600496%22"]}]},{"efo_id":"EFO_0000564","efo_label":"leiomyosarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000564","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03761095"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03761095%22"]}]},{"efo_id":"EFO_0001071","efo_label":"lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001071","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00600496"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00600496%22"]}]},{"efo_id":"EFO_0002890","efo_label":"renal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002890","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00600496"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00600496%22"]}]},{"efo_id":"EFO_0003869","efo_label":"breast neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003869","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00600496"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00600496%22"]}]},{"efo_id":"EFO_1001950","efo_label":"colon carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001950","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00600496"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00600496%22"]}]}],"mechanisms_of_action":[],"adverse_events":{"significant":[{"event":"febrile neutropenia","count":19204,"llr":466.0976181},{"event":"pulmonary toxicity","count":1545,"llr":291.7355412},{"event":"hodgkin's disease refractory","count":28,"llr":169.2703107},{"event":"hodgkin's disease","count":1257,"llr":160.1967034},{"event":"second primary malignancy","count":2158,"llr":130.9200897},{"event":"hodgkin's disease recurrent","count":47,"llr":107.876494},{"event":"neutropenia","count":41585,"llr":107.8122334},{"event":"febrile bone marrow aplasia","count":1608,"llr":89.89374823},{"event":"myelitis","count":530,"llr":70.7092218},{"event":"cardiotoxicity","count":2240,"llr":69.28819497},{"event":"thrombocytopenia","count":35327,"llr":55.02335302},{"event":"acute myeloid leukaemia","count":3032,"llr":54.72229686},{"event":"disease progression","count":21531,"llr":49.90141877},{"event":"malignant neoplasm progression","count":14458,"llr":47.68244933},{"event":"pyrexia","count":87334,"llr":42.64605507},{"event":"autoimmune neutropenia","count":103,"llr":42.52964389},{"event":"systemic candida","count":416,"llr":36.6268105},{"event":"intestinal perforation","count":2470,"llr":36.57560382},{"event":"pneumonia salmonella","count":10,"llr":36.41319611},{"event":"mucosal inflammation","count":9134,"llr":36.36573574},{"event":"ichthyosis","count":81,"llr":34.1560486},{"event":"pancytopenia","count":17598,"llr":33.51404095},{"event":"meningitis streptococcal","count":49,"llr":32.45729773},{"event":"myelodysplastic syndrome","count":4118,"llr":29.4723442},{"event":"neutrophil count decreased","count":11062,"llr":29.25778474},{"event":"pneumonitis","count":6754,"llr":28.03384151},{"event":"sarcoidosis","count":1486,"llr":27.58084186},{"event":"guillain-barre syndrome","count":1520,"llr":27.28141693},{"event":"metastatic malignant melanoma","count":361,"llr":26.17555053},{"event":"chronic myeloid leukaemia","count":1057,"llr":25.76296207},{"event":"premature menopause","count":239,"llr":25.58049312},{"event":"metastases to lung","count":2171,"llr":25.19694818},{"event":"left ventricular dysfunction","count":2183,"llr":25.12036515},{"event":"foetal growth restriction","count":1834,"llr":24.81204206},{"event":"pain","count":94786,"llr":24.76575197},{"event":"autoimmune pancytopenia","count":26,"llr":24.66291317},{"event":"leukopenia neonatal","count":26,"llr":24.66291317}],"critval":24.28489354},"number_of_indications":18,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":18},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":5},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":4},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":3},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":3},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":3},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":2},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL53","_score":1,"_source":{"id":"CHEMBL53","internal_compound":false,"type":"Small molecule","pref_name":"APOMORPHINE","year_first_approved":2004,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["APL-130277","Apomorphine","Apomorphine HCl","Apomorphine Hydrochloride Hemihydrate","Apomorphine hydrochloride hemihydrate","Apomorphine hydrochloride hydrate","Diamorphine hydrochloride ","NSC-11442","VR-040","VR040"],"trade_names":["APO-go","APO-go PEN","APO-go PFS","Apokyn","Apomorph hcl","Britaject","Bromophin","Dacepton","Diagesil","Diamorph HCl","Diamorph Roche","Diamorph,cocaine,chlorpromazine","Diaphine","Euphorin","Uprima"],"cross_references":[{"source":"ChEBI","ids":[48538]},{"source":"DailyMed","ids":["apomorphine%20hydrochloride"]},{"source":"PubChem","ids":["11114270","144204518","170465297","26752261"]},{"source":"Wikipedia","ids":["Apomorphine"]},{"source":"drugbank","ids":["DB00714"]},{"source":"PubChem","ids":["11533000","56373918","56462998","85273689"]},{"source":"ChEBI","ids":[31228]},{"source":"PubChem","ids":["144210030","144213789"]}],"canonical_smiles":"CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3","indications":[{"efo_id":"EFO_0000546","efo_label":"injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000546","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00761228"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00761228%22"]}]},{"efo_id":"EFO_0002508","efo_label":"Parkinson's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002508","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N04BC07"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N04BC07"]},{"source":"ClinicalTrials","ids":["NCT00040209","NCT00346827","NCT00472355","NCT00758368","NCT01039090","NCT01504178","NCT01693081","NCT02228590","NCT02339064","NCT02469090","NCT02542696","NCT02702076","NCT02864004","NCT03187301","NCT03292016","NCT03391882"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00040209%22OR%22NCT00346827%22OR%22NCT00472355%22OR%22NCT00758368%22OR%22NCT01039090%22OR%22NCT01504178%22OR%22NCT01693081%22OR%22NCT02228590%22OR%22NCT02339064%22OR%22NCT02469090%22OR%22NCT02542696%22OR%22NCT02702076%22OR%22NCT02864004%22OR%22NCT03187301%22OR%22NCT03292016%22OR%22NCT03391882%22"]}]},{"efo_id":"EFO_0003829","efo_label":"alcohol dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003829","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00437177"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00437177%22"]}]},{"efo_id":"EFO_0002508","efo_label":"Parkinson's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002508","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00142545","NCT00145171","NCT00200512","NCT00200525","NCT00610103","NCT00955318","NCT01058291","NCT01063621","NCT02006121","NCT03292016"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00142545%22OR%22NCT00145171%22OR%22NCT00200512%22OR%22NCT00200525%22OR%22NCT00610103%22OR%22NCT00955318%22OR%22NCT01058291%22OR%22NCT01063621%22OR%22NCT02006121%22OR%22NCT03292016%22"]},{"source":"DailyMed","ids":["3235535d-9ef9-4657-8b2a-176a807d091c"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3235535d-9ef9-4657-8b2a-176a807d091c"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00003822","NCT00004049"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003822%22OR%22NCT00004049%22"]}]},{"efo_id":"EFO_0003882","efo_label":"osteoporosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003882","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00078026"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00078026%22"]}]}],"adverse_events":{"significant":[{"event":"injection site nodule","count":2274,"llr":119.6484252},{"event":"injection site necrosis","count":675,"llr":115.7655635},{"event":"on and off phenomenon","count":228,"llr":92.91104639},{"event":"hallucination","count":16074,"llr":88.3037609},{"event":"dyskinesia","count":7974,"llr":87.8776826},{"event":"fall","count":67604,"llr":78.78900763},{"event":"hyperkinesia","count":313,"llr":75.62656626},{"event":"haemolytic anaemia","count":3565,"llr":72.96576016},{"event":"hallucination, visual","count":5602,"llr":64.91704808},{"event":"soft tissue mass","count":109,"llr":59.41469502},{"event":"nodule","count":3063,"llr":57.58686569},{"event":"oral discomfort","count":1838,"llr":51.55124138},{"event":"yawning","count":384,"llr":50.80197475},{"event":"illusion","count":479,"llr":48.1650538},{"event":"infusion site necrosis","count":59,"llr":45.55154316},{"event":"somnolence","count":38949,"llr":41.48290086},{"event":"skin mass","count":1245,"llr":40.93229923},{"event":"nasal discomfort","count":1152,"llr":37.74617167},{"event":"pelvic fracture","count":1707,"llr":36.90609396},{"event":"psychotic disorder","count":11057,"llr":34.41336828},{"event":"skin necrosis","count":1769,"llr":32.70167923},{"event":"hyperhidrosis","count":28377,"llr":32.16401346},{"event":"formication","count":1429,"llr":27.54022765},{"event":"skin haemorrhage","count":1895,"llr":24.79543955},{"event":"hip fracture","count":6191,"llr":23.47717847},{"event":"sensory disturbance","count":4051,"llr":23.13827835},{"event":"panniculitis","count":760,"llr":21.14554669},{"event":"coombs positive haemolytic anaemia","count":182,"llr":20.50010701},{"event":"blood pressure decreased","count":13298,"llr":19.80095329},{"event":"akinesia","count":510,"llr":19.56510354},{"event":"hypersexuality","count":568,"llr":18.92856179},{"event":"tremor","count":36500,"llr":17.86235951},{"event":"confusional state","count":40628,"llr":17.1342734},{"event":"nausea","count":165652,"llr":17.06392006},{"event":"injection site infection","count":783,"llr":17.03853536},{"event":"depressed mood","count":8822,"llr":16.73459129},{"event":"injection site haematoma","count":2980,"llr":14.66265636},{"event":"hypotension","count":55121,"llr":13.53465186},{"event":"camptocormia","count":76,"llr":13.37723199},{"event":"autoimmune haemolytic anaemia","count":792,"llr":13.249744},{"event":"injection site abscess","count":797,"llr":13.21911707},{"event":"coombs direct test positive","count":92,"llr":12.80676052},{"event":"infusion site mass","count":103,"llr":12.46979158},{"event":"coombs test positive","count":104,"llr":12.44097424},{"event":"recall phenomenon","count":412,"llr":12.28117848},{"event":"injection site induration","count":4525,"llr":11.57949784},{"event":"impulse-control disorder","count":530,"llr":11.29360509},{"event":"injection site inflammation","count":1309,"llr":10.824267},{"event":"dopamine dysregulation syndrome","count":182,"llr":10.77526148},{"event":"blood pressure increased","count":25616,"llr":10.69526824},{"event":"facial paresis","count":1360,"llr":10.64172502},{"event":"pain","count":94786,"llr":10.02600142},{"event":"drooling","count":1621,"llr":9.807762043},{"event":"application site necrosis","count":33,"llr":9.771164924},{"event":"transient ischaemic attack","count":11886,"llr":9.766833051},{"event":"paranoia","count":4316,"llr":9.583652787}],"critval":9.340819777},"child_chembl_ids":["CHEMBL1256708","CHEMBL1616","CHEMBL3187985"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000149295","approved_name":"dopamine receptor D2","approved_symbol":"DRD2"},{"ensembl":"ENSG00000151577","approved_name":"dopamine receptor D3","approved_symbol":"DRD3"},{"ensembl":"ENSG00000069696","approved_name":"dopamine receptor D4","approved_symbol":"DRD4"}],"target_type":"protein family","target_name":"D2-like dopamine receptor","action_type":"agonist","description":"D2-like dopamine receptor agonist","references":[{"source":"DailyMed","ids":["setid=ab5d4084-3121-4043-bc88-a77c5277bc35"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ab5d4084-3121-4043-bc88-a77c5277bc35"]},{"source":"ISBN","ids":["0443-059748 PP. 511"],"urls":[]}]}],"number_of_indications":6,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":3},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":2},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL305686","_score":1,"_source":{"id":"CHEMBL305686","internal_compound":false,"type":"Small molecule","pref_name":"CORDYCEPIN","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["3'-Deoxyadenosine","Cordycepin","NSC-401022","NSC-63984"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[29014]},{"source":"PubChem","ids":["47193882"]},{"source":"Wikipedia","ids":["Cordycepin"]},{"source":"drugbank","ids":["DB12156"]}],"canonical_smiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)C[C@H]1O","indications":[{"efo_id":"EFO_0000565","efo_label":"leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000565","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00003005","NCT00709215"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003005%22OR%22NCT00709215%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1908305","_score":1,"_source":{"id":"CHEMBL1908305","internal_compound":false,"type":"Small molecule","pref_name":"SULOPENEM","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["CP-70429","Sulopenem"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB15284"]}],"canonical_smiles":"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@H]3CC[S@@+]([O-])C3)S[C@H]12","indications":[{"efo_id":"EFO_0000544","efo_label":"infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000544","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03358576"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03358576%22"]}]},{"efo_id":"EFO_0003103","efo_label":"urinary tract infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003103","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03357614"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03357614%22"]}]},{"efo_id":"EFO_0003106","efo_label":"pneumonia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003106","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00759564"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00759564%22"]}]},{"efo_id":"EFO_1001272","efo_label":"bacterial pneumonia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001272","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00797108"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00797108%22"]}]}],"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":3},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":2},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1237","_score":1,"_source":{"id":"CHEMBL1237","internal_compound":false,"type":"Small molecule","pref_name":"LISINOPRIL","year_first_approved":1987,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["Lisinopril","Lisinopril dihydrate","Lisinopril hydrate","MK-521"],"trade_names":["Acemin","Carace","Lisinopril","Lisopress","Prinivil","Qbrelis","Zestril"],"cross_references":[{"source":"ChEBI","ids":[43755]},{"source":"DailyMed","ids":["lisinopril"]},{"source":"PubChem","ids":["50085996"]},{"source":"Wikipedia","ids":["Lisinopril"]},{"source":"drugbank","ids":["DB00722"]},{"source":"PubChem","ids":["56463367"]},{"source":"ChEBI","ids":[6503]},{"source":"PubChem","ids":["11113057","170464907"]}],"canonical_smiles":"NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O","indications":[{"efo_id":"EFO_0000279","efo_label":"azoospermia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000279","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01409837"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01409837%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01009918"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01009918%22"]}]},{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01313702"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01313702%22"]}]},{"efo_id":"EFO_0000400","efo_label":"diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000400","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02070510"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02070510%22"]}]},{"efo_id":"EFO_0000401","efo_label":"diabetic nephropathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000401","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00004266"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004266%22"]}]},{"efo_id":"EFO_0000537","efo_label":"hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000537","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00171067","NCT00347360","NCT00508365","NCT00549510","NCT00552708","NCT00553969","NCT00557128","NCT00624065","NCT00883064","NCT00883506","NCT01491919","NCT02623036"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00171067%22OR%22NCT00347360%22OR%22NCT00508365%22OR%22NCT00549510%22OR%22NCT00552708%22OR%22NCT00553969%22OR%22NCT00557128%22OR%22NCT00624065%22OR%22NCT00883064%22OR%22NCT00883506%22OR%22NCT01491919%22OR%22NCT02623036%22"]}]},{"efo_id":"EFO_0000712","efo_label":"stroke","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000712","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01066572"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01066572%22"]}]},{"efo_id":"EFO_0001360","efo_label":"type II diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001360","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01324388","NCT01398267"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01324388%22OR%22NCT01398267%22"]}]},{"efo_id":"EFO_0003144","efo_label":"heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003144","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01437371","NCT03422705"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01437371%22OR%22NCT03422705%22"]}]},{"efo_id":"EFO_0003896","efo_label":"left ventricular hypertrophy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003896","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00108082"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00108082%22"]}]},{"efo_id":"EFO_0004236","efo_label":"focal segmental glomerulosclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004236","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00814255"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00814255%22"]}]},{"efo_id":"EFO_0004264","efo_label":"vascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004264","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02045459"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02045459%22"]}]},{"efo_id":"EFO_1000948","efo_label":"gastroparesis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000948","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02232308"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02232308%22"]}]},{"efo_id":"EFO_1002032","efo_label":"primary hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1002032","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02603809"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02603809%22"]}]},{"efo_id":"Orphanet_416","efo_label":"Primary hyperoxaluria","efo_uri":"http://www.orpha.net/ORDO/Orphanet_416","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00280215"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00280215%22"]}]},{"efo_id":"Orphanet_79292","efo_label":"Fish-eye disease","efo_uri":"http://www.orpha.net/ORDO/Orphanet_79292","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01735344","NCT01827878"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01735344%22OR%22NCT01827878%22"]}]},{"efo_id":"EFO_0000537","efo_label":"hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000537","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["00f67e1a-6999-4295-9c9f-fcb1ce9711b8","019ac336-0dc3-ec89-3e0a-09110e0fc30b","033a79c7-71dd-7b29-8dc5-21af1e4de8c5","0566df92-8e8d-4849-ae1c-46eb13fef34a","0876897e-32e6-4999-a37c-d11e8609a859","08fdfb9c-3516-4ee9-9e7c-80c22b74dc49","0e7e3947-be0e-4407-a424-a365f99f4350","13ac45e5-59b1-456a-87fc-8e60107818a1","215e1940-0da1-4967-8ff4-a5bff861b55a","2937de2e-8c86-4248-917a-589b092e95ea","2b673c5a-f3ed-483c-aae1-abe8f63dcd7b","37b5287d-d520-4853-88f4-6f4cbde5a321","3984e6b9-2d88-47f0-af09-cce428bba14f","3d801e51-e675-45eb-bc7e-407e610f4009","40a5d859-a506-4aef-890d-6071ca53dd8c","4700340f-4f77-48f2-bef2-bf6391bc25da","490ae8f3-a518-4fc2-bc2a-351688133fc7","5aa18b0b-4688-493a-a5ae-cb056ea6c0e3","5afb48a3-2221-4b88-8e5d-acd6a6c92f93","5cd06f7f-fe34-49c1-956a-b2bc4ece3526","5e906b5f-1c16-42ae-bcc8-588f59d4f820","636aa584-97e2-124b-1c9e-3897f1adcc84","63fa5147-fb3e-47ec-bea1-a80e1f551866","6414f16f-c3e0-4ca1-ad58-ed081a9c0b09","6573671e-3386-43d0-8f7c-bb8456bdfcbd","7cd68095-12a7-446d-8ee6-4301cdf3f934","859ddd10-3c37-43c1-9580-376fe5e35cea","875916f8-fbf2-4db2-b979-088c570377f0","8808879d-8c7e-45d1-8a49-c05d2cf845d3","8ed7f3a4-e03c-4121-89d7-57b8764779b2","93c8fc6b-4a19-4f55-b7cf-8b0e1255cdf9","a3f250f0-d993-48cd-b68d-e8b5de89b796","ab5e9ae4-e575-4a63-99f3-2bde36bdd508","ae316da6-4254-4178-ad5a-20b2a2b0024c","af0b3bef-be36-432a-884e-ea81e2d5c08e","b8f4d730-fd8e-4692-aabd-e2b7e63fabe1","beab3768-51ba-4717-8e02-9ea64b5f324c","c97e38f2-7163-4d4e-a694-4d0612423e53","cd5b847a-c41a-4c87-89c2-cc46db1e8c4a","d7214539-6c3d-466a-a474-6fde096fa182","d8a0d15e-5efe-497e-a5b1-066c2ecc6190","ded8505d-441c-4154-a41e-5f641137466a","e7b68ea6-4fc8-441a-9640-1ccd3a482d8e","eac8c44f-cf77-6a30-cfd7-7cffffc79bd6","ec23c75d-68d5-46d0-be56-b96ddba19ed6","ed89116e-5aa1-47e0-933e-c71f244da508","f1999037-913a-49ae-a8e3-ed6f4b8df79f","f1edafb4-0cc4-4dd7-b2a3-5b83a7db4114"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?00f67e1a-6999-4295-9c9f-fcb1ce9711b8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?019ac336-0dc3-ec89-3e0a-09110e0fc30b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?033a79c7-71dd-7b29-8dc5-21af1e4de8c5","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0566df92-8e8d-4849-ae1c-46eb13fef34a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0876897e-32e6-4999-a37c-d11e8609a859","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?08fdfb9c-3516-4ee9-9e7c-80c22b74dc49","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0e7e3947-be0e-4407-a424-a365f99f4350","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?13ac45e5-59b1-456a-87fc-8e60107818a1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?215e1940-0da1-4967-8ff4-a5bff861b55a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2937de2e-8c86-4248-917a-589b092e95ea","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2b673c5a-f3ed-483c-aae1-abe8f63dcd7b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?37b5287d-d520-4853-88f4-6f4cbde5a321","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3984e6b9-2d88-47f0-af09-cce428bba14f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3d801e51-e675-45eb-bc7e-407e610f4009","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?40a5d859-a506-4aef-890d-6071ca53dd8c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4700340f-4f77-48f2-bef2-bf6391bc25da","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?490ae8f3-a518-4fc2-bc2a-351688133fc7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5aa18b0b-4688-493a-a5ae-cb056ea6c0e3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5afb48a3-2221-4b88-8e5d-acd6a6c92f93","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5cd06f7f-fe34-49c1-956a-b2bc4ece3526","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?5e906b5f-1c16-42ae-bcc8-588f59d4f820","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?636aa584-97e2-124b-1c9e-3897f1adcc84","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?63fa5147-fb3e-47ec-bea1-a80e1f551866","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6414f16f-c3e0-4ca1-ad58-ed081a9c0b09","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6573671e-3386-43d0-8f7c-bb8456bdfcbd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7cd68095-12a7-446d-8ee6-4301cdf3f934","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?859ddd10-3c37-43c1-9580-376fe5e35cea","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?875916f8-fbf2-4db2-b979-088c570377f0","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8808879d-8c7e-45d1-8a49-c05d2cf845d3","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8ed7f3a4-e03c-4121-89d7-57b8764779b2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?93c8fc6b-4a19-4f55-b7cf-8b0e1255cdf9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a3f250f0-d993-48cd-b68d-e8b5de89b796","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ab5e9ae4-e575-4a63-99f3-2bde36bdd508","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ae316da6-4254-4178-ad5a-20b2a2b0024c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?af0b3bef-be36-432a-884e-ea81e2d5c08e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?b8f4d730-fd8e-4692-aabd-e2b7e63fabe1","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?beab3768-51ba-4717-8e02-9ea64b5f324c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c97e38f2-7163-4d4e-a694-4d0612423e53","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cd5b847a-c41a-4c87-89c2-cc46db1e8c4a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d7214539-6c3d-466a-a474-6fde096fa182","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d8a0d15e-5efe-497e-a5b1-066c2ecc6190","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ded8505d-441c-4154-a41e-5f641137466a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e7b68ea6-4fc8-441a-9640-1ccd3a482d8e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?eac8c44f-cf77-6a30-cfd7-7cffffc79bd6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ec23c75d-68d5-46d0-be56-b96ddba19ed6","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ed89116e-5aa1-47e0-933e-c71f244da508","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f1999037-913a-49ae-a8e3-ed6f4b8df79f","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f1edafb4-0cc4-4dd7-b2a3-5b83a7db4114"]},{"source":"FDA","ids":["00c3be4a-c9a4-4ad8-8b0b-431098943256","04435d0d-5103-6cca-cc70-606641fe347f","0d8fd775-950a-465d-8d32-4fe40234bc11","20b4f8df-8a90-4494-ac54-c3a45eb7e6c8","416d1d73-a0d2-4576-9354-407eb4ff3b14","47871aa3-18d1-425d-a906-f76810eaf90c","4c7d8cd0-6c4c-48be-a9f1-1364252a6037","4d6eb160-a5b4-4b0f-b1ee-cde7df810b81","4fba7c87-ba00-44e2-bc44-f02273afdf57","52be6388-b142-4a4f-8109-99afbbb9f8d8","543f84b1-a040-48aa-8628-0809e114448d","6e453a4f-34b9-4f07-92b6-bfc28609ce22","6e98e79a-7de2-4152-8077-ea2c7d342aef","6ed2d03e-0c8f-4ec7-b836-0683a848a762","707a3bc2-4e33-4307-9755-947e7c8dfaf9","71b26af0-a90e-49f8-98b7-7fe05e003fee","7ab194e4-0183-4823-a343-d9f7504662e1","88d32118-a2a2-4bb3-a609-b44d46a3c295","8f4ab655-b165-4786-b8d2-ae0f620eea5a","912fd522-731c-4ed7-b9c7-b6507c5e39a2","934d724c-c02d-42d7-acba-34cf06cacd70","93fa9ed4-db75-4f8a-98a6-9e5d54b022b6","9452abd6-5f5e-4dd8-b9a4-abb9679de57e","98bbb5a8-f952-4e79-bc67-c1ca02b72159","9c0e9351-eeb2-40f3-a26f-530b642eb197","a4a380d5-6c22-4d1f-9c49-cdc5bef308cf","a71ed1b7-a995-493c-b89d-bede289956ea","ac114cc0-70d3-4593-af05-55d6687fd01d","b9e456da-010c-48fc-9efc-6209b5d569e9","c5aa1c63-31c4-49d2-b8f6-6c754dcc0a5c","caa8f69c-2a33-4b0c-baad-725d4112f8f8","d3e06392-a5e7-4ea3-ad02-9e6ed3472d47","ef59dd07-6d03-46da-88f1-e86045936b2b","label/2003/19558se5-043_prinivil_lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A00c3be4a-c9a4-4ad8-8b0b-431098943256","https://api.fda.gov/drug/label.json?search=set_id%3A04435d0d-5103-6cca-cc70-606641fe347f","https://api.fda.gov/drug/label.json?search=set_id%3A0d8fd775-950a-465d-8d32-4fe40234bc11","https://api.fda.gov/drug/label.json?search=set_id%3A20b4f8df-8a90-4494-ac54-c3a45eb7e6c8","https://api.fda.gov/drug/label.json?search=set_id%3A416d1d73-a0d2-4576-9354-407eb4ff3b14","https://api.fda.gov/drug/label.json?search=set_id%3A47871aa3-18d1-425d-a906-f76810eaf90c","https://api.fda.gov/drug/label.json?search=set_id%3A4c7d8cd0-6c4c-48be-a9f1-1364252a6037","https://api.fda.gov/drug/label.json?search=set_id%3A4d6eb160-a5b4-4b0f-b1ee-cde7df810b81","https://api.fda.gov/drug/label.json?search=set_id%3A4fba7c87-ba00-44e2-bc44-f02273afdf57","https://api.fda.gov/drug/label.json?search=set_id%3A52be6388-b142-4a4f-8109-99afbbb9f8d8","https://api.fda.gov/drug/label.json?search=set_id%3A543f84b1-a040-48aa-8628-0809e114448d","https://api.fda.gov/drug/label.json?search=set_id%3A6e453a4f-34b9-4f07-92b6-bfc28609ce22","https://api.fda.gov/drug/label.json?search=set_id%3A6e98e79a-7de2-4152-8077-ea2c7d342aef","https://api.fda.gov/drug/label.json?search=set_id%3A6ed2d03e-0c8f-4ec7-b836-0683a848a762","https://api.fda.gov/drug/label.json?search=set_id%3A707a3bc2-4e33-4307-9755-947e7c8dfaf9","https://api.fda.gov/drug/label.json?search=set_id%3A71b26af0-a90e-49f8-98b7-7fe05e003fee","https://api.fda.gov/drug/label.json?search=set_id%3A7ab194e4-0183-4823-a343-d9f7504662e1","https://api.fda.gov/drug/label.json?search=set_id%3A88d32118-a2a2-4bb3-a609-b44d46a3c295","https://api.fda.gov/drug/label.json?search=set_id%3A8f4ab655-b165-4786-b8d2-ae0f620eea5a","https://api.fda.gov/drug/label.json?search=set_id%3A912fd522-731c-4ed7-b9c7-b6507c5e39a2","https://api.fda.gov/drug/label.json?search=set_id%3A934d724c-c02d-42d7-acba-34cf06cacd70","https://api.fda.gov/drug/label.json?search=set_id%3A93fa9ed4-db75-4f8a-98a6-9e5d54b022b6","https://api.fda.gov/drug/label.json?search=set_id%3A9452abd6-5f5e-4dd8-b9a4-abb9679de57e","https://api.fda.gov/drug/label.json?search=set_id%3A98bbb5a8-f952-4e79-bc67-c1ca02b72159","https://api.fda.gov/drug/label.json?search=set_id%3A9c0e9351-eeb2-40f3-a26f-530b642eb197","https://api.fda.gov/drug/label.json?search=set_id%3Aa4a380d5-6c22-4d1f-9c49-cdc5bef308cf","https://api.fda.gov/drug/label.json?search=set_id%3Aa71ed1b7-a995-493c-b89d-bede289956ea","https://api.fda.gov/drug/label.json?search=set_id%3Aac114cc0-70d3-4593-af05-55d6687fd01d","https://api.fda.gov/drug/label.json?search=set_id%3Ab9e456da-010c-48fc-9efc-6209b5d569e9","https://api.fda.gov/drug/label.json?search=set_id%3Ac5aa1c63-31c4-49d2-b8f6-6c754dcc0a5c","https://api.fda.gov/drug/label.json?search=set_id%3Acaa8f69c-2a33-4b0c-baad-725d4112f8f8","https://api.fda.gov/drug/label.json?search=set_id%3Ad3e06392-a5e7-4ea3-ad02-9e6ed3472d47","https://api.fda.gov/drug/label.json?search=set_id%3Aef59dd07-6d03-46da-88f1-e86045936b2b","https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2003%2F19558se5-043_prinivil_lbl.pdf"]}]},{"efo_id":"EFO_0000373","efo_label":"congestive heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000373","max_phase_for_indication":4,"references":[{"source":"FDA","ids":["label/2003/19558se5-043_prinivil_lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2003%2F19558se5-043_prinivil_lbl.pdf"]}]},{"efo_id":"EFO_0000612","efo_label":"myocardial infarction","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000612","max_phase_for_indication":4,"references":[{"source":"FDA","ids":["label/2003/19558se5-043_prinivil_lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2003%2F19558se5-043_prinivil_lbl.pdf"]}]},{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["C09AA03"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C09AA03"]}]}],"adverse_events":{"significant":[{"event":"angioedema","count":18080,"llr":13580.47494},{"event":"hyperkalaemia","count":12419,"llr":2034.49242},{"event":"drug hypersensitivity","count":71246,"llr":1617.02623},{"event":"swollen tongue","count":8894,"llr":1042.059784},{"event":"renal failure acute","count":23893,"llr":989.6321184},{"event":"angioneurotic oedema","count":1610,"llr":879.3251429},{"event":"hypotension","count":55121,"llr":842.001754},{"event":"lip swelling","count":7601,"llr":809.2041409},{"event":"cough","count":52232,"llr":654.8212268},{"event":"acute kidney injury","count":33030,"llr":522.0938633},{"event":"intestinal angioedema","count":125,"llr":394.213238},{"event":"swelling face","count":15924,"llr":352.6341524},{"event":"wheezing","count":9665,"llr":225.593754}],"critval":220.4030903},"child_chembl_ids":["CHEMBL1729579","CHEMBL419213"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000159640","approved_name":"angiotensin I converting enzyme","approved_symbol":"ACE"}],"target_type":"single protein","target_name":"Angiotensin-converting enzyme","action_type":"inhibitor","description":"Angiotensin-converting enzyme inhibitor","references":[{"source":"FDA","ids":["label/2016/019777s074lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2016%2F019777s074lbl.pdf"]}]}],"number_of_indications":20,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":10},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":5},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":5},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":4},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":2},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":2},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":2},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":2},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL689","_score":1,"_source":{"id":"CHEMBL689","internal_compound":false,"type":"Small molecule","pref_name":"MANNITOL","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Alexitol sodium","D-Mannitol","E-421","E421","INS NO.421","INS-421","Isomalt impurity, mannitol-","Manna Sugar","Mannite","Mannitol","NSC-407017"],"trade_names":["Aridol Kit","Bronchitol","Diosmol","Mannite","Mannitol","Osmitrol","Resectisol"],"cross_references":[{"source":"ChEBI","ids":[16899]},{"source":"DailyMed","ids":["mannitol"]},{"source":"PubChem","ids":["144205645","144208685","144210801","170465566","26757663","56322640"]},{"source":"Wikipedia","ids":["Mannitol"]},{"source":"drugbank","ids":["DB00742"]}],"canonical_smiles":"OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO","indications":[{"efo_id":"EFO_0000546","efo_label":"injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000546","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00810940","NCT01028339"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00810940%22OR%22NCT01028339%22"]}]},{"efo_id":"EFO_0000712","efo_label":"stroke","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000712","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00569088"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00569088%22"]}]},{"efo_id":"Orphanet_586","efo_label":"Cystic fibrosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_586","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00117208","NCT00251056","NCT00446680","NCT00455130","NCT00630812","NCT00792714","NCT01883531","NCT01887197","NCT02134353"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00117208%22OR%22NCT00251056%22OR%22NCT00446680%22OR%22NCT00455130%22OR%22NCT00630812%22OR%22NCT00792714%22OR%22NCT01883531%22OR%22NCT01887197%22OR%22NCT02134353%22"]}]},{"efo_id":"HP_0002110","efo_label":"Bronchiectasis","efo_uri":"http://purl.obolibrary.org/obo/HP_0002110","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00277537","NCT00669331","NCT00730977","NCT01076491"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00277537%22OR%22NCT00669331%22OR%22NCT00730977%22OR%22NCT01076491%22"]}]},{"efo_id":"EFO_0002890","efo_label":"renal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002890","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01606787"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01606787%22"]}]},{"efo_id":"EFO_0005251","efo_label":"hypotension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005251","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01520207"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01520207%22"]}]},{"efo_id":"EFO_0000341","efo_label":"chronic obstructive pulmonary disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000341","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00446667"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00446667%22"]}]},{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01843088"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01843088%22"]}]},{"efo_id":"EFO_0000326","efo_label":"central nervous system cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000326","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01233492"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01233492%22"]}]},{"efo_id":"EFO_0000519","efo_label":"glioblastoma multiforme","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000519","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02861898"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02861898%22"]}]},{"efo_id":"EFO_0001068","efo_label":"malaria","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001068","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00113854"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00113854%22"]}]},{"efo_id":"EFO_0005611","efo_label":"opioid dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005611","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01718964"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01718964%22"]}]},{"efo_id":"EFO_0006834","efo_label":"septic shock","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006834","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01485315"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01485315%22"]}]},{"efo_id":"EFO_1000783","efo_label":"diabetic neuropathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000783","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02728687"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02728687%22"]}]},{"efo_id":"EFO_1000992","efo_label":"intracranial hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000992","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00359697"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00359697%22"]}]},{"efo_id":"EFO_1001291","efo_label":"ciguatera poisoning","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001291","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02570971"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02570971%22"]}]},{"efo_id":"EFO_1000845","efo_label":"brain edema","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000845","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["0d914965-7001-45cb-ba51-d7c5964b05bc","d12cc802-b538-4065-a264-f474ff3b3043"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0d914965-7001-45cb-ba51-d7c5964b05bc","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d12cc802-b538-4065-a264-f474ff3b3043"]}]},{"efo_id":"EFO_0000270","efo_label":"asthma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000270","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03505489"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03505489%22"]}]},{"efo_id":"EFO_0000339","efo_label":"chronic myelogenous leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000339","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03747679"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03747679%22"]}]},{"efo_id":"EFO_0009715","efo_label":"wheezing","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009715","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01142505"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01142505%22"]}]},{"efo_id":"EFO_1001139","efo_label":"pulpitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001139","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03749408"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03749408%22"]}]}],"adverse_events":{"significant":[{"event":"renal failure acute","count":23893,"llr":74.17397477},{"event":"paresis","count":831,"llr":41.40044078},{"event":"hyperkalaemia","count":12419,"llr":40.51988381},{"event":"paralysis","count":2931,"llr":32.88378351},{"event":"maculopathy","count":841,"llr":31.22268985},{"event":"nephropathy toxic","count":3566,"llr":30.7707394},{"event":"tick-borne viral encephalitis","count":11,"llr":21.72733999},{"event":"ataxia","count":4833,"llr":20.73596347},{"event":"organic brain syndrome","count":45,"llr":17.50346666},{"event":"cytomegalovirus infection","count":5010,"llr":17.23843627},{"event":"appetite disorder","count":997,"llr":16.31969673},{"event":"brain oedema","count":2176,"llr":16.0745027},{"event":"small bowel angioedema","count":75,"llr":15.97313245},{"event":"condition aggravated","count":52909,"llr":15.72868029},{"event":"intraocular pressure increased","count":2955,"llr":14.29350518},{"event":"disorientation","count":10841,"llr":13.88571153},{"event":"acute kidney injury","count":33030,"llr":13.41289413},{"event":"anaphylactic reaction","count":16695,"llr":10.41015978},{"event":"chills","count":26715,"llr":10.2305627},{"event":"quadriparesis","count":527,"llr":10.15627984},{"event":"altered state of consciousness","count":6397,"llr":9.902957623},{"event":"toxic epidermal necrolysis","count":4052,"llr":9.525361593},{"event":"toxic optic neuropathy","count":123,"llr":8.850046165},{"event":"toxic neuropathy","count":141,"llr":8.578185404},{"event":"hyponatraemia","count":21598,"llr":8.436962529},{"event":"angle closure glaucoma","count":1026,"llr":8.193258574},{"event":"cardio-respiratory arrest","count":2972,"llr":7.941938226},{"event":"ketosis","count":220,"llr":7.694113189},{"event":"cataract subcapsular","count":226,"llr":7.640728396},{"event":"deafness neurosensory","count":1280,"llr":7.5478279},{"event":"pulmonary oedema","count":9905,"llr":7.5280227},{"event":"anaphylactoid reaction","count":1507,"llr":7.074263772},{"event":"embolism arterial","count":316,"llr":6.976765749},{"event":"optic nerve disorder","count":363,"llr":6.702813831},{"event":"cyanosis","count":4608,"llr":6.304236044},{"event":"medication crystals in urine","count":11,"llr":6.140736274},{"event":"carbohydrate metabolism disorder","count":12,"llr":6.053796839},{"event":"coma","count":13175,"llr":6.048019868},{"event":"product label confusion","count":510,"llr":6.033336412},{"event":"incontinence","count":2356,"llr":5.79439748}],"critval":5.793803857},"number_of_indications":21,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":7},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":4},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":4},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":3},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":3},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":2},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":2},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL207538","_score":1,"_source":{"id":"CHEMBL207538","internal_compound":false,"type":"Small molecule","pref_name":"BREXANOLONE","year_first_approved":2019,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["Allopregnan-3.alpha.-ol-20-one","Allopregnanolone","Brexanolone","SAGE-547","SGE-102"],"trade_names":["Zulresso"],"cross_references":[{"source":"ChEBI","ids":[50169]},{"source":"DailyMed","ids":["brexanolone"]},{"source":"PubChem","ids":["144205595","26756639"]},{"source":"drugbank","ids":["DB11859"]}],"canonical_smiles":"CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C","indications":[{"efo_id":"EFO_0000249","efo_label":"Alzheimer's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000249","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03748303"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03748303%22"]}]},{"efo_id":"EFO_0000546","efo_label":"injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000546","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT04003285"],"urls":["https://clinicaltrials.gov/search?id=%22NCT04003285%22"]}]},{"efo_id":"EFO_0003108","efo_label":"essential tremor","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003108","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02277106"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02277106%22"]}]},{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03665038"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03665038%22"]}]},{"efo_id":"EFO_0003829","efo_label":"alcohol dependence","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003829","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT04015869"],"urls":["https://clinicaltrials.gov/search?id=%22NCT04015869%22"]}]},{"efo_id":"EFO_0007453","efo_label":"postpartum depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007453","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT02285504","NCT02614547"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02285504%22OR%22NCT02614547%22"]},{"source":"FDA","ids":["label/2019/211371lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2019%2F211371lbl.pdf"]}]},{"efo_id":"EFO_0008526","efo_label":"status epilepticus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008526","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02052739","NCT02477618"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02052739%22OR%22NCT02477618%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000022355","approved_name":"gamma-aminobutyric acid type A receptor subunit alpha1","approved_symbol":"GABRA1"},{"ensembl":"ENSG00000145864","approved_name":"gamma-aminobutyric acid type A receptor subunit beta2","approved_symbol":"GABRB2"},{"ensembl":"ENSG00000113327","approved_name":"gamma-aminobutyric acid type A receptor subunit gamma2","approved_symbol":"GABRG2"},{"ensembl":"ENSG00000166206","approved_name":"gamma-aminobutyric acid type A receptor subunit beta3","approved_symbol":"GABRB3"},{"ensembl":"ENSG00000109158","approved_name":"gamma-aminobutyric acid type A receptor subunit alpha4","approved_symbol":"GABRA4"},{"ensembl":"ENSG00000182256","approved_name":"gamma-aminobutyric acid type A receptor subunit gamma3","approved_symbol":"GABRG3"},{"ensembl":"ENSG00000268089","approved_name":"gamma-aminobutyric acid type A receptor subunit theta","approved_symbol":"GABRQ"},{"ensembl":"ENSG00000011677","approved_name":"gamma-aminobutyric acid type A receptor subunit alpha3","approved_symbol":"GABRA3"},{"ensembl":"ENSG00000094755","approved_name":"gamma-aminobutyric acid type A receptor subunit pi","approved_symbol":"GABRP"},{"ensembl":"ENSG00000187730","approved_name":"gamma-aminobutyric acid type A receptor subunit delta","approved_symbol":"GABRD"},{"ensembl":"ENSG00000163285","approved_name":"gamma-aminobutyric acid type A receptor subunit gamma1","approved_symbol":"GABRG1"},{"ensembl":"ENSG00000163288","approved_name":"gamma-aminobutyric acid type A receptor subunit beta1","approved_symbol":"GABRB1"},{"ensembl":"ENSG00000102287","approved_name":"gamma-aminobutyric acid type A receptor subunit epsilon","approved_symbol":"GABRE"},{"ensembl":"ENSG00000151834","approved_name":"gamma-aminobutyric acid type A receptor subunit alpha2","approved_symbol":"GABRA2"},{"ensembl":"ENSG00000186297","approved_name":"gamma-aminobutyric acid type A receptor subunit alpha5","approved_symbol":"GABRA5"},{"ensembl":"ENSG00000145863","approved_name":"gamma-aminobutyric acid type A receptor subunit alpha6","approved_symbol":"GABRA6"}],"target_type":"protein complex group","target_name":"GABA-A receptor; anion channel","action_type":"positive allosteric modulator","description":"GABA-A receptor; anion channel positive allosteric modulator","references":[{"source":"FDA","ids":["label/2019/211371lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2019%2F211371lbl.pdf"]}]}],"adverse_events":{"significant":[{"event":"status epilepticus","count":3754,"llr":18.54005814},{"event":"treatment failure","count":12895,"llr":14.84039291}],"critval":9.748882161},"number_of_indications":7,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":5},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":4},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":2},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1},{"therapeutic_code":"OTAR_0000014","therapeutic_label":"pregnancy or perinatal disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545331","_score":1,"_source":{"id":"CHEMBL3545331","internal_compound":false,"type":"Small molecule","pref_name":"RPR749","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["RPR-749"],"trade_names":[],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000163485","approved_name":"adenosine A1 receptor","approved_symbol":"ADORA1"}],"target_type":"single protein","target_name":"Adenosine A1 receptor","action_type":"agonist","description":"Adenosine A1 receptor agonist","references":[{"source":"PubMed","ids":["15133532","16654164"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15133532+OR+EXT_ID%3A16654164"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545026","_score":1,"_source":{"id":"CHEMBL3545026","internal_compound":false,"type":"Small molecule","pref_name":"FAMITINIB","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Famitinib","SHR-1020","SHR1020"],"trade_names":[],"indications":[{"efo_id":"Orphanet_44890","efo_label":"Gastrointestinal stromal tumor","efo_uri":"http://www.orpha.net/ORDO/Orphanet_44890","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02336724"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02336724%22"]}]},{"efo_id":"EFO_0004252","efo_label":"nasopharyngeal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004252","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01392235","NCT01462474"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01392235%22OR%22NCT01462474%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01762280","NCT01994213"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01762280%22OR%22NCT01994213%22"]}]},{"efo_id":"EFO_0000681","efo_label":"renal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000681","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01829841"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01829841%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02356991","NCT02364362"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02356991%22OR%22NCT02364362%22"]}]},{"efo_id":"EFO_0000365","efo_label":"colorectal adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000365","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01762293","NCT02390947"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01762293%22OR%22NCT02390947%22"]}]},{"efo_id":"EFO_0003869","efo_label":"breast neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003869","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01653574"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01653574%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01762293"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01762293%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000157404","approved_name":"KIT proto-oncogene, receptor tyrosine kinase","approved_symbol":"KIT"}],"target_type":"single protein","target_name":"Stem cell growth factor receptor","action_type":"inhibitor","description":"Stem cell growth factor receptor inhibitor","references":[{"source":"ClinicalTrials","ids":["NCT02390947"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02390947%22"]},{"source":"DOI","ids":["10.1158/1538-7445.AM2011-3604"],"urls":["http://dx.doi.org/10.1158/1538-7445.AM2011-3604"]},{"source":"PubMed","ids":["24043137"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24043137"]}]},{"target_components":[{"ensembl":"ENSG00000102755","approved_name":"fms related receptor tyrosine kinase 1","approved_symbol":"FLT1"}],"target_type":"single protein","target_name":"Vascular endothelial growth factor receptor 1","action_type":"inhibitor","description":"Vascular endothelial growth factor receptor 1 inhibitor","references":[{"source":"ClinicalTrials","ids":["NCT02390947"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02390947%22"]},{"source":"DOI","ids":["10.1158/1538-7445.AM2011-3604"],"urls":["http://dx.doi.org/10.1158/1538-7445.AM2011-3604"]},{"source":"PubMed","ids":["24043137"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24043137"]}]},{"target_components":[{"ensembl":"ENSG00000122025","approved_name":"fms related receptor tyrosine kinase 3","approved_symbol":"FLT3"}],"target_type":"single protein","target_name":"Tyrosine-protein kinase receptor FLT3","action_type":"inhibitor","description":"Tyrosine-protein kinase receptor FLT3 inhibitor","references":[{"source":"ClinicalTrials","ids":["NCT02390947"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02390947%22"]},{"source":"DOI","ids":["10.1158/1538-7445.AM2011-3604"],"urls":["http://dx.doi.org/10.1158/1538-7445.AM2011-3604"]},{"source":"PubMed","ids":["24043137"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24043137"]}]},{"target_components":[{"ensembl":"ENSG00000113721","approved_name":"platelet derived growth factor receptor beta","approved_symbol":"PDGFRB"},{"ensembl":"ENSG00000134853","approved_name":"platelet derived growth factor receptor alpha","approved_symbol":"PDGFRA"}],"target_type":"protein complex","target_name":"Platelet-derived growth factor receptor","action_type":"inhibitor","description":"Platelet-derived growth factor receptor inhibitor","references":[{"source":"ClinicalTrials","ids":["NCT02390947"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02390947%22"]},{"source":"DOI","ids":["10.1158/1538-7445.AM2011-3604"],"urls":["http://dx.doi.org/10.1158/1538-7445.AM2011-3604"]},{"source":"PubMed","ids":["24043137"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24043137"]}]},{"target_components":[{"ensembl":"ENSG00000128052","approved_name":"kinase insert domain receptor","approved_symbol":"KDR"}],"target_type":"single protein","target_name":"Vascular endothelial growth factor receptor 2","action_type":"inhibitor","description":"Vascular endothelial growth factor receptor 2 inhibitor","references":[{"source":"ClinicalTrials","ids":["NCT02390947"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02390947%22"]},{"source":"DOI","ids":["10.1158/1538-7445.AM2011-3604"],"urls":["http://dx.doi.org/10.1158/1538-7445.AM2011-3604"]},{"source":"PubMed","ids":["24043137"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24043137"]}]},{"target_components":[{"ensembl":"ENSG00000037280","approved_name":"fms related receptor tyrosine kinase 4","approved_symbol":"FLT4"}],"target_type":"single protein","target_name":"Vascular endothelial growth factor receptor 3","action_type":"inhibitor","description":"Vascular endothelial growth factor receptor 3 inhibitor","references":[{"source":"DOI","ids":["10.1158/1538-7445.AM2011-3604"],"urls":["http://dx.doi.org/10.1158/1538-7445.AM2011-3604"]},{"source":"PubMed","ids":["24043137"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24043137"]}]}],"number_of_indications":8,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":8},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":4},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":3},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1}],"number_of_mechanisms_of_action":6}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1448","_score":1,"_source":{"id":"CHEMBL1448","internal_compound":false,"type":"Small molecule","pref_name":"NICLOSAMIDE","year_first_approved":1982,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["BAY-2353","NSC-178296","Niclosamide","WR 46234"],"trade_names":["Ex A Lint","Lintex","Niclocide","Nicloside","Yomesan"],"cross_references":[{"source":"PubChem","ids":["104171199","11111533","11111534","124880876","144203760","144211066","170465184","174006693","26747596","26753613","50100291","50106712","50106713","56463356","85231153","90341111"]},{"source":"Wikipedia","ids":["Niclosamide"]},{"source":"drugbank","ids":["DB06803"]}],"canonical_smiles":"O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O","indications":[{"efo_id":"EFO_0000196","efo_label":"metastatic prostate cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000196","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02807805","NCT03123978"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02807805%22OR%22NCT03123978%22"]}]},{"efo_id":"EFO_0000685","efo_label":"rheumatoid arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000685","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03160001"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03160001%22"]}]},{"efo_id":"EFO_1001950","efo_label":"colon carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001950","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02687009"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02687009%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02519582"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02519582%22"]}]}],"mechanisms_of_action":[],"child_chembl_ids":["CHEMBL3794255"],"number_of_indications":4,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3989993","_score":1,"_source":{"id":"CHEMBL3989993","internal_compound":false,"type":"Oligonucleotide","pref_name":"COBOMARSEN","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Cobomarsen","M-11667 FREE ACID","M11667","M11667 FREE ACID","MRG-106","MRG-106 FREE ACID"],"trade_names":[],"indications":[{"efo_id":"EFO_1001051","efo_label":"mycosis fungoides","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001051","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02580552","NCT03713320","NCT03837457"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02580552%22OR%22NCT03713320%22OR%22NCT03837457%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1201610","_score":1,"_source":{"id":"CHEMBL1201610","internal_compound":false,"type":"Protein","pref_name":"CORTICOTROPIN","year_first_approved":1950,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Corticotropin","Corticotropin, Repository","Repository Corticotropin"],"trade_names":["ACTH","Acthar","Acthar Gel","Adrenocorticotropic Hormone","Adrenocorticotropin","Adrenomone","Corticotropin","Cortigel","Cortrophin","H.P. Acthar Gel","Purified Cortrophin Gel"],"cross_references":[{"source":"DailyMed","ids":["corticotropin"]}],"indications":[{"efo_id":"EFO_0003821","efo_label":"migraine disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003821","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01813591"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01813591%22"]}]},{"efo_id":"EFO_0003885","efo_label":"multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003885","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00947895","NCT00986960","NCT01049451","NCT02290444"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00947895%22OR%22NCT00986960%22OR%22NCT01049451%22OR%22NCT02290444%22"]},{"source":"DailyMed","ids":["7b48ddec-e815-45f4-9ca0-5c0daaf56f30"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?7b48ddec-e815-45f4-9ca0-5c0daaf56f30"]}]},{"efo_id":"EFO_0000685","efo_label":"rheumatoid arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000685","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01984268","NCT03511625"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01984268%22OR%22NCT03511625%22"]}]},{"efo_id":"EFO_0000401","efo_label":"diabetic nephropathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000401","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01601236"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01601236%22"]}]},{"efo_id":"EFO_0000253","efo_label":"amyotrophic lateral sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000253","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01906658","NCT03068754"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01906658%22OR%22NCT03068754%22"]}]},{"efo_id":"EFO_0000253","efo_label":"amyotrophic lateral sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000253","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01906658","NCT03068754"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01906658%22OR%22NCT03068754%22"]}]},{"efo_id":"EFO_0000401","efo_label":"diabetic nephropathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000401","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01601236"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01601236%22"]}]},{"efo_id":"EFO_0004255","efo_label":"nephrotic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004255","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02132195"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02132195%22"]}]},{"efo_id":"EFO_0000685","efo_label":"rheumatoid arthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000685","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01984268","NCT03511625"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01984268%22OR%22NCT03511625%22"]}]},{"efo_id":"EFO_0003840","efo_label":"chronic progressive multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003840","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01950234"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01950234%22"]}]},{"efo_id":"EFO_0003885","efo_label":"multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003885","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00947895","NCT00986960","NCT01049451","NCT02290444"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00947895%22OR%22NCT00986960%22OR%22NCT01049451%22OR%22NCT02290444%22"]}]},{"efo_id":"EFO_0003929","efo_label":"relapsing-remitting multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003929","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02315872"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02315872%22"]}]},{"efo_id":"EFO_0003929","efo_label":"relapsing-remitting multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003929","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02315872"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02315872%22"]}]},{"efo_id":"EFO_0003821","efo_label":"migraine disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003821","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01813591"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01813591%22"]}]},{"efo_id":"EFO_0007405","efo_label":"optic neuritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007405","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT01987167"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01987167%22"]}]},{"efo_id":"EFO_0003840","efo_label":"chronic progressive multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003840","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01950234"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01950234%22"]}]},{"efo_id":"EFO_0004255","efo_label":"nephrotic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004255","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02132195"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02132195%22"]}]},{"efo_id":"EFO_0007405","efo_label":"optic neuritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007405","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT01987167"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01987167%22"]}]},{"efo_id":"Orphanet_797","efo_label":"Sarcoidosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_797","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02348905"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02348905%22"]}]},{"efo_id":"Orphanet_797","efo_label":"Sarcoidosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_797","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02348905"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02348905%22"]}]},{"efo_id":"EFO_1000637","efo_label":"acute respiratory distress syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000637","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02113735"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02113735%22"]}]},{"efo_id":"EFO_1001231","efo_label":"uveitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001231","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02931175"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02931175%22"]}]},{"efo_id":"EFO_1000637","efo_label":"acute respiratory distress syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000637","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02113735"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02113735%22"]}]},{"efo_id":"EFO_1001231","efo_label":"uveitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001231","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02931175"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02931175%22"]}]},{"efo_id":"EFO_0000398","efo_label":"dermatomyositis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000398","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01906372"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01906372%22"]}]},{"efo_id":"EFO_0000474","efo_label":"epilepsy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000474","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00004758"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004758%22"]}]},{"efo_id":"EFO_0000621","efo_label":"neuroblastoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000621","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00033293"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00033293%22"]}]},{"efo_id":"EFO_0003063","efo_label":"polymyositis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003063","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01906372"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01906372%22"]}]},{"efo_id":"EFO_0003884","efo_label":"chronic kidney disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003884","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02486744"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02486744%22"]}]},{"efo_id":"EFO_0004254","efo_label":"membranous glomerulonephritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004254","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00805753"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00805753%22"]}]},{"efo_id":"EFO_0000398","efo_label":"dermatomyositis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000398","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01906372"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01906372%22"]}]},{"efo_id":"EFO_0000474","efo_label":"epilepsy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000474","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00004758"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004758%22"]}]},{"efo_id":"EFO_0000621","efo_label":"neuroblastoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000621","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00033293"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00033293%22"]}]},{"efo_id":"EFO_0003063","efo_label":"polymyositis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003063","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01906372"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01906372%22"]}]},{"efo_id":"EFO_0003884","efo_label":"chronic kidney disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003884","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02486744"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02486744%22"]}]},{"efo_id":"EFO_0004254","efo_label":"membranous glomerulonephritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004254","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00805753"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00805753%22"]}]},{"efo_id":"EFO_0000660","efo_label":"polycystic ovary syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000660","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT03905603"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03905603%22"]}]},{"efo_id":"EFO_0008520","efo_label":"primary progressive multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008520","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01950234"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01950234%22"]}]},{"efo_id":"EFO_0008522","efo_label":"secondary progressive multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008522","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01950234"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01950234%22"]}]},{"efo_id":"EFO_0009538","efo_label":"chronic inflammatory demyelinating polyneuropathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009538","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02574962"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02574962%22"]}]},{"efo_id":"EFO_1001129","efo_label":"proliferative vitreoretinopathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001129","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT03727776"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03727776%22"]}]},{"efo_id":"EFO_0000660","efo_label":"polycystic ovary syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000660","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT03905603"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03905603%22"]}]},{"efo_id":"EFO_0008520","efo_label":"primary progressive multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008520","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01950234"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01950234%22"]}]},{"efo_id":"EFO_0008522","efo_label":"secondary progressive multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0008522","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01950234"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01950234%22"]}]},{"efo_id":"EFO_0009538","efo_label":"chronic inflammatory demyelinating polyneuropathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009538","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02574962"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02574962%22"]}]},{"efo_id":"EFO_1001129","efo_label":"proliferative vitreoretinopathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001129","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT03727776"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03727776%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000185231","approved_name":"melanocortin 2 receptor","approved_symbol":"MC2R"}],"target_type":"single protein","target_name":"Melanocortin receptor 2","action_type":"agonist","description":"Melanocortin receptor 2 agonist","references":[{"source":"FDA","ids":["label/2015/008372s044lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F008372s044lbl.pdf"]},{"source":"IUPHAR","ids":["3633"]}]}],"adverse_events":{"significant":[{"event":"epidural lipomatosis","count":110,"llr":27.59733158},{"event":"infantile spasms","count":208,"llr":24.41855717},{"event":"nuclear magnetic resonance imaging brain abnormal","count":730,"llr":22.90660823},{"event":"nail pigmentation","count":105,"llr":21.36474623},{"event":"lipomatosis","count":80,"llr":15.97059731},{"event":"irritability","count":14353,"llr":14.43428417},{"event":"paraplegia","count":990,"llr":12.44883133},{"event":"cushingoid","count":1073,"llr":12.13233611},{"event":"thirst","count":2942,"llr":11.35382176},{"event":"skin hyperpigmentation","count":1558,"llr":10.67293278},{"event":"hypertension","count":52519,"llr":10.39570946},{"event":"retinogram abnormal","count":133,"llr":8.820990297},{"event":"weight increased","count":33631,"llr":8.743129593},{"event":"developmental delay","count":1019,"llr":8.399858284},{"event":"myositis","count":2909,"llr":8.265510254},{"event":"condition aggravated","count":52909,"llr":7.504562944},{"event":"diabetic ketoacidosis","count":6771,"llr":7.440855291},{"event":"choreoathetosis","count":347,"llr":6.917431432},{"event":"malignant hypertension","count":377,"llr":6.753608313},{"event":"blood catecholamines abnormal","count":7,"llr":6.655856802},{"event":"palpitations","count":23550,"llr":6.571471116},{"event":"swelling","count":18005,"llr":6.513376027},{"event":"thecal sac compression","count":9,"llr":6.404677396},{"event":"rhinovirus infection","count":521,"llr":6.116283763},{"event":"multiple-drug resistance","count":550,"llr":6.009897818},{"event":"ocular dysmetria","count":15,"llr":5.894256838},{"event":"peripheral swelling","count":26462,"llr":5.831332976},{"event":"hyperglycaemia","count":9767,"llr":5.808621329},{"event":"cerebrovascular arteriovenous malformation","count":17,"llr":5.769228718},{"event":"alkalosis hypokalaemic","count":18,"llr":5.712137815},{"event":"fluid retention","count":10070,"llr":5.676056646}],"critval":5.538256903},"number_of_indications":46,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":28},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":18},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":14},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":10},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":8},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":6},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":4},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":2},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":2},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":2},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":2}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL35","_score":1,"_source":{"id":"CHEMBL35","internal_compound":false,"type":"Small molecule","pref_name":"FUROSEMIDE","year_first_approved":1966,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":true,"synonyms":["Frusemide","Furosemide","LB-502","NSC-269420","furosemide"],"trade_names":["Aluzine 20","Aluzine 40","Aluzine 500","Aquamed","Disal","Diuresal","Dryptal","Froop","Frumax","Frumil","Frusemide","Frusetic","Frusid","Frusol","Furosemide","Hydroled","Lasix","Lasix Ret","Rusyde","Tenkofruse"],"cross_references":[{"source":"ChEBI","ids":[47426]},{"source":"DailyMed","ids":["furosemide"]},{"source":"PubChem","ids":["11112125","144203873","144209411","144213288","170464879","17389872","47193739"]},{"source":"TG-GATEs","ids":["78"]},{"source":"Wikipedia","ids":["Furosemide"]},{"source":"drugbank","ids":["DB00695"]}],"canonical_smiles":"NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl","indications":[{"efo_id":"EFO_0000373","efo_label":"congestive heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000373","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT01210365","NCT02579057","NCT03730961"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01210365%22OR%22NCT02579057%22OR%22NCT03730961%22"]},{"source":"DailyMed","ids":["11f60f1a-42a4-426a-98b3-7e6cfbee3407","1b9117d5-0dd9-4577-a1fd-bb0aaf7e68ec","1d2a8ab4-48a1-47f9-8ac8-d04b100fcbd8","2b0cbe8e-f1c0-4883-94ff-ad603af20655","342a0b3b-3638-4c43-9ff6-1f8cfd6c5b6c","39fd32f2-6bb7-4a65-d298-e48d26bc80c7","3a2efcd1-9490-4113-974d-21da8ebd7e03","4b635500-474a-4944-a66a-b305443344ae","682d3324-7989-4784-9b1d-9f9257f00fec","6c252efd-080a-46dd-9c50-e1d3ed126c8d","6cd695c7-13d6-4444-9db5-2b8c8e163376","708b157c-845d-4776-9ced-6ae4aae10210","71b48f4d-9936-448c-9e3a-33f1182e1039","79d9aef8-cfb9-4f6e-ac15-f830d7ea2324","8610f683-1459-479f-9ced-5c766e134542","869c9eeb-baae-4189-aa5e-0b4e1ee172d2","8e0bac29-5a8b-4d4e-93b3-2e21eb3b0650","9ec7808e-9201-4b8c-9790-d329320dc6c4","a6fce940-8009-4f80-99dc-a67be052d45a","a9bc9926-229c-4563-803c-df8f9e13717b","bc37912e-d5f8-468c-bb55-f2328649dfc7","d30e72ae-dff7-065d-3aff-d70758bc8590","d562faea-2800-4ed6-9213-88f072e21134","d680e40c-5126-46dc-a44d-8ff95e66e920","f2dcb470-240b-4919-8b12-aa1f6faacd49"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?11f60f1a-42a4-426a-98b3-7e6cfbee3407","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1b9117d5-0dd9-4577-a1fd-bb0aaf7e68ec","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1d2a8ab4-48a1-47f9-8ac8-d04b100fcbd8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2b0cbe8e-f1c0-4883-94ff-ad603af20655","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?342a0b3b-3638-4c43-9ff6-1f8cfd6c5b6c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?39fd32f2-6bb7-4a65-d298-e48d26bc80c7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3a2efcd1-9490-4113-974d-21da8ebd7e03","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4b635500-474a-4944-a66a-b305443344ae","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?682d3324-7989-4784-9b1d-9f9257f00fec","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6c252efd-080a-46dd-9c50-e1d3ed126c8d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6cd695c7-13d6-4444-9db5-2b8c8e163376","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?708b157c-845d-4776-9ced-6ae4aae10210","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?71b48f4d-9936-448c-9e3a-33f1182e1039","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?79d9aef8-cfb9-4f6e-ac15-f830d7ea2324","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8610f683-1459-479f-9ced-5c766e134542","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?869c9eeb-baae-4189-aa5e-0b4e1ee172d2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8e0bac29-5a8b-4d4e-93b3-2e21eb3b0650","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9ec7808e-9201-4b8c-9790-d329320dc6c4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a6fce940-8009-4f80-99dc-a67be052d45a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a9bc9926-229c-4563-803c-df8f9e13717b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bc37912e-d5f8-468c-bb55-f2328649dfc7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d30e72ae-dff7-065d-3aff-d70758bc8590","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d562faea-2800-4ed6-9213-88f072e21134","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d680e40c-5126-46dc-a44d-8ff95e66e920","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f2dcb470-240b-4919-8b12-aa1f6faacd49"]},{"source":"FDA","ids":["012141a6-7c5d-4598-91ed-3960ed0c57d7","0c50f82b-e9f0-4aab-b47e-b1113aa3862f","0ce6239f-f2b3-44cc-abd6-9d0a304ef0d4","1d95a4e7-6db4-4e90-b240-d08203733664","2633c775-8a3e-44d4-8909-0f34dc59d405","2f5bc0c3-b2a8-4426-b648-799c0d0648ba","3a731de9-de4e-b384-ede3-aea16c156e8b","4576e871-14c2-4d9e-b0be-2f0054b92514","50c48b11-8a70-435e-9028-4748bd82593f","513a6195-7dc6-4fd3-8de6-2b8aa069d90c","6040a2ec-3385-44dd-9f8e-f87ad6474be7","7abe8819-6aab-4b1c-841e-bd2830d49faf","9d9475f1-1ab5-4187-b784-943dad2f6dea","a5c17058-c920-4d20-97c8-89b8b712cbce","abda01bf-7391-40f2-a3d5-04deec6789ab","af062839-6f6d-4949-9ddb-76dba7cee92c","b609768a-43a0-4cb9-8eca-b42e217ecd3b","b75e6570-c96a-4362-b1e6-2690b859816a","bcd8df1e-1145-47a2-ae17-4a8759e89fa6","bf2513c1-49f5-4f6a-a76d-1c6a9e6c5dfb","d71487aa-c181-4549-a16a-61551490dec0","f20176fb-205c-4368-b510-cbd296cb8152","f3369d36-68a4-4737-91fa-34de6ab9ad94","fc626d03-a44c-4a9b-b87c-d57450d45e35"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A012141a6-7c5d-4598-91ed-3960ed0c57d7","https://api.fda.gov/drug/label.json?search=set_id%3A0c50f82b-e9f0-4aab-b47e-b1113aa3862f","https://api.fda.gov/drug/label.json?search=set_id%3A0ce6239f-f2b3-44cc-abd6-9d0a304ef0d4","https://api.fda.gov/drug/label.json?search=set_id%3A1d95a4e7-6db4-4e90-b240-d08203733664","https://api.fda.gov/drug/label.json?search=set_id%3A2633c775-8a3e-44d4-8909-0f34dc59d405","https://api.fda.gov/drug/label.json?search=set_id%3A2f5bc0c3-b2a8-4426-b648-799c0d0648ba","https://api.fda.gov/drug/label.json?search=set_id%3A3a731de9-de4e-b384-ede3-aea16c156e8b","https://api.fda.gov/drug/label.json?search=set_id%3A4576e871-14c2-4d9e-b0be-2f0054b92514","https://api.fda.gov/drug/label.json?search=set_id%3A50c48b11-8a70-435e-9028-4748bd82593f","https://api.fda.gov/drug/label.json?search=set_id%3A513a6195-7dc6-4fd3-8de6-2b8aa069d90c","https://api.fda.gov/drug/label.json?search=set_id%3A6040a2ec-3385-44dd-9f8e-f87ad6474be7","https://api.fda.gov/drug/label.json?search=set_id%3A7abe8819-6aab-4b1c-841e-bd2830d49faf","https://api.fda.gov/drug/label.json?search=set_id%3A9d9475f1-1ab5-4187-b784-943dad2f6dea","https://api.fda.gov/drug/label.json?search=set_id%3Aa5c17058-c920-4d20-97c8-89b8b712cbce","https://api.fda.gov/drug/label.json?search=set_id%3Aabda01bf-7391-40f2-a3d5-04deec6789ab","https://api.fda.gov/drug/label.json?search=set_id%3Aaf062839-6f6d-4949-9ddb-76dba7cee92c","https://api.fda.gov/drug/label.json?search=set_id%3Ab609768a-43a0-4cb9-8eca-b42e217ecd3b","https://api.fda.gov/drug/label.json?search=set_id%3Ab75e6570-c96a-4362-b1e6-2690b859816a","https://api.fda.gov/drug/label.json?search=set_id%3Abcd8df1e-1145-47a2-ae17-4a8759e89fa6","https://api.fda.gov/drug/label.json?search=set_id%3Abf2513c1-49f5-4f6a-a76d-1c6a9e6c5dfb","https://api.fda.gov/drug/label.json?search=set_id%3Ad71487aa-c181-4549-a16a-61551490dec0","https://api.fda.gov/drug/label.json?search=set_id%3Af20176fb-205c-4368-b510-cbd296cb8152","https://api.fda.gov/drug/label.json?search=set_id%3Af3369d36-68a4-4737-91fa-34de6ab9ad94","https://api.fda.gov/drug/label.json?search=set_id%3Afc626d03-a44c-4a9b-b87c-d57450d45e35"]}]},{"efo_id":"EFO_0003818","efo_label":"lung disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003818","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00618852"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00618852%22"]}]},{"efo_id":"EFO_0003827","efo_label":"pulmonary embolism","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003827","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02268903"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02268903%22"]}]},{"efo_id":"EFO_0003144","efo_label":"heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003144","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00372762","NCT00577135","NCT00953303","NCT01125514","NCT02329834","NCT02350725","NCT02689180","NCT02721511","NCT02877095","NCT03296813","NCT03837470","NCT03901729"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00372762%22OR%22NCT00577135%22OR%22NCT00953303%22OR%22NCT01125514%22OR%22NCT02329834%22OR%22NCT02350725%22OR%22NCT02689180%22OR%22NCT02721511%22OR%22NCT02877095%22OR%22NCT03296813%22OR%22NCT03837470%22OR%22NCT03901729%22"]}]},{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["C03CA01"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C03CA01"]}]},{"efo_id":"HP_0011950","efo_label":"Bronchiolitis","efo_uri":"http://purl.obolibrary.org/obo/HP_0011950","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00261937","NCT00512811","NCT02469597"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00261937%22OR%22NCT00512811%22OR%22NCT02469597%22"]}]},{"efo_id":"HP_0001919","efo_label":"Acute kidney injury","efo_uri":"http://purl.obolibrary.org/obo/HP_0001919","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00978354","NCT02983422"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00978354%22OR%22NCT02983422%22"]}]},{"efo_id":"Orphanet_70589","efo_label":"Bronchopulmonary dysplasia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_70589","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02527798"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02527798%22"]}]},{"efo_id":"EFO_0003086","efo_label":"kidney disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003086","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00702728","NCT00936923"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00702728%22OR%22NCT00936923%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02575963"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02575963%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02501213"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02501213%22"]}]},{"efo_id":"EFO_0000400","efo_label":"diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000400","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03010475"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03010475%22"]}]},{"efo_id":"EFO_0000537","efo_label":"hypertension","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000537","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT02450773","NCT03556761"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02450773%22OR%22NCT03556761%22"]},{"source":"DailyMed","ids":["11f60f1a-42a4-426a-98b3-7e6cfbee3407","1d2a8ab4-48a1-47f9-8ac8-d04b100fcbd8","2b0cbe8e-f1c0-4883-94ff-ad603af20655","3a2efcd1-9490-4113-974d-21da8ebd7e03","4b635500-474a-4944-a66a-b305443344ae","557fee5e-166c-4f0f-bb4d-37c6ce3496ad","682d3324-7989-4784-9b1d-9f9257f00fec","6c252efd-080a-46dd-9c50-e1d3ed126c8d","6cd695c7-13d6-4444-9db5-2b8c8e163376","708b157c-845d-4776-9ced-6ae4aae10210","79d9aef8-cfb9-4f6e-ac15-f830d7ea2324","9ec7808e-9201-4b8c-9790-d329320dc6c4","a6fce940-8009-4f80-99dc-a67be052d45a","bc37912e-d5f8-468c-bb55-f2328649dfc7","cfe67179-fbfe-402d-9326-07373bd93951","d30e72ae-dff7-065d-3aff-d70758bc8590","d562faea-2800-4ed6-9213-88f072e21134","d680e40c-5126-46dc-a44d-8ff95e66e920","f2dcb470-240b-4919-8b12-aa1f6faacd49"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?11f60f1a-42a4-426a-98b3-7e6cfbee3407","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1d2a8ab4-48a1-47f9-8ac8-d04b100fcbd8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2b0cbe8e-f1c0-4883-94ff-ad603af20655","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3a2efcd1-9490-4113-974d-21da8ebd7e03","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4b635500-474a-4944-a66a-b305443344ae","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?557fee5e-166c-4f0f-bb4d-37c6ce3496ad","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?682d3324-7989-4784-9b1d-9f9257f00fec","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6c252efd-080a-46dd-9c50-e1d3ed126c8d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6cd695c7-13d6-4444-9db5-2b8c8e163376","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?708b157c-845d-4776-9ced-6ae4aae10210","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?79d9aef8-cfb9-4f6e-ac15-f830d7ea2324","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9ec7808e-9201-4b8c-9790-d329320dc6c4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a6fce940-8009-4f80-99dc-a67be052d45a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bc37912e-d5f8-468c-bb55-f2328649dfc7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?cfe67179-fbfe-402d-9326-07373bd93951","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d30e72ae-dff7-065d-3aff-d70758bc8590","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d562faea-2800-4ed6-9213-88f072e21134","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d680e40c-5126-46dc-a44d-8ff95e66e920","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f2dcb470-240b-4919-8b12-aa1f6faacd49"]},{"source":"FDA","ids":["012141a6-7c5d-4598-91ed-3960ed0c57d7","0c50f82b-e9f0-4aab-b47e-b1113aa3862f","0ce6239f-f2b3-44cc-abd6-9d0a304ef0d4","11d45137-e4cf-4791-ad37-05e1247ddeef","13d83c0c-6328-4d64-99c1-5a68b132fed9","19926550-0376-42b1-bf67-56871e5bd7a3","1d95a4e7-6db4-4e90-b240-d08203733664","2f5bc0c3-b2a8-4426-b648-799c0d0648ba","3a731de9-de4e-b384-ede3-aea16c156e8b","4576e871-14c2-4d9e-b0be-2f0054b92514","50c48b11-8a70-435e-9028-4748bd82593f","513a6195-7dc6-4fd3-8de6-2b8aa069d90c","529fe6c0-c1ef-4fe1-bb8e-cf748e3a3a85","7abe8819-6aab-4b1c-841e-bd2830d49faf","8611f3c2-b182-4aca-a0a6-ad40d13a34e0","9d9475f1-1ab5-4187-b784-943dad2f6dea","a5c17058-c920-4d20-97c8-89b8b712cbce","abda01bf-7391-40f2-a3d5-04deec6789ab","af062839-6f6d-4949-9ddb-76dba7cee92c","b609768a-43a0-4cb9-8eca-b42e217ecd3b","b64c46ee-621e-4dd9-8458-beaa654a7c19","b75e6570-c96a-4362-b1e6-2690b859816a","bcd8df1e-1145-47a2-ae17-4a8759e89fa6","ea5805d3-400b-4978-b27d-bd2b5b1cb636","f20176fb-205c-4368-b510-cbd296cb8152","f3369d36-68a4-4737-91fa-34de6ab9ad94","fc626d03-a44c-4a9b-b87c-d57450d45e35"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A012141a6-7c5d-4598-91ed-3960ed0c57d7","https://api.fda.gov/drug/label.json?search=set_id%3A0c50f82b-e9f0-4aab-b47e-b1113aa3862f","https://api.fda.gov/drug/label.json?search=set_id%3A0ce6239f-f2b3-44cc-abd6-9d0a304ef0d4","https://api.fda.gov/drug/label.json?search=set_id%3A11d45137-e4cf-4791-ad37-05e1247ddeef","https://api.fda.gov/drug/label.json?search=set_id%3A13d83c0c-6328-4d64-99c1-5a68b132fed9","https://api.fda.gov/drug/label.json?search=set_id%3A19926550-0376-42b1-bf67-56871e5bd7a3","https://api.fda.gov/drug/label.json?search=set_id%3A1d95a4e7-6db4-4e90-b240-d08203733664","https://api.fda.gov/drug/label.json?search=set_id%3A2f5bc0c3-b2a8-4426-b648-799c0d0648ba","https://api.fda.gov/drug/label.json?search=set_id%3A3a731de9-de4e-b384-ede3-aea16c156e8b","https://api.fda.gov/drug/label.json?search=set_id%3A4576e871-14c2-4d9e-b0be-2f0054b92514","https://api.fda.gov/drug/label.json?search=set_id%3A50c48b11-8a70-435e-9028-4748bd82593f","https://api.fda.gov/drug/label.json?search=set_id%3A513a6195-7dc6-4fd3-8de6-2b8aa069d90c","https://api.fda.gov/drug/label.json?search=set_id%3A529fe6c0-c1ef-4fe1-bb8e-cf748e3a3a85","https://api.fda.gov/drug/label.json?search=set_id%3A7abe8819-6aab-4b1c-841e-bd2830d49faf","https://api.fda.gov/drug/label.json?search=set_id%3A8611f3c2-b182-4aca-a0a6-ad40d13a34e0","https://api.fda.gov/drug/label.json?search=set_id%3A9d9475f1-1ab5-4187-b784-943dad2f6dea","https://api.fda.gov/drug/label.json?search=set_id%3Aa5c17058-c920-4d20-97c8-89b8b712cbce","https://api.fda.gov/drug/label.json?search=set_id%3Aabda01bf-7391-40f2-a3d5-04deec6789ab","https://api.fda.gov/drug/label.json?search=set_id%3Aaf062839-6f6d-4949-9ddb-76dba7cee92c","https://api.fda.gov/drug/label.json?search=set_id%3Ab609768a-43a0-4cb9-8eca-b42e217ecd3b","https://api.fda.gov/drug/label.json?search=set_id%3Ab64c46ee-621e-4dd9-8458-beaa654a7c19","https://api.fda.gov/drug/label.json?search=set_id%3Ab75e6570-c96a-4362-b1e6-2690b859816a","https://api.fda.gov/drug/label.json?search=set_id%3Abcd8df1e-1145-47a2-ae17-4a8759e89fa6","https://api.fda.gov/drug/label.json?search=set_id%3Aea5805d3-400b-4978-b27d-bd2b5b1cb636","https://api.fda.gov/drug/label.json?search=set_id%3Af20176fb-205c-4368-b510-cbd296cb8152","https://api.fda.gov/drug/label.json?search=set_id%3Af3369d36-68a4-4737-91fa-34de6ab9ad94","https://api.fda.gov/drug/label.json?search=set_id%3Afc626d03-a44c-4a9b-b87c-d57450d45e35"]}]},{"efo_id":"EFO_0000565","efo_label":"leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000565","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01756677"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01756677%22"]}]},{"efo_id":"EFO_0000692","efo_label":"schizophrenia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000692","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00611741"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00611741%22"]}]},{"efo_id":"EFO_0001360","efo_label":"type II diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001360","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00671424"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00671424%22"]}]},{"efo_id":"EFO_0004610","efo_label":"acute lung injury","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004610","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00624650"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00624650%22"]}]},{"efo_id":"EFO_1000391","efo_label":"Nasal Cavity Polyp","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000391","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03362515"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03362515%22"]}]},{"efo_id":"EFO_0004255","efo_label":"nephrotic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004255","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["11f60f1a-42a4-426a-98b3-7e6cfbee3407","1b9117d5-0dd9-4577-a1fd-bb0aaf7e68ec","1d2a8ab4-48a1-47f9-8ac8-d04b100fcbd8","2b0cbe8e-f1c0-4883-94ff-ad603af20655","342a0b3b-3638-4c43-9ff6-1f8cfd6c5b6c","39fd32f2-6bb7-4a65-d298-e48d26bc80c7","3a2efcd1-9490-4113-974d-21da8ebd7e03","4b635500-474a-4944-a66a-b305443344ae","682d3324-7989-4784-9b1d-9f9257f00fec","6c252efd-080a-46dd-9c50-e1d3ed126c8d","6cd695c7-13d6-4444-9db5-2b8c8e163376","708b157c-845d-4776-9ced-6ae4aae10210","71b48f4d-9936-448c-9e3a-33f1182e1039","79d9aef8-cfb9-4f6e-ac15-f830d7ea2324","8610f683-1459-479f-9ced-5c766e134542","869c9eeb-baae-4189-aa5e-0b4e1ee172d2","8e0bac29-5a8b-4d4e-93b3-2e21eb3b0650","9ec7808e-9201-4b8c-9790-d329320dc6c4","a6fce940-8009-4f80-99dc-a67be052d45a","a9bc9926-229c-4563-803c-df8f9e13717b","bc37912e-d5f8-468c-bb55-f2328649dfc7","d30e72ae-dff7-065d-3aff-d70758bc8590","d562faea-2800-4ed6-9213-88f072e21134","d680e40c-5126-46dc-a44d-8ff95e66e920","f2dcb470-240b-4919-8b12-aa1f6faacd49"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?11f60f1a-42a4-426a-98b3-7e6cfbee3407","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1b9117d5-0dd9-4577-a1fd-bb0aaf7e68ec","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?1d2a8ab4-48a1-47f9-8ac8-d04b100fcbd8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?2b0cbe8e-f1c0-4883-94ff-ad603af20655","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?342a0b3b-3638-4c43-9ff6-1f8cfd6c5b6c","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?39fd32f2-6bb7-4a65-d298-e48d26bc80c7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?3a2efcd1-9490-4113-974d-21da8ebd7e03","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?4b635500-474a-4944-a66a-b305443344ae","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?682d3324-7989-4784-9b1d-9f9257f00fec","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6c252efd-080a-46dd-9c50-e1d3ed126c8d","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?6cd695c7-13d6-4444-9db5-2b8c8e163376","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?708b157c-845d-4776-9ced-6ae4aae10210","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?71b48f4d-9936-448c-9e3a-33f1182e1039","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?79d9aef8-cfb9-4f6e-ac15-f830d7ea2324","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8610f683-1459-479f-9ced-5c766e134542","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?869c9eeb-baae-4189-aa5e-0b4e1ee172d2","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8e0bac29-5a8b-4d4e-93b3-2e21eb3b0650","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9ec7808e-9201-4b8c-9790-d329320dc6c4","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a6fce940-8009-4f80-99dc-a67be052d45a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?a9bc9926-229c-4563-803c-df8f9e13717b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?bc37912e-d5f8-468c-bb55-f2328649dfc7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d30e72ae-dff7-065d-3aff-d70758bc8590","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d562faea-2800-4ed6-9213-88f072e21134","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?d680e40c-5126-46dc-a44d-8ff95e66e920","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f2dcb470-240b-4919-8b12-aa1f6faacd49"]},{"source":"FDA","ids":["012141a6-7c5d-4598-91ed-3960ed0c57d7","0c50f82b-e9f0-4aab-b47e-b1113aa3862f","0ce6239f-f2b3-44cc-abd6-9d0a304ef0d4","1d95a4e7-6db4-4e90-b240-d08203733664","2633c775-8a3e-44d4-8909-0f34dc59d405","2f5bc0c3-b2a8-4426-b648-799c0d0648ba","3a731de9-de4e-b384-ede3-aea16c156e8b","4576e871-14c2-4d9e-b0be-2f0054b92514","50c48b11-8a70-435e-9028-4748bd82593f","513a6195-7dc6-4fd3-8de6-2b8aa069d90c","6040a2ec-3385-44dd-9f8e-f87ad6474be7","7abe8819-6aab-4b1c-841e-bd2830d49faf","9d9475f1-1ab5-4187-b784-943dad2f6dea","a5c17058-c920-4d20-97c8-89b8b712cbce","abda01bf-7391-40f2-a3d5-04deec6789ab","af062839-6f6d-4949-9ddb-76dba7cee92c","b609768a-43a0-4cb9-8eca-b42e217ecd3b","b75e6570-c96a-4362-b1e6-2690b859816a","bcd8df1e-1145-47a2-ae17-4a8759e89fa6","bf2513c1-49f5-4f6a-a76d-1c6a9e6c5dfb","d71487aa-c181-4549-a16a-61551490dec0","f20176fb-205c-4368-b510-cbd296cb8152","f3369d36-68a4-4737-91fa-34de6ab9ad94"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A012141a6-7c5d-4598-91ed-3960ed0c57d7","https://api.fda.gov/drug/label.json?search=set_id%3A0c50f82b-e9f0-4aab-b47e-b1113aa3862f","https://api.fda.gov/drug/label.json?search=set_id%3A0ce6239f-f2b3-44cc-abd6-9d0a304ef0d4","https://api.fda.gov/drug/label.json?search=set_id%3A1d95a4e7-6db4-4e90-b240-d08203733664","https://api.fda.gov/drug/label.json?search=set_id%3A2633c775-8a3e-44d4-8909-0f34dc59d405","https://api.fda.gov/drug/label.json?search=set_id%3A2f5bc0c3-b2a8-4426-b648-799c0d0648ba","https://api.fda.gov/drug/label.json?search=set_id%3A3a731de9-de4e-b384-ede3-aea16c156e8b","https://api.fda.gov/drug/label.json?search=set_id%3A4576e871-14c2-4d9e-b0be-2f0054b92514","https://api.fda.gov/drug/label.json?search=set_id%3A50c48b11-8a70-435e-9028-4748bd82593f","https://api.fda.gov/drug/label.json?search=set_id%3A513a6195-7dc6-4fd3-8de6-2b8aa069d90c","https://api.fda.gov/drug/label.json?search=set_id%3A6040a2ec-3385-44dd-9f8e-f87ad6474be7","https://api.fda.gov/drug/label.json?search=set_id%3A7abe8819-6aab-4b1c-841e-bd2830d49faf","https://api.fda.gov/drug/label.json?search=set_id%3A9d9475f1-1ab5-4187-b784-943dad2f6dea","https://api.fda.gov/drug/label.json?search=set_id%3Aa5c17058-c920-4d20-97c8-89b8b712cbce","https://api.fda.gov/drug/label.json?search=set_id%3Aabda01bf-7391-40f2-a3d5-04deec6789ab","https://api.fda.gov/drug/label.json?search=set_id%3Aaf062839-6f6d-4949-9ddb-76dba7cee92c","https://api.fda.gov/drug/label.json?search=set_id%3Ab609768a-43a0-4cb9-8eca-b42e217ecd3b","https://api.fda.gov/drug/label.json?search=set_id%3Ab75e6570-c96a-4362-b1e6-2690b859816a","https://api.fda.gov/drug/label.json?search=set_id%3Abcd8df1e-1145-47a2-ae17-4a8759e89fa6","https://api.fda.gov/drug/label.json?search=set_id%3Abf2513c1-49f5-4f6a-a76d-1c6a9e6c5dfb","https://api.fda.gov/drug/label.json?search=set_id%3Ad71487aa-c181-4549-a16a-61551490dec0","https://api.fda.gov/drug/label.json?search=set_id%3Af20176fb-205c-4368-b510-cbd296cb8152","https://api.fda.gov/drug/label.json?search=set_id%3Af3369d36-68a4-4737-91fa-34de6ab9ad94"]}]},{"efo_id":"EFO_0002496","efo_label":"actinic keratosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002496","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03684772"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03684772%22"]}]},{"efo_id":"EFO_0003917","efo_label":"premature birth","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003917","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT03946891"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03946891%22"]}]},{"efo_id":"EFO_0009373","efo_label":"edema","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009373","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01887379"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01887379%22"]}]},{"efo_id":"EFO_1002048","efo_label":"kidney failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1002048","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00298454","NCT01724788"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00298454%22OR%22NCT01724788%22"]}]},{"efo_id":"HP_0002094","efo_label":"Dyspnea","efo_uri":"http://purl.obolibrary.org/obo/HP_0002094","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01440764","NCT02524054","NCT02881866"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01440764%22OR%22NCT02524054%22OR%22NCT02881866%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000074803","approved_name":"solute carrier family 12 member 1","approved_symbol":"SLC12A1"}],"target_type":"single protein","target_name":"Sodium-(potassium)-chloride cotransporter 2","action_type":"inhibitor","description":"Sodium-(potassium)-chloride cotransporter 2 inhibitor","references":[{"source":"DOI","ids":["10.1056/NEJMra0907219"],"urls":["http://dx.doi.org/10.1056/NEJMra0907219"]},{"source":"DailyMed","ids":["setid=c794c95a-654e-48fe-9596-201fc122ff75"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c794c95a-654e-48fe-9596-201fc122ff75"]},{"source":"Wikipedia","ids":["Furosemide","Loop_diuretic"],"urls":["https://www.wikipedia.org/Furosemide","https://www.wikipedia.org/Loop_diuretic"]}]}],"adverse_events":{"significant":[{"event":"acute kidney injury","count":33030,"llr":3002.499815},{"event":"hypokalaemia","count":14556,"llr":2383.742443},{"event":"hyponatraemia","count":21598,"llr":2037.344615},{"event":"hyperkalaemia","count":12419,"llr":1761.047779},{"event":"dehydration","count":36809,"llr":1724.052255},{"event":"renal failure acute","count":23893,"llr":1625.956443},{"event":"hypotension","count":55121,"llr":1613.924233},{"event":"syncope","count":31191,"llr":1023.683536},{"event":"orthostatic hypotension","count":6478,"llr":620.5266841},{"event":"cardiac failure","count":15275,"llr":526.257647},{"event":"fall","count":67604,"llr":502.340865},{"event":"drug interaction","count":53526,"llr":475.7169649},{"event":"metabolic alkalosis","count":568,"llr":454.351137},{"event":"renal failure","count":27897,"llr":395.9253322},{"event":"blood creatinine increased","count":21684,"llr":380.1358739},{"event":"renal impairment","count":20843,"llr":362.2232487},{"event":"bradycardia","count":20091,"llr":356.8798901},{"event":"torsade de pointes","count":3618,"llr":354.3822421},{"event":"hypomagnesaemia","count":4347,"llr":343.8917757},{"event":"electrocardiogram qt prolonged","count":12378,"llr":326.8368331},{"event":"hypovolaemia","count":2138,"llr":301.2936783},{"event":"blood urea increased","count":6508,"llr":300.2397695},{"event":"presyncope","count":6977,"llr":271.1191101},{"event":"oedema peripheral","count":40474,"llr":255.8114067},{"event":"nephrocalcinosis","count":365,"llr":254.6319321}],"critval":238.3585632},"child_chembl_ids":["CHEMBL1788133"],"number_of_indications":24,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":6},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":5},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":5},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":4},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":3},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":2},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":2},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":2},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":2},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL408701","_score":1,"_source":{"id":"CHEMBL408701","internal_compound":false,"type":"Small molecule","pref_name":"TAUROLITHOCHOLIC ACID","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Taurolithocholate","Taurolithocholic acid","Tauroursodeoxycholic acid"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[36259]},{"source":"PubChem","ids":["518640"]}],"canonical_smiles":"C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C","indications":[{"efo_id":"EFO_0000253","efo_label":"amyotrophic lateral sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000253","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00877604","NCT03800524"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00877604%22OR%22NCT03800524%22"]}]},{"efo_id":"EFO_0000270","efo_label":"asthma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000270","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03878654"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03878654%22"]}]},{"efo_id":"EFO_0001359","efo_label":"type I diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001359","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02218619"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02218619%22"]}]},{"efo_id":"EFO_0003885","efo_label":"multiple sclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003885","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03423121"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03423121%22"]}]},{"efo_id":"EFO_1001486","efo_label":"primary biliary cirrhosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001486","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01857284"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01857284%22"]}]}],"child_chembl_ids":["CHEMBL2028239"],"number_of_indications":5,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":2},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL404","_score":1,"_source":{"id":"CHEMBL404","internal_compound":false,"type":"Small molecule","pref_name":"TAZOBACTAM","year_first_approved":1993,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["CL-298741","CL-307579","Tazobactam","Tazobactam sodium","Tazobactam sodium salt","YTR-830H"],"trade_names":["Tazocillin"],"cross_references":[{"source":"ChEBI","ids":[9421]},{"source":"DailyMed","ids":["tazobactam%20sodium"]},{"source":"Wikipedia","ids":["Tazobactam"]},{"source":"drugbank","ids":["DB01606"]},{"source":"ChEBI","ids":[85192]},{"source":"PubChem","ids":["144205137","170465148"]}],"canonical_smiles":"C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O","indications":[{"efo_id":"EFO_0000544","efo_label":"infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000544","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01147640","NCT01994993","NCT02266706","NCT02466438","NCT02725216","NCT02739997","NCT03217136","NCT03830333","NCT04042077"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01147640%22OR%22NCT01994993%22OR%22NCT02266706%22OR%22NCT02466438%22OR%22NCT02725216%22OR%22NCT02739997%22OR%22NCT03217136%22OR%22NCT03830333%22OR%22NCT04042077%22"]}]},{"efo_id":"EFO_0001076","efo_label":"Pseudomonas infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001076","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01577368"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01577368%22"]}]},{"efo_id":"EFO_0001642","efo_label":"lymphoid neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001642","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00044759"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00044759%22"]}]},{"efo_id":"EFO_0002618","efo_label":"pancreatic carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002618","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03269994"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03269994%22"]}]},{"efo_id":"EFO_0003030","efo_label":"abscess","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003030","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00629135"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00629135%22"]}]},{"efo_id":"EFO_0003102","efo_label":"osteomyelitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003102","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT02099240"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02099240%22"]}]},{"efo_id":"EFO_0003106","efo_label":"pneumonia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003106","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00253955","NCT01853982","NCT02387372"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00253955%22OR%22NCT01853982%22OR%22NCT02387372%22"]}]},{"efo_id":"EFO_0004992","efo_label":"Otitis media","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004992","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02817347"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02817347%22"]}]},{"efo_id":"EFO_0006834","efo_label":"septic shock","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0006834","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02820987"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02820987%22"]}]},{"efo_id":"EFO_1001272","efo_label":"bacterial pneumonia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001272","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02493764"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02493764%22"]}]},{"efo_id":"EFO_1001289","efo_label":"Cholecystitis, Acute","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001289","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02619149"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02619149%22"]}]},{"efo_id":"EFO_1001459","efo_label":"diabetic foot","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001459","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00229112"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00229112%22"]}]},{"efo_id":"HP_0100806","efo_label":"Sepsis","efo_uri":"http://purl.obolibrary.org/obo/HP_0100806","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00873327","NCT02473263"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00873327%22OR%22NCT02473263%22"]}]},{"efo_id":"EFO_0003103","efo_label":"urinary tract infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003103","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03687255"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03687255%22"]}]},{"efo_id":"EFO_0005741","efo_label":"infectious disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005741","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03485950"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03485950%22"]}]},{"efo_id":"EFO_1001865","efo_label":"ventilator-associated pneumonia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001865","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02070757"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02070757%22"]}]},{"efo_id":"EFO_0003103","efo_label":"urinary tract infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003103","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["70ac1d90-eff3-4f0b-9f46-5846c571b32f"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?70ac1d90-eff3-4f0b-9f46-5846c571b32f"]}]},{"efo_id":"EFO_0000544","efo_label":"infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000544","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00389987"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00389987%22"]}]}],"adverse_events":{"significant":[{"event":"acute kidney injury","count":33030,"llr":295.1385234},{"event":"drug reaction with eosinophilia and systemic symptoms","count":9050,"llr":216.4047553},{"event":"thrombocytopenia","count":35327,"llr":184.7835558},{"event":"renal tubular necrosis","count":3219,"llr":174.2456989},{"event":"rash maculo-papular","count":8035,"llr":172.1270168},{"event":"eosinophilia","count":6224,"llr":164.3093724},{"event":"tubulointerstitial nephritis","count":4806,"llr":155.4028795},{"event":"pyrexia","count":87334,"llr":153.3906085},{"event":"nephropathy toxic","count":3566,"llr":142.3789849},{"event":"agranulocytosis","count":6607,"llr":125.8554971},{"event":"clostridium difficile infection","count":4220,"llr":114.6040442},{"event":"clostridium difficile colitis","count":3199,"llr":105.3950301},{"event":"clostridium test positive","count":466,"llr":102.4620488},{"event":"renal failure acute","count":23893,"llr":100.6917259},{"event":"nephritis interstitial","count":806,"llr":96.3483619},{"event":"fatigue","count":147738,"llr":96.16821629},{"event":"clostridial infection","count":1423,"llr":83.47943605},{"event":"toxic epidermal necrolysis","count":4052,"llr":82.81806894},{"event":"rash","count":97330,"llr":70.76672481},{"event":"cholestasis","count":6825,"llr":68.79085746},{"event":"pancytopenia","count":17598,"llr":68.59299333},{"event":"blood creatinine increased","count":21684,"llr":67.22006773},{"event":"linear iga disease","count":698,"llr":64.10262315},{"event":"headache","count":120638,"llr":63.84435172},{"event":"dizziness","count":99375,"llr":63.04468822},{"event":"pseudomembranous colitis","count":778,"llr":51.37368654},{"event":"injection site pain","count":56727,"llr":51.05793853},{"event":"neutropenia","count":41585,"llr":49.03109077},{"event":"drug rash with eosinophilia and systemic symptoms","count":2240,"llr":48.88886449}],"critval":48.53447111},"child_chembl_ids":["CHEMBL1439"],"mechanisms_of_action":[{"target_type":"single protein","target_name":"Bacterial beta-lactamase TEM","action_type":"inhibitor","description":"Bacterial beta-lactamase TEM inhibitor","references":[{"source":"PubMed","ids":["10511459"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10511459"]}]}],"number_of_indications":18,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":10},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":3},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":3},{"therapeutic_code":"GO_0008150","therapeutic_label":"biological process","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":2},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"MONDO_0021205","therapeutic_label":"disease of ear","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL139835","_score":1,"_source":{"id":"CHEMBL139835","internal_compound":false,"type":"Small molecule","pref_name":"CYPROTERONE ACETATE","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Cyproterone","Cyproterone Acetate","NSC-81430","SH-714"],"trade_names":["Androcur","Androcur 10","Cyprostat","Diane"],"cross_references":[{"source":"ChEBI","ids":[50743]},{"source":"PubChem","ids":["144204615","144208884","144213258","170465682","17389953","26752883","46500455","49737417","90340797"]},{"source":"drugbank","ids":["DB04839"]}],"canonical_smiles":"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C","indications":[{"efo_id":"EFO_0000660","efo_label":"polycystic ovary syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000660","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03264638"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03264638%22"]}]},{"efo_id":"EFO_0000673","efo_label":"prostate adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000673","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01011751"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01011751%22"]}]},{"efo_id":"EFO_0001065","efo_label":"endometriosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001065","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01973816"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01973816%22"]}]},{"efo_id":"EFO_0001663","efo_label":"prostate carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001663","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00003653","NCT00055731","NCT00196339","NCT00363285","NCT00392535","NCT00849082"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003653%22OR%22NCT00055731%22OR%22NCT00196339%22OR%22NCT00363285%22OR%22NCT00392535%22OR%22NCT00849082%22"]}]},{"efo_id":"EFO_0003894","efo_label":"acne","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003894","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00280657"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00280657%22"]}]},{"efo_id":"EFO_0003922","efo_label":"menopause","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003922","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01933204"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01933204%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000169083","approved_name":"androgen receptor","approved_symbol":"AR"}],"target_type":"single protein","target_name":"Androgen Receptor","action_type":"antagonist","description":"Androgen Receptor antagonist","references":[{"source":"PubMed","ids":["12695529","1838080","2956461","2988566","438696","6237068","6260040","6279337","6458025","6771095","7166160","7584530"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12695529+OR+EXT_ID%3A1838080+OR+EXT_ID%3A2956461+OR+EXT_ID%3A2988566+OR+EXT_ID%3A438696+OR+EXT_ID%3A6237068+OR+EXT_ID%3A6260040+OR+EXT_ID%3A6279337+OR+EXT_ID%3A6458025+OR+EXT_ID%3A6771095+OR+EXT_ID%3A7166160+OR+EXT_ID%3A7584530"]}]},{"target_components":[{"ensembl":"ENSG00000113580","approved_name":"nuclear receptor subfamily 3 group C member 1","approved_symbol":"NR3C1"}],"target_type":"single protein","target_name":"Glucocorticoid receptor","action_type":"antagonist","description":"Glucocorticoid receptor antagonist","references":[{"source":"PubMed","ids":["12695529","1838080","2956461","2988566","438696","6237068","6260040","6279337","6458025","6771095","7166160","7584530"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12695529+OR+EXT_ID%3A1838080+OR+EXT_ID%3A2956461+OR+EXT_ID%3A2988566+OR+EXT_ID%3A438696+OR+EXT_ID%3A6237068+OR+EXT_ID%3A6260040+OR+EXT_ID%3A6279337+OR+EXT_ID%3A6458025+OR+EXT_ID%3A6771095+OR+EXT_ID%3A7166160+OR+EXT_ID%3A7584530"]}]},{"target_components":[{"ensembl":"ENSG00000082175","approved_name":"progesterone receptor","approved_symbol":"PGR"}],"target_type":"single protein","target_name":"Progesterone receptor","action_type":"agonist","description":"Progesterone receptor agonist","references":[{"source":"PubMed","ids":["12695529","1838080","2956461","2988566","438696","6237068","6260040","6279337","6458025","6771095","7166160","7584530"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12695529+OR+EXT_ID%3A1838080+OR+EXT_ID%3A2956461+OR+EXT_ID%3A2988566+OR+EXT_ID%3A438696+OR+EXT_ID%3A6237068+OR+EXT_ID%3A6260040+OR+EXT_ID%3A6279337+OR+EXT_ID%3A6458025+OR+EXT_ID%3A6771095+OR+EXT_ID%3A7166160+OR+EXT_ID%3A7584530"]}]}],"adverse_events":{"significant":[{"event":"dementia alzheimer's type","count":1115,"llr":581.5171296},{"event":"meningioma","count":1004,"llr":499.4543057},{"event":"meningioma benign","count":123,"llr":50.58756929},{"event":"prosopagnosia","count":31,"llr":39.53247916},{"event":"rhabdomyolysis","count":16457,"llr":37.49706819},{"event":"reading disorder","count":291,"llr":26.12174261},{"event":"frontotemporal dementia","count":149,"llr":24.18768263},{"event":"femoral neck fracture","count":1653,"llr":23.37779006},{"event":"prolactin-producing pituitary tumour","count":48,"llr":22.97630515},{"event":"drug-induced liver injury","count":7265,"llr":19.88418258},{"event":"inhibitory drug interaction","count":481,"llr":18.36044605},{"event":"pulmonary embolism","count":25452,"llr":18.28674592},{"event":"hemiparaesthesia","count":59,"llr":15.74845462},{"event":"transgender hormonal therapy","count":3,"llr":15.63967945},{"event":"drug interaction","count":53526,"llr":15.03115603},{"event":"aphasia","count":8046,"llr":13.72579625},{"event":"calculus urinary","count":492,"llr":13.71059721},{"event":"ventricular extrasystoles","count":4152,"llr":13.3274166},{"event":"deep vein thrombosis","count":21525,"llr":11.02234233},{"event":"eye haematoma","count":33,"llr":10.84683698},{"event":"peliosis hepatis","count":44,"llr":10.2725538},{"event":"language disorder","count":447,"llr":9.711420781},{"event":"diarrhoea","count":126514,"llr":9.151235131},{"event":"cholestatic liver injury","count":564,"llr":9.025402259},{"event":"hyperbilirubinaemia","count":3507,"llr":8.722349307},{"event":"hepatitis fulminant","count":671,"llr":8.514746148},{"event":"acoustic neuroma","count":124,"llr":8.208231601},{"event":"cytolytic hepatitis","count":2476,"llr":7.440919338},{"event":"hyperprolactinaemia","count":1065,"llr":7.167487221},{"event":"cardiac valve disease","count":1161,"llr":6.91797801},{"event":"quality of life decreased","count":1259,"llr":6.684477668},{"event":"hepatitis","count":8668,"llr":6.572736955},{"event":"mood swings","count":5761,"llr":6.460599562},{"event":"rash","count":97330,"llr":6.45157685},{"event":"hepatotoxicity","count":5998,"llr":6.282164324},{"event":"pain","count":94786,"llr":6.220966485},{"event":"coordination abnormal","count":3529,"llr":6.12644716}],"critval":6.082797125},"number_of_indications":6,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":4},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":4},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":3}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108531","_score":1,"_source":{"id":"CHEMBL2108531","internal_compound":false,"type":"Small molecule","pref_name":"POLIFEPROSAN 20","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Polifeprosan","Polifeprosan 20"],"trade_names":[],"indications":[{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00003878"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003878%22"]}]},{"efo_id":"EFO_0000326","efo_label":"central nervous system cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000326","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00003463","NCT00003467","NCT00003876","NCT00004892","NCT00045721","NCT00814593"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003463%22OR%22NCT00003467%22OR%22NCT00003876%22OR%22NCT00004892%22OR%22NCT00045721%22OR%22NCT00814593%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297819","_score":1,"_source":{"id":"CHEMBL4297819","internal_compound":false,"type":"Unknown","pref_name":"ROPEGINTERFERON ALFA-2B","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Aop2014","P1101","Ropeginterferon alfa-2b"],"trade_names":[],"indications":[{"efo_id":"EFO_0000339","efo_label":"chronic myelogenous leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000339","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01933906"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01933906%22"]}]},{"efo_id":"EFO_0002429","efo_label":"polycythemia vera","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002429","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03003325"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03003325%22"]}]}],"mechanisms_of_action":[],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":2}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL371064","_score":1,"_source":{"id":"CHEMBL371064","internal_compound":false,"type":"Small molecule","pref_name":"BALICATIB","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AAE-581","AAE581","Balicatib"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12239"]}],"canonical_smiles":"CCCN1CCN(c2ccc(C(=O)NC3(C(=O)NCC#N)CCCCC3)cc2)CC1","indications":[{"efo_id":"EFO_0002506","efo_label":"osteoarthritis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002506","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00371670"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00371670%22"]}]},{"efo_id":"EFO_0003882","efo_label":"osteoporosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003882","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00100607","NCT00170911"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00100607%22OR%22NCT00170911%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":2}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1743025","_score":1,"_source":{"id":"CHEMBL1743025","internal_compound":false,"type":"Antibody","pref_name":"GANTENERUMAB","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Gantenerumab","R-04909832","R-1450","RG-1450","Ro-4909832"],"trade_names":[],"indications":[{"efo_id":"EFO_0000249","efo_label":"Alzheimer's disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000249","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00531804","NCT01224106","NCT01656525","NCT02051608","NCT03443973","NCT03444870"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00531804%22OR%22NCT01224106%22OR%22NCT01656525%22OR%22NCT02051608%22OR%22NCT03443973%22OR%22NCT03444870%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000142192","approved_name":"amyloid beta precursor protein","approved_symbol":"APP"}],"target_type":"single protein","target_name":"Beta amyloid A4 protein","action_type":"binding agent","description":"Beta amyloid A4 protein binding agent","references":[{"source":"PubMed","ids":["21955818"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21955818"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1086997","_score":1,"_source":{"id":"CHEMBL1086997","internal_compound":false,"type":"Small molecule","pref_name":"LUCERASTAT","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["ACT-434964","Lucerastat","N-N-Butyl Deoxygalactonojirimycin"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB14872"]}],"canonical_smiles":"CCCCN1C[C@H](O)[C@@H](O)[C@@H](O)[C@H]1CO","indications":[{"efo_id":"Orphanet_324","efo_label":"Fabry disease","efo_uri":"http://www.orpha.net/ORDO/Orphanet_324","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02930655","NCT03425539","NCT03737214"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02930655%22OR%22NCT03425539%22OR%22NCT03737214%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4301163","_score":1,"_source":{"id":"CHEMBL4301163","internal_compound":false,"type":"Small molecule","pref_name":"ELSULFAVIRINE","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"cross_references":[{"source":"drugbank","ids":["DB14929"]}],"canonical_smiles":"CCC(=O)NS(=O)(=O)c1ccc(NC(=O)Cc2ccc(Br)c(Oc3cc(Cl)cc(C#N)c3)c2F)c(Cl)c1","child_chembl_ids":["CHEMBL4297377"],"synonyms":["Elpida","Elsulfavirine sodium","R-1206 SODIUM","R1206(SODIUM SALT)"],"indications":[{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03730311"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03730311%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4066936","_score":1,"_source":{"id":"CHEMBL4066936","internal_compound":false,"type":"Small molecule","pref_name":"VERICIGUAT","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Vericiguat"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB15456"]}],"canonical_smiles":"COC(=O)Nc1c(N)nc(-c2nn(Cc3ccccc3F)c3ncc(F)cc23)nc1N","indications":[{"efo_id":"EFO_0003144","efo_label":"heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003144","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02861534"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02861534%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL142438","_score":1,"_source":{"id":"CHEMBL142438","internal_compound":false,"type":"Small molecule","pref_name":"NITROGEN","year_first_approved":2015,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["E-941","E941","INS NO.941","INS-941","Nitrogen","Nitrogen, liquid"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[17997]},{"source":"drugbank","ids":["DB09152"]}],"canonical_smiles":"N#N","indications":[{"efo_id":"EFO_0002496","efo_label":"actinic keratosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002496","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01459393"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01459393%22"]}]},{"efo_id":"EFO_0000373","efo_label":"congestive heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000373","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00060840"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00060840%22"]}]},{"efo_id":"Orphanet_586","efo_label":"Cystic fibrosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_586","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00570349"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00570349%22"]}]},{"efo_id":"EFO_0007512","efo_label":"tinea pedis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007512","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00771342"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00771342%22"]}]},{"efo_id":"EFO_0000341","efo_label":"chronic obstructive pulmonary disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000341","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01355809"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01355809%22"]}]},{"efo_id":"EFO_0003818","efo_label":"lung disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003818","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00551642"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00551642%22"]}]},{"efo_id":"EFO_0004278","efo_label":"sudden cardiac arrest","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004278","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03079102"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03079102%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00781352"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00781352%22"]}]},{"efo_id":"EFO_0000289","efo_label":"bipolar disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000289","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT03748446"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03748446%22"]}]},{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT03748446"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03748446%22"]}]},{"efo_id":"EFO_0004242","efo_label":"obsessive-compulsive disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004242","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03826693"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03826693%22"]}]},{"efo_id":"EFO_0009516","efo_label":"burn","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0009516","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00643357"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00643357%22"]}]},{"efo_id":"HP_0002093","efo_label":"Respiratory insufficiency","efo_uri":"http://purl.obolibrary.org/obo/HP_0002093","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00041561"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00041561%22"]}]}],"adverse_events":{"significant":[{"event":"air embolism","count":105,"llr":24.01256241}],"critval":19.7333002},"number_of_indications":13,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":4},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":3},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":3},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":2},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"OTAR_0000009","therapeutic_label":"injury, poisoning or other complication","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2110922","_score":1,"_source":{"id":"CHEMBL2110922","internal_compound":false,"type":"Small molecule","pref_name":"AMEZINIUM","max_clinical_trial_phase":0,"withdrawn_flag":false,"black_box_warning":false,"canonical_smiles":"COc1cc(N)cn[n+]1-c1ccccc1","child_chembl_ids":["CHEMBL2106667"],"synonyms":["Amezinium Metilsulfate"],"indications":[{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":0,"references":[{"source":"ATC","ids":["C01CA25"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C01CA25"]}]}],"cross_references":[{"source":"drugbank","ids":["DB13330"]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109474","_score":1,"_source":{"id":"CHEMBL2109474","internal_compound":false,"type":"Antibody","pref_name":"TRX-1","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["TRX-1"],"trade_names":[],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000010610","approved_name":"CD4 molecule","approved_symbol":"CD4"}],"target_type":"single protein","target_name":"T-cell surface antigen CD4","action_type":"inhibitor","description":"T-cell surface antigen CD4 inhibitor","references":[{"source":"PubMed","ids":["16308668"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16308668"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108594","_score":1,"_source":{"id":"CHEMBL2108594","internal_compound":false,"type":"Protein","pref_name":"EPTOTERMIN ALFA","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Bone morphogenetic protein 7","Eptotermin Alfa"],"trade_names":[],"cross_references":[{"source":"DrugCentral","ids":["5175"]}],"indications":[{"efo_id":"EFO_0004616","efo_label":"osteoarthritis, knee","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004616","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01111045","NCT01133613"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01111045%22OR%22NCT01133613%22"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1767164","_score":1,"_source":{"id":"CHEMBL1767164","internal_compound":false,"type":"Small molecule","pref_name":"GSK-1004723","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["GSK1004723","Gsk-1004723","Gsk1004723"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12806"]}],"canonical_smiles":"O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1","indications":[{"efo_id":"EFO_0003956","efo_label":"seasonal allergic rhinitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003956","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00694993"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00694993%22"]}]}],"child_chembl_ids":["CHEMBL1767170","CHEMBL3215857"],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297946","_score":1,"_source":{"id":"CHEMBL4297946","internal_compound":false,"type":"Unknown","pref_name":"ENDOSTATIN, N-TERMINAL-MGGSHHHHH","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Endostar","Endostatin, n-terminal-mggshhhhh"],"trade_names":[],"indications":[{"efo_id":"EFO_0000211","efo_label":"unspecified peripheral T-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000211","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02520219"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02520219%22"]}]},{"efo_id":"EFO_0000305","efo_label":"breast carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000305","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02865304","NCT03907098"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02865304%22OR%22NCT03907098%22"]}]},{"efo_id":"EFO_0000621","efo_label":"neuroblastoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000621","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02615106"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02615106%22"]}]},{"efo_id":"EFO_0000637","efo_label":"osteosarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000637","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01002092"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01002092%22"]}]},{"efo_id":"EFO_0000702","efo_label":"small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000702","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00912392"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00912392%22"]}]},{"efo_id":"EFO_0001061","efo_label":"cervical carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001061","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03086681","NCT04121975"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03086681%22OR%22NCT04121975%22"]}]},{"efo_id":"EFO_0001071","efo_label":"lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001071","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03706703"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03706703%22"]}]},{"efo_id":"EFO_0002916","efo_label":"esophageal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002916","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01368419","NCT03649945"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01368419%22OR%22NCT03649945%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01158144","NCT01531790","NCT01687439","NCT02579564","NCT02652234","NCT03123445","NCT03614065"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01158144%22OR%22NCT01531790%22OR%22NCT01687439%22OR%22NCT02579564%22OR%22NCT02652234%22OR%22NCT03123445%22OR%22NCT03614065%22"]}]},{"efo_id":"EFO_0004252","efo_label":"nasopharyngeal neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004252","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02237924","NCT02444949","NCT02902432","NCT02907710","NCT03932266"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02237924%22OR%22NCT02444949%22OR%22NCT02902432%22OR%22NCT02907710%22OR%22NCT03932266%22"]}]},{"efo_id":"EFO_0005842","efo_label":"colorectal cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005842","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00853684"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00853684%22"]}]},{"efo_id":"EFO_0005922","efo_label":"esophageal squamous cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005922","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02665702","NCT03797625"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02665702%22OR%22NCT03797625%22"]}]},{"efo_id":"EFO_1001411","efo_label":"Radiation Pneumonitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001411","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03796364"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03796364%22"]}]},{"efo_id":"EFO_1001968","efo_label":"soft tissue sarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001968","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01812018","NCT03121833"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01812018%22OR%22NCT03121833%22"]}]}],"number_of_indications":14,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":13},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":8},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":4},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":2},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3545385","_score":1,"_source":{"id":"CHEMBL3545385","internal_compound":false,"type":"Small molecule","pref_name":"WX-037","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["WX-037"],"trade_names":[],"indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01859351"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01859351%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000145675","approved_name":"phosphoinositide-3-kinase regulatory subunit 1","approved_symbol":"PIK3R1"},{"ensembl":"ENSG00000051382","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta","approved_symbol":"PIK3CB"},{"ensembl":"ENSG00000105851","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma","approved_symbol":"PIK3CG"},{"ensembl":"ENSG00000121879","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha","approved_symbol":"PIK3CA"},{"ensembl":"ENSG00000105647","approved_name":"phosphoinositide-3-kinase regulatory subunit 2","approved_symbol":"PIK3R2"},{"ensembl":"ENSG00000171608","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta","approved_symbol":"PIK3CD"},{"ensembl":"ENSG00000141506","approved_name":"phosphoinositide-3-kinase regulatory subunit 5","approved_symbol":"PIK3R5"},{"ensembl":"ENSG00000117461","approved_name":"phosphoinositide-3-kinase regulatory subunit 3","approved_symbol":"PIK3R3"}],"target_type":"protein complex group","target_name":"PI3-kinase class I","action_type":"inhibitor","description":"PI3-kinase class I inhibitor","references":[{"source":"Other","ids":["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=750893","http://www.wilex.de/press-investors/announcements/press-releases/20130807-2/"],"urls":["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=750893","http://www.wilex.de/press-investors/announcements/press-releases/20130807-2/"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL753","_score":1,"_source":{"id":"CHEMBL753","internal_compound":false,"type":"Small molecule","pref_name":"PHENOXYBENZAMINE","year_first_approved":1953,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Bensylyte HCl","Phenoxybenzamine","Phenoxybenzamine HCl","Phenoxybenzamine chloride"],"trade_names":["Dibenyline","Dibenzyline","Phenoxybenzamine HCl"],"cross_references":[{"source":"ChEBI","ids":[8077]},{"source":"DailyMed","ids":["phenoxybenzamine%20hydrochloride"]},{"source":"PubChem","ids":["104171113","124879342","124879343","144203638","170465147","174007411","26752309","26752310","90341231"]},{"source":"Wikipedia","ids":["Phenoxybenzamine"]},{"source":"drugbank","ids":["DB00925"]},{"source":"ChEBI","ids":[8078]},{"source":"PubChem","ids":["144208786","144213295","17389764","26747462","26752311","50105976","855636"]}],"canonical_smiles":"CC(COc1ccccc1)N(CCCl)Cc1ccccc1","indications":[{"efo_id":"EFO_0000319","efo_label":"cardiovascular disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000319","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["C04AX02"],"urls":["https://www.whocc.no/atc_ddd_index/?code=C04AX02"]}]},{"efo_id":"EFO_0005207","efo_label":"congenital heart disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005207","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00770705"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00770705%22"]}]}],"adverse_events":{"significant":[{"event":"premature baby","count":8946,"llr":30.55001478},{"event":"low birth weight baby","count":2450,"llr":28.71137017},{"event":"caesarean section","count":5212,"llr":14.38674641},{"event":"phaeochromocytoma","count":241,"llr":11.8710586}],"critval":9.002603339},"child_chembl_ids":["CHEMBL1200787"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000120907","approved_name":"adrenoceptor alpha 1A","approved_symbol":"ADRA1A"},{"ensembl":"ENSG00000150594","approved_name":"adrenoceptor alpha 2A","approved_symbol":"ADRA2A"},{"ensembl":"ENSG00000184160","approved_name":"adrenoceptor alpha 2C","approved_symbol":"ADRA2C"},{"ensembl":"ENSG00000171873","approved_name":"adrenoceptor alpha 1D","approved_symbol":"ADRA1D"},{"ensembl":"ENSG00000170214","approved_name":"adrenoceptor alpha 1B","approved_symbol":"ADRA1B"},{"ensembl":"ENSG00000274286","approved_name":"adrenoceptor alpha 2B","approved_symbol":"ADRA2B"}],"target_type":"protein family","target_name":"Adrenergic receptor alpha","action_type":"antagonist","description":"Adrenergic receptor alpha antagonist","references":[{"source":"DailyMed","ids":["setid=4fcdf9ca-78a8-4e4b-958e-2f795bbbf9ca"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4fcdf9ca-78a8-4e4b-958e-2f795bbbf9ca"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":2},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL4297777","_score":1,"_source":{"id":"CHEMBL4297777","internal_compound":false,"type":"Unknown","pref_name":"LMB-100","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Lmb-100","RG-7787","RG7787","RO-6927005"],"trade_names":[],"indications":[{"efo_id":"EFO_0000588","efo_label":"mesothelioma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000588","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02798536","NCT03436732","NCT03644550"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02798536%22OR%22NCT03436732%22OR%22NCT03644550%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT04027946"],"urls":["https://clinicaltrials.gov/search?id=%22NCT04027946%22"]}]},{"efo_id":"EFO_0003860","efo_label":"pancreatic neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003860","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02810418"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02810418%22"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL283120","_score":1,"_source":{"id":"CHEMBL283120","internal_compound":false,"type":"Small molecule","pref_name":"AXL-1717","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AXL-1717","NSC-36407","Picropodophyllin","Picropodophyllotoxin","Podophyllotoxin picropodophyllin"],"trade_names":[],"cross_references":[{"source":"ChEBI","ids":[75251]},{"source":"PubChem","ids":["29216394"]},{"source":"drugbank","ids":["DB12802"]}],"canonical_smiles":"COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC","indications":[{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01466647","NCT01561456"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01466647%22OR%22NCT01561456%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01062620"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01062620%22"]}]},{"efo_id":"EFO_0000707","efo_label":"squamous cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000707","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01561456"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01561456%22"]}]},{"efo_id":"EFO_0001642","efo_label":"lymphoid neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001642","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01725555"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01725555%22"]}]},{"efo_id":"EFO_0002499","efo_label":"anaplastic astrocytoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002499","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01721577"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01721577%22"]}]},{"efo_id":"EFO_0002501","efo_label":"anaplastic oligodendroglioma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002501","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01721577"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01721577%22"]}]},{"efo_id":"EFO_1001465","efo_label":"gliosarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001465","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01721577"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01721577%22"]}]},{"efo_id":"EFO_0000571","efo_label":"lung adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000571","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01561456"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01561456%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000140443","approved_name":"insulin like growth factor 1 receptor","approved_symbol":"IGF1R"}],"target_type":"single protein","target_name":"Insulin-like growth factor I receptor","action_type":"inhibitor","description":"Insulin-like growth factor I receptor inhibitor","references":[{"source":"PubMed","ids":["15334055","20698809"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15334055+OR+EXT_ID%3A20698809"]}]}],"number_of_indications":8,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":8},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":3},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":2},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108995","_score":1,"_source":{"id":"CHEMBL2108995","internal_compound":false,"type":"Small molecule","pref_name":"CARBOMER 910","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Carbomer","Carbomer 910"],"trade_names":["Blephagel","Carbopol 910"],"indications":[{"efo_id":"EFO_0007214","efo_label":"common cold","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007214","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02832362","NCT03005067"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02832362%22OR%22NCT03005067%22"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00385554"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00385554%22"]}]},{"efo_id":"HP_0000989","efo_label":"Pruritus","efo_uri":"http://purl.obolibrary.org/obo/HP_0000989","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03997851"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03997851%22"]}]}],"adverse_events":{"significant":[{"event":"exophthalmos","count":524,"llr":13.97857892}],"critval":13.90259541},"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":1},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":1},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3833406","_score":1,"_source":{"id":"CHEMBL3833406","internal_compound":false,"type":"Small molecule","pref_name":"PAPAVERETUM","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"canonical_smiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5.COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC.COc1ccc2c3c1OC1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314","child_chembl_ids":["CHEMBL3833334"],"synonyms":["Papaveretum"],"trade_names":["Omnopon-Scopolamine"],"indications":[{"efo_id":"EFO_0003843","efo_label":"pain","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003843","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["N02AA10"],"urls":["https://www.whocc.no/atc_ddd_index/?code=N02AA10"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1231723","_score":1,"_source":{"id":"CHEMBL1231723","internal_compound":false,"type":"Small molecule","pref_name":"POLIDOCANOL","year_first_approved":2010,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Polidocanol"],"trade_names":["Asclera","Varithena"],"cross_references":[{"source":"ChEBI","ids":[46859]},{"source":"DailyMed","ids":["polidocanol"]},{"source":"DrugCentral","ids":["4614"]},{"source":"PubChem","ids":["144205947","170466791","29218048","50111750"]},{"source":"drugbank","ids":["DB06811"]}],"canonical_smiles":"CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","indications":[{"efo_id":"HP_0002619","efo_label":"Varicose veins","efo_uri":"http://purl.obolibrary.org/obo/HP_0002619","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00442364","NCT00758420","NCT00928421","NCT01072877","NCT01231373","NCT01428076"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00442364%22OR%22NCT00758420%22OR%22NCT00928421%22OR%22NCT01072877%22OR%22NCT01231373%22OR%22NCT01428076%22"]}]},{"efo_id":"EFO_0001365","efo_label":"age-related macular degeneration","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001365","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00569569"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00569569%22"]}]},{"efo_id":"EFO_0000389","efo_label":"cutaneous melanoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000389","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03754140"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03754140%22"]}]}],"mechanisms_of_action":[],"adverse_events":{"significant":[{"event":"deep vein thrombosis","count":21525,"llr":180.663484},{"event":"skin discolouration","count":8819,"llr":37.47798041},{"event":"unintentional use for unapproved indication","count":27,"llr":20.59922089},{"event":"swelling","count":18005,"llr":19.28909855},{"event":"pain","count":94786,"llr":18.42370536},{"event":"product availability issue","count":416,"llr":12.4111029},{"event":"phlebitis deep","count":35,"llr":12.39746576},{"event":"injection site necrosis","count":675,"llr":10.96995892},{"event":"injection site pain","count":56727,"llr":9.842634834},{"event":"blister","count":11140,"llr":9.738207011},{"event":"erythema","count":35163,"llr":8.738684651},{"event":"therapy change","count":1627,"llr":8.370829703},{"event":"phlebitis","count":1786,"llr":8.097824798},{"event":"medical device site vesicles","count":4,"llr":7.67101806},{"event":"peripheral embolism","count":481,"llr":7.175378053},{"event":"hypokinesia","count":2834,"llr":6.75697323},{"event":"temperature difference of extremities","count":12,"llr":6.572747757},{"event":"nodule","count":3063,"llr":6.533533558}],"critval":6.532473672},"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1684984","_score":1,"_source":{"id":"CHEMBL1684984","internal_compound":false,"type":"Small molecule","pref_name":"PA-799","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["CH-5132799","CH5132799","PA-799","PA799"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB13051"]}],"canonical_smiles":"CS(=O)(=O)N1CCc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc21","indications":[{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01222546"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01222546%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000145675","approved_name":"phosphoinositide-3-kinase regulatory subunit 1","approved_symbol":"PIK3R1"},{"ensembl":"ENSG00000051382","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta","approved_symbol":"PIK3CB"},{"ensembl":"ENSG00000105851","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma","approved_symbol":"PIK3CG"},{"ensembl":"ENSG00000121879","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha","approved_symbol":"PIK3CA"},{"ensembl":"ENSG00000105647","approved_name":"phosphoinositide-3-kinase regulatory subunit 2","approved_symbol":"PIK3R2"},{"ensembl":"ENSG00000171608","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta","approved_symbol":"PIK3CD"},{"ensembl":"ENSG00000141506","approved_name":"phosphoinositide-3-kinase regulatory subunit 5","approved_symbol":"PIK3R5"},{"ensembl":"ENSG00000117461","approved_name":"phosphoinositide-3-kinase regulatory subunit 3","approved_symbol":"PIK3R3"}],"target_type":"protein complex group","target_name":"PI3-kinase class I","action_type":"inhibitor","description":"PI3-kinase class I inhibitor","references":[{"source":"PubMed","ids":["15705718","21316229"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15705718+OR+EXT_ID%3A21316229"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108208","_score":1,"_source":{"id":"CHEMBL2108208","internal_compound":false,"type":"Protein","pref_name":"LENERCEPT","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Lenercept","Ro-452081"],"trade_names":[],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000232810","approved_name":"tumor necrosis factor","approved_symbol":"TNF"}],"target_type":"single protein","target_name":"TNF-alpha","action_type":"inhibitor","description":"TNF-alpha inhibitor","references":[{"source":"PubMed","ids":["1660140"],"urls":["https://europepmc.org/search?query=EXT_ID%3A1660140"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109224","_score":1,"_source":{"id":"CHEMBL2109224","internal_compound":false,"type":"Antibody","pref_name":"ROVELIZUMAB","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Hu23F2G","Rovelizumab"],"trade_names":["Leukarrest"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000160255","approved_name":"integrin subunit beta 2","approved_symbol":"ITGB2"},{"ensembl":"ENSG00000169896","approved_name":"integrin subunit alpha M","approved_symbol":"ITGAM"}],"target_type":"protein complex","target_name":"Integrin alpha-M/beta-2","action_type":"antagonist","description":"Integrin alpha-M/beta-2 antagonist","references":[{"source":"PubMed","ids":["16100700","9784282"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16100700+OR+EXT_ID%3A9784282"]}]},{"target_components":[{"ensembl":"ENSG00000005844","approved_name":"integrin subunit alpha L","approved_symbol":"ITGAL"},{"ensembl":"ENSG00000160255","approved_name":"integrin subunit beta 2","approved_symbol":"ITGB2"}],"target_type":"protein complex","target_name":"Integrin alpha-L/beta-2 (LFA-1)","action_type":"antagonist","description":"Integrin alpha-L/beta-2 (LFA-1) antagonist","references":[{"source":"PubMed","ids":["16100700","9784282"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16100700+OR+EXT_ID%3A9784282"]}]}],"number_of_indications":0,"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL573","_score":1,"_source":{"id":"CHEMBL573","internal_compound":false,"type":"Small molecule","pref_name":"NIACIN","max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["NSC-169454","Niacin","Nicotinate","Nicotinic Acid"],"trade_names":["Niacin","Niacin Td","Niacor","Niaspan","Niaspan Er","Niaspan Titration Starter Pack","Nicangin","Nicolar","Simcor","Wampocap"],"cross_references":[{"source":"ChEBI","ids":[15940]},{"source":"DailyMed","ids":["niacin"]},{"source":"PubChem","ids":["104171277","11112153","144203888","144208618","144213221","170465044","174007257","8139875"]},{"source":"TG-GATEs","ids":["81"]},{"source":"Wikipedia","ids":["Niacin"]},{"source":"drugbank","ids":["DB00627"]}],"canonical_smiles":"O=C(O)c1cccnc1","indications":[{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00152893","NCT02018965"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00152893%22OR%22NCT02018965%22"]}]},{"efo_id":"EFO_0005407","efo_label":"psychosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005407","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT01720095"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01720095%22"]}]},{"efo_id":"Orphanet_309005","efo_label":"Disorder of lipid metabolism","efo_uri":"http://www.orpha.net/ORDO/Orphanet_309005","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00111891","NCT00626392","NCT00630877","NCT00664287","NCT00728910","NCT00903617","NCT00943124","NCT00944645","NCT00961636","NCT01071291","NCT01104519","NCT01984073","NCT02890992","NCT03510884"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00111891%22OR%22NCT00626392%22OR%22NCT00630877%22OR%22NCT00664287%22OR%22NCT00728910%22OR%22NCT00903617%22OR%22NCT00943124%22OR%22NCT00944645%22OR%22NCT00961636%22OR%22NCT01071291%22OR%22NCT01104519%22OR%22NCT01984073%22OR%22NCT02890992%22OR%22NCT03510884%22"]}]},{"efo_id":"EFO_0000378","efo_label":"coronary artery disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000378","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00000461","NCT00000482","NCT00000512","NCT00000553","NCT00431145"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000461%22OR%22NCT00000482%22OR%22NCT00000512%22OR%22NCT00000553%22OR%22NCT00431145%22"]},{"source":"DailyMed","ids":["068b9b2e-0ec1-4635-8257-62bb852f0d71","09bccfc6-71eb-420f-92d3-cd21789a0dbc","0dd18020-c211-423d-b3d8-a926ae626e14","35433c7b-556c-49a0-bfb5-0d498359925b","414b3d30-cc7f-4f91-b21e-5090b7f5b529","62efc71c-9746-d603-3e9d-a8786f7d4de8","8e290f96-e8c6-47fd-863f-1c9480f28d9b","92b3ec1d-0dc7-4bde-9817-57b1bdf7f0b9","c64d7717-8e8e-4e17-8f00-2b18f496b321","ccc64ee7-f581-493b-b8c2-6147a0db197e","f9b97613-c62e-40b0-a2aa-a7fde6bd5bc7","fc312806-1441-478d-95a2-68ce9a7a796d"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?068b9b2e-0ec1-4635-8257-62bb852f0d71","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?09bccfc6-71eb-420f-92d3-cd21789a0dbc","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0dd18020-c211-423d-b3d8-a926ae626e14","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?35433c7b-556c-49a0-bfb5-0d498359925b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?414b3d30-cc7f-4f91-b21e-5090b7f5b529","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?62efc71c-9746-d603-3e9d-a8786f7d4de8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8e290f96-e8c6-47fd-863f-1c9480f28d9b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?92b3ec1d-0dc7-4bde-9817-57b1bdf7f0b9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c64d7717-8e8e-4e17-8f00-2b18f496b321","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ccc64ee7-f581-493b-b8c2-6147a0db197e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f9b97613-c62e-40b0-a2aa-a7fde6bd5bc7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?fc312806-1441-478d-95a2-68ce9a7a796d"]},{"source":"FDA","ids":["0dfe662a-f2ac-4f10-9a08-54cbd0c6dec6","0f049ee9-ab85-401c-b1d7-06c98d559055","eac1abb4-58bf-4cd0-aa66-a93e116f516c"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A0dfe662a-f2ac-4f10-9a08-54cbd0c6dec6","https://api.fda.gov/drug/label.json?search=set_id%3A0f049ee9-ab85-401c-b1d7-06c98d559055","https://api.fda.gov/drug/label.json?search=set_id%3Aeac1abb4-58bf-4cd0-aa66-a93e116f516c"]}]},{"efo_id":"EFO_0000195","efo_label":"metabolic syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000195","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00300365"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00300365%22"]}]},{"efo_id":"EFO_0001360","efo_label":"type II diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001360","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00485758","NCT00618995","NCT01368328","NCT03540758","NCT03685773"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00485758%22OR%22NCT00618995%22OR%22NCT01368328%22OR%22NCT03540758%22OR%22NCT03685773%22"]}]},{"efo_id":"HP_0003124","efo_label":"Hypercholesterolemia","efo_uri":"http://purl.obolibrary.org/obo/HP_0003124","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00080275","NCT00082251","NCT00271817","NCT00378833","NCT00533312","NCT00536510","NCT00652431","NCT00769132","NCT01071525","NCT03510715"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00080275%22OR%22NCT00082251%22OR%22NCT00271817%22OR%22NCT00378833%22OR%22NCT00533312%22OR%22NCT00536510%22OR%22NCT00652431%22OR%22NCT00769132%22OR%22NCT01071525%22OR%22NCT03510715%22"]},{"source":"DailyMed","ids":["ce739d68-d89c-437c-90fb-3c0c45140f22","dbdee4c0-86fa-4857-b536-79bf9ebb911a","dd749fb9-e279-4958-9534-ad75a5b6754b"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ce739d68-d89c-437c-90fb-3c0c45140f22","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dbdee4c0-86fa-4857-b536-79bf9ebb911a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?dd749fb9-e279-4958-9534-ad75a5b6754b"]},{"source":"FDA","ids":["4d6b509c-7b9c-4c53-d8b1-ef9539f17039","fbe83466-aaea-49ab-9f00-4ff6e0930c44"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A4d6b509c-7b9c-4c53-d8b1-ef9539f17039","https://api.fda.gov/drug/label.json?search=set_id%3Afbe83466-aaea-49ab-9f00-4ff6e0930c44"]}]},{"efo_id":"EFO_0000266","efo_label":"aortic stenosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000266","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT02109614"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02109614%22"]}]},{"efo_id":"EFO_0003914","efo_label":"atherosclerosis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003914","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00127218","NCT00150722","NCT01221402"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00127218%22OR%22NCT00150722%22OR%22NCT01221402%22"]}]},{"efo_id":"EFO_0005672","efo_label":"acute coronary syndrome","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005672","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00855257"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00855257%22"]}]},{"efo_id":"EFO_0001073","efo_label":"obesity","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001073","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01083329"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01083329%22"]}]},{"efo_id":"EFO_0004272","efo_label":"anemia (phenotype)","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004272","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["0722734e-5a30-47af-99a3-2512848b45cd"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0722734e-5a30-47af-99a3-2512848b45cd"]},{"source":"FDA","ids":["5e273c62-e582-4a40-90aa-c7c723cbcdf1"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A5e273c62-e582-4a40-90aa-c7c723cbcdf1"]}]},{"efo_id":"EFO_1001157","efo_label":"retinal vein occlusion","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001157","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00493064","NCT00500045"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00493064%22OR%22NCT00500045%22"]}]},{"efo_id":"EFO_0000180","efo_label":"HIV-1 infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000180","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01426438"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01426438%22"]}]},{"efo_id":"EFO_0000311","efo_label":"cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000311","max_phase_for_indication":0,"references":[{"source":"ClinicalTrials","ids":["NCT00957359"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00957359%22"]}]},{"efo_id":"EFO_0000612","efo_label":"myocardial infarction","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000612","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000482"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000482%22"]}]},{"efo_id":"EFO_0003144","efo_label":"heart failure","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003144","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01005303"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01005303%22"]}]},{"efo_id":"EFO_0003774","efo_label":"hyperlipidemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003774","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00378833","NCT00536510","NCT00652431"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00378833%22OR%22NCT00536510%22OR%22NCT00652431%22"]},{"source":"DailyMed","ids":["068b9b2e-0ec1-4635-8257-62bb852f0d71","09bccfc6-71eb-420f-92d3-cd21789a0dbc","0dd18020-c211-423d-b3d8-a926ae626e14","35433c7b-556c-49a0-bfb5-0d498359925b","414b3d30-cc7f-4f91-b21e-5090b7f5b529","62efc71c-9746-d603-3e9d-a8786f7d4de8","8e290f96-e8c6-47fd-863f-1c9480f28d9b","92b3ec1d-0dc7-4bde-9817-57b1bdf7f0b9","c64d7717-8e8e-4e17-8f00-2b18f496b321","ccc64ee7-f581-493b-b8c2-6147a0db197e","ce739d68-d89c-437c-90fb-3c0c45140f22","f9b97613-c62e-40b0-a2aa-a7fde6bd5bc7","fc312806-1441-478d-95a2-68ce9a7a796d"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?068b9b2e-0ec1-4635-8257-62bb852f0d71","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?09bccfc6-71eb-420f-92d3-cd21789a0dbc","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?0dd18020-c211-423d-b3d8-a926ae626e14","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?35433c7b-556c-49a0-bfb5-0d498359925b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?414b3d30-cc7f-4f91-b21e-5090b7f5b529","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?62efc71c-9746-d603-3e9d-a8786f7d4de8","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?8e290f96-e8c6-47fd-863f-1c9480f28d9b","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?92b3ec1d-0dc7-4bde-9817-57b1bdf7f0b9","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?c64d7717-8e8e-4e17-8f00-2b18f496b321","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ccc64ee7-f581-493b-b8c2-6147a0db197e","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ce739d68-d89c-437c-90fb-3c0c45140f22","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?f9b97613-c62e-40b0-a2aa-a7fde6bd5bc7","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?fc312806-1441-478d-95a2-68ce9a7a796d"]},{"source":"FDA","ids":["0dfe662a-f2ac-4f10-9a08-54cbd0c6dec6","0f049ee9-ab85-401c-b1d7-06c98d559055","eac1abb4-58bf-4cd0-aa66-a93e116f516c"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A0dfe662a-f2ac-4f10-9a08-54cbd0c6dec6","https://api.fda.gov/drug/label.json?search=set_id%3A0f049ee9-ab85-401c-b1d7-06c98d559055","https://api.fda.gov/drug/label.json?search=set_id%3Aeac1abb4-58bf-4cd0-aa66-a93e116f516c"]}]},{"efo_id":"EFO_0003781","efo_label":"carotid artery disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003781","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00804843"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00804843%22"]}]},{"efo_id":"EFO_0003876","efo_label":"intermittent vascular claudication","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003876","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00062556","NCT00071266"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00062556%22OR%22NCT00071266%22"]}]},{"efo_id":"EFO_0004242","efo_label":"obsessive-compulsive disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004242","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03356483"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03356483%22"]}]},{"efo_id":"EFO_0004911","efo_label":"familial hypercholesterolemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0004911","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00384293","NCT01583647"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00384293%22OR%22NCT01583647%22"]}]},{"efo_id":"EFO_1001375","efo_label":"Myocardial Ischemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001375","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00000461","NCT00000482","NCT00000512","NCT00000553"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000461%22OR%22NCT00000482%22OR%22NCT00000512%22OR%22NCT00000553%22"]}]},{"efo_id":"Orphanet_232","efo_label":"Sickle cell anemia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_232","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00508989"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00508989%22"]}]},{"efo_id":"Orphanet_3389","efo_label":"Tuberculosis","efo_uri":"http://www.orpha.net/ORDO/Orphanet_3389","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00170404"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00170404%22"]}]},{"efo_id":"Orphanet_79211","efo_label":"Combined hyperlipidemia","efo_uri":"http://www.orpha.net/ORDO/Orphanet_79211","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00269204","NCT00289900"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00269204%22OR%22NCT00289900%22"]}]},{"efo_id":"EFO_0003884","efo_label":"chronic kidney disease","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003884","max_phase_for_indication":4,"references":[{"source":"FDA","ids":["2e1625cd-7337-4eed-95b1-b371c7169b97","54753dd9-dd90-40ee-a50d-47a7fa5b4754","6a02aaa1-92d1-43ae-841c-0f991e10c60f","d92a09ae-017e-487c-bbd7-b284dce406ee"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A2e1625cd-7337-4eed-95b1-b371c7169b97","https://api.fda.gov/drug/label.json?search=set_id%3A54753dd9-dd90-40ee-a50d-47a7fa5b4754","https://api.fda.gov/drug/label.json?search=set_id%3A6a02aaa1-92d1-43ae-841c-0f991e10c60f","https://api.fda.gov/drug/label.json?search=set_id%3Ad92a09ae-017e-487c-bbd7-b284dce406ee"]}]},{"efo_id":"HP_0001891","efo_label":"Iron deficiency anemia","efo_uri":"http://purl.obolibrary.org/obo/HP_0001891","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["025fee85-53a8-4161-a806-44fd95d0ca74"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?025fee85-53a8-4161-a806-44fd95d0ca74"]}]},{"efo_id":"EFO_0001358","efo_label":"post-traumatic stress disorder","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001358","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03752918"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03752918%22"]}]},{"efo_id":"EFO_0003761","efo_label":"unipolar depression","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003761","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03866174"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03866174%22"]}]},{"efo_id":"EFO_0003894","efo_label":"acne","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003894","max_phase_for_indication":4,"references":[{"source":"DailyMed","ids":["e25686be-d652-4ac5-8d52-4d9de03eec3b"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e25686be-d652-4ac5-8d52-4d9de03eec3b"]}]},{"efo_id":"EFO_0005952","efo_label":"non-Hodgkins lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0005952","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02702492"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02702492%22"]}]}],"adverse_events":{"significant":[{"event":"flushing","count":18642,"llr":2475.488244},{"event":"pruritus","count":57095,"llr":536.3568329},{"event":"drug hypersensitivity","count":71246,"llr":419.8980622},{"event":"skin burning sensation","count":3095,"llr":304.3035359},{"event":"high density lipoprotein decreased","count":1359,"llr":190.2367808},{"event":"feeling hot","count":10305,"llr":152.9041361},{"event":"erythema","count":35163,"llr":134.928546},{"event":"blood glucose increased","count":20555,"llr":101.3402522},{"event":"rhabdomyolysis","count":16457,"llr":97.56859031},{"event":"burning sensation","count":12178,"llr":96.26470629},{"event":"paraesthesia","count":35881,"llr":95.76823689},{"event":"myalgia","count":42953,"llr":92.54734614},{"event":"generalised erythema","count":2521,"llr":73.35394115},{"event":"rash","count":97330,"llr":69.99633266},{"event":"blood triglycerides increased","count":5126,"llr":69.11700979},{"event":"low density lipoprotein increased","count":2639,"llr":66.10252793},{"event":"urticaria","count":39524,"llr":64.34412859},{"event":"hot flush","count":10860,"llr":47.10091031},{"event":"blood creatine phosphokinase increased","count":14851,"llr":46.16128762},{"event":"myopathy","count":3383,"llr":43.14549359}],"critval":40.42895489},"number_of_indications":32,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":11},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":7},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":7},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":6},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":6},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":4},{"therapeutic_code":"MONDO_0002025","therapeutic_label":"psychiatric disorder","count":4},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":4},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":4},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":3},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":3},{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL235363","_score":1,"_source":{"id":"CHEMBL235363","internal_compound":false,"type":"Protein","pref_name":"SUBSTANCE P","max_clinical_trial_phase":1,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Substance p"],"trade_names":[],"cross_references":[{"source":"PubChem","ids":["50112420"]},{"source":"Wikipedia","ids":["Substance_P"]}],"canonical_smiles":"CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCN=C(N)N)C(N)=O","indications":[{"efo_id":"EFO_0001359","efo_label":"type I diabetes mellitus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001359","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT02820558"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02820558%22"]}]},{"efo_id":"EFO_0003956","efo_label":"seasonal allergic rhinitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003956","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01280149"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01280149%22"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1},{"therapeutic_code":"MONDO_0024297","therapeutic_label":"nutritional or metabolic disease","count":1},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":1}],"number_of_mechanisms_of_action":0}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3622533","_score":1,"_source":{"id":"CHEMBL3622533","internal_compound":false,"type":"Small molecule","pref_name":"FIMEPINOSTAT","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["CUDC-907","CUDC907","Cudc 907","Fimepinostat"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB11891"]}],"canonical_smiles":"COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1","indications":[{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02674750"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02674750%22"]}]},{"efo_id":"EFO_0002892","efo_label":"thyroid carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002892","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03002623"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03002623%22"]}]},{"efo_id":"EFO_0000403","efo_label":"diffuse large B-cell lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000403","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01742988"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01742988%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000171608","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta","approved_symbol":"PIK3CD"}],"target_type":"single protein","target_name":"PI3-kinase p110-delta subunit","action_type":"inhibitor","description":"PI3-kinase p110-delta subunit inhibitor","references":[{"source":"Other","ids":["http://www.curis.com/pipeline/cudc-907"],"urls":["http://www.curis.com/pipeline/cudc-907"]},{"source":"PubMed","ids":["22693356"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22693356"]}]},{"target_components":[{"ensembl":"ENSG00000051382","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta","approved_symbol":"PIK3CB"}],"target_type":"single protein","target_name":"PI3-kinase p110-beta subunit","action_type":"inhibitor","description":"PI3-kinase p110-beta subunit inhibitor","references":[{"source":"Other","ids":["http://www.curis.com/pipeline/cudc-907"],"urls":["http://www.curis.com/pipeline/cudc-907"]},{"source":"PubMed","ids":["22693356"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22693356"]}]},{"target_components":[{"ensembl":"ENSG00000121879","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha","approved_symbol":"PIK3CA"}],"target_type":"single protein","target_name":"PI3-kinase p110-alpha subunit","action_type":"inhibitor","description":"PI3-kinase p110-alpha subunit inhibitor","references":[{"source":"Other","ids":["http://www.curis.com/pipeline/cudc-907"],"urls":["http://www.curis.com/pipeline/cudc-907"]},{"source":"PubMed","ids":["22693356"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22693356"]}]},{"target_components":[{"ensembl":"ENSG00000116478","approved_name":"histone deacetylase 1","approved_symbol":"HDAC1"},{"ensembl":"ENSG00000171720","approved_name":"histone deacetylase 3","approved_symbol":"HDAC3"},{"ensembl":"ENSG00000094631","approved_name":"histone deacetylase 6","approved_symbol":"HDAC6"},{"ensembl":"ENSG00000196591","approved_name":"histone deacetylase 2","approved_symbol":"HDAC2"},{"ensembl":"ENSG00000108840","approved_name":"histone deacetylase 5","approved_symbol":"HDAC5"},{"ensembl":"ENSG00000061273","approved_name":"histone deacetylase 7","approved_symbol":"HDAC7"},{"ensembl":"ENSG00000147099","approved_name":"histone deacetylase 8","approved_symbol":"HDAC8"},{"ensembl":"ENSG00000163517","approved_name":"histone deacetylase 11","approved_symbol":"HDAC11"},{"ensembl":"ENSG00000068024","approved_name":"histone deacetylase 4","approved_symbol":"HDAC4"},{"ensembl":"ENSG00000048052","approved_name":"histone deacetylase 9","approved_symbol":"HDAC9"},{"ensembl":"ENSG00000100429","approved_name":"histone deacetylase 10","approved_symbol":"HDAC10"}],"target_type":"protein family","target_name":"Histone deacetylase","action_type":"inhibitor","description":"Histone deacetylase inhibitor","references":[{"source":"Other","ids":["http://www.curis.com/pipeline/cudc-907"],"urls":["http://www.curis.com/pipeline/cudc-907"]},{"source":"PubMed","ids":["22693356"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22693356"]}]}],"number_of_indications":3,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":3},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":1}],"number_of_mechanisms_of_action":4}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL1291","_score":1,"_source":{"id":"CHEMBL1291","internal_compound":false,"type":"Small molecule","pref_name":"METIPRANOLOL","year_first_approved":1989,"max_clinical_trial_phase":4,"withdrawn_flag":true,"withdrawn_reason":["Uveitis"],"withdrawn_year":1990,"withdrawn_country":["United Kingdom"],"withdrawn_class":["Opthalmic toxicity"],"black_box_warning":false,"synonyms":["BM-01004","Metipranolol","Metipranolol HCl","Optipranolol","VUAB-6453","VUAB6453 (SPOFA)"],"trade_names":["Glauline","Metipranolol","OptiPranolol","Optipranolol"],"cross_references":[{"source":"ChEBI","ids":[6897]},{"source":"DailyMed","ids":["metipranolol"]},{"source":"PubChem","ids":["144205272","29215465"]},{"source":"Wikipedia","ids":["Metipranolol"]},{"source":"drugbank","ids":["DB01214"]},{"source":"ChEBI","ids":[34845]}],"canonical_smiles":"CC(=O)Oc1c(C)cc(OCC(O)CNC(C)C)c(C)c1C","indications":[{"efo_id":"EFO_0000516","efo_label":"glaucoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000516","max_phase_for_indication":4,"references":[{"source":"ATC","ids":["S01ED04","S01ED54"],"urls":["https://www.whocc.no/atc_ddd_index/?code=S01ED04","https://www.whocc.no/atc_ddd_index/?code=S01ED54"]}]}],"child_chembl_ids":["CHEMBL1200947"],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000043591","approved_name":"adrenoceptor beta 1","approved_symbol":"ADRB1"}],"target_type":"single protein","target_name":"Beta-1 adrenergic receptor","action_type":"antagonist","description":"Beta-1 adrenergic receptor antagonist","references":[{"source":"DailyMed","ids":["archiveid=129928"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?archiveid=129928"]}]},{"target_components":[{"ensembl":"ENSG00000169252","approved_name":"adrenoceptor beta 2","approved_symbol":"ADRB2"}],"target_type":"single protein","target_name":"Beta-2 adrenergic receptor","action_type":"antagonist","description":"Beta-2 adrenergic receptor antagonist","references":[{"source":"DailyMed","ids":["archiveid=129928"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?archiveid=129928"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1}],"number_of_mechanisms_of_action":2}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL3137313","_score":1,"_source":{"id":"CHEMBL3137313","internal_compound":false,"type":"Small molecule","pref_name":"AXELOPRAN","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["Axelopran","Axelopran Sulfate","TD-1211","TD-1211 Sulfate"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB12013"]}],"canonical_smiles":"NC(=O)c1cccc([C@@H]2C[C@@H]3CC[C@H](C2)N3CCN(CC2CCCCC2)C(=O)[C@@H](O)CO)c1","indications":[{"efo_id":"HP_0002019","efo_label":"Constipation","efo_uri":"http://purl.obolibrary.org/obo/HP_0002019","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01040637","NCT01333540","NCT01401985","NCT01459926","NCT01655771"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01040637%22OR%22NCT01333540%22OR%22NCT01401985%22OR%22NCT01459926%22OR%22NCT01655771%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000112038","approved_name":"opioid receptor mu 1","approved_symbol":"OPRM1"}],"target_type":"single protein","target_name":"Mu opioid receptor","action_type":"antagonist","description":"Mu opioid receptor antagonist","references":[{"source":"Other","ids":["http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM401679.pdf","http://www.theravance.com/cns_pain"],"urls":["http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM401679.pdf","http://www.theravance.com/cns_pain"]},{"source":"PubMed","ids":["23549670"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23549670"]}]}],"child_chembl_ids":["CHEMBL3137319","CHEMBL3895543"],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL584","_score":1,"_source":{"id":"CHEMBL584","internal_compound":false,"type":"Small molecule","pref_name":"NELFINAVIR","year_first_approved":1997,"max_clinical_trial_phase":4,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["AG-1343","Nelfinavir","Nelfinavir mesilate","Nelfinavir mesylate","Nelfinavir methanesulfonate","Viracept"],"trade_names":["Viracept"],"cross_references":[{"source":"ChEBI","ids":[7496]},{"source":"DailyMed","ids":["nelfinavir%20mesylate"]},{"source":"PubChem","ids":["56320472"]},{"source":"drugbank","ids":["DB00220"]},{"source":"ChEBI","ids":[7497]},{"source":"PubChem","ids":["144204572","144208119","170465351","17388868","49681600"]}],"canonical_smiles":"Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C","indications":[{"efo_id":"EFO_0000313","efo_label":"carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000313","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT03256916"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03256916%22"]}]},{"efo_id":"EFO_0000326","efo_label":"central nervous system cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000326","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01020292"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01020292%22"]}]},{"efo_id":"EFO_0000365","efo_label":"colorectal adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000365","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00704600"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00704600%22"]}]},{"efo_id":"EFO_0000519","efo_label":"glioblastoma multiforme","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000519","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00694837"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00694837%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01445106"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01445106%22"]}]},{"efo_id":"EFO_0000681","efo_label":"renal cell carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000681","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01079286"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01079286%22"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00001766","NCT00099359","NCT00146380","NCT00234091","NCT00307502","NCT00336778","NCT00624195"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00001766%22OR%22NCT00099359%22OR%22NCT00146380%22OR%22NCT00234091%22OR%22NCT00307502%22OR%22NCT00336778%22OR%22NCT00624195%22"]}]},{"efo_id":"EFO_0000765","efo_label":"AIDS","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000765","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00433056"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00433056%22"]}]},{"efo_id":"EFO_0001061","efo_label":"cervical carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001061","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01485731","NCT02363829"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01485731%22OR%22NCT02363829%22"]}]},{"efo_id":"EFO_0001071","efo_label":"lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001071","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01447589"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01447589%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01555281","NCT02188537"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01555281%22OR%22NCT02188537%22"]}]},{"efo_id":"EFO_0002690","efo_label":"systemic lupus erythematosus","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0002690","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02066311"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02066311%22"]}]},{"efo_id":"EFO_0003060","efo_label":"non-small cell lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003060","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00791336","NCT01108666"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00791336%22OR%22NCT01108666%22"]}]},{"efo_id":"EFO_0003860","efo_label":"pancreatic neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0003860","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT01086332","NCT02024009"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01086332%22OR%22NCT02024009%22"]}]},{"efo_id":"EFO_1000910","efo_label":"dysplasia of cervix","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1000910","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01925378"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01925378%22"]}]},{"efo_id":"EFO_1001951","efo_label":"colorectal carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001951","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00704600"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00704600%22"]}]},{"efo_id":"HP_0002014","efo_label":"Diarrhea","efo_uri":"http://purl.obolibrary.org/obo/HP_0002014","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00650637"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00650637%22"]}]},{"efo_id":"HP_0100806","efo_label":"Sepsis","efo_uri":"http://purl.obolibrary.org/obo/HP_0100806","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00346580"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00346580%22"]}]},{"efo_id":"EFO_0000574","efo_label":"lymphoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000574","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03422874"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03422874%22"]}]},{"efo_id":"EFO_0000569","efo_label":"liposarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000569","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00233948"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00233948%22"]}]},{"efo_id":"EFO_0000326","efo_label":"central nervous system cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000326","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00915694"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00915694%22"]}]},{"efo_id":"EFO_0000558","efo_label":"Kaposi's sarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000558","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT03077451"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03077451%22"]}]},{"efo_id":"EFO_0000691","efo_label":"sarcoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000691","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00003008"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00003008%22"]}]},{"efo_id":"EFO_0000764","efo_label":"HIV infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000764","max_phase_for_indication":4,"references":[{"source":"ClinicalTrials","ids":["NCT00000872","NCT00000885","NCT00000893","NCT00000899","NCT00000902","NCT00000903","NCT00000912","NCT00000913","NCT00000924","NCT00000941","NCT00001087","NCT00001091","NCT00001094","NCT00001108","NCT00001122","NCT00002164","NCT00002171","NCT00002178","NCT00002184","NCT00002219","NCT00002224","NCT00002235","NCT00002240","NCT00002372","NCT00002374","NCT00002378","NCT00002380","NCT00002381","NCT00002423","NCT00002429","NCT00002440","NCT00002442","NCT00004583","NCT00004736","NCT00004985","NCT00004998","NCT00004999","NCT00005002","NCT00006211","NCT00008554","NCT00009061","NCT00028067","NCT00028327","NCT00541463"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000872%22OR%22NCT00000885%22OR%22NCT00000893%22OR%22NCT00000899%22OR%22NCT00000902%22OR%22NCT00000903%22OR%22NCT00000912%22OR%22NCT00000913%22OR%22NCT00000924%22OR%22NCT00000941%22OR%22NCT00001087%22OR%22NCT00001091%22OR%22NCT00001094%22OR%22NCT00001108%22OR%22NCT00001122%22OR%22NCT00002164%22OR%22NCT00002171%22OR%22NCT00002178%22OR%22NCT00002184%22OR%22NCT00002219%22OR%22NCT00002224%22OR%22NCT00002235%22OR%22NCT00002240%22OR%22NCT00002372%22OR%22NCT00002374%22OR%22NCT00002378%22OR%22NCT00002380%22OR%22NCT00002381%22OR%22NCT00002423%22OR%22NCT00002429%22OR%22NCT00002440%22OR%22NCT00002442%22OR%22NCT00004583%22OR%22NCT00004736%22OR%22NCT00004985%22OR%22NCT00004998%22OR%22NCT00004999%22OR%22NCT00005002%22OR%22NCT00006211%22OR%22NCT00008554%22OR%22NCT00009061%22OR%22NCT00028067%22OR%22NCT00028327%22OR%22NCT00541463%22"]},{"source":"DailyMed","ids":["303c9bc8-eaff-4a65-9c60-7de6bddec348","91152af4-a9c8-4b14-acbb-e4b6f2be145a","9b370904-d2cd-4585-bc48-a8110621c8bd","e72c2bc6-9462-4a2e-8e1d-b97592376cbd"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?303c9bc8-eaff-4a65-9c60-7de6bddec348","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?91152af4-a9c8-4b14-acbb-e4b6f2be145a","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?9b370904-d2cd-4585-bc48-a8110621c8bd","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?e72c2bc6-9462-4a2e-8e1d-b97592376cbd"]},{"source":"FDA","ids":["84948e6a-971f-4e86-928e-7d32a1883a23"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3A84948e6a-971f-4e86-928e-7d32a1883a23"]}]},{"efo_id":"EFO_0001071","efo_label":"lung carcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001071","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00589056"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00589056%22"]}]},{"efo_id":"EFO_0001378","efo_label":"multiple myeloma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001378","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03829020"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03829020%22"]}]},{"efo_id":"EFO_0007313","efo_label":"HIV-associated nephropathy","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007313","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT00002397"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00002397%22"]}]}],"adverse_events":{"significant":[{"event":"lipodystrophy acquired","count":879,"llr":295.1770056},{"event":"drug resistance","count":7341,"llr":242.0125797},{"event":"mitochondrial toxicity","count":279,"llr":240.1310217},{"event":"progressive external ophthalmoplegia","count":60,"llr":207.4383544},{"event":"premature baby","count":8946,"llr":187.5318114},{"event":"hypertriglyceridaemia","count":2168,"llr":173.4839464},{"event":"viral mutation identified","count":1049,"llr":173.3817013},{"event":"maternal drugs affecting foetus","count":3468,"llr":156.1243376},{"event":"virologic failure","count":2156,"llr":148.8074696},{"event":"eyelid ptosis","count":2847,"llr":143.4036845},{"event":"pregnancy","count":9039,"llr":136.6532021},{"event":"caesarean section","count":5212,"llr":133.9510771},{"event":"blood lactic acid increased","count":1442,"llr":128.2615191},{"event":"congenital anomaly","count":2033,"llr":115.0852071},{"event":"cryptorchism","count":432,"llr":105.9926376},{"event":"stillbirth","count":1542,"llr":104.9219138},{"event":"atrial septal defect","count":3155,"llr":84.56124477},{"event":"cardiac murmur","count":2852,"llr":81.0522185},{"event":"pathogen resistance","count":2318,"llr":73.38465286},{"event":"polydactyly","count":508,"llr":73.06955793},{"event":"hiv infection","count":440,"llr":71.14947229},{"event":"optic nerve neoplasm","count":20,"llr":69.06268662},{"event":"diplopia","count":6509,"llr":68.59873349},{"event":"neonatal disorder","count":694,"llr":66.89971915},{"event":"hypospadias","count":879,"llr":66.37028822},{"event":"immune reconstitution syndrome","count":646,"llr":63.93054936},{"event":"portal hypertension","count":1106,"llr":57.73405739},{"event":"trisomy 21","count":497,"llr":55.24815607},{"event":"neutropenia neonatal","count":87,"llr":52.91611069},{"event":"anaemia neonatal","count":217,"llr":52.87910354},{"event":"hyperlactacidaemia","count":751,"llr":52.80367818},{"event":"abdominal hernia","count":957,"llr":52.64242997},{"event":"intra-uterine death","count":618,"llr":51.80742591},{"event":"patent ductus arteriosus","count":1500,"llr":51.78799957},{"event":"abortion spontaneous","count":14396,"llr":51.48363576},{"event":"hyperlipidaemia","count":5013,"llr":46.62035544},{"event":"ophthalmoplegia","count":459,"llr":43.23158992},{"event":"osteonecrosis","count":10916,"llr":41.87616853},{"event":"lactic acidosis","count":8744,"llr":41.71810704},{"event":"multiple-drug resistance","count":550,"llr":40.91470359},{"event":"live birth","count":1539,"llr":40.90357272},{"event":"facial wasting","count":52,"llr":40.04166553},{"event":"lipoatrophy","count":316,"llr":38.8146116},{"event":"astrocytoma, low grade","count":62,"llr":38.63833285},{"event":"blood lactate dehydrogenase increased","count":5771,"llr":38.13162406},{"event":"treatment failure","count":12895,"llr":36.95086502},{"event":"extraocular muscle paresis","count":154,"llr":36.37480911},{"event":"cachexia","count":1081,"llr":35.82864898},{"event":"premature labour","count":2380,"llr":33.80926945},{"event":"premature rupture of membranes","count":1019,"llr":33.0754376},{"event":"normal newborn","count":1776,"llr":32.21370095},{"event":"foetal distress syndrome","count":821,"llr":32.11417369},{"event":"haemangioma congenital","count":249,"llr":32.08631326},{"event":"macrocytosis","count":421,"llr":31.51129528},{"event":"graft dysfunction","count":157,"llr":31.24147219},{"event":"congenital abdominal hernia","count":12,"llr":29.99480095},{"event":"ventricular septal defect","count":2152,"llr":29.47517927},{"event":"abdominal distension","count":15793,"llr":29.40661552},{"event":"hepatic fibrosis","count":1098,"llr":28.73029589},{"event":"hepatomegaly","count":2754,"llr":28.70428523},{"event":"hydrocele","count":394,"llr":28.01119062},{"event":"small for dates baby","count":1938,"llr":27.97968203},{"event":"lactate pyruvate ratio increased","count":19,"llr":27.6997996},{"event":"dyspnoea","count":124409,"llr":27.61976006},{"event":"glucose-6-phosphate dehydrogenase deficiency","count":72,"llr":26.36106128},{"event":"developmental delay","count":1019,"llr":26.20154475},{"event":"pain","count":94786,"llr":26.06134186},{"event":"platelet count increased","count":3955,"llr":25.7694373},{"event":"gastroschisis","count":186,"llr":25.23115242},{"event":"sickle cell anaemia","count":190,"llr":25.08372879},{"event":"gynaecomastia","count":2425,"llr":25.02527437},{"event":"aspartate aminotransferase increased","count":21532,"llr":24.20435003},{"event":"congenital cystic kidney disease","count":244,"llr":23.35321497},{"event":"mitochondrial cytopathy","count":121,"llr":23.26492446},{"event":"drug hypersensitivity","count":71246,"llr":23.1042624},{"event":"ileal atresia","count":12,"llr":23.10281192},{"event":"abortion induced","count":4087,"llr":22.89139858},{"event":"pulmonary artery stenosis congenital","count":288,"llr":22.20936925},{"event":"neonatal hepatomegaly","count":16,"llr":21.95360484},{"event":"blood triglycerides increased","count":5126,"llr":21.80246089},{"event":"liver transplant","count":1171,"llr":21.56560274},{"event":"headache","count":120638,"llr":21.19671392},{"event":"herpes simplex","count":1665,"llr":21.04508987},{"event":"congenital naevus","count":74,"llr":20.92257158},{"event":"blood pyruvic acid increased","count":21,"llr":20.8677715},{"event":"acute hepatic failure","count":3420,"llr":20.58804179},{"event":"drug-induced liver injury","count":7265,"llr":20.44400573},{"event":"talipes","count":1004,"llr":19.82385467},{"event":"fatigue","count":147738,"llr":19.51518008},{"event":"cholestasis","count":6825,"llr":19.49307881},{"event":"congenital teratoma","count":30,"llr":19.44449447},{"event":"maternal exposure timing unspecified","count":718,"llr":19.29247106},{"event":"gamma-glutamyltransferase increased","count":9889,"llr":18.93338671},{"event":"congenital hydronephrosis","count":255,"llr":18.84297962},{"event":"dyslipidaemia","count":1671,"llr":18.19940046},{"event":"trisomy 15","count":7,"llr":18.07926651},{"event":"pneumonia","count":65209,"llr":18.00717175}],"critval":17.32737783},"child_chembl_ids":["CHEMBL1205"],"mechanisms_of_action":[{"target_type":"single protein","target_name":"Human immunodeficiency virus type 1 protease","action_type":"inhibitor","description":"Human immunodeficiency virus type 1 protease inhibitor","references":[{"source":"DailyMed","ids":["setid=e72c2bc6-9462-4a2e-8e1d-b97592376cbd"],"urls":["https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e72c2bc6-9462-4a2e-8e1d-b97592376cbd"]}]}],"number_of_indications":27,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":19},{"therapeutic_code":"EFO_0009690","therapeutic_label":"urinary system disease","count":8},{"therapeutic_code":"OTAR_0000017","therapeutic_label":"reproductive system or breast disease","count":6},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":5},{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":4},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":4},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":4},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":3},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":3},{"therapeutic_code":"OTAR_0000010","therapeutic_label":"respiratory or thoracic disease","count":3},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":2},{"therapeutic_code":"EFO_0000651","therapeutic_label":"phenotype","count":2},{"therapeutic_code":"EFO_0001379","therapeutic_label":"endocrine system disease","count":1},{"therapeutic_code":"EFO_0009605","therapeutic_label":"pancreas disease","count":1},{"therapeutic_code":"EFO_0010285","therapeutic_label":"integumentary system disease","count":1},{"therapeutic_code":"EFO_0000319","therapeutic_label":"cardiovascular disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2109625","_score":1,"_source":{"id":"CHEMBL2109625","internal_compound":false,"type":"Antibody","pref_name":"MGAWN1","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["MGAWN1"],"trade_names":[],"indications":[{"efo_id":"EFO_0007545","efo_label":"West Nile encephalitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0007545","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00515385"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00515385%22"]}]}],"mechanisms_of_action":[{"target_type":"single protein","target_name":"E protein","action_type":"inhibitor","description":"E protein inhibitor","references":[{"source":"PMC","ids":["PMC2876374"],"urls":["https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876374"]}]}],"number_of_indications":1,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":1},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2108881","_score":1,"_source":{"id":"CHEMBL2108881","internal_compound":false,"type":"Antibody","pref_name":"SEVIRUMAB","max_clinical_trial_phase":2,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["EV2-7","MSL-109","SDZ MSL 109","Sevirumab"],"trade_names":["Protovir"],"indications":[{"efo_id":"EFO_0001062","efo_label":"cytomegalovirus infection","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0001062","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00004642"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00004642%22"]}]},{"efo_id":"EFO_1001302","efo_label":"Cytomegalovirus Retinitis","efo_uri":"http://www.ebi.ac.uk/efo/EFO_1001302","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT00000135"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00000135%22"]}]}],"mechanisms_of_action":[{"target_type":"single protein","target_name":"Envelope glycoprotein H","action_type":"inhibitor","description":"Envelope glycoprotein H inhibitor","references":[{"source":"PMC","ids":["PMC2800955"],"urls":["https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800955"]}]}],"number_of_indications":2,"indication_therapeutic_areas":[{"therapeutic_code":"EFO_0005741","therapeutic_label":"infectious disease","count":2},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":1},{"therapeutic_code":"MONDO_0024458","therapeutic_label":"disease of visual system","count":1}],"number_of_mechanisms_of_action":1}}
{"_index":"20.06_drug-data","_type":"_doc","_id":"CHEMBL2105728","_score":1,"_source":{"id":"CHEMBL2105728","internal_compound":false,"type":"Small molecule","pref_name":"CRENOLANIB","max_clinical_trial_phase":3,"withdrawn_flag":false,"black_box_warning":false,"synonyms":["596-26","ARO 002","ARO-002","ARO-002-26","CP 868596","CP-868","CP-868,596","CP-868,596-26","CP-868596","CP-868596-26","Crenolanib","Crenolanib Besylate","Crenolanib besilate"],"trade_names":[],"cross_references":[{"source":"drugbank","ids":["DB11832"]}],"canonical_smiles":"CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1","indications":[{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02270788","NCT02283177","NCT02298166","NCT02626338","NCT03250338","NCT03258931","NCT03324243"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02270788%22OR%22NCT02283177%22OR%22NCT02298166%22OR%22NCT02626338%22OR%22NCT03250338%22OR%22NCT03258931%22OR%22NCT03324243%22"]}]},{"efo_id":"EFO_0000326","efo_label":"central nervous system cancer","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000326","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01229644","NCT01393912"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01229644%22OR%22NCT01393912%22"]}]},{"efo_id":"EFO_0000503","efo_label":"gastric adenocarcinoma","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000503","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT03193918"],"urls":["https://clinicaltrials.gov/search?id=%22NCT03193918%22"]}]},{"efo_id":"EFO_0000519","efo_label":"glioblastoma multiforme","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000519","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT02626364"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02626364%22"]}]},{"efo_id":"Orphanet_44890","efo_label":"Gastrointestinal stromal tumor","efo_uri":"http://www.orpha.net/ORDO/Orphanet_44890","max_phase_for_indication":3,"references":[{"source":"ClinicalTrials","ids":["NCT02847429"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02847429%22"]}]},{"efo_id":"EFO_0000222","efo_label":"acute myeloid leukemia","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000222","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01522469","NCT01657682","NCT02400255","NCT02400281"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01522469%22OR%22NCT01657682%22OR%22NCT02400255%22OR%22NCT02400281%22"]}]},{"efo_id":"EFO_0000616","efo_label":"neoplasm","efo_uri":"http://www.ebi.ac.uk/efo/EFO_0000616","max_phase_for_indication":1,"references":[{"source":"ClinicalTrials","ids":["NCT00949624"],"urls":["https://clinicaltrials.gov/search?id=%22NCT00949624%22"]}]},{"efo_id":"Orphanet_44890","efo_label":"Gastrointestinal stromal tumor","efo_uri":"http://www.orpha.net/ORDO/Orphanet_44890","max_phase_for_indication":2,"references":[{"source":"ClinicalTrials","ids":["NCT01243346"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01243346%22"]}]}],"mechanisms_of_action":[{"target_components":[{"ensembl":"ENSG00000113721","approved_name":"platelet derived growth factor receptor beta","approved_symbol":"PDGFRB"},{"ensembl":"ENSG00000134853","approved_name":"platelet derived growth factor receptor alpha","approved_symbol":"PDGFRA"}],"target_type":"protein complex","target_name":"Platelet-derived growth factor receptor","action_type":"inhibitor","description":"Platelet-derived growth factor receptor inhibitor","references":[{"source":"Other","ids":["http://arogpharma.com/crenolanib"],"urls":["http://arogpharma.com/crenolanib"]},{"source":"PubMed","ids":["22745105"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22745105"]}]},{"target_components":[{"ensembl":"ENSG00000122025","approved_name":"fms related receptor tyrosine kinase 3","approved_symbol":"FLT3"}],"target_type":"single protein","target_name":"Tyrosine-protein kinase receptor FLT3","action_type":"inhibitor","description":"Tyrosine-protein kinase receptor FLT3 inhibitor","references":[{"source":"Other","ids":["http://arogpharma.com/crenolanib"],"urls":["http://arogpharma.com/crenolanib"]},{"source":"PubMed","ids":["24623852"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24623852"]}]}],"child_chembl_ids":["CHEMBL2146086"],"number_of_indications":8,"indication_therapeutic_areas":[{"therapeutic_code":"MONDO_0045024","therapeutic_label":"cell proliferation disorder","count":8},{"therapeutic_code":"OTAR_0000018","therapeutic_label":"genetic, familial or congenital disease","count":4},{"therapeutic_code":"EFO_0010282","therapeutic_label":"gastrointestinal disease","count":3},{"therapeutic_code":"OTAR_0000006","therapeutic_label":"musculoskeletal or connective tissue disease","count":2},{"therapeutic_code":"EFO_0005803","therapeutic_label":"hematologic disease","count":2},{"therapeutic_code":"EFO_0000540","therapeutic_label":"immune system disease","count":2},{"therapeutic_code":"EFO_0000618","therapeutic_label":"nervous system disease","count":2}],"number_of_mechanisms_of_action":2}}
